gfi1
transcriptional
repressor
myeloid
lymphoid
haematopoietic
lineage
haematological
malignancies
progression
myelodysplastic
syndromes
mds
leukemia
aml
stratified
karyotype
cn-aml
poorer
paralleled
flt3
mutated
flt3-itd
knock-down
fujioka
prognostic
hematologic
malignancy
curable
chemotherapy
relapses
uniformly
prognosis
allogeneic
transplantation
myeloablative
preparative
regimens
tolerated
andor
frailer
prohibitive
treatment-related
devoid
comorbid
reduced-intensity
transplants
graft-versus-leukemia
indications
cutis
cutaneous
manifestation
precede
concurrently
aleukemic
systemic
symptom
leukemias
monocytic
lymphocyticlymphoblastic
lesions
erythematous
rash
violaceous
macules
papules
subcutaneous
nodules
clinically
mimicked
eruption
overarching
histologic
atypical
perivascular
infiltrate
nodular
dermal
histiocytoid
myeloperoxidase
mpo
distinguish
non-myeloid
cd68
cd14
monocyte
maturity
marrow
biopsy
cytometry
non-contributory
morphologic
remission
cr1
unrelated
urd

hla
umbilical
ucb
transplantations
cyclosporine-based
graft-versus-host
gvhd
prophylaxis
neutrophil
slower
hla-matched
transplantation-related
trm
leukemia-free
lfs
allotransplantation
grafts
urgently
randomized
tipifarnib
orally
cri
toxicities
predictors
unwarranted
transient
melastatin-2
trpm2
nonselective
cationic
ca2-permeable
transmembrane
pore
preferentially
modulates
signaling
pathways
converging
nf-kb
nf-κb
pathway
mediating
leukemia-initiating
inhibition
synergistic
overexpressed
fab
subtypes
depletions
mll-af9-driven
trpm2--
mll-af9
phosphorylation
translocation
inxa0vivo
latency
wild-type
tertiary
bcr-ablnup98-hoxa9
dna-damaging
neuroblastoma
trpm2wt
doxorubicin
cytarabine
etoposide
ic50
inxa0vitro
decitabine
unaffected
toxa0play
leukemogenesis
augment
cytotoxicity
chemotherapeutic
clarify
nucleostemin
diagnosed
m1
m3
positively
correlated
percentages
cd34
cd117
cd123
antigen
wt1
poor-risk
better-risk
intermediate-risk
residual
mrd
novo
leukemia-associated
cd34cd13
cd34cd33
cd33cd7
cd33cd10
cd33cd19
cd33tdt
follow-up
relapsed
relapse
persistence
impending
distinctive
supportive
comorbidities
palliation
therapies
encountering
epigenetic
cytogenetically
abnormal
h3k27me3
enrichment
70xa0kb
hist1
6p22
blasts
alteration
npm1-mutated
npm1mut
imatinib
dasatinib
nilotinib
cml
mutations
preexist
eventual
efficacy
mathematically
preexisting
nontrivial
incorporates
toxicity
hurdle
oncology
ara-c-based
targeting
eukaryotic
initiation
eif4e
inhibitor
ribavirin
monotherapy
yielded
remissions
ara-c
hedgehog
glioma-associated
gli1
udp
glucuronosyltransferase
ugt1a
enzymes
elevated
ugt1as
glucuronic
modifying
tissues
ugt1a-dependent
glucuronidation
pharmacological
revealing
tp23q34
wingless-int
wnt
hematopoietic
hsc
malignant
counterpart
dna-methylation
infer
differentiate
symptomatic
venous
thromboembolism
vte
peripherally
catheters
picc
survivin
apoptosis
cancers
undetectable
differentiated
vivo
cancer-related
splice
variants
survivin-2b
survivin-deltaex3
rt-pcr
predominant
variant
maturation
cytogenetic
amlcg92
aml-bfm93
eventfree
long-term
octogenarian
cured
relapse-free
survived
surviving
leukemianet
intermediate-i
leukemianet-associated
alterations
flt3-internal
tandem
duplication
npm1
octogenarians
tyrosine
tki
progression-free
etr
bcr-abl1
axa0long-term
treatment-free
tfr
feasibility
nccn
administration-approved
whereby
restarting
pathogenesis
unclear
histone
deacetylase
hdac
inhibitors
specificity
anti-cancer
hdac1
negatively
krüppel-like
klf4
knockdown
k562
hl-60
u937
inhibited
proliferation
vpa
mocetinostat
overexpression
markedly
vitro
mechanistic
competitively
promoter
oppositely
repressing
inducing
interplay
modulation
glycolysis
metabolic
atp
tp53-induced
regulator
tigar
inhibits
aerobic
protects
intracellular
reactive
ros-associated
fms-like
progenitor
ligand
flt3l
detectable
homeostasis
hypoplasia
cytoreductive
conversely
depletion
depressed
refractory
kinetics
proportionate
cellularity
ncri
aml17
subgroup
mutation
lestaurtinib
placebo
attainment
mann-whitney
pgml
efs
near-significant
adjusting
proportional
transplant
illustrates
noninvasive
poi
complication
hsct
ric
lacking
oncarbide
interferon
pregnancies
cml-sct
i-bfm
hypergonadotropic
hypogonadism
menstruations
resumed
cesarean
newborns
neonatal
chimerism
engraftment
adolescents
s-aml
therapy-related
evolving
antecedent
hematological
ahd
prognostically
high-risk
ts-aml
myelodysplasia
myeloproliferative
neoplasm
aplastic
anemia
categorized
-
responsive
coronavirus
covid-19
pandemic
methylation
cpg
methylated
cyclin-dependent
2b
cdkn2b
2a
cdkn2a
myelodysplasticmyeloproliferative
neoplasms
mdsmpn
5-azacytidine
twenty-six
methylation-specific
multiplex
ligation-dependent
amplification
ms-mlpa
aberrant
tendency
ipss
azacitidine
leukemic
hypermethylation
heterogeneous
clonal
genomic
extracted
stemprogenitor
dysfunction
bioinformatics
methylation-related
biomarkers
univariate
multivariate
regressions
suboptimal
transported
slc22a1
transporter
hoct1
lympho-myeloid
hematopoiesis
lm-ch
methyltransferase
3a
dnmt3a
t-cell
compartment
sequenced
leukemia-related
indeterminate
mds-type
co-mutations
tet2
runx1
ezh2
preleukemic
founding
non-lm-ch
mrd-positive
interleukin-2
il-2
cytokine
disease-free
dfs
cr2
undergoing
favorable
unfavorable
-56
cytogenetics
modestly
sibling
poorly
prognoses
tq22q22
p7626
p7543
platelet
9l
postremission
harbored
compromised
alfa
ifn-alpha
heterogeneity
therapeutics
intensification
regulators
hypomethylating
chimeric
underwent
ric-cbt
antigen-level
hla-identical
transfused
chimera
tapering
tacrolimus
decreasing
discontinued
pancytopenia
agranulocytosis
graft
coombs-positive
thrombocytopenia
itp
rituximab
cbt
conditioned
transplanted
diagnoses
amlmyelodysplastic
n43
hodgkins
lymphoma
n30
n3
n2
n1
cohort
succumbed
transplant-related
non-relapse
nucleated
post-transplant
lymphoproliferative
aza
forty-nine
untreated
ineligible
compassionate
patient-named
post-myelodysplastic
post-mpn
wbc
×
remissioncr
recoverypartial
responders
non-responders
p⁹
ecog-ps
iwg
landmark
intensively
stratification
meningioma
mn1
real-time
polymerase
tended
multivariable
predicts
cost-effectiveness
high-dose
normal-dose
interferon-α
intolerant
accumulation
anomalous
transcriptome
deregulated
non-coding
rnas
protein-coding
mrnas
harboring
mirna-binding
converse
regulate
contending
mirnas
endogenous
cernas
unifying
attributing
evidently
elucidate
post-transcriptional
x-linked
xiap
iap
intuitively
transcriptase-polymerase
extramedullary
ormedian
3-yr
relapsefree
collectively
hispanics
non-hispanic
whites
nhws
self-identified
nhw
event-free
upfront
mdr1
reversal
p-glycoprotein
p-gp
psc-833
daunorubicin
p-gp-positive
inhibitory
drug-resistance
hbv-related
hepatocellular
carcinoma
hcc
interleukin-6
il-6jakstat3
modulating
polarization
myeloid-derived
suppressor
mdscs
cd8
erkil-6stat3
icaritin
anticancer
neutrophils
macrophages
balbc
cytokines
checkpoint
histologically
hbv
bulky
tumors
child-pugh
metastasis
end-points
treatment-induced
il-6
il-8
il-10
necrosis
factor-α
soluble
tim3
lag3
cd28
cd80
ctla-4
iiiiv
time-to-progression
positivity
neoantigens
stenotrophomonas
maltophilia
biomarker
high-level
α-fetoprotein
helper
th1th2
regimen
leukemia-t-mdsaml
well-known
chemoradiotherapy
hodgkin
non-hodgkin
lymphoblastic
sarcoma
ovarian
testicular
t-mdsaml
autologous
hct
causative
alkylating
agentradiation-related
topoisomerase
inhibitor-related
inter-individual
variability
susceptibility
genotoxic
exposures
double-mutant
cebpa
cebpadm
genotype
favourable-risk
mutant
flt3wt
short-term
favourable
pxa0xa
arteritis
gca
manifested
headache
artery
arterial
dysregulation
nkd1
implication
elusive
mononuclear
pu2009u
french-american-britishworld
karyotypeskaryotypic
classifications
nkd1low
nkd1high
kaplan-meier
whole-cohort
non-m3
disclosed
ratiou2009u
paired
comorbidity
well-established
nrm
allo-sct
characterize
differing
hypothesized
exerted
regimen-specific
retrospective
renal
hypoalbuminemia
hepatic
fludarabinebusulfan
flubu4
pulmonary
pre-existing
fludarabinemelphalan
fludarabinetreosulfan
exert
coexpression
ligands
tnf
receptortnf-alpha
superfamily
apoptotic
disrupted
fas-associated
fadd
transmitting
fas
tnf-related
apoptosis-inducing
blot
aml-10
negativelow
fadd-low
standard-
good-risk
ten-eleven-translocation
sequencing
multicenter
aml-shg
clinicaltrials
nct00209833
nmp1
idh
ras
concomitant
resequencing
tet2-mutated
npm
mutually
mll
mll-ptd
subclones
progenitor-derived
assays
stepwise
confers
originates
acquires
transformative
clinicalbiological
precluding
mutational
prospectively
nct03013998
sub-study
7u2009d
centrally
investigational
palliative
sub-studies
cytarabineu2009u2009daunorubicin
7u2009u20093
hypomethylation
feasible
adversely
impacting
disinhibiting
icb
cytotoxic-t-lymphocyte-associated
death-ligand
notable
tumours
tumour
infiltration
correlates
pre-clinical
mediated
suppressive
infiltrating
pharmacologic
isoform
phosphoinositide
3-kinase
pi3kγ
restores
nct02637531
reshape
microenvironment
cytotoxic-t-cell-mediated
ipi-549
myelomonocytic
monocytosis
dysplasia
lineages
abnormality
oligomonocytic
monocytes
unclassifiable
subset
overt
-l
clinicopathologic
hemoglobin
erythroid
predominantly
progressed
asxl1
srsf2
cbl
similarities
dysplastic
numb
chin
ncs
cranial
neuropathy
numbness
inferior
alveolar
neoplastic
nonmalignant
confronted
occult
differentiation
etiologies
intermittent
penile
erection
priapism
leukocyte
intravenous
hydration
hydroxyurea
allopurinol
persisted
unresponsive
opioids
terbutaline
gliomas
lethal
infiltrated
interleukin-4
receptor-α
il-4rα
mediates
polymorphisms
glioma
causal
glioblastoma
upregulated
glioma-infiltrating
periphery
genetically
deficient
exhibited
arginase
marrow-derived
il-13-induced
glioma-derived
suppressed
il-4rα-dependent
mdsc
granulocyte
macrophage
colony-stimulating
gm-csf
microenvironments
gm-csf-induced
upregulation
11q23
chromosomal
abnormalities
non-11q23
translocations
t11vq23v
unbalanced
deletions
chromosomes
5q
7q
karyotypes
unfavorable-risk
aberrations
intention-to
dt388il3
catalytic
diphtheria
toxin
fused
interleukin
inter-patient
escalation
infusions
doses
chemo-refractory
maximal
microgkgdose
transaminasemia
fevers
chills
hypotension
titer
anti-dt388il3
evaluable
prolonged
infusion
relapsedrefractory
p15
ink4b
p15ink4b
9p21
encodes
induces
g1-phase
cdk
silenced
deletion
homozygous
myeloblastic
conflicting
methodological
pitfalls
translational
inactivation
single-center
idarubicin
cladribine
iac
neutropenia
thirty-two
mucositis
diarrhea
fungal
irrespective
retrospectively
npm1mut-based
nucleic
acid-containing
primers
cutoff
cause-specific
cross-validated
npm1mutabl1
triggers
ecotropic
evi1
strikingly
mll-rearranged
genomewide
deregulation
chip-seq
rna-seq
profiling
disruption
evi-induced
binds
downregulates
cebpe
downstream
serpinb2
jak-stat
atp-dependent
p2x
purinoreceptors
evi1-induced
primitive
cases100
ph-positive
haploidentical
sub-optimal
proliferative
ets
erg
underlie
stemness
promoters
enhancer
heptad
combinatorially
hscs
promoter-stem
amls
somatic
cooperate
cell-like
contributes
modulate
post-therapy
multiparameter
post-remission
instability
subpopulations
coexist
false-negative
aberrancies
explored
chemotherapy-resistant
subpopulation
rearrangements
3q26
recurrent
mecom
3q
cryptic
fluorescence
situ
hybridization
leukemiamyelodysplastic
chromosome
banding
cba
inv3t
t3q26
3q21
3q25
homogenously
staining
hsr
breakpoints
masking
3qq25
rearrangement
intrachromosomal
metaphases
pcr
underlining
underestimated
genemicrorna
hyperleukocytosis
multi-targeted
breakpoint
region-abelson
bcr-abl
kinases
pharmacokinetic
pharmacodynamic
bilateral
uveal
melanoma
surgically
contralateral
mll-gene
karyotypically
reaction-pcr
cml-cp
endpoint
bcr-abl1is
allograft
cytosine
arabinoside
cyclophosphamide
irradiation
cgy
nonfatal
veno-occlusive
incidences
graft-vs-host
five-
salvaged
donor-leukocyte
cgvhd
low-toxicity
castration-resistant
crpc
expression-based
non-overlapping
captures
lethality
glutathione
s-transferase
gstm1
gstt1
gstp1
genotyping
gsts
duplex
polymerase-chain-reactions
confronting-
two-pair
primer
pcr-ctpp
non-null
genotypes
allele
etiology
leukemia-1
mcl‑1
anti-apoptotic
bcl-2
mcl-1
gastric
pcdna-mcl-1
sirna
vectors
overexpress
snu638
tmk1
tunel
assay
ki-67
caspase-3
-7
parp
smacdiablo
omihtra2
cytoplasm
cyclin
d1
cdc2
suppress
jak2
stat3
cascades
labeling
ki
mucosa
lymph
regulates
measurableminimal
wilms
age-specific
standardization
prerequisites
lysozyme
subtyping
pretreatment
sixty-three
m4
m5
non-monocytic
m0
m2
m6
bimodal
l-1
indicative
analysed
cut-off
m4-m5
cns-aml
allo-hct
pretransplant
cerebrospinal
csf
tp53
clinicians
risk-adjusted
comparatively
chronic-phase
evidence-based
concordance
elts
nu2009u20091197
sokal
non-high-risk
low-risk
jeopardizes
outperformed
eutos
prevalence
hyperglycemia
neutropenic
hospitalized
therapyu2029
hemorrhage
therapy-induced
myelosuppression
transfusion
platelets
activating
coagulation
recombinant
rfviia
hemophiliac
vaginal
salvage
phenotype
ipss-r
underway
paradigm
disease-stabilizing
valproic
all-trans
retinoic
atra
myelogenous
chemoresistant
low-dose
6-mercaptopurin
atravalproric
acidtheophylline
cytotoxic
atravalproic
acidatratheophylline
routinely
post-induction
debated
allelic
flt3-internal-tandem
itd
screened
itd-ar
forty-one
1st
patient-specific
real-time-pcr
low-mrd
acetylation
cyclina1
oncogenic
sporadic
tqp13
utilizing
clinicopathological
next-generation
blasts-2
bcr-abl1-positive
myelofibrosis
mixed-phenotype
tmyeloid
mpal
workups
in-situ
nu2009u200911
etv6
nu2009u20097
nu2009u20099
mds-related
myelodysplasia-related
heterogenic
employing
tetrasomy
gtg-banding
primed
prins
aml-m4
aml-m2
metaphase
constituted
trisomy
disomy
coexistence
interphase
nuclei
anomalies
tncs
determinants
infused
disparities
patient-
nonrelapse
predictive
t-mn
reframe
aetiology
illuminating
kruppel-like
klf
prompted
klfs
putative
granulocytes
klf2
klf3
klf5
klf6
promyelocytic
atra-treatment
nb4
ht93
apl
atra-resistant
nb4-r
lastly
knocking
attenuated
repression
functionally
analyse
rbmt
rpbsct
ubmt
cp1
nxa0xa0531
accelerated
cp2-ap
nxa0xa0342
blastic
nxa0xa0189
nxa0xa0205
nxa0xa0507
nxa0xa0226
nxa0xa0124
95xa0
superiority
cohorts
advent
high-throughput
revolutionized
pathobiologically
two-part
hematologists
dlx4
isoforms
bp1
up-regulated
dlx7
down-regulated
bp1high
bp1low
ds-aml
inhibiting
upstream
wee1
first-in-class
mk-1775
arac
broadened
impetus
optimizing
scores-the
hasford
metrics-have
formulations
endeavor
respects
optimally
cutoffs
tomography
sarcopenia
allo-hcst
twenty-five
allo-hsct
ct-based
skeletal
smi
attenuation
l3
nu2009u200952
nonsarcopenia
nu2009u200973
correlations
muscularity
hospitalization
ct-defined
poor-prognosis
allohct
optimism
bispecific
tempered
paradox
receptorligand
evasion
clin
©2018
aacr
raebt
prognostication
aml30
raeb2
morphology
ukmrc
microtransplantation
micro-stem
mst
permutation
alloreactive
nonengrafting
ne-dli
angiogenesis
angiopoietintie
ligand-receptor
circulating
angiopoietin-2
ang-2
predictor
enzyme-linked
ngml
recursively
pre-estimate
risk-adapted
jude
aml-83
-se
aml-3
aml-4
aml-2
aml-91
aml-97
aml-87
prolonging
sequential
aml-80
nonmyeloablative
subtype-specific
uncertain
nu2009u2009431
nontransplantation
nu2009u2009211
hru2009u
post-hct
-34
biases
heightened
integrin
adhesion
antigen-4
vla-4
sct
gemtuzumab
ozogamicin
go-containing
proceeded
probabilities
cd33
modality
lscs
cd38-
leukapheresis
harvested
morphological
proportions
apheresis
inadequate
purging
reliably
enriched
cml-bp
historically
dismal
in-frame
n-terminal
aml1
c-terminal
eto
viability
clarified
pfs
grouped
monosomal
mk
oncologyeastern
swogecog
allosct
grouping
5-yr
poorest
predicting
separates
notably
non-mk
mk-
prognosticator
overlapping
derivative
obscure
abl-bcr
abolished
reverse-transcription
reflecting
predisposition
t315i
axitinib
low-income
endpoints
ccyr
deleterious
ameliorated
flt3itd
abnormity
m14
seldom
domestically
statistically
unchanged
in-depth
efficacious
bypassing
shaping
2-hydroxyglutarate
2-hg
isocitrate
dehydrogenase
idh1
idh2
oncometabolite
metabolite
chromatograph-time-of-flight
spectrometry
log2-transformed
moderately
biochemical
glutamine-related
metabolites
gene-expressiondna
sarcomamsthat
spleen
60s
complainant
low-grade
implant
antibiotic
levofloxacin
meropenem
vancomycin
abdominal
contrast-enhanced
lda
occupying
splenic
abscess
ct-guided
puncture
splenectomy
mitosis
cd43
cd45
single-agent
lenalidomide
del5q
unacceptable
fourteen
hospice
modest
s0605
nct00352365
aml-mrc
multilineage
mld
subgroups
dysgranulopoiesis
95ci
aml-mrcs
suppression
brain-resident
microglial
bmdm
hampered
mating-type
sirt1
succumb
refinements
emerged
sorely
attain
benefiting
gvl
eradicate
initiating
lentiviral
expressing
stimulate
eradication
chronically
stimulated
exhausteddepleted
escaped
pancreatic
ductal
adenocarcinoma
pdac
pdac-induced
chemotherapy-derived
kras
blockade
monoclonal
cocultured
supernatants
chemotherapy-treated
defeating
mdsc-mediated
t-mns
hematology
retinoid
arsenic
trioxide
ato
anthracyclineanthraquinone
auxiliary
administrated
t-mds
t-aml
pml-rarα
re-induction
-18
-126
-39
cytopenia
accompany
polycythemia
vera
pv
who-defined
amc
leukocytosis
tet2srsf2
myelofibrosis-free
mffs
borderline
pu20099
akin
morbidity
front-line
inconsistency
decision-making
meta-analysis
nma
px2009x02
px2009x10
px2009x01
px2009x04
registries
astrocytoma
ependymoma
morbidities
recurrently
comprehensively
aml201
accumulated
runx1-runx1t1
cbfb-myh11
il6
conferring
cd4
cell-mediated
antitumor
trans-signaling
sil6r
tumor-bearing
cell-specific
il6r
abundant
cd11b
tumor-free
il6-mediated
th1
tumor-specific
rescued
myeloid-specific
c-maf
il6-dependent
loss-of-function
il6sil6r-induced
defective
t-cell-mediated
cell-derived
counteracting
rationale
©2017
dok-1
dok-2
dok
rearranged
rq-pcr
rq-msp
bisulfite
bsp
hypermethylated
demethylation
5-aza-2-deoxycytidine
thp-1
low-expressed
hypermethylations
saml
hct-ci
n180
n84
propensity
antigens
cd13
cd19
cd20
cd38
cd56
myeloma
β
2-microglobulin
lactate
albumin
creatinine
histology
ldh
subtype
plasmablastic
cd33-
implicating
transformed
termed
protumor
dictates
accumulating
regulating
metastatic
overcoming
ifn
tumor-cell
intrinsic
evading
ifn-induced
innate
tumor-induced
dictating
clinician
p22
q22
flt3tkds
duplications
flt3itds
susceptible
flt3tkd
inversely
hybridisation
thirty-eight
twenty-eight
categorised
inv16
leukaemia-related
correlate
saprochaete
capitata
sepsis
originated
cough
malaise
klebsiella
pneumoniae
antimicrobial
lesion
exudative
pleural
effusion
desorption
ionization-time
antifungal
cavity
cleansing
videothoracoscopy
laparoscopic
metabolizing
udp-glucuronosyl
transferases
ugt1a1
rs8175347
cytarabine-based
mortal
dnr
calcium-binding
calreticulin
crt
endoplasmic
reticulum
unfolded
exocytosis
anthracyclin
cell-surface
n-terminus
elastase
cleave
peptide
vasostatin
atra-triggered
vascularization
antiangiogenesis
benefited
impairs
resource-limited
non-apml
apml
curative
administer
interpreting
stem-cell
soochow
-58
fab-types
m4m5
χ509
hr95ci
non-cr
adn
brca1-brca2-containing
brcc3
metalloproteases
cleaving
lys-63
polyubiquitin
implicated
nonsense
n12
frameshift
n4
n5
marginal
dominance
hemizygous
phenotypically
-y
murine
sca1
c-kit
2-fold
defect
tumor-associated
sequela
radiotherapy
comprising
multicomponent
covariates
evolves
stratifying
biologic
ifn-α
imatinib-induced
pegylated
ifn-α2b
peg-ifn-α2b
randomization
intention-to-treat
tolerability
retaining
fludarabine
consisted
24-hr
g-csf
crp
aplasia
nineteen
eradicating
cedecea
enterobacteriacea
inherent
antibiotics
unpredictable
line-related
bacteremia
lymphocyte
alc
subsets
warranted
prt
time-dependent
allogenic
allohsct
n337
n271
autohsct
n152
rfs
n157
intermediate-
metronomic
cpa
vaccination
ppv
treg
seventy
randomly
peptides
pooled
antigen-specific
humoral
injections
peptide-specific
ctl
pronounced
simultaneous
6th
organization-defined
forty-three
twenty-two
harboured
v617f
calr
mpl
phenotypes
splenomegaly
jak2-mutated
calr-mutated
anaemia
leucocytosis
thrombotic
indolent
hematolymphoid
solitary
phenotypic
extralymphatic
unequivocal
b-lymphoid
categorize
classify
bimixed
cytometric
daunting
ineffective
hesperidin
silibinin
cytotoxicy
in-vitro
nm-5000
hesperidin-25
silibinin10
mtt
reprimo
rprm
unmethylated
dose-dependent
lentivirus
transfection
rprm-overexpressing
dysregulated
rprm-induced
fci
10-color
100u2009000
sti571
iris
tkis
phase2
second-generation
cytopenias
gastrointestinal
-6
dasatinib-associated
hyphemas
cd318
cdcp1
precursor
anthracycline-based
receiver-operating
cd318lo
cd318hi
facs-based
noncoding
lncrnas
lncrna
linc00152
oncogene
histological
mir-125b
qrt-pcr
affirmed
mcl-1-mediated
mitochondrial
cerna
reversing
setbp1
leukemia-specific
uncovered
cooperating
hitherto
pathophysiology
angiogenic
elisas
quantify
fibroblast
bfgf
vascular
endothelial
vegf
hepatocyte
hgf
factor-alpha
tnf-alpha
angiogenin
metalloproteinase-9
logistic
indoleamine
-dioxygenaseido
g-csfr
cd11a
cd11c
1000microliter
febrile
effected
midostaurin
multikinase
elicited
flt3-mutant
metabolized
cytochrome
pa4
cyp3a4
mastocytosis
excision
ablation
inherently
hiding
bladder
derive
diminish
unmet
necessitating
vosaroxin
quinolone
site-selective
double-strand
preclinical
vosaroxins
anthracycline
multidrug-resistant
armamentarium
compelling
evidences
mediator
reciprocal
non-tumoral
cell-to-cell
exosomes
intricate
crosstalk
niche
stromal
tumorigenesis
niche-specific
bmt
dlis
fast-growing
debulk
g-csf-primed
cd105
endoglin
repopulation
sfi
advanced-stage
genomics
continuum
singleton
well-annotated
implicate
genotype-phenotype
logistical
recaps
imatinib-based
allografting
undergo
granulocytic
pancreas
specimen
pretherapeutic
biopsies
anticipate
expectancy
nears
sustaining
relies
disease-related
ctcs
dissemination
dendritic
dcs
comprised
plasmacytoid-pdc
myeloid-mdc
ctc
ibc
enumeration
twenty-one
mdcs
tnf-α
toll-like
tlr
il-12
tlr-activation
ccr7
costimulatory
cd86
tlr-activated
pdcs
mdc
induce
abstractu3000u3000acute
recurrence
emergence
chimeric-antigen
car-t
pd-1
cart33
anti-cd33
fragment
my96
effector
xenografts
progenitors
xenograft
permanently
cd33-specific
transiently
electroporation
potent
self-limited
forty-four
2nd
one-time
hypocellular
non-hypocellular
pu200au200a001
leukopenia
pu200a
u200a809
pu200au200a019
pu200au200a139
pu200au200a629
pu200au200a169
pu200au200a215
older-aged
triggering
trem-1
unmanipulated
hbmt
alc-30
alc-
mismatches
loci
nk
alloreactivity
kirs
kir
patient-donor
mismatched
agvhd
bx1
haplotype
telomeric
centromeric
cb-tatb
ca-ta
ca-tb
motifs
cen-b
hla-c1
hla-c2
confer
albeit
epidemiology
sapacitabine
unfit
renewed
anti-leukemic
nucleoside
appealing
eagerly
awaited
well-characterized
phf6
cd25
improves
2-
hydroxyglutarate
idh-mutant
discoveries
pathogenic
bisulfite-treated
denaturing
gradient
electrophoresis
hic
cdh
concurrent
early-stage
thrombocyte
hic1
cdh1
diffusely
f-18
fluorodeoxyglucose
fdg
uptake
positron
scans
cessation
usefulness
cns
infrequent
leukosis
clones
onset
ensured
reversion
unfavourable
8th
exceeds
detecting
p53
inactivated
predominately
hypodiploid
p53-regulatory
mdm2mdmx
cdkn2aarf
mdm2
p53-mediated
proteasome-dependent
degradation
mdmx
stapled
rg7112
thrombopoiesis
pathological
measurable
droplet
ddpcr
quantification
pre-transplant
disease-positive
restricting
non-myeloablative
markers-also
secreted
protumorigenic
gaining
osteoclast
osteolysis
carcinomas
©2013
unsuccessful
mrd-a
adverse-risk
factor-is
sixty-eight
mrdpos
pu2009neg
contrasted
mrdneg
confirms
mk-aml
accounted
pre-hct
liposarcoma-
ets-related
tls-erg
serially
relapse-related
non-relapse-related
pcr-positive
post-hsct
flt3-tyrosine
tkd
flt3-tkd
flt3-tkd-positive
flt3-itd-positive
flt3-wt
casesu2009u200910
frequenciesu2009u200910
paediatric
hampers
nras
nxa0xa0198
non-french-american-british
non-down
hotspot
aberration
hrxa0xa
cytologic
overlap
non-neoplastic
megaloblastic
non-hematopoietic
warrants
diagnostically
predominance
universally
exceedingly
inability
discriminate
proliferations
mimickers
pronormoblasts
clear-cut
megakaryocytic
utmost
fibrosis
-10
-12
int-2
earlier-stage
dictate
viable
bc-cml
attained
ablative
haplo-identical
characterizes
exome
hiseq-2000
cohesin
stag2
splicing
u2af1
interestingly
clonality
arises
subclonal
unstable
mesothelioma
mpm
asbestos-induced
microrna
micrornas
mir-192
mir-193a-3p
mir-200
pleura
specimens
-fold
mir-8-fold
mimic
mcl1
recapitulated
rnai-mediated
silencing
aml-mk
multidrug
mdr
rhodamine-123
efflux
withwithout
verapamil
efsos
ras-pathway
nkras
sub-clonal
mhr
incorporating
dipss
ruxolitinib
nonsignificant
resistanceintolerance
later-generation
reverses
mesylate
trough
im-treated
pharmacokinetics
transporters
pharmacogenetic
single-nucleotide
abcb1
abcc2
abcg2
cyp3a5
slco1b3
dose-adjusted
abcga
421cc
abcgca
pq141k
prevalent
han
africans
caucasians
cml-ap
cross-intolerance
imatinib-intolerant
nonhematologic
intolerance
ninety
chr
alleviation
ae-related
well-tolerated
nct00471497
colony-forming
cfu-c
qualitative
reducedabsent
thirty-nine
oncogene-induced
senescence
hepatocytes
secrete
senescent
hccs
bypassed
context-specific
ccr2
outgrowth
recruited
precursors
worsen
chemokines
accelerate
intensified
aml-bfm
n413
n499
cytochemistry
npm1-mutation
n253
hr-group
monosomy
flt3wt1-mutation
der12p-aberration
n101
karyotyp
n558
sorafenib
non-selective
flt3-positive
flt3-targeting
fda-approved
flt3-targeted
rs16754
polymorphism
embase
subjected
favorable-risk
cost-effective
mast
mcs
extra-cutaneous
organs
hemopoietic
allo-
auto-hct
lower-intensity
undergone
melphalan
cytosolic
5-nucleotidase-iii
nt5c3
arabinose
surrogates
emr
surrogate
adherence
off-target
measureable
hallmark
interpret
3u2009-u2009156
hypodiploidy
thyroid
tumor-1
heterogenous
uncontrolled
aproximately
identifiable
cytogenic
nc-aml
cebpalpha
baalc
af1q
cd7
cd9
47xy
downs
french-american-british
cd7-
cd9-positive
remarkably
co-expression
phosphatase
pp2a
chromosome-positive
b-cell
lymphocytic
forskolin
caspase-dependent
akt
erk
additive
hyperphosphorylation
cip2a
downregulation
subunits
activators
fty720
conclusive
expressional
c-myc
cebpα-β
sybr
qrt
cml-bc
outweighs
incorporation
antibody-drug
conjugates
asct
trade-off
cisplatin
haep
encode
catalyze
α-ketoglutarate
high-
intermediate-dose
hidac
neutropenia-associated
clofarabine
risk-stratification
ambiguous
pre-treatment
insufficient
aml1-mtg8
cbfbeta-myh11
pml-raralpha
core-binding
origination
fusions
pgf
newborn
qpcr
neonates
b-lineage
tel-aml1
mll-af4
unexpectedly
∼4
p190
∼
hypothesize
eliminated
acas
ph-negative
apbc
karyotyping
detects
dehydrogenases
idhs
caspases
cleavage
devd
devdase
fragmentation
drug-induced
tumor-promoting
hallmarks
il-18
critically
vk∗myc
txa0cell-dependent
il-18-driven
txa0cell
ill-defined
apoptosis-related
speck-like
asc
il18
gp130ff
spontaneous
intestinal-type
augmenting
caspase-8-like
epithelium
mucosal
caspase-1
il1β
il1α
il1
epithelial-specific
neutralizing
anti-il18
crisprcas9-driven
augmented
ascil18
cancersignificance
elevates
approvals
utilized
paucity
10th
mrc
emphasizing
purposed
abl
imatinib-treated
imatinib-resistant
amplified
transcription-polymerase
purifying
met351thr
hematologically
estimating
population-based
cladribine-
fludarabine-based
rr-aml
xa0
not-poor
chemotherapy-refractoriness
purine
analogue-based
inv16p13q22tp13q22
occurrences
justification
attributable
lymphocytes
histocompatibility
hlas
kir3dl1
allelic-mismatched
reconstitution
kir3dl1-expressing
diminished
kir3dl1-null
alleles
1000ngml
pharmacotherapeutic
paramount
basophils
physiologically
allergies
parasitic
manuscript
basophilia
pmf
chiricuta
cluj
napoca
spanning
post-pv
post-et
post-pmf
bcr-abl-negative
mpn
aml-negative
pre-therapy
basophil
emphasize
mpns
tme
tme-related
tcga
categorizing
differentially
degs
chemokine
dominated
ccr5
itgam
ppi
validated
target-aml
tme-associated
manifestations
nonleukemic
myeloblasts
resonance
unusually
localized
n10
n7
evolved
noncomplex
cytopeniasmds
aggressiveness
earlyevolving
fms-related
extensively
itds
sequence-dependent
conformational
tends
autophosphorylate
constitutive
localization
mutants
glycosylation
flt3-d835y
tcmc
cd3
patient-derived
flt3-directed
initated
triiodothyronine
t3
thyroxine
t4
thyroid-stimulating
microsomal
autoantibodies
tma
thyroiditis
corticosteroids
1½
ischaemic
characterised
4u2009h
dyscrasias
sickle
andrology
idiopathic
metastases
bladderu2009×u20093
urethral
chondrosarcoma
pelvis
leukaemiau2009u2009×u2009u20092
abnormally
haemoglobin
u2009gdl
bing-neel
bns
peking
waldenström
macroglobulinemia
cytology
myd88l265p
intrathecal
chlorambucil
r2
chemotherapies
flt3-itdwild
aberrantly
mirna
mir
mir-1
mir-486
let-7a
mirs
lympho-
lymphogranulomatosis
beacopp-14
polychemotherapy
first-line
intercourse
validate
epi
or60
reproducible
pd-l1
higher-risk
cd33-positive
aya-cml
subcontinent
scarce
phase-ii
imidas
nu2009u2009146
nu2009u20093
up-front
eln-criteria
unsatisfactory
sub-cohort
sct-related
nu2009u20092
pns
hpc
niches
reactivation
chulalongkorn
kcmh
pbsct
mccs
auto-hsct
150-fold
ml-ds
tmd
gata1
probable
asan
msd
predictable
multi-agent
unselective
accelerates
fatality
high-grade
syndromeacute
tmdstaml
systematically
intensive-timing
ccg
hepatomegaly
hepatosplenomegaly
16q22
standard-timing
presumed
alkylator-induced
topoisomerase-induced
proliferating
oxidative
o2
warburg
citrate
biosynthesis
diminishes
acidity
acetyl-coa
deacetylation
favoring
aiming
acly
inhibit
dedifferentiation
sensibility
dli
recurred
graft-vs-leukaemia
bolster
priming
non-hematological
aes
second-line
occlusive
paod
inconsistent
micro-rna
proteomics
premature
nucleophosmin
mir-96
considerably
furnishes
ngs
vastly
plateau
memorable
first-generation
drastically
ponatinib
sub-categorized
reportedly
ph-like
engagers
kinase-3
antibody-calicheamicin
conjugate
middle-aged
applicability
amlcg-1999
tet
srsf
asxl
idh1-mutated
idh1-wildtype
pidh1
chemorefractory
nct00266136
hsps
postulated
hsp70
elucidated
non-apoptotic
agonistic
anti-fas
jo2
ligation
cross-linking
orthotopic
4t1
mechanistically
prostaglandin
e2
impairing
p-p38
nfκb
cox-2
anti-il-6
signaling-initiated
externally
strata
auc
pretransplantation
rpam
rdri
easix
ebmthematopoietic
transplantation-specific
ebmt
comorbidity-age
biomarker-driven
discriminative
vorinostat
suberoylanilide
hydroxamic
ferritin
chelation
infection-related
attenuate
overload
end-organ
alongside
microarrays
tailored
ncounter
targetable
ayas
micrornamir-335
mir-335
bosutinib
srcabl
multinational
e13a2e14a2
chromosome-negative-
acceleratedblast
drug-related
ast
transaminase
elevations
juxtamembrane
d835
sarcomas
mediastinal
rarer
vena
caval
obstruction
radiography
haemopoietic
pre-treated
pref
destined
technically
cytomegalovirus
seropositivity
npm1maml
seventy-one
roc
segregation
investigating
hyperdiploid
non-random
helix-loop-helix
id1
constitutively
flt3-
refining
id1-
pharmacotherapy
aml-related
classically
autosomal
monosomies
ck
stratify
one-third
nucleophosmin1
difficult-to-treat
health-related
hrqol
intentional
unintentional
adhering
severity
non-adherence
homogenous
generalized
medication-taking
behaviors
drug-resistant
leukaemic
lspc
48-h
mylotarg
cd34cd38-cd123
cd34cd38-
haemapoietic
insensitive
underpinning
p-glycoprotein-negative
chemosensitivity
nlrp3
nucleotide
snps
imatinib-
nilotinib-resistant
y253h
e255kv
f359vc
dasatinib-resistant
f359v
methodologies
longitudinal
proposes
pivotal
sub-microscopic
interferon-alpha
all-trans-retinoic
marrows
ccr
ph-
dormant
post-bmt
mitoses
pml-rara
p02
maskedvariant
bcr
mediate
flt3-tki
ap24534
transfected
multi-resistant
f691i
stably
harbouring
n676d
g697r
stat5
incubation
blotting
fifty-seven
corticosteroid
covariate
-416
refraining
indispensable
avoided
mir-146a
clustered
nonreceptor
nonexhaustive
cytoplasmic
exon
-8
aml-ds
complicating
congenital
chd
enrolment
fcγ
iiia
fcgr3a
rs396991
g-to
t-point
substitution
valine
phenylalanine
v158f
fcgr3a-v158f
158v
ii-iv
gvhd-related
antileukemia
cd123-redirected
myeloablation
mandates
mitigation
anti-cd123
rna-electroporated
rna-cart
alemtuzumab
lentivirally
transduced
anti-cd-1bb-cd3ζ
cart123
cd20-coexpressing
cart123-cd20
antibody-mediated
impair
time-course
overwhelming
gas5
riborepressor
glucocorticoid
glucocorticoids
encoded
nr3c1
genotyped
rs55829688
txa0xa0c
rs6195
rs41423247
rs6189rs6190
iranian
co-dominant
orxa0xa
cixa0xa-
over-dominant
ggat
cggt
gggt
haplotypes
p-valuesxa0xa
exhibiting
asp816
asp835
possessed
bcrabl
oncoprotein
up-to-date
disease-specific
midh1
bay1436032
dose-escalation
twice-daily
half-life
non-linear
dosing
r-2hg
mlfs
decreases
cp-cml
enrolling
ranged
bayesian
mixed-treatment
mtc
trivial
new-generation
well-conducted
rcts
5-fluorouracil
5fu
myelotoxicity
nonlinear
hmas
frontline
treatment-refractory
differed
crcri
fibroblasts
constituents
differs
contexture
determinant
non-small
tumor-suppressing
tumor-infiltrating
diagnostics
hypermethylation-mediated
id4
leukaemia-free
hl60
harbors
life-threatening
icu
eighty-three
hemodynamic
impairment
vasopressors
ventilation
hemodialysis
fibrinogen
appropriateness
continuation
life-sustaining
telomerase
rs2736100
transcriptase
tert
subunit
heterozygous
tg
recessive
inversion
bowel
venetoclax
exposure-efficacy
exposure-safety
hma
ldac
modeled
exposure-response
qd
ncrnas
comprise
well-studied
unannotated
noting
progresses
bcr-abl-induced
mena
resultant
aubmc
runx1runx1t1
cbfbmyh11
kmt2amllt3
cepba
etv6runx1
kmt2aaff1
tcf3-pbx1
cytogenetics-normal
npm1flt3
b-
t-lymphoblastic
b-all
t-all
lebanese
epidemiological
oncologists
haplo-hsct
mud-hsct
u2009110
non-inferiority
reduced-toxicity
mostly-myeloablative
graft-vs-host-disease
ebv
cmv
gvhd-freerelapse-free
unenrolled
nct01751997
fit3
fit3itds
responsiveness
nodscid
emphasized
fit3itd
non-mutant
progenitorstem
cobblestone
cafc
engraft
cd33⁺
hla-dr⁻
chromatin
exposes
mll-fusion
self-renewal
spliceosome
irf
establishes
internal-tandem
missense
quizartinib
flt3-mutated
inhibtors
cpx-351
guadecitabine
sgi-110
crenolanib
volasertib
cytomorphology
pcr-based
biologically
well-defined
subentities
microarray
quantifies
intensities
epigenetic-modifying
synergize
newly-diagnosed
thirty-four
twenty-nine
5xa0d
14xa0d
dose-limiting
qtc
prolongation
sequentially
warranting
hotspots
exons
wt1-mutated
flt3-d835
heathy
patientsthe
markerthe
hgb
plt
flt3-itdtkd
patientsall
amlcg
antineoplastic
comutated
synergism
nonoverlapping
jointly
divergent
biallelic
prognosticators
cancer-
co-occurring
good-
remodeling
co-mutation
sf1
npm1-mutant
105abl
aspirate
2y-os
low-level
duplicationsitds
dividing
t-depletion
isrctn
eln
unselected
or2009
nu2009u7
sor2009
nu2009u1
fail2009
or2013
war2013
fail2013
nu2009u4
ffs
advanced-phase
nonresponders
cd47
anti-phagocytic
abundance
ubiquitous
qpctl
post-translational
practicing
mll5
sbp
satisfactorily
vacuolization
subcellular
del16q
mns
inv16pq22
transcriptomic
nonmast
sm-ahnmd
multifocal
aggregates
spindle-shaped
cd2
hyperplasia
monocytichistiocytic
ahnmd
pdgfra
tryptase-positive
nk-aml
comprises
analogue
backbone
aiding
individualized
cytidine
deaminase
cda
79ac
rs2072671
-451ct
rs-nucleotidase
cn-ii
7ag
rs10883841
deoxycytidine
dck
3utr
948tc
rs4643786
itd-positive
79cc
-451tt
flt3-itd-positivenpm1-positive
analogues
flt3-itd-negative
tp11q22
fus-erg
tq24q22
runx1-core
cbfa2t3
berlin-frankfurt-münster
runx1-cbfa2t3
109l
m1m2
c-myb
bcrabl-expressing
pi-3kakt-dependent
interacting
leucine
zippernegative
interfering
denaturing-high
chromatography
d-hplc
exon-intron
spliced
anthracycline-
cbfbetamyh11
n17
nonrelapsed
non-relapsed
tki-based
siblings
progressing
overrepresentation
underrepresentation
intercalating
shortens
standardized
impeding
comparability
cimf
volumetric
quantifying
morphometric
practicability
semiquantitative
reproducibility
influencing
hum
pathol
-401
deoxynucleotidyl
transferase
tdt
hladr
multi-variate
cd34hladr
ascites
serous
hgsc
ascites-derived
density-gradient
centrifugation
bdca-1
bdca-3
cd16
cd123bdca-2
cytoreduction
co-stimulatory
co-inhibitory
del7q
karyotypic
concurrence
-7del7q
hemizygoushomozygous
haploinsufficiency
chr5q
whole-exome
csnk1a1
g3bp1
cdrs
5q-5q
ddx41
7qq34
cdr
cuxq22
luc7lq34
ezhq
mdsaml
pathologically
motility
quantitively
acml
sf3b1
t-mds-rs
nu202fu202f38
d-mds-rs
nu202fu202f174
tp5
tet1
sf3b7
asxl4
runx4
srsf3
pu202fu202f
zrsr2
˜90
d-mds
erythropoiesis
flt3-itddnmt3a
sanger
r882
leukocyte-free
frontiers
entree
influx
pathogenetic
löwenberg
postinduction
tallman
milestones
worsening
7xa0xa03
tolerate
detrimental
maranhão
cytochemical
hemogram
hemopoiesis
completeness
humara
nsclc
minimally
invasive
new-targeted
carcinogenesis
bm-derived
parenchyma
sorting
fractions
transcriptomes
intratumoral
compartments
counterparts
polymorphonuclear
inconspicuous
osteopontin
opn
c-c
motif
ccl7
thrombospondin
tsp1
tumorigenic
homogeneous
antithymocyte
globulin
atg
thymoglobulin
-antigen
1-allele
grfs
acutechronic
post-transplantation
polycomb
repressive
prc2
trimethylation
h3
lysine
h3k27
condensation
attributed
methylating
lymphomas
zeste
inactivatinghypomorphic
n469
eedsuz12
locus
diploid
spliceosomal
u2af1srsf2
hox
hoxa9
ezh2spliceosomal
amkl
myelopoiesis
mll-partial
aml99-down
low-density
ldn
tumor-supportive
high-density
hdn
cytof
ldnhdn
modulations
-80
nxa0xa064
nxa0xa035
nxa0xa015
obstructive
copd
nxa0xa013
cd66b
cd10low
cxcr4
pdl1inter
plasticity
ci-r
standard-of-care
anthracyclines
busulfan
bu
cy
7th-16th
antigen-identical
sinusoidal
umin-ctr
idc000000156
platelet-derived
pdgfr-mediated
pdgfr
pdgfrb
eosinophilia
cgmp-dependent
flt3d835
insignificant
⁹l
colorectal
crcs
microsatellite
msi-h
mss
msi
resection
crc
stroma
lymphatic
budding
cd8-positive
cd68-positive
pd-l1-positive
m2-type
plasmacytoid
bpdcn
diseased
mixtures
inequalities
sparser
socioeconomic
tki-induced
60u2009mlmin
cardiotoxicity
myocardial
infarction
atrial
fibrillation
decitabine-treated
ima
camelia
ecog
charlson
fromu2009u
pu2009cml
inanalysis
oscml
insignificantly
ac220
mediators
mtor
mek
plk1
aml1-eto
flt-3
mfc
wt1-rna
thresholds
lr
evi-1
septic
time-to-event
infection-associated
mortalities
prophylactic
granulocyte-colony
stimulating
anc
catheter
microbiologically
tli-atg
fdc
cytokine-induced
cik
donor-derived
1u202f×u202f108kg
cd3cd8nkg2d
cd3cd56
nct01392989
survivals
cloretazine
vorexolin
hematogones
hgs
regenerating
busulfanfludarabine
busulfancyclophosphamide
fip1l1-pdgfr
fgfr1
fip1l1-pdgfra-positive
fip1l1-pdgfra
long-lasting
25oh
d3
cation
transports
dubious
antileukemic
hhy
hy
aspergillosis
cll
disappearance
ig
pneumonia
extrinsic
cytokine-mediated
rna-sequencing
srsf1
bcr-abl1-
conferred
untransformed
prevented
prkch
plch1
srsf1prkchplch1
single-arm
two-stage
nct02984995
hydrochloride
treatment-emergent
teaes
discontinuation
qtcf
xa0ms
qtcfu2009u2009500xa0ms
torsade
pointes
arrhythmia
uniparental
aupd
homozygosity
oncogenes
underappreciated
9p
arrays
pv-defining
jak2v617f21
jak2v617f
jak2v617f29
deficiency
hospital-based
case-control
folate
cyba
dnmt1
dnmt3b
gpx1
keap1
mtrr
neil1
nfe2f2
ogg1
slc19a1
sod1
sod2
xrcc1
speciestotal
antioxidant
8-hydroxy-2-deoxyguanosine
5-methylcytosine
nfe2l2
modulated
altogether
©
periodicals
massively
aaml0122
peptidase
senp1
senp1--
sumoylated
stat3-mediated
sumoylation
suppresses
dephosphorylation
malignancy-related
worrying
subgroup-directed
risk-group
high-intensive
tailoring
matched-sibling
matched-unrelated
manipulation
bidirectional
procedure-related
unanswered
radioresistant
erp57
radioresistance
laryngeal
stat3-regulatory
sirna-mediated
sensitized
erp57-stat3-mcl-1
phosphorylated
erp57-stat3
cnas
ccaatenhancer
protein-α
lbl
arbitrarily
all-derived
xv
cerebral
thrombosis
infarcts
avascular
avn
femur
judes
relapsing
steroid
stage-specific
diametrically
exerts
therapeutically
demonstrating
derepresses
bivalent
feto-oncogenic
plag1
phenocopies
retains
aml1-dependent
aml1-eto-positive
ezh1
aml1-eto-expressing
wd
nhr1
methylates
lys43
augments
aml1-eto-dependent
aml1-eto-repressive
non-histone
site-specific
signalling
attenuating
receptor-like
rptp
cd45ptprc
ptprc
knock-out
bred
knock-in
shortened
haematopoiesis
splenohepatomegaly
transforming
histopathology
osteoporosis
ectopic
unappreciated
presumably
anomaly
diffuse
dlbcl
vincristine
prednisolone
r-chop
chop-therapy
bh3
chop
dependencies
bh3-mimetics
bcl-xl
dependency
chop-induced
chop-resistant
underline
cml-chronic
das-treated
dmr
interrupted
definitively
onoff
overregulated
genome-based
revise
appropriately
adopting
kmt2a-ptd
cbfa2t3-glis2
nup98-jarid1a
1c
cdkn1c
cdkn1c-positive
-negative
low-proliferative
treatment-naïve
antiproliferative
differentiation1
survival1
underserved
axl
tyro3
mer
secretion
arrest-specific
gas6
bmdscs
chemoresistance
axl-expressing
gas6-axl
paracrine
chemoprotective
abrogated
axl-targeting
atp-binding
abcc1
syk
over-expression
y348
bp-cml
psyk348
observing
r406
classifying
lymphoma-2
cascade
vimentin
2p
vim
pseudogene
stanniocalcin1
stc1
-intolerant
nct00123474
nxa0xa0670
hypertension
ischemic
hematol
external-beam
xrt
post-xrt
mtd
dlts
hsp90
17-allyamino-17-demethoxygeldanamycin
17-aag
bortezomib
co-administration
17-amino-17-demethoxygeldanamycin
17-ag
encompasses
refinement
-e2
-e
α-subunit
itga5
antigen-5
quantified
aaml03p1
q4
standard-risk
exploratory
exemplified
risk-stratify
suppressors
definitive
vtrna
transcribed
monoallelically
monoallelic
5-azanucleosides
down-regulate
rna-dependent
ppkr
mono-
biallelically
nonhealing
enlarging
asymptomatic
nodule
thigh
debates
reluctance
icus
emerge
musculoskeletal
ctcae
persisting
imperative
failureintolerance
allo-bmt
n83
cannot
under-represented
cytomorphologic
preceded
promyelocytes
promyeloblast-like
coagulopathy
histiocytes
hemophagocytosis
erythrophagocytosis
acquiring
antagonists
id2
lsc
mll-af9-leukemia
e-protein
suppressing
mll-af9-aml
tumor-suppressive
conserved
id2e-protein
bcr-abl1-negative
thrombocythemia
evolve
mpn-bp
mpn-ap
portend
preclude
cd44
mabs
a3d8
mab
ligate
stabilizes
p27kip1
p27
complexes
antisense
kg1a
cd44-targeted
risk-based
9x
copiesx
gapdh
flt6
dominates
non-malignant
gold-standard
reappearance
smoothened
smo
patched-1
ptch1
precedes
gatekeeper
contemporaneously
paving
all-cause
blacat1
polypeptide
ddx43
cancertestis
cta
favorable-prognosis
q21q26
hiv-infected
antiretroviral
haart
nonrandom
hiv-positive
tolerable
peculiar
hivaml
low-toxic
repositioned
anti-leukaemia
confirming
s-phase
rad51
mitigate
oci-aml3
multiplexed
near-infrared
labelled
repositioning
unsuited
nordic
haematology
oncology-acute
nopho-aml88
nopho-aml93
dose-intensive
timed
orbital
smear
proptosis
incision
squamous
hnscc
exophytic
endophytic
adjuvant
recurrence-free
foxp3
microscopically
hierarchical
clustering
infiltrates
cd3cd8
tgf-β
arg-1
nests
twenty-three
⩾iii
n6
⩽30
pre-sct
⩾10
noneone
salvageable
multiparametric
cytogeneticsgenetics
posttreatment
fatigue
disabling
myeloidxa0leukemia
proteomes
proteome
spectrometers
tens
lysate
posttranslational
ptm
isolate
proteomic
phosphoproteomic
relapsed-refractory
first-salvage
anti-aml
antiapoptotic
iaps
proform
hla-dr
idh1-r
idh2-r140
idh2-r172
idh-mutations
s1
s2
idh-mutated
mrdcons
mrdcons-
poorintermediate
mdr1-positive
intermediateunfavorable
standard-dose
mobilization
cbl-inactivating
ubiquitin
ligase
inactivates
sfk
rtk
r420q
gdm-1
thp1
granulocyte-macrophage
hypersensitivity
sunitinib
pp2
phosphoprotein
uniquely
tyr721
tyr705
promiscuous
guanidine
extracts
affymetrix
hgu133a
ontology
pbef1
g6pd
tnfaip3
tnfaip8
bcl2a1
bax
bnip3l
kiaa0179
cd34-
non-hla-matched
ex-vivo
χ046
χ814
χ346
a2
subdivide
govern
tissue-resident
tissue-specific
predispose
forty-two
amlmds
co-occurred
flt42
χ320
p45
elicit
aml-dc
gmp
injected
-13
elispot
granzyme
releasing
recognizing
prame
alyvdslffl
bead
deoxyribonucleic
elaborate
proactively
personalization
realizable
non-trial
concentrating
real-world
high-resolution
imagined
graft-versus-host-disease
anti-thymocyte
cyclosporine
mycophenolate
mofetil
methotrexate
fludarabine-busulfan
transplantation-eligible
hôpital
haematopathologic
sm-aml
toluidine
tryptase
tq22q23
d816v
race-based
large-scale
age-
race-
age-related
aya
persist
extra-medullary
bromodomain
extra-terminal
jq1
triptolide
tpl
circumvent
exerting
triggered
mitochondrial-mediated
downregulate
cotreatment
engrafted
xloc109948
histiocytic
belonging
ultrastructural
histiocyticdendritic
ras-raf-mek-erk
resemble
kmsurv
latent
lpia
pathway-pathway
visualized
cytoscape
sub-pathways
hk3
hnmt
sult2b1
kynu
ptgs2
arachidonic
fragments
mutantwild-type
hyperleucocytosis
pre-induction
leucoreduction
100xa0×xa
leucoreductive
hydroxycarbamide
28xa0d
nxa0xa0702
xa0×xa
wbc100xa0×xa
nxa0xa0166
leucostatic
fifty-one
chemotherapy-based
cgh
cytogeneticfish
8q
11p-p
akt1
ltb
sdc1
runx1t1
imbalanced
correspond
imbalances
non-cutaneous
confined
sinonasal
uncharacteristically
spared
poses
multidisciplinary
allo-hematopoietic
unraveling
cytogenetic-risk
successive
unprecedented
gynecologic
debulking
recurs
disseminates
gcs
upregulating
microrna-708
syngeneic
dosages
c57bl6-derived
id-8
dexamethasone
dex
rap1b
il-1β
downregulated
tams
still-debated
mlds
npm1⁺
eighty-five
maturing
fc-assessed
morphology-assessed
highlighting
clinical-biological
ll-mc
sixty-seven
wt3
discourage
cholangiocarcinoma
cca
precipitated
undoubtedly
patientsa
180u200arr
hads
hcs
respectivelyboth
hads-anxiety
hads-depression
pu200au200a05anxiety
reinduction
oct-1
gipap
non-imatinib
ninety-five
fanconi
heterozygosity
loh
17p
scin
weakly
ru2009u265
scinlow
scinhigh
prevents
oligonucleotide
ly2181308
pharmacodynamicsefficacy
post-amendment
gm2
4-hour
30-minute
needing
maternal
fetal
pregnancy-associated
pa-aml
anthracycline-cytarabine-based
acbrs
∼30
chemotherapy-subjected
high-quality
tumour-associated
facilitating
antitumour
b7-h3
transgenic
macroenvironment
gists
prototypes
c-kit-driven
fms-tyrosine
multitargeted
15a
potency
c-kit-mutant
gist
gist430
c-kit-
flt3-driven
conception-related
spouses
fathered
diagnose
misdiagnosed
appendicitis
appendectomy
postoperatively
laparoscopy
masses
pelvic
lymphadenopathy
workup
emd
diagnosing
elongation
duplicated
multiples
preserved
elongated
non-aml
proofs
onward
mandating
pcyr
cyr
indefinitely
mcr
discriminated
lethargy
bruising
hypercellular
trilineage
g-banding
46xy
statins
anti-tumor
anti-neoplastic
evidenced
statin
brainstem
potentiate
ld-mel
non-curative
stabilization
myelosuppressive
conclusively
furnish
concise
mobilised
tgfβ1
dual-drug
liposomal
encapsulation
mixed-effect
2-compartment
bilirubin
formulation
mildmoderate
quartiles
risk-benefit
individualization
secondary-type
cohesion
t11q23
opportune
post-consolidation
histamine
dihydrochloride
myelomonocyticmonocytic
h2
histamine-based
cbf-aml
apollon
transfusions
pdlts
fractures
64-yr-old
remineralization
mir-655
mir-655-related
emt
evaluates
radiofrequency
rfa
epitopes
taa-derived
hcc-specific
tetramer
taa-specific
interferon-γ
epitope
hla-dr-low
epstein-barr
ebv-driven
ptld
bpdc
post-allogeneic
cd4cd56cd45racd123tcl1
suggestive
bcl11a
bdca-2
cd2ap
tcl1
s100
47xxtq21q-13u2009u20092mar
46xx
biopsyaspirate
enlarged
cervical
supraclavicular
lymphoadenopathy
lactic
ebv-dna
lytic
cd45dim-
cd4cd56
k-chain
cd19cd20cd21cd22cd38cd43cd79β-cd5-cd10-
monomorphic
insufficiency
informing
n475
n428
n230
-24
-52
-65
-68
-59
-64
-54
-60
marrowperipheral
n903
groupe
francophone
cytogenetique
hematologique
gfch
-5del5q
dup1q
-17del17p
del20q
responsedmr
leukemiacml
imatinib-naοve
gy
disappeared
etv6-acsl6
putatively
originating
cell-lineage
myeloidnk-cell
nk-cell
leukemialymphoma
nasal-type
nasal
extranasal
lymphocytosis
affliction
granular
c3435t
5q33
disappointing
nonselected
leukostasis
leukocytes
ciprofloxacin
disproportionately
or75
emerges
5q-
7q-
farnesyltransferase
mutation-
icc
anti-p53
do-7
optimized
mutation-accumulation
substrate
p-gp-mediated
t1236c
2677ta
1236t
ctcc
g2677ta
agataa
ttgtgg
ttct
g2677t
swog
ascertain
myelosarcoma
unperformed
karyotyped
translates
mpd
derp10q10
apc
underpinnings
categorizes
individualize
array-based
acgh
facilitates
44k
undetected
spans
17p-q
provisional
single-
double-mutated
whereupon
gata2
runx94
gata2-mutated
gep
cebpasm
raf
vegfr-2
cont
-82
dlt
sirt2
nad
deacetylases
expressio
gene-expression
il10
mapk
sirt2high
sirt2low
flt3-itdxa0mutated
ranimustine
gilteritinib
flt3axl
fulminant
clostridioides
difficile
fecal
microbiota
fmt
life-saving
pseudomonas
aeruginosa
post-procedure
stool
excessively
1b
treatment-naive
intravenously
subcutaneously
nausea
constipation
hypokalemia
appetite
lysis
mos
nct02203773
clinicoepidemiologic
imatinibs
tunisian
outcome-overall
pfs-were
cpap-cml
non-optimal
caveats
ap-cml
ncas
mosaicism
nca
integrative
unrivaled
extrapolation
predetermined
age-matched
propagation
third-generation
multi-tki-resistant
lieu
profound
effusions
morisky
mpr
impacted
adherent
translating
iii-iv
p001
owing
in-vivo
mixed-lineage
work-up
neoplasia
incompletely
proliferate
aml-positive
recapitulate
zebrafish
drosophila
rodent
suitability
low-intensity
3u200au200a7
pathologic
modalities
geared
allele-specific
disadvantages
tests-including
cons-that
graft-vs-leukemia
longstanding
reinduce
exacerbations
adcs
retransplantation
lasts
aml-targeting
demethylating
thalidomide
antiangiogenic
riskbenefit
controversies
approaching
non-cardiac
non-transplanted
censored
1-
2-yr
actuarial
cbf
hypofibrinogenemia
hf
tat
fpa
fibrinolysis
d-dimer
fdp
disseminated
intravascular
coagulationhyperfibrinolysis
prothrombin
thrombin
clotting
reptilase
m7
normalized
hemorrhagic
forkhead
foxo
transduction
foxo3a
transporter-1
oa
oct-1-mediated
mncs
nonhematopoietic
u5
snrnp200
complex-specific
receptor-dependent
aml-specific
gain-
manipulations
knockout
mir-126
surprisingly
aml1-etorunx1-runx1t1
aml1-eto9a
aml1-eto9a-mediated
cellsleukemia
lscslics
enhances
activates
errfi1
spred1
fzd7
2-faceted
uncover
sensitize
noninterventional
piaza
mdss
personalize
intra-patient
chemotherapyradiotherapy
urokinase
plasminogen
activator
supar
nxa0xa0493
all-berlin-frankfurt-münster
bfm
etp
4-fold
leukaemiasworld
mrd-based
very-high
all-bfm
antibody-based
egrq31
24-color-fish
subdivided
interstitial
strongest
ucbt
single-unit
random-
fixed-effects
n2026
n4736
means-
ethnicity
risk-
response-based
high-income
resource-rich
interleukin-3
il-3ralpha
b-acute
t-acute
linkage
scarcely
deprivation
transducer
pertaining
il-3
eosinophilias
encompass
non-hematologic
costly
advancements
sparse
enasidenib
ogozamicin
gpx3
unmethylation
concludes
point-of-care
ensue
envisioned
triphosphate
ara-ctp
biosensor
post-treatment
27-fold
steady-state
achievable
dwindling
ru202fu202f-
laip-positive
geriatric
micro-rnas
inguinal
right-sided
cryptorchidism
alpha-fetoprotein
beta-hcg
normalcy
abdomen
contiguity
ipsilateral
retroperitoneum
hydronephrosis
germ-cell
undescended
testicle
orchiectomy
testis
psc
valspodar
alters
dose-finding
mitoxantrone
mec
attaining
continuous-infusion
hyperbilirubinemia
cerebellar
ataxia
paresthesia
two-fold
q-
tentatively
uneventful
larger-scale
multicentre
unaddressed
consume
prone
fructose
glut5
compensates
glut5-encoding
slc2a5
blockage
ameliorates
potentiates
retinal
fundus
oculi
waldenstrom
lymphoplasmacytic
familial
anti-cd20
seminal
myd88
l265p
whim
abbreviated
hyperviscosity
multitude
cell-survival
ibrutinib
brutons
off-study
chemosensitive
transplant-eligible
disease-negative
state-a
cure-is
longterm
brighter
replicated
interrelationships
bcl2
indo
n-ras
k-ras
cebpadmsm
doublesingle
univariable
evl1
separating
condensed
-5
②incidences
ⅱ-ⅳ
ⅲⅳ
aldehyde
aldh
cd34aldhbr
cd34cd38-aldhint
denote
reagents
indirectly
disulfiram
dimethyl
ampal
thiolester
dimate
distinguishing
protections
abl1
sixteen
failure-free
thirteen
ninety-eight
myeloblast-associated
monocyte-lineage
regeneration
hyper-recovery
serinearginine-rich
p05
worsened
p03
n29
n135
cytogenetic-based
weighing
kmt2a
gc-resistance
impede
antibody-directed
randomised
oligoblastic
vitd
25-hydroxyvitamin
1α25-dihydroxyvitamin
polyadp-ribose
whos
pharmacovigilance
vigibase
obstacles
g-mdscs
irf7
s100a9
transrepressed
g-mdsc
youngfit
youngunfit
glasdegib
ivosidenib
m-mdscs
anti-tumour
extranodal
ipi
il-17
tc17
clofarabine-based
cholecistytis
nocardia
unexplained
signaling-1
socs-1
pbmnc
non-progression
persistently
tetraploidy
near-tetraploidy
near-
sry-related
sox2
sox3
sox11
sox14
sox18
incurs
submicroscopic
der9
d-fish
non-deleted
der9-deleted
endosteal
extracellular
glycosaminoglycans
propagating
sheltered
detachment
suspend
biphasic
triphasic
interferon-alfa
ifnalpha-based
short-lived
dac
homoharringtonine
hht
troxacitabine
farnesyl
ftase
fti
high-intensity
adoptive
leucocyte
sparing
re-evaluation
eras
non-disease-related
2-chlorodeoxyadenosine
2-cda
underscores
aml96
ctnna1
orraeb2
ctnna1-repressed
correlating
non-5q-
3-internal
non-flt3-mutated
hoc
daco-016
rbc
deriving
discontinue
multi-center
euro-ski
nct01596114
subclasses
non-relapsing
naïve
cd56bright
tnf-αifn-γ
polycythaemia
thrombocythaemia
clearer
deploy
disorderacute
runx1-mediated
nonmuscle
myosin
iib
myh10
megakaryocyte
ploidization
paris-trousseau
fli1
megakaryopoiesis
tyrosine-kinase
exponential
turnover
inference
observable
clag
nanotechnologies
transplantation-censored
ac-os
non-nk-intermediate-risk
non-nk-intermediate
more-refined
9q
two-step
tq34q11
breakage
ionizing
topoisomerase-ii-inhibitors
antimetabolites
leukaemogenesis
susceptibilty
modelled
await
jeopardizing
8sole
instable
third-line
eliminating
unveil
p53-r248q
eliminates
r248q
macroautophagy
pyruvate
kinase-1
pdk1
dichloroacetate
dca
autophagy
co-treatment
hsc70
chaperone-mediated
cma
non-stress
contexts
degrade
cma-mediated
inv16t
eighteen
pre-cytogenetic
precytogenetic
resuscitate
hm
discharged
fchsd2
chemo-protector
tw
mak
unpublished
shrna
coincided
p21
puma
htert
inverse
r-
non-responder
remission-induction
socio-economic
myeloproliferativemyelodysplastic
whole-arm
wat
tx12p10p10
casein
α
serine-threonine
hspcs
shrna-mediated
rps6
p53-null
d4476
topoisomerase-ii
evade
intragraft
γδ
tcr
repertoire
γ-chain
trg
cmv-
overrepresented
skewed
v9-jp
pairing
clonotypes
variable-joining
v2-jp1
v4-j2v5-j2v8-jp2
cdr3
catwdgpyykklf
reshaping
bevacizumab
saes
ntr904
nederlands
crises
-11
fdbuatg
allografts
medically
web-based
non-ds
bcp
12-fold
9-fold
amsacrine
16-fold
20-fold
6-thioguanine
3-fold
5-fold
23-fold
21-fold
bcp-all
corresponds
i-fish
autophosphorylation
factor-independent
c-28
methyl
ester
oleane
triterpenoid
cddo-me
multifunctional
nfkappab
nucleus
ikappab
beta-mediated
ikappabalpha
flt3itd-positive
caspase-3-mediated
flt3itd-expressing
pkc412
hd98b
lipid
phosphate
nanoparticle
versatile
encapsulating
nucleotides
pdna
co-encapsulated
adjuvants
cgamp
5pppdsrna
p-ah1-a5
ct-26
fl3
implanted
cecum
rig-1
unvaccinated
inciting
t-regulatory
sting
remodel
advancing
worsens
pracinostat
panobinostat
receptor-3
barasertib
rigosertib
gentuzumab
lintuzumab-ac225
selectively
chemotherapy-induced
ipa
amphotericin
l-amb
inhalation
placebo-controlled
erasmus
prophylactically
inhaled
standardised
probableproven
per-patient
€patient
compensated
voriconazole
-1816
azole
non-azole-based
opportunistic
thirty-three
cellskg
dpcr
nucleolar
chaperoning
ribosome
biogenesis
dislocation
npm1c
gain-of-function
exon-12
npm1-tyk2
npm1-haus1
incidenceclinical
trisomies
blasts-ii
raeb-ii
gating
cd45ssc
spss
cd74
cd21
cd95
rarcmd
aml-m1
cd15
cd5
cd10
cd22
ccd79a
expresses
cebpa-
npm1mut-negcebpadm-negflt3-itdneg
50th
percentile
unmutated
delineate
mo-mdscs
mbc
estrogen
negativity
liver-
er-positive
imply
unlabeled
antibody-targeted
beta-particle
emitters
alpha-particle
small-volume
well-designed
mesenchymal
profibrotic
myofibroblasts
cd163
co-expressed
stellate
chromosome-negative
sponge-like
reticular
faflag
iaiag
resistance-1
snp
c1236t
posttherapy
evaluator
objectivity
investigates
nonparametric
glomerular
filtration
egfr
crae
whichever
first-free
nu2009u2009360
nu2009u
non-tki
crae-free
nu2009u-h
urine
urinary
β2-microglobulin
nxaxa0at
nu2009u200965
nu2009u200974
second-
glomerulus
tubular
dyspoietic
neurotoxicity
nct00382954
tp15p15
prdm16
mel1
nup98-nsd1
mds1evi1
prdm16abl1
high-prdm16-expression
noncomplete
low-prdm16-expression
retino-choroiditis
acuity
vitreous
toxoplasma
gondii
anti-toxoplasma
igg
bcr-ablabl
co-trimoxazole
regressed
nu2009u2009790
nu2009u20091096
disease-
unrecognized
believing
bloods
bik
ccna1
fut4
il3ra
homer3
jag1
aldha1a
pelo
plxnc1
prune
serpinb9
trib2
rtpcr
over-expressed
normals
alox12
hs3st2
fzd9
subcategory
subcategories
nos
implicates
wnt5a
non-canonical
wntca2pathway
canonical
promoter-exon
aml-derived
15vs
61vs
non-methylated
gc-induced
intermediately
autotransplantation
matched-pair
co-morbidities
3u202fu202f7
cytarabin
20th
21st
paradigms
stagnant
concomitantly
trafficking
transitioned
compensatory
untargeted
cd11bcd18
inflamed
agonist
adh-503
repolarization
agonism
reprograms
bypasses
overwhelmed
english-speaking
perceptions
effectors
aldh1a1
jak3
nonobese
diabeticsevere
lics
sorafenib-resistant
conjugated
calicheamicin
perfusion
haemorrhage
gasto-intestinal
epistaxis
ocular
melting
mutkit17
mutkit8
48h
engager
constructs
cell-dependent
polyclonal
anti-cd19
blinatumomab
non-hodgkins
hemato-oncology
anti-epcam
anti-cea
anti-psma
pertinent
minimizing
idhmt
d-2-hydroxyglutarate
cross-sectionally
lower-
idh1mt
idh2mt
ancestral
illustrating
spectra
on-treatment
bcr-ablu
preferable
site-1
evi1high
evi1lowabsent
calcinosis
salts
multifactorial
pretibial
tibial
ulceration
debridements
split-thickness
nomogram
coxs
c-index
stratifications
c-indexes
eosinophil
low-
widened
cd133
postallogeneic
longitudinally
cellsl
unsupervised
a-d
lymphoidmyeloid
mantel-byar
benefitted
taa
taas
5-azac
ki67
ki67-negative
deceases
decease
m5a
m5b
family-derived
non-toxic
banked
germline
rs2736100c
choke
gfi-1
zinc-finger
panobinostat-resistance
heme
oxygenase-1ho-1
ho-1
gfi-1u202fhad
hdac2
hdac3
panobinostat-induced
znpp
eased
pi3k
reversed
pi3k-akt
microorganisms
tlrs
up-regulation
tlr2
tlr4
tlr9
monoblastic
allergic
complaining
shortness
x-ray
echocardiography
congestion
connective
mctd
raynaud
swollen
sclerodactyly
hypocomplementemia
anti-u1-rnp
tapered
diatheses
coincidence
inv16tp13q22
cooperates
bpr1j373
5-phenylthiazol-2-ylamine-pyriminide
proapoptotic
bak
caspase
kasumi-1
cell-cycle
kg-1
grafted
scid
c-kit-null
cos-1
plasmid
deserves
ther
©2016
epochal
myeloid-lineage
gene-rearranged
flt3d835mt
mll-td
copiesmicrogrna
cml-accelerated
open-label
cyrs
manageable
notch
multicellular
embryo
paraffin-embedded
notch-1
cytological
hyperexpression
preliminarily
clag-m
bridging
allo-hcts
injecting
ctas
testis-specific
aurkc
oip5
piwil2
taf7l
noticeably
gender-dependent
pcat18
bead-based
bio-plex
react
tgf-β3
mcp-1-each
corresponded
languished
genomes
non-parametric
rarity
illustrate
cross-complementing
xrcc3
thr241met
time-consuming
nu2009u2009155
nu2009u200983
bsc
nu2009u2009117
allo
didnt
proto-oncogene
mds1
mds1-evi1
mds1-evi
evi1-
belonged
-q-
frizzled-related
sfrp1
m1m2m3
well-differentiated
non-aggressive
gimema
wilm
gene-1
v-kit
creb
response-element
transductiontransplantation
xx-
co-activator
cbp
creb-driven
cbp-creb
governed
lymphoid-specific
rag
recombinase
-2
igh
contradictory
rag-1
tmn
tmds
nu2009u200928
taml
nu2009u200956
rasmapk
hijacking
middle-income
resembles
glivec
forthcoming
counteract
gene-positivity
gene-positive
n22
n19
guiding
pcnsl
invasiveness
kmt2d
cd79b
pim22
myd22
gna13
pu202fu202f05
pim1
backgroundmyeloid-derived
gbm
evaluatedmethodsa
0i
capecitabine
time-of-flight
cytometryresultseleven
escalating
armsconclusionslow-dose
microenvironmenttrial
nct02669173fundingthis
musella
bcured
nih
sontag
pendleton
miriam
sheldon
adelson
mylan
lam-003
prodrug
lam-003a
mv-
synergy
equipotent
inhibitor-resistant
f691
stromal-conditioned
genome-wide
crispr
kdm6a
3u2009u20097
inv
two-thirds
benign
tailor
hydroxyurealow-dose
haemato-oncology
rd-negative
-positive
ci-
95ci-
unregulated
occlusion
microvasculature
ophthalmic
neurologic
complained
calf
ambulatory
orthopedic
unrevealing
casualty
hemorrhages
fundoscopy
retrospect
2677gta
1236tt
1236c-2677g-3435c
endometrial
hormone-dependent
uridine
5-diphospho-glucuronosyltransferase
detoxify
exogenous
hormones
carcinogens
ugt2b17
ugt2b17-transfected
si-ugt2b17-transfected
ishikawa
cd34-positive
haemopoiesis
compensate
vasculogenesis
microcirculation
hypoxic
po2
hypoxia
fixing
two-
threefold
sdf-1
tgfβ
radiosensitivity
tregs
irradiated
radiation-induced
virotherapy
tumor‑selective
oncolytic
measles
gfp
converts
5‑fluorocytosine
5‑fluorouracil
cd46
profoundly
tumoricidal
oncolysis
combinatorial
site‑specifically
incurable
deplete
depleting
chronic-
dose-response
seventy-eight
ccgr
nct00510926
progressively
patient-tailored
mtorss
proteasome
tumorigenicity
hsp27
s100a4
prame-induced
analysing
shrna-silenced
micro-arrays
cancerogenesis
igfbp-2
impairments
non-completion
multi-dimensional
agedu
innsbruck
myeloidnk
mnkpl
cytochemically
mpo-
cd56cd3-cd7cd34
mnkl
mpodim
cd56cd16-cd3-cd33hla-dr-
yat-sen
l-asparaginase
seemingly
trmn
cand
stringent
bridged
preventive
intent-to-treat
and64
-20
hes1
lps
hes1-low
mir-9
g0
xenotransplant
mri
optic
neuritis
herpes
simplex
swab
hsv-related
deteriorated
infarct
leptomeningeal
regained
stains
complementary
aml1-eto⁺
cag
agust
effecacy
-43
10⁹l
-⁹l
-128
mobilized
clinal
ifis
southeastern
anti-fungal
ifi
all-category
candida
tropicalis
pathogen
insults
conceptualized
dameshek
nowell
hungerford
invariable
vainchenker
janus
activate
standpoint
wasserman
unites
tiziano
barbui
skillfully
jak
smns
one-hundred-and-eighty-nine
smn
intergroup
cps
mismatch
amenable
lifelong
lifespan
side-effects
cure-ie
instruct
bedside
rationally
straightforward
revolutionised
exploiting
coexpressed
analyzing
transcend
non-type
cr1-d
non-a
ldc
chaperone
nucleoli
preribosomes
centrosomes
arf-p53
behaves
normal-karyotype
karyoptype
flt3-itdmut
heterochromatin
antigenic
hp1alpha
-beta
di-
trimethylated
h3k9
eosinophils
monomethylated
dimethylated
hp1
q34q11
developmentally
biased
time-to-remission
advisable
donor-recipient
disparity
amid
non-hla
hscts
nu202fu202f872
nu202fu202f1553
hla-mismatched
pu202fu202f25
pu202fu202f46
cmv-positive
cmv-negative
muds
definite
80s
thirds
antibioticsantifungals
exceptionally
fludarabine--idarubicin
pathologist
devastating
signaling-2
socs2
6000-fold
untested
multistep
perturb
differentiation-arrested
intertwined
phenomena
bcr-abl1-independent
grb10
mitogenic
flt3-itd-mediated
flt3-ligand
stimulation
phospho-tyrosine
residues
grb10-flt3
oci-aml-5
baf3-flt3
fl-induced
p38
baf3-flt3-wt
baf3-flt3-itd
transduces
p85
semisolid
2nd-tki
disturbance
intracerebral
bone-marrow
aspiration
p15p15
nup98-hoxa9
hematoma
evacuation
spinal
npmc
amonafide-l-malate
amonafide
intercalator
treatment-failure
australasian
abmtrr-based
flumel
n166
n64
tremendously
neuropilin-1
nrp-1
subserosa
synchronous
pericolic
peculiarities
incidental
arose
conceivable
complementation
overlap-mutations
ckit
overlapped
irregular
cooperatively
distinguishable
voluntarily
withdrawn
bloodwise
aml18
principally
mitogenesis
permeability
valuexa0in
set-binding
hoxa-protein
schinzel-giedion
hoxa-pathway
i17q
attenuates
myb
significances
supportive-care
nopho-aml
aml-01
fab-m3
full-length
fab-m1
cebpa-mutated
cebpa-nonmutated
successes
moderate-intensity
agedor55
or15
anthracyclineara-c
ageor80
supportivepalliative
distinctions
delaying
near-normal
later-emerging
motivator
telomere
tl
intriguing
telomere-targeted
unknownwe
intergenic
hotairm1
ir-aml
orp
33-microrna
mir-196b
strengthened
33-mirna
myeloproliferation
proving
securing
breakthrough
theallele-specific
jak2-v617f
hrma
xa249
srsf2-mutated
prednisone
rapidity
superseding
inductions
macroglobulinemialymphoplasmacytic
lpl
myd88-mutated
del6q
myd88-unmutated
del13q
ighv
del11q
del17p
imposes
prohibitively
somatically
modifiers
holistic
practiced
injectable
cc-486
prolong
relapseprogression
nu202fu202f
nu202fu202f4
nu202fu202f19
postallograft
nct01835587
nadh
nd4
heteroplasmic
damaging
nd4wildtype
nd4mutated
npm1flt3-itd
cmin
cmr
sub-population
refractoryrelapsed
alpha4beta1
heterodimer
fibronectin
vcam-1
beta1
alpha4
migratory
oxygenase-1
dyscrasia
urological
protein-derived
peptide-based
vaccine-treated
vaccination-induced
azacytidine
olderunfit
co-encapsulation
high-risksaml
cyto-genetic
rs2454206
rs2454206aggg
rs2454206aa
4-hydroperoxycyclophosphamide
4-hc-purged
dropout
complicates
calibrated
plasma-kinetics
t8semi21
and÷or
ccaat
÷enhancer
dissection
aml-m3
tailor-made
pathobiology
initiate
lic
thirty-six
fishcd34cd38-
fluorescence-activated
facs-fish
non-invasive
quadrupole
differentiative
apa
dissimilar
dissimilarity
plsda
fingerprinting
ida
neurological
2-cdaida
disease-eradication
aml1eto
repetitive
cmt
b-lymphocyte
hg
u2009-u
sensitivities
s-phase-specific
eighty-seven
exceeding
aractp
pharmacodynamics
arac-based
illumina
non-treated
rs4694362
pbonferroni
slc29a1
rs3734703
tyms
rs2612100
divergence
caucasian
snp-snp
individualised
high-expressed
breg
secreting
multicolor
hds
medium-risk
isochromosome
17q
ringed
sideroblasts
erythropoietin
reverted
normalization
dispensable
humeral
non-leukaemia
e-box
zeb1
zeb2
epithelial-mesenchymal
zeb1-regulated
gsea
zeb1-bound
il8
elisa
secretory
dobd
discriminating
dobdu2009u20095
pu2009u20095
leukemianet-based
histomorphometric
trephine
hcru
1l2l3l
slc25a12
hyperleukocytic
exitus
intracranial
nct03128411
as-treated
sixty
phu2009and
2-sided
transformations
alanine
aminotransferase
aspartate
methionine
serine
taurine
abundances
receptor-positiveher2-negative
hrher2-
stil
mir-206
mir-206-overexpressing
harmonized
five-color
5xa0×xa
mrd1
leukemogenic
self-renewing
smc1a
single-cell
perturbation
syndecan-1
glycocalyx
serologic
eosinophilic
treatment-responses
reevaluate
2g-tki
rosai
dorfman
subtotal
myocardium
hypertrophic
cardiomyopathy
synovial
atrioventricular
infantile
fibrosarcoma
etiopathogenesis
nkg2d
nkg2dl
micab
ulbps
snkg2dl
aza-
dac-treated
nkg2d-nkg2dl
shedding
mica
micb
ulbp2
timp3
adam17
antibacterial
antiemetics
refractoriness
non-cytotoxic
afflict
supplanted
busulphan
recurring
rnai
crisprcas9
∼50
mll3
hspc
mll3-suppressed
validates
haploinsufficient
telomeres
flow-fish
leucocytes
pbl
t-cells
cpbp
fifty-five
sided
shortening
proband
-48
tad
pg36afs124
penetrance
categorization
ash2l
trithorax
h3k4
rppa
co-occurrence
amlm2
ael
redefined
non-erythroid
myelodyspalstic
nucleocytoplasmic
amlsg
double-induction
c-terminus
phenotypical
npm1-mutatedflt3
itd-negative
hla-compatible
subclass
young-adult
macrocytic
erythrocyte
corpuscular
mcv
flag-idarubicin
aml-r11
overexpressing
delineation
7q35
cntnap2
7q35-q36
culprit
gclac
centerfred
hutchinson
distress
extracorporeal
oxygenation
fostered
risk-categorization
risk-defining
supplemented
dynamically
counterbalance
nonetheless
genotype-
purely
epstein
barr
etiologic
infecting
ubiquitously
abundantly
breadth
-61
rtks
blinded
semi-quantitative
reaction-based
auer
rods
pathogeneses
proteincoding
tumor-normal
hiseq
bcorl1
smc3
rad21
transferrin
tf-conjugated
polyethylene
glycol
peg-poly-l-lysine
pll-polylactic-co-glycolic
plga
peg-pll-plga-based
micellar
edelfosine
micelles
nanosized
spherical
nanoformulations
eds-tm
g2m
eds-m
24h
nanoparticulate
bioavailability
worthwhile
eds-loaded
plwh
anti-retroviral
rivaling
hiv-negative
mutagenic
well-controlled
contraindication
standardize
workflows
formalin-fixed
archival
densities
papilloma
adenocarcinomas
neoadjuvant
gvax
mono-myelocytic
txa0cells
exhaustion
inxa0situ
pipelines
alpha-based
imifn-alpha
durability
pegifnalpha
longer-term
judged
non-intensive
organ-targeted
analogs
cross-expressing
lineage-associated
cross-expressed
cd13cd33
marker-cd7
marker-cd19
marker-cd2
cd2cd19
marker-cd56
cd56cd19
cd56cd2
ly
my-
ly-
concretely
bcr-abl1-dependent
-independent
jak2-dependent
relapsedtki-resistant
growth-promoting
pim-1
bim
stat5-silenced
bv173
pim
azd1208
antagonist
sabutoclax
stat5-regulated
diseasesignificance
demyelinating
dpn
dysphagia
hoarseness
weakness
conduction
ivig
re-initiation
manifest
clonally
invariably
tropism
hematogenous
hepatotoxicity
abnl17p
forty-seven
thrombohemorrhagic
reappraisal
delineating
aspirin
phlebotomy
cytostatic
cai
codon
allosteric
p21-activated
pak
rac
abrogates
rac1
rac2
guanine
gef
vav1
kit-bearing
vav
gefs
ehop-016
gtpases
patient-reported
dutch-belgian
hovon
german-austrian
unequally
sane
hctci
post-stem
subdividing
ir-i
intermediate-ii
ir-ii
rejection
laa
laas
t-cell-based
proteinase-3
hyaluronan-mediated
oligodenucleotides
iron-chelators
chelators
iron-chelating
deferoxamine
dfo
deferasirox
dfx
g1
ros
c-jun
jnk
h3k79me2
h3k27ac
h3k4me3
distal
monocyte-specific
tfs
co-regulators
collaborate
deregulate
leukocyte-antigen
hla-haploidentical
non-nk
killer-cell
nk-alloreactive
non-nk-alloreactive
ligand-matched
possessing
inv3q21qtq21q
tqq
a-c
non-3q
neutrophilic
dermatoses
aseptic
malignancy-associated
nod-like
pyrin
domain-containing-3
unacceptably
ameliorate
prosurvival
msk1
atf1
stat6
short-hairpin
nomo-1
myeloblast
starvation
knocked-down
mitogen-activated
mapkbp1
datasets
mapkbp1high
mapkbp1low
mycn
cdk6
ccnd2
thatsome
micrornasincluding
mir-155
anti-oncogenic
mir-148a
mir-193a
mapkbp1highis
unfavourably
hd-ara-c
nu2009u200923
nu2009u200922
mrd2
nct
nonsmall
remision
non-apl
mrd-thresholds
overcomes
rtc
outpatient
adenosine
obstacle
curing
morphogenic
bmp
spirit2
acv1c
inhba
smad7
snail1
smurf2
irreversible
bmp4
pluripotent
ipsc
alk
cml-ipscs
cml-ipsc
meso-endodermal
reliant
leukaemia-associated
infidelity
asynchronous
counselling
genotypic
fms
dna-methyltransferase
hsa-mir-146b
hsa-mir-181c
hsa-mir-4786
leave-one-out
has-mir-181c
kit-8
cck-8
3-microrna-based
mirnas--a
posttranscriptional
regulation--have
congruence
double-minute
dmin
homogeneously
myc
19q
11q
15q
17q12
haa
aclarubicin
synapse
fine-tuning
subverted
b7
cd276
b7-h3-positive
b7-family
merits
2idh2
leukemiaaml
cladribine-cytarabine
aml97
2-h
haematologic
inappetence
tachypnea
quantifiable
haematocrit
bicytopenia
chemotherapeutics
canine
guarded
harms
cochrane
inception
haematologyoncology
diseasesinusoidal
ratioxa0xa
5-aza
5-aza-induced
lasted
halving
cell-signaling
struma
ovarii
teratomas
follicular
papillary
ptc
coexisting
pv530i
ptcs
fibromatosis
microdissection-based
subtelomeric
locus-specific
probes
non-proliferating
rasa3
neglected
cks
kmt2a-r
kmt2a-mllt1
ell
mllt1
47xyder11tqpder16tppder19tqpder19t16pter→p19p→19qpp16p→16pter
16pp
19pp12
ldi-pcr
16p
rt-qpcr
4-
10-fold
t19
wt1mut
wt1mutflt3-itdpos
wt1mutflt3-itdneg
solute
slc2
c213
gcarg72pro
rs1042522
sex-
pcr-rflp
non-homogenous
youngers
tp53-gg
atp53
necrotic
forearm
scedosporium
apiospermum
casopfungin
nxa0xa080
nxa0xa0123
mr4
transformation-free
18-
susmr
behçets
aml-associated
steroid-dependent
ptpn11
hbf
leukemia-oriented
adjunct
or61
atra-arm
n122
standard-arm
n120
n31
atra-
atra-compared
anti-pd-1
pmn-mdscs
lox-1
nivolumab
pmn-mdsc
cell-to-lox-1
nmr
nmrs
inv3q21q26tq21q26
cn-amlcn-mds
inv3p24q26
tq26q11
der7tq26q21
evi1abl1
inv3p24q3
3q26evi1
nrip1
chondroitin
sulfate
proteoglycan-4
cspg4
membrane-bound
proteoglycan
hybridoma
cspg4-specific
reactivity
p62
sqstm1
ubiquitinated
cargos
autophagosomes
dysfunctional
mitochondria
superoxide
respiration
autophagy-dependent
mitophagy
midh2
possiblexa0but
bex1
flt3-itd-driven
pro-b
flt3-itd-dependent
flt3-itd-induced
wounds
cml-related
n1926
treatment-unrelated
unspecified
outweigh
radically
renders
tpa
quiescent
usefullness
clinically-defined
hypereosinophilic
hes
methylator
cimp
recruit
sh2
domain-containing
slap2
intact
prob
ubiquitination
differentiations
ckr
ckr-supported
g-csfcsf3
g-csf-induced
nfkb1
©2014
aspergillus
differentiating
sargramostim
bexarotene
bex
entinostat
response-evaluable
hi-n
dyspnea
nxa0xa01063
log-rank
trem1
ctgf
tca19
staging
boxxa0a1
foxa1
pcdna6‑myc
localize
paraffin‑embedded
403xa0patients
transferase‑mediated
dutp
nick‑end
ki‑67
cleaved
caspase‑polyxa0adp‑ribose
modulator
leukemia‑1
tran-scription‑3
lymphovascular
foxa1‑positive
foxa1‑negative
cd1d-restricted
invariant
nkt
inkt
cd1d-expressing
neutralization
tgf-beta
discordant
unravel
traditionally
tosedostat
aminopeptidase
s-transferases
isoenzymes
polymorphic
dna-reactive
electrophiles
metabolizer
t1
p1
bodys
leukemogens
clues
ireal-time
quantitatively
2-δδct
wt1-positive
cancer-promoting
purpuric
dermis
chemotherapy-related
pediatricians
demographics
efficacies
first-
chopfnd
prognosticate
evidence-base
durvalumab
igg1-k
urothelial
unresectable
olaparib
adp-ribose
mcrpc
gene-abelson
age-dependent
prpf4
histologies
14th
post-american
61st
topical
abl1-tyrosine
activin
traps
fibrous
deposition
metaplasia
osteosclerosis
megakaryoblastic
aml-m7
non-megakaryoblastic
sclerotic
bony
trabeculae
intervening
cd61
vwf
e-cadherin
triosomy
graft-anti-fibrosis
constituting
inadvertently
cnl
sm-ahn
myeloidlymphoid
pcm1-jak2
mln-eo
t-amlmds
beacoppescalated
beacopp
2u2009y
ric-allo
teratogenic
case-cohort
ceased
pre-
post-conception
conception
reestablished
interruption
resumption
cp-aml
minimized
accentuated
ap-
gemcitabine
gr-1
intraperitoneal
ifn-γ
gem-treated
cell-depleted
facilitated
rigorous
dc-based
vitro-generated
monocyte-derived
cd1c
nxa0xa0116
xa0d
stomatitis
hypokalaemia
crcrp
27xa0d
30-d
60-d
nct00607997
cell-cell
scarcity
confronting
ud-hsct
73xa0
12xa0
mutualistic
microenvironmental
ssgsea
lgals1
galectin-1
spectrums
predominate
gbms
remodels
ecm
integrins
β3
itgb3
alphavbeta3
αvβ3
cytogenetic-normal
co-culture
bmscs
insensitivity
mechanically
β-catenin
phosphatidylinositol
pi3kaktglycogen
synthase
gsk3β
αvβ3pi3kaktgsk3ββ-catenin
αvβ3β-catenin
cd96
nu2009u2009199
-247
-751
pre-emptive
alpha-interferon
treatment-free-survival
cytometry-based
exvitech
escalates
interruptions
beta2
microglobulin
beta2m
tumor-related
oscc
sti-571
bucy
octamer-binding
oct4
fifty-two
k-m
convincing
effectivity
mir-24
147xa0patients
100xa0healthy
trastuzumab
epidermal
her2-overexpressing
antibody-dependent
phagocytosis
adcp
adcc
hdaci
saha
hdaci-induced
trastuzumab-mediated
restrictive
i-bu
unpurged
reversible
-119
multi-step
cpu2029
tbi
well-matched
insulin-like
igfbp3
11qq23mll
3q7q-
p-
11pq23mll
lesion--the
22q-
surpassed
everyones
declining
allo-pbsctbmt
leukemia-free-survival
biochemistry
altalanine
astaspartate
alpalkaline
tbiltotal
tbil
or-
imatinib-sensitive
heralded
enhancer-binding
cross-linked
non-haematological
aml-m0
flt3-itdflt3-tkd
idh1idh8
runx9
n-rask-ras
asxl3
seventy-nine
p056
menin-mll
transcription-regulatory
governs
mll-r
subtoxic
chidamide
mi-3
co-exposure
chk1
chk2
atr
recombination
nhej
rnaseq
anti-leukemia
poor-prognostic
satisfying
karnofsky
pbsc
non-specific
thrombus
infiltrative
t2
hemochromatosis
subendocardial
mris
amyloidosis
loculated
rim-like
mrp1
caspase3
hypereosinophilia
thrombocytopenic
purpura
successively
telangiectasia
multisystem
degeneration
at-aml
minimise
dose-intensified
undecided
tsgs
tsg
intra-class
esr1
cdkn2bp15
igsf4
traits
neutrophillymphocyte
cancer-associated
fingerprints
estrogens
17ß-estradiol
erα
e2-esr1
amlmethods
regulationresults
fifty-three
estrogen-regulated
amlimpact
plausibility
epidemiol
aml-nos
blast-specific
segregated
diagnosable
atkd
yielding
ascertained
1-associated
tradd
fas-induced
maximally
accomplishments
on-targetoff-tumor
soon-to-open
suboptimally
deliberated
b-cells
tibs
intratumorally-produced
terra
incognita
unexplored
aca
vph
oca
crisprcas9-mediated
dihydroorotate
isobavachalcone
psoralea
corylifolia
enzymatic
isothermal
titration
calorimetry
adriamycin
intraoral
maxillary
gingiva
cd3-
cd10-
cd19-
cd20-
cd30-
cd56-
cd79a-
s100-
chloroacetate
esterase
fland
paralysis
misdiagnosis
lysine-specific
demethylase
1a
lsd1
kdm1a
histones
h3k4me
h3k9me
impedes
intricacy
predisposing
cyp1b1
alpk2
irf1
parp9
gradual
veterinarians
discern
devised
hematocrit
unilineal
multilineal
thwarted
cd135
cxcr4whim
wpss
assayed
male-to-female
-201
multifactor
cxcr4whim-mutated
myd88l265pcxcr4whim
myd88l265pcxcr4wt
hyper-viscosity
aleukaemic
blueberry
coloured
mucous
membranes
palms
soles
rubella
toxoplasmosis
reviewedchronic
gov
asthenia
edema
spite
weaker
lr-aml
cog
non-infection
ventricular
systolic
lvsd
precludes
unilineage
intestinal
hepcidin
factor-15
hemosiderosis
exacerbation
o3a
reevaluated
foxo3aβ-actin
semisynthetic
humanized
biphenotypic
stat3α
stat3β
truncated
dominant-negative
stat3α-independent
antitumorigenic
stat3βα
engineered
decelerated
pten-
mll-af9-dependent
tumor-intrinsic
up-
midst
in-hospital
wbp5
tceal9
understudied
unbiased
expressers
thatxa0patients
hoxa5
hoxa7
hoxa10
meis1
foxc1
ifntreme
tremelimumab
tlrgm
mart-1
gp100
tyrosinase
tlr-9
t-reg
cd4cd25hicd39
lowcd14
tlr-9gm
vaccinations
ctla4
ida-flag
cec
four-color
resting
rcec
acec
cepc
cecannv
undergoes
three-step
triphosphosphate
detoxification
exploited
nontransplant
re-treatment
pre-hsct
glutathione-s
nadphquinone
oxidoreductase
nqo1
detoxication
gstt1-
flamsa-ric
cams-2005
cams-2009
non-core
non-cbf
postautograft
inoculum
harvests
autografting
quantitated
abmt
normalised
p2000
level2000
n21
autografted
bcr-abl-specific
refractive
so-called
ab-directed
displace
withstand
objectively
nucleophosmin-1
dram
re-stratifying
redefining
consequent
lifesaving
cd157bst1
glycosylphosphatidylinositol-anchored
glycoprotein
evolutionary
dual-function
β-nad-metabolizing
ectoenzyme
adp-ribosyl
cyclases
cd157
delineated
physiological
diapedesis
affinity
heparin-binding
β1
β2-integrins
outside-in
epithelial
hyperdiploidy
segmental
18p
19p
l3mbtl4
reside
interpretations
jalsg
non-cebpa
inevitable
lybc
cml-lybc
leukaemia-specific
ikzf1
pax5
alal
bilineal
berlin-frankfürt-münster
cycd22
cycd79a
all-directed
fos
etv6-runx1
pakistani
q22q22
auto-hematopoietic
trans-plantation
uneasy
pnbs1
patm
γh2ax
descriptive
kaplan
meier
neutrophile
x109l
check-up
nxa0xa016
hid-sct
post-ap
apap-cpn
post-bp
bpbp-cpn
t315ixa0
cpap
post-hypomethylating
up-regulate
pd-l2
pd-1pd-l1
5-azacitidine
coping
outpatients
tkisu2029
cd105lo
cd105hi
monozygotic
her2-receptor
endocrine
tnbc
estrogen-
progesterone-
lacks
ge-based
probed
predisposed
fcm-based
jplsg
aml-d11
fcm
non-mc-lineage
kit-independent
pro-oncogenic
2cda
iemr
nu2009u2009446
nu2009u2009120
bmr
emrs
omacetaxine
accelerated-phase
tp11p13
hoxa11
ret
perp
gga2
explores
implicit
particularities
subdistribution
u2002
unreported
microrna-expression
hoxb4
tcfec
spi-1
hoxb4-positive
hoxb4-positivity
multidrug-resistance
distinguishes
f317l
understandings
cell-material
polymers
chiefly
orchestrates
dextran
c-dextran
polyethyleneimine
pei
tumouricidal
reactivating
4-mediated
re-polarize
polymer-based
metabolomics
glycogenic
udp-d-glucose
pervasively
glycogen
rate-limiting
gys1
glycolytic
glycogen-responsive
ampk
hyper-activation
gys
gbe1
branching
sustain
disrupts
tyrosine-protein
malignances
tq11q11
der20del20q11q13tq11q11
der21tq11q11
i20q-
20q
dataset
numericalstructural
postconsolidation
cd34kg
mobilizers
3xa0×xa
outlines
umin
r000014052
n136
n46
n8
germ
salient
ovid
-36
non-seminomatous
unclassified
platinum-based
leukemia-directed
glutamine-dependent
glutaminase
gls
cb-839
hyperpolarized
interrogating
interfered
citric
nadhnad
basal
capacities
ocr
glutamine
equivalents
fadh2
redox
catalyzed
pyruvatelactate
ner
ercc2-ercc8
rpa1-rpa3
lig1
rad23b
xpa
xpc
ercc5
499c-939a
non-ca
gdl
responsetreatment
eighty-four
-1794
ck-aml
ck-amls
tp53-altered
qamp11q
outweighing
profiled
supervised
chemotherapy-resistance
n85
mitoxantrone-etoposide
underscore
q11q22
risk-stratified
e2a-
pbx1
stark
trajectories
pan-tyrosine
multirefractory
nu2009u200913
nu2009u20095
nu2009u20091
seventeen
nu2009u200915
non-sct
melanogaster
vertebrate
vertebrates
invertebrates
tumor-tissue
biologists
hemato-oncologists
wingless
runt
syndromemds
decitabine-based
tq35p
co-existence
nup98-nsd1-positive
retrovirally
strain-dependent
co-expressing
flt3-signaling
latencies
underlines
allotransplants
-phase
nobel
ttagggn
capping
end-to-end
end-replication
repeats
erosion
telomerecentromere
tc-fish
fractionated
fgo
n13
n9
free-survival
problematic
unfitness
chronologic
palpable
cml-pertinent
demanded
peg-nlg-based
nanocarrier
peg2k-fmoc-nlg919
co-delivery
ido1
nlg919
paclitaxel
ptx
ptx-loaded
dual-functional
peg5k-fmoc-nlg2
co-load
multitarget
peg-nlg
ptx-mediated
peg5k-fmoc-nlg9192
bcor
advancedrefractory
pret
thioguanine
valproate
originality
cyp1aa
cyp3ab
cyp2eb
delgstt1
delgstm1
nqo
nqo1-negative
undeleted
methylcytosine
dioxygenase2
who-classified
microrna-155mir-155
late-stage
neutropenia2
pathogens
cd71ter119
epcs
growth-associated
accumulate
outnumbering
epc
epc-mediated
k562flt3-itd
runx3
luciferase
cd79a
cytcd79a
lineage-specific
mu-bmt
ms-bmt
rdw
low-rdw
high-rdw
n53
autograft
time-limited
reappears
chemotherapy-refractory
enestnext
nct01227577
substantiate
3-kinaseakt
thr
phenotyping
heavy-chain
ighv-m
receptor-associated
irak4
factor-κb
annexin
gelatinous
gbmt
adipose
atrophy
alcian
malnutrition
cachexia
reversibility
philadelphia-negative
therapeutic-mediated
mepesuccinate
treosulfan
chimaerism
nauseavomiting
anti-leukaemic
conveying
cytogenetical
daunorubicine
reevaluation
hyperstimulation
re-administration
intentionally
trail-r1
trail-r2
trail-r3
trail-r4
decoy
flow-cytometric
pro-apoptotic
down-modulation
manipulating
cd247
micro-
macro-environments
pro-cancer
milieu
advantageous
regiments
directing
-therapy
dastinib
n183
tki-therapy
tki-resistance
vegfa
-2578ca
rstc
rsgc
rs2010963
rs3025039
ccct
disequilibrium
ctg
acg
atc
novoacute
amlis
besylate
vnp40101m
sulfonylhydrazine
orr
real-life
ninety-three
orr-complete
hi-was
pre-aza
mf-0
mf-1
orphan
inaccessibility
socio-demographic
25xa0
81xa0
15xa0
g-csf-combined
protracted
formulate
tumor-resident
agonists
b16-ova
ovalbumin
odn1826
flank
b16-f10
intra-tumoral
cooperated
co-administered
systemically
uninjected
anti-ctla-4
9d9-igg2a
bi-lateral
acknowledging
tq24q22runx1-cbfa2t3
tp22q22runx1-usp42
emphasizes
sheds
deepening
torrent
barcoding
twenty-seven
noncleared
non-dnmt3a
fkhr
akt-pkb
phospho-fkhr
-either
6-
mdsmpns
cross-sectional
deep-sequencing
concordant
ras-family
pursued
requisite
modulators
host-related
mks
adipopenia
sarcopenic
non-sarcopenic
pu2009u20092
procoagulantproangiogenic
kdr
kappa-b
mekerk
nfkappab-binding
anti-tf
trended
proangiogenic
mechanism-based
transduction-related
cbfs
response-adapted
timed-sequential
conformation
synergic
physiopathology
supersede
mainstay
adequately
epidemiologically
colonization
m4eo
×l
cd64
distinctly
selectivity
late-phase
deficiencies
pids
equilibrative
ent1
mtor-dependent
chemoprotection
bmsc
samlsmds
n24
smds
n15
p04
p0018
p0005
realizing
patientphysician
plausibly
cd71
tfr-1
e13a2
e14a2
hasfords
nonlymphocytic
anll
age40
wbcxl
suppressionxl
g-group
inductionconsolidation
nct00801489
geratic
patients´
likelihood-based
4-ges
il2ra
npdc1
phgdh
quiescence
exploitable
crr
non‑elderly
cytarabinexa0a
daunorubicinxa0d‑based
dxa0xa0a‑based
81xa0patients
non‑m3
demethoxydaunorubicinxa0i
‑100
‑
xa0crr
observational
xa0vsxa
relapse‑free
poly-c
protein-1pcbp1
pcbp1
pcbp1in
idarubicin-based
skull
craniospinal
cautious
vigilance
hardest
1960s
instituted
experimenting
ara
c-based
adulthood
disrupt
symposia
vaccines
r882h
n49
statuses
npm7
2-os
2-dfs
n33
n48
appreciable
1980s
p210
culminated
gleevec
necessitated
chondrosarcomas
lna-modified
pr132c
pr132g
pr132h
pr132l
pr132s
pr140q
pr172k
biotinylated
barcoded
microbeads
phycoerythrin
streptavidin
fluorescent
luminexcorp
blood-derived
n87
flt3-lm
cytomorphological
who-classification
multimodal
burgeoning
harness
checkpoints
lymphocyte-associated
antigen-presenting
homing
nuanced
expands
bcrp
mrx
placenta
abc-p
abcg
subfamily
enforced
drug-sensitive
topotecan
taqman
imbalance
prooxidant
carbohydrate
pathologies
mellitus
dyslipidemia
negligible
parvovirus
b19
itsn
lymphoblast
scanty
discussedn
virological
infectionn
igm
diagnosedn
methodsn
duringn
linkedn
sera
5n
rbcs
plateletn
respectivelyn
withn
b2
pcrn
usedn
presencen
serological
requiredn
naive
ahr
aor
fragility
powerfull
325-fold
non-asian
noncompartmental
ninety-seven
tki-naïve
multi-tki
analytic
cd97
protein-coupled
gpcrs
cd97s
undifferentiated
credential
eighty-eight
factorcbf-aml
non-cbf-aml
early-death
χ410
χ508
χ812
χ682
χ606
χ471
dissect
mir-99a
non-lscs
agent-mediated
bioinformatic
e2f
venetoclax-based
decipher
mtorc1
overactivated
switch-off
glucose-independent
pentose
ppp
pro-survival
glucose-6-phosphate
pinpointed
6-aminonicotinamide
synergistically
sensitizes
centromere
extrachromosomal
recurrences
tobacco-related
trcs
bmi
idarubicin-containing
cytarabine-containing
recherche
respiratoire
réanimation
onco-hématologique
onco-hematological
girona
restraining
tadalafil
lowers
primes
cd8t
modulatory
pde5
nct02544880
mucin1
muc1
polyiclc
muc1polyiclc
pdl1macrophages
upregulate
pdl1
instauration
microscopic
myelodysplastic-myeloproliferative
clue
regionsto
hematopathology
ffpe
trephines
amplicon-based
-412
tet7
srsf5
asxl6
neoplasias
npm1mutant
exone
mlaa-34
dnmt3amut
dnmt3awt
flt3npm1cebpa
favorableintermediate
nu2009u2009262
nu2009u200946
pivot
tumor-initiating
iacs-010759
me-344
oxphos
imipridone
onc201
onc206
onc212
clpp
protease
complexities
seventy-two
interquartile
iqr
restart
progressions
selinexor
xpo1
localizes
rationalizing
cebpadouble-mut
cebpasingle-mut
high-performance
mutation-positive
mdsmpn-u
resemblance
cosegregation
cytogenetics-based
igp
anthracycline-free
bcr-abl1t315i
resistantintolerant
mcyr
-log
aoes
elective
exposure-adjusted
pretreated
nct01207440
fluctuations
laboratory-specific
reinforces
ng2
ng2-positive
ng2-negative
multicentric
philadelphia-positive
mpn-related
mrp
lrp
m0-m6
henan
sorafeinb
wbc9l
aza-dlis
benefitting
aza-dli
methylations
pan-leukemic
copies104
abelson
eighty
mrd-wt1
post-sct
post-allo-sct
preemptive
mbp
twenty-four
singly
harringtonine
ifn-alpha-based
phcml
hubu
cytogenesis
aml-patients
mutation-biased
mb-pcr
infers
-9
cdk4
microvessel
cytometer
n51
n52
n39
numberml
mastocytic
glomerulopathy
enlarges
proteinuria
mesangial
sclerosis
hypercellularity
microangiopathy
intracapillary
pdgf
aggregation
capillaries
resembling
midscs
tumor-draining
dye-reduction
time-points
arsenic-containing
qinghuang
qhp
initiates
b-myeloid
lymphomatous
transdifferentiation
intriguingly
coactivation
endows
bach2
cebpα
lymphoma-to-myeloid
gr1
stat1
indoleamine-pyrrole
-dioxygenase
inductionfunction
diminishing
b-raf
braf
v600e
v600e-wildtype
histiocytoses
p11
p13
moz-cbp
milestone
tki-treated
thexa0risks
pregnancy-specific
malefemale
oedema
vomiting
diarrhoea
rashes
weighed
60kg
tias
hemiparesis
bilaterally
anterior
posterior
subtraction
angiography
steno-occlusions
cerebrovascular
strokes
lef1
lef1-as1
n28
hela
lef1-independent
spectrometry-based
fumarase
fumarate
registry-based
allografted
hazrd
pu202fu202f010
pu202fu202f017
ud
myelotoxic
mds-acute
promoter-methylation
non-abnl17p
encompassed
nonremission
tyrosine-3
compassionate-use
sorafenib-induced
stat-5
spectral
-p-3q
-p-
21q
-1p
pan-flt3
resistance-conferring
toxa0investigate
residue
flt3-independent
co-occur
poor-responders
post-crenolanib
geneticepigenetic
protein-alpha
consistant
2gtki
1is
10is
microl
azacitdine
intermediates
mpo-positive
unsubstantiated
potassium
supplementation
nephrotoxicity
infusion-related
ifd
amb
deterioration
sirs
urogenital
steep
co-opt
hsc-related
eta
flt3-itdrunx1
cnsaml
achieves
typified
amlprofiler
skylinedx
technologies-cytogenetics
analysis-to
genechip
reagent
3000dx
v2
centralized
dap12
signal-regulatory
dap12-associating
lectin-1
cells-
-3
monocytesmacrophages
macrophage-specific
brc
relapse-predicting
preformed
rq-rt-pcr
simplicity
pconclusions
myeloiod
factor-related
apo2l
interacts
cognate
dr4
dr5
dcr1
dcr2
osteoprotegerin
opg
cancerous
intensely
cellular-flice
c-flip
avoids
down-regulation
trail-resistant
hopeful
phenylbutyrate
somnolencefatigue
correlative
reacetylation
h4
ahsct
kitmut
sall4
bmi-1
purified
declines
differentiationmaturation
nonacute
mutant-positive
su11248
ct53518
cep-710
multi-kinase
crenolinib
myriad
dsb
temozolomide
tmz
nown
riskn
decisionsn
retrospectiven
aga
khan
2016n
trypsin-giemsa
karyotypesn
nomenclature
iscn
resultsn
yieldedn
n176
ofn
n112
q22q12
includingn
favorablen
patho-morphologic
single-stranded
grb2-associated
binder
gab2
scaffold
receptor-
grb2
bcrabl-positive
cellsbone
gab2-positive
nuclearperinuclear
supplementary
npm1mamlpatients
npm1wt-aml
monocyte-associated
npm1mamlthese
inxa0chronic
one-half
multi-drug
mdr3
runt-
tk
tks
kit-d816v
wherein
mut
mpds
13q
erythrocytosis
thrombocytosis
strengthens
calrasxl1
nras-mutated
nrasmut
runx
u2af
sf3b
graft-versus-tumor
regimen-related
antigen-g
hla-g
hla-g-positive
hla-g-negative
cytolysis
multi-state
depleted
denoted
extracting
micellized
gynecological
asymptoma-tic
nitric
js-k
autophagy-related
swerdlow
4th
edn
lyon
erythroleukemia
prognosisthe
c-reactive
dermatologic
administering
thirty-five
comb-like
antigen-dr
asxl1-mutated
asxl1-wild
btmyeloid
ambiguity
all-like
multiple-drug
compromising
kinetic
a3
mage-a3
mage
multigene
mir-21
mir-26b
mir-451
regionv-abl
deepest
response-a
response-may
throughput
exomes
insertionsdeletions
aneuploidy
amplifications
cna
leukemiaremission
ru2009u
p11q22
pbc
stagehistological
pp65
antigenemia
anti-cmv
fifty-nine
serology
pp65-positive
pneumonitis
heterodimeric
cbf-encoding
cbf-amls
cols
cor
bbl
glucocorticoid-induced
tnfr-related
gitr
gitrl
tendentially
portends
tq21q23kmt2a-aff1t
q23pkmt2a-mllt1
tp22q23kmt2a-mllt3
tq35q23kmt2a-maml1
downward
circrnas
circhipk3
pbmc
loss-function
clonogenic
reflective
jam-c
endowed
jam-c-expressing
exacerbated
operationally
prefibrotic
blast-phase
variantsmutations
pipobroman
p32
triple-negative
sh2b3
meantime
rassf6
rcc
jnk-dependent
interactively
age-sex
xpd
2251ac
rs13181
postchemotherapy
4138ct
rs3092856
tpcg
etiological
bicepba
bicebpa
zf1
bicebpa-positive
cebpa-mediated
identifiers
nct01382147
perifosine
synergizes
paroxysmal
nocturnal
hemoglobinuria
interleukin-1
il-1alpha
initiationmaintenance
thymine
-889
il1a
transplant-outcome
c17
abns
optimal-dose
shrank
units-erythroids
bfu-es
non-ccr
non-increased
zeburaline
seventy-five
forty-eight
∼10
well-described
autosomal-dominant
runx1-fpd
fpdaml
∼44
leucegene
germline-mutated
parametric
dividends
dissecting
syndromempn
pdgfra-
pdgfrb-rearranged
eosinophilia-associated
fusion-driven
cel
nonspecific
undetermined
reclassifying
actionable
peroxiredoxin-6
prdx6
widening
n-terminally
swt1
fwt1
swt1-expressing
un-expressing
reinforcing
c-terminally
asxl1-mt
bap1
monoubiquitination
hyperactive
asxl1-mtbap1
runx1-eto-driven
hoxa
irf8
h2ak119
leukaemogenicity
asxl1-mt-expressing
hypocellularity
cumbersome
uncomfortable
facto
radotinib
iy5511hcl
phase-chronic
newly-occurring
imatibib
cml-pbm
thapsigargin
sarcoplasmicendoplasmic
ca2-atpase
serca
lithium
inositol
5-triphosphate
insp3
hematologist
score-matched
dacia
wasxa0independent
intermediate-high
linc00899
mir-328
pi3k-akt-mtor
pi3kmtor
aml-supporting
non-leukemic
mscs
runx1-mutated
runx1mut
n94
n323
⩾2
pegfilgrastim
philadelphia-
phenotype-driver
fibrotic
2-like
1-like
rux
intermediate-2
alleviates
prpf8
evolutionarily
conveyed
whole-rna
missplicing
prp8
experimentally
proof-reading
interpretable
m0m1m2
ml1
28ml2
favourableintermediate
survivin-positive
survivin-negative
likelihood-ratio
cxcl10
gender-matched
heampoitic
cbc
esr
leucocytic
basophile
less-intensive
unequivocally
contemporaneous
fingerprint
pan-hematopoietic
genome-scale
erg-expressing
ergpim1
underscored
codons
protooncogenes
nilotinib-like
cloning
pre-hospitalization
fungi
pre-chemotherapy
hygienic
provenprobable
cocaine
renovation
hospital-independent
nct01315925
re-classifications
exclusivity
correcting
bcl2l10
treatmentin
ipss-revised
endophthalmitis
efe
fusariosis
25-gauge
vitrectomy
antifungals
blurred
opacity
herpetic
retinitis
right-eye
ceftazidime
culturing
fusarium
solani
tractional
coherence
retina
fusarium-associated
hla-drlowneg
non-remission
wt-1
cd33highcd11b
e1a2
e19a2
endocan
thp‑1
hl‑60
knocked
g0g1‑phase
b‑cell
bcl2‑associated
adp‑ribose
factor‑κb
nf‑κb
inhibitorxa0α
iκbα
p‑iκbα
p‑p65
p65
dna‑binding
sanctuary
glycometabolic
fasting
ifg
massarray
calca
rarb
lasso
tertile
high-methylation
mcrc
m-mdsc
tem
multicolor-flow
sub-types
pet-2-positive
pet-2
ligand-mediated
serine339
cxcr4-s339
re-expression
lines-expressing
s339e
abrogate
s339a
cxcr4-s339e
cxcr4-s339a
amd3100-induced
nonintensive
lengthy
high-dimensional
idiosyncrasy
bottlenecks
embedding
cell-level
accuracies
fractionated-dose
psr
materially
clinical-laboratory
clinical-hematologic
-14
intakes
non-systemic
inexplicable
tpq
12p
bac
contig
prdm3
myelodysplatic
intron
evi
thada
zfp36l2
proximity
juxtaposition
tinv16
validating
bad-prognosis
bcr-abl-positive
cml-studies
ifnhu
ifn-treated
age-adjusted
bucy2
ida-bucy2
-4
gm2d
elevate
dysmegakaryopoiesis
5-hydroxymethylcytosine
5hmc
tet2mut
idh1mut
idh2mut
log5hmc
sub-classified
tertiles
tcc
moffitt
mcc
ihc
nu202fu202f51
nu202fu202f84
oncogenesis
lacked
flt3itd-r
flt3wtwt
flt3itdwt
flt3itd-
cd147
ac-73
arabinosylcytosine
erkstat3
anti-proliferative
ara-c-induced
ato-induced
cd371
inducer
dual-specificity
dusp5p1
ibiia
nct00850382
hypoplastic
pleuralpericardial
°
cid
eighty-nine
nu2009u200937
edhd
95-ci
confirmatory
nct02013648
flt3-itd-mutated
dormancy
fast-growth
osteosarcoma
liposarcoma
dormancy-associated
dmirs
prevailing
mir-580
dmir
mir-
over-expressing
mir190
dmir-
pro-angiogenic
timp-3
tgfalpha
bv8
epha5
angiomotin
matrix-assisted
ionization
rs2293157
pathophysiological
cg-rich
cpgs
nu2009u2009196
maldi-tof
non-polycomb
pcg
underlay
urd-hsct
preconditioning
irradiationcyclophosphamide
cyclosporin
implantation
-19
i-ii
long-time
formulary
foetus
non-randomised
eukaryotes
mirna-directed
interlaboratory
lineage-assignment
mpal-associated
3xa0gm2
1xa0gm2
nct00820976
s100a8
esophagus
ovary
lymphoblasts
xa
myag
topological
gene-regulator
inferred
pairwise
alleviate
perturbed
epigenomic
analyzes
-line
ponatinibs
benefit-risk
treatment-associated
cardiologists
snp-as
copy-neutral
snp-a
diagnosisprognosis
mcsnp-a
mdsmyeloproliferative
normalnoninformative
snp-a-detected
alphainterferon
á-ifn
neuro-psychiatric
á
-interferon
aza-treated
r-ipss
p-4
ieu
tumor-derived
il-1beta
redirection
response-supporting
il-1ri
il-1ricomp
il-1ri-deficient
il-1ri--
cdna-transformed
salmonella
typhimurium
sl-il-1alpha
lysates
methycholanthrene-induced
il-1comp
il-1--
il-1alphabeta--
il-1alphacomp
overridden
anti-cd25
coped
il-1alphabetacomp
il-1alpha--betacomp
interfere
expansionactivation
preferential
kiaa0125
gse12417
heterozygozity
snp-array
complemented
nu2009u200944
nu2009u2009208
next-generation-sequencing
amalgam
technologic
avenues
2g-tkis
ccyrs
sixty-two
ccyr-survival
c-ccyrs
bcr-abl1abl1
case-matched
allotransplant
gratwohl
cp2
parenteral
donor-male
mismatching
interferon-alpha-2b
intron-a
schering
plough
histomorphological
normalreactive
cd33-cd15-
cd33cd15-
cd33cd15
cd33-cd15
shortest
youngest
renewing
permeabilization
aif
anti-apoptosis
baxbcl-2
oblimersen
apoptosome
apaf-1
elucidation
lays
hoxb-as3
hoxb
confounding
propensity-score
uu2009
u2009
catheter-related
cmins
cgp74588
chromatographymass
quartile
myalgia
nct00333840
sfg-retroviral-vector
anti-cd123car
anti-cd33car
cd123-low-expressing
cd123-specific
low-expressing
eml
sarcoma-ms
preleukemias
disease-modifying
microrna-340
mir-340
underexpressed
non-apl-aml
flt3-itds
reinforced
alfa-9000
post-relapse
intensify
underrepresented
illnesses
polypharmacy
extra-hematological
procaspase-8
p170
gp-p
mdr-1
mdr-1gp-p170
non-favorable
mdr-1-group
d816
d816a
bcc
jichi
repeated-measures
paraneoplastic
leukemoid
conventionally
long-recognized
questionable
east-asia
insufficiently
cancer-free
kaposi
bcsc-related
cfdna
histocompatible
imperfect
arisen
complete-responders
frount
frount-deficiency
anti-alcoholism
dsf
interferes
frount-chemokine
receptor-binding
macrophage-targeted
diagnosesacute
drugsacute
drs
keating
willman
goldstone
avivi
giles
kantarjian
armand
irit
cheryl
hagop
imatinib-resistant-intolerant
dasision
accelerated-
superficial
nct00481247
microrna-34b
coli
recombination-dna-double-stand
hr-dna-dsb
complementing
rad51c
reaction-restriction
g135c
clarifies
leukemia-chronic
umrd
n150
non-sense
indel
cebpamut
tpml-rara
asxl1mut
idh2r7
idh1r9
antioncogene
subdural
aneurysm
arteriovenous
malformation
left-sided
paresthesias
non-traumatic
deficits
evacuated
pd1pdl1
lintuzumab
pyrrolobenzodiazepine
maytansine
sgn
33a
anti-123
sl-401
anti-cd56
lorvotuzumab
mertansine
radioactive
131i
213bi
225ac-labeled
proximity-induced
cd33cd3
ipilimumab
pd1pd-l1
unleashing
npm9
pu202fu202f001
pu202fu202f046
overcame
tlsfus-erg
vacuolation
numbered
coefficient
r174q
9q34
22q
5-abl
3-bcr
8p
2q
-×l
mllaf
mllell
mllsetp6
werent
non-received
prr
mllaf9
polo-like
serinethreonine
plk
antimetabolite
lam4
myelogram
medullary
myeloblatespromyelocytes
fagots
pathognomonic
questioned
objectify
cytologically
cht
kda
b2a2
b3a2
n451
n496
n158
identifier00055874
thirst
polyposia
polyuria
myeloperoxidase-positive
inv3q21q
hyposthenuria
anti-diuretic
adh
hyperintensity
neurohypophysis
t1-weighted
insipidus
desmopressin
n134
alogeneic
autonomous
thymidine
m-csf
thrice
forty-six
nu202fu202f36
nu202fu202f10
all-grade
nct01242774
eudract
-42
noxious
stimuli
bcl
rs2279115
rs1801018
-938
blc2
bcl-2-mediated
2hg
poliovirus
receptor-related
nectin-adhesion
junctions
prr1
prr2
facs-analysis
phycoerythrin-labeled
r12
r1
fluorescein
gated
cut-off-values
qui-square
fab-type
prr-status
metabolisms
picc-related
cicc
3-y
3-mo
interventional
tigecycline
noncancer
revisit
mds-eb2
hraml
haplo-sct
firstsecond
ptcy-based
oslfs
hla-matchedhaplo-sct
non-relapse-mortality
gvhd-free
cgrfs
pxa0u
hypoglycemia
quadrants
dislocated
suspicion
parasitis
interleukin-
androgen
adt
portended
leveraging
chaarted
adtu2009-u2009docetaxel
hormone-sensitive
mhspc
localizations
anecdotal
m1-m7
liver-enriched
microrna-122
mir-122
29xa0
concentrates
culture-proven
azole-resistant
fumigatus
posaconazole
trl98h
cyp51a
spp
moulds
pharmacogenomics
papillomavirus
hpv16-slps
hpv16-induced
premalignant
hpv16-positive
hpv16-slp
carboplatin
hpv16
e6e7-positive
tc-1
tc-1-bearing
chemotherapy-mediated
carboplatin-paclitaxel
hpv16-specific
fosters
vigorous
vaccine-induced
branded
imatib
reintroduction
novartis
cml-study
five-arm
im400
im800
run-in
nct00055874
rtw
sick-listed
anxiolytics
antidepressants
genders
gocyt
go-based
outset
homeodomain
hoxb3
b4
myst3
crebbp
fuels
monophosphate-activated
bioenergetics
epigenome
acetyl-coenzyme
coa
displacing
drug-drug
ddi
flt3-tkd-itdmut-acute
cyp3a4-related
neglecting
live-saving
inhere
foreseeable
spms
spm
st-elevation
stemi
thrombolytic
emergently
antiplatelet
anticoagulation
contraindicated
ecchymosis
gingival
catheterization
english-language
drug-eluting
stent
approach--balloon
angioplasty
bare-metal
stents--might
frail
emergent
gm-csf-ralpha
solgm-ralpha
aml-m43
cd116
multi-institutional
core-binding-factor
t-cbf-aml
flt8
tet9
asxl9
bcrabl1
witnessed
multiple-treatments
cd122
granulocytemacrophageal
gm-
colonies
semi-solid
agar
pertain
hemorheology
cultivated
rheological
granulocytesmacrophages
therapeutical
5th
segregate
prescribing
cibmtr
2nd-generation
reductionsinterruptions
cla-ida
lam-
-87m
-92
associazione
italiana
ematologia
oncologia
pediatrica
aieop
lam92
lam-87
87m
postremissional
ever-increasing
lam-92
lam-2002
stratifies
kir-hla
non-t-depleted
campinas
n37
n27
n18
kir2ds2
eurocare
pe355g
pg398r
bcr-
similarity
treatment-resistant
fv
phage
broadly
reacted
c-type
lectin-like
cll-1
undescribed
anti-cll-1
cd34cd33-
cd34cd38
tp12q23
mllt10
10p12
farnesoid
fxr
gallbladder
gbc
qualitatively
biomedical
waldenströms
∶1
isswm
pconclusion
mcf
laip
4-color
release-free
consolidate
multi-parameter
moderate-risk
mll-ell
mll-af10
mll-af17
mll-af6
mll-enl
mll-af1q
mll-cbp
mll-af1p
mll-afx1
mll-afx23
economical
risk-score
n95
7xa0
6xa0
flt3-itdpos
unsuitable
u2009m-u2009m
cd65s
disappears
sialylated
cd65slow
morphologically
m0m1
p55
cd65shigh
orchestrators
anamnestic
attribution
multi-lineage
reiterated
mfc-based
ips-related
tn-aml
ips0
censoring
infancy
denominator
nf1
hypersensivity
granulo-macrophagic
macrophagic
multisystemic
noonan
neurofibromatosis
rasopathies
splenomagaly
palor
adenopathy
endogeneous
thrombopenia
foetal
recapitulates
rgs10
fam26f
ecmo
oxygenator
mpn-restricted
receptorjak2
leukemialymphomas
five-category
icr-aml
evi0
27-hydroxycholesterol
27hc
ers
lxrs
cyp27a1
cyp7b1
catabolism
lxr-dependent
id8
cyp27a1--
conceptualize
agap2-as1
ril-2
ril-2-activated
lenaza
cytarabineidarubicin
-1
pre-planned
nct01132586
s0106
riz1
retinoblastoma
rb-interacting
proline
insertion-deletion
pro-704
as-pcr
pro704
insdel
ins-ins
del-del
ins-del
thrombocytopia
shanxi
meltinghrmand
polymorphismsnpand
amlp
gaaa
chemotherapyp
groupp
significantpbetween
higherhr
acot
participates
awt1
n-terminal-truncated
anthracycline-arac
pu200au200a
wtth
agexa0xa08xa0gdl
cellxa09
agexa09
low-riskno
pxa0xapxa0xa
multiagent
viridans
streptococci
vgs
ics
decontamination
dose-effect
better-tolerated
d25-d3
vd3
vdas
potently
exxa0vivo
supraphysiologic
hypercalcemia
-d3
-d3s
roadblocks
non-ael
mutatedrearranged
nup98
hoxb9
rb1
ntrk1
trk
n373
n688
purged
n217
withdrew
n186
reserving
abrogation
axl-fc
relieves
inductionre-induction
carboplatin-topotecan
alvocidib
flavopiridol
flam
sirolimus
s-mec
powerfully
cell-lines
chemo-sensitive
chemo-resistant
phospho-p38
phospho-jnk
phospho-bad
il-beta
representes
non-responsive
aza-resistant
skm1-r
structurally
speculated
chromothripsis
catastrophic
aml2003
non-core-binding-factor
abnormality17p
g34a
c421a
abcb
ttataa
c1236g2677c3435
diplotype
a34a421
abcbgta
nst
leukemiaal
hla-a0201
correspondingly
t-lymphocyte
high-avidity
pcg-specific
ctls
ctl-positive
elucidating
hdac8
foxo1-
foxo3-mediated
transactivation
deacetylates
reactivates
tki-mediated
22d
kinase-activating
mutation-harboring
myelogeneous
pathogenetically
durations
aforementioned
bmn
cortical
overproliferation
open-access
pfkfb4
u937xa0cells
gene-editing
e2f6
fuses
8p11
16p13
myst3-cbp
retroviral
mutagenesis
integrations
distantly
proto-oncogenes
eph
a4
gus
ephb2
ephb4
ifn-β
ifn-λ
il-4
il-13
cell-cytokine-specific
deconvolute
tuberculosis
ifn-β-specific
il-4il-13
opposing
hif-1α
2-methoxyestradiol
2me2
glut1
2me2-induced
supression
pbfc
discrepancies
atra-combined
itd-
single-gene
clarifying
ultra-deep-sequencing
uds
cn-
childhood-onset
t11q
16q
noteworthy
saglio
amp-cml
amplificationhybridization
assaytmahpamethodwas
wished
ifn-adue
ifn-a
administrating
receptor-engineered
reminded
inhibitorsxa0tkis
succeeded
altering
proviral
virus‑1
pim‑1
smi‑4a
imatinib‑resistant
k562g
wst‑8
annexinxa0v‑propidium
iodide
dose‑
time‑dependent
hoechst
p‑ser9‑glycogen
gsk
3βpgsk3β
β‑catenin
polyadp‑ribose
polymerase‑1
bcl‑2
proto‑oncogene
fortunately
biotechnical
disease-driven
justified
insertions
flt3-itdbp
flt3-itdneg
60bp
medium-sized
cci
ecog2
cci2
reduced-intensive
r-ic
allocating
mimics
metachronous
ighbcl2
difficult-to-characterize
histiocyticmonocytic
disease-specificdisease-associated
pbp
expression-proteomics
two-dimensional
2-de
label-free
lc-msms
followed-up
sixty-four
discriminates
tam
personalized-medicine-model
propagate
deepen
42-gene
multi-gene
resides
ptcy
flt3-itdflt3
npm1wt
microbiological
orchestrating
cytokinesis
mitotic
aurora-a
barasertib-hqpa
aurora-b
extremes
vague
overviewed
adolescent-oriented
escorting
taiwanese
intolerable
interrupting
discontinuing
disease-initiating
cxcr2
il8-cxcr2
g0g1
cell-enriched
sphingosine-1-phosphate
s1pr1
transcription-3
transwell
crlm
p-stat3
carboxyfluorescein
succinimidyl
cfse
s1pr1-stat3
cd14hla-dr-low
s1pr1-stat3-il-6-mdscs
premetastatic
organ-specific
metalloproteinase
membrane-anchored
mzf1
mirna-p
mir-p
nascent
repressed
argonaute
mzf1-facilitated
under-expressed
repress
mzf1-facilitatd
svm
classifier
gse62254
gse26253
omnibus
non‑recurrent
caret
e1071
penalized
constructing
recurrence‑free
a‑kinase
anchoring
angiopoietin‑like
cysteine‑rich
mixed‑lineage
translocated
neuron
neurobeachin
nephroblastoma
pleiotrophin
high‑risk
10‑gene
1-hour
2-hour
flushing
headaches
myelosuppression-related
nopho
viaxa0production
r-2-hydroxyglutarate
dsxa0has
anecdotally
touches
steadily
pre-clinically
patient-based
multicolour
laips
entail
driftshift
haematologist
mrd-guided
dnam
pyrosequencing
epimutations
homeobox
analogy
let-7a-3
fabwho
idh1idh2
nk-ras
d816y
kd
izmir
ataturk
chi-square
criterias
tki-mutation
flang
prompts
53rd
convened
post-ash
estancia
jolla
provisionally
approximated
sm-mpn
sm-mds
with-acute
cebpa-dm
cytofluorimetric
nonhematological
hypophosphatemia
non-targeted
metabolomic
ultra-high
performance-liquid-chromatography-mass
mapped
cysteinemethionine
tryptophan
carnitine
oxidation
lysophospholipid
∼40
attendant
medico-legal
abyss
dominate
dialysis
cirrhosis
reigns
withholding
subspecialty
dermatologists
cd26
cd26-
robustly
non-clonal
cd178
fasapo-1
cd137
cd137l
scd178
scd137l
higherlower
nhl-patients
m1m470
bm-blasts
monocytoid
m4m
jsph
histiocytosis
b-precursor
lymphoblastic-b-precursor
langerhans
itdve
quantitative-pcr
npm1veflt3
itd-ve
re-classified
low-allelic
eradicated
tasigna
cxca
triple-color
confocal
microscopy
intraepithelial
cd14cd33-cd163-
matured
t-celltreg
heatmap
reinforcement
mir-29b
methyltransferases
escalated
bortezomib-related
bortezomib-induced
sp1
sp1nf-κb
transactivated
cures
characterizing
influenza
off-label
hand-foot
pml-retinoic
receptor-alpha
rara
amsacrine-based
delicate
epirubicin
ewing
manifesting
irreversibly
congestive
15-fold
risk-reducing
noncardiotoxic
contemplated
mcrs
non-low
bx
kir3ds1kir3dl1
presenthla-bw4
sirpα
semi-quantitatively
non-cml
xa050
verge
reinstitution
oncoproteins
cml-202
cml-203
responseimprovement
abstractobjective
cnsl
siginificant
long-range
ptd
cd11
convictions
skeleton
mrd-targeting
mrd-independent
cmdcs
biogenic
amine
between-group
pyrexia
luminal
lgc
-2008
-2016
pu2009pu200950
dek-can
p23
q34
weakened
predication
spurred
pan-target
on-
rationalize
prioritize
on-target
likelyexperimental
simulationsresults
traced
mutationsconclusions
pan-inhibition
msc
aml-msc
n106
n71
constellations
relapserefractory
osteogenic
p53p21
β-galactosidase
galectin-3
dyskeratosis
congenita
dkc
paradigmatic
late-onset
daurismo
pfizer
glasdegibldac
one-sided
dysgeusia
embryo-fetal
moderate-to-severe
approvalsee
fathi
analogous
cxc
cxcr-4
factor-1
sdf-1-induced
chemotaxis
flt3internal
flt3wild-type
subordinate
g-csf-r-expressing
32d
sdf-1cxcr-4
succumbing
unparalleled
certainty
instigation
myelo-monocytic
fus1
mir-378
non-m3-aml
shifted
rests
hct-related
deciding
flt3-tid
npm-1
cebp-α
hct-specific
etoaml1
mir-142
epitome
ehlrichs
promyelocyte
del7p
s34
q157
erythroblast
transformation-specific
ses
tax-supported
individual-level
low-education
high-education
three-color
aspirates
mrd-negative
epigenetics
dnmts
dioxygenases
tets
catastrophe
stressful
cytostatics
calgb
itc
ihdac
sensitively
cbf-positive
chemotherapy-sensitive
supralethal
alkylator
msds
anti-t-cell
pmlrarα
cbfβmyh11
ethnogeographic
coronary
unsuspected
nondeleted
risk-directed
chemotherapyautologous-hsct
chemotherapyauto-hsct
mrd-directed
chictr-och-12002406
csf1r
icis
pd-1ctla-4
pd-l2ctla-4
tgca
pd-1pd-l1pd-l2
pd-1lag-3
jiansu
hansoh
xinwei
n89
n56
prdmp36
tp36q21
1p36
rpnq21
over-representation
n421
n189
non-complexnon-rare
medians
seventy-six
capillary
delta-pcr
triple-primer
burdens
glyceraldehyde
3-phosphate
logrank
wt1-positivity
1-log
logarithmic
hla-e
nk-alloreactivity
incompatibility
hla-e-mediated
notwithstanding
confirmational
kermanshah
classification-based
haplo
factor-c
vegf-c
aml-cells
vegf-cvegfr-3
vegf-cvegfr-3-pathway
pcm
patchy
pcm-associated
cig-fish
cig-fish-negative
preparations
rearrangement-associated
ubiquitin-like
uhrf2
compares
paralleling
mislocalized
positioned
optimistic
serine-phosphorylated
k-ras-dependent
s727
y705
abrogating
cytokine-independent
mitochondrially
stat3-y705f
transcriptionally
inert
k-ras-mutant
stat3-s727
rehospitalization
distinctively
discordance
ocfosfate
hydrate
physiologic
neutrophilia
csf3r
t618i
csf-r
co-operative
necessitate
pharmacokineticpharmacodynamic
bcl-x
amlthe
bcl-xs
galectin
lgals3
catenin
sclerosing
mistaken
nonchronic
pejorative
paraffin
anaplastic
todelineate
substituted
non-branded
dnmt3a-mutated
dnmt3a-wild-type
cmlbc
bolus
tete
pancytopenic
gwass
descent
takotsubo
abrupt
apical
midventricular
hypo-akinesia
hypercontractility
ami
retreatment
ber
corrects
oxidatively
s326c
mutyh
q324h
ape1
d148e
r194w
r399q
ninety-four
oru2009u
ciu2009u-
group-american
radiology
e1900
nct00049517
aflt3-itd
24dnmt3a24
musashi2numb
msi2
risk1
followup
mpp1
pdz-domain-containing
abcc4
replate
methylcellulose
crucially
pdz-binding
chemically
mpp1-dependent
replating
antimycin
abcc4-mpp1
hsp
stress-induced
hsp70hsp90
aml-stabilizing
theophyllin
il-1
il-1ra
serum-cytokine
hsp70hsp90il-1rahgf
plethora
inheritance
q-pcr
pltconclusions
1-mutated
npm1m
hotair
hairpin
yes-associated
yap1
tensin
pten
crc-derived
p-akt
p-p65
pro-tumorigenic
disease-associated
myelocytic
robo4
hereinto
sti
chanced
favorably
il-6r
streptococcal
vsss
6xa0mo
13xa0y
preponderance
mf-
3xa
58xa0
5xa0
non-adherent
80xa0
arginase-1
spearmans
rho
cryopreservation
flowcytometric
aldh1
csc-like
ph-chromosome
polymerase-1
parp-1
expansions
npm1-mut
mutation-negative
stretches
20mb
substitutions
linker
pis
abl-kinase
p210bcr-abl
exponentially
elacytarabine
elaidic
hent1
elacytarabine-idarubicin
aml-nk
midostaurinu2009u2009cytarabineu2009u2009daunorubicin
placebou2009u2009cytarabineu2009u2009daunorubicin
third-party
payer
ebc
characteristically
5q-mds
5q-patient
expectation
obd
maximum-tolerated
misexpression
self-renew
methlylguanine
inactivate
permitting
sensitization
harnessed
metallothionein
mt2a
mt2a-nf-κb
gbm-mediated
gbm-derived
uninvolved
mc-deficiency
vitro-
kit-targeting
scf-induced
ic01
µm
imatinib-therapy
mc-development
serostatus
cmv-seronegative
seronegativity
donorrecipient
tils
inconclusive
cd45cd11b
hla-dr-
amlcg99
aul
bona
fide
queried
competing-risks
wntβ-catenin
ctnnb1
pu202fhigh
ctnnb1low
ctnnb1high
debilitating
ducb
-21
cgvhd-lfs
cetlam
outcome-related
mir-644
mir-135a
genesmutations
leukemia-not
micromegakaryocytes
hypogranulated
acrylate-embedded
histopathological
re-emerging
egf-r
adam17-mediated
proteolytic
il-6--
sgp130fc
egf-r-mediated
β-catenin-dependent
treatable
pre-cbt
broad-spectrum
cathepsin
ctsl
endolysosomal
cysteine
expressionactivity
pbmcs
fak
cd-
culture-initiating
upregulates
frizzled-4
phosphorylates
pyk2
wnt5afrizzled-4lrp5
endocytosis
wnt3a-controlled
wnt5a-controlled
eradicates
sub-continent
overgrowth
rpb1
polr2a
runx2
cdc25a
amlexperimental
aaml0531results
flt3alm
wes
asxl2
intratumoural
heterogeneities
asxl1asxl2
bcorbcorl1
tfr-that
response-is
tallied
55xa0
voltage-gated
heag1
kv
dexrazoxane
cardioprotective
cardioprotection
accumulative
cumulated
cardioprotectant
asseveration
daratumumab
fc-dependent
complement-dependent
cdc
ectoenzymatic
host-anti-tumor
cd55
cd59
antibody-induced
cd38-based
thromboembolic
aaml0531
ccg2961
omni
copy-number
ascat
gistic
reoccurring
nct01407757
nct00070174
nct00003790
embryonic
angiogenesis-related
angiopoietin
δ-like
dll4
notch1
vegfr-1
ang-1
tie2
mobilize
breakthroughs
interrogation
sitc
reconvened
resected
caspase-8
procasepase-8
p10
incapable
dimer
l491
f493
interdimer
dimerization
mpn-associated
ageing
phbcr-abl1-positive
life-long
sex-matched
harmonization
pharmacoeconomy
reimbursability
monitorization
tki-class
kit-positive
kit-signalling
pdfgra
intestine
tightly
withxa
networkeuropean
nccneln
claims-based
incur
hospitalizations
physician-perceived
familiarity
guideline
adoptions
multifaceted
dysmyelopoiesis
intracytoplasmic
basophilic
granules
cd31
non-clinical
carer
preselection
misleading
overly
higly
unrandomised
unrealistic
p-aml
preterm
full-term
deliveries
balancing
hidac-based
nonanthracycline
characterizations
reassess
smad
factor-β
smad3
smad6
low-expression
lss
reconstituting
lsss
decision-analytic
extrapolate
rkip
ras-mitogen-activated
kinaseextracellular
signal-regulated
uni-
nad-dependent
usp22
deubiquitinase
c-myc-related
persists
mucin
cd10⁺
factor-β1
tgf-β1
fronts
muc2
muc4
muc5ac
stained
pan-cytokeratin
cd227
chemoattractant
anthelminthic
ivermectin
dysfunctions
nbm
cd34u202fcells
nac
rescues
ivermectins
repurpose
bal
antibodys
mcab
lymohocyte
pcns-dlbcl
fifty-four
homozygoushemizygous
y196
azd2171
cediranib
flt-1
cediranibs
accrual
dehydration
srcabl1
nct00261846
im-resistant
im-r
nxa0xa0196im-intolerant
im-i
nxa0xa090
-81
progressiondeath
-94
attainedmaintained
bosutinib-sensitive
liver-related
im-rim-i
dehydrogenease
inﬂuenced
amlmdsmethods
sequencingresults
co-mutated
co-mutational
runx1-mutatedaml
u2af8
ahec
nciccc
buckthorn
hippophae
rhamnoides
berries
canina
rosehips
salvia
officinalis
oregano
origanum
vulgare
water-ethanol
potentiated
hormonal
type-dependent
peroxidation
erythrocytes
hypoosmotic
p14arf
hdm-2
p53-targeting
prima-1
75th
uterine
upsc
malignanciestype
hma-treated
relapsedeath
zhengzhou
mrd-
χ58
consolidatory
χ11
npv
coefficients
abn11q23
hla-dr-negativity
cd34-negativity
hla-dr-positivecd34-negative
hla-dr-positive
hla-dr-negativecd34-negative
demography
collaborations
atp-competitive
flt3itd-harboring
c-myc-dependent
myc-dependent
flt3itd-targeted
1q
dup1q21q32
1q21
1q32
inverted
dup1q32q21
q21
q32
dinucleotide
deoxyguanosine
maximise
non-ds-amkl
paediatrics
grim
underlies
cbfa2t3-glis2-positive
inducible
gnf-2
dissected
shp2raserk
pi3kaktmtor
axes
gab2-mediated
y452
nvp-bez235
tki-resistant
p14
p16
p53mdm2-p21-phenotype
p27cycline-phenotype
posttransplant
n298
n100
pefs
pef
flt3itd-negative
methyl-thiazol-tetrazolium-based
wt-flt3
autocrine
cell-controlled
researches
vegf-targeted
appoints
regimensmedical
nu200au200a46
cagdag
nu200au200a30
nu200au200a27
mea
nu200au200a17
iadama
nu200au200a12
haahad
nu200au200a10a
pu200au200a621
pu200au200a385
pu200au200a537
clag-based
pu200au200a165
numerically
pu200au200a093
pu200au200a016
osflag-
cagdag-
clag-
mea-
iadama-
haahad-based
prioritized
rt-npcr
leukemiaamlfusion
ppro737his
pasp868asn
pser885arg
teff
treg-mediated
mds-to-samltransition
elapsing
who-determined
elapses
adhered
firmly
minireview
gravitate
bcr-abl-independent
lamp3
migrate
lns
slc40a1
busulfanfludarabine-based
cr1cr2
toxa
non-cr1cr2
endostatin
collagen
xviii
proteases
keratinocyte
palifermin
acral
erythrodysaesthesia
disease-causing
22q11
invaluable
misses
reverse-transcriptase
autophagic
speculations
midac
myags
well-documented
indecisiveness
cd66c
--
carcinoembryonic
antigen-related
ceacam6
telaml1
mllaf4
adapt
19-gene-based
double-negative
npm1mutflt3wt
npm1wtflt3wt
npm1mutflt3-itd
npm1wtflt3-itd
cebpαmut
cox-model
predefined
phase-1
pruritus
crs
nct00890929
chronicaccelerated
musclessubcutaneous
chloroma
mimicking
myositis
limbs
aurora-kinase-inhibitor
5-azacyticline
pyrimidine
lonafarnib
lestaurinib
tandutinib
pkc
zosuquidar
trihydrochloride
r132h
ag-881
ds1001
blood-brain
redefine
tpq23
⩾4
intermediateadverse
allg
mds3
int2-high
mths
low-blast
rai
clb
microm
g-csfs
gm-csfs
low-poverty
urges
combs-like
promoter-driven
flag-asxl1n
y588xn
asxl1n
flag-asxl1aa
recapitulating
atac-
asxl1aa
truncating
chromatography-tandem
brd4
truncation
∼33
consolidating
nu2009u200998
non-promyelocytic
morphologies
genechromosomal
gut
seoul
u2009y
130u2009mo
n116
n65
sixty-nine
assessable
contractions
satiety
sweats
erythromelalgia
mildly
myeloiderythroid
megakaryocytes
seminested
imatinib-failure
head-to-head
justifies
aml16
5q35
npm-rar
rar-
d3transforming
tgfβ-mediated
rar-npm
d3tgfβ-induced
ahct
aml-drg
transplant-composite
hct-cr
consecutively
nu202fu202f944
nu202fu202f470
aml-hct-cr
patient-related
assigning
leukaemianet
positiveunknown
indexage
tolerogenic
shla-g
g01
g02
g5
unitsml
g03
sry-box
sox17
displaced
twenty-first
factor-like
egfl7
anti-egfl7
ifn-γ-inducible
degrades
kynurenine
cultured
circuitry
ido-expressing
ido-nonexpressing
mtlc
blunted
ido
susceptibilities
in-house
depths
xa237
xa127
xa244
xa0xa225
xa238
ligand-independent
trans-phosphorylation
categorizations
cml-paed-ii
analyzable
38xa0
10xa0
lowering
s9333
s9500
neurotoxicities
car-related
encephalopathy
cres
blocker
grading
concomitance
gene-expression-based
cross-validation
laptm4b
mir155hg
10-gene
risk-assessed
cyt
incubated
48u2009h
fulfilled
maxspse
responder
in-time
nu2009u200921
non-tumor
arg1
tripterygium
wilfordii
pharmacologyactive
drug-likeness
kegg
oncolnc
databasewe
drug-compounds-genes-disease
nf-kappa
hif-1
pathwaythis
treats
btk
ccl17
ccr4
ccr8
ccrcc
tadham
daunorubicinhigh-dose
s-ham
cytopaenias
ankrd26
terc
srp72
pedigrees
unidentified
well-recognized
vacuoles
bilobed
dyspoiesis
coagulopathies
deletionmutation
nonprioritized
wt1-wild
aml1runx1
fab-classification
jehovahs
microtransplant
patienths
gum
hypertrophy
iga
disease-free-survival
conventional-intensity
n93
n20
nup98-hoxd13
collaborates
transgene
nxa0xa037
nxa0xa08
-74
cixa0xa
conditioningxa0xa
long-chain
acyl-co
synthetase
acsl
oncomine
prognoscan
acsl1
mybph
ptpre
pfkfb3
socs3
lrrfip1
tsc22d1
anchorage-independent
acsl3
snupn
trip13
sema5a
acsl4
serpin2
hnrnpcl1
itih2
procr
acsl5
tmem140
tapbpl
birc3
serpinb1
acsl6
sox6
darc
acsls
acsl-coexpressed
abelson-transformed
interferon-β
aca-dc
stat5-mediated
ep400
prdm2
ank3
chd5
bcs
tri-methyl
k4
gata4
ets1
recrudescent
e-aml
kmt2a-af9
es-aml
prf-aml
graft-mediated
plaques
cheek
hypodermis
cd23
alk-1
raeb
tumour-infiltrating
il-17-producing
encapsulated
asparagine
auxotrophic
enzyme-loaded
bioreactors
bloodstream
avoidance
abo
cell-encapsulated
3l
comparator
matching-adjusted
maic
unadjusted
study-drug
jagged-1
angiopoietin-1
non-contact
vesicle
neoplasm-derived
vesicles
mir-7977
cd34cells
polyrc
hematopoietic-supporting
jmd
tkd1
hinge
beta1-sheet
futility
overtly
influential
argues
center-
undertreated
al-related
mir-128
let-7b
mir-223
mir-181a
mir181a
21xa0single
il-4xa0il-9
il-12a
il-22
tbx21
stat5b
gata3
irf4xa0and
il2raxa0il6r
nfkbia
in-patients
sequenom
iplex
hardy-weinberg
p-values
bonferroni
rs2227491
5b
stat-5b
rs6503691
rs6887695
b-cell-specific
deprived
nutrients
tim-3
kg-1a
jacls
aml99
fancg
β-actin
llgl1
larvae
egr1
compositions
prototypic
progenitor-like
monocyte-like
cbf-myh11
aml-m5
co-exists
filgrastim
ninety-two
osteomyalgia
caudal-type
cdx2
intercalates
tp53-independent
i-iii
valor
mutationally
blood-related
post-transcriptionally
costal
gata
double-mut
1xa0
single-mut
gata2-wild
clinic-biological
implying
aminopyrimidine-based
high-affinity
abl-associated
enestnd
cardiac-related
proliferationsurvival
signal-transduction
n-rasmut
pcr-sscp
pxa0conclusion
bcr-ablis
pf-04449913
multidrug-associated
crt-based
cervix
granulocyte-stimulating
d-clag
topographic
patient-mortality
land-marking
relative-survival
post-allohct
nrm-deaths
mortality-risk
dicentric
overlooked
mfish
multi-centromeric
g-bandingmfish
monocentric
stabilizing
pkc412-resistant
pkc412-sensitive
tp-0903
exosome-derived
microrna-532
disomies
upds
fhit
upd13q
underreported
cr-aml
nr-aml
5-os
shwachman-diamond
ck2
protein-1
slco1a2
abca3
infirm
antigen-matched
radiolabelled
anti-cd45
gruppo
malattie
ematologiche
delladulto
nct00514488
bcl3
favorableintermediate-risk
m1m4m5m6m7
m1m2m6m7
bcl3low
bcl3high
interleukin-23
il-23
γδt
γδt17
microbial
tumorous
inf-dc
inf-dcs
uncovers
inf-dc-γδt17-pmn-mdsc
mdsc-meditated
tumor-elicited
daunorubicinara-c
amlhigh-risk
daunorubicinclofarabine
dclo
randomisations
v3
ara-cdaunorubicin
precursor-b
adenoids
rnase2
gcsfr
prtn3
clc
s100a12
lcp2
fgf6
amlxa0we
amlxa0cases
atxa0five
hematologyxa0centers
stritifiedxa0according
intermediate-1
nu2009u200925
riskxa0nu2009u20099
femoral
stir
g1-s
kip
staged
faint
ercc1
χ2
lys
gln
lysgln
lys751gln
ms-pcr
cd117cd7cd34cd15-
comethylated
phoshoprotein
shuttles
sub-group
cut-offs
copenhagen
copdiff
encompassing
registers
ors
99th
twofold
approached
mild-to-moderate
subsequentsubclinical
appraises
forty-five
conform
non-gs
ccat
pvt1
ccat1
-aml
folds
lncpvt1
inconsistencies
nonadherence
cytarabineanthracycline
nonhypocellular
d14
pbscs
n67
n78
granulocyte-macrophages
cfu-gms
harvesting
bcr-abl1abl
nct00845221
disease-directed
-358000
k562a02
sorcin
sorcin-
sorcin-mdr1-
mir-204
v-domain
pearsons
hpaii-tiny-fragment-enrichment-by-ligation-mediated-pcr
nanohelp
megakaryocyte-erythrocyte
methylome
131i-anti-cd45
bc8
fifty-eight
131i-bc8
eighty-six
cd45-targeted
nct00008177
enterocolitis
nonsurvivors
ultrasonographic
mural
thickening
ultrasonography-driven
exome-sequencing
non-cancer
cosmic
heterozygote
utero
shg
hannover
hovonsakk
mutationspolymorphisms
iprs
rs6935207
rs1045642
rs2032582
1236t-2677g-3435c
runt-related
runx1b
pre-mrdu2009u2009before
fcmu2009u2009pu2009u
combinative
mrdco
mrdcou2009u2009post-transplantation
mrdcou2009u2009was
azac
hindering
post-dli
ccaph-
inevitably
imidazoquinoxalines
imiquimod
derivatives
eapb0203
eapb0503
imidazoquinoxaline
pre-g0
synergized
eabp0503
mediastinum
xa0×xal
dic
thoracoscopic
-asparaginase
⩾60
mir-3151
six-microrna
four-colour
factor-associated
myocyte
2c
mef2c
ausct
sixty-one
prolongs
candidatesthis
nct01452646
meningeal
tubercular
meningitis
steroids
antitubercular
sensorium
ventriculoperitoneal
shunt
hydrocephalus
neurosurgeon
cytospin
cd48
sistema
único
saúde
sus
specialised
hypoxia-inducible
microvascular
mvd
size-
shape-related
microvessels
vascularisation
circularity
roundness
vegfc
aml-mrc-c
aml-mrc-h
aml-mrc-ts
aml-mrc-m
aml-mrc-maml-mrc-h
typhlitis
pneumatosis
intestinalis
perianal
anll91
cclsg-aml9805
jplsg-aml05
iii-v
4‑aminobutyrate
abat
syndromexa0mds
152xa0patients
29xa0patients
leukemiaxa0aml
40xa0controls
survivalxa0os
g1sxa0phase
skm‑1
γ‑aminobutyrate
micro-environment
featuresfunctions
capitalizing
combating
ifitm1
nps
multimeric
trunsduction
leucosis
mll-baby
embraced
amounted
p300
sclc
dnamt3a
clinic-biologic
pre-leukemic
lymphoid-associated
impart
outlining
treatment-
survivalwas
corroborate
-naïve
reactivations
pu2009u011
p-glycoproteinpgp
n141
foxo1
n204
hyperactivation
nicotinamide
underpin
pgp-positive
esophageal
escc
4e
mcl-1l
tof
lgg
affluent
12th
18th
acceleratedblastic
envisions
c-flag
ci-flag2
blastxa0xa00
crcrpcri
c-flga
operative
risk-scoring
good-prognosis
sudden-onset
transferring
hospitalised
coxsackie
virus-induced
myopericarditis
colchicine
pericarditis
rediagnosed
severely
etv6-prebound
corroborative
cohesin-mediated
n252
cell-replete
nk30u2009u2009150
sharply
compendium
shifts
newfound
taxonomy
5abl
3bcr
promylocytic
nb-4
mugg
intraperitoneally
buthionine
sulfoximine
ms-5
logistic-regression
dic-
adipocytes
flt3wth
flt3wtl
aspartic
flt3d94
trail-rs
trail-r
death-inducing
caspase-
ubiquitin-mediated
proteasomal
feed-forward
oligonucleotides
aeg35156
first-in-human
phase-i
-ii
cd11bcd33lowhla-dr-
doubling
noyes
cytarabine-anthracycline
nanog
ssea1
ssea3
7th
gstp1m1t1
austrian
hd98a
hd98-b
gstp
clear-cell
variably
favorable-
re-evaluated
rs12459419
t-allele
100u2009000-fold
cd33-targeted
gos
meloid
arsenicifn
fundamentally
minimalmeasurable
approachmutational
doubled
5-trisphosphate
itpr2
itpr2high
2g-tyrosine
refusing
remission-according
criteria-was
transfusion-independence
stigmata
thrombocytes
nonresponse
tq22q21
m-fish
a-cgh
inversions
18q
3p
1p
tcf4
ets2
ddx6
trib1
microrna-186
mir-186
huntingtin
hip1
endocytic
cancer-causing
mir-16
mir-15a
mir-28
mir-660
interfereing
kasumi
cml-dpmns
cml-dpmn
jilin
dpmns
cml-mdpmn
non-treatment-related
posed
de-escalation
regimensacute
casually
jspho
hematologyoncology
sequencer
jalsg-stim213
umin000011971
re-achieved
mir-210
-acute
gpi-80
mrcc
spreads
three-dimensional
latency-associated
peptide-1
flt-3-itd
nct01254890
inv3
loss-of-heterozygosity
cn-loh
q-arm
terminus
substantiating
discernible
philapelphia
wtflt3nonhsct
wtflt3hsct
flt3-itdnonhsct
flt3-itdhsct
tv22
major-route
signify
aml39
xian
jiaotong
score24
gene-partial
mrp-1
pfaffls
mdr-1317
mrp-8409
g3139
18-mer
phosphorothioate
nonagenarian
eighty-one
judgement
cramps
⩾50
⩾70
α2
itga2
itga2high
itga2low
non-acute
normal-aml
methylation-independent
transplantationp
diagnosis9lp
age35
cgvhdp
diagnosis9l
χ873
tagraxofusp-erzs
elzonris
stemline
cytotoxin
cd123-expressing
stml-
crcrc
leak
cls
antidrug
dri-r
comorbidityage
hct-ciage
low-risk-patients
lowintermediate
hct-ciageu
nu2009u2009272
intermediate-risk-patients
nu2009u2009168
high-risk-patients
highvery
nu2009u2009284
nu2009u2009184
c-indices
microrna-20a
mir-20a
exhaustively
leukaemogenic
transgenes
synergisms
retroviral-mediated
denoting
co-transduced
lin-cd38-cd34
plsc
cd90
multi-parametric
mitelman
proton
n38
hinders
proactive
enteral
etf
anti-infective
pleiotropic
irradiation-
doxorubicin-induced
ra-mediated
tlr9-ligands
dna-damage-induced
overestimated
c-statistics
hsct-based
dicpq
centromeres
chemo-resistance
etp-all
campanas
cd1a-
cd8-
cd5dim
non-etp
non-etp-all
nu2009u2009118
nu2009u200975
nu2009u200939
nu2009u200924
-tetradecanoylphorbol-13-acetate
disease-poor
mk-t
mk-p
suffers
drug-conjugated
speculate
basel
imatinb
non-happy
persistency
miligrams
cardiotoxic
l-dnr
higher-than-equivalent
therapy-optimization
plogrank
pgray
subclinical
nct00111345
accrued
target-specific
5-
hindered
transfusion-associated
tabc
spontaneously
resolving
escherichia
isolates
causality
picalm-mllt10
n72
ζ
l-arginine
cell-based
antigen-negative
-nonspecific
selectins
selectin
predictability
ikirs
autoreactive
unlicensed
untransplanted
kirhla
nct01347996
ncr
nkp46
autoreactivity
deoxynucleoside
1-h
ema
pre-specified
-based
karyotying
n-
decisively
sequencingngs
myeloidnatural
cd7cd56
light-microscopic
patientsn
npm1n
forn
95n
reactionn
sequencingn
costn
mirna-204
flanking
rs718447
au2009u2009g
rs112062096
trpm3
nonrandomized
noninferiority
trajectory
insq22q22q22
lncrna-based
candidate-genes
resequenced
silico
seed-genes
lats2
fu2009u2009ara-c
ci-fla
remitters
monitorized
u2009×u200910e6
exon4
reappeared
neuropilins
vasculature
rtq-pcr
early-phase
formally
ecchymoses
maculopapular
eruptions
pyoderma
gangrenosum
eccrine
hidradenitis
lobular
panniculitis
histopathologic
down-regulates
standard-dose-resistant
tet3
tumornormal
thrombophlebitis
hemorrhoidal
plexus
cellulitis
microchimeric
thawing
contaminating
nadir
ric-hct
single-centre
amlall
mac-hct
inter-study
harbinger
engender
normokaryotype
mutagens
subfamilies
double-null
assisting
induction-associated
redundant
anticipating
outweighed
falsely
dnaml
tppupd
cux1
tp4
saml-associated
foxp1
e1a9
e19a4
e13a1
e14a3
e13a3e14a3
mal
bmyeloid
tph
11q23mll
cnloh
mdr-related
t-mdst-aml
lingering
foxm1
oxaliplatin
electrophoretic
emsa
-635acaaacaa-628
foxm1mcl-1
icd
hdc
interfant-06
myeloid-style
abandon
oncogene-driven
mousehuman
11-gene
cell-resembling
therapy-outcome
nonepithelial
medulloblastoma
bmi-1-driven
responds
l-malate
non-atp-dependent
evades
phase-cml
government-sponsored
clinicobiological
sizeable
systematization
pah
dasatinib-related
cardiopulmonary
forcing
reprogram
leukemogenicity
macrophage-like
differentiation-promoting
pu1
resembled
recombined
vdj
wt-irf8
sv-irf8
wt-
pu202fu202f002
pu202fu202f003
monochemotherapy
pu202fu202f035
pu202fu202f011
pu202fu202f019
three-lineage
microelectronic
q23
abn3q
haemorrhagic
colitis
african-american
colonoscopy
perinatal
aml-05
nxa0xa0103
nxa0xa0413
endanger
morecules
fourty
vyas
appelbaum
craddock
aracytine
anthracene
transfusion-dependent
re-evaluate
leukemia-derived
probands
cells-containing
blast-containing
mnc
mlc
dcmnc
fluorolysis
unstimulated
tcm
β-integrin
tnaive
activationdifferentiation
unstimulateddc-stimulated
xenobiotics
cnki
revman
stata
softwares
gstm1gstt1
gstt1gstm1
one-log
rapamycin
threonine
cci-779
rad001
ap23573
characterise
2009-february
gastro-intestinal
transaminitis
ineligibility
represses
phagocyte
gp91phox
p67phox
dusp4
mkp2
de-phosphorylated
shp2
protein-tyrosine
nonphosphorylated
dephosphorylate
exaggerated
extramedulary
nodal
majorities
thymic
palate
cytosinarabinoside
anagrelide
helical
interferon-α2b
expectantly
obtainment
mdrtap
abcb1mdr1
c1236ct
c2677gta
c3435ct
transportmetabolism
2677g
3435t
1236cc
leukemogeneisis
gsk3
1990s
glycemic
pauls
university-based
cml-blast
bloodbone
ssc
under-diagnosed
total-body
upd
upd11q
c-cbl
e3
interferon-alpha2
ifn-alpha2
convincingly
non-pegylated
revived
neoplasms-essential
mpns-and
cornerstone
low-jak2v617f
revert
dna-hypomethylator
envisage
stage-and
before-vaccination
ceplene
del5q31
hisher
higher-dose
ancillary
cd57
interleukin-8
protein-10
ip-10
mcp-1
macrophage-colony
clinical-grade
purity
abt-199
venetoclaxabt-199
leg-type
pclbcl-lt
evolutive
koreans
bioavailable
gm-6
waxed
waned
3-way
t11ppq
24-color
aspirated
47xyt11p22p13q23der6tp22q48sl48sl8der12tq11p
48sdlderyty1q12q7
oligo-acgh
6p22qter
11qqter
cmahp
6p
rreb1
mll-involving
remission6
epipodophyllotoxins
kmt2amll-mllt3
vulnerabilities
aml209-flt3-sct
end-point
exceeded
cooccurring
umin000003433
antigen-positive
postulate
antigen-expressing
southwestern
e-cag
cytarabine-
daunorubicin-based
regnase-1
ccch
rnase
tal1
regnase-1-mediated
hdac-123
hdac-135
u2009gl
progeny
amplifying
neuroblastomas
removes
t-killer
multiplying
antigens-mismatched
107kg
cr5
der9q
gestation
postpartum
unplanned
obstetrical
malformations
fetus
diathesis
10u2009×ul
pmlrara
n99
skipping
tet2e2s
predominated
tet2e2shigh
tet2low
leukemia（aml）is
myelopoietic
lnc
incrna
uca1
anril
h19
zfas1
hoxa-a52
neat1
tug1
irain1
pandar
snhg5
kcnq1ot1
nsd1
nup98-nsd1-negative
nup98-nsd1-like
nup98-nsd1-related
signature-negative
tp15p15nup98-hoxa13
tq27q23mll-mllt4
tp22q34dek-nup214
non-r882
effects-unfavorable
high-powered
q26q22
q26
kaplan-
mds-aml
aml1-mds1
amlt-aml
non-hsct
r132
r140r172
melt
hrm
nxa0xa07
south-eastern
32-yr-old
pmlraralpha
dichotomized
udp-glucuronosyltransferase
interindividual
single-chain
cd3-ζ
cd123-car-redirected
granulocytemacrophage
lyse
xenogeneic
cd54
cd58
b-positive
b-negative
pbasct
flt
prematurely
nu2009u200955
nu2009u200954
67xa0
56xa0
48xa0
96xa0
89xa0
97xa0
underpowering
ntr674
bpdcn-like
npm1-wt
pu2009npm1-mutated
11q13
d8rd
detailin
allogeneichaploidentical
all-patients
antimycotic
possesses
mllmu
methylationexpression
cytosine-5-methyltransferase
patientseligible
patientseight
hru200au200a
ciu200au200a-
non-cn-aml
pu200au200adnmt3a
charité
virchow
crp-based
constituent
conventional-dose
escalated-dose
sensitizing
hovon-42
ntr230
ccaatenhancer-binding
pcr-ce
nu2009u200912
k-methyltransferase
aff1
af4
mllt3
af9
enl
mll-r-all
peaks
pediatricyoung
hyaluronic
mantle-cell
mcl
smallpox
vaccinia
first-ever
tecovirimat
inadvertent
autoinoculation
phu2009cml-cp
n126
n91
musashi2-numb
musashi2
uicc
down-regulating
graft-versus
galectins
cancer-like
galectin-
inpatient
nci
cairo
lgals12
lgals4
galectin-12
mrp4
abcc5
mrp5
abcc11
mrp8
cyclic
-monophosphate
guanosine
near-complete
saturation
saturating
internalization
cd33-antigen
preferably
crohns
work-ups
endoscopic
ileal
narrowing
ileum
cd0
cd78
cd71-
and-negative
crf
leukemian
patient’s
itn
thisn
quasi-experimental
post-test
includedn
briefn
tenth
interventionn
low-costn
supplanting
overproduction
jak2-negative
trapped
formalin
aso-pcr
lagging
disadvantaged
dna-
rna-based
postinductionconsolidation
ev-mirnas
-16
myeloid-antigens-expression
non-expression
one-course
good-response
poor-response
χ680
pthe
χ185
2-and
with-myeloid-antigens-expression
pprr
applauded
regimenstwo
nu200au200a144
nu200au200a42
nu200au200a62after
patientsstandard-dose
emi
amyloid
amleto
sirnaapp
imids
pomalidomide
co-stimulation
repairing
imid
serbian
npm1flt3-
npm1-flt3-
de-
leukemia（aml）with
t（
genotype-specific
explanations
drug-free
dago
seventy-four
disordered
q-rt-pcr
microarray-based
ciclosporin
adc
s0112
s0301
undue
unveiled
reexpression
2-e-4-dihydroxyphenylvinyl--methoxyphenyl-h-quinazolinone
iccb280
haploid-identical
electrocardiogram
neutrophil×l
platelet9l
antiacute
underused
attenuated-dose
m-flai
nct01247493
azacitine
tq21q
non-complex
allo-transplanted
spur
end-of-life
nonwhite
enroll
ambitions
upwardly
colonic
cd11bly6gly6clo
il6-stat3
il6-sufficient
il6-deficient
il6-expressing
hif1α
echinomycin
propagated
spares
ahn
ism
nu2009u200926
apoptogenic
caspasedependent
initiator
c-related
cracdep
posttransplantation
catabolizes
trp
kyn
kyntrp
cd11c-positive
adhesive
beta2-integrin
mac-1
fluorescein-conjugated
aml-cg
thrombo-
granulocytopenia
pancytopenias
constellation
cdk2
cyclins
e-type
a-type
a1
cdk2-bound
proteolytically
g1s
4q24
arraycgh
snpacgh
normalaltered
mnp
sang
cmd
factor-beta1
stgf
subdivides
interleukin-10
proteinase3
pr3
multiple-myeloma
wt1-
pr3-
muc1-derived
i-restricted
padre
muc1-helper
cpg7909
montanideisa51
repetitively
vaccinated
wt1-pr3-muc1-specific
vaccine-specific
padre-specific
il2
montanide
bre
bre-expressing
mll-af9-positive
hd-ct
d2hg
idhmut
idh2-mutated
circadian
sharp1
mll-af6dot1l
tn-pmf
mds-f
mdsmpn-f
nu2009u200914
nu2009u200918
2016-who
nu2009u20096
nu2009u200919
disruptionaneuploidy
chromatin-spliceosome
teratogen
checkpoint-based
cell-intrinsic
kras-induced
impediment
microbiome
curtail
cell-
retinoids
pharmacist
oncologist
trackingmonitoring
resultsresponse
noncompliance
fractionated-dosing
re-approval
drug-antibody
re-emergence
hid
post-allo-hsct
my-all
progress-free
geotrichum
capitatum
geotricosis
vitek
maldi
unsuccessfully
micafungin
hoxa10-as
kmt2a-rearranged
rna-
acid-conjugated
lna-gapmer-mediated
hoxa10-as-knockdown
hsc-specific
chemiluminescent
cantonal
aggregated
age-standardised
non-classifiable
-84yrs
85yrs
5yrs
65yrs
nihilism
justifiable
berlin-frankfurt-muenster
-type
qq
tet2mt
nu2009u20091084
epistatic
tet2wt
lower-risk
pu2009mt
mitigated
asxl1wttet2mt
asxl1mt
cd38-targeted
isatuximab
car-transfected
corroborated
plasma-based
tp53-mutated
tp53-wild-type
ic50s
tenfold
lsc-enriched
t-helper
boosted
stat3-based
ccl2ccl12-ccr2
ccl5-ccr5
ccl15-ccr1
cx3cl1ccl26-cx3cr1
cxcl1-cxcr2
cxcl8-cxcr
ccl21-ccr7
cxcl13-cxcr5
heat-shock
hsp60
hsp110
mrk
peaked
2000s
non-cag
better-
non-aml-m
non-m
phospholipasexa0cxa0δ1
plcd1
3p22
k1
msp
5-aza-2deoxycytidine
1970s
48xa0380
on-therapy
reliableness
embolism
anticoagulants
bleedings
ctv-1
cndo-109
cell-resistant
cndo-109-activated
cndo-109-nk
3u2009×u2009105
nu2009uu2009×u2009106
3u2009×u2009106
lymphodepleting
fludarabinecyclophosphamide
u2009×u
1u2009×u2009106
u2009×u2009106
post-trial
microchimerism
cryopreserved
exhaustive
rhinosinusal
exserohilum
rostratum
filamentous
hasnt
sixty-six
phosphate-binding
p-loop
non-p-loop
nxa0u200929
nxa0u200911
post-ind
post-cons
amelioration
cd127
cd127lo
hvs
magnetic-activated
coculture
diacetate
succinimidylester-labeled
cd25-
il-4il-2
ymtn
11th
bsa
①the
②age
③patients
dacryoadenitis
sweets
y779
ahd-aml
rasraferk
5-to
core-binding-factor-aml
cytarabinefludarabinegranulocyte
ozagomycin
one-size-fits-all
alone-as
cure-clinical
doseschedules
solubility
chemopreventive
ezh2-specific
epz011989
nanoparticles
hsanps
synthesized
desolvation
noncovalent
nanocomposites
epz011989-loaded
blot-based
nanoformulation
h2ak119ub
compaction
interacted
biodistribution
aqueous
dispersibility
biocompatibility
alleviated
regulation-based
gli2
compounded
chloride
clca-1
clic1
clic3
trpm7
trpm8
kca
contrasting
inv16-positive
3h
t-positive
deaminases
adars
adar1
u-937
phorbol-myristate
acetate
d3granulocyte
gm-csf-driven
adar2
a-to-i
ubiquitin-proteasome
adar
mutationtet2mut
panmyelosis
apmf
freshly
firstline
contra-indication
mir-4262
ser585
betac
survival-only
138-gene
ser585-regulated
pi3-kinase
ser585-survival
cytokine-regulated
ser585pi3-kinase
who2008
re-recognized
non-refractory
micro-transplantation
auto-pbsct
mir-19
mir-19ab
mir-19a
mir-19b
comprizes
17q-
non-balanced
broad-based
failurerelapsed
u200990
pdli
u200920
transendothelial
transmigration
extravasation
t-cell-progenitor
mebmt
5u2003yr
pu2003u
one-two
∼15
itt
per-protocol
versa
explorative
-95
hla-dr-negative
hypogranular
infrequently
m-bcr
e13a3
p200
p225
limb
hematoxylin-eosin
stain
intoleranceresistance
baselines
cd57cd14-
pdcd5
risksee
wei
cdfs
erm
erm-
erythema
multiforme
attracting
flares
isavuconazole
tr34-l98h
rhizomucor-a
co-infection
galactomannan
pcrs
mucorales
glycaemia
cardiologist
systematical
transglutaminase
tg2
adhesionreduced
ingestion
anatomic
subtherapeutic
morbidly
obese
gastrectomy
preoperative
acadesine
aza-sensitive
oci-m2s
oci-m2r
cd34cd38lo
karyotype-
logit
avid
β-cell
toxins
bedeviling
thirty-one
pu2009pu2009u
stim1
restarted
hovon-51
efficiencies
maturation-stage-dependent
go-induced
genotype-prognostic
setd2
regiment
darwinian
intratumor
pemt
excised
intussusception
quadrant
tenderness
guarding
distension
ascending
herniation
ileocecal
laparotomy
thickened
invaginated
gangrenous
hemicolectomy
paml
nucleoporin
11p
cytokine-stimulated
cocultures
nod-scid
eight-fold
downmodulated
globin
cullin-4a-mediated
nup98-hox-transduced
intranuclear
g-protein
thoracic
prioritizes
silhouette
radiographs
neoplasia-but
dna-protein
replicative
dsbs
sensed
melphalan-total
tumorxa01
80xa0of
transcription‑quantitative
195xa0patients
early‑stage
factorxa01‑runx1
leukemia‑retinoic
receptorxa0α
allo‑hsct
n261
hereafter
bm-mdscs
alloantigen-
mitogen-stimulated
bm-mdsc-mediated
promyelocyte-like
radiographic
inv16p13q22
factor-aml
mareschal
etxa0al
stk1
dot-blot
inductive
tk1
predicating
sqiv
rangeu2009u
21-t-q22q
tq22q
excretion
adme
dmet
slco1b1
rs2291075
c597ct
oatp1b1
rs2306283
c388ag
rs4149056
c521tc
aml-directed
substrates
ortholog
oatp1b2
oatp1b2-deficient
misuse
hypoxia-regulated
48u2009hours
hypoxia-induced
apl-aml
nk-cytotoxic
nk-cytotoxicity
more-effective
less-toxic
psychosocial
caregivers
expansive
contiguous
derangements
engendered
whole-genome
fueled
accumulates
pi3k-delta
investigator-sponsored
ctgnct00481052
bcl2l12
cloned
m3-aml
cd19cd7
cd33cd19cd7
cd34cd11b
hrql
haemacare
groupings
conspicuous
prognosis-based
oncologyworld
cis
donor-versus-no
18u2009mb
101u
7q-119u
nu2009u2009464
pathomechanism
apoptosis-regulating
granulocytosis
cytopathology
cytopathological
diagnosticrelapse
haemato
cadherin
se-cad
matriptase
condtions
b-nhl
indisputable
lymphomagenesis
acmls
pgly870ser
exogenously
-53
-75
nadir-first
rtrn
subtractive
sept5
mier1
kpna6
pan3
tob1
itch
κb
non-transplant
chronological
post-icu
misplaced
cd30
surrounds
time-point
time-to-response
lor
vasoactive
cells-1
strem-1
mass-spectrometry
phacute
nilotinibdasatinib
5-way
46xytq11p13q19q22q
gtg
arterio-thrombotic
terminated
frontline-ponatinib
nu2009u20094
inevaluable
cardiacvascular
post-ponatinib
hyper-proliferative
cell-of-origin
gmps
permissiveness
preserves
naturally-existing
rapidly-cycling
perpetuated
ccnd1
elucidates
preventative
zf2
clinico-biological
zf
zf1-mutated
zf2-mutated
tnc
u2009×u2009107kg
-match
hla-a
-b
-dr
-drb1
isd
hid-hsct
isd-hsct
sqle
keenly
intensifying
cpx
8q22
21q22
runx1-runxt1
tq23q22
syne2
utaf1
dhx29
ski-606
brc-abl
v299l
low-to-moderate
toxicitis
btb
7a
zbtb7
pozbtb
krüppel
5‑fu
cck8
zbtb7-shrna
dose-
sn50
zbtb7-induced
adrenal
pa-dlbcl
cohesive
nucleolus
neuroendocrine
reed-sternberg-like
carcinoma-like
rs-like
hellenic
fpss
-73u2009m2
base-line
under-treatment
n266
sixty-five
enestfreedom
illness-death
orand
myeloid-relevant
qol
cxxc5
5q31
cell-cycling
co-downregulation
p53-dependent
aml-cku2009
palg
cku2009mk-
cku2009mku2009
20u2009gl
mku2009
amk-ck
probabilistic
averaging
bma
nob1
ddx47
igsf2
ltb4r
scarb1
slc25a3
6-gene
dcag
readministered
inhibitor-withdrawal
umin000005904
aldh-rare
aldh-numerous
aldh-
xenogenic
resistance-associated
cytosine-5--methyltransferase
merged
dcog
onwards
db-aml
off-trialwe
rrs
off-trialof
trial-patients
off-
off-trialdespite
off-trial
extrapolated
mirna-193a
mutations-n-terminal
bzip-domain
mutations-were
multiple-factor
rang
bcr-ablis10
cgr
flt3mut
non-a-type
fat1
reln
srsf8
pentasomy
hexasomy
polysomy
kir-genotyping
scts
2dl5a
2ds1
3ds1
whole-transcriptome
evi1-overexpressing
chi3l1
eoc
time-polymerase
paclitaxel-induced
up-regulating
phosphodiesterase
n--dichloropyrid-4-yl-3-cyclopentyloxy-4-methoxybenzamide
piclamilast
raralpha
retinoid-sensitive
nb4r2
camp-dependent
transitory
camp-responsive
element-binding
camp-regulated
ligand-dependent
kinase-dependent
retinoid-dependent
cebp
cytodifferentiation
epac
atra-induced
disease-intrinsic
non-cytopenic
virus-1
hterc
kreatech
28th
pml
druggable
foxn3
ches1
borne
abstracted
non-monotonic
non-trivial
d-loop
mtdna
hypervariable
hv-i
hv-ii
100-
200-fold
t--c
c--t
a--g
16126t--c
16224t--c
cell-driven
outcompete
model-based
demonstrable
proof-of-concept
metabolismdisposition
abcc3
mrp3
c-211t
cnt1
slc28a1
g565a
nat1
nat2
radiological
rheumatology
inpm1m
auto-sct
α7
itga7
microdeletions
microdeletion
ests
prdm12
hiv-associated
hiv-aml
non-opportunistic
intensively-treated
prl-3
ptp4a3
metastasis-associated
sustains
dependently
lin28b
let-7
prl-3lin28blet-7
leukemogenesisimplications
medicinal
chmp
granting
eeigthe
alfa-0701
mf-3
lancet
oncol
infectionthe
aplthe
rapporteur
co-rapporteur
variances
pdc
derives
bpdcn-specific
lxr
triphosphate-binding
abca1
abcg1
growthsurvival
acceptor
apolipoprotein
bpdcn-induced
nu2009u2009301
s1203
nu2009u2009261
s0703
nu2009u2009133
s1117
nu2009u2009277
covariate-adjusted
groundbreaking
oblimersengo
incremental
receptor-interacting
1（ripk1）
rg4
17-gene
group-specific
npm-untranslated
illegitimate
t-deletion
microrna-mediated
single-institution
osccs
dysplasias
mucosae
pi3kα
p110
il13rα2
phospho-stat3
t-cell-replete
lessening
hsa-mir-509
hsa-mir-542
hsa-mir-146a
hsa-mir-3667
4-mirna
kyoto
leukemia-relevant
4-mirna-based
fab-based
20s
19s
wbcc
u2009×u2009109l
pil-8
atezolizumab
anti-pd-l1
muc
cd8u2009t
antigen-presentation
il-8-mediated
ial
apaf-1s
apaf-1lc
apaf-1ln
apaf-1xl
wd-40
apaf-1xlapaf-1ln
procaspase-9
reactants
cfa
confounders
kps
-70
micm
×109l
pvs
-72
-175
tfr-eligible
markov
hospitalphysician
co-payment
maximums
complied
¥7xa0625xa0174xa0640
us66xa0567xa0775
willingness
out-of-pocket
payers
tidel
non-achieving
faisal
ink4aarf
nonallogeneic
stepping
capitalizes
dnmt
paad
p‑values
mir‑1301
mir‑125a
mir‑376c
mir‑328
mir‑376b
mitogen‑activated
decapentaplegic
five‑mirna‑pool
uu2009u
wide-type
post-breast
results-medicare
95xa0-ci
chemotherapyradiation
anthracyclinecyclophosphamide-containing
anthracyclinecyclophosphamide
originate
cytokine-dependent
oligometastases
stereotactic
sbrt
caucasus
wt1gaaa
wt1gg
subclassification
full-dose
formulating
re-bounces
n-4-hydroxyphenyl
xa0retinamide
anti-angiogenic
kdm
polyclonalcompound
imatinib-binding
m244v
exon7
pr362fs
35bpintron-derived
insertiontruncation
variates
post-chemotherapy
leukemic-regenerating
lrcs
re-growth
therapy-naive
lrc
one-step
der22
precedent
aggravation
pna
clamping
over-costing
chemotherapy-only
nu2009u2009115
nu2009u200995
nu2009u2009124
standardizing
cdi
inversion3q21q26
7u202fu202f3
cfu-gm
ssm
asm
non-mast
asm-ahnmd
multi-mutated
single-cell-derived
ismssm
d816v-
xkg
mafosfamide
focussed
nxa0xa0190
pharmaflow
nxa0xa074
pethema
multiresistance
cyp2b6
myelomonoblastic
fragmentary
ctdna
post-allosct
mp1
mp3
cp3
comparably
non-mp9
non-cp6
non-mp
non-cp4
dta
20u2009000
gestational
trophoblastic
gtn
cell-free
nu2009u200920
nu2009u200910
entailing
95u2009u-
moz
cbp-moz
introns
16cbp
2moz
tbicyclophosphamideanti-thymocyte
flamsa
flamsa-treosulfancyclophosphamideatg
substituting
bloating
paracentesis
keisuke-matsusaki
concentrated
reinfusion
km-cart
transjugular
contracted
pneumocystis
aoe
2ndg3rdg
dnmt3a⁺
leukemia（cn-aml）patients
rate（orr）and
caglike
myelocytes
bcr-ablsrc-family
p53-positive
syndromechronic
carebsc
awaits
undoubted
therapy-resistant
remodelling
11q23-rearranged
desorptionionization-time
selditofms
unitary
leukemia-granulocytic
aml-gran
leukemia-monocytic
aml-mon
m3829
m1593
m2121
m2536
m1016
aml-gra
proteomic-based
credibility
bps
cytokinecytokine
α-chain
il-2rα
il-2rβ
il-3rα
il-5rα
il-6rα
il-7rα
β-chain
βc
γc
gm-csfrα
c-fms
c-mpl
gp130
sitescell
ilt
hla-g5
stabilizer
hβ2m
hla-g5-
dampened
t-and
t-
counteracts
microscope
leukemia-partial
logferritin
3-level
ich
leukapharesis
sdf-1cxcl12
cross-talk
β2
tgfβ2
stimulates
pro-proliferative
understated
improvement-platelet
hi-p
prcc
chemo-
foamy
cxcl16
chemerin
lipids
senile
traces
unidentifiable
institution-
assay-specific
extracranial
neuroblastoma-driven
hamper
mfc-mrd
fine-tune
hippo
hemostasis
yap
coactivator
taz
kirsten
cdna-based
cystic
conductance
cftr
elapsed
fab-m
qualifies
11q23-aberrations
igf-1r
factor-binding
protein-7
igfbp7
g2
lin-lowhla-dr-cd11bcd33
cd39
cd115
cd124
reminiscent
substantiates
microrna-335
chemotherapya
analysesthe
chemotherapyour
ablbcr
ablbcl
intrinsically
thrust
exploitation
unbridled
dna-hypomethylating
anti-bcl-2
populating
deviating
dominating
ontological
pro-tumoral
cancer-microenvironment
conidiobolus
coronatus
rhino-facial
conidiobolomycosis
pachyzygosporus
onco-haematologic
mpfc
8-color
mrdχ348
pχ08
χ42
multivariates
nanostring
methylcap-sequencing
mir-133b
devise
hereditary
epipodophyllotoxin
131i-metaiodobenzylguanidine
131i-mibg
mpnlpn
coexistent
lpn
lpns
seventy-three
connects
p230
micro-bcr
inhibitor-tki
sahlgrenska
nu2009u200970
interviewed
nine-item
aml-type
trd
tq22q22runx1-runx1t1
inv16p13q22tp13q22cbfb-myh11
tq22qpml-rara
hemangioblast
erythroidmyeloid
reticulin
lagged
judging
g565v
voluntary-unrelated-donor
reconstitutes
watchful
substitutional
antilymphoma
nfc-aml
fltitd
m13
m12
m9
fltitd-
normalfavorable
atp1b1
nak-atpase
electrochemical
gradients
atp1b1high
oncogenesonco-micrornas
atp1b1s
numbering
durably
overshadowing
perioperative
cystectomy
muscle-invasive
mibc
inoculated
2xa0×xa0105
mbt2
c3h
controlxa0vehicle
anti-mpd-l1
sutured
margins
lr-free
cancer-specific
oncological
mhc
ii-associated
antigen-binding
hla-dm
catalyzes
dissociation
hla-do
down-modulates
cliphla-dr
dodm
drclip-
drclip
transcription-pcr
clipdr
nonlymphoid
scnp
dxscnp
scnp-evaluable
classifiers
auroc
dxclinical2
aml-non
aml-
size-between
northeastern
cells-of-origin
leukemia-private
antigen-directed
anti-cd117
cd117-positive
xenografted
cd117-expressing
cd117-negative
transductionselection
rqr8
osrfs
vegf121
vegf145
vegf148
vegf165
vegf183
vegf189
clinicopatholologic
g-csf-mobilized
g-pbsc
un-bm
g-bm
ecog-acrin
expectancies
agexa0xa090
converting
5-mc
5-hmc
raeb-1raeb-2
embryogenesis
orthologs
morpholino
l-plastin
pan-leukocyte
mpeg1
lck
rag1
embryos
d835y
nu2009u2009200
nu2009u200988
achievedmaintained
1wt1
quantitation
b7-h1
hcg
npm1flt-itd
oligoclonal
relapse-initiating
rna-binding
musashi
preemptively
monophosphate
structure-activity
sar
naphthol
as-e
creb-binding
salicylamides
creb-cbp
biphenyl
salicylamide
physicochemical
bcr-abl-targeted
sall
seer
rectum
bap
neuropeptide
cgrp
calcrl
coreceptor
ramp1
migraines
cgrp-calcrl
c57bl6-based
receptor-positive
olcegepant
ykl-40
abcb5
abcb5-targeted
translationally
xenotransplantation
ftl3-itd
drug-refractory
multipronged
flt3-dependent
aml14
plateletneutrophil
buflu
allo-hpct
etv6-abl1
etv6-abl1-positive
leukemia-like
myeloproliferations
bcr-abl1-like
cdkn2ab
vicinity
irrespectively
tricarboxylic
tca
2-hydroxygluterate
re-sequencing
haloplex
klhl6
pot1
n137
repeating
stand-alone
del9q
gkap1
kif27
c9orf64
hnrnpk
rmi1
slc28a3
ntrk2
ribonucleoprotein
cdkn1a
four-tube
cd45dimlow
cd4bright
cd33dim
cd56heterogenous
cd123bright
cd36
hypercvad
affordability
beneficiaries
cost-sharing
subsidies
seer-medicare
initiators
por60
antecedents
tyro-sine
3flt3itd
nucleophosminnpm1
caat-enhancer
alphacebpα
auspices
tdm
interpatient
aml-m4m5
age-associated
sub-grouping
post-hematopoietic
prostate-specific
psa
biochemically
mushroom
wbm
supernatant
dclsg
dclsg-anll87
dclsg-anll
dclsg-anll97
m1m2m3m4eo
4-log
3-log
dek
nup214
mircorarrays
leukemagenesis
3u2009u20093
rp2d
deciphering
mastocytes
heparin
leukotrienes
anti-tumorigenic
concluding
multilocus
microsphere-based
hpaii
ligation-mediated
xmelp
interrogate
forest-based
idr
non-cross-resistant
aml209
unrevealed
factor-mobilized
hdacis
non-epigenetic
synthesizes
δn
suspicious
misdirect
germinal
deprecated
ecosystem
low-resolution
metrics
hemoblastoses
transplantable
disease-like
uca1-mdr1
hscy
intragenic
dmr2
fourth-line
-163
2gtkis
c-findings
d816hy
f522c
sarpos
slowed
thrombopoietin
cdh-1
dapk-1
h3h4
damage-associated
nct00101179
divides
speeding
robustness
randomizationregistration
protocol-defined
non-protocol-mandated
nct00085124
nct00416598
nct00651261
nct01238211
nct01253070
200xa0×xa0109l
electrolytes
disturbances
ominous
halt
neuraminidase
chymopapain
glycoprotease
pasteurella
samplespatient
rdrs
tms
ccss
encounters
rs129081
rs212090
rs212091
nu2009u2009160
radioiodine
integration-1
evid
evi1me-
evi1me
atp-tca
hr-qol
patient-report
caregiver
chq-pf50
discrepant
factor-acute
impls
1000u2009ngml
effluxinflux
self-reported
994u2009ngml
1066u2009ngml
814u2009ngml
nu2009u2009177
impl
diaries
chemotherapyautologous
shortcomings
remedial
clinicodemographic
abandonment
updatingmonitoring
clever
weighting
para-tumor
halted
ttp
phall
override
non-competitive
2-phenylaminopyrimidin-based
bms-354825
ap23464
pd166326
amn107
ns-187
inno-406
succession
on012380
vx-680
birb-796
eremothecium
coryli
dimorphic
fungus
saccharomycetes
phytopathogens
shm
androgen-dependence
gland
3xa0xa03
nxa0xa03
pericardial
meg3mir-155alg9
method-specific
discrepancy
stratifier
custom-designed
capture-based
u2009bp
dual-tested
highlow
d835i836
comprehensiveness
transitioning
realization
adjunctive
neutrophilmdsc
cxcr
adjuncts
checkpoint-targeted
identities
mdsc-targeted
carcinogenic
plasmids
-0702
log10
valueexperimental
ciresults
rs11554137
r140
r172
-conclusions
vaf
6exon
e6e2
e7e2
e8e2
microrna-99a
mir-99ahigh
mir-99alow
chemo-responsiveness
b-content
hla-bwi
cd200
aml-nc
pd1pdl1-inhibitors
pdl1-up
pro-tumor
s100a8a9
hla-abc
hla-efg
reactivate
pdl1-upregulated
cxcl12cxcr4
cxcl12-mediated
sequestration
cx-01
low-anticoagulant
cx-01-associated
untransfused
20u2009×u2009109l
derq10p10
disadvantage
evidence-
opinion-based
adc-ribose
c-parp
mnk
cgp57380
genitourinary
intermediate-size
extirpation
epididymis
rs12036333
rs10758713
rs9883101
rs6550826
irx2
rs2897047
rs7729269
cytarabine-induced
pkr-like
kinase-phosphorylated
2α
perk-p-eif2α
stress-related
eif2α
p-eif2α
c-x-c
cxcl5
mfi
cd16hi
cd33hi
lpclsc
laa-specific
cfclpc
cfucfi
laa-directed
anti-pd1-directed
cytogentically
sub-hr
eln-2017
re-assigned
eln-2010
digital-droplet
malignantn
accessn
foldn
phasesn
expressionn
atn
mir-21n
conclusionn
protein-protein
pull-down
cytoplasmnucleus
ncor
smrt
lncap
co-repressor
rit
chemotherapy-rit
fludarabine-rit
cvp
prednisone-rit
underestimate
mid-risk
dmrs
shores
uhrf1
trim71
dcc
rpk
rpo6
eomesodermin
fab-subtype
acla
dau
antileukaemic
4-d
5-dimethylthiazol-2-yl--diphenyl
tetrazolium
bromide
one-way
anova
fab-m4
debatable
atpsyn-β
adriamycin-resistant
hl-60adm
aml-berlin-frankfurt-münster
n47
n16
phk
coincide
31st
malaysian
executioners
pan-caspase
polyadenosine
diphosphate
smac
caspase-independent
risk-groups
idh2r140
wildtype
asxl1mutatedrunx1mutated
d835-positive
itdd835-positive
calculating
dn-
dn-mn
bioprocesses
transcriptome-wide
non-leukemia
stat4
atf-2
elk-1
loc285758
depicts
unreasonable
discontinuations
discarding
cauda
eqina
m2-subtype
q22q
incontinence
s1-s5
presacral
encasing
exiting
s2-s4
tradeoff
bu2
bu4
bu1
single-antigen
sirolimus-based
bu5
bu7
bu9
nonadverse
nu2009u200917
mld-who
mld-nrw
non-reaching
non-evaluable
acanthosis
nigricans
dermatomyositis
erythroderma
osteoarthropathy
pemphigus
pnp
mucocutaneous
castleman
dyskeratotic
acantholysis
intercellular
dermoepidermal
c3
ulcer
crusting
antimicrobials
instituting
olig2
aml00331
non-significant
cpg4
event-free-survival
early-deaths
early-response
leucaemicus
unspecific
haemograms
periorbital
aml1-myeloid
eto-positive
aml1-binding
acetyltransferase
acetylate
aml1-eto-negative
c646
trichostatin
leukemianon-m3
c4
-m5
myh11-cbfβ
adagio
nonadherent
modifiable
exon17
exon8
hypothesised
metabolism-related
time-to-relapse
ttr
ctps
rs12144160
aaag
dctd
rs9990999
aggg
rs693955
aaac
mrdu2009as
100-copy
malignacies
il-3r
sorter
facs
aml-cfcs
toxin-il-3
il-3rbetac
cd34cd38-cd71-
glyceraldehyde-3-phosphate
beta2-microglobin-deficient
il-3r-targeted
mir-338
unbeneficial
ptc-209
reverse-phase
mono-ubiquitinated
h2a
phosphatidylserine
externalization
cd34cd38low-
prominently
cyrmr
nct01244750
nu2009u2009416
nu2009u2009418
nu2009u2009408
-september
dasatinib-
nilotinib-treated
mrcyr
parp15
trials-newly
fto
phasecml-cp
glutathione-s-transferase
sfks
hyperactivated
atra-mediated
undertook
prolongations
deranged
cbfβ
cbfβ-aml
cut-point
wbcs
increment
3-
therapywe
analysismultivariate
p1u200au200a001
p2u200a001
p1u200a001
pu200au200a9
pu200au200a004this
lymphomatoid
papulosis
lyp
mainspring
at-101
stem-like
kg-1α
pdx
knonc
amed
spearman
syndrome-related
ds-al
tkiinsensitive
phytopharmaceuticals
invitro
1-beta-arabinofuranosylcytosine
rsnps
-360cg-201ct
-360gg-201tt
-360cc-201cc
luciferase-reporter
-360g-201t
-360c-201c
co-transfection
four-fold
pi3-k
tlril-1r-mediated
pi3-kv-akt
thymoma
kinase-3β
snail
pi3-kakt
dadi
newer-generation
nilotinibs
literatures
glycosylation-targeting
flt-deoxy-d-glucose
tunicamycin
fluvastatin
n-glycosylation
oglycosylation
glycosylated
13q12
mannose
golgi
abbreviations
atf
ccaat-enhancer-binding
2-dg
2-deoxy-d-glucose
epo
epor
gpi
glycosylphosphatidylinositol
ire1a
inositol-requiring
mapkerk
mitogen
pi3kakt
phosphatidylinositide
3-kinasesprotein
perk
rna-activated
kinase-like
ptx3
pentraxin-3
transcriptions
upr
replete
marginally
paradoxical
pave
4-bp
slippage
gc-rich
n-nucleotide
tracts
polypurine
polypyrimidine
stacking
syntheses
n-regions
ρ
e19a2-positive
subtype‑specific
three‑lncrna
expression‑based
non‑protein
rnaxa0926
30xa0memberxa0a
lrrc75axa0antisense
rnaxa01
lrrc75a‑as1
rna‑seq
amlxa0patients
cut‑off
co‑expression
cistranscompeting
proteinxa053
variantxa06
npm1mutation
itdnegative
cebpadouble
ngs-based
statecomplete
bronchoalveolar
lavage
biopsy-proven
breathhypoxia
x-rays
opacities
consolidations
ccl5
ccl5-deficient
th2
ccr3
cd4⁺
boosts
prometastatic
graded
cd62p
cd42b
cd63
pac-1
haemostasis
p-selectin
thromboplastin
willebrand
fluorochrome
vorinostatgemtuzumab
nct00673153
pdgfrab
standardisation
optimising
optimise
r115777
p020
p016
p013
p022
antitumoral
enrich
masked
prognostics
caml
aaml
2981xa0×xa0per
amplicon
protein-changing
mutationspatient
idhxa0
npmxa0
35xa0
gnaq
smarcb1
n97
leucemogenese
src-family
n109
lbp
mbp-cml
lbp-cml
or6
interruptionsreductions
androgens
tg101384
incb018424
pathogenicity
hif-2α
preleukemia
vector-transduced
mutliclonal
exacerbate
pu202fu202f55
pu202fu202f93
pu202fu202f64
readmission
pu202fu202f045
mrp2
non-elderly
flt3-itdwildtype
flt3-itdwt
n212
n143
ue2f
egfrerbb1
erlotinib
non-small-cell
meg-01
cem
sko-007
intimately
egfr-positive
cetuximab
hla-a02
b07
b40
c07
npm-derived
epialleles
patterning
epiallele
promoter-associated
evi1-positive
fertility
abortions
counselled
childbearing
semen
oocyte
gonadal
postrelapse
cenersen
azd1152
pro-drug
phosphatase-mediated
raralpha-pml
escalate
insertional
3000-fold
vp16
amlhd98-b
proliferationself-renewal
b3
e19
b2a3
chemotactic
client-owned
once-daily
nu200au200a
nomograms
nomogramsthe
marital
respectivelythe
one-compartment
enterohepatic
recirculation
emax
xa0ngml
simulated
d15-blasts
nct01015196
tle1
tle4
cooperativity
xa0nct01546038
all-causality
npm1mtno
npm1mt
reassignment
inv4
q-sole
del9qsole
21sole
non-irradiated
t11q6
dosescourse
coursescycle
iukg
intervalscycle
unitskg
hypothesis-generating
dc-to-myeloid-derived
il-2-induced
dc-to-mdsc
maturational
gata-2
gata-2-dependent
p38-dependent
chemokinecytokine
p38erk-dependent
autoregulation
il1b
cxcl2
gata-2-mediated
p38erk-gata-2
customarily
readministration
republicthe
curatively
mll-aml
cdk9
mll-driven
cdki-73
majorly
contrastively
deliverable
ic-induced
socs1
harnessing
therapeutically-targeted
vividly
hampering
mdscs-targeting
anti-angiogenesis
anti-metastasis
leukocytic
phosphoinositide-3
ptdins5p3
ptdinsp2
hydrolysis
ptdins5p-phosphatase
ptdins5p-phosphatases
ptdinsp-phosphatases
inpp4b
phosphatases
5-phosphatases
c842a
endogenously
sequencing-based
modified-truseq
gene-
de-novo
hand2-as1
microrna-1275
mir-1275
npm1-amls
bicebpα-amls
apls
splicing-gene
cell-signalling
nxa0xa028
aml99-m3
plateaued
reposted
anti-cd34
micro-vessel
mvg
flt3r
hoxb8
cre-induced
abolishes
il-3-dependent
tf-
th17
th-associated
il-17a
tgf-
scc-ll
worlwide
ido-expression
cd1a
langerin
cd207
ll-sccs
ido-positivity
ido-positive
stainings
cd11cs100cd68-
ll-scc
inv3qq
aml-inv3t
11-fold
mutationdeletion
adolescentyoung
ushered
sh3-domain-binding
glutamic
acid-rich
protein-like
sh3bgrl
accompanies
sh3grl
ponatinib-resistant
wgs
dna-pcr
endonuclease
m53
lsi
dose-intense
etoposide-cyclophosphamide
d-i
ecy
fab-criteria
nxa0xa03541
nxa0xa0251
nxa0xa0422
-37
-29
wheatley
ppms
burdened
graft-versus-leukaemia
t-replete
jaundice
stricture
bile
duct
obstructing
gastritis
csg
atrophic
dys
frailty
ambulation
cfs
gérontopôle
myeoloproliferative
leptin
aml-mf
①mf
χ119
②flt3-itd
③the
χ412
④the
χ032
aml-mf1
mybl2
mir-30a
mir-30b
mir-30c
r-banding
der11
der12
der7
der14
der15
der17
misidentified
epn
pd-l1pd-1
cmpn
olomouc
anthracycline-plus-cytarabine
ind1
ind2
c1-int-bm
crar
valuations
disutilities
hpv-induced
usual-type
vulvar
uvin
outnumber
cd8tim3
enestchina
trials-china
phaseblast
nct01275196
sensitivityreliability
2g
e2f1
cip2ac-myce2f1
pp2ac
stabilising
discontinuance
p2
posttranscriptionally
repeatedly
tcd
r-atg
bumelflu
cd34-selection
e-rosette
soybean
agglutination
secondarytreatment-related
overall-
thioredoxin-1
txn
rs1128503
rs4148350
rs2231142
meningioma-1
mdmtg
risk-assessment
cd11bgr-1
ankara
mva
pan02
c57bl6
mva-survivin
survivin-specific
splenocytes
γ-interferon
advocated
impractical
re-assessment
hrk
disrupting
a-1331852
bcl-xl-selective
rs11554137ct
reasoned
lsc17
non-core-binding
elam02
95ciu2009u-
tlr4-
myd88-associated
referent
defensin
tlr4myd88nf-κb
disruptions
microrna-10
mir-10
mir-10a
patients19
-q
reclassification
temsirolimus
lower-dose
50in
s6
ribosomal
gpg
ppg
ppp2ca
me3
ccdn2
glo1
anxa2
bmi1
hybridized
trib3
xrn2
nonpalpable
gfp-labeled
time-domain
imager
picosecond
pulsed
diode
decouple
autofluorescence
inclusions
phantoms
imageable
nb4-gfp
degrading
proteolysis-targeting
chimeras
protacs
hcc-related
kinaseras
pervasive
nraskras
convey
architectures
prenatal
laboratorial
cell9l
blastsp
n42
authorised
unblinded
better-assessed
ncald
cell-types
clinically-relevant
nct01349972
methylflashtm
r882a
reactionhere
leukemia-
-ap
zymography
rbps
interrogated
rbp
domain-focused
rbm39
sox4
stimulatory
non-solid
cellscd8
cd4cd8
amltim-3
cd40
td-pcr
swisnf
aktpi3k
translocate
p53rb
4q
epigenetically
normal-like
globally
non-remitting
ricbt
rg-csf
4u2009gy
hla-antigen
post-ricbt
fludarabinemelphalan4u2009gy
secures
pu200950
richters
carcinogen-
drug-metabolizing
p450
derivation
anti-nf-kb-treatment
cal-1
shutoff
proposing
hdcil-2
h2rs
h2r
relapse-preventive
conceptually
epigenome-associated
oct1
perceptive
mobilizing
pre-asct
refusal
apbsct
aphereses
cfu-gmkg
co-purified
elutriation
ifnγ
cd14hla-dr-
lumbar
shr
myelofibrotic
v617f-positive
v617f-mutated
v617f-negative
v617f-unmutated
adamts-13
morrow
chemotherapy-induction
lbcs
lbc
decetabine
nonmyeloid
mpn-mdsmpn
bag3
acue
underreport
neuropsychological
u2009×ul
derepression
hoxb7
cdk1-dependent
thr487
stabilized
cdk1
re-establishment
corepressor
mirna-223
firstly
apbp-cml
apbc-cml
explanatory
flt3npm1
intermediate-riskhigh-risk
sub-classifications
nxa0xa024
nxa0xa018
28xa0
rq-pcr-based
amlmonitoring
gene-specific
b-b-lbl
t-lbl
paracortical
blastoid
mantle
burkitt
b-lbl
γ
twenties
axillary
cava
tracheal
all-type
regimes
ies
salivary
cortisol
il-1rα
cd33hla-dr-negcd15cd11b
cd11bcd15
cd33hla
dr-neg
51xa0
benzene
hematotoxicity
aneuploidies
unit-granulocyte-macrophage
benzene-exposed
unexposed
n14
10u2009ppm
ptrend
pentoxifylline
pcd
aminothiol
amifostine
complements
ubiquitin-specific
usp9x
deubiquitylating
context-dependent
meningiomas
pseudo
ptk7
planar
polarity
ptk7-positive
anthracycline-induced
anthracycline-mediated
ptk7-fc
conveys
promigratory
s133
enest1st
kumamoto
-sd
microgml
intolerability
better-to-intermediate
kdms
non-mutation
azacitidine-
nct00926731
nct00952588
premise
exploit
sex-specific
thromobocythemia
cel-nos
tq
eortcgimema
13xa0
31xa0
42xa0
24xa0
pu2009u2009ns
yinishu
hubei
itching
reassessment
ching-hon
pui
pharmacogenetics
pharmacogenomic
contends
omitted
schrappe
sensitivityresistance
succinctly
raul
ribeiro
central-nervous-system
niemeyer
ras-dependent
non-gc
cd5-positive
extra-nodal
best-characterized
extrusion
jc-1
wavelength
rhodamine
level--measured
flt3itdwtflt3flt3itdwtflt--on
wtnpm1
dose-efficacy
dose-safety
dosebw
chemosensisitivity
ckmk
non-cknon-mk
non-recurrent
unravelled
cd52
gpi-linked
campath-1h
campath
gelatinase-a
collagenase
gelatinase-b
digesting
bm-mncs
postoperative
caf
mastectomy
locoregional
progesterone
cvt
her2neu
d-bmi
kgm2
u2009u20092
d-bmiu2009u2009-u20092
syndrome-like
mds-associated
mrna-binding
igf2bp3
leukemia-rearranged
cellmyeloid
cross-link
igf2bp3-regulated
untranslated
igf2bp3-mediated
quality-of-life
tnfα
lif
mds4
cessations
lenalidomideazacitidine
progression-
actrn12610000271000
flt3-aml
nu2009u2009119
cr-hr
nu2009u200931
nu2009u200950
adapting
aunps
peg-aunps
conjugation
bioactivity
sub-g1
histogram
ultrastructure
internalized
cml-specific
gsaml
facets
autobmt
allobmt
heacthy
includied
dmscs
acr
behenoyl
bhac
psl
devising
overall-survival
non-cr2
3--internal
multidimensional
n41
kmt2a-rearrangement
nup98-kdm5a
cbfa2t3-glis
flag-amsacrine
crcr
30-
amlu2009
3u2009u20093u2009u20093
pathway-related
birc5
aurka
ttk
ccnb1
pathway-specific
seondary
kappa
multi-layers
toleration
genotypephenotype
sf3b1-mutation
nosologic
nonmutated
discriminant
comutation
three-way
9qq
parameterized
quality-adjusted
qalys
circrna-sequencing
iron-deficiency
circ0009910
sponging
mir-20a-5p
mrunx
co-existing
mrunx1
abl-specific
withu200a
u200a
ofu200a
ofu200a1000
erythropoietic-stimulating
maxillofacial
gingivae
edentulous
clarification
i1
flow-based
flinders
fta
inverse-pcr
genescan
m6xa0
m9xa0
9xa
0xa0
30xa0
underdeveloped
micronuclei
clot
u200930
npm1-related
p22q22
q16q16
inv16-aml
clofarabine-containing
venoocclusive
vod
transplant-specific
jordanian
rt-polymerase
l248v
g250e
h396r
t277a
f311i
m318t
q252h
f359a
f359i
y326h
retested
all-1
tp22
mllptdwt
coincident
imf
chornobyl
anamnesis
ribonucleoside
reductases
juxtamembranous
mdsacute
raeb-t
dhaka
short-
shp-1
dephosphorylates
aminoterminal
multi-scale
sub-cellular
mimetics
antagonize
mimetic
bv6
ara-c-resistant
tnfr1
bv6-sensitive
bv6-resistant
mimetic-based
mll1
11q23-aml
arih2
granulopoiesis
triad1
antagonized
mll-ell-transduced
prognosticprogression
flt1
nme4
pcna
5q-syndromercmdraebde
observedexpected
taqman-based
cd56dim
cd107a
lymphoma-like
classification2016
hypogastralgia
colporrhagia
leukaemiasmall
cllsll
vulva
stageⅰ
stageⅲ
ⅳ
invaded
tissuse
maltoma
fli-1
ets-1
elf
elf-1
mef
nerf
exonic
2nd-
3rd-generation
t-test
fishers
tdt-
tdtaml-m0
chfr
cr-1
hematopoiesis-specific
97xa0×xa0109
-342
amounting
xa0gdl
66xa0×xa0109
harbours
tccsg
plr
non-haematolymphoid
cytokine-secreting
csts
localising
dilution
maximizing
cells-targeting
len-containing
plerixafor
plerixafor-based
dinucleotides
pt-cy
tbf-based
thiotepa
tbf
nu202fu202f77
nu202fu202f23
pu202fu202f016
counterbalanced
nu2009u200933
dfn
4-colour
relanf-kappa
contradicted
heredity
arg194trp
polymorphism-polymerase
cc421
abcg2tt3435
abcg2tt27157
diplotypes
aml60
osefs
auto-phosphorylation
mead
bartholomews
ucl
leukemiaxa0in
thames
mpals
who2016
snas
cpg-1826
encapsulate
nanostructures
lys-snas
codelivery
lys-mix
py230
py8119
oxidizing
oxlys-snas
nonoxidized
peritumorally
emt6
oxidized
rechallenge
packaged
lysate-loaded
u2
fixed-effect
random-effects
u2af1q157r156
associating
intermediate-1-ipss
u2af1s34
non-tyrosine
romiplostim
ipss-defined
group-defined
out-patients
predisposes
overhang
3-overhang
n896ga
n1079cg
n1451gc
overhangs
lengths
multivariant
plagued
multi-centre
500k
abbot
7qq31
mband
7p
fish-screened
dmcebpa
smcebpa
wtcebpa
npm1wtflt3-itdwt
m0mxa0
68xa0
22xa0
conditioningnonmyeloablative
pbpc
4xa0×xa
6xa0×xa
iiib
lipase
1-interacting
mlf1ip
cbf-kitwt
cebpamutmut
transcription-related
nu2009u200979
genecxcl12
constrictively
cxcl12
inhibitor-
bcrabl-negative
agnogenic
n57
n25
af10
-110
lomustine
alternating
mercaptopurine
norethandrolone
nct00700544
allotted
schoenfeld
irrelevant
⩽10
vegfc-targeting
amlsignificance
gf
fn
patientsu
9793ecog-swog
rituximabu2009u2009chop
gfs
reductiondose
non-febrile
nfn
ageu
hemoglobinuu2009gdl
chop-based
atll
chemoradiation
provokes
flu-bu
augmentation
flu-bu-tt
venocclusive
xa0assessing
xa0addition
tps
pre-lfs
500microl
wbcor
ia10
phr
snp-a-based
39-yr-old
d20s108
11q-q25
20q-q
infiltrations
cd45cd33cd11bcd11c
cd64-
hla-dr-myeloid
overlaps
biologically-based
attenuatedpalliative
sub-internal
sub-ilm
ilm
foveal
anatomical
two-directional
unqualified
cbfβ-myh11
plzf-rarα
npm-rarα
set-can
tel-pdgfr
duringafter
tyrosin
trimesters
trimester
wks
vesicularis
gram-positive
bacilli
bacillus
anthracis
septicemia
echocardiogram
dilated
ventricle
mugkg
acrocyanosis
shallow
sacral
dimple
digits
frontal
macrognathia
postnatal
moderate-sized
membranous
septal
fas-mediated
mir-193b
mir-193b-5p3p
mir-193b-3p
hoxa9meis1
restoring
g1s-phase
kit-ras-raf-mek-erk
managementaml
forefront
tumor-mediated
fab-m2
risk-indeterminate
ann-based
nonpromyelocytic
parsimonious
3-gene
cd109
lsp1
β-values
ann-derived
refines
hypotheses
licorice
isoliquiritigenin
isl
bioactivities
flt3-itdf691l
flt3erksignal
docking
aromatic
bioactive
single-filing
desmoplastic
keloid-like
seed-and-soil
non-marrow
metastasize
⩽65
duplications-negative
transplantation-aged
d-index
c-d-index
c-d-index-guided
1-barabinofuranosylcytosine
prioritization
multivalent
galinpepimut-s
cd8-relevant
induration
nct01266083
meta-analyses
patientsmethods
rmst
proportionality
measuresresults
violated
mcyrconclusions
nct01595295
nu2009u2009302
aza-001
mds-iwg-2006
response-related
who-aml
engrafting
pmf-relevant
calr-mutant
jak2-mutant
manipulated
infusing
haploidentical-related
donor-selected
possible-as
apheresis-derived
antibody-selected
il-2-activated
xa0×xakg
il-xa0×xa
unitsm2
nxa0xa010
bexa0xakg
pxa
ligand-mismatched
kir-b
exxa0vivo-expanded
contemporize
sal
aml15
outgrows
matricellular
cd146
prototypical
sparc--
thrombopoietin-induced
betwen
apcmin
thirty-seven
ph-cas
trisomy-
trisomy-y
monosomy-7
494u2009×u2009109l
326u2009×u2009109l
sdac
auto-bmtallo-bmt
3xa0xa07
unaltered
3xa0xa07will
ratiometric
flt3xa0mutated
arsenal
histomorphologically
admixed
consternation
pathologists
unfamiliarity
samhd1
dntp
triphosphohydrolase
cleaves
dntps
deoxyribonucleosides
inorganic
nucleoside-analog
dgtp-activated
hydrolyzes
drastic
activity-through
virus-like
particles-potentiates
ara-c-containing
ara-c-refractory
alkaloid
cephalotaxus
harringtonia
scmc-aml-2009
hht-containing
censors
high-dosage
homoharringtonine-based
multipotential
urgently-needed
cd34cd117cd133
genital
bartholin
cyst
mononucleated
prb1
p130rb2
pkcαβ
sunitinib-elicited
sunitinib-induced
fasl
caspase-2
caspase-9
mitochondria-dependent
azd8055
mtorc2
multisite
eif4e-binding
mtorc1-dependent
azd8055-treated
tmas
scc
beclin-1
factor-1α
havent
myelodisplastic
neoplasma
chemotherapyhematopoietic
crossvalidation
loocv
illustrative
a2971
rubidomycindaunomycin
dcter
ccdc26
mdm4
p53-signaling
mdm4fl
mdm4s
spindle
hepg2
bubr1
securin
nocodazole
polyploidy
p53-signal
equipments
mn1-tel
hpcs
npm1mutatedflt3itdnegative
alfa-9802
retrospectivelyprospectively
ctrt
wwox
15-dimensional
pppp
rtrs
mobilisation
forxa
subsequent-line
n259
n260
cccyr
fivefold
narrower
reduced-dose
metagalaxy
disease-relevant
mcl1-m
bortezomib-based
preplasmablast
cell-intrinsically
inadequately
signature-based
mechanism-guided
ganciclovir-associated
association-9801
-9802
dnmt3a-conserved
amino-acid
npm1flt3-internal
duplicationcebpa
autophagy‑inducing
prompting
amlxa0nb4xa0cells
microtubule-associated
proteinxa01
3-green
69xa0inhibitors
kinasexa01xa0plk1
ro3280
andxa0bi2536
lc3xa0lc3-ii
rapamycinxa0mtor
unc-51-like
kinasexa01
bi2536
mln0905
sk1-i
sbe13
hcl
nb4xa0cells
andxa0hl-60
lc3-ii
andxa0hl-60xa0cells
myths
misconceptions
rectal
wt4
log-clearance
generalizability
subcohorts
pre-diagnosis
error-corrected
variant-associated
higher-frequency
r882hc
lower-frequency
low-frequency
ccg-2891
0-
154-fold
dickkopf-1
dkk1
md-related
mrcs
flt3--tyrosine
mld-
npm1-mutatedflt3-itd
n1091
luminometric
luma
humanmethylation27
4patient
grmdsc
momdsc
ib
iia
pfi
narrowly
nongerminal
non-gcb
hydroxydaunorubicin
oncovin
chop-like
gcb
post-asct
stagingreevaluation
20q-
moderatesevere
q33
q11
q12
q31
2q31
abn17p
abn17q
inv16del16t
d14bm
pbb
pbb-rc
nxa0xa0164
5xa0xa
deployed
mf-hr
n553
treatment-specific
hd-asct
anti-myeloma
thyrosine
t11q34qq23
adipogenic
aldo-keto
reductase
1c1
akr1c1
aml-mscs
adipogenesis
osteogenesis
co-cultured
wild-
non-fit
chemotherapeutical
polychemotherapies
growths
safingol
sphingolipid
liposome
liposomes
square-root-of-time
zeta
u937-inoculated
n34
poorly-tolerated
anti-vegf
cd11bgr1
saev
blockers
icbs
never-before-seen
nonresponder
iraes
icb-based
thwart
tme-instigated
nonsquamous
dn-all
pm-all
thr315ile
timeous
time-frames
rasrtk
gigyf2
dhx15
g2e3
precedence
rasrtkmutated
∼42u2009000×
kithigh
duplicationhigh
trios
exome-wide
collaborating
co-overexpressed
conceivably
cd34cd38-cd45-low
leaded
sldh
nu2009u200985
dlc-1
os5y
fla
slamf8
anthracycline-containing
transaminases
grasp
incidenceprognostic
-q-72
intermediate-2high
-p
mir-144
taget
microgkg
or1
deadliest
tumor-host
s204
plb985
phorbol
pkc-mediated
pbx
phorbol-ester
ester-induced
homeoprotein
nsclcs
f-box
containing-7
fbxw7
top2a
i-specific
ms-275
taxol
taxol-resistant
full-blown
prodromal
thrombo-hemorrhagic
addicted
bh3-mimetic
abt-737
hgsoc
chemo-naïve
sliced
cleaved-caspase
phospho-erk
navitoclax
interleukin-2-inducible
itk
over-proliferation
mpnmds
de-methylation
gf1
cross-lineage
c-aml
-nucleotidase
dnt-1
aplasia-inducing
trecs
antibody-coupled
δrec-ψjα
trec
low-trec
high-trec
leukemia-based
cythemias
teardrop
npm1hi
methylthiazolyl
②the
antiapoptosis
hemangioma
pediatr
strabismus
e64-e68
homodimeric
krebs
decarboxylation
α-kg
neomorphic
enantiomer
midh
idh1-r132
scf
skp1
cul1
f-box-protein-type
ligases
intra-s-phase
dna-damage
taxanes
paclitaxel-sensitive
mda-mb-468
paclitaxel-resistant
mda-mb-468r
subclone
fbxw7-silenced
paclitaxel-treated
cd3cd4
cd3cd4cd3cd8
cd3-cd56
sepsissevere
rel2
rel3
cr3
rel
gli
pf-04691502
gant61
impeded
promotor
flt3in
exquisitely
m541l
buccal
rt-pcr-negative
2xa0log
xa0log
brain-derived
neurotrophic
bdnf
tropomyosin-related
trkb
carcinogen
diplolotypes
ct3435
cc2677
patient-centered
educates
patient-physician
advocates
linifanib
tr-cml
inf-α
moravia
rt-q-pcr
adulto
region-v-abl
receptor-1
florescence
pap
4q12
uncontrollable
ph-cmpn
leukemialymphoma-2
casitas
ikaros
phenotype-modifying
kinasesignal
or50
n32
p3
5del5q
7del7q
reinforce
consenting
shah
unaware
counseled
mdf
bma-1
bma-2
3y-efs
3y-os
xy
myelodydysplastic
pcrthen
hadextremely
hypermethylationis
e6a2
polyvalent
microg
delayed-type
wt1-specific
hla-a0201-positive
tetramer-positive
6tg
8-h
tgn
106-h
30-fold
nkg2a
degranulation
co-incubation
competence
scr
non-scr
plum-colored
ulcerate
cases--129
dasatinibnilotinib
hematopathy
bilatest
malignancyn
vegf-a
marrown
q-real
analyzedn
versusn
hif1an
celln
changhai
frame-shift
ush2a
europeans
rs115543896
rs72552079
rs111454937
rs60369023
ctl-
th1-
type-1
cyclooxygenase
cox2
pge2
inosnos2
self-limiting
cox2-pge2
d-first
nct01464411
cues
myeloid-biased
mll-af9-expressing
mll-af9-mediated
refinedly
three-fourth
one-fourth
fas-ligand
fade
blebbing
aml--indicating
panorama
haplo-insufficiency
haplo-insufficient
higs
neighbouring
flanked
lrmp
hcls1
hig
egil
cdw65
disclosing
panmyeloid
redundancy
enrollments
bostinib
re-started
myocet™
flag-myocet
-dimethyl
hydrazine
dichloride
attaches
enediyne
bcvac
bcnu
unresolved
nilg
pbc-defined
mrd2-related
pbchigh
mrd1neg
mrd2-negativity
pbclow
mrd1pos
pbcmrd1
punched-out
foci
osteosclerotic
osteolytic
humerus
incipient
fracturing
plasmacytosis
fixation
grade-3
nasopharyngeal
npc
pre-radiation
pre-rt
rt-40
rt-finish
3m-post-rt
cd127low-
hla-dr-cd11b
ⅲ-ⅳ
ⅰ-ⅱ
cd33-postive
upar
cd87
cd87high
cd87low
subcompartments
gpr56
subcompartment
provoked
low-cost
cancer-chronic
astrocytomas
flt-itd
fluctuating
stop-im
ccr7-
cd45ro
minimization
idh1idh2tet2
fbw7
scf-type
tmz-based
transfection-induced
u251
u373
tmz-resistant
combination-increased
antagonizes
underscoring
tnfα-blocking
enbrel
bv6arac-induced
autocrineparacrine
necroptosis
rip1
necrostatin-1
mlkl
nsa
arac-induced
bypass
o1
protumoral
microenviroment
mhc-ii
ciita
exacerbates
hypoxia-triggered
fukuoka
transplantation-comorbidity
standardising
cd8-expressing
mzh29
flt3-d835hyv
flt3-k663q
f691l
mzh29-treated
ac220-treated
pdgfr…
genomically
microrna-375
mir-375
agedu2009high
reclassified
sbt
fidelity
xrcc5
ku86
vntr
0r0r
1r
0r
error-prone
co-express
scant
non-genetic
interaction-based
nxa0xa
inefficacy
umr4
levine
nilotinib-related
two-yr
three-yr
kir2ds1
kir-ligand
kir2dsdl2
absentc1
repertoires
kir2dl2
withdraw
high-frequency
clears
unattainable
normo-
hyperplastic
erdheim-chester
ecd
cd68cd1a-
brafv600e
map2k1
lch
aorta
atrium
pseudo-tumoral
as-yet-unknown
venetoclaxazacitidine
unwilling
attainable
p034
p023
p004
favored
countires
80-fold
fab-m7
toxic-death
nonsynonymous
atp-binding-cassette
clec12a
1u202fcycle
innovating
snvs
rs2853669
-228c
-250c
karyotype-aml
mayo
post-bone
bromodomain-containing
dinaciclib
inducers
dinaciclib-induced
l23
rpl23
chg
runx1wt
osteonecrosis
cortisone
endoprothesis
innovator
nosology
t-mdsmpn
cytotoxic-radiotherapy
pgpaml
pgp-
lyaml
ly-aml
differentiation-based
differentiation-associated
dequalinium
dqa
embelin
marker-positive
p53-targeted
exposing
extensibility
isapl
kinase-3-internal
δnp73tap73
kmt2e
internally
bootstrap
resampling
bcr-ablt315igus
ct00109707
nct00384228
ca180013
ca180005
ca180006
allo-pbsct
themself
mk-positive
esf
mk-negative
non-adverse
exprassion
cellstregs
cellsmdscs
instructive
cml-mpn
jak2mpl
tp53mut
tp53wt
oci-aml2
romidepsin
re-sensitize
lct
larynx
n66
lymphoidplasmacytoid
poorly-differentiated
anchored
cross-talking
stp
resistances
mr4mr
mr5
ifnimatinib
24th
cd41
glycophorin-a
ards
hemophagocytic
lymphohistiocytosis
hlh
sil-2r
autopsy
junctional
tolerised
vaccinate
granzyme-b
appreciably
idh1and
bcl6
-mb
7q-q33
transcriptase-quantitative
cytometers
subclassify
mllkmt2a
anti-microrna
mir-19a-3p
non-mll
pknox1
ternary
pbx-containing
antagonistic
meis1hoxa9
-mediated
dce-mri
time-intensity
amplitude
vascularity
jakstat
kinase-2
synonymous
a830g
maldi-tof-ms
nt5c2
hdmp
leukaemia-berlin
münster
aml-targeted
1u2009gm2
chemo-responsive
pu2009uand
flt3-itdaml
runx1-runx1t
pχ47
perturbs
amplificationsequencing
npm1-mutatedflt3-internal
duplication-negative
idh1idh2-wild-type
idh1idh2wt
mir-133
embryonal
conceived
-198
hypospadias
four-way
mirna-mrna
sample-paired
mirnamrna
mutation-modulated
mirnasmrnas
responsea
nonoptimal
risk-related
wondered
pcrrflp
-3435
-2677
nongg
noncc
homozygote
nongc
receptor-9
∼25
microrna-155
growth-inhibitory
cebpb
idara-c
excepting
sdara-c
endure
wiley-liss
step-wise
organ-invasion
metastasis-like
sarcoma-like
destructive
re-distribution
transmigrate
invade
-71
stahlhut
slack
bouchie
biotechnol
fluids
fabris
calin
allegra
snornas
atl
imatinib-resistance
-resistant
crkl
bcr-abl-dependent
mds-refractory
castrate-resistant
sub-groups
bmc
blood-based
four-gene
whole-blood
sampled
host-tumor
interrelationship
treatmentdisease
subfractions
cd45dimcd34cd38dim-
cd45dimcd34
lend
oligoclonality
leukemia-type
cytogénétique
hématologique
prevail
pu2009double-mutation
formulated
dek‑can
non‑tumorous
kaplan‑meier
snp-based
rs4353685
rs4908185
rs7709207
rs12034
rs1554844
rs17241868
rs13385610
rs11210617
rs11169282
rs4438401
rs16894846
pu2009uu2009×u200910-u200913
cdbright
nk-like
bsi
3xa0aza-aml-001
one-hundred-twenty
n59
n23
short-course
methylprednisolone
-m2
-m3
-m4
-m7
accelerating
ld-ara-c
cnv
rs243327
ptpn22
rs2476601
mll-mllt10
htra2
gs87
gs87s
gsk3-dependent
jcclsg
pbe
bme
paraclonal
rcmd
canct00777036
imatinib-resistantintolerant
adoptively
uncovering
standard-but
experimental-treatment
resource-efficient
cyp-c
doseexposure-response
interspersed
element-1
line-1
morphology-based
manifests
data-driven
phenograph
blown
underpins
non-european
arabs
recapture
imatinib-refractory
ml-1
monocytemacrophage
non-
non-hiv-associated
hiv-infection
cup-like
cuplike
desmoplasia
dtc
hematopoietic-stem-cell
turnaround
cooperative-group
uric
s-ua
fifty-six
modifier
targeted-capture
cyp
non-caucasians
tgfbeta
cyclo-oxygenase
mdsc-inducing
cd3cd28
secondarily
cd33cd11bcd66bhla-drlowil-13r
alpha2int
nadph
oxidase
plague
hysteria
syphilis
int-2high-risk
f317ivc
t315a
sensitiveinsensitive
sgi
relieve
nanocapsules
lncs
lauroyl-modified
physico-chemical
nanosystems
mir-181b
3-untranslated
mir-181b-based
ct26
draining
relieved
spectratyping
derangement
bv
phosphotyrosine
anti-phosphotyrosine
py20
anti-py20
13a
13b
hoxa10-overexpressing
cdx4
hoxa10-binding
cdx4-binding
hoxa10-dependent
cdx4-dependent
hypersensitive
phosphoinositide-dependent
ruijin
dbc
dasatinib-treated
dosed
abw
undernormal
overweight
mll1-fusion
fgf2
βcatenin
syk-activation
fgf-r
βcatenin-
hox-expression
peritoneal
intrahepatic
car-ts
carcinomatosis
cea
re-challenges
shifting
cd25pos
cd25neg
non-lics
l-ltc-ic
fdf
nsg
nonengrafters
nongenetic
non-in
tempting
non-kit
χ559
χ192
diets
unrestricted
analyzer
mpxi
technicon
h1
bayer
first-choice
octn1
oatp1a2
rs1050152
rs60023214
mir-181
ca-aml
pbx3
nonfavorable
myelodys-plastic
plzf
itpa
fhcrc
mdacc
conceive
lactation
bcr-abl1-targeted
bcr-abl1-derived
standard-imatinib
side-effect
characterising
characterisation
mirnas-based
multidrug-related
pgp-mediated
high-mobility
box-a
recruits
procedures-karyotype
technology-each
cbfb-myhq23
preserving
stilbene
gnetin-c
aktmtor
self-selected
hrd-hsct
chemotherapy-alone
arthralgia
mdrpa
metallo-beta-lactamase
mbl-producing
colistin
sinusitis
cellulites
nu2009u-2005
nu2009u-2008
nu2009u-2011
pu2009u001
desperately
endothelium
astrocytes
non-cellular
3-dimensional
b-lymphocytes
lakhani
joks
barişta
giardini
brogi
topalovski
sbl
domchek
talwalkar
aminoglycosides
amikacin
gentamicin
cmax
aminoglycoside
vindicates
p-syk
extinguishes
at-risk
mir-183
adr
adr-resistant
hl60adr
mir-34a
counteracted
singular
a1062t
mansoura
sequence-specific
cns-gcts
non-germinomatous
germinomas
hdctautosct
cte
carboplatin-thiotepa-etoposide
cyclophosphamide-melphalan
hdct
nggcts
rostock
or2000
gptl
nct00070499
gamut
alwpebmt
tq27q23
death-1
ofxa0soluble
intermediate-cytogenetic
dek-nup214
6pqp22
nupq34
racp22
5-end
col12aq13
nup214-rac1
rac1-col12a1
3-ends
col12a1
genesnup214-rac1
rac1-
n201
n208
gothenburg
denosumab
rankl
tnfsf11
metastasis-free
doxorubicin-resistant
doxorubicin-sensitive
polymerization
ep2ep4
pka
cd4cd25-
pge2mir-10aampk
misfolded
pmns
wielding
pten-deficient
retarded
pmn
ensued
mediation
hla-c
c1
c2
c1-negative
c1-positive
kir2ds5
kir3ds1-genotyping
c1-ligand
countsconclusions
cytokeratin
non-specifically
epcam
imatinib-naive
-treated
imatinib-responsive
-unresponsive
nnd
igfs
igf-binding
igfbps
igf-system
igf-i
igf-1
vhdjh
hypermutation
anti-human
redness
subconjunctival
lacrimal
forearms
incisional
heralds
dnmt3a-mutant
long-lived
mir-3065
mir-95
mir-6718
tp22q23-positive
gmi
ela2
cytarabinedaunorubicin-based
hox-gene-embedded
anticipation
histories
non-familial
circumstance
cell-lethal
ddx4
q13
q24
tx10p10p10
wcp
aml4
n318
cd184
multi-color
cd123-positive
cd44-positive
cd184-positive
toulouse
23-
yew
gse1159
survival-associated
multiple-gene
six-gene
casp3
chaf1b
klhl24
optn
vps37c
autophagy-associated
luad
infiltration-based
infiltration-mirna
cell-associated
mir-550a
coupling
m420del
rs35191146
m408v
countered
rs628031
cytogenetically-detected
tq23q11
tp13q21
clathrin
11q21
10p13
cma-676
raeb-2
raeb-1
rars
effectuated
ms-cr
aml-like
reallocated
y-
sub-clone
flt-30
npm-30
tet-15
practically
economically
watch-and-wait
alpha-ifn
kilogram
dwk
gram-negative
very-low-dose
triphosphorylated
5-nucleotidase
5nt
ara-cmp
chictr-opc-15006492
ld-dac
id-ara-c
15areas
amlexpert
grouptrisomy
disagreement
unwillingness
randomize
teno
torque
lupus
erythematosus
atopic
dermatitis
eotaxin
bivariate
n792
misinterpreted
tyro3axlmertk
aged60
n199
gas6-
gas6-associated
cxcr7
lymphohematopoietic
lhns
lhn
fourfold
nerves
pharynx
ultraviolet
radiation-
mini-review
small-interfering
csf1
gw-2580
csf1r-expressing
hs-5-conditioned
cytokinegrowth
mds-derived
hdi
organ-systems
mediator-related
osteopathy
symptomatology
ige-dependent
psychiatric
capturing
inter-
intrapatient
arguing
organoids
open-minded
quicker
prespecified
odonnell
glimpse
non-chemotherapy
galectins-
galectin-9
dcdc-like
four-parameter
informs
bacpac
ptges
1α
cdcl2
re-susceptibile
adr-resistance
hif-1αs
adriamycin-based
cd81
tetraspanin
eln-favorable
cystatin
up-regulator
hypomethylated
5-aza-cytidine
cstl
withhold
consuming
nanopore-based
s5
nanopore
phasing
ccrs
preselected
nct01074047
i20q
budd-chiari
liver-transplanted
aml-cr
cck
risk-oriented
aml-d05
setbp1-mutation
fm140
fb3
ctsb
spectrofluorimetry
upregulator
activitiesexpression
inhibitorupregulator
ru2009u920
ru2009u580
d100chim
rfs6
rfs12
equated
expose
cvts
irc-aml
non-allogeneic
transplantation-based
hopx
aldh2
gpr44
tp53inp1
4-gene
p53-deleted
mtss1
pkc-412
pharmacologically
nononcogenic
alb-r26met
perturbations
phosphokinome
livers
kinasebcl-xl
lipolysis
regrowth
35bcr-abl-positive
flt3-npm1u2009status
flt3-npm1u2009older
preb
lowly
t-lineage
seperated
manganese
dismutase
mnsod
superoxides
hypothetically
t-containing
obstinate
flt3-itd-associated
tar-gets
underexpression
erythropoiesis-associated
ank1
cdkn1b
withxa0runx1-runx1t1xa0aml
qrt-pc-based
ofxa0runx1-runx1t1xa0transcript
tls
mrxa5
mrxa0after
andxa0pxa
mrd-xa0in
36xa0pxa
55xa0pxa
70xa0pxa
47xa0pxa
150xa0runx1-runx1t1xa0tls
50xa0runx1-runx1t1xa0tls
thexa0kitxa0mutation
byxa0runx1-runx1t1xa0tls
inxa0runx1-runx1t1xa0aml
epigeneticspliceosome
six1
sine
oculis
eya
mll-af9-induced
six1-knockdown
risct
readmissions
isrctn86187144
autosomes
biotransformation
bioactivation
pollutants
benzoapyrene--diol--epoxide
bpde
diol
epoxides
polycyclic
hydrocarbons
catalyses
propanols
isoleucine
ile
metabolically
ile105val
ileval
valval
r-2-hg
diversely
mosaic
upn
upn4
upn5
pancreatitis
upn7
heterogenicity
depicted
cd11bcd14hla-dr-
4-nitroquinoline
1-oxide
4-nqo
4-nqo-induced
4-nqo-
abcgcau2009u2009aa
curednot-cured
aml-cgi
a-cimp
a-cimpnot
cimp-
450k
a-cimp-
cgis
cginon-cgi
pluripotency
curability
idus
disease-evolution
5q-and
epo-responsive
erythropoiesis-promoting
epo-production
h-y
f-m
b2a2b3a2
computerized
midam
snp-chip
e135k
kit-d816
conjectural
eln2013
nci-ctcae
n60
n55
zubrod
involvements
kmt2ar
patientsxa0xa060
52u202fvs
apoptosis-resistant
bv6-induced
rip3
bv6-mediated
pgam5
tnfα-dependent
18f-fluorodeoxyglucose
annum
roswell
smoked
smokers
categorical
r0
e-26
sequence-based
masq
multiplexes
musashi-2
tqp
tp21q
agilent
6q
2p21
proximal
neoangiogenesis
chylothorax
prevalences
statistic
ntrk
entrectinib
larotrectinib
ntrk-fusion
npm1mutflt3-itdneg
laparosc6pic
mycloid
evidencing
bcr-abl1u2009u200910
alox5
ltb4
ltb4r1
5-lox
blt1
5-hepte
lta4
extrapolating
runx1t1runx1
46x-xt8q25q22q
t8
lyn
acceleration
or-in
or-d
cp-in
lynpten
non-src
apbc-in
aml-mds
pathogenesisheterogeneity
malat-1
lentiviral-mediated
theranostic
il30
ducts
ductules
acini
her2
cd33cd11b
kiss1-dependent
stat1stat3
pharmacoproteomic
nxa
dose-reduction
bruton
pediatrics
npm1-
flowcytometry
nonsurviving
paraspinal
sacrum
prevalenceseverity
patientsin
calculatedthe
pu200au200a05
pu200au200a178
pu200au200a512
nonanxiety
pu200au200a013
pu200au200a015
nondepression
pu200au200a007anxiety
whole-
accuvate
fore
hindrances
repaired
lentivirus-delivered
alkaline
comet
h2ax
transplanting
lentivirus-infected
sublethally
etoposide-induced
ku70
deacetylating
subanalysis
post-allo-hematopoietic
g-csf-producing
anti-gr-1
mdsc-targeting
distal-less
5-aza-dc
ru2009u202
ru2009u049
-medical
entrée
tkis-nilotinib
ponatinib-as
negates
p53-mir-34a
tp53altered
tp53unaltered
alteration-associated
mir-100
down-
expression-linked
p53-associated
tp53biallelic
p53-independent
15-deoxy-δ-prostaglandin
c000000157
hydroxychloroquine
ldf225
bms-833923
karachi
copiesml
pt-aml
50xa0yr
transplant-to-aml
xa0yr
5xa0yr
m6m7
bi-allelic
notoriously
gc-content
false-positive
double-mutation
double-loop
detections
dual-fusion
cpd
belinostat
nct00357032
ttf
dot1l
mn1-expressing
origin-derived
mn1-mediated
mn1hi
mn1hihoxa9hi
binders
densely
interconnected
cmpds
cmpd
survivalexperimental
prophage
survivalresults
incalculable
survivalconclusions
preimatinib
glioblastomas
pre-lscs
1p19q
kmt2c
chd4
pik3ca
fip1l1
fubp1
kmc2c
panel-based
clinseq-aml
tcga-aml
n142
p-value
myeloid-associated
b-cll
plx3397
asp2215
bone-related
bemd
rib
vertebrae
bisphosphonates
petcomputed
discovering
petct
leukemiacancer-associated
miseq
smarca2
ptprm
illuminate
ultrasound
coarse
echotexture
slc38a1
non-inv16
race-ethnicity
tp22q23mllt3-mll
azanucleoside
chloromas
skulls
orbits
epigastric
endoscopy
hyperemic
hematogone
reviewers
interobserver
non-mutated
second-most
znf382
bisulfate
bgs
prodrome
rigorously
nct00715637
non-supervised
mistic
integrates
visualization
co-variations
preloaded
17p13
protocolsa
accord
ifnldac
osteoblasts
bloodbm
lyl1
dnmt3
spi1
tsc22
selenium-containing
selenoprotein
af1qlow
af1qhigh
kinase3
npm1-mutflt3-itd
npm1-wtflt3-itd
mutkit
multipotent
dicer1
osteoprogenitor
confirmations
hsa-mir-30d-5p
hsa-mir-p
hsa-mir-30a-3p
hsa-mir-1275
hsa-mir-4462
eln2017
pejoratively
-98
srsf2-unmutated
allo-sct…
evaluation-27
luigi
turin
transcriptxa
thexa
ofxa
bcr-abl1xa
study-level
significantly-mutated
∼60
adaptor-linked
low-prevalence
benchmarked
dilutions
outperforming
monotone
computationally
misspecification
wbcratio
relied
re-initiate
receptor-4
reproducibly
skov-3
ntera2
intactfunctioning
tlr4myd88
csc
ela-2
pr-3
ebmt-gratwohl
prog-nostic
domain-coding
vegfvegf
cross-resistance
feared
aml-cr1
conditioning-related
deepened
pausing
peg-ifn-α
preparatory
csa
fk506
n35
n61
synribo
omacetaxine-related
pvr
pvrl2
itim
tigit
cytolytic
tigit-pvrpvrl2
reconstituted
pvrpvrl2
aven
bloodpbof
subtyper
significantp
sporadically
cllmpn
thrombocytemia
mpnmyelodysplastic
binet
pseudo-positive
hsc-like
piasy
background-matched
ofxa0aml
retreated
analyzedand
3itd
moroccan
t-lymphoid
double-blind
resistance-related
nct00046930
cmlwe
chongqing
methodthe
densityim
rct
prism
disperse
cataloguing
utilised
intensifies
scrutinise
personalised
triple-mutated
q48r
p88a
y245h
rsag
qpy
rah
hla-fully
ecm3
epithelial-to-mesenchymal
isogenic
foundxa0that
depended
aminobisphosphonates
sparc-overexpressing
doxil
thatxa0sparc
htrx1
hrx
all1
mirnome
oncomirs
type-specific
actin
filament-based
stimulus
phagocytic
mir-331
partnering
fluoresecent
pyroptotic
plk2
plk3xa0plks
g2-m
volarsetib
prs
decades-long
ncam
lympho-hematopoietic
cytotypes
company-sponsored
glycated
lipoprotein
triglycerides
natural-killer
kir2dl5a
2dl5b
2dl5all
2ds2
adtree
boosting
nxa0xa0148
κ-statistic
fpr
nxa0xa069
visualize
diversified
empowered
roadmap
dnx
daunoxome
galen
craigavon
groupthe
groupwhile
abnormalitieswhich
syndromemyeloproliferative
t-mdsmpns
tpp
47xytpp21
individalized
indexhct-ci
cd45ra
cmpl
agc
icd-10
xa0million
bavaria
eraser
tranylcypromine
weaknesses
fruitful
deliberations
goldman
colloquium
estoril
9th
10th-11th
56th
interferons
questionnaires
prepuberty
htsds
pppconclusions
syndrome-associated
pseudodiploidy
peri-transplant
mfc-detectable
n63
mrdnegmrdneg
mrdnegmrdpos
peri-hct
spi1pu1
gata1a
lcp1
lyz
mpx
nup98-hoxa9-expressing
nup98-hoxa9-induced
nup98-hoxa9-transgenic
fit3-itd
unrelation
tls-related
hyperhydration
enlisted
geno-sens
quantitate
authenticate
pearson
8-positive
hepatoma
phosphorylating
p65ser536
cxcl1
activatory
chemo
-67
undeniable
atherothrombotic
3xa0
xaxa0
xa3
100xa0
xa5
potencies
indefinite
cml212
⩾6
those6
msh6
mutation-specific
abc-transporters
autohct
-17
stps
negate
single-target
pkcalpha
erk2
perk2
pakt
pkcalpha-erk2perk2-pakt
cross-activation
multiply
runx1-eto
dual-luciferase
trans-activates
runx1-eto9a
philadelphia-chromosome
pre-excitation
thp
g-csfctg
mds-transformed
prognosis-related
ph1
allo-hsct-45
varied-bone
acidic
lm3
validations
cox-2-mediated
cox-2-independent
disengagement
lungs
sparc-driven
her2-enriched
antimetastatic
cancerimplications
azav
aza67
azav85
post-allobmt
tki-only
dli-only
outright
prelude
theses
cd4cd25foxp3
costimulator
icosl
costimulation
icos
tnf-a
cd4icosfoxp3
cd4cd25icos
cd4cd25icos-
anti-icosl
c1498
obesity-associated
nlrc4
adipocyte-mediated
metformin
very-high-risk
iag
myeloablative-conditioning
k-
8xa0
noncanonical
siderophores
2-hydroxybutyrate
bdh2
bdh2mrna
bdh2-kd
retardation
tq34q
signalizes
denotes
1-yr
re-transplant
myeloidleukaemia
non-specificwe
non-leukaemic
kit-al
⩾40
characteristicsare
osho
5q-5
7q-7
abn
no-donor
pwe
r2875
r3630
r0828
kinase-3beta
gsk-3beta
p-gsk-3beta
ser9
proteasome-mediated
unfeasible
minorities
under-representation
minority-rich
bronx
time-to-transplantation
salvagability
neoplasmsmpn
terminally
necessitates
interleukin-34
il-34
ogg-oxoguanine
glycosylase
catalysing
8-oxoguanine
ogg1-expressing
sub-stratify
pog
pericytes
jt
nonreciprocal
jts
imatnib
tradeoffs
flt3multikinase
itdxa0acute
yesno
time-varying
survivalprogression-free
ospfs
d68
one-quarter
aml02
relegated
lowered
hcts
bcl-2-
alkalosis
post-imatinib
lethally
dnmt3a-deleted
mna-sf
flt3-wild-type
baf3
hypoxia-mediated
pi-3k
inaccessible
biomaterial
scaffolds
ingrowth
biopsied
implants
inoculation
sentinel
elisseeff
ribonucleic
prognosis‑related
treml2
cysteine‑glutamate
slc7a11
nacht
lrr
pyd
domains‑containing
proteinxa02
nlrp2
damage‑inducible
4xa0protein
ddit4
lymphocyte‑specific
c‑type
lectin
familyxa011
memberxa0a
clec11a
low‑risk
pe‑06
cytoskeleton
credible
cyp2d6
rs16947
gsto2
rs156697
nu202fu202f42
nu202fu202f143
nu202fu202f66
nu202fu202f119
hla-drβ5-dp
fared
sulforaphane
pioneered
converged
dose-dependently
lessen
48xa0h
60xa0µm
oncomir
mitigating
n822
flc
pbcc
lymphocytopenia
rejuvenation
ever-aging
epidemiologic
leukemogenenic
interrelation
kcna5
ppm1j
folr1
il1r2
myof
vsig2
microenvironment-related
hemopathies
dizziness
amygdala
aregenerative
mpo-negative
lal
mds-u
mds-defining
⩾65
⩾3
n36
intermediate-low
n147
smears
adged
hoxa9-
fgf2-expression
fgf2-dependent
fgf-receptors
vocimagene
amiretrorepvec
toca
replicating
extended-release
5-fluorocytosine
preclinically
rhgg
flt3-length
hoxa9-induced
hoxa9meis1-induced
grossly
hoxa9-transduced
gprcs
anti-gpr56
l-selectin
cd62l
redistribution
ccaph-negative
raml
hidcs
single-blind
non-randomized
classificationor
-22
abc-transporter
hst
neurofibromin
thr676
nf1-mutated
fam19a5
patientsto
k313dup
adherence-enhancing
drug-screening
lmc
yopougon
abidjan
quasi-constant
globules
vitality
hlv
llv
agent-related
hlv-aml
llv-aml
pathogenesis-oriented
survivorship
oci-aml-20
mutz-3
aml--supportive
care--and
aphsct
post-aphsct
nct00566228
cd4pd-1-
cd4pd-1
cd8pd-1-
cd8pd-1
a-lmr
nkp30
dc1
αcd19
non-phosphorylated
beta-catenin
npbc
anti-npbc
differentiation-resistant
co-activation
rxr
telomerase-targeted
nu2009u2009129
p-mds
nu2009u2009108
proportionately
microscale
enhancers
cebpa-p30
cebpalp30
nt5e
cd73
cross-species
cd73a2ar
aml-transplanted
cfb
gfr
mutant-to-wild-type
low-ratio
hrflt3-itd
lrflt3-itd
supplant
extra-calvarial
epidural
testes
conforming
curative-intent
appraise
semaphorin
neuronal
concentrative
cnt3
t-negative
-1377
-1377a
destroys
leukemianon-apl
histone-modifying
hmp
conut
malnourished
non-malnourished
nu2009u2009144
posttransplantion
quinolone-derived
crcomplete
vosaroxin-containing
chr12
ph-neg
post-polycythemia
12qqq24
12q24
pla
viremia
abo-matched
abo-mismatched
①of
-63
②all
r882-
flt3-itd-
ppconclusion
centro
hematología
medicina
interna
puebla
méxico
flow-cytometry
isgc
radiomics-based
replication-competent
adenovirus
obp-301
chemosensitizing
chemosensitization
microrna-29
virally
e2f-1
telomerase-specific
virus-mediated
sex-adjusted
in-icu
imv
aml3
morphogenesis
hoxa5‑targeted
shrna‑containing
kit‑8
caspase‑3
socal
suboptimal--in
ineffectiveness
treatment--in
response--in
rage-1
-matched
psu2009u20091
polyadenylation
utr
length-variation
3utrs
scrna-seq
ccg-2961
daunomycin
5-drug
fludarabinecytarabineidarubicin
non-white
npm8
flt0
asxl5
asxl1tet2idh
ercc
xrcc
rs11615
multigenic
adaptors
dok4
dok5
dok7
mhrf
troxacitabine-based
empowerment
unnecessarily
housekeeping
mir-191
mir-199a
wt5
nf2
radiosurgery
tp13q22
tq34qbcr-abl1
cbfb
tpq22
aml-defining
flag-ida
cholesterol-lowering
hypercholesterolemia
nilotinib-induced
atherosclerotic
atherogenic
tcr-engineered
tcr-t
mbc-
lbc-cml
mcyrs
mahr
abnl12p
mk-r
crci
30min
ergometer
myofascial
verbalspatial
self-perceived
state-of-the-art
npm1abl1
gstt1-gstm1-
gstm1-
gstm1-group
pim2
pim3
infectiontransplantation
il3
indistinguishable
de-induction
continual
nu200au200a15
non-telomeric
nu200au200a39
tp73
multi-partner
precised
tq32q21
pazopanib
everolimus
sunitinib-treated
sunitinib-naïve
sunitinib-pretreated
digests
tissue-digest
circumvented
tolerant
samd9
mirage
mendelian
genitalia
histomorphologic
postapproval
dreaded
sequelae
privileged
double-hit
polymicrobial
peritonitis
mca205
sham-operated
post-septic
ly6ghigh
sepsis-enhanced
tlr-4
sepsis-induced
tlr-dependent
tumor-suppressor
non-cpg
utx
enigmatic
blast-like
metachromatic
basophil-related
leukemiasystemic
crm1
leucine-rich
kpt-185
nutlin-3a
c-m-dcs
c-l-dcs
neuroectodermal
presumptive
re-examination
surveying
pathobiologic
sterile
nsaid-activated
nag-1
myd88-positive
myd88-negative
nag-1-activated
smad-linked
tgfβ-activated
tak-1-activated
nf-κb-dependent
egf
receptor-linked
nag-1-linked
smad-4-
non-smad-tak-1-linked
copious
cell-stimulating
gemtuzumab-ozogamicin
humanized-anti-cd33
toxin-calicheamicin-γ
reemerging
cell-death
cd33-antibody
drug-transporter
pgp-1
abcb1-snps
genomic-dna
cog-aaml0531
minor-t-allele
cttt
go-arm
survival-efs
relapse-rr
no-go
hl60-cells
rs1045642-t-allele
cell-viability
cd33-snps
go-therapy
cd38-cd123
cd34cd38-cd96
cd38-tim-3
cytogeneties
theray
n69
intermediate-high-dose
very-high-dose
n336u2009n
aac➔aat
asn358thr
fs14
gly251ala
fs16
-bp
il2racd25
cxcr4cd184
prognostification
antiviral
biosynthetic
inosine
impdh
parallels
cell-type
cancertissue
owning
sirt6
genome-guardian
dna-replication
compromises
dna-pkcs
ctip
sirt6-mediated
dna-repair
recur
antiangiogenic-treated
survives
markersmarker-combinations
k-specific
kmt2a-usp2
ischemia
infarctions
t-lymphocyte-associated
dendriticaml
out-study
95-confidence
non-high
one-phase
two-phase
abormalities
n130
median102
median435
mir-143
erk5
mapk-family
electrocardiography
doppler
bnp
troponin
ejection
90ci
crd
thr308
ser473
thr308high
thr308low
e17k
akti-
tmem18
or3
il-11
at1413
cd43s
t-cell-engaging
btce
t-cell-targeting
chemo-enzymatic
coinjected
btce-format
healthstar
biosis
isi
runx1high
runx1low
genemicrornas
oncogenesoncogenic
anti-oncogenes
antracycline
fludarabine-containing
c480g
a1222g
value-assessment
frameworks
blockstm
value-based
allo-sct-related
multimodality
schemas
ttinv16
3b
rs2279744
paved
vault-transporter
florid
hsa-mir-203
3-microrna
strides
basing
hydatidiform
occurred4
ⅰ
ⅱ
dlbclpp
line-associated
clabsi
complicate
mclabsi
oclabsi
nxa0xa073
bmpsc
hla-mismatch
non-caucasian
preventable
gene-to-function
snapshot-to-dynamics
biology-to-clinic
gene-sets
function-centric
gene-set
dnm
radiotherapeutic
backward
bootstrapping
re-acquisition
scopus
random-effect
metaxl
xa0after
elderlyunfit
stabilize
carnitines
tissue-based
nu2009u5
nu2009u3
nu2009u0
afforded
affording
nxa0xa032
mrdmud
nxa0xa049
ric-based
well-balanced
synthesise
ipd
myeloid-lymphoid
50xa0
ribosomes
rpl28
genespathways
proteosynthesis
proliferativeneoplastic
hydroxymethylation
cancergruppo
hmc
nct00004128
anthracycline-cytarabine
infirmity
treatment-intensification
treatment-stratification
non-conventional
cell-kill
ozogamycin
single-payer
flt9
runx8
myelod
speculation
cd14cd16
cd127negcd25highfoxp3
cd85j
liar
nkp44
dnam-1
thbs1
hyperferritinemia
aml5
aml6
aml0
myelogysplasia
discrimininatif
backwards
bloodplasma
imipridones
gpcr
gpr132
gαq
cmor
cd65
ptds
utilising
mll-ptds
n276
mlpa
mll-rearrangement
dna-mlpa
screenings
bev
egfr-mutated
andxa0the
eortc
mda
practised
c1061ct
pthr354met
segregating
multigenerational
c10631065delaca
pthr355del
dna-binding
els
sprouty
spry4
imppressive
coinhibitory
spt-ada-gcn5-acetyltransferase
chromatin-remodeling
krasn
g12dn
usp22-deficient
deubiquitylase
ras-induced
andu2009u200910
isu
nedd8
phosphorylation-dependent
interactomes
arg2
arginine
bct-100
polarized
serinethreonine-protein
akt-dependent
crest-derived
denovo
angiogenesis-mediated
sflt-1
lipofectamine
expressionsecretion
pvax-sflt-1
mts
vein
huvecs
nonviral
nord-pas-de-calais
disappearing
dna-damage-inducible
ddit3
tempo
xa0xa0xa0xa0
overalll
re-vamping
hematopoetic
αβ
marker-negative
granulocytic-mdscs
monocytic-mdscs
mo-mdsc
cd14hla-drlow-cd86low-cd80low-cd163low-
visceral
intervai
combinational
cd15cd19cd56
aml-m
aml-m4eo
lymag
lymag-
dcp-001
multi-leukemia-associated
intradermal
50xa0million
fromxa0the
startxa0of
multi-functional
cd56high
p48
p38a
p30
p24
nf-kappab
rna-mediated
overactive
runx1cd56nf-kappab
idh4
tet4
co-existed
nonengraftment
megabases
super-enhancer
hierarchies
mx1-cre-mediated
gfi1b
benc
hijacked
eps8
pcr-negative
agedxkg
varicella
zoster
remnant
realistically
componentwise
skewness
mean-variance-dependency
mean-variance
variance-stabilizing
box-cox
rank-based
outperform
crna
tumor-activated
plasmas
tumordisease
hscscancer
camfs
agonistinhibitor
peritumoral
aml-m6
blueberry-muffin
mrc-12
abgg2
abcg2-
neighboring
heterodimers
αiib
αv
vitronectin
secondly
homeboxa9
osteopontin-induced
omega-3
polyunsaturated
pufa
prostaglandins
assessor
inv3q21q26gata2-mecom
tp23q23kmt2a-asxl2
gata2-mecom
predominating
tp23q23
mate-pair
kmt2a-asxl2
tranplantation
-26
alfa-0702
blood-mrd
pb-mrd
subhazard
aldhs
flt-3-mutated
-u2009×u2009107
nct01181258
-90
host-derived
non-responding
2u2009u
pu20092u2009u
il-15
expertise-dependent
blast-to-plasmacytoid
myeloidmyelogenous
pacritinib
momelotinib
pentraxin
individualizing
src-related
grafting
m4-aml
coexpressing
tbcr-abl1
nonotherwise
underlined
explorations
etiopathology
busulfan-based
volunteer-unrelated
tbi-based
post-mf
noncurative
blindly
tet21
who2016-reviewed
post-diagnosis
setbp
etnk
ptpn
etnk1
hb67
gmdl
peaking
anthracyclin-based
structual
raeb-
erythroblast-predominant
mdsael
2xa0yr
non-mrc
three-gene
unraveled
handful
multi-target
clone-specific
high-sensitivity
glycan
case-reports
tp13q12
setbpq12
setbp1-set-pp2a
autochthonous
triazene
dacarbazine
monofunctional
alkylators
o6-position
o6-methylguanine
o6-meg
mispairs
o6-megt
→
non-self
xenogenization
cx
o6-methylguanine-dna
adduct
autoinactivating
stoichiometric
triazenes
lomeguatrib
blastolysis
pfsrfs
（hsct）
ulcerations
erosions
dnmtis
cripartial
dnmti
fluidity
anisotropy
ristocetin
epinephrine-altered
cd41cd61
hcag
thexa0systemic
gata-1
eklf
therapy-associated
mll-related
mll-aff1
mll-mllt
mll-mllt3
septin
sept2
sept6
sept9
ct45a2
mll-mllt4
pca
pcas
pu2009u2009u
normohypercellular
countu
hematopoiesis-cd90
cd123-in
present-ed
establishedafter
treatmentare
describedthe
resultof
argentinean
m351t
n586
discerned
pathomorphological
dominantco-dominant
intermediated
enthusiasm
periosteum
peritoneum
brutally
ascitic
showes
dok6
neurite
rs361525
rs1800750
rs1800629
rs1800896
rs1800872
rs1800795
rs1800470
rs2430561
thrombomodulin
rtm
gabexate
mesilate
rtm-treated
fibrinfibrinogen
anti-dic
t-leukemia
outdated
topo
ii-related
hct-
hck
fgr
pyrrolopyrimidine
a-419259
tf-1
tf-1flt3-itd
a-419259-resistant
n676st
pram1
cd99
enriches
sarc
anti-cd99
cclg-all
normal-acute
npm1mutflt3-itd-group
npm1wtflt3-itd-
npm1mutflt3-itd-
igm2
histidineaspartic
hydrolyzing
damage-inducing
vancomycin-resistant
enterococcal
vre
non-vre
flt3d0
aml1eto-positive
c-kit-mutated
oma
pre-ponatinib
n263
n114
lymphocyteleukocyte
calgb-
calgb-9665
calgb-20202
mir-203
creb1
autologous-hct
allogeneic-hct
wm-urd
partially-matched
pm-urd
familial-mismatched
intermediate-to-poor-risk
peroxide
scavenger
catalase
α-galactosylceramide
αgalcer
southern-eastern
mpt
transducers
transcription-induced
effaced
distorted
socs1flt3-itd
homotypic
renal-cell
trait
hybrids
beta-branched
oligosaccharides
myeloid-tumour
vyxeos
cltr
active-controlled
elemental
interchanging
proline-rich
tyr-397
tyr-881
fak-
fak-positive
kg1
daunorubicin-mediated
mediated-drug
intermediatepoor
pr1
hla-a2-restricted
proteinase
hla-a2
pr1hla-a2
tetramer-specific
pr1-specific
bmi1p1
post-cr
solexa
mir-10a-5p
mir-181b-5p
mir-320d
6-mirna
pan-histone
single-group
nct01912274
wt1h
bothxa0fixed
fab-m0
m2m3
abt-199venetoclax
urgency
side-by-side
s63845
a1331852
sirnas
pro-
s63845-induced
displacement
bh3-only
bak-dependent
abt-199-induced
non-redundant
alisertib
mid-cycle
identifier01779843
meningioma1
polyphosphate
4-phosphatase
pathway-associated
mutation-internal
allo-transplantation
identifiedwe
homeodomain-containing
hemocyte
cux1-associated
xa0xa021
gynaecological
syndrome-raeb
mds-raeb
myelocyte
bastest
reaserch
advanves
lentivirus-mediated
histomorphology
phenotypegenotype
pre-mrna
atuveciclib
tg02
cytarabinedaunorubicin
multifarious
idarubicincytarabine
daunorubicincytarabine
-49
-62
-76
roche
lightcycler
inv8
corroborates
mycobacterium
mycobacteria
histoplasmosis
deoxycholate
fluconazole
wyeth
renca
b16f10
paradoxically
restrained
catabolizing
1-methyl
1mt
colorimetric
personalizing
inhibitor-based
sorbent
il17
rorγt
bcl-2bax
receptor-type
flt-ligand
factor-antibody
anti-scf
human-resistant
drugs-induced
daunorubicin-induced
apoptosisnecrosis
post-polycythemic
thiotepa-busulfan-fludarabine
pair-matched
ciap-1
ciap-2
potentials
multicentromeric
35-gene
mn-focused
non-dnmt3atet2asxl1
nonspliceosome
clinicallaboratory
landmarks
nct01460693
biochip-based
amlfusionchip
amlfusionchipv01
biochip
3race
noncross-resistant
leukaemia-initiating
gtp
ns-gfp
generics
reimbursement
del16q22
anti-ccr4
cell-deficient
anti-class
ccl17-induced
th1-polarized
ccr4-expressing
pna-based
ft3-itd
free-disease
idh1r132
idh2r172
tet2-induced
5-hydroxymethylation
tq21q32
disappointingly
aminopeptidase-inhibitor
chr-2797
metalloenzyme
re-synthesizes
kt
autosct
nxa0xa02243
triumphs
rigor
tp15q13
disastrous
yeasts
clo
70-patient
body-surface
niraparib
fallopian
brca
gbrcam
non-gbrcam
brcam
insomnia
nasopharyngitis
aacrsee
konstantinopoulos
matulonis
fusobacterium
nucleatum
pathway-targeted
avian
v-ets
erythroblastosis
e26
ewings
dlbcls
p63
erg-
pola1
psmd8
axin1
gnb2l1
erg-negative
receptor-mediated
erg-related
non-east
fluid-related
asians
2-log
indisulam
cheson
mebe
pu
sprycel
factor-8
pu2009lo
irf8hi
macrophagelo
irf8lo
pu2009xa
clofarabine-arac
aracmitoxantrone
mitoxantronetopotecanearac
penetrant
floxed
flt3itddnmt3a-mutant
rescuing
remethylation
transforms
methylation-sensitive
monocytopenia
mycobacterial
emberger
lymphedema
diffusion
ventilatory
proteinosis
warts
vascularlymphatic
sensorineural
miscarriage
hypothyroidism
∞
fludarabine-cytarabine
tagsnps
tu2009u2009c
rs55829688u2009cc
rs55829688t
rs55829688c
tp63
aggravate
chictr-ppc-14005297
kinase-specific
duarte
nu2009u200930
phf15
hr-mds
abnl
nu202fu202f2
ongoingfuture
smad4
ccl15
ccr1
non-biological
non-aml-mrc
nrp1
disparate
re-activating
preleukaemic
b-non
anti-foxp1
glycophorin
anti-foxp1anti-glycophorin
anti-foxp1anti-myeloperoxidase
gylcophorin
linages
reduced-intensitynonmyeloablative
lag
twoxa0time
allo-hct2
c0
protease-activated
par1
sch79797
treatment-responsive
monosomal-karyotype
non-monosomal-karyotype
stressing
paracancerous
chromosomally
casc15
runx1aml
flagida-lite
idarrubicin
nucleosomal
aml12
anthracenedioneanthracycline
mitoxantronecytarabineetoposide
daunorubicincytarabineetoposide
aml10
pirarubicin
ipl
ultra-performance
intraindividual
kinesin
kif2a
me-1
ht-93
digestive
peri-operative
pre-operative
post-operative
factor-based
tfr1
2tfr2
tfr2-alpha
tfr2-beta
non-membrane
tfr1r
tfr2
tfrs-independent
aml1-evi1
aml1-mtg16
aml1-prdm16
aml1-lrp16
aml1-clca2
aml1-prdx4
aml1-cacl2
calls1000
hospital-wide
triaged
fulfill
p006
fbg
morewith
bhac-dm
hla-restriction
hematopathologists
sm-eo
non-mastocytic
sm-cel
mastocytoses
mpn-eo
fulfils
premalignancies
conditionally
p38aktfoxo
oncosuppressor
bcr-abl-targeting
pharmacists
point-of-contact
trephinobiopsy
fibers
abdullah
ksa
valuesxa0xa
valuexa0xa
leucopoenia
preleukaemia
maturation-inducing
progranulocytic
burdensome
v617
hu-intolerant
ftis
farnesylation
relapse-
bms-214662
l-
r-115777
sch66336
prenylation
three-amino-acid
tgif1tgif2
uncharacterized
repressors
tgif1
mll-af9-transformed
meis1-dependent
meis1-bound
meis1tgif1
circuitries
f1
economiceducational
f2
foreign-born
language-isolation
crowding
f3
f4
ses-defined
residential-stability
moderately-high
housing-instability
ahr95
ses-indicators
pattern-based
public-health
economic-educational
ifnalpha
post-ifn
investigative
n203
cells-blasts
mitochondrial-encoded
mutations-in
synthase-were
low-regulatory
refractoryrelapse
microrna-195
autophagy-inducing
becn1
caveat
alteration-prone
ac220-resistant
high-value
dioxygenase
intermediate-i-risk
antileukaemia
flai
induction-remission
risk-classification
laborious
experimentation
dmp
nkaml
receptor-human
um2
kir-mismatched
tungsten
tungsten-based
intraoperative
66cl4
post-surgeryu2009uu2009ngml
opted
metalloproteinases
prf
trapianto
midollo
osseo
terapia
cellulare
injection-site
tbicy
signiﬁcantly
transcriptase-pcr
rist
ecp
lcp
non-randomly
nxa0xa088
nxa0xa042
non-consensual
chelator
vd
25-hydroxycholecalciferol
dfxvd
nu200au200a4
dfxvd-treated
prostaglandin-e2
pge2-regulated
cellstromal
haic
ifn5-fluorouracil
ifnfuxa0xa0cisplatin
xa0cm
internationale
contre
bcr-abl-1
ph-1-negative
rubra
trichrome
other-than-aml
degranulate
tgf-beta1
gmall
v-type
mirna-133
exportin
tss
cytoplasmic-nuclear
decitabine-
control-treated
t1q22q22q32
bmixa02
underweight
ow
e-mdsc
e-mdscs
cd123high
basogranulin
leakage
plasmaserum
cytokineschemokines
lam
thrombocytopeniaand
ifosfamide
infective
empiric
ileo-cecal
distention
ileostomy
colectomy
necrotizing
ife
stat5-related
mirna-expression
mir-221
kbm5
mir-221-stat5
taurine-upregulated
ckk-8
v-fitc-propidium
cyclophospamide
genic
dnmt3b-mediated
tetracycline-inducible
inmyc-bcl2-induced
bodiesmll-af9-induced
cell-related
aml-mld
gstt1-present
gstt1-null
cd33-ab
ambivalent
caner
lymphangiogenesis
npmi-mt
cd14-
cd2pos
cd56pos
npm1-mt
cd34pos
tdtpos
sub-telomeric
paired-end
unassociated
extremities
predilection
tgfbr2
tgfbr2myeko
metastasis-promoting
rabdosia
meta-analyzed
petos
inverse-variance
combined-modality
involved-field
weigh
tumour-suppressor
favours
mpn-blast
radionuclide
prrt
tumor-targeted
particle-emitting
somatostatin
factor-kappa
jsh23
rela
envisaged
cd25il2ra
dfsrelapse-free
rfsevent-free
dfsrfsefs
concurs
module-containing
mucin-like
emr2
tm7
scramble
sf767
g55
prohibit
d15
tet2-specific
tet2-dmcs
pro-b-all
spiking
echovirus
subsided
enterovirus
fis1
pdcd7
ang2
seventy-seven
group-
group1
group-designated
cbfalpha-aml
cbfalpha
cbfbeta
stocked
imaginative
depart
case-based
familiarize
first-remission
12xa
49xa0493
vignettes
mrps
outward
hras
hot-spot
rflp
over-represented
tq21
25q31
q35
k12
overalldisease-free
under-used
tki-related
imatinib-first
carcinomagenesis
imprecise
ontogenesis
erroneously
cd56tdtxa0blastic
hematodermic
receptor-2
afflicts
clllymphoma
bcl-2-like
co-dosing
mcl-1-selective
wehi-539
ec50
noxa
bcl2-associated
bclca
bax-248ga
reaction-
bax-248gg
bax-248a
bclcaaa-bax-248gg
1236ct
3435ct
multiethnic
xxxx
ri-cbt
tetraploid
agvhdcgvhd
p-mdscs
mp-mdscs
ifn-alpha-2
crossed
minimising
resource-intensive
prohibiting
apoptotic-inducing
all-pairs
purvalanol
resource-intensity
unleash
sin3a
c10orf53
ptprr
rergl
hot-zone
ppp1r10
transitions
b1
type-
subcellular-specific
base-specific
desorptionionization
methylation-based
mnki-8e
mnks
shrnas
mapk-mnk-eif4e
ara-c-treated
at406
osi-027
kinase-dead
at406-induced
reversely
forced-activation
sc79
s6k1
t389e
at406s
gpbsc
eisai
veliparib
femalescd-subpopulation
malescd19
bonferroni-p
bleak
tims
mir-29a
csf1-ets2
mir-processing
dicer
col4a2
spry1
non-classical
sdf-1α
pu200au200a000
rfi
pu200au200a047
ratiou200au200a
pu200au200a010
pu200au200a048
rs67437265
p122s
extra-haematological
pcytabnl
n50
coherently
non-stochastic
age-predictions
pml-para
chromophobe
coordinately
flt3-activating
disruptive
revlimidtm
celgene
haplodeficiency
33xa0
60xa0
inactive
harmonizing
pu2009mut-negcebpadm-negflt3-itdneg
pdgfrᵝ-positive
pdgfrᵝ
pdgfrᵝ-rearranged
pdgfrᵝ-gene
p51
psycho-social
mds-raebt
cephalotaxine
cr-patients
non-monosomal
mkneg
hovon-criteria
swog-criteria
cnmkneg-npm1mut
cnmkneg-npm1-wild-type
cnmkneg-npm1wt
mkpos
hematopoietic-stem-cell-transplantation
flt3-tld
m3v
kitd
flt3-lmtkd
mll-ptdtkd
unfavorably
exosome
blast-derived
cd34microbeads
linearly
aliquot
cup-shaped
biologically-active
non-captured
proof-of-principle
survial
del9qq
practice-changing
btg1
atra-treated
classifiable
geneticcytogenetic
microrna-34c
mir-34c
enforcing
re-direction
re-directed
cns-directed
ceasing
atr-selective
az20
cdk1-independent
rrm1
rrm2
azd6738
atir101
recipient-alloreactive
graft-versus-infection
-leukemia
t-cell-depleted
tcd-haplou2009u2009atir101
tcd-haplo
nu2009u200935
nu2009u200964
postxa0hsct
donor-cell
circumvention
t-amlt-mds
ultradeep
reservoirs
e1
regorafenib
striving
tumor-favoring
stat3-nf-κb-ido
stat3irf-8
ptenakt
mdsdcs
msdcs
leukemiogenesis
hyderabad
unfold
postimatinib
osto
cebpa-double
germ-line
cebpa-mutant
cebpa-single
karyotypecebpa-wild-type
gata2-mutant
cebpa-doubleflt3-inernal
non-virally
y253f
genetic-based
non-viral
flttkd
aml-array
900xa0oligonucleotide
hybridize
118xa0samples
33xa0patients
french-american‑britishxa0fab
15xa0healthy
volunteersxa0hv
83xa0genes
hv
stmn1
kitlg
mcm5
angpt1
srgn
rplp0
eno1
fcn1
add3
fcer1g
ptrpe
tmsb4x
cpa3
3xa0genes
anxa3
2xa0studied
flt3npm1-
kir-human
-u20097
-u20096
-u20092
-u
-u2009×u2009106
kir-hla-mismatched
nct00703820
dlcl
dose-dense
megaceop
pleckstrin
mcl-1ph
phkd
mcl-1-binding
ph-687
mcl-1akt
mechanism-driven
correation
lsc-specific
relocalization
multiinstitution
foxm1-overexpressing
ixazomib
hypomethylator
mutant-type
cd7-cebpa
co-sponsored
fda-nci
roundtable
expeditious
coi
coii
non-synonymous
oligodendrocyte
non-expressing
pl-21
cd34u2009u2009cells
leukemia-suppressing
65resistance
n40
equaled
moths
double-edged
topology
capitalize
purulent
unsettled
dutch-belgian-swiss
entropy
approximation
genome-informed
hematinics
b12
folic
by-far
vera-1
sgis
aml-mll
amlmll
senses
stresses
vrcz
t-lymphatic
spark
fulfillment
mito
co-morbidity
hidacmito
myelomatous
parapneumonic
plasmacytomas
meyloid
but-due
data-their
neoplasmdysplasia
foreskin
phimosis
fibres
circumcision
balanitis
xerotica
undiagnosed
nu2009u2009495
4u
nu2009u2009526
organomegaly
nxa0xa083
italian-speaking
˂3
nxa0xa030
nxa0xa012
microanatomical
non-infectious
nitrcs
post-cbt
konan
kosei
nitrc
virulence
sebaceous
lymphadenoma
parotid
glands
parotidectomy
submandibular
radiologic
aki
ckd
tumor-enhancing
copd-type
airway
anti-il6
fizz
t-regulatoryth17
nos2
th1cd8
reeducates
non-good-risk
80p
mif
mif-dependent
tumor-targeting
methodsthe
groupsp
reconsidered
hpv-associated
hpv-positive
hpv
hpv-negative
prom1
muc19
od
pegifn
m15
m18
fb
antigenallele
-c
-dqb1
1-antigenallele
antigenallele-mismatched
uk-ncri-aml17
uk-ncri-aml16
randomisation
n393
subgroup-adjusted
q1
cd33-positivity
ncri-aml17
n464
cd33-low
cd33-high
hdt
eft
he-matological
biosystems
bigdye
terminator
l387m
m388l
d276g
tree-structured
tssa
bw4
allele-level
confounded
host-versus-graft
loses
pr3-involved
inhibiter
pter
akir
ikir
rrm
ligand-ligand
gvh
group2
2dsds5
inferential
tcd-ric
hd-arac
gmh
neutrophilmyeloid-derived
neutrophilsmyeloid-derived
pd1
n44
p055
risk-stratifying
myeloid-type
wt1-negative
neg
lin-
enocitabine
fibonacci
umin000002603
hla-drlow
i-iv
mdsc-associated
ra-based
atra-based
differentiationapoptosis-inducing
ofxa0the
ra-induced
temozolomide-resistant
youtube
patientscaregivers
emotionalpsychological
uncertainties
expectancyprognosis
patient-focused
baalcs
bystander
χ387
χ435
χ009
emesis
cell-initiated
progenitor-driven
ablate
glivek
12h
microgm2
188rhenium
anti-cd66
mabcampath
dna-damaged
hcinap
double-stranded
senp3-dependent
desumoylation
rap80
ctip-dependent
brca1
fluorometric
microculture
sigmoid
emax-model
emaxec50
tyrosineserinethreonine
tnk2
ptpn11-mutant
phosphorylate
dephosphorylated
tnk2-mediated
humax-il8
rottweiler
prostration
hyporexia
onycholysis
sloughing
claws
phalanx
ungual
hydroxyurea-induced
ligand-induced
chictr-trc-10001202
reinfection
telotaggg
porphobilinogen
pbgd
localisation
ubc
ppbc
nulliparous
involution
wound-healing-like
ibuprofen
panleukemic
cixa0xa-9
cixa0xa-10
pre-allo-sct
ims
t-aml-t
aml-t
cd19cd56
aml-tq22q22
gst-θ1
gst-π1
gstp1b
rs1695
srs
intensity-modulated
image-guided
megavolt
tomotherapy
anatomically
sculpt
inoperable
justifying
anti-mdsc
ihdarac
ihdarac-based
authored
ambitious
delphi-like
osteopenia
zoledronic
absorptiometry
dxa
telopeptide
untx
osteocalcin
zometa
jaw
enrichment-capture
onco-hematology
better-adjusted
previously-untreated
-mrd
individual-mrd
individual-mrdneg
-mrdneg
individual-mrdpos
-mrdpos
lsc-
nu2009u2009908
avoidable
nonstudied
hl60pac-gfp
hl60pac-gfp-shpim2
drawback
n375
n521
n380
amlcr1
subset-specific
ideally
excludes
bcr-abl-tyrosinkinase
appearence
del11q23
del6
del21q12
neartetraploid
resistence
flamsa-reduced
treosulfan-based
aviv
moderate-severe
4-hydroperoxycyclophosphamide-purged
-51
clonogeneic
cfu-l
4hc
4hc-purged
retinoid-inducible
rinf
iaspp
fhl2
t-lak
cell-originated
topk
ots514
flt3-inhibitor
mv-engrafted
anaemic
metacentric
ider20q10del20q11q13
dual-colour
20q12
g-aramy
synergizing
ds-amkl
saussele
hebei
yanda
daopei
kitcbf-aml
χ076
χ557
χ305
χ130
survivalrfs
normative
pre-ic
6-min
6mwt
qlq-c30
subscales
fact-fatigue
e13a2b2a2
e14a2b3a2
hyper-cvad
hyperfractionated
imatinibdasatinib
short-lasting
p190bcr-abl
aldehyde-dehydrogenase-positive
dislodge
protooncogene
flt3‑itd
differentially‑expressed
leukemia‑
1‑like
3-color
myeloperoxydase
paint-a-gate
wbcin
pitfall
foxo3
circ-foxo3
3end
5end
antigen-compatible
irfa
crclm
ccl2
axa0ccr2
100u2009unitsm2
remissionu2009u2009complete
50u2009unitsm
75u2009unitsm
100u2009unitsm
50u2009unitsm2
75u2009unitsm2
tolerating
86xa0
54xa0
84xa0
triple-alkylating
-x
cd4-
sines
causatively
tritiated
serum-free
cytokine-free
racialethnic
spc
asianpacific
islander
raceethnicity
biobehavioral
intra
quantiﬁed
half-course
therapy-refractory
n11
campath-1
real-time-polymerase
genome-shattering
rejoining
cytoscanhd
chromothripsis-positive
cox-hr
1type
2type
thrombosis-free
mpl-mutated
npm1-wild-type
gapmer
spleens
emhp
hematoxylin
eosin
glycophorin-c
mixed-nodular
preponderant
cords
parsed
multimerin-1
-tkds
epigenetic-targeted
jcbbn
enterococci
nxa0xa072
nup98-ledgfpsip1
n9-l10
nup98-ledgf
ledgf
azacitidine-based
n642h
stat5b-mutated
cr51-release
hla-dr-binding
ol8
non-senile
npm1flt3-itd-
flt3-negativenpm1-mutated
expecting
mdr1-overexpressing
supratentorial
lower-grade
mucormycosis
hyperbaric
emboli
diplopia
avwd
normalisation
subsidence
pyomyositis
subacute
pyogenic
mll-menin
castrate
factor-beta
tβrii
tβrii-b
acid-induced
n68
ptrial
nct01281735
muts
b23
numatrin
turku
runxl
edger
clusterone
ecm-receptor
prkacg
ankrd7
rnfl7
ropn11
tex14
prmt8
otoa
cfap99
nrxn1
dmrt1
runx1-mutation
hsp90α
evoked
tq25q34
add5qdel5q
add7qdel7q
tp11
13q23
tp21
22q23
tq23p13
isrctn55678797
isrctn17161961
close-to-normal
renin
renin-positive
renin-negative
homogeneus
bcrp-positive
expedite
tp21q31
serotype
dt388
dt388il-3
dt388il-3k116w
exon2
d2-cd33
igv
antibody-binding
five-course
ktrs
angiopoietins
stie2
wp1130
eoai3402143
g9
aggresomal
autophosphorylated
aggravated
k63-linked
polyubiquitination
ubiquitinproteasome
mitochondria-mediated
ibfm-ambi2012
combined-type
all-
single-population
pregnancy-cml
unsafe
skm-1
g0g1-phase
bcl-w
cdc40
angeio
mistranslation
myeloid-related
question-and-answer-based
selenium
b-symptoms
graft-versus-tumour
gvt
m4-type
m6-type
risk-modification
behaviours
her2-positive
gefitinib
crizotinib
vemurafenib
npm-mutated
npm-aml
non-detectable
u20094-log
npm-cr
npm-rel
h-rel
cytometric-
wt1-based
dcl
retransplanted
14-yr-old
dasatinib-induced
17p12-pter
pleuripotent
ort
runx1aml1
otc
rasopathy
progressiontransformation
znf521
znf521-silenced
mll-af9-directed
highrisk
forecasting
attention-based
bi-directional
shortterm
att-blstm
chemotherapeuatic
limitatious
remissionas
drug-resstance
prognisis
conjugateadc
sk-hep-1
skm
cell-expressed
snedd4
chromatography-mass
flanks
deprivation-induced
nutrient
lymphocytexa0til
tilxa0infiltrates
localised
mefs
toxicants
quinone
metabolize
carcinogen-metabolizing
cyp1a1
cyp2c19
sult1a1
cyp1ab
high-inducibility
partialcomplete
by-product
purposen
intersect
empirically
nu2009u200916
misunderstood
reversals
conclusionsn
abl-kd
late-cp
e355g
g208g
e292ee
xa0y
vegfrs
g-csf-expressing
mock-expressing
aldh-high
non-csc
aldh-low
mdsc-decreasing
vegf-r2
solid-phase
ria
k-100
lowintermediatehigh
fluctuation
fat4
idh3b
relapse-specific
dnmt3a-transformed
escapes
transversions
igf2bp2
fee-for-service
enrollees
nu2009u2009265
retinoid-responsive
cxxc5rinf
rinfcxxc5
ome
signaling-related
lef-1
jakinhibitors
helicobacter
pylori
foxp3cd4
foxp3cd8
il-32
ccl21
cyclooxygenase-2
4a2
fmslike
n-ethyl-n-nitrosurea
enu
trp53
senescence-associated
well-accepted
multi-team
formations
neo-antigens
neo-angiogenesis
clinico-pathological
ascertaining
npm1wild-type
18u2009-u2009inv16
resurgence
non-primary
directedpreemptive
hypercytolysis
scrutinized
interferon-based
documenting
mir-29
α-kg-dependent
idh-directed
fp-mutated
nct00611247
single-mutated
nd3
sdhb
atp6
neutrophil-to-lymphocyte
nlr
anti-trem-1
6bg12
roc-analysis
u2009pgml
youden-index
monocyte-macrophage
ontogenetic
extra-
csf-1
semaphorins
wnt7b
converge
rorc1
mir-125a
mir-511
gene-dependent
disease-based
delineates
sw1990
panc-1
sihotairm1
migration-related
downregulating
panc
related-genes
flt3-itd-expressing
hf6flt3-itd
pretreating
hif1a
hif-1alpha
sclerodermia
terminate
ng-tkis
vitreal
triceps
homo
sapiens
n822k
group-based
t334g
cyp3a
high-coverage
leukemia-m1
conjunctival
tarsal
conjunctiva
multiorgan
rnaxa0sequencing
bcl11b
tyk2
vafs
aza-cr
concentration-time
methyltransferasehistone
whole-brain
repopulating
parthenolide
bilineage
pt-pcr
cd5-
myelomonocyte
cd34cd7
del7
q1-q4
q1-q3
mutation-independent
single-strand
tlc
regain
reinitiation
mds-iwg
endorse
mds-raeb-t
prevails
cornerstones
deviations
nct02196857
cricrp
hct-cixa0xa02
akaike
transplantation-associated
classifies
councilnational
mrcncri
ignoring
npm1neg
npm1negcepbaneg
honoring
cd70
cd70cd27
cd70-expressing
cusatuzumab
αcd70
nct03030612
mir223
novel-targeted
lmo2
french-american
fabworld
aneuploid
peripheral-blood
afflicted
myd88cxcr4
qms-pcr
leucaemia
monomyelocytic
haemorrhoids
hierarchically
cell-containing
rapid-onset
ectopically
cord-blood
cd34⁺
myeloerythroid
lymphopoiesis
broaden
expansiondifferentiation
differentiation-stage-dependent
predictive-
monitoring-biomarkers
2de-ms
fdr
α-1-antichymotrypsin
α-1-antitrypsin
transthyretin
proteomexchange
pxd002757
alpha-1-antitrypsin
acute-phase
vapa
etoposidecytarabine
mrc-10
glutamine-encoding
xeroderma
pigmentosum
omega-6
pufas
lipidome
fortunate
nonchemotherapy
leukemia-retinoic
berlin-frankfurt-munich-83
her2-reactive
cd8xa0t
checklists
purposeful
patho-mechanism
read-depth
10x
ais
pooling
nu2009u2009253
leukocytopenia
leukemia-m2
mllt11
mir29b
mir29belevated
idh-2
unambiguously
simpler
unambiguous
lymphadenectomy
s-1
tegafurgimeraciloteracil
diaziquone
cbfα-eto
recognizable
adaptable
tq35p15
locationms
predate
bridge-to-transplant
60-
liposome-based
unencapsulated
nanodrug
totaling
granulocyte-monocyte
il1rap
clonogenicity
spcs
merkel
reciprocally
interfollicular
macrophagedendritic
il35
pathogenesis-targeted
int-dac
shms
wdtc
iodine
thyroidectomy
prca
philedelphia
apcs
dc-therapy
antigen-loaded
h3k79
dnmt3a--
canyons
canyon-associated
epz5676
cfc
cml-unrelated
reinitiated
u20095
z-transformed
metabonome
1h
spectroscopy
metabonomic
glycolysisgluconeogenesis
lipoproteins
choline
nmr-based
metabonomics
manipulate
coinfused
tcons
treg-tcon
irradiation-based
full-donor
unopposed
tcon
alloantigen
mir-638
12-myristate
13-acetate-
erxa0breast
rna-29c
mir-29c
flt3-single
sequencing-determined
simplifies
standardizes
cytometry-
multiprobe
myeloidleukemia
eec
eecs
nonmelanoma
ribonucleotide
nonalkylating
patients-glasdegib
venetoclax-have
apoptotsis
prdm
prdm5
zo-1
sp600125
prdm5-induced
cell-adhesion
cd56-positive
subfertility
hysterectomy
salpingo-oophorectomy
postsurgery
melthio
fresenius
flamsa-based
trans-dominant
-αu2009-u2009β
lymphocyte-to-monocyte
lmr
1xa0×xa0109
wbcxa09
-xa0×xa0109
pre-phase
anticipates
forwards
phagocytes
heal
macrophagesmyeloid
dictated
re-education
authorisation
a2301
ratify
midostaurindaunorubicincytarabine
placebodaunorubicincytarabine
95u2009ci
d2201
iwg-mrtecnm
treatmenteuropean
adrs
exfoliative
petechiae
herpesviridae
greenebaum
saint-louis
cytopeniadysplasia
blastsacute
mfir
liposomal-encapsulated
inv16pq22tpq22cbfb-myh11
thr280
thr280ala-mutated
cycle-directed
runx1mtg8
copiesmicrog
ascribed
l-tryptophan
l-kynurenine
n125
medium-to-large
imprints
kp1-
pgm1-
34-
kp1
pgm1
79a
dnmt3aflt3npm1
24xa0hours
24xa0h-d-amb
triazole
24xa0h-d-amb-group
end-stage
antiinfective
ara-cldac
ratioor
bela
accelerated-blast-phase
non-median
generalizable
dichotomization
subid
coxph
pan-cancer
inpp4blow
leukmianet
patched
ptch1smo
pkm2
non-metabolic
cell-cycle-specific
12gy
pre-allogeneic
nu2009u2009426
gvhd-relapse
pu2009
rihru2009u
hematosepsis
post-random
daf
m-2
prbc
alopecia
circulatory
polyneuropathy
bofore
aml1cbf
betamyh11
low-response
tq23q
material-enhanced
dce
profiler
skyline™
remnants
abd-npm1
non-abd
tsga10
hif
pravastatin
s0919
well-being
dioxygenase-1
ido-1
pre-metastatic
4a
cyp4a
vegfr1
pro-metastatic
cyp4a10high
macrophage-derived
m-mdsc-mediated
inos
cbmf
allo-sct2
neutropenialeukopenia
dermatological
heavier
pim-2
low-fbxw7
high-fbxw7
fbxw7-mediated
ubiquitylation
iiiii
n829
n238
thiazolidinedione
pioglitazone
dlx
dlxs
dlx5
leukemia-freeoverall
logisticcox
cell-line
functioned
sfrp2
bcxa0we
withxa0bc
phenotyped
fluorescently
antihuman
statusxa0by
pathophysiologic
prisma
contraception
precautions
tq22q11-q12
tad-ham
dnrida
derivates
dailyxa0×xa03
dailyxa0×xa05
leukaemiaacute
dna-based
type-i
type-ii
d-cag
fnab
second-course
factor-secreting
reinfused
nct00116467
atp-cassette
inefficiency
neutralize
aortic
stenosis
exertional
pleuritic
posteroanterior
md-aml
ruralfarm
habitats
end-of-induction
fcm-mrd
jccg
aml-d16
pharmacokinetic-pharmacodynamic
arresting
underglycosylated
endoplasmatic
rna-like
c-lectin
hmicl
nxa0xa040
pan-aml-associated
aml-82
bfm-87
bfm-93
auto-
re-induced
aml13
n855
cebpz
spry2
nct00180115
nct00180102
nct00893373
non-comparative
nu202fu202f40
cru202fu202fcriu202fu202fmlfs
7u202fu202f
flag-treated
consolidative
i-cml-ped
alemetuzumab
based-ric
topography
non-inflamed
topographies
elude
witnessing
decades-since
1970s-treatment
med12
perturbing
cytotoxic-based
cml8
opgs
sheath
mpnsts
smr
non-nf1
adolescence
non-pruritic
cancerct3n3m1
high-moderately
afp
hematology-oncology
vrc
nct00546897
diseaserelapse-free
95u2009ciu2009u-
p38δ
cell-selective
keratinocytes
-dimethylbenzaanthracene
multiplicity
chemically-induced
p38δ-cko∆m
modifies
stage-
ly2
nonmetastatic
b4b8
stat1--
perforin
cd69
ly6g
acid-schiff
cd235a
electroporated
polyepitope
hypersensitivity-infiltrating
mrna-electroporated
nct00965224
autotransplants
-38
-50
offsets
detailing
menses
fgf-19
melfalan
bumel
vp-
buvp16
bem
diseasefree
ciap1
naip
ciap2
nucleosides
efficacysafety
substudy
mutationsvariants
nct01043874
lsc-engrafted
anti-cd47
fludarabin
fla-go
formidable
sgn-33
hum195
double-blinded
phosphorylated-gsk3β
psmd2
ppard
xpnpep
axin2
pcdh17
metastasized
sq-1979
heterotopic
cbf-associated
residing
kctd15
kctd
kpotassium
tetramerization
reh
tom-1
sem
pokeweed
cd34-specific
beadchip
ankyrin
ankrd28
gna15
udp-glucose
pyrophosphorylase
ugp2
n163
n218
docetaxel
lapatinib
her2-amplified
s63845-resistant
interspaced
palindromic
repeats-cas9
crispr-associated
cvcs
coagulopathic
cvc-related
post-discharge
enoxaparin
non-ac
g1-g4
cml-associated
disorientation
polydipsia
tachycardia
calcitonin
target-directed
hematuria
spatially
remittent
two-2d
3d-fluorescence
transitional
3d-fish
2d-fish
radial
d2r
given-type
urds
domain-
neverthelsess
rejecting
malignancyin
remissionin
112xa0acute
aml‑associated
62xa0patients
61xa0gene
nucleophosminxa01
kinasexa03
methyltransferasexa03α
notchxa02
notch2
french‑american‑british
co‑mutation
dnmt3a‑ccaat
αxa0cebpa
co‑mutations
flt3‑notch2
setbp1‑crebbp
dnmt3a‑cebpa
trl
trl-associated
trlpos
trlneg
lshigh
nu2009u2009303
csf2
csf3
nu2009u20099984
flt3-selective
cep701
flt3-inhibitory
curcumin
turmeric
dnr-insensitive
curcumin-induced
dnr-sensitive
bone-marrow-derived
u202f
pu202fu202f097
autopbsct
non-actuarial
atgg-csf
int-risk
alcoholic
ald
gmdsc
gmdscs
nk-induced
onco-microrna
pre‑microrna
mir-p3p
mir‑p
klotho
metabolizes
a6986g
g14690a
χ²
df2
minorpoor
gha
therapy-relevant
aml-m9
exporter
ferroportin
fpn
fpnlow
fpnhigh
b-cell-like
dlbcl-ss
dombret
xanthine
peroxidase
monoamine
t-aoc
malondialdehyde
8-hydroxydeoxyguanosine
thioredoxin
trx
gsh
8-ohdg
bcr-abl-target
myoblasts
covalently
sponges
non-emi
f317il
y253fh
f359cv
haemopathies
revolutionizing
well-validated
hma-refractory
coregulator
fprdm16
sprdm16
gtpase
mll-translocated
corroborating
ofxa0thexa0most
thexa0possible
ofxa0such
thexa0presence
ofxa0myeloid-derived
thexa0question
ofxa0prostate
thexa0level
ofxa0mdsc
thexa0patients
ofxa0granulocytic
gr-mdsc
emdsc
thexa0blood
ofxa0patients
axa0combined
thexa0obtained
ofxa0gr-mdsc
thexa0other
ofxa0mo-mdsc
ofxa0thexa0psa
thexa0tumor
ofxa0thexa0patients
axa0potential
thexa0course
northernwestern
5y
nxa0xa022
efs5y
toxicity-related
azacytidinethis
wt1wt
mutation-associated
snrpn
insr
irs2
prkaa1
deregulating
homeostatic
nct00900224
tcko
ifn-γ-response
coordinating
mir-34c-5p
p53-p21cip1-cyclin-dependent
cdkcyclin
exosome-mediated
rab27b
reinitiate
mirna-mediated
sil-2rα
iialpha
apbp
medianu2009u
neo-adjuvant
paclitaxelanti-her2
euchromatic
localizing
xxy
xo
amenorrhea
klinefelter
sex-determining
sry
uncultured
amniotic
chorionic
villi
small-number
unrestrained
tq34
flagship
mechanisms-either
signaling-have
anthracenedione
consolidationseveral
proteosome
non-catalytic
3bnc
flt3itdtkd
dnmt3b3bnc
cll1
αcll1-αcd3
unnatural
p-acetylphenylalanine
tu2005cells
inu2005vitro
co-
manuscripts
leukocytosisxaxa0×xa0109l
precursorsxa
thanxa020
thusxa0acml
aggressively
noninfectious
noncardiogenic
lymphoid-including
erythroblasts
deubiquitinating
dub3
deubiquitinates
patrin-2
tabulated
nu2009u2009101
nu2009u20098
oru2009u20093
hct-ciu2009u20093
scoreu2009u20093
gss
decompression
positivecytogenetics
negativecytogenetics
mid-positive
sdmr
peer-reviewed
fairview
plasmacytoma
ocas
ppten
non-haemopathic
evolution-free
spls
pan-european
pancaresurfup
non-langerhans
99technetium
scintigraphy
tracer
pik3
voreloxin
resistancemoreover
discontinuedall
diseasein
abl-directed
secondthird
u20093-log
u20091
ua
crystallization
tubules
atls
ch17
area-under-curve
131i-labeled
absorbed
mci
mbq
antibody-treated
prohibits
acid-resistance
ocid-resistance
-32
g-to-a
schizophyllum
basidiomycete
rhinosinusitis
sinus
spacer
socs
slc
cations
neurotransmitters
electrogenic
gtmz
gmtz
pxr
ribosomopathies
disassociation
antagonism
repopulates
informatics
bti
imia
region-abelson1
abcgcc
umin000004935
amlflt3-itd
1cr
wtxa0xa
ar-high
ar-low
aml1mtg8
pmlrar
myh11cbf
copiesmicrogram
pesistently
histochemical
obeseoverweight
30xa0gl
csf-1r
pu1-mediated
e-mailed
ldara-c
cep-701
wntbeta-catenin
ivg-csfr
anti-gd2
3f8
osteomedullary
metaiodobenzyl-guanidine
mibg
antimouse
3f8u2009u2009scgm-csf
pre-enrollment
post-cycle
13-cis-retinoic
predecessor
3f8u2009u2009gm-csf
3f8u2009u2009ivgm-csf
fcgr2a
activations
myelomonocytic-lineage
e-m4m5
megakaryocytic-lineage
e-m7
myelocytic-lineage
e-m0m1m2
subtype-dependent
imprinting
tollinterleukin-1
tir
tyrosine-based
itam
cd79ab
1-c-terminal
muc1-c
cell-penetrating
go-203
muc1-cflt3
midostaurinpkc412
go-203-induced
alvespimycin
geldanamycin
wide-reaching
agnostic
snp309
li-fraumeni
arabinoside-based
ercc5rs76871136
ercc5rs77569659
ercc5rs873601
xpcrs2228000
xpcrs2228001
xpcrs1870134
xpcrs2228001aacc
proportional-hazard
p-valueu20091
eif4g1
top1
col14a1
mrpl49
psma2
vcam1
reactome
hsa-mir-520a
proportional-hazards
non-informative
shgf
svegf
bcdr
interferon-era
tie-2
kindlin-2
kindlin-3
nontumorous
jurkat
mediocre
quadruple
coexisted
laps
lappatient
aberrancy
scattering
basophiles
hla-kir
ptditd
co-duplicated
flt3mll
coduplicated
coduplication
itdptd
idac
hospitalization-time
induction-chemotherapy
idac-p
consolidation-cycle
afterward
inadequacy
ph-mpn
headingspubmed
headings
gliterinib
blast-free
gti-2040
20-mer
cd38low
therapeutic-resistance
vasohibin-2
vash2
lsl-krasg12d
lsl-trp53r172h
pdx-1-cre
kpc
vash2-knockdown
orthotopically
vash2-deficient
tubulin
carboxypeptidase
detyrosination
vash2-induced
mocebpa
os-hazard
efs-hr
os-hr
mutatedflt3-itd
physiopathology-based
synthesize
t11q23mll
haplosct
fludarabine-melphalan-based
cyclophosphamide-based
intermediate-good-risk
restrain
cik-cell
cik-based
cp-4055
lipid-conjugated
lipophilic
moiety
cytarabine-refractory
fast-track
undrugable
circumvents
enmd-2076
orally-active
vegfr2
nxa0xa09
nxa0xa05
dysphonia
typhilitis
syncope
outnumbered
neutrophil-lymphocyte
or-intolerant
hyperfusogenic
gibbon
ape
retroviruses
adenoviruses
heterologous
sindbis
infects
laminin
laminin-r
sindbis-virus-based
cytopathic
dose-expansion
multiple-dose
quizartinib-related
ac886
studytrial
nct02675478
rel1
pif
ssdna
purine-rich
purα
purβ
pura
purb
ssdna-binding
bloodmarrow
withu2009u200910
factor-
igf
igfbp-1
igfbp
igfbp-directed
dysmaturation
retrospectived
mpo-high
χ773
pχ078
②dnmt3a
χ905
sf3b1srsf2u2af1
χ246
χ577
χ951
χ936
χ340
χ197
cd7-positivity
siah2
vitamink3
chemo-sensitivity
k562-imatinib-resistant
k562-r
phd3
normoxia
k3
siah2-phd3-
hif-1α-vegf
response-oriented
fixed-schedule
χ347
z-
blastic-phase
mk-0457
home-brew
17l7
248j22
risk-categories
reconsideration
touching
bookended
vignette
-31
non-lineage
beclin
vps34
rubicon
alfy
uvrag
ulk1
lc3
nbr1
high-expression
n442
n246
a-69
n333
airtum
slowing
pioneering
ecil-4
afebrile
bacteraemia
strains
dhplc
n-benzoylstaurosporin
v22
numbersd
χ21
χ04
cd56⁺
pb-dlbcl
abc-like
card11
clb-dlbcl
chois
rlcs
unsurprisingly
vailable
5-triphosphate-binding
rebastinib
powder-in-capsule
dysarthria
unformulated
capsules
identifier00827138
mpsl
nilotinibnil
sapacitibine
tp13q14q21
calm-af10
hdot1l
calm-af10-positive
leukemia-af10-positive
double-unit
calm-af10-
hypomorphic
2adverse
karyotypesgenotypes
non-hematologicalnon-infectious
eighty-two
aml-colony
aml-cfc
5637-conditioned
re-plating
wnt3a
recursive
partitioning
j-curve
chemotherapy-associated
urea
myelablative
lr-mds
abbreviated-scheduled
mldac
bcl2l1
cnvs
ofxa0bcl2l1
non-amplifications
tnm
discriminatory
delongs
nxa0xa0184
chromatinspliceosome
diagnosis-remission
tcd10
scd10
icd10
vegfr
nonablative
e255k
fukui
behenoylcytarabine
6-mercaptopurine
6-mp
vp-16
spac
-chemotherapy
specialization
mr3
domain-mutation
context-therapeutic
flt3itd-npm1
flt3itd-npm1-
flt3itdnpm1
flt3itdnpm1-
etoposide-mitoxantrone-cytarabine
mini-ema
idh2r
1-y
5-y
iibeta
gstpi
mrp-positive
pcr-positivity
biologicalclinical
n26
cd34cd45
sub-type
guanine-to-adenine
adenine
htert-dependent
tumorsphere
kmt2ahtert
trdv4
trdv
vδ
intravital
two-photon
leakiness
diagnosis-relapse
mutations--including
mutations--showed
flt3-non-itd
enpp2
prune2
art3
lame
elam
lame89
elam9
literature-based
pp2a-activating
set-overexpressing
p38β
set-mediated
cx-4945
set-pp2a
p38βck2set
set-dependent
explosive
inhibin-β
60u2009gdl
cpne3
ca2
-dependent
phospholipid-binding
erbb2
cpne3low
cpne3high
ph-rearrangements
cg-richest
one-
multiple-step
daurismo™
ibii
cd33cd11bhla-dr-
anti-ctla4
endeavors
shb
2-domain
bcrabl1-induced
mined
uppsala
hdac7
mds-myeloproliferative
inferences
predestination
interconnections
nation-wide
philadelphiaph
dusseldorf
duss
prognosticating
adl
cannup214
em-positive
h-aml
nu2009u2009106
post-mrd
cytopeniascytosis
cd33-targeting
dsrt
taxonomic
drug-response
dsrt-guided
ater
ntr291
adma
sdma
dimethylarginines
arf
pli
pneumopathy
alp
uni-centre
non-ma
pseudo-chèdiak-higashi
pch
pan-t
later-line
n3307
n858
n943
n358
n1148
mutdel
tp53mutdel
tp53del
all-based
aulbal
aucroc
prognosticpredictive
instituto
nacional
enfermedades
neoplásicas
inen
il-17r-positive
il-17r
jakstat3
bsbmt
procedural
pseudotumor
ipt-like
hyaline-vascular
castlemans
hvcd
hepatosplenic
mesenteryomentum
mesentery
schizophrenic
multinucleated
cd35
fascin
lymphoreticular
hhv-8
ebv-encoded
eber
mesenteric
hvcd-like
lymphocyte-rich
histogenetic
myh9
scd86
ligand-mismatching
inapplicable
treatment-sensitive
affords
benefitrisk
gauges
longerterm
secondgeneration
interleukin-13
hladr-
lin1low-
il-5
p70
skewing
microrna-370
mir-370
palmitoyl
cpt1a
fatty-acid
fao
cpt1alow
cpt1ahigh
n334
n173
omics
enrichments
cpt1as
cpss
groups-low-
high-risk-with
ibcs
myeloid-like
more-intense
g-csf-supported
titrated
idhneg
r132c
r140q
r172k
hs-438
baf3wt
t315i-mutated
baf3t315i
adverse-event
1a1
aldehydes
aldh1a1-
4-hydroxynonenal
emulate
countalc
chemotherapycc
epithelioid
sef
ewsr1-creb3l1
fibromyxoid
lgfms
fus-creb3l2
ewsr1fus-creb3l
prrx1
kmt2aprrx1
lgfmssef
extremity
13u2009cm
sef-like
lgfms-like
10u2009hpfs
321u2009mo
ockhams
razor
mln-518
informations
nap
typed
leukemia-1-long
leukemia-1-short
mcl-1s
pleomorphic
adenoma
mpa
kaplan-merier
sublingual
higher-expression
lower-expression
lipocalin
lcn2
neucleophosmin
lcn2high
lcn2-overexpression-enhanced
pu202fu202f0049
pu202fu202f008
pu202fu202f030
teratogenicity
hids
european-leukemia-net
diverged
expectedly
phosphoproteins
phospholipase
γ-1
paxillin
48-linked
deubiquitinases
labile
maxilla
svc
write-up
n856
n250
ps29mrc
dichotomous
mdr-pgp-negative
negve
mdr-pgp-posve
mdr-pgp-negve
mir-128a
-128b
leukemia-i
para-carcinoma
zhejiang
χ086
χ766
wt375
cell-activated
dc-cik
3rd
hives
liver-renal
c-mpl-
standard-high-dose
osr
renin-angiotensin
fluidelectrolyte
hla-class
c1c2
hla-cw
faecal
soft-tissue
midlevel
educating
tet2-wt
npm1mflt3-itdm-
maternally
meg3
bonding
mir-184
risk-associated
compulsory
chi-squared
r86
ibw
obesity-related
5-fu
cddp
hnc
t-lymphocytes
cmvpp65-ctls
cmvpp65
cmvpp65-ctl
cddp-resistant
hsc-3cddp-r1
tq22p
tq23p15
tp13p13
tp21p21
tq31q22
tp11q15
transfusional
thalassemia
io-associated
totolerability
tdlns
mapcs
anti-tumor-specific
tdln
endobronchial
ultrasound-transbronchial
ebus-tbna
cd80cd86
mapc
tolerance-inducing
tibsovo
agios
crh
ag120-c-001
ars
splicing-related
self-assessment
fpms
seriousness
portending
optionally
infertility
thiostrepton
tst
gpl570
fam213a
mrna-based
astonishing
t11q23mll-rearrangements
flt3-overexpressing
flt3l-conjugated
g7
polyamidoamine
pamam
dendriplex
mir-150
flt3l-guided
viabilitygrowth
mir-150-based
evolutional
nonmutational
wtp53
rationalized
p53-based
s417y
e450k
e459k
1u2009u20095
acid-mediated
cd168
beti
otx015
anti-lsc
niche-like
aneuploidytp53
footprint
alkaloids
hht-including
runx1cbfa2t1
t8p12q22q22
2p12
q34q
minimizes
egt
lbh589
phasexa0ibii
nor-1
nur77
p21waf1cip1
bcl‑xl
non‑responders
nd-cml-cp
cbfβ-myh15
idh1wild-type
mn-eo
sample-size
gly-a
cycling1
cycg1
polyploidization
pcfl
pcmzl
anchorage
celecoxib
e7123
non-cox-2
p130cas
c-src
aldehyde-dehydrogenase
aldh-positive
stemness-associated
unmask
tumoral
fbxl20
usp40
intronic
oncohematological
prognosis-dependent
patient-friendly
quality-of-life-based
orv
hetil
-1628
lim
only-2
mir-101
mrd-testing
precluded
nkt-cell
α-galcer
langerincd8α
compass-like
mll4
lung-specific
kmt2d-inactivating
super-enhancersenhancers
per2
quantitative-polymerase
normalizing
nds
approximating
age-stratified
standardly
percutaneous
non-surgical
rfa-mediated
lymphogenic
ccl-2
ccl-4
itd-mediated
outs
sub-populations
differencing
effectes
myelosupression
il-33
leukemia-bearing
leukemia-reactive
evoke
aml-rc
mds-rc
pnot
complex-karyotype
rcs
andn
wen
markersn
performedn
mutationsn
howevern
orn
revealedn
mdr1-negative
osn
concerningn
genesn
attracted
splitting
10-lncrna
mahak
tehran
intra-clonal
cnpm
air-dried
bikdd
howerver
p-erk
bikdda
ser124
confirmedly
b3a
b2a
e18a2
survival-based
interferon-α-based
ade
adep
nct00006363
bcr-ablt315i
etiologyn
primaryn
individual’s
rs2066807cg
rs187084tc
nucleotiden
egyptians
100n
reactionrestriction
fragmentn
frequentn
ourn
susceptibilityn
clln
ref1
fulfilling
ref2
folfox
folfiri
folfiri-like
cpt11
deleting
ras-mediated
iκbζ
permissive
ras-transformed
myd88-dependent
ras-initiated
probing
ras-driven
cell-autonomous
aml1cbfa2
smouldering
toxic-and
effective-than
autologousallogeneic
cna-based
observer-dependent
none-of-the-targets
tracers
slc7a5
lat1
translocator
tspo
tspo-pet
18f
fluoroethyltyrosine
fet
fet-pet
microglia
tcga-data
aif1
iba1
isocitrate-dehydrogenase
idhwt
fet-
free-of-cost
mandated
off-treatment
dcleu
regaining
knownunknown
dcdcleu-induced
t-cell-response
nonradioactive
beforeafter
antileukemic-activity
subtypesqualities
dcdcleu
transplantationdonor
infusiontherapy
culture-priming
dc-mediated
dc-vaccination
cysteine-rich
osteonectin
integrin-linked
kinaseakt
ilkakt
prognosticative
resistantrefractory
antigen-targeted
bcrs
tnfr
traf2
higer-risk
remissionpr
diseasesd
diseasepd
enterococcus
aml-m2a
il-2-diphtheria
il2dt
il-35
nct00274846
nct01106950
assessment（cga）
illuminated
survival-related
sfs
geps
exomic
ir-induced
tkiin
cmlbased
①with
-41
surviva
②univariate
significanlyt
③multivariate
pre-conditioning
mll-positive
gastroenteropancreatic
gep-nens
quandary
paranasal
ethmoidal
whitish
sinuses
concisely
biology-based
second-choice
vigilant
microrna-34a
acutexa0myeloid
unmodified
i-disparate
ligand-incompatible
i-identical
factorial
tp13q12mn1-etv6
t22
p13q21q13
mn1-etv6
mn1-stat3
triadic
mn1-fusion-negative
orchestrated
kbps
enlighten
mn1-driven
machineries
cd204
tim-3-expressing
tim-3-negative
anti-tim-3
trem2
tyro
kinase-binding
plotter
p0001
pathomechanisms
algorythm
therapy-dependent
pu202fu202f04
pu202fu202f01
sequencers
cancer-testis
tumor-restricted
-mismatched
ctnna1-methylated
ctnna1-unmethylated
reconstructed
subpathway
low-throughput
mirna-gene
subpathways
ncrna
lncrna-mrna-mirna
demrnas
linc00471
hsa-mir-100
hsa-mir-150
anp32e
ermp1
myo1b
papd7
ptgis
terf1
relatedunrelated
macric
flt3i
treatmentexperimental
heatitup
decrement
determinations
unpredicted
ag-013736
vegfr-3
pdgfr-beta
placental
composite-risk
transplant-comorbidityage
-40
well-developed
syndactyly
deformity
hdm
-69
hdm-based
upwards
recognising
re-suspended
quadruplicates
methycellulose
phytohaemagglutinin
gm-cfuc
l-cfuc
discarded
alfa-9801
ril-
ida3
ida4
intravenous-busulfan
fiba
2u202fa
non-phosphorylable
cm-1231
re-activates
mirna-181a
surviva1
ppphr
mir-200s
sccs
siteoral
hypopharynx
bu-flu
idasanutlin
nonclinical
ugt1a3
ugt
bcl-2-associated
athanogene
es2
mim1
abt737
mono-ovular
mono-chorionic
recoveries
pu202fu202f0003
pu202fu202f39
pu202fu202f1
pu202fu202f23
waas
oct-4sox2
pca-associated
decisive
residency
anti-androgen
lipogenesis
bilayers
shotgun
lipidomes
ceramidesphingolipid
pathobiochemical
ric-matched
fludarabine-melphalan
t-lymphocyte-depleting
amlmyelodysplasia
livin
pecoma
spindled
myogenic
melanocytic
pecomas
tfe3
rearrangementin
tfe3-expressing
hmb45
sma
sfpq-tfe3
fusionin
xenobiotic
glutathione-s-transferases
multiplex-pcr
liferation
pa-
tients
a4apkerk
prolifera-
as-
sociated
midkine
h3k9me3
cis-binding
crebcrematf1
cre-driven
1like
2like
asxl1srsf2
dipss-plus
careggi
signifies
consonant
cd30-positive
cytoplasmicmembranous
blush
lymphoidlymphoproliferative
obviate
vuds
vud
umpcmp-kinase
umpcmp-k
diphosphokinase
ndpk-b
5-nucleotidases
cn-iii
cdn
mdn
lymphadenopathies
multiomics
arabinofuranosyl
methyltransferase-3-alpha
categorically
tolerantresistant
rics
adrenomedullin
adm
adm-calcrl
rowley
pioneers
druker
harmonize
indefatigable
tributes
testimonies
indelible
impressions
passionate
affable
appreciating
resilience
haplo-hct
disease-freerelapse-free
conjugating
90xa0
trans-membrane
aml-ma
aml-im
tli
okt
csp
taqmanr
hypo-
ecogps
downtrend
-819
-592
-819aa
-819a
-819tc
-592ac
haploid
tata
hunan
provincethe
intermediate-2-
rigors
leap
fcss
aetiological
tonicity-responsive
tonebp
cofactor
lef1high
lymphopoiesis-related
diseasebcl2
bcl2flt3
lowpatients
imparting
thromboses
embolic
osseous
under-diagnosis
radiologist
splanchnic
uninformative
diagnosedxa0
nu2009u2009222
ntr2294
nederlandstrial
reapproval
ozogomycin
t16311c
strenuous
ici
11p15
mdr1high
mdr1low
2-step
rejoined
pericentric
1-step
breakages
ultra-low-dose
syndrome-transformed
syncytial
rsv
rtl
25th
replicate
bu-cy
flu-bu12-tg
alpha-1b
iti
pingdingshan
dimerizes
cddome
rosai-dorfman
olfactory
glycylcycline
d-ia
12u2009hours
u2009×u2009109
phosphatidylinosityl-3-kinase
ilk
propitiation
vor
patientsresults
treatmentconclusions
aza-based
notorious
pyrithione
ptpt
26u2009s
proteasome-associated
dubs
effecting
20u2009s
bcr-abl-t315i
inhibition-induced
ptpt-induced
ipps-r
arexa0thus
hif-1α-deleted-leukemias
hepatopancreatoduodenectomy
indentation
grooving
∼87
nongovernmental
sub-saharan
gabon
ascr
surfacing
transcript-positive
pro-mdsc
wilcoxon
chemonaive
interleukin-17
80u202fbce
mdsc-related
il-17stat3
muc13
high-muc13
muc13-deficient
cd103
gsk-3β
colitis-associated
m0-m5
nu2009u200948
drawbacks
interpreter
n038
prognosticated
leukemia-study
exosomal
shuttling
p19arf
tetranucleotide
npm1-wild
inter-assay
observers
ikkβ
krasg12d
urethane
pro-il-1β
cell-fate
nm005187
gcn5
arrests
iiα
e1a
ep300
juxtramembrane
patientsexperimental
eurocord
geographically
scoreresults
imputations
respectivelyconclusions
elam-2011
-77
syndrom
htert-expressing
htert-dcs
osteoblastic
chondroblastic
fabp4
osteoclasts
g-pbscs
antigen-mismatched
exemplify
non-disease
geriatricquality
syndromesacute
n132
n73
n75
lifefatigue
non-intensively
ifnα
crosses
phis
icu-level
privately
hama
cml-
n124
⩾2-fold
pbmncs
stromanon-blast
increments
5a
stat5a
donor-lymphocyte
confidence-interval
cox-regression
hyponatraemia
dyspnoea
esterification
backgrounddespite
hccmethodsusing
peri-
2-feature-based
l1-penalized
cohortsresultsthe
mrs-based
hccconclusionwe
subtypesfundingthis
guangzhou
guangdong
postdoctoral
n188
karyo
nct00002549
aml-12
pharmaceutically
revolutionize
epigenomes
theoretically
speculative
vizome
pde7b
investigator-initiated
d-interval
transaminatis
defibrotide
safetyefficacy
transcriptosome
atrx
nbs1
rad50
meis2
maximization
mitoxantrone-induced
untimely
85xa0
beta-2
antigen-class
hla-i
free-circulating
shla-i
n209
n98
shla-1
beta2-m
stimulator
ebv-associated
npc-derived
imprinted
runx1-cbfbeta
radiogenomics
mri-associated
cd83
cd49d
cd3e
rna-level
flair
t1wi
diffusion-weighted
microgliamacrophages
ncbv
293t
p42
k562-cebpα
cxcr4-mediated
bcr-abl-
3gm2
bsis
aml-92
nxa0xa02194
nxa0xa0220
nxa0xa10
nxa0xa01066
nxa0xa0263
difficult-to-diagnose
cd123-targeted
nucleolin
ncl
supposedly
cfus
bcr-abl-overexpressing
inter-laboratory
automatization
cd4cd56hematodermic
plasmocytoid
sice
ulcerated
scalp
painless
diagnostic-blastic
nm23
nm23-h1
nm23-h2
obstructed
phosphate-dependent
cml-mbc
leukemia-eleven-nineteen
lysine-rich
mll-ell-positive
minor-route
stressed
atg7
firefly
evi1-binding
couplets
racially
cytarabinemitoxantrone
non-response
vsxa
salvage-like
re-transplantation
cavernous
19g
intracavernous
phenylephrine
familialxa0cebpa-mutated
sporadicxa0cebpadm
amlxa0
germlinexa0mutations
secondxa0cebpaxa0mutation
domainxa0
tumorxa0
adultsaged
changzhou
wuxi
flt3-itd15
dnmt3a7
flt3-tkd9
carried4
nonmutant
pdlim4
pdz
evagreen
m4m5m
beating
2-drug
etv6-runx1-positive
instigated
orchestrate
microrna‑135a
mir‑135a
delocalizing
i17q10
aml-not
advises
unintended
schedule-optimization
id-arac
gpbscs
d-gpbscs
accurateto
inefficient
poorly-understood
ascertainment
underreporting
rises
mds-specific
uniformly-defined
hypopigmentation
riyadh
genetics-based
dbma
cru2009u2009cr
asp868
ser869
gly870
ile871
asp880
sgs
7deletion
nfatc1
nfat
vivit
nfatc1-mutant
gh
catch-up
delayed-onset
clinico-pathologic
pmutasxl1mut
runx1mutsrsf2mut
runx1mutphf6mut
runx1mutidh2mut
p35
il-27
ebi3
awaiting
mcgkg
centrosome
gravin
unsatisfying
fractionation
circumventing
genasense
oblimersen600
oblimersen800
interlekin-3
csl360
igg1
moab
neutralizes
proportionally
abolition
t-amls
ccbs
angiotensin
arbs
amlodipine
diltiazem
4-hydroxy-tamoxifen
hoxa9-dependent
model-free
infantil
cabral
santo
domingo
pondtm
logbook
microbiology
childs
arcgis
esri
binomial
gastroenteritiscolitis
stewardship
cns-
n70
13u2009gl
sf-mutated
sfmutation
graft-versus-1eukemia
pre-tki
baraitser-winter
bwms
fryns-aftimos
craniofrontofacial
cffs
cerebrofrontofacial
bwcff
dysmorphism
coloboma
β-
γ-acting-encoding
actb
actgq
bwsm
ccf
actinopathies
cancer-predisposing
lir
χ030
χ037
χ811
χ929
χ045
nxa0xa0121
nxa0xa060
flt3-inhibitors
quizartenib
cd4u2009u2009cd25u2009u2009foxp3
interferon-γifn-γ
factor-αtnf-α
d816v-mutated
ki-1
tissuefaxs
hmc-1
pd-1hitim-3
exhausted
antigen-experienced
temra
halved
nct00006343
nct00124748
actrn12607000614493
actrn12607000325404
andxa
scorexa
wald
reproduces
refocused
cell-engaging
mab-based
lymphobalstic
pan-macrophage
poor-
bottleneck
nyström
csiscn
pgp-170
côte
dor
steadfastly
icd-o-3
der9tq34q11
ur-bmt
ur-cbt
nu2009u20091494
nu2009u20091106
melanoma-associated
mage-a4
melanomas
phosphosphorylated-signal
crispr-cas9
nucleate
co-activators
xpf
xpg
2251au2009u2009c
22541au2009u2009c
3507gu2009u2009c
u2009t
valueu2009u
2920au2009u2009c
xpf-673cu2009u2009t
11985au2009u2009g
hr-patients
2-chloro-2-deoxyadenosine
m4m5mll
-198p
hla-drhigh
cd303
cd304
ctcl1
ccd3
ccd22
myelemia
asparaginase
aspa-mtx
numa1-pdgfrb
5q32
break-apart
narrowed
150u2009kb
numa1
coiled-coil
homodimerization
heteroassociation
numa1-rara
haematopietic
myelodysplasticmpn
epidithiodiketopiperazine
nt1721
gsqm
cd34-pbsc
x106kg
net-2010
nonhigh
cr1-aml
eight-color
sokals
eutos-certified
32radiophosphorus
eliciting
phagocytosing
wgcna
n151
n119
shcrip1
shhist1h1c
shhist1h1e
crip1
hist1h1c
hist1h1e
pif-aml
5xa0yrs
hyaluronan
glycosaminoglycan
kv562
pro-senescent
4-methylumbelliferone
agedxa
dnmt3amutant
dnmt3awild-type
cecal
appendiceal
polyphosphate-4-phosphatase
inpp4bhigh
phosphatase-dependent
akt-independent
lymphodepletion
l-pam
staurosporine
flt3-transformed
kit-transformed
anti-targets
k562-specific
nct00478985
chemotherapy-sensitization
calicheamicin-conjugated
anti-cd
33-positive
rationalise
lincrnas
repurposed
lincrna
dichotomize
linc4
t-way
epidermis
subcutis
tissue-homing
furthering
coinfiltration
flicc
high-sensitive
insertiondeletion
indel-qpcr
post-hcst
ngs-mrd
ascent
weaning
46xxxxxx18
runx1eto
founderdr
tariq
mughal
thrombocythemiaand
b7-h2
th-cell
th1-associated
b7-dc
ihl-60-t-cell
co-cultures
zinc-dependent
endopeptidases
gse13204
χ
flumelbu
flumeliv
hmscs
kumc
vimxa0is
filament
122-not
nct01707004
pentag
macrophagemonocytoid
syngenic
hhsmo
5-lipoxygenase
5-lo
apex
replenish
ageing-associated
regenerative
fraught
very-low
case-by-case
axa0chronic
axa0disease
polyserositis
steer
m2a
differencep
single‑cell
scrna‑seq
87xa0cells
sub‑populations
annotate
at‑rich
domainxa02
synaptotagmin
ifn-based
causally
clinicohematologic
panhandle
mll-af
mll-af1
mll-msf
mll-lcx
mll-larg
mll-sept6
mll-cbl
mllt11q23
mplw515lk
kitd816v
mir-494
mir-616
aml-201
3-risk
4-risk
3d
2d
may-grünwald
giemsa
streptoavidin-biotin
ten-eleven
catalyzing
under-expression
m2m3m4m5m6
cge
non-cge
vaes
ankle-brachial
abi
cardiology
uc002jit1
d43770
brela
parp1
parylation
diagnosticprognostic
tlr2-ligand
pam3csk4
slps
tlr2-l
amplivant
sparked
tantalizing
tackled
gene-based
statistically-significant
re-purposing
widely-prescribed
bromocriptine
mzb1
221286sat
223565at
dll-1
notch-1-ic
cd34peripheral
a-dependent
thr9
traf-interacting
tifa
tifa-inhibitory
xenograft-recipient
chemotoxicity
chl
stringency
pre-allo-hct
r-e
connectivity-map
r-e-mediated
betamethasone
r-es
reactivated
post-hoc
npd-l1
mipd-l1
mipd-l1-
pd-1-expressing
-infiltrating
kinder
type-a
der7tq31q21
13-bp
myh11
pcr-single-strand
anti-ras
myst
particularity
myst3-crebbp
tp11q13
16-crebbp
deceased
fascin-1
versican
tnfrsf2
tnfrsf9
e1905
thee1905
nct00313586
10xa0d
myelosyspastic
azaentinostat
50xa0xa010
perilimbal
biomicroscopy
hypoechoic
reflectivity
sarcomamyeloidu2009sarcoma
haematopathological
mn-ep
pel
ukmrc-r
acromegaly
pituitary
adenomas
factor-i
alkros1
dctn1-alk
ranbp2-alk
tbl1xr1-ros1
fusion-positive
ptpn11nf1
cebpa-positive
rete
ematologica
lombarda
tq22q22runx1-runx1t
16p13q22
tp13q22cbfb-mih
cbfb-mih11
18xa0gsqm
irain
stubbornly
unsolved
75xa0
non-eligible
19xa0
45xaxaxa0
83xa0
non-eligibility
biologies
nu2009u2009497
gfm
tgspi1-sox4-egfp
epoxide
hyrolase
ephx1
nrf2
chemoresistance-promoting
2m2
bsa2m2
os-associated
19-gene
2000×
uniformity
indels
three-hundred
fas-fasl
snpstats
haploview
-670
-844
genotype-or
pu2009g
pdtc
carcinoma-derived
obatoclax
pan-inhibitor
contraindicate
mdr1-
wt1-mrna
correspondent
tq35q21
tp23p13
npclc-aml97
adhere
inhibitor-mediated
definable
pscs
flt3-receptor
derivate
flt3-rtk
mvr
flt3-l
amlxa0is
pb-mds
bm-mds
nu2009u200947
hyphae
nonpulmonary
encapsulates
cr1mrd-
nonconsolidation
21-
∼35
totality
nct01607892
ebf3
laromustine
60-minute
factor-unfavorable
ninety-six
gene-rearrangement-positive
mll03
expresser
flt3high
t-alls
kinome
hla-drlow-
gr-mdscs
resp
computer-assisted
diagnosescharacteristics
ttfx
non-emr
ank
interleukin-2-dependent
nk-92
bms
course-dependent
co-operate
akirs
dearth
tenet
azanucleosides
ny-eso-1
vaccinating
provoke
ny-eso-1-specific
mds-directed
responseexperimental
hla-unrestricted
cdx-1401
poly-iclc
decitabineresults
cd141hi
responsesconclusions
fuchs
ambra1
n155
genesloci
flt3itd-high
flt3tkd-high
cblhigh
swelling
nuclearcytoplasmic
para-aortic
amln
evaluaten
confidencen
–
casesn
developmentn
classificationn
non-germinal
monitoring-guided
first-dose
sainte
justine
600ngml
clots
4-hoo-ifosfamide
futurethe
comprizing
tyrosinekinase
benefitreal
hma-failure
responsestable
responsesd
lin-hla-drcd11ccd123
unsaturated
gene-pathway
bipartite
alas2
bcat1
blvrb
pdgfr-
cycr
mdr1abcb1
resistant-related
mrpabcc1
mvp
bcrpabcg2
lrpmvp
mdr1bcrp
cd34-related
ncr2
cytokine-activated
nkp44itim
nkp
nkp44itim-
nkp46nkp44
nkp46nkp44-
transfection-based
nkpnkp
pcna-mediated
synapses
forges
centred
erythropoiesis-stimulating
esas
esa
pfsxa0hazard
aml-hd93
aml-hd98a
cox-proportional
rs4148405
gstm1-gstm5
rs3754446
ancestry
meningitismeningoencephalitis
lymphopenia
cytomegalovirus-dna
ganciclovir
hacettepe
overdiagnosis
overtreatment
non-transformed
rarres2--
tumor-inhibitory
rag1--
aml80
aml83
aml87
aml91
cns1
n205
wbcmul
cns3
cns2
cns5
cns1cns2
decentralised
94-micrornas
re-expressed
cross-correlation
renilla-luciferase
pre-micrornas
mir-218
mir-27b
mir-195
sub-genome
chloroquine
hcq
2000u2009ngml
imhcq
seriousxa0adverse
unimpressive
entails
inconvenience
rad51g135c
xrcc3c241t
single-dose
divided-dose
pre-mrd
msdt
pre-fcm
u2009cr
vasculogenic
andp
rasgrp1aptx
rasgrp1
aptx
aprataxin
2-gene
treat-ment
chemikine
chemicon
eramethods
non-moderate
hbu2009u200990u2005gl
comparedresults
groupsconclusion
sloan-kettering
mskcc
hftbithiotepafludarabine
hftbithiotepacyclophosphamide
busulfanmelphalanfludarabine
cell-rosette
tacrolimusmini-methotrexate
antioxidants
alpha-enolase
rhogdi2
a10
peroxiredoxin
tromomyosin
lipocortin
pathogenesis-based
ara-c-triphosphate
flagm
long-acting
anxa1
kcl22
kcl22s
kcl22r
interactors
shp1
annexin-mediated
deposited
pxd000030
sideroblast
mycbcl2bcl6
large-cell
dusp22irf4
bonen
aimedn
demonstratedn
underwentn
rdir
completen
specificityn
therapyn
xenotransplanted
lsc-selective
fq-pcr
-alls
ebv-
ebv-positive
exposition
twist-1
twist-1-mediated
occured
c584589dup
acccgc
c690gt
chemomodulation
shai
n326
f-shai
leukemia-m2a
neurosurgeons
sixty-threedifferent
g250
m351
m244
f359
3nm
nct00101660
nct00103844
tcl-1
mir130a
u6
mir-130a
bcl-2mcl-1xiap
3untranslated
region-based
drug-sensitization
p53-attenuated
response-predictive
nct01061177
deduced
δtm
r80
within-run
between-run
mdscsexperimental
ds-8273a
evaluatedresults
rebounded
biopsiesconclusions
rs2306744
rs602950
rs3215400
rs9937
rs532545
rs11598702
coherent
cvc
p39
p67
cn-aml-associated
relevancy
t315
hyper
cvad
spectacularly
bcr-abl61
il-
flad
hl-a
long-surviving
staving
resynthesized
pateamine
pata
macrolide
cap-dependent
eif4a
des-methyl
des-amino
dmdapata
apcmin-dependent
on-ct
off-ct
dsx
transfusion-independent
transfusion-independency
discouraging
mesorectal
pursues
costtime
node-positive
unfortunate
on-going
ii-iii
igimrt-sib
anti-diabetic
loco-regional
aldh1-positive
tdt-positive
tdt-negative
differentials
cholecystitis
cholelithiasis
gb-ms
-imatinib
m-hlh
shlh
aptt
ebv-negative
hlh-
59xa0yr
pxa0xa001
mds-previously
preleukemias-are
berbamine
bisbenzylisoquinoline
imatinib-associated
nxa0xa034
nxa0xa029
explanted
nme1
nme2
nme
myelo-proliferative
maxillo-ethmoidal
cyto-histological
ctx
surges
ctx-based
lin-lo
dr-
doxorubicin-cyclophosphamide
ddac
reponded
ipilimumab-treated
m1c
m1a
tlr8
anti-egfr-specific
primingexperimental
preoperatively
motolimod
cellsresults
egfr-specific
cd27
tigitconclusions
wolfson
blood-borne
candidiasis
prudent
echinocandins
hydralazine
5stable
pediactric
etv
sds
exon12
al-mds
dmt
sh3
domain-binding
sh3bp5
shrna-encoding
anisomycin
gdc--methyladenine
pi3k-mtor
cdc25b
25b
ace-27
geriatrics
cirs-g
ace-27-assessed
consolidationmaintenance
formyl
fpr1
operable
regionally
×2
bracketing
biospecimens
n2b
iiic
n2c
diarrheacolitis
lin1-hla-dr-cd33⁺cd11b⁺
cd4⁺cd25hi⁺foxp3⁺
cd8⁺
cd69⁺
cd3⁺cd4⁺
cd3⁺cd8⁺
inductionpotentiation
cd45ro⁺
angiosarcoma
patient-level
cyclespatient
favourable-intermediate
hi-hsct
msd-hsct
pr-ct
anti-glioma
rerise
nxa0xa079
nxa0xa081
radotinib-treated
gse7696
rbsurv
xa0seed
xxviii
α1
col28a1
pds5
cohesin‑associated
pds5a
zinc‑finger
dhhc‑type
zdhhc2
znf24
myo5a
mllt4
adherens
‑monophosphate
mdm-2
highbad
best-known
inhibitor-imatinib-might
ph-pos
linc00265
confounds
27-antibody
cytomic
unwanted
off-leukemia
nu2009u2009356
nu2009u200934
cd244
cd33tim3
cll1tim3
aggravating
ras-mapk
pecam
vla2
vla-
vla4
vla5
low-leukocyte
visually
linguistic
cytogps
jaccard
unlocks
n105
wt1abl
hoxa9meis1pbx3
chip-seqqpcr
nu2009u2009132
nu2009u200929
naïveresponding
nu2009u200927
bcrabltranscript
nu2009u8
mr2
disputable
hr-aml
extragonadal
leukocyte-associated
lair-1
fasay
inactivating
cytoprotective
efflux-mediated
one-hundred-one
panmyelopathy
aberration-the
cancer-induced
fixed-scheduled
ubenimex
9xa0
18xa0
14xa0
fueling
230-kda
predicative
miyazaki
prefecture
cycle-related
p16ink4a
proliferation-associated
samples-
samples-127
samples-were
mirna-based
amlmir36
aaml1031
mir-106a-363
mir-106a-5p
mir-106a
v-crk
ct10
avian-like
iiβ
cd56-negative
cd56-high
cd-15
cd15-high
ingenuity
developmentfunction
dna-associated
heritable
maturation-type
conformations
il-6-positive
lmic
ccaph
new‑generation
second‑generation
cml‑cp
first‑line
dampen
foxp3cd25highcd4
thymic-derived
ntregs
nct00002798
occurved
twist1
endued
twist1-overexpressing
mrdwt1
mrdwt7
pwt1-positive
mrdwt1-negative
pwt1
prognosis-associated
ascorbic
t-mdss
-30
-15
patient-assessed
bfore
therapy-leukemia
fact-leu
log-reduction
mrlr
pu20095
weakest
goodintermediate-risk
cytogeneticgenetic
goodintermediate
k-mrd-
k-mrd
optimizes
mri-derived
elpi
nct01385423
nct02395822
rhil-15
rhil-0
hypothesizing
tocilizumab
non-haematologic
scld
indolently
ima901
tumaps
prevaccine
a-i
apoa1
oi
pre-hematopoietic
ric-sct
induction-related
byep
incuding
aep15
krasp53
pancreas-specific
minichromosome
mcm7
mcm
rs2070215
n144s
corru2009u
ht1
ht2
corru2009u-
rs1534309
polichemotherapeutic
barrage
spliceseq
aurkb
ppp2r1b
htlv-i
hnrnph3
calhm-at
spliceosomes
ab1
bcl-2-specific
hypo-aml
electrocardiographic
echocardiographic
≈
generallyxa
osevent
-efs
unimultivariate
following-up
cml023
ven
ven-hma
pathogenetics
biostatistical
extrude
dye
tedious
dose-dependency
mtx-associated
non-hispanics
usa-born
antitubulin
noticeable
nopho-aml84
p22q23
timings
lively
low-favorable
low-adverse
wt1prame
4-yr
hundred-ten
nbpf14
odf1
nup98-rearranged
dysregulations
tranfusion
kappab-dependent
athough
folfox-bevacizumab
tregth17
cd39cd73
ectonucleotidases
anti-pd-1pd-l1
triapine
nct00381550
zbtb7a
evolutions
sfrp4
sfrp5
dkk3
tcf1
popliteal
fossa
ulcerative
reconsider
adam28
igfbp-3
igf-i-induced
hl-60u202fcells
postmyeloproliferative
nct00674479
leukemiasmall
hemisphere
sarcomatous
syrian
state-of-art
in-patient
auto-pbhsct
ibu
precondition
leuekmia
bmyeloidb-m
tmyeloidt-m
27）the
survivaldfs
survivalos
leukemia（all）
χ²，p
advancedactive
anti-t-lymphocyte
unfavorableunknown
group-aml92
ifds
3a-r882h-r882c
log10-transformed
that--when
patients--separated
classifier-derived
adequacy
sm-ahn-myeloid
mobilizes
cscs
dehydrogenase-1
aldh1bright
cd11bgr1ly6g-ly6chi
cd14hla-drlow-
nkg2acd94
hla-b
dimorphism
-21m
21t
better-educated
il-2-based
21m
-21t
cell-activating
5-ht3
palonosetron
administrations
cinv
aprepitant
phcd34cd38-
lpcs
phcd34cd38
nct00852566
lpc
q24q32
hiperdiploidy
tqq21
vγ9vδ2
mhc-unrestricted
ul-16
ulbp1
nitrogen-containing
nbp
mevalonate
pre-dli
failure-
fgfs
admixture
gm²
foothold
mihc
m1-like
bcd57cd8
m2-like
pd1tim3
double-positive
cd4pd1tim3
patients-including
thrombopoiesis-stimulating
treonine--isoleucine
d-hlpc
elution
t315t
v339l
c305r
d325d
i360s
8-gy
tbifludarabine
unsatisfied
fam3a
ca6
klrf1
atcay
ggt5
pb-wt
allotransplanted
mutb
timp-2
npm1mutb
ph-aml
transfecting
gas7
imitated
τhis
cell‑cell
connexins
cx26
cx32
cx37
cx43
cx45
connexin
npm‑1
il‑17
interferon‑γ
g3
p0
intra-uterine
oligohydroamnios
apgar
ru2009upu2009u
ru2009u443pu2009u
hsm
epi-
tax-
granulocyte-type
monocyte-type
tax-based
cml-t315i
-206
and001
histocompatability
--urinary
tsgf
leukemia（al）
fissure
excisional
n103
n255
tp53-mutation
1ikzf1
n247
ikzf1-deleted
non-allohsct
emtree
acut
leukemamlleukaemleucemleucaem
nonlympho
myelo
cd33hladr-
cd14-cd15-
cd15cd14-
cd15-cd14
gr1-low
gr1-high
vehicle-treated
transposable
unpenalized
tep
highlow-risk
mutation-based
coding-gene
escalations
ac133
mpog-h
mpog-l
palliativesupportive
w515
exonxa09
g12c
g12d
g13d
chemoattracting
antimalaria
quinacrine
nfκb-p65rela
meta-data
additivesynergistic
pstat3
gata-binding
leukaemiacml
leukemiacll
conductivity
scatter
vcs
cflar
c-flipl
c-flips
cflarl
cflars
c-flipls
rtrail
hdac6
feedforward
c1-ffl
incoherent
i1-ffl
c1-
k562-associated
c1-ffls
state-marked
hcfc1-nfya-abl1
thap1-usf1-brca2
znf263-usf1-uba52
myc-atf1-uba52
elk1-egr1-cct4
yy1-egr1-ino80c
state-mediated
australian-born
tiredness
breastfeeding
metabolizers
observational-retrospective
itraconazole
nxa0xa0114
apf
possibleprobableproven
alltrans-retinoic
dihydrofolate
dhfr
pyrimethamine
pmt
ffi
non-pretreated
relapse-free-survival
nct00151255
phase-2
p22q
e255v
t315i-bearing
att
mhc-i
low-avidity
low-affinity
gas6-mrna
gas6-mrnahigh
inv16cbfβ-myh11
gas6-mrnalow
servival
cebpadm-
、、、
leukemia（mll）gene
peroxisome
proliferator
receptor-γ
pparγ
lipid-activated
gm-csf-secreting
pparg
ccl22
gm-csf-stimulated
generalization
distilled
pre-trained
averaged
transferability
ud-hcts
1cp
b-c
drb1-dqb1
hla-matching
-33
ud-hct
allele-matched
intervene
idh2-flt3-itd
inaccurate
realised
scrupulous
idh1m
idh2m
ag-120
nct02074839
growth-suppressive
npm-alk
npm-raralpha
npm-mlf1
indentifies
tnull
karyotpe
microsatellites
bat25
bat26
d13s1267
d13s174
d2s123
d5s346
mdf15
msh3
tgfbrii
igfrii
hmlh1
mlh1
msi-high
msi-low
dehychogenase
companing
cell-directed
cd33-directed
71-yr-old
msk
trunx1-runx1t1
16tcbfb-myh11
tumor-selective
vpa-associated
vpa-induced
lbh
anti-cxcr4
post-therapeutic
deltapeak
nct00172562
stragen
ifnarac
bcr-ablbcr
ifnarac-treated
dispensing
smr4
deciphered
cross-hybridized
alpha-fucosyltransferase
fut8
recovery-based
gene-negative
χ23
pχ866
pχ647
pχ505
χ302
χ505
χ527
χ533
χ817
χ883
lnc-snhg1
aml-intergroup
mx1-cre
cre
ontogeny
broadening
intra‑cellular
garnered
isolating
chromosome‑positive
region‑proto‑oncogene
tyrosine‑protein
bcr‑abl1
fusion‑gene
treatment‑free
plausible
tumor‑derived
cp‑cml
musashi-numb
eos-mpd
non-hodgkin-lymphoma
extracutaneous
non-mc
arid1a
g1254s
npm-positive
enroled
cd34-cd15
cd110
cd45cd123cells
bench-derived
sluggishly
cd123-
χ861
χ121
χ911
dutations
χ874
χ939
limited-resources
divoire
atypicalaberrant
hd-dn
nu202fu202f44
sd-dn
nu202fu202f33
culture-negative
culture-positive
prolificans
aml-m5a
acralubicin
agranulocytic
β-d-glucan
co-primary
nct01361334
off-the-shelf
microfluidic
consumable
time-to-answer
t790m
thirdly
conducive
4xa0×xa02xa0gy-based
dose-adapted
melphalan-based
11qq
22q22
gainamplifications
emdscs
pbpftt
pbpf
blood-circulating
argidoil-10-expressing
m-
leucapheresis
phosphoinositol
3-kinase-dependent
fgf2-stimulated
selects
tnbcs
micrometastases
polymorphonuclear-mdsc
cd66bcd11bcd15cd14-
il-29
il-31
il1-β
administration-approval
tagraxofusp
metatasis
leukocytic-vegf
pbmn
directionally
all-russian
tkls
g-ha
calr-
cytosis
jak2calrmpl
genetic-pathologic
scrotum
iul
gonadotropin
×4
××
hilar
seminoma
teratoma
pt1
igccc
compe
mtx
pep
-human
retroperitoneal
inclusion-exclusion
nu2009u2009236
lrs
ihc-positivity
haemato-oncologic
gln504lys
ala499val
lys939gln
asp1104his
ccnh
val270ala
non-diploid
accc
sociodemographic
mir-216b
mir-216
composites
cd4cd25
instincts
treg-specific
demethylated
tsdr
foxp3-tsdr
crc-related
nxa0xa01057
bmixa0xa
nxa0xa092
-25
nxa0xa0746
nxa0xa0219
ilt3
sokal-low-risk
accidental
polydactylia
im-
matched-pairs
reassuring
anti-s100a8
mechanismspathways
pi3akt
foxo3a-p27
wbc50xl
well-characterised
inductionfirst-line
a2ar
a2br
anti-lymphoma
adenosine-mediated
xeno-transplanted
ecto-enzyme
s6k
pkcα
nu2009u2009201
nu2009u2009270
cml-t1
patientsxa0that
meticulous
contemplate
cdc42
rhoh
antagonising
zap-70
deactivation
gtp-rac
xr
mrhrxr
timepoint
u200950
nu2009u2009109
re-achieve
equivalence
nu2009u20091265
nu2009u20091456
ft14
nu2009u2009403
ft12
fb4
fb2
bcr-abelson
co-target
two-cohort
bl-8040
motixafortide
pembrolizumab
nct02826486
dcr
mitt
bor
tlymphoblasts
age30
myag-positive
myag-negative
amlmrc
vertebral
osteomyelitis
aided
flt3d835y
mn1-associated
microrna-20
microrna-181b
squares
plsr
collapses
2x
aml-npm1
dn
comutations
aml-npm
uniformed
multi-centered
afap1l1-pdgfrb
cytogeneticsfish
mds-like
mdr-negative
hel9217
tf1-alpha
tnfalpha-induced
mdr-
p100
blots
wst-1
tumor-adjacent
mcf-7
cox-adjusted
coughs
as-qpcr
liposome-encapsulated
biologics
omitting
nxa0xa0109
nxa0xa011
nxa0xa8
nxa0xa2
bmn673
talazoparib
nl101
saha-bendamustine
syndromesmyeloproliferative
somaticacquired
pbhsct
univarite
admitting
rraml
inter-related
anthracyclinecytarabine-based
cg-sh
nod
alternation
npm1-based
cd34dim
cryptococcosis
cryptococcus
neoformans
livid
papulovesicles
exudativum
contagiosum
spores
tzanck
ozogamicinxa0xa0daunorubicin-cytarabine
goxa0xa0da
materialsxa0
hdarac
2u2009gmu2009gm2
idarac
ldarac
3u2009gm2
anti-relapse
cyto-
methyl-thiazolyl
granulation
warburg-effect
nxa0xa027
mir-23b
mir-26a
tumorsuppressor
mir-124
hdac4
nxa0xa06
prevailment
microrna-215
standard-intensity
weill
age-standardized
non-melanoma
kti
hsr11q23
nu202fu202f54
nu202fu202f27
non-11q
nu202fu202f17
two-tailed
nu202fu202f29
nu202fu202f3
ncamcd56
bloomfield
succinct
reiterate
relevantly
isoform-specific
adultory
antracyclin
cytosin
arabinosid
gene-therapy
oncologic
11q23-related
wp-1034
ocim2
monocytesmicroglia
polarize
coexpress
bpcdn
evi1h
icr
⩾
n79
cd13cd33cd117cd34
gly
mll-mll
cd11a-c
cd50
cd102
tnfr2
apoptosis-receptors
subtype-related
cbf-rearranged
thom
westcott
astellas
takeda
mid-range
headcount
resourcing
osaka
biometrics
redesigned
pharmd
searle
takedamillennium
cyp2bgt
g15631t
15631ggtt
15631gt
15631gggt
15631tt
15631gg
gttt
rbm15-mkl1
cbfa2t3-glis2-negative
o6
-methylguanine
×7xa0d
×xa0d
pre-selection
refractoryrelaspse
progonistic
lowreduced-dose
gambogic
oil-in-water
nanoemulsion
tween-80
squalene
pseudoternary
diagrams
phosphate-buffered
saline
phu202fu202f
l929
24u202fh
48u202fh
ld50
engrafts
jurket
eyelid
recalcitrant
bpall
seeming
urate
nephropathy
hdmtx
lags
tamxa0cm
factor‑1
igf1
igf1r
linsitinib
p53-mdm2
mirros
nct02545283
tp53-wt
mid-2017
polymorphism-based
homozygotes
ileile
cyp1ai
tid
azoles
incited
ppis
h2-receptor
h2ras
dasatinib-alone
actinic
keratoses
sun-exposed
ointment
csf-1r-dependent
long-terminal
region-driven
polyoma
m-dcs
m-dc
anti-csf-1r
mrna-expression
cox-lasso
nct00136084
plsc6
low-plsc6
nu2009u200997
high-plsc6
nu2009u200966
1-mrd
flt3-status
wbc-count
aml-target
nu2009u2009205
single-predictor
multiple-predictor
beta-1
reaction-sequence-specific
finetti
multivariateanalysis
gccgcc
genotypeshaplotypes
thegg
adipocyte
im-associated
phph-
pre-im
itd-d835
mis-spliced
notch2-va
mis-splicing
disproportionate
cell-extrinsic
bitter
tas2rs
aversion
sensing
tp53-
tas2r
denatonium
benzoate
substantiated
pdgfrs
trkc
fgfrs
lymphnodes
nct00474006
graf
glucuronidase
azithromycin
doxycycline
ureaplasma
range-
bgmt
4xa0808xa0175
344xa0676
165xa0567
179xa0109
sexes
causation
xpd751aa
751ac
751cc
cd117-
neurography
brachial
arguably
rs2234593
ex7
rs2234593aaac
rs2234593cc
ex7-mutant
rs2234593-a
rs16754-g
dhrs6
ketone
-dhba
enterobactin
24p3
lcn2-mediated
e14a2n
kinasen
imatinibn
cohortn
mainn
‘e1a2’
‘e13a2’
‘e14a2’
positiven
phve
transcriptsn
age-group
rangesn
whatsoever
5-fuorouracyl
fine-needle
cytochromes
salsa
p128-c1
cyps
darbepoetin
anemic
tripe
survexpress
miner
adaptively
nct00088218
nagasaki
intermediatepoorvery
bcr-abl⩽
cves
cytogeneticist
cgl
mitogens
m8
nic
predicament
id1high
remission-rate
mir-650
ponatinib-related
cardiologic
five-yr
or70
nct00093990
transplant-ineligible
n58
nct01893320
cbfbeta-myh11abl
seràgnoli
bologna
n86
eoi
ogho
disease-monitoring
recentin
svegfr-2
gtt
glycine
progranulin
pgrn
controversialto
assayplasma
u200angml
pu200au200a025
high-pgrn
low-pgrn
pu200au200a027
pu200au200a008pgrn
monoblasticmonocytic
leukostasis-related
b55α
time-series
growth-
cxcl
ccl
amlmds-pts
serum-levels
blast-proportions
cytogenetic-risk-groups
ccl5-release
ccl2-release
ccl5-values
aml-pts
antitumor-reactive
90th
relapsingrefractory
undertreatment
g-1082a
rs1800871
c-819t
c-592t
bcr-abl0032
integrally
17-probe
cross-platform
faithfully
intensity-conditioning
nct01188174
cell-essential
men1
kat2a
stem-progenitor
intravoxel
ivim
microcapillary
diffusivity
ivim-derived
pseudoperfusion
pseudodiffusion
rsna
fromxa0thexa0aurora
lats1
phasesxa0and
vegf-c-induced
endothelin-1
et-1
vegf-c-mediated
endothelin
etra
bq
cell-cycle-related
vegf-cet-1cox-2
axis-mediated
vegf-ccox-2
ameliorating
sos
go-associated
carolinanational
rare-presenting
priapism-specific
dehydrogenase-2
ag-221
iiiiii
maturating
revertant
cholestasis
biliary
microbiologic
abscessus
axa0portable
igs
gadolinium
mundane
neurocognitive
tmdsaml
alphabeta
dnah11
r882mut
urokinase-type
upa-r
plasmin
extravasations
invasions
pe-conjugated
upa-r-positive
myelomonocytoid
tuned
consanguineous
nu2009u200987
kir2dl1c2
2ds2c1
kir2ds1c2
kir2dlds1
pcgs
mds-ra
mds-raeb-i
mds-raeb-ii
ml-pcr
mdf-detectable
eoi1
eoi2
antithymocytic
p15q13
nonelderly
hematopoiesis-associated
single-base-pair
hrmds
azacitidine-resistant
azacitidine-sensitive
anti-dnmt1
amlresults
mir-126low
resistanceconclusions
pre-relapse
24xa0d
mll-translocations
12xa0d
detoxifying
ile195val
mll-ptd-positive
double-cebpa-mutation
disulfide-crosslinked
cll1-targeting
dc-ctm
dc-ctm-dnr
anti-lscaml
crpr
hpn
n-kras
log10wbc
nu202fu202f18
nu202fu202f6
dacu202fu202fdlis
dac-only
dacu202fu202fdli
ptk
prescribe
myhi1
dnmt34
ptp
pip
hag
rnm23-h1
cd34locd34-
1β
mirrored
deltet2
er-pr-her2-
stroma-rich
amplifies
p22q34
realtime
microrna-494
mir-494-overexpressing
cellls
physiol
erythroid-2
over-express
hdd
cdd
scielo
lilacs
cautiously
underestimation
anorexia
cholangitis
extrahepatic
strictures
appearances
transhepatic
cholangiogram
drains
cytogentic
treatment-limiting
cd141
myeloidconventional
differentiating-agent
improvementtransfusion
pre-emptively
erase
kidneys
tubule
electrolyte
structure-function
clathrin-binding
octapeptide
motif-leucine-zipper
om-lz
calm-af10-mediated
calm-af10-induced
truven
no-switch
nscu2009u2009did
one-switch
oscu2009u2009switched
two-switch
tscu2009u2009switched
meanu2009u200954
ageu2009u
nsc
osc
tsc
utilizationcosts
osctsc
hospitaloutpatient
axa0revision
axa0more
axa0better
axa0mere
u200910
micrograms
retrotranscribed
bio-rad©
microdroplets
bio-rads
qx200
ddpcrwt1
-nonmutated
withxa0idh1-mutant
receivedxa
gradexa
crcrh
bounds
independentxa0idh1xa0mutation
dhodh
hadm
d-daunorubicin-dnr
m-mitozantrone-mtz
triple-drugs
47xa0
32xa0
acetyl
porto
pde
bestows
pretherapy
expresser-status-associated
diuretics
glucocorticosteroids
tq13q32
ccnd1-igh
t-a
tmns
conditionings
staphylococcus
aureus
124xa0cases
myelodyspastic
sydrome-related
fro
antioxidative
aos
apelin
blunting
inhibitor-induced
normalizes
h243y
n244s
phosphoethanolaminephosphocholine
etnk1-mutated
tf1
etnk1-n244s
etnk1-h243y
etnk1-wt
pre-transplantation
fibrinolysis-proteolytic
threexa0complement
cfh
cfd
serping1
trabectedin
translocation-associated
lurbinectedin
rhabdomyolysis
neutropeniainfections
nxa0xa04
nxa0xa02
5-arm
clou2009u2009ara-c
clou2009u2009ara-c-
invq23
cellspbmcby
myeloid-rich
cd8pmn
anti-pd1
sx-682
ifn-γ-responsive
2xa0
1xa0gdl
overweightobese
chang
gung
non-overweight
vosaroxincytarabine
placebocytarabine
unstratified
affection
spanned
unfractionated
survival-time
dominantly
cytopenic
ci5
ci8
ci7
alma
e-alma
stela
duplication-mutated
xa0kb
pcnsl-treated
chordoma
vdcie
cyclophosphamideifosfamide
clivus
clival
protein-14
ci-flag1
24-hour
ci-flag
non-m0
ds-associated
nonconstitutional
non-ds-associated
12m
18m
24m
setcxc
dii
mini-gene
out-of-frame
gc-related
ano1
tumor-node-metastasis
progression-related
leukemiampn
crcp
cases000
36u2009gm2
ara-36
daunorubicin-containing
txa0cell-replete
d30
d100
cga
iadl
mcirs-g
、
χ615
oncopathological
teenagers
aktobe
uteri
trachea
bronchus
agian
lymphosarcoma
articular
cartilages
appendages
accruing
dynamicchronologic
phenocopy
mutationsalterations
pathomorphologic
fbxw7-deficient
non-cell-autonomous
fbxw7notchccl2
ges
lcss
cehigh
celow
circ-vimentin
circ-vim
intermediateundetermined
patient-adjusted
imaging-based
pz
ouabain
oua
pz-
oua-induced
demise
mdr1p-gp
pfas
software-based
pfa
c3hhen
32d-flt3itd
pre-incubation
max16h5
pre-incubated
lncrna-associated
dlcn
dnb
dlcncp
dleu2
dlcnap
snhg3
dlcnbc
outbreaks
arg882
characteristics-mean
360x
-were
cgrs
chemo-dli
uneven
pt-cy-based
calcineurin
disease-donor
90-kda
hsp90-
p170-positive
17-allylamino-demethoxy
no-remission
compa-red
co-variates
fetalmaternal
placentalmaternal
delocalization
nucleus-restricted
npmc-
branched-chain
bcaa
non-stem-cell
α-amino
bcaas
αkg
αkg-dependent
egl-9
egln1
demethylases
egln1-mediated
bcat1high
idhwttet2wt
idhwttet2wtbcat1high
bcaa-bcat1-αkg
17xa0
aml-13
and00014
clofarabine-
fork-head
nonmethylated
two-variable
preanalysis
del5q-5
del7q-7
distributes
boluses
–y
del12p
in-intensive
early-icu
wards
late-icu
spo2
brugada
ara-cg-csf
non-tbi
non-trisomy
ghvd
inhibitor-of-apoptosis
sfts
sft
malate
igg4
function-associated
lfa-1
lfa-3
icam-1
sooner
dasperseca
nct01660906
imatinib-related
lifesymptom
arteries
cvd
collateral
npm1-positive
near-tetraploid
nt-aml
erythroblastic
pmlrarαaml1eto
mll-ptdflt3-itd
flt3-d835npm1
ergmn1
prognosticdiagnostic
depsipeptide
fk228
1d10
leukemic-specific
remitted
ct60
lam03
mdsc-like
δct
tlr82
tlr29
tlr06
tlr38
mutationsmethods
mutationsresults
pu2009pu2009pu2009u
pu2009conclusion
aldh3a1
fanconis
prr-aml
hid-hct
md-hct
stromal-derived
myeloid-cox-2
neu
neu-transformed
factor-1-dependent
cox-2-deficient
ctl-mediated
hijack
blockages
mutant-idh2
procalcitonin
translocation-carrying
intensitytoxicity
anti-thymoglobulin
irf4
mdsc-specific
lysm
irf4flox
lysm-specific
ly6g-specific
whoaml-m2
x-y
tq13q22
xtx2q22q37tq21q36tp15q11del8q22
xx5
der21tq22q22
der21
isrctn17833622
pre-b
pre-t
rs62527607
pcr-rflp-based
pre-b-all
g424t
bcrpxa0mrna
alfa-2a
ccaph-patients
ccaph-were
ccaph-and
ccaph-appears
ccaph-may
shorten
mobilising
nuances
aimins
prognosisnkp30
statusin
nkp30high
therapythe
subtype-that
ar-the
ar-and
countryside
incurability
im-cmin
lysosome-associated
lamp5
organism
reconstitute
⩽xa010
post-transcription
numb-notch
cpi-613
lipoate
pdh
α-ketogluterate
kgdh
leukemiaexperimental
cr5cri62
respondersconclusions
non-m4m5
ems
8p1
b-linage
pdgfr-a
pdgfr-b
dovitinib
fgfr-1
pemigatinib
genexpert
cepheid
xpert
monitortm
qd-ish
post-hybridisation
tissue-microarrays
pellets
spiked
triplex
hoxa4
scrambled
pellet
nxa0xa0135
npm1-mutatedflt3-itd-negative
elicits
bmdcs
re-organization
m2mφs
cd206
aml1‑eto‑positive
ae‑aml
next‑generation
64xa0patients
xa8
2xa‑10
c‑kit
xa2
exonxa
exonxa010
mrds
nephrotic
membrano-proliferative
glomerulonephritis
dysfunctioning
i-nhl
tositumomablodine
i-131
tositumomab
rit-based
busulfancyclophosphamideetoposide
lepr
prdm1
cancer-type
mir-217
fluorouracil
n510
dnmt3a-positive
azacitidinelenalidomide
imatinib‑based
bcr‑abl‑dependent
imatinib‑sensitive
ir‑related
irg
real‑time
qf‑pcr
irxa0cell
reverse‑transcription
rt‑pcr
dose‑dependent
irxa0cells
bcl‑2caspase
sulfation
heparan
proteoglycans
sulf1
sulf2
mbc-cml
goldengate©
cpg-sites
gnmt
erpgr-positive
ⅲb
fec
characterises
daunorubicincytosine
prmrd
hamlet
expedited
transcriptomics
user-friendly
soft-clipped
anti-cml
small-scale
diversification
outgrow
ancestor
rediscovered
cytophagic
s-100
aide
cytophagocytosis
t-ms
procaspase-3
slows
ictu2009u2009go
ictictgogo
ldacbsc
12a
cholecystectomy
well-
12c
stump
lymphoma-based
ucart123
2xa0dli
amlexcluded
31th
mutationsfusion
asxl99
dmnt3a
tet2are
patients50
moph
microrna-binding
poly-mirts
ara-canthracycline
lca
polynomial
gleaned
nxa0xa0258
vemr
efs-a
efs-b
tp53-knockout
euploid
eeb
tp53-deficient
tp53-proficient
tp53-wildtype
perpetuation
non-smoker
tomographypositron
ctpet
adenopathies
ahm
clagm
mdro
chemotherapy-a
option-has
cd34aldh
cd34cd38-aldhxa0and
cd34cd38aldh
cd34aldh-h
cd34cd38-aldh-h
cd34cd38aldh-h
withxa0xa03-log
mrd-h
mrd-l
cd34aldhxa0status
cd34aldh-lmrd-h
cd34aldh-lmrd-l
cd34aldh-hmrd-l
cd34aldh-hmrd-h
cd34aldh-l
cd34aldhxa0at
more-sensitive
benchmarks
spliceosome-associated-gene
high-km
cn-iidck
haemi
excavation
cmcd
2006-february
19th
lt-hsc
dispersed
lt-hsc-derived
evi1evi1
ergerg
emt-related
rnasxa0lncrnas
rna-seqxa0v2
lncrna‑lncrna
networkxa0llcn
8xa0aml
lncrnaxa0znf571-as1
kinasexa0jaksignal
transcriptionxa0stat
fashions
hmcls
ld5
ld2
ld9
non-t
citrate-lyase
bcr-jak2
tld
tq36p13
mnx1etv6
tp36p13
flt3-itdfms-like
intenal
n117
seldi-ms
seldi-mass
biobank
repeatability
preprocessing
skew
noisy
ciphergen
segment-wise
paga
binning
orthogonal
least-squares
o-pls
chromatographic
purification
msms
one-dimensional
seldi
premenopausal
menstrual
intrauterine
contraceptives
convergent
single-case
no-treatment
fatigued
acceptability
ostensibly
overshadowed
co-activating
chibby1
c22orf2
22q12
downmodulation
responsesurvival
rs2826063
rs12791420
rs11623492
rs2575369
reults
flow-mrd
p032
flow-detected
p41
δwt1
q34p15
6pqq
46xyt22p22q34q
der46xy2xa0
is-ncn
g250ca9
lamr1
prame-p3
g250ca9-g2
t8q21q22q22
discomfort
salmon-pink
46xxt8q21q22q22
backbones
multiple-locus
microsphere
melp
digestion
microspheres
branched
segregates
tq15q23
46xxtq15q23
tq13
q15q23
tq13q23
tianjin
indice
χ647
χ528
χ288
sizeχ073
χ724
χ430
χ714
ptnm
ptnmp
levelp
retard
flag-im
flag-i
three-quarters
mandarin
rem
homogeneity
aclacinomycin
study-entry
autotransplant
⩾5
efss
rfss
non-quiescent
pxa01
pxa0itd
partitioned
tnk
juxtaposing
case-pair
non-chinese
nanometer
mass-spectra
autoflex
spectrometer
cliprotoolstm
mz
pf4
edo-s101
bendamustine
casepase-3
γ-h2ax
cd1a-positive
ms-lch
lch-associated
chm
non-chm
prescriptions
-hydroxyglutarate
incidentally
mllwt
maturationfrench-american-british
idh1wt
cebpahigh-meth
cebpalow-meth
n165
two-way
above-mentioned
pathologist-initiated
ddr-related
chk-1
chk-2
ddr-sensor
o3
dephoasphorylation
mdsaml-derived
skm-1s
smk-1r
checkpoint-inhibitors
id8-fluc
bs7-rag1tm1momj
bp2sjl-myd88tmdefrj
clodronate
anti-cd8a
anti-gr1
anti-colony
anti-csf1
tmβ1
anti-cd122
cl-induced
-median
zipper
over-expresses
beta-like
itgbl1
itgbl1-hypermethylated
ru2009u328
co-deleting
paralog
mll2
mll1mll2
nu202fu202f28
re-nice
nu202fu202f52
dock2
rac1dock2
mk8776
cn-amlexperimental
cml-cpexperimental
reductionconclusions
nct01511289
lesser-differentiated
trilineal
compose
abruptly
cell-selected
n164
score⩾3
survival90
-pcr
transplantationhr
snp-pcr
azacitidines
leukemialymphoma-type
procaspase
d2
socs-2
procaspases
ag490
ociaml3
mo7e
up-regulates
jak-stat-dependent
beacon
growth-stimulatory
one-size
leukemia-berlin-frankfurt-münster
plog-rank
relapsenonresponse
cirnr
plog
f359c
g251e
v289f
n368s
h369r
a397p
e355a
inter-individually
activation-loop
cxa010
mdr1-pgp
-nitro-3-benzoxadiazol-4-ylthiohexanol
nbdhex
mpo-positivity
mpo-low
fyn
non-receptor
liberation
a66
uftlv
nu2009u2009379
nu2009u2009128
pq
lumbago
indispensible
ethnical
inhabitants
health-care
tpd52
droplets
nu2009u2009142
nu2009u2009162
nu2009u200978
gse84881
disease-stages
cll-related
myd
birc
un-mutated
fludarabine-resistant
briefer
45xy-7tpq12
48xytpq21
46xxadd8p
40xa0
geth
relapse-treatment
dek-nup214-positive
prerelapse
researching
deserving
dementia
asses
extrahematologic
eighth
acmlin
sm-mpnhypereosinophilia
allo-hsctthe
pcgr
cd3-negative
zap70
dna-level
ultrasensitive
baalcabl1
mn1abl1
prehsct
aaml0431
nct00369317
vad
multi-cell
ker
htl
lipopolysaccharide
triacylated
lipopeptide
keru2009u2009dcu2009u2009htl
line-specific
u266b1
multi-cellular
maligne
tryptophans
nes
relocated
diagnostic-prognostic
poor-resource
vlr
rella05
fernando
figueira
recife
cellxa0alloreactivity
advancedhigh-risk
5xa0patients
arranging
peritransplantation
physician-patient
a-ham
go-a-ham
n140
n761
remissioncomplete
covariables
cell-stroma
pymttgfβriilysm
a2a
a2b
metabric
col1
tgfβcd73
gstt1and
cyp2d6present
gstm1present
hma-containing
cd5cd19cd23
mcl-1bcl-xl
co-regulated
post-essential
pet-mf
ppv-mf
n616
ppvpet-mf
petppv-mf
smpc
nanyang
xinhua
m2b
setbpit
her-2
α-interferon
revisited
extramedullar
off-therapy
leukemia-clearing
c2982cu2009u2009t
cdh11
c945gu2009u2009a
lcgs
complete-remission
interval-
snai1
fcu2009u
apaf1
lymphoma（t-lbl）combined
leukemia（aml）
vstm1
v-set
vstm1-v1
reaction-sequence
a11
pu2009u2009055
non-mutually
icsbp
interferon-regulatory
lymphomawaldenström
lplwm
lymphoplasmacytoid
rouleaux
myd88wt
lplwm-transformed
mrnamirna
ago1
rs636832
gemin4
rs2740348
rs799917
rs61764370
cd34hla-dr
pml-rara-
stag1
stag8
stag3
best-described
mynd
nervy
deaf-1-type
zmynd8
cml-aca
thrive
withers
carcinomaa
33-
lump
lumpectomy
vesicular
her2neuepithelial
investigatory
follow-upalthough
significantlythe
mir-592
disease-initiatingleukemia
abmtasct
illumina-based
well-organized
decides
qols
piloted
aml-mo
thorotrast
1q11
5q11
5q3
1qqter
msd-sct
dli-associated
haplohct
alwp
gvhd-freerelapse
idarubicine-based
pncs
pnc
mpnc
nct03332511
ovaries
diffuse-positive
mucinous
lmp
survivalu202fu202f24
aclaara-c
drp
presenceabsence
npm1a
non-separated
bmpb
congruent
278-fold
oct-4
pou5f1b
pou5f1blow
pou5f1bhigh
×10⁹
l⁻¹
eortc-gimema
elaborating
microanatomy
uncoupling
differentiates
m0-m2
disease-acceleration
basophil-lineage
accumulations
aml11
idarubicincytarabineara-cpravastatin
idarubicin-
tq22q12
tq22q1
tp13q1
tq22q4
tp22q2
tp13q
nomogram-based
deg
disassembly
cytokine-cytokine
abca5
cyp7a1
herc5
tripartite
trim-62
hospitalisation
practicable
network-based
rwr
sub-network
81-gene
ssvm
non-recurrence
ssvm-based
cimps
demethylator
dmps
dmp1
dmp2
pu202fu202f63
pu202fu202f54
pu202fu202f83
fancj
preventim
deseese
hyperproliferation
vδ2
pd-1tim-3-
pd-1-tim-3
pd-1tim-3
phosphoantigenxa0xa0il-2
anti-pd-1tim-3
revival
cytogenetically-normal
cn-myelodysplastic
cn-mds
r822
nxa0xa0846
nxa0xa023
nxa0xa025
one-fits-all
reap
envision
hypothesis-based
designs-from
pre-clinicallaboratory
trials-provide
societal
pressures
clinic-pathologic
uniqueness
p9
im-related
leucopenia
syndromelow
tmdsstaml
i131
annualized
mitochondrion
oxygenventilatory
-475u2009×ul
-259u2009×ul
nu2009u200940
preferring
versus-host-disease
ashct
factor-combined
cytarabinecyclophosphamidetotal-body
hdcacytbi
cbfalphabeta
toll‑like
b76huh7
inner‑tumoral
interleukin‑6
factor‑α
hepatocarcinogenesis
tq23q13
mll-ep300
encephalomyelitis
non-severe
nsaa
χ539
χ455
χ849
χ330
χ394
χ082
pand
χ798
pbetween
dimensionality
shrinkage
calibrate
dnaepigenetic
aryl
hydrocarbon
micro-environmental
x-chromosome
rheumatic
behcets
rheumatoid
spondyloarthropathy
roiic
preset
contradicts
ipnv
birnaviridae
contagious
chse-214
chinook
laddering
postinfection
cycloheximide
genistein
edta
aprotinin
leupeptin
tryphostin
antivirion
quercetin
flavonoid
phytochemicals
sensitise
anti-cd95
leukaemia-1
sensitising
apncd13
bestatin
glycol-polylysine
copolymer-ubenimex
peg-b-plysube
apn
peg-b-plys
isobologram
microenvironment-like
nonconvulsive
epilepticus
ncse
epileptic
eeg
seizures
realgar-indigo
naturalis
rif
n45
score4
junduqing
extractive
hne-1
hne-2
hone1
v-fitcpi
embracing
structurefunctional
boswellia
carterii
birdwbcb
non-lymphocytic
leukemicanll
m4a
bcb
alkyl
sugars
c-2
c-3
inactivity
leukemics
kcl-22
passages
hypoxanthine-guanine
phosphoribosyltransferase
homoherringtonine
sapooro
fever-associated
hypercreatininemia
mycosis
homoeostasis
kinase-driven
antagonises
diabetic
interferences
overlay
vinblastine
desacetylmethylcolchicine
trimethylcolchicinic
treatment-a
glaxo
bcg
heaf
pre-colony-forming
oligomer
flavonoids
ethyl
alaternus
polyadp
ribose
anti-lipid
ic₅₀
mapks
pi3kaktfoxo
potentiation
erythroleukemic
dox
hemoglobins
gower
epsilon2
nf-e2
uninduced
intercalation
supratherapeutic
hydrazones
dpph
frap
orac
hydroxyl
photoprotective
spf
benzofuran
bcl-xl-specific
mcl-1-specific
synergies
mda-mb-435
mda-mb-231
3α
racgef
tiam1
pak1
faktiam1rac1pak1
4e-bp1
p70s6k
lvef
idh1-r132h
-r132c
-r132g
-r132s
-r132l
intracerebrally
idh1r132h
bfm-78
fourths
infusional
pan-resistance
ldl
rldl
protein-free
emulsion
lde
behave
decay
rabbits
14ccholesteryl
fractional
fcr
h-1
radioactivity
99mtc-label
repopulate
separator
sulphoxide
cryoprotective
ii0
leucoagglutination
phagocytose
albicans
nitroblue
nbt
cfuc
microbicidal
-oh2d3
distamycin
fce
octamer
nfe
-156
h2b
at-rich
dnase
footprinting
distamycins
academia
chemotypes
servier
hurdles
non-pml
rar
early-appearing
pcr-amplified
ccgg
philadelphia-chromosome-positive
ynk01
deamination
eclap
casistic
anti-platelet-
bcl-2-regulated
momp
gossypol
permeabilizing
competes
hydrophobic
bax-like
pore-forming
podophyllotoxin
protein-bound
chiral
trans-isomer
isomerisation
cis-lactone
ultrafiltrates
isomers
hplc
cis-isomer
non-protein-bound
teniposide
chloroform
isocratically
spherisorb
phenyl
reversed-phase
fluorometrically
exem
ultrafiltration
ultrafiltrate
ng50
ten-fold
whole-body
unassessable
post-graft
myelosclerotic
wich
misplacement
leucoencephalopathy
occipital
d816-induced
pkc412midostaurin
proteasome-inhibitor
hmc-
bim-specific
pkc412-induced
organ-expressed
brca1-a
microarray-detected
radiotherapy-treated
bre-encoding
degraded
autoregulate
autoregulatory
normalize
retarding
13-acetate
pma
alamar
pma-mediated
hdacs
hydroxamate
pan-hdac-inhibitors
st13
st34
st80
α-tubulin
acetylated
growth-inhibition
p21waf
unilateral
anthelmintic
mebendazole
mbz
huvec
cx-5461
brca-deficient
nitrogens
pyrazine
synthesizing
copper-complexed
cucx-5461
copper-containing
30u202fmin
phu202f
longevity
cx5461
hct116-b46
capan-1
low-ph
zygomycosis
rhizomucor
pusillus
delayed-release
anti-antiangiogenic
butyric
pivalyloxymethyl
butyrate
an-9
dna-specific
anti-metabolic
dna-reacting
erythrocythemia
platelet-lowering
antithrombotic
mutagenicity
phosphorus
satisfies
semin
38suppl
-28
lengthened
psychologic
pessimism
gloom
gratifying
peat
cp-fa
fourier
ft-ir
13c-nmr
antiallergic
rbl-2h3
beta-hexosaminidase
ca2i
fluo
ige-sensitized
antigen-antibody
antibody-receptor
a23187
pma-
ku812
pge
monocyte-cfu
acumulation
idarubicin-induced
ida-induced
pha-stimulated
trans-retinoic
t-wave
torsades
radiograph
pleuric
ecg
transthoracic
tamponade
biventricular
polyserosit
bufalin
chansu
fragmented
agarose
camptothecin
differentiation-apoptosis-inducing
host-mediated
b16
dxr-sensitive
glutathione-depleting
dxr
disease-permissive
obrien
ayalew
tefferi
metaplasiamyelofibrosis
valent
undesired
plated
rubidazone
rdz
pulse-modulated
harmonic
microscopes
pm-shims
signal-to-noise
snr
shims
abt-869
flavoprotein
quinone-based
quinones
rh1
ncis
time-
concentration-dependent
dicoumarol
radicals
cytodestruction
non-cytodestructive
sqccy1
tissue-like
by-pass
marcellomycin
n-glycosidically
6-thiopurine
deoxyribonucleoside
regrettably
overidentification
a549
htb56
chou-talalay
brdu
24-h
thrb
biopharma
companys
gene-edited
nanovesicles
citrus
ultracentrifugation
gml
trail-mediated
8-oxo-guanine
ros-driven
biology-driven
flt3syk
exemplifies
off-patent
marketed
retrovirus
transductiontransformation
rtta
furazolidone
fzd
protozoan
recognizes
intermediate-1-risk
jak1jak2
incb18242
ptt
lnt
taxane
no-chemotherapy
mir-134
sf3b1srsf2u2f1zrsr2
tet2dnmt3aidh1idh2
asxl1ezh2
runx1bcor
nraskrasnf1
cfu-e
herbimycin
vbcl-2s
bhrf1
vbcl-2
virus-associated
burkittxa0lymphoma
myc-induced
site-directed
α-smooth
α-sma
fibrocyte
myofibroblast
nutlin-3
mdm2p53
p53wild-type
p53mutatednull
p53-dependence
oci
ubiquity
paramagnetic
epr
photocytotoxicity
k-562
-tetramethyl-4-piperidone
trapping
-dimethyl-1-pyrroline-n-oxide
illumination
aerated
photoexcited
o2-
fe2
-1582
nalm-6
17-allylamino-17-desmethoxygeldanamycin
hl-60-treated
9-cis
13-cis
atra-differentiated
p-170
energy-dependent
antiblastic
jejunum
monoblast
flucytosine
hiv-1
ritonavir
saquinavir
indinavir
du145
pc-3
androgen-independent
microsomes
hormonally
elisa-based
kappab
bnx
uft
microliters
polynucleolar
deviate
populationn
outcomesn
drug–drug
phn
rate-corrected
rectifier
ikr
coded
ether-a-go-go-related
herg
hek
dose-responses
amn-107
adenylate
cyclase
spermine-fbs
2-adrenoceptor
propranolol
aminophylline
indomethacin
cyclooxygenases
ldls
14c-sucrose-labeled
14csucrose-ldl
radiolabeled
sucrose
lysosomal
125i-labeled
hypocholesterolemia
postmortem
adrenals
gram
leaflet
procoagulant
prothrombinase
7-
8-fold
nontumorigenic
nanorods
gnrs
microbubbles
usmbs
aml-5
definity
vv
gnr
ultrasound-microbubble
centrifuged
fluence
wcm2
vpi
propidium
∼4-folds
usmbgnrlaser
vpi17
gnrlaser
vpi68
gnrml
nanorod
thermal-therapy
vii-x
fibrin
fibrinopenia
gingivorrhagia
honokiol
magnolia
honokiol-induced
p21waf1
unbilicial
abt-263
purines
2-deoxycoformycin
trimetrexate
top2
runx1-
top2b
top2b-dependent
juxtaposed
pgx
mismatched-related
acyclovir
dili
steroid-refractory
codified
apparent-de
drugsradiation
diseaserelapse
1-beta-d-arabinofuranosylcytosine
micromabstract
antiemetic
linezolid
antidepressant
serotonin
norepinephrine
amines
citalopram
mirtazepine
20nml
40nml
80nml
uml
lumi-aggregometry
coated-platelets
convulxin
lumi-aggregometer
coated-platelet
top2-mediated
higher-order
single-copy
elmpcr
topoisomerase-mediated
caspase-activated
nucleases
poisoning
topoisomerases
aml-cases
hydroxystyryl-acrylonitrile
ls104
phosphoprotein-facs
inhibiton
11h
c-abl
simulate
anti-oxidants
bcr-abl-transformed
3-aminopyridine-2-carboxaldehyde-thiosemicarbazone
3-ap
vinca
sns-595
sunesis
mistletoe
fraxinus
abnobaviscumxa0f
rpmi-8226
l1210
abnobaviscumxa0f-induced
jnk-
erk-
pkb
grp78
eif-2α
z-vad-fmk
jnk-1
biopharmaceuticals
nonlymphoblastic
unconjugated
dna-conjugated
high-clearance
dna-complexes
cellplasma
daunorubicinol
doxorubicinol
intracellularly
spectras
dna-conjugation
dna-conjugate
synchronization
mitotically
ilp
dnr-lp
post-insertion
cd123-ilp
mabliposomal
s100pc
l-cd123-ilp
h-cd123-ilp
ketobemidone
analgesic
morphine
anionic
significative
phosphoramidates
mx-1
toxicologic
chemistries
first-order
half-lives
bcr‑abl
pyrvinium
pamoate
wntβ‑catenin
wild‑type
polyphenolic
cmn
ferulic
cinnamoyl
fer
mito-chondrial
apop-tosis
phosphatidylinositol-3
pi3
akt-
erk-dependent
hypophosphorylation
4e-bp
eif
4e-binding
adopts
5-region
stochastically
b7-related
uo126
azd6244
inducibility
b7-h1-mediated
pepchip™
kinomics
cluster-2
cluster-1
tq23p
at-hooks
cdc25
shi-1
cytarabine-treated
shi-1-derived
cytarabine-resistant
prominence
leverage
alemtuzumab-based
genzyme
macrocycle
sulforhodamine
srb
er-stress
shikonin
disulfide
isomerase
bcr-abl-driven
carboxyamidotriazole
dependent-
independent-signaling
isoenzyme
cyp3a4-mediated
coadministered
coadministration
simvastatin
predose
postdose
0-inf
clf
aucs
two-three-fold
quenching
polyisohexylcyanoacrylate
nanospheres
dox-ns
polyglutamic
ns-dox
carrier-bound
110-kd
lrp-56
lrp-negative
exhilarating
surmount
scavenging
lactide-co-glycolide
p210bcrabl
ifnalpha-peg
prodrugs
monobutyrin
tributyrin
half-maximal
ftir-msp
pre-screening
tetraspanins
sperm-egg
conformation-dependent
pains-13
precipitates
divalent
mn2
transfectant
alpha6beta1
nh2
integrin-mediated
rasrafmekerk
anti-metabolites
plicamycin
anti-plicamycin
plicamycin-bovine
diazotized
p-aminobenzoic
cross-linker
125i-plicamycin
chloramine-t
intra-
variabilities
chromomycin
mlminm2
ng-hml
asiii
crispr-based
txndc17
thioredoxin-like
aqp3
znt1
mtf1
eefsec
secisbp2
sephs2
sepsecs
pstk
selenocysteine
componentsprocesses
genus
scutellaria
baicalensis
barbata
orientalis
ssp
carica
endemic
subspecies
fucose-bound
o-fucosylation
l-fucose-bound
fucosylated
positive-aml
avidly
elevating
bcl-2bim
bcl-xlbim
bcl-wbim
trail-induced
3h-cytosine
microgramsml
insoluble
microgram
resisting
confronts
5q-syndrome
farnesyl-tranferase
postdiagnosis
mechanismsfactors
costbenefit
atgcsa
nursed
antiseptic
mouthwash
pan-aurora
isoform-selective
akis
aurora-b-selective
azd1152-hqpa
p-glycoprotein-expressing
megakaryocyte-lineage
cd42
chrf-
p-histone
antimitotic
3-deoxy-f-fluorothymidine
18fflt
tomographic
pet-ct
acyl
deprotection
myristic
12-thioethyldodecanoic
5-o-substituted
2-o-substituted
-disubstituted
-dimyristoyl
ccrf-cem
carbobenzoxyl-l-leucyl-l-leucyl-l-leucinal
p53-regulated
arsenite
as2o3
as2o3-induced
coincides
as2o3-mediated
necrosis-like
annexin-vpropidium
as2o3-triggered
daunorubicyne
6-mercapropurine
prednisone-vincristine
prednisone-vincristine-dnr
prednisone-vincristine-dnr-cyclophosphamide-l-asparaginase
noncycling
saponins
panax
ginseng
tspg
stomatological
ulcers
qing
gypsum
decoction
gargling
hemostatic
yin
slc221a1
ganoderma
lucidum
polysaccharide
ps-g
ps-g-stimulated
psg-mnc-cm
mnc-cm
mnc-derived
differentiation-inducing
incubate
venoms
l-amino
bpirlaao-i
hl-60bcr-abl
methanol
condurango
cortex
bark
marsdenia
reich
asclepiadaceae
pregnane
glycosides
deoxylated
aglycones
condurangoglycosides
camptothecins
pheophorbide
chlorophyll-breakdown
protoporhyrin
cytoprotection
photosensitivity
protoporphyria
abcg2-associated
vcm
nephrotoxic
vcm-induced
poisons
enzyme-mediated
microliter
nanofibrous
quaternized
chitosan
qch
polyl-lactide-co-dl-lactide
copla
fabricated
electrospinning
xps
qch-
dox-based
graffi
hamsters
qchcopladox
taps
intrathecally
ultracorten
irritation
meninges
fluoroquinolone
g6pd-
hindsight
predictably
multilevel
oral-anticancer
allium
sativum
codex
ebers
allicin
sulfide
ajoene
9-trithiadodeca-11-triene-9-oxide
garlic-derived
anti-thrombosis
anti-microbial
cd34-negative
hel
ocim-1
anti-proliferation
abivertinib
mv-nsg
organoid
gene-modified
anti-cd33-anti-cd3
bsab
biocompatible
star-shaped
glycol-heparin
cryogel
macroporous
biohybrid
bsab-releasing-mscs
overtime
paves
bsab-based
abt-199-sensitive
cd117c-kit
frg
midostaurin-inhibited
tumour-type
lactacystin
mrp-
gsh-
irinotecan
failedmodified
function-based
broadens
fda-approvedin-clinical-trial
tamibarotene
am80
water-soluble
nanostructured
am80-nlc
peg-nlc
am80-peg-nlc
stearate
single-factor
entrapment
mrt
carinii
pcp
seropositive
pentamidine
aerosol
ventilator
pneumothorax
thoracostomy
trimethoprim-sulfamethoxazole
tmp-smx
gancyclovir
sib
weight-loss
73-y-old
ambd
premedications
acetaminophen
diphenhydramine
meperidine
chill
bronchospasm
cyanosis
albuterol
nebulizer
reinstituted
ankylosing
spondylitis
alpha-emitter
224ra
sub-classification
pyrrolo--benzoxazepines
pbox-6
jnk1
jnk2
pbox-6-induced
jip-1
mkk7
nlcs
stearylamine
dodecylamine
spermine
etoposide-loaded
emulsion-solvent
evaporation
sonication
amide
surface-exposed
carboxyl
ringer-hepes
polydispersity
tf-coupling
sa-containing
sp-containing
sa-
da-containing
tf-nlcs
oropharyngeal
anti-bacterial
septicaemia
mitozantrone
pemetrexed
fcie
cd3cellskg
c-phycocyanin
c-pc
non-mdr
k562-lucena
sub-family
babcb1
feps
cabcc1
5-dimethylthiazol-2-yl--diphenyltetrazolium
72u202fh
trypan
c-pcu202fu202fvcr
c-pcu202fu202fdnr
energies
mus
musculus
scads
143b
hos
saos-2
huo9
cucurbitacinxa0i
time-dependently
phospho-cyclinxa0d1
p-gp-transfected
gpr109a
hm74a
nicotinic
lipid-lowering
pertussis
gi-mediated
adenylyl
na-induced
cell-permeable
endophytes
asteraceae
22e24r--epoxyergosta--diene--dione
diterpene
aphidicolin
papulaspora
nigrospora
sphaerica
culminating
disarming
microtubule
thymosin
micrographs
b-treated
autophagy-
oncosis-like
marinopyrroles
sulphone
spacers
fluorescence-quenching
fq
benzyl
mcl-1bim
disruptors
marinopyrrole
drug-cyclosporine-a
mycophenolate-mofetil
drugs-csau2009u2009mtx
lin-cd34cd38-
lin-cd34
abcb1mdr
homo-aza-steroids
esterified
homo-aza-steroid
beta-hydroxy-13
alpha-amino--seco-5
alpha-androstan-17-oic--lactam
alpha-amino--seco-5-estratrien-17-oic-
-lactam
dose-reduced
histone-deacetylase
hydroxy
kh1060
9-cis-retinoic
9-cra
4-hydroxyphenyl
retinamide
4-hpr
kh-6
kh
cd11b7-aad
illicit
unhealthy
self-report
sle
aic-47
pkm
pkm1
tract-binding
ptbp1
cpt1c
naoh
cone
iodination
acid-insoluble
l-929
myeloperoxidase-containing
prof
umezawa
generously
bleomycin
peplomycin
acalcinomycin
thp-adriamycin
neothramycin
chorioepithelioma
rhabdomyosarcoma
methoxy-9-ellipticine
navelbine
4-demethyl-epipodophyllotoxin-beta-d-ethyledene
glucoside
ad-32
ad-143
recovers
eager
nunu
reinjected
1-beta-d
dihydroxy
oh2
underexploited
centrosema
pubescens
benth
dichloromethane
cpde
p27cki
nmp
merocyanine
concanavalin
agglutinin
reticulocyte
enucleation
novantrone
dihydroxyanthracenedione
leukaemiamyelodysplastic
thiopurine
thiopurine-induced
dissociated
cellsdrug
sedimented
centrifuge
counterstained
transitional-cell
small-cell
myelomas
okt4
okt8
eluding
cispt
reestablishing
ptii
undesirable
pdii
tdtn
4-dichlorophenylimino-n-2-thiazolin-2-ylthiazolidine
thiazoline
ptcl2tdtn
pdcl2tdtn
ht-29
5-dimethylthiazole-2-yl--diphenyltetrazolium
stipulated
deoxynucleotides
pol
cdatp
cdamp
3-end
carbonyl
c2-c3
ortho-position
hydroxylation
nonhydroxylated
c5
c6
mertk
unc569
unc1062
alpha-naphtol-acetate
antrodia
cinnamomea
bxpc3
apoptosis-associated
catastrophe-associated
hms
microflora
non-regenerative
subclassified
cxxc
nonmethyl-cpg
ions
tetrahedrally
cgxcxxc
cross-saturation
mll-associated
osmotic
cbls
nals
hypotonic
nacl
lysed
hyperpyrexia
shock-like
coma
bleomycin-induced
hyperpyrexial
asphodeloides
ethanol
etoh
rhizomes
fractionized
4-hydroxyacetophenone
β-hexosaminidase
bovine
co-treated
1940s
antagonistically
co-encapsulating
irinotecanfloxuridine
rarα
all-transretinoic
lg-362b
caspases-mediated
trimethoprimsulfamethoxazole
atovaquone
hydroxynaphthoquinone
anti-pneumocystis
oligodeoxynucleotides
odns
nuclease
encapsidation
drug-delivery
capsule
ms2
bacteriophage
capsid
vlps
vlp
p120
drug-to-drug
ddi-related
ddis
mir-519d
t-47d-cancer
cisplatin-induced
scd
cq
anti-malarial
anti-rheumatoid
hemoglobinization
8-bromo-camp
br-camp
lps-treated
cgmp
hemoglobinopathies
dyes
time-lapse
fluid-phase
porcine
prrsv
yasml
plaque
tlr3-dependent
apoptosis-induction
tlr3
contractures
sclerodermoid
clofazimine
leprosy
palmoplantar
pustulosis
patientswho
sjögrens
exercised
sich
tahitian
mucormucosis
caspofungin
cyp2c9
pro-arrhythmogenic
allele-mismatched
ratg
exquisite
tractable
unclarified
differentiation-related
proliferated
four-drug
rotated
artemisia
nilagirica
ane
methanolic
xa0µgml
ane-b
anm-9
tdt-mediated
poly-adp-ribose
2-inhibitor
learnt
palpitations
photophobia
tq22q11
cerebrum
cerebellum
resistancesensitivity
lympholytic
steroid-resistance
brincidofovir
bcv
herpesviruses
polyomaviruses
foscarnet
tq24q21
fusing
rxra
hetero-oligomeric
rararxra
homodimerize
host-
disease-biology
celator
sanofi-aventisnci
ecthyma
papule
bulla
sore
shinpi-to
leukotriene
leukemia-2h3
anti-ige
ltc4
ige-mediated
hydrolase
3harachidonic
pla2
lta4-free
epipodophylotoxins
aspirations
cytoxic
myeloblastosis
merging
drugs-including
few-have
reapproved
begs
risen
impact-major
manumycin
methoxyamine
base-excision
leukemia-supportive
apoptosis-resistance
anti-tumoral
cll-targeting
nano-vesicle
u202fnm
nano-vesicles
messengers
gsk-3
physiologicalpathological
abt--bromoindirubin-3-oxime
gs-87
ly2090314
heterotrimeric
multi-subunit
functionalities
epi-drugs
unanticipated
long-circulating
parametersabstract
imitanib
cmlthe
pharmacophore
docked
powderml
mcf7
ar230
chronic-myeloid
non-tumorigenic
miltefosine
cisplatinum
hep2
saos2
cc531
equitoxic
perorally
powderkg
ribulose
bis-phosphate
carboxylase
rbcl
ximenia
americana
galactose
tryptic
ribosome-inactivating
ricin
mailuoning
1950s
anaphylactic
electrospray
flight-mass
harpagoside
anaphylaxis
cdx
utilizes
designates
phamacogenetics
notch-
p21cip1waf1
pfdd
sores
chemobrain
none-severe
nu2009u20091182
pu2009p-values
patient-advocacy
8-chloro-adenosine
8-cl-ado
ribose-containing
rna-directed
mir-155erbb3
1ebp1p53pcna
reestablish
cobalt
alkyne
acetylenehexacarbonyldicobalt
propargylic
esters
lama-84
nonsteroidal
acetylsalicylic
naproxene
mll-93
myeloid-
lymphoid-directed
lymphoid-
myeloid-directed
inbred
tubing
jugular
wf
burrowed
fastened
neocarzinostatin
myeloblastoma
f14512
polyamine
apoptosis-sensitizing
cgp57148b
p185
hl-60neo
transdominant
ara-c-
oligosomal
preincubation
dinitrophenol
energy-requiring
endonucleolytic
-dichloro-1-beta-ribofuranosylbenzimidazole
puromycin
colcemid
cis-platinum
lamin
degradative
topoisomerase-directed
topoisomerase-binding
huangqi
astragalus
membranaceus
hex
beta-globin
acetylcholinesterase
ache
labrador
rhododendronxa0tomentosum
harmaja
ledumxa0palustrexa0subspxa0decumbens
tundra
greenland
ailments
botanical
ursolic
streptococcus
etest
penicillin
cefotaxime
piperacillintazobactam
geometric
beta-lactam
inferiority
beta-lactams
polypharmacology
deconvolution
nonkinase
off-targets
drug-affected
sik2
salt-inducible
melk
repurposing
cabozantinib
proteomicsdb
hyperfibrinolysis
antifibrinolytic
dilute
euglobulin
epsilon-amino-caproic
eaca
cellulose-acetate
trasylol
acetic
expiry
algebraic
appraised
life-cycle
£
qaly
cinacalcet
willingness-to-pay
lcs50
pred
bcc8
ito
cavities
ym155
gi50
-nm
ym155-induced
mek1
anti-allergic
rhizome
japonica
rbl-1
sesquiterpene
atractylenolide
ic6
ad-like
feline
mcdonough
more-precise
toposiomerase
hyperthermia
azidothymidine
azt
cml-derived
hyperthermic
microml
rapa
punctate
keratitis
corneal
pd184352
ly-allylamino-17-demethoxygeldanamycin
2-me
dl-buthionine-sr-sulfoximine
bso
dose-independent
lhm2
lm2
13-dihydroderivative
idarubicinol
metaboliteparent
resveratrol
ingredient
aml-2dx30
aml-2dx100
aml-2dx300
aml-2wt
-carboxyfluorescein
overriding
mode-of-action
--δ9-tetrahydrocannabinol
isomer
dronabinol
mesoporous
silica
msns
functionalized
succinic
anhydride
anti-b220
b220-positive
b220-negative
forsythia
suspensa
ethanolic
fsree
fslee
fsfee
bcl‑extra
bcl‑2‑associated
phorbol‑12‑myristate‑13‑acetate‑induced
caspase‑9
caspase‑8
extracellular‑signal‑regulated
te‑13
fseer
resectable
giardiasis
prion
sterilization
quinacrines
verografin
verografin-ficoll
isopaque-ficoll
lymphoprep
spofa
eac
rosette
multi-targeting
necroptotic
mitochondria-derived
mimetic-induced
mimetictumor
tnfα-induced
fadd-deficient
sub-
mimetic-mediated
domain-like
mimetictnfα-stimulated
necrosome
necroptosis-inducing
roxadustat
imetelstat
apr-246
alrn-6924
magrolimab
dehdyrogenase
hemopathy
myeloïd
fusariosiss
antithrombin
alpha-2
antiplasmin
fibrinolytic
apck110
dermatosis
indurated
diffused
vasculitis
nilotinib-
reconstructive
equina
neurotoxic
kbm3bu
atm-chk2-p53
p73
atm-chk2-cdc25-cdc2
cytosol
analog-busulfan
trfr-targeted
sterically
anti-bcr-abl
asodn
postinsertion
resazurin
trf
trf-liposomes
bsa-liposomes
nontargeted
nt-liposomes
cy3-sirna
bsa-
sublines
cytarabine-related
nonsense-mediated
cytarabine-resistance
untoward
5-aminolevulinic
5-ala
gnps
electrostatic
photodynamic
functionsinglet
sog
sre
figuring
5-ala-gnps
protoporphyrin
ppix-gnps
bondingcell
ppix–gnps
ppix
lfe
plasmon
lspr
gnp
2r
5-ala-conjugated
cholestatic
aiha
mankind
virulent
drug-efflux
reviving
multifunctional-targeted
druggene
responsein
elderly-aml
expressiongiven
higher-than-standard
teva
benefit-to-risk
overwhelmingly
long-established
trialists
mcl-propagating
cd34cd38─
nsghscf
kitcd34-
il-1rap
lsc-depletion
lsc-eradicating
licensure
rhgm-csf
cycle-specific
over-all
pyridoxine
b6
caspase-3-dependent
gsdme-mediated
pyroptosis
thp-1xa0cells
mlkl-dependent
egfr-negative
egfrher2
-difluorodeoxycytidine
dfdc
hanover
amsa
4-wk
wk
phlebitis
remission-maintenance
prp19
non-ara-c-containing
cefuroxime
erythromycin
dixyrazin
compliances
malleable
accentuate
transdermal
nanometric
permeation
scaling
vis-à-vis
u2009h
patient-oriented
agent-associated
buffy
bioassays
mechanisms-of-resistance
countermeasures
pro-drugs
deoxynucleotide
depletes
methyltranseferase
thymidylate
compensating
dnmt1-depletion
out-growth
noncytotoxic
illudins
dihydroilludin
cytokinetic
illudin
cytotoxins
pan-pim
n-acetyl
short-pulse
1-hr
magnitudes
phea
polyethyleneglycol
moieties
polymeric
colloidal
solubilize
solubilization
peg
endow
nfs-60
phea-peg5000-hexadecylalkylamine
atractive
pdgf-r
oxidase-mediated
ks62
spermine-fbs-adenosine
adenosine-aminophylline
vindesine
maf
4-hydroperoxy-ifosfamide
mustine
unpaired
nitro
stimulus-induced
35-fold
anion-generating
marcellomycin-treated
alpha-naphthyl
2-deoxyfucose
musettamycin
cinerulose
carbomethoxy
c-10
pyrromycin
monosaccharide
carminomycin
refractoty
fluconazol
abelcet
infectin
buttercup
reversibly
c-ha-ras
c-mos
dissociates
clarithromycin
lyme
cim
empower
system-specific
culture-dependent
artifacts
pml-raralpha-positive
prophase
prometaphase
microtubule-active
microtubules
culminates
psidium
guajava
myrtaceae
consumed
guajavas
drug-scheduling
schedule-dependent
toxicity--particularly
dysfunction--although
cytotoxics
stasis
combinatory
shh
ifns
lpstnf-αifns
cyclopamine
sant-1
nonstandard-risk
platelet-released
anthracyclins
activation-associated
gpiibiiia
phenazone
nk-related
defenses
suppressiveregulatory
tumor-reactive
nk-mediated
nk-based
glucuronidates
ta-repeat
ta7ta7
glucuronidated
evergreen
chs
pyridyl
cyanoguanidine
72-h
subadditive
cpldidfyc
skno-1
cpldidfyc-binding
cpldidfyc-nonbinding
cpldidfyc-phage
cpldidfyc-receptor-ligand
warfarin
podophyllotoxin-induced
saccharomyces
cerevisiae
can1-cyh2
leu2
can1
cyh2
canavanine
ise2
drug-permeable
recombinants
cleavable
neutron
l1
l2
bun
microgramsl
constancy
phase-specific
apl-associated
haemorrhages
acutely
stiffness
hydrogels
arg-gly-asp
rgd
softening
nontoxic
op449
oligodeoxynucleotide
oligomers
complexed
transferrin-polylysine
dnarna
antisensetransferrin-polylysine
oncogene-targeted
bch--deoxy-3-oxacytidine
dioxolane
l-isomer
exchanging
sulfur
endocyclic
lamivudine
3tc
stereochemistry
d-nucleosides
doxy
minocycline
mino
exposure-dependent
vpropidium
equivocal
pancaspase
dissipation
deamidation
exome-
chronologically
founder-
far-reaching
globulins
atgs
cd7-positive
no-atg
nu2009u200932
cd7-negative
mongolian
bfm-aml2004
shortage
hcv
clinically-available
tranylcypromine-derivative
signalling-rraga
mlst8
wdr24
lamtor2-as
sensitizers
b-igg
170-kda
triphosphate-dependent
reserpine
3h-thymidine
lenograstim
indole
jerantinine
jb
af4enlp-tefb
functionally-distinct
prognostic-risk
lsd
kappa-light-chain-enhancer
nf-κbxa0have
cpi
roquinimex
linomide
quinoline
goreisan
aquaporin
-tetraiodobenzimidazole
cancerogenic
30xl
oncogens
cul4-ddb1-crbn-rbx1
crl4crbn
glue
degraders
disease-driving
gspt1-selective
cereblon
cc-90009
coopts
gspt1
xenografting
ilf2
ilf3
ilf2ilf3
crbn
tsc1
tsc2
cc-90009-induced
gcn1gcn2atf4
cc-90009s
nct02848001
nct04336982
vibsanin
diterpenoid
hydroxymethyl
substituent
pharma
kotobuki
flk2
ufo
jtk11
cd246
flt3-itd-d835y
trichosporon
beigelii
miconazole
norfloxacin
glufosfamide
oxazaphosphorines
4-hoo-cyclophosphamide
cyclohexylamine
ofloxacin
tarivid
trimetroprim-sulfamethoxazol
biseptol
polfa
ketoconazol
mycotic
resistent
flora
subclavian
sympathetic
pyrrolo--benzoxazepine
pbox
microtubule-targeting
pbox-induced
amp-activated
n-acetylcysteine
fk866
superset
dna-intercalating
1-methyl-3-nitro-1-nitrosoguanidinium
mnng
fk
superset-9
and--to
extent--
parp-activating
mnng-induced
3-aminobenzamide
fk866-pretreated
sustained-release
dasatinib-loaded
dsb-gnps
neovascularization
2-phenylpyrimidine
c-kit-positive
highgrade
synchronously
bioluminescence
non-topo
protein-positive
iialpha-positive
expressionpercentage
deoxyadenosine
mustard
embo
natl
acad
limb-bud
pulse-exposure
dendrogenin
dda
oxysterol
lxrβ
sterol
lxrβ-dependent
nontransformed
stress-inducing
glucose-regulated
caatenhancer
ire1α
stress-mediated
cflip
maturation-resistant
retinoid-resistant
nb4-rar
southern-blot
northern-blot
pml-rar
unresponsiveness
rotating
hd-ara
mamsa
aldesleukin
teceleukin
nonglycosylated
interleukins
lymphokine-activated
lak
averages
withheldabstract
orderly
tangible
sequester
lysosomes
basicity
visibly
polysaccharides
fi0-c
sulfated
fi0-c-s
cxcr4sdf-1
cml-like
bcr-abl-expressing
5-diphenylacetamido-indirubin-3-oxime
ldd398
mitochondria-targeting
indirubin
collapsed
ldd398-induced
mptp
executes
destroying
lipotoxicity
steatotic
phospholipidosis
amphiphilic
hyperinsulinemia
steatosis
attains
lipotoxic
rbl2h3
lipid-enriched
kpt-330
anti-hiv
nelfinavir
transporting
3hpaclitaxel
3hvinblastine
photoaffinity
3hazidopine
eu-5346
cancer-drug
cranberry
vaccinium
proanthocyanidin
a-pac
a-pacs
dna-topoisomerase
tri-lineage
low-complexity
oncotumour
chemiluminescently
ha-ras
embryofetal
obstetric
hydrops
transplacental
imputability
egfr‑tyrosine
non‑small
egfr‑tkis
coptisxa0chinensis
ecc
gefitinib‑resistant
egfrakt
anti‑apoptotic
egfr‑tki
egfr‑tki‑resistant
radiations
brains
necropsies
liquor
arachnoidal
dural
intrathecal-administered
transbronchial
oncornavirus
baboon
simian
leukaemia-sarcoma
anti-hl
23-specific
xmo-10
perfluorocarbon
surfactant
emulsions
micron
emulsification
lecithin
widely-used
emulsifying
emulsified
calcifications
parkinsonian
neurons
chelate
phosphates
calcification
bisphosphonate
disodium
etidronate
methyltransferases--enzymes
hyperhistaminemia
famotidine
chlorpheniramine
antihistaminic
non-culture
intermediate-to-severe
leukemiaretinoic
swallow
absorb
gstm
gstt
additively
pu200au200a2xa
nat2xa0genotypes
ssx2ip
rodents
adip
trail-
docetaxel-induced
ph-sensitive
copolymer
dioctadecyl
n-isopropylacrylamide
methacrylic
hl60-bearing
fab-lp
scidhl60
ph-insensitive
ara-c-loaded
sti571-resistant
bsabs
major-histocompatibility
manufacturability
cd19-direct
segmented
histidine-rich
hrg
neutrophil-like
hanks
nets
microcapillaries
proxies
chomosomes
epypodophyllotoxin
trated
acy241
anti-multiple
cd138
hla-drlow-cd11bcd33
heteroclitic
xbp1unspliced
yispwilav
xbp1spliced
ylfpqlisv
cdbb
cd40l
ox40
perforincd107a
ifn-γil-2tnf-α
aktmtorp65
bcl-6
eomes
t-bet
platinum-resistant
anti-mcl-1
anti-bcl-xl
skov3
igrov1-r10
calmodulin-mediated
bapta-am
calmodulin
hopping
16a
16i
2nm
gly71arg
glucuronosyl-transferase
b-ugt
hyperbilirubinaemia
heterozygotes
7-pentahydroxyflavone
ebs
rutin
3-rhamnosylglucoside
competed
3hestradiol
dose-related
dihydrotanshinone
tanshinone
cryptotanshinone
tanshinones
raji
phase-contrast
deoxyuridine
hydrocortisone
cystosine
synchronize
cycle-dependent
synchronized
drip
5ac
5-aza-2-deoxyazacytidine
untreatable
toxicity-profiles
platinating
topotecancarboplatin
backboneexperimental
damage-induced
fancd2
veliparibtopotecancarboplatin
mpn-
cd4t
replenishment
gavage
galt
nonenzymatic
proteomicepigenomicmutational
lsd1-containing
glycerophospholipid
1-octadecyl-2-methyl-rac-glycero-3-phosphocholine
et-18-ome
et-16s-oet
dimyristoylphosphatidylcholine
phospholipids
dipalmitoylphosphatidylcholine
calorimetric
enthalpy
pce
pinus
parviflora
sieb
zucc
cytocidal
fucose
uronic
abc-superfamily
non-pgp
lrps
vaults
organelles
localise
zoledronate
oncogenicity
ras-related
cd34xa0and
cd117xa0in
cd117xa0and
cd117xa0cells
mirna-101
sertraline
psychotropic
actue
rubidomycin
incubating
cytosar
cerubidine
r-verapamil
blanching
papular
crusted
forehead
confluence
syringometaplasia
metaplastic
apoptoses
radiosensitization
polymerases
heat-shocked
d0
ter
quasi-threshold
dq
d25d
carnosic
rosemary
nrf2antioxidant
nrf2are
are-luciferase
are-responsive
nadph-quinone
γ-glutamylcysteine
wtnrf2
dnnrf2
ap-1
atf2
wtnrf2-transfected
pro-differentiation
polyphenol
leishmaniasis
leishmania
donovani
vl
anti-leishmanial
promastigotes
amastigotes
non-dividing
assaying
detergent
96-well
mdr1-g1199t
g1199a
g1199t
g1199
mdr1wt
mdr1g1199a
mdr1g1199t
gsqmd
allmy
waldenstöm
macroglobulinemias
itrt
beta-galactosidase
hsv-tk
biotin-streptavidin
stoichiometrically
controllable
tf-r
bindings
reacting
tf-beta-galactosidase
lysosomotropic
lipofection
m7609
tmk-1
tf-hsv-tk
lqts
currents
brefeldin
bfa
fexofenadine
astemizole
channel-chaperone
ranolazine
human-induced
cardiomyocytes
hips-cms
apd
mtxcsa
follow-ups
ptcyatg
intertwining
limitless
nonce
in-class
tzd
area24
96-h
mlminm
non-downs
dose-calculation
course-to-course
pharmacokinetically
virus-infected
comprehension
forged
nanolipoplex
nanoliposomes
cellstissues
dioleoyl-sn-glycero-3-ethylphosphocholine
ecl-based
ecl
1-specific
simcl1
nanolipoplexes
luciferase-specific
sigl2
intratracheal
hypoxia-activated
th-302
tretinoin
non-cross
incriminated
mir-15a-5p
pdcd4
arl2
btg2
slot-blot
k562r
azd5991
macrocyclic
nct03218683
ponicidin
rubescens
zymogen
89-kda
tnf-r
engages
acridine
coriolus
versicolor
nucleosome
mitomycin
apoptosis-dependent
6-azacytidine
6-aza
5-aza-treated
gha-priming
mlaa34
mlaa
tet-mediated
5mc
11q23-balanced
htrx
targetting
cosmid
100-kb
der16
5mll3cbp
dyserythropoiesis
chromatin-association
zidovudine
dideoxycytidine
didanosine
aids-related
erythroid-specific
nfe-2
-142
hemoglobinized
reacts
lymphoblastoid
cd138-
arh-77
mcl1s
qpcrdigital
ncounter™
gonadotoxic
simulates
johnsens
mices
follicles
primordial
follicle
gonads
nilotinib-received
spongiotrophoblast
decidual
14c-omacetaxine
feces
168xa0h
excreted
24xa0h
tra
matrices
4-desmethylhomoharringtonine
4-dmhht
20xa0
dmhht
14c-omacetaxine-derived
bifunctional
pharmocophores
optima
epipodophyllotoxines
anthracyclin-containing
violacein
pigment
attracts
infliximab
tnf-alpha-induced
nah
exchanger-1
nhe-1
acidification
dihydronicotinamide-adenine
reductive
delphi
coauthors
setbacks
bim-el
bcl2-α
counter-regulation
aifs
teenager
scopulariopsis
brevicaulis
five-drug
pdfs
ribonucleotidereductase
p53r2
125i-low
fab-m5
125i-ldl
hypomethylatingdifferentiating
liposome-associated
5-position
methylation-mediated
spurious
vidaza
pharmion
bloomington
dacogen
anemias
hindrance
methylation-dependent
monograph
cxl
acute-myeloid-leukemia
hl60mx2
mll-fusions
mll-protein
triblock
methacrylate
scavenge
abts
hypochlorite
u-266
wistar
pdmaema-pcl-pdmaema
eskd
abbott
bfl-1
pan-bcl-2
fragment-based
affinities
smilax
well‑known
anti‑cancer
mucoepidermoid
mesc
mc‑3
interacting‑domain
lymphoma‑extra
signal‑regulated
c‑jun
n‑terminal
co‑treatment
pd98059
interleukin-2-activated
pc-9
pc-14
pc-9cddp
pc-14cddp
k-562adm
coined
lsc-targeting
bi-specific
car-nk
imatinib-sensitiveresistant
isobolographic
carotenoids
crocus
sativus
saffron
dmcrt
crocetin
seminatural
u3
differentiation-dependent
virus-related
mink
focus-forming
virus-derived
fdc-pmix
subversion
destabilization
overexpressions
mrp-negative
n-methylpyrrole-n-methylimidazole
polyamides
sequence-specificity
dna-alkylating
polyamide
chlorambucil-pi
seco-cbi
cbi
bind-n-seq
mermade
dervan
120u202fnm
63u202fnm
seco-cbi-pi
sesquiterpenoids
salplebeones
axa0-xa0c
plebeia
eudesmane
lactone
peroxides
cuso4
ociaml-2
adefovir
dipi-voxil
adefovir-dp
octadecyloxyethyl
ode-adefovir
hexadecyloxypropyl
hdp-adefovir
adefovir-based
ph2ax
phospho-p53
kurarinone
sgc7901
g2mphase
dendrimers
maltose
ppi-m
dendrimer
ccrf-1301
adsorptive
cholesterol-dependent
clathrin-dependent
repercussions
glycodendrimers
nitrosoureas
pcnu
glycosphingolipids
glycoproteins
teratocarcinomas
gal
fuc
glcnac
gal----
gangliosides
glycolipids
dispersions
ganglioside-containing
marrow-ablative
purge
semi-reverse
semi-rt-pcr
2-deoxycytidine
5-aza-dr
replated
plating
fret
stressdna
pan-hdaci
entinostatromidepsin
ms-275fk228
rgfp966
marbostat-100
non-steroidal
nsaid
myelocytomatosis
destabilizes
caspase-dependently
-independently
cross-regulation
tpmtis
thiopurines
tpmt
substiantially
rp2
alaacbu
ferrochelatase
vacuolar
fmca
intra-individual
cgp
anthracycline-resistant
subline
a2780adr
cytometrically
cytofluorometric
a2780
arac-resistant
arac-sensitive
staurosporine-induced
-sensitive
rehabilitated
thalidomide-mechanisms
priviligiate
thalidomide-specific
selcids
-dihydroxyvitamin
d25-oh2d3
acetone
bamboo
bafetinib
strive
ibd
lobectomy
30th
borrman
epidermoid
bf11
disease-term
genotoxins
alarmingly
albino
copanlisib
pan-class
pi3kδ
copanlisib-based
mzl
sakk
radionuclides
mp67
hp67
anti-carcinoma
hctm01
ha33
colo
125i
iodogen
111in
90y
percoll
sds-page
routed
125imonoiodotyrosine
radioiodinated
catabolites
internalizing
antibody-antigen
methyl-cellulose
pha-leucocyte
m4fab
cytosine-arabinoside
bromodomains
burkitts
steered
smd
fluorimetric
bilayer
sphingolipids
bioeffector
ceramides
s1p
glucosyleceramide
sphingosine
sk-1
ceramide-metabolizing
c8ceramide
pdmp
xtt
ceramide
generationaccumulation
cers
cers1
phytochemical
ppe
frutescens
vit
calcidiol
25ohd
n4-behenoyl-1-beta-d-arabinofuranosylcytosine
thereupon
microassay
agar-containing
bromodeoxyuridine
sister-chromatid
sce
anti-epileptic
sces
intubated
bronchoscopy
extubated
advising
single-point
p85α
rxrα
trxrα
oroxylin
scutellariae
radix
hl-60-resistant
fanc
fdps
decetylase
ep3000
plk-2
aurora-like
aukrb
pam50
emboss
matcher
scleroderma
antifibrotic
calcitriol
side-chain-modified
pri-1906
side-chain
pri-2191
calibur
doxorubicin-
cisplatin-
taxol-induced
adhesion-mediated
cam-dr
beta1-integrin
ultra-deep
∼5000×
non-silent
stop-gain
pl526f
pa400v
pq88x
clinvar
sift
polyphen2
cadd
deleteriouspathogenic
snv
pt358p
pl258fs
ptt-119
granulo-monocytic
cerebri
papilledema
unremarkable
mutagen
melc
h-
g2-phase
isothiocyanate
annona
muricata
linn
acetogenins
subtropical
viz
autodock
benzylisoquinoline
azathioprine
2-deoxy-5-azacytidine
supressor
p53-apoptotic
decitabine-induced
p53-inducible
histonedeacetylase
activation-induced
aicd
promonocytic
fas-
tnf-induced
sub-lines
cpp32
herpesvirus
hhv-6
antivirals
ci-hhv-6
nvcs
euphorbia
formosana
hayata
rheumatism
scabies
photoaging
hot-water
efw
µgml
a-549
danggui
longhui
indirubins
src-like
gp170
nk-dependent
tera-2
platelet-activating
paf
paf-r
pseudomembranous
clindamycin
leukaemia-ie
therapy-has
oha
co-adjuvant
aquired
mds92
mds-l
damage-mediated
p53-
biogroups
ploidy
phase-related
calu-1
calu-3
bid007
melanogenesis
gametogenesis
two-class
arrest-inducing
lama84
monolayer
ve-cadherin
reorganization
matrigel
plugs
sophora
flavescens
melanotic
lavandulyl
c8
hepatocarcinoma
lavandulylflavonoids
c4c5
schisandra
fructus
sfwe
ionophore
a23187-induced
factor-kappab
manners
payload
diphthamide
tagraxofusps
adp-ribosylate
dph1
drug-dependent
adp-ribosylation
silica-coated
erythroleukaemia
13-cis-ra
9-cis-ra
irr
mrk16moab
ctr
seashell
haishengsu
hss
activeinactive
expressionfunction
resistome
cis-aconityl-daunomycin
polylysglui-dl-alam
eak
polycationic
polylysseri-dl-alam
sak
dppc
phospholipid
cad-sak
amphoteic
cad-eak
bezafibrate
bez
medroxyprogesterone
alpha-ketoglutarate
succinate
redeployment
mdr1gene
hematoglobin
vincristeine
mitoxanthrone
lympoblastic
artesunate
semi-synthetic
artemisinin
annua
wormwood
pbm
non-mds
nanoscale
actives
clx-sln
clx-nlc
clx-ne
clx
homogenization
diffraction
photon
storing
200u202fnm
payloads
efficaciously
trimethoprim-sulfamethoxazol
neutropaenia
coagulase-negative
staphylococci
enterobacteriaceae
granulocytopaenic
n-hydroxycarbamide
rfm
g-banded
apogossypolone
apog2
wst-8
internucleosomal
five-fold
in-gel
dige
promyeloid
microtubule-stabilizing
peloruside
100xa0nm
cytoskeletal
nl-101
mip-1alpha
fdcp-mix
v-abl
125i-mip-1alpha
desensitisation
contributory
sterols
ccl4
bryozoan
cryptosula
pallasiana
spectroscopic
hr-esi-ms
farnesyltransferases
humanised
stepping-stone
mind-altering
antinausea
miconidin
hydroquinone
hiemalis
fasr
chromo
some-positive
nelarabine
pegaspargase
related-donor
abl2
cycle-active
temporally
beta-cytosine
hsa
cd2f1
l-1210
ara-ckg
q8
lbn
72-hour
daunorubicinkg
chemotherapy-free
2（bcl-2）and
singal
leukemia（aml）patients
leukemia（cll）
lymphoma（nhl）and
results．at
time，some
venetoclax-resistant
demethylase-1
aerodigestive
protein-
chromophore
n-methylation
oxaunomycin
bct
dox-rflc1
mdr-positive
steric
incurring
fbw7--
-7del
17p-
-5del
32p
non-alkylating
coronaviral
papain-like
attacking
highly-conserved
subdomain
usp2
usp21
slow-binding
usps-related
ph1-positive
6-yr
ph1-chromosome
cytarabine-associated
pan-b-cell
cds15
antiparkinsonian
non-twin
oligolysine-based
trilysinoyl
oleylamide
tlo-based
tlol
gfp-expressing
sigfp
ptlol
kb-xenografted
sigl2-treated
saha-loaded
pstlol
aerosolized
cushioned
mouthpiece
coughing
airways
cvt-e002
quinquefolius
ameliorative
protein-targeted
solvents
msh
tumour-derived
etoposide-containing
ginsenosides
antiaging
gsl
co-antineoplastic
n4-behenoyl-1-beta-d-arabinofuranosyl-cytosine
nausea-anorexia
lipidomic
cerebrosides
glucosylceramide
c6-ceramide
-phenyl-2-palmitoylamino-3-morpholino-1-propanol
ppmp
kccc
non-lymphoblastic
mitoxantrone-containing
m4-acridinylamino-3-methoxyphenyl
methansulfamide
methylglyoxalbisguanylhydrazone
3hthymidine
biobanking
phospho-flow
fedratinib
fed-mediated
phospho-stat5
pstat5
fed-responsive
jak2-independent
nanoliposome
chromatography-inductively
lc-icp-ms
asv
conversions
drying
nanoliposomes-encapsuleted
assures
histo-compatible
cephalon
frazer
ige-class
polymyxin
x-irradiation
thymocyte
transplatation
rhinorrhea
perinasal
urtication
reaginic
ige
prausnbitz-küstner-type
hemagglutination
iatrogenically
nvp-bkm120
bkm120
bkm120-induced
glycolitic
unicellular
bacterium
bakers
proficiency
bioremediation
arsenic-contaminated
soils
k562mdr
unwinding
fadu
leukaemiclymphoma
km3
daudi
mitozantone
behaved
dexa-beam
cfu-gm14
cfu-gm7
hdc-regimen
reconstituton
hdc-program
cisplatin-resistant
igrov1
oaw42
oaw42-r
nonresponsive
ha-induced
pan-inhibitors
sedimentation
polymyalgia
rheumatica
pmr
uterus
ahs
flavored
vanc
ii-targeted
zalypsis
ad0157
pyrrolidinedione
ku812f
subg1
lamin-a
caspases-8
caspases-
cyp3a-dependent
contaminants
cyp3a1
cyp3a3
2-dimethylamino-n--methoxy-benzenesulfonyl--dihydro-1h-indol-7-yl-acetamide
mpt0b169
mdr1-mediated
hl60taxr
concentration-
mpt0b169-induced
adp
nonresistant
hdis
post-culture
gcsf-stimulated
neo-natal
hdac5
sirt4
hyperacetylation
hdac11
tsa
hdac9
hdi-based
extraordinarily
overtreated
dactinomycin
relaxed
supercoiled
re-ligating
strands
helix
re-ligation
cleavage-re-ligation
irreparable
ii-mediated
dysprosiumiii
coumarin-3-carboxylic
hcca
nitrates
raman
metal-ligand
lniii
vibrational
cca-
carbonylic
carboxylic
atoms
samarium
lanthanide
coumarins
ra-sensitive
ra-resistant
bhac-dmp
bhac-dmpii
m-85
jalsg-aml87
-all87
miltiorrhiza
bunge
danshen
curine
vasodilatory
orangeethidium
double-labeling
57xa0
depolarization
vigor
aids-associated
staggered
damage-inducible
gadd
stress-inducible
gadd45
insult
disseminate
pharmacologists
eaft
cancerinvasive
mycoses
eortcmsg
desoxycholate
antagonised
6-tg
peripartum
bh3-mimicking
steroidthyroid
herceptin
her-2neu
galvanized
kinase-inhibitor
dmso
uncouple
jnp
serum-starved
prednimustine
tamoxifen
thrombocytopenias
futile
myh9-related
bernard-soulier
ankrd26-related
metabolization
chemotherapy-exposed
nonselectivity
thiosemicarbazones
chemoselective
thiosemicarbazone
lap17
δψm
hma-based
factor-gm-csf
3-il-3
preincubated
andrographis
paniculata
diterpenoids
glucosides
dimers
cct241736
flt3-itd-tkd
quizartinib-resistant
ptpn6
mecp2
mbd2
garner
cancer-relevant
front-runners
chemogenomic
chemoproteomic
emanating
focussing
spectrum-selective
monospecific
constructively
pi-103
pyridofuropyrimidine
dnr-induced
pi-103dnr
lscs-specific
sildenafil
bosentan
ara-c-metabolizing
noninfants
trancriptase-polymerase
nucleotidase
pn-i
deoxycytidylate
dcmpd
nonrearranged
dictyostelium
discoideum
rattus
norvegicus
cross-toxicity
eosinophil-rich
chondritis
cystitis
dgtpgtp-activated
aicardi-goutières
ags
nucleoside-based
fucoidan
therapieswhen
sub-therapeutic
sub-g0g1
vpi-positive-apoptotic
aplin
apl-bearing
fucoidanatra
fucoidanato
patientsour
imatinib-coper
interferon-a
re-achievement
flutter
hypogranulation
g-band
chemiluminescence
anti-mpo
realgar
mpn-like
j53z1
sca-1
ter-119
cd317
cd8a
b220
cd42d
nk-
fcer1
∼18
fbw7-dependent
mcl-1-ki
anti-hypoxic
degradation-resistant
sequestered
mcl-1-targeting
recently-
predecessors
inquiring
fournier
gangrene
groin
pancytopaenia
inr
leucopaenia
hydridization
healed
mpt0g211
lymphomalike
myelodysplasiaacute
radioisotopes
autostimulatory
tnf-beta
oaf
b2m
cal-la
h-ras
melphalan-prednisone
featuresabstract
hbsag
hepatitis-b
neurokinin-1
nk1r
anxiolytic
nk-1
osteoblastoma
annexin-v
hoescht
emh
tnfsf7
cip1waf1
ikbkb
stathmin
ctsg
potentiator
srebf2
srebp2
restorative
adults-acute
exanthematous
urticarial
hsv-2-hepatitis
hsv-2
hsv-⁴
hsv
mhh225
life-prolonging
rafmitogen-activated
mekextracellular
hep3b
u0126
dox-induced
counteraction
sti571imatinib
mesylategleevec
3β
sorafenibato
flt3-itd-targeted
c-21
anti-virus
steroidal
glycoside
bw18
cynanchum
atratum
blockades
otto
warburgs
beginnings
epiphenomenon
re-modeling
tmp-smz
trimethoprim
sulfamethoxazole
prevalently
cocci
ahi-1
dynamin-2
-å
pd1r
arg-arg-trp
tiazofurin
c-ki-ras
microcirculatory
inotuzumab
anti-cd22
cd22-expressing
internalised
cd22-positive
benzidine-positive
diesters
diester
12-o-tetradecanoyl-phorbol-13-acetate
mcl-1-dependent
dtic
colo829
nucleocounter
nc-3000
inhibitor-mim1
domperidone
suppository
suppositories
mbs
tga
100u2009mb
k562r1
-r2
-r3
ku
k562r3
cpt
dna-pk
caspase-mediated
resensitize
imatinib-mediated
46xydel6q21
curiosity
asciminib
vrije
universiteit
bfm-aml
aegera
idera
aeg-35156
19-mer
caspase-10
3-methyl
nitroprusside
hydroxy-staurosporine
ucn-01
ucn-
bag-1
flavopiridol-induced
ucn-01-stimulated
taxotere
nonrestricted
mhc-nr
ov-2774
cross-over
itra-peg
pelleted
itra-pel
washout
atresia
sarcoidosis
psoriasis
acrylamide-based
2-acrylamidobenzoic
naphthyl
double-digit
acrylamide
2-position
fluoro
benzoic
anti-arthritic
1alpha25-dihydroxyvitamin
d25d3
calcemia
wehi-3b
d-
low-calcemic
-dihydroxy-16-ene--trans-cholecalciferol
-dihydroxy-z-diene-20-epi--hexafluoro-19-nor-cholecalciferol
chemoprevention
optimisation
eu-openscreen
harnesses
antimalarial
endoderm
chaperones
inborn
tankyrase
cmf
intractable
azanucleotide
reassessed
product-derived
pgpmdr1
4deoxydoxorubicin
4-demethoxydaunorubicin
protein-based
auristatin
daci
drug-treatment
2677gt
-diaziridinylbenzoquinone
dzq
9-carbonylacridine
polymethylene
non-acridine
5-methyl-dzq
derivatized
interstrand
cross-links
h596
h460
ht29
dt-diaphorase
dtd
non-aziridine
19b
propyl
bdf1
peptidases
pepsin
deoxythioguanosine
position-dependent
ii-induced
plumbagin
double-stained
chromsome
vpi-
transcriptionchromatin-remodeling
osteoblast
mc3t3
w-
contact-independent
cxcr4-dependent
sdf-1-driven
cxcr4-expressing
bnml
assesses
experimentalists
aml-6-trial
interrupt
aml-7-study
hematotoxic
lsc-derived
anti-aging
tianshengyuan-1
tsy-1
innately
tdzd-8
bccml
thiols
hd-a
bacteremic
sloreta
brodmann
fronto-parietal
attentional
base-pair
expression--which
gene-directed
remission-inducing
daucus
carota
dcoe
annexinv
mapk-dependent
enumerate
2-aminobenzamide
trifluoromethyl
mtt-based
nci-h661
6h
9b
10a
noncomparative
anti-acute
revolutionise
advanced-age
cyanobacterial
biofilms
gastropods
brackish
symbiotic
lichen
ipc-81
microcystins
nodularin
hek293t
l26-o
l30-o
l1-o
cyanobacteria
prolific
categoriesthe
mu-bcr
reinducing
ctcl
naphthalimides
phenalenone
fluorophores
long-wavelength
3-isopropyloxy-6-morpholino-2-phenylphenalen-1-one
crm1-ran-ranbp1
kpt-251
occupies
penetrates
crm1-directed
kpt-sine
triads
microscopical
perisinusoidal
clinical-pathological
structurefunction
spurring
affinity-purified
dapi
counterstain
excitation
em-3
median-effect
chou
talalay
imatinib-containing
emetogenic
epilepsy
vomited
anti-emetic
51cr
hcnt3
sodium-coupled
nucleoside-derived
rhoa
sk-7041
quinine
microbes
alopecuroidea
e-selectin
disturbing
3-dependent
leukemia-driven
outperforms
p53null
p53wt
leukemic-initiating
berberis
vulgaris
wehi-3
bvfce
wehi-3cell
ferrokinetic
rubidomycine
doubtful
bfm-83
rub
protector
neutrophil-activating
peptide-2
nap-2
tgfbeta1
factor-rich
pf4-treated
cfu-megakaryocyte
cfu-mk
cfu-granulocytemacrophage
burst-forming
units-erythroblast
bfu-e
protamine
bcl-2-related
fitc
mrk16
mrpr1
β-thalassaemia
noncontrolled
midazolam
crossover
repeated-dose
infinity
aucinf
spicamycin
krn5500
dissolution
krnm
blm-induced
acanthamoebiasis
acanthamoeba
monocyte-depleted
kasumi-3
n-acetyl-l-cysteine
scattered
nondiabetic
hypoglycemic
pdgfrβ
gm-csfras
resolves
genotype-based
niosomal
mal-peg2000-dspe
niosomes
antibody-modified
cd123-ns
antibodyspan
l-cd123-ns
h-cd123-ns
density-dependent
dnr-loaded
dnr-h-cd123-ns
acivicin
acid-binding
p-450-mediated
l-atra
l-atra-treated
parasites
allergen
granule
fluorogenic
microplate
al1
triclosan
solvent
dissolved
stirring
uv-vis
spectrophotometry
craf
rafmekerk
re-populating
idh2140
co-operatively
--gossypol
--g
rosiglitazone
--g-induced
dusp16
--g-triggered
dusp16jnkmcl-1
singling
histonedeacetylases
multi-protein
antiepileptic
trioxideas2o3
polyhydroxylated
topsensterols
sponge
noesy
l-3
δ
sgc-7901
calla
supravital
2000microliters
unsatisfactoryarea
patientsexpert
cautions
mucor
chromatin-targeting
suv39h1
methyl-transferase
tri-methylation
chaetocin
death-receptor-related
ros-dependent
chaetocin-induced
decryption
read-out
withaphysalins
c28-steroidal
lactones
ergostane
actvity
withaphysalin
acnistus
arborescens
time-and
5-bromo-2
-deoxyuridine
non-viable
hematoxylineosin
12-o-tetradecanoyl
phorbol-13-acetate
non-induced
fibronectin-
matrigel-coated
tpa-activated
rgd-dependent
fibronectin-specific
grgds
cs-1
garcinia
hunburyi
pharmacoeconomic
antiprogestatin
mifepristone
p-gp-mifepristone
p-gp-related
chemosensitizer
down-modulate
ecv304
pulses
ccnu
meanmedian
equals
arabinosyl
comparingl-dnr
faired
idiosyncrasies
wntb-catenin
junb
sod
novobiocin-resistant
wehi-3bs
wehi-3bnovo
novobiocin
cross-resistant
ii-reactive
-acridinylaminomethanesulfon-m-anisidide
g0-g1
tcm-wm
hom
hemocytopenia
hypertensive
eclampsia
auto-regulation
radiographically
vasogenic
subcortical
doubts
bioequivalence
ipcxa
ipcs
flourished
fe3
ferrireductase
ferricyanide
ferrocyanide
tf-independent
assimilation
vmax
actinomycin
cis-platin
cellsabstract
ubiquitin-conjugating
ubch8
ubiquitin-ligase
siah1
kinase-inactive
morphological-identified
heterogenity
patient-to-patient
intraclonal
response-associated
pro-erythropoietic
registrational
mds-004
mds-003
lenalidomide-treated
alkyl-lysophospholipids
lysophosphatidyl
acyltransferase
ctpcholinephosphate
cytidylyltransferase
nak
atpase
pkcβii
plasmatic
hsb-2
cytokine-
oncogene-mediated
4-hydroxytamoxifen
4ht
fdc-p1
raf-1
raf-responsive
ly294002
arylamines
arylamine
2-aminofluorene
2-af
-14caf
myristate
sulfoxide
covalent
n-acetylation
2-acetylaminofluorene
2-aaf
azide
dmso-differentiated
hypermetaphase
hmf
ipf
mll-induced
coap
pomp
srcbcr-abl
im-induced
angelica
polymorpha
maxim
apre
stomachache
pi3kaktgsk-3β
sh-sy5y
non-caspase
stress-ros
nicotine
nicotine-induced
gm-cfc
autografts
incompatible
re-engraftment
granulomatous
tubulointerstitial
nephritis
hypercoagulable
mll-af10-associated
apo
af10om-lz
dot1l-af10
tuberculostatic
two-drug
anll-ns-02
cytologic-mathematical
nonclonal
hla-sibling
anticd33
iall
all-1mll
interfant
leukopeniathrombocytopenia
untenable
culture-based
nonculture-based
up-and-coming
antigensantibodies
mannan
antimannan
d-arabinitol
panfungal
β-glucan
acid-
dose-intensity
hsf1
cantharidin
shock-induced
hct-116
co-chaperone
hsf1-dependent
p-tefb
p-tefb-dependent
pp2ca
okadaic
2a-independent
demethylate
methylation-silenced
isotope
pml-positive
stems
doxorubicin-promoted
ablsrc
12-o-tetradecanoylphorbol-13-acetate
thiotriazole
ftt
n-n-heptyl-5-chloro-1-naphthalenesulfonamide
sc-10
--fluorophe-nylphenylmethylene-1-piperidinylethyl-7-methyl-5h-thiazolo-apyrimidin-5-one
r59022
-4-bis-4-fluorophenylmethylenepiperidin-1-ylethyl--dihydro-2-thioxo-h-quin-azolinone
r59949
diacyl
glycerol
p21wafcip1
c-fos
epsilon
tpa-mediated
vp-16-treated
abscesses
vasculitic
125i5-iodo-2-deoxy-uridine
iudr
zeocin
bleomycinphleomycin
centrifugal
serine-392
zhebei
czg
dissatisfying
sketch
ampicillinesulbactame
fluconasole
nonhistone
acetyltransferases
anacardic
p300cbp
pcaf
sscmap
testable
toxicological
prioritise
maximised
gene-signature
letrozole
ppar
microgramsm2
multi-organ
reconditioning
drugsadvances
state-of
the-art
oligonucloetide
transduction-active
preconceived
notions
abound
mikkael
sekeres
anthracylines
long-standing
new-onset
b-lymphoblastic
hypersplenism
operationally-defined
unproved
therapy-free
cdks
f-ara-a
repair-deficient
adducts
ethidium
intrastrand
whole-cell
fn-coated
substratum
arg-gly-asp-ser
rgds
hemin-induced
trypsinization
f-actin
attaching
ventral
cytochalasin
microtubule-disrupting
microfilament
electrophoretically
polypeptides
fns
nitrocellulose
eluted
octylglucoside
radioactively
ganciclovir-resistant
broncho-alveolar
nonleukemia
coculturing
cd40-ligand
cd154-expressing
apoptosis-regulatory
hk-induced
hk-mediated
anti-cd44
cd44-dependent
michels
shulman
mertens
ballen
antin
pedersen-bjergaard
high-cost
secondline
11-exon
tk6
10-bp
palindrome
midpoint
palindromes
nuclease-sensitive
tmds-aml
postalkylating
bcrp1
drn
calcein
k562doxdr05
k562abcg2-z
pyrene
dodecanoic
p12
medium-chain
monomeric
excimeric
spectrofluorometric
cmc
dispersion
unilamellar
phosphatidylcholine
negatively-charged
spectrofluorometer
epsilon-
hemin
hem
acm-treated
canonic
promoter-containing
nonerythroid
cos7
carbohydrates
dsat
claat
lactulose
mannitol
abasic
scission
distortions
dodecamer
tetrahydrofuran
apurinic
scissile
phosphodiester
extrahelical
biopolymers
co-trimoxazole-colistin
ketoconazole
zingiber
ginger
zowe
amphiphile
dic14-amidine
non-miscible
phosphatidylethanolamine
chloramphenicol
cmls
-trimethoxybenzoyl-2-nn-dimethylamino-benzobfurans
3-iodoacetylamino-6-methoxybenzofuran-2-yl-trimethoxyphenylmethanone
tr120
kcl22-r
bcr-abl-mediated
hquinazolinimines
chlorides
brd2
brd3
brdt
i-bets
oligonucleosomal
egcg
epigallocatechin-3-gallate
prb
prb-e2f
tf-1a
prb-cdks
kinase-independent
rafts
raft
10-octyloxy
odpc
alkylphospholipid
silac
lipid-raft-enriched
palmitoylation
lat2
palmitoylated
odpc-induced
proteasomes
3×
alkylphospholipids
chemotherapeutic-drug-sensitivity
suspensions
vitroin
vivo-representative
aclacinomycin-a
coinciding
36u2009µml
20u2009µml
25u2009gl
supra-therapeutic
neurovegetative
ototoxicity
libido
offspring
sub-families
organellar
promiscuously
95th
centile
underdosing
sedentary
methamphetamine
meth
craving
accumbens
drug-associated
enzyme-inducing
eiaeds
carbamazepine
phenytoin
oxcarbazepine--as
non-eiaeds
levetiracetam
lamotrigine--are
isozyme
mk-886
esculetin
guillain
barrè
so-treated
anti-type
foxos
relentless
outlying
surpass
radiophosphorus
myelosupressive
nonmutagenic
fullfilled
17p-syndrome
drug-protein
tyr
serthr
ddr1
nqo2
hydroxamate-based
cg200745
e-2-naphthalen-1-yloxymethyl-oct-2-enedioic
-dimethylamino-propyl-amide
8-hydroxyamide
hormone-independent
pc3
mono-treatment
hormone-refractory
hrpc
15th
22nd
hallucination
auditory
sex-mismatched
laminar
54th
psychosis
dimeric
abietane
hongencaotone
prionitis
ether-linked
4b
eif4b
melk-eif4b
roscovitine
mfcyclophosphamide
cocoa
cps-gelatin-chitosan
fld
procyanidin
monomer
fabrication
zeta-potential
ftir
gelatin
nanoencapsulation
mdr-associated
mdr1p-glycoprotein
t-lymphoblastoid
sublethal
cdna-pcr
nanocarriers
free-drug
cii
biitu
ciitu
therapeutictoxic
bcl-2-dependent
benchmarking
fluorimetry
dsf-based
a-1210477
phenocopied
mcl-1-independent
a-1210477-induced
drp-1
000microl
palpitation
osteomyelofibrosis
vm-0
cytostaticcytotoxic
rp2ds
emodin
3-azido-3-deoxythymidine
clsc-human
kg-la
depriving
triazinoaminopiperidine
t-leukemic
ccrf-cemvlb
ic10
post-incubations
postincubation
post-incubation
30-min
membrane-associated
head-to-tail
flt3-postive
mhlw
dfg-dout
ff10101
multi-factorial
q23p
eia-binding
steroid-receptor
tetrazolium-based
line-dependent
additivity
upkeep
holoclones
holoclone
gadd153
eif5a
deoxyhypusine
dhs
cni-1493
dhsi-15
deoxyspergualin
25-
28-fold
k562-cat
alpha-activated
lipophilicity
intercalate
x-methyl
9-methyl
antifolate
folate-like
kras-mutant
farthest
zarnestra
ortho
biotech
raritan
sarasar
schering-plough
kenilworth
drugs-and
hcmv
cleavages
mtor-mediated
non-cardiotoxic
phenformins
gleevecs
trumpeted
overblown
phenformin
13c-guided
hyperlipidemia
biguanides
pyridine-
phenyl-guanidine
phenylcarbamoyl
lipitor
emblematic
flawed
oncotargets
ailanthone
ail
quassinoid
ailanthus
altissima
vestibular
first-pass
monkeys
budd-chiari-like
antemortem
arsphenamine
relapse-risk
triazoles
viscin
viscum
betulinic
oleanolic
granularity
triterpenoids
lupeol
beta-sitosterol
stigmasterol
oleic
linoleic
palmitic
stearic
fistula
fistulae
anastomosis
interposition
mandril
run-off
semiautomated
microtiter
dmax
cdaarac
multiplicative
cdadnr
araccda
genera
azelastine
epinastine
fcepsilonrialpha
fcepsilonri
ige-bound
aunps-drug
gelatin-coated
quizartinib-loaded
leukaemia-lymphoma
histopathologically
leukaemialymphoma
glues
concur
multifactoral
mdssecondary
mdssaml
methylation-associated
dmfs
gfra1
irx1
npy
znf300
non-growing
chemo-differentiation
pyrrolo-b5benzothiadiazepine
-dioxides
pbtds
smrp
tioguanine
methyl-thiazol-tetrazolium
assaysmdr1
abc-transportersmtt
anticonvulsant
1-methyl-1-cyclohexanecarboxylic
mcca
advsm
kit-inhibitors
avapritinib
colony-forming-units
midostaurin-treatment
ocoxin
oos
ralentization
quadriceps
nyha
cystatin-c
nt-probnp
diastolic
circumferential
pertinently
2-deoxyglucose
2dg
ampkmtorc1
cap-independent
ascribe
5utr
few-layer
graphene
flg
mek-erk
de-phosphorylation
p53aip1
moderne
setback
geranylgeranyl
cortisone-acetate
ehrlich
eaf
strain-specific
methylcholanthrene-induced
b-16
rnr
arabidopsis
thaliana
catalase-mediated
decomposition
catalase-activated
unfamiliar
cost-benefit
exploits
ratio-dependent
palliating
chlorhexidine
nystatin
rinses
gingivitis
rinse
cxcr4cxcl12
cxcr4-specific
pentixafor
68gapentixafor-positron
cxcr4cxcl12-defined
krn8602
mx2
krn
coutinuous
endocarditis
agl
cd19-liposomes
imatinib-cd19-liposomes
flt3pml-rar
su11657
st1571
achromobacter
xylosoxidans
piperacillin-tazobactam
doxorubicin-dna
noncomplexed
daunorubicinm2
daunorubicin-dna
complex-binding
danusertib
non–small-cell
atn-224
atn-224–dependent
h2o2
atn-224–induced
h2o2-dependent
bcl2bclxl
kras-driven
nanotubes
f-swnts
swnts
sirna-f-swnts
phialemonium
obovatum
fungemia
caseating
crohn
serologies
wedge
septate
globular
crypt
distortion
simulating
c-mycmaxdna
potentiality
drug-dna
microdoses
14c-labeled
accelerator
dox-dna
microdosing
viably
keystone
blood-csf
dispel
non-obese
diabetic-severe
resistance-a
battleground
grail
recreate
invulnerable
imidazoacridinone
c-1311
null-flt3
fuse
mll-fps
mll-fp
her2-
rafrasmapk
intermediate-poor
cytarabine-daunorubicin
pevonedistat
p-crkl
pro-death
lc3b
3-methyladenine
3-ma
mir-17
differentiation-inducible
m1-b24
alpha25-dihydroxyvitamin
d-2-dodecyloxyethoxyethyl
2-pyridinioethyl
nanomicellar
leukemiaapl
oren-gedoku-to
gargle
gualenate
povidone-iodine
cease
transplantability
opioid
methadone
dl-methadone
methadone-induced
chromosome-linked
apoptosis-sensitive
epha2
tumorogenesis
lipoplatin™
cisplatin-based
lipoplatin
sirna-epha2
gvhd-induced
cfu-aml
aml-193
dnr-mediated
ara-c-mediated
rituxan
anti-her2
mab-guided
16alphah17-isovaleryloxy-ent-kauran-19-oic
acanthopanax
koreanum
trypsin-stimulated
kdnr
kdox
kepr
kida
chemist
aligned
structure-based
conserve
troubles
lapse
bracketabstract
ellipticine
synthesised
60-cell
7-hydroxyisoellipticine
isoellipticines
faslfas
homotrimeric
sfasl
scfvcd7sfasl
leukemia-restricted
scfv
cell-surface-expressed
ptcl
cd7-restricted
l-744832
velcade
millenium
pbls
il-2cd3-activated
revitalizes
fcepsilonri-mediated
rbl
3xa0xa
idarubicinxa0xa07
healthier
reluctant
sasp
p16ink4a-expressing
aml-induced
nox2-derived
nox2
leukemia-generated
p16ink4a-dependent
gsk-3α
computer-aided
g2814
33u202fnm
218u202fnm
-3β
isoform-selectivity
isoform-selectively
in-cell
thistle
hepatoprotective
aml-bfm-83
outpatient-based
occupancy
22t-q34q11
mscv-bcr-abl-gfp
mig-bcr-abl
researchmoreover
anti-mitotic
dynamical
constrained
high-order
aminoacyl-trna
synthetase-interacting
aimp2
non-enzymatic
aimp2-dx2
aimp2-dx2aimp2
subclassifying
urging
c225
zd
iressa
2-chloro-2
deoxy-adenosine
hairy-cell
premetrexed
hematoendothelial
etv2
hipscs
niehs
toxicology
tox21
endothelial-to-hematopoietic
berberine
benzoapyrene
non-hemogenic
fates
tf-based
nonaccidental
denbinobin
hansenula
anomala
endodontic
naf
hsc-2
cresol
phenic
varnish
dna-processing
ii-inhibiting
c609t
grandparents
québec
log-linear
grandparental
telomerase-dependent
htert-ad
titers
mcl-1-sirna
virochemotherapy
ifn-ε
ifn-κ
down-stream
-oligoadenylate
distemper
keratoconjunctivitis
sicca
reformulation
moyamoya
non-st-elevation
echinocandin
dab
dabc3h
whole-animal
ctl-based
70s
marrowexamination
reactionpcrrevealed
chromosome-
factorchemotherapy
gfct
4-hc
terminates
bmb
midway
mets
cyp1a12a
imparted
cyp1a12c
exon3
gene-gene
4-deoxy-4-iododoxorubicin
idx
microspectrofluorometric
dxr-resistant
k562dxr
nondestructive
blast-crisis
subtyped
benzodiazepine
enterocytozoon
bieneusi
microsporidiosis
fumagillin
amides
piper
nigrum
helaptx
piperine
phospho-akt
sterility
phenomenon--partial
menopause
planed
pregranulosa
ivf
biopter
embryocryopreservation
infertile
doxo
annexinvpi
stat3-regulated
caspases--9
il-6-induced
stat3-target
ato-insensitive
bso-mediated
atobso
alkylphosphocholines
erufosine
erpc3
glutathion-s-transferase
thiazolides
anti-infectious
gstp-dependent
gstp-mediated
thiazolide-induced
inducibly
genike
chiatai
tianqing
glevic
groups205
χ123
③cumulative
χ084
χ660
④cumulative
χ617
χ628
⑤at
χ293
χ124
⑥genike
injectables
signaled
self-insured
rar-β
1xa0h
self-administer
tricyclic
tetra-acridines
decatenation
hl-60mx2
acridines
nix
ms-based
neosubstrates
cc-885
rotenone
cryoprecipitateprothrombin
methylbenzoic
adjustedthe
anti-coagulation
anti-fibrinolytic
jcml
u-pa
bronchiolitis
obliterans
boop
nonidentified
acid-base
antacids
po-
kaliuresis
hypokalemic
hyponatremia
hypocalcemia
hypomagnesemia
normokalemic
interrelated
cotrimoxazole
carbenicillin
bacteriologically
tha
photopheresis
steroid-sparing
radiochemotherapy
weak-base
hl-60adr
organising
endosomes
juxtanuclear
microtubular
tethering
ig-like
cd95fas
kappabalpha
nf-κb-inhibitor
iκb
stress-response
bcl-3
che
polyenic
lts
cd40-dependent
bwa4c
cd40-induced
cd150
protein‑protein
cmap
mitox
cip
lvx
tp10-nh2
fluoroquinolones
congeners
mics
bactericidal
hek293
llc-pk1
mr1
mdr1aml
dyedrug
mdr1-modulating
myelosarcomas
complement-mediated
chlorambucil-antibody
angiotensin-converting
angiotensinogen
recognisable
bh3-binding
mcl1-dependent
baxbak-dependent
cancer-derived
bortezomibvelcade
deactivates
26s
usp14
uchl5
translatable
parity
proves
rifn-alpha
adv
enz
regul
ed90
anti-hiv-1
daunorubicin-cytosine
dnr-arac
projective
us1261
t-q34q11
arsenicals
pharmacopeia
redeveloped
piecemeal
anthracycline-treated
4-o-tetrahydropyranyladriamycin
zanthoxylum
schinifolium
pericarp
culinary
lignans
pnas
pentostatin
dcf
nsaids
akt-related
indomethacin-treated
mirna‑26a‑loaded
mirna‑26a
leukemiaxa0cll
concentration‑dependent
hoechstxa033342
leukemiaxa01
cyclin‑dependent
kinasexa06
apoptosis‑inducing
marine-derived
petromurin
candidus
kufa0062
epipolasis
clinically-used
sub-toxic
pha-lcm
semi-liquid
pha-induced
3h-tdr
coloniesclusters
methoxy
stilbenes
-tetramethoxy
4-tri-ms
-tetra-ms
contend
wastes
unreliable
28-hr
seeded
asparaginases
l-asparagine
asparagine-deprived
transamidation
erwinia
chrysanthemi
deamidating
glutamate
non-all
ptpl1
pkcδ
intermediary
ptpl1-mediated
wea
milder
pd1tim3-cd8
highxa0pb
mll-enl-er
mdm2-mediated
johnstonii
gastrointestial
geneticsgenomics
cocktails
nr4a
myc-driven
nr4a1
dihydroergotamine
dhe
se-associated
nr4as
aml-selective
dismissing
se-bound
coactivators
p300-dependent
2-dependent
erna
se-dependent
awry
firsts
caffeine
tpt
nonintercalating
microcalorimetry
bathochromic
hypochromic
intercalators
exothermic
misregulated
prodeath
asfsf2
anastrozole
ans
aromatase
postmenopausal
nanotechnology-based
ans-loaded
pla-peg-pla
ans-nps
tumour-specific
t15qq21
atra-dependent
atrachemotherapy
cyp2e1
attendants
hexamethylene
bisacetamide
hmba
no-releasing
membrane-permeable
guanylate
undisturbed
hmba-induced
alpha-globin
sp-1
aml-2idac
trisenox
subcytotoxic
lonidamine
dna-targeting
executioner
anion
pro-oxidant
mniiitetrakis4-benzoic
acidporphyrin
p38-mitogen-activated
nh2-terminal
phosphorylationactivation
kinaseerk
2-amino-3-methoxyflavone
-diamino--dicyano--bis2-aminophenylthiobutadiene
-morpholinyl-8-phenyl-4h-1-benzopyran-4-one
restrains
cur
downregulator
doxcur
p-450
proadifen
non-peptidomimetic
nonpeptidomimetic
cyp2b6g15631t
bsri
procarbazine
ha-cur-lps
cur-lps
akterk
entrants
lmi
lmis
anti-helminthic
ptl
cd34cd19-
cd34cd7-
nodltsz-scid
il-2rγc-null
beta-tubulin
epothilone-a
tubulin-active
tubulin-modifying
aa9
mt-associated
protein-4
map4
mt-polymerizing
-stabilizing
tubulin-binding
paclitaxeltubulin
epothilonetubulin
epothilone
haemostatic
t-paag
pai
fibrinopeptide
hl-60amsa
m-amsa
etoposides
ii-dna
topoisomerization
enzyme-dna
pivaloyloxymethyl
retroelements
eres
genuinely
ccsg
cyclocytidine
cyclo-c
one-hundred
m-1
m-2a
rvd
swelling-induced
barium
conductances
cadmium
gramicidin
isotonic
permeable
impermeable
methanesulfonate
rall
antifolates
polyglutamatable
edatrexate
edx
zd1694
gw1843u89
ag337
15-h
tsi50
3-h
14-fold
85-fold
--fold
zd3-fold
gw1843u-35-fold
-4-iodophenyl--nitrophenyl-2h-5-tetrazolio--benzene
disulfonate
zvad-fmk
ampki
pampk
coincubation
antimyeloma
hct116
cmet
l1-cmet
demethylation-dependent
mhs
miniaturized
copolymerization
adhesions
cis-diaminedichloroplatinum
cyotochrome
interference-mediated
extinction
bcl-2bcl-xl
caspases-3
95-d
abt-737-resistant
bcl-2-as
hl-60-dox
bcl-2-as-induced
predominates
springboard
mapk‑interacting
kinase1
mknk1
shrna‑mediated
mutating
mknk2
sirna‑mediated
mapkextracellular‑regulated
mir‑145
contraction
nonsustained
supraventricular
antiarrhythmic
refectory
anti-topo
-kb
alu
poly-a
trinucleotide
gaa
gaa4
gaa5
gaa6
heterozygotic
mum
nonexchangeable
cephalothin
mugml
1d
hrms
single-crystal
azaphilones
subtilis
streptomycin
generalist
suspending
ca2-independent
kcl
egta
quin
cloaked
rbcm
drug-release
rbcm-cloaked
surveyed
co-exist
pathobiological
sinensis
asps
kg1alpha
aging-related
small-interference
pkmyt1
chek1
mk1775
97-fold
sirna-kinome
sensitizer
ablates
ge-hts
celastrol
4-hydroxy-2-nonenal
primarysecondary
modificationsearly
crosslinks
brca2
cancer-prone
helicase
brip1
bach1
crosslinking
targetted
fibrinogenopenia
a-ring
pyridine
d-homo
17α-picolyl
crystallography
androstane
cuii
cyp17
1c3
estrogenicity
pcr-generated
pcr-dnas
pcr-dna
fbs
liposome-mediated
non-lis
oop
ly188011
rpmi-8392
difluoro
atropisomers
tetrabromo
congener
seven-fold
carbapenemase-producing
xdr-cpkp
double-carbapenem
ertapenem
cytolethality
chx
indiscriminate
tlck
krge
tuberculous
pleurisy
fortuitum
antituberculosis
inh
rmp
emb
mycobacterioses
gpx
tiopronin
mercaptosuccinic
msa
gumbus
nasids
pharyngalgia
melena
transarterial
embolization
microcoils
colonoscopic
clipping
vasopressin
nsaid-induced
accomplishes
launching
canditates
smai
xmai
refseq
100-fold
phenazine
fermentation
broth
streptomyces
tnf-α-induced
lps-induced
pge₂
substituents
lys20
chemotoxicity-induced
iron-dependent
gallium
nitrate
desferrioxamine
gallium-induced
nn-biso-hydroxybenzylethylenediamine-nn-diacetic
67ga
hdj-2
deltapsim
bms-214662-induced
analog-resistant
thymectomy
plasmapheresis
one-fifth
transfusion-free
underexplored
malfunction
interactionsequestration
a-770041
wh-
lck-specific
inhibitor-sensitive
reusing
lmics
nitroglycerin
rpmi-1640
heat-inactivated
vap
ngvpa
compusyn
boron
oxybiguanido
monohydrate
biboric
hydroxosalicyl
hydroxomato
dual-kinase
dual-targeting
kinasehistone
kinasetubulin
proteolysis
protac-based
pump-like
pump-blocking
on-study
9q-
210-kd
src-abl
inno
mk0457
precipitate
excitingly
typifies
oligodeoxyribonucleotides
odn
bcr-abl-directed
permeabilized
streptolysin-o
sl-o
methylphosphonodiesterphosphodiester
linkages
b2a2-
b3a2-directed
n-octyl-oligo-oxyethylene
dodecanol
lipofectin
kyo1
odnlipofectin
b3a2-targeted
unpermeabilized
overpermeabilized
gadph
complexing
liopfectin
short-time
3htdr
arabinoside-cytosine
casesin
methodes
microgramsm2d
prephase
kinetically
quiescient
antimutagenic
anticarcinogenic
p21wafi
p27kipl
n-formyl-l-methionyl-l-leucyl-l-phenylalanine
ionic
isht
raffinose
lactose
inulin
trail-apoptosis
hydroxychavicol
hch
betel
transmethylation
ari
3-deazaadenosine
ado
doublings
nih3t3
s-adenosyl
homocysteine
67-yr-old
him6-pad-ara
him6-plga-ara
him6
t-40
poly-l-glutamic
cytotoxicities
antibody-reactive
pad-ara
plga-ara
non-target
biarylalanine
chromatographically
flag-tagged
ds-19
benzidine
mutation-related
niche-based
ut-7
array-comparative
feeder
crotoxin
venom
crotalus
alkylation
abolish
arabinofuranosylcytosine
3il-3
ara-ctpdctp
junfos
c3bi
bioluminescent
biosensors
self-bioluminescent
transposition
cdd-deficient
luxcdabe
operon
biosensor-based
mir-30α
stumbling
non-responsiveness
membrane-resident
rho123
thiazolyl
doxorubicine
rubomycinum
impared
bcrp-overexpressing
p-gpmdr1
unconditional
transporter-proteins
admittedly
singularly
dascern
nct01593254
nu2009u2009174
nu2009u200986
ivbu
fludarabine-ivbu
tbi-cy
flutbi
urology
beta-deoxythioguanosine
leukemiaabstract
mdm2mdm4
p53-reactivating
usher
undepleted
nurselike
c-raf
so-rafenib
sorafenib-mediated
xiii
nf-kκb
cbl0137
extinguish
carbonate
bioerodible
microparticles
interfacial
methylene
devil’s
oplopanax
horridus
anti-tyrosine
hoxb2
deletional
genotoxicity
autotransplanted
hgnhl
lgnhl
busulfan-cyclophosphamide
codifies
reversors
disagreements
haematologists
monoxide
biliverdin
catabolic
end-products
survival-enhancing
c-mediated
extractable
pma-induced
pma-treated
etoposide-mediated
factor-2
brusatol
oxatomide
ip3
fluxes
antigen-induced
45ca2
antigen-
store-operated
hydroxymethylglutaryl-coenzyme
myocytes
histone-associated-dna-fragments
hacm
hydrophilic
atorvastatin
pyrophosphate
lasker
debakey
lydon
sawyers
supercoiling
oncofetal
structuring
at-hook
ramifications
fragile
subtelomeres
supercoil
constrain
supercoils
compacted
merbarone
finalizing
corticosensitivity
corticotherapy
j8j1
silac-based
phosphoproteome
phosphorylations
lucrative
cmlhowever
superlative
experimented
kruzei-related
micropustular
kruzei
glutaminolysis
carboxylation
cholesterogenesis
megakaryocytosis
able-dependent
non-myelosuppressive
phased
allogenous
o6-alkylguanine-dna
alkyltransferase
atase
pgp-expression
kawasaki-like
exanthema
desquamation
roentgenology
cardiomegaly
dilation
reinstatement
adlay
coix
lachryma-jobi
ma-yuen
stapf
testa
ate-etoac
nkg2d-specific
ul16-binding
ulbp
bryostatin-1
nkg2d-dependent
re-establish
vd3-induced
cebpbeta
electromobility
mithramycin
vd3-
pu1c-jun
tnf-alpha-resistant
u937tnf
interleukin-1beta
pterocaulon
ether
coumarin
cd88
-dihydropyridines
-dhps
axa0class
heterocyclic
medicinally
hantzsch
-dhp
qsar
a375
hacat
wl-38
dhp-8
caspase9
paktser473
gsk3βser9
antithyroid
methimazole
cell-induced
luminol
pdgfralpha
pdgfrbeta
alpha1-acid
metabolised
3a4
bodyweight
5-aminoimidazole-4-carboxamide
t315i-bcr-abl
ecs
fertile
a-activated
vegf-dependent
disallows
quinidine
antiarhythmic
adrmito
stem-
gfin
hdac-
hemoglobin-producing
etosis
rapamycin-enhanced
etotic
roseomonas
16s
rrna
α1-adrenergic
α1-adrenoceptor
lipofuscin
α1-adrenoceptors
non-adrenoceptor
p210-bcrabl
re-activation
phosphatase-activating
kinase-inhibiting
pdmsdtcln
palladium
chloromethyl
n-dithiocarboxy-ksks-n-methylglycinate
pdmsdt
brn
bromomethyl
methylsarcosinedithiocarbamate
chelating
sulfur-containing
ii-based
id50
ml-3
id-fold
pdmsdtbrn
id90
myelomonoblast
dithiocarbamate
beta-lapachone
apl-ascites
a-nb4
ninth
supplying
neovasculation
vascular-epithelial
vegfr-
tie2angiopoetins
ofvascularization
availing
angiogenesis--semaxinib
su6668
thalidomid
ofangiogenesis
metabolising
ondansetron
ond
relieving
resin
ipomeolides
saccharide
acetonide
glycosidic
lineage-dominant
megakaryocytopoiesis
r-methug-csf
gleevectm
inhibitior
c-kit-receptor
zd1839
iressatm
osi-774
tarcevatm
imc-c225
erbituxtm
avastintm
ptk787zk
zarnestratm
velcadetm
rous
histondeacetylase
atm-s1981p
ser139
childrenadolescents
topo2
phospho-specific
facile
inside-out
cavitation
discontinuous
melvcr-6
melo
methotrexate-resistant
sidedness
inward
p-glycoprotein-overexpressing
grincamycins
gcns
angucycline
actinomycete
grincamycin
gcnxa0b
gcnxa0b-selective-induced
1idh1
2-oxoglutarate
2-og
gcn
idh1r132c
cryptosporidium
malabsorption
megacolon
anti-protozoal
cryptosporidiosis
refeeding
fgf
pleiotrophic
properities
hgfcmet
dentritic
augumentation
cocl2
hypoxia-mimicking
m2b-type
cocl2-mimicked
3-morpholinosydnonimine
cocl2-induced
target-based
coagulative
chemosensitizers
5-pentamethoxyflavone
azidopine
substrate-stimulated
methoxylated
hydroxylated
non-transportable
azidopine-binding
granule-associated
lipid-derived
macelignan
fragrans
cyclooxygenase--lipoxygenase
monocytogenes
acylfulvenes
acylfulvene
hmaf
median-drug
antimetabolite-antimetabolite
leucovorin
acute-myeloid
irinotecan-induced
century-old
cin
cep55
apcc
anaphase-promoting
complexcyclosome
bak1
bh
bh3-interacting
bcl2-interacting
bub
uninhibited
benzimidazoles
cadherin-1
centrosomal
escrt
endosomal
gin
mad2
mps1
monopolar
myt1
myelin
p53-upregulated
sac
readouts
polyoxyethylated
castor
cremophor
synchrotron
synchrotrons
brightness
beams
crystals
ablc
flavus
fungizone
abated
yiqi
yangyin
yyr
assembling
dispelling
absorbance
lyses
uv2000
spectrophotometer
coefficience
multiparemeters
anti-and
pro-fibrinolytic
capcity
azc
azide-alkyne
aphidicholine
rnaseh
pull-down-and-release
χ65
polystyrene-bound
dnp-amino
dnp
cys
aliphatic
igeadnp
multispecific
feijoa
sellowiana
bert
acetonic
flavone
adenomatous
polyposis
cox-2-dependent
regiospecific
n-butyric
monoesters
xylitol
transesterification
monobutyric
phenylacetic
4-phenylbutyric
neuromuscular
beta-hemoglobinopathies
subrenal
rii
prima-1-triggered
caspase-7
factor-κb-regulated
disputed
cucurbitacin-i
daltons
ril-15
imitate
opnαvβ3
polystyrene
cycloarg-gly-asp-d-phe-val
crgdfv
hypo-methylating
≈325-fold
24-well
rpmi
humidified
incubator
co2
erythromyeloid
125i-dna
amphotropic
ut-
adenosinergic
mim1tmz
factor-α-related
peo1
tnfrsf10b
parp2
parp3
parp4
facet
rnf113a
trichothiodystrophy
cisplatin-dependent
ferroptosis
sat1
noxa1
myelodysplasticmyeloproliferative-overlap
multilobar
degenerating
interstitium
exudates
pneumonopathy
amd3100
downmodulate
hpsc
thioridazine
antipsychotic
scs
dopamine
hpscs
csc-targeting
toceranib
38-fold
34-fold
45-fold
33-fold
69-fold
54-fold
demonstrably
portent
45xy
contractile
impedance
deteriorating
safeguard
linc00467
etoposide-
anti-proliferativeanti-survival
trigged
synergetic
survivin-targeted
myeloprotection
mpa-preincubated
non-phase-specific
-hour
stat-dependent
pimozide
bepridil
structurally-
functionally-divergent
glccer
glycosphingolipid
glucosyltransferase
ugcg
d-threo-4-ethylenedioxyphenyl-2-palmitoylamino-3-pyrrolidino-1-propanol
etdo-p4
monosialotetrahexosylganglioside
abcc-mediated
glycophenotype
pluronic
khz
pbs
hypertonicity
gels
hyaluronidase
trypsin
diameters
maximized
itra
reinduced
higher-
lower-volume
nonacademic
volume-outcome
s116836
kbm5-t315i
post-lvef
edible
aele
monomac-1
r-aml
ceca
reappearing
idps
populate
ensembles
interconverting
stabilities
folded
sixfold
nodosum
reiters
bullous
internal-tandem-duplication
-diarylmaleimides
dhf125
inhbition
flt3-itd-related
granulocytopenic
scaled
periodontitis
azacitidine-panobinostat
topmost
non-atp
cleft
myristate-pocket
esc
smoker
atherosclerotic-free
proteasome-pathway
upp
explode
upp-mediated
ubiquitination-associated
dcmp
hypochondrial
grocott
granuloma
amph-b
français
myélodysplasies
newerxa0drugs
taq
angiogenesis-dependent
32d-p210-transfected
vegf-r2kdr
pkbakt
sti-571-resistant
sirtuin1
17th
34th
40th
juglanone
-diphenyl-2-picrylhydrazyl
danio
rerio
sensory
neuropathies
ebosin
tnfalpha
tace
fas-demethylation
fas-re-expression
micronized
liposome-entrapped
entrapping
bms-3548125
hyalohyphomycosis
corticoids
arthrospira
spirulina
platensis
braun-type
questionaire-c30
ghq
subscalescml
non-del5q
fingolimod
bronchitis
lymophopenia
tetracycline
tcnas
tetracycline-3
col-3
-100
tcnas-treated
tcnas-induced
cxcr4sdf-
tweezers
dielectrophoresis
dep
softens
penicillin-resistant
trimethoprim-sulphamethoxazole
specter
futhermore
sfr
stearns
q28
q7
dropping
actuarially
rh123
psc833
mk-571
anti-glycophorin
antibody-conjugated
tumor-transforming
pttg1
agaricus
blazei
4-epi-adriamycin
4-epi-am
4-demethoxy-daunorubicin
4-ddm
n-trifluoroacetyl-am-14-valerate
ad32
salvianolic
arvms
ionoptix
myocam
sarcoplasmic
ca2er
developement
piperazine
piperazin-1-yl
triphenyl
self-administration
magnetofection
dg-based
lipoplexes
mcl1-specific
mangiferin
xanthone
mylogenous
cisplatin-dmso
uv-spectrophotometer
inflated
granulopoietic
gpc
micronucleoli
porphyrias
porphyrins
aminolevulinic
porphyritic
porphyrin
polyphenols--curcumin
acid--at
nonproliferating
curcumincarnosic
caspase-8-dependent
marizomib
piebaldism
depigmented
huangdai
6mp
99tcm-mibi
cardiolite
cya
zarnestrar
broviac-hickman
indwelling
drug-based
traceable
refocuses
blueprint
spectrophotometric
phage-displayed
reengineered
curbed
bottom-up
acd33lns
aso
deoxycholate-polyethylenimine
doc-pei
acd33
acd33lngti-2040
lngti-2040
endosome
doc-pei2k
fascd95
egr-1
ctcf
blimp-1
rfx1
mxi1
swabs
saliva
mutans
gluconate
mouthrinses
pyridineor
pyrimidine-based
benzo-fused
quinolines
quinazolines
arthritides
precipitant
keratoderma
blenorrhagica
b27
arthritogenic
clpd
tki-insensitive
ribotide
aicar
clerodendron
interferon-r
mitoxantrone-resistant
crithidia
fasciculata
kinetoplast
decatenating
antisera
thymus
160-kda
sdsabstract
8-chloro-camp
8-cl-camp
8-cl-adenosine
74-fold
bcr-abl1-specific
3-substituted
-disubstituted-2-carboalkoxy
indoles
3-substituted-2-carboalkoxy
heck
arylations
acrylate
cinnamates
ββ-disubstituted
acrylates
cadogan-sundberg
β-tubulin
depolymerization
destabilizer
rsu202fb-all
dexamethasone-treated
b-progenitor
dmes
cess
hydrolytic
tad-induction
speculating
radiologically
folylpolyglutamate
fpgs
fpgs-specific
263-base
nanogram
auxb1
polyglutamate
500-foldabstract
glc756
-cyclic
lps-stimulated
morphogen
as4s4
nano-particles
constraining
oti
otis
ld003
ld009
d816h
d816n
cdnas
c-kit-bearing
mcd
revolves
mitosis-selective
p53-functional
nutlin-1
p53-nonfunctional
p-gp-atpase
cebpβ
quorum
autoinducers
hnts
hent
xenopus
laevis
oocytes
hcnt
hcnt2
3hgemcitabine
14cazacitidine
3hdecitabine
hnt-expressing
hnt-deficient
hcnt1
hent3
≫
hent0
hcnt8
⋙
hent2
transportability
drug-transport
transport-mediated
cemvlb100
bi-exponential
saturable
temperature-sensitive
drug-accumulation
polyphenols
theaflavin
thearubigin
contrasts
aurintricarboxylic
60-or
60-fold
uptakes
bi-aryl
nexavar
tyrosin-kinase-3-
shut-off
b-chronic
inibitors
choriocarcinoma
6-azauridine
cost-limited
myelo-dysplastic
self-maintenance
arabinosyl-cytosine
gx
mastocytoma
viral-mediated
pik-75
p110α
concordantly
pik-75-mediated
cotarget
mcnu
microcytotoxicity
formazan
microtitre
calcineurin-mediated
mutation-mediated
1-methyl-1h-indol-5-yl-5-trimethoxy-phenyl-methanone
mpt0b002
baf3p210
proteosomal
elastin-like
elp
thermally
elp-bound
vhl
mpd-t
rotterdam
prepolycythemic
histopathology-based
nosological
thrombophilic
thrombophilia
thromboreductive
antiaggregation
thromboreduction
thrombopheresis
ellagic
ocs
camellia
conjunctivitis
aglycon
ketotifen
tranilast
cytokine-producing
hyperpermeability
dezocitidine
pharmachemie
supergen
crada
decitabines
host-protective
enrol
rubitecan
sns-032
sns-
cisplatin-adapted
ukf-nb-3
ukf-nb-3rcddp1000
antineuroblastoma
cdk7
inhibition-mediated
baculoviral
birc2
htrf
piribedil
mll1-wdr5
mll1-dependent
piribedil-induced
hmt
kallichrome
lymphocyteskg
rhinocerebral
debridement
blebs
tmtp1
5-amino
nvvrq
flagella
micro-metastases
fitc-tmtp1
tmtpl
el-4
fitc-conjugated
lymphoma-bearing
tumor-homing
unilinear
multilinear
inductors
pumped
p170-directed
mrk-16
2-hours
p170-related
thiophene
-chloro-2-methoxy-acridin-9-ylamino--tetrahydro-4h-cycloheptab-thiophene-3-carbonitrile
acs03
thiophene-acridine
antileishmanial
ic03
acs5
selenite
macroglobulin
paraproteins
engulfing
ginkgo
biloba
egb761
melanocytes
egb761-induced
tryptamide
phenylbutazone
ddp
ddp-pretreated
cyclosporine-a
mdac
ozogamicin-containing
cd16-
podophyllotoxines
n--acridinylamino-3-methoxyphenyl-methanesulphoneamide
recycles
asialo-tfr
sialyltransferase
resialylation
surface-to-golgi
hypertonic
d25oh2d3
hypercalcaemic
plant-derived
preservative
oh2d3
hematopoietic-derived
jmjd3utx
gskj4
gskj4-induced
ser133
p-ser133-creb
enforces
gskj4-based
phxa0xa0all
pnt
pnt-induced
tccysr
maritoclax
mega2stir
sb216763
phxa0xa0leukemia
i-mediated
7-ethyl-10-hydroxycamptothecin
sn-38
multimers
singlet
oxygen-mediated
singlet-oxygen
quenchers
ni-chelate
quench
inhibitions
deuterium
lifetimes
microsecond
chelates
anomalously
nonuniform
de-regulated
fli-1-expressing
transactivating
emc
pkcas
pkca
fli-1-induced
cancersby
over-activation
pkc-mapk-fli-1
particurarly
amine-containing
bio-available
aumtx
glutathione-mediated
u2009nm
organosulfur
phenolics
67lr
dreadful
colonized
teicoplanin
carriage
staphylococcal
pulsed-field
colonizing
nosocomial
herzegovina
nf-kappabrel
nfkappab2
c-rel
n81
cmps
coln
tetrazolium-positive
lps-sensitive
lps-resistant
diminuta
il-1-inducing
rtnf
preneoplastic
nf-kappab-activatory
isothiocyanate-labeled
eahy926
regionabelson
leukemia-positive
pyridopyrimidine
pd166326-treated
necropsy
mesylate-treated
leukemia-cell
mesylate-resistant
p210h396p
p210m351t
top1-targeting
top2-targeting
top2-alpha
top1-alpha
topotecancytosine
htb9
axa0malignant
axa0replacement
axa0tyrosine
axa0liposomal
axa0cd33
axa0special
axa0combination
nk-1r
spnk-1r
antinociceptive
leukemia-induced
alleviating
-chlorophenylthio
8-cpt-camp
cardiotonic
proliferator-activated
eroding
thiazolidinediones
kb-p65
species-mediated
-2α
cbpp300
transactivator
gluasp-rich
carboxy-terminal
cited2
regulons
mafb
anti-dopaminergic
calichaemicin
celltech
wyeth-ayerst
nda
fdas
ahp
emaa
merill
lynch
lehman
us200
us150
royalties
us300
pia
cgp52421
anthracyclinecytarabine
n-butyrate
nab
obsolete
conjugations
m195
studies--131i-labeled
213bi-labeled
state-of-the
mainstays
mrp1-specific
-bis2-carboxyethyl--carboxyfluorescein
bcecf
non-atp-competitive
3d-qsar
comfa
comsia
chalcones
five-point
contour
extrudes
th-ed
nxa0xa0683
10xa0×xa0109l
pxa030xa0×xa0109l
nevi
hbs
hbc
anti-hbs
ph-partitioning
compartmentalization
choroidal
farcinica
perphenazine
capnocytophaga
azelaic
trxr
-dithiarsinan-2-yl
phenyl-azelamide
a-z2
collapsing
trxrtrx
a-z2s
a-z2-treated
ccr5-δ32
i-directed
nuclease-mediated
protein-linked
val135
p53-deficient
multidirectional
transcription-dependent
diels
annonaceae
zebularine
non-nucleoside
rg108
bml-210
gnf-5
abl-001
luteum
liliaceae
6a
xa0µm
area-adjusted
hispolon
phellinus
linteus
b16bl6
nitrite
antimelanoma
anti-melanoma
arsenical
b-alls
sbe
bmcs
baicalin
y216
momordica
cochinchinensis
esmc2
mda‑mb‑231
dose‑dependently
kinasejnk
ang
stools
fuu
defeverescence
trimethylates
s-adenosyl-l-methionine
co-factor
h3k79me
pinometostat
lqb
pterocarpanquinone
annexinpropidium
dioc
fluo-3-am
caspase-12
topoiromerase
auto--or
famp
seeding
phospho-erk5
p-erk5
drug-derived
complexation
mto
palmitoleic
palmitoleyl
pal-mto
monopalmitoleyl
mono-pal-mto
dipalmitoleyl
di-pal-mto
md11-pal-mto
protein-specific
b16f10-rfp
rfp
simcl-1
2000-mediated
diphenylmethyl
piperazinyl
cetirizine
uncharged
dipalmitoyl
nr-104098
atpr
atpr-induced
additives
glc-8
implanting
e2f-tfdp
oos-deregulated
bcr-abl1t315i-mutant
myristoyl-binding
co-operates
adenylate-cyclase
permeant
phosphodiesterases
bordetella
camp-elevating
cell-targeted
etoposideara-c
metoclopramide
mcp
lorazepam
sedation
poison-type
overproliferates
cultivation
formazans
acidified
isopropyl
photometer
true-positive
true-negative
assay-ci
fcdsa
-47
t-lymphoblasts
drug-target
ph-low
phlip
ato-based
dds
mnassio2-phlip
controllably
brighten
auspicious
theranostics
cellsmicrol
-diaziridinyl--benzoquinone
p21waf1cip1sdi1
dzq-mediated
p53-negative
dzq-inducibility
p53-p21
gene-regulatory
aziridinylbenzoquinones
vincristin
diluents
postbinding
diluent
proferroptotic
ferrostatin-1
anxiety-associated
aurantium
diazepam
psychometric
state-trait
stai
stai-s
nonaggressive
traverse
oxyfluoride
lonp-based
lonp
metal-thiolate
dodecameric
pmi
anticd33-lonp-pmi
antagonizing
diosorders
cafda
bcx-1777
forodesine
8-chloroadenosine
dado
datp
arabinosylguanine
ara-g
ara-gtp
deoxyguanine
dguo
guo
dgtp
imposing
grna
slc29a
dck-defective
bxh-2
dck-negative
erbb
prioritaire
biotechnological
patenting
mtdna-targeted
fbxo4
diclofenac
diclofenac-induced
ac-ietd-cho
and-3
bioanalysis
ultra-violet
mixed-mode
cation-exchange
analytes
linearity
-3500
run-time
--epigallocatechin-3-gallate
nanomedicine
egcg-rnps
nano-realgar
coprecipitation
72u2009h
epoxomicin
pr-171
autocrine-
chymotrypsin-like
hsp32
hsp32-targeting
protoporphyrine
peg-znpp
styrene
maleic
acid-micelle-encapsulated
sma-znpp
ifn-alfa
genespring
dav
leukemiaxa0cml
clonexa0cml-t1ir
y235h
cml-t1ir
2-de-ms
exchanger
factorxa01xa0nherf1
ionomycin
cyclosporinexa0a
tacrolimusxa0fk-506
punctal
eczema
eyelids
g1κ
self-inactivating
thymineless
thymidylate-synthase
5-fluoro-
2-deoxyuridine
fudr
fudr-induced
arabinoside-induced
mean-sd
us2137
cost-reductive
rhtrail-induced
sw948
lovo
colo205
colo320
caco-2
∼four-fold
u2009µm
trail-sensitive
rhtrail
lipoxygenase
13-hpod
hydroperoxides
tert-butyl
hydroperoxide
luminescence
scavengers
poison-mediated
top2b-dna
mpo-dependent
phosphatidylserines
fitc-annexin
phosphatidyl
heterogeneously
4-amino-2-trifluoromethyl-phenyl
resinate
wright-giemsa
angles
dead-box
ddx23
ablated
pkis
pki
3-oh
fecl3
nicl2
ironiii
nickelii
hydroxy-
methoxy-substituted
1h-nmr
spectroscopies
hematopietic
phosphorylase
patented
inventions
tonsil
admonishes
non-fatal
decrements
endotoxin-stimulated
methemoglobinemia
anesthesia
benzocaine
orogastric
intubation
hyperplenism
chimaeric
3-azido
deoxythymidine
aztalpha
aztalpha-ifn
3hazt
alpha-
hiv-related
mnud
nud
cytospins
magnification
starving
methodical
mxnud
bioelectrochemical
impulses
reordering
capacitively
wavelengths
actinomycin-c
decaying
eo
kvcm
constants
pemf-treatment
u100
i55
electrochemotherapy
electromagnetic
pemfs
niclosamide
creb-mediated
treatment-mediated
creb-dependent
seliciclib
olomoucine
transcriptase-multiplex
rt-mlpa
roscovitine-treated
proficient
histochemically
ed50
dirca
occidentalis
thymelaeaceae
ed14
bioassay-guided
genkwanin
--lariciresinol
sitoindoside
internalisation
mrp6
e2f4
gepia
scutellarin
scutellarin-treated
pig7
pig7-induced
lc3iii
atg5
serinecysteine
spi2a
neuroguidin
ngdn
k562a02-ngdn
ne‑deficient
procession
gw311616a
apoptosis‑associated
3‑kinaseakt
leukemia-targeted
lusitaniae
beta--glucan
fks
fks1
hs1
candidemia
adenoviral
rapd
p4
p5
anidulafungin
cas-resistant
s638y
s631y
s638p
candin
facilitator
mfs7
5-flurocytosine
candins
g9a
unc0638
jq
inhibitorsabstract
pre-existence
fated
diagnosisrelapse
tngs
dsrp
tts
malignantly
cells-the
drugs-these
cd66
non-self-renewing
egress
intersecting
vatalanib
dihydroxyvitamin
granulocyte-like
vdr
calcitrioic
cyp24a1
cyp26
nadph-cytochrome
toxicodermia
penicillins
cephalosporins
conformed
dearrangement
organo-arsenic
template-directed
ring-opening
epoxy
hydride
2-chloro-2-dioxaarsolane
nucleophilic
peg-as-ra
self-assembles
buffers
microgg
leukemia-retinoic-acid
retinoic-acid
rexinoids
ceramidase
ac-mediated
behçet
neoenzyme
srarp
preempt
bacteriological
oropharynx
non-absorbable
neomycin
disappear
co-morbid
progenitorsprecursors
inasmuch
da-resistant
prophalytic
non-mrp
half-transporter
passage-treatment-regrowth
proteinlrp
rnases
onconase
bs-rnase
intermedius
binase
artificially
testifies
superantigenic
hormonotherapy
misadministration
socio-educative
psycho-sociology
s--
-dihydro-2-methyl-3-phenylpyrido-bpyrazin-7-ylcar
bamate
enantiomers
epithelial-like
ptk2
substoichiometrically
preassembled
liganded
el4
oad
s-dimethylarsino-thiosuccinic
mer1
maximally-tolerated
mer1-induced
bond-reducing
dithiothreitol
ros-mediated
4-hr
d25oh2d-alpha25-dihydroxycholecalciferol
r2ab2
disintegration
hepg-2
adria
low-dose-homoharringtonine
factories
-β
antitopoisomerase
melarsoprol
-diamidino-2-phenylindole
transferase-mediated
plasma-cell
nonseparated
arsenic-induced
mitogen-induced
nfkbie
anti-epidermal
contaminant
ee-muconaldehyde
carcinogenicity
diastereomers
heptacyclic
bis-adduct
gua
6-ring
epimerization
equilibrating
nabh4
interchain
dcyt
ε-amino
imidazole
histidine
termini
rauscher
103a
xenotropic
thymocytes
125i-labelled
quercus
suber
phenolic
phenols
qu2009suber
extractives
qse
externalizing
by-products
cork-based
siddha
semecarpus
anacardium
12b1
gluconeogenic
fhl
diffusing
trf-adr
spectrofluorometry
quenched
conformationally
lateral
fluorescein-labeled
pre-requisites
replacements
adaphostin
17-allylamino-17-demethoxygeldanamycin
stemness-related
17-aag-mediated
cox-2-inhibitory
cd44-overexpressing
cd44highk562
mutp53
aktmtorp70s6k4ebp1
hsf1hsps
17-aag-induced
priori
amlareas
nct00005962
rgm-csf
dctp
7-fold
dehydroleucodine
xanthatin
lad2
stabilizers
hydrolyzed
aal
csfs
cyclosphosphamide-etoposide
cecy
rhugm-csf
morbimortality
fucosterol
lscm
cyt-c
pro-caspase-3
washed
sfv
subcloning
purify
non-permissive
ethylene
infectivity
peg-induced
stress-activated
sapkjnk
pulsatilla
hl-60ra
recently-developed
opaque
yellow-white
well-demarcated
antiparasitic
retinochoroiditis
oridonin
hhtexert
benzodiazepines
stereospecific
3s
stereoisomer
3r
methoxyl
2-carbonyl
p-glycoprotein-medicated
8-s-fluoroidarubicin
p-glycoprotein-mediated
extruded
grunwald
antidiabetic
myeolid
multiresistant
water-insoluble
entrapped
yolk
symbolized
thrombocytopenian
hematopoiesisn
domino
agen
2-hydroxy
alphan
ketoglutarate
approachesn
docker
retrieven
schembl16391748
pubchem
cid-117816179n
admet
cid-117816179
showsn
re-rank
validatedn
deoxypodophyllotoxin
diterpenes
apoptosis-
nbt-reducing
7alpha-hydroxysandaracopimaric
microvesicles
mvs
kg-1-bone
genexa0osteopontin
cxcl-12
stat-3
treated-kg-1
treated-cell
obs
kg-1u2009u2009bmscsu2009u2009obs
reducexa0drug-induced
apoptosisxa0in
thisxa0suggests
mvs-mediated
bmscs-induced
drug-treated-kg-1
exposurehsp
stochastic
imatinib-like
polychemotherapeutic
monochemotherapies
t-lymphotropic
myelopathy
uveitis
sjögren
anti-viral
fniii14
22-mer
vla-4-to-fn
alpha4-integrin
stavudine
-dideoxy--didehydrothymidine
d4t
phytohemagglutinin
3hd4t
microci
dapsone
ddc
ranitidine
rifampin
sorivudine
radiometric
k562mdr1
multifactor-resistant
pan-hdac
de-represses
17-dmag
demethylates
de-repression
de-repress
csf-inducing
brm
divinyl
mve-2
csf-mediated
brms
tween
surfactants
co-surfactant
triterpene
cyclodextrins
solubilised
triterpenes
lectins
viscumtt
viscumtt-treatment
m20
lpa96
lpa99
hemrel
or40
mechanismsthe
hyperintense
synovitis
alpha-pinene
sb203580
cordyceps
pbncs
co-incubated
brmt
cajal
pdgfr-alpha
luckily
imatinibsensitive
alzheimers
umi-77
sub-lethal
lc3a
appps1
thiazol
tetrazoliumbromide
proteinlung
mymy-p-gp
mymy-
promiscuity
inhibitors-a
phthalocyanine
alpcs
photosensitizer
alpcs-dox
myeloid-skewed
aging-associated
reverts
biophysical
dendriplexes
hydrodynamic
dichroism
1-b-d-arabinofuranosylcytosine
daz
ara-5-azacytosine
aac
subvariant
hl-60ara-c
deoxycytidinedeoxycytidine
anti-oncogene
o4-dinitrophenyl-ethoxycarbonylpiperazin-1-yldiazen-1-ium--diolate
p123
micelle
tonsillar
sasvári-székely
biochem
pharmacol
g-phase
2-chloro-2-arabino-fluoro-2-deoxyadenosine
2-fluoro-1-beta-d-arabinosyladenine
faraa
1-beta-d-arabinosylcytosine
2-chloro-riboadenosine
cra
dcyd
5-aza-dcyd
cotyleninxa0a
cn-a
phenethyl
peitc
miapaca-2
gemcitabine-resistant
isir-005
isir-042
fusicoccinxa0j
cn-a-related
trolox
liproxstatin
canceled
q-vd-oph
necrostatin-1s
3-metyladenine
as₂o₃
gaucher
croatian
zebrafish-based
pathophysiologically
painfully
phenotype-based
dehydrogenase-positive
kusabira-orange
post-fertilization
salinomycin
high-content
lsc-xenotransplants
phenotype-driven
electroencephalographic
phenobarbital
eegs
discharges
spikepolyspike-and-wave
myoclonic
normality
epileptiform
viraemia
mrpm6
moabs
sdz
pgp-lrp-mrp-
non-over-expressing
pgp-lrpmrp-
lrpmrp-
pgplrpmrp-
daedalea
gibbosa
oleyl
s--hydroxymethyl-2-methyl-propyl-3-octadec-9-enyl-urea
oleylaminocarbonyl-l-n-valinoloroleylaminocarbonyl-s-2-isopropyl-n-ethanolamineoleylamine-carbonyl-l-valinol
r--hydroxymethyl-2-methyl-propyl-3-octadec-9-enyl-urea
oleylamineocarbonyl-d-n-valinol
oleylaminocarbonyl-r-2-isopropyl-n-ethanolamine
oleylamine-carbonyl-d-valinol
supb15
janus-associated
pkh67
labelling
tetrapeptide
acsdkp
acsdkp-nh2
coloniser
neutropaenic
conservatively
alpha-2b
aethiopica
infantum
stibogluconate
meglumine
antimoniate
sbvml
sulphate
lodac
-chloroethyl-3-cyclohexyl-1-nitrosourea
amb-actinomycin
amb-induced
amb--chloroethyl-3-cyclohexyl-1-nitrosourea
dihydroartemisinin
dha
estrogen-related
2-deoxythymidine
5-monophosphate
66-
beta-carboline-benzoquinolizidine
deoxytubulosine
dtb
alanguim
lamarckii
emetine
s-phase--specific
phospha
4-tribromo-3-methyl-1-phenylphospholane
tmpp
-dibromo-3-methyl-1-phenylphospholane
dmpp
3-methyl-1-phenyl-2-phospholene
bromine
kis
p21cip1
aldhhi
hinder
detoxifies
subentity
peroxidemyeloperoxidase
h2o2mpohalide
ros-induced
s55746
baxbak
co-targeting
concede
cause-directed
cardiometabolic
invites
mitoxantrone-sensitive
isopaque-dextran
double-layer
leukopenic
incubations
hl-
farnesyl-transferase
farnesylinhibitor
ambisome
famata
krusei
crystalline
lcrcs
pharm
hydroxide
mume
himeg
anti-
wortmannin
sti571wt
ph1-negative
sti571ly
simplify
bioassay
sialic
rhuepo
multi-channel
resourceful
desialylated
digested
n-glycan
acid-related
histaminergic
neurodegenerative
nontraditional
qprc
constrictions
in-vivo-like
anti-metastatic
daunomycin-induced
tg-induced
equivalency
quintessential
glitazones
hif2α
guardians
erodes
octs
-dnp
preincubating
zvad
kynureninetryptophan
ido-blocking
region-abl
-transporters
lucena-1
as4
s4
nu2009u200942
hemiplegia
deaminase-resistant
favourably
deoxycoformycin
macroglobinaemia
as2o
tetra-arsenic
tetra-sulfide
as4s
starry
dots
trypanosoma
brucei
sickness
trypanocidal
melon
trypanosomes
boswellic
bc-4
birdw
melatonin
indolamine
potentiating
r-csfs
mocm
investigationabstract
i-bet
chromatin-bound
arsenic-resistant
nb4-asr
nb4-r1
as2o3-
differentiativeapoptotic
ra-triggered
as2o3-treated
raas2o3
anticd20
interferring
pcdh10
lymphoid-lineage
697bcl-2
p26bcl-2
697neo
non-damaged
mdr-expressing
kb-
kb-c1
accumulationefflux
two-colour
effluxing
effluxretention
volunteersabstract
itraq
ebp1
bms-214662-treated
platelet-vessel
de-endothelialized
haematocrits
anti-platelet
maststem
german-speaking
abnobaviscum
fraxini
640-fold
caspase-9-mediated
lymphoma-specific
idiotype
chelonae
isothiocyanates
erysolin
erucin
cruciferous
ato-mediated
atoisothiocyanate-mediated
sero-positive
desensitization
hnsccs
cisplatinabt-737
target-oriented
impressing
lbd
pml-b2
multimerization
mido
nmacm
trfr
pre-sensitization
demethylzeylasteral
ubiquitin-dependent
nocardiosis
cavitations
tmpsmx
a-g
sw480
bh-3
spheroids
abt-737–induced
abt-737–treated
normoxic
mcl-1–sparing
nucleoplasm
preribosomal
pre-rrnps
co-localized
translocates
tripled
im-resistance
mta
pbox-15
im-sensitive
c-kit-phosphorylation
c-kit-dependent
cdc37
ckii
angiogram
thoracentesis
imt
fabricating
biomimetic
imt-loaded
imt-gnps
imt-nps
pdi
pathogenomic
irf2
interferon-beta
ifn-beta
daunorubicin-resistant
overexpresses
-kilobase
cotylenin
9-mo
raarsenic
arsenicra
atrafk228
h3-lys9
nf-ya
electrokinetic
pericentromeric
decitabine-mediated
glivec™
ohk9511
ohk9511-treated
moa
reengineering
del17p13
lingzhi
reishi
ethanol-extracted
tsugae
k562u202fcells
beclin-1bcl-2
organelle
p62sqstm1
gt-induced
r763
aurora-kinase-ab
ic-50u2009nm
ic-10u2009nm
rosakit
ic-500u2009nm
mcpv-
ic-1000u2009nm
10u2009nm
overrides
hepatotoxic
supersomes
albendazole
amiodarone
n-desethylamiodarone
dea
erythrina
esb
dcfh-da
ladders
i6
gingerdione
i6-induced
cdki
anti-hl-60
salvicine
eichelbaum
varleys
bratton-marshall
sulfadimidine
32p-labeled
coprecipitated
s3a
oligonucleotide-based
asos
aptamers
heteroduplex
b-lymphoproliferative
fcg
oncohematology
pentacyclic
line-originated
crisis-and
vincristine-resistant
k562-lucena1
expire
predicated
country-specific
mkn-28
mfc-7
hff-1
dual-stage
80u2009
hyaline
nondematiaceous
mycologic
buona
monoacetone
3-butyrate
3but
peginterferon
pyrido-dpyrimidines
pyrido-d
pyrimidines
coccidiostat
mllr
hemotoxicity
hubs
aggresomevesicle
responsetogether
non-hemotoxic
nonexpressers
proteasome-
multispectroscopic
denaturation
viscosity
3-hydroxy-3-methylglutaryl
coenzyme
k562-xenografted
lama84-r
k562-transplanted
myelosan
meg-1
psf1
gins
gfp-positive
xmd
bez235
bms-3
azd7762
r-bi-2536
rejuvenating
senolytic
erythropoietic
granulocytopoietic
pappenheim
caryological
granuloblasts
granulocytopoiesis
arised
go-phase
1-asparaginase
microencapsulation
semipermeable
poly-l-lysine
volvol
microcapsule
cellsml
sulfoxide-induced
non-circulating
sequestering
exaggeration
cytogenicity
idavudicine
armentarium
neuropoenia
myelo-ablative
abating
cytotoxiccytostatic
skw
non-genotoxic
p53-transcriptional
sfn-3sigma
western-blot
hivmp
pseudolaric
pab
pseudolaricis
imatinib-insensitive
unidirectional
flurry
jak2-inhibitors
fibrogenesis
32-fold
37-fold
83-fold
p32-fold
p65-fold
66-fold
61-fold
bacteroides
neglectingxa0the
inter-gene
inferring
tafluposide
epipodophylloid
num
lc50
epoetin
antiproliferativecytotoxic
sulphated
disaccharide
glycosaminoglycan-like
ion-exchange
cytotoxically
tp53-dependent
bak-deficient
peroxidase-negative
md-al
megakaryoblastplatelet
alternans
t-u
qrs
quadrigeminy
hypochloremic
hypopotassemia
frequencyincidence
nxa0xa01051
nxa0xa09203
hc-treated
10xa0000
diagnosisascertainment
intervalxa0xa-
stillborn
aminosteroid
differentiation-
all-trans-ra
two-color
hgfs
hgfs-mediated
pan-bcr-abl
h396p
aml-2d100
d250
d500
cyanide
mxt
-240
ic75
underestimates
serum-supplemented
microclonogenic
perforations
binocular
granisetron
rarbeta
inhibitorand
tw-37
bax-dependent
derepress
metamorphosis
chalone
acutal
impure
ebm
iccno
auto-sctother
allo-grafting
safrole
betle
inflorescence
sacrificed
mac-3
hormographiella
aspergillata
sino-orbito-cerebral
rhpdcd5
ibrutinib-sensitizing
glycohydrolase
parg
ethacridine
btk-independent
gemcitabine-
epitherapy
lymphocitic
vr
l-asp
starasid
stearyl
phosphoric
c-c3pca
ca2-channel
nifedipine
prothazin
withdrawing
ca2-antagonists
effector-target
ca2-requirement
ca2-influx
infectants
infection-induced
autolysis
niacin
sir2
6-h
proton-pump
cola
dendrobium
glutamate-induced
pc12
hsv-1
acv
valacyclovir
cidofovir
translocation--characterised
t--
co-workers
lopac1280
nci-60
nextbio
gfi1-deficient
hyperactivity
bipotential
idadnr
non-significantly
monocytic-macrophagic
serratum
lse
baxbcl-xl
incedentally
orpiment
indigo
tonic
cal-101
gs1101
verruciform
xanthoma
arylazo--diaminopyrazole
aap1742
ic28
40af
d₃
hpk1
p38mapk
sb202190
ddcs-induced
d-sensitive
d-resistant
hpk1-c
fl-hpk1
dcs-induced
d-induced
guaianolide
sesquiterpenes
autoagglutinins
phytohemagglutinin-stimulated
leukocyte-conditioned
l-cfu
pe2
obstetricians
neonatologists
anaesthetists
non-pregnant
prematurity
3xa0xa010
quinolones
tetracyclines
sulphonamide
magnesium
analgesia
80xa0×xa
1xa0×xa
caesarean
rupture
ground-glass
interlobular
ild
acid-fast
rhabdoid
veins
acalculous
colloid
scintigram
polyphenon
h1299
co-payments
mcl-derived
ladder-type
piperacillin
gram-negatives
bhac-edm
maintenanceintensification
ifi-ff
onco-haematological
guanine-to-thymine
enzymatically
jh2
pseudo-kinase
jh1
aetiologies
haemoglobinuria
unalternative
acidraaclacinomycin
acmdimethylformamide
dmf
rpm11640
-conditioned
80nm
dimethylformamide
ra80nm
epz-r3r4s5r--amino-9h-purin-9-yl-r3s--5-tert-butyl-1h-benzodimidazol-2-ylethylcyclobutylisopropylaminomethyltetrahydrofuran--diol
mll-rearrangements
epz-5676
chromatin-modifying
non-mll-r
remission--303
ptfcs
paradisi
macfadyen
bhac-dmpv
behenoylcytosine
cytogenetic-hematological
non-rearranged
k562adr
bcrabl-jak2stat3
pi3kakt-jnk
proliferation-inducing
hcclm3
bel7402u202fcell
jq1-triggered
inhibitor-resistance
cem-vlb
hl60vinc
k562-dox
non-pgp-mediated
hl60ar
at-mdr
cem-vmi
hamster
lr73-r
mdrl
feulgen
stainability
g0g1-selected
textural
decondensation
clumps
drug-selected
hl60-vinc
non-p-gp-mediated
lr73
gnf-7
kyo-1
phospho-crkl
cfcs
beta-interferon
prostate-apoptosis-response-gene-4
par-4
that--in
cells--par-4
par-4-positive
par-4-
daxx--whose
chemosensitivity--as
procaspases-
procaspases-3
hel--in
rbm15-mkl1-positive
rbm15-mkl1-negative
themdied
biodegradable
polyelectrolyte
microcapsules
thyroidal
autoxidation
unitsg
microgramsg
unitsmicrograms
hyperthyroidism
candidaemias
trichosporum
fungaemia
bacteraemias
seroconversions
menogaril
7-con-o-methylnogarol
nogalamycin
-79
rhino-orbital-cerebral
horwich
bonnet
lapidot
yilmaz
al-hajj
fang
lawson
ricci-vitiani
xin
bao
csc-associated
jin
cd24
sagiv
mikkola
multifrequency
rhythms
infradian
circannual
chronograms
cosinor
high-amplitude
time-qualified
chronodesms
synchronizers
activity-rest
light-dark
synchronizer
circaseptan
chronopharmacology
collie
syndromeabstract
suberoyl
anilide
bishydroxamide
karyotpyes
gas2l1
tfiis
ehd3
enolase
mx1
dral
astml
pxdn
alpha-catenin
-9-fold
growth-protective
ades
e9
icd-9-cm
paeonia
lactiflora
pall
andr
6-penta-o-galloyl-beta-d-glucose
pgg
anti-oxidant
anti-mutagenic
anti-invasive
lps-activated
cox-1
gallate
gallic
--epigallocatechin
gallacetophenone
pgd2
excrete
three-
6-hydroxymethylpterin
excretory
pterin
graphically
conveniently
receptor-ck
saponin
protopanaxadiol
pdg
protopanaxatriol
ptg
ginsenosides-rb
-rb
-rc
-rg
-re
daunorubicin-
photolabeling
lipo-atra
atraidarubicin
lead-like
mtn
txl
dna-interactive
non-dna-interactive
npmwt
ncl-npm
nclnpmwt
terrestrial
epothilones
oceans
prefractionated
fluorescent-labeled
nodscidinterleukin
9-
90-fold
lll-3
ta98
ta100
ta102
ta104
salmonellamicrosome
ames
micronucleus
flowcytometery
sirna-etoposide
flavonol
hg3
ng106
3-only
unliganded
citrovorum
lin-sca1
lna
dematiaceous
relationed
non-promoter
meiosis
mda-mb‑435s
vx680
c-flip-overexpressing
expel
inquires
sufferers
painstaking
tumour-necrosis-factor-related
super-additive
cd11ccd18
-tetradecanoylphorbol
ap-1-dependent
upmodulation
upmodulated
upmodulating
agents-based
pu1vav1
apl-derived
agent-based
process-specifically
process-and
drugs-axitinib
inlyta
tivozanib-that
stereoisomers
cd67
subtherapeutical
hepato-splenomegaly
idarubicin--although
disease--represents
interleukin-24
il-24
moderation
athymic
metastasis-related
lung-cancer
carmustine
stationary
blockading
il-1the
dinarello
mcl-1-induced
growth-regulated
katoh
cmk86
solidarity
mortalityareas
non-negligible
interleukin-5
antirheumatic
non-steroid
tofacitinib
rituximab-resistant
rituximab-mediated
chemosensitize
chemosensitized
dehydroxymethylepoxyquinomicin
pd098059
survivalantiapoptotic
radiochemotherapy-resistant
dt388-gmcsf
hl60vcr
c219
nonapoptotic
lapatinib-induced
lapatinib-treated
chaperon
benzoquinon
ansamycines
radicicol
obscured
synergises
salviae
miltiorrhizae
csmi
carfilzomib
oprozomib
delanzomib
bortezomib-resistant
onx-0914
lu-102
surmounting
antidiphtheria
anti-dt
dt-granulocyte
gmcsf
dt-gmcsf
classifcation
stratifcation
monly
-3-ethynylphenylamino-7-methoxyquinazolin-6-yloxy-n-hydroxyheptanamide
cudc-101
ato-resistant
noncancerous
hdac-dependent
oncomir-21
antimirs
antimir-21
monodansylcadaverine
ao
pre-treating
neddylation
gate-keepers
principals
cassettes
k562-adm
traversing
cargoes
vpr
hosttarget
carboxy
inhibitiontoxicity
timentin
tds
tobramycin
agranulocytopenia
septicaemias
epidermidis
alkaligenes
faecalis
serratia
marcescens
amphocil
imi
lenalidomide-triggered
bortezomib-
lenalidomide-
serendipitously
cys828
dfg
jungermannenone
tetracyclic
liverworts
peroxiredoxins
ent-jungermannenone
biomethylation
monomethylarsonous
iasiii
ic5
mk571
trivalent
melphalanautologous
hdm-asct
iggiga
monoclonal-protein
m-protein
nontreatment-related
bclxl
k-means
codependencies
bcl2mcl1
bclxlmcl1
a1210477
mcl1bak
a1210477-resistant
recaptured
el9611h-2d
cb6f1
powdered
dysmenorrhea
contaminated
eluded
heavy-metal
incentivized
gamboges
transfect
propane
dotap
lipiddna
tpck
n-tosyl-l-phenylalanine
chlorometyl-ketone
znso4
topo-isomerase
multivitamins
mvi
pruritic
dextrose
tapl
difluoromethylornithine
dfmo
methylglyoxal-bisguanylhydrazone
polyamines
spermidine
putrescine
intramuscular
starved
cardiomyocyte
hl-1
hcavsmcs
β-blockers
atenolol
metoprolol
carvedilol
nebivolol
at1r
losartan
at2r
cgp42112a
np-6a
xcelligence
rtca
np-6a4
wga
msc-induced
p21-mediated
befitting
combined-modal
triphosphate-competitive
hmcl--327
hmcl-1
amorphous
cd19cd3
redirects
cd3-positive
cd19-positive
relapseresistant
rigid
hydrogel
pores
usability
apigenin
apigenins
k562ima3
k652
actim
add-on
squibb
porton
remissionsthe
carotovora
antigenically
colithe
5-aza-cdr
groupssingle
drug-treated
drugs-treated
time-dependency
concentration-and
takstat
amrubicin
pixantrone
fibric
antihyperlipidemia
fibrates
clofibric
gemfibrozil
leukaemia-derived
pharmacotoxicological
mirna-21
anti-mir-21
amo-mir-21
apotosis
giemsas
pdcdutr
liposome-coated
lipoplex
l-cl
asodns
peg-modified
tumor-engrafted
druggability
unveils
troglitazone
interchangeable
hypoxanthine
interoccasion
iov
iiv
dose-to-dose
absorption-related
multidrug-based
phu200aacute
duplicationpoint
semipurified
crotolaria
juncea
cassia
marginata
ficus
racemosa
cicer
arietinum
l-532
gossipium
indicum
g-27
melia
composita
acacia
lenticularis
meletia
ovalifolia
catechu
peltophorum
ferrenginium
leukoagglutinating
lymphoproliferativehaematologic
agglutinated
leukoagglutination
nuclease-resistant
oligos
dnmt-inhibitor
conductive
transferrin-aunps
tf-aunps
microelectrodes
homemade
pwizgfp
aunpstf-aunps
hgc-27
-dimethyl-celecoxib
dmc
kinase-signaling
obtention
inhibitable
kit-expressing
olopatadine
non-recipients
candidosis
surmised
microemulsion
ldedaunorubicin
image-based
tunable
naringenin
salicylate
depict
plzfrarα
transduction-transplantation
lafp
aml1eto-
plzfrarα-expressing
sca1lin-
dacinostat
plzfrarα-positive
daci-mediated
bristol-myers
rizoma
chinensis
regel
ar-42
poly-l-methionine
radiolabeling
solubilizer
penetrate
l-methionine
gkg
carotid
ptl-mediated
lsc-targeted
greenish
chlorosis
tattoos
apocrine
chromhidrosis
biliverdinemia
oncocardiology
diuretic
tolvaptan
imide
concentration-effect
shielding
sdf-1cxcr4
counterproductive
pips
stupendously
invigorating
chlorohexidine
paromomycin
effortless
anti-metabolite
ts-1
palpebral
fl-flt3
autoactivation
crosslinked
glutaraldehyde
diferric
antiport
activity-based
diagnosis-related
drg
out-of-group
anti-a
anti-b
fucoxanthin
imat
loss-gain-of-function
up-down-regulation
2-deoxy-5-azacitidine
histone-tail
sphingomyelin
dose-intensification
densification
vsli
20-based
anti-cd52
cell-targeting
antibody-toxin
ii-a
anti-oxidative
tanshione
crocodile
cgg
mtspms
deconvoluted
alcl
adherence-related
antineoplatic
esterases
e-rosettes
hutla
po-me
vincristine-
1-beta-d-arabinofuranosylcytosine-
tallimustine
distamycin-a
wasting
aziridinylbenzoquinone
azq
dataset-accessible
vizome-that
leveraged
anti-psychotic
l121c
l5178
kb-v-1
behenoyl-ara-c
periodical
gleevec-resistant
redox-mediated
t315i-positive
non-purged
2c9
prolymphocytic
t-pll
t-pll-specific
n4-hexadecyl-1-beta-d-arabinofuranosylcytosine
nhac
arabinofuranosyluracil
co-incubating
c-resistant
transporter-independent
dcyd-kinase-independent
tri-
tetra-
sjt
sjts
8qqqqqq24-qq22
14q32
radiosensitive
syousaikotou
providone-iodine
painkilling
smells
m2yn
extents
hyperforin
mcl-1bak
m2yn-treated
abt-263-induced
abt-263-triggered
cotreatment-induced
vina
pyrx
drar-cpi
chemical-protein
interactome
ii-targeting
voreloxins
eg5
oligofectamine
isorhamnetin
nitraria
retusa
antigenotoxic
phu2009u2009all
phospho-proteomic
hpc-lsk
jak1stat1
phospho-signaling
iap-
pak1-
m07e
diphenylene
iodonium
apocynin
sub-unit
p47phox
nox
hinting
transmodulates
k562dox
5-dimethylthiazol-2-yl--carboxymethoxyphenyl--sulfophenyl-2h-tetrazolium
postdischarge
homecare
knowledgeable
algorithmic
dss
interpolation
cancer-selective
open-source
extendable
drug-ldl
n-trifluoroacetyl-adriamycin-14-valerat-ldl
ad-32-ldl
paclitaxel-ldl
autoradiographic
tumour-bearing
cholesteryl-linoleate
autoradiography
anchors
laboratory-confirmed
mobilises
mobilise
kinase-mediated
rb-mediated
hypophosphorylated
pre-g1
calyculin
arrest-
apoptosis-specific
e-
hyperphosphorylated
persistant
sanctuaries
monoblasts
individualisation
flcz
trichosporonous
flcz-resistant
chorioretinitis
trichosporonosis
light-density
three-compartment
idaoh
medial
growth-inhibiting
hgprt
pyrophosphatase
impdh1
impdh2
ivsca
ivsga
94ca
irf3
tir-domain-containing
trif-dependent
icariside
epimedium
nakai
zymosan
calmette-guérin
tuberculin
protein-derivative
t-lymphoma
t-lymphomas
cytostasis
lower-than-desired
dianhydrogalactitol
dag
metalloproteinase-2
dual-suppression
vegfvegfr2
fgf2fgfr1
kit-driven
transphosphorylation
pdpk1
trka
audited
gnb
carbapenems
beta-lactamase
cefepime
esp
worrisome
piperacillin-tazobactamtigecycline
semi-automated
hylteritinib
csk
mitramycin
displaces
flame-shaped
igb
ipscs
re-differentiation
drug-testing
rxrs
uneventfully
seated
cytokinins
kinetin
isopentenyladenine
benzyladenine
cytokinin
ribosides
riboside
isopentenyladenosine
ipar
cytokinin-like
redifferentiation-inducing
stakes
therapy-specific
non-anthracycline
abl1abl2bcr-abl1
non-kinase
affirm
nanomedicines
hexim1
minute-2
hdm2
jci
labelle
thpo
thpo-mpl
ly2457546
vegf-driven
pkdr
maks
depigmentation
cartilage
chromic
triple-cross-resistant
microevolution
divisiondeath
neopterin
vcr-
dau-resistant
dau-sensitive
cytochalasins
pertinence
sbd
drug-biomarker
luteolin
mapk1
besançon
nantes
francs
hydrolyticenzymatic
ils
alkylated
nipam
ph-sensitivity
decorated
isotype-matched
ils-cd33
tautomycin
cla
phosphatase-1
pp1
-2a
thr696
thr853
mypt1
25kda
kinase-enhanced
kepi-like
cla-induced
tm-induced
flag-kepi
saq-no
p70s6
lopinavir
no-derived
latently
beta-escin
chestnut
pi-
nucleus-cytoplasm
mislocation
amyloid-like
three-helical-bundle
thioflavin
wide-angle
amyloidogenicity
fibrils
flt3-specific
toxin-conjugated
obstruct
recovering
chu-2
intercalated
h33342
disposable
idarubicine
intercalative
51cr-release
conjugatedextran
nontumor
monocyte-mediated
interdigitations
apposed
quinolinone
quinolinones
kr65367
kr65370
kr
nclmir-221nfκbdnmt1
nls
peptide-targeted
co-loaded
anti-221
as1411
npsn-as1411a221
multiple-functional
nclmir-221nfκbdnmt1-targeted
nanotherapy
j16
ramos
-dibromo-4-dibromophenoxyphenol
p01f-tribromo-4-dibromophenoxyphenol
p01f08
5-epi-nakijinone
p03f03
monotherapeutic
s-phase-fraction
27th
antimetabolite-type
archaeal-human
versatility
24-meric
archaeglobus
fulgidus
transferrin-iron
ferritin-encapsulated
regimen-trampcol-incorporating
colaspase
trampcol
dpp
a549dpp
mcl-1in
inpatients
lymphotoxin
gelatinase
metalloprotease
timp1
tnf-
lt-stimulated
feverfew
hypercapnia
autopsies
m-in
pro-caspase
signifying
radium-ra
pycnogenol
nse
z-devd-fmk
induced-apoptosis
synergistical
phosphatidylinositol-3-kinase
duplication-positive
traf6
tlr-signaling
syto16
4-epidoxorubicin
seahorse
xf-24
leaks
hcc-m
huh7
zstk474
ly290042
akt1-targeting
m-chlorophenylhydrazone
3-bromopyruvate
vinorelbine
iacs-010759vinorelbine
mitoxantroneetoposide
ivv
dexter-type
aumsdtcl2
dichloromethyl
n-dithiocarboxy-ksks-n-methylglicinatogoldiii
aumsdtbr2
dibromomethyl
goldiii
platinumii-based
3h-histamine
3h-h
temperature-dependent
iodacetamide
impromidine
4-mh
aet
pea
cimetidine
oxmetidine
dph
amitriptyline
imipramine
clomipramine
viabilityabstract
doxo-
overdosage
shaking
neutro-
leflunomide
solid-organ
virologic
cmv-dna
leukocyte-derived
flu-like
antibody-coated
seronegative
hyperreactivity
raynauds
nailfold
vasospasm
vitiligo
cryoglobulinemia
kytococcus
sedentarius
harmless
activationinactivation
eif2alpha
ires
physalis
peruviana
vero
5-aza-cr
methylase
3h-methyl-s-adenosylmethionine
3h-sam
templets
phialophora
chromoblastomycosis
prosthetic
verrucosa
h3k9ac
h3k9me2
cytoametry
formaldehyde
monooxygenase
mtx-resistant
abcg2-overexpressing
cbcrp
mc-1
reparation
mtx-induced
artemisinins
antimalarials
sor
3-drug
sav
artemisinin-derived
trioxane
diphenylphosphate
art838
ccattenhancer-binding
ddit3chop
primagraft
5mudaily
demential
antidotes
stiochiomertic
ceacam
epithelia
homo-and
hetero-philic
anoikis
subnormal
glandular
polymorph
myelomatosis
supposition
polymorphs
jak3-selective
pf-956980
p53-elevating
nutlin
il-4-induced
unsurpassed
unquestionably
erb
cd29
cd18
postgrafting
graft-v-host
cd53
evs
csnk2a1
ptk2b
abbreviating
sagramostim
adm-resistant
k562adm
q4d
p388-bearing
26-bearing
pathway‑dependent
hgh
hgh-transfected
fcca
seop-so-95
mopp
abvd
5qmonosomy
7qmonosomy
ras-braf
18-h
minmicrogml
maturationdifferentiation
co-development
förster
pickles
case-dependent
-epoxy-5
beta-cholestane
triglycoside
bulbs
ornithogalum
saundersiae
e-ring
neplanocin
kinase-ineffective
preexposure
short-chain
diphosphate-ribose
myeloid-cell
aeg
decursin
pyranocoumarin
gigas
isozymes
myeloleukemia
tur
betaii-deficient
betaii-independent
betaii
oligopeptides
tp3
thymopoietin
multilamellar
mlv
im9
drug-loaded
nsc-127716
hancornia
speciosa
popularly
antihypertensive
eehs
fungicidal
quinic
catechin
atcc
cathepsins
enafr
nvg
pra
kell
glycosaminglican
4mu
4muxa0xa0imatinib
paktakt
perkerk
linage
nanostrategies
adalimumab
etanercept
maturation-arrested
hemoglobinic
globins
run-on
tki-targeted
flies
focusses
justicidin
lignan
phyllanthus
linum
antiprotozoal
resorption
3t3-l1
pre-adipocytes
retards
gate-keeper
diarylamide
life-threating
cellsn
annexinpi
kg-1and
treatedn
phytoestrogens
isoflavones
daidzein
flavones
k562a
zorubicin
amsa-ara
anthracycline-ara
capsaicin
peppers
mip-1
palmitate-induced
palmitate
kinase-related
ffa
oleate
stimulators
palmitoyltransferase
β-oxidation
hbsag-positive
amylase
hbv-dna
sittings
rads
rheumatologists
egfpluciferase
rosa26
r26
jarid2
t-allt-lbl
luciferase-positive
structurally-independent
-diprenylated
chalcone
e--hydroxy-4-methoxy--diprenyl
phenyl--
pyridinyl-propene-1-one
c10
p38ampk
carcinogene
additionallytreatment
3ab
akt-mtor
tet2-mutant
tet2-deficient
top1-targeted
crispr-cas9-induced
tyrosyl-dna
tdp1
top1cc
heme-peroxidase
mpo-deficient
c15
p170-glycoprotein
anti-rheumatic
saards
-dpg
erythro-sol
coats
electronmagnetic
antipyretic
reri
t3151
tecomella
undulata
swellings
healers
leucorrhoea
leukoderma
gonorrhea
gout
sl401
receptor-modified
refractoryrelapsing
mb-102
nonreactive
nonidentity
ftbi
anti-cd3
lymphocyte-depleted
arachnoiditis
papilloedema
candidal
thrombopoietins
gelatin-containing
gelatin-lenograstim
aml-dbt
hsa-containing
hsa-lenograstim
cnc
mare
homodimers
dimerizing
stressors
evolutionprogression
ap-cmlbc-cml
5d
ifa
brucine
aoeb
annexin-vpi
irofulven
-hydroxymethylacylfulvene
dire
overdosing
valcytarabine
liposomal-cytarabine
pacira
mdr-type
ag957
calcein-am
bisdesmosidic
aglycons
lupane
acid-catalyzed
gnf-
cocrystal
5h
sedative
hiv-1iiib
thp-1hiv-1iiib
uninfected
productively
virions
extracellularly
alpha-linolenic
n-3
subculture
acid-treated
n-6
nf-1
position-specific
infra
u2009×u200910⁸
u2009×u200910⁹
m⁻¹
a-like
n191
nsd
nsd2
catalyse
misregulation
vivoantileukemic
-dihydroxy--hydroxy-3-methyl-butyl-19-nor-cholecalciferol
19-nor-gemini
32d-parental
theorically
usefull
csf-induced
civilizations
fowlers
bicarbonate-based
as2o3solution
1930s
mid-20th
reintroduced
trioxide-containing
1970ssubsequently
microbubble
bbb
viia
cytosine-beta-d-arabinofuranoside
pca-modulating
upa
pre-formed
pro-coagulant
hs-asa
asa
g₀g₁
β-catenintcf
cyclind1
compendia
pboxs
pbox-16
ldm
emt-6
lipidic
btz
jeko-1
anti-mcl
nabumetone
waived
revocation
esr2
ovulation
polycystic
alpha--
overactivity
mdr1-specific
cyclosporin-a
cy-a
cy-a-induced
perinuclear
nanotubular
angiotube
factor-limited
dasatinib-sensitive
inacceptable
lactide-coglycolide
n-desmethyl-metabolite
hydroxymethylphenyl
n-oxide
3-r-ho-metabolite
protean
cleavage-religation
dnr-resistant
k562d
whichs
philosophies
network-like
structural-based
malesfemales
2-drugs
3-drugs
stealth-like
cd154
cd154-transduced
dulacia
egleri
eglerisine
sesquiterpenoid
tropolone
spectrometric
hresims
non-t-all
anti-cd7
anti-cd5
isotopes
antigrowth
reinvigorated
maytansinoids
auristatins
taxoids
chemotherapy-susceptible
-amino-2-methylpyridine-5-yl-methyl--chloroethyl3-nitrosourea
acnu
blm
vp--fluorouracil
vlb
drugdrug
lamella
drug-excipient
copperii
gluconatetriethanolamine-based
promyeloblastic
hyposensitive
ciks
interleukin-15
cik-mediated
ldh-release
ciks-mediated
1-β-d-arabinofuranosylcytosine
k562s
k562ac
aldh1a2
under-
overwinding
knotting
tangling
enzyme-cleaved
ii-active
dissociating
expression--but
activity--of
jak2β-catenin
survivalself-renewal
pp2a-mediated
hscprogenitor
jak2pp2aβ-catenin
tki-refractory
rasmap-kinase
phosphoinositide-3-kinaseakt
phenylaminopyrimidine
pdgfbeta-receptor
quinoxaline
ag1296
bis1h-2-indolyl-1-methanone
d-65476
indolinones
su5416
indolocarbazoles
piperazonyl
quinazoline
tac-induced
tac
slow-release
prolonged-release
rii-52
rii-54
methylisobutylxanthine
8-br-camp
kilobases
pre-mrnas
exported
anti-fibrotic
liver-x-receptor
nor1
autolysosome
biosynthesizing
3β-hydroxysterol-δ-isomerase
d8d7i
pu2009u20093u2009×u
ar-positive
liposome-incorporated
methylphosphonate
liposome-entrapment
epipodophillotoxins
hrxt
etiopathogenetically
interinstitutional
bakbax
luvs
cardiolipin
polyanionic
ants
quencher
dpx
permeabilize
enterobacteria
ulcersangular
cheilitis
lactobacilli
angular
hepatically
drug-sensitivity
multidomain
permeabilizes
derepressing
chemotherapy-naïve
permeabilizer
metvan
vanadium
gelatinolytic
tyrosine-phosphorylated
proerythroblasts
sh-rna
chromatographytandem
premyelocytic
iia-induced
pneurokinin-1
fosaprepitant
kinase-selective
subproteome
resin-retained
flavine
imatinib-regulated
activity-regulating
mcl1δnδc
mom-like
chol
ra-dependent
identically
cross-reactivity
fluorescence-based
imp
difluorodeoxycytidine
3924a
5-hydroxymethyl-2-deoxyuridine
5hmdurd
5hmdurd-induced
3h5hmdurd-derived
tranexamic
cytosine-phosphate-guanine
islandsleading
curcuma
longa
curcumins
femtosecond
fs-laser
anthracyclinecytosine
camp-kinase
pka-i
pka-ii
ser118
camp-increasing
theophylline
pro-differentiating
non-beneficial
polycythemic
fv-p
cellulose
adrenergic
fv-p-infected
butoxamine
pge1
noscapine
opium-derived
phthalideisoquinoline
antitussive
apoptosis-proficient
nucleation
noscapine-induced
fas-null
fas-independent
3h-leucine
resistant-disease
qingdai
surflex-dock
sybyl
pharmacodynamically
isdirubin
isoindigo
n-phenyl-2-naphthylamine
isatin
x-radiation
life-span
busulif
iclusig
ariad
advantageously
fluorochromes
etop
cross-activities
cross-activity
mdr1-related
medicalization
hôtel-dieu
r72
underevaluated
abstractu3000u3000
therapys
inhibitor）
rhepo
fulfills
isoelectric
dodecyl
sulphate-polyacrylamide
truncations
densitometry
synthetic-lethal
nbs
bclw
psmd14
ubl5
subcomplex
sart1
5-splice
ubl5prpf8sart1
bcl2-dependent
sf3b-interacting
spliceostatin
mcl1-s
bn82865
gqds
gqd-based
nanoplatform
coniugated
pll
cd5cd19
co-trmoxazole
chromosomic
methylprednisone
rt-pct
nb1
abl3
ca3
ph1-
uremic
d1s80
d17s30
single-pass
everted
slices
basolateral-to-apical
transepithelial
mdr1-mdck
co-transport
oats
p53-induced
wip1
executors
episomal
eucaryotic
3-like
tpck-sensitive
cpt-treated
101m
chloroethylating
g-c
isocyanate
agt
o6-benzylguanine
a9
fq-rt-pcr
nh2-oh
hn2-oh
choline-independent
choline-dependent
12xa0hour
impediments
200-
meg-01ima-
meg-01ima-1
bcrabl-independent
abandoning
mium2
miu
bcl-2-positive
antisense-treated
ras-independent
er-related
watercress
k562xa0cell
oxygenase‑1
ho‑1
cytochromexa0c
protoporphyrinxa0ix
anti‑tumor
peitc‑induced
histochemistry
nitro-blue
cinobufagin
digitoxigenin
-acridinylamino
methanesulphon-m-anisidide
-bisbutylaminobenzogphthalazine
abp
sdskdna
protein-dna
non-intercalator
remaking
3-brp
silico-designed
bromodomain-4
brd-4
ith-47
acetyl-lysine
bromdomain
extraterminal
brd
annexin-v-fitc
ith-47-exposed
3-brp-treated
ser70
antiglycolytic
sapl
2-nitroflavone
self-congratulatory
rejoicing
midostautin
gilteritnib
wonders
temperate
mesc-derived
bcr-abl-transduced
op-9
feeders
nontransduced
itcs
nci-h1299
sk-mes-1
perk-eukaryotic
2α-chop-noxa
tauroursodeoxycholic
peitc-gefitinib
post-autologous
framycetin
fracon
coryneforms
ceftazidimegentamicin
enterobacter
cloacae
anaerobic
anaerobes
clostridium
fluconazole-resistant
ciferrii
papulae
spotted
flucanozole-resistant
microorganism
em-x
anti-oxidation
em-x2
mda-mb231
antiproliferation
anchorage-dependent
sv40
thle-2
disulfide-linked
55-kd
homodimer
scd27
protrusion
nonspecifically
rotundus
pks
h2o2uv-photolysis
thiobarbituric
tbars
galloyl
3-hydroxy
125iododeoxyuridine
natriuresis
hyperkaluria
aminoaciduria
hyperphosphaturia
reabsorption
glomerulo-tubular
lysozymuria
acidaemia
4-trihydroxy--dimethoxybibenzyl
tdb
bibenzyl
ellipsophyllum
tang
h292
h23
papilla
dpcs
approximatelyxa0xa0300xa0µm
50xa0µm
pro-apoptosis
tdb-treated
picholine
mule
death-in-mitosis
short-interfering
schemata
suppresser
expended
lc-50
instigating
avocado
persea
lauraceae
seed-derived
alcohols
polyols
avocadene
avocadyne
diet-induced
self-emulsifying
sedds
self-assembly
microemulsions
nanometers
avocatin
avo
eutectic
triglyceride
polysorbate
polyol-sedds
c57bl6j
naproxen
drug-specific
death-defying
octn2
reabsorbs
filtered
sodium-dependent
secretes
octn2-mediated
hoctn2
moctn2
acetylcarnitine
hoctn2-mediated
transcellular
apical-to-basolateral
disturb
forodesine-sensitive
dgk
ent2
ara-g-sensitive
conspicuously
non-donor-dependent
nhd13
h3k36me3
weakens
ikba
exercised-not
inlet
gox
acrylated
120h
pegylation
carbonic
anhydrase
ca9
lysyl
lox
bio-medical
enduring
polyacrylamide
rubomycin
non-clonogenic
haemin
cochleovestibular
sketches
pml-rar-alpha
all-trans-
nonterminal
kratzer
givinostat
itf2357
6-diethylaminomethyl
naphthalen-2-yl
n-4-hydroxycarbamoyl
carbamate
multiprotein
nd10
pods
zn2
c3hc4
rms
cysteines
equine
3t3
sul
alegre
rar-alpha
alpha-tocopherol
9ctt
tocoferil
pmlrar-alpha
retinobenzoic
post-marketing
hps
diarylheptanoids
diarylheptanoid
tacca
chantrieri
-dihydroxyheptane
5r
exciton
chirality
-bis-p-bromobenzoyl
scurrula
parasitica
aminopterin
amt
3hmtx
tetrazole
noncompetitive
uacc-1598
7500x
indolocarbazole
ec-70124
flt3-stat5
akt-mtor-s6
pim-bad
noxa-
bim-dependent
r-123
r123
nonpumping
idarubicin-responding
sappan
yac-1
microlitersml
7d
three-stage
smoothly
mage-a
alfa-2b
diflunisal
co-culturing
leukoreduction
re-express
nats
scm
drug-gene
curated
non-anthracyclines
saa
re-incubation
repeatable
antigen-redirected
targetoff
k-562-j
vm-26
vp-16-induced
chk1i
gdc-0575
arac-mediated
stemprogenitors
aracchk1ig-csf
core-shell
pcl
pecs
hepatocelluar
cynara
cardunculus
artichoke
cynaropicrin
mefloquine
vacuole
lysosome
lamp1
lamp2
disrupters
bombay
gums
pallor
pseudomoniasis
shengfu
therapyfor
leuke-
entitiessubtypes
strategylargelydepends
mainlybased
actuallyconsists
usuallyharbor
discoveryof
compiling
newlydeveloped
ml2
8-hydroxyquinoline
omadine
4-h
human-mouse
radioisotope-conjugate
q23p13
shrna-containing
cell-sorting
cycle-
dissolve
shc1
sos1
ccbl
p85a-pi3k
sts1
ship2
malignance
hypothesis-driven
chlorprothixene
oncofusion
accession
gse124316
nampt
entangled
betalains
nitrogenous
pigments
caryophyllales
betanin
betacyanin
opuntia
ficus-indica
infirmed
xq11q
ra7
dac-resistant
rclo
14q21-q22
rcla
rcld
rd1
sscp
biomodulatory
inconvenient
tpo
eltrombopag
imr-90
iterations
levothyroxine
physiopathological
db-friedoolean-type
3β-acetoxyglutin--en-6-oxo
scorzonera
austriaca
bel-7404
extra-copies
n-myc
th2-type
bcl-2-selective
ntx
evodiamine
rutaecarpine
evodia
rutaecarpa
rita
iκb-α
rita-treated
atr-chk1
atrchk1
triton
reverting
agent-free
idfs
nct03150134
deathbased
mcl-1a1
multi-nanosecond
candidum
peg-dox
peg-dox-based
inhibitors-induced
nxa0xa0117
lubricants
shp2e76k
uk711
1-beta-d-arabinofuranosyl
peptidomimetics
pi3kaktmtorc1
rewiring
idh-inhibitor
idh-inhibitors
mindful
cml-patients
erent
rulers
interparticle
photobleaching
blinking
ruler
tethered
dipole-dipole
c3spr
znfeo4sio2au
dielectric
znfeo4sio2-shell
virus-encoded
transformation-associated
ebv-seronegative
ebv-seropositive
ebv-infected
alpha-interferons
vogt-koyanagi-harada
vkh
build-up
abberrations
bet-
dot1l-
set-
men1ledgf-inhibitors
dot1l-inhibitor
lipoic
acid-crosslinked
lacha-dox
lp-1
183u2009nm
u2009wt
targetability
ara-cmx
antibiotic-free
anti-pseudomonal
half-dose
guanazole
induction-treatment
seaweed
phlorotannins
il-3ralpha-
src-kinase
chryseobacterium
meningosepticum
postneonatal
epididymitis
theophyllamine
untapped
co-regulation
essentiality
standalone
deacetylate
akiis
ftir-spectroscopy
lipid-protein
schwann
alpha-sc
sciatic
axonal
f10
fluoropyrimidine
f10s
pgp-dependent
bhm-97
a2058
a-1
a-2
a-4
a-6
dimethylsulfoxide
vincristine-induced
conceptional
drug-armed
maytansin
venclexta™
abbvie
genentech
co-developed
genentechroche
diffusa
transverse
leukonychia
striata
transretinoic
non-phase
aml-cfu
sintamil
3h-methylthymidine
asta
cfu
chemopurified
mtorc1s
formaldehyde-fixed
ps6
pre-sirolimus
rejuvenated
jak-signal
tg101348
anti-jak1-mediated
vanguard
cyt387
oxidantantioxidant
tas
ug
hypoploidies
hyperploidies
del6p
der12q
pharmacotherapeutics
mdr-1-transfected
cystoides
tetrahydrofolic
unabsorbable
cads
il-12p70
litre
intralipid
jak2mpl-negative
drugswe
type2
tre
ts1
ts2
vhdjh4
igvh
antigen-driven
cd34-cd19
otolaryngologist
rxr-selective
acid-resistant
rar-rxr
desubordination
rexinoid-camp
reestablishes
raralpha-rxr
rexinoid
anthracyclic
nine-fold
cpm
scatchard
suberate
sulfate-polyacrylamide
phenylphthalimide
tc11
crbns
ikzf
ck1α
crbn-silenced
cgp74514a
tc11-induced
g₁
p57kip²
cki
p27kip¹
buildup
heretofore
imatinib-dependent
precocious
ailing
chf
swan-ganz
pimobendan
amrinone
peculiarity
promyeloleukemic
hl-60bcl-xl
ajoene-induced
ajoene-mediated
beta-d-glucosyl-ifosfamide
glu
ifo
cyc
fixation-permeabilization
cytofixcytoperm
perm
intraprep
intrastain
permeacyte
permeafix
fixationpermeabilization
erythrocyte-lyse-washed
paraformaldehyde
mpo-7-pe
ucht-1-pe
hm57-pe
lag-3
btla
cd200r
pseudopterosins
pseudopterosin
bch
spd
troxatyl
adis
l-nucleoside
shire
leukaemia-blast
madhuca
longifolia
prosopis
cineraria
flacourtia
indica
bengal
kir2d
unobserved
extractsbe
apoptosis-modulating
dmso-free
-diethyloxocarbocyanine
effluxed
3h-labelled
14c-labelled
by-passed
protracting
ccrf
transferable
stranded
iialpha-negative
lamiaceae
litwinowii
bornm
sint
cytodestructive
uncomplicated
phamdr1a
mechlorethamine
trans-flupenthixol
trxr1
grx
daunorubicin-cytarabine
plk1-targeting
ltbmc
adhesiveness
multisignal
photoelectrochemical
manganese-doped
cdszns
mncdszns
photocurrent
devd-biotin
streptavidin-labeled
phosphatise
sa-alp
biotin
2-phospho-l-ascorbic
aap
hpct
schirmer
andrographolide
nb4-r2
r-roscovitine
tyrosine-kinases
90β
hsp90β
dynamin
dy
hel7
h-j
sars
target-cell
cfu-blast
later-acting
lineage-restricted
anll83
anll86
hivaids
hiv-resistant
ccr∆32
hiv-resistance
inventories
fnc
h22
s180
abstractu3000u3000chronic
physcion
matrine
ligustrazine
solanine
monomers
reviwe
protein-binding
non-egfr
fbw7-inactivating
fbw7-wild-type
fbw7-mutant
vae
vasculopathies
vae-triggering
mll-all
mutant-specific
2dc
mda-mb
mcf-10a
rapd-pcr
sendai
dequenching
octadecylrhodamine
zg
zsf
nh4cl
lumen
fusogenic
diffusion-controlled
ghosts
preconditioned
13q14
clls
ror1
cirmtuzumab
mir-15b
ansamycin
19-allylaminoherbimycin
thiol
2-mercaptoethanol
thin-layer
o-n-butanoyl--o-isopropylidene-alpha-d-mannofuranoside
g-o-n-butanoyl-dl-xylitol
f-o-n-butanoyl
-o-isopropylidene-dl-xylitol
promyelo-metamyelocytes
maturative
hydrolysed
drug-independent
chemosensitising
clove
syzygium
aromaticum
merrill
crategolic
oleananes
ursanes
nanobiocomposites
functionalization
jacalin-conjugated
nanoconjugate
jacalin
galβgalnac
g4
fitc-labeled
aunpsjacalin
nanoconjugates
dls
entropic
aunpsjacalin-fitc
nucleoside-specific
widely-expressed
employs
tightly-bound
saenta
fluorescein-stained
tki-
developmental-specific
tardis
i-targeting
willmore
drug-stabilised
i-dna
visualised
cooled
slow-scan
stabilise
encephalitis
glial
dbp
mimetic-resistant
tpf
neoadjuvant-treated
akt-mediated
drug-mediated
cisplatin-mediated
epidoxorubicin
edox
doxm
doxh
edoxm
hemoglobin-containing
morpholine
beta-thalassemia
5-aza-2-deoxycitidine
adrenoceptor
reticulate
hyperpigmentation
triepoxide
kb-7d
kb-tax
1-beta-d-arabinofuranosylcytosine-induced
ribozymes
ribozyme
brachycephaly
midface
synostoses
coronal
metopic
sutures
four-finger
radii
baller-gerold
fronto-orbital
mid-face
retarded--neurodevelopment
units-granulocyte
cfu-cs
4-hcvp-16
s-odns
lo-vodxr
s180dxr
kbchr
s-odn3
lovodxr
s-odn1
atheromatous
obliterative
recluse
panoramic
addictive
achilles
anti-adhesion
anti-stromal
taxane-based
bis-aryl
drug-binding
¹²⁵iiodoarylazidoprazosin
¹²⁵i-iaap
abcb1-overexpressing
k562abcg2
8226mr20
masks
ikkα
triepoxyde
shrub-like
vine
trypterygium
twhf
nf-κb-regulated
ikkβ-selective
ps-1145dihydrochloride
mln120b
bms-345541
lc-1
dimethylamino-parthenolide
dmapt
ato-c
ku-812
meg-a2
kcl-22u202fcells
foxoa
myc-
e2f1-target
meg-a2-derived
subcloned
phorbol-12-myristate-13-acetate
promoter-reporter
trans-activation
ii-directed
10-
zn
tetrachloride
metalloporphyrins
cos-7
fibroblast-like
limonoids
toonacilianins
a-j
norlimonoids
toona
ciliata
henryi
meliaceae
positive-slope
drug-sequence
cyhu
huamsa
drug-sequence-dependent
17aag
pharmocodynamic
stabilisation
pragmatic
viewpoints
upheld
roentgenologic
uracil
oldunfit
ic27
unbound
hdara-c
single-drug
bxp-34
bcrp-
amkbl
par-1
annexin-v-propidium
pan-cadherin
h3-k4
hematologiocal
helichrysum
zivojinii
soška
broad-acting
q13q14
3qq23
imatinibresistant
k562iii
non-ionic
oligonucleoside
methylphosphonates
calpain
er-located
mathematicalxa0model
steeper
supplementing
optimizations
uncompromisingly
mid-1970s
arabinosidetomice
premedication
fractionating
humulone
brewing
hemidesmus
indicus
3-d
precisions
11β-hydroxy-13-chloro-eudesm-5-en--olide
inula
helenium
eudesmanolides
germacranolide
jagged1
delta1
ligand-coated
stroma-mediated
culture-plates
methylationacetylation
sar302503
cytokine-containing
jak2stat5
bone-targeted
dose-limited
bone-homing
dose-regimen
drtox
pharmacokineticspharmacodynamics
pkpd
mtd-regimen
mixed-effects
phorbol-12-myristate
p39tsu
p31fuj
retinoid-related
subnuclear
promyelocitic
sumo-1
liter
mcl-l
bak-
myricetin
dal
ethnopharmacological
synthetically
bacteriocidal
uni-directional
p-glyco-protein-pgp
p-gly-coprotein
elaborated
p2y12
dabigatran
piloting
citarabine
recombinational
recombinagenicity
recombinagenic
that--despite
cancer--a
blood-forming
guglielmos
reticuloendothelial
radiomimetic
permeability-related
shortcoming
detergents
domain-exhibiting
fcs
cholera
ganglioside
gm1
nonraft
decidedly
diffusional
mobilities
methyl-beta-cyclodextrin
misfolding
anticoagulant
anti-xa
nafamostat
acquisitionn
chemo-resistanr
well-definedn
isoformn
chemotherapeuticn
drugsn
drugn
opn-related
opn-b
chemotherapyn
regimen-induced
concurrentn
aktvegfcxcr4stat3
opn-bn
mrdn
quantative
samplesn
paclitaxel-resistance
ec109ptx
tw37
two-inhibitor
mef2c-dysregulated
clusterearly
negative-2a
cd1
coall-97
18mer
anti-myb
32p-oligos
anti-cd32
anti-cd2
antibody-linked
peg-ifnalpha-2a
ifnalpha-2a
withdrawals
qi
nourishing
sqnych
7q22
orthologous
synteny
5a3
loxp
5a3fl
7qa3
bci-2
arrest-induced
multi-site
s70
serine-70
s87
threonine-69
t69
endoperoxide-containing
art-838
88-fold
nod-scid-il2rgnull
8h
primagrafts
gcts
pxd101
suz12
hdac-2
p300cbp-associated
k9
k27
cebpε
pik3cd
p110δ
puquitinib
lysophospholipids
aalp
bn
temperature-independent
tdr
egfr-mutant
non-intuitive
2-phenylaminopyrimidine
cgp57148
as3mt
elaboration
t-leuk
nongermline
mutator
oesophageal
sorafenib-taxotere
gk2
akg
kkp
nci-n87
ig50
map-kerk
p-bad
48-hr
antityrosine
multidiploid
docetaxel-sorafenib
oxysterols
beta-hydroxycholesterol
beta-oh
25-hydroxycholesterol
25-oh
dohh2
k422
typifying
100nm
bench-to-bedside
avidity
researched
coptidisxa0rhizoma
multi-domain
cr-induced
fsf
cerubidyne
desmofibrin
pluripotential
ahaematological
cd38xa0antigen
anti-cd38xa0monoclonal
anti-cd38xa0mab
anti-cd38xa0possess
anti-cd38xa0mabs
back-bone
axa0part
cd38xa0targeted
cd20xa0targeted
axa0subset
leukemiaxa0-
cd38xa0-
daratumumabxa0-
isatuximabxa0-
rewired
glul
pantothenic
sensitiveresistant
grb-2
p21ras
non-functional
lovastatin
inf-alpha
saiboku-to
syoseiryu-to
ogon
koboku
kanzo
mao
rp-hplc
lt-synthesis
mdi
picolinate
oci-m2
cell-substrate
hl60-injected
urologic
urologists
nonionic
i3c
tfh
bcl-2bcl-xlbcl-w
noxa-dependent
pervanadate
shp-2
k-sensitive
gelation
cross-react
type-beta
fr-beta
phosphatidylinositol-specific
nitrous
deglycosylation
nonfunctionality
jf
cho-fr-beta
fr-mediated
folate-coated
f-l-calcein
f-l-dox
fr-beta-expressing
l1210jf
l-dox
atra-facilitated
kcl22u202fcells
lv-sfrp2
lv-control
coip
wnt1
wnt3
coip-ms
generality
modernization
recombinations
respirator
aml1-eight-twenty-one
aml1-eto-targeting
hdaci-treated
drug-targeted
determinate
redeployed
contraceptive
lipid-regulating
non-oxidative
cglutamine
emphasised
refractorines
eukaryote
signle-stranded
formalized
mascc
non-oncology
p-gp-
daunorubicinrhodamine123
ms-209
mdr-reversing
daunorubicinrhodamine
atcs
essesvi
pre-consolidation
egfr-driven
bim-independent
deletion-containing
deletion-mediated
thrombography
bisantrene
bishydrazone
extrahaematological
bisantrere
ochroconis
gallopavum
dactylaria
gallopava
darkly
pigmented
sabouraud
mycological
drugschemicals
postmitochrondrial
ficoll-hypaque-separated
substrate-induced
aminopyrine
aniline
troughs
na-butyrate
nabu
dibutyryl-
bu-camp
antiserum
persistance
near-haploid
28xyt
near-haploidy
multi-omic
smarca4
highxa0smarca4
anthracycline-sensitive
digitized
hydrophobichydrophilic
membranecytoplasmic
two-compartment
folch
sra1
sc35
lipoatra
anti-apl
zeylanicum
macrophagemonocytic
titrations
late-acting
differentiation-like
caspase-3-independent
caspase-2-
3-mediated
wounded
pyrs
toxicosis
170-kd
mdri
valspondar
1-beta-d-arabinosyl
delta-aminolevulinic
naphthoquinones
nq
heterocycles
h-triazoles
glycosidase
h-triazole
cores
-furanonaphthoquinones
-fnqt
12o
12b
three-fold
enormously
sto
χ138
χ390
coulf
agp2
dur3
sam3
permeases
agp2δ
caenorhabditis
elegans
ceoct-1
unknotting
georgian
gelled
warmed
cm-treated
donors--2
nk-sensitive
nk-resistant
t-24
obtundation
dol
scintillation
jaksignal
deacetylasedna
pi3k-inhibitors
halting
6-mercaputopurine
anthracycline-type
cbdca
microrna-21
40u202fcml
mir21
intermediaries
relaying
duality
lyn--
lynupup
receptorintegrin
bcll
liriodendron
tulipifera
cd-200
tunel-positive
4-azaindole
plx51107
bet-inhibitory
ketoreductase
antinuclear
cytomorphologically
fluoride
phagocytoses
insidious
paramyeloid
dsrna
dnmti-treated
ifn-stimulated
oas-rnase
oass
oas1
jnks
l-dependent
l-induced
aza-induced
edits
pde12
akap7
ifn-dependent
mcgr
skepticism
hlg
protein-ligand
rescored
δg
gromacs5
drug-bank
db07107
db06977
st013616
db04200
st007180
st019342
db01172
72xa0h
noncalcemic
19-nor-oh2d2
paricalcitol
apl-related
zn2-inducible
pr9
d-hydroxylase
co-administrating
clitocine
studywe
clitocinetrail-induced
trail-based
gcs-100
gcs-100abt-199
gcs-100abt-737-induced
gcs-100abt-737
radiolucent
renoureteral
ureteral
alkalization
g24
policy-makers
deterrent
therapy--therapeutic
index--is
lc90s
rhd
rhd-defective
k83n
n109d
suffice
rt-pcris
cml-bt
flavobacterium
bcl-b
polyubiquitinated
bh1
bh2
k128
k119
k120
k181
k48-linked
linkage-specific
lysineless
nonubiquitinated
c-glycosides
isatis
indigotica
indole-3-acetonitrile-4-methoxy-2-c-β-d-glucopyranoside
n-methoxy-indole-3-acetonitrile-2-c-β-d-glucopyranoside
mata
aplidin
l-carnitine
myotoxicity
four-
crossresistance
am7577
transferrable
symptomsmortality
factorinterleukin-3
diseasedeath
arabinosyl-2-fluoroadenine
antisignalling
ara-c-sensitising
dimethylthiazol-2-yl-5
diphenyltetrazolium
tyrphostin
a48
nordihydroguaiaretic
ndga
ara-c-sensitisation
sensitisers
sensitisation
beclinxa01
stroma-free
ltc
aml-ltc
vw-mri
concentric
atherosclerosis
revascularization
nilotinib-associated
prostacyclin
dc-pgi2
5-aminoimidazole-4-formamide
ifn-α-2b
ptks
crosslinkers
tether
ligand-inducing
vivo-expanded
ul16
cd3γδ
effector-to-target
4-o-benzylated
wp744
tighter
rts
bulbar
muscular
hmtases
rar-pml
rar-plzf
mistargeting
proms
nucleo-cytoplasmic
radio-labelled
lycium
β-hexo
etoac
5-hmf
heuristic
palsy
auricles
paramyeloblasts
dysrhythmia
del10
q11q12
perforation
duodenal
are-c
rhg-csf
nk-cell-activating
contact-dependent
noncytolytic
cd3ζ
developmentacceptance
stereotyped
hbeag
allo-mud-pbsct
seroconversion
tp21q23
eht
caspase-driven
caspase--
s139-posphorylation
ultra-small
lymphatics
ly6chi
ly6g-
skin-draining
mc-tg
post-injection
eg7-ova
ly6clo
gr1int
mo-
mdsc-depleting
ova-specific
ova
over-the-counter
analgesics
leukopenias
leucomax
sandoz
benign-phase
shengma
biejia
msbd
ydtss
glycochenodeoxycholate
gcda
methylxanthines
abducens
chemobyl
radiation-associated
bcl-21
effluxes
igg-melphalan
k-18
gpt
cebpα-mimetics
amantadine
anti-parkinson
monocyte-macrophage-like
amantadine-dependent
pro-il-1
anti-il-1
il-1-mediated
il-1-induced
lining
silvestrol
mir-99
mir-143-p3
mir-146b
mir-181c
mir-4786
mir-98
mir-128b
mir-1208
als
dandelion
negotiating
apoptosis-suppressing
dominant-inhibitor
posaconazole-associated
ld-vp-16
ld-vcr
ch-11
ld-anticancer
vcp
sums
broad-range
gg120918
vx710
furtive
nanoparticular
hemophiliacs
exonuclease
rias
serums
rits
rg7787
mesothelin
recombinantly-engineered
exotoxin
nab-paclitaxel
anti-msln
catalytically
non-msln
rg7787-mediated
rit-mediated
taxane-mediated
cfu-m
cfu-g
barbarum
gene-rearrangement
lozenges
colonization-resistance
nasogastric
lsc-like
cd34u2009u2009cd38-
lscs-targeting
monoblast-like
1-b-d
trans-ra
3-independent
break-point
solvation
enzyme-inhibitor
energetic
met318
ba2
crac
monovalent
voc
cordycepin
g2-m-phase
bh3-
smac-mimetics
smac-mimetic
ciaps
braf-inhibitors
alexanders
mdt
drug-addict
iridaceae
eluate
halogenated
120-hour
ailanthoides
zac
pheophorbide-a
pheophorbide-b
2-hydroxyl
-r
dolastatin
growth-factor-stimulated
dolastatins
12-o-tetradecanoylphorbol
bryostatin
i3-o-r
cosy
hmqc
hmbc
interrupts
rhdhfr
dtpa
dtpa-mtx
111in-labeled
pretargeted
111in-dtpa-mtx
nonconjugated
111in-dtpa
radionuclide-labeled
norastemizole
ni2
alfa-2
switch-control
particulate
extravasate
gene-silencing
dispersing
interfer
alcaloids
anti-hormonal
womans
45xa0
plurality
ed50s
ara-chmba
equipotency
graft-versus-myeloma
graft-versus-breast-cancer
inhibititors
ligand-expressing
microns
equivalently
fibrodysplasia
ossificans
progressiva
fop
ultrarare
ossification
re-purposed
flare-ups
hif1-α
pdgfrα
his113his
dnas
wash-out
auclast
bioequivalent
sevenfold
prioritizing
weisenthal
all‑trans
naphthoquinone
zi
cao
concentration‑
p‑p38
p‑p38mapk
p‑c‑jun
p‑jnk
p‑erk
c‑myc
non-suitable
anthrapyridazone
bs-121
redox-state
density-induced
anthrapyridazones
c-123
clastogenic
initiationpromotion
cisplatins
leukemogen
cisplatin-treated
xa030
d835n
rationalised
protein-drug
drug-bound
onco-
stk11
xq
mir-424
vegfvegfr
epipodophyllotoxin-related
often-a
catechol
ccls
p-sites
contextualize
pgr
raloxifene
ak1
pentapeptide
lh
donkey
hydrolysates
slopes
carry-over
d10
freezing
pre-cfuc
predetermination
penfluridol
oncostatic
3-hydroxy-3-methylglutaryl-coa
myristoyl
gliptins
epigenetically-based
comedications
zol
kolmogorov-smirnov
mpf
mesf
watson-crick
base-pairing
non-mrna
phosphorothioates
tyrode
dmem
diluted
reculturing
24u2009h
anti-ova
bis1h-indol-2-ylmethanones
methanones
methanone
17b
epoxyketone-based
onx
β5
β5i
β1i
β2i
β5iβ5
β1iβ1
β2iβ2
absorbable
septicemias
fl-prazosin
naphazoline
oxymetazoline
benoxathian
4gr-6grm2
5mcgkg
r4
jsh-009
kinasesmutants
cdk9-mediated
catalysis
imatinib-mesylate
tdz
af6
neuroleptic
frat
frat2
dvl
chopxa0cyclophosphamide
ic90
suv
headgroups
mlvs
suvs
ph-dependent
freeze-fracture
asnase
jurkate
cemo
cemara-cgasnase--1
cemara-cgasnase-
txr
fit-1fc
flt-1fc
10pgml
microphotography
cemara-ci
iuml
erbstatin
tyrphostins
piceatannol
precipitating
non-atn
tricentric
intermittently
mcvs
reticulocytes
expels
cd34low-
non-sp
diabetic--severe
ruthenium
procreation
organogenesis
dexniguldipine
dnig
felc
pulsechase
80-kda
laks
lysability
plasmaphereses
dystrophic
aminoacid
aminoacids
quotient
valleuilephetyr
emergencies
transversal
niño
dif
folinic
drugsinpatient
four-hundred
cadm1
anti-microtubule
ubx
originators
em-2
ap180
clathrin-mediated
epsin
monolayers
lattices
ap2
pits
pan-bh3
pan-cdk
drug-naïve
bimel
biml
biknbk
flavopiridolobatoclax
inexorable
silverman
30-question
reducingskipping
food-drug
well-educated
nu2009u200962
forgetting
skipped
misunderstanding
vinflunine
lipaseamylase
acd
p388
par-p388
mdr-p388
resistance-modifying
rmas
140-fold
rma
acd-sensitivity
mitoxantrone-treated
oxindole-1
ox-1
cdc2cyclin
polyploidy-inducer
zm447439
zm
polyploid
acetaldoifosphamide
bis-acetate
aldoifosphamide
carboxylate
pkmts
f-inducing
over-activated
divulged
ato-plus-aprepitant
senescence-suppression
senescence-promoting
sensible
senescence-based
triptonide
12nm
kinase-3p38
multiple-hits
unit-leukemic
single-cycle
f23
-hydroperoxycyclophosphamide
cfu-granulocyte-macrophage
mo-conditioned
cresting
dcc-2036
siramesine
primaquine
tafenoquine
tafenoquine-
mefloquine-induced
tafenoquine-induced
pdb
md-
pmlretinoic
alphapml
liposomally
lipo
b6c3hf1
blunt
-dihydroxy--bis
-hydroxyethyl
aminoethylamino-
adj-pc6
sinai
aspartate-specific
casp-3
casp-4
casp-6
casp-2
bcl-2-transfected
casp
cs-ii
pbms
nai
na-pump
ouabain-sensitive
3h-ouabain
ouabain-binding
sn-1
dominant-negatively
myeloiud
pbt-3
re-established
anti-mirna
amos
aunp
kgn
amo
heartwood
caesalpinia
non-growth
left-shift
lsmp
right-shift
rsmp
affections
erythremia
lenght
scrutinizing
calcium-induced
serca-dependent
tbhq
cyclopiazonic
nb4-derived
differentiation-induction
top2-based
-dimethylbenzaanthracene-treated
top2beta
skin-specific
top2beta-knockout
top2beta-dependent
top2beta-dna
top2alpha-dependent
top2alpha-specific
sulindac
gadd45α
mapkjnk
jnk-inhibitor
fra-2
myocarditis
ligand-based
drugbank
quiescence-associated
diminution
re-entry
resupplementation
apoptosis-inhibiting
crl4
crbn-binding
cc-122
cc-220
linker-based
alpha-ts
cml--and
phases--are
axa0wide
volume-activated
vbl400
fluo3
tonicity
outwardly
rectifying
i-
cl-
nppb
volume-sensitive
stat5-dependent
dt-061
myristoylated
t58
t58a
βphosphorylated
pim-1lpim-1s
s95s4
inhibition-dependent
gsk-3β-mediated
20nm
mito-treated
colc
colchicin
mechanotype
deform
constricted
deformation
timescales
milliseconds
occluded
fabricate
elastic
modulus
sclcs
torc
bim-mediated
cousin
bombay-type
manitol
anti-h
galangal
neutraceuticals
iodinin
-dihydroxyphenazine
-dioxide
actinomycetes
mutateddeficient
dna-strand
aml-patient
cardiomyoblasts
replenishing
pma-evoked
ssat
ornithine
decarboxylase
c-beta
dx-
u-2os
dx-resistant
saos-2dx-resistant
u-2osmtx-resistant
coamplified
preexistent
p2x7
p2x7r
p2x7ra
p2x7rb
disease-promoting
hek-293
facilitation
az10606120
armistice
singled
epi-podophyllotoxins
romanowsky
unremitting
somber
cardinal
recourse
acumen
skillful
monocyte-colony
downside
cytarabines
pancreas-related
retinyl
chylomicron
c-all
retinol
digoxin
pxde-n-hydroxy--phenylsulfamoylphenylprop-2-enamide
hmti
3-deazaneplanocin
dznep
5r-4-amino-1h-imidazo-cpyridin-1-yl-3-hydroxymethyl-3-cyclopentene-1s2r-diol
inductor
eed
hyperacetylated
biscoclaurine
cepharanthine
neutrally
electronegative
heralding
overwhelm
abl-positive
precipitously
half-time
curb
receptor-bound
protein-2
y177
pamidronate
geranylgeranylation
3h-dthd
dthu
deoxyribonucleotide
triphosphates
wehi-3bcpx
ii-dependent
hettmann
didonato
karin
leiden
ogasawara
suda
nagata
vallejo
weyand
gronzy
yajima
akashi
traver
miyamoto
weissman
kaufmann
findley
gu
yeager
zhou
dis-regulated
tumourigenesis
pre-requisite
p-gpabcb1
weaken
nanotechnology
reagins
self-potentiation
-difluorodeoxyuridine
fixed-dose
instillation
gemcitabines
rationales
prexasertib
-beta-d
glucan
beta-d
500microliter
2-test
hdac-inhibiting
bcrabl-targeted
rosy
pesticides
resource-poor
label-lmic-coined
capita
proliferates
ditercalinium
7h-pyridocarbazole
bisintercalation
monointercalators
stathmokinetic
froze
monointercalating
mid-1987
cmk-7
stim
twiser
gdna
precursor-b-cell
anti-il-6il-6
siltuximab
anti-il-6-based
il-6-targeted
mtz
eto2
atgccccag
atgccctag
caelyx
k562k
p-glykoprotein
p-gp-expressing
k562dnr
k562vcr
k562nov
k562ida
chromatograghy
bence
vadastuximab
talirine
carbon-carbon
ky-821
ky-ra
ky-vcr
ky-mtx
nil-1
acquirement
lysines
phosphorylationubiquitination
noxamcl-1
benthic
chemotherapy-resistance-associated
ledgfp75
m44
culturable
nf
lipid-substituted
co-delivered
rps6ka5
mda435
mcl-1rps6ka5
well-selected
synergestic
hypotention
anthracycline-like
cis-platine
subadditively
mds-and
aml-with
mezerein
mezerein-differentiated
tumoristatic
pma-differentiated
pdthp-1
macrophage-mediated
alloantigens
€
emea
equate
re-engineering
drug-like
ium2
white-cell
dnr-vcr-ara-c
ninety-nine
tretinoin-loaded
uvc
lipid-core
uva
caloric
mod3
okm1
okm5
secretions
chemoradio-resistance
exosomes-loaded
exosome-based
parkinsons
gtg-banded
pisosterol
8q24
hsrs
doxorubicin-transferrin
dox-trf
endo
formamidopyrimidine-dna
fpg
dna-ladder
annexinxa0v
sj-n-kp
imr5
af-8
sk-n-sh
sk-n-be
p50
anti-nb
photoactivated
pmc540
photoproducts
non-receptor-dependent
c1-induced
uppsim
bryo
12-o-tetradecanoyl-phorbol
josk-i
josk-m
tpa-
stromal-protected
stromal‑mediated
β‑phenylethyl
saha‑upregulated
saha‑mediated
cardilopin
deglutathionylation
co‑cultured
sahapeitc
nscs
hb1f3cd
hb1f3cdifn-β
5-fc
trans-well
migrated
existent
rocaglamide
aglaia
khat
catha
edulis
forsk
rubrolides
terreus
h1n1
sulfonamide
retreating
htc
ds19
butanol
cinnamic
p-flt-3
17-allyl-amino-demethoxy
polyubiquitylation
im-refractory
recombine
scaffold-associated
t-amlt-all
d25
incb059872
pro-seq
corest
gfi1-regulated
gfi1gfi1b
lineage-negative
non-smokers
factor--tlco
tlco
kco
fev1
airflow
fev1vc
receptor-a
non-rara
pml-rara-associated
ara-c-sensitive-all
6x
lenolidamide
5-fu-induced
glycyl-glutamine
hasten
mitochondria-specific
inductionrelapse
preexposed
thymoquinone
proteinwe
gzd824
pan-pi3k
byl719
p110γp110δ
ipi145
pathwayzstk474
mannerthese
pt-based
rpmi8226
imatinib-selected
nippon
shinyaku
shionogi
toko
saporin
saponaria
intoxication
intoxicated
5-aza-cdr-induced
5-aza-cdr-mediated
reexpress
affirmative
cx3cr1
ccrl2
emr1
gpr114
p2ry2
p2ry13
lphn1
gpr125
celsr3
gpr126
f2r
f2rl1
frizzled
fzd6
hdarac-containing
hexokinase-ii
hk-ii
bromopyruvate
3-bp
multi-fold
y371h
kit-induced
hyperresponsiveness
cbl-dependent
hexokinase
desirability
pathognomic
nephrogenic
ndi
antidiuretic
panduratin
roxb
pma-stimulated
alu-poor
j0443
presentgstm1
nullgstm1
constructure
5-o-esters
2-deoxyadenosine
2-chloro-2-deoxyadenosine-chlorambucil
2-deoxyadenosine-chlorambucil
5-o-ester
methanesulfon-m-anisidide
chh-1
add11q23
tumor-forming
pyrrolo-aquinoxaline
-4-substitutedpiperidin-1-ylbenzyl-phenylpyrrolo-aquinoxaline-carboxylate
1a-l
u266
a6730
1e
1g
hydroxylxanthones
benzoxanthones
-trihydroxy-12h-benzob
xanthen-12-one
l02
antimetabolic
uridine-cytidine
inosine-5-monophosphate
ff-10501
ribosylmonophosphate
ff-10501rmp
iron-mediated
ii-poisoning
etoposide-triggered
etoposidestimulated
hl-5
etoposidetriggered
polyadp-ribosepolymerase
butyrate-responsive
splenectomized
osthol
apiaceaous
sciencedirect
osthols
spotlights
luffariellolide
gypenosides
gyp
atf6-α
atf4-α
segmentation
cytoplasma
negligibly
drug-membrane
vitally
enucleated
folates
methylxanthine
bl-th
un-stimulated
4-hydroxy-ra
4-oxo-ra
4-hydroxyphenylretinamide
dosedependent
ch55
am-hpr
retinoylation
czbg
no-drug
ic70
2-d
baculovirus
m21
tr3a
tf-mediated
59fe
pms
supraadditive
non-interactive
physic-chemical
sirt
myelofiblosis
tranfromation
jak2stat
sirt1-binding
penicillamine
if-enhanced
abk562
dihydrocytochalasin
h2cb
phi-mediated
filaments
phi-abk562
pseudopodia
apposition
mtoc
microtubule-depolymerizing
monensin
cjx1
ver-stimulated
cjx1-stimulated
tetrandrine
isobolographically
fixed-ratio
fixed-ratios
tedizolid
isr
triplet
garuana
euphorbiaceae
thromboxane
cyclooxygenase-1
cox-1cox-2
atraas2o3-induced
atraas2o3-treated
pha-767491
cdc7
sectioned
pha-
overlooking
lipid-laden
pulsating
pemf
post-exposure
ph-value
sti571-induced
apicidin
ms275
mitocans
mitocan
cccp
prostatectomy
abiraterone
60th
hypercatabolic
drenching
doxr
baalc-expressing
dbn1
actin-binding
spines
drebrin1
baalc-dbn1
baalc-activated
nkm-1
16-h
g-csf-stimulated
3hetoposide
g-csf-responsive
vegf-expression
mtor-targeting
vp-16-resistant
subculturing
thp-1e
18-fold
pkhs
toto-3
emitting
daunorubicin-treated
reprotoxic
miscarriages
4-amino-1-β-d-arabinofuranosyl-h-pyrimidinone
components-sterile
powder-are
unpackaged
high-field
freezer
syringes
vials
aliquots
mycmyc
humanmouse
haptenation
dinitrophenyl
dnfb
compound-specific
2d-page
nfkb
hapten
dryness
clofarex
bio-envision
ilex
clofarabines
junctures
bioenvision
co-marketing
wholly
ilexs
us1
genzymes
ferro
pfanstiehl
bioenvision-sponsored
39th
asco-2003
biov-111
postinhalation
polylactic-co-glycolic
mps
sirna-loaded
clsm
hca
anti-tnfα
sirna-mps
psoriatic
arthritits
antipsoriatic
crisantaspase
pegc
ven-pegc
ven-azacitidine
pegc-mediated
4ebp1
eif4e-4ebp1
cap-binding
mechanistically-rationalized
-chloro-oxo-4-phenyl-cyclobutyl-quinoli-8-yl-oxy
hydrazide
cqah
annexinxa0vpropidium
cqah-mediated
camptothecin-11
position-4
azetidine
loquat
lte
polyadpribose
baxanti-apoptotic
actinidia
arguta
hardy
kiwi
rae
anti-cca
arsenic-combined
lymphoma-derived
o₂⁻
arsenitehydrogen
arsenitecape
livedead
calceinam
carboxyfda
quantitating
recognise
stagnancy
enflam
pgp-related
downmodulator
area-under-the-curve
bilirubine
csa-treated
r140q-mutated
genesproteins
genemania
kbm7-mu
medium-based
kbm7
6u2009fa
ctc1
fcrla
got1
lpr5
m1ap
map2k5
lyrm9
rediscovery
persister
cpts
l-mp
uninsured
caseload
subsidized
mophs
retinopathy
taf273
sprouting
chorioallantoic
quassinoids
jasmonate
jasmonates
methyl--didehydrojasmonate
29-fold
hbo
hif-1a
transgenesis
scrotal
paralytic
ileus
suction
autonomic
butyroyloxyalkyl
butyroyloxymethyl
glutaric
diethyl
butyroyloxyethyl
10b
acetaldehyde
formaldehyde-releasing
ic50ed50
underpinned
macop-b
bcepp
promace-cytabom
contradictions
overemphasized
gsls
arglabin
micheliolide
cd34⁺cd38⁻
dmamcl
dimethylamino
ample
anti-csc
phytosphingosine
as2o3-resistant
thiol-containing
-dihydro--1-piperidinylbutoxy-h-isoquinolinone
parp-1small
mapk-mediated
nonredox
a4c
flap
mk886
e2f1-mediated
р73
р53
δnp73
tap73
e2f1p73
polyamine-metabolizing
hcmv-infected
тнр-1
dox-treated
mdl
δnp73тар73
collagen-based
units-megakaryocyte
methylcellulose-based
brentuximab
vedotin
ado-trastuzumab
emtansine
terracina
paralias
caco2
iec-6
terpenes
terpenoids
apolar
ferric
5-hydroxytryptamine3
free-drugs
dhm
hl60a
aml1-eto-c-kit
chemodrugs
multi-drugs
akt2
promonocytes
β2ar
ser474
hplc-msms
concentration-dependently
bronchial
sideroblastic
aisa
alip
contra-indicated
sunitinib--targeting
c-kit--a
tryptanthrin
-dihydro--dioxoindolo--b-quinazoline
naturally-occurring
ban-lan-gen
jcs
tryptanthrin-treated
rewire
ascorbate
kf-19
neutrophil-
stimulations
kf-19arac
kf-19adr
kf-19vcr
presynthetic
subdiploid
deceleration
ccis
malawians
qech
carcinogenetic
7qter
7pp11
14qter
pseudolymphoma
methotrexate-induced
malignomas
agent-induced
dna-mismatch
misrepaired
mopp-based
granulocyte-colony-stimulating
polygonum
ph-indicator
adb
-diacetoxy--dicyanobenzene
dna-dye
aml-marrow
g2m-phase
arthralgias
enthesopathy
sacroiliitis
spondylarthropathy
hla-b27-positive
hla-b27-associated
spondylarthropathies
insonified
albumin-stabilized
bubbles
sonochemical
99mtc-mibi
thorax
mibi
tumour-to-background
carrots
β-carotene
polyacetylenes
carrot
anteroposterior
cofactors
meis
hox-pbx
t3m4
mjt1
non-cancerous
9-amino-acid
hoxpbxdna
16-amino-acid
16-carbon-acyl
coatings
phema
biofilm
surface-tethered
linkers
regenerated
amination
species-dependent
synthase-mediated
poly-adenosine
pegasys
peg-ifn
ifn-alpha-2a
methoxypolyethylene
preapoptotic
ensuing
sphingoid
sphinganine
mutz-2
mse
tartrateresistant
proliferatively
p13q11-q12
factor-responsive
nanocapillary
cief
uv-activated
pgnl
ptyr207-crkl
ptprccd45
renieramycin
mcl-1-
bcl-2-targeting
tm---18
tm---4a
kinase-targeted
d816v-blocking
cytomery
rh-il-3
rh-gm-csf
nicergoline
a-loop
instill
abl1-targeted
asco
under-dosing
heaviness
scrutiny
cgp57418b
apo-1-mediated
sd1
cryopreserved-thawed
non-splenectomized
microdissected
target-mutant
d816v-targeting
d816v-positive
surface-bound
c3c
opsonization
intersegmental
isv
subintestinal
siv
vegf-induced
aktenosno
2-pyrones
sub-units
2-pyrone
5-bromo--hydroxyprop-1-ynyl-2h-pyran-2-one
pyrone
5u-6
5u2009×u
cdk2-
cdk4-
cdk6-associated
p-raf
p-pdk
p-pten
wehi-3bd
9-treated
probe-target
alexa
488-dasatinib
488-dasatinib-abl1
micro-wells
pc-spes
lml
ed043
cebpepsilon
prodifferentiative
bardoxolone
drug-combinations
stat5-targeting
heme-oxygenase-1
heat-shock-protein
sub-clones
t315i-compound
emanated
lymphocytotoxicity
rotational
chdt
oligomerization
evodiamine-induced
compelled
n-cadherin
icam
hike
shattered
ccaat-enhancer-binding-protein
n-ethyl
nitroso
antiperoxidase
relaps
wasnt
s645p
mortem
z-val-ala-aspoch3-ch2f
caspase-3-specific
z-aspoch3-glu-val-aspoch3-ch2f
seifem
sorveglianza
epidemiologica
infezioni
fungine
nelle
emopatie
cytoenzymochemical
purinethol
endoxan
vinchristine
latic
reinfecting
anti-parasite
aml-bfm-78
aml-bfm-87
induction-consolidation
efi
thiazole
reactive-oxygen
index-isobologram
lscs-like
recombination-associated
recombinase-mediated
rearrangements-a
20-kb
hprt
bcl2igh
non-lymphocyte
before-etoposide
x107
non-lymphocytes
x108
t-bearing
etoposide-based
adzuki
hwea
byproduct
boiling
ag-stimulated
etex40
ca²⁺
ca²⁺i
suppressions
sialylation
α--sialyltransferases
st3gal1
α-
disease-progression
apoptosis-mediators
dapk1
promoter-demethylation
f-mel
favoured
leukaemia-aml
leukaemia-all
lymphoma-dlbcl
cm-272
interferon-stimulated
g9adnmts
chemosensitivities
rsk
dephosphorylations
carcinoma-bearing
3-methylcholanthrene
fungoides
autopsied
intravascularly
cirrhoses
erythroleukemias
thorotrast-administered
non-thorotrast-administered
annals
coptis
dna-synthesis
n-acetyltransferase
af-dna
n-acetyl-2-aminofluorene
aaf
n-acetyl-p-aminobenzoic
n-ac-paba
paba
hypnotics
antipsychotics
systeme
données
santé
snds
midi-pyrenees
pre-cml
prescription-f-tki
f-tki
pdxa0initiation
consultations
cytodifferentiating
autoinduction
exporting
transporter-mediated
polyether
fourniers
resuscitation
globularifolin
acylated
iridoid
-200
pha
hiroshima
azurophilic
diploidy
d-cs-sb
mek-1
p-thr286
thr202tyr204thr185tyr187
p35nck5a
cdk5
co-operating
p35nck5a-activated
trifluoperazine
ca2calmodulin-dependent
a47
hesitancy
enumerating
chemosensitisation
haematolgical
thoc5
tho
y225
motile
1000-fold
mitomycin-c
amethopterin
locomotive
k562-wt
k562-vinc
bak-mediated
freed
lqb-118
blindness
enophthalmitis
nystatine
ampho
5-flucytosin
unavoidable
omission
asxl1setbp1-mutated
alk5-td
asxl1setbp1
cclsg
pladienolide
pla-b
unspliced
indigofera
tinctoria
irisquinone
latea
pallasii
10-hydroxy
camptotheca
accuminata
ginsenoside
rh2
antimutagen
antipromotor
chemotaxonomic
hainanesis
taxus
mandibular
periodontal
temporomandibular
kaki
north-east
kv-1
ht-22
nonreceptor-mediated
cystine
imputed
cdd-transduced
gemcitabine-induced
gemcitabine-containing
cytocentrifuge
waldenstroms
icam-2
l-cam
revimid
actimid
pde-4
nonchemotherapeutic
esrd
rtx
inappropriately
evi1-mediated
heterochromatin-like
smis
antineoplastics
jeopardize
lc3ii
gate-16
autophagosome
chloroquine3-methyladenine
hl60-diff-r
endothelial-cell
ceramide-increasing
ultrasound-stimulated
kht-c
astrocyte
ultrasound-activated
2u2009gy
asmase
biomechanical
tracing
pre-determined
stemness-dependent
damage-response
zanguebarica
mtt-assay
extractml
repositories
countering
inhibitor-dominant
ono-4007
1d6
3b1
ono-
phospholyrated
imidazoline
3hrx821002
bmax
yohimbine
prazosin
adrenaline
phenylethylamine
guanine-nucleotide
g-proteins
clonidine
2a-adrenoceptors
agonist-induced
skf
nitrendipine
reemerged
lapachol
2-hydroxy--methyl-2-butenyl--naphthoquinone
vincristine-sensitive
my-4
harmed
cycle-independent
remission-or
radiotherapy-may
r-epo
ocim-i
67-kda
mistakenly
naranjo
organization-uppsala
antihistamines
byproducts
rhusxa0verniciflua
stokes
rvs
urushiol
allergenic
allergen‑removed
arvs
du-145
z-vad‑fmk
extract-induced
extracellular-regulated
wnt-signaling
vpas
pre-exposure
mitoxantrones
mitoxantrone-associated
flt3-expressing
siadh
lassitude
lobe
vcr-induced
acidxa0vpa
cytarabinexa0ara‑c
retrovirus-mediated
ara‑c
ara‑c‑induced
cy-induced
pause
zarnestra-farnesyl
unit-leukemia
vitis
vtt
grape
--vitisin
tetramers
b-induced
monoclonal-antibody-directed
qin-jiao
dahurica
gentianaceae
pharmacopoeia
tonsillitis
urticaria
phosphatase-2a
-dideoxy-forskolin
drugable
radiosensitized
lapatinib-adapted
starvation-induced
egf-stimulated
erbb1
death-promoting
xofigo
radium-223
223racl2
thorium-th
thorium-227
cd33-ttc
227th
multinucleate
hedysarum
ory-1001
h3k4me2
retinoid-induction
fr-targeted
drugs--including
epipodophyllotoxins--and
peliosis
hepatis
ectasia
blood-filled
lacunar
kbm3bu2506
p53-wild-type
bu4hc
bu4hcdac
p53-mutated
wattakaka
volubilis
ayurvedic
piles
leucoderma
boils
lymphoscintigraphy
metronidazole
fms-like-tyrosine
arabinofuranosyl-5-azacytosine
ara-ac
diastereomeric
furanose
monocytic-like
nf-e2-related
decitabine-increased
nadp-quinone
oxidoreductase-1
nrf2keap-1
undiscovered
thp-lncs
thp-t80-lncs
decitabine-loaded
thp-t80-lnc
stealth
folate-targeted
frβ
dope
malian
hopital
wasted
bio-energetic
detach
phophatase
baustinib
data-set
50xa0ns
understoodexperimental
miz1
c-myc-trail
hdaci-based
trialsconclusions
myrtol
teat
cisterns
udder
cereblon-dependent
crystallographic
degron
neosubstrate
fenretinide
apoptosis-based
fenretinide-induced
fumonisin
fenretinide-treated
ceramide-mediated
rnase-sensitive
menin
cross-reaction
s64315
hybridization-based
impoetant
bgc-823
imine
pei-complexed
cd33-expressing
ellipticines
isoellipticine
7-formyl-10-methylisoellipticine
7-formyl-10-methyl
ataxia-telangiectasia
a-t
vector-based
transformants
streptonigrin-resistant
pcat
17p11
radio-resistant
magnesium--a
hypochloremia
lysozyme-induced
parathyroid
pth
pth-like
cyclophosphamide-
l-asparaginase-induced
hypoparathyroidism
nonreabsorbable
tx-induced
militaris
overexpresion
lovo109
d-isomer
dvrp
epipodophylline
pre-mir-21
anti-mirna-21
pdcd
coinfection
insisted
japan-made
staggering
1-phase
2-phase
inviolate
flaws
naphthol-asd-chloroacetate
pterocarpanquinone-lqb-118
k2
esterase-positive
monocytemacrophage-like
5xa0µgml
5xa0µm
economists
insurers
acetonitrile
formic
c18
20min
mlmin
pbpk
drug-disease
ddzi
renally
perforating
folliculitis
pinpoint
infundibular
il-7-dependent
alpha-particles
il-7
tyroxine
dermatofibrosarcoma
protuberans
fipili-pfgfra
terfenadine
strophanthidin
budesonide
halcinonide
mometasone
postdiscovery
countless
snuff
derivatives--vinblastine
electro-osmotic
polynipaam
softer
life-table
anll-
anll-9205
anll-861
nbq-2
a431
nbq-59
benzazolo
technetium-99m
sestamibi
99mtc-mibi-peg-liposomes
peg-liposomes
b-labelled
radiotracer
confounder
polyribosomes
quintet
rasch
over-
saha-induced
polyurethane
pupoly-l-lactic
plla
micro-nanofibrous
puplla
decellularized
adsorption
cd34cd38-cd33-
bcl2-specific
abt
cxcr4bcr-abl
bv-173
sdf-1alpha-mediated
fbmd-1
sdf-1-mediatedvcam-1-associated
shear
stroma-dependent
4-deoxydoxorubicin
esorubicin
4-deoxy
antedating
coplapolyethylene
photoelectron
gos-loaded
non-coated
qch-coated
72nd
45th
sanguisorba
meso
bcl‑2‑like
mcad
irritable
fibromyalgia
u200917u2009
unwittingly
emphasises
c-myc-driven
nanoparticle-based
p53-mdm2mdmx
pmibcrabl
arg-repeating
hexapeptide
tetrameric
pmibcrabl-r6
alpha-helical
32u202fnm
p53-inspired
trioxide-based
haemotological
weed-killers
insecticides
benzene-ring
dtt
mono-mac
subthreshold
90min
caspase-4
q21q23
t11x
tq23q23
anti-tumoural
hexamethylenebisacetamide
diseminated
candidiasis--mainly
form-
mieloid
hepatoesplenic
computered
axial
encapsuled
maze
angiopoietin1
ang1
evi1-deficient
p18
ink4c
tie2fc
ang1tie2
bmf
ineffectual
trialed
aml-bearing
genotoxics
abt-737-like
noxa-like
hl60-chol
n-ethyl-n-nitrosourea
ldd731
fertilization
positional
histidine-to-tyrosine
stagnation
aml-aza
azacitidinechemotherapy
arm-a
arm-b
hl-60s
hl-60i
arabinosylcytocine
dawning
jerald
radich
ever-expanding
tack
iscoves
--3
herg1
-phosphonylmethoxyethyladenine
pmea
acyclic
phosphonate
rcho
flavin
fad-dependent
pereskia
sacharosa
cacti
hemin-treated
4-ooh-cyclophosphamide
butylate
cxcr4neglow
nodshi-scidil-2rγnull
nog
yh239-ee
yh239
co-crystal
vinca-alkaloids
cd34hla-dr-
cytokinechemotherapy
synergise
das-induced
das-loaded
ptf
osf
altast
tbili
simplification
lqfm030
p53mdm2
nf-ĸb
status-independent
forerunner
planopilaris
non-scarring
ara-c-sensitivity
s3
bh-ac
zyj-34c
zy-34c
zyj-34c-induced
semiologic
leukoencephalopathy
lhermitte
isoprinozine
allergens
ectosome
pmn-ect
ectosomes
plb-985
plb-ect
modc
niso4
modcs
niso4-induced
pdl-1
il-12p40
pan-regulatory
gilz
catc
c1qa
nmes1
niso4-treated
ii-inhibitory
all1af4
noninfant
long-evans
trimethylbenz
non-electrolytes
l-p
minute-1
atm-1
thiourea
micra
phloretin
glycols
receptor-mutated
bcl2-like
bim-polymorphism-associated
p-glycoproteinmdr1
pml-rarα-positive
necrosis-inducing
rnp
sphk1
im-insensitive
invaginations
-5b
isre
v-src
d-α-tocopheryl
tpgs
liposomal-emodin-conjugating
methoxypolyethyleneglycol
2000-derivatized
distearoyl-phosphatidylethanolamine
mpeg2000-dspe
phosphatidylcholinecholesterol
amethopterine
repetition
cleavege
oligonucleosome-length
endonucleases
marginalization
disregulation
revolutioned
waterformic
dm-induced
adm-sp
dm-sp
channel-blocking
bz
sulfhydryl
sh-dependent
purinerpyrimidiney
recombinogenic
ry
p-benzoquinone
peroxidase-mediated
catenated
nicked
agarose-ethidium
microm-dependent
bq-adducted
kdna
decatenated
pryg
religation
iii-dna
bz-induced
first-trimester
pcv
abt-263navitoclax
abt-199gdc-0199venetoclax
a-1155463
monotherapies
bcl-2highbcl-xl
cdk8
supressing
rosmarinus
supercritical
rosmarinic
nci-h82
hep-3b
soxhlet
lowintermediate-risk
92-kda
72-kda
collagenasesgelatinases
cost-saving
microspectroscopy
microftir
pre-diagnostic
mercury-cadmium-telluride
mct
cm-1
globar
cycle-associated
fostriecin
h7
n-octyl
avadomide
iberdomide
hydrochoride
cc5013
cc4047
cullin-4
ubiquitinates
ikzf3
aiolos
argonaute-2
basigin
monocarboxylate
cytosine-guanine
barack
obama
moonshot
high-impact
emphasise
unsustainable
policymakers
extruding
jsb-1
cytotoxic-modifier
8-drug
cytosinearabinoside
7-drug
cell-mass
oesophagus
monogenic
haemopoetic
modifed
ciclopirox
olamine
skp2
histiocyte
macrophage-activating
bovis
phagocytosed
boiled
phagocytosable
differenetiated
drug-conjugate
internalize
bidens
azanucleoside-based
flt3u2009aml
mpdmyelodysplastic
mpdmds
eosinophilbasophil
cd34blasts
3q26-related
dysmegakaryopoesis
evi1-related
case-series
myeloid-blast
interferonalpha
seborrheic
leukemia-initiatingrepopulating
t-lic
cd34-cd7
continous
allogeneous
patientsabstract
peanut
peanut-skin
pse
psel
esi-ms
horseradish
bhk
-trihydroxy-6-methoxyflavone
ic44
ic23
ozogamicinwhich
cyclophosphamidedoxorubicinvincristineprednisone
detude
lymphomes
ladulte
gela
r-cvp
hexadecylphosphocholine
clastogenicity
dna-interacting
ddavp
ddavp-dependent
microinfiltration
hypothalamic-pituitary
oridonin-triggered
c57
ae-expressing
t-harboring
d188
nano-sized
albumin-based
hydrazone
degradable
shells
nanoscopic
megadose
purifications
kinship
non-shared
scrophularia
frigida
boiss
slacken
p-flt3
hl60wt
mvitd
myelomonocitic
karyotipe
preminent
overlimit
clinicalbiologic
cytoreduce
mcl1i
cdk9i
cul5
rnf7
ube2f
cullin-ring
crl5
resensitized
proteasomally
re-sensitization
speciesminerals
formulae
tetraarsenic
tetrasulfide
ubiquitinationdegradation
g1g0
biagents
aquaglyceroporin
a-mediated
joints
safingolc2-ceramide
αvβ5
agent-integrin
chromatography-triple
h9c2
beta-blockers
b-resistant
pp242
aktmtorc1eif4e
eif4f
7-methyl-guanosine
p-eif4e
ser209
sup-b15
birinapant
mdr1i
aml-burdened
differentiationapoptosis
proliferativesurvival
tfsptks
tfs-targeting
sti-571imatinib
oncoprotein-targeting
log-term
imps
fgf-2
vascularized
membrane-type
rao
trehan
pteridines
contradiction
leukocytopenic
4-methylbenzenesulfonate
larocca
kudoh
vegfr3
t-ml
c2df1
microgramskg
solubilized
hl-60mri
ncr-nu
ro-liposome
treatmentabstract
lipopolymers
peis
α-linolenic
αla
pei-αla
αlapei
pei-chol
cholpei
pei-la
lapei
60u202fnm
frelin
d835v
as602868
jnk2p54
jnk1p46
c-junap-1
methlytransferase
tranferase
jiexinkang
jxk
anti-toxicity
ifnr
extravascular
alpha-1
aag
drug-selection
thiazole-4-carboxamide
oxidants
nano-formulations
eme
anti-folate
mtx-treated
synthesis-regulating
cholesterol-importing
dnr-treated
taxoid
rhone-poulenc
rorer
antony
pre-eclampsia
trophoblast
spiral
microrna-29b
computer-based
targetscan
pictar
mirbase
htr-8svneo
bewo
3-utrs
sweating
sch
gom
mip-1β
granulocyte-macrophage-colony
suppurative
thyroglobulin
ultrasonography
sucessfully
pyriform
chemotheragy
melanin
nigella
sativa
tlr4-positive
tlr4-negative
triad
trimethroprimsulphamethoxazole
non-productive
hypoxaemia
alveolar-interstitial
sputum
polichemotherapy
macroscopically
cmp
programed
neurodegeneration
grooves
ramaswamy
sarma
efavirenz
filtrate
liquefied
papaya
reprograming
drugging
tpa-induced
anti-myeloid
anti-lymphoid
non-b
ba-1
cyig
6-hydroxy--tetramethylchroman-2-carboxylic
smt
malvaceae
manihot
eaten
volatile
peroxyl
s27a
rps27a
extra-ribosomal
cml-apbp
k562g01
-486
-478
wp1066
chemoresistancesusceptibility
schiff
sgc
-oxoarsanylphenyliminomethylphenol
2-methoxy--oxoarsanylphenyliminomethylphenol
aml-lsc
wdr5
wdr5-mll1
peptidomimetic
methytransferase
fi0-b
acid-modified
fi0-b-h
g-quadruplexes
amantadineprazosin
er-releasable
non-alcoholic
nafld
glutaminyl
isoqc
pyroglutamate
aminopeptidases
qcisoqc
destabilizing
telmisartan
ballooning
f-positive
steatohepatitis
azacytidine-induced
proof-of-mechanism
pursuing
kaiser-permanente
photosensitizers
haematoporphyrin
hpd
meso-tetrahydroxyphenylchlorin
mthpc
drug-only
light-only
shenqi
fuzheng
diaminopyrimidines
metoprine
etoprine
lipid-soluble
micrometer
varitions
retinate
33342pi
bnip3
obligatorily
abl-imatinib
icrf-187
granulomas
cnssystemic
fab-subtypes
steeply
protomers
encircles
pip-box
ing1
interdomain
idcl
equalled
-57
10058-f4
underly
drug-transporters
signalling-
patterned
cytokinetics
schedule-dependency
sdac-refractory
milligram
cyp1aat6235c
cyp2ebc-1019t
cyp3aba-290g
nqoc609t
mthfrc677t
2r3r
drug-metabolising
qrtpcr
v-abl-
erosive
lichenoid
dorsum
planus
pomegranates
pomegranate
pje
v-fitcpropidium
propidum
dehydrocostus
dispirocyclopropyldehydrocostus
ddl
dmaddl
single-channel
clamp
2-aminoethoxydiphenyl
epitheliums
isotopically-labeled
pgp-lacking
pgp-expressing
dmso-induced
flurbiprofen
bw755c
bacitracin
irritant
carrier-mediated
acid-decitabine
hpept1
l-val
l-phe
4c
gly-sar
leptin-treated
hpept1-mediated
homogenates
coadministrated
hpept1-targeted
aloe
anthraquinones
aloesin
aloe-emodin
barbaloin
verectin
tumor-transplanted
ascite
eacc
dld-1
intererstingly
tgpx
chemo-preventive
cyp3a4-v
conformation-sensitive
cyp3a4-w
viburnum
grandiflorum
vge
h1650
hcc827
invitrogen
pro-caspase-
viability-inhibitory
obliterate
menin-
mll1-regulated
coregulated
every-8-hr
mislocalization
non-nucleated
elasticity
alsg
intensified--during
hookf
13c
cedrus
p-rb
evofosfamide
hypoxia-dependent
nct01149915
nu2009u200938
esophagitis
caix
parasvm
dct
il-2-
cd40l-expressing
recipient-derived
hil-2
hcd40l
il-2cd40l
890-fold
mhc-restricted
t-cytotoxict-helper
lent
ukrain
blister
nara
mcculloch
post-deterministic
5637-cm
bromodeoxyuridinedna
brdurddna
parapsilosis
liver-spleen
ikkbeta
anabolic
dthd
digitonin
deae-cellulose
thymidine-sepharose
dttp
ptp1b
tonb210
ii-interactive
gses
gse
cinnamon
sanyangxuedai
convenional
acds
psc-mec
kbm-5
lymphoma-extra
salix
safsaf
salicaceae
lymphokine
subleukemic
myelosis
slm
proper-myl
n1-guanyl--diaminoheptane
gc7
5a2
eif5a-2
edu
eif5a-2mcl-1
vcr-based
drug-insensitive
proclivity
cels
bromouridine
5-bromo-2-deoxyuridine
transcription-start-site
mllenl
e2ahlf
rna324
linc00324
cbioportal
nejm
mtp
doxorubicin-selected
zevalintm
90yttrium
ibritumomab
tiuxetan
idec-y2b8
biogen
idec
bexxartm
131i-tositumomab
corixa
glaxosmithkline
haga
anti-globulin
humanize
anti-idiotype
feasibly
target-inhibiting
int-0091
nonrandomly
alphakg
d-2hg
alphakg-dependent
mutant-idh1
lagunamides
cyanobacterium
lagunamide
u2os
a-induced
insightful
assaults
whole-life
extermination
diseasexa0relapse
microrna-153
mir-153
substrate-2
irs-2
pulsing
hydrea
prejudiced
fasfas-l
proteinenzymatic
thh
cholesterol-rich
atomistic
staples
-106
helices
staple
meg01
hemapheresis
cytapheresis
acd-a
nolvadex
arimidex
anastrazole
targretin
anti-infectives
no2b
unravelling
zeb
p57kip2
s-transferase-pi
cytoskeletons
gns
specificities
freshwater
planarians
planaria
species-malta
psm
cd11b-
cd14-positive
cdkn2c
product-based
dock6
glide
plp
co-crystallized
rmsd
u202fµm
moxetumomab
pasudotox-tdfk
lumoxiti™
astrazeneca
optimised
cat-3888
pasudotox
38xa0kda
pe38
ribosylation
ef-2
phototoxicity
sunlight
phototoxic
hidac-induced
miliaria
sweat
nonpruritic
nightsweats
exanthem
crystallina
idarubucin
target-therapy
abate
pseudoporphyria
culprits
photoprotection
alstoyunines
a-h
cox-
ic73
frb
acid-conjugates
high-power-field
lymphohistiocytic
intimal
lamina
adventitia
implements
gleditsia
consented
mts50
pro-apoptic
anti-apoptic
phospho-erkp-erk
leukemogenesis-related
transductivity
csls
ap-2α
monorden
gcsf
neutrophil-rich
episodic
needless
ushering
predated
17ptp53
laboratory-based
exomegenome
impactful
one-pot
arsenic-based
nanodrugs
as-prepared
nanocomplexes
porous
ph-responsive
cloara-c
myeloleukaemia
k562p
b669
g0model
g0phase
resonances
cycle-non-specific
-phase-specific
sharpness
chronotherapy
lpa
apoa
danazol
5-az
hyperleucocytic
beta-aescin
aesculus
cfu-k562
mrc-5
dhpg
platelet-specific
activation-dependent
angina
pectoris
hypercoagulability
ischaemia
procaine
platinum-triamine
dpr
ocm
higher-spending
behaving
lower-spending
needsxa0remain
pericardiocentesis
chemogenomics
apl-induced
plotted
7-nitro-3-benzoxadiazole
tripeptide
glutathione-peptidomimetic
lipophylic
glc-4
ros-independent
jnk-mediated
arming
perfused
adaptor-related
leukemia-modified
collagen-vi-α-1
pharmacodelivery
doxorubicinverapamil
mx3
sn38
9-aminocamptothecin
bxp34
lz
spirogermanium
prostatic
plasmodium
falciparum
tricostatin
20u2009
abl1t315i
influxefflux
cpps
ir15
sr11
abrus
peptide-drug
ccwgg
chromatid
radio-
purulia
birbhum
bankura
herbals
picrotoxinin
10-deacetylbaccatin
isoorientin
hirsutrin
vitexin
rhoifolin
4-nitrobenzyl-6-thioinosine
nbti
9-beta-d
arabinofuranosyladenine
ara-a
tubercidin
5-bromodeoxyuridne
budr
3h-ara-c
rna-rna
rnatotal
tightness
anxious
restless
orthopnea
act-d
act-d-induced
novo-induced
glycol-bisbeta-aminoethyl
nnnn-tetraacetic
egta-
verapamil-treated
sp-potentiation
calcium-dependent
gsk2879552
film-coated
nfkbrel-blocking
ikk
ps1145
cpx351
henceforth
antimediator
accomplishing
early-
leaky
tetramethylpyrazine
granulocytopoenia
tanreqing
lm975
diethylaminoethyl
lm985
widr
licr
lon
hn-3
dimethylthiazol-2-yl-diphenyltetrazolium
redifferentiation
inflatum
sphenoidal
posttraumatic
n-substituted
r263
hot-spots
24d
hit-to-lead
compartmentprimary
iccs
lin28
superimposed
galactose-binding
postpone
acan
araliaceae
acan-induced
cfu-s
lcfu-s
d9
d4
renewaldifferentiation
simplistic
erb-b2
ras-raf-mitogen-activated
proteinextracellular
kinase-extracellular
nonprogression
prescient
tempranillo
cultivars
sephadex
g-200
260-fold
accustomed
methylseleninic
fradcarbazole
3-chloro-5‴-fluorofradcarbazole
quinquagenarians
nonagenarians
death-inhibiting
polarizing
fibrillar
smenospongine
cipkip
akn-028
icu2009nm
ld95
blast-forming
amifostine-induced
ruptures
rhenium
bonded
pc-series
pc6
anthraquinone
hemoperfusion
echocardiograms
zygomycetes
tetrahydroisoquinoline
xestospongia
mcl-1-ubiquitin
ubiquitin-proteasomal
mcl-1-targeted
sf5
v-fitc
aminonucleoside
6-dmap
g2-arrest
superinduction
inept
divers
diacylglycerol
factor-induced
cpt1
whole-tumor
obtainable
b7-mediated
gene-transfer
postponed
gdc-0980
n-2-hydroxypropylmethacrylamide
hpma
copolymer-cytarabine
stevens-johnson
sjs
juggling
lymphokines
astonishingly
suppressants
anti-cd28
unquestionable
helleborus
anthroposophical
fuo
gsh-dependent
free-radical-type
cell-cycle-enriched
ml-2
gsh-related
presumption
glutathione-dependent
impressively
vasculitides
leucocytoclastic
periarteritis
nodosa
micropolyangeitis
wegeners
granulomatosis
polychondritis
polyarthritis
oligoarthritis
serositis
contemporarily
nml
gi-agvhd
profuse
pbxexd
hox-dependent
arthropods
heterodimerize
pknox1-prep1
superclass
hoxb1
cross-regulatory
pbx-hox
meis-enhanced
homeodomains
topologically
half-site
spacing
enhancer-directed
hindbrain
trimer
interdependent
meis-related
akr1c3
cycloxygenases
resonance-based
bcrabelson
bbr
hyper-acute
frustrating
population-wide
georgiasouth
consultative
regressive
polyps
microemboli
ctm
polypharmaceutical
exportin-1
sobering
csln
-dioleoyl-sn-glycero-3-ethylphosphocholine-based
solidification
pcsln
ecsln
fluorescence-labeled
simcl
cell-xenografted
chlorodeoxyadenosine
prima-1-based
adp-ribosen
n-methylnicotinamide
n-met-nam
noninducing
leftward
formamide
homocamptothecin
hcpt
mrp1-expressing
mcf7vp
mcf7dox
probenecid
mrpi
well-correlated
dnr-hcpt
lfrh2
rg3
lc-ms
m1-type
non-granulated
peroxidase-positive
disregards
3-nitrobenzothiazolo-aquinolinium
nbq
nbq-induced
okt3
25-fold
525-fold
oci-ly8
pegld
near-cr
anthracycline-refractory
bortezomibpegld
post-mitotic
cyanotic
spasms
a549cddp
dqa-peg2000-dspe
dissipating
co-therapy
cel-noc
pdgfr-rearranged
hes-like
pdgfr-mutated
interferon-alfa-2a
mepolizumab
loratadine
descarboxyethoxyloratadine
-dinitrophenyl
fura-2
passively
dnp-bsa
malignanciesresults
prognosisconclusions
pharmacoresistance
surprising-and
counterintuitive-responses
primine
miconidine
dihydroqinghaosusuccinate
flagellatae
leptomonas
nano-encapsulation
lactide
co-glycolide
anticd44
plga-anticd44-ptl
sann-joong-kuey-jian-tang
sjkjt
bxpc-3
tctp
tnf‑α
sutdies
infantpaediatric
genasensetrade
pharmacostatistical
non-induction
exacerbating
e2a-pbx1
alls
nvp-auy922
fop2-fgfr1
plcγ
nsc606985
kinase-carrying
cdelta
pkcdelta
rottlerin
pkcdelta-specific
nsc606985-induced
z-devd-fluoromethyl
p324
p330
p323
acetyl-transferase
f412b2tk-
transfectants
geneticin
hl-60tax100
hl-60tax1000
m-rna
anti-pgp
3htaxol
bundling
examinating
imipenem
penicillinaminoglycoside
disc-assay
razoxane
t-apl
biflavonoid
isochamaejasmin
stellera
chamaejasme
bcl-2-induced
attested
de-differentiation
orchestration
hmts
hdms
deliberate
posited
epigenome-based
tonb
adeath
foresee
perinucleolar
a5
clustercolonies
thioguanine-daunorubicin-1-beta-d-arabinofuranosylcytosine-prednisone
gm-cfu
ltmc
log-kills
log-kill
temoporfin
mc540
wehi
ld90
kjm2
coincubated
photosensitized
rhug-csf
hscmicrol
kgbw
rhug-
-rhugm-csf
cell-entering
b19v
erythropoietin-dependent
vp1u-neutravidin
proerythroblast
viral-based
cis-retinoic
n--acridinylamino-3-methoxyphenyl-methanesulfonamide
clintapp
thp-dox
fluoro-doxorubicin
me2303
auge
guaranties
il-3-stimulated
calphostin
glabrata
amphotericin-b
candidaemia
analytically
ploy
adm-rflc
dnr-rflc
crossresistant
imatinib-acquired
deoxysappanone
deox
v-atpase
huang
dai
pianrif
diseases--chronic
cancer--that
equilibration
86rb
36cl-
permeabilities
nernst
ok-432
36th
abruptio
placentae
bernstein
octanolwater
anaesthetics
anaesthesia
non-differentiating
pyrimidin
purine-
adsorbed
alphaifn
ynk
smd-09
permeabilisation
bad-bh3
ms1-bh3
agents-notably
inhibitors-sensitise
torin1
sensitised
bad-bh3-mediated
co-operation
lipid-based
codeliver
lp-gem-simcl-1
lp-simcl-1
lp-gem
co-deliver
poly-epsilon-caprolactone
nanosystem
wool-like
nanomixures
actinium-lintuzumab
ac-lintuzumab
backdrop
hep-g2
fluorescence‑activated
half-maximum
transcription-5
stat5as711f
gab2--
gab2-independent
tel-jak2
agent-resistant
abl001
atp-binders
deterministic
invoke
non-cycling
bifurcation
reproducing
trophic
non-autonomous
non-autocrine
aspire
self-antigen
non-bcr
aa13
ldlr
aa13-anchored
dspe-peg2000-maleimide
decoration
peptides100pc
ection
fip1l1-pdgfralpha
kaposis
cooh
w288
re-localizes
malfunctions
officinale
roscoe
nerium
oleander
sulphorodamine
diblock
copolymers
self-assemble
monodisperse
luciferase-based
pnps
deteriorates
criteria--myeloblastoid
debilitated
chromosome-containing
unpredictably
transformationabstract
encompassingxa0preleukemia
wexa0found
ipsc-based
disease-stage-specific
demarcating
hydroxypropyl
zilactin
hydrolytically
3ll
t2684c
c2007t
c2012t
c2665t
drug-responsive
aml-eto
enema
amputation
colostomy
cartinogenic
erythrodysesthesia
ppes
pharmacotherapists
peg-ifn-alpha
mesylate-induced
stimulant
archetypal
remethylated
demethylation-resistant
sialoglycoconjugates
vibrio
cholerae
metaperiodate-sodium3h-borohydride
galactosyl
3hglucosamine
neuraminidase-labile
ctp
3-deazauridine
curtailed
glycoconjugate
acidabstract
antimyeloblast
heteroantisera
cdc42-associated
ack1tnk2
ack1
cyclopentenone
beta-unsaturated
70-kda
subspecialist
cognizant
accountable
generalists
subspecialists
cur-loaded
mnp-cur
hpaf-ii
surface-associated
self-nanoemulsifying
sne
alkeran-prednisone
drug--a
standard--interferon
kinase-imatinib
hsm911
ril-3
rscf
ril-1
ril-4
ril-5
ril-6
repo
anti-gm-csf
anti-il-3
cd41a
vla1-vla5
lam1
down-modulated
beclin1
cellsand
dnrol
pcaobs
co-modeled
aucobs
pcaprd
dnrdnrol
aucprd
medication-related
mronj
antiresorptive
onj
diaryl-oxazole
pc-046
dpc4smad4
synthetically-derived
deregulates
stis
5-dimethylthiazol-2-yl--carboxymethoxyphenyl--sulfophenyl2h-tetrazolium
potentiators
kinesin-5
k5i
ksp
mulehuwe1
antimitotics
myalgias
atra-associated
t27a
docosahexaenoic
sn-l
sn-2
moribund
charted
dha-containing
spaced
tsap6
sidney
brenner
revertants
judith
karp
fmulv
amarus
modelsthe
n-methylpiperazine
bu-resistant
cloflubu
smc1
cloflu
triple-drug
bu-mediated
perpetuates
on-site
metabolome
choronie
self-control
hplc-ms-ms
tmax
auc0-τ
auc00
hcr
cl2mdp
taxodione
methide
taxodium
distichum
taxodione-induced
taxodione-caused
2-associated
athanogene-1
gadd34
ire-1
stressunfolded
bag-1bcl-2
rhus
verniciflua
rxa0verniciflua
pan‑caspase
cefmenoxime
cmx
bestcall
pyelitis
drugstoxins
eightfold
caspase-3-like
3-deoxy-3-fluorothymidine
dehydroilludin
mv522
ctr20150246
hao472
l-alanine-14-oridonin
trifluoroacetate
hengrui
wo2015180549a1
cn201410047904x
i-type
hewed
m-3
nanostructure
apoptosis-promoting
s-transferase-crkl
gst-crkl
acrylic-functionalized
protein-acrylamide
non-protective
cephaloridine
orabase
sterilized
fever100
infections100
inspire
ro6839921
dose-proportional
crimlfs
auranofin
adenanthin
anti-bcp-all
folate-polyethylene
distearoyl
f-peg-dspe
fr-beta-targeted
baicalein
long‑circulating
pro‑apoptotic
sub‑g1
20xa0µm
isothiocyanatepropidium
p-iodonitrotetrazolium
violet
posteriori
tetrazolium-reducing
24-epi-oh2d2
oh2d7
1alphaohd
1alpha-hydroxyvitamin
d7
polyporus
pps
lentinan
1h-tdr
decades-old
miliary
anti-tuberculosis
isoniazid
rifampicin
ethambutol
eb
pyrazinamide
pza
inh-resistant
lvfx
prexisting
non-hodgkins-lymphoma
vegf-rtk
goose
counter-staining
haematoxylineosin
flavonoid-rich
fermented
dna--topoisomerase
mt-npm1
deguelin
rotenoid
low-deguelin
pseudo-gvhd
pseudo-gvhd--namely
chemotherapy-antibody
sgn-cd33a
contraindications
m-amsacrine
hepatoxicity
amsa-related
mould
scedosporiosis
amr
class-
su5614
confound
dual-laser
sr101
fitc-labelled
densitometric
p64c-myc
lowry
additive-to-synergistic
metabolicenvironmental
autophagy-specific
as3o3
c-beta2
plc-beta2
atra-responsive
atraas2o3
maturate
ninefold
antiglycophorin
signed-rank
pains
pta
pte
leukopenianeutropenia
controlled-release
antihistamine
zinc-layered
nanocomposite
cetn
å
zlh
representativity
nationals
haa2020
nicely
cyclind3
gangraenosum
impinge
p39-ras
pkc-independent
homoharringtoninehht
inadequacies
oncogenetic
subdued
targeted-silenced
ikb
ikk2
as602868-induced
sf-36
fact-leukemia
euroqol5d
poised
research-based
ormeloxifene
serm
tp22q23
4-piperidinamine
--methyl-3-oxetanylmethoxy-1h-benzimidazol-1-yl-8-quinolinyl-
monobenzenesulfonate
abcb1-specific
500xa0nm
7-amino-actinomycin
7-aad
pgpve
pgp-specific
uic2
factor-deprived
psc-
pgp-ve
sphingomyelin-ceramide
sm-ceramide
ic30
acetoxymethyl
bl2
incontinentia
pigmenti
nitrotetrazolium
chinensis-treated
109203x
chelerythrine
h-7
diuresis
hyperuricemia
nonlytic
target-binding
michaelis
kappm
killer-cell-independent
kcil
rate-determining
et-18-och3
limofosine
aza-derivative
k562-adr
adryamicin
hl60-dnr
vinblastin
tak-733
hl-60ar
verapamil-containing
3hvincristine
vincristine-free
pmdr1
20-min
prednisolone-resistant
mutagenized
azd1480
cyt-387
m929i
groundwork
apolipoproteins
14c-cholesteryl
cholesteryl
ldl-cholesterol
ldl-like
stabilizations
hydrogen-bond
biopharmaceutical
collaboratively
octanol
myelodysplasiasecondary
tmdssaml
retrotransposon
β-globin
lcr
abcd
flasks
lifecell
gas-permeable
feeder-layer
leukemiaallogeneic
photochemistry
electrically
excitable
540-mediated
photooxidation
arachidonate
oximetry
2h2o
alpha-cholest-6-ene-3
beta5-diol
intermediacy
h2o
phototherapeutic
papaverine
papaver
somniferum
opium
poppy
antispasmodic
papaverines
peg-fmoc-nlg
4t
built-in
peg-derivatized
nlg
dox-loaded
self-assembled
∼120
a20
doxpeg-fmoc-nlg
knocking-down
kit-dependent
mtsc
sudlows
entropically
enthalpically
nr4a-regulated
nr4a-dependent
paused
alpha-streptococci
trimethoprimsulfonamide
imipenemcilastatin
aminoglycosidepiperacillin
aminoglycosidethird
cephalosporin
aminoglycosidetrimethoprimsulfa
isoxazolylpenicillin
capizzi
ascomycota
dichotomomyces
cejpii
callyspongia
gliotoxin
6-acetylmonodethiogliotoxin
methylthio-gliotoxin
polyketide
heveadride
epimonothiodiketopiperazine-derived
dau-ol
akr1abc3
7a2
cbr1
akr1b10
ic50u2009uxa0µm
kiappu2009uxa0µm
1xa0µm
atra-dau
non-controlled
tube-forming
vegfvegfr-containing
59-yr-old
pneumonic
roentgenogram
sirt7
mef2d
betweenness
closeness
coreness
system-related
deliverer
b-lymphoblastoid
hu-induced
hypo-diploid
hu-mediated
distearoylphosphatidylcholine
distearoylphosphatidylglycerol
p-glycoprotein-based
high-risksecondary
stroma-supported
cd34-enriched
overlaid
confluent
cd34poscd38pos
cml-pb
wk-1
wk-
cd34poscd38neg
cml-bm
cd38pos
cd38dim
cd38neg
cd34poscd38
rhps4
phosphatidic
antimycobacterial
body-like
ablpa
nonprofessional
ca2-dependent
phagolysosomes
mtb
mtb-infected
on-line
turboflow
vantage
vortex
hypersil
apci
multiplexing
r99
intra-assay
rsd
persicae
amygdalin
d-form
beta-glucosidase
dimitroulakos
nohynek
backway
hedley
yeger
freedman
minden
lovastatin-induced
cerivastatin
cerivastatin-induced
statin-induced
microarchitecture
collagen-i
npm1-driven
net-related
netosis
oh-dox
pumping
break-points
blood-counts
glucoselactate
mcts
erythroid-
glycolysis-generated
biomass
mct1
bromopyruvic
bpa
57th
long-awaited
bis-chloroethylnitrosourea
id50s
o6-bg
ethacrynic
vesnarinone
dhad
deaths-2
high-speed
intactness
tnfα-mediated
nf-кb
nrh
usable
ubiquitinylation
nuclear-cytoplasmic
co-ordinate
pten-deubiquitinylating
herpesvirus-associated
hausp
usp7
opposes
daxx
domain-associated
pml-daxx-hausp
deubiquitinylation
deubiquitinylation-dependent
d₂
pri-1916
pri-1917
pri-1907
24z
24-cis
dr3-type
categorising
differentiation-18
display-derived
αmβ2
macrophage-1
c12hc6hk21
cml1
ccmut3
cpp-ccmut3
antioncogenic
baf3-p210
quinazolinone
erastin
nrasq61l
nrasg12d
krasa18d
erastin-induced
cytarabineara-c
doxorubicinadriamycin
transporter-based
vault-associated
tariquidar
laniquidar
ont-093
resistomycin
hypericin
hypericum
perforatum
ad-induced
ci1
meaningfully
antibodiesstandard
epigenetic-acting
indubitably
markersthe
nabhan
ps-341
genta
ofatumumab
obinutuzumab
idelalisib
amegl
amegls
thr92
cdk1-cyclin
lowspecificities
spongean
aaptamine
aeroplysinin-1
s139-phosphorylated
p-chk-2
daunorubicin-stimulated
p-kap-1
p-chk-1
s10
importexport
agent-specific
cytomegalovirus-associated
physician-administered
costs-including
care-increased
g4s2
dtlil3
il3r
receptor-negative
hd-myz
z-ietd-fmk
tnfalpha-mediated
faddcaspase-8-dependent
gene-targeted
snpcopy
imperatorin
furanocoumarin
microgranular
gimemapethema
lap0389
aida
instructed
cotrimoxasole
vo
indwelling-catheter-related
pseudomona
entamoeba
hystolytica
enteritis
usdpatient
preadolescent
pneumococcal
condoned
therapyabstract
cml-mc
stageabstract
daunorubin
ly293111
ly293111-induced
aspc-1
pgdf-receptor
pan-bcr
second-and
alm
intolerably
n-desmethylvosaroxin
0-∞
auc0-∞
excreta
hydrogenation
nexstar
teratogenesis
orienting
peptic
radiculopathy
leukencephalopathy
cerebral-spinal
ske
b-raf-v600e
pericarpium
reticulata
jiao
gan
pcrj
gcms
nobiletin
tangeretin
na-independent
maneuvers
lmp-1
lcls
ebv-transformed
laboratory-derived
sarcoma-associated
herpesvirus-8
hippuristanol
okinawan
isis
hippuris
jund
post-second
q33q34
dids
na-dependent
nigericin
intratumour
ingenol
mebutate
keratosis
3-o-angeloyl-20-o-acetyl
aai
20-o-acetyl-ingenol-3-angelate
pep008
cδ
pkcδerk
dry-eye
collagen-shield
sf91mrp
sf91gcs-mrp
bicistronic
ltr
antimony
tartrate
aml-endothelial
5-aza-deoxycytidine
4-phenyl
14c-daunorubicin
mvxa0cells
xa0nm
dfg-in
lks
attractiveness
fostamatinib
avl-263
bms-387032
multi-tyrosine
vandetanib
zd6474
tki258
chir-258
gw786034
ag013736
3-kinases
gs-1101
pi3kδ-specific
lk
anaphylaxic
saishin
bushi
antigen-mediated
ephedrine
pseudoephedrine
nano-scale
fzkbg
re-sistancemdr
chemothera-peutics
manydrugs
theatp-binding
scfskp2
cpda
scfskp2-
p27-dependent
bh-ac-dm
bh-ac-edm
nonblind
stimulusleading
glivicgleevec
intraocular
catara-bine
schedulethe
-87
granulocyte-
chemo-radiotherapy
coax
qlcs
extra-cellular
preejection
lvet
systole
lvid
invadosome
as-yet
pericellular
hfddde
anti-invasion
droppingdisappearance
arsenous
organoarsenic
organometallic
anti-head
anti-hnscc
sq20b
scc-9
provoking
aktxa0restored
microtubule-destabilizing
vbl
vnr
myoblast
2536vcr
2536vcr-induced
non-degradable
siah-1
ps1
tpt1tctp
β6
α12
β24
o-
β-d-glucopyranoside
glutathione-sensitive
acid-mercaptopurine
ha-gs-mp
ic9
equivml
cy5-labeled
sulfide-linked
17β-hydroxysteroid
testosterone
dihydrotestosterone
castration
scifinder
n-phenylsulfonyl-indoles
n-benzimidazoylylcarbonyl-
n-indoylylcarbonyl-
n-pyridinepyrrolyl-
piperidines
n-benzimidazoles
n-benzindoles
n-phenylanthranilates
propionic
isoquinolines
estrenes
akr
-butanediol
bfs
a-bearing
substitutes
monocytemacrophages
alpha-napthyl
sis
emitted
downup-expressed
cdkn2a-cdkn2b
pha-739358
as703569
smo1
bcr-ab
non-liposomal
lysimachia
clethroides
duby
autocatalytically
misbalancing
un-selected
adduce
glomerulosclerosis
non-nephrotic
complemente
apposite
antidiabetics
microanalysis
deduce
subcultures
alpha-minimal
recultured
determination-like
follow-upthese
infusion-associated
il-1-ra
amblipid
amb-related
readable
microtiter-plate
photometric
desensitizes
11-ketoreductase
pgf2alpha
akr1c3-inhibitors
pgj2
15-deoxy-delta-prostaglandin
jdelta-pgj2
gw
akric3
d3-induced
diversion
non-cyclooxygenase-dependent
daunorubucin
pyrrolo-acarbazole-3-carbaldehyde
pyrazolo-ccarbazole
pyrazolo-aphenanthridine
pyrrolo-gindazole
vs-ii-173
pim-kinase-mediated
pyrazolo-analogue
litr
coincidently
galectin-1-mediated
stls
helenalin
sclareolide
stl
differentiation-enhancing
pe1
bioconversion
bipotent
diverted
l-lysine
de-aggregatory
odq
aggregometric
metabolises
acalabrutinib
dit
orthochromatic
rna-specific
pyronin
py
rna-containing
dna-containing
rnase-treated
dfi
anti-scfc-pit
fasfasl
c-jun-n-kinase
alpha-positive
idarubicincytarabinethioguanine
uncensored
thiol-dependent
polymerize
ptc596
ptc-028
ptc028
akabli
akalumine-hcl
akaluc
benzamide
p38α
mnk1
osteoclastogenesis
osteoclast-like
osteoclastic
autophagia
plamacytoid
spn
ncam1
clec4e
ctla1
gzmb
leukaemia-like
neuromeningeal
α6
itga6
β4
itgb4
small-hairpin
shevi1
evi1low
werners
wrn
recq
addyq12
igf2bp1
photoactivatable
ribonucleoside-enhanced
par-clip
cp11
ap8
900-fold
deductible
coinsurance
localisations
processus
tracheobronchial
fibroscopy
brushing
4-epi-doxorubicin
microviscosity
tempamine
ag6000
74-aa-long
open-reading
wasabi
dinitrophenylated
allyl
cysteinyl
cyslts
non-dosing
anti-pd-1antibody
nondosing
thrombo-haemorrhagic
hyperleucostasis
disease-modulatory
expression-levels
pagerank
hitsauthority
radiality
focusheuristics
disgenet
gene-disease-association
haemophagocytic
ch-hlh
ppy-a
xl-228
sgx-70393
tg101113
proanthocyanidins
gspe
a-427
j774a1
pigmentosa
juvenile-onset
eruptive
-containing
arrhythmias
beta-l-dioxolane
bch-4556
ousted
carbapenem
cr-bacteria
cr-infections
cr-related
selvage
cr-enterobacteriaceae
cr-bacterial
spectroscopically
high-metastatic
microenvironment-mediated
extra-hematologic
bcl2s
post-translationally
agonist-activated
cytosine-arabinosid
grs
differentiation-mediated
behenoyl-cytosine
nadirs
205microliters
ligustri
lucidi
fll
fll-
oa-induced
radio-chemotherapy
extraleukemic
serin-threonin
dntpase
allosterically
crystallized
cladribine-tp
clofarabine-tp
fludarabine-tp
vidarabine-tp
cytarabine-tp
gemcitabine-tp
deoxyribose
plks
carbon-based
horizons
inv16-encoded
beta-smooth
d3-treated
inv16-containing
timeshere
mra
prescreening
ubiquitin-activating
uae
tak-243
ubiquitin-protein
atf-6
tubulin-monomer
protein-synthesis
parasite
eosinophil-lowering
ctx-r
puzzling
hs-5
imatinib-era
cytocentrifuged
peripheralization
g-csf-
lineage-independent
verticinone
macroautophagyautophagy
bnip3lnix
sqstm1p62
mitochondria-targeted
dihydroethidium
nao
10-n-nonyl
trc
torc1
torc2
eu2009g
inu2005vivo
degrader
gne-987
degrader-antibody
anti-cll1
gdp-releasing
proliferation-inhibiting
spasm
detrimentally
arvensis
inositide
inositides
knockin
porokeratosis
dsp
hyperkeratotic
cataract
mick
annexin-v-fluorescein
hypoxemia
dac-induced
hdacitranscriptome
kdm2b
ach3k
chibby
cby1
tcflef
scaffolding
σ
hyper-methylation
contingent
stress-associated
y90-hum195
ji6
flt3-itd-containing
hcd-57
aptamer
∼230
pegaptanib
macugen
cd20-positive
homo-dimer
objectve
hl-60vinc
sodns
caski
perforin-mediated
kaempferia
prechemotherapy
transplantation-pbpc
curaxin
nongenotoxic
chemopotentiating
procaspase-10
etoposide-treated
chemotherapytreatment
non-ph
pav
supersensitivity
jeopardising
anthracycline-derivates
therapyalternative
uti
chymotrypsin
hi-8
b-pre
course-dependently
hepatoblastoma
podia
elicitation
hyperosmotic
elicitor
anti-hbc
cancerand
enthusiastically
deoxyribonuclease
pgplrp-mrp-
lrp-cases
arriving
diazaspiro
bicyclo
hydantoin
lcms
chronicity
ad-directed
paraclinical
factors-alpha
phosphorolysis
thalidomides
stroma-induced
pdna-pkcs
therapy-resistance
mir-23a-5p
gf109203x
20-kda
c-dependent
ifs
coiling
bundles
eccentric
cytokeratins
retrodifferentiation
redirecting
bcma
stromal-mediated
proteinmessenger
heterologously
foretinib
im-s
foretinib-mediated
2-mediated
calcemic
danilenko
jnci
hl60-g
organoselenium
ebselen
cad3
sulfoxime
raf-mitogen-activated
wogonoside
wogonin
beta-glucuronidase
telomerase-associated
thrombopoietinrhtpo
interleukin11rhil-11
n--diacetoxypentyldoxorubicin
intercalator-resistant
cotemporal
alpha-hydroxyvitamin
3-race
family-donor
unrelated-donor
avermectin
strongyloidiasis
onchocerciasis
infestations
nematodes
hyperpolarization
ivermectin-induced
dna-identical
photolabeled
nimodipine
be-
cyp1ac
rs1048943
maldi-tof-ms-based
reverse-transcribed
homo-
androgenic
heptocellular
q-rtpcr
chemo-sensitizing
etomoxir
etomoxir-ato
non-tumour
lkb-1ampk
ampatp
ribonucleases
amphibia
pulldown
zwitterionic
chaps
heterodimerization
dissociate
60-min
non-hemopoietic
ceritinib
t-alk
p-alk
t-akt
t-erk
unleaded
detoxified
r934
cyp1a2
pro-angiogenesis
rubus
parvifolius
rpts
pkciota
adenovirus-mediated
clts
txa2
bristolmyerssquibb
sbu
decision-makers
concerted
overviews
gynaecology
gynaecologic
scientifically
fulfil
pyrrazolopyrimidine
caki
hsf
c-enhanced
c-treated
c-stimulated
fa-induced
benzene-induced
echogenic
sonographic
cb-1
cellsinto
cxcr4sdf1
maculopathy
redundantly
knocks
myc-bcl2
topo-ii
dipyrone
mosquitocidals
baygon
mllve
mll-ve
carbamate-based
carring
dot1-like
anti-all
reviwed
walterinnesia
aegyptia
wev
wevnp
cancer-bearing
cxcl9
cxcl13
cxcr3
cxcr5
cxcr6
chemokine-dependent
igf-1-
egf-mediated
nanoparticle-sustained
32-p
myeloid-antigen
75-fold
all-samples
one-carbon
methylenetetrahydrofolate
dehydrogenase-cyclohydrolase
mthfd2
conifer
insolubility
bioleaching
rbs
leaching
tcmf
frbs
reassured
reminders
apl-atra
acute-type
iminosugars
lc3-i
mtx-cf
mcl-1p53
streptolysin
slo
20mers
c-
slo-mediated
c5-propyne
antisense-specific
all-phosphorothioate
2-methoxyethoxy
methylphosphonate-phosphodiester
-methoxytriethoxy
oligonucleotide-mrna
questioning
imposition
crowds
arabinoside-cytoxan
ca-cyt
mini-coap
vcr-prednisone
oap
stichoposides
cucumbers
stichopodiidae
myt-1
cdc25c
serine-128
serine-216
mutation-dependent
u-937re
9-nitrocamptothecin
oncogene-transformed
-inhibitory
rassf1a
vpau2009u2009cq
epigenomics
auto-inhibition
orthosteric
prednisolone-sensitive
prednisolone-resistance
prednisolone-sensitizing
fcgr1b
polyglutamation
tmq
mtx-resistance
raltitrexed
wiskott-aldrich
wasp
bcr-abl1-induced
thermotolerance
interpretability
originator
gall
arduous
risky
non-natural
denature
lonicera
lj
trypsin-induced
il-2-generated
il-2-resistant
il-2il-12
phenothiazines
hydrophobicity
conforms
non-metastatic
phosphorylationdephosphorylation
peg-polycaprolactone
pclpluronic
p105
peg-pclp105
peg-pcl
p105-mediated
peg-pcl-mediated
factor-dependent
deng
carr
-11673
dichotomy
phosphorylation-negative
s70a
pkcalpha-transduced
equilibrate
rebinding
kon
anti-dnp
saprophytic
htr
digitoxin
30xa0kda
map30
map30-induced
bafilomycin
map30‑induced
9-amino-camptothecin
9-accd
13-oxyingenol
dodecanoate
13od
kansui
13od-induced
nongenomic
retinoylated
ra-differentiation
cytodifferation
falconensone
p-bromophenylhydrazone
bromophenyl
dioxime
nonirradiated
cd44-specific
dnr-triggered
steroid-induced
depressive
obeying
gompertzian
exercising
nondetection
bcrpmxrabcp
nucleotide-binding
nbd
canaliculi
ingested
gf120918
hckstat5
scaffolding-dependent
bcr-abls
fel
g2mitosis-blocking
semi-intensive
flugaza
fluga
xa0pxa
-foldxa0pxa
non-oncogene
glasdegibs
eclipsed
blastogenic
anti‑leukemic
l‑deprenyl
anti‑mitochondria
kg‑1α
ecar
xf
oxidase‑b
mao‑b
mao‑a
‑b
respiration‑
glycolysis‑related
inxa
ultrafine
polyethylenimine
caged
nanoclusters
pei-caged
zerovalent
bv173xa0cell
bio-markers
aml-1cbfbeta
hhr
znf
amleto-eto
znfs
ets-1-dependent
fortuitous
2q37
tq37q23
irfs
irf5
snyder
detectably
intermediate⁻high-dose
fdp-d
2-pi
phosphospecific
leukocytapheresis
beta-actin
bcl-2beta-actin
2000-fold
multi-directional
verbascum
thapsus
mullein
scrophulariaceae
antiquity
iroid
phenylentanoids
gpxin
verbascoside
intrinsic-type
blocker-related
membrane-modifying
graft-versus-leukemiatumor
fucose-rich
alga
cladosiphon
navae-caledoniae
kylin
co-treatments
4-hydroperoxy-cyclophosphamide
pmlrarα-positive
sca-1lin-
pmlrarα-expressing
5-lo-mediated
15kb
epipodophyllotoxic
4qp22
19p13
9p22
palmar-plantar
dnasei
cpg-rich
2kb
trihydochloride
z3hcl
inclusionbackward
zero-order
leukemiamyelodysplasia
granuloblastic
thioproline
fluorbiprofen
a1bfl-1
cd40-stimulated
cd40-triggered
cyclopentenyl
cpe-c
chemo-therapeutic
polycytostatic
raspi3-kinase
rafmap-kinase
map-kinase
p70s6-kinase
pi3-kinasepkb
mci-1
factor-mediated
peptidic
developmentprogression
bim-bh3
072rb
co-localization
l94a
at-9283
astex
ligand-efficient
pyrazole-benzimidazole
scgvhd
21-localized
cystathionine-beta-synthase
polyglutamates
nullify
cd-40
rutaceae
lansiumamide
cell-independent
separable
genetical
dih
kinase-pseudokinase
sh2-jh2
ferm
resurfaced
mlt
superimposable
hplc-uv
fk-506
scf-dependent
rhscf
nucleotidases
anthraquinone--disulfonic
tk-targeting
doxycycline-inducible
u2009m
dnrcytarabine
flu-cpx
chemoprophylaxis
si-27
tnf-alpha-mediated
si-27-induced
methylstat
jumonji
eviction
evicted
topoisomerase-negative
vitroat
progenitorsalthough
bryostatin--8
granulocytemacrophage-colony
factor-neutralizing
cross-infection
tonsillectomy
plasma-cells
8d
pre-established
non-profit
wistarfurth
wfu
myeloblastomas
hyperlysozymemia
cytoxan
bu-sulfan
asta-z
zvp
sequencesabstract
poncirus
trifoliata
plentiful
cyp3a4-a-290g
puberty
p-valuexa0xa
19-fold
genomicchromosomal
anti-nuclear
unit-erythroid
bursts
csfplasma
tukeys
crisisi
idarubicin-aracytine
extrarenal
epuration
deoxyribozymes
dnazymes
rzs
ribonucleotides
serum-resistant
cytofectin
gilead
cfu-mix
anti-b2a2
dnazyme
rz
rna-cleaving
bulls-eye
shp2-selective
ptpn11-associated
ptps
phosphopeptide
shp2-mediated
e76k
anti-shp2
doseschedule
pattern-targeting
k562-ns
impdh-positive
hl60-m
toxicitysensitivity
anti-b1
anti-b4
anti-leu-9
anti-leu-1
reed-sternberg
myelocytemacrophage
antimonocyte
atrag-csf
myeloid-to-erythroid
cheilosis
pkcalpha-mediated
non-pkc
staurosporine-resistant
srk
raf-1mek-1-mitogen-activated
mekmapk
erk1
srks
cardiotoxicities
underrecognized
vasotoxicities
vegfis
head-and-neck
vasculopathy
cvrf
ketonucleosides
electrophilic
kn-35
kn-43
mik1
gardos
rectification
clotrimazole
clt
clt-sensitive
voltage-clamped
hypergranular
mres
rhil-3
dnabromodeoxyuridine
dnaki67
viabilityclonogenicity
diacetatepropidium
paralled
fdapi
e7
mln8237alisertib
alisertib-treated
e7-expressing
destabilized
alisertib-induced
non-hpv
sterilizing
hpv-driven
sapheno-cavernous
dt388-gm-csf
bcl2-overexpressing
toxindrug
drugs--ricin
dff45
sonidegib
odomzo™
bavc
motivations
killer-like
cd11bcd14-cd33
naïvememory
il12
mig
ip10
tilted
lsc-containing
cd34cd123
sl-101
lscsexperimental
il3-induced
p-stat5
impairedconclusions
cd123-targeting
stat5mir-16
flt3-itdstat5mir-16cdc25a
microenvironment-generated
finely
brafi
anti-egfr
misinterpretation
loc100289656
mll-enah
transcriptomics-based
cytarabineanthracycline-based
ndaml
dl1
dl2
dl-1
quantum-first
nct02668653
46xytq22q47xyidem4del6q13q21cpxy4
zeb2-bcl11b
erbin
pi3kaktfoxo3a
mir-perbin
2d-qsar
3d-pharmacophore
gfa
information-rich
descriptors
electrotopological
escountaasn
essumaaac
dipolex
pmiy
thermodynamic
logd
r2pred
schrödinger
pharmacophoric
adhhprr
q2
root-mean-square
rmse
keeper
embryotic
high-binding
killers
acid-soluble
basp1
ae-positive
ae-mediated
thoracotomy
tumor-promotive
hemoblastosis
chernobyl
dosimetry
mfish-method
receptor-t
-301
-253
mzf1-binding
deadh-box
exemplary
kdm3b
hoxa1
mono-methylation
di-methylation
eschewing
vector-mediated
d171n
dysregulating
provirus
transduce
proviruses
itpkb
ccdc12
nbeal2
cbf-2006
runx1-runx1t1abl
nct00428558
aids-defining
nadcs
r-epoch
gvaxαpd-1
sdf-1α-cxcr4
sdf-1α-cxcr4-autophagy
leukemia-causing
adiponectin
apnko
el4-challenged
el4-bearing
cd11bly6chigh
phospho-smad2
mll-tet1
mt1
mt1-related
•
tumor-dependent
hainan
mtor-like
ctor
raptor
ctorc1
rictor
sin1
ctorc2
larp1
ctorc
alpha-chain
il4ralpha
unveiling
folic-acid
camouflaged
type-2
t2dm
sarcoglycan
sgcd
rnd3
cmland
gene-to-gene
scalene
rasrafmitogen-activated
trametinib
mek1mek2
il3-receptor
resections
u2009cm
snail2
non-cell
cross-reconstitution
il-18r
cells-derived
5-fu-resistant
c57bl6n
bcrabl1-stimulated
faulty
bcr-abl1-expressing
mrc-aml
mutationspatients
no-mrc-aml
mrc-amls
interpretive
ipp
mutation-guided
rna-guided
foki
rfns
matures
polyic
3toll-il-1
ticam-1
5ifn-β
ips-1
tumor-implant
tumor-supporting
mfs
fgr1-
tnf-α--
polyic-injected
anti-tnf-α
ticam-1--
88--
ips-1--
cross-priming
cellar
π
θ
gst1
xpo1-selective
ril175
bnl
kc
25course
methylomes
methyl-binding
island-associated
hypomehtylated
decitabine-related
probe-based
npm1cflt3-itd-
npm1cflt3-itd
mubritinib
ubiquinone-dependent
function-related
oct1pou2f1
jmjd1akdm3a
superficially
chemotoxic
cytopenia-associated
megakaryocyte-primed
atg-containing
hfd
nu2009u200993
hfd-hct
nu2009u200959
msd-hct
udhfd-hct
gvhd-modulating
neonate
diethylstilboestrol
pdgfra-rearranged
d-glucosamine
3-o-sulfotransferase
hs3st3b1
3-o-position
glucosamine
heparanase
suramin
3-o-sulfation
vegf-activated
hemoglobinopathy
hhv8-positive
xa0gl
del8qq
clo-tor
g₀g₁-phase
cd34⁺cd38⁻cd123⁺
guanine-adenine-thymine-adenine
monomac
avium
dcml
embergers
deafness
hypochlorous
hocl
mpo-expressing
qua
lin-hla-dr-cd33cd11bcd15
lin-hla-dr-cd14
proteaseprotease
adam12
serpin
ts13
fetuin
leukaemia-founding
interrelations
insidiously
gri
grii
alk-negative
kp-1-positive
8q21
ofmdscs
abrogatingan
heterogeneitythey
gr1cd11b
mhciilo
ly6c
spermatogenesis
unstressed
c-myc-induced
53bp1
p-atm
p-atr
p-chk1
p-chk2
p-tp53
end-joining
γh2ax53bp1
mc38
factor-regulated
imc
imcs
ectoenzymes
mir-215
mirna-215
pvsg
pvsgwho-defined
jak2v617f-positive
ecmp
normocellular
who-et
mpl515
jak2mplcalr
hetero-homozygous
hyperlobulated
stag-horn-like
dysmorphic
cloud-like
hyperchromatic
who-ecmp-defined
who-ecmp
palmitoylationdepalmitoylation
k-ras4b
n-rasg12d
c181s
second-site
nonpalmitoylated
nrasg12dg12dc181s
floly-6c
ccr2-dependent
ag-specific
fhi
vap-1
vap-1-deficient
gr-1cd11b
dampening
combinatorial-therapeutic
cxcr1
death-axis
pd-axis
mdsc-infiltrated
phosphatidylinositol-5-phosphate
4-kinase
pip4k2
pip4k2a
pip4k2b
pip4k2c
related-gene
prediagnostic
pre-mds
male-predominant
mdschronic
t300
ccdc50
chemoattractants
rantes
ptprs
nonactivated
rack1
kitd814v
hscps
mcps
phosphoinositol-3-kinase
kitd814v-induced
kitd814v-expressing
nc23766
kitd814v-bearing
intravasation
colonisation
multi-faceted
haplo-pbsct
pediatric-onset
hla-b51
mucin-domain-containing-3
cholangiocellular
pha-blastogenesis
hypoproteinemia
tet-family
oxidize
fully-penetrant
phospho-h2ax
pertuzumab
tchp
cytogenomic
fret-based
two-component
small-angle
saxs
thermophoresis
revelator
rolontis
eflapegrastim
dsn
adjuvantneoadjuvant
cps-treated
re-exposure
9p24
tp22p24
tp24q11
short-termed
rnai-specifically
2d-dige
differentially-represented
nlc-esi-lit-msms
energyprimary
transcriptiontranslation
gluconeogenesis
glyceraldehyde-3-phosphate-dehydrogenase
α-enolase
70kda
78kda
mentioning
chromobox
e2f-
myc-responsive
protein-jк
rbp-j
rbp-j-deficient
pmn-mdscsxa0but
andxa0stat3
signalling-deficient
cibp
hind
paw
disruption-based
zfns
tlr9-dependent
mb49
regressing
myd88nf-κb-mediated
tlr9-
stat3-deficient
tlr9stat3-regulated
tlr9-mediated
tlr9stat3
tp22q22
runx1-usp42
supervened
ultrasound-guided
core-needle
anti-aspergillus
malignancy-
echinocandin-based
hla-dqb82
dqb01
perforingranzyme
homed
microrna-mir-
runx1-runx1t1-containing
heterochromatic
runx1-binding
eponymous
egf-like
xanthogranuloma
jxg
haematopathology
eahp
co-existent
apotential
cd11bgr-1-expressing
implantable
virus-polyomavirus
cnt
cytokinechemokine
nontumor-bearing
gli-luciferase
activiation
phosphorylatedactivated
wtflt3
leukemic-derived
anti-cd33-calicheamicin
arbitrariness
sdfa
confusable
cd2cd9cd11bcd13cd34hla-drcd117
3-component
cd34cd117hla-dr
acid-based
tumor-acquired
vagus
videoendoscopy
videofluorography
hypointense
petroclivus
npm1b
usp42
semicryptic
usp42-runx1
usp
ave9633
dm4
ave9633-induced
limelight
poison-based
complex-dependent
complex-inhibitor
checkpoint-mediated
bubr1-mediated
post-t-mdsaml
cd11bcd14-mhcii-
cd14-mhcii-
co-purify
inos2
three-marker
mdsmpn-rs-t
mcl1-haploinsufficient
angiotensin-ii
at1
time-pcr
cac
adipose-derived
adscs
mir-92a-3p
antiadipogenic
co-dependency
cebpα-regulated
vlc
restricts
cancer-the
relapse-has
metagenome
evolution-induced
granulomonocytic
colocalizes
gfis
colocalize
miat
microrna-495
mir-495
ihc-aml
ihcaml
quantidex
administration-cleared
armored
calibrators
calculates
thexa0test
50is
single-site
andxa0is
glucose-lipid
hyperglycaemia
hypertriglyceridemia
hyper-low
ldl-cholesterolemia
cardio-
cerebro-vascular
hyperglycaemia-
hypertriglyceridemia-free
n217219
n31005
il3rα
sgn-cd123a
pbd
sgn-cd123a-mediated
nct02848248
cell-clot
hirudin
mhcii
gene-deficient
ifn-γr
ifn-αβ
ifnar1
ifn-γr-deficient
cd8-mediated
ifn-γrifnar1
double-deficient
mhci
lower-level
chicagos
16qp
ccna2
ccne2
bub1
rps14
caudal
cdx1
dysregulates
long-latency
meis1a
armament
htlv-1
htlv-1-associated
myelopathytropical
spastic
paraparesis
hamtsp
evi-1-positive
tamltherapy-related
im-sensitizing
imsgs
imsg
pkcη
sun-induced
skin-homing
no-producing
cd11c-
β-defensin
hbd3
ccr2hbd3
imiquimod-treated
microrna-p
spag9
46xytq24qtq34q
tq24q
46xytq24q
der22t
46xytqq
trc8rnf139
dysgerminoma
chylous
lymphangioscintigraphy
cisterna
chyli
parenchymal
capped
uncapped
predictions-the
relationships-which
scalable
700-kb
atg2b
gskip
cd34brightcd133
cd45dim
mdsc-induced
autophagy-marker
vegfjakstat
paradoxal
bptes
sc-203048
hoxa9meis1-transduced
ahi1
pitpnb
ak039950
collaborators
nsg-s
n77
co-injection
1xa0cll-1
cll-1-specific
cll-1car-ts
specificxa0activity
formationxa0of
cll-1car-t
mdsc-exosomes
exo
mdsc-exo
c262t
pro198leu
ala16val
afflicting
intricacies
pharmaco-economic
gelsolin
gsn
pip₂ca²⁺-regulated
hypogelsolinemia
traumatic
gsta1
leu21arg
bcl2larg
leuarg
argarg
relapseresistance
non-ds-aml
treatening
cutting-edge
hdac2-mediated
hdac2-downregulated
mutateddeleted
tet2--
lin-sca-1c-kit
lsk
monocyticgranulocytic
tet2-
mpd-like
α-2-antiplasmin
antitrombin
chmfl-abl-039
cellsxenograft
mutant-mediated
hoxc6
gmpscmps
hoxc6-induced
genes-
tp53-have
pre-apoptotic
ecto-crt
mc-mdsc
hdc--
il-17-expressing
aomdss
30xa0nm
cotyleninxa0axa0cn-a
lc3-iilc3-i
bafa
rs3865444
rs12459419t
ad-relevant
ldlt
pd-1-exhausted
optical-based
thirties
acetylome
rarest
cd68-kp1
cd68pg-m1
brca1-associated
antiglioma
gl261-ova
siinfekl
hindleg
cd4t-bet
cd8siinfekel
indolamin--dioxygenase
papulo-nodular
mono-nuclear
7q31
astrocytic
80-yr-old
47xx46xx4
myelodysplasic
atra-suppressed
maturation-related
itga4
itgax
integrin-controlled
hscprogenitors
expediting
sg2
mir-29a-expressing
tet2--flt3itd
cd48cd150-
remodeled
elf-mf
shocks
nocca
populated
pauf
pauf-overexpressing
cell-injected
tlr4-mediated
pauf-induced
pauf-neutralizing
iat
directional
stereotypical
neglect
cd45-positive
ctc-mdsc
amegakaryocytic
amegakaryocytosis
myelography
benign-like
gls1
gls2
gac
gack320a
tricarboxyclic
cbfaaml1
devolution
clec5a
dnax
mdl-1
pu1-null
mir-1206
rs2114358
pre-mirnas
acidragmtorc1
slc1a5
l-ase
l-ases
l-ase-induced
adaptations
pattern-recognition
pam2
lipopeptides
pam2csk4
dc-priming
progressioninvasion
eg7
cfse-labeled
tlr2-positive
pam2csk4-triggered
nonsensitive
cll-like
venetoclax-sensitive
7-trihydroxy-4-methoxy--hydroxy-3-methylbutyl-flavone
icariin
ica
herba
epimedii
mrp8mrp14
4t1-neu
s100a
s100b
ca2-binding
tq12q24
ho-1-
chemoattractant-induced
ho-1-induced
lncrna-h19
effectortarget
cd33-redirected
knockouts
crisprs
activator-like
talens
talen
talen-based
crisprtalen-based
kos
deletionsmutations
post-transcriptionalpost-translational
-3σ
cby-σ
nontumoral
ccr1-deficient
cyclin-a1
a0201-restricted
peptide-pulsed
a0201-positive
cyclin-a1-specific
leukemia-testis-antigen
kmt2amll
12p13
bcr-pdgfra
mucocutateous
glanzmann
thrombasthenia
iibiiia
macrophage-secreting
bitransgenic
megakaryocyteerythrocyte
mep
lin⁻
emphysema
bca
intra-tibially
intra-cardially
lysmcretgfbr2floxe2floxe2
lysmcretgfbr2
tgfbr2floxe2floxe2
mda-mb-231-injected
tibiae
mapk-extracellular
erk-cfos
p-smad2
signaling-mediated
linc00662
rho-associated
rock1
overexpression-mediated
linc00662mir-prock1
brink
multi-serine
cfu-fs
cfu-f
cfu-f-derived
r72p
cfse-labeling
becn1-deficient
myeloid-deficient
becn1δm
hypersusceptible
mekk3
neutrophil-b
cxcl9cxcr3
il-21stat3irf1
cd40lerk
reintroducing
klf4-mediated
klf4-regulated
myc-regulated
klf4-overexpressing
occupationally
organochlorine
pesticide
polychlorinated
pcb
cmst
mthfr
c677t
a1298c
haptoglobin
1298aa
1298ac
brg1
brahma-related
m52
dusp10
mtmr11
ptpn4
time-sequential
state-space
state-transition
developmentsee
kuijjer
consortia
anthracyline-intensive
nrasg12v
promoter-tetracycline
vav-tta-driven
repressible
tre-nrasg12v
raserk
nonautonomous
oncogene-activated
nsc95397
bn82002
alx1
alx2
alx3
alx4
atras
atra-elevated
atra-elicited
ischemia-reperfusion
unrelenting
parethesias
fasciotomy
srt
ligand-activated
stemregenin
sr1
sr1-treated
ltc-ic-derived
non-sr1-treated
ficz
breast-cancer
il-1α
tslp
il-1α-tslp-mediated
idh2-mutant
fluorizoline
prohibitins
phbs
pmfs
copies104abl1
aucu202fu202f
transcribe
tcr-ligation
tcr-activated
signaling-relay
il-6-to-il-4
gm-csfil-4-to-il-10
il-4r
il-10r
il-10-mediated
undiminished
meis1ahoxa9-driven
re-instigation
differentiation--which
mir-29b-3p
p38mapks
mek5-erk5
transmits
vdds
bix02189
vdd-induced
-omics
featuresin
blastscombining
mirror-like
evolutionoverall
nontarget
telomere-mediated
development-a
decoded
ptms
δnpm1
ligandome
δnpm1-derived
hla-a-binding
claveevsl
peptide-hla
hla-a-positive
tcr-transduced
neoantigen
hcps
semi-structured
worries
peroxynitrite
il-1β-expressing
cancer‑associated
leukaemia‑1
metformin‑induced
mitochondria‑dependent
metformin‑treated
mir‑26a
anti‑proliferative
mir-26a-induced
ly6ghighly6clowgr1highcd11b
ly6g-ly6chighgr-1intcd11b
infringe
re-inducing
ifx
idh1-specific
nod-scid-il2rγnullmice
checkups
hybridomas
isotype
sephacryl
s-200
sc1
ag-identical
pp65-antigenemia
asxl2--
asxl2-
lin-ckit
aml-dcs
nf-κbp65
chemotherapyfour
cd45-
amlallogeneic
pseudokinase
exited
p19
non-censored
g-formula
right-censoring
pseudo-observations
petrous
mastoid
e-twenty-six
alboflavescens
saprophyte
lilrb
lilrb2
shp
lipidcholesterol
delta-like
dlk1-maternally
3meg3
dlk1-meg3
dlk1
fpd
ihc-based
non-pr132h
reaction-negative
flt3-f691l
mutation-selective
amlsee
998this
lung-recruited
ccl12
asn80
lys80
kir2dl1
hla-c1c1
hla-c1c2
67pu2009u
nonreactivated
hla-c2-negative
signalling-1
jak1-stat3
cue
cuedc2
amlaccording
high-cuedc2
elongin
cullin-2
cul2
socs1s
enteroendocrine
5-ht
peristaltic
re-uptake
sert
nu2009u2009319
nu2009u2009297
5-httlpr
rs25531
httlpr
bowel-blood
papc
sfa
cnf1
microbiologists
colonised
shotgun-based
perls
siderotic
circumference
rcmd-rs
rars-t
tq22
q22tq34
tp24
oxidant
oxidase-deficient
p47
phox--
oxidase-independent
parenchymaexperimental
i-mdsc
nephrectomy
mip-1α
mdscresults
anti-il1β
growthconclusions
anti-cxcr2
skk-1
f-36p
ohn-gm
best-matching
t8p23q23p23
cltc-alk
guthrie
etv6-lyn
four-break
tp13p
der1
8qq
1p13
phb-cell
tyr177
grb2gab2
bcr-abl1-evoked
bcr-abl1-transducedgab2--bone
2-containing
gab2-shp2
phhematologic
mirna-126
traf7
e2a
e12e47
ebf1
b-lymphopoiesis
c-kitsca1lineage-
subunit-1
ebf1-deficient
-dihydroxy-vitamin
vitd3
vitd3-mediated
e2f7
v-myc
hetero-bifunctional
hbl-4
protac
mvu202fcells
fusion-gene
usemonitoring
gene-length
receptor-ligand
tunneling
tnts-long
cross-talk-are
tnts
light-electron
open-ended
trans-silac
tnt-mediated
stroma-provided
vivo-morpholino
vmo
chemotherapy-sensitized
hla-drlo
best-defined
cd14hla-drlo
idohi
cll-cells
anti-cd40
trimerized
tmz-cd40l
cd40l-mediated
copiesµg
trigeminal
hypoesthesia
anthracycline7
hypothesia
felis-infected
linc00319
ucsc
fus
fus-dependent
auto-bmt
30u2009000
idh-mutants
idh-targeted
primary-
secondary-aml
r2u2009u
clinical-use
cross-reacting
il2-receptor
nsgs
macrophageshistiocytes
entirety
ligandomes
25u2009000
litaas
ligandome-derived
litaps
maged1
multipeptide
anti-ley
postinfusion
in111-labeled
ley
car-t-cell
census-based
network-wide
bicebpα
hypermutator
adaptability
response-monitoring
chip-like
motivate
ccas
icterus
cd200-cd200r
monocyte-dc
mlrs
mlr
cd200-cd200r-blocked
interleukinil-27
toxicity-free
il-27s
il-27receptorr
cxcl3groγmip2β
oct4a
nestin
snai1snail
snai2slug
macrophage-driven
colliquative
cxcl3
pluripotency-
il-27r
pre-cancerous
advancer
stemness-
cd15high
cd33low
cd15low
cd33high
chemokinescytokines
ccl3
abnormalitiesgenetic
p22q24
dnmt3ar882
spt-16
torsional
samd9-like
samd9l
miki
subband
samd9l-deficient
samd9l-
samd9l--
ligand-bound
tumor-conditioned
b16f10-bearing
tumor-infiltrated
cxcl1-
cxcl2-induced
cell-differentiation
dichorionic
diamniotic
low-birth
l-mdsc
interchromosomal
ihr
jak2v617f-mutated
chromatids
jak2v617f-mutant
nup98hoxa10homeodomain
na10hd
ltc-ics
lenti-na10hd
virus-transduced
phbcr-abl
factor-producing
repopulated
na10hd-transduced
adapts
hifs
sabotaging
dual-role
msi2-reporter
spatiotemporal
syndecan
β7
sdc1-itgβ7
consequentially
t334i
bcr-abl-nilotinib
compactness
re-orientation
inwards
solvent-exposed
resistive
atopy
flexural
metagenomic
gallolyticus
azoxymethane
sulphate-induced
colorectums
myeloid-cell-derived
arg72pro
p53arg
p53pro
misrepair
murill
pabm
pstat1
nether
tlr2--
paraplegia
hyper-
hypo-methylation
cis-regulatory
fine-tuners
neutrophil-specific
cherkasy
traction
847-amplicon
raindance
deepseq
paired-sample
unmatched
hapmap
artifactual
nonunique
replicates
nonreproducible
microdroplet-pcr
biotinylation
cd166alcam
cd166
h8
duocarmycin
8nm
compound-mutant
e255vt315i
stromal-
tdfs
ordinarily
irf8--
mitigates
fatalities
mylofrance
46xxadd1p36
der2tq21q21del3q21der10tq32q24derqter--2qpqppterxx2
fuserg
16p11
nm004960
sub-band
nm004449
tr1
tr2
hospitable
disseminating
colonize
intravasate
stoi
constructions
conceptions
co-determine
un-conscious
microrna-204
theapoptotic
birc6
anti-carcinogenic
-449
amlxa0most
flt3-itdxa0cell
species-generating
dsorder
subverts
receptor-deficient
tnfr--
tnfr-2
tnfr-1
flice-inhibitory
tnfrs
oxidase-derived
oxidasenox2
ag-presenting
th0
nox2-deficient
nox2-sufficient
lc-msms-based
remodelers
hydratase
agonist-driven
hepatotoxicityexperimental
chemokinesresults
interleukin-27
melanomaconclusions
interleukin-27-producing
kupffer
lissencephaly-1
lis1
rs4790348
rs4790353
rs7209748
glucosylxanthone
anacardiaceae
nrf2-antioxidant
rosemarinus
llc-bearing
anti-growth
anti-lung
freund
cfa-induced
n-nitro-l-arginine-methyl
objectice
cd52-positive
saline-injected
hematologistoncologist
macro-
4d
sema4d
hnscc-secreted
line-derived
cd33cd11bhla-dr-low
anti-sema4d
cd8t-bet
hydoxyurea
cd34thy
all-sil
publically
gse-database
genomeexome
innocuous
resisted
bmi1-transfected
collaborated
chip-pcr
zmym3
deacetylase-containing
mir-32
mirna-processing
drosha
antisense-mediated
arabinocytosine
m909
c30-frβ
t6q26q25q21
g-
suppressive-function
organ-and
bz-aml
bz-exposed
novo-aml
bz-exposed-
bz-
bortezomib-treated
nrf2-regulated
bortezomib-mediated
nrf2-inhibitory
bach1-inhibitory
rs62527607gt
pvt
downsizing
fragment-length
677tt
677ct
1298cc
677ct1298ac
677tt1298cc
klrk1
hnk1hnk1
high-cytotoxic
activity-related
hb-1
hnk1
tyr174
maffucci
nonhereditary
enchondromas
hemangiomas
enchondroma
invagination
c863864instctg
pw288xa0fs
c392395gtcgxa0xa0ctct
pg131r132xa0xa0al
hemangioblasts
haematodermic
pathogen-induced
ly6c-
trem-1-expressing
mor
slaughtering
aides
janitors
decalcified
amplifiable
t-mdsc
t-cell-dependent
fao-related
brca-proficient
dr⁻lin⁻cd11b
dr⁻lin⁻cd15
dr⁻lin⁻cd33
dr-lowcd14
cfse-based
cryopreservationthawing
csfe-labeled
dr⁻lin-cd15
β-glucans
ly6clow
dectin-1
yeast-derived
end-expiratory
thc2
ankrdutr
c-125tg
c3ga
c105cg
bosutinib-treated
cp2l
cp3l
helicase-like
abnormalitiesp
cd34hematopoietic
tgfbr2-deficient
propria
1-phosphate
eif2α-p
matrix-modifying
factor-4
atf4
eif2α-patf4
cells-stroma
burkholderia
cepacia
infect
disinfectants
tumourigenic
tki258-treated
early-age
i-aml
prenatally
i-amls
adjor
rs1051740
rs1051740-rs2234922
c-g
fully-pledged
scholastically
superseded
somatically-acquired
polyp
mir-146a--
traf6nf-κb
mir-146alow
traf6-mediated
p62-traf6
mir-146a-deficient
v-myb
pax-5
ccng1
ccng2
hist1h4c
maz
arnt
brafv600epten--
ccl11
dendritic-cell
phagocytize
ikkβca
dnpparγ
dnpparγ-flag
il-7rα-lin-c-kitsca-1-
lin-scalc-kit
cd11bly6g
doxycycline-treated
myeloid-autonomous
portability
nanoprobes
hemato-oncological
3u2009min
9u2009db
genosensors
ohsv
itu
r84
virotherapy-mediated
mirtarbase
mv-xa0cells
kat6a
leutx
19q13
kat6a-related
atp-gated
atp-mediated
vivooverall
mir-26a-5p
mir-23b-5p
cd34-selected
nu2009u200969
krba2
rrbp1
hist2h
2be
response-like
atf4-bound
stress-responsive
isrib
nodshi-scid
il-2rγnull
tam-derived
prl-3-depleted
cd274
cd279
cd152
1d8
cd273
european-descent
life-style
myeloperoxidase-negative
cd11bly6gly6clow-
tumor-imposed
lymphangiogenic
vegfs
quantityquality
posit
cellular-based
ire1α-xbp1
xbp1
xbp1s
mkc--hydroxy-1-naphthaldehyde
hna
stf-083010
toyocamycin
p-jnk
p-pi3k
p-mapk
disturbs
paclitaxel-
carboplatin-based
postpaclitaxel
twentieth
underdiagnosed
bac-based
membrane-targeted
venus
mvenus
fibrocytes
scapula
vertebra
7p22
environment-dependent
autophagy-deficient
autophagy-mediated
tgf-β-dependent
87-yr-old
runx1-mecom
jak2v617ftp53-mutant
-iodobenzoddioxol-5-ylthio--isopropylaminopropyl-9h-purine-6-amine
pu-h71
pursuance
1-translocation-ets-leukemia
tp13q11
e26-transformation-specific
cd4-cd8-
mn1-tel-positive
n-ethyl-n-nitrosourea-induced
hes-1
lmo-2
ink4aprb
arfp53
nonlineage-specific
npm1-unmutated
18d
pd-1ctla-4mdscs
zrf1
ra-regulated
nosxa0gt
894xa0gt
nos3
rvsp
trump
jshct
nullified
ionising
bm-mononuclear
endotype
stat6-dependent
nobiletin-treated
nobiletin-mediated
-therapeutic
l-bpdcn
cutaneous-involved
poromas
adnexal
poromatosis
occuring
precancerous
antigenicity
co-opted
tweak
cog-national
mbnl1
elf1
myc-itd
convergently
finger-encoding
age-tailored
seer-18
mds-sld
lactobacillus
rhamnosus
species-specific
myb-binding
gfi
mybs
differentiation-blocking
south-asian
provenprovable
lasting30
ab-producing
elotuzumab
lesions-what
myeloid-in-myeloma
compartment-variably
deters
myeloma-associated
myeloid-derived-suppressor
marrow-the
niche-or
myeloma-infiltrating
redressing
sars-cov-2
prognosticates
habitual
setups
notch4
pan-rar
mdsc-il-10-stat3-dnmt3b-irf8
amlclinical
tp23q34dek-nup214
chromatin-modifier
cd98
perfusing
bm-mscs
economicn
furthern
non-aspergillus
neutropenicn
between-patient
reanalyzing
genomic-clinical
multistage
likelihoods
high-purity
4xa0×xa0108
pedigree
shelfshore
leaps
cd33∆e2
membrane-distal
cd33fl
cd33e7a
cd33∆e2e7a
cd33fl-mediated
greater-than-previously
nadp-dependent
alpha-kg
ecmv
cmv-seropositive
tumorgenesis
ve-465
mitoxantron
ky821
synergisticadditive
phospho-chk2
chk2-mediated
types-including
cells-that
flow-sorted
cd34cd38low
anti-cd36
pre-vaccination
premalignancy
intraductal
ipmn
muc1-specific
aesculetin
mono-nucleated
cd40cd40l
glioma-bearing
ifn-γ-production
tumor-antigen-specific
myoglobin
creatine
ck-mb
ctnt
ctni
heart-type
h-fabp
gpbb
tumor-expanded
apoptoticsurvival
tgf-β1-induced
haem
htra2omi
non-tuberculous
nct00018044
nct00404560
nct00001467
nct00923364
leukemicpreleukemic
preleukemicleukemic
leukemia-stabilizing
zhang
receptive
trendu2009u
drinkers
non-coffee
amendments-approved
ultralow
nr1iag
8055ct
cyp3aga
abcbga
nr1igg
8055tt
7635a
8055c
receptor-regulated
nr1i2
hepatobiliary
intermediate-thickness
in-transit
morphogenetic
3-kinase-related
non-balansed
aneuploidias
ptprg
chptprg
tpγ
cancers-ie
cancer-to
igk
oct2
bob1
chronicize
intergroupe
leucémies
myéloïdes
chroniques
bites
darts
redirect
xenotransplantion
tumor-favorable
k562-derived
dickkopf-related
exosome-treated
ofxa0no
leukemia-reinforcing
trem-1-positive
pd-l1-blockade-mediated
tam-induced
tam-associated
kinasenf-κβ
ccr6
tam-mediated
pre-stable
ten-eleven-translocation-2
t11
succumbs
biddye
y253c
s265r
f359y
n374s
d363g
tumor-directed
tumor-based
pyroxd2
luciferase‑based
sk-hep1
fingerxa01xa0mzf1
trans-activator
cis-element
tgggga
self-association
dot-1l
t-rearranged
ras-guanosine
mll-af6-rearranged
ras-gtp
co-silencing
sagittal
ssst
seizure
nicotinamide-adenine-dineucleotide-dehydrogenase
cytochrome-b
cyt-b
oxidase-i
cox1
atp-synthetase
f0
subunit-6
t-c
adaptive-response
pre-leukaemic
acetylations
hhtacr
byty
rosine
inhibitorstkis
tkisimatinib
ichinomiya
decem-
hypophosphatemiabgrade
dasatinibtreated
improvementp
-in
20-lb
wright-stained
microrna-577
glutaredoxin-1glrx1
glrx1
controversially
6kg
mlkg
cd34cd19
cd34cd45dimcd19-cd10-
endowing
ecm-mediated
ecm-myeloid
m-csfr
glutamine-derived
glutamate-nmda
icb-resistant
urd-sct
5cbfb-3myh11
slit-robo
myelo-
idh1r¹³²
idh2r¹⁷²
flt3l-mediated
tkflt3l
therapy-mediated
yd‑15
post‑translational
t‑bid
myc-associated
sel24-b489
g-749
ttt-3002
ff-10101
uncontrollably
r-as4s4
well-demonstrated
cml-mscs
gene-profiling
bmp1
mitf
pdpn
podoplanin
mr-mscs
changedthe
bcr-abli
-177
x-box
er-resident
erse
nfy
atf6
yy1
gcsf-mobilized
post-auto-hct
anthropometric
nt-1
ph-bcr-abl-
passaged
str-pcr
array-cgh
tq31p13
mycoplasma
petrochemical
lentiviruses
suppressivetolerogenic
p-ampk
mtorp70s6k4ebp1
post-surgery
humara-positivemsi-negative
humara-negativemsi-positive
humaramsi-
cross-present
bdca3
ifn-i
srpk1
med24
hypofractionated
carneus
liposomial
ingravescent
defervescence
vermiform
flavipedes
terrei
tq26q24
hla-well-matched
hla-partially-matched
hla-partially-
riskor
mdsc-produced
cellsmultipotent
cfu-s12
unirradiated
5-flurouracil
nonstem
cxcr2-dependent
cd81-deficient
dc-10
hla-g-expressing
mutationinactivation
hippel-lindau
vegfr1cd11b
avastin-mediated
rcc-conditioned
4-hydroxy-2e-nonenal
gck
mutant-driven
10d
10g
11i
single-digit
10k
baf3-nras-g12d
rate10p
non-syndromic
hedgehog-initiated
cxcr4-cxcl12
axl-gas6
cd33cd11bhla-drlo-
aged-matched
cfse-tracking
rgd-engineered
adrgd-il-24
inducement
grp78bip
mll-afq31-positive
cebpɛ
gene-promoter
ure
runx25
mll-af4-positive
lsc-gene
antagomir-126
pmel-1-specific
adoptively-transferred
ccr2--
counter-regulatory
maculo-papulous
deformability
curti
theirex
vivogmp
inhibitor-2
tfpi-2
regimen-
g6pdu2009
g6pd-u2009patients
g6pdu2009u2009patients
ciu1
g6pdu2009-u2009patients
nct01252485
xa00
upd-
pig3
anti-cd30
highly-upregulated
titrating
mirna-seq
kitw-sh
sash
littermates
rns
rosrns
rosrns-associated
rli
neuro2a-bearing
effect-elicited
reactivity-does
anti-solid
ifn-γ-expressing
ifn-γ-and
b-expressing
neuro2a
intra-tumor
systemic-and
intra-tumoral-expansion
rli-induced
anti-neuroblastoma
host-type
cardiogenic
cardiogram
non-sole
nu2009u2009131
nu2009u2009716
leukocyte-platelet
thrombogenesis
nilotinib-binding
let-7c
pbx2
let-7c-pbx2
marrow-based
interleukin-33
damp
st2
ilc2s
nagoya
eytan
stein
seishi
ogawa
analysis-based
poisson
phomogeneity
nonsignificantly
bonejoint
atra-containing
nested-reverse
blood-proliferative
ze
less-frequent
68u2009000
correlation-based
subclone-specific
non-human
cmp-n-acetylneuraminate-beta-galactosamide-alpha--sialyltransferase
st3gal
mir-224
let-7i
st6gal
iv-induced
ips-ml
ips-mlinterferon
system-mediated
ips-mlifn
es-mlifn
es-mls
β-ml
γ-ml
e14
h-2b
h-2kb
i-ab
h-2d
colon26
infiltratedxa0into
mhc-deficient
hla-deficient
ips-mlifn-β
idarubicin-related
mirna101
repressesed
ctbp2
microrna101
mdscs-microrna101-ctbp2-stem
extrinsically
9q13
9q21
9q32
daenaehaeia
n-glycoproteins
carcinoma-induced
n-linked
thrombospondin-1
melanocyte
interconnects
favouring
instigate
tnf-stimulated
peak-like
mitflowc-junhigh
log-normal
cmtm5
cmtm5-v1
t17q21q23q
long-distance
mll-mllt11
myo18a-mll
myo18a
vsv
rhabdovirus
vsv-binding
tumor-killing
incapability
evi1-high
evi1-internal
ires-green
hsc-reporter
evi1-ires-gfp
cd34cd38-cd90
evi1-low
receptor-signaling-induced
finger-1
eatp
eatp-mediated
cd39-targeting
pom1
anti-cd39
lung-infiltrating
anti-cd39s
nalp3
il15
outcomes--disease
relapse--are
discard
intricately
homingadhesion
aml-niche
melanoma-induced
foxp3cd4cd25
water-drinking
melanoma-bearing
judicious
shca1
bcr-albt315i-driven
cd4cd25regulatory
tregs-derived
stimulation-dependent
cd4cd25-effector
teffs
il-35-derived
transfusion-related
trali
pneumocystosis
cd11b⁺
gr1⁺
bm-cd11b⁺
ptr
parous
pf-0444913
pf-913
gli-nanog
gli-target
receptortoll-like
c-mir146a
mir146a
irak1
t-cell-induced
monocyte-dependent
cd19-specific
nf-κb-related
mdsl
irf-8
irf8-mutant
tgcoro1amertk
neoplasia-like
irf8-mediated
pang
dimethylation
mir-22
c17orf91
exploded
monocytic-mdsc
granulocytic-mdsc
fah
chronicled
∼6000
searchable
doi
sights
orthogonally
regulatable
hscmpps
myeloid-restricted
rasrafmapk
pik3r1
microrna-125b
mir-nc
p-iκb-α
simutaneously
catecholamines
β2-ar--
β2-ar
arginase-i
β2-ar-mediated
β-ar
β2-ars
ptpip51
aas
duolink
dpla
clinicobiologic
apl-like
cd15-
leukaemia-retinoic
kmt2a-mllt3
53xxx6tpqder9tpqdup13q31q22
multiplex-fish
mllt3-kmt2a
surface-expressed
anti-vap-1
videomicroscopy
metastasis-the
lymphoendothelial
m-lecps
myeloid-lymphatic
m-lecp
pitoctunc
pou
pou4f1
ae-dependent
intuitive
alv-j
chickens
breeders
egg-type
scau11-h
scau11-xg
myelocytoma
broiler
breeder
hprs-103
env
gag
3-utr
alv
multi-pathotypes
elusiveness
backtracking
non-t315i
endothelia
laser-microdissected
anti-npm
mismatched-unrelated-donor
49th
hemoptysis
parent-of-origin
cognition
adaption
embryonic-like
cbah
sfpi1
two-mutation
x-ray-
neutron-exposed
neutron-induced
x-ray-induced
rbe
neutrons
mtgs
corepressors
mtgr1
mtg16
mtgr1--
mtg16--
goblet
apc1638-dependent
sex‑determining
y‑related
high‑mobility
anti-cytotoxic
epigenetic-modulating
escaping
latrophilin
rapamycin-dependent
cancer-expanded
anergy
rivaroxaban
fxa
hiwi
n-desmethyl
tumor-propagating
nonhierarchically
near-identical
contextually
tumor-borne
transmissible
cross-presentation
medlinepubmed
isiweb
noninvasively
11u200au
314u200a×u200a10l
13u200as
31u200as
30u200as
16u200as
aggregometry
adenine-di-phosphate
epinephrine
pp95r
pg12d
ps471fs
pr204x
nfe2
pq139fs
tribbles
variously
non-therapy-related
hemophilia
aha
hemorrhaging
jiroveci
gestant
sarcomaacute
lymphomaleukemia
lymphomasleukemias
preceeding
escalated-beacopp
sapporo
hokuyu
diabeticltsz-severe
il2rγcnull
stss
dysgalactiae
subsp
equisimilis
sdse
stg2078
hemodiafiltration
fasciitis
influenza-like
eosinophil-induced
fip1-like-1-platelet-derived
endomyocardial
valvular
tricuspid
annuloplasty
non-dominant
reminds
pt110i
pq510l
polyomavirus
mdsc-containing
cd84
overproduced
permissible
tatton-brown-rahman
tbrs
parg882his
hypotonia
fissures
hernia
chiari
u20093
denies
unfaithful
h2o2-induced
damagerepair
baf3-migr1
baf3-bcrabl
apg-2
baf3-bcrablt315i
dnmt3a1
dnmt3a2v
uba2
wtip
uba2-wtip
e1enzymefamily
vaeubl
wtip-mediated
2polycomblike
mtf2pcl2
mtf2-prc2
mtf2-deficient
mtf2
discov
duy
melnick
1348this
enos
pxa0
factor-1-positive
myelodysplestic
cervical-uterine
amland
bilateral-flank
peri-sacral
pou5f1
lin28a
t-distributed
tsne
pseudotime
fgfr
ifi-related
cd3zeta
cytokine-targeting
dipeptidylpeptidase-iv
dppivcd26
sdf-1-cxcr4-axis
chemotaxin
nod-scid-il-2rγ--
cd26─
bcrabl1-
emt-regulated
sicam-1
pai-1
emt-transcription
emt-derived
emt-positive
long‑term
cd11bgr-1xa0cells
lymphocytesxa0ctls
cd8xa0t-cell
sil-2rboth
concentrationp
tq26q22
eap
anabolism
bi6727
1foxm1
high-fat
clusterization
overactivates
jak3stat3
anti-m
alloantibodies
isoagglutinins
ahg
crossmatch
antiglobulin
auto-regulate
il-32θ
no-il-32θ
il-32γ-induced
5-methyl
5-hydroxymethyl
tpen
h2o2xa0≫xa0jnk
nf-κbxa0xa0c-jun
p73xa0xa0puma
baxxa0xa0loss
δψmxa0xa0caspase-3xa0xa0nucleidna
n-acetyl-cysteine
hpblcs
os-mechanism
curettage
multi-disciplinary
post-menopausal
endometrium
pf-06747143
fc-effector
17cxcr4-low
p15cxcr4-high
pf-06747143-treated
cytotoxicity-activating
ncrs
hd-nk
ncr1nkp46
ncr2nkp44
ncr3nkp30
ncrbright
ncrdull
negativepositive
erased
microrna-326
mir-326
lap-positive
mrdlow
eal
dnbs
i-all
proxi
ethnic-geographic
precursor-all
cd226
reflex
procarcinogenic
tff2
vagally
denervation
tff2-expressing
pu1-mutated
pu1-binding
reorganisation
k607n
k607
e877
k607a
k607g
e877a
k607r
e877d
jh1jh2
jak2-stat5
4nqo-induced
romanian
clinico-hematologic
pl21
hdaci-mediated
deprive
mdsc-driven
disseminateinfiltrate
microtextured
videoscopically
topographically
inter-population
velocities
traveled
homogeneoussorted
cryoprotectant
identifications
buffered
washes
hdac8-selective
hdac8i
hdac8-mediated
p53-inactivating
variegation
programbe
8qq22
n-cor
c₂h₂
2-kb
microrna-92a
mir-92a
polyfunctional
ccna1hla-matched
ccna1-specific
non-protein
peptide-mhc
iatrogenic
noxae
non-physiological
peptidyl-prolyl-isomerase
pin1
acute-promyelocytic-leukemia-specific
pin1-targeted
client-protein-binding
wearable
actigraphy
ptn
anti-ptn
mdsc-dependent
mdsc-independent
kmt2a-mllt10
nxa0xa019
nephrosclerosis
2xa0h
cardiography
synonym
brd9
swi-snf
bromodomain-swap
domain-swap
paralyzing
dicarbonyl
methylglyoxal
semicarbazide-sensitive
micrometastasis
anakinra
pyroptosis-induced
amplify
gene-5
mda-5
engulfed
mda-5-activated
allo-grafts
ly6chigh
allo-grafts-transplanted
allo-skin
rpm-caused
metabolism-relevant
mdscs-mediated
studys
cox-2pge2
tlr2cd14
tlrmyd88
gm-csf-
il5-dependent
il5
epigenetics-based
enforce
non-biased
super-resolution
egfr-independent
preexistingexpected
hml
nct00413439
low-quality
oncology-dutch-belgium-hong
strictness
hnrnp
rested
tg-mediated
ly6gcd11b
4-pba
reducer
cxcl1kc
reducers
patientsu2009age
k562ir
meterk
metjnk
pro-apoptoticxa0agent
e₂
gliomagenesis
mdsc-attracting
cd11bly6ghily6clo
ccl2-mediated
cox2-deficient
ccl2-deficient
asa-treated
cxcl10-deficient
gr-1cd11
capillary-like
anti-ccl2
anti-cxcl16
monocytic-
granulocytic-like
cd11bgr-1high
cd11bgr-1int
cd11bgr-1low
tumor-released
ihd
suita
framingham
nanotheranostics
cellsb
tbreg
tbregs
tgfβr1tgfβr2
tgfβr
kinase-inhibitors
slowincomplete
cbfb-myh11-positive
inv16-type
prc2-mediated
linc-223
therein
cts
radiologists
over-diagnosis
β3-integrins
β3-integrin
sβ3-integrin
nk-κb
morgana
nonrecurrent
underexpressing
mll‑af9
amlxa0with
gse68643
gse73457
mll‑af9‑associated
chip‑seq
usingxa0reverse
setdb1
desilencing
retrotransposable
dsrnas
dsrna-sensing
asb2
dna60
dna90
prc1
prc1-target
hsc-associated
recreated
t-cell-directed
dual-affinity
retargeting
dart
cd3×cd123
vh
3ra
target-effector
b-lpd
polymorphous
rna-1
hodgkinreed-sternberg
tumor-microenvironment
cell-secreted
secretome
lymphotoxin-α
lta
jak2stat6
tnfrsf14
pd-l1pd-l2
gene-activity
surmise
rectus
cell-transplanted
cd82
pkcα-mediated
macroporous-biomaterial
toll-like-receptor-9
cytosine-guanosine
sourced
evoking
biomaterial-based
cd157bst-1
receptor-enzymes
ribosyl
mo5
bst-1
nad-metabolizing
mt3
nonlife-threatening
multi-omics
lipidomics
isotopic
u-13c
monounsaturated
misdiagnosing
therapy-based
septins
mll-sept2
subjacent
mll-sept2-associated
tetanus-toxoid-specific
diethylnitrosamine
trem1-deficient
den-induced
inxa0silico
hoxab
foxc1-repressed
foxc1high
derepressed
anti-cd244
ago2
custom-made
sh-s7ar13as--dimethoxy--dimethyl-aatetrahydro-3h-chromeno-bpyrano-hchromen-7-ol
ago2-mediated
non-hepa-filtered
eortc-msg
anc500
p139
amlthirty-six
fungusintensive
rheb
primersprobes
parallelly
n6-methyladenosine
m6a
fb23
ftos
chemoaml
pgc-1α
chemotherapy-driven
cd11bgr-1dullint
no-dependent
gr-1dullint
cd49d-
needy
aml-initiating
u133a
beta-catenin-dependent
oncogeneic
transducing
y-box
sox4-expressing
sfpi1ko
cell-sorted
dysregulate
stat3y640f
sta21
kinase-signal
headway
methylation-modulating
tcf12
ubl7-as1
tq21q22
demonstrations
healthspan
rapalogues
debilities
infection-prone
suppression-mediated
metagenomes
meriting
gfrs
mpps
high-penetrance
inflicted
subvert
programa
español
tratamientos
nct01193400
mono-allelic
mre11
msh2
helicases
unwell
peripancreatic
antituberculous
lymphadenitis
nf-κb-inducing
nik
nik-induced
querying
arexa0present
nik-stabilized
verteporfin
17-yr-old
non-proliferative
cml-triggered
neoplasm-associated
scf-kit
cells--a
bso-induced
prolyl
hydroxylase
kinasepkc-δmtor-dependent
redox-dependent
activation--an
template-based
snaq
epo-independent
hsccmp
all-stage
strauss
ror1c
aml-affected
dcleudc
ifnα-dc
leukemia-patients
infα-containing
ifn-git
gm-csfifnα
dcleucells
aml-mnc
mcm-mimic
picibanil
calcium-ionophore
dcleudc-stimulated
dc-stimulated
dc-generating
mncwb
pici
ifnα-containing
gm-csfifnαtnf-α
non-ifnα
ifn-git-produced
troublesome
nhe1
cariporide
bcrabl-dependent
pkc-β
nrf-2
nhe1-induced
pkc-βp38-mapk
non-genomic
targetome
co-enriched
radiosensitizer
myeloid-origin
tumor-secreted
host-secreted
inhibitor-treated
rt-qpcr-negative
ligand-loaded
pten-long
pten-l
16u202fbp
cug513
rs12573787
cug
argentine
rs1257378
parpi
brca-mutated
olaparib-mediated
myeloproloferative
birdem
e14a
haemato-oncological
il-6-mediated
rebalance
bcr-ablstat5c-myc
stat3multi-drug
redress
chapters-except
malignanices
dkk
sfrp
wif
cd14cd33cd34
gm-csfil-4-supplemented
ctl-suppressive
cd11bcd33
cancer-promoted
ep2
ep4
ctl-inhibitory
vaccine-derived
mumps
n-mdsc
ironically
sunitinibs
mdsc-conditioning
stat3-dependent
peroxynitrate
mpc
mpcs
demargination
pbrm1
constitutions
ecog1900
aml-42
aml2
pten--
pim-induced
chk1-dependent
thr11
unphosphorylated
280ala
pim-dependent
amlcml
relapsedsecondary
barretts
l2-il-1β
barretts-like
k14-cdx2l2-il-1β
cirrna
hsacirc100290
rab10
mir-203rab10
artocarpus
tonkinensis
maesopsin
4-o-β-d-glucoside
tat-2
oci-aml
maesopsin-dependent
sulphiredoxin
srxn1
hemeoxygenase
hmox1
bcas3
lppmir-28
lipoma
stat5-p53
lep
atp5j
gtf2a2
npy1r
npy5r
m133k
fms-like-tyrosine-kinase-3
cyto-protective
40-yr-old
directs
wild-typenpm1
wild-typecebpa
neo-telomeres
telomere-based
autotaxin
atx
lysophospholipase
lysophosphatidylcholine
lysophosphatidic
g-protein-coupled
atx-expressing
virus-size
gof
trp53r172h
tp53r175h
foxh1
typesthis
imr2
imr3
overactivation
mpm2
mitochondrion-mediated
tafs
sdf-1acxcr4
taf-treated
t-mdscs
taf-derived
sdf-1a
taf-mediated
acetylators
341t
590g
14a
5c
14e
6b
6f
slow-acetylators
vpa-conditioned
il-4rαarginase
anti-ra
armas
ra-binding
co-migrated
nf1-
neointima
neointimas
gene-dosage
rosuvastatin
neurofibromin-deficient
f-fdg
c-choline
re-expansion
calibrator-normalized
a-containing
calibrator
aabl1
gastro-esophageal
reflux
anti-topoisomerase
intermitting
prokinetic
hypokinesis
depressing
transcriptionxa05
regulationcheckpoints
xxa0proteinxa0bax
non-bcr-abl1
speciesxa0ros
h2axxa0γ-h2ax
sh-
minutexa02
tpp53bp1
hemato-oncologic
turn-around
short-range
presynthesized
pretested
amortized
post-cml
non-post-cml
rtr
pi3kprotein
rheb1
positive-predictive
negative-predictive
well-managed
phu2009u2009primitive
mi-219
p53-activating
534xa0ngxa0ml-1
iq
-xa0ngxa0ml-1
500xa0ngxa0ml-1
xa0ngxa0ml-1
re-initiating
aml-containing
disease-unrelated
co-transplanted
car-based
cd123dim
cart123-based
nexus
dendrites
aminopeptidase-ncd13
anti-cd13
hl-60m2
nb4m3
thp-1m5
u937m5
anti-cd13-mediated
∼200-fold
suppressorregulatory
cd4foxp3
ifn-γ-producing
proautophagic
lymphocyte-induced
contradicting
mutz3
hla-binders
hemopoietin
ras-addicted
cre-loxp
krasg12d-associated
p110α-selective
mek162
ras-mutated
urgenly
gm-csfr
fip1-like1
fip1l1-pdgfa-positive
fip1l1-pdgfrα
hes1-transduced
interleukin-3-dependent
t674i
d842v
flp1l1-pdgfrα
etpmf
tnfrsf19
foxd4
pde4a
mnda
coro1a
gnai2
non-macrophage
tumor-permissive
apc-driven
interception
post-kidney
aspects-from
regimen-have
subcohort
microrna-125a
rt-pcr-based
rdb
recklinghausen
ras-activity
long-bone
fracture
engendering
progeny-osteoclasts
osteopeniaosteoporosis
qpcr-based
prmt1
h4r3
co-recruitment
kdm4c
kdm4cprmt1
moz-tif2
felv
clone33
ltrs
47-bp
gm-scf
high-levels
domest
widely-applied
bml
odk-1201
otsuka
spatio-temporal
lymphocyte-variant
v-cbl
reconcile
pfg
diseasesimplication
hoff
ace1
ace2
angts
scn
next-
llgl2
zc3h18
aml1eto9a
ae9a
trypsin-like
hat-l4
exocrine
clavicle
facultative
g9aglp
ehmt
chip-sequencing
repositions
aml-enriched
heterochromatin-associated
p-valueu2009u
erroneous
6p21
drb1
marmoset
callithrix
jacchus
ataxia-pancytopenia
samd9ls
nystagmus
expert-based
pineal
ruvbl2
mpsss
lentinus
edodes
xylose
mcgr32
mdscs-related
fcmrd
signification
k562-ir
cd34-cd38-
tissueorgan
leukemiccancer
tyrosine-kinase-3
stat5pim-2c-myc
ccndcdk
mir-128alin28a
egr2
zfp36
macrophage-oriented
aplaml
stakeholder
interleukin-1β
cxcl11
pheno-types
engrafters
nodscidil2rγnull
opn-32xa0kda
timp-1
opn-32kda
mir-125as
de-methylating
mir-125a-low
inaccuracy
qcc
qrt-pcr-based
coamplification
pme-2
out-of-control
qccs
re-training
hands-on
andxa0malignant
wexa0observed
jak2v617f-induced
serms
b-all-derived
tumor-expressed
nos2ros
ifn-γrstat1
mpv
valuesthe
chemotherapythere
levelshigher
ifn-γ-deficient
il-4rα-deficient
balbc-derived
mdsc-macrophage
30xa0530
secondarytherapy-related
samltaml0
samltaml
extraintestinal
germ-free
pathogen-free
hyper-susceptible
recolonized
early-life
mdr1-c1236t
mdr1-c3435t
adjusted-or
t-mdstaml
apc-haploinsufficient
stunted
pfu
gkt-aml8
znf465
znf466
hgnc
near-kozak
mnpm1-
cebpαp30
cebpαp42
fixed-
funnel
val105
gstt1p
q-value
i9
i74
diversify
axa0spectrum
limitxa0tumor
micexa0in
myeloidxa0cell
bloodxa0showed
timsxa0this
metastasis-suppressor
hla-a0201-restricted
azurophil
reinstate
perpetually
bearers
ductility
hematopoietically
hhex
wgp
wgp-treated
fcd11c
dectin-1-dependent
cd14-hla-dr-cd11bcd33
cells-mediated
osteopetrosis
nonexistent
conquered
tolfenamic
tol
ampiroxicam
yd-15
abl-1
disease-propagating
microenvironment-derived
h-like
hlx
pparδ
hlx-induced
lectine-1
rs16910526
rs3901533
rs7309123
rs5743708
rs4986790
rs4986791
rs4988453
rs4988457
gtgg
cd56brightcd16neg
cd56brightcd16low
kir-expressing
dosage-dependent
subverting
pirin
pir
eight-twenty-one
bindung
proteinp300
anti-pd1anti-pd-l1
--4-o-4-o-β-d-glucopyranosylcaffeoyl
qa
pi3kδγ
reshaped
resultantly
diseaseifd
followings
10xa0to
non-metastasis
nme3
nsc67657
cd11bcd14
valgus
accorded
hox-associated
chemical-induced
nrf2-deficient
selenocysteine-trna
trsp
selenoenzymes
-cyano--dioxooleana-11-dien-28-oyl
cddo-im
sudanese
khartoum
rick-sudan
inhibitors-based
regionimprinting
dmricr
anthracycline-associated
dexrazoxane-associated
butxa0is
undruggable
hoxa9meis1-driven
butein
butein-induced
p53-downstream
proteasome-independent
p53-expressing
butein-mediated
prame-expressing
prame-specific
subtype-selective
chidamide-induced
cd200-positive
j558
p815
cd200-negative
tamc
il-10-deficiency
dms
r-hyper-cvad
dm-containing
tq21q26
vent-like
ventx
xvent-2
non-tumor-bearing
nod-2
mis416
anti-cd11b
chronic-type
leukemia-lymphoma
q27
remissive
nano-meter
glioma-stem
gsc
gcs-derived
gsc-derived
pulp
periarteriolar
pals
strategically
normal-density
runx1-cbf2t1
pro-leukemic
lipocalin-2
lipocalin-2-induced
jak2v617f-harboring
jak2v617f-
silymarin
synthases-2
ciapin1
k562cml
ciapin1-depleted
p40-related
ebv-induced
il-35r
il-35-producing
rag-deficient
il-35-treated
broad-scale
stymied
mutation-bearing
hybrid-capture
umis
str-based
trackable
relapse-associated
timepoints
kdm6a-null
axiomatically
division-to-death
shrink
hypotensive
hyperkalaemia
nopho-aml-88
-93
trds
jmjd1c
mll-af9-
a9-driven
hoxa9-driven
hoxa9-controlled
ctfh
ctfr
s1p3
gse24946
atoamn107
deviationaverage
dab2
ap2m1
e13
redox-sensitive
rna-induced
riscs
d3-dependent
mir-p20a106a
endocrinological
pi3kptenakt
pt618i
ps715x
pq774r
ps783q
pq754k
pr769h
pl777f
pt781i
s795r
pl367
th9
skm-1azac
expressionefflux
1-chloro--dinitrobenzene
fasl-deficient
post-infection
generalisable
tdtcytocd3cd79aweakly
tdtcd79acytocd3weakly
tp11q12
zmym2
hyper-cyclophosphamide
multivesicular
mvb
explicating
obligatory
edged
smarter
reverse-transcription-polymerase
tibd
multi-facetted
aligning
promotors
osteoclast-mediated
1d11
tgf-βrii
tgf-βriimyeko
argininosuccinate
synthetase-1
ass1
ass1-deficient
importing
deiminase
adi-peg
20-resistant
auxotrophy
posttranslationally
mll-wildtype
mll-wt
slc5a8
protein-smct1-short-chain
smct1-expressing
silences
hematopathologyeuropean
cd34lineage-cd38-
muc1high
muc1low
cell-conditioned
erases
pge2-dependent
pge2-
dnmt3a-dependent
pseudozyma
aphidis
rdna
fustls
co-occupies
rxrrara
myeloid-differentiation
hl-60r
daunorubicin-sensitive
hyperbasophilia
⩾1000
-baso
özdemir
zc
düzenli-kar
canik
küskü-kiraz
bör
ö
presepsin
soluble-triggering
turk
pre-sep
presep
master-tumor
epitomized
motolimod-induced
cd3cd28-activated
6-fold
tdg
tdg-dnmt3a
dnmt3-like
dnmt3l
s714c
unrearranged
bmncs
ccl9
metalloproteinasexa09
ips-ml-ifn
ips-ml-ifns
cd169
metabotropic
grm4
grm4--
rb1-
il23
osteosarcoma-conditioned
grm4-dependent
osteosarcomas
il23il12
il23--
interventionsee
1484this
l-arg
arginase-dependent
clik-148
z9
hgf-expressing
coactivated
aki603
aura
iarc
dispersive
spectroscope
matter-derived
manova
highly-reactive
non-biocompatible
non-biodegradable
organicinorganic
intra-bone
marrow-bone
ibm-bmt
bmttt
microbe-host
tuft
mucus
thexa0colonic
cell-epithelial
resorting
cc-chemokine
gr-1-
outgrowths
bl5923
cd11bgr1lo
cd11bgr1hi
pi3kγ-mediated
α4
rasgrpcaldag-gef-iii
rap1a-dependent
α4β1
caldag-gefi
rap1a
rap1
riam
p110γcaax
rapv12
pi3kγ-rap1a-dependent
hyphomyocetous
keratomycosis
onychomycosis
viscera
crust
floccose
grayish
crescent-shaped
macroconidia
microconidia
falciforme
gl261
pc61
cd4cd25hifoxp3
brain-infiltrating
pc61-treated
cd34cd38-aldhhigh
transcript-1
re-introduction
therapy-failure
sequence-independent
3p-sirna-mdr1
reduced-drug
mechanisms-of-action
acid-inducible
protein-i
rig-i
ddx58
complex-i
phosphoinositide-3-kinase
byl-719
ds-5272
hif1α-pd-l1
wt1…
non-parenchymal
npcs
factor-a
granulocyte-monocyte-colony
synthase-2
nos-2
t5
antral
lipopolyplex
gti-2040-tf-lps
tf-lps
il-17f
il-23r
il23r
rs2275913
g-197a
il17f
rs763780
a7488g
his161arg
rs11209026
g1142a
arg381gln
npm1-muta
matings
120-kda
ilt4
tfl
pxa0cd1c
ilt4cd1c
edmondson-steiner
ilt4-
ctd
beetle
atmatr
cgk733
ctd-induced
cell-killing
tothova
hla-a2-binding
pan-dr
hla-a2-positive
pwt126hla-a0201
re-stimulation
acs
overestimation
haemangioma
ih
smc4
condensing
structuremobility
oncogeneanti-oncogene
translationsynthesis
hinges
direst
obscurewe
dtx
cd11bly6gly6clow
cd11bly6g-ly6chigh
dectin-1-m1
chemoresistence
secretorycytoplasmic
clusterin
sclu
family-s100a8
anti-cd14
s100a9high
lipopolysaccharideinterferon-γ
vegfr2kdr
cd34u2009stem
106kg
u2009stem
si-a20
predispositions
blackfan
reclassify
leo1
serine-dephosphorylated
sustenance
ch-related
cancer-suppressing
relb-p52
jsi-124
nf-κb-mediated
stat3nf-κbido
mtg8
mtg16-null
mtg16-deficient
e2f2
memory-like
preactivation
interleukin-12
restimulation
chromatin-associated
dnachromatin-binding
protein-genome
unheard
masquerading
otitis
externa
hrct
etv6-pdgfrb
inhibitor-imatinib
currentlymyeloid
ko143
mddcs
superantigen-specific
cd25foxp3
il-10-dependent
t315i-mutant
gclm
glycolysis-related
artefactual
carcinogen-induced
model-specific
microbead-based
ahfrt
cfrt
oligometastatic
telpdgfrb
hepipdgfrb
rabaptin-5pdgfrb
git2pdgfrb
tp53pdgfrb
wdr43pdgfrb
heterogenetic
circulate
il-6stat3
p53r273h
puma-dependent
roslow
roshigh
subfraction
megakaryoblasticerythroid
erythro-megakaryocytic
gata1s
mk1775mk8776
ve-821
mk1775-mediated
tet2nras
23rd
berman
flt3itdneg
pre-malignant
tcrζ
kmt2a-usp10
usp10
mll-mllt1
48xx8tq23p
non-leukemia-restricted
cell-recruiting
resultswhile
rangtpase
rangap1
mir-1301
rangap
tyr-99
p73-dependent
stat3sirna
tlr9-positive
cpg-stat3
cpgtlr9
two-pronged
tlr9-targeted
pre-mirna
mirnamirna
duplexes
mir-223mir-223
receptorphosphatidylinositol
hmd
arsentrioxid
mir-155-targeting
anti-correlation
microrna-tumor
microrna-oncogene
insertional-mutagenesis
cooperators
deregulations
reverse-engineering
gene-ontology
pharmacoeconomics
biosimilar
intracardiac
cv-ae
cv-aes
high-very
5cpg
dab2ip
h-cadherin
methylation-controlled
cd45low
cd117⁺
cd13-
drhigh
cd203c⁺
capacityin
intra-abdominally
∼3
nonangiogenic
asxl1-driven
p53dd
trp53-deficient
myelodysplasiamyeloproliferative
re-named
hlx1
ct-3
radgc-5
weaver
craniofacial
ppro132leu
smaml
amlsm
hypothesise
reminiscence
subset-associated
mags
cd34cd38cd45ra-
megakaryocyte-erythroid
meps
cd34cd38cd45ra
granulocytic-monocytic
regularised
multinomial
regularisation
gse6891
tet-off
tolerized
coinoculation
il-4r-deficient
il-4-mediated
csf-treated
diseaseevent-free
patients-320
nilotinib-was
n-glycans
st3gal5
st8sia4
hl60adriamycin-resistant
mutative
cmt167
tumorsimplications
myelo-monocytitc
ly6cg
tumour-conditioned
tasquinimod
survaxm
superantigen
m2-polarized
withxa0haematological
tet-induced
5hmc5mc
withxa0myeloid
alterationsexperimental
parametersresults
relapseconclusions
purposefms-like
inhibitionexperimental
vivoresults
amlconclusions
egr3
rectify
neutrophil-predominant
misspliced
one-mutation
receptor-bearing
lymphoma-associated
fc-engineered
fc-optimized
4g8sdiem
university-owned
recruitmentmigration
gelectin-3
erect
flaccid
corporeal
shunting
tractor-binding
protein-associated
psf
redistributive
hl60dox
recurrentunusual
polycomb-repressive
ring1b
enhancer-interaction
thexa0myc
genome-editing
etps
ofxa0pre-leukemic
ras-signalingxa0pathway
setbp1-induced
setbp1-mediated
nurd
tcf-responsive
γ-catenin
catenins
γ-
tcf-dependent
sertraline-induced
sertraline-caused
furnishing
gene-fusion
multiplex-nested
kmt2a-mllt11
kmt2a-mllt6
embryological
hla-a-restricted
p3-expressing
pr1-ctl
34a
pd-lutr
disfiguring
integumentary
nu2009u200945
cp-chronic
pyrrole
gene-selective
48-hour
210u2009kda
p210bcr-abl1
major-breakpoint
high-mobility-group
sox12
tcfwnt
e2f-1-driven
m1e2f-1egr-1
m1e2f-1
il-6-treated
nonfunctional
amlnpm1m-aml
mir-708
microrna-9
pan-raf
azacitidineu2009u2009venetoclax
cutissubcutis
rasrafmek
jakstat5
dodns
stat3-specific
stat3dodn
cpg-stat3dodn
cpg-stat3dodns
blockingtlr9
reducedcbfbmyh11mplaml
cd8cd4
2stat3
waxing
waning
monocytedendritic
mdc2
r-loop
e7107
h3b-8800
lsc-associated
camkii-γ
its-associated
malignanciesthere
factor-1alpha
u937t
cells-specific
shrnas-inhibited
hif-1beta
differentiation-critical
hif-1alpha-mediated
nontranscriptional
protozoic
viña
lophomonas
protozoa
self-administered
monochrome
b220cd19cd43sigm-
rearrangedmyeloid
cd11bmac1
il-7-
ligand-containing
mll-af4-induced
noninstructive
q21q33
usingeosinophilia
childandpdgfrbas
wanfang
eosinophils×l
irf9
ociaml-3
obtains
oppose
sirt1-p53
sdh
fronto
temporo
parietal
duramater
macrophage-colony-stimulating
prepubertal
nf1but
3-modified
prmts
carm1
2b4
tolerates
empyema
tapping
hypochondrium
jak2v617f-expressing
vera-like
countspercentages
gr-1mac-1
cd56cd3-
donor-versus-recipient
nct00799799
papillomavirus-
hpv-related
hrhpv
cafs
prosperous
cancersxa0it
thatxa0the
demonstratedxa0to
essentialxa0forxa0obtainingxa0better
thexa0hpv-tumor
microenvironmentxa0has
thexa0host
b3a3
p203
labor-
facilitators
tbo-filgrastim
lcs
langerhans-like
mutz-lcs
tlr-
il-23p19
tlr2-activated
tlr2-mediated
cu-cpt22
migrating
peroxynitrites
subdermally
lymph-node
mca207
aml-style
prame-negative
prame-positive
5-aza-2dc
nxa0xa-log
ifish
qpcr-ifish
stent-graft
mycmir-150mybmir-155pu1
mir150
300uu2009000×
ngs-q
in-house-designed
laboratorys
analyzers
rs1801157
rs2228014
cd11bgr1highlow
c26gm
reconstruct
aml-afflicted
polyphyllin
polyphylla
cleaved-caspase-3
phosphorylated-jnk
ppi-induced
cy-mdsc
16-associated
tu-mdsc
cd86mhcii
estrogenic
endocrine-disrupting
bisphenol
bpa-induced
bpa-suppressed
nfat1
readout
pla-flow
olfactomedin
olfm4
myeloid-lineage-specific
alpharetinoic
leukemia-193
e-bp1
phosphorylationdeactivation
olfm4-mediated
non-transplantation
cd34cd38cd117hla-drcd13cd33
ζ-chain
verifying
phosphodiesterase-5
fip1l1pdgfra
chic2
multimodality-based
disruptor
edcs
butyl
phthalate
bbp
lipoamide
pdk4
bbp-induced
mir-15b-5p
mir-15b-5ppdk4
ko-induced
ko-reduced
t157
mis-localization
tnf-α-mediated
pi3k-akt-p27
picalm
consequential
endocyctosis
homo-oligomerize
multitasks
v600epten-null
aomori
prefectural
countermanding
azd-2281
ku-0059436
h2afx
blockade-resistant
mϕ
havexa0been
mycoplasma-infected
mϕ-protective
mcd16
mϕxa0xa0nkxa0xa0cml
trioculture
sheddase
mϕ-mediated
granulo-monocyte
cd34u2009u2009cd38u2009u2009
376a-3p
376c-3p
mir-4739
-4516
unilineages
mir--5p
-29b-3p
morbiditymortality
sirtuin
divalproex
dvpx
k562-s
k562-g
p-bcr-abl
up-modulated
scan-zinc
scan-zf
co-repressors
syndromea
full-thickness
flaps
analysishistopathologic
follow-upin
nf-κb1
traf3
rs28362491
rs11160707
rs12147254
rs201786064
rs5743836
rs187084
eif3b
lof
setd2-mutant
setd2f2478lwt
setd2ex6-kowt
mll-af9setd2
resensitizing
setd2-like
ltd4
lt1
bronchoconstriction
coincubations
γ-glutamyl
transpeptidase
ggt1
serine-borate
sbc
ggt
affirming
leukocytoses
insq11q34q34
p190-type
mllptdwtflt3itdwt
mll-wt-to-mll-ptd
mllptdwtflt3itditd
tbgfp
tr-fret
mirnomes
mir-214-pre
mir-19a-5p
mir-19b-p
mir-27b-pre
mir-23b-pre
mir-320e
mir-200a-pre
mir-33-pre
mir-766
cancers1
states-collectively
biologyxa0linked
variant-to-function
chek2
fap1
vsv-interferon
ifnβ-sodium
symporter
nis
ifnβ
vsv-murine
mifnβ-nis
vsv-mifnβ-nis
c1498-green
vsv-specific
gfp-specific
pentamer
vsvanti-pd-l1
fold-change
tf-gene
tf-mirna
mirna-tf
subnetwork
tcf3
counter-balanced
tamcs
cd200-cd200
activationeffector
cd200-cd200rs
cd200-cd200r-targeted
nash
ire1α-ko
diabetes-nash-hcc
nash-hcc
hottip
crel
heat-killed
vaccae
obuense
eqtl
cml-susceptible
rs963193
rs6931104
rs9371517
rmnd1
meiotic
rfx3
moxifloxacin
re-establishing
6-benzylthioinosine
6-bt
glut-1
mkxa0
arrayed
barcodes
tnfsf13
tnfsf13--
tnfrsf17
l-mscs
hematopoiesis-supporting
osteo-chondroblastic
developmentalembryonic
l-msc
tes
erv
ervs
erv-derived
13u2009810
n9963
n3847
high-stage
ficz-responsive
ficz-induced
lsc-regulating
ficz-mediated
enacts
perduring
a--control
b--vaccination
c--vaccination
p53-specific
ablδexon7
abl35ins
hematopoiesis-regulating
kit-ligand
ltc-ic
mpn-mf
jak1
jaki
mass-cytometry
il-7r
hsp90i
ruxolitinib-persister
ruxolitinib-resistant
beti-based
stat3c
ccsp-rttateto7-cmv-stat3c
bronchioalveolar
mdsc-stimulating
inf-γ
proto-oncogenic
assertive
water-emulsion
dpcrddpcr
protein-vorinostat
nano-vorinostat
myopathy
mpn-u
rasburicase
3xa0d
protectant
actrn012605000095662
listeria
listeriaat-infected
f16-il2
cytokine-release
card9
dysbiosis
card9--
aom-dss
mycobiota
cxa0tropicalis
factor-88
aβ
carcinognic
tumorspecific
mb49c57bl6
adcd40l
cd11bgr-1intlow
splenocyte
tilts
allogeneicautologous
alloauto-sct
aml-free
angioregulatory
angioregulation
tipe2
factor-α-induced
8-like
specifying
protein-β
tipe2-deficient
mfp
syncytin-1
membrane-localizing
fusogen
syncytin-1-expressing
gbm-associated
bregs
cd155
cell-depleting
up-taken
booster
8-finger-breadth
re-administered
palpated
4-finger
polyradiculoneuropathy
intraneural
eifs
eif3d
age-sex-matched
36b4
age-corrected
acrtl
smf
∼14
off-tumor
frβ-specific
frβ-redirected
ha-frβ
stat3-inducible
s100a9-null
calicheamicin-g
sfpi1bnbn
th22
non-complete
rorc
conjointly
reanalysisxa0of
sex-related
reanalysis
bio-availability
pharmacogenes
introductions
brafv600
ndcs
ndc
intramural
sisbh
jejunal
haematochezia
bleed
ucp2
6-phosphofructo-2-kinasefructose--bisphosphatase
multisteps
signaling-3
socs-3
eng-t
cd123cd3-bispecific
cd123-eng
antigen-dependent
redirected
homeotic
clt030
cll1-adc
cll1-expressing
cd33-adc
currend
anti-coagulant
hydroxycarbamidum
ccnt2
tki-free
ii-restricted
cml-exclusive
data-mining
abl-bcr-derived
hla-restricted
tumor-exclusive
furtherly
tnf-α-tnfr2
cd4cd25high
th17u2009cells
rad
ﬁxed-
newcastle-ottawa
metmet
thrthr
carcinoma-associated
f-mulv
f-mulv-infected
cb17
non‑erythroleukemic
lm-pcr
f-mulv‑infected
il-3u2009rαcd123
csl362
affinity-matured
fcγriiia
csl362-dependent
ik6
car-redirected
arexa0a
sequence-binding
erkmapk
r-mediated
5‑aza‑2‑deoxycytidine
methylation‑specific
tumor‑suppressor
ac-220
irc-083864
onesimportantly
re-induce
sanger-sequencing
single-mutant
fragment-analysis-based
inconsistently
licenseidentification
soot
creosote
inks
tanning
orsu2009u-
malat1
reovirus
overturn
oncotherapy
virus-based
post-go
semi-nested
foundational
sponged
inversed
abolishing
myelolipoma
yellowish
reddish-brown
well-circumscribed
subtotals
hesc
hhscmpp
h3k4me0
iroquois
il-21
pba2
cytcl-1
tq33p13
g-mdscin
cell-cytotoxicity
il-1-αβ
tb-cells
macrophagesthis
q-statistic
egger
oru200au200a
pu200au200a518
pu200au200a262
pu200au200a820
pu200au200a186
pu200au200a376
gagg
pu200au200a024
unconventional
prefoldin
rpb5
interactor
surpluses
uri-induced
17a
hepatitis-associated
xiap1
cml-lscs
ma9
ma9-driven
knockdowns
ma9-aml
allo-hsct-related
brca-1
ret-mutated
cancerexperimental
t-cell-suppressive
hncresults
cd66bcd11bcd16
cd11bcd16
hncconclusions
misdiagnoses
ven-hmas
sheaths
outflow
pcop
csf-t-cell
subarachnoidal
spheres
positivenegative
negativenegative
positivepositive
high-hyperdiploidy
cluster-forming
rma-s
lymphoma-infiltrating
ccr5-deficient
cpg-mediated
zic2
aml193
oci‑aml2
assam
cyclic-amp-response-element-binding-protein
coactivatorshistone
mll-p300
t11q44q13q23
q8h
q6h
cd34cd38cd123hitim-3hi
c82
kbm5t315i
leukemiamsc
bcr-ablt315ie255v
pri-724
nodscidil2rγ
nodscidil2rγ-null-3gmsf
polprasert
myelodsyplasia
myd88-tlr
b16f1
sca-1ly6a
ves
per-formed
lppqqpqpq21
llqlqqqpqpq
patietns
cmns
ppm1d
aneugen
v79
peptide-loaded
nitration
nitrotyrosine-positive
nonresponsiveness
nitrotyrosine-negative
pathogenically
keratinization
clippings
-induced
mir-20a106b
dram2
curcumin-mediated
side-to-side
blockade-mediated
irf1irf8
11q23kmt2a
2a-rearranged
tkat6a-crebbp
kmt2a-mllt3-driven
chordc1
kat6a-crebbp
plcbeta
plcbeta1pkcalpha
plcbeta-dependent
degenerative
nox2--
cd40--
cd40-expressing
cd80-positive
cd40-positive
cd14hla-drlow
myeloid-dependent
vδ1
dot-cell
polyclonality
b7-h6
lcl521
c16
lcl521-induced
necroptosis-independent
heterolysosomes
let-7e
mir-99b
cd14hla-drneg
tamoxifen-inducible
gata2-estrogen
ert
gata2-ert
gata2-ert-expressing
nmyc
anti-cd64
h22scfv-eta
u937scid
loosely
nonstimulatory
tumor-myeloid
t-cell-interacting
crossroads
allies
ripk3
il1r1--
pycard--
hru
standardise
donor-activating
kir2ds3
diagnosesmethods
well-powered
outcomesimpact
apc-like
vγ9vδ2xa0t
n-bps
isopentenyl
arg882his
non-cooperative
methylate
dnmt3b-specific
dnmt3a3b
arg878his
dnmt3a-preferred
dnmt3b-preferred
akxd
retrovirus-induced
nf-k9
jsh-23
iztrail
g-protein-coupled-receptor-1
ogr1
ogr1--
coinjection
tramp-c2
ogr1--mice
2rγnull
cntrl-fgfr1
ezh2-silenced
wntβ-catenin-related
ezh2-knockdown
gsk3α
tivantinib
arq197
pan-gsk3
licl
gsk3αβ
hla-a02-restricted
prame-peptides
hla-a02prame
alphabetatcr-peptide
sb743921
e1a3
e8a2
e12a2
garenoxacin
elr
tumor-bone
multifunctionality
chilean
non-self-limiting
kansl1
lnk
rt-qpcr-based
consumes
nonhuman
mll-
mir-106b25
mir-137
mir-a
semi-resistant
caspase8
circrna
hsacirc0075001
subgroup-specific
adcy7
recovery-a
re-
hospital-acquired
kinase-associated
mydgf
c19orf10
monocytemacrophage-derived
upf0556
p4hb
rcas1
bxel
glu-leu
macrophage-expressed
dehydrogenase-a
ldh-a
cd86high
mcp-1high
ifnγ-producing
tc1
lactate-driven
wac
dis3
cd11bcd33cd14-hladr-
bdca1cd14
bdca1
leucin
ll-37
prokineticin
vegf-independent
ceacam1
ceacam1-deficient
anti-bv8
anti-g-csf
anti-ceacam1
rag--
g-csf-bv8
kir-m
cripple
dentist
neutropenias
extra-hematopoietic
r396q
reportedgata2
r204x
e224x
r330x
a372t
m388v
low-penetrance
modest-sized
nominal
penrich
discernable
rs10836347ct
rs13347ct
rs1425802ag
rs11821102ga
rs713330tc
rs13347c
rs13347cc
oru
ciu34
rs13347t
sh-2
cytokinesreceptors
pseudoneutrophil
pcss
pseudocell
fcɛriγ
vβ
il-2il-7
il-7il-12
antibodyil-2
antibodyil-7
il-12il-7
cd3cd28il-2
cd3cd28il-7
phosphoenolpyruvate
2-phosphoglycerate
regresses
regress
megakaryoblasts
non-blast
migraine
ukm
pu2009high
crispr-cas9-mediated
ct8m
8pq
ube2v2
golga7
fnta
mir486--a
mosaicisms
hna-3a
hna-3
nasopharynx
retropharyngeal
perivertebral
6x4
vallecula
preepiglottic
--epigallocatechin-3-o-gallate
egcg-induced
sphingomyelinase
aktenos
anti-erectile
probeset
dap-kinase
isoflavone-provoked
erk1-erk2-directed
p38-mapk
tyr15-phosphorylationinactivation
genistein-provoked
over-accumulation
genistein-induced
raf-1mekerk-mediated
pi3k-dependent
uncoupled
thisxa0hierarchy
prototypically
lineage-determining
de-differentiate
reacquire
hypopyon
glaucoma
masquerade
uesd
prr95ci
rr95ci
poorit
α-related
shrna-resistant
wt1-silenced
transactivates
wt1-dependent
geneticists
blnk
cd79
engulf
freeze-thaw
uvb-irradiation
fibroadipose
cd99-deficient
exchangeable
bm12
graftversus-host
calcium-calmodulin-dependent
iiγ
camkiiγ
deceasing
schiff-positive
intra-alveolar
bronchiolar
inextricably
blt2
lps-potentiated
myd88-blt2
aggression
lps-driven
myd88-blt2-linked
visfatin
52-kda
adipokine
si-visfatin
mir-135ail-17pi3kakt
ldh-a-depleted
lactate-treated
ketogenic
aml-most
tumorigenesis-initiation
tα1
ta1
tlrsmyd88
nonclustered
mll-enl-induced
cdkn2a-encoded
h3k27me3-mediated
strand-specific
cx3cr1-positive
maladies
nongranulocytic
cx3cr1-negative
cd11b-positive
cn-specific
elane
reappear
hostile
tumor-linked
activating-transcription
chop-deficient
mdcpdcs
mdcspdcs
insq23pp
btn3a1
butyrophilin
mir-4792
pre-mds-sc
mds-sc
cell-focused
rad3-related
stalled
forks
vx-970
granzymes
il4
il4-induced
crisprcas9-genetic
manner-findings
prostanoid
sw780
urothel
class-negative
dcll9718a
mcll0517a
disulfide-labile
xa080
96xa0hours
non-binding
nkl-code
nkl
hmx-group
data-available
hmx1
hmx2-indicate
hmx2
circa
eol-1
hmx3
hmx
il7-
wnt-signalling
tnfanfkb-
ets-site
nfkb-site
sp1-site
reporter-gene
ets1elk1-
epx
receptor-encoding
htr7
erk-signalling
gw1929
gw9662
t0070907
γ-transduced
dimerize
dnmt3a-
invading
tinnitus
vertigo
e6
e8
e12
e20
c3a2
e6a3
rs683369
rs776746
rs628031a
gau202fu202faa
rs683369g
cgu202fu202fgg
ggu202fu202fag
affymerix
genechips
u133
p21cip
ifit1
gdf-15
redd1
redd1mtor
deferasirox-treated
tuberin
up-stream
e7-specific
interferon-
invasionmetastatic
lmp1
extra-mitochondrial
k48-ubiquitination
p62-dependent
autolysosomal
lmp1-mediated
j173
lmw-ha
l178
neutrophiliashift
nadsirtuin
1-mediated
hif1α-driven
α-fp
off‑target
panning
m2‑derived
kasumi‑1
aml‑selective
isxa0lessxa0understood
system-wide
flt3-itd-specific
cml-im
cnp
cnp3
canines
gd3-based
mhcii-
leukemia-particularly
leukemia-as
laminated
sited
piedmont
rtextig
cristae
hif1αhif1β
tq25p
tpr-fgfr1
neoplasm-like
tpr
phosphatidylserine-targeting
2ag4
repolarized
m2-
bavituximab
inv11q21q23
magnet-activated
gag-p24
pd1-based
vaccine-elicited
ab1-gag
vaccine-mediated
wt-ab1
spreading-induced
pd1-tim3-
cd45＋cd13＋cd33＋cd34-hla-dr＋
cd45-negative
cd13＋cd33＋cd19-cd10-cd34-hla-dr-
mpo-cd13＋cd33＋
mtase
r635w
r736h
r771l
p777r
f752v
s124c
r45w
r146h
r181l
p187r
f162v
one-site
cpg-containing
dnmt3a-cd
motives
dnmt3a-mediated
adomet
tp12q11
mn1-tel-transduced
mn1-tel-expressing
il-3stem
irradiation-induced
idhifa
celgeneagios
2-hydroxyglutarte
enasidenibs
non-inv16pq22
il1r3
effector-cell-mediated
il1rap-targeting
anti-il1rap
∼12
ag-221cc-90007
nonresponding
bi-6727
captivity
duloxetine
dul
snri
k-luc
tr-mns
time-0
time-1
aspecific
neuroimaging
cns-related
opacification
tumor-recruited
neovasculogenesis
post-aza
fcd11cmhc
ii-positive
mip-2
sequence-analyzed
pe573
pp606
pf590
pr595
sequences-analyzed
card8
rs2043211
rs16944
rs1946518
insins
deldel
gr-1low
mφ-imcs
gr-1mid
stab
neutstab-imcs
gr-1high
neutseg-imcs
neutseg-imc
spleen-mφ-imcs
mφ-mdscs
tdf
neutseg-mdscs
anti-il-6r
electrochemiluminescent
tctg
ccctc-binding
looping
relocalized
hydrolases
bio-derived
cre-ertezh2floxflox
ezh2-deficient
cxcl15
il1ra
resistin
ly6glow
purported
unknownexperimental
genetically-encoded
pkc-epsilon
pkcε
progressionresults
ros-buffering
otherwise-lethal
ros-inducing
transportconclusions
upsurge
ly6chighly6glow
ly6ghighly6c
maneuver
mpt0b392
b392
sirolimus-resistant
p-gp-overexpressing
instituteadriamycin-resistant
radio-resistance
inpp4b-mediated
p-h2ax
inpp4b-silenced
p-brca1
p-rad51
knockdown-induced
ku55933
treatmentcollectively
atm-dependent
isodicentric
idic13p
180k
47xyidic13px46xy2
pantelomeric
oligo-based
i13q10
antigen-2
lineage-
refractoryxa0cases
mutation-directed
deluge
drought
end-user
dysuria
peptide-fc
peptibodies
peptibody
gr-1-specific
cdk-activating
p21-
p27-bound
ckis
prmt
prmt5
shsirna
hlcl-61
yin-yang
prmt5-mir-29b-flt3
fusion-protein
retinoid-nuclear-receptor
rarα1
rarα2
pml-rar-negative
apl-cell
ser-369
cd11b-cell-mediated
k7m2neo
ocrextracellular
2-deoxy-2-d-glucose
2-nbdg
mir4319
elts-score
withheld
detriment
stemprogenitor-like
zfx
ptpmt1
zfx-deficient
stem-cell-related
syndrometherapy-related
medicamentous
p53--
mutates
3-phosphoinositide
p53pdk1s6k1
addictions
ccl23
orthologue
tgfβ-targeted
soulier
menorrhagia
glycation
corycepin
treatement
aml-rca
missedwrong-call
16t
sensitivityspecificity
aml-rcas
beenxa0found
non-cmc
nonpreleukemic
tmtnf-α
stnf-α
tmtnf-α-induced
pyrrolidine
tmtnf-α-mediated
uncleavable
neurotransmitter
gr-1cd115
d1-like
ifn-γ-induced
trithorax-related
ezh1ezh2
pathogen-derived
mdscsxa0in
il-17br
20xx
pon
20xx＋4
re-considered
fip1l1-pdgfra-associated
dhh
rhebl1
dhh-rhebl1
cbfa2t3-glis2-rearranged
dhh-rhebl1-positive
ly6chily6g-
prognosissession
outcomethe
tumor-educated
msc-derived
c1q
l-arginase
exosome-dependent
frameshifts
overproliferate
polygenic
ps0rs1c1-rs2285803
uu2009×u
irak4-long
irak4-l
assembles
myddosome
improperly
cd93
k3-mediated
curbs
ctla-4-binding
k3-sirna
disease-inducing
karotype
pre-messenger
heterozygously
non-constitutional
intermingling
sdf-1-rich
sunitinib-associated
ras-promoted
triple-transgenic
rage-null
kcr
postweaning
cd11bgr1-f
region-c-abl
transcription-quantitative
rt-dpcr
tohoku
4xa0
macrocytosis
114xa0fl
acquisitioninfection
vre-colonized
pre-analytical
n352
n113
disordersno
world-wide
f1f0
puk
cb-1158
orally-bioavailable
ad-trail
egf-tm7
amlhigher
rho-a
expressionour
theragnostic
antibody-independent
coexists
suppressant
sepantronium
ym155-mediated
sellar
neuroradiology
space-occupying
parasellar
sub-totally
trans-sphenoidal
abt-737-mediated
bcl2l11
mcl-1bcl-2bcl-xl
mxd1
cd14hla-dr-lo
antigen-independent
subsites
stattic
stat3-targeted
mdsc’s
stat3-binding
non-engrafting
neact
donor-host
i-positive
pioglitazone-treated
marrow-transplanted
lys-m-crepparγfloxflox
pparγ-macneg
pparγfloxflox
papillomaviruses
nmsc
hpv-infected
hpv-mediated
interbreeding
hpv8
epidermal-derived
uv-light
regeneration-induced
philadelphia-chromosome-negative
pleckstrin-2
plek2
occlusions
jak2v617f-knockin
silencer
snag
lsd1kdm1a
phosphoproteomics
differentially-phosphorylated
s15a
rps15a
40s
mrnaribosome
lentivirus‑delivered
annexinxa0v7‑aminoactinomycinxa0d
voluminous
κb-site
mirna-knockdown
nf-κb-driven
motif-containing
fcγriib
cd32b
re-plaiting
bcr-abl-fcγriib-btk
unrestrain
tamcs-dependent
tamc-targeting
cbf-leukemias
n108
uninterrupted
ameliorations
gams
pres
cni
integrator
bin1
rab
rin1
bin1-rin1
5s
rnp-mdm2-p53
s19
rps19
therapyrelated
trametinib-sensitive
cd8cd44
cd8cd62l
associatedxa0with
alarmin
tetratricopeptide
ttc5
hypoacetylation
k148
k157
labor-intensive
intends
c2h2
tumour-secreted
re-creates
nucleosome-depleted
chromatin-based
beta-glucan
proteoliposomes
ephrin
anti-interleukin
self-antigens
tcr-tg
abortive
mir-363
rgs17
hipk3
hypervascular
aat
vegf-vegfr
gw2580
cd202b
tck1
cxcl7
suv39h1-deficient
myc-overexpressing
myc-transduced
lengthening
nitrated
nitroproteomic
3-nitrotyrosine
lymphocyte-specific
tyr394
anticytotoxic-t
anti-crpc
rns-reducing
large-t
tramp
kitwsh
kitwsh-tramp
cd40l-cd40
tumorxa0suppressor
il-1r-myd88
non-cell-intrinsic
targetxa0for
mtorc
azd2014
ampkα
polysome
fostering
restraint
hypomethylation-associated
mrd-positivity
ngs-defined
imparts
ic1st
ic1st-resistant
ic1st-sensitive
ic1st-resistance
luxol-fast-blue
tcrs
restrictedly
exemplarily
hla-b-hla-b7-restricted
nanobodies
heavy-chain-only
camelidae
natively
99mtc
thp-1-tumor-bearing
nb7
promyeloctyic
tlr8myd88p38-dependent
tlr7tlr8
r848
kts
-kts
chip-chip
arraystar
lncrna-mrna
enst00000435695
enst00000415964
bbdiagnostic
cmlmyeloproliferative
observed-to-expected
dlx2
nkx
dlx6
notch-pathway
anti-apoptosis-factor
mir17hg
misexpressed
stomach-specific
il-1rinf-kappab
preneoplasia
pillar
rekindled
hoxa9murine
mekextracellular-signal-regulated
typexa0of
r107l
ds-related
sirna-based
pepm
pepr
dengue
bioportides
168h
bioportide
housekeepingcell
rpl13a
hprt1
cpp
pepm-sirna
activity-independent
canonically
unequal
pcm1
jak2-pcm1
pd-1-blocking
pd-1fflysmcre
pd-1ffcd4cre
pdcd1
cancer-driven
pd-1-deficient
circumscribed
ultrasonography-guided
14-gauge
sonography
hamartoma
suspicions
cd14cd11bhla-drlow-
caspase-1-dependent
moc1
panc02
thalidomide-treated
myd88-silenced
thymopoiesis
rhesus
macaques
kvp
midline
platelet-related
emigrants
tlr-7
bdca2
encroachment
h3k4me1
demarcation
eroded
bmi1--
ink4a
bmi1--ink4a-arf--
faithful
cd44s
kdm5c
srit6
prpf6
ss18
bcl10
pb-mdscs
c57-black
pb-mdsc
ac0010
abivertinib-involved
tq24q32
practicality
predictivity
g8
ves13
failure1
pre-aml
anti-cd27cd20
hucd27
anti-hucd27
varlilumab
anti-cd27
chemo-attractants
mab-opsonized
tumor-stroma
educate
stroma-derived
extraskeletal
anti-dkk1
mucositis-related
unc
narcotic
life-time
cancerxa0are
precancer
flt3cd150-
ccr9
flt3-cd150-
notch1-mediated
threonine-rich
d155g
l174s
d155h
mpseq
tq12p15
nup98pdgfra
nupp
contentious
multilayered
recombinase-based
pdx1-flp
myeloid-targeting
lyz2-cre
notch2-ic
rbpj
notch-induced
phenotypessignificance
accentuates
philadelphiabcr-abl
tpc
nigerians
lysm-cre
sc-injected
el4-ova
cd45cd3
tgfbr2myewt
antigen-presented
coopting
sublineage
fibrillary
granulocyticmonocytic
kdrid2
aml-infiltrated
stanniocalcin
lys1025
lys1100
ubc9
sf3a1
prpf40b
u2af2
quo
fms‑like
flt3‑mutated
flt3‑mutations
sever
back-up
raspi3kstat
multiantigenic
tricistronic
self-differentiation
smartdctwt1
twt1
nodrag1--il2rγc--
huctls
orthostatic
supine
remitting
ab-mediated
tgf-β-blocking
congenic
systemras
leukaemiaamlthe
sialyl
cd15s
fucosyltransferase
fuct
fut7
st3gal4
disease-guided
ifn-γ-dependent
cd1d
shugan
jianpi
sgjpf
itim-containing
lair1
phosphatase-independent
camk1
lair1-shp-1-camk1-creb
11qupd
ddb1
chromosome-centered
pd1129fs
pk1005fs
pp95h
pl287fs
ras-responsive
microrna-145
mir-145
hinted
npm1m-
fcm-npm1m-
fcm-npm1m
fcmnpm1m-
fcmnpm1m
single-positive
angiogenesis-associated
dc2
allo-stimulatory
aging-signature
pre-tmn
16xa0
full-matched
gr1highcd11bhighf-cd80il4ralpha-arginase
carboxylated
anti-carboxylated
sub-fraction
myleoid
akirin-2
trafficked
e-gel
cot1l
evs-treated
sirt7-expression
sirt7-overexpression
-ε
cebp-binding
granulocytic-myeloid-derived
prok2
matrixour
polya
iap-family
akacid
amf
oligoguanidine
biocidal
airborne
g0-arrested
ki67-positive
amf-treated
pten-loss-induced
dual-acting
cudc-907
cudc-907-induced
5-phosphatasexa01xa0ship1
ship1
microrna-155xa0mir-155
mir-155ship1
ship1pi3kakt
amlxa0m4
onco-mir
mir-155ship1pi3kakt
biomed-1
e13a
positives
il-1β-induced
ly6cneg
outbred
skh-1
hairless
uvb-induced
uvb
cell-type-specific
mis-regulated
reconstitutions
sparganosis
gun-biopsy
sparganum
paternal
rna-splicing
cd33hla-dr-
tet5
presumable
ps21fs
pf235fs
pr339h
germlinesomatic
ps21fspr525h
pr339hpk494t
pr525h
pf438l
pk494t
discovers
remarked
α-mannosidase
swainsonine
biopanning
multi-tumor
tri-t
antigen-encoding
antigen-restricted
epha4
kit-mutations
levels-that
erk-signaling
dasatinib-sensitivity
mllt3-mll
q21q
rpn1-evi1
atp-buffering
ckmt1
evi1-expressing
arginine-creatine
ckmt1-directed
cyclocreatine
phosphocreatine-mediated
evi1-driven
imq
growth-regulator
vegr1flt-1
flt-4
nrp-2
300-fold
kinase-active
lymphocyosis
analog-based
chemokine-independent
anti–human
monochromatically
“multiplexing”
target-to-background
fluorophore-conjugated
optimizedapplication
cellxenografts
pvax14flipper
pvax14
pvax1
anti-rara
memt
circ0000370
mir-1299
mir-1281
mir-640
broadest
s100a7a
sall4-expressing
risk-status
hsacirc0004277
circrna-mirna-mrna
nonleukemogenic
meis1-related
trans-activating
trans-repressing
engrailed
vp16-meis1
engrailed-meis1
vp16-meis1-mediated
ntd
replaces
meis-pbx
hox-pbx-meis
co-occupy
co-occupancy
rna-sequencing-based
iterative
adultsand
beck
distended
muffled
paradoxus
breathlessness
reaccumulated
contractility
146a
mir-146a-
mir-146b-ko
colitis-induced
c-kitd814v
c-kitt417iδ
runx1-etoc-kitd814v
short-latency
pre-b-cell
runx1-etoc-kitt417iδ
fishmouth
proteasome-dependant
sta-9090
wt1-hsp90
tumor-evoked
decect
lna-clamped
tlt-2
ot-i
b7-h3-transduced
ova-expressing
b7-h3eg7
anti-b7-h3
anti-tlt-2
b7-h3-tlt-2
fsc
pattern3
ssclowcd2cd13cd33cd34cd117
granulocytesmaturing
sschighcd10-cd16cd117
-uq-
myeloidxa0neoplasm
mutationscytogenetic
msv
tq23q25
mll-sept9
add1pdel6q
dual-color
1p--pter
11q23--qter
8sept9
9sept9
46xytq23qxytpq23
mll-sept9-positive
rarbeta2
activityresistance
dna-methyl-cpg
sirna-aml1eto
fkbp51
multiple-drug-resistant
canbe
old-boy
daptomycin
usb1
poikiloderma
genodermatosis
deletionsduplications
nxa0xa0126
usbutr
c-83gt
c-66ag
ivs3
cdupt
grs200924980
intangible
phenomenology
schutz
mato
grosso
composing
singularity
contextualized
bmdc
ters
ters-imprinted
cross-prime
initio
hallmarked
unchecked
unsurfaced
asxl1δδ
nf1δδ
toxa0saml
wbi
radiation-naïve
1alpha
sdf-1alpha
post-li
tie2-gfp-labeled
myelomonocytesmacrophages
atac-seq
cat-1
cat-2b
arginine-recycling
transcarbamylase
settling
tumour-activated
haml
parg222trp
nodcg-prkdcscidil2rgtmlwjlsz
co-inhibition
bage
ofa-ilrp
laa-driven
calciumcalmodulin-dependent
camkk2
camkk2--
myeloid-selective
indoleamine--dioxygenase
cxcl12sdf-1
oligoclonally
vβ9
complementarity-
3-itd
c-cbls
tumour-intrinsic
cdk20
ccrk
clic
non-clic
study-specific
leukoerythroblastosis
charcot-leyden
hypotoxic
heparin-tocopherol
lmwh-tos
lmwh
p-selectinpsgl-1-mediated
tos
phenylboronic
pba-modified
αgc-coloaded
pltdoxαgc
pba
self-delivery
antimetastasis
circpan3
bioinformatically
ampkmtor
long-read
tq22p13
pcr-free
u202fbp
dusp13
grin2b
coincidental
mislocalizes
myeloid-focused
-dasatinib
-bcr-abl1is
avnfh
osteoblast-activated
foxo1activated
instigator
ev-generated
tlr4--
ret-ev
hsp86
hsp86-deficient
tlr7--
pd-l1cd11bgr1
ev-mediated
redistributed
β-adrenergic
redistributes
cxcl2cxcl3
sb225002
cxcr2-cxcl2cxcl3
myeloperoxidase-
51xxtq13pr1mar
episome
tq13p11
b7-h4
b7-h4-deficient
balbcj
dampens
outgrowing
all-trans-retinoic-acid
arrestdifferentiation
lyn-
c-raf-containing
c-rafps259
lyn-associated
ksr1
c-raferk
s259
ksr1-scaffolded
quantifiability
mrd-signal
runx1-inhibition
compensative
runx1-p53-cbfb
strategizing
post-replicative
cohesin-mutated
ship-1
mir-155mir-21-based
hla-bwthr
hla-bwile-
hla-bwile
hla-bw4
kir2dl
hla-c2c2
tissue-associated
elderly-derived
hematopoietic-cell
sequential-group
safetytolerability
eliminatereduce
generationdifferentiation
n-r-amino-3-mercaptopropylamino-2-phenylbenzoylmethionine
fti-277
2-methyl--trityl-1h-imidazol-4-ylmethylaminomethyl--biphenyl-2-carboxylic
fti-2153
free-calcium
tipifarnib-induced
ca2-free
gd3
la3
borate
2-apb
tipifarnib-evoked
orai3
tipifarnib-resistant
8226r5
cepbα
sox7
sg2m
cd33cd34
post-surgical
neem
nlgp
nlgp-treated
polyinosinic-polycytidylic
tlr-3
4t1-luc
coulter
saline-treated
4t1-tumor-bearing
trombositopenia
antihbc
m0-fab
amlxa0harboring
2-phenyloxypyrimidine
tgi1002
baf3-p210t315i
togo
henri
mondor
créteil
b3-a2
b2-a2
67gl
867gl
780gl
aetiologic
aml-mrd
transfersxa0plasma-derived
laminectomy
mpn--and
mf--are
pv-mf
et-mf
rna-seq-based
tec
bmx
hif-dependent
cell-nonautonomous
microenvironment-dependent
y-27632
cd1d-mediated
fasudil
dhph
inkt-cell
rock-mdc
growth-permissive
hematopoiesis-suppressive
osteolineage
rab27a
aml-engrafted
cell-supporting
kitl
self-strengthening
postgraft
ociaml-3xa0cells
generalise
seom
nr2c2a93v
proteotoxic
hiv-pi
ps-targeted
1-positive
diabeticsevere-combined
interleukin-2-receptor
γ-deficient
androgen-deprivation
androgen-deprived
intra-tumour
f311l
k294rgg
two-nucleotide
six-nucleotide
h2afy
46xytq27q31add14p11
h2afy-mecom
hemimethylated
catalytic-independent
jq1experimental
jq1-sensitive
jq1-resistant
lipidation
jq1-induced
pthr172ulk1
pser555
lscsconclusions
ampkulk1
sdf-1-related
rk39
rdt
metamyelocytes
region-tyrosine
rdts
serendipitous
aza-aml-001
x7
nu2009u2009240
nu2009u2009245
bestxa0supportivexa0care
inxaxa0of
leukemianet-defined
azacitidine-treated
withxa0monosomal
genexa0mutations
ccr-treated
1αcxcr4
sdf-1αcxcr4
sdf-1α-mediated
unprocessed
yy1-mediated
responseresistance
non-neutropenic
possibleprobabledefinite
malaria
hypogonadotropic
gonadotropins
stalk
rathkes
uninterpretable
il-15rα
il-15il-2rβ
rag2--γc--
il-15-mediated
bolstering
assessment-combined
age-improves
endomembranes
flt3-itdras
live-cell
pm-resident
pm-restricted
k-rass17n
pm-bound
estrogen-insensitive
antiestrogen
polymononuclear
metformin-induced
cd39cd73-dependent
patientssignificance
antidiabetes
bystanders
barometers
jak-2
gsk1120212
msc1936369b
mhc-mismatched
gm-csf-producing
cul4b
cul4b-ring
crl4b
nod2
arg702trp
gly908arg
leu1007fsinsc
fluorescence-labelled
reintegration
acti-pro
acti-pro-
tumor-mdscs
txa0cell-mediated
nrf2-driven
perk-deficient
sting-dependent
perk-ablated
tumor-mdsc
mds-eb-2
hcb-cd34
hamls
deaminates
201x
lgl
suspecting
anti-cd206
xa0m
pacs
pacss
2ds4del
pɑ
bx13
inhibitorsexperimental
determinedresults
sp1-dependent
regressionconclusions
dnmt-dependent
rtk-based
mrp8-pmlrara
promyelocytic-like
tumourigenicity
mir-342
n-a-acetyltransferase
naa10p
mir-342naa10p
pbdc
il-ga
yunnan
uncoordinated
51-like
pd-1ex
αcd3αcd33
bite-like
avidity-dependent
cd33pd-l1
bronchoscopic
co-transfected
faslg
si-faslg
up-regulative
p-fadd
anti-vegf-a
bv8-dependent
constrains
th1-type
myeloidb
cpg-stat3sirna
multiphoton
cyp1a
ivs
non-smoking
ever-smokers
icp
post-transfection
kiaa1524
mll-kiaa1524
d835-
f691-activating
flt3-itdd835y
d835hy
tki-naive
hypoxia-driven
hdac-containing
hdaci-binding
pml-rarα-hdac
2-aminoanilide
mc2392
pml-rarα-binding
mc2392-induced
platelet-associated
1st-line
cd33s100a9
papillomas
cirrhotic
epithelium-associated
cancer-initiating
intraprostatically
epithelium-specific
orf
ras-mapk-erk
combination-based
resistancethis
90y-octreotide
177lu-octreotate
bronchopulmonary
brieau
coworkers
erc
cell-suppressive
g⁵¹⁶t
rcr-rflp
lightsnip
ccc
cccc
ccccc
cccccc
ccccccc
-500
deformylase
hspdf
actinonin
myc-positive
myc-negative
neuropsychiatric
anp32b
hur
proteomics-based
caspase-3-deficient
ala-glu-val-asp
asp-163
cat2
cat2--
l-arg-dependent
elf5
milk-secreting
anti-estrogen
virus-polyoma
co-opting
ccr2ly-6c
ccl20
accrue
mixed-bone
ccr4-deficient
ccr2-deficient
cd163-positive
fearful
werner
nijmegen
age⩽60
magea3a6
lad
thrush
chromosome-8
tm40d
tm40d-mb
risk-mitigation
lna-based
afm
aurk
aurk-a
aurk-b
14-d
cdc2-p34
psb1115
th1-like
lineage-inappropriate
mnf116
ck7
phosphoantigen-activated
vδ2-targeted
tumor-
glycosylphosphatidylinositol-anchor
gpi-ap
randomforest
gse4619
gpi-anchor
pign
transformationprogression
retentions
phs001027v1p1
suppressionelimination
mad1
cxcl4
mir-containing
mir-4532
-increased
p110αδ
lineage-derived
pre-coated
sirpαcd11c
cd47-deficient
bcr-ablins
bxh-2-specific
myls
arginine-to-cysteine
icsbp1
r294c
nramp1
actomyosin-mediated
force-driven
actomyosin
non-muscle
nmiia
yaptaz-mediated
mechanotransduction
silico-generated
predesigned
fusion-and
recollect
bells
pfp
karyogene
resequencinganalytical
zygosity
difficult-to-detect
partial-tandem
mll-diaph2
dependable
sequencingwe
npm259
mthfr-c677t
mthfr-a1298c
age-gender-ethnic
-a1298c
677-tt
uncx
tp22p14
low-methylation
somitogenesis
neurogenesis
uncx-positive
uncx-transduced
ce-ges
dancr
duplicationflt3
methyl-cpg-binding
jak2stat3
cd172a
his48
rp-1
yeats
acetyl-lysine-binding
paralogue
co-localizes
enl-target
abovementioned
bioengineering
hsp70-mediated
anti-hsp70
tlr2-myd88-dependent
regeneration-associated
wnt10b
ac133bright
unproven
wnt10br
ivs1
wnt10bivs1
ht-wnt10b
intronless
wnt10b-fzd
wnt-ligands
porcupine
iwp-2
tumor-initiated
hl-60s4
eu-heterochromatin
epichromatin
∼1kb
nucleosomes
nrl
10xa0bp
body-associated
leukaemia-driving
tcf3-hlf
tagging
suppressiveanergic
hypo-functionality
tinks
associatedtumor
onco-fetal
irf2-inositol
hemopoeitic
diseasedespite
non-transplant-based
quantifiably
venetoclaxu2009u2009azacitidine
glutathionylation
hnrnpa0
au-rich
disproportionally
leukemia-gene
vacuolated
pericardium
progenies
megakaryo-erythroid
espl1
cmlxa0patients
remainingxa0patients
t-cell-stimulatory
abl-selective
cml-pdc
cml-pdcs
cmlsignificance
dc-population
no-related
no-scavenging
tetravalent
iggl-scfv
tdcc
igg-scfv
cd38-cd34
mrfs
negativerna
positiverna
mrfsu2009u200957
mrfsu2009u200920
cd47-sirpα
cd47-directed
antibody-derivatives
licmab
licmabs
cd33-negative
cd47-positive
confine
pan-tki-resistant
circrna-dleu2
hsacirc0000488
mir-496
prkacb
hsa-mir-496
gse9476
hematopoietic-related
il7r
colocalized
gm-csflynstat3
delocalized
rs1801131
hwe
hu2009u
autonomously
xvent2
mesodermal
34-positive
ips-cell-derived
myeloidmacrophage
anti-senescence
m-csf-dependent
peritoneally
nugc-4
intra-peritoneal
amkls
gsd
amlmds-related
gsd1b
thioctacide
milgamy
supervisory
linneghla-drnegcd33poscd11bpos
cd14poshla-drlow
sensitiser
complementarity
sensitises
bcl-2-inhibitory
noxa-bh3
synergised
chemoresponsiveness
aml-m1m2
pbbm
6-phosphogluconate
nih-aarp
quintile
meat-cooking
doneness
drank
alox5--
msr1
arg1-expressing
hla-dr-cd33cd14-cd15-mdscs
hla-dr-cd33-cd11b-cd14-cd15-mdscs
hla-dr-cd14mdscs
mirna-193b
off-line
orbitrap
hla-bound
pim-
p4ebp1
p-p70s6k
pharmacodynamic-pharmacokinetic
cby1-encoding
im-responsive
dnmt1-driven
bcl2-like11
cd64-targeting
fcαri
cd89
apoptosis-mediated
cd89-specific
cd89-eta
146xa0cm3
xa0cm3
engraftments
pu20093
phneg
-7sole
-7dual
time-to-detection
trials-extending
enestxtnd
dose-optimization
re-escalation
nct01254188
hmrp8
hippel
lindau
dss-induced
gr-1-positive
hif-2a
car-engineered
car-t-cells
cll1-positive
promoteru
rs2249650
rs2268276
supershift
susceptibility-associated
gam
socs3-deficient
mllt10af10
10p-nebl
abi1
crim1
smad5
bmp7
frequency-matched
overcrowding
aors
birthweight
gender-age-matched
17-page
non-occupational
occupation-specific
workplaces
planting
unloading
eateries
fertilizers
adhesives
paints
fbt200
fbt400
evenly
fbt
trem
trem-2
cis-apcdelta716
smad4-
cis-apcsmad4
atypia
myeloproliferative-type
myelofibrosis-like
hypolobated
myelodysplasia-associated
non-driver
imc-mediated
scrnaseq
polarizationactivation
pre-polarized
facs-sorting
abl-tyrosine
therapy-cessation
ibd5
cause-to-effect
irf1--
ca-crc
hyper-susceptibility
colons
enterocyte
mnkeif4e
mnk2
mnki-85
dual-specific
mnki-19
thienopyrimidinyl
chemotype
mnk2eif4e-mediated
lin-hla-drcd123xa0xa0
lin-hla-drcd11c
pm01183
nfi-a
eto2-glis2
ontogeny-dependent
eto2-glis2-induced
ontogeny-related
statesee
hernandez
1653this
mst1r
prostates
tk--
mst1r--
aav6-cd33
mock-treated
aav6
nha9
ptgscox
sub-monotherapeutic
nha9-induced
macrophagestams
reinstating
vigorously
ion-torrent
re-analysis
pindel
intra-run
work-flow
htert-deficient
k-562xa0cells
senescence-like
aldh-lsc
auto-inductive
cross-talks
impotence
9ploh
p27kip
rarγ
cdc25ac
photons
milligray
err
nested-case
mcl-1deltahep
mcl-1floxwt
fludarabine-
alkylator-based
dna-topoisomerase-ii-inhibitor-associated
re-invigorated
re-biopsy
non-healing
misclassification
a-bomb
simplest
ensues
chaperonin
clpb
cristae-shaping
opa1
mannersee
savona
rathmell
831this
nedd8-activating
nae
nxa0xa026
mof
haplotype-tagging
snp-
nu2009u2009511
nu2009u2009481
rs147960238
pu2009uu2009×u
rs17138945
congruencies
nxa0xa059
paxgene
rneasy
qiagen
5p
chk
lv
balb-neut
c-erbb-2neu
hyperproduction
amino-biphosphonates
amino-biphosphonate
p185her-2
vicious
pu1-cooperating
arg753gln
asp299gly
thr399ile
cosegregating
-164
46xxdel5qtq22q46xx2
der8tq22q22
5q33-q34
tq22q22runx1runx1t1
endeavours
cellular-equivalent
nup98-associated
leukemogensis
tp15p13
phf23
nup98-phf23
il-1il-18toll-like
helicobacter-induced
myd88-deficient
myd88--
infection-driven
lpd
cold-like
4ml
cβ1
ebv-related
207u2009859
heighten
piwi
hiwis
step-by-step
pgpxiap
pre-allohsct
post-allohsct
antagonists-secreted
1-on
cd11bly6chiccr2hi
ctxcd4
tolerization
pd-1-pd-l1
ophthalmoplegia
motions
3-hour
superolateral
periocular
canthotomy
cantholysis
orbitotomy
orbitopathy
all-related
annotations
tumour-necrosis
tlr6
llc-conditioned
lcm
co-receptors
tlr2tlr6
usurp
mirnap
bcr-abl-inhibited
repeats-mediated
mir182
δ182
amphibians
lecs
lymphangioblasts
postnatally
20p13
multipoint
lod
hlod
tgm6
nmc1550tg
pl517w
cosegregated
candidacy
pten-null
sivelestat
cfos
mdscsimplications
autoencoders
hone
depletion-induced
lipoxygenases
lipoxin
rydapt
f691u202fl
repeat-containing
birc6p53-mediated
prr14l
oligopotent
mpp
lymphoid-primed
lmpps
clps
credited
rna-interference
xab2
lilr
lilra
motifsxa0itam
pirb
lilrs
tumour-reactive
cd279pd-l1
pdcd1lg1
cellxa0differentiation
ofxa0lsd1s
demethylase-defective
rcor1
snag-domain
lsd1rcor1
thc
activity--however
radio-therapy
countermeasure
high-salt
hsd
hsd-induced
pmn-msdc
sirna-vegf
u973
hypoxia-response
il16
non-pharmacological
srnas
srna
isomirs
tdrs
multiple-tubes
cll-1tim-3cd7cd11bcd22cd56
multiple-tube
hn
jeon
ccl2-ccr2
anti-pd-1-resistant
unmasked
kr158
cd11bly6chipd-l1
ccx872
gbm-bearing
circrna-mirna
hsacirc0080145-mediated
hsacirc0080145
cbsct
chemosis
annular
mice-derived
inos-2
card9-nf-κb-ido
clinic-pathological
10603ratify
phytoalexin
resveratrol-induced
mt-ret-1
l-nil
stat3ros-expressing
vegf-depleting
inos-dependent
host-expressed
mt-ret
panhypopituitarism
3q21q26evi-1
f158s
two-steps
lymphomamyeloma
β-d
t2-enhanced
hyperdense
th11
myelitis
diaphragm
dura
lal-deficient
lal--
corrective
ficolins
mannose-binding
mbl
ficolin-1
ficolin-2
ficolin-3
fcn2
fcn3
mbl2
-u2009542
gu2009u2009a
ficolin-
mib-1
mlcs
leukaemic-cell
d2mit15
agpcrs
agpcr
adgrb1
adgrc2
adgrd1
adgre1
adgre2
adgre5
adgrg1
adgrg3
mefv
m694v
m680i
v726a
e148q
m694i
e148qe148q
m694ve148q
erbeta--
erbeta
p53-mrna
3n-n-2-metabolites
abstained
cml-cd34
dasatinib-mediated
leukemia-initiation
oxaliplatin-conditioned
beta3-containing
loxp-flanked
beta3-integrin
kop
kom
beta3kop
beta3kom
beta3-integrins
beta3--
processes-morgan
schneider
baroni
uluçkan
heller
hurchla
berdy
piwnica-worms
teitelbaum
weilbaecher
ap-2
sparc-rnai-lv
nc-gfp-lv
citrobacter
braakii
trepidation
straits
patient-doctor
limk1
rnai-
limk2
mitosis-associated
limk
palbociclib
pro-lymphatic
conflictive
compiles
anthracycline-related
unweighted
ugrs
irs1
grb14
arl15
pepd
ankrd55map3k1
pdgfc
lyplal1
rspo3
fam13a1
prediabetes
prediabetesdiabetes-free
pu001
prediabetesdiabetes
amplicons
aml-amp
myc-dmin
neocentromeres
circpvt1
comedication
421ca
421aa
bonespine
hematochezia
colonofiberscopic
hnrnpr
matr3
zfr
ybx3
hypermethylation-induced
kruppel
siha
mzf-1
toxin-carrying
il-12rβ1
il-12rβ2
scid-nod
cxcl6
alanyl
noxa0negative
bdca2cd303
mxa
cxcl5cxcr2
neutralized
cxcl5-induced
pbbs
rearrangement-positive
richness
shannons
firmicutes
bacteroidetes
proteobacteria
otu
h-evi1
lpxn
leupaxin
etv6-lpxn
fluconazoleposaconazole
p13q22
ai-
pu200930
pu200920
tq21q23
multiple-lineage
deemphasized
syndrome-excess
mds-eb
--19
mb49r
mbt-2r
t24r
α-pd-l1
pmn-
α-gr1
α-ly6c
pan-mdscs
bleeds
haemogram
microgl
non-overload
hemangiosarcoma
viii-related
hemangiosarcomas
differentiationxa0
cd11b-diphtheria
intrasplenic
diminishment
angptl7
angiopoietin-like
antisense-oriented
blue-cell
ecrg4
thrombin-processed
course-specific
log-binomial
vasopressor
enlargements
mirna-controlled
micrornome
microarraysequencing
racer
sample-specific
tfmirna-gene
formalism
mirnatf
mir-548p
cunningham
entities-some
features-that
familiarizing
pathogenesis-related
1glipr1
glipr1
curation
clingen
functionalultrastructural
genedisease
phenotype-specific
benignlikely
pathogeniclikely
vus
runx1-specific
mddc
gr1-positive
localdistant
invigorate
sema3b
neuropilin
nrp
metastatis
variantcryptic
genes-piezo2
rxfp1
mamdc2-
32-kda
fi-lmc
occasioning
sangers
preinvasive
tumor-enabling
intra-abdominal
nrasv12-driven
nrasv12
nrasv12-independent
nri
ralb
tbk1
cdk5-mediated
ralb-dependent
oncogene-independent
mechanismsxa0
cinahl
self-experience
fisetin
anti‑metastatic
f‑actin
chou‑talalay
median‑effect
metastatic‑related
pro‑survival
d390
number-neutral
cand1
nid2
ptprt
precusors
mastermind
pancreaticoduodenectomy
fibroma
mspi
vmp1
autophagic-flux
venetoclax-induced
transplantation-induced
drak2
ink4
azavpa
mage-specific
cjun
teae-related
sgrnas
cas9
sgrnacas9
erbb2-driven
erbb2-induced
cdc42-binding
erbb2-responsive
lineage-specifying
late-differentiation
redressed
fortuitously
n-methylhemeanthidine
nmhc
amaryllidaceae
zephyranthes
pre-inhibition
maml
nmhc-mediated
docks
nrr
non-tnbc
δnp63
δnp63-dependent
cxcr2ccr4
chitinase
secreted-frizzled
sfrps
attrition
censor
cyclindependent
non-exposed
extrapulmonary
acei
high-very-high
pfkfb1
pfkfb2
pfk15
hcg-pr
pu1-
myd88-mediated
pig-a
pig-a-null
∼×
∼--7
hypermutability
cxcr3ko
semaphorin4d
ly6ghi
cancer-1
sema4d-driven
leukemia-1mcl-1
proteogenomics
datatypes
nu2009u200992
equilibrated
pneumonias
ante
α-difluoromethylornithine
anticarcinogenesic
odc
tumor-inhibiting
cd39cd73-mediated
mdsc-depletion
car-modified
cd19-negative
mll-b-all
tki-sensitive
tkos
superoxide-producing
nadph-oxidases
nox4
p22phox
noxs
nonphagocytic
tko-transformed
alanine-rich
c-kinase
marcks
triplebodies
sctb
bsscfv
33xds16
33xds16x33
tu-mdscs
cy-mdscs
5ac-treated
tc-1a9
mhc-defined
swine
euthanized
herd
transductionbone
nup98-hox
l359v
qmsp
ficoll‑separated
sorting‑sorted
bm‑derived
differentiation‑associated
cg1574a
ribosomopathy
causexa0aml
b-1
hdl
lipoprotein-like
np-mediated
neutered
burmese
cd1b
calprotectin
myeloid-macrophage
expressionpathway
age-independent
3kg
kir2dldlds
12cxcl12
4cxcr4
phosphop-stat5
mrpu2009u
otological
provenprobablepossible
fungus-free
cd45rau2009u2009central
tcmra
tscm
cd62lu2009u2009and
survivability
tbet
eczematous
dermatology
maculosquamous
microwell
cosecreting
cost-efficient
tp24q
5bcr3jak2
fpt674i
fpd842v
t674it874i
frustrates
lowcado48
maternal-fetal
endometriosis
pof
ptpn13
icsbp-knockout
fap1-dependent
bcr-ablcells
icsbp-
fap1-blocking
fas-resistant
first-hit
pre-leukemia
cell-context
firstxa0emerging
cd19-il-7r
genome-engineered
andxa0produce
genexa0expression
mono-mac-1
oci-aml-2
difficult-to-transfect
polyethyleniminesirna
nanoparticle-mediated
acid-coated
bm-msc
runx1-runx1t1s
angioinvasion
bronchoesophageal
oci-aml-3
ser2448
thr389
ser65
dc-
cost-
maturation-induction
tnf-α-containing
that-
donors-
ptsins5p
-bisphosphate
ptdinsp₂
nkt-like
nkp80
cart-33
cart-33-induced
nct01864902
cxcl8
sbf2-as1
zfp91
dnmt3-r882
xa2717
m2xa0
nu2009u9xa0
∼70
npm1-ccdc28a
trip12-npm1
mllt10-dnajc1
tbl1xr1-rarb
runx1-fnbp1
myb-gata1
npm1-mlf1
etv6-ncoa2
etv6-mecom
etv6-ctnnb1
runx1-prdm16
runx1-cbfa2t2
alfa-interferon
hybidization
luc7l2
exon-level
maytansine-derivative
leukemogeneic
antizyme
oaz
oaz1
fingers-containing
inv3q21q26
tgfbeta-mediated
inducer-mediated
mel18
scml2
cbf-mutated
pcg-regulated
skov3ddp
psc-derived
pmcs
dc-like
pmc-dc
il12p70
pmc-dcs
h-2kb-restricted
mir-23a-3p
rt-qrcr
smca
pppppconclusion
benzene-caused
ods
prestages
sc-rt
larc
radio-induced
lin-hla-dr-cd11bcd14-cd15cd33
cd14hla-dr-lowcd11bcd33
cd4cd25hifoxp3-
ctla-4pd1
t0
t2-t5
t9
t10
treg-pd-1
treg-pd1
hipsc-derived
mir-223s
myelogenesis
-β-d-glucan
terbinafine
mitral
prolificans-disseminated
mtorc1-deficient
macrophagesmetastasis-associated
cd11bfhigh
glioblastoma-conditioned
gcm
glioma-conditioned
palsies
mastoiditis
antedate
ruptured
macroscopic
hemoperitoneum
1000ml
monotonous
pg-m1
forensic
factor-stimulated
shp2e76k-induced
withdrawal-induced
intrinsicmitochondrial
shp2e76k-transformed
tf-1shp2e76k
api-2
rheumatological
glut3
enterotoxigenic
fragilis
etbf
il-17-dependent
minapc-
etbf-induced
pksescherichia
etbf-associated
etbf-triggered
il-17-driven
enterotoxin
bft
pim-3
abnomal
metastasis-targeted
c5a
monocytogenes-based
promoter-region
dimethyl-h3k4
-bisn
3-diphenylpropyl-n1-biguanido--diazapentadecane
di-methylated
caretakers
landscaper
factorsconditions
fas-deficient
multipath
d13s319
gse40442
gse40870
pre‑processing
tf‑gene
protein‑dna
acid‑repeat
acrc
tf‑pairs
tata‑box
ccctc‑binding
acronyms
ccus
l-mdscs
gm-csf-r
janus-activated
gm-csfjak2stat3
microchip
pcr-microchip
pcr-capillary
breakpoint-associated
12bp
b-zip
myleofibrosis
rs2029253
rs2228064
rs2228065
alox5ap
rs10507391
rs4769874
cyp2c
nonresident
gliomasexperimental
rcas
azd1480results
anti-cd3anti-cd28
analysis-defined
anti-cd15
cd15-cd
anti-cd33cd15-coated
gadolinium-enhanced
dephosphorylating
polymorphisme
humain
ceu
yoruba
ibadan
yri
y3a
k47r
q136r
ceu12
5-untranslated
rs11191612
zabriskie
iiiα
imr
gata2-related
sphingobacterium
spiritivorum
68-yr-old
℃
angiopoietin2
angpt2
angiopoiesis
anti-angpt2
liver-associated
bbi608
bbi608-treated
ɛ
p27cyclin
p16cdkn2a-null
a79c
c360g
taui
loeys-dietz
fatigability
marfan-like
sb939
polymorphism-induced
tki-sensitivity
deletion-associated
mir-p-mimic
gata2-deficient
transcriptopathy
pim2-depleted
rsk2
90u2009kda
rps6ka3
artngfra3
nrtngfra2
ligandco-receptor
mtorc1-mediated
ret-mtorc1
nkg2dls
oun-1
ulpb2
anti-nkg2d
aerodynamic
pollutant
pm-treated
microrna-100
granulocytemonocyte
rbsp3
phosphatase-like
prbe2f1
microlocalization
osteoblast-derived
niche-derived
dna-damage-mediated
ct2
rxr-deficient
cell-assisted
lipid-sensing
hormone-inducible
nrasq61k
hrasg12v
krasg12v
biotagging
serpinb1l4
fgf1
stature
facies
saa3
apo-saa
saa3-tlr2
tq26p13
tpq26
mta3
flj30838
il-17r-deficient
il-17-mediated
shrnamir
nsc-74859
βii
prkcb
cancer-mediated
4to7
cd11bgr1f-ly6cmidly6g
fly6c-ly6g-
per-cell
catechins
bethesda
t-driven
asxl2-deficient
aberrantly-expressed
iseh
webinar
mavens
ravindra
majeti
idicph
cml-blc
caesar
u200agm2u200a×u200a6
multiple-agent
proven4
ampkα1-coding
complementarily
re-routed
ampkα1
20s-rh2
shnur77
20s-rh2-induced
20s-rh2-mediated
nur77-mediated
apoptosis-induced
reovirus-induced
pbs-treated
stimulator-1
signaling-dependent
exon-array
exon-specific
espcr
qespcr
aeus
inhibin-α
im-9
mrc-ciii
mrc-ciii-generated
ros-scavenging
rac2-mrc-ciii
electrochemiluminescence
interferon-inducible
chemotherapy-naive
chimaeras
hage
hage-negative
non-monoblastic
outpaced
atg-treated
atg-pretreated
bxd12
cd11bgr1cells
myoglobinuria
l445p
tdes
llc-exo
mir-21a
gain-and
aak
7u2008u20083
airapl
arsenite-inducible
rna-associated
proteostasis
airapl-deficient
insulininsulin-like
insulin-related
ipsc-derived
offal
seedsnuts
fluidigm
biomark
residual-disease
tx17q28q21
kansl1-mtcp1
kansl1-cmc4
5-utr
mtcp1
cmc4
chronicacute
bcr-jak2-driven
lipopolysaccharides
gram‑negative
ester‑bound
hexaacyl
lipidxa0a
escherichiaxa0coli
lipooligosaccharide
de‑o‑acylated
exa0coli
los‑oh
jaws
marrow‑derived
bm‑dcs
metastasis‑bearing
6q25
tq25q22
mir1202
proline-
serine-
t-runx1
ivf-embryo
nutraceutical
pttg1-knockdown
luteolin-triggered
proliferation-related
pdac-associated
co-engaged
chemo-protection
two-event
postulates
all-transretinoic-acid
survivalxa0
cyto-c
curdlan
1xa0→xa03-β-glucan
agrobacterium
thexa0anti-tumorxa0propertyxa0ofxa0curdlan
m6-er
retrovirus-negative
4-y-old
spayed
viruspro
vector-borne
rubriblasts
iba-1
dmxaa
muc1-cnf-κb
promoter-specific
epigentic
outbreak
revisits
substructure
microrna-196b
microrna-25
tmd-related
fetalis
a3d8-induced
methyl-β-cyclodextrin
attenuator
gene-3
kir2dl3
un-activated
bcr-abl315i
cd34u200acell
non-315
1964-g
energy-depleting
rapamycinp70s6k
lkb-1amp
polypoid
desmin
seasonality
microbeshost
fortification
microbiotasystemic
oculo-facio-cardio-dental
tlr-mediated
mapkap-1
ikknf-κb
serex
runx1-mt
csf2rb
better-defined
tortuous
pericyte
isograft
rhizopus
oryzae
subretinal
s3i-201
sies
gitmo
consensus-based
cucurbitacin
cub
lin-dr-cd33
lin-drcd33
16hbebpde
interferon-γ-related
postthoracotomy-related
moderate-to-vigorous
mvpa
study-ii
stearoyl-coa
desaturase
scd1
nontemplated
n-nucleotides
igtcr
scalability
intraset
centrality
eya4
epidemic
co-morbidityies
sars-cov-
mir-196a
mir-138
crk
raf1
ever-widening
pre-bmt
obviated
stimuli-
alloantigen-induced
unusing
ofxa0hematopoietic
dnaxa0repair
mcm8-
mcm9-knockout
tumorsxa0phenocopying
mcm9
ras-association
multiracial
un-manipulated
lin-cd33hla-dr-
fna
znf224
krab-zinc
emergency-hematopoiesis
dhx9
dexdc
polyinosine-polycytidylic
helicc-ha2-duf
remissionrelapsed
leukemia-leukemic
allotype
leukemia-cd34cd38-
zoglmeier
r878h
lin-sca1ckit
cdk1-mediated
dnmt3ar878hwt
adriamycinxa0adr‑resistant
k562adr200
k562adr500
atp‑binding
subfamilyxa0b
memberxa01xa0abcb1
wye‑354
sub‑cytotoxic
abcb1‑mediated
adr‑mediated
multiparous
igg-class
hla-antigens
standardbred
gelding
rami
granulated
intercontinental
all-ic
relapse-causing
cancer-impaired
lpc-targeted
repsox
repsox-treated
sulfoxide-treated
mucin-3
neoplasms-
hps-are
plasma--cell
kdm1alsd1
syndromes-such
diamond-blackfan
thrombocytopenias-also
wiskott
aldrich
conditioning-regimen
genomics-driven
rna-crnde
β-n-acetylglucosamonyltransferase-2
β3gnt-2
β3gnt-8-the
glycosyltransferases
poly-n-acetyllactosamine
polylacnac
glycans
β3gnt-5
sphingoglycolipids
β3gnt-8
β3gnt-4
sept11
sept7-fold
diosmetin
erβ
well-understood
unduly
transcript-genotyped
ltcs
non-engineered
overestimate
nodscid-il-2rγ
chain-null
gene--member
aebp2
codeletion
hypoxia-associated
tans
stat5-docking
overproduce
micro-fluidic
phylogeny
dnm3ta
refs
tumor-stromal
ccr1-mediated
cmt93
sub-lethally
ccr1--
anti-ccr1
km5908
snail-expressing
snail-high
ableson
sight-threatening
leucostasis
myeloma-specific
myopathies
imnm
mt-rtks
d814v-dependent
kit-mediated
chlorpromazine
cpz
pd-1pd-1
benzimidazole
flubendazole
flubendazoles
cd31pecam-1
phospho-tyr705
spleen-derived
mdscmast
endotoxemia
c26
66c4
4t1-bearing
epinephrine-exposed
explant
stress-exposed
contextual
pseudogenes
oct4-pg1
mock
chemotherapics
decisional
alfa-9803
nippostrongylus
brasiliensis
adoptive-transfer
mc-deficient
kitwshwsh
hematopoisis
mir-181abcd
prkcd
prkcd-p38-cebpα
ctdspl
camkk1
mir-181d
lenti-mirzip-181a
mpl-jak-stat
mpn-initiating
tadcs
exudation
ser16
ser25
ser38
ser63
nucleophosmin-mutated
tq25q35
2-related
nrf2and
nrf2--balbc
tantalising
placentas
myelopoeisis
mtret
-like
unit-level
7u2009u20093-like
p-fold
stellettin
stel
jaspis
stellifera
5×ic50
e255u2009k
f317u2009l
m351u2009t
e255u2009v
folliculocentric
follicular-based
angiotropism
stratum
corneum
lumina
transfolliculartransepidermal
acer3
endothelial-
derived-
apoprosis
alternations
myelosytes
fator
tumorbearing
slc22a12
1236tc
480gc
prdm16s
megakaryocyticerythroid
prdm16s-induced
ablating
reinstated
trail-related
trail-tolerant
cybars4673
ncf4rs1883112
rac2rs13058338
ncf4
f359vci
f317lvic
msi1
msi-targets
msis
mn-n-2-hydroxyacetophenone
glycinate
t618i-expressing
checkpoint-blocking
89zr-labeled
single-domain
vhhs
phenotype-genotype
46xxder7tqq
u2009mb
3q-3qter
7q-7qter
bonesoft
cvrfs
myb-driven
structure-guided
mybmim
mybcbpp300
myb-dependent
aberrantxa0transcriptional
spalt
sall4a
sall4b
colony-formation
arg280his
arg399gln
pleu301ile
ptyr320his
pglu373asp
pasp381asn
pval256gly
pthr315ile
pgly250glu
ptyr253his
pphe317leu
pmet351thr
pglu281
ptyr393
eg-vegf
prok1
amlxa0their
cbfbeta-smooth
cebpd
matrix-targeting
engraftment-related
cysts
linneg
cd11bpos
cd33pos
hla-drneg
cd14neg
cd15pos
cd14pos
cd15neg
s-kitl
s-icam-1
pi3kaktnuclear
pi3kaktnf-κb
een
mll-een
mlleen
thymuses
mlleen-expressing
mac-1gr-1-
eed2
k562ima-3
imatinib-non-resistant
bounded
ezh2-h3k27me3
methyllated
amu-aml1
snorna-focused
snornanome
snord42a
snorna
2-o-methylation
18s
18s-u-o-methylation
type-ab
npm1m-aml
ignorance
bangabandhu
sheikh
mujib
opd
∼5
mngp
mngp-related
filtered-in
tumor-only
cd11bc
his48cd11bc
inhibitorblocking
csc-specific
15-lipoxygenase
alox-lo
alox15
15-lo
alox15-deficient
adenoid
myb-activated
myb-reporter
ionophores
myb-regulated
myb-dependence
myb-nfib
myb-inhibitory
collaterally
luciferase-expressing
metastases-free
cc10tg
r01
ca108573
pan-resistant
larger-sized
covert
recombination-activating
aid-driven
etv6-runt-related
behavioural
engenders
lifestyles
lys27-specific
noncatalytic
y-chromosome
uty
kdm6c
lossmutation
gata-factor
compass
sh2-containing
5-phosphatase
uke-1
ship1y643h
ship1-induced
cathepinsaberrant
cystatins
dkk-3
wif-1
dnt
dnts
assaysresults
donor-unrestricted
dnt-mediated
dnam-1-blocking
antibodiesconclusions
usfda
5-formylcytosine
5fc
5-carboxylcytosine
5cac
multi-compartmental
hemi-methylated
tet1-catalytic
cd-gfp
tet1-cd-gfp
hdm4
hdm4-s
amlxa0and
lg-mds
nalm6
nxa0xa043
nxa0xa046
punctures
gwas
mir-3662
rs66650371
three-base-pair
mir-3662s
sparsely
low-let
high-let
chromatid-type
gastroendoscopy
dnmt1-dependent
fabp4-dnmt1
bms309403
aml-promoting
cmv-induced
adaptive-like
nontransplanted
relapse-prevention
hdcil2
nonself
ns-ikir
cmv-driven
gemc12
gemc12-loaded
fluorochrome-labeled
uptaken
gemc12-lncs
monocyte-targeting
trans-cellular
idh-independent
unhealed
tie2-expressing
lm-llo
papanicolaou
liquid-based
thinprep
contours
agranular
pharmaceuticals-incyte
br-ifd
ma-pap
key-questions
gsk126
ifnγcd8
gemcitabine5-fluorouracil-depleted
single-car-based
ccar
safety-switch
ratioxa
estimable
and-where
studied-displayed
rpci
prci
host-defence-associated
polymorphonuclear-
nilotinib-resistance
e3-ubiquitin
k562-rn
resensitizes
e3-ligase
axlsyk
neovascular
intracameral
trabeculectomy
iop
post-operatively
bleb
vitreo-retinal
hyphema
globulin-based
cell-proliferative
kitn822k
tf-1xa0cells
er-stressed
xbp-1
stress-signaling
stress-conditioned
aml1-eto-mediated
transrepression
myelodysplasias
methyltransferasehmt
cd40high
cd40low
tlr1
cxcr5-cxcl13
infraorbital
paresis
stemlike
slcc
stochastics
front-loading
slcc-slcc
poissonization
subatomic
picoseconds
anoxic
byxa0hypoxia-induced
oxygen-carrier-free
physoxia
insertion-specific
obviates
hypoxia-mimetic
housed
altitude
nr4a3
h2az
nr4a3-targeted
light-chain
noninvolved
byond
nu2009u2009156
ph-negativebcr-abl1u2009cml
1990-january
radiotherapy-related
nu2009u200949u2009879
nu2009u2009237u2009439
nu2009u200916u2009208
siru2009u
bi-
tri-specific
rag1⁻⁻c57bl6
hyper-phosphorylation
ppp2r2a
b56α
ppp2r5a
fty-720
micrornamir
myelopoiesis-associated
speciesextracellular
thr254
peptidyl-prolyl
cis-trans
r-2hg-activated
r174x
uncinate
p120-catenin
l2-crep120ctnff
oral-esophageal
cd38high
hematooncological
s101
hla-b14
rrq-pcr
nanofluidic
pre-amplification
sizable
chromatography-electrospray
i2pp2a
niche-related
amino-bisphosphonate
cd47-signal-regulatory
cd47-targeted
cd47-binding
pan-allele
anti-sirpα
multi-allele
multi-species
pan-allelic
v1
cd47sirpα
6nmv
6nmu
6nmt
6nms
6nmr
bl6
crystallizable
fcγr
mdm⊘
sirp
diphosphate-glucuronosyltransferase
ugt1a6
asxl1-depleted
hdc-knockout
hdc-egfp
egfp
hdc-deficient
hev
subgenotype
anti-hev
transfusion-transmitted
bang-bang
pontryagins
mys
myelofibrosisprimary
axilla
megakaryoblasticmegakaryocytic
post-hctd21
clearances
vaf-post-hctd21
nu2009u200949
dntt
rag-mediated
dntt-mediated
rag-binding
phd-like
rarα-fusion
h2azac
h3ac
hypoacetylated
46xytp
46xxdel5q13qxxdel5q13q33tq24q23
plzf-rara
tumour-initiating
tics
tic
interleukin-12-treated
laboratory-developed
ot-1
ova-257
4070a
mo-mulv
nb-tropic
fv1
activationclustering
cd82-pkcα
studyidentify
ptprd
∼80
∼20
hoxa10-induced
niche-dependent
host-dependent
south-east
colony-stimulating-
tp25q21
factor-3
csf3r-t618i
ero1-α
ero1-α-overexpressed
mdsc-prone
ifn-responsive
p150
adenosine-to-inosine
adar1-based
ppk
pnkc
ox40l
ox40-ox40l
ox40ox40l
ox40-targeted
mab-mediated
enlisting
mab-dependent
runx1runxt1
latrophilin-1
skm-1vcr
latrophilin-3
cereus
foodborne
neuropathologic
petechial
breaches
bananas
meningoencephalitis
neuropathologists
mir-34a-5p
dcdt
mrna-mirna
mir-23b-3p
prxiii
non-reversal
c-myb-gfp
c-mybhyper
c-myb-associated
bombings
del2
chr2
r235
sfpi1pu1
79ramls
unprecedentedly
array-
148bp
ramls
sfpi1pu1dna
re-define
clinico-radiological
technetium
il-1il1-ra
th-1-oriented
57xa0and
50xa0cases
pik3xa0pathways
flt3-itdn676d
milieus
micro-ribonucleic
acid-155
mir‑148a
dual‑luciferase
mir‑148
5‑cytosine‑phosphate‑guanine‑3
idh1r132h-dependent
runx1-bound
c-induced
amurensin
ex527
auy922
cd44high
csc-related
hsf1heat
k562-cd44high
eqa
neqas
ukneqas
unconverted
realise
recepteur
dorigine
nantais
sfron
sfron-mediated
bcl2-family
sfron-negative
cmetron
non-tki-
sub-divided
chemokine-related
cmklr1
cmtm3
chemokine-associated
replication-deficient
adcrgd-mil12p70
gl261-based
il-12-mediated
pgc-gv-sparc
sparc‑overexpressed
organ-
ci66
ly-6c
cd11bgr-1dullly-6chigh
cd11bgr-1brightly-6clow
esrp1
riboflavin
imid-induced
hla-drneglow
cd14⁻
4rα
gtx
mycer
mycertrade
m1mycertrade
msi2-interacting
syncrip
syncrip-depleted
cvads
cvad-associated
piccs
hickman
cvad-related
hyperproliferative
pari
replisome
mir-519
mir‑519
antigenxa0r
multigene-acquired
tumorgermline
streamline
rheum
palmatum
phosphoration
6q14
6q-
clavatum
multivisceral
heat-treated
rmflt3-l
mdc∶pdc
mhc-ⅱ
interlukin-12
interlukin-6
pppppconclusions
polyangiitis
nonameric
jclininvest
-647
mp3-expressing
anti-low
lrp1
vec
vecs
kdm5
kdm5b
i-bet151
super-enhancers
cytosplasmic
hl-60ara-c20
barasertib-hydroxyquinazoline-pyrazol-aniline
m-phase
greater-than-additive
barasertib-hqpa→ara-c
ara-c→barasertib-hqpa
mycofenolate
mir-365
pre-mir-365
lkb1
thr172
tuberous
ampk-dependent
nu202fu202f95
nu202fu202f64
drowsiness
varianceu202fu202f10
varianceu202fu202f35
may-grunwald
ε
cebpγ
extrinsic-induced
igfbp2
bm‑mscs
gse79695
bm‑msc
interactionxa0ppi
leukemia‑related
markertherapeutic
228xa0hypermethylated
183xa0gene
523xa0hypomethylated
362xa0gene
4xa0genes
pm20d1
hsa‑mir‑596‑encoding
mir596
hsa‑mir‑596
familyxa01
memberxa01
hsa05221
hsa05220xa0chronic
mapk3
demethylasexa02b
mir‑159‑encoding
mir159
sqstm1sequestosome
pro-autophagic
disassociating
beclin1-bcl-2
nas
non-users
13q-
cas-positive
45ra
aml-lscs
anti-cd45ra
cmyc
kg1α
observedxa0according
eus-fna
gwhas
gse32462
p1e-5
fgfr2
rs7090018
rs2912759
e-06
cd11bcd14-hla-dr-lowcd33cd15
mdsc-osteoclast
legumain
probiotics
pft
kefir
kefiri
p-if
lxa0kefiri
caspasexa03
piercing
blasts-1
renamed
split-1
helix-loop-helix-type
hes1-
rbpj-null
hes1-null
anti-notch2
hes1-wild
cd158b
cd158a
cd158e1
epitranscriptomics
m⁶a
erasers
self-regeneration
tet-inducible
dnm3
lims1
cd14xa0and
p21q24
pdc-specific
pdc-signature
vsmc
aml-conditioned
vessel-like
mo4
irf-4
corosolic
brca1brca2-containing
63-specific
dub
retinoid-induced
membrane-proximal
tp34q34
non-erythrocytic-1-spectrin-alpha
sptan1
cycline1
zfx-silenced
two-yr-old
mir-425
sars-cov
co-infected
cd45cd13cd33cd14-cd15-
fmdscs
anti-cd3cd28
mab-induced
ido-dependent
1-methyl-l-tryptophan
tfme
lp07
ind-treated
cebp-β
c-peptide
metalloprotease-9
paradoxic
7del
dock4
samd9lsamd9
biologythis
monosomy7del7q
type1
screen-approach
cd34⁺cd38⁺
cd34cd38⁻
surfaceannexin-v
brd4-targeting
brd4-inhibition
nucleoplasmin
nols
c-term
oligomeric
outmost
leukomogenic
self-recognition
assemblies
self-degradation
cml-cp-like
zfp423
ipa3
rarαs77
cak
fgf8f
osteoblast-conditioned
phosphorylation-defective
rarαs77a
cross-mediate
rfgf8f
fgf8f-mediated
ra-resistance
pax2
oxysporum
verticillioides
mir-1mir-133
tdp-43
polycistronic
ggcc
lymphoid-myeloid
cyp2c17
ultrarapid
cyp2c19-guided
mechanismsin
polymorphonucleargranulocytic
precursorsthese
diverging
dysmorphia
hpv-16-associated
hpv-16
runx1-mtg8
runxutr
runx1-mirna
pulmonologists
intensivists
revue
respiratoires
reinterpreted
iswi
smarca5
snf2h
sliding
s5ko
karyorrhexis
ghrh-gh-igf1
ghrh-arginine
stimulable
glucagon
neurosecretory
thrombin-receptor
collagen-related
crp-xl
trap-induced
crp-xl-induced
gpiibiiia-positive
cd11bcd33hla-dr-cd14
thoractomy
preoperation
surgery-induced
expending
il2rγ
mtor-hypoxia-inducible
sirt1-mtorhif-1α
high-abundance
low-abundance
masort
msdb
α1-trypsin
prealbumin
a-iv
hp2
cbfb-myh
isodisomies
upids
2case
1case
utrs
tnfaip2
dicer-dependent
mirnaome
no2
cd80-
tqq22
radiogenic
high-energy
lower-energy
haplocord
nu2009u200968
nu2009u200941
placental-like
plap
t22q22q22q
lest
plexody
mcm-related
fluorescently-tagged
chromogenic
pixelarea-based
mcm-associated
cd68cd163
cd68cd163cd206
tumort
dff40
gm-csf-dff40
refolded
nci-designated
unstudiedmethods
ccccog
aboveresults
non-ccccog
15-
22-
ccccogconclusions
publicuninsured
americanhispanic
raceethnicityimpact
cd14hla-drlo-
stat-3-dependent
early-passage
myeloid-suppressive
∼88
n⩾4
par2
par2--
il-33-treated
treg-cell
neferine
plumule
phospho-extracellular
spermatorrhea
synergisticxa0effect
bmsc-derived
mspcs
ebf2
fate-mapping
angptl1
spp1
kmt2
pd348n
pc394y
interfant-99
ortho-topolin
otr
populus
robusta
1pqq25
3qqq11
xp11
cdkn2a2b
tlx1
aff4
timp-2-deficient
timp2--
vascular-endothelial-growth
vegf-r1
ccl-5rantes
avrainvillamide
ava
syntetic
phagocytotic
typexa0m2
mir-psix1
der8
rothia
mucilaginosa
microrna-29a-3p
mir-29a-3p
sequence1
superrepressor
iκbαsr
p65rela
bcr-abl1-transformed
ikkαikk1
ikkβikk2
ikks
1-myeloid
invadopodia
anti-s100a9
tumour-cell
primary-care
authenticated
mir-193acdk9
mdscs-t
4-arm
i-cloflu
ii-
iii-
iv-single-agent
werewas
mini-methorexate
rabbit-atg
thymoglobulin™
soce
er-localized
pm-localized
orai1
stim1orai1
er-pm
puncta
tmem178
tmem178stim1
arthritic
-related
dnmt3a-associated
mydc
th1-cytokine
p38i
birb0796
p38-mk2
microsporus
tag-driven
tag-specific
creloxp
tag-tolerant
tag-activation
recombinase-encoding
anti-tag
hyporesponsiveness
tumor-unrelated
macrophage–colony-stimulating
ric-allosct
macropopulation
mrn
mre11-rad50-nbs1
rs2735383
rs1805794
rs1805794cc
rs1805794gc
rs1805794gg
rs2735383cg
c26-bearing
p-stat1
tyr701
high-priority
fuelled
regulators-matricellular
proteins-with
expansionrecruitment
expressed-likely
form-directly
one-class
binary-class
ocsvm
f-measure
indolopyrrolobenzodiazepine
ethyl-2-amino-5-dimethoxyphenyl--ethoxy-2-oxoethyl-4h-chromene-3-carboxylate
cxl017
resensitization
hl60mx2cxl017
isthssc
impaireddecreased
self-renews
once-fatal
exemplar
cda-2
phenylacetylglutamine
llc-cm
nonresolving
suppressor-cell
ripk3-independent
mcl-1-related
psz
n-acetyltransferase-2
populationa
rs1799930
rs1799931
onseta
pu200au200a05our
eml-c1
antigen-1
add-back
cd66bcd33dimhla-dr-granulocytes
unclearthe
cd66bcd33dimhla-dr-cells
evaluatedcd66bcd33dimhla-dr-cells
cd66bcd33dimhla-dr-
progressionpbmcs
g-mdsc-mediated
tef
tumor-primed
tpnk
red-brown
mll-af9-transduced
atg5-dependent
pups
founders
vav-hoxa9
mir196b
9n
pointn
residuen
t315in
bcn
optimizen
mutationn
dose-halving
cyp2c8
autoinhibition
rsc
rs11572080
rs10509681
rs1058930
i4
i2
between-study
nanochannel
nep
beacons
20-folds
self-protection
multidelivery
apto-253
informatic
g-quadruplex
ferrous
non-g4
tractability
colony-stimulatingxa0factor
ampk-ulk1
over-fitting
generalize
dirac
familys
nontransplantation-related
interdisciplinary
accomplishment
lower-performance
trusight
structurally-related
irf-ets
iecs
irf8⁻⁻irf4⁻⁻
irf8⁻⁻
irf4⁻⁻
erk5-deficient
coincidentally
erk5-deleted
stat3-induced
npm1-ma
mir-10b
mir-10bklf4
nourishment
temcs
gene-knockout
4pd
cd124il-4rα-targeting
stat3-
cebpβ-specific
temc
diplopic
somnolence
blood-count
ho-1hsp32
flipl
flips
flipr
apoptotic-resistant
tnfchemotherapies
death-resistant
flt3-activated
pi3kδflt3
cal101
flt3-inhibitor-resistant
chitotriosidase
chit
chit-coding
chit1
mbl-coding
proliferativeapoptotic
modal
pseudodiploid
methylcytosines
cxcr4myeδδ
cxcr4wt
fasl-expressing
fasl-dependent
axa0patient
flt1-mediated
vegfflt1
cmlexperimental
ponr
bgb324
bcr-abl1-unmutated
imatinibresults
statusconclusions
pdpdl
kirclass
dna-histone
modification-related
regulation-related
modification-regulator
cyr61
amlwe
rs2297141
rs6576776
controlsthe
pu200au200a04
pu200au200a004
gau200au200agg
pu200au200a01
gcu200au200agg
respectivelyour
receptor-beta
27-kda
hspb1
regu-late
gr-1cd11bf
rae-1
palliatively
transposon-based
liquid-phase
sbcapseq
transposon
sb-driven
neurofibromin1
500-fold
pre-associated
nf1-deficient
doxorubicin-treated
doxorubicin-mediated
freezingthawing
granulocyte-related
momdscs
arginase1
grmdscs
sequenceshere
thiol-modified
non-cross-linking
nanoprobe
gold-silver
unamplified
50xa0min
p14arf-hdm2-p53
npm1-interacting
p14arf-npm1
csl
nucleolus-located
nonenrolled
antibody-targeting
humanization
hm3a4
nontreated
dismutases
sods
pkd2
pmapkd2-mediated
sod1-dependent
paraffin-wax-embedded
ghisi
dnase1
-28k
d7s2554
d7s2460
i-mfa
myod
mdfic
intron-exon
hydroxyurea-treated
co-incidental
haitian
hschpcs
b-lymphocytic
double-knockout
dko
derq10p10-positive
nutlin-treatment
nutlin-sensitivity
nutlin-induced
nutlin-based
enlmllt1
crisp-cas9
enls
alpha-2a
over-time
low-burden
ccrt
cells4
disease5
antigens6
tcrc4
epstein-bar
virus-specific
ttcr-c4
nct01640301
ultra-low
tlr4-independent
restaging
w515s
extra-osseous
schwannoma
neurofibroma
intra-operative
hcfc1
ogt
o-glcnacylation
leukemogenecity
hcfc1ogt-interacting
asxl1-ogt
co-induced
hsa-mir-106b-5p
hsa-let-7f-5p
12c-x-c
vegfvegfr1
vegfr1-tyrosine
mitogen-activating
oligomerizes
wt-npm1
evi1-negative
hsj2
mpp11
brap
jkappa
rbpjkappa
hotairm1hoxa1
gag-myb
murine-induced
pristane-treated
a-kinase
akap12
-1673
-135
fluctuated
ring-ch1
march1
hsc-induced
cox2-pge2-ep4
hsc-derived
pigmentary
aphthous
hyperhidrosis
tbi-induced
a2ars
adora2aff-lysmcre-
enhancer-promoter
enhancer-rich
ctcf-deficient
stag2runx1-deficient
high-pausing
stag2-cohesin-mutated
stag2-runx1
deficiencythis
rara-responsive
pre-nilotib-post-allo-sct
rr3
trending
cd11bmc
hbccd11bmc
igmloigdhi
cd11b-dependent
lm-induced
fas-fasl-mediated
apoptosed
stat6--
cd1--
stat6--fasl--
cd1--fasl--
apoptose
retaliatory
age-stratify
ncicog
wxs
dhx30
tumour-induced
aggravates
mzf-1-fpn
iron-related
fpn-driven
ap4
mir-492
conus
medullaris
intramedullary
chronic-stage
frequentinfrequent
double-disease
unsorted
diesease
bcl-abl-positive
oncoprint
p53-pathway
multiple-tumor
widen
antigen-loss
steminitiating
cd44v6
cd44v6-expressing
il-7il-15
cd44v6-targeted
hyperacute
suicidal
detumescence
urologist
childbirth
n533
n556
n1301
irf8-deficient
a-e
c-s
a-e-
c-s-mediated
t-kasumi-1
inv16-me-1
kasumi-1rx1-kd
runx1a-e
tcf3-znf384
znf384-rearrangements
pro-b-cell
znf384
post-translation
breakpoint-cluster
obovatol
magnoliae
caspase-glo
gstti
gstp1-val
myeloid-based
promissing
brafi-resistant
attractant
depletionblockade
hyperleukocytotic
nf-κbtnf-α
surface-enhanced
sers
sphkap
ultra-hplc-tandem
uplc-msms
skip-transfected
aggregating
cdc20
periportal
hypodensity
prcs
trithorax-group
fine-tunes
prc
ezh2-containing
prc2-related
single-induction
7u2009u20093u2009u2009evaluation
thrombocytopaenia
angiodysplasia
pfa-100
nonresponders-cases
socscistatistics
graphpad
instat
rs1799782
rs25487
aaga
xrcc1arg399gln
aml-dn
aml-mpn
region-cabl
kinase-induced
receptor-t618i-induced
g12d-kras-induced
leukemiathymic
marrow-deficient
csf3rt618i-induced
g12d-kras
ccr5-
ccr5ccr5
mccr5-ig
vaccine-associated
peptidehla-a0201
postvaccination
mrna-loaded
blisters
p15ink4bflfl-lysmcre
p15ink4b-deficiency
cd11bcd45low
cd11bcd45high
tnfα-expressing
cd45high-expressing
bindarit
bone-cancer
inoculating
bindarit-treated
cd36-fao-oxphos
670this
alternately
resveratrol-downregulated
plkb1
senescence-related
sa-β-gal
dsg
pmasg
dose-rate
pu1-inactivated
gmcsfrα
dose-rate-dependent
tp13q14
genexa0bmi1xa0is
ptc-596
mir-103
cop1
frmd8
dhx32
shank3
mkln1
cathelicidin
ll-37hcap-18
cathelicidin-related
cramp
non-tumorous
cramp-deficient
cramp-dependent
relap65
cramp-positive
cs-induced
rarg
cpsf6
npm1-rarg-npm1
rarg-translocation
batf
differentiation-defective
shenling
baizhu
sbs
postoperational
aom
cacrc
phospho-proteomics
cdcp-1
signaling‑1
ixa0initial
iixa0relapsedrefractory
iiixa0remission
ivxa0normal
ms‑pcr
tgf-b
tpoconcentration
fc-parts
mapkmakmrk
mok
mok-hypomethylated
gfap
luminex
hpf
mdsc-promoting
il-6granulocyte
cd11bcd33cd15
supernatant-mediated
flll32
tm-mdscs
pec
tbm
nctu-322
hsp90-dependent
gadolinium-diethylenetriamine
penta-acetic
il-8tg
nucleosidase
n704
rna-sox
lnc-sox
short-tandem
kilobase
myo
leukogenesis
myeloid-targeted
anti-csf1r
pro-angiogenictumorigenic
bhlhe40
endosteal-lining
mineralized
ccl-3
leukemic-dependent
hu5f9-g4
nct02678338
th1-oriented
m2-oriented
ly6cf
ly6c-f
arginase-expressing
pge₂-forming
mpges1
pge2-catabolizing
15-pgdh
pgt
pge2-forming
pge₂-degrading
pr1-ctls
fusion-mediated
nonredundant
hi-c
h3kme3
tads
ccctc
therapy-resistant-aml
anticancerous
9cra
hx630
pca3
tq25q
elovl6
galig
galig-induced
l3mbtl1
l3mbt
del20q12
bcr-abl-inhibitor
hyper-phosphorylationactivation
cx-5011
ck2-inhibition
mek-inhibitor
ck2-mediated
resiquimod
aml-reactive
gm-csfil-4
txa0xa0lxa0xa0r
txa0xa0r
txa0xa0l
lxa0xa0r
erbb3-binding
mln518
flt3-aurora
cct137690
cd34xa0xa0cells
ptprg-negative
cytosine-5-methyl
regulative
itd-mutated
eicosapentaenoic
leucoblasts
disorganization
6u2009h
lineage-defining
sik3
ykl-
mef2c-expressing
mef2c-addicted
druglike
cnaml
co-acquire
c57bl6-d715
patient-mimicking
r139g
r174l
csf3r-mutated
kshv
vflip
fusiform
kics
kshv-associated
nonpharmacologic
ampk-mediated
omentum
tnfr-associated
traf
tlr-induced
traf3-deficient
m-traf3--
nf-κb2
igg3
igg2b
22-mo-old
autophagy-independent
ulbp4
transcriptome-based
sequencing-highlighting
ifngr1
ifngr2
hla-dra
hla-drb1
icam1
leukemia-driver
pre-leukemiapre-lymphoma
21-yr-old
gynecomastia
aya-specific
q-7q
-5q-7q
melphalancyclophosphamide
abnormalitiesunbalanced
microrna-26b
nflfs
nci-h466
nci-h1688
nci-h196
mir-26b-based
p15nk4b
3mll
inverse-polymerase
mll-sept5
chtrt
bcr-abl1-transduced
granulocyte-monocytic
signatures-a
bcr-abl1-initiated
mutationsdeletions
stemnesslineage
cd123-directed
bearing-animals
ngp
67nr
4t1-conditioned
vesselsfield
ngp-expressing
invasionmetastasis
kinase-directed
fluitra
dynamics-guided
bp-
hydrogen-deuterium
domainbp-
limited-gene
tso500
nextseq550
50x
recorded-for
inter-run
tmb
semi-essential
car-dnk
dnk
car-nk-92
interleukin-17a
granulysin
non-lch
nonmegakaryocytic
megakaryocyte-unique
styryl
quinazolinones
ethynyl
thienopyrimidinones
5-nitro
furan-2-yl
3-position
heteroaryl
aveevslrk
ccyslaveevsl
efferocytosis
dimerizer
ap20187
apoptosis-inducible
coimplanted
cxcl5-deficient
efferocytic
cxcl5-mediated
infrequency
non-haematopoietic
mulitparameter
strtified
screening-analysis-based
reassemble
expression-silencing
sitesxa0demethylation
gaussian
geogse63409
enhancementdiminution
fl-dependent
fdfms
ezrin
factor‑β1
anti-cell
pro-complexes
tgf-β-binding
ltbps
leucine-rich-repeat-containing
lrrc32
lrrc33
runx1cbfb
c-kitgr-1-
runx1cbfb-deleted
hemostasis-related
thrombin-activatable
cdkn1ap21
aml1-eto-induced
par-1-deficient
limiting-dilution
cell-dose-dependent
airspace
lobes
bronchialpulmonary
islet
il-6-deficient
murine-transplanted
cotransplanted
pralpha
pralpha-positive
pim2-pralpha
healthy-donor
chemoattractive
broccoli
sprouts
hyper‑proliferation
cancer-restricted
cd33-deficient
impervious
w515l
hypolobulated
irm
tumour-promoting
ebrt
brachytherapy
cyclophosphamidedoxorubicincisplatin
sternal
furthered
patients-phenotype
tissue-potential
six-color
sc-mst
fully-human
h9
previously-described
reformatted
s293d
i332e
bite™
scfvokt3
bitecsl362okt3
biteh9okt3
myt-all
tet2-mediated
anticorrelate
tet2idh1idh2
inxa0dna
4t1-induced
cbpp300-interacting-transactivator-with-an
ed-rich-tail
engraftability
nodcg-prkdcscid
il2rgtm1wjlszj
dnmt3ab-dependent
dnmt3ab
tightest
lfd
hfd-induced
hfd-associated
lipid-modified
polyethylenimines
pa-substituted
lipidspei
lipofectamine™
pa-substitutions
septum
curvularia
spicifera
scabby
vestibule
bi-associated
stablished
cancerleukemic
self-feedback
self-expansion
acetylase
ropn1
scp-1
sllp1
spo11
aml-restricted
ropn6
sllp4
ssx-2
cta-specific
underlain
secondary-to-treatment
tamc-derived
p1a-specific
il-10-deficient
il-10⁻⁻
rag-2⁻⁻
il-10⁺⁺
tlr7
stat-mediated
autoinhibitory
arms-polymerase
pdxk-an
pyridoxal
b6-as
pdxk
plp-dependent
odc1
got2
ocv-501
ocv-501-specific
wt1-killer
class-ii
ocv-501-pulsed
ccml
pinellia
pedatisecta
ppa
coxsackie-adenovirus
scar-ppa
ad-egfp
mannose-exposing
allostimulation
tnf-α-related
lends
hormone-resistant
tramp-c1
sub-line
tramp-hr
ermyb
myb-mediated
q311p
bzip
mu-tant
multi-generational
eif3a
p-raf-1
srsf2p95h
cascading
overused
devasting
decapping
dcps
rg3039
zoonosis
ccnk
c14orf177
setd3
unperturbed
bcl11b-rearranged
t-cell-specific
32dgcsf-r
atf3
discoidin
collagen-activated
denatured
qstar
secretogranin
inad-like
anti-huiv26
huiv26
june-august
december-february
march-may
september-november
seasonally
prc-interacting
co-localize
prc2-independent
i-producing
anergytolerance
lipofectaminex
annexin-vfitc
isohemagglutinins
abo-incompatible
isohemagglutinin
786o
mdscsg-mdscs
suprapubic
kindlins
ferm-containing
cell-extracellular
ß1
ß2
ß3
tails
activated-c
α5ß1-akt-mtor-p70s6k
ikzf2
cebp-driven
11p13
ch80
11p12
ch49
11pter-11p
ch-
11p-11p13
ch00
ch50
11q-11q24
marred
cd300f
4-encoded
cd300f-specific
dcr-2
up-d2
n214
11q5q-
ednra
nutrient-sensing
aktmtorc1
age-unstratified
clean-up
npp
hexanucleotide
cggcat
g801a
grancalcin
lys63
gca-traf6-ulk1
cmlabbreviation
actbβ-actin
anxa5
cul3
cullin
e-64-d
2s3s-trans-epoxysuccinyl-l-leucylamido-3-methylbutane
imres
klhl20
kelch-like
lymphoid-restricted
map1lc3lc3
sequestosome
tap1
toll-
unc-51
bioinformatical
leukaemia-stimulating
68ga
-909ca
lok
nayak
2-δct
non-thrombocytopenic
intervalu2009u-
-909a
-909aa
heterochronic
lin28b-expressing
basophil-mc
lin28b-induced
polycomb-mediated
hhex-ert2
n-terminal-repressive
hhex-induced
hhex-transformed
βcv449e
nepalese
carvernosal
intracavernosal
corporoglandular
fa-related
pk700e
births
reimplantation
reseeding
15-hydroxyprostaglandin
pgdh-mediated
m1-oriented
preestablished
sti-571-sensitive
iodide-stained
mtas
pbox-6sti-571
disorientated
convulsive
permeated
intractability
idh1-
r-2-hg-mediated
biologicalgenetic
mie
postreconstitution
tumour-mediated
unacknowledged
myogenesis
mcsfr
pu1mcsfr
notch-1pu1
dbd
ccaat-enhancer
n26mds
por4
first-degree
svs
deletioninsertion
npm1-dim
cpca
logcamkiiγ
318-bp
elk1
challengingly
trans-migratory
hydrochloric
acidedta
persistentrelapsed
q33p13
rank-rankl
nk-inhibitory
mapk-erk
post-myeloproliferative
bpcs
tcf7l2
bc2059
tbl1x
tbl1
jaki-sensitive
jaki-persisterresistant
arv-771
anti-post-mpn
betp
macinflam
r848-dependent
mir-139
cd34-hematopoietic
eif4g2
suppressor-mir
cancer-driving
aml-engraftment
substrains
aml-lics
epicardium
microrna-199
switchsucrose
nonfermentable
fbj
b5
tg101209
fluconazoleitraconazole
nxa0xa06359
neighbourhood
institute-designated
ccl5-null
nanoparticle-delivered
maraviroc
post-transfusion
hpa-1a
hpa
epigenetic-targeting
inf-γ-producing
il-2-producing
hur-deficient
ccr2-mediated
tgfb
-14kb
aglycone
negletein
fzu-
nn-dimethylamino
ethoxyl
c-6
multisignaling
mcp1
mip1α
p65ko
rnap15as
two-hit
multi-hit
r2-hydroxyglutarate
r2-hg
egln
4-hydroxylases
occupy
gata-dna
monomacdcml
syndromic
lipid-complex
step-down
cd49dbeta1
vla-4cd49d
hdac-inhibitor
hoxb6
hox-binding
hoxb6-induced
2d-e4
s-g2-m
cell-regulating
tte
cmlthis
interleukin-7
pan-genomic
nineties
sub-entities
hcv-related
fcrs
fcr-mediated
therapyexperimental
agentresults
cancerconclusions
tia
wingspan
hnrnpl
thril
ci--
mdm2-p53
p53-mdm2-mdm4
sd-208
signified
granulocyticpolymorphonuclear
tgf-β-driven
portray
one-round
cloche
weve
ahnmds
continously
co-stimulus
cd137-cd137
11q23-rearrangements
q21q22
anti-neutrophil
antibody-positive
oncokinase
pci-32765
chmfl-flt
nm42
170-fold
tel-fusion
flt3c-kit
antibodies-based
mishaps
rbc5
rbc5-bound
v7-aad
imidazo-bpyridazine
sgi-1776
aml-cell
-xenograft
-primary
c-mycser62
thr36thr47
cd68kp-1
amp-ngs
multitudinous
syndrome-refractory
mds-rcmd
c416417del
s34f
etv6-hic1
accretion
wingless-type
paralogs
paralog-selective
asp133→glu196
gsk3α-
gsk3β-selective
gsk3α-selective
brd0705
pan-mutant
idh1r132g
idh1r132l
idh1r132s
flt3-mediated
c817
doubly
bcr-abl1jak2v617f-mutant
sec23b
mad1l1
predetermines
adenosine-generating
11q-aupd-positive
cbl-b
cblb
c-cbl--
flt3lg
co-transduction
c-cbl-mutated
s222
mef2cs222as222a
marksik
mrt199665
mef2c-activated
aacrthis
de-ubiquitinating
hematopoietic-restricted
3xflag
hcf-1
o-linked
n-acetylglucosamine
asxlbap1
myelopiesis
reviewthe
antagomir
anti-mir
2-o-methyl-modified
pso
pso-antagomir
hyperproliferate
tetracycline-regulable
mds1evi1-expressing
well-conserved
dnnumb
space-flight
crews
hze
mevn
28si
56fe
c3hhencrl
protons
1972spe
137cs
cd11bfhi
cd11bmhciihicd11chi
cd11bgr-1hi
trem-1l
endotoxaemia
kmt2amll-me2
mlv-induced
non-transplantable
evi1da-3
cps-ii
152xa0090
1xa0unit
nxa0xa07117
hrpooled
xa0xa
13-acetate-induced
tgf-β-activated
1map3k7
tamc-induced
intensity-reduced
il-2-expanded
myelocyticmonocytic
artifact
nk-deficient
rs6999622
rs13051066
rs61750222
sppss
clxa0xa-25
gtxa0xa0tt
hoxameis1pbx3
pbx3meis1
hoxa9pbx3
mll-fusion-mediated
pbx3meis1-mediated
hox-overexpressing
meis1pbx3
bucloflusor
flt3-wild
bucloflu
smacdirect
diablo
perpetuate
chemo-based
better-personalized
polrmt
polrmt-knockdown
mitochondrially-encoded
cox-ii
theonyltrifluoroacetone
2-c-methyladenosine
2-cm
µmdid
toxin-producing
glycopeptides
no8
fibrosis-associated
prt062607
toxin-induced
intra-hepatic
trans-differentiation
fibrogenic
hepato-protective
tnfαlow
cd206hi
mll-af9nrasg12v
resealed
cd69high
cd36high
above-mentimed
surveil
contrariwise
laminins
co-conspirators
ag-free
1ionomycin
her-2neu-specific
cbd
re-occurred
at101
atra-sensitive
coinhibition
pubertal
parenthood
deoxyribonucleotides
synthesisrepair
5-azac-induced
rr-mediated
10xa0aml
13xa0controls
pre-differentiate
d381n
waals
per-residue
glu481
ser453
ala452
tyr454
phe401
asp400
met337
phe336
ile334
val275
azd4547
-activating
mir-34b
transfection-mediated
miranda
wnt-β-catenin
sporopachydermia
cereana
cactus
region-engineered
cd33mab
flt3-itd-cells
atm-dbc1-sirt1
nuclear-localized
nuclear-localization
wnt-responsive
wnt-unresponsive
prmt5-specific
enhancerpromoter
mutations-induced
keeg
hsa-mir-425
hsa-mir-1201
hsa-mir-1978
target-genes
gtsf1
rtn4r
mirna-target
mirsnps
nedd8-dependent
mln4924
mln4924-induced
microrna-targeting
outcomes-based
ribonucleoprotein-based
csf3r-activating
inductionsalvage
itraconazolefluconazole
fungal-free
haploidenticalpartially
ciom
electroporation-induced
lf2000
il-12-transfected
fierce
p90
p90rsk2
consonance
fmk
cac-espaillat
snider
qiu
channer
coant
schuchman
kew
sheridan
hannun
obeid
crm1-mediated
kpt-276
kpt
xla
myeloid-intrinsic
gadd45β
gadd45b
tmesignificance
t-lymphoblast
ofxa0lkb1
mef2c-bound
deprives
mef2c-dependent
toxa0on-target
sik
m-cre
lysm-fbxw7ff
lysmfbxw7
bmdms
lysmfbxw7ff
mam
sdf1
sox9
tgfb1
azd1775
p53-wild
-deficient
cdc2cdk1
y15
s296s317s345
t14
sequencing-defined
cd34cd123cd38-
neutrophil-enriched
macrophage-enriched
mes
mes-to-nes
ly-6g
monocyte-related
ag-restricted
receptor-abl
peptide-reactive
nct00460629
withania
somnifera
ashwagandha
wre
withaferin
tumor-rejecting
neuron-like
uv-induced
pyrimidine-pyrimidone
cyclobutane
cpds
transcription-coupled
non-transcribed
ggr
dar
mn1-induced
mn1s
lympho-leukemia
progentiors
mn1-cmp
δ-cmp
mn1-responsive
btk-targeted
ibrutinibs
m⁻²
cyarabine
meridianin
compoundsxa07a‑j
pro‑viral
meridianinxa0c
compoundxa07a
lymphoma‑2
ser112
pan‑pim
anti‑survival
caspase‑9xa0andxa
dr‑4
dr‑5
x‑linked
eif‑2α
grp‑78
z‑vad‑fmk
compoundxa07a‑induced
containing-3
nlrp3-dependent
curtails
chemotherapy-triggered
mdsc-derived
nlrp3--
casp1--
nationality
vyatka
homozygotic
carriership
transcripts--complete
cmr--is
gbcr-abl
transcript-negative
gbcr-abl-negative
cs2164
chiauranib
cs2164-induced
srcfynp38
erkmek
hoxa9-bound
positive-feedback
hox-a
wt1-lk
copiesabl
10e4
wt1-reverse
-specific
polyinosinicpolycytidylic
ic-treated
b16-bearing
function-blocking
monclonal
mavs
ifnar
s14
nonstandard
5-kmt2a
insx11q28q23q23
kmt2a-flna
flna
exonxa016
codon-816
cxcr2--
aomdss-induced
or2dgdecreased
aminating
keto
stable-isotope
msi2-bcat1
struggled
flt3cre
macrophage-csf
success-a
januskinase-2
ligand-1
vst
cd123-car-vst
cd123-car
aifa
istat
mdsmpds
inducer-obliterator
dido
dido1
dido2
dido3
mdsmpd
dido-targeted
pim-1l
sotrastaurin
pim-1flt3
phosphorylation-mimicked
pim-1l-s65d
pim-1l-s65a
pim-1l-wildtype
-s65d
sotrastaurin-mediated
arhgef3
rhoa-specific
benzamide-based
monoblastic-like
rhoarho-associated
arhgef3rhoa-dependent
ms275-induced
exoenzyme
y27632
connectivesoft
hypoattenuating
jb6
mith
hn22
hsc-4
tumor-cell-derived
phosphate-oxidase
lobulated
protein-level
ck2-catalysed
akt-ser129
co-sedimentation
ck2bcr-abl
ck2α
normal-sized
mtor-phosphatidylinositol
retrograde
revokes
re-phosphorylation
001-induced
toluene-based
hoses
toluene
non-remissionrelapse
β2-microglubinβ2m
2-δct×100
non-remittedrelapsed
spp-1
spp1--
granulocyte-oriented
tumour-infiltrated
emtcsc
lung-derived
epirubicincyclophosphamide
mitoxantrone-based
tq23q32
kiaa0284
mll-kiaa0284
cd34cd11c-
intrigue
pro-leukemogenic
inhibitedxa0the
ifn-γ-mediated
rbc-units
myloid
paracelsus
salzburg
rhccee
alloantibody
allo-group
non-allo-group
anti-e
anti-wra
-lua
-d
-jka
ageu20099l
100u2009×u2009109l
afro-descendance
ganglioneuroblastoma
her2erbb2
sumo-directed
s27
mzf1-ps27
mzf1-s27
prkca
single-cells
erbb2-expressing
poly-sumoylation
k23
pak4
invasion-promoting
re-stenoses
angioplasty…
arteriosclerosis
azd1897
azd5363
pimakt
atradasatinib
indigenously
g---tetra-o-acetyl-β-d-glucopyranosyl--trifluoromethylphenylhydrazono-3-trifluoromethyl--dihydropyrazol-5-one
g-11
ccrf-sb
bj
itd-flt3
leu616
asp698
cys694
mpap
afp-dr
lin-dr-cd11b
above-median
gv1001
62u2009y
combats
logistic-regression-model
pp-ifd
epigenetic-based
swallowing
factor-erythroid
element-luciferase
pyrazolyl
-tert-butylbenzyl--chlorophenyl-n-hydroxy-1h
pyrazole-5-carboxamide
4f
tert-butylhydroquinone
4f-induced
bcl-2bcl-2-associated
mitochondrial-dependent
aimp1
α-tocopherol
oxide-dependent
aomdextran
producing-neutrophils
kiaa1509-pdgfrβ
vardiman
jw
rebounding
cml-scs
blast-crisis-specific
cell-population
cmpo
ligandc-kit
reframing
discoloration
non-dependent
tme-profoundly
evasive
entry-points
baf47
snf5ini1
smarcd2
baf60b
swisnfδ
smarcc1
baf155
amlimplications
abdulaziz
jeddah
abnormalitiesxa0methodsxa0
zbtb46
batf3
hi-myc
klf4fflys-cre
klf4ff
cebpβfflys-cre
cebpβff
fizz1
pro-atherosclerotic
burden-dependent
genyoi005-a
non-previously
pthr196ala
non-integrative
yamanaka
pluripotency-associated
148u2009215
⩾2u2009cm
rhoa-gtp
myofibroblast-conditioned
dectin
cc-486u2009300
crcripr
responsenonresponse
ly6chighly6ghigh
cd11bcd27
cd11bhighcd27high
cd27high
cd11bhighcd27low
ifnγ-expressing
deactivate
stage-dependent
neoplasm-relevant
33-gene
ezh
chronic-blast
all-inclusive
astronauts
m3-type
rna-sequence
ac-
p300pcaf
garcinol
ces
coccygeal
rootlets
herniated
lumbosacral
reticulohistiocytosis
p8
cd112
co-receptor
ale
crprale
mir-21a-5p
crtc1
mycbp
tet1gfi1ezh2sin3a-mediated
tet1gfi1ezh2sin3amir-22creb-myc
epigeneticgenetic
mir-22-based
ac-3
cparp
cparps
ac-0
connotes
stomatococcus
tp24p13
etv6-jak2
helix-loop-helixleucine
bhlhlz
n-myc-overexpressing
c-myc-overexpressing
n-myc-
c-jun-nh2-kinase
p19arfp53
transcribes
stat3-consensus-binding
stat3--
-210
stat3-knockout
stat3-wild
stat3prl-3
epigenetic-associated
p66a
gatad2a
k63
rna-transfected
p66a-transfected
chroloma
tamoxifen-responsive
cdh5-creert2
tamoxifen-injected
cdh5-creert2wt
cdh5-creert2shbfloxflox
floxing
non-renewable
endothelial-specific
arid5b
ethnicities
rs4509706
rs11761922
rs11761922-g
rs4509706-c
rs11761922-c
rs4509706-t
sloan
kettering
dcis
lnksh2b3
cblcbl-b
cbln
mutn
293c3
293c3-wt
s239di332e
293c3-sdie
cd133-positive
nodcg-prkdcscidil2rgtmwjlsz
polymorphism-array
mdrs
11q7
lsamp
analogdna
aplmaterials
pu2009pu2009uconclusion
bronchiolo-alveolar
predator-prey
prey
predator
four-dimensional
time-scale
cd115-
ly6cint
activation--including
cytotoxicity--is
stat-1
irf-1
cd162
fasl-mediated
intolerances
hif-prolyl
hydroxylase-2
phd2
phd2-deficient
bone-pain
mir155
mir155-deficient
inserts
sarcomas-containing
bmecs
angiocrine
pdgf-ab
rtki
hypervascularity
rtkis
lipopolysaccharidetlr4
cdk4cdk6
cdk6--
-flt3hckcdk6-
kga
bis--phenylacetamido-
4-thiadiazol-2-yl
liver-x
preclinic
gw3965
rgx-104
homograft
residualrelapsed
evolutionswitch
imprecision
quality-assessment
interchange
initiationprogression
amyotrophic
frontotemporal
ftd
ggggcc
c9orf72
c9-alsftd
dipeptide
c9orf72--
hyperresponsive
protein-a
mirroring
alsftd
repeat-rich
primerprobe
translocation-positive
lactoferrin
metastasizing
ire1
hypersecretion
fth
ftl
insulin-akt-mtor
monocyte-macrophages
plec
plectin
niche-directed
dnmt3a-arg882hiscys
mutants-transduced
dnmt3a-r882hc
pyroxiredoxin-2
prdx2
dnmt3a-r882ch
dnmt3a-wt
r882ch
mutation-induced
c866delgpgly289aspfs22
nm001754
b-isoform
nm001001890
c785delgpgly262aspfs22
exon9c872gu2009u2009apg291e
nm001015877
exon3c1111au2009u2009cpt371p
nm001184772
exon4c2076duptpp693fs
nm001123383
ode
prevailed
takayasus
dna-templated
kat
single-donor
pims
withmyeloid
sarcomaandpleural
effusionsas
hownet
thoracoscopy
twist2
twist2-p21
hil-24
adcn-il-24
double-regulated
adcn205-il-24
cytotoxocity
cd3-cd16cd56dim
dasatinib-specific
anti-nkg2a
gata-3
mir-23a
rko
axl-mrna
mzf1-induced
chicken-embryo-metastasis
telomerase-independent
e6-induced
telomerase-positive
telomerase-negative
tel-
5-azc
alt-associated
apb
h3-k9
h3-k14
interconvert
structure-mediated
cell-environment
n-glycome
maturation-associated
turko
ut-scc
metastasis-derived
mal-specific
aprt
h22d3
5acdr
region-specific
hemidemethylation
gsk-j4
5-aza-c
5-aza-c-sensitive
late-replicating
activatable
zthe
5-aza-c-dependent
gene-modifying
tumorigenically
anomer
alpha-5-azadcyd
beta-5-azadcyd
s-3-dihydroxypropyladenine
s-dhpa
isobutyl
rs-3-adenin-9-yl-2-hydroxypropanoic
rs-ahpa-ibu
s--hydroxy-2-phosphonomethoxypropyl-5-azacytosine
s-hpmpazac
5-fluoro-zebularine
f-pymrf
gic50
-3b
cpg-poor
hemimethylation
insulin-secreting
aza-pretreated
pdx-1
oestrogen
skbr3
pre-invasive
beta-positive
beta-negative
dhas
gm-csffetal
gm-csffbs
re-added
p16ink4
cdkn2
2deoxycytidine
p16ink4rb
krab
proteinxa0382
cancerxa0gc
mkn45
transitionxa0emt
notch3
factorxa04xa0oct4
dnmt-inhibiting
cem-6
-overexpressing
caspase-9-deficient
hscshpcs
5aza
5azad
5azad-
tsa-pretreated
fujian
pcrmsp
pcrrtfq-pcr
pcrbsp
rtfq-pcr
intermediate-and
d1-d5d28
treatmentp
hpasmc
hpcasmc
haec
17-β-estradiol
pla2g7
tfap2c
c-erbb2her2
tfap2a
selenium-dependent
hippocampus
n-methyl-d-aspartate
nr2b
dna-demethylating
nonclassical
semi-allogeneic
cobra
et1
edn1
et1-non-expressing
chondrocytes
et1-expressing
mimcd-3
cis-regulation
tgfbeta2
tgfbeta3
casp8
ednrb
tslc1
medulloblastomas
cerebella
riz
tumour-specificity
nestin-expressing
nonexpressing
ta-gvhd
factor-primed
rpmixa08226
v-fluorescein
polymerasexa01
parp‑1
caspase‑
cytosine‑5‑‑methyltransferase
g0‑g1
colo320dm
infinium
humanmethylation450
tet1-depleted
radiosensitizing
radiosensitizers
er-negative
mll5tm1apa
mll5tm1apatm1apa
nup98-hoxa10
demethylation-induced
5-azadeoxycytidine
demethylating-agent
18u2009kda
bisulphite
chemo-therapy
caki-1
more-over
epiretinal
vitreoretinopathy
tgf-β-induced
rpe
5-aza-2-deoxycitydine
i-related
neoplasia-associated
epigenotype
5-penta
chlorobiphenyl
mf-bp
cbpp300-interacting
ed-rich
cited4
mda-mb-453
hs578t
o²
slc2a1
myo1a
a8
myo1a7a
cycloheximide-chase
non-msi
snu-719
ebvagc
blu
fsd1
bcl7a
mark1
scrn1
5-azacytosine
erythropoietin-granulocyte-colony-stimulating
hugl-2
kirc
ualcan
methhc
wanderer
linkedomics
laterality
unmasking
isogeneic
cisplatin-sensitive
scc25
c8orf4
lamb3
tubb
g0s2
mcam
s100p
methylation-induced
disorderly
jeg-3
5-aza-2´-deoxycytidine
aza-treatment
timps
scriptaid
scriptaid-induced
onearray
euchromatin
acetyl-h3-k9
dimethyl-h3-k4
dimethyl-h3-k9
sub-ic50
nonepigenetic
5aza-dc
development-specific
growth-regulatory
methylation-inhibitory
redevelopment
derepressive
tn5
transposase
nice-seq
nicking
ocss
eralpha
trans-active
eralpha-negative
large-conductance
ca2-activated
bkca
kcnmb1
resistance-sized
near-term
∼300
acclimatized
high-altitude
channel-mediated
relaxations
lobar
ftld
grn
dose-escalating
non-alpha-globin
hbff
cdf1
dba2f1
tumor-implanted
pyran
mve-4
l1210-tumor-bearing
aza-dc
crypts
weanling
torula
yeast-based
dimethylhydrazine
dmh
selenium-deficient
seleniumkg
dnmt-i
hdac-i
-pyrrolidine-1-ylbenzoyl
hexanoic
an-8
lactotransferrin
ltf
hpvs
anogenital
hpv-18
linearization
valosin-containing
mir-pvcp
hospitalists
imperatives
traumatized
hbmscs
chondrogenic
runx-2
osteoid
e-cad
trans-acting
qgy7701
hepg15
histotypes
acid-precipitable
high-pressure
eluting
hph
pasmcs
btg3anaapro4
src-mediated
btg3
5aza-c
a498
achn
bisulfite-modified
2h3kh3k4
5-dimethylthiazole-2-yl--biphenyl
isoflavone
spinocerebellar
ataxias
polyglutamine-containing
fmr1
hyperacetylating
nbl-w-s
or3-fold
hsp47
collagen-specific
sulfasalazine
235-
743-fold
abcg2-dependent
promoter-luciferase
12-
abcg2-silenced
hic-1
mdamb231
deoxyc
esrra
wnt11
mir-125a-mediated
3p21
gattii
basidiomycetous
cryptococcal
biparental
matα
2a-c
4a-c
-3a
explants
promoterenhancer
transretinoicacidatra
5-aza-2-deoxycytidinedac
rarβ
delder
g2-block
lps-challenged
stimulatorydestructive
suppressiveprotective
mechamisms
a2780cp70
sw48
fourth-leading
well-founded
error-proof
tezacitabine
dmdc
cndac
ecyd
mir-200c
medip-cpg
medip-cgi
2-amino-1-methyl-6-phenylimidazo-bpyridine
phip
angptl4
rgd1304982
tmem37
ndn
cmas
mpb
ghr
laron
dwarfism
dwarf
ghr-as
ghr-s
e10
lmh
dwarfs
syndromes-refractory
shank1
shank2
excitatory
22q13
shank
hippocampal
5-aza-2-deoxycytidineaza
hyperhomocysteinemia
undisputed
d-aza
phosphoramide
4-hydroxycyclophosphamide
ohcp
bud
cd-1
dna-active
fetuses
postexposure
timed-recovery
embryonicfetal
adi-peg20
asl
neoplasia-specific
bloodbrain
remethylating
pervaginal
colposcopic
fornix
chloromatous
decitex
recist
methyltransferases1
5-azadc
dnmt1-mediated
low-apoptotic
flare
hervs
herv
anti-antinuclear
antisickling
benzaldehyde
antiadhesion
administrable
desferioxamine
parenterally
distressing
satb1
lymnaea
stagnalis
snails
operantly
pre-training
submersion
effluent
predatory
crayfish
5-ht-enhanced
aplysia
pre-exposed
memory-enhancing
l--aza
non-enhanced
mir-196b-5p
tff1
hhcy
cystathionine
β-synthase
cbs-
hcy
wall-to-lumen
acetylcholine
sahh
tetrahydrofolate
cited1
transactivators
d-rich
daza
hindlimb
phocomelia
compound-
mesenchyme
endopeptidase
restriction-digested
nep-specific
androgen-dependent
neuropeptide-stimulated
prss8
prostasin
proliferation-
gsk3482364
hbg1
hbg2
ie1
nct01420926
omicron-acyltransferase
wnt-induced
baboons
papio
anubis
neuroactive
monoamines
tyramine
sp3
-246
-99
-261
sp3sp1
bcsg1
synuclein
5-flanking
type-nonspecific
bcsg1-positive
skbr-3
t47d
bcsg1-negative
epiregulin
ereg
methyl-array
ach3
h3k27me2
azanucleotides
methyltransferase-1
dna-hypomethylation
5-regulatory
maa
hla-a1
-a2
antigen-3
mage-1
weight-maa
wolffe
genet
baylin
ß-galactoside
glycoconjugates
butyrate-induced
iubmb
sirt3
sirt5
aml-relevant
egfegfr
wnthedgehognotch
-binding
recoverin
5-fluoro-2-deoxycytidine
procainamide
microinjected
lacz
5adc
reexpressed
5adc-treated
reexpressing
tandemly
41a3
1-beta-d-arabinosil-cytosine
maspin
lineand
rdf
triples
flexibly
semantic
variegated
explicate
corvus
sparql
saturated
concentrationsdoses
damagecytotoxicity
effectscytotoxicity
r-wpss
lr-pss
dmtis
nonpromoter
disabled-2
multi-function
epigenetic-related
flavonolignan
-dimethylaminophenyl-n-hydroxy--dimethyl-7-oxohepta--dienamide
invasionmigration
tdq
polluted
bohai
hep
pegfp-c3
prolactinomas
scara3
nei
viii-like
hk-2
caki-2
a-498
ach4
deacetylasehdac
alpha-thalassemia
f-cell
spleen-focus
sfpi-1
unconstrained
synaptic
reelin
memory-consolidation
suberoylanalide
3microm
ngml-1
1ngml-1
tetrahydrouridine
preeclampsia
pregnancy-induced
dnmt-1
dnmt-1-mediated
death-associated
dapk
cacalmodulin-regulated
cne
radioresponsiveness
mir-196s
paralogous
cku2009u2009mk-
cku2009u2009mk
apnea
sleep-disordered
chromaffin
apneas
depsi
-3sigma
events2
germline-specific
spermatogonia
nxf2
taf2q
fthl17
tdrd1
tex15
cancer-germline
kip1
combind
ignores
nek2
nima-related
micrococcal
mapit
p53-repressed
azadc
dacogentrade
monopoiesis
il-6v
accessibilities
reorganized
par4
trefoil
restitution
knockdowned
proteinase-activated
pars
tffs
bucyfluara-c-modified
hepacam
rassf1
rassf1a-rassf1g
rassf1b
rassf1c
te13
methylcellulose-induced
imprint
prospero-related
prox1
prox1-overexpressing
mock-transfected
prkcb2
prox1-expressing
5-promoter
thy-1
ccd19lu
hucs
ias-hucs
mesotheliomas
mesothelial
mech-anism
5-aza-cdr-treated
kato-iii
mir-432as
olfm1
neurogenic
reanalysed
ajcctnm
map3k14
ikappa
dft
kirbys
1prod
7prod
3prod
post-decitabine
post-initial
app-sw
secretase
early-onset
app-sw-mediated
app-sw-expressing
ctif
cbp80cbp20-dependent
nxt2
ddr2
-271
-505
-341
-432
interferon-induced
ifitm3
me15
re-set
cyclable
s100a2
branchial
1-ba
azad
palatogenesis
methylcap-seq
azad-exposed
1-bas
12-h
interferon-mediated
igf-ii
igf2r
igf2r-air
dmr1
spretus
interspecific
k9-ac
k4-me
deacetylated
gametes
gametic-imprint
gametic
neurotensin
nts
ntsr1
ntsr2
ntsr3
ntsr
growth-related
carcinoid
retinoblastoma-interacting
caudal-related
het1a
seg1
crypt-like
columnar
atoh1
cisplatin-sensitiveresistant
resensitizaton
27u2009578
parental-sensitive
arhgdib
armcx2
col1a
flnc
mest
psmb9
col1a1
mdk
cancer-sustaining
mechanoreceptor
photosens
glia
pdt-induced
nisch
nischarin
serousmucinous
ho8910
pf-562271
fakpyk2
peritonealpelvic
sk-ov-3
perineum
agr2
alu-associated
pu2009pu20092d
lowrisk
effectthere
aflibercept
agatolimod
ags-004
alglucosidase
aliskiren
apixaban
aripiprazole
armodafinil
atazanavir
atomoxetine
aspart
choriogonadotropin
desvenlafaxine
dienogest
doripenem
dtap-hepb-ipv
dutasteride
e-7010
ecstasy
aciddocosahexaenoic
emtricitabine
enfuvirtide
eszopiclone
estradiol
etoricoxib
everolimus-eluting
ezetimibe
ezetimibesimvastatin
ferumoxytol
fesoterodine
fumavate
fluticasone
furoate
fondaparinux
fulvestrant
hib-tt
hpv-
ic-51
icatibant
h1n
inhalable
glargine
glulisine
ixabepilone
maleate
l-citrulline
lexatumumab
lopinavirritonavir
lutropin
glycol-epoetin-beta
metreleptin
mycophenolic
natalizumab
norelgestrominethinyl
olmesartan
medoxomil
paclitaxel-eluting
paliperidone
panitumumab
octasodium
pegvisomant
pimecrolimus
pitavastatin
plitidepsin
pregabalin
raltegravir
ramucirumab
ranelic
distrontium
rhfsh
sinecatechins
sirolimus-eluting
sitagliptin
talnetant
tapentadol
tasocitinib
tenofovir
disoproxil
teriparatide
ticagrelor
tiotropium
ulipristal
ustekinumab
varenicline
vicriviroc
agalsidase
anecortave
botulinum
brivudine
canakinumab
dapagliflozin
eplerenone
eritoran
tetrasodium
escitalopram
oxalate
g-207
gabapentin
enacarbil
golimumab
istaroxime
klh
levodopacarbidopaentacapone
miglustat
mitumprotimut-t
mp-470
pan-811
patupilone
pc-515
rasagiline
rotigotine
sch-697243
sumatriptan
succinatenaproxen
tmc-207
valganciclovir
sulfatelamivudine
dipivoxil
ambrisentan
besylateolmesartan
an-2728
atrasentan
clevudine
phosphatebenzoyl
daidzeol
darunavir
deforolimus
degarelix
denenicokin
dexlansoprazole
entecavir
eribulin
eslicarbazepine
etravirine
fosamprenavir
ivabradine
lacosamide
belotecan
fentanyl
ly-207320
mecasermin
mkc-253
ngr-tnf
alfa-2bribavirin
perospirone
pf-734200
phenterminetopiramate
ramelteon
ranibizumab
regadenoson
rhitf
ruboxistaurin
rufinamide
sapropterin
saracatinib
sb-73
sc-599
tanespimycin
tegaserod
telbivudine
fumarateemtricitabine
fumarateemtricitabineefavirenz
ticlopidine
tst-10088
tularemia
valsartanamlodipine
vardenafil
yttrium
tiuxetan--gossypol
abacavir
acam-1000
ace-011
agomelatine
becatecarin
bms-690514
casopitant
fenofibrate
ck-1827452
conivaptan
etexilate
dc-wt1
ecogramostim
eculizumab
edoxaban
tosilate
enzastaurin
flibanserin
i-131-l19-sip
idrabiotaparinux
liraglutide
lisdexamfetamine
mdv-3100
rinfabate
naproxcinod
nb-002
nesiritide
nk-012
pl-3994
pm-10450
reot3d
r3
rozrolimupab
sabarubicin
salinosporamide
tipranavir
trifluridinetpi
volociximab
ximelagatran
ziprasidone
monohydrate-dapoxetine
123i-bza
amsilarotene
anacetrapib
apricitabine
atazanavirritonavir
banoxantrone
bazedoxifene
bromfenac
cachectin
calcipotriolbetamethasone
dipropionate
cat-354
ccx-282
certolizumab
pegol
cnto-328
corifollitropin
crofelemer
exenatide
farglitazar
febuxostat
fx-06
hivis
incb-
indacaterol
detemir
jnj-26854165
landiolol
l-name
lumiracoxib
glycol-
epoetin-beta
mk-0493
mva-cmdr
nepafenac
neratinib
neridronic
omalizumab
poliglumex
pha-848125
prasugrel
prucalopride
retigabine
revaprazan
rilpivirine
rwj-676070
sar-109659
stavudinelamivudinenevirapine
telaprevir
up-780
vitespen
monohydrategateways
congresses
prous
ac-2307
aclidinium
adh-1
alefacept
apaziquone
asm-8
atiprimod
ave-0277
ave-1642
ave-8062
azd-0530
bi-2536
bms-663513
bq-123
brivanib
alaninate
bsi-201
cdx-110
ciclesonide
cr-011
cypher
dexmethylphenidate
dna-hsp65
drotrecogin
dtap-hbv-ipvhibvaccine
dtap-ipv-hb-prp-t
eplivanserin
farletuzumab
sealant
gsk-1562902a
imc-11f8
imp-321
incb-18424
indiplon
hydrochloridefloxuridine
itf-2357
krn-951
lasofoxifene
lgd-4665
lubiprostone
lumiliximab
mdx-1100
melan-amart-1gp100ifn-alfa
methyl-cddo
mln-2704
na-asp-2
npi-2358
odanacatib
pbi-1402
perillyl
4-aminobutyrate
peviprobreast
pf-03814735
prasterone
prx-08066
raav2-tnfrfc
rcd154-cll
retapamulin
rtsssbas2
rv-psa-tricomrf-psa-tricom
sg-2000
sp-1640
strontium
malonate
succinobucol
teduglutide
telavancin
telmisartanhydrochlorothiazide
v-5
xience
xl-184
xl-647
xl-765
y-39983
zibotentan-dapoxetine
r-etodolac
abatacept
abt-510
as01b
as02b
as02v
bevirimat
bremelanotide
caiv-t
canfosfamide
clevidipine
desloratadine
dmxb-anabaseine
eletriptan
gsk-690693
h5n1
hypericin-pvp
iclaprim
iss-1018
l19-il-2
lapuleucel-t
laropiprant
lp-261
ly-518674
mirabegron
myocell
nashadx
niacinlaropiprant
ocrelizumab
padoporfin
pf-00299804
reolysin
rimonabant
satraplatin
sch-697243selenite
silodosin
talarozole
tolevamer
ttp-889
v-260
varespladib
voclosporin
vx-001
zotarolimus-eluting
stent--epigallocatechin
188re-pb-12
ad-rh
ai-700
alvimopan
ap-12009
apomab
arformoterol
as-1404
bht-3009
biapenem
ca9-scan
gene-related
canertinib
cannabidiol
celgosivir
cp-751871
cx-401
dexamet
drospirenone
drospirenoneestradiol
dtpw-hepb-hib
efalizumab
ferumoxtran-10
dimeglumine
ghrelin
gimatecan
pmed
la-419
l-blp-25
lidocaineprilocaine
ly-2076962
methylnaltrexone
mitiglinide
myristyl
nicotinate
niacinlovastatin
medoxomilhydrochlorothiazide
ozarelix
alfa-
pexelizumab
picoplatin
pro-1762
caproate
prulifloxacin
reparixin
sipuleucel-t
slit-cisplatin
sndx-275
solifenacin
tgaac-94
xl-880
tiuxetangateways
a6
ragweed
bms-188797
catumaxomab
dexanabinol
edaravone
gestodene
hydrochlorideisosorbide
dinitrate
levocetirizine
pro-2000
r24
rilonacept
rotavirus
shl-749
su-6668
teverelix
tirapazamine
treprostinil
veglin
zileuton
integrityr
z-4-hydroxytamoxifen
alfimeprase
dronedarone
gadofosveset
galiximab
gemifloxacin
isatoribine
rupatadine
valdecoxib
almotriptan
bimatoprost
cilansetron
clopidogrel
cpg-7909
darifenacin
hydrobromide
dx-9065a
elacridar
epratuzumab
lanthanum
motexafin
ospemifene
parecoxib
pirfenidone
rebimastat
roflumilast
semustine
sitaxsentan
wort
torcetrapib
hydrochlorideacetaminophen
ximelagatrangateways
acclaim
agi-1067
androgel
aod-9604
cb-1954
del-1
genemedicine
dnajp1
esomeprazole
gepirone
hbv-iss
ly-156735
meclinertant
metelimumab
morphine-6-glucuronide
nyvac-hiv
osanetant
rofecoxib
maleatemetformin
safinamide
squalamine
secretin
telithromycin
tg-1024
travoprost
abetimus
ademetionine
caldaret
combretastatin
ed-71
no-aspirin
pyridoxamine
r-744
rhgad65
tetomilast
vildagliptin
y90
atvogen
bimosiamose
efaproxiral
fampridine
humax-cd20
rha
rostaporfin
tta
ad-cd154
adeno-interferon
apc--aminocamptothecin
asimadoline
bi-20
binodenoson
bivatuzumab
186re-bivatuzumab
bms-181176
carboxy-
amidotriazole
cc-4047
cdp-860
ctl-4-dap
dha-paclitaxel
eniluracil
enmd-0997
erlosamide
exatecan
fr-901228
hexyl
isv-205
nddp
maxacalcitol
melagatran
ns-1209
nsc-601316
nsc-683864
plevitrexed
posurdex
pramlintide
sdz-sid-791
sibrotuzumab
su-11248
targinine
theracim
zofenopril
alosetron
atlizumab
cetp
edodekin
frovatriptan
indium
las-34475
peg-filgrastim
pleconaril
roxifiban
tesaglitazar
tezosentan
arzoxifene
buffergel
cp-461
eberconazole
emd-72000
lutetium
glucagon-like
peptide--36
tecadenoson
andolast
bms-188667
dalbavancin
e-5564
idraparinux
lafutidine
oritavancin
ro-
soblidotin
tenecteplase
zyc-00101
methylation-demethylation
feii-
2og-dependent
β-n-acetylglucosamine
cannabinoids
cannabinoid
cb1
5-triacetyl-5-azacitidine
18q21
mbd1
cpg-binding
cxxc1
sma-
mad-related
4-mb
chromosome18q21
cadherins
-55
calorically
nrk-52e
beta-
5-azacytidinedecitabine
non-mutagenic
thalassemias
mi-2nucleosome
huntingtons
striatum
fdcyd
htt-induced
striatal
microrna-124mir-124
syndromesmds
cellsmnc
azacr
juxtacentromeric
fleb14
azacdr
multibranched
isochromosomes
azacr-
azacdr-treated
icf
er-β
re-expressing
erβ1
diarylpropionitrile
cpnpg
rmsp1
angiogenesis-regulatory
antiangiogenic-drugs
formin
fmn2
retroelement
mda5
mimicry
inverted-repeat
alus
negative-feedback
1u2009×u
azadeoxycytidine
cse-induced
cse
cseaza
mttfa
smoke-induced
lm7
dlm8
5-azadeoxycitidine
azadc-treated
jurkatdoxorubicin-resistant
abcb1p-gp
oxa
oct3
inductively
diseaseckd
mineralization
cellsvsmcs
osteoblast-like
methyltransferasesdnmts
vsmcs
monomethyl
γ-globin
rn-1
hemoglobin-inducing
γ-globin-inducing
primates
10u2009gdl
asxl1wt
sf3b1mut
k562dac
ddx43h19mir-186
oma-bl-1
anti-chicken
sds-polyacrylamide
er-alpha
prb2p130
icbp90
locus-
pathway-
mim
machesky
mim-b
non-tumourigenic
uro-epithelial
asc-like
ascl
ascl-transfected
methylation-silencing
extravillous
evt
arterioles
serpinb5
cytotrophoblasts
antigens-a
mage-a-9
eca109
mage-a8
-a4
mage-a9
-a10
combing
alpha1-adrenergic
alpha1ars
alpha1ar
alpha1aar
alpha1bar
alpha1dar
sk-n-mc
promoter-proximal
episomally
platinum-containing
pdxs
representativeness
lysozymeclinical
pr693x
decitabinediscussion
deadetylase
-dihydroxycholecalciferol
tdec
matrigel-derived
mdec
receptor-signaling
24-hydroxylase
cyp24
calcitriol-mediated
8p12-p22
ww-domain
bone-metastasis
wwox-protein
kocl48
kopn-1
kocl33
kocl51
kocl44
rajimex-
n-methyl-n-nitrosourea
hmsh6
n-methyl-n-nitrosourea-resistant
msssi
damage-related
cyclooxygenase-2-prostaglandin
β-thalassemia
thalassemic
isobaric
receptor‑type
ptpro
lscc
h520
sk‑mes‑1
non‑transfected
theorized
gasdermin
gsdme
dfna5
rarbeta-negative
lysine-9
lys-9
lys-4
longest-term
bm-1jimro
5-aza-2
sparking
neuropathic
methyltranferase
incision-induced
allodynia
aza-2-deoxycytidine
hindpaw
proopiomelanocortin
pomc
β-endorphin
oprm1
mu-opioid
naloxone
nociceptive
preimplantation
pronuclear
8-cell
2-cell-stage
uncompacted
8-cell-stage
blastocysts
4-cell
dnmt1o
2-cell
cx31
blastocoel
topoisomerase-dna
runx3-methylated
ovcar3
earths
arsenic-associated
cyclin-d1
blackfoot
bfd
non-bfd
arsenite-treated
sv-huc-1
dioxide
gravimetric
solubilities
ltbp-2
safeguards
tetracycline-regulated
activational
activitiesphenotypes
meylodysplastic
functionless
doubtless
reperfusion
camp-response
-4408
-3896
-3425
-3034
ischemic-sensitive
noninherited
aneusomy
cep17
brca1-methylated
uacc3199
albert-ludwigs
freiburg
threefive
glycosyl
phosphatidylinositol-anchored
smoking-related
5-aza‑2-deoxycytidine
5‑aza
transcription‑polymerase
enzyme‑linked
c‑c
5‑aza‑treated
5‑aza‑induced
il-13rα2
anti-il-13rα2
proliferation-inhibitory
re-methylation
5-aza-2-deoxyxytidine
weaned
corticosterone
utero-exposed
5-deletion
mobility-shift
non-expressive
repressional
chromatin-
5-f-zebularine
diazepinone
er-beta
erαerβ
erα-erβ
knocked-in
a549ddp
gda
wisp2
loxl1
timp4
clmp
hsp8
gas1
bmp2
gonda
diseasesee
5-methyl-2-deoxycytidine-5-triphosphate
5-methyl-dctp
pseudo-pronucleus
development-related
insulin-producing
nonendocrine
isletlike
ilccs
cytokeratin-19-positive
c-peptide-positive
glucagon-positive
bix01294
mc1568
tnfrsf1
wm35
arhi
1p31
vipr1
profibrogenic
methyl-cpg-dependent
cbf1
corepression
deteriorate
mehtylation
mutz1
836858-opsonized
nk-cell-mediated
836858-induced
836858-mediated
pre-dac
post-dac
aldosterone
α-epithelial
αenac
methylationdemethylation
aldosterone-stimulated
mimcd3
cytosines
mbd-4
dnmt3b-
mbd4-dependent
dispersal
aldosterone-induced
parpis
npb
pano
ku80
three-drug
virusxa0×xa0protein
hbx
76xa
40xa
line1
nct00067808
ls174t
aza-dcyd
-dihydro-5-azacytidine
h2-aza-cyd
14cthymidine
alkali-labile
prelabeled
pulse-labeled
aza-dcyd-treated
pdz-lim
pdlim2
nf-kappab-targeted
tumorigenicities
activityexpression
erα-dependent
erα-binding
ifi27
krt19
oncocytomas
769-p
bacterially
hdpcs
p-iκbα
cotransformed
gal1
5az
galactose-
glucose-containing
flocculation
dnmt-gene
flocculin-encoding
flo1
hdeoxycytidine
cytosine-phosphate
adriamycin-induced
5-aza-2-deoxycytidine-induced
ipmns
ugt1a1-metabolizing
transurethral
maspin-positive
maspin-negative
rt4
soft-agar
c19mc
mir-517a
mir-517c
elements-1
hin-1
keloids
keloid
scars
igfigf-binding
igfbp5
dermatopontin
dpt
jagged
mz-crc-1
neurotrophin
ecmreceptor
ngfr
ngfr-mapk10-tp53-baxbcl2
anti-ngfr
igfbp7-negative
igfbp7-positive
bisulphate
resetting
scnt
guangxi
bama
minipig
5-aza-2-deoxycytine
igf2
blastocyst
ac2f
methyl-sensitive
370-bp
hindiii
hescs
ectoderm
mesoderm
xci
eralpha-a
eralpha-c
eralpha-b
mdd
ventrolateral
vlo
antidepressant-like
depressive-like
fst
locomotor
intra-vlo
region-dependent
caecal
clp
industrialized
quisinostat
quisinostat-
decitabine-deregulated
bio-informatic
quisinostat-deregulated
t-helper-1
4p
slit2
robo1
aktglycogen
3beta
gsk3betabeta-transducin
betatrcp
upward
e-cadherinsnai1
aktgsk3betabetatrcp
trβ1
q-msp
mkn-45
snu-1
mda-mb-436
cgi2
adrenocortical
steroidogenesis
nci-h295r
dehydroepiandrosterone
bu2camp-induced
steroidogenic
17alpha-hydroxylase-lyase
21-hydroxylase
11beta-hydroxylase
3beta-hydroxysteroid
dehydrogenasedelta5-delta4-isomerase
sf-1
dax-1
dosage-sensitive
reversal-adrenal
λ-paraproteinemia
niemann-pick
npc1
npc2
unesterified
juveniles
npc1npc2
β-cyclodextrin
s110
dinucleoside
β-hemoglobinopathies
enzyme-based
ms-hrm
5-aza-dc-treated
single-locus
mage-2
mage-3
mage-
mage-negative
condensate
bep2d
serum-induced
csc-induced
csc-treated
anchorage-independence
bzm
nimblegen
7b1
5alpha-androstane-3beta17beta-diol
3betaadiol
enteritidis
salmonella-susceptible
salmonella-resistant
tlr21
znf493
toll-interacting
tollip
znf493-related
noti
itga9
wnt7a
npc-cases
wnt-antagonist
hbl-2
b104
namalwa
ents
analog-like
bendamustine-based
liver-3
down-expression
bcl-2adenovirus
e1b
bnip3-negative
junction-related
claudin-7
cldn7
facs-purified
bromate
bro3-
disinfection
nrk
sub-chronic
tsa-
rar-β2
aim1
lgpucc
ccnd
ccna
nid
ucc
slc22a4
ⅰ-ⅱgastrointestinal
cd34cxcr4
5azadtsa
jak2v617f-negative
estrogen-stimulated
er-negativepr-negative
src-1a
allelotype
allelotyping
styi
bani
clump
cancer-linked
wdtcs
pdtcs
udtcs
dedifferentiated
evinced
medium-dose
p7
p003
p34
time-schedules
anti-ny-eso-1
cta-based
emas
phainterleukin-2
il-2-dependent
virus-transformed
anti-mage-1
mca-f
uv-b
1-methyl-3-nitro-1-nitrosoguanidine
uv-b-induced
uv-irradiated
antivariant
antiparental
cross-protection
intervariant
multiplicities
c3hhej
cytofluorography
haplotype-specific
anti-kk
anti-dk
iak
cross-reactive
cgi-associated
ethylmethanesulfonate
anti-thy-1
thy-1-
ems-induced
thy-1-variant
5-daza
fibulins
fbln
ipps
epz-6438
hstl
derl2
nk-cell-associated
down-expressed
5-aza-dc-substituted
dnmt3a-dnmt3b
dnmt-dna
dnmt3-dna
dnmt1-dna
watery
remdesivir
convalescent
hroql
delta-likexa03
dll3
deltaserratelag-2
huh2
carcinomaxa0hcc
5-azadeoxycytidinexa-aza-dc
densely-methylated
lysinexa09xa0h3k9me2
lysinexa027xa0h3k27me3
methylationxa0h3k9me2
sw1116
ncm460
aktmtors6
xiap-associated
xaf1
nonnucleoside
quinoline-based
sgi-1027
sssi
ic-13
s-adenosylmethionine
sgi-1027-induced
h4iie
hmsh2
cbf-b
sstrs
anti-secretory
somadex
re-fed
5-aza-containing
sstr
smssomadex
sstr5
1histone
methyl-cpg
proteinhdac
er-alpha-negative
element-regulated
bm742401
cd19-sorted
wac3cd5
caspase-9-dependent
completes
decondenses
decondensing
5-iododeoxyuridine
idu
non-demethylating
at-specific
berenil
minor-groove-bound
dna-ligand-binding
chromosome-associated
realloted
gadd45a
ghulam
mufti
aloysius
alg
ifn-related
p16ink
t1d
islets
cadaveric
glucose-responsive
ipc
high-glucose
streptozotocin-induced
normoglycemic
interferon-responsive
dsrnas-containing
lgr5-positive
h6c7
dna-hypermethylation
dna-methyltransferase-1
coinoculated
co-tumors
mono-tumors
ges-1
hxa0pylori
pik3ap1
ges-1xa0cells
unessential
sperm-derived
pronucleus
maintenance-type
waits
paternally
zygotes
pronuclei
pre-1
polyspermic
spermatozoa
multilateral
non-conserved
braf-
6q21
del6q21
factor-5
irf-5
bls
promoter-a
lcl
mutu
akata-4e3
ebvagcs
necs
two-tiered
gsk3b
ulbp3
epigenenic
alphaer
co-regulatory
caveolin-1
caveolin
sk-er
caveolin-
caveolin-silencing
allostimulatory
5azadtsa-expanded
grounded
mts1
undermethylated
cells--macrophages
azadc--an
dna-methylase--significantly
exonfirst
dnaasei
dhss
differentiators
ptprk
dact2
dapper
dishevelled-associated
dact
6q27
2-m
tcf-4
mir-29abc
tnps
nanomaterials
tnp-induced
anatase
α-lipoic
tnp-triggered
sox30
spermatogonial
sertoli
hypo-methylated
gc2
tm3
tm4
cytotoxitic
mutated-dependent
ser15
5-azacdr
york-esophageal
endometriotic
oncopathogenic
near-centromeric
epithelial-
morphotype
e-cadherin-dependent
macroarray
plakoglobin
e-cadherincatenin
mage-4
hgmw-approved
mage4
mage-4a
mage1
dok1
ere
-498
e2f1-driven
thf
dgn
apyi
ecorii
hhai
5-azadeoxcycytidine-treated
dr-a
0n
0k
14q
erβesr2
bt-20
exonxa00n
advanced-stages
brms1
methyltransferase1
tam-resistant
tamr-mcf-7
tam-responsive
acinar
hsg
cdkn2bp15ink4b
mdspatients
cellplatelet
nadp
fluorinated
18f-fac
peroxidasexa03
selenoproteins
cpt-11
hct-15
antikinetochore
undercondensed
kinetochores
kinetochore
virology
deformable
youngs
peroxide-induced
cbasp1
n-methyl-n-nitro-n-nitrosoguanidine
-aza-dcyd
inst
expressors
kk
ek
i-a
myoepithelium
sce-prone
mage-as
-a8
-a9
urothelia
mage-a9-specific
14a11
spermatocytes
4-phenylbutyrate
hin1
nonseminoma
tgcts
nt2d1
gdf3
sox15
gper
propertiesgeo
gse42647
alpha9
cpg-island
itga9-negative
5-aza-dctrichostatin
cne-1
cne-2
np-69
low-differentiated
high-differentiated
sprague-dawley
5-aza-cdr-exposed
cd-exposed
seminiferous
5-aza-2-deoxycytidine-5-aza-dc-induced
-tetrahydrouridine
mlminkg
lkg
endo-beta-glucuronidase
time-dependant
laminaran
cis-inhibitory
metalloproteinase-3
5-aza-2deoxycytidine-mediated
propensity-matched
four-cycle
abhd9
adfp
aldh1a3
areg
cav1
cdh2
cldn3
eef1a2
fads1
gpr54
grem1
kiss1
mlf1
msx1
pax6
plagl1
plau
ppic
rbp4
rora
tbx3
tnfsf9
wif1
znf177
znf559
non-hypomethylating
dedifferentiate
fibroblastoid
osteoarthritic
sox5
aggrecan
atms
obesity-induced
γ1
pparγ1
deoxycytosine
demethylationreexpression
1-beta-d-ribofuranosyl--dihydropyrimidin-2-one
a2780cp
ras-associated
mutl
5-aza-2-deoxycytydine
foxp3-
cd4cd8-
cd4cd8-foxp3
cd4cd8-cd25foxp3
dac-treatment
cd4cd8-cd25
cy-potentiated
cy-nod
jnj-26481585
g0g1-
b02
⩾1
decitabinego
hdpr1
wnt16
fz3
goitrogen-induced
goitrogen
goitrogen-treated
metastasising
goitrogens
medcially
retrotransposons
environmentally
methionine-deficient
line--untranslated
arabinosyl-5-azacytosine
5-azacytidines
cytosine-c5
180-kilodalton
snu-620
satb2
unalterable
reconfigure
non-resistant
rrx-001
npdac
npdox
mb-mda-231
vaso-occlusive
industry-sponsored
d0007
daco-020
remissionmarrow
crhematologic
okmi
granulocytesmonocytes
hoxd10
4xa0ptc
cellxa0cycle
hoxd10-overexpressing
tissuesxa0p
agexa
connexin43
mrnaprotein
cx43-positive
growth-controlled
constrast
cx43-negative
junctionally
noninducible
porphyromonas
gingivalis
gingivalis-mediated
embarked
4-methylnitrosamino--pyridyl-1-butanone
nnk
cadherin-13
nnk-induced
litter
nile
buds
postdosing
litters
dams
decreasedabstract
methyltransferase-mediated
sigma-non-expressing
fluorodeoxyuridine
trl1215
arsenic-transformed
c-met
dismutase-1
glutathione-s-transferase-pi
metallothionein-1
non-carcinogenic
foveolar
fundic
pyloric
inhibitor-1
prec
pai-1upa
occurence
quadratic
qpop
rar-beta
promoter-first
linc00162
hnrnph1
rr-chl
cpis
sintilimab
avd
accidentally
leukemia5-aza-2-deoxycytidine
mir-663
mda-mb-231adm
hspg2
5-aza-29-deoxycytidine
microrna-based
pro-remodeling
aza-cdr
pdgf-induced
rasm
asthmatic
pdgf-stimulated
③except
⑥the
25ohd3
50-fold
coga1a
caco2aq
coga13
ht-
med1
ssx
i-deficient
ssx2
ssx1
ssx5
microarrayed
hla-a2-specific
a2dr1
amplification-representation
tazarotene-induced
tig1
retinoic-induced
trophoblasts
axa0fundamental
exonxa01
pregrancy
pregnancyxa0ttp
spe
ffp
cpgxa01
5-aza‑dc
addtion
β-thalassemias
hba
hbfs
2-deoxy-5azacytidine
chemo-sensitisation
mage-a1
transdifferentiate
α-actinin
rounded
cows
neb
granulosa
bhb
vnn2
beta-estradiol
pldr
gene-activating
u2009um
exon-skipping
metastasizes
emt-like
5-hydroxylmethylcytosine
bace1
β-amyloid
bv-2
bisulfite-sequencing
stat3ctcf-binding
-1136
cpg-free
pcpgl-bace1
pcpgl-bace1-aa
carboxyl-terminal
uchl1
540-bp
pigs
cenrep
fertilized
lysing
hla-a0201-negative
oocyte-specific
h1foo
two-cell
tissue-dependent
t-dmr
ovulated
oogenesis
skm-1we
calcusyn
cixa0pxa0xa
cics
atxa0least
mda5mavs
thexa0ability
mda5mavsirf7
gage-based
-a3
-a6
mage-a2
expression-negative
concomittant
high-cpg
5-aza-2-deoxycytosine
streptavidin-peroxidase
dpscs
n-aza
inducesenhances
hypomethylators
b-methylated
t24
paraquat
pq-induced
neuro-2a
post-natal
parturition
chubb
tumoroids
15q25
chrnb4
chrna3
rs421629
rs1948
rs660652
rs8040868
rs2036527
nicotine-addiction
n82
pa05ph001
nachr
dopaminergic
underlied
best-studied
bio-cobra
bioanalyzer
interrogates
deoxynucleosides
5-triphosphates
dnmt2
trnaasp
trna
u87
gw4869
5-aza-2-
deoxycitidine
adenomyosis
pr-b
endometriosisadenomyosis
myoma
stromall
svf
c24
fut3
lea
gp220
5aza-2deoxycytidine
drewinkos
semiadditive
lengauer
1997a
n-benzyloxycarbonyl-val-ala-asp-fluoromethylketone
bv6dac-induced
necrosulfonamide
d-type
hgpin
hyperplasias
bph
npt
gleason
l-428
l-1236
low-intermediate
14-kb
17-kb
i-hypersensitive
kms12pe
khm11
inkrs
cruzi
effectormemory
parasite-specific
sevs
sev
3-hydroxy-3-methyl-glutaryl-coenzyme
cholesterol-driven
grosshistopathology
toxicokinetics
urinalysis
thymiclymphoid
fermt-3
talin
migrationinvasion
cyp2w1
1-intron
re-transformants
u-fcmss
tp53p53
undermines
exits
proliferation-terminating
myc-antagonizing
chromatidchromosome
pre-replicative
unifilarly
polycomb-group
ring1
prognosis-risk
acid-specific
interleukin-1beta-converting
il‑10
occludin
hct15
β-galactosideα-sialyltransferase
ordinal
dddr
non-reduced
rectified
imperceptible
ny-eso-1-one
ctas-following
ht29u202fcells
low-sensitive
ic20
l-ohp
ros-generating
trail-like
trail-receptor
trail-associated
aza-dcr
caspase-8-mediated
22rv1
pedpea-15
c-iap-1
lincs
stitch
webgestalt
polypharmacological
quartz
microbalance
qcm
galr2
alpha2i
tgf-beta-mediated
nhf
collagen-induction
5-adc
smad3-accessible
tgf-beta-induced
type-specificity
protein-3
appropriated
photothermal
mdsmps
crpartial
d-0007
cr11
mir-383
prdx3
mir-383-transfected
bleaching
photoactivation
pagfp-dnmt1
activity-dependent
tantalizingly
k1735m2
dendrite-like
apopotosis
bcl6b
winged-helix
nonintronic
ntreg
tgfbeta-induced
tieg1
normal-1
remission3
non-reaction
enteric
becomed
complication-related
hp1beta
tif1beta
5-deoxyazacytidine
5-dazac
tsa-stimulated
chromocentres
chromatin-packaged
hesc-derived
2-deoxy-beta-l-5-azacytidinel-decitabine
beta-l-5-azacytidine
stereospecifically
l-ribose
l-xylose
l-enantiomers
2-deoxy-beta-5-azacytidine
beta-5-azacytidine
l-xylo-analogues
cdaalthough
2-deoxy-beta-d-5-azacytidine
beta-d-5-azacytidine
nucleophiles
catalysed
shafiee
griffon
j-f
gosselin
cambi
vincenzetti
vita
erikson
imbach
j-l
maury
beta-l-enantiomers
beta-l-nucleoside
2-deoxy-beta-l-5-azacytidine
l-decitabine
1-beta-l-xylo-furanosyl5-azacytosine
-deoxy-beta-l-threo-pentofuranosyl5-azacytosine
beta-d-deoxycytidine
enantioselectivities
mbu-1
csrnp-3
converses
de-differentiated
thyroidologists
enzymelinked
thyroid-specific
aro
wro
npa
trancription
ttf-1
rarbetamrna
dacazacitidine
ck5-dependent
icn1
ck5
ck5-related
adrb1
shrs
myocardia
csr
5-aza-cdr-incorporated
aid-positive
aid-negative
-aza-deoxycytidine
lownormal
nicotine-mediated
perinatally
bmps
bmp3b
bmp6
mpms
hla-dp
hla-dq
dna-cytosine
methylation-inactivated
anticytokine
flt3-itdthe
double-mutations
serpini1
pdcd10
851-bp
175-bp
5-catgcg-3
5-catgmcg-3
pdcd10-serpini1
protocadherin
homophilic
methylation-driven
cta-directed
prodifferentiation
totipotency
erasing
zygote
1dnmt1
alizarin
alpl
hydroxyapatitetricalcium
sost
sclerostin
zeta-associated
zap70-
cautionary
subventricular
dentate
gyrus
neuron-specific
kcc2
gaba
anesthetics
syndromerefractory
revlimid
5-azcr
5-azcdr
cfu-5
gvhr
two-hour
cfu--azcdr
gpx4
non-chromatin
3a--
3b--
ubiquitin-e3
placebo-treated
romiplostim-treated
lidocaine
ropivacaine
bupivacaine
unforeseen
maldi-tof-msms
cpt-induced
bisulfite-pyrosequencing
p73beta
ntn4
b-cell-inappropriate
decitabine5-aza-2-deoxycytidine
muscarinic
m3r
a253
sgt
carbachol-induced
pseudoisocytidine
hypernomic
pcdna-arhi
pcdna‑arhi
tsadac
arhi-targeted
arhi-dependent
mda-mb-435s
epileptogenesis
excitability
bioengineered
mossy
trophectoderm
dnmt1nn
cytosine-dna
pneumocytes
17β-estradiol
oatps
estrone
e1-s
intra-tissue
oatp
oatp3a1
oatp4a1
asns
h1355
zbtb38
5-azacytidine-
c--fluorodeoxyuridine
5-fluorocytidine
bromo-adjacent
survivin-targeting
nci-h460
surkex1
down-regulatory
rvegfc
phenylacetate
10t
adenosyltransferase
mat1a
mat2a
5-aza-
expressionphosphorylation
-85
kb-long
flron
short-form
bmprii
epigenetics-targeting
bioanalytical
maximising
boris
11zn
11zf
50-bp
ctcfdna
mecpg-sensitive
ctcf-
5-methylcytosine-deficient
11zf-binding
ctcfboris
boris-positive
hypermethylatedsilenced
hypomethylatedactivated
anti-boris
basal-like
tmu-35435
tmu-35435-induced
methylation-insensitive
p-glycoprotein-positive
inhabit
species-
atg3
tnfa
del4q12
pnh
hemoglobinurea
polymerases-1
16hbe
silica-associated
m-16hbe
chromatic
drugs--azacitidine
lenalidomide--were
osteoarthritis
-104
sw1353
tgf-beta-smads
hypermethylaion
nhls
neurobiology
intra-hippocampal
prader-williangelman
15q11-q13
ipw
pwcr1
magel2
vidarabine
trifluridine
cgg-repeat
tou
fxs
re-silencing
cgg-repeats
programing
exon-1
ifn-γ-inducing
il-18bp
ifnγ-inducibility
curbing
il18bp
ifnγ-induced
cpg2
γ-activated
h3k9-acetylation
rna-polymerase-ii
il-18-related
patho-physiological
il-18-dependent
s-4-nitrobenzyl-6-thioinosine
nbmpr
magea1
p14arfp16ink4a
post-infusion
dlec1
opcml
huh-7
macroh2a1
anti-hcc
thy1
hat1
axin
be1
scanning-rlgs
drd4
ependymomas
pnet
qcobra
drd4-mediated
cholangiocytes
enzyme-1
hasj4442
map3k8
hras-transformed
peptidylpropyl
c-associated
timp2
fe-8
mekerk-
hypermethlyation
il-6-responsive
kas
reestablishment
resilence
erasure
mucin-producing
muc2-producing
pb2
receptornuclear
ag1478
pd153035
conway
tms1
aroused
3-du
dose-schedule
l1210ara-c
thudecitabine
protein-interacting
kyse150
kyse510
ec9706
caesl7
ec109
5-aza-cdr5-aza-2-deoxycytidine
x-sirna
retinol-binding
crbps
crabps
crbpi
crbpiv
crbp1
beta-d-arabinofuranosyl-2-fluoroadenine
msra
severance
pleomorphism
pms2
nne
cne1
cne2
two3
hne1
np69
collectedmethylation-specific
t98
bex2
deoxy
indole-3-carbinol
p21waf1cip1-dependent
belgian
non-interventional
rfc1
glut4
leptomeninges
-transferases
-methylguanine-dna
-transferase
anti-caspase
dolastatin-10
anti-vascular
antigen-i
il-12rbeta2
hril-12
il-12rbeta2-transfected
hmigcxcl9
il-12rbeta2-expressing
box-1
lfu
non-squamous
desmocollin
dsc3
uacc
supra-additive
er-α
ovine
estrogen-mediated
nonpregnant
hormone-mediated
hormone-induced
betararbeta
-46
usp44
270-fold
slco2b1
slco2a1
mig-6
rbp7
casz1
pr188w
pm655i
pn343s
mcas
mir-589
mir‑phdac5
slc22a18
5-aza-2‑deoxycytidine
5-aza‑cdr
cm³
5x10⁻⁷
lownegative
additivesynergic
mpn-apbp
dose-escalated
toxicityadverse
-not
elapse
lrp1b
mlrp1b4
elovl2
intravitreal
electrophysiological
autofluorescent
underneath
drusen
macular
morula-blastocyst
nm-5
q-pcr-based
megaplex
pre-amp
morula
mir-452
edg2
abcg4
tmsb10
5-aza-dc-modified
u2009n-3
colonocyte
cideb
tnfrsf25
50u2009µm
2u2009µm
ltbr
griffiths
high-definition
melanoma-derived
chrdl1
tmem47
rarres1
plcxd1
kox15
2-fluorinated
4r-2-deoxy--difluoro--tetrahydrouridine
n-glycosyl
acid-stable
pharmacoenhancer
cda-mediated
irregularities
vics
calcified
terahertz
high-power
mir29
diffuse-type
mcadna
hes5
hes2
hes4
notchhes
svct2
sodium-vitamin
co-transporter
usf
nf-y
usf-binding
nf-y-usf
tfap2e
5-fluorouridine
gelatinases-stimuli
coencapsulate
mage-type
vitro-methylated
suffices
lage-1
5-ac
p16ink4a-deleted
h841
ma-10
ma-1
h209
hmsh3
bifilarly
unifilar
undercondensation
aspc1
synergystic
psve3
cmt3
dac-substituted
flameless
faas
slug
emtmet
emtmets
htr8svneo
pgl3-basic
imr90
deoxy-analog
dna-methylating
global-
deaminate
scc4
coding-region
scc15
scc40
scc9
eae
mog
peptide-induced
cd4gfp-
ring-associated
sra
time-resolved
uhrf1-sra
384-well
dose-responsive
toxicant
cotransporter
tangential
neurodevelopmental
tdi
hayashibara
verdine
tdi-c
5-ch
footprints
repressor-ol1
lambda-ol1
beamer
pabo
lys3
c7
unnoticed
alkane
nonconsensus
peptide-dna
azapyrimidine
u2009u037
u2009u016
u2009u904
u2009u002
unleashed
laq824
consensus-formation
dnmta
paca-2
promoter-chloramphenicol
wbc13gl
hi-e
folate-binding
fbp
kb1bt
hsueh
c-t
dolnick
mtx-free
transfusions--a
mds--have
bmp-2
improper
beg
depolarize
radioresistance-induced
promoter-cpg
radioresistance-related
topo2a
plxdc2
etnk2
il12b
t-nhl
flc-7
astrocyte-mediated
colo-320
cdkn2a-associated
estrogen-induced
estrogen-responsive
e2-induced
msh4
20-methylcholanthrene-treated
cnci-pm-20
robertsonian
metacentrics
single-minute
passage-20
p-32
p-36
p-20
p-27
pprb
p-42
cyclinb1
phospho-atm
phospho-chk1
dramatize
cddp-resistance
dap
me180
me180-derived
cddp-sensitivities
cddp-sensitivity
erα36
neuroprotection
erα66
antimitogenic
decytabine
tamoxifen-mediated
tamoxifen-bound
er-responsive
corepressor-hdac3
hmecp2
rett
rtt
f155s
r294x
compaction-related
zigzag
30-nm-fiber
van-gogh-like
vangl2
romidepsindecitabine
hererb-b
cama1
mb435
mb453
meddle-
×5
daccag
，cytarabine
q12h
aclaromycin
，g-csf
protocadherin8
pcdh8
downregulationsilencing
antigen-bearing
interleukin-21
mixes
mage-a1-
mage-a3-
nhbe
1170-i
hbe
beas-2b
dcb
box-behnken
lyophilized
best-fitting
poloxamer
labrasol
azacyd
azadcyd
non-tregs
prf1
gcb-dlbcl
icam-1-deficient
164t2
galectin-7
50u2009×u2009109l
expressin
inhibitive
epigenetics--particularly
methylation--plays
mir24
age65
mayo-french
nephrin
neph3
podocyte
slit
diaphragms
fludarabinebuanti-thymocyte
blood-mobilized
crmcr
cpx-351vyxeos
tetra-stranded
2000nm
pyridostatin
lymphadenomegaly
footpads
ezh2-mediated
s-adenosylhomocysteine
gages
substratre-1
irs-1
igfr
ha-degrading
hyaluronidases
hyals
tropomyosins
tpm1
tpm2
sw620
ebv-derived
prac
androgen‑insensitive
androgen-sensitive
lncap-r
cw22r
arlts1
trp149stop
tov-112
homozygously
ov-90
arlts1-mut
protein‑coding
cell‑expressed
nedd
nedd4xa0family
e3‑ubiquitin
nucleotide‑ras
cnrasgefs
cardia
neddxa0targeted
cnrasgef‑mediated
invasion‑promoting
nedd4
hypomethylate
non-uniform
t2d
ocm-1a
cold-treatment
apm
hre
-966
5ut
topotecans
cancer-testiscancer-germline
woodcliff
two-sided
non-proportional
rosettes
etmr
bradykinin
184a1
sgcβ1
sgcα1
snp-induced
egfr-tki
pc9
pc9gr
defaulting
wider-scale
seladin-1
homebred
rcc2
under-investigated
suberanilohydroxamic
tia-1
tia-1-dependent
yb5
gfp-negative
resilencing
h3k9-tri-methylation
h3k27-tri-methylation
blastula
somites
blastula-stage
gastrula
midblastula
notochord
gastrulation
5-azac-treated
dorsal
mage-a3-low
5m3-low
mage-a3-high
14m3-high
sub-cloned
dha-treated
dha-modified
replications
adozelesin
ds-dna
a-t-rich
high-potency
rna-synthesis
adozelesin-tetraplatin
5-aza-2-cdr
tetraplatin
nu-gc-3
ssh
keratin
hhb1-deltan
ebv-dependent
dld1
inactivator
rap1gap
sn12c
chemoradionuclide
tacedinaline
bon1
qgp1
γ-irradiation
sstr2
68ga-dotatoc
radioligand
dissimilarities
ep300-mutated
nonsmokers
de-repressed
xpc-inactivated
benzoapynrene
myo18b
bgc823
demethlylating
purinergic
p2rx7
bzatp
5-aza-cdr-treatment
mir-596
prdx1
p16cdkn2a
cdkn
p27cdkn1b
p21cdkn1a
sub-cutaneously
wexa0previously
clmet
3h-dac
michaelis-menten
vmaxmet
-deoxycytidine
microghcm2
trihydroxy
taurocholate
glycocholate
microgcm2h
deoxytaurocholate
deoxyglycocholate
ocum-2m
ocum-12
mkn-74
cardiomyoblast
h9c2-fluc3
perimenopause
hypothalamic
hypothalamus
mage-b1
-b2
v5
smcs
ultraconserved
ucr
ucr-encoded
ucrnas
tissue-
ucrna
chip-on-chip
oligo
60-mer
azatsa
231er
anti-estrogenic
hl-60-s
hl-60-r
rhubarb
ppenk
wif‑1
gbc‑sd
wif‑1‑expression
untransfected
gbd‑sd
pkcepsilon
inheritable
methyltranferases
articulate
differentiation-specific
5-lo-negative
hl-60tb
5-lo-positive
68-
655-fold
nuc013
nuc041
protein-90
ganetespib
fear-potentiated
startle
event-related
cortices
d2pp
d9pp
d5pp
separation-decreased
d28pp
miapaca2
bowes
u937and
ht-1080
about--1800
40-fold
pai-i
pai-
regiontrancription
pylori-induced
gerbil
gerbils
mnu
he6
hg2
sb1
sb5
sf12
sh6
methyl-group
allelotypes
-575
gc3c1
-548
fasl-induced
p53-binding
ad-wtp53-induced
nevus
mage-1-negative
888-mel
mage-1-specific
5-aza-cdr-inducible
sox-2
phase-arrested
5-hydroxy-methylcytosine
g1-arrested
non-replicating
ifn-γ-signaling
cleaved-parp
casp1
aicda
scar
tenons
htfs
6xa0h
scratch-wound
collagen-1a1
tgfβri
sb-431542
fibrosis-inducing
eaml
r-ras
rhob
rho6
r-ras-expressing
r-ras-signaling
cdk-rb1-e2f
neuroblastoma-suppressive
p19-ink4d
neurite-like
ngf-ntrk1-signaling
mycn-mediated
s100a6
s100a10
cellanaplastic
morphophenotype
rarβ2
17-β-hydroxysteroid
hsd17b1
epg
mesalazine
raeb-i
andriol
5-aza-2-dc
mcf-7l
p3tp-lux
rii-chloramphenicol
5-aza-2-dc-treated
cyclohexamide
androgen-resistant
n74
5-methylcytosines
cmv-gfp
dnmtihdaci
proscillaridin
retinoblastomas
rhabdomyosarcomas
carcinoids
hepatoblastomas
hrc51
hrc59
igfbp1
gdf15
tgm2
pharmacogene
5azadc
nr1i3
un-identified
resion
low-concentration
lysosome-dependent
in-tube
thermocycler
3ost2
ebna1
ebna2
ebv-specific
ebv-ctls
monoclonality
nanograms
5-azacitidinethalidomide
lrrc3b
snu-601
lrrc3b-expressing
he-stained
epigenome-wide
generationhere
defectsour
5-aza-2-deoxycytidine-3h
dms79
grα
gr-p
1j
1f
ru486
patched1
ptch
rms-like
e-e
afteraround
p97
e6e7
expressionto
e2-independent
destabilize
associated-carcinogenesis
cholangiocyte
tgs
smc
analog-induced
hifα
epas1
hypoxia-responsive
nonneoplastic
unearthing
hpms1
hpms2
kallikrein
klk6
5-aza-dctsa
eb1089
nucleophosmin-alk
pinx1
pin2trf1
gitcs
gitc
agctgc
scc30
cho-k1
5azadcyd
5-methyldeoxycytidine
5medcyd
estimations
5azacyd-resistant
5azacyd
deoxycytidines
non-essential
ndrg1
dec10-ven
trms
10c
tnfrsf10c
basophiliaeosinophilia
leukemiamds
hhip
pancreata
disease-oriented
neurobehavioral
plasticity-related
sevoflurane
exposure-induced
oxygenair
mwm
hippocampus-dependent
pyramidal
sevoflurane-induced
decidua
placentation
cd49a
5-dimethyl-2-thiazolyl--diphenyl-2h-tetrazolium
nu200au200a23
nu200au200a1
nu200au200a11
nu200au200a7
punctual
kdm5i
dac-responsive
receptivity
decidualization
progestin
supergens
doxorubicindecitabine
sykl
syk-negative
aza-inducible
node-negative
dystrophy
fshd
4q35
d4z4
fshd1
dux4
cytidine-5-triphosphate
d-galactosamine
arabinoside3-deazauridine
rassf-1a
aci
dmnt3b
-204
-489
over-treatment
sscs
femurs
nmri
sham
extract-5-aza-dc
β1-
α6-integrins
germ-like
cripto-1
lrh-1
gcnf
ntera-2
dr0
zr
disallowed
mir-34b-3p
mir-181c-5p
mir-517a-3p
29a-3p
34b-3p
e2f3
reic
reic-expressing
karyoplasmic
lamellipodia
anti-reic
g₁s
akt3
wave2
p15cdn2b
maged4
glioma-specific
shg44
a172
ube2l6
isg15-conjugating
isg15-conjugation
lds
atgl
myelomagenesis
wts
kip2
aza-c
friedreichs
frda
frataxin
ganglia
ligament
active-caspase
iron-sulphur
neuregulin
mir-132
idebenone
deferiprone
dnmt3׳s
smads
emt-tfs
skm-1cells
apoptosisdifferentiation
wingless-type-
hyper-cross-linked
monolithic
polymethacrylatoethyl
trimethyl
chloride-co-divinylbenzene
mate-co-vbc-co-dvb
quaternary
monolith
mesopore
polymate-co-vbc-co-dvb
exchangereversed-phase
saxrp
nucleobases
15u2005min
repulsion
signalnoise
10u2005ng
cyp19
pii
i3
t98g
∼10-fold
brain-specific
pdha2
e1α
-122
tata-less
6-methylguanine-dna
h3me2k9
unexpressed
pain-related
tibia
ganglion
microinjection
adeno-associated
aav5
cells-induced
nalp1
paratumoral
reactivant
methyl-h3k4
acetyl-h3k9
dimethyl-h3k9
aebp1
dysf
loc361288
nnat
rgd1308119
-dimethyl-4-aminobiphenyl-induced
dorsolateral
muc2-expressing
non-mucinous
goblet-like
pgcs
pluripotentiality
anti-silencing
luc
suvh1
suvar
cisplatin-resistance
myod1
myod1-transfected
unstructured
cornification
keratins
k10
involucrin
filaggrin
myod1-transfectants
desmosomal
surface-glycoprotein
gp90
mesenchymalmyogenic
fibroblastic
myf3
myogenin
5-aza-2-deoxycytidi5-aza-dc
early-relapsed
bcl2-positive
cdkn2d
p19ink4d
sm-mirna
decompose
adjacency
reacquired
noises
phospholipases
spla2s
spla2
hgiia
hgiii
hgx
mbd4
hmt1
hypermethyaltion
h3k18
h3k14
thbs-1
tig-1
recruitedtargeted
h3k9me1
display-pcr
brushings
dnaj
mcj
ov202
mcj-nonexpressing
mcj-transfected
ov167
kunitz-type
h3-lysine
methyl-h3-k9
methyl-h3-k4
paradigm-dna
zmynd10
zmynd
topo-i
oxidase-like
loxl2
crosslink
collagens
elastin
invasivemetastatic
8p-
loxl2-expressing
less-differentiated
cxcl14
il-2-independent
htlv-i-infected
thioredoxin-binding
tbp-2
hyal3
hyal2
hyal1
tusc2
nprl2
tmem115
cacna2d2
184ab5
combinated
inhibin
fsh
gonad
inhibin‑α
5‑utr
snu‑1
snu‑5
snu‑484
kato
snu‑668
5‑azac
cpg5
pr-a
d54
imr-32
14cmitoxantrone
dnmt-targeted
dnmt1-targeted
htlf
akap12b
mt1a
cp-4200
myotonic
mrcks
dmpk
rhoa-binding
rok
citron
mrckalpha
lhx6
95d
h358
osteoporotic
supraphysiological
osterix
5-aza-deoxycystidine
glucocorticoid-stressed
trabecular
adiposity
uxt
curtailing
seh
estrogen-dependent
ephx2
ovariectomized
ov
ove
17β-e2
ara-caphidicolin
ara-ccladribine
ara-cgemcitabine
ara-cflavopiridol
ara-cucn-01
ara-cdecitabine
lrp15
lrp15-positive
lrp15-negative
azacytdine
incoherence
claudin
cldn
cldn4
cldn3-negative
claudin-3
ganglioneuroma
tfap2b
sh-ep
catecholamine
dbh
sk-n-be2c
noradrenergic
-590
snu-
-719
exhaustion-associated
dcar
memory-related
sema3f
mds-mscs
sp7
c-ros
spatio-temporally
-384
-132
c-ros-negative
mds--lenalidomide
d2-negative
irf-8-deficient
irf-8--
chemokinechemokine
nrf2-mediated
arsenite-induced
methyltransferase-3
arsenite-transformed
ap-pcr
daoy
meb-med-8a
hic-5
sporangia
macroplasmodia
physarum
polycephalum
s-adenosyl-homocysteine
l-ethionine
plasmodia
sporulation
8-azaguanine
aza-g
6-aza-uridine
aza-u
quinn
conundrum
organ-related
steinberg
anti-sickling
anti-endothelial
hcc1954
dmti-mediated
pkd1
suramin-induced
camrelizumab
epigenesis
tff
tff3
akap12α
akap12β
akn1
mir-433
mir-127
mapk4
-cell
decoupling
3-chlorophenylhydrazone
trichostatin-a
blastomeres
5-methyl-cytosine
erythro-magneto-hemagglutinin
virosomes
emhvs
shielded
emhv
confining
knudsons
6q23-q24
tcf21
lucifer
gjic
disintegrin
metallopeptidase
adamts1
fnu4hi
mcrbc
eliminatingdecreasing
latency-reversing
lras
lra
degenerated
primer-binding
pervs
ltrharvest
perv
perv-γ1
perv-γ2
perv-β3
perv-associated
second-exon
pax-6
myf-3
independency
bournemouth-
spanish-
düsseldorf-
lille-
lille-score
rarars
blast-i
5q-minus
unearth
ibet762
ibet151
epidrugs
invasion-suppressor
5-cpg
ec1
∼6
apyrimidinic
aza-cytosine
alkali-catalyzed
azacytosine
ring-opened
alkali-induced
beta-elimination
alkali
lability
myelodsyplastic
pote
pericentromeres
sub-set
potes
pan-pote
cef
patient-matched
chip-qpcr
h-nps
aipc
adpc
850k
sunitinib-nonresponsive
-responsive
qpct
co-ip
noncolitic
cuc
45s
medwatch
ismp
e-mail
anonymously
mir-217-binding
ocurring
4-methyl-nitrosamino--pyridyl-1-butanone
tansfected
glycogenes
glycogene
trangenes
promoter-controlled
anti-mds
p57
ntn1
netrin-1
α-globin
parent-of-origin-dependent
undermined
pasxl1
phf2
chd8
trimethylationacetylation
tissue-chromatin
h3k27-acetylated
h838
cdh13
ecad
adipoq
paqr3
paqr-aza-cdr
eca-109
ubiquitin-independent
odc-independent
zinc-inducible
um1
dna-dependent
radio-sensitivity
proliferention
ere-regulated
half-way
descendants
dose-schedules
histocompatibilty
piv
erms
sjrh30
lmp2
lmp7
oa-associated
traf1
c-x3-c
1cx3cl1
cx3cl1
5-aza2-deoxycytidine
premeiotic
end-labeling
spermatocytic
35s-methionine
gonia
dogma
nonrefractory
burned
lys9
neurogenin
neuro-endocrine
ngn3
betacellulin
ductalendocrine
dca-naive
t3q
del3q
kank1
ankyrin-repeat
litaf
chemotherapy-
receptor-induced
nuclear-transferred
tsa-treated
pax4
pax
beta-cells
shsy610
endometrioid
endometria
mesenchymal-epithelial
anti-sense
transplantion
non-ablative
talpaz
fused-core
2-deoxyguanosine
5-methyl-2-deoxycytidine
5mdc
rend
repair-related
cdcl2-induced
35th
cdcl2-treated
tcs
cd-induced
hogg1
laying
vitrification
cancerization
methylation-susceptible
methylation-resistant
cd20-negative
ms4a1
trichostation
sin3a-hdac1
il-7ralphahigh
il-7ralphalow
il-7ralpha
il-7ralphahighcd8
il-7ralphalowcd8
il-7-mediated
megakaryocytic-erythroid
precocity
pro-aging
arcs
adamts9
adamts9-as2
gain-loss-of-function
gtd
jeg3
yan
azanuceoside
resilenced
reassembly
bzlf1
zp
h3k9me2me3
h4k20me3
suv420h1
h4k20
kgd
cd-stimulated
hmy2cir
centromere-related
signalization
soy
5-azn-2
hematopathological
eortcgerman
itemizing
mage-a3-specific
cell-xenograft
dismissed
translocase
ant1
ant2
ant4
cpg-demethylating
dac-free
frizzed-related
ara-5-aza-cyd
decitabiner
pkc412r
hexabromocyclododecane
hbcd
17-beta
oestradiol
three-spine
stickleback
gasterosteus
aculeatus
ngl
sticklebacks
oestrogenic
hh-interacting
tssc3
non-motile
5-azadecitabine
cdk-retinoblastoma
snu
dnmt3b3
5-aza-2-deoxycytidine-treated
nondividing
dgc
igc
dgcs
igcs
miraculous
hsc-t6
protein-related
igfbp-rp1
nd-1
pc-3-rp1
nontransfected
semiparametric
loewe
quantitative-real-time-pcr
nucleotidase-i
rp-
dckpn-i
dckcda
oxidization
mbds
mbd3-gfp
mbd3
dna-replication-independent
5mc5-hydroxymethylcytosine
precursory
hypoxia-sensitive
insensitivetolerant
neuroplasticity
anxiety-like
sprague
dawley
reared
nadnadh
nct01409070
loi
1related
vespid
glipr1rtvp-1
glipr1rtvp--region
blastemal
nrs
increased-dose
id-flu
l-g
tls-erg-expressing
ynh-1
tls-erg-associated
cdf
l1210-bearing
-225
triexponential
mucins
digestibility
anaesthetic
tscc
scc-4
flice-like
trail-receptors
topo1
formaldehyde-induced
dt40
tdp1-deficient
itchiness
palpation
conglomerated
hyperechogenicity
hypoechogenicity
trex
transcriptionexport
p84n5
htrex84
hhpr1
htrex-fold
alpha-myosin
natriuretic
gata-4
mef-2
düsseldorf
5q-patients
dec-treated
carboxylesterase
ces1a1
thioester
primate-specific
amino-terminal
spectrin-like
uc06
wa01
es03
es02
es04
pote-2alpha
wa09
unknown-risk
index-hma
time-to-aml
5acdr-induced
hemi-demethylation
hmcs
egfr-tyrosine
egfr-tkis
e746-a750
5-aza-2-deoxy
cytosine-5-methyltransferases
jurkat-t
fdft1
wm-
dipeptidyl
dpp4
omeprazole
ckmb
ekg
st-t
non-obstructive
troponins
unrepaired
mlh1-methylated
mir29a
12-hour
claudins
tj
fucosylation
gmds
glycosyltransferase
skm-
confines
neoplastic-related
cost-prohibitive
anti-felv
dickkopf
dkk1-dkk4
dkk2
es-2
eocs
dkk2-transfected
pde4c
mir-639
myst2
rassf10
rassf
nci-h157
nci-460
spca-1
nci-h446
5-aza-2-deoxycytiding
p33ing1b
errα
epigenetics-driven
spermiogenesis
spermatids
tri-methylated
xii
dnmt1was
snf2-related
srcap
nome-seq
methylome-sequencing
srcap-mediated
aza-2deoxycytidine
ltgt
organ-confined
ar-regulated
bisulfite-direct
p69
flutamide
bu-based
re-examine
cytosine-5-carbon
cpg-islands
thermodynamics
mecpg-dna
mecpnpg-dna
mecpgmecpnpg-dna-demethylation
dna-demethylation
termingdesignating
alterations--ie
epimutagens--is
flj32130
hygr-egfp
f117
cellsmay
herv-positive
herv-k
progestins
frankly
transporterxa01
trichostatinxa0a
xq28
42-kb
mage-related
mageb1
mageb2
mageb3
mageb4
mage-b
magea
mage-b2
ca1
memory-associated
ctsg-pml-rara
euchromatin-associated
nmv
nmvs
oe33
eacs
bromouridine-labeled
bru-seq
wntegfigf
laminin-5
ln5-encoding
reck
intron-1
promoterexon-1
reck-inducibility
n62
erpr-
erg2
erg3
be13
erg3deltaex12
erα-positive
jmjd2b
pcna-binding
mutt
mth2
mutt-related
8-oxo--dihydrodeoxyguanosine
8-oxo-dgtp
pcna-mth2
5-methyltetrahydrofolate
mtf
5-mtf
5-mtf-induced
serum-mediated
fa-mediated
5aza-cdr
5aza-dctp
tata-box
coreproximal
methicillin-resistant
mrsa
hormone-regulated
mrsa-induced
tlrs-mediated
mrsa-mediated
prominin
cd133-
tightening
tjs
paracellular
transketolase-like
tktl1
transketolase
pentose-phosphate
qbc-939
rass1fa
epas-1
ec-specific
aza-dc-treated
10q
ebf3-mediated
crpcs
rwpe-1
dna-targeted
rigi
anti-pd1pdl1
786-o
anti-rcc
acetylator
toxemia
criteria-national
rho-guanosine
triphosphatase-activating
rho-gap
8p-22
methyl-dna
lamc2
nore1a
nci-h727
htb-119
enterochromaffin
tartaric
silveri
t-47d
aza-d
er-breast
e4
methylatable
pk15
viral-like
arabinofuranosyl-cytosine
kg-
pxrcyp3a4
thu-dac
2×wk
cytosine-5
c-5
murine-competitive
tet2-null
neurotrophins
neurotrophin-3
nt-3
i-ix
ib-ii
-3622
utilises
muc4-negative
a427
muc4-positive
nci-h292
chemosensory
st-
lt-ih
apnoea
cardiorespiratory
medulla
pmbl
medb-1
u2940
foxo1-negative
med-b1
bcl2l1bclxl
cscdimethyl
dmso-treated
5azac
trychostatin
csc-exposed
5azac-
dba2
15-hr
5-aza-dcyd-treated
methyl-accepting
huridine
ph6
demethylation-independent
sex-correlated
msp-pcr
unit-derived
fech
e-boxes
9bp
umuc
5-azara
sodium-iodide-symporter
pax-8
re-differentiated
pitx2c
isoproterenol-induced
atria
isoproterenol
angii
re-activate
microinjecting
5-methyl-2-
deoxycytidine-5-triphosphate
mid-blastula
deoxyribonucleotidyl
triphosphate-digoxigenin
5-aza-cdr-injected
5-methyl-dctp-injected
osteocytes
osteocytic
bmp-4
bmp-6
azadc-induced
bmpr1a
smad-dependent
cannula
fullness
dilatation
ivc
inspiratory
breslows
thicknesses
thinintermediate
intermediatethick
di-methyl
lys4
hpce
alpha-emitting
cytoplasmatic
rlrs
rlr
polyicpei
re-challenge
rig-i-like
hif2α-associated
hypoxia-like
azara
dnmt-mediated
fast-acting
tfpi2
ciona
neurula
12-h-old
gene-body
nbt-positive
concentration-dependence
campll-37
zrtirt-related
zip8
slc39a8
cadmium-resistant
metallothionein-null
a7
di-methyl-h3-k9
di-methyl-h3-k4
paca44
chemoterapeutic
pdquest
medium-sensitivity
coomassie
cofilin
profilin
coactosin
peptidyl-propyl
stress-70
log-log
leveled
leveling
fn2
viale-a
viale-c
chemically-treated
seedlings
ddm1
semis
seminomas
gct
carcinoma-in
yolk-sac
non-seminoma
seminoma-like
tcam-2
5-aza-2-deocycytidine
monaminooxidase
tranylcipromine
endoderm-
throphectoderm-associated
tcam-2-nanog
albuminuria
dbdb
nfκb-p65
podocytes
sp1nfκb-p65
sp1nfκb
p65-dnmt1
p107
p130
phosphatase-induced
s260
rasff1a
kdm4a
retrovirus-like
intracisternal
r-type
irp
mesocricetus
auratus
bhk21
semi-purified
prkcdbp
rt‑qpcr
lentivirus‑mediated
cisplatin‑sensitive
reinduces
survival-changes
dnmt3b2
3b3
satellites
3b2
dnmt3b3-like
dnmt3b6
instabilities
histograms
5-h
chromodomain
phototherapy
indocyanine
icg
photo-activated
nir
synoviocytes
flss
nlrc5
freunds
pescs
epiblast
episc-like
porcine-hatched
liver-specific
dr1
dr2
pparγrxrα
dysplasiablasts
abiotic
cross-adaptation
heat-tolerance
cold-acclimated
brassica
acclimation
brakat2
brashm4
bra4cl2
photosynthesis
backgroundn
szu-106
szu-106-dac-aml
mcos
outlay
indication--azacitidine
decitabine--in
moderating
rassf2a
c13
a2780ddp
fr901228
nickel-containing
nicl2-induced
methyl-specific
dll1
katoiii
snu601
snu719
snu16
mkn1
nicd
hath1
ins-gas
erythroids
non-erythroids
post-hma
mis-interpretation
calcium-sensing
casr
casr-unmethylated
hct-8
leukemia-promoting
md-mba-453
tsas
timeframe
supb
bp6t
supb-
epi-stimulated
can19
genbank
1q21-q24
s100-related
growth-factor
methylation-
structure-
c-nt
t-nt
risk-adaptive
bone-forming
lillo
osuna
tumorssee
hypermethylation-associated
te-1
te-2
te-10
ctsl2
fabp5
mhc-class-1
hla-cw16
46-kda
mage-1-mrna-positive
mage-1-positive
mage-1-mrna-negative
deproteinized
aps-2
nh₂
interfaced
daidzin
mrm
-2000
blood-brain-barrier
disparition
decitabine-reactivated
hierarchical-clustering
pfs6
cellstumors
repairreplication
cell-matrix
platinum-resensitization
uv-1591
tsta
h-2kk
ic-50
cyclin-d
rasmekerk
rasmekdnmt1
re-examined
hla-g6
hla-g1
methotrexate-sensitive
methotrexate-resistance
oligodendroglioma
oligodendrocytes
oligodendroglial
one-to-one
one-to-multiple
multiple-to-one
re-analyzed
-452
-340
dpysl2
multiple-to-multiple
azacytosine-substituted
5-aza-dc-induced
mir-microarray
collaborator
carf
5-aza-2-deoxycytidine-substituted
anti-estrogen-blocked
dnadna
colo-rectal
tsa-upregulated
mir22
extronic
h3k27trim
toggled
npm1pu1
cebparunx1
npm1flt3-mutated
pu1cebparunx1
-725g
miscarriage-associated
chaotic
differentiation-driving
mechanism-of-action
more-is-better
empiricism
pharmacodynamic-based
drug‑resistance
ddp-resistant
ddp‑resistant
especial
bmrf1
brlf1
maperk
gcv
tbetars
smad-2
tbetari
tbetarii
-244
-140
microdissection
gleasons
tbetar
hpdlscs
ligaments
5-aza-dc-rescued
mir-409
mir-129
side‑effect
5‑azacytidine
5‑aza‑dc
‑2xa0µm
jak‑stat
transcription‑activating
bcl2bcl2l1
abt263
sh‑
kp
qnz
extraterminalxa0bet
apcmin-induced
pneumoconiosis
cwp
col-i
col-iii
squamous-cell
3-mb
prtfdc1
gene-silenced
svltag
svltag-induced
bph-1
m13mp2
antimycotics
vasodilation
high-opn
gbm-skh
binge-like
eod
tegmental
vta
ethanol-induced
non-neuronal
5-azadc-induced
1-deficient
nhem
hmv-i
hsct-eligible
hmt-related
pamr1
n485
fibrillin
quiescin
q6
angiogenesis-suppressing
mcf-7adr
u200945
nanogels
pff
fibroblast-derived
hsulf-1
ov207
chi2
hdac10
pycard
scgb3a1hin1
h-295r
delta-opioid
mdor
ns20y
mecp1
mecp1-like
schneiders
hypercalciuric
stone-forming
ghs
vdr-oh2d3
umr-106
hypermethylate
oh2d3-induced
hla-a1-restricted
eadptghsy
kifgslafl
a05
itdqvpfsv
ck3h6
hlapeptide
hle
ifn-
-oh-yne-cholecalciferol
23-d
-oh2-delta-yne-cholecalciferol
double-expressor
maturation-responsive
phosphoribosyl
crossovers
snu‑719
mkn28
snu‑16
mkn‑45
kato‑iii
unmethylation‑specific
mkn‑28
phospho‑retinoblastoma
wpe1-na22
wpe1-nb26
mir-205
mir-31
bcl2l2
agents-induced
neurospheres
neurosphere
tsaazac
neurosphere-derived
v600ebraf
rasal1
gtpase-activating
peg1
mestpeg1
dnmts--the
methylation--are
1-beta-d-ribofuranosyl-h-
pyrimidinone
5-fluorodeoxycytidine
neurologicalpsychiatric
cytosine-analog
minimal-dose
gst-m2
mpn-derived
veraessential
methylomic
hbf-inducing
cxcr4-negative
cxcr4-positive
foxp3-expressing
cd25cd4
tgf-beta-dependent
dec-205-mediated
exacts
hepatocarcinomas
snu387
snu449
snu398
plcprf5
ht1080
cd-transduced
cdigfp
cd-containing
selectable
5aza-dc-induced
hsv1
rqnestin
blastema
forelimb
lesch-nyhan
hatr
sympathoadrenal
neuronatin
imr32
mhh-call-4
nkg2d-ligands
igfbprp1
g12
feii-2-oxoglutarate-dependent
u2afl-rs1
dnase-i
encouragement
thiamine
thtr2
slc19a3
diras3
gtp-binding
ras-like
phenylbutyratespb
5-aza-2-deoxycytidine5-aza-cdr
octamers
dna-nucleosome
transcripted
o-n-butanoil--o-isopropylidene-alpha-d
-mannofuranoside
mutz-1
endoplasmicreticulum
factor-6
atodac
ros-related
adipose-
-g3
hla-g3
hgf-met
spint2
hgf-induced
cytokine-receptor
vstm2a
top-downregulated
lrp6
lysosome-mediated
hiv-induced
rcan1
glomeruli
hiv-
glucose-induced
arhgef16
arhgap27
enc1
ppp1r3c
ppp1r14c
intestine-specific
t84
5-azac-activated
black-footed
pluripotent-related
dac-triphosphate
dac-tp
within-
dac-based
bipolarity
ephb6
efnb2
efnb3
cs055
combination-treated
ttaggg
shelterin
telosomal
shelterin-associated
21nt
k500e
5-rapid
5-race
ks-untranslated
rfc-b
ks43
5-non-coding
ipmscs
emscs
epz6438
oversized
recbcd-dependent
hr-deficient
hr-proficient
dpc
muc3a
30cpg
-660
muc3a-negative
9cpg
-345
-75bp
muc3a-positive
vezt
specific-pcr
sequence-pcr
mir-43c
episensitization
long-held
reuse
pointless
exhausts
floodgate
therapy--epigenetic
accs
dmr0
ctcf3
ctcf6
heparansulfate
cell-to-extracellular
riboprobe
anti-syndecan-1
lymphnode
syndecan-1-negative
stage-independent
analog-treated
5-azacytosine-
xcl1
nbc4
5-aza-2-deoxycytidinedecitabine
re-expressor
htsnp
pcr-restriction
rs159153
rs125701
rs1052133
rs293795
methylation-positive
methylation-free
hlmec
vegf121a
vegf165a
vegf121b
vegf165b
vegf189b
nonpolyposis
nahso3-sequencing
-248
-178
methylation-suppressed
rt-pcrqpcr
destabilised
destabilises
cd117abcg2
casplatin
h157
lac
cg--gc
cbf-beta
singaporean
cuboidal
pathway--specifically
rrm2--enzymes
pools--form
nmibc
ej
btg2tis21pc3
antiretrovirals
j-lat
nef
ach-2
u1
promonocyte-derived
tnfα-stimulated
anti-dna
ae7
mø
anthocyanin
bagging
pigmentation
mdmyb1
linger
mda-231
αnon-α
globin-chain
hbg
intermedia
nct00661726
dal-1
dual-action
-dimethylbutyrate
hep-2
3runx3
lipid-encapsulated
mda-mb-231xa0cells
bt-549
c-scc
crabp-ii-mediated
fabp5-mediated
colo16
crabp-ii
cyp26a1
cyp26b1
crabp-i
rarαβγ
rxrαβγ
pparβδ
crabp-ii-expressing
5-aza-enhanced
c-sccs
januaryxa02009
adenocarcinogenesis
hypermethylating
derail
hypermethylation-dependent
mir-b-5p
-34c-3p
mir-34c-3p-predicted
btrc
bart
cpwp
pitx2
paired-like
arrhythmic
hli
dachli
nct01690507
endometrial-like
beadchips
bis-seq
cpg-level
element-level
slc22a23
hand2
nr5a1
osr2
jazf1
nominate
tfk-1
qbc939
protein-tagged
map-lc3
non‑tumor
5‑aza‑cdr
hecc
renoprotective
uremia
uninephrectomized
b-6
indoxyl
p-cresyl
hk2
lbc-aml
estrogen-exposed
observes
cedazuridine
cdz
underacetylated
7u202fcycles
nu202fu202f68
nu202fu202f106
oru202fu202f
tet2mutasxl1wt
hru202fu202f
cblmut
pu202fu202f005
mca
mcaden-induced
iodized
intra-bronchial
5-methycytosine
ms-ap-pcr
sts
lymphotropic
htlv-1-infected
themis
or21
aging-altered
bmscs-derived
cd31pecam1
cd105eng
488-ac-ldl
5-azaz-dc
fgf9
fgf3
etv1
etv4
galactoside-binding
1566bp
α-anomer
α-dac
dhac
2-deoxy--dihydro-5-azacytidine
dhdac
kp-1212
α-dhdac
2-pyrimidone
5-methyl-2-deoxycytidine-5-monophosphate
pediatric-intensive
1hmlh1
crte7
antipneumonococcal
hemoglobin-enhancing
clorgyline
lsd1i
lsd1-driven
enriching
interferon-signaling
glp
hypopharyngeal
hscc
grks
grk6
grk6-shrna
signinficantly
institute-
gcs-positive
gcs-negative
westernblot
thwe
gcsphenotype
hippocampus-derived
ht22
41xa0
sfrp6xa0
sfrp1xa0
sfrp7xa0
sfrp4xa0
dkk-1
kpc-brca1
anti-vista
chi3l3
ym1
nephew
habenula
lhb
e-cadherin-mediated
cellhematopoietic
dys-regulation
h2o2-scavenging
restriction-mimetic
ermas
therapyprevention
erma-mediated
epi-sensitized
decitabine-vorinostat
epi-sensitization
b6c3f1
c3hhe
sp6c
cmt64
protein-1α
hp1α
h3y41
h3y41ph
cp-r
14c-carboplatin
3hfolic
125iepidermal
3hglucose
3hproline
73as5
73as3
rab5
2-deoxy-5-aza-cytidine
14ccarboplatin
3hfa
kb-cp1
integromics
isotopic-labeled
smoke-associated
ribonucleoproteic
5aza-2-deoxycytidine
lan-1
co115
semiquantified
il-1-triggered
dachshund
dach1
lung-1
epb41l3
mpp3
parasitoid
nasonia
vitripennis
allocate
cofoundress
fluid-derived
af-mscs
cardiomyogenesis-related
tnnt2
myh6
cardiomyogenic
h4hyperac
cardiomyogenesis
chlorin
e6-mediated
whole-tumour-cell
sccvii
5-aza-cdr-based
5-carbon
promoter-regulatory
tubule-specific
pt-dnmt1
ftc
ftcs
oncocytic
numberloss
presumptively
nonimprinted
ftc133
syndrome-eb
stromalosteoblastic
population-specific
1alpha25oh2
bone-resorbing
neurobiological
prefrontal
self-administering
189u2009000
synaptogenesis
rho-gtpase
dapk-2
dapk-3
allopolyploid
allotetraploids
napus
pre-rrna
oleracea
under-dominant
megabase
trail-sensitivity
trail-resistance
complex-restricted
antigen-a2-restricted
ny-eso--specific
chondromodulin-i
chm-i
chondrocyte-specific
core-promoter
chm-i-negative
c-52
methyl-cytosine
chm-i-positive
plga-peg
nanovector
glycolic
acidify
anti-gbm
embryo-uterine
postattachment
5-aza-2-deoxycytodine
postimplantation
slc16a3
dnm-inhibition-induced
5-cm
cgg-3
fpdm
methyl-insensitive
enzyme-cleavage
fp-ratio
hpaii-
mspi-restricted
submicrograms
255-bp
hpaiimspi
inhibitorinduced
dac-enhanced
dac-pretreated
ac-5
ac-8
ac-12
ac-16
gastric-carcinoma
p16-protein
ankrd18a
18a
nci-h522
hintprotein
hintpkci-1
dvl1
trp-1
translocation-negative
tel-aml
cytochrome-c-dependent
5aza2dc
light-induced
d-glucosaminyl
3-o-sulfotransferase-3b-ost-3b1
3-ost-3b1
monoactylation
cytopenia-related
patientincluding
stanniocalcin-2
stc2
caov3
bxp3
iose
co-packaging
alendronate-conjugated
bone-targeting
btnps
btnp
h226
pre-interference
methy-lation
laq
depression-like
5-aza-2prime-deoxycytidine
5-azad
spt
oft
micturition
5-azadcyd
5-azadcyd-substituted
azacitidinexa0aza
decitabinexa0dac
peptidylarginine
padi4
mean-∆ct
non-hcc
∆mi
mean-∆∆ct
copyml
r248w
cgg→tgg
anti-epigenetic
ms-275-mediated
ccd18co
5-aza-2-deoxycytidinetrichostatin
factorlymphoid
-143
-145
mirs-143
mirna-143
fam107a
ese3
11q23-q24
6-mb
larg
arhgef12
phase-3
ven-based
antigen-processing
blockade-based
dck-transduced
a-549-dck
dfdu
deaminated
tk2
dfdc-induced
rassf1-rassf10
uninvestigated
rassf2
methylight
5-aza-2-deoxcytidine
orrs
hlj1
dnajb4
hsp40
sk-br-3
zr-
nu2009u2009230
nu2009u2009100
nu2009u200953
kmt2d-mutated
lymphoma-characteristic
p-fifty
inhibitor-alpha
pft-α
cardiomyocyte-like
cx-43
escs
caspase-6
kai1
tig3
tigcpg
tig1-negative
x666
hk1
tig1-expressed
nkl-cell-mediated
mta1
β-induced
tgfbi
cartography
vbl-induced
holocarboxylase
carboxylases
mir-539
folate-dependent
mhc-encoded
antigen-reactive
photosensitiser
p1a
re-inoculation
erythropoietin-based
gpa
deregulator
pathway-based
transcriptomically
prc1-
prc-driven
decitabineprc1
prc-silenced
nr4a2
epitect
adam23
penicillinstreptomycin
host-cell
cis-acting
silencers
retrovirusesretroviral
pcr-ssp
pppconclusion
nt-aza
cdaii
3h-labeled
decode
s-adenosyl-methionine
caspase-1-overexpressing
re-cultured
progeria
cd-dst
d-flow
oscillating
pro-atherogenic
os-induced
apoe--
mechanosensitive
camp-response-elements
atherogenesis
copperplatinum
ctr1
aki-to-ckd
crotonate
apabetalone
atfs
18-bp
atf-mediated
atf--aza-2-deoxycytidine
600-fold
chromatin-binding
hjv
smpd3
cross-study
ifn-i-induced
ifn-i-mediated
dacifn-i-treated
dacifn-i
corning
kennebunkport
me-based
hepatotropic
shelteringprotection
hepato-tropic
extra-hepatic
cda-rich
metastasis-regulating
binucleate
bnc
lactogen
bpl
bcsh1
prolactin-related
bprp1
ghprolactin
prl
mir-141
effectsxa0in
4-thio-2-deoxycytidine
t-dcyd
5-aza-4-thio-2-deoxycytidine
aza-t-dcyd
mip101
crb3
4q12-q32
te85
myotubes
house-cleaning
yjjg
b4374
jw4336
5-fluoro-2-deoxyuridine
5-fduridine
5-fluoroorotic
5-foa
5-fdump
dtmp
hdhd4
5-formyluracil
5-hydroxyuracil
decitabine-depletion
inactivation-is
2m
hspgs
cell-tissue-organ
sulfotransferase
h-hemc-ss
3-ost
3-ost-ost2
3-ost3a
anion-exchange
gel-filtration
hemc
hspg
hs-3-o-sulfation
epithelial-derived
keratocytes
corneas
specimes
rt-pcr-sscp
receptorxa0ar
aza‑dc
re-acetylated
deme-thylated
3h5-aza-dcyd
overabundance
zygotic
four-cell
eight-cell
luspatercept
fathead
minnow
pimephales
promelas
l8057
megakaryocyte-like
klf1
7-dehydrocholesterol
dhcr7
-179
sterol-mediated
dko1
hct116-derived
5-aza-2-deoxycytidin
rr-dlbcl
cholinergic
n-18
c6-glioma
apaf-1-positive
apaf-1-negative
apaf-1-defective
dnmt1-overexpressing
exertion
cggnsequence
non-mosaic
bcl2e1b
ec-sod
maximasybr-green
carbonyls
c1420t
a66g
homocysteine-dependent
cst6
apoptosis-inducer
tspyl5
tspyl
dapper2
bt549
aktgsk-3
tgf-βsmad
tgf-βsmad-dependent
crispr-mediated
choriodecidual
methylationepic
cg03988660
cg16804603
cg18166936
cg11308319
cg09095403
cg18493214
cg01443536
cg16030878
cg10143426
tbc1d16
tbc1d-utr
fancf
bcl-2-interacting
-a12
huh6
dnmtase
dna-methylation-induced
kgf
4c8
fibrosarcomas
dna-methyltransferases
five-times
biu87
rbp1
alpha-negative
sickle-cell
lre1
bisulphite-polymerase
underutilization
underuse
tgct
mlo1302
nccit
rt2
mcf‑7adr
mulitdrug
mcf‑7
gaseous
p44p42
tiling
anti-methylcytosine
smad2
smad-utr
cytoxicity
arrest-hallmarks
atm-rad3-related
dnmt1-deficient
dnmt3b-deficient
hdac-is
radiosensitize
zebra
finch
neuroscience
rrbs-generated
aza-upregulated
beta-acetylglucosaminyltransferase
gnt-v
trimannosyl
betaglc-nac-bearing
cloudman
s91
macrophage-melanoma
lamp-1
isotypes
tap63
deltanp63
cgh-array
dbc1
terminators
phytostilbene
rap2
rapgefs
rapgaps
dac-loaded
nanogel
mesoderm-specific
preadipocytes
clbl-1
rasal3
rddm
sbc10
tgfbetarii
promoter-targeting
integrator-1
ms-rt-pcr
wrights
dose-and
panoply
extant
effectuating
meiotically
suc-cess
high-and
clini-cal
ar-negative
self-tolerance
treg-associated
cd25ctla4gitrcd127-
nanos2
foxd3
conundrums
anti-tnf
glycerolipids
acylation
glycerol-3-phosphate
gpat
gpat2
pirna
cytofluorometry
humanhamster
acdr-treated
unreactivated
invoking
a-sensitive
proteincell
mir‑29
mir‑29abc
bl41
mir‑29ab1
mir‑29b2c
unstably
mscv
repeat-based
mscv-based
dazap2
opm-2
sss
hhvpa
one-cell
cardaminopsis
arenosa
polymorphism-cdna
7q32
mc12
c4xx
containment
nucleobase
threatens
hiv-1-infected
mulv
mulv-based
lp-bm5murine
maids
inovalon
more2
len-hma
hma-len
len-hma-treated
p009
disenrollment
pp017
tbs
ltp
rln
s80
s421
tetanic
single-as
β-binding
ltbp4
ltbp4l
ltbp4s
rgs5
irf-3
irf-7
ifna
interferon-sensitive
isreirf-e
isgf3
2ftgh
dnmt1-dnmt3a
dnmt1-dnmt3b
3h-5-aza-cdr
fmr1s
heterochromatinization
dmt-initiation
n351
therapy-exposure
treatment-exposure
-tetrachlorodibenzo-rho-dioxin
dioxin
hepa1c1c7
hepa-1
c3h10t
three-part
autism
mecp2mecp2
tumordevelopment
agentens
photoreceptors
rd2
p23h
s334ter
photoreceptor
organotypic
cep131
ldquohingerdquo
15xa0×xa
10xa0×xa
10xa0gdl
100xa0×xa0109l
mdapss
organization-based
highest-risk
egc
post-endoscopic
post-treatments
wash-based
micronutrients
wil2-ns
fa-deficient
cytokinesis-block
cytome
cbmn-cyt
fa-deficiency-induced
deficiency-induced
acid-fish
pna-fish
acentric
cyb5r2
cyb5r2-negative
sacii
dpf
xa0dpf
subjecting
pffstatic
pff-induced
static-cm
allocortical
aversive
post-training
one-trial
intra-ventral
intra-vs
training-induced
2signal
sbot
lt-infected
sbot4
sbot4-lt
mpsc1
gad67
schizophrenia
gabaergic
interneurons
nt-2
5-cdr
small-activating
q44h
dshic
sarna
dex-sensitive
dex-resistant
gr-1c
dex-mediated
serpine1
bucc
itraq-based
mst1
tgf-β-stimulated
anpep
hsks
β3-tubulin
doublecortin
neun
foxp2
anemia-altering
lewisy
thinner
cd4tconvs
cyp19a1
oestrogen-producing
bafs
breast-specific
mcf10a
single-knockout
dnmt1dnmt3b
hemimethylase
ldb1
zf-ldb1
sickling
oligodendrocyte-like
cytosine-arabinoside-induced
icca
ecca
tcga-chol
nxa0xa036
alpha2
ssd
sall3
per1
clu
dpep1
icsi
anti-5-methylcytosine
post-hcg
vitro-derived
post-ivf
ivf-derived
5-azadc-
pronuclear-stage
000-fold
pregnancy-related
pre-eclampsia-associated
re-plated
cyp11a1
hsd3b1
∼40-fold
hsd11b2
significantlycompared
rhorho
sample-to-sample
co-purification
co-measurement
non-radioactive
tcf-cea
one-color
heparg
hc-04
higher-throughput
leptins
granulocyte-colony-stimulating-factor
ahh-1
nmda
nmdar
d-aspartate
ddo
flavoenzyme
bicarboxylic
d-amino
ddo--
overstimulation
substantia
nigra
compacta
lipufuscin
nonphysiological
logarithmic-
plateau-phase
tumor-expressing
tumor-sensitized
fimbrins
plastins
t-fimbrin
fimbrin
uv-mediated
hcc38
promoter-methylated
hvh
mk2
lübbert
haematologica
eortcgmdssg
completepartial
mk1
mk4xa0
mk3xa0
99xa0
gage-1
yrprprry
hla-cw6
gage-
gage-7b
yywprprry
-7b
hla-a29
retroposon
p-p
bc-2
bc-3
bc-1
hbl-6
bcbl-1
5-aza-2-deoxycytdine
set-up
herv-fc1
5ltr
methylationhistone
pavlovian
intra-la
thalamic
awake
neurophysiological
reconsolidation
training-related
auditory-evoked
aefps
stm
aefp
ltm
amplitudes
post-retrieval
δνp73
1-dna
slfn11
ehmt1
ehmt2
stablely
ihns
ihn
spc-a-1
kras-dependent
kras-mutated
epigenotoxicology
methy-sens
plp1
ethmoid
post-mds
hyperadditive
ng-nitro-l-arginine
cd19-directed
neoplastically
dnmt1dnmt3b-deficient
proteinsxa0and
e-twenty
dermo1
shox2
nct01546038
mdsexperimental
rp2dresults
settingconclusions
glasdegib-based
nanomedcine
lipid-polymer
f9
8a
deoxyazacytidine
methylation--at
genomes--than
extraembryonic
h3k27me-deazaneplanocin-a
s-only
ns-only
cpeb1
emilin2
layn
marveld3
robo3
igdcc4
core-expressing
deacetylase-1
acetyl-histone
h3-binding
protein-promoted
core-induced
rccs
hspb7
hsbp7
microrna-137
progressive-free
tc620
cse1
cse1l
senescense
compounds-5-azacytidine
decitabine-have
hts
epigenome-targeted
electroconvulsive
ect
post-ecs
4h
ecs-treated
ecs-induced
kg--aza-cdr
uterine-exposed
mated
spermatid
oral-recombinant
methioninase
o-rmetase
usts
pdox
nude-mouse
o-rmetase-dac
glas
glasxa0xa0ldac
cisternae
metastable
clearest
pin-pointed
wnt-related
sox11-dependent
rhox
rhox5
rhox6
rhox9
rhoxf1
rhoxf2
n-2-aminophenyl-4-n-pyridine-3-ylmethoxy-carbonylaminomethylbenzamide
rie-1
ral
mek-dependent
myostatin
mstn
sfn
p-cadherin
less-than-favorable
nct00538876
morbid
5-d
dtccik
platinum-resistantrefractory
platinum-sensitive
fresher
sca
fit-for-purpose
c9orf3
verticillin
avp
supraoptic
paraventricular
pvn
functional-related
dehydrated
salt-loaded
duel
oxidored-nitro
solute-linked
slc39a
zrtirt-like
znt
slc30a
importer
zip1
zip14
znt3
s100a8s100a9
ldlr--
adminisered
cd62l-selectin
2mcp-1
ccl2mcp-1
lxrα
5-aza-dcs
atheroprotective
noncovalently
fc-specific
anti-igg1
comigrates
laser-induced
lifp
ce-lifp
nm-10
chemical-cell
resists
5-hydroxymethyl-cytosine
early-treatment
sarcomatoid
mixing-allografting
azoospermia-like
dazl
htatip2
caners
hypermethylator
g-cimp
gic
gics
nu2009u2009151
ageu2009u200970
representational
9p13
ciitapiv
decondensed
synchronised
aza-moiety
triazine
gscs
hyperoxia-induced
methyltransferase-specific
hyperoxia
hydroxyproline
kms-18
tropomyosin-1
tm1
reemergence
microfilaments
2-mb
dhl-60
balf
butyrates
beta-d-anomer
5-aza-cdrf
anomers
asci
grm7
methylaiton
1616-amino
endonuclease-coupled
laccaic
dna-bound
epha1
response-1
egr-1-inducible
nab-2
egr-1hif-1alpha
k-ras-
egfr-carrying
zolinza
istodax
21xa0nucleotide
mir-148a-dnmt1
alterative
dna-pk-dependent
c-nhej
a-nhej
windhofer
candidate-a-nhej-modulators
cell-growth-dependent
growth-state
suppression-strategies
e2f-2
p53-deficiency
hrasg12v-transformed
de-silenced
hrasg12v-activated
subordinated
acetylated-h3h4
acetyl-l-carnitine
fraxa
capeox
oxaliplatin-resistant
capeox-resistant
fluorouracil-resistant
apoc1
serinethreoninetyrosine
interchangeably
ganglioneuromas
m-type
pla2r1
s100a4-positive
colo201
sw837
-insensitive
s100a-aza-2-deoxycytidine
bode
sv40-infected
pretransformed
hdfs
nrf2-keap1
srebp-1c
hg-induced
supergene
sex-dependent
agexa05-aza
rotarod
akap12gravin
gsps
anti-skin
scc13
h3-lys
gsp
cip1p21
treatmentprevention
dupro
nd1
pcna-labeling
msp-positive
msp-negative
myelo-depletive
eps
adenovirus-transformed
operatorrepressor
di-beta-d
galactopyranoside
pvtts
nu202fu202f11
epityper
pvtt
alternated
tnfrsf10a
nu202fu202f48
rh-trail
ha-hdis
ha-hdi-resistant
hl-60lr
ha-hdi
claudin-11
cldn11
ripk1
tak1
5z-7-oxozeaenol
ripk1-dependent
sncg
securinine
securinines
non-related
hematemesis
dnamti
cd11bxa0xa0gr1xa0xa0mdsc
dna-mi
hdacidna-mi
two-gene
rhoj
prdi-bf1
pfm2
pr-domain-containing
fes
snu-1040
sw-480
abysmal
sp17
incrementally
gtl2
meg3a
nonfunctioning
wnt2
erythroparvovirus
parvoviridae
mvm
aav
chromatin-like
phelper
post-allotransplantation
igan
iga1
core1ßgalactosyl
cosmc
iga1in
alk-expressing
5-aza-2-deoxy-cytidine
25c
tp53bp1
zcyt
c5-mtases
zcyts
mhhai
zcyt-odns
co-factors
adohcy
2p13
unscheduled
exfoliated
gh3
ghrh-cl1
dna-mtase
att20
90o
avai
hp75
asic2
amiloride-sensitive
na-channel
degenerin
glial-derived
-1551
-133
hypomethylates
uec
mfe-296
nak-atpase-β
nak-β
stoprepress
n167
five-cell
dld-1ch2
hmsh6-
tpa-resistant
fgfr4
ruffling
fgfr4-r388
fgfr4-wt
progression-associated
fgfr4-g388r
crip-1
neuromedin
cdrinduced
wntβ-
matched-diagnosis
skeletons
supernumerary
ribs
hindlimbs
longbone
prelamin
laminopathies
progeroid
n-acetyl-s-farnesyl-l-cysteine
methylester
afcme
non-farnesylated
farnesylated
lap2
unevenly
afcme-treated
er-
promoter-dna
hypermethlyated
p-jak2
pifithrin-α
energetics
tattooing
interferon-γ-producing
anti-tgfβ
morin
hmec-1
hper3
chb
revolved
small-sized
co-loading
redox-responsive
gem-conjugated
poeg-co-pvdgem
pgem
ptxpgem
nucleotides-based
large-sized
prodrug-based
neuroglioma
cn6ct
protein-9
adh1a
adh1b
adh1c
beta-hydroxysteroid
hsd2
mineralocorticoid
beta-hydroxyglucocorticoids
sp1sp3
methylated-cpg-binding
mcf-7tam-r
4-oht
ps2
sw620oxr
non-dnmt-inhibiting
microrna-200c
g-to-c
5-aza-ctp
5-aza-dctp
5-aza-ctpin
baculovirus-mediated
meki
dnmti-meki
mirna-149
mir-149
p-gp-induced
operant
xa0h
xre
xre-1383
xre-983
xre-895
14q32-encoded
metastasis-suppressive
meg3-dmr
testosterone-producing
leydig
5-aza-derived
h3kme
bix-01294
g9a-like
proteineuchromatic
glpeu-hmtase1-mediated
tet1null
tet1-mediated
xa0cd25-
treg-cell-specific
5-aza-2-deoxycitidine-treated
azacitidinedecitabine
methylation-regulated
duplicates
testin
transcription-regulating
ci-994
relevances
χ996
hist1h2ae
hgu0
igsf4-expressing
downregualted
alphafetoprotein
disintegrin‑like
typexa0ⅰ
motifsxa0adamts
19xa0secreted
rpmi‑8226
adamts9‑silenced
crippling
h-chain
chl-derived
kmh2
l1236
l428
proteinoct-binding
bob1obf1
kallikreins
rrad
mt1g
marrow-repopulating
assayable
d5
dl3
methyaltion
amog
atp1bp
apod
3q-qter
dmxlq
drr1
tu3a
psd3
kiaa09428hca67efa6r
8p22
doc-2dab2
hdab2ip
m2b-methylated
spermatogenic
microspectrometry
cp70
paraffin-adsorption
hypomethyated
5-methylcytosinecytosine
pex19p
mortalin
remodeling-dependent
remodeling-independent
p16-positive
5-azadc-enhanced
trop-2
trop2
tumour-forming
h322m
signalling-mediated
aktβ-catenin
tsa-induced
kbvj300
vincristine-resistance
kbcdr-1
kbcdr-2
kbcdr-3
mspihpaii
yb-1
axon
cells--hence
restricted--is
5-aza-2-deoxyctidene
shorteningrelengthening
relengthening
tr90
depressant
fura
5-fluorodeoxyuridine
fdurd
internucleotide
postsynthetic
adamts18
ccrcc-derived
alcohol-drinking
two-bottle
alcohol-exposure
alcohol-induced
ntf3
receptor-trkc
alcohol-related
fgfr3
gja1
bcl7c
gadd45g
phonotypes
dtert
rta
chp-100
equid
herpesvirus-1
ehv-1
idoxuridine
rk13
benzene-derived
hq-induced
papillomavirus-16
w12e
w12i
integrants
integrant
concatemers
replicons
fuhrman
3p25
tumorsgist
markersnovel
a549dox11
resistanceresponse
and4
dys-regulated
has-mir-
29b-3p
a549dox11cells
profilemirna
markerstargets
doxorubicinepigenetic
ems1
myeov
myeovand
nitric-oxide
non-endothelial
hdca1-mediated
-k27
kcyc
orf73
thermo
hyperpcarb
graphite
isocratic
acetateacetonitrile
5min
sciex
000ngml
s-adenosyl-l-
sah
niwa
pylori-promoted
provocative
sash1
mpa-induced
antiprogestin-responsive
constitutive-resistant
antiprogestin
ru-486
antiprogestins
pre-mutation
x-associated
tremorataxia
fxtas
cggs
full-mutation
x-syndrome
fmrp
flp-in
t-rex
fmr-utr
gonzalgo
mip-3α
microrna-378
mir-195mir-378
rad9
hrad9
schizosaccharomyces
pombe
scc-25cp
nasopharayngeal
slit3
robo
trimodality
pleotropic
mir-218-resistant
malt
polydactyl
intein
split-luciferase
l1pa2
luminescent
polyposis-associated
ccaat-binding
cotransfected
promoterluciferase
mcf-10
loxl2-induced
retrovirions
icap
intramitochondrial
imap
m-432
lrpprc
invmed1
lucena
skeletal-muscle
ryanodine-receptor
ryr1
multiminicore
ryr1-mutation
nonexpressed
aza-7d
subcutaneouslyu2009×u20097
dec-5d
intravenouslyu2009×u20095
prmarrow
crprmarrow
cdx2-negative
rugao
5-azadcu2009u2009tsa
6xa0d
trophoblast-derived
score-1
consulted
gynaecologist
synaptophysin
chromogranin
dli-related
rf1
rf48
ajcc
biochemotherapy
s1p1
s1p-induced
s1p2
receptor-b
tyrosinase-related
tyrp1gp75
dopachrome
tautomerase
dcttyrp2
melanocyte-specific
tyrps
extinguished
tyrp1
box-dependent
tyrp1-
cis-elements
brl
diseasesuctd
blood-transfusion
notablely
howeverthe
normalbetween
uctd
thalidomidean
igfbp-3s
negating
negated
ap2-α
9q32-q33
yac
dbccr1
yacs
761-amino-acid
tccs
urothelium
hypermethylation-based
overloaded
thrombopoietic
important129
5q22q35
chemoagent
cne-1taxol
ftaxol
hne-2taxol
coeffect
dlc1
peg10
rnd1
rnd1-suppressed
emt-mediated
apurinicapyrimidinic
cancer‑testis
tumor‑associated
nxf2‑negative
bronchocentric
p53-target
oncoming
rad51-mediated
fancg-deficient
hr-mediated
inter-chromosomal
cytotrophoblast
n-formylamidino-n-beta-d-2-deoxyribofuranosylurea
decomposed
1-beta-d-2-deoxyribofuranosyl-3-guanylurea
pseudo-first-order
chromophoric
no-induced
mek-e
rk-hif-1
pk-1
hypoxia-inducibility
v-ki-ras
repeat-activated
oncogene-bearing
neor
single-institutional
ncr-nunu
ptc299
myeloidstem
ctdt
dimly
modified-cag
1-h-d-arabinofuranosylcytosine
sinefungin
dialdehyde
ty1-
copia
suspension-cultured
liverwort
marchantia
paleacea
diptera
isoschizomers
self-enforcing
1u2009×u200910⁹l
platelets100xl
dexamethasone-mediated
medip
flexiccnd2
binucleation
dexamethasone-induced
dexamethasone-elicited
6bt
d1sp
reaction-single
oscc-derived
dnmt-azadc-induced
xrcc1-dnmt1
ndrg2
ndrg2-negative
pci-35
pk-45p
guillain-barré
gbs
ean
α-dystroglycan
α-dg
like-acetylglucosaminyl
poag
meshwork
htm
glaucomatous
gtm
ntm
herv-khml-2
herv-k-specific
ahas
α-hydroxy
peels
aim2
dnmt-3b
shdnmt-3b
ga-containing
trc105
dactrc105
ras-regulated
ras-binding
k2d3
isoschizomer
cohesive-end
hpaii-induced
azdc
tetradecanoyl
snu1
desimone
atweh
nagel
mir-720
sncg-positive
sncg-negative
sncg-nonexpressing
ipeptide
msr3-mel
mage-3a1
popularized
addiction-related
opiate
morphine-induced
mcpp
prelimbic
opiate-related
suppressor-reactivating
nbcs
cd37
1q42
5-bromodeoxyuridine
identifed
mir-345
electrode
template-free
dual-step
solution-phase
catalysis-based
ump
umpk
dac-mediated
ntera
p4501a1
smoking-induced
poln
poli
polk
polq
polh
rev3l
replication-blocking
karyotype47xy47xydel7q7
frequency16
hut-78
ho-8910
n4-substituted
antiulcer
6-amino-5-azacytosine
5-triacetate
mapk-hur-tnf
stat3-bcl2
f32
benzene-treated
pfos
pfosxa0xa0sam
offsprings
transgenerational
microrna-29c
3da-ado
autographa
californica
polyhedrosis
acmnpv
polyhedrin
ns1
5a-dcyt
glypican
glycosylphosphatidylinositol-linked
gpc3
cal51
microcell
gabaa
gabarap
extra-long
tip30
5-fluouracil
mcpg
kaiso
cys2-his2
halves
tp53abn
cst6-negative
differential-high
d-hrma
um-dna
m-dna
acetylcholinesterase-encoding
ascidian
ci-ache
32-cell
tailbud
16-cell
110-cell
ci-myod
aphidicolin-treated
handsplit
dss1
dss1-methylated
re-establishes
deoxycytidineaza
atsa
hbf-inducers
uncertainity
sickle-associated
dihydropyrimidine
dpd
dpyd
oci-ly1
all-or-none
broadness
oncostatin
osm
osmr
ptch-associated
deacetlyase
5-aza-dcvpa
bisulfite-pcr
lrp1b-nonexpressing
mullerian
mis
rhmis
fkbp12
ob-viously
assοciated
curvature
nucleoside-related
monophosphorylated
3h-uridine
10xa0s
5xa0min
sirna-
sirna-transfected
thin-layered
sirna-treated
monophosphates
dck-knockdown
ent1-knockdown
voided
7000-fold
3300-fold
2alpha
ap-2alpha
severalfold
hdac-ida
rcl0
70-
73xa0nodes
147xa0interactions
47xa0nodes
66xa0interactions
32xa0candidate
16xa0were
rightly
5xa0key
pik3r2
cdc6
absenceloss
f1-f3
fertilisation
effects-in
inheritance-when
anti-cancer-therapies
tumor-surrounding
bowens
-c-phosphate-g-
s100a4-negative
demethylator5-aza-2-deoxycytidine
5-aza-cdr-resistant
3-deaza-adenosine
5-aza-cdr-sensitive
synthetized
benzamides
2-y
noncuratively
radiation-sensitive
scc-61
radiation-resistant
rscc-61
α-oxidation
5-aza-2deoxycitidine
methylthioadenosine
mtap
mtap-deficient
dhl-9
beta-chain
schematic
thca
hormad2
96-gene
ccl25
il1f8
il13rai
tlr5
malt1
ccl18
ccl6-fold
states--azacitidine
decitabine--to
afap1-as1
afap1
ngx6
endotoxemia-induced
enos-cav1-mlc2
endothelial-cadherin
lipopolysaccharide-induced
paragangliomas
ppgl
sdhb-mutated
sdhb-deficient
tumor-prone
5-azadctsa
atp1b2
dusp2
foxj1
rasv12-mediated
t29h
hrasv12
tif1γ
cmyb
nct01098084
rap-536
um-scc-14a
um-scc-17a
um-scc-38a
crabp2
slc15a3
crabp1
wnt10a
lipogenic
srebp1c
preadipocyte
wnt-regulatory
gd9
gd10
gd11
resorptions
gd12
interspecies
carcinog
auger
267b1k-ras
ctmp
bakt
ctmp-homozygous
ctmp-hypermethylated
stability-indicating
csh
methanolwater
postsurgical
µgg
muc5b
muc6
gel-forming
post-confluent
ln18
ln428
nxa0xa0523
methyl-deficient
5-ccgg-3
1-globin
anti-fibrosing
lde225
anti-jak2-mediated
prm-151
tms1asc
reengagement
bisulphite-treated
h2170
igfbp-rp1-positive
mti
15-lipoxygenase--lox-1
15-lox-1
13-s-hydroxyoctadecadienoic
mtis
chordomas
pulposus
uch-1
β-value
cataracts
diabetics
ech
nrf2-dependent
cataractous
tumorized
hlec
hlecs
redox-balance
ppp1ca
ft-1
ms4
compounding
t-ll
arsenical-mediated
arsenical-induced
lxn
hoxb13
choriocarcinomas
igf2-h19
locus-wide
s1pr2
confinement
smad1
telomere-dependent
sftpb
msftpb
mle-15
3-lysine
sftpb-expressing
icm
chromatin-relaxing
division-permissive
action-absence
hnf4α
4α
protein-was
mecl
senescent-like
bff
nabu-treated
hypermathylated
intravesical
bbn
submucosa
submucosal
l-lactate
gsto1
nqo-1
fluctuate
encephalomyocarditis
emcv
emcv-sensitive
irf-9
skeletrophin
dystrophin
two-hybrid
1p-
mewo
cytoskeleton-related
t-cadherin
t-cadherin-mediated
crustacean
daphnia
magna
daphnids
vinclozolin
biochanin
environment-induced
-tetrachlorodibenzo-p-dioxin
tcdd
dre
tcdd-inducible
pwr-1e
tcdd-responsive
factor-specific
ifn-response
ifn-alpha2a
ifn-resistant
ntsrs
sr48692
behcet
mesalamine
bs-like
b-dlcls
b-dlcl
16q24
d16s507
d16s422
user-defined
tale-mediated
dtales
esc-derived
dtale
dtale-mediated
acegener
mkn74
kato3
dnajd1
gaged2
nmu
dnajdcpg
hint1
pylorieb
o6-methylguaninemethyltransferase
myeloprotective
cd44-negative
cd44-expressing
demethylation-mediated
5-aa-cdr
o-6-methylguanine-dna
p16-
deoxcytidine
multi-module
bio-chemo-informatics
superpred
biogrid
autodoc
polb
p53-hdm2-p21
gene-focused
antiacetyl-h4
-945
-646
hdac-mediated
tcflef-dependent
1γ
tif1g
5-azadeoxycytidine-sensitive
typify
lymphocyte-deficient
gene-1-null
treg-depleted
toxin-treated
foxp3dtr
treg-deficient
influenza-induced
manipulable
steroid-responsive
neuropathologies
nt2
nt2-n
cpwpg
wadenine
bxh2
cebpalpha-mutated
as1413
behenoylara-c
arry520
terameprocol
em-1421
neurotoxins
bonts
neurospecificity
motoneurons
polysialo
ld4
sv2
bonta1
sv2c-ld4
png
igg-fc
prokaryotic
sv2c
gsv2cld-fc
n534
n559
n565
bonta
n559-glycan
n565-glycan
gsv2c-ld4
core-fucosylated
typexa0with
tetra-antennary
bisecting
n559a
spr
etiologically
vil-6
cellsincreased
one-hour
re-activated
smir
rwns
cultrue
steroid-resistant
hbmec
hbmp
5-aza-2-dexoycytidine
weakly-metastatic
72h
sub-cytotoxic
tackles
adam8
tnfsf12
malic
tnsf12
erbb-2
her2estrogen
esrprogesterone
her2presr-dependent
phyto-pharmaceutical
foremost
us-fda
pepp2
pepp-279
pepp2-positive
anti-pepp2
geneticchromosomal
cd117cd123
betaig-h3
betaig-h3-silenced
betaig-h3-negative
zolinza™
p-aza-2-deoxycytidine
vidaza--currently
ldr
ldr-induced
bio-effects
rip1-dependent
clae
downstream-regulated
hgc27
a-treated
pan-deacetylase
ld419
or4-fold
pi3kaktpten
bio-fluids
transferrin-conjugated
tf-np-mir-29b
pralatrexate
circumnavigate
pdx-resistant
1000u2009nm
carrier1
sulpiride
placentaxa0using
anxa0ex
vivoxa0placental
blood-placenta
hoct
hmdr
hbcrp
carnitineorganic
octn
hoctn1
hmdr1
hoct3
nmdars
nmdar1
nmdar2a
nmdar2b
9-beta-d-arabinofuranosyl-2-fluoroadenine
hormone-responsive
low-invasive
hormone-insensitive
radioligands
cd24-
bcscs
tspan5
igf-2r
tissue-specifically
species-dependently
icr2
3-terminal
tumour-related
fresh-frozen
5-aza-20-deoxycytidine
pmaip1
tgfb2
e2-
dac-independent
5-deletions
-556
gel-shift
sl2-cells
methylation-bisulfite
low-axl-expressing
colo206fwidr
high-axl-expressing
withinaround
sp-binding
acth
corticotrope
rnap
littleno
intronicantisense
glt-1
glutamate-aspartate
glast
dihydrokainate
midbrain
24s-hydroxycholesterol
cyp46a1
inhibitor-dependent
sp3hdac
cta-derived
anti-cta
peptidomes
peptidomics
pxd003790
gse80137
sdhx
paraganglioma
fh
5azac-dr
clastogen
2-deoxyriboguanylurea
guaure-dr
phosphoramidite
hdnmt1
mecorii
fra1j
fra9e
cgu2009→u2009gc
transversion
cgu2009→u2009ta
gene-rich
hct116chr2
-proficient
hct116chr3
aza-dc-induced
dac-tnps
dac-nps
pylori-dependent
resurrected
saga
legitimacy
dmnt
ms-
spike-
fepsp-ltp
elevated-platform-stress
ep-stress
mr-
erβ-mrna
non-stressed
late-psa-
-fepsp-ltp
psa-ltp
ltp-reinforcement
erβ-
mr-mrna
early-stress
emotionality
emotion-induced
late-ltp
rab25
nxa0xa097
rab25-negative
um-scc-74b
pyrimidin-2-one
lsd-1
β-like
non-anemic
pnb
pnbdac20
pnbdac10
encumbered
gfp-positivity
lowlow
vll
pvp
reclassifies
pdacs
gene-associated
cau
probe-sets
abcg5
patients-derived
dap-kinase-expressing
b-cell-lineage
tspy
chromosome-specific
cwf
sex-distinct
x-ist
1ae1m
355-fold
sex-based
sex-differential
stylopod
zeugopod
autopod
d-aza-induced
c-11
hoxa-11
hoxd
dysmorphogenesis
pt2
pt3
activating-like
humicola
grisea
thermoidea
hgvt
thermophilic
ascomycete
lignocellulolytic
cellulase
xylanase
bran
96u2009h
cellobiohydrolases
xyn2
crea
ph-response
pacc
non-ccc
ccc-specific
hnf
hnf1
elects
nonmigratory
dnmt-3a
pmepa1
androgen-inducible
lapc4
microtus
agrestis
chromomere
mbd
hpc2
colocalization
neuroglobin
ngb
oxygen-binding
-306bp
gc-boxes
30bp
gc-box
nrse
-359
-127bp
dnmt1--
dnmt3b--
phrd-ires-luc
ny-eso1
ny-sar35
prostratin
acf1-iswi
acf1
atp-utilizing
nonfermenting-2
acf1-snf2h
micrometastatic
metastatically
-3090
-3922
exon1alpha
-396
-233
rlcnr
cos1nr
histiocytoma
mfh1nr
clinical-pathologic
9-dimethylaminomethyl-10-hydroxycamptothecin
dx-3
dms4c
up-1
chors
28s
parp1-dna
aml-fs
risk-tailored
het-1a
oe21
kyse-270
kyse-410
sk-gt-4
ms-275aza
faim
hdaciaza
int-1
damageapoptotic
ligand-binding
lifr
h-35
rlgs
intratumorally
p16inka
lpar6
yetxa0been
biospecific
tpfs
npd
smpd1
asm-deficient
c33a
protocadherins
hzip1
hzip3
uptake-a
dnmt1c
arry-142886
5-azadc-mediated
hspc117
timp
pegfp-c1-hspc117
non-transfected
c1-transfected
cba-sp1
uncloned
-aza-dcyd-treated
delayswithdrawal
gadd45beta
hepg2-gadd45beta
hep3b-p53gadd45beta
co-transfectant
cb2
sy5y
rdna-containing
5-azadeoxicytidine
adcr
acrocentric
non-satellized
satellized
constriction
mir-199b
podocalyxin
zic1
zic4
desmoid
fibroproliferative
curiously
ugs
ugss
dht
lsh
lsh-deficient
lsh--
multipolar
spindles
lsh-dependent
mhags
hematopoiesis-
ha-1
risking
mhag
ha-1neg
ha-1-specific
contrarily
reparative
dentinogenesis
odontogenic
hypoxia-related
vhl-hif
non-rcc
metabisulfite
phytoestrogen
cyld
phosphorylated-akt
tensional
force‑triggered
ascs
disease‑free
5-mc-binding
caffeic
capes
hmaclax
venetoclaxhma
cdkn2mts1
gdf11
debris
mirna-122
qsg-7701
glioma-differentiated
gdcs
glioma-initiating
nacl-resistant
matrix-like
enzymic
parthenogenetic
cbaxc57bl6f1
somite
≈-fold
≈155-fold
≈29-fold
c-to-g
≈80-fold
outliers
extinguishing
nlc
xrd
crystallinity
4-folds
dendrite
mage-a11
kyse
decomposes
deformylation
anomerization
xenoestrogens
self-regenerating
progenitor-containing
diethylstilbestrol
lys27
p53-related
cancer-cell
bidirectionally
ifn-inducing
nucleoplasmic
mir-302c
group-containing
unactivated
activation-labile
leukopathic
bombyx
mori
all-in-one
dcas9-tet1
grnas
collated
xerostomia
hypofunction
c57bl6crslc
aqp5
hyposalivation
n-methyltransferase
pnmt
normotensive
msap
ligated
met1
atmbd9
rac-gef
p-rex1
prex1
5-aza-cdrcould
inhibitors--azacitidine
decitabine--have
non-infant
spheroid
dimethylated-h3k4
dimethylated-h3k9
pi-class
hbv-associated
peutz-jeghers
pjs
hamartomas
kin
lkb1-induced
p73-mediated
abnormalties
e-cadherin-negative
beta-cateninmitf
glypican-3
simpson-golabi-behmel
dysmorphisms
gpc3-deficient
agent-treated
il-6-overexpressing
mbd-seq
binucleated
glioblastoma-derived
duly
fetal-placental
pnk
tgfß-1
idnk
nap1l2
midgestation
ntds
spina
bifida
anencephaly
guanidines
nap1l2nap1l2
genetic-environmental
ribo-analog
5-azacytosine-substituted
tight-binding
azacytosine-containing
aberrance
biofilm-gingival
eventsaesin
blastsmdsraeb
mds-
raeb1
mds-raeb2
cyclesrange
cycleswere
twenty-
menscs
refreshing
connexin-43
connextin-43
osx
osteoblast-specific
nonosteogenic
transcribing
c2c12
terminating
ar-pmepa1
nedd4-e3
micro-dissected
cricr
linearizing
azactidine
abberant
reductiondelay
cc-1065
cdkl5
reawaken
xist
reinvestigated
lp1
wl2
wnts
fzs
study-consisting
cancer-was
gpcr-stimulated
rgs
rgs2
androgen-deficient
rgs2-targeted
castrated
unmasks
nct02076191
good-prognostic
subclusters
hlxb9
hoxa13
cyfip2
p6
rutheniumii
arene
multi-drug-resistant
rm175
hc29
hc11
bi-dentate
ethylenediamine
tetrahydroanthracene
a2780cis
cisplatincarboplatin
2780ad
non-cross-resistance
onvansertib
c-met-dependent
hgfc-met
lowintermediate-1-risk
intermediate-2high-risk
class-i
ach3k9
cdkn2aink4
cip1sdi1waf1
only-treated
hydroxurea
hydroxyurea-refractory
cpt-11sn-38
endocannabinoid
2-arachidonoylglycerol
monoacylglycerol
magl
abhd6
abhd12
wwl70
task-specific
photothrombotic
contralesional
staircase
mnss
medullar
oblongata
5-azd-dc
s-adenosyl-homocysteine-hydrolase
a204
bt16
g401
adjudicated
dac-39
aza-56
dac-58
unitsl
ths
th-responsive
hypothyroid
forelimbs
limb-dependent
fore-
dac-insensitive
patients65
inhibitorsthe
limitedclinical
inhibitorsdecitabine
eif1a
col5a2
vp64
zf-atfs
zf-tet2
zf-tdg
epb41l3-zf
epb41l-fold
de‑methylation
d‑loop
colo‑205
6th7th
ls‑174t
ht‑29
bead-array
ctla‑4
mage‑as
co‑antigen
5dc
cck‑8
anti‑ctla‑4
10xa0µm
taxo
calu-6
tm-negative
tm-positive
pes
tsp-1
neuroblast
tsp-1-positive
h11
crystallin
tetracycline-sensitive
deoxynucleotidyltransferase-mediated
benzyloxycarbonyl-val-ala-asp-fluoromethyl
h11-triggered
p38mapk-dependent
h11-w51c
h11-induced
aza-c-treated
forkhead-associated
sng-ii
hec108
fas-based
vorinostat-mediated
tumor-suppression
fasgld
methyltransferase-dependent
oscillatory
rrbs
sn38-resistant
sn38-sensitivity
dapk-pcr
sn38-sensitivities
dctpp1
dutpase
nucleotidohydrolases
aza-dctp
5-aza-2-deoxycytidine-5-triphosphate
aza-dump
misincorporation
hydrolyses
bpd
domain-deleted
c-termini
allo-nk
cellslsc
orf50
hh-b2
dually
justifiably
b-like
tceb1
itga1
carg
srf
non-megakaryocytic
promoter-luc
alpha1beta1
homeobox-1
t-84
mir-503
polycistron
formylpeptide
bacterial-
aquaporin-5
ns-sv-dc
osmotically
sp1-binding
cgs
mcf-12a
hb2
txb2
ptgds
tbxas1
hypomethylation-induced
phytohemagglutinin-induced
wi-38
va-13
t-cell-receptor-based
alpha-d-anomer
penciclovir
jmjc
lncap-ln3
dehydrogenase-b
ldhb
bisulphite-modified
cwr22
bph45
cfpac1
5-aza-dc-mediated
insurmountable
tk-10
uo-31
bik-previously
growth-appears
sm-associated
criticized
gendicine
imlygic
provenge
cimavax-egf
sm-exposed
tsm
tk-
mt-
ems-mutagenized
backreversion
backrevertants
reactivable
reactivants
temperature-induced
high-expressers
decreasingly
ductal-endocrine
tgct-derived
5xa0cycles
pcdna
ppr
intermediate-risk-1
htlv-i-mediated
htlv-i-transformed
cthrc1
co-regulate
bisulfite-converted
per3
growth-factor-binding
igfals
peritumorous
restriction-enzyme
331-bp
acacyd
furd
fcyd
feed-back
kle
5‑aza‑20‑deoxycytidine
phosphorylated‑extracellular
mir-34
icr-
mir-34a-deficient
hind-
5-aza-exposed
growth-arrest-specific
teratogen-resistant
teratogen-sensitive
9q22
new-age
bandshift
9-nitro-camptothecin
9-nc
5-azacdr-treated
5-azacdr-mediated
5-azacdr-treatment
sired
erythropoietin-stimulating
2-aminopurine
2ap
methylation-directed
2ap-induced
leukemia-stromal
azd4573
venetoclaxdecitabine
leukemia-stroma
heifers
hyper-acetylating
aza-tsa
post-lps
il-0-fold
il-5-fold
saa3-fold
ajap1
prkd1
1620-bp
mn9d
nf-κb-p65
mesencephalic
transactivate
aza-dcams-acrine
erythro-
ara-camsacrine
9-bp
ccaccacca
hk-1
mir-376a
ad-p53
z-lehd-fmk
ad-p53-induced
n6556
2001-june
2004-december
bu-resistance
b5bu
pifithrin-alpha
dacbu
pgbms
sgbms
plu-1
lsd1corest
aptamer-functionalized
45-base
hncs
cd34cd90
5azadtsa-treated
ecto-calreticulin
cd4-positive
adhesion-related
cadm1-methylated
cdk10
genethat
althoughmutation
mir-152
mir-185
cd-1cd-1
docetaxel-resistant
docetaxel-sensitive
beta-catenint-cell
suppressor-like
sfrp-1
dukes
nine-exon
gralpha
grbeta
glucocorticoid-resistant
b-lymphoma
cyp19a1a
hermaphroditic
ricefield
eel
ovotestis
1adrenal
forskolin-induced
cre-binding
eels
male-specific
teleosts
15-min
jorge
cortes
wm-115
or16-fold
prompter
tmem7
28-kda
tmem7-deficient
v-src-transfected
3y1
shapiro
hydrolase-like
bphl
5-esters
5-o-l-valyl-decitabine
l-val-dac
oligopeptide
pept1
catk
l-valine
cannulated
double-targeted
β-defensin-2
hbd-2
occs
osc-19
bsc-of
hsy
noks
escc-related
rarbeta2-downregulated
erα-negative
-1374
akr1
-447
bw5147
ep-cam
ep-cam-negative
578t
fibrinous
brushes
pla2g2a
spla2-r
spla2-ib
spla2-iii
spla2-x
spla2-iia
spla2-v
-111
χ857
χ273
χ049
χ840
ceg
dceg
ramp3
frat1
sprr1a
tcdd-dependent
phlebotomized
5-azauridine
d-azac
reticulocytosis
cadmium-induced
glutamic-oxaloacetic
mt-i
cd52-negative
pigh
cytosine-binding
reassociation
cr-t24
pu1-knockdown
pu1kd
pu1-overexpressing
pu1oe
retionoic
mrk-nu-1
celltiter
s-
g2m-phases
j82
j82cisr
six-fold
add-ons
epirubicine
5-dimethylthiazol-2-yl--diphenyltetrazoliumbromide
metastasis-relevant
inhibitor-i
fec-mediated
starburst
hub-genes
inppl1
k-rasp53
calu6
ezh2-target
5-aza-2-deoxycitydine5-aza-dc
pitting
knees
90s
hypoxemic
promptness
expeditiously
post-failure
post-azacitidine
failurelack
responseintolerance
fa-brca
myometrium
kisspeptin
kiss1gpr54
metastin-10
figo
myometrial
gpr54-expressing
metastin-gpr54
unacetylated
il-2r
il-2r-associated
gene-coding
splice-junction
follistatin
proliferationapoptosis
ho-1-u-1
mcf10at1
p20e
p20c
az-induced
tcf
ahr-overexpressing
tbetar-ii
precrisis
boyden
gm6001
gm1489
methylation-expression
lress
bentonite
biocatalyst
batches
scale-up
biosynthesize
ara-5ac
depresses
schedule-independent
cic
acetylating
azac-
tk-deficient
l61-m
uroplakin
ib-negative
sp1nfkappab
paca
prehematopoietic
mutated-chk2
krab-associated
vitro-fertilized
neuroepithelium
21q--
b-lineage-specific
5-deoxy-2-azacytidine
deacetylese
dock8
dedicator
alkylate
thiolate
hspb8
sst
gastrin-stimulated
nct01902329
thirty-
tapped
xi-linked
mln8237
pituitaries
d-30
d-60
d-80
tsh
gstp1-pgl3
tsa-sensitive
βpossibly
ctcfl
20q13
improbable
psitpte22
tpte
psitpte22-herv
chimps
402-nt
15-kda
orf-containing
psitpte22-herv-expressing
herv-related
human-specific
ribonuclease
angiogenin-induced
5-aza-cdrcan
polar-planar
nn-dimethylformamide
linesabstract
hrecs
hrpe
epimutagens
i-motif
schwannomas
mediated-gene
splitomicin
intergenerational
ctgcag
jumps
hcd44s
sis-transformed
ras-revertant
iiia4
exogenously-added
hcd44s-nonexpressing
hcd44s-expressing
credence
f344
deoxycholic
chenodeoxycholic
cholic
lithocholic
ursodeoxycholic
bromodichloromethane
bdcm
runt‑related
factorxa03
fifty‑five
hec1‑α
xa53
idc
annulare
bmal1
rpmi8402
oscillation
rpib9
hct-aza-cdr
-1087
dpsc
adenoma-carcinoma
neotreg
foxp3gfp
rag2--
5-aza-inducible
unfolding
anti-citrullinated
acpa
autoantigens
fls
synovium
ppia
thymus-derived
extrathymically
ptreg
cd4foxp3-
itreg
tcr-stimulated
roundabout
dutt1
lctsgr2
u2020
3p12
5-gataaa-3
htb-19
cc-rcc
hemi
lysate-based
melcancervac
ddm
tlecs
tlec
-435
non-cpgi
revoked
ln229
u251n
expression-related
gabpα
heparanase-expressing
neovessel
mtds
fischer
choline-deficient
acid-defined
rlc-16
rlc-27
ectopeptidases
signal-transducing
h4k16
allometric
virol
wth3
mcf7adrr
hhua
polyanhydride
met-5a
h28
methylationacetylation-associated
thrombospondin‑1
thbs‑1
tumor‑node‑metastasis
hep‑2
ht1376
cataloging
l-asparaginase-sensitive
6c3hed
auxotrophs
prototrophs
asparagine-independent
weanlings
forebrain
methylation-subtraction
4q--a
fbxl7
fra16d
cotransport
hepes
peff
d-val-dac
l-phe-dac
l-trp-dac
co-perfusing
glysar
homogenate
pept1-mediated
enterocytes
pinpointing
2-deoxy-n-4-nitrophenylethoxycarbonyl-5-azacytidine
npeoc-dac
10microm
carboxylester
cd49dtrisomy
cd49d-no
richter
d6s306
d6s258
d6s273
d6s1666
d6s1051
d6s1560
ro1-a
dck-deficient
vitro-induced
arac-resistance
ro1-adck
ro1
arac-
epithelioid-appearing
sheet-like
amelanotic
pax5-expressing
38b9
2pk-3
tata-containing
sp-
mb-1
psychopathologies
defeated
randomized-controlled
40-
125-fold
lysine9
mevastatin
mev
-bis-2-methoxy-4-nitro-5-sulfophenyl-2h-tetrazolium-5-carboxanilide
flourescence
casp9
mev-alone
β-peptide
aβaβ
τ
presenilin
sirt1app
tu159
epi-alleles
post-repair
uncut
rewrite
hypoxanthineguanine
mouse-human
hypoxanthineaminopterinthymidineglycine
5-fluoro-2-deoxycrytidine
recuperation
thera-peutic
5‑aza‑2
-d3-mediated
-d3-treated
death-repressor
suitably
mir-124a3
mir-148
expression-depending
bio-marker
bi-potential
il4il13
keyed
cellcell
5-aza-cr-treated
5-fluoro-2-deoxycytidinefcdr
6-aza-cr
dh-aza-cr
post-hypoxia
methtylation
familyla
hemojuvelin
prepost
asf
iron-overload
arsenic-exposed
metalloproteinases-3
hp4
methylation-response
t-cadherin-negative
inaction
col1a2
nbes
gbm8401
svgp12
map2
socs3-negative
socs3-positive
10-induced
96h
tazemetostat
cggccg-repeat
hmof
coup-tfii
endocrine-resistant
lcc2
lcc9
antiestrogen-resistance
endocrine-sensitive
nr2f2
chemists
weight-melanoma
hmw-maa
hasve
hmw-maa-negative
gbgt1
globoside
alpha--n-acetylgalactosaminyltransferase
forssman
pentaglycosyl
globo
glycosidases
2-deoxy
m111
smelus7
mewo-derived
samhd1-mediated
decitabine-resistant
3h-aza-dc
14c-thymidine
dna-als
glycosylases
basally
erβ-deficient
tnfalpha-responsive
dif-2
tfiih
adventitious
petunia
shoot-
callus-inducing
opu
cdc48
mads-box
cgcg
ldoc1
dacbz
female-biased
mates
ellers
insect
cll-phases
untransformed-cll
cll-phase
psma
chronicization
criticisms
epitranscriptome
uni-parental
c9710
outcomedetection
27-gene
cryptically
mvih
over-treated
pedaml
staml
gata1gata2
krasnras
cbfc-myh11
sil-tal
mll-af9as
del21
unevaluable
-y-3
transcript-2
ccat2
calr-unmutated
eligiblexa0
continuous-time
tri-factorization
realizations
pdc-aml
poising
dffpe
decalcification
edta-based
armoury
e2993
e2a-pbx1-positive
bcl6-targeted
leukaemia-propagating
one-tube
rpearson
pxa0high
lsclow
positivemrd
dcpdc
dcmdc
dcmodcs
baff
function，which
redefinition
del3q5q7q11q12p20q
mds-aberrations
der9p
chromosomescell
i17q-17
der12p
del5q26
del7q36
del20q11
cared
cvds
a-bmt
randomising
sppb
4-m
mini-mental
vasomotor
cd10-negative
tp2
mrd-high-risk
mrd-low-risk
relapse-rate
mrd-medium-risk
lhc
plcb4
pplcb4
plcb4-associated
picu
acta
five-randomised
conventionally-dosed
mini-transplantation
non-myelo
host-vs-graft
trolled
gene-sequencing
dri
nxa0xa0489
tkmt2a-aff1
translocated-chromosomes
multi-layered
non-recurrentnon-silent
non-mll-rearranged
non-expanded
pre-vdj
rasmut
af4-mll
af4-mll-expressing
af4-mllhoxa-expressing
phenomenal
re-ignited
municipalities
psur
prednisone-poor-response
blastsmicrol
hematologistsoncologists
machine-learning
humanitys
baylor
thoroughness
u2af35
mileu
54-gene
aa-related
circ-anxa2
daunorbicin
circ-rps6kb1
circ-csmd2
circ-ptk2
circ-pwp2
circ-rbm5
circ-zzef1
circ-gsk3b
circ-foxp1
bore
respondersnon-responders
rpkm
modularization
lncrna-loc646762
loc646762
ccnd3
c10orf54
bloc1s1
lncrna-ccdc26
erythroidmegakaryocytic
emk
ucinconclusive
kmt2a-rearrangements
clinicsn
cytogeneticn
descriptiven
undergoingn
analysisn
groupn
1stn
65n
favourablen
n5the
foundn
df12
adversen
df6
hten
providedn
precluden
predictiven
axa0clonal
exonxa014
exonxa012
post-pcr
7q-q-
der3q
espl1separase
separase
concurred
karyotypegene
multi-whole-genome
h3f3a
plys28met
ubtf
nipbl
catchment
face-to-face
breast-feeding
ear-nose-throat
greaves
glu255lys
tyr253his
negatives
gly255lys
swaps
equitable
rs3730485
rs4245739
mdm
mb-mdr
pog-9421
zeb2-as1
five-gene
lmd
kpam1
2xa0bp
17xa0bp
bordeaux-toulouse
dataml
xpo1mut
fbxw7mut
myd88mut
notch1mut
exclusiveness
ttt
deliverability
latium
10gdl
hundred-fifty
factor216
factors31
tuscany
bournemouth
mdap
fcγrs
cd32
3q21q26
⩽2
decentralized
cumulative-incidence
-cir-
iamp21
crlf2
6-methylmercaptopurine
s-adenozyl-l-methionine
g-1
tpmtc
entity-defining
nrip1-mecom
so-far
ctdsp1-cflar
mir181a1b1
pathomechanistically
afferent
lombardia
biomarker-predicted
clinico-biologic
under-explored
event-based
splicing-regulatory
setd5
assortment
dic-positive
femalemale
invdel5q
non-first
diseaseabstract
cd0018
cd0131
emp2058
tspan0234
stab3658
mbtps1
mpg-membrane
mpg6
t-myelodysplasticmyeloproliferative
iwg-pm
wpss-r
t-myeloid
v-ras
v-raf
4-mixed
etv6-runx11
sil-tal1
chitinase-3-like-1
n624
hct-comorbidity
icos-l
polarisation
m3m3v
gesmd
unanimously
graft-versus-leukemic
escale
second-degree
family-based
over-transmission
non-family-based
aieop-bfm
all2000
macrovascular
therapyxa0
akip1
cml-csg
mll-partner
5-mll-partner
5-partner
gene-mll-3
stem-loop
schematically
adult-onset
backgroundrare
rs5030317
rs5030320
reaction-ligase
codominant
pre-menopausal
three-arm
lef1low
sanz
cellshematopoietic
bfm-based
cd65w
myagall
double-fluorescence
pre-pre-b-all
myag-all
del16
logarithm
pml-rarang
mrd-target
additional-potentially
toxic-therapies
work-in-progress
denomination
aml-8
aml--similar
incautiously
distored
substractions
triage
pstat1cmaf-
cbfl
non-ptpn11
pu2009uconclusion
apml4
atraidarubicin-based
apml3
actrn12605000070639
mllt10r
classification-defined
non‑coding
178xa0patients
event‑free
follow‑up
95xa0ci
intermediate‑risk
poor‑risk
ccaatenhancer‑binding
x109xa0cellsl
fertilizer
diagnostic-driven
tomographic-scan
dosimetric
radiobiological
oncokidsⓡ
turn-around-time
solcd44s
pngml
cd44s-adjusted
predicator
nct00372593
procuring
time-effective
non-standardized
individual-mutation
stromal-relevant
gse14468
omnibusxa0geo
del5q1
tq12p13
consensual
l1l2
designs--from
preclinicallaboratory
trials--provide
bcr3
intertermediate
1-dfs
nonmonocyte
risk-stratification-directed
cbfa2t3glis2
nup98kdm5a
rbm15mkl1
berlin-frankfurt-munster
rbm15mkl1-rearranged
nck-7
nck-7-patients
rbm15mkl1-other
jak2-positive
dualcolor
tq22p15
nalysis
ostxcens
misperceptions
nu2009u2009460
haplo-stem
pre-mrdneg
pre-mrdpos
post-mrdneg
post-mrdpos
pu2009negmrdneg
peri-sct
three-tiered
mll-mlllt10
kras-mt
kras-wt
mllt10mllt4mllt1
intermediate-to-low-risk
mllt3ellothers
umin000000511
marker-based
sio
liver-iron
cbc-score
deteriorations
multitasking
cd13cd33cd117
cd35cd36
cd15-ma
mb-aml
ncccr
hamad
doha
aml-induction
linc00649
dysmegakaryopoietic
methylc-capture
mcc-seq
hyper-differentially
m-value
12-gene
non-down-syndrome
nup98-kdm5u2009a
aurora-abcaur-abc
meta-training
meta-testing
lasso-cox
amlrs
oru20099l
one-shot
mrd-negativity
atrau2009u2009chemotherapy
toranomon
stabilin-1
stab1
stab1high
stab1low
pxa0478
pxa0354
inter-group
couldnt
n409
mir-212
wt1high
wt1low
wt1int
11q23mll-rearranged
supersedes
workgroup
all-hsct
npm1wtflt3-itd-neg
arlvd
chemotherapy-response
d-dimers
short-read
bulk-sample
conceal
point-mutations
b-cell-precursor
agr
são
paulo
faculdade
universidade
samls
ribeirão
preto
ouh
alkkmt2a
rearrangement-negative
breakdancer
clusterfast
hydra
fish-positive
fish-negative
finer-scale
slicing
repairtumor
m-bc
pertains
mrd-test
histocytochemical
i17qdel7q
cxcrs
cempo
m-b
deletion6q
tx6pq21
tq37p
tp21q32
cccg-all-2015
cmpns
rs2234582
rs1799925
rs5030315
rs2234583
rs2234581
tumour-free
fxiiia
cytometric-based
ihc-positive
clotparticle
reduced-intense
comorbidity-related
n532
n886
time-intensive
re-explore
beataml
eepd1
pmf-associated
tendencies
jak2-
nondriver
ropeginterferon
factor-positive
n115
n144
cbf-minimal
d60
irgs
gse71014
ccch-type
elav
unc-93
dana-farber
dfci
end-induction
vhr
nct00400946
ficoll
trizol
bcrl
starters
uptrend
nonlaboratory
int-
int-5
deterministically
patient-to-infrastructure
sconut
ifn-2
diseaseoperational
hoxahoxb
al-
c1-mediated
re-occurrence
tdt-positivity
tdtu2009u2009patients
nu2009u2009405
flt3-itdnegnpm1wt
flt3-itdnegnpm1mut
pu2009negnpm1mut
flt3-itdposnpm1mut
flt3-itdposnpm1wt
lacusc
ethnically
aml-jak2mut
pu202fu202f0402
pu202fu202f0095
pu202fu202f0421
aall
osxa0there
sr-aall
soxa0they
shenzhen
nhlbi
bm-based
hu2009u2009
hu2009u2009was
cycd79alpha
ig-h
cd79alpha
nct00932412
p15del
p16del
p15p16
p15met
bcp-
p15delp16del
p15metp16met
retrovirus-
electroporation-mediated
p16-deficient
p16--
leukemo-
tko
17f
dfg-out
p38alpha
zak
anti-granulocyte-macrophage
anti-rat
hara
overexpresssion
cd19-redirected
cart19
t-cell-centered
bsccd19×cd3
fcγri
gm-h22scfv
b9
hcfps
lsc-mediated
recalcitrance
3-hydrogenkwadaphnin
3-hk
daphnane-type
dendrostellera
lessertii
moosavi
yazdanparast
sanati
nejad
2005a
post-g1
-2379
anti-proliferating
aoetbr
lilrb4
anti-lilrb4
lilrb4-specific
drug-to-antibody
lilrb4-mediated
lilrb4-positive
pe-a
fine-tuned
osrga
mos-j
pos-1
osteoblasticosteolytic
phospho-receptor
pdfgfrβ
ryk
carotenoid
actinin
actn1
chtcr
killingeffector
antigen-recognizing
leukemia-all
leukemia-cll
growthviability
fusion-induced
decay-accelerating
70kd
anti-daf
1c6
complement-fixing
pm-81
c-fixing
nf-x03bab
antiapotptic
inhibitiors
cd32-
cd25-positive
cycle-quiescent
glycolipid
control-derived
α-galactosylce-ramide-treated
α-galactosylceramide-induced
α-galactosylceramide-treated
fludarabine-treated
coagulationbleeding
hemocoagulation
intervenes
kmt2a-fusion
preclinicalclinical
process-protein
synthesis-that
tlll
sf3b155
sap155
urp
splice-site
functionalbiological
nonautocrine
cytokine-deprived
hexose
il-3-
mean-sem
p53-and
apoptomirs
trdmt1
tat-ct3
trdmt-untranslated
pml-nd
pml-nds
presage
endotoxin
n-benzoyl-staurosporine
cgp41251
γ₉δ₂
gdt
anti-cd33-ζ
receptor-redirected
receptor-expressing
4-hours-⁵¹chromium-release
impossibility
hr-all
blood-cell
3-mutated
flt3-mut
trace-labeled
131i-p67
radiolabel
131i-p67-cd33
antimyeloid
anti-cd33--namely
u2009nt
glycol-polyethyleneimine
peg-pei
-g-pei1800
psd
nci-bl2347
peg-peimirna
pbiu2009u
esccs
hsa01200
bounding
sk053
probe-labeling
bait
rin9815bcr-abl
pmnl
85n
incidencen
clinicaln
mn1expression
lowern
highern
comparedn
mn1n
long-since
abt-199gdc-0199
glioblastmas
donor-vs-recipient
alloresponses
haplotype-mismatched
allospecificities
alloreactions
pathomechanistic
cmlscs
stat4-mediated
ineffectively
monoclonal-based
α-galcer-loaded
il-12-dependent
spike
aml-eto9a
β-mannosylceramide
239pu
241am
233u
autoradiographs
femora
plutonium
uranium
sarcoma-derived
v-ha-ras
amp-responsive
mir-34bmir-34c
polyamide-chlorambucil
1r-chl
alkylates
h4c
6r-chl
distamycin-based
phosphokinase
antineoplasic
cd437
idh2r140q
dbl
guanine-exchange
rhoarocklimcofilin
ha-2
ha-1h
ha-2v
ha-1r
ha-2m
north-south
tcm-based
millennia
pharmacophores
manifold
ligand-protein
t-sne
cellularly
executable
tki‑resistant
at9283
tki‑sensitive
r882c
r882p
c-kit-mediated
pi-3kakt
scf-independent
apoptin
apoptin-derived
decapeptide
32dp210
shay
polymerised
ppd
apposited
slender
e545k
braf-driven
amino-terminus
mll-interacting
interconnection
oligohistidine
size-exclusion
ic-10
histidine-tagged
thp-1-engrafted
multiclass
hehlmann
hochhaus
berger
reiter
pim-1pim-2
dcsxa0known
sirnalipid
co-stimulate
dotap-formulated
arexa0urgently
survivalxa0outcomes
gastroesophageal
icer
noncontact
cd5cd8-depleted
cd34dr
enumerated
ltcic
il-2-supplemented
as-on
inspiring
pml-rarα-knockin
m3-like
a1-knockout
2-bromopalmitate
rarα-target
srsf2-deficient
srsf2floxflox
polyipolyc
syndromes-associated
msd-l
p95h
p95-to-r102
8-amino-acid
vegfvegfr-2
plagl2
pirh2
hox-based
oligoadenylate
interferon-treated
a-antisense
pkr
parahox
locating
hr-associated
parpi-induced
perpetrator
transcendental
myofibroblastic
ligand-tnfsf10
β-emitters
α-particle-emitting
bismuth-bi
213bi-lintuzumab
α-emitter
mir-20b-5p
self-replication
210-kda
nonapeptide
hairyenhancer
dnmaml
notch-mediated
effectivelywith
mds-ipsc
refolding
rarß2
medip-chip
oxindoles
oxindole-based
k562xa0cells
fuelling
non-cmr
cml-therapeutic
foxp3-dependent
signal-deprived
apoptotis
de-escalated
mediatorsreceptors
hyper-cdt
lin28a-dependent
flt3-lms
il-3-independent
flt3-lmtkd-mutation-transformed
flt3-lmtkd-mutation
t-lgl
antigen-primed
sharpen
g418
siirf2
nucleoside-activating
competitor
survival-inducing
shines
minigrafts
pml-rarα-specific
biomodelanalyzer
network-model
hla-disparate
preventingtreating
hla-dpb1
ii-expressing
hla-dp-specific
hla-dpb1-mismatched
spotelispotanalysis
hla-dpb
hla-dpb1-specific
hla-dp-expressing
hla-dp-mismatched
transposontransposase
et74at393a
ergs
factorc-kit
dako
avidin-biotin-peroxidase
stainer
40u2009
transcriptionu20053
rhodiumii-catalyzed
proximity-driven
naphthalene
halts
temporizing
tki-persistent
ezh2i
t-cell-derived
all-atom
apoptosis-linked
ste20
camk2g
graft-versus-leukemia-effective
reactionthe
againstthe
cases--2
imatinib-interferon-alpha
imatinib-cytarabine
inferferon
curcumin-loaded
mpeg-pcl
end-capped
mpeg-pcl-pheboc
myxoma
myxv
moi
systems-level
genome-
proteome-wide
nonobvious
--expressing
--specific
donor-specific
bcr-abl1-driven
p2x5
lrh-1-specific
p2x5-encoded
alpha-amanitin
lysolecithin
polyadenylated
a-
mycotoxin
apatinib
cd40l-stimulated
atf5
protein-3-like-2
creb3l2
sequence-1
leukemia-2
atf5-mediated
atdc5
microrna-136
mir-136
cytokinexa0expression
u2009u
d3-phosphoinositide
d3-phosphoinositides
trxg
rejuvenate
gw5074
maturation-uncoupled
6-formylindolo-bcarbazole
davids
c-terminal–truncating
asxl1-mts
human-associated
2–mediated
asxl1-mt–induced
cpg-a
pdc-related
stimulus-specific
nur77-as
fas-l
cell-bound
urchin
enterokinase
agrin
andxa0βxa0chainsxa0
dmb-5f3
anti-muc1
cd34lin-cd38-
aml-bound
gelonin
module-drug
muc1-expressing
upgraded
interconversion
kit-mutated
fos-b
fra-1
jun-b
revolve
ctlp
lk-ctlp
ly-ctlp
existance
β-catenin-independent
mll-cscs
hsc-enriched
myeloid-granulocyte
lsk-derived
abolishment
β-cateninhoxa9
β-cateninhoxa9prmt1
crossreact
unicar
target-dependent
mtdh
carcinogenesis-related
p210bcr-abl-mediated
ptefb
cdk9cyclin
az5576
myc-expressing
ser62
cd19-that
expendable
cd19-expressing
alisertibara-c
-fold-change
atra-and
ato-containing
protein-templated
ligations
protein-induced
mannich
biocatalytic
1h-tetrazoles
rasbrafmekerk
t163
pmcl-1
bcl-2mcl-1
ph⁺
e255
y253
saturate
supersaturating
anti-hum195
low-passage
bclxl-dependent
cotargeting
rowe
dynamin-related
drp1
fission
drp1-k38a
mcl-induced
drp1-mediated
ros-mitochondrial
much-needed
c-terminal-truncating
setbp1-mt
asxl1-mutant
asxl1-mt-induced
hands-off
cml-initiating
phospho-activated
cytosolicnuclear
p60-srcgsk3β
mapkp60-src
pro-differentiativeapoptotic
c-ebpα
side-population
lymphoproliferations
disappointments
anti-cd38
cd38-specific
phage-display
cd38-bearing
signalingxa0networks
pin1s
aquaporin-9
nurr1
nr4a-family
stimulus-
hypoallelic
possessinduce
motility-related
vasodilator-stimulated
vasp
cxcl12-induced
bcl-2high
if-then
prc2enhancer
bruedigam
inv11p15q22
ddx10
11q22
inv11
nup98-ddx10
ddx10-nup98
phospho-eif4e
hsc-driven
acriflavine
acf
less-severe
nononcological
nf1--
eml4-alk
her2neu-positive
pi3-akt
polymerase-associated
pafc
cdc73
prmt5-mediated
h4r3me2s
antibody-cytotoxic
non-cleavable
tiar
mkk3
il2rg
blc-2
nu2009u2009195
5-azaabt-737
∆ψm
hvem
cyclodextrin-based
cddspe-peg-fab
antibody-tagged
cyclodextrin
tcl
miha-specific
chromium
host-specific
miha
cross-hybridization
bcrabl-induced
arqule
arq
unspectacular
thawed
activityabstract
sfkabl
crk-associated
lossesgainsuniparental
mecom-rearranged
downre-expression
cross-comparison
mir449a
unravels
evi1-mir449a-notch1bcl2
arsenic-dependent
s6k2
leukaemialymphoma-2
jaks
fgf2-mediated
stat5ab
fgf-2-mediated
fgf-2-driven
rsa
non-absorbed
fab2
phhsc
dt-il3
-il3
sl-501
-il3k116w
kbm5-sti
il3-targeting
neighbours
autoagressive
tames
noramlizes
lepromatous
destruct
nkrs
i-like
nkr
fbl
envelope-specific
zbc260
dbet
jq-1
varicella-zoster
vzv
mis-matched
peroxide-activated
pendent
bicyclic
mir‑107
kcl‑22
cacna2d1
mir-107
multi-unti
multi-unit
multiunit
follic
acid-polylysine
benzamide-type
tyrosyl-phosphoproteins
cd20xcd3
cd20xcd3-sensitive
sialophorin
bsab-mediated
o-glycosylation
cell-tumor
anti-adhesive
-substituted
mcl-1bfl-1
energy-stress
crisprcas9-based
txnip
glucose-feedback
cnr2
transport-independent
methyl-conjugates
gatekeepers
hsp90alpha
2d-lc-msms
adaptative
lps-
mitogen-
landscaping
reevolution
bafpbaf
baf
acbi1
biophysics-
atpases
mek5erk5
cd26-expressing
mekerk5
hnk-1
2-proliferative
lytically
bt3t8
bt3t8-
hnk-1-t3t8
bt3-t8-
hnk-1-t3-t8-
hnk-1-t3-t8
substantiation
chromatin-focused
mll-af9nrasg12d-driven
brd4-dependent
self-transcribing
bet-resistant
remodelled
chromatin-targeted
kinase-based
poly-specific
p16-relative
hox11l2
p13q34
p62sqstm1-mediated
autolysosomes
cd28-cd3ζ
il2r
γnull
icasp9
car-mediated
tnf-αifn-γ-
influenza-a
cytokine-based
wt-1-specific
ifn-γtnf-α
ifn-γtnf-α-
ifn-γ-tnf-α-
ar00459339
tfitd
kdm1
r-2-hydroxy-glutarate
re-discovered
trpm4
fine-grained
epiphenomena
weighs
potentialities
-nucleotide-long
micro-rna-1
motilitymigration
mir-1-expressing
n417
mcf-7-derived
tamoxifen-
fulvestrant-resistant
jnj-7706621
antiestrogen-resistant
tamoxifen-resistant
t47d-derived
igg2a
leukemiaphiladelphia
mir-302
osteohematopoietic
irregularity
make-up
tak1-depleted
c2-ceramide
c6-ceramide-induced
nct02516553
super-enhancer-regulated
p-ser2
ras47
pten48
phf
runx145
non–polymerase
reaction–based
bodily
hydroxymethylcytosine
tet2idh
dot1l-targeted
mll51
tcralphabeta
cd6-fold
cd6
pauses
staccato
elderlyhigh-risk
honma
bloch
n-nitroso-n-methylurea
step-up
differentiation-uninduced
differentiation-induced
carcinogen-mediated
α-helical
all-hydrocarbon
ionized
iono
1500microl
vod-related
importantto
epicenter
tces
bivalently
monovalently
knob-in-hole
kih
cd3ε
cd43s-expressing
cd43-negative
classificationxa0and
non-mhc-restricted
pre-absorption
cytotolytic
cd94
cd94-nkg2
micro-rna-23a
overexpressionknockdown
mtt-cell
arac-treated
topoisomerase-2-beta
disialoganglioside
gd2
rbl5
a13
balbrve
c57b
resided
cd4-cd8
anti-natural
gd2-oligosaccharide-specific
gd2h-2b-tap2
gd2-specific
h-2
nucleoprotein
gd2-negative
h-2-binding
haptens
trinitrophenyl
o-beta-linked
acetyl-glucosamine
jak-2stat-3
propelled
pacemaker
kitpdgfra
dli-induced
endocytosed
granulocyte-csf
granulocyte-macrophage-csf
aza-mediated
psgl-1
apcd
αβt
αβtcr
self-reactivity
βtcr
γ9δ2tcr
γ9δ2tcr-transduced
biphosphonates
f1-atpase
γ9δ2
αβtcrs
mir--encoded
all-cells
mir-b
tel-pdgfrbeta
fip1-like-1
reoccurs
hg-u133a
gata1-mediated
neuroblastoma-derived
amkl-m7
discerning
self-regressive
neurolysin
nln
supercomplexes
letm1
sdha
cysteine-degrading
aml-ipscs
ilscs
hne
pr3hne-specific
pr2
rvv
hhdii
rvv-pr3
pr3-specific
pr2-specific
nct00716911
nonexcitable
trpms
trpvs
trpcs
trpps
trpv2
trpm5
trpv5
trpv6
self-propagate
nkcf
phytohemoagglutinin
lectin-dependent
ldcc
posttarget
alak
campath-1-depleted
cd56-cd3
carbon-11
stage-restricted
fbxl19
fbxl19-as1
haplosufficiency
predictmonitor
agecomorbidities
graft-versushost-
preventdelay
post-allo
pe-bm
ihs
kdrflk-1
dual-negatives
dual-positives
colony-growth
ribonucleoproteins
hnrnps
echinoderm
alk-eml4
factor-t790m-targeted
osimertinib
burger-kelland
verona
antigen-receptor
prame-stimulated
leukemia-fusion
brd4-mediated
c-myc-independent
dnmt3anpm1-mutated
self-associate
well-suited
mk-csa
multi-csf
mk-csf
wehi-3-conditioned
primate
histone-3-lysine
h3k
h3k27me-demethylases
h3k9me1-demethylases
kdm6
h3k9me-demethylases
wtflt3-transfected
wtfltd
flt3itd-transfected
flt3itd-32d
il-3-or
fl-deprived
natural-killer-cell-mediated
human-leukocyte-antigen
hla-haplotype-mismatched
hyper-acetylation
mapkapk2
hsp90aa1
hsp90ab1
mutation-derived
hla-presented
neoepitopes
receptor-transduced
npm1mut-specific
neoantigen-specific
aml1-eto9a-induced
exemplifying
flt3-itdmutations
bromo-
h4-dependent
effector-mediated
mab-coated
dle-hum195
diffusable
thiol-depleted
domain-encoding
reversine
hipc
maspin-kd
v-propidium
mcl-2
gemcitabine-treated
mdsamls
med13
med23
g12s
mutant-flt3
oncogenic-flt3-driven
abl-related
diseasestreatment
myelosuppressionseveral
non-leukemogenic
cosmids
cn2900
cn1323
thwarting
tetracycline-repressible
nrasg12v-mediated
mac-1low
resistance-all
metformin-
agent-is
prls
prl1
prl2
prl3
pur
gvh-nonreactive
balbcf1
h2bxd
gvl-effect
gvl-reactive
semi-allogenic
gvh-reactive
dba
nadph-producing
6pgd
nadh-dependent
sirtuin-1
anti-ig
drugability
non-atp-binding
mdm4-specific
cellsmultiple
basedapproach
polyphen
based-approach
1x0o
f363l
r430q
nssnps
cancer-targeted
46xa0kda
6xhis-tag
n-termini
ni2-nta
cell-binding
fpt
aging-induced
gametogenic
odf
mir-101-overexpressing
b-regulated
cd34cd38-lin-
thomsen-friedenreichcd176
cytokine-regulation
activation-status
cd203c
cd117kit
arousing
translocation-generated
lymphomyeloid
cru
5-fu-treated
kl
5-ends
back-splicing
thienopyrimidine
relapse-inducing
dynole
gnas
tail-modifying
paired-box
pax7
multi-level
myf5
cluster-specific
sfmbt1
cbx7
hemap
derailed
matrix-associated
microspeckles
hbmb
anti-fc
50-
65-
38-kda
5-s
p72syk
calcium-independent
irp1
irp2
ire
ire-containing
propensities
pilocarpine-induced
tle
video-eeg
gabra1
deconvoluting
tas-based
co-addiction
rxa0package
reﬁnement
stratiﬁcation
identiﬁcation
glycine-rich
csrp2
17-allylamino-17-demethoxygeldamycin
belies
chromatin-reader
enl-dependent
-c-c-type
utilise
tumour-1
hu-m195
computer-modeled
complementarity-determining
region-grafted
67-kd
131i-murine-m195
imaged
131i-hu-m195
double-minute-2
rg7388
p53-non-functional
lethality-induced
-renewing
therapy-target
3rasc-rafmitogen-activated
biologicals
advances--capturing
micrornas--have
wogonin-containing
chrysin
ser2
flavone-induced
enterotoxin-derived
superantigens
sags
tumour-directed
man-made
biotherapeutic
hypusination
eif5
pupasuite
q1198p
k1203q
nssnp
rs1784246
ptpases
ptpase
dc-al
hemocytes
tunicate
styela
plicata
rrbc
pdia3
wt-p53
nutlins
adaptorcoactivator
t-associated
bkt140
cxcr4-targeted
mir-628
cks1-skp2-containing
biorepositories
thaw
quick-thawing
cytokine-enriched
-a11
-b7
-b8
-b27
-b44
hla-a3a11
glivecgleevec
phagosome
deadenylases
deadenylase
ngf
p75ntr
trkangf
ngf-blocking
ngf-trka-p75ntr
skin-derived
cytokine-treated
ikbke
tank-binding
ikbketbk1-sensitive
ikbketbk1
surfaceome
pairings
myocd
myocardin
cytokine-driven
phb1
phb2
kit225
pde4
stat5a-deficient
stat5a--
stat5a5b
p210-transduced
p210stat5a
p210stat5a--reconstituted
p210stat5a--
cmlall
kshv-transformed
kpt-8602
pml-
cellsimportance
bcl-2-family
alpha3
cd47-blocking
hla-b61
inefficiently
nk-cells
phosphoinositide-specific
pi-plc
cml-lsc
gas2
fas-resistance
ks99
myelodysplastic-related
single-nucleotide-polymorphism
mk-2206
cebp-alpha
beta-emitters
beta-emitting
mbqkg
213bi-hum195
hypopigmentations
depigmentations
clitocine-induced
mir-30e
buzzword
overuse
mir-2278
mir-1245b-3p
stam2
hsa-mir-2278
mec-1
aur
gold-containing
proteasome-inhibitory
vel
aur-induced
proteasome-inhibiting
metal-containing
phh3
phospho-signal
glutamyl-trnagln
amidotransferase
set1c-compass
ap-3
p-body
hap1
stress-directed
self-ligands
tlr-myd88
cd4-mediated
hla-dr1-restricted
b-lcl
pha-blasts
treatmentfor
24-mer
lynx
inx-3001
inex
pi-positive
iwr-1
sal-induced
ptg-0861
hdac6-selective
ic50xa0xaxa0nm
cellulo
ricolinostat
receptorprotein
foxo4b
y361
combretastatin-a4-phosphate
ca4p
ca4p-induced
neovessels
vascular-adherent
organ-infiltrating
bibr1532
bibr1532-induced
lll12
pilo-sebaceous
propionibacterium
acnes
acnes-by
k59r
htlv-1-transformed
zinc-thiolate
redox-active
abrogatory
ki-ras
ki-ras4b
annexins
oxidoreductases
ki-ras-transformed
mutation-driven
ki-ras-associated
ac7
mir-192-mediated
iex-1
ier3
damage-based
borregard
cowland
non-volatile
griess
etv6-pdgfrbtyrosine
phytohemagglutin
hla-drdq
microlymphocytotoxicity
aurkab
sh-s7ar13as--dimethoxy--dimethyl-aa-tetrahydro-3h-chromeno
-bpyrano-hchromen-7-ol
sh-03
multi-spectral
rbcc
sumo
conjugase
sumoylationubiquitination
arsenic-caused
pml-multimerization
bcl-xlbcl-2
va1
32d-lg7
u1-fusion
vector-expressed
ikappabalpham
l-ohp-induced
nf-kappab-dependent
usp3
sgk1
siegel
jemal
clogging
iu
namalva
ifn-amplified
non-major
pbpcs
-tkd
tpml-rarα
itdu2009u
tkdu2009u
flt3-wildtype
non-good
syk-associated
cd34cd38-cd25
nsgj
diversifies
drugsensitive
polyphosphoinositides
pi-plc-β1
phosphoinositides
suboptimalin
enrichment-based
inka
testedheterogeneous
phosphopeptides
phosphosites
mutationour
py-phosphoproteomics
mir‑
mir‑19b
mircury
lnatm
pathway‑associated
ser727
proproliferative
domain-3
s-g2
cd-20
develope
serologically
spindle-associated
nusap1
p60
chaf1b-specific
nusap1-specific
american-indian
factorscatter
koc1
pawr
dlg5
fn1
n-cam-1
itgb5
sui1
bard1
pglyrp
biomics
cellsareas
presentexpert
crispcas9
prenylated
phloroglucinol
bakt1
non-phosphorylation
unbalancing
adcmv-ifn-alpha
units-granulocyte-macrophage
transcriptasepolymerase
oxidases
contested
non-transgenic
b-lymphomagenesis
il10r
myc-transformed
dubitative
adhesionsurface
kdm5a
kdm5a5b
menacing
endoprotease
13th
ezh2-null
eed-null
ezh2--
neoplasmssee
4e-bp5
receptor-b4
hematopoietic-reconstituted
act-wise
macrochimerism
donor-related
post-act-wise
in-training
seven-
corollary
myelofibrogenic
co-fuse
samples-enriched
igh-myc
igh-whsc1
menin-mll1
d2d3-cdk6
kras-expressing
rapamycin-insensitive
cell-context-dependent
counter-screen
metazoans
aff1-
aff4-containing
sec-like
sec-l2
sec-l3
aff2
aff3
af9mllt3
mrna-seq
aff4sec
scltal1
multipotency
scl
lps-based
lp-mir-29b
mir-29b-treated
lp-mir-nc
therapy-nucleic
e84
doimtna
noxamcl1
lsc-directed
pre-lsc
nox-derived
pyrido-dpyrimidine
multistate
navigating
protein-peptide
amped
sortcery
parameterize
peptide-binding
bcl-2-binding
iodine-i
radmci
131i-m195
slam-seq
thiolsh-linked
chemical-genetic
betis
de-mirnas
metascape
mir-10a-3p
mir-133a-3p
mir-99b-5p
lamc1
col3a1
apob
fstl1
slc14a1
arhgap5
tk-activated
alt-nhej
lig3
ezh2-expressing
hsanps-peiezh2sirna
hemocompatibility
hsanps-peiezh2sirna-treated
aml-responsive
mo-dc
b2a2-pulsed
b2a2-specific
hla-dr7
tbp
shh-neutralizing
wnt3a-neutralizing
anti-wnt3a-induced
autoactivated
interferon-alpha-resistant
-29b
-29c
plagl2-expressing
pu1-chromatin
diamidine
pu1lo
aml-inhibited
type-related
brd9-sustained
brd9-stat5
alkbh5
self-renewalmaintenance
death-responsive
caspase-8flice-inhibitory
lifedeath
eosinopoietic
tk-blocking
shingles
plg
vtn
tmt
alphaherpesvirus
chickenpox
postherpetic
neuralgia
human-based
tmts
mir-130an
antimir-155
anti-mir-155
mcl-1-shrna
untethers
abt-737-roscovitine
abt-737-induced
abt-737roscovitine
panned
phages
subtracted
pgv-1
modifier-activating
uba1
uba3
uba6
ubiquitylated
adenylation
single-patient
forwardsideward
stem-cell-specific
in-silico
non-personalized
l-aspartic
anti-chronic
lc3-positive
autophagy-like
asparaginase-induced
qn
asparaginase-treated
kinase-3α
pre-neoplastic
wntaktmtor
gsk-3α-
gsk-3β-regulated
scll
phosphoactivation
azd5582
p-xiap
azd5582-induced
p-akt-inducible
hif-inhibitor
hif1α-notch
natural-food-based
biotherapy
pi3kpkb
cd302
bh3s
bcl-xl-addicted
orient
ews
kinaserasmap
hoxa9-overexpressing
hoxa9-mediated
rpp2
phb
mir‑21
sivegf
il‑12
self-antigen-specific
tissue-restricted
self-antigen-directed
mtrunx1
mtrunx1-expressing
editing-out
er1
bet-proteolysis
1000-connectivity
expression-mimickers
narciclasine
p-valueu200au200a05
turquoise
tp53bp2
trialled
eberle
dodi
hla-a3
b7-restricted
mhc-peptide
dedication
hvg
fbatg
aborted
dna-regulatory
gpcr-mediated
-kg
r-2-
agi-6780
standpoint--whether
independent--has
cd200cd123
pt-1
hdac1-binding
dyslocalization
cognci
passageable
il-2-cultured
phosphoinositide-phospholipase
pi-plcβ1
bcl-xltargeted
re-proliferate
bcl-xland
annihilation
usp18
isg15
p210-bcr-abl
p210-bcr-abl-induced
nsc23766
p210-bcr-abl-mediated
mihas
jak2t875n
myomarker
muscle-specific
chromatin-regulator
break-fidelity
chemorefractoriness
devdases
microvesselsx500-field
target-mediated
postmarketing
tet-regulated
mir30-shrna
negative-selection
streamlined
siglec
siglecs
disubstituted
lsd1-bound
cytosine-methylated
chromatin-activating
crispri
lsd1-mediated
regulatorthis
analytics
discards
processable
braf-targeted
dalpha25oh2d3
1alpha25oh2d3
to-date
c-24
hyper-proliferation
novel-signaling
co-ordination
corrupt
m-csf-induced
morphology-aided
npm4
tidel-ii
cmts
relocalize
rin
uhplc-ms
pls-da
biomarkers-targets-pathways-disease
hormone-naive
ras-raf
farnysltransferase
treatmentsirnas
mcl1l
lineby
ca2c
fluo-3am
o-phthalaldehyde
opa
vanilloid
trpv
microrna-101
transition-associated
sphere-forming
microrna-101-ezh2mcl-1fos
telomerase-deficient
terc--
karyotype-selective
haplodeficient
pp2acalpha
coregulators
nondel5q
photofrin-based
repairable
bcr-abl-stat5-irf-8
widens
mrnas--the
transcription--the
antigene
hsu
gupta
extracellular-signal-regulated
perturbagens
dimethylfasudil
dimf
h-1152p
anti-amkl
shrna-
editing-based
milne
stat3myeloid
bcl-2-inhibiting
mcl1-proficient
wp-1066
sorafenib-dependent
stat3-c
sptlc1
tyr164
phe
mdm2i
bet-family
evict
mdm2i-induced
kabuki
ks1
kmt2dβgeo
endochondral
chondrocyte
chondrogenesis
igf-ir
kinasexa0mapk
rethink
capture-c
a572v
cmk
v560g
isotype-specific
prx
folate-conjugated
hfr
tim-3⁻
log2fc
1u2009gdl
ripk1ripk3mlkl
ecfcs
angiogenetic
ltg9
diabeticscid
fenretinide-down-regulated
non-lethal
line-based
misl
lethals
sls
acaca
lentiviral-based
mv411
ociaml2
nomo1
eol1
kasumi1
f36p
gene-kos
already-approved
deko
disko
vitellogenesis
fp-induced
meninwt
mllmll-fp
brd4-related
mll-fp-induced
m-525
mll-regulated
tmprss2
psa-screened
tmprss2ets
hla-a-
3-specific
btz-induced
zeb-1
tet2-mutations
wntbeta
bcr-abl1-inhibitors
ray-casting
top-scoring
mirna-124
mirna-124-mediated
voltage-dependent
hek293t-herg
e-4031
-extrinsic
uncouples
leftcf
ros1
myelocyic
pkc412-treated
nvp-ast487
anteceded
neoplasia-microenvironment
rapport
fadraciclib
cyc065
aminopurine
cdk9-
cdk2-dependent
nct02552953
nct03739554
nct04017546
bcr-targeted
bcr-related
epithelial-free
2-cyano--dioxooleana--dien-28-oic
cddo
cddoatra
betarare
t007
cddo-induced
cddo-methyl
tamls
lin-sca1-ckit
t-gene
tumor-driven
orgrade
t100
jimt-1
ifn-mediated
lak-mediated
p53-mcl
p53ser15p
centrosome-loss
numeral
atm-
osi-930
nci-h526
multienzyme
overwrites
allaml
inter-dependencies
fbl-3
9-mer
pr-1
i125-labeled
pr-1-specific
micromirnas
iav
iav-na
epidemics
pandemics
host-virus
galv
pseudotype
mir-372
mir-373
mir-124a
mir-7
mir‑193b
mir‑193a
genome‑wide
mir-193a-transfected
arhgap19
erbb4
alpha-ifn-treated
tyrosine-specific
factorbeta
neuroepithelial
caia
ptcls
oncogene-1interferon
tp25q
tcra
ptcl-us
alcls
irf4tcra
mum1irf4
hla-a3-
-b8-positive
beta2-microglobulin
7-d
unpulsed
hla-a3-b8
cd25hi
trispecific
selectivly
tumorigenesis-relevant
circmybl2
cytoactivity
mds-initiating
hematopoietic-stromal
msc-like
plcvarepsilon
zizimin1
shrunken
taspase1
tfiiaalpha-beta
non-oncogenes
coagulpathy
80u200a
substatially
30u200a
90u200a
intermeditae
pathiobiologic
gvl-related
tp11q11
receptor1
bcr-fgfr1
bgj398
non-myeloma
cdk11
wbscr22
non-multiple
usp8
ckap5
genomically-defined
genomically-agnostic
apprehended
strategiesfocusing
autonomy
cholangiocarcinomas
α-ketoglutarate-dependent
allogeneic-hematopoietic
p25
dapt
γ-secretase
amidohydrolase
asnases
break-through
drop-out
foreseen
f317lm351t
t315i-
e255k-
y253f-
g250e-expressing
pre-exist
pre-existed
leukemia-niche
oxygenase
ho1
hnp
mesoporphyrin
snmp
ho1-inhibitor
non-covalently
ho1-inhibiting
t-hnp
t-hnpsnmp
ho1-inhibited
trib
pseudokinases
tribs
phosphatidylinositol-3-kinaseakt
a-443654
disease-sustaining
sirpα-mediated
sirpα-fc
sirpα-cd47
tf-lpn-g3139
nuclease-containing
tf-lpn
1u2009µm
all-encompassing
basophil-derived
anti-hgf
noncultured
metylase
erk3
trans-matrigel
alrmll4
recombination-
monomethylation
on-based
bcl-abl
allude
leukemia--not
multikinasekit
tk-linked
adaphostin-mediated
kbm5-r
kbm7-r
kbm
dubbed
myeloid-depletion
myeloid-mediated
dtctgmcsf
nox1
pxa0xaxa0×xa
bonferroni-adjusted
top-ranked
enticing
cct068127
dusp6
cb-based
cbus
nima
7kg
cbu
nu202fu202f8
nu202fu202f1
cbu-derived
nu202fu202f5
flt3-induced
aals
anthrax
monobody
del5q-associated
laa-peptide
ha1
smcy
adp-cml
pr1-peptide
fusewstaf15
ews-fli
conspire
ews-ets
cofilin1
cfl1
apgi
y416
3d-organotypic
socs1-transfected
prostate-selective
cd20-targeted
rituximab-treated
pi-plcs
ca-074
oligomycin
18f-fdg
line-
2-meopsmir
2-meopsmir29b
biotargets
2-meops-modified
candidatesexperimental
gainloss-of-expression
therapyresults
high-mcl1low-noxa
pimasertib
noxa-mediated
degradationconclusions
protein-regulated
environment-mediated
bcr-abl1-related
-unrelated
mv-r
abt-869-mediated
e804
hypermorph
retroviral-induced
epithelium-derived
tethers
chromatin-tethering
diseases-hiv
heat-sensitivity
mk-8057
l-cfu-s
t2-weighted
fluorodeoxyglucose-positron
srpks
srpk2
srpk
n-2-piperidin-1-yl-5-trifluoromethylphenylisonicotinamide
srpin340
map2k2
srpksrpin340
srpk-ligand
tcrαβ
b6d2f1
myd88ko
gvhdgvl
propulsion
rrd-251
motivates
ps608
s608
rare-driven
rac-rafgsk-3rarα
ra-effects
moieties--a
haptophore
toxophore
synthesis-inactivating
haptophores
toxophores
ag1024
encouragingly
tim-4
co-blockage
anti-tim-4
htr1s
htr1b
htr1
within-subtype
pirnas
myasthenia
gravis
bxa0cell
controllability
switchable
unicar-t
tm123
tm123-redirected
nct04230265
polysomal
iron-restricted
il-6-dependent
cold-shock
csda
mekp90
phospho-deficient
rat1
mhag-specific
mhag-based
rijke
hla-b7-restricted
mhag-mediated
proteinnucleic
erp5
chain-related
pdis
sialic-acid-binding
siglec-3
siglec-2
trojan
siglec-8
siglec-9
pj-68
dishevelled
dvl3
mllr-b-all
neuron-glial
vxl
chondroitinase-abc
anti-ng2-specific
anti-ng2
brca1-mutated
brca1-deficient
oncogenomics
myc-overexpression
reshapes
rb1cc1
cytarabinemdm2
il-2-stimulated
killer-sensitive
ebv-lymphoblastoid
aml-i
51cr-labelled
co-cultivation
isoprenylation
alteration-specific
proteoforms
mll-af4-bound
dot1
tumor-autonomous
apprised
pharmacist-patient
physiopathologically
bcr-abl-transfected
mkpl-1
5race
rbm6
tp21q33
rbm6-csf1r
unc1666
merflt3
knockdown-initiated
il-9-dependent
abl-targeted
tacg
mlh1-deficiency
centrilobular
sinusoids
krn383
asp835tyr
multicycle
promyelotic
apl-
machinesignalsome
linemodel
signalsome
ps376slp76
nearer
slp76
ergo
retrovirus-transduced
cgp76030
comprehending
apoc2
chylomicrons
very-low-density
cd36-mediated
lyn-erk
apoc2-cd36
tii
poly-adenylated
translators
adsorbing
single-driver
mutations-a
mll-af9-a
myb-coordinated
karyotype-specific
dcone
t-lymphocyte-mediated
ser10
phospho-c-mycser62
restenosis
neointimal
cell-stromal
3kinase
mds-enriched
shipptenpi
phosphatase-deficient
mir-210ship-1akt
22-nucleotide-noncoding
marrow-infiltrating
anti-cd25il-2
anti-ido
anti-pi3k
tregbased
anti-pdgfr-alpha
survivalpdgfr-alpha
therapy-responders
subarachnoid
arsenics
gpr84
gpr84-deficient
hoxa9meis1a-transduced
coeffectors
gpr84β-catenin
fba
proteinprotein
starch
humanmurine
14-
17-fold
exchanged
nkg2d-ligand
nkg2d-car
hdac-inhibitors
uf-1
et-ketone
alt-803
il-15-based
lfa-1-
cd2-
macroh2a
fv-induced
cellsmouse
ril-000
hematopoiesis-restricted
agm130
cclcxcl
anti-angiogenesiscancer
tyro-3
biotechnologies
natures
evolution-informed
embrace
michip
mirna-specific
mir-qrt-pcr
anti-c-myc
antagomirs
pri-mirna
bcr-abl-c-myc-mir-
cllsmall
sll
anti-cd200
nf-kappab-activating
i-kappab
ikk1
atg6beclin-1
atg10
atg12
bioenergetic
lor-1284
tf-np-lor-1284
mhf
kmt6a
affinity-purification
eef1a1
ptl-induced
mpo-specific
4-aminobenzoic
gleevecsti571
extrapolates
hematoproliferative
microrna-223
pkc412a
itd-transfected
compound102
non-myelotoxic
dose-range
32d-flt3-itd
n676
flt3-tkis
monoubiquitin
h4k20me1
setd8-the
methyltransferase-reduces
bap1-mutant
51-cr-release
freshcryopreserved
antisoma
as-1411
hybridization-requiring
oncogene-specific
sirnashrna
amenability
rna-depleted
pi3k-dependant
trb-1
trb-2
trb-3
trb-1trb-2
trb
tribbles-mediated
cebpalpha-responsive
fgfr-derived
bcr–abl1
fgfr-positive
wingless-intβ-catenin
lmtk2
genotype-tissue
drugradiation
upmost
survivin-reporter
hts-derived
hit-lead
fl118
fl118s
body-weight-loss
dipeptidylpeptidase
bcrabl1p210
cellxa0population
mllhrxall-1
mlln320c180
triphosphatases
hoxa-upregulated
β-catenintcflef
jak2flt3
circumstantial
ro-3306
-chlorophenyl1-dimethylethyl-1h-pyrazolo-αpyrimidin-4-amine
sk6
cycle-arresting
wgas
donor-type
sk-n-as
imr-5
nlf
bcl2-sensitive
bcl2-w-x
gzmb-mediated
gzmbtc
bim-
bakbax-deficient
3t9
virus-sv40
gzmbtc-mediated
sv40-transformed
gzmbtc-induced
multiplication
bets
nk-ys
stat3-active
stat3-inactive
stat3-mcl-1
npi-0052
cell-responses
6-formylindolo-b
carbazole
c-cbllync-raf-centered
ewsr1
cltc
egfrviii
alloantigenic
tc2
b6c3f
h-2k
cellsrecipient
tc1-mediated
tc2-mediated
menin-deficient
alpha-helix
ub-e2
ma-11
genotypically
graft-versus-leukemia-based
rab38
tbce
dusp12
sbf-1
caspase-8-
oxidant-dependent
histone-h3
mssndx-275
caspase-8-deficient
stress-dependent
beta5
glioblastomata
medulloblastomata
v-erbb
multi-pronged
bipolar
disorganized
sub-class
kat6b
morf
cell-states
denominated
dynamism
negotiate
tying
microenvironmentleukemia
postresection
micrornas--short
genes--and
vaccine-based
low-energy
earmarking
promsing
subfractionation
bona-fide
fap-1
mkp-1
lmwptp
like1
mixl1
paired-type
bcl2a2
mixl1-zinc
bmpr1
ldn-193189
mixl1-c
mixl1-
ds-all
ofa-ilrp-specific
ofa-ilrp-expressing
ofa-ilrp-derived
ofa-ilrp-negative
ofa-ilrp-coding
leukotoxin
aggregatibacter
actinomycetemcomitans
lfa1
lfa1-knockout
leukotoxin-mediated
l-cfc
p124
within-patient
auto-transplantation
amlsince
reflectance
atr-ftir
s-ftir
rk-20449
pyrrolo-pyrimidine
nodsevere
scidil2rgnull
non-stem
pro3
18-hour
hne-loaded
hne-specific
rxralpha
experienced-based
oncoprotein-directed
atra-resistance
rn28s1
11b
κ
igkv
cog1
rn28s1-bcl11b
tq25q32
igkv-rn28s1
cog1-rn28s1
hbl-5
rn28s1-related
rbp-jkappa
raftk
atl-derived
mt-2
bcl-2-targeted
incompatibilities
helper-inducer
suppressor-cytotoxic
okt10
non-gvhd
demethoxydaunorubicin
nonalloreactive
colds
allelic-peak
formulas
transfusion-induced
hsp73
hsp72
autoantibody
contingency
major-mismatched
minor-mismatched
nonsplenectomized
non-bmt
defervesced
oromucositis
denudement
convulsions
csa-induced
rosetting
macaque
farber
lipogranulomata
psychomotor
-cd57
nk-associated
kp43
non-lineage-restricted
doesnt
indented
desmosomes
breached
lymphocyte-to-epithelial-cell
chemoradiotherapy-induced
extra-intestinal
unmaintained
anaphylactoid
autopsy-proven
microparticle
thrombin-antithrombin
cd55-
cd59-deficient
sézary
ctcls
repolarizing
annl
post-transplanted
abbrev
campath-
transplantationabstract
cmv-infected
polyarteritis
seroconverted
marseille
aft
hematopoeisis
chicken-pox
unconfirmed
nonabsorbable
abo-compatible
glycosuria
pelger-huët
porphyria
cep
uroporphyrinogen
uiiic
uroporphyrin
erythrodontia
famciclovir
ox40cd4
cgvhd-associated
transcription-1
tumor-challenged
gvhdgvt
paecilomyces
hopelessness
engulfment
intrusiveness
construe
caries
diarrheal
1-antitrypsin
cmv-associated
cd13-specific
patients--to
allo-response
polyomavirus-associated
bk-pyvhc
bkv
graft-versus-malignancy
cd8-depleted
stable-phase
78th
histoplasma
tropic
parainfluenza
bkv-associated
rt-pa
olt
foreground
tritium-labelled
streptavidin-coated
amersham
peribronchial
symptomatically
non-bacterial
-308
tnfd
0-ii
supersaturated
uln
fie
growth-stimulating
non-endemic
incriminating
taxol-treated
cr4
transplant-associated
nccr
b7h1
pifs
protein-rna
adrenoleukodystrophy
vlcfa
hetastarch
zeta-chain
gene-marked
lmp2-specific
nmdp
vial
digene
cbaca
cbk
anti-cd40l
avium-intracellulare
ceftriaxone
neosartorya
fischeri
confuse
non-candida
irritability
haematopoeisis
hypercalcaemia
deformities
necrolytic
greffe
moelle
sfgm
suppressor-inducer
cdh4
cdb4
cd8hla-dr
leu7
pre-engraftment
non-routine
bacteraemic
asplenic
haemophilus
titres
mesna
2-mercaptoethane
sulfonate
mustargen
ankl
extraocular
lak-sensitive
antibody-enriched
coombs
watsons
neoral
circulates
intestines
epithelialization
bfue
spongiosis
mini-allogeneic
under-recognized
buffy-coat
grade-ii-iv
phenylhydrazine
capsular
serotypes
7f
pneumococci
lupus-like
hhv8
cell-lymphocyte
meclr
overdose
45xx-7
puva-therapy
sclerodermatous
contracture
rejections
mini-dose
area-forming
complex-mismatched
anti-lymphocyte
sialadenitis
bmtx
septa
mock-infected
herpesvirus-6
hhv6
seroprevalence
confusing
mini-allo
confront
horning
kaminski
bexxar
iodine-labeled
ytrium-labeled
graft-versus-lymphoma
champlin
haemochromatosis
hfe
cys282tyr
ferritins
saturations
venesection
radiation-free
enteropathy
diphtheroids
broviac
nontuberculous
odynophagia
hyposplenism
cpk
tachypnoea
expiratory
ud-bmt
hf-tbi
f-tbi
out-of-field
ankle
biopsyxa0of
mandible
add12p
cmv-specific
virion
sphenoid
azospermic
mct118
ynz22
fathering
tbi-containing
paternity
hypouricemia
catheter-directed
thrombolysis
thrombectomy
thalassaemia
fty
non-mhc
caryotype
rinsing
desaturation
chediak-hegashi
bmts
cgymin
transplantabstract
7s
conidia
cyclosporine-induced
non-depleted
jackknifed
o-i
hastening
vip-signaling
viphyb
mcmv
kuala
lumpur
vca
ebv-carrying
interferon-alpha2b
ifn-alpha2b
alpha2b
pr1hla-a0201
non-mixture
monotonically
drug-food
hql
norms
jirovecii
non-aids
lsg
htlv-
taper
ebv-ptld
reassurance
astute
hcmv-dna
hcmv-positive
rifi
parallel-group
qid
efficacy-evaluable
aspirin-triggered
atla
host-donor
eicosanoid
aspergilloma
nonsterile
silastic
hyperalimentation
ifn1
polymyositis
tracheostomy
hcv-infected
anti-hcv
correctable
mannose-6-phosphate
flare-up
ifn-sensitive
ultra-high-risk
uhrf
ccg-1921
unmobilized
non-infants
dah
neuromyelitis
optica
nmo
averting
non-tbi-containing
cell-depletion
gvhdabstract
huddinge
p31
p49
tcr-specific
flow-rate
hyperhypopigmented
consanguinity
maroteaux-lamy
mucopolysaccharidosis
n-acetylgalactosamine
arsb
deficiency-iii
lad-iii
ptcpc
hpp-cfc
nonfermenting
notch1fbxw7
p-gp-dependent
hypodense
lisofylline
lsf
rrt
transplant-derived
gene-corrected
auto-reactive
odors
donor-
recipient-specific
odor
electromyography
acetylhydrolase
paf-ah
v279f
c3hsw
mhag-mismatched
205-np
t4t8
thyrotoxicosis
-45
mtx-
pfts
downbeat
neurones
n80
n90
rrd
diagnosis-bmt
cyclosporinemethotrexate
microangiopathic
maha
bmd
dual-energy
dexa
radiation-based
gcm2
ticarcillin
-mcl
bc3
mantel-haenszel
reticulated
hyperpigmented
lichenified
spl
tetanus
toxoid
unscreened
aciclovir
bmt-associated
rna-positive
rna-negative
penicillium
fungemias
ivs-
ssos
2-moe-ssos
ricin-conjugated
cd6-
anti-cd6
t12
nationality-matched
substitutive
graft-vs
erythroblastopenia
mucotoxic
portals
portosystemic
stent-shunt
amelogenin
kgf--
b10br
intranasally
defences
recapitulation
antibody-producing
toxoids
influenzae
cd134
ox40l--
phacoemulsification
spectratypes
t-cell-repertoire
non-manipulated
ptcd
ftcd
campath-1m
cd45racd45ro
extra-thymic
gva
eae-susceptible
donor-chimerism
glycoprotein-specific
nonsusceptible
antibiotic-resistant
durans
generalised
filgrastim-mobilized
demarcated
necrolysis
bacteremias
kaohsiung
imis
glucocorticosteroid
anti-hla
rna-rich
sysmex
versus-host
vanishing
preeminent
stressor
emotion-focused
problem-focused
stressor-coping
dosimeters
consumptive
csa-associated
hypomagnesaemia
tremor
expressive
aphasia
haematologically
murmur
swog-8612
ftbivp16
blume
kopecky
henslee-downey
forman
stiff
maistre
allamlcml
tdel11q
hypotetraploidy
8i17q
ctn
transcranial
sot
maribavir
re-infused
itga2b
rabies
intraventricular
polyspecific
ebna
b10d2--balbc
anti-tcr
wolfs
dermatomes
tolerizing
dst
anti-erythrocyte
pmrd
ebv-lpd
6-methylprednisolone
6mpred
earlyadvanced
cyclosporincyclosporin
intraluminal
hemofiltration
venogram
microsporidia
obligate
degenerate
transplanation
microsporidial
cryostat
cytokine-mobilized
lymphoglobulin
sequels
gvdh
microgliter
transposed
del7q22
17q25
del12p12
treatment-oriented
myelokathexis
pbct
stormy
ketoacidosis
wary
hyperglycemic
lavages
il-4-producing
unseparated
ceprate
bab
almuadham
mini-allotransplant
effective-free
polytypic
monotypic
unfolds
relational
reciprocity
doorway
thrombocyto-
post-allograft
anti-cd154
fall-off
bt563
il-17--
centromere-specific
peroxisomal
multiinstitutional
complex-matched
b6dom1
dr15
--14
scfas
scfa
cd326
iec
clostridia
salutary
aboi
high-titer
expressionabstract
extraneurologic
oralis
mitis
elam-1
npr
clinicohematological
ventilated
undertaking
globuline
curse
mucoceles
alk-positive
capsulatum
hyperendemic
sibling-donor
folliculorum
pgk
m27
lyonisation
undigested
indium-labeled
apheresed
scintigraphic
s-alcl
biopsy-confirmed
anti-hbe
decompensation
amotosalen-treated
polyglandular
antiglutamic
ema-g
amlabstract
mdsmds-aml
cellbone
toenail
quickest
easiest
bartonella
blood-
culture-pcrs
henselae
bartonellosis
strs
hakodate
antibody-negative
pan-b
l26
macrophagemyeloid
ln-3
leu22
abmtabstract
aurothiomalate
hypoplasiaaplasia
coalescing
sensation
keratopathy
hypertransfusion
non-contaminated
gene-engineered
cd19-targeted
mitobronitolcytarabine
kelemen
bbbb
receptor-facilitated
anti-donor
spiramycin
mouthwashes
roentgenographic
nondiagnostic
adem
normal-appearing
p09
haplobmt
cd8s6f1
cd8cd57
cd8cd57-
ustus
fungistatic
electrocardiograms
post-allo-bmt
plaque-forming
oh-itra
hhv-7
hhv-6-positive
c2h
c4h
single-sample
2-sample
cuff
triazole-resistant
c-ara
rhug-csf-treated
spotting
laterocervical
absidia
corymbifera
leukoplakia
fibrohistiocytomatous
ilium
a-gvhd
methodically
-kd
device-related
ebv-lymphoproliferative
bals
alveolitis
leukoreduced
3-antigen
-511
38c13
idiotype-specific
keyhole
limpet
hemocyanin
anti-idiotypic
exuberant
rflps
beta0-thalassemia
grdl
transcriptsmicrograms
campath-1g
pmlraralpha-positive
pmlraralpha-negative
gastroenteritis
sibs
absent-mild
mini-allograft
cyclophosphamidetbi
campathfludarabinemelphalan
haemodialysis
microgramskgd
plateletsl
graft-host
cgd
practice-compliant
mrna-transfected
post-grafting
cd8cd11
cd8cd11-
cd8leu7
chaetomium
aml4eo
sepo
post-conditioning
36vs
50vs
55vs
angiokeratomas
planus-like
vegetative
hla-b7
b8
pleocytosis
pre-outbreak
post-outbreak
novoseven
rviia
urines
viruria
thromboemboli
magnified
trichoderma
longibrachiatum
antiphospholipid
birc4
presensitized
rar-alpha-rearranged
pmlrar-a
dxs255
patientdonor
leuprolide
supranormal
vbeta
pvb19
ebstein-barr
post-engraftment
photodistributed
lentigines
gvhd-associated
nonlethal
perforin-deficient
fasl-defective
antirecipient
cytosin-arabinoside
6-thioguanin
constrictive
ois
hftbi
nonstructural
p002
posttransfusion
hsvtk
cd8cd56
pre-selected
drift
chagas
postthaw
p0006
oxymetholone
pre-renal
rhodopseudomonas
ie2
protozoal
pt-lpds
pbcl
ml-ib
ursodiol
csamtx
bicnu
psoralen
electron-beam
denileukin
diftitox
ngmlh
hus
anti-iga
fundeni
schistosomal
schistosomiasis
listeriosis
listerial
effect™
hvt
villus
mpa-treated
anti-host
autoptic
thymoglobuline
sangstat
mhc-matched
tsoi
mhc-restricting
hbsag-negative
electromyographic
cunninghamella
bertholletiae
neurotropic
pons
hcmv-seropositive
dna-positive
hadv
pneumotropic
sumo-e2a
sumo-pml
fdg-petct
peritransplant
non-cryopreserved
plateletsmicrol
pneumothoraces
minisatellite
hostdonor
corticosteroid-treated
acidotic
non-gvhd-related
adherence-depleted
fibronectin-coated
characteristics-such
wlllebrand
flk-1kdr
bandeiraea
simplicifolia
uptake-but
p1h12
intraosseous
nonautologous
brt
fabl2
bullae
totalling
phlebotomies
delta-sds
nonsecretory
effector-memory
angioinvasive
fluorophore
cd8brightcd28-
myeloic
msl-109
tnbmc
non-engraftment
idcsa
idmtx
gyd
meql
fek
pseudohypoaldosteronism
idiosyncratic
randomizing
idealized
post-discontinuation
adlt
⩾30
inspite
mic-2
uchl-1
pan-t-cell
gene-expressing
société
française
cytbi
mtx-csa
gvm
allo-reactive
patient-adapted
novia
pmnmicrol
co-blocking
trx1
arabian
ci-973
mic2
ewingsprimitive
transferase-positive
12e7
m1-
m3-
transfer-mediated
mllall
histocheck
more-interstitial
deltanp73
tatp73
deltantp73
rga
non-rga
deltantp73tatp73
pha-transformed
pre-transfusion
non-restricted
ara-cdnr
hd-ara-cdnr
aracytin
92pmod
hla-typed
mafosfamide-purged
540xl
mfd
drip205
sybr-green
heterologous-mimic
scnp-based
∼65
inter-unit
hla-match
hla-loci
non-reactive
tuberculoma
two-hundred-forty
nxa0xa045
hypothalamic-pituitary-adrenal
corticorelin
grains
hybridizations
bam
48u2009111
pcds
embaseovid
cytogenetic-
flt3itdwtnpm1mutidh2r140
flt3itdwtnpm1wtidh2r172
allogenetic
co-amplified
10⁷kg
10⁵kg
tq13q11
men1112
men1112-mediated
marow
cutaneous-mucous
catalogued
irf-2
ifn-inducible
oas
menstruation
anti-müllerian
amh
interval-free
association-9802
nct00880243
nu2009u200990
pbsctbmt
aml-bfm-
cmitoxantrone
busulfex
gd-dtpa-enhanced
mepm
nonleukaemic
as-d
ultrastructurally
electron-dense
autogenic
lenfant
ladolescent
medium-
coordinators
pu202fu202f032
licrlonr10
sialoglycoprotein
glycophorin-a-positive
allo-cohort
amlcg-85
aminoanthraquinone
detectability
ccgrs
antrum
pdn
4-drug
-89
inhomogeneity
eortc-lggimema
intensieve
badvery
preempting
cd33-based
231bi
vud-bmt
cr1first
cr2cp2
atg-s
cr1cp1
cml-cp1
delaysreductions
1nl
lb-reactive
peroral
eti
medium-term
non-t-cell-depleted
product-limit
graft-versus-
hla-b35
hla-dr11
g0-phase
newly-developed
reconfirmed
corynebacterium
parvum
carts
article--the
survivorship--focuses
wt1-derived
peptideprotein
angiostatic
incorrectly
posterolateral
extradural
t6
3-loci
haplo-hscts
coagulationdic
apl14
bleedingsepsis
iodine-i-anti-cd45
2xa0gy
1561xa0mci
27xa0gy
84xa0gy
21xa0gy
28xa0gy
43xa0gy
-donors
m-pb
progressionrecurrence
donor-patient
hla-disparity
tp15q21
barotrauma
high-flow
bronchioles
lmin
-44
auto-transplant
anl
mononeuropathy
plexopathy
aldhbright
aldhlow
patients--25
mucosa-associated
all--
fa-derived
brca2-mutated
brca2δe
brcaness
sct2
donor2
nu2009u2009163
sibsib-112
udud-51
nu2009u2009305
sibdifferent
sib-44
sibud-93
uddifferent
ud-168
haplo-donor
sibhaplo-45
udhaplo-43
4-hydroxy-ifosfamide
ifos
gstalpha
p026
gstmu
po009
13-fold
gst7pi
ifos-sensitive
ifos-resistant
xiiib
leukocytesmicrol
atraumatic
antimetabolite-based
etoposide-related
factornm23
f5
post-abmt
edta-bm
ps-bm
n-acetyl-calicheamicin
complement-purged
ichthyosis
udli
ph-negativity
post-autograft
gm-csf-deficient
arenas
washouts
imagining
reasserted
ex-tcd
antilymphocyte
in-tcd
fibrosing
fch
hbv-infected
48-yr-old
universalis
eyelashes
hla-a31
-287
cd11bcxcr4
endocrinologic
overallrelapse-free
cd25-expressing
cart-cell
restrictively
ac133-positive
ac133-negative
intraparenchymal
focality
intervened
non-cns
cd15cd34
nmb
lbm
nonpurged
cd45ra-positive
pbss
philadelphia-like
all-associated
kurume
mfsézary
mfss
epidermotropic
pai-2
rral
daily-infused
clo-cyx4
clo-mediated
rrals
exanthematic
mid-dermal
periadnexal
accentuation
nasdcl
ebmt-score
terminal-deoxynucleotidyl
patronage
asbmt
hamburggermany
cd45cd34cd7
cd45cd34cd38-
cd96-
n304
p9l
paclitaxel-mediated
tlr4-expressing
quell
msc-mediated
n-cadherin-mediated
n-cadherin-β-catenin
wnt-mediated
cd1acd207
self-resolving
apaap
e2fs
pymt
e2f3a
plos
nonirradiation-containing
bu4cy
flubu
flubu2
higher-intensity
20-um2
cpx-
nkg2c
ldca
phosphoglycerate
x-inactivation
aim-v
certifying
endotoxins
basle
hrxa6
non-chronic
hrxa7
nonidentical
neomycin-resistance
resurgent
intermric
pue2fa
non-advanced
lymphohaematopoietic
non-peritoneal
thioquanine
7-methyl
m7g
eif4e-dependent
brs
pds
ribavirin-induced
nct00559091
nxa0xa091
p9407
whartons
jelly
dwjm
lumican
ecm-based
tmi
mn-sod
phosphoglucomutase
pgm
autochtonous
action--at
patient--by
i12p
judgments
readmitted
61xa0
46xa0
39xa0
23xa0
sr-1
rt-competitive
toxoplasmic
sulfadiazine
match-related
match-unrelated
investigationcyclophosphamide
non-haploidentical
minimec
cru2009u2009cri
nu2009u2009246
ghvd-free-relapse-free-survival
chronic-gvhd
rhu
il-1r
amsacrin
tbicyclophosphamideatg
hovon97
ntr1810
peroxidase-antiperoxidase
colourimetric
chemoradiotherapy-resistant
alloactivation
third-
hematopathologic
tq21p13
nu2009u2009462
wehi-conditioned
sa7hd
re-treated
pbsch
ighj
planimetric
argyrophilic
cytophotometry
non-lymphoid
pre-pre-b
allt
x-
y-chromosome-specific
dna-probes
percursors
17q21
microclusters
sequence-associated
pml-rara-positive
2gy
ltc-initiating
craniocaudally
morphologists
non-thymoglobulin-based
pleurodesis
talc
radioinduced
non-rio
anti-recipient
allorecognition
secondhand
ureter
self-reinforcing
regressional
re-synthesized
arjas
erola
patientss
transcriptsmicrogram
nkg2a-
cmv-reactivation
haematopoietic-stem
cmv-polymerase
enumerations
26xa0d
cd28-
cd45ra-
anti-adenovirus
b-allthe
-xl
ba1
j5
tq11q32
shlush
mdli
lin
assoc
biostatistics
asymptotic
astrocytosis
hs-27a
aml-stromal
cyr61-mediated
cyr61-syk
0-i
phosphatase-labeled
biotine
ap-lsab
jsb1
cd34mdr
nnt
csashort
-×107kg
-×105kg
-27
180d
jena
-91
quintiles
meagre
endstage
42-yr-old
tars
endosteum
cellsgroup
intertrabecular
marques
valdecilla
marsden
pre-hpct
post-hpct
motivating
mcrpc-infiltrating
bchn
pb-sc
cd26xa0xa0fraction
cd34xa0xa0cd38-cd26
cd34xa0xa0cd38-cd26-and
cd34xa0xa0cd38xa0xa0cells
il1-rap
s15a2
pclo
va0d1
cklf5
cd26xa0xa0lscs
majoring
mlh3
nolc1
chemotherapy-directed
cd54icam-1
cd58lfa-3
transfusing
leukopheresis
esophagectomy
aml1314
mitoxantrone-cytarabine
3-course
6-course
adnexae
cytoxane
heminested
dna-pcr-
e5kts
e5-kts
e5kts-
e5-kts-
e5
unanimous
bromide-assay
mo7
reoccurrence
bm-mvd
fm-ratio
n324
non-cgvhd
cns-positive
-66
wt1-targeted
west-berlin
cell-diameter
macrolymphoblasts
multi-modal
loco
ambt
cyclical
ik1
ik2
ik4
ik8
pathohistological
anhl
cnop
icnop
tiw
n107
rcbt
mllaf9-transformed
nu2009u200996
sequencingxa0n
pg60r
pv637e
pr295c
gnb2
pg77r
mll-negative
model-driven
glycosilated
kds
continuous-flow
separators
lymphopoietic
indifferentiated
straightforwardness
amsacrine-
fai
pdclow
tk-cells
tk-cellskg
karolinska
nonrelapse-related
accurint
calendar-specific
22-fold
cardioprotectants
emds
angioedema
dna-fingerprint
dna-f
remission-phase
gtg5
dna-digestion
hinfi
haeiii
fludarabine-cyclophosphamide-antithymocyte
fludarabine-cytarabine-idarubicin
20000microl
non-progressors
thromboplastic
course--at
quazar
cc-486-aml-001
glycolipid-reactive
ets-like
non-translocated
mantle-field
abll
tamoxifen-treated
radiobiology
assert
radiobiologic
dead-band
radiobiologists
age-driven
underanalyzed
stage-number
se-selectin
cxorf48
cxorf48-specific
ctl-negative
nonurothelial
congested
nk-dli
successfully-treated
donor-origin
relapse1
mice4
nkg2d-a
cells-are
cd34-expressing
non-cd34-expressing
nkg2dl-negative
re-transplantable
nkxa0cells
tbc
hepatopathy
microlymphoblastic
allodepletion
anti-ebv
allodepleted
stim-3
high-tim-3
anticardiolipin
igg-
igm-aca
respectivelyabstract
patients--predominantly
toxicity--the
activity--resulting
elderlycomorbid
hla-matched-related
good-enough
leukine
non-differentiated
cdw75
genito-urinary
tonsils
transcription-mediated
acridinium
ester-labelled
ngtriplicate
waterbaths
luminometer
lal1205
calla-positive
feam
etoposid
temozolomides
allwe
leukemiaall
n519
cml-lb
n515
n512
responsecr
transplantationgrades
tpq23mllt3-mll
inhibitor-containing
-86
-23
diagnostical
ig-jh
tcr-beta
aortitis
pseudocyst
kir-haplotype
kir2ds4
kir3ds1
edematous
erythemas
cssbu
⩽60
ricnma
hla-mlc
relapseprogressive
subside
flooding
supervening
cyclophosphamidebusulphan
wcc
phenoconversion
genotype-guided
klinefelters
gvlr
wagrij
l4415
hybrid-to-parent
parent-to-hybrid
histoincompatible
smo--
retransplantable
alloresponse
pcr-single
remissional
csfr
metalloprotease-2
granulocyte-macrophage-csfr
granulocyte-csfr-positive
topisomerase
non-identical
20nl
numa
intra-laboratory
t-lymphocytic
revising
nomo-1adr
nb4mdr
video-microscopic
lung-related
ms209
allohcpt
allohpct
overstated
greenberg
upbsct
fgf2-containing
despair
perkin
elmer
quencher-dye
hybridizes
longer-lasting
inmc
①total
atg-6
atg-
atg-9
atg-3
③among
gmr
thematic
r-squared
allmer
heterotypic
liang
chos
papavassiliou
mirna-colerectal
giovannetti
ellinger
müller
vasconcelos
mir-106b
methotrexate-cyclosporin
cy-tbi
cd34-dcc
high-doses
dae
pustular
-83
aythmic
radio-therapeutic
fixed-dose-rate
toxicityour
patientsdose
malaiseabstract
rarf
raferkmek
cbm
bio-medicine
veno-occlusion
leucemic
autologic
non-it
armory
civ
bcr1
nks
viral-infected
posture
nkrls
ulbp6
myelodyplastic
clq-ba
ibmtr
nondepleted
cyamtx
pseudo-obstruction
neostigmine
nma-conditioning
dsdna
ev-dsdna
genescan-based
nta
chimerical
inv16cbfb-myh11
numberreference
ncn
secondsecondary
nu2009u200963
49xa0
59xa0
34xa0
multi-cycle
australians
wbc20xl
platelets50xl
v654a
v560gv654a
leukaemia-berlinfrankfurtmuenster
--2004
all-trans-retinoid
anamorph
pseudallescheria
boydii
hla-d
plts
leucocyte-depleted
l-d
villin
lgr5
hla-non-identical
urd-bmt
heels
otomycosis
superinfection
earache
otic
yeast-like
1il-1r1
butyrylcholinesterase
bche
humbling
mch
dispose
truncus
microcytic
hypochromatic
kp-1
aml-bfm-studies
fad
omi
5-transmembranous
facscan
miltenyi
biotec
cd34-antigens
hpca-2
pbsc-transplantation
41aml
ac133-
macs
6p23
cd15cd117
¿mrd
100¿
well-reduced
phosphataseantialkaline
q24q11
tq24q11
haplo-pbhct
150kb
d16s405
multi-clonal
blood-guided
minitransplantations
double-labeled
kw-3
sada
posttherapeutic
myeloid-dc1
lymphoid-dc2
dc1dc2
cnis
cni-free
18-yr
unretrievable
time-period
gender-related
-2189
2log
c-lambda
hesitated
bai
60co
cmv-infection
pre-therapeutic
lnamlint2004230
non-total
allopbscts
allobmts
allopbsct
pgp1
flt4
venules
fourthly
18xa0d
100xa0d
4xa0yr
epitope-specific
vβ-families
clonotypic
hgs-etr1
hgs-etr2
hmcl
mfac
mylotarg-containing
recurrentrefractory
chromatographic-mass
sct1
non-senescent
re-entered
wnt-dependent
p53-regulatable
a-triple-v
camal-1
fplc
30-kd
aml-xh-99
overal
riak
mortaility
cath-d
hypersecreted
m-bcr-abl
cd34pbsct
double-bmt
amish
grandfather
grandfathers
nonverbal
non-b-cell
nonnasal
angiocentric
cd3leu4-
cd3epsilon
cd57-
t-chronic
lymphocyticprolymphocytic
re-increase
glycoprotein-iiia
aubmt
arabinosil-cytosine
iododeoxyuridine
below-median
vla-5
vla-6
extensive-type
related-mortality
methotrexatecyclosporin
graft-vs-tumor
myleran-based
prograf
leukemiaacute
anemiarefractory
th2tc2
tcells
matched-related
non-mr
lymphopenic
stemlines
triploid
nonradiation-based
79xa0second
competing-risk
nxa0xa01463
sfpr
busulfan-containing
pd-1ctla-4tim-3lag-b4klrg1gitr
early-differentiated
bm-t
pd-1eomest-bet-
bm-tscm
abo-incompatibility
flt-
eag-related
herg1b
flt-1herg1beta1
pro-migratory
herg1-positive
flt-1-dependent
ia-like
leu-1
lestaurtinib-treated
giemsa-stained
alveoli
one-antigen
atgcy
taicy
retransplantations
mitobronitolara-ccy
methotheraxe
mitobronitol
dbmara-ccy
leukaemia-
lymphoma-free
intent-to-transplant
pre-il-2
n-formyl-methionyl-leucyl-phenylalanine
fmlp
reaction-variable
killer-
leeuwen
haematol
dielectrophoretic
chip-based
same-single-cell
sasca-a
anthracyline
fold-increase
mdr-ve
debuted
ril2
roussel-uclaf
romainville
stimu-lation
cytoreduced
hyperfractionation
herpes-simplex
ig-
clearcut
diva
bdca4
bamhi
tki-associated
lgf
gethgitmo
lifrα
yxxq
lifrα-ct3
amlapl
mdr1beta
cell-cycle-dependent
tlserg-fus
antitelomerase
lc30
450mul
s-all
tai
6-d
bcrabl-
treatment-resistance
nonconventional
nn-bis2-chloroethyl-n-nitrosourea
bavcs
6-thioguanine--dat
hhvs
hhv-6a
hhv
leuakemia
evaded
maligancies
adult-focused
prioritisation
29th
counterflow
all-cr1
plasmacytoses
nmosd
dural-based
promyelocytic-retinoic
cd20cd34
agcd19
fluorine
tomographycomputed
antibody-chemotherapeutic
photosensitizing
piperazinedione
hematopoietics
oligoastrocytoma
statbeta
thr-315
tyr-253
p112l
tyr-393
induced-fit
mdr-modifier
ozogamicin-based
32xa0vsxa015
lymphoid-cell-specific
bmag
cr-2
triplication
variabilis
posthematopoietic
md2
tlr4md2
related-
alkrt-related
tentative
transplantationabmt
michelia
killer-based
non-hla-identical
methylationgene
lupane-type
birch
ba-dependent
switchover
melphalantbi
apprehension
re-enter
unsure
ebv-smt
transnasal
pearls
pre-empt
alpha-nbe
umbrella
gst-pi
dmnc
pdcd2
drosophlia
zfrp8
pdcd2s
eab
arabinosidecyclophosphamide
cd38-expressing
nonplasma
daratumumabs
cd38-positive
cd38-negative
daratumumab-treated
cd8treg
rs4
telaml
rh-cr
ew-le
g74
g77
homooligomerization
lipoprotein-mimicking
lung-resistance
nhml
echography
orchectomy
iiid
leukeran
formallin
nk1
leukemization
pernicious
ancs
perineal
two-arm
moodie
estimator
aad
color-flourescence
dc-fish
sbh
wide-ranging
meticulously
non-muscle-invasive
instillations
ilc2
cell-to-mdsc
ilc2il-13
cytotoxicity-linked
ric-hsct
procedures7
intradermally
hsct2
hsct1
l-929-conditioned
l-929-cm
wehi-cm
leukemia-enriched
gene-containing
helper-free
lnl6
dusp1
growth-factor-induced
clob2a2
bi-phenotypic
leukemiabi-phenotypic
nct00863148
blastcrisis
m1m
jh
clinicalcytological
dna-rearranged
ph-re
narcotics
mafr
mafnr
ncr3lg1
aminotransferasealanine
in-breast
doxorubicincyclophosphamide
1-antigen
drb3
drb5
dqb1
tq22q34
cumulatively
bm-mnc
precultured
leukemia-reducing
distributing
umbilical-cord
hematological-oncological
antigen-typing
non-medullary
tvtc
transcription-repressing
turbt
im-loaded
gres
pcc
in-
maphosphamide
6l
hyperchemosensitive
141xa0×xal
normochemosensitive
hyperchemosensitivity
9exon
e9e3
e10e3
e11e3
mll-duplication
gp70
baev
non-atg
one-antigen-mismatched
post-mortem
omit
90y-ibritumomab
mcikg
y-ibritumomab
polyradiculopathy
prp
plasma-derived
gvle
uhsct
uhscts
melphalan-tbi
clofarabine-cytarabine
nonrecurrence
bus-resistance
curbus
cur-
curbus-treated
leukaemia-initiating-cell
extensive-stage
cd95-
bcnu-induced
interactome-based
hsctu2009mo
5u2009mo
double-ucb
double-ucbt
pu202fu202f025
cht-l
thirty-seventh
thirty-ninth
glycerin
fifty-third
ninetieth
ikirls
ikirl
test-retest
omdq
etretinate
yr-old
fnac
one-antigen-missmatched
vp--70
bmt-related
antileucemic
raralpha2
ra-responsive
untranslocated
agnors
facstar
agnor
p01
imanitib
mini-transplant
n226
tbi-1200u2009cgy
bucy200
bu-cy200
cifn
non-g-csf
1-choloro--dinitro
self-specific
nkg2acd57-nkg2c-
hidac-
flt3itd-positivenpm1
all-l2
oxygen-dependent
abstention
sorafenib-related
cd8cd107aifn-γ
irf7-il-15
flt3-itd-mutant
pleuropericardial
rcp
pcr-str
cd45cd19
cd45cd14
cd45cd15
b10d2
99mtc-mdp
scintyscan
myelo-suppressive
parameningeal
gymin
discontinuationinterruption
versus-disease
unrecorded
p34p
rna-pk
categories--acute
leukaemia--for
hla-related
no-allo
photochemotherapy
cd3cd56-
perforin-dependant
anti-serum
non-tnon-b
hla-locus
tq12q13
8tq12q13
idarubican
47xy8
tq22q21tq12q13der22tp22q13
pt-al
chemotactically
dtcs
cancer-educated
1400w
haplo-pbsc
remission-autograft
del9p
ato-associated
counter-suppressive
anticipatory
alpha-d-galactosyl
pseudo-gaucher
iron-laden
lectin-histochemical
bsa-i
carbohydrate-binding
determinable
post-pbpc
two-antigen
patiens
sbds
eortc-giemema
goelam
mk-1775-
mini-pool
rhu-g-csf
gkgd
oncogen
hastens
rdd
braf-v600e
pi3kcd
busulfan-melphalan-fludarabine
bu-mel-flu
×10
ducbt
dfsos
shortlong-term
allo-scts
pro-tumoural
vlb100
chemotherapy385
allograft391
chemotherapy174
alone140
care43
intraaxial
extraaxial
dosevolume
cribriform
haplo-cord
ptcy-haplo
transplantation-age
aplasia-related
mylotargr
patientx92s
contaminate
c-abl-specific
isotope-assisted
hai
15range
febris
septemia
glutamic-pyruvic
dnrara-c
11qq22
3q21q
tp11p
tp23q
tp13q13
tp36q
tq13q
pediatric-associated
tachyarrhythmia
flt3itditd
fl--
nup98-hox13
cd10tdt
markertdt
dose-attenuated
cag-go
ration
haematoma
near-normalization
asynchrony
helsinki
irradiation-containing
intraretinal
cotton-wool
detachments
bmt-tm
microthrombosis
p22p24
ii-iiib
ctcb
estrogenprogesterone
erpr
erpr-negative
macrogranular
cd2cd34
m2d
one-tailed
irridiation
hradj
risk-standardized
quality-of-care
microgkgd
hda
hda4
hda6
hdal-asp
oma-aml-1
progentitor
cheng
t-allbcr
rbtn-2
intra-vesical
xa0g
cystoscopy
nct01118351
whole-chromosome
trisomic
amltmds
amlnon-tmds
homeorr
rad51py315
migrates
phosphorylation-less
second-primary
4e3
non-p-gp
anti-cd95-induced
cd95-sensitivity
rhodamine123
leukemic-cell
family-related
phmpal
subphrenic
endoscopically
nct00476541
p75
essen
gnotobiotic
jak-mediated
limitedly
trem-like
rivaled
l-ics
l-ic
all-sct-bfm-2003
centromerictelomeric
ct-kir
two-to-one
rothmund-thomson
poikilodermal
recql4
subepithelial
re-infusion
non-t-lymphocyte-depleted
lumps
cancer-care
fludarabine-treosulfan
fludarabine-bu
early-intermediate-stage
nongrafted
sl-selectin
isolex
300i
clinimacs
tmbl-1
coexpresses
dna-cytometry
nonpegylated
myocet
levamisole
dinitrochlorobenzene
blastogenesis
stie2predicts
transplantationhsct
cytogeneticsmutational
intervalci
multimarker
leukemiacorrelated
intent-to-cure
rockne
remit
proprioceptive
single-exposure
β-emitting
211at
sjlj
211at-anti-murine
30f11
idg
211at-bf11
µci
211at-anti-cd45
otalgia
mastoidectomy
ldarac-atra
unsupported
smdssaml
mbcr
lam2001
igm-associated
practice-altering
cd33cd34-negative
laa-targeted
photofrin
benzoporphyrin
tetram-hydroxyphenylchlorin
foscan
mono-l-aspartylchlorin
texaphyrin
pdt-treated
photofrin-pdt
lrp56
lrp-
moabapaap
neutral-loss
outlier
12mb
27mb
r80c
aml-cl
aml-ps
presecond
obliteration
g3p2
coitus
pouch
vaginoplasty
dilatory
rs4553808
cd34cll-1
cd34cd38-cll-1
cll-1-
antigen-targeting
educ
-84
sheikhha
awan
tobal
liu
meshinchi
arceci
sanders
auclair
yatsula
pickett
sflc
n-acetyl-l
-cysteine
rtmac
tbiflucy
amplification-hybridization
tma-hpa
1m
full-time
auto-grafting
22a
sonograms
non-colonized
hsct-comorbidity
msq
first-time
tcrvbeta
clcs
affinity-selected
pre-processing
obviating
mcp-1ccl2
proof-in-principle
elegantly
sibling-matched
prednisone-containing
dcbased
nearing
deacelylation
pre-pre
cellsmicroliter
checkup
cell-wall
n-cws
apl-specific
trialsacute
cytosine-arabinosidedaunorubicin
promethazine
phenothiazine
allogeneic-stem
d7at
civi
male55
puva
shd
idarubicin-cytarabine-etoposide
cell-supported
nct00495287
non-renal
vosaroxin-induced
r-chemotherapy
technic
isel
4iwcl
6iwcl
less-complicated
cd44-deficient
balm-
balm
balm-26
diagnosisand
b-iv
pthrp
reactivities
ha-1-
ha-2-specific
unprimed
ha-2-negative
vivo-generated
neurcognitive
ino
my10
bgli
vitro-selected
oxidation-regulating
progressionrelapse
cml-dc
teamed
teemed
cyto-differentiating
bp1-expressing
42-fold
regrow
transporter-associated
beta-2-microglobulin
preremission
taa-dopachrome
addct
paratesticular
allogeneic-hsct
cmv-reactivated
gcv-treated
cmv-undetected
tad9
chemotherapy-mobilized
busulphancyclophosphamide
tcrd
vdelta2-ddelta3
tcrg
self-renewal-associated
arabino-side
re-affirms
microaneurysms
choroid
ich-1
sucbt
ntd-haplo
rrdlbcl
referential
aminotransferaseaspartate
nonquantitative
post-sorted
dresden
dnr30
ida8
rugosa
pancreatico-duodenectomy
peri-ampullary
pdacxa0xa011
ampullary
aaxa0xa015
ccxa0xa06
ipmnxa0xa07
pancreatitisxa0xa02
facs-isolated
48hr
xa0hrcell
cd105xa0xa0cd14xa0xa0myeloid
spheroid-like
cc-derived
cenocepacia
cardiothoracic
gr-positive
myeloablative-unrelated
alleleantigen
nonpermissive
complex-unrestricted
il-2lak
amlmrm
intra-lineage
inter-lineage
stereotypic
quinidine-induced
mrd-hsct
advantagous
mud-pbsc
full-intensity
ikirl-mismatch
gravft-versus-host
57148b
scd8
-tetra-decanoyl-phorbol-13-acetate
non-accelerated
t-cll
pre-t-all
dli-reinduction
tetraethylenepentamine
tepa
2nd-5th
re-admitted
6th-9th
moderate-dose
amsacrine-containing
-associated
crush
sectioning
mixed-lymphocyte-culture-identical
plateau-effect
p21q23
target-independent
irak
flt3-irak
polypharmacologic
early-b
tacrolimusmini-methroxate
mini-mtx
tacrolimussirolimus
efflux-blocking
psc7
mk-7
fcip
fcdna
fish-based
gene-marking
lp-cy
cdr3-specific
co-ordinated
all-cr
al-cr
prit
ab-streptavidin
dota-biotin
α-emitting
213bi-dota-biotin
α-imaging
ab-sa
213bi-
90y-dota-biotin
12xa0gy
standard-fractionation
one-daily
sarasin
centigray
millicurie
131i-antibody
inroads
post-allo-hct
hd-dnr
ld-dnr
oshr
relref
flt3i-containing
nxa0xa075
growth-inhibited
ht-plus-quercetin
heat-induced
protein-70
hsp-70
thermosensitivity
vadx
two-cycle
inductioncontinuation
bcr-positive
myeloidb-lymphoid
bcrigh
bcrigh-
tp32q22
compressive
ptosis
mydriasis
sopor
hastened
chemoreduction
6-hour
gait
high-signal
monophasic
allo-pbt
neurosurgical
peri-arteriolar
theoretic
anti-glioblastoma
histo-pathological
translocation-specific
light-cycler
late-chronic
early-chronic
subscalpal
bcrpatp-binding
weightheight
attests
undesirability
cross-tabulation
cvc-associated
upper-extremity
vtes
calmette-guerin
thioguanine-cytosine
scandinavian
100microl
defervescence-time
antimicrobic
antedated
previously-reported
n941
n3158
epiphora
g1n
phosphotransferase
bact
msd-pbsct
①after
χ620
χ681
χ337
χ042
moxe
kopn-8
less-mature
alemtuzumab-containing
pdlis
mrdurd
aml-relapse
faring
multi-inhibitor-resistant
315ti
2-macroglobulin
pols
translesion
templating
error-proneness
arac-damaged
polη
polι
polν
ref-al
postmyelodysplastic
pmd-al
s-al
mit-idac
ctlps
tcr-vbeta
gene-panel
customized-ngs-rna
atra-chemotherapy
atraato
ngs-analysis
leukemiathe
dxrx
phosphoprotein-1
ifn-on
ifn-off
ccr7-cd45ra-
ccr7cd45ra-
i5p10
idic5q11
q22q21
cells-enriching
apoptosiscell
complicons
der21t
eto-aml1
dbm
arabinosidecyclosphosphamide
disadvantageous
ru2009u2009-u
-xa0mlmin
nonstimulated
mitogen--neupogen
mu4
convulsion
paretic
tendon
reflexes
shocking
c1-bearing
allotypes
c1x
c2c2
left-truncated
m4-eo
lfsos
formingreplating
drug-sensitizing
5u2009u20093
mll-af9-leukemic
tp36p21
turbidimetric
heat-aggregated
heteromorphisms
ida-dcter
blastosis
presaged
premaintenance
cd7gp40
tbucy
butbi
tertium
first-relapse
antibiotherapy
t-mpd
leukemia-propagating
tumorlike
188-re
familiy
46xxph1
surgeries
re-installed
methclone
epiallelic
cell-reconstituted
rag2
rag2il-4
cd1-restricted
mlminutem2
alphoid
phosphatase-antialkaline
pan-myeloid
my7
my9
my4
gpiiia
corticoid
aeromonas
hydrophila
mosquito
bout
non--t-cell
arid1b
ph-positivity
t-depleted
anti-ccr2
xpo1-mediated
relapse-driving
bcl-2-xl-w
erk-mediated
egfrerk
idrcytarabine
pame
idrara-c
ara-cmitoxantrone
vindesineprednisone
non-hr-all
hd-mtx
ara-chd-ara-c
aall0031
rearrangments
jaksequence
leukostatic
kmt3a
setd2-dependent
setd2⁻h3k36me3
constitutionally
paracentric
nu2009u200989
u20096
bleomycinetoposidedoxorubicincyclophosphamidevincristineprocarbazineprednisone
doxorubicinbleomycinvinblastinedacarbazine
nu2009u2009148
nu202fu202f232
nu202fu202f102
europeere
surv
non-t-cell
preventiontreatment
ctla4-cd28
ctc28
ctc28-transduced
primary-response
protein-88
clm002
myd88-independent
3m002
cd83-targeted
allo-activated
tconvs
muta-
plati-
num-sensitive
brca-positive
che-
motherapy
advan-
tage
longed
inher-
ently
p-glycopro-
tein
sat-
isfactory
treat-
harm-benefit
bal-
ance
ben-
efit
mutationscase
falx
spices
activitiesfunctions
mapk10
9a
atg9a
pre-blastic
ev-rna-based
ev-rna
antecedant
p-glycoprotein-induced
thexa0fba
thexa0bucy2
thexa0fbaxa0group
groupxa0pu2009u
rer
lackunavailability
pair-mates
anti-t
atlg
nu202fu202f80
d98or
kr12
x-irradiated
sulfamethoxazole-trimethoprim
2-chloro-deoxyadenosine
methyl-prednisolone
analog-containing
clínica
puerta
hierro
post-ch
melphalan-total-body
cyclophosphamide-tbi
cyclosporine-methotrexate
il-2-treated
persistentrefractory
uhkt-911
1x
46xxdel1p32px
46xx16p
47xxmar
46xxdel5q22q33
aml-bfm-98
-2004
stem-cell-transplantation
study-98
study-2004
olds
nonaml-like
clinicaltherapeutic
repeat-vntr
relapse-with
hla-flow
4-times-daily
asecond
mcgml
cns-prophylaxis
rho-
leukmia
milliliter
normocalcemic
freeze-thawing
normocalcemia
lange
cdls
post-autografting
buttock
mrdt
mudt
hidt
post-hidt
cellsinitiating
csccic
perish
propitious
absct
ki-67-positive
haplo-chimerism
gvl-effects
iph2101
anti-killer
anti-kir
beas2o3
pml-nbs
idic20q-
irradi
ation
relapsedisease
projecte
-468
t-phenotype
metastasis-initiating
zeb1-positive
e-cadherin-positive
41-kda
alpha1-antitrypsin
alpha1-at41
excreting
ef-hands
non-well
s100a9-mediated
density-cut
ldf-cfc
ida-
vp16-intensified
amsacrineetoposidecytarabine
patientsthere
testicles
relapsers
tau
multiple-criteria
hailed
safest
retrace
rapamycin-sensitive
ar-
contributive
munster
cit
neuraminidase-treated
intradural
l-2
beta-thalassaemia
aktnf-κb
sele--
gmi-1271uproleselan
niche-mediated
qsc
cdlo⁻
sldl
non-drug
drug-loading
inductionmaintenance
incracranial
54-yr
right-side
ring-enhanced
gliosis
caseous
tuberculous-polymerase
perilesional
severest
nct01435343
csa-based
⩽120u2009ngml
120u2009ngml
hue
geno-
embmt
embmt16
ebmt11
embmt13
ebmt19
socioeconomics
significanse
coverted
non-remitted
nu2009u2009157
cif
-alpha
gst-alpha
nhl-
iodinated
prfs
g----a
growth-factor-independent
contigs
interphase-fish
rhil-2
icasp9rimiducid
stromal-leukemia
mdscml
busulfan-fludarabine
climacteric
luteinizing
follicle-stimulating
-dqb10
non-inherited
dkms
nima-matched
acgvhd
nu2009u2009445
nima-mismatched
7p15
tqq32
qter
dixon
-t
regenerate
unchanging
midplane
-gm2
raebit
tpa-treated
haemoptysis
dnaemia
pu20099l
hla-a-b
hla-
f--m
donorpatient
igfbp-5
intralineage
bronchopneumonia
aldolase
donryu
dbla-6
nbu
fdpf1p
zymogram
ald-a
1-methylinosine
n2n2-dimethylguanosine
bclbax
mcl-1bax
and02
receptor-fas
fasr-fasl
co-cultivated
pho
f-ara-atp
graft-vs-leukemic
nk-lymphocytes
post-intensive
plateaus
nonmarrow
p93
p29
p58
t-anll
t-mdst-anll
cytarabinedoxorubicin
good-performance
moppabv
extended-field
apcp1
vudsibling
allele-genomatched
hla-c-matched
hla-c-mismatched
hla-c2-positive
non-amplified
u95a
aml-sp1
exophthalmos
mlc-identical
revaluation
busulfan-treated
peca
pj34
fc-r
c3d
c3b
ccdecreasing
mcincreasing
protocol-indicated
deathlast
non-engrafted
azd9291
3x
non-alternative
biopsyresection
emts
marrow-only
dcbt
pendulum
alkylating-agent
nmaric
lymphomaleukemia-2
unloaded
dc-vaccinated
abl-tkis
abl-tki-resistant
dual-resistant
gdc-0941
pictilisib
hla-haplotype-matched
remissionabstract
cyclophilin
cypd
bcl-xl-mediated
-microl
leukemia-68
leukemia-blastic
syndrome-blastic
mdsmpd-bt-and
organomegalylymphadenopathy
cd56cd8alphacd3-
fa-aml1
8415gt
k2729nand
8732ca
s2835stop
fancd1brca2
howlett
8731tg
2835e
caretaker
rrts
small-to
medium-size
antineutrophil
acrolein
iliac
nonhomogeneous
large-volume
leukaphereses
tad-vp-scheme
prel-hsc
mrt92
apoptosisautophagy
epo-epo-r
ucb-transplanted
hbo-treated
8xa0h
relapsemortality
hla-a-specific
cd-73
aiisgdspv
cd33-ctls
peptide-
cell-specificity
peptide-tetramercd8
affinitystability
yiisgdspv
kir-ligand-compatible
-incompatible
n197
hla-a3-a11
hla-c-b
kir-ligand-
hla-a-a3-a11
kir-ligand-incompatible
3hara-c
single-fraction
③all
-78
④bone
⑤the
-deoxy-2-methylene-beta-d-erythro-pentofuranosylcytidine
alpha-2a-interferon
um2d
aml-1eto
bms-936558
isc
5-di-methyl-thiazol--diphenyl
mvplrp
lin-sca-1ckit
bacteriaemia
25-dihydroxyvitamin
incite
haplo-bmt
cervicothoracic
mvc
previously-treated
syk-zap
ionomicin
adult-type
fbm
bcl-
class-iidim
class-bright
leu-m1
alpha-1-antichymotrypsin
unavailability
ewog-mds
ebmt-pediatric
pro-bnp
nt-pro-bnp
125xa0pgml
relapse-median
217xa0pgml
gp100-specific
amlin
mapkinase
rft5-smpt-dga
ebv-b-lymphoblastoid
ric-urd
lymphoid-depleted
subsamples
alcs
d29
marrowxa0recovery
vldl
mhc-compatible
mhc-incompatible
b10
anll-85
anll-88
kyushu-yamaguchi
0y4m-16ylm
0y3m-17ylm
periodontist
busulfanantithymocyte
bu-atg-based
to83
bu-atg
sucb
am-80
saiseikai
maebashi
hla-specific
non-isotopic
mrnapg
hierarchic
cd138-enriched
c-maf-
mafb-
ccnd1-
ccnd3-
ric-allo-sct
e6-associated
e6ap
stic
mdm2x
vss
intersubject
k051
k052
g--c
mdr1-mrna
mdr1-protein
verapamile
cyftbi
moab-purged
readiness
paperclip
m3-variant
p-logrank
hemangiopericytoma
anti-cd8
metaphase-fish
aats
tme-directed
amll
one-tenth
llc-ln7
granulocytemacrophage-colony-stimulating
suppressor-inducing
paediatricians
mcd7ccd3
b-precursors
mcd19ccd22
mcd33ccd13
mcd13
mcd33ccd11
cd4cd34
apl93
allogeneic-hsct-related
beta-galactoside
lgals9
gnai1
epato-splenomegaly
cholangiopancreatographyercp
antitryptase
vincents
mismatchedhaploidentical
mdc1
mdcpdc
hexamethylmelamine
ds-rna
propidium-iodide
estimators
2-phenylalaminopyrimidine
or60-yr
or10
mhc-identical
chimerism-based
fabratg
ric-haplo-pbsct
glucagon-producing
trousseaus
complex-mhc
re-tested
20p
nu202fu202f650
nu202fu202f222
vla-4-positive
pi-3kaktbcl-2
vla-4-specific
vla-4-negative
egfr1
post-cart
hct-eligible
3-antibody
-antibody
cgy3fr3d
vascular-targeted
shutdown
verteporfin-pdt
doses--called
mc--has
allo-pbtcd34
vsci
hla-compatibility
ned
late-relapse
pombace
conserving
balances
alpha-satellite
cbmr
cemr
melflu
roferon
non-modifiable
troubled
survivorhood
affective-like
cancercancer
sch900776
chk1-mediated
nae1
neddylation-dependent
cml-bearing
csi
splenectomised
gustave
roussy
aml8
lal16
mo1
disease-stage-
toxicity-reduced
x150
add-backs
p145
p145-positive
presumptions
mononeuritis
δlngfr
ii-specific
otologic
aural
replicationrepair
mtormek
diseasegvhd
benefical
great-ulcerated
analysespatient
stabilised
statusabstract
m1-related
daratumumab-mediated
nephritic
digital-pcr
isav
not-relapsed
dpcr-
busulphan-treated
l6
tbi-treated
5-fu-mediated
msc-2
dha-enriched
dha-mediated
β-arrestin-2-dependent
β-arrestin-2-mediated
v5-tagged
5-fu-based
vδ2negγδ
dna-synthesizing
myleran
uncharacteristic
dna-histograms
s-phase-index
550-cgy
refractoryuntreated
cebpawt
25-probe
allo-ct
tcd-bmt
ic4
nipcs
phl
kilodalton
marrow-grafted
unphysiological
bcr-abl-derived
dth
cd4cd45ro
retro-orbital
bea
backtracked
reoccurred
litershm2
litershkg
120-h
pro-proliferation
metalloproteinases-2
labialis
cerebellopontine
tisagenlecleucel
cd22-negative
q11p11
cyclosporinshort
occurredabstract
ros-removing
redox-regulation
sternum
flag-go
nonsurgical
gsis
anti-cd34-
anti-cd133-coated
reconditioningstem
allnon-hodgkin
allnhl
getmon
anc⩾
tt-containing
bu-flu-tt-atg-conditioned
bu-flu-tt-atg-conditioning
50u2009gigal
loci-mismatched
-dq
-dp
x-vivo
nckg
cd34cellskg
ltc-ickg
700microl
410microl
nodulecavitation
lobectomies
cdk3
chemotherapyatra
anthracyclineatra
cihr
higher-grade
geriatricians
iaca
anicteric
fab-m4eo
factor-dependence
blood-type
ric-ahsct
aplasic
cd11c-cd123-
dric
localnodal
singlecenter
adriablastin
intraspinal
purinetol
boths
inter-observer
sub-categorization
remissionthe
cml-kls
nove
chemopurged
4hc-treated
full-course
abmt-related
pediatric-inspired
graall-
⩾18
recipient-origin
pronucleotides
apototic
b-pll
bl22
radio-isotopes
antigen-pulsed
cycd3
ss-bm
bmperipheral
q23p15
q32q21
ba-2
1g10
cumulating
endeavored
post-first
rhgm-csf-treated
rt-hct
ma-hct
anti-malignancy
ghag-csfhomoharringtonincytarabine
regimensghaaghta
co-stimuolating
crds
irds
foxo3a--
atra-related
aml-bfm-1998
aml-bfm-2004
excellently
ct-scan
pleuracarcinosis
neoplasmas
t-helpers
tdli
nxa0xa099
nxa0xa014
nxa0xa062
nxa0xa051
salvages
atg-fresenius
⁶kg
atg-mediated
matched-donor
prophylaxes
mtxmycophenolate
mtx-containing
advanced-risk
anti-mrp
qcrl-1
qcrl-3
qcrl-1qcrl-3
ig-positive
lymphocyte-like
eshap
solumedrol
non-anthracycline-based
juxta-membrane
mutant-wild
ccg-2941
-2961
itd-ars
flt3itd-ar
meningosis
leukaemica
allaul
allopecia
ceratitis
erythrodermia
fluid-acute
csf-acute
nup98-kdm5a-driven
nup98-kdm5a-transformed
selp
mpig6b
neo1
high-fatality
mepron
nonhyperdiploid
diaminobenzidine-reactive
anti-transferrin
51xy
tp31q
prussian
alltrans
amplifiability
negativelow-level
and0014
and0038
dpp-4
stbartholomews
low-2
non-life-threatening
cclow-level
mctransient
doxorubicin-based
58-yr-old
analoga
cgyminute
pml-regulated
plzfrar-alpha
fgt
focally
tki-cessation
n-region
n-pcr
abmtrr
emrwe
bmrthe
pu200au200a02
pu200au200a009
pu200au200a014emr
nonmyelogenous
non-serious
kostmanns
zidovudine-induced
sct3
nxa0xa01
g-csfriv
g-csfriv-overexpressing
stat5mir-155
stat5-associated
vdelta1
hoxd13
tbicyca
tbicytt
myelotarg
cr-transplant
-cll1
resuming
--epicatechin-3-gallate
egcg-
egc-and
ecg-treated
invoked
enzyme-dependent
hematopoeitic
sips
sirtinol
cbx8
cbx
pre-megakaryocyteerythrocyte
pre-mege
dual-fluorescence
pre-meges
fate-determining
zfpm1
stress-resistant
mege
scleroderma-like
xa0are
endangers
labyrinth
idh3
ailt
peptidescpg-odnanti-bb
zogamicin
hvod
survivorsabstract
perarubicin
fractioned
idd
human-leukocyte
inconplete
undetective
resudial
relapsecir
χ274
mortalitynrm
χ913
survivallfs
χ256
χ140
crpcri
③compared
non-icr
χ687
χ234
χ253
χ002
④mulitvariate
wer
chemoinduced
atg-based
mxr
abcp
allelesantigen-mismatched
non-tcd
2-loci-mismatched
anesthetic
basic-leucine
overexpressionactivation
p-src
integrinβ3
adhesionmigration
cd200hi
cd56dimcd16
cd200lo
cd200-
cellkg
platinum-dna
hla-mud
all10
iii-vi
pcr-mediated
mrd-pcr
patternsabstract
rhigfbp7
graft-nucleated
graft-infused
cd34hladrcd38
isrctn24251487
noncyclosporine-based
sdac-mrd-
hdac-mrd-
sdac-mrd
hdac-mrd
ung2
ugi
ouabain-resistant
mds-raebraebt
t10b9
normaldecreased
probability-of-treatment
iptw
n7765
within-cohort
tad9high-dose
hamham
aml-cooperative
tad9ham
subpopulation-acute
secolignan-
peperomin
pepe
6-methyl
hydroxyethyl
amino--dihydropeperomin
dmape
apcs-like
reductase-derived
sectrap
anti-apcs
dmape-induced
dmape-related
apheretic
unrecognised
stem-cell-like
lymphoid-cell-directed
intra-retinal
white-centred
aml-pt
amsan
legionnaires
non-cardiogenic
delirious
leukemids
prurigo-like
mucinosis
-gy
overshoot
fac
very-poor-risk
jmdp
uterial
mds-saml-specific
simple-to-use
indispensably
transplantation-related-mortality
niche-imposed
ss-like
fish-detectable
ppear
nct00466895
adhesion-induced
co-transfusion
uc-mscs
testify
minimal-intensity
diseasegraft-versus-leukemia
clubbing
anll-m7
black-b
14q11
der7tp14q22
nasba
550-fold
stray
interlineage
vumon
lqb-
lqb-118-induced
survivin-small
survivin-sirna
ahtcg
calicheamicin-g1
dinndorf
larson
guglielmi
balduzzi
cotter
zwaan
cuf-l
pi3k-ras
in-mc
clobu4
mcabs
progenitor-associated
4n
hypotetraploid
bm-auto-sct
pb-auto-sct
olaparib-treated
factor-guided
mll11q23
mll-nonrearranged
grm2
cr-5
crp-4
mnckg
-180
pronormoblast
myeloblastnec
nec-cr
esss
ud-sct
serotherapy
100-d
nonblinded
28-gene
different-from-normal
t-lineage--associated
hand-mirror
intermediate-grade
pcr-
pcr-negativity
all-l1
x-raralpha
raralpha-fusion
leukaemiamyelodysplasia
french-british-american
unitxa0xxa
shrna-based
mapk14
th01
may-grünwald-giemsa-stained
del11
-diaminobenzidine
3-amino
3ac
fixatives
em-po
phakomatosis
bournevilles
implantations
collagenase-based
30u2009gm2
u2009gm2
treo-based
aging-acquired
kanto
ksgct
-1677
onxa0data
brevity
entailed
palatal
recipient-cell
e571k
y641n
il-9
tet-dec
tet-contained
plasma-augmented
vcz
cen
subcategoriesabstract
evaluat
csamethotrexate
leukapheresed
post-pbsct
leukemia-generating
clfs
polymorphonuclear-neutrophils
γδ-t
hypercholesterolemiahigh
topically
tacrolimusmethotrexate
nct01323920
12q13
hoxc13
signals-survivin
aven-in
mxc
multi-separated
degranulated
hyposegmented
dyserythropoietic
dysmegakaryocytic
hypogsegmented
metaphase-fluorescence
hoxb4-expressing
ms-5hoxb4
malignanciesxa0however
scfv-based
dermoid
infratentorial
diencephalon
hitchhiking
ukall-viii
ukall-xi
hkccsg
long-rank
pre-eminent
jeffreys
dna-fingerprints
dna-fingerprinting
paravertebral
primary-active
hepato-
tad-tad
de-intensification
requestioned
cpg-methylation
m6b
experimentalclinical
pre-alip
no-relapse
itgamf
csf1csf1r
hd-mel
human-leucocyte-antigens-compatible
recoveryrelapse
mtc-refractory
allograft-related
reduced-intensity-conditioning-allo-sct
ceacm6
polynuclear
villous
（aml）
（ucbt）
apl0406
atra-ato
atra-cht
ato-atra
pg-dli
dimethylarginine
histonenon-histone
y969
methylation-deficient
phosphorylation-deficient
flt3-transduced
ms023
-182
p007
lpa2005
sacrificing
nct00408278
orbito-ocular
geno-identical
hla-drb1-identical
nonneutropenic
phm
high-curability
chms
stillbirth
fertility-sparing
unaccountably
myeloreductive
merited
relapse-2
treatment-related-6
mll-af6-positive
cd56cd16cd69cd158b
late-activated
cd3cd69
hla-dependent
kmt2amll-gene-r-associated
kmt2a-aff1mll-af4
kmt2a-mllt1mll-enl
non-bu
csa-1
cihdac
ad-oap
amsa-oap
fcr5
ad-oapamsa-oap
ara-ctpss
cihdac-treated
high-blast
ahf
hisopathologically
acidmethanol
ie35
3q-
dbmp-85
lvp
12p-
vesical
leukaemoid
et-ln
chiapas
dieter
hoelzer
pseudotumors
leukocytoclastic
clflcv
faciale
elevatum
diutinum
fungating
flexor
eosinophilic-rich
small-vessel
storiform
gf-like
intralymphatic
c4d
bouts
gf-eosinophilic
clflcv-the
vocs
finger-prints
wt1expression
jalsg-aml92
idr-containing
bmpbpc
hyperploidy
paradoxes
polarizes
cytofluorogram
cytofluorograms
suc
hla-dr53
dr53
staminalization
wt1-ctl
allotcd-hsct
relapsein
invested
pmls
bcr-abl-kinase
cmb-401
ca125
calicheamicin-linked
cmb-
treatment--as
monopolistic
manner--is
rhgh
ncgs
ighd
domain-1
hd93
nct00146120
nct00151242
b-cell-associated
t-cell-associated
polymerase-chain
reanalyzed
xa4xa0
xa6xa0
comforting
-nmp
myeloidosteoclast
mocp
high-plasma
recurrencesignificance
gll
hla-mismatchedhaploidentical
unshared
11q9
outcomes-leukemia-free
no-transplant
dillerentiating
aml-hpg-90
aml-hpg-95
non-trisomic
retinioc
unit-granulocyte
post-tki
rejects
c-gvhd
lfis
lfi
histologically-confirmed
chemotherapyatra-resistant
relapsedresistant
mrd-like
mtxcya
transluminal
stents
circumflex
prothrombotic
seldomly
postponement
myelodisplasia
ovis
neutrophilsl
preenrichment
ph1-cases
allogeneic-related
allogeneic-unrelated
m4e0
bcl-1
emits
electrons
wide-field
hd-etcy
mcl--350
mcl-1wtwt
mcl-1deltanull
cd34cd56
b-non-hodgkins
haemonetics
cytaphereses
all-l3
thiothepa
gvhd-like
germanaustrian
treosulphan
treosulphan-containing
non-compliance
buttocks
ulcerating
eschars
pats
gvh-d
karnovsky
prevaccination
umin000003083
umin000001482
3itds
12ppqqq
i--appearance
ii--trisomy
iii--lose
inseparable
nu2009u2009221
nu2009u2009234
nu2009u2009207
josé
campos
davi
davii
500microliters
hyperdiploidies
snp-positive
snp-negative
reexamined
well-identified
brilliantly
oxygenglucose
3-party
csclsc
metabolically-modulated
bdr
edr
fourty-nine
idamit
arry-520
cd8xa0xa0t
tcrγδ
cells--the
unseparable
3-group
bmpr1b
gi-3
granuloid
usc-hn2
heterotransplantation
sccl-mt1
egfrcd44v6fabp5keratin
f-met-leu-phe
locomotion
tkd816
tt-fluda
xy-fish
p-ctnnb1
interconnectivity
transductants
iha
prednol-l
kerato-hypopyon
clonospecific
pcr-elisa
mtorc1-p70
mtorc1-s6k1
rapalink-1
reinforcements
fluoresceinated
red-blood-cell
incidenceseverity
one-hundred-and-sixty-eight
tbiabstract
intra-c219
dwdrb1
cd49e
patient-derived-xenografts
pebp2
leiomyomas
obstetrician-gynecologists
ivrs
co-transplantation
prets
self-leukemia-
emr-s
emr-b
presentin
whole-body-targeted
lt12
5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside
x-gal
passaging
p185bcr-abl
hyperkeratosis
host-reactive
th-p
ctl-p
nalm-20
tgkg
cyatarabine
14-base
14-bp
mcd86
microdensitometry
mastocarcinoma
bone-infiltration
cns-involvement
csf-b2m-concentrations
csf-b2m
cns-dissemination
csfserum-ratio
cfu-granulocyte
light-scatter
fscssc
submicrospopic
methodologic
pre-relapsed
alip-like
rfd
pretreatment-ara-c
hyperphagia
b-antigen
gvhd-prophylaxis
foretell
identical-twin
tems
cd14cd16tie2
radio-ablation
pivka-ii
germline-associated
o-ay-29
unlinked
hla-typing
fb-ric
ctcd34
signle
rate5
paquin
tto
gamble
normal-range
l-selectin-dependent
tnf-alpha-activated
tat-cc
competively
co-located
neh
coils
facsfishbudr
cm3
anll-m4
y-spot
hts-based
cbfa2
etocdrmtg8
8q-
plucked
hm-fish
ip-fish
facs-sorted
anatomopathologic
mac-387
nxa0xa021
ɑβ
leukemo-genesis
hd-rit
131i-anti-cd20
c-hdt
gbq
be076
and086
nk-lineage
neat
ecmf
sib-hsct
buflutbi
sonographically
micro-organisms
alerting
r10
smoothed
martingale
fipc
ara-c-free
abstinence
self-efficacy
clinical-haematological
ck-
non-germline
ahl
12-binding
ubbc
relapsedabstract
ilr
pcxcr4
idarubicine-cytarabine
amsacrine-cytarabine
wild-typeflt3
hovon-102
ntr2187
self-degradative
leukemia-eleven
atg7-deficient
procured
d1d2
allo-pbsc
c34
grade-2
grade-4
malignization
lted
lted-selected
lysis-positive
lysis-negative
whole-lung
translocations--including
t--were
calla-
rds
238-item
neurosensory
neuromotor
iodine-i-rituximab
131i-rituximab
leiomyosarcoma
cxcl12-
ivbu4
ivbu1
arabinocide
breast-conserving
bak-apoptotic
local-regional
bf12
idahd-ara-cvp-16
rlgs-m
rp18
wit-1
fom
double-purging
carboplatin-ara-c
dsms
udc
nalm-30
nalm-31
nalm-32
scfr
cd126
cd119
perforated
acetazolamide
affective
relapsedprogressed
hypoxia-selected
lc1
lc2
progenitor-type
bz-resistant
epicardial
triamcinolone
e-rosetting
karyogram
karyograms
caruncles
still-growing
bcr2
microsome
pseudo-pelger
chop-bleo
disarranged
normal-size
stroma-produced
lestaurtinib-mediated
leukaemia-stroma
ucla
hydroperoxidase
sem-k2
lymphoblastosis
scid-human
scid-hu
chimaera
transcriptional-polymerase
mll-1
ric-ucbt
udbmt
phylogenetic
multi-region
wt1ag
wt1aa
remission-cmr
relapse-hr
aggressivity
nonadvanced
5-group
lowest-
cardioxane
5aml
intercept
hl-60r196rz
vector-transfected
hl-60rneo
nm030917
naming
rhe
rhe-pdgfralpha
thrx-165724
intrabone
e-05
e-02
apl-m3
retroauricular
diagnozed
d7s1517
d4s2366
tho1
se33
dyrk1a
acr-ara-c
nonseminomatous
hexamers
panmyelopathia
matched-unrelated-donor
cy-ftbi
polyrcdg
24-fold
telvysion
flamsa-
transplant-conditioning
-125
cell-contaminated
cytokine-supplemented
kasumi-6-fold
kg-6-fold
prepurging
agallele
clínicas
aryl-hydrocarbon
um729
allo-hscts
pmrdt
n131
nonavailability
cdriii
second-round
veino-occlusive
anti-my9
cd33-purged
cd9cd10-purged
cd6-purged
ts-negative
ts-positive
ctg-csf
16d
allo-transplantable
unimportant
postthymic
dong
quai
¿early
insufficiencies
acceptors
188-labeled
carboxy-fluorescein
undivided
non-caseating
crohns-like
pre-abmt
cd41a-
lymphoid-oriented
myeloid-oriented
135th
superfluous
receptorfas
cytomertic
myelo--than
post-initiation
post-drug
confrontation
3dl
kir2ds
anti-cd3cd19
myleodysplastic
procedure-employing
cell-enrichment
profiling-without
cd123hi
th2-biased
drics
rhg-csf-mobilized
hpbsct
method-based
n168
fbc
fludarabine-busulphan-alemtuzumab-based
cytoreductin
ph-chromosomes
abberations
aviding-biotin-peroxydase
uci2
pgp-rh123
pgprh123-
anthracyclin-ara
123-
fmc
pgprh123
tyrosines
thr315
transrectal
13-
19-
hybridizing
gene-content
cen-bb
cen-aa
ph-all
non-hct
combination-agent
pocal-dna
x-chromosome-linked
preb-all
transplantleukemia
cd44myd88
cox-i
cox-iv
pcr-detectable
intraindividualex
vivoapoptosis-related
secretomes
confocal-microscopy-based
factors-containing
vesicle-mediated
deoxynucleotidyltransferase
u108
cd3and
mv-flt3-itd
hl-60-flt3-wt
flt3-itd-aml
flt3-short
diseaserefractory
resource-constrained
nmvp-16
tnckg
-236
vp-16ml
individual-adjusted
extrahematological
percentiles
hybridzation
biomonitoring
sxrf
micro-xrf
micro-xanes
lymphoglandular
leukemic-dcs
donor-dcs
leukemic-
efficacyt
aelaml-m6
bmt1
beta-thal
bmt2
adamantyl
st1926
allo-mandatory
recurrencexa0stillxa0remains
axa0major
aml-6
vepeside
ice-aml-10
protocoleortc
etopside
ice-i
kolmogorov
smirnov
relapserefractoriness
p-gp-negative
ice-
ice-i-treated
non-pumping
non-p-gp-related
aml-tld
aml-nontld
allo-thsc
auto-thsc
cct
atypically
lasp1
hla-b27
spondyloarthritis
myopathic
anteroseptal
interventricular
ara-u
mecc
ara-cara-u
6-o-methylguanine
between-runs
microabscesses
methotrexate-based
drb01
hla-dr15
unconscious
zeal
child-bearing
neurologically
aps
growth-stimulated
hsa-induced
hsa-perturbed
evince
tad-9
pericardiac
hydroxyurea-interferon
fpv
fpv-bt20
fpv-cef
vsv-bt20
tp1
activationup-regulation
ii-vi
t-antigen
dc-32dp210
rebuilding
provascular
shrinking
tlr4-dependent
extra-cns
cpc
cellscscs
cellslscsare
anisopliae
reinfusing
chemotherapyabstract
antiandrogen
gml200
hypovascular
ring-like
non-fab
type-m3
omental
pd0325901
pd901
kraskras
n676k
ucbts
t-ubmt
nonmanipulated
ubmts
t-ubmts
nonadjusted
acceptably
mononucleate
ldt
mixed-lineage-leukemia
nct00015873
33p
63-yr-old
tq34q11x
idem
positive-acute
p210-type
myeloidt-lymphoid
4y-pos
y-pos
dibromomannitol
dbmcytosine
histocompatibilityantigent-cell
tyrosyl
hypercdt
bradycardia
my31
metamyelocyte
cd56cd34
pilsen
flt3-abnormalities
nu202fu202f34
ctx-refractory
pu202fu202f0346
pu202fu202f073
pu202fu202f0005
pu202fu202f0001
hmasu202fu202fdonor
phlegmon
2-chloro-2-fluoro-deoxy-9-beta-d-arabinofuranosyladenine
erythrodysesthesias
leu-12
cd15-positive
cd15-negative
skin-colored
pbpct
17d
gviid
90d
cotransfection
mlc-negative
azyklovir
acl
pseudohypopyon
settingpazopanib
reinterpretation
rs16754gg
rs16754ga
rs16754aa
rs16754gaaa
diagnosis-before
invader
polymerase-chain-reaction
-dpb1
hlbi
tru-cut
coexpressions
treosulfanetoposide
leu-7
leu-11-
leu-7-
ukg
polymer-stabilized
st1926-np
induced-growth
nanoprecipitation
duodenum
involved-site
h-tert
laa-expressing
laas-expressing
ebv-sensitized
hmy2
peptides-pulsed
tumorhmy2
hdara-c-containing
idarub
n88
time-to-neutrophil
chemotherapy--in
duration--in
age-adapted
abm
peculiarly
cell-motility
re-organized
rock-limk-cofilin
therapy-elicited
resistance-promoting
deprivation-driven
6-diazo-5-oxo-l-norleucine
unclearxa0therefore
survivalacute
transplantationallo-sct
ibn
sina
sex-ratio
lals
cl3
stat3alpha
wt1-infected
wt1-uninfected
stat3beta
etvp13
7q36
t12q31q36p13
t12q25q36p13
prudently
cd33-bearing
e2-conjugating
2-d08
accumulation-mediated
laryngitis
si-
splice-isoform-specific
inxa0splicing
amlxa0models
17s-fd-895
kir-ligands
nsgct
charing
teratomatous
gvh-directed
rhg-csf-responsive
rhg-csf-unresponsive
i-131-tositumomab
rit-containing
mrk16-positive
cording
pancreatosplenectomy
down-staging
post-autobmt
ebmtr
iemr-associated
rituxamab
ve-822
ve-822-induced
hcd45
-tetraazacylodode
cane
tumor-to-blood
anti-hcd45
high-contrast
blood-pool
90y-labeled
muci
anti-murine
mcd45
131i-a20-ab
111in-dota-biotin
projections
interstitially
fried-egg
gli3
oci-aml5
gli3-knockdown
c11
abcc11multidrug
mtxcsp
bucy4
avail
activeadvanced
5q-deletion
le-mon-5
eudract-10
duesseldorf
fish-34
wipe
108kg
u-87
ln-18
enrichment-
cellprogenitor
cd24aldh
cd146cd73
cd73cd90
cell-2
counter-flow
kanti
induction-type
calgb-type
low-dosage
maintenance-related
revisiting
crosstrial
fab-l2
fr3
txa0cell-depleted
relapsed-
refractory-aml
refractory-
relapsed-aml
salvaging
suprapharyngeal
garcins
atoatra
ctxatrau2009u2009ato
ctxatraato
ctxatra
nu2009u2009259
pu200910u2009×u2009109l
ninety-one
flai-go
good-intermediatepoor
intermediate-favourable
i5p
transmural
wtaa
logarithms
wtaawt1
hubmann
burkhardt
rlc
n216
pbsct-hr
nu202fu202f12
cd45ra-depleted
r65
m5p
non-survivors
post-transplants
nu200au200a20
flamsa-reduced-intensity
flamsatreosulfan
flamsa4gy
flamsatbi
treosulfan-
bcl2bcl-xl
aml-bfm-93-ost
aml-bfm-93
cd3cellsinfusion
acna
acnacnloh
proximally
leukocyteblast
kiel
compensators
bmat
heparinized
sgpt
electromyogram
cobe
gfpcd44myd88
mcherrycd44-myd88-
mcherrycd44myd88
well-experienced
tbi-cyclophosphamide
ct-2
t-cell-depletion
cd4cd56cd123lineage-mpo-
cbv
genoidentical
gvh-related
toxicityabstract
pml-raralpha-negative
isodisomy
nullisomy
pbg-s
myelogenic
11q23-translocations
gsq
clomiphene
h-ss
n-ss
125i-iododeoxyuridine
prolifigen
daiichi
bxp-21
g2a
fumitremorgin
non-primed
cona
cesame
5-aminosalicylic
nk30
2dsds1
nkmicrol
ucbtmsd-hsct
①compared
-96
③there
mds-ebaml-mrc
siblingunrelated
2ds3
steap
vegf-co-receptor
npm1-wild-typeflt3-itd-negative
p23q34
purine-analogue-based
radioresistance-associated
beta-d-glucan
thexa0effects
tumorxa0aggressiveness
anthracycline-ara-c
t-tests
pab1620-pab240
1620pab240-
high-dnr-uptake
intronexon
sc-2001
melanoma-initiating-cells
combination-induced
hdara-cdnr
ida-pretreated
neutrophilsmicrol
u-test
25000microl
ida-treated
bhac-me
ccd3tdt
thymic-acute
del9
bfm-protocols
rsso
c1c1
pu202fu202f02
pu202fu202f03
pound60
sctmrd2
sult1c2
sxr
cetlam-99
viper
biomedicine
d-r-
topoisomerase-i
ru-sst
lin-cd34cd38-cd90
cd93-
survival-specific
dade
behring
bericrom
abscopal
topotecancytarabine
1-cm
reddened
faucets
sinks
etv6-abl
drawbacks--the
leukamia
mitochondrial-processing
pmpc
pmpcb
sorafenibxa0
pink1-parkin
sorafenib-treated
or5
hdtasct
kit-
somr
lms
mpnst
pus
msand
somrs
t-iv
α1-acid
agp
msm
farreras
valentí
solid-tumor
time-changing
ffr
out-patient
bucymel
respectable
sct-bfm
myeloid-marker
non-cscs
ocscs
pfkl
pfkp
pgls
6an
plgf
post-h-sct
gmp-compliant
knowledge-based
mutated-npm1
peri-allogeneic
karyotype-based
three-colour
rasrapidly
salirasib
concordia
membrane-binding
non-dose-limiting
consolidationintensification
birthrate
richsct
ab-triple
rod-positive
wr-2721
ethyol
allelic-matched
arlin
dnc
tcr-haplosct
xaxa0×xa0109l
catalytic-site
intensive-
gm-csf-related
treatment-covariate
n102
all2
cns-rt
neutrophil-endothelial
endothelium-substratum
intercurrent
hovon-43
ntr212
isrctn77039377
self-renewable
oncogenic-specific
missing-ligand
matched-siblings
c1c
multivariate-analysis
arabinoside-c
poly-chemotherapy
cytokine-non-responsive
iap-1
intentions
pravd
pomp-pravd
rebiopsy
×105
copiesµgrna
massively-exposed
group-all2008
rs7251
rs2304205
diseasemrd
markersand
genese
leukemiacharacteristic
mass-forming
kostmann
hs-5-derived
sfm-dr
outcome-determining
individuation
m1-aml
t19p22q23q
tq37q11q23q11
cd4dim
raebraeb-t
hccr
hccr1
hccr2
lymphoblastocytosis
q21qter
lsb
non-hcv
reinduction-responders
cckine
cckines
cytognetic
tacc
transmissions
tumourigenecity
salvage-induced
ageor70
12hoxa9
ider17
syntenic
induction-resistant
accelerators
rice-bag
im-tbi
cobalt-60
teletherapy
lung-shielding
co-tbi
nu2009u2009181
nu2009u2009126
ip-related
vac
hcst
mtbi
ritbi
intermediate-does
bmft
late-relapsed
p-gp--overexpressing
protocol-treated
llc-ln7-bearing
lessened
spermatic
remissionrelapse
nct00079482
poppk
0903a-us
myelosclerosis
quadriparesis
t-3
and-concerning
cancer-lbl
dsa
dfsp
fs-dfsp
cd209
therapy-requiring
cgvhd-free
crfs
i-hct
blast-cell
ilcs
ilc1-like
hla-e-positive
cytotoxic-related
transfer-based
ilc
minidose
hrd
gvhd-
usp1
deubiquitination
as3
del15
ube3a
15q22
fourty-six
ddrb1
lansky
nk-killing
do-1
dexverapamil
nordexverapamil
sideeffects
non-engraftments
mki
x103
col4a3
n139
bcr-ablt315i-driven
full-haplotype
cylex
g-csf-treated
nonmobilized
cd25lowfoxp3low
oppression
ptca
high-rates
-dihydroxy-delta
-yne-cholecalciferol
15mer
multi-specific
taamix
hla-type
barabl
chemo-protective
mate1
vegetations
thrombi
autochthonously
differential-diagnostic
nk-cell-based
bendamustine-rituximab
drc
oculomotor
intra-thecal
basiliximab
emp
gvl-gvh
fetal-maternal
ql
qlq-c
nauseaemesis
backgroundaims
probability-in-state
aalen-johansen
cox-type
shiny
three-state
non-epithelial
carbamazepine-induced
h2b-gfp
cycle-restricted
haplodli
iuliter
statisticaly
apoptosis-insensitive
fluda
cd90-
protein-death
allo-ric
cell-membrane
t212r
t212r-induced
radioisotope
pmrd-bmt
edge-to-face
dyrk2
aml1-eto-containing
aetfc
heb
bhlh
diagnostictherapeutic
tq21q21
nucleotide-polymorphism
veto
5-phosphate
tiazofurinallopurinol
transplant-
interfraction
cyclophosphamidetotal
nu2009u20091600
nu2009u20092113
rop
insuring
multi-institution
atac
tsgh
supra-lethal
enzyme-
visualizing
lysozyme-expressing
hemotopoietic
5e6
ly49ci
h2kb
inhibitory-receptor
2-activated
scid-mouse
runx1-runx1t1-
runx1-runx1t1-positive
rank-sum
l-enantiomer
kühnle
cisplatin-refractory
cystadenocarcinoma
cisplatinepirubicin
m5b-subtype
cisplatincytoxan
pre-pre-b-acute
ca-125
cancerabstract
dia
pers
15-positive
sba
colony-cells
antipyrine
mlhkg
-dqa1
precludesxa0conclusions
sdarac
-drbeta1-matched
ssv
rd-114
anti-ssv
slab
idiotypic
bronchogenic
napbsct
p190bcr-abl-specific
leukemic-antigens
t-cell-responses
t-cell-response-patterns
functionalflow-cytometryfluorolysis-assays
donor-t-cells
patients-t-cells
blast-containing-mononuclear-cells
dcleu-containing
t-cell-activity
non-naive
mnc-
dc-stimulation
anti-leukemic-activity
cd45rocd45ra
mlc-stimulating-phase
t-cell-memory
efficacytoxicity
atu
lsa
extracorpuscular
replenished
bu-containing
nxa0xa0495
nxa0xa0331
nxa0xa096
k-nearest
afterxa0treatment
boyd
mrc5
microkg
foregoing
pelger-huet
5q-q
z-statistics
squared
bioconductor
hla-haploidentical-related
ctxatoatra
telo
taggg
mannheim
xhtertpbgd
gscf
rr0
1000microliters
nonstandardized
graft-contaminating
ctc-ncic
ida-ol
b-a
edc1
hnc1beta
head-neck
pathophysiology-targeted
genomic-sequencing
leukemiamarrow
periapical
dentition
pulpal
oesophagitis
pseudomembranes
cr-mda
cell-inhibitory
pcilp
statesabstract
tlr2-myd88-nfκb
6-keto-prostaglandin
2-antiplasmin
trem-
anti-alkaline
acute-non-lymphocytic
abcg2-mediated
aminopyrimidine
iaap
reaction-single-strand
asp419
tcrb
cord-chimerism
ifnl4
ifnλ4
dri-matched
relapsed--103
varied--44
rates--children
iv-bu
oral-bu
pro-gvhdgvl
pro-gvhd
pro-gvl
ivbucy
noneligible
carcinosarcoma
clumped
periradicular
abatement
apd-1
hsc-platelet-apd-1
tu2009cells
combination-mediated
averted
translocationsinversions
cog-aaml03p1
n257
swog-9031
swog-9333
swog-9500
n274
v71i
relapseprogressionloss
endotheliocytes
gr-1-cd11b
intra-tumorally
large-size
onsite
arthroplasty
histiocytomas
periosteal
prosthesis
midterm
high-hyperdiploid
rs-
11q23mll-aberrations
cereblon-modulating
platelet-leukocyte
vitagram
cml-myeloblastic
custom-built
lcgranulocytic
monocenter
prd
ungrafted
stem-cell-associated
rituximab-containing
lenolidomide
non-bsi
bsi-related
tamlmds
morphometrical
morphometrically
ixabstract
self-differentiated
idcs
first-in-man
integrase-defective
de-centralized
atp-site
factor-receptor
bh3-like
bims2a
188re-labeled
allorestricted
hla-a2-
p1218-specific
mrppkc
non-isoform-selective
leukocyte-restricted
p110delta
pi3ks
p110delta-selective
ic87114
aktpkb
unaffectedly
tolerisation
-c-mismatched
raptor-deficient
clofarabine-melphalan-alemtuzumab
progression-free-survival
vitreoretinal
vrl
humor-based
41bb-containing
cd28car
first-course
shen
thall
costimulatoryadhesion
dnam-1-
il-10-secreting
eurocordeuropean
cifs
contrastingly
u202fu202f02
u202fu202f01
profilequant™
ipsogen
nxa0xa017
nxa0xa0207
il-2-mobilized
post-recovery
aii
donor-inhibitory
markerabstract
×107kg
hemato-logical
thrombopoietin-receptor
tpo-ra
celiac
non-itp
spherocytosis
off-protocol
protocol-monitored
insq23p22p23
myelomonocyte-associated
mutatedcytoplasmic
inv12
qt-pcr
eif4e-targeted
prodli
flu-bu-atg
eln-risk
groupu200aconsequently
liposomatic
cd33u200a
antibody-drug-conjugate
allo-bsct
re-appearance
sml
ctla-4-ligand
cd86pdc
ppdc
ifn-antibody
titre
inuml
high-titred
nifn-alpha
dose-equivalent
npm2
slc26a4
ratesxa0and
sek
disappointment
clonotype
hasct
measles-like
tremors
amnesia
wernicke-korsakoff
electroencephalogram
vamp
neuroleukemia
necrotising
sulfonylhdrazine
hdacplacebo
laromustinehdac
dsmb
nct00112554
electively
relatedness
pu202fu202f018
pu202fu202f134
pu202fu202f850
fab-l1
autogeneic
farbercenter
researchdisease
procaspase-2
procaspases-7
cd2-positive
trihydrate
cytological-mathematical
pml-rara-driven
progenitor-cell
avert
toolsapproaches
d5s89
somatic-cell
lymphokine-activated-killer
aml-bm
cytok1
cytok2
cocultivated
less-fit
lymphotoxic
system-active
u2009mlminkg
biotin-labelled
prooncogenic
m7g-capped
importin
lymphocytotoxin
klh-pulsed
forxa0relapse
auc-directed
higherxa0cir
disappointingfor
all-specific
oacgh
collagenosis
sex-dependant
time-trend
gvhdrelapse-free
anti-gvhd
amlacute
bucyvp
tbicyvp
acute-gvhd
cancer-conditioned
β-cells
anti-stroma
cmlmds
hemalog
2-o-ribose
refuge
nsabp
pbscts
mdc1s
mdc2s
neupogen
-35
mismatch-repair
t-mdsal
disease-adapted
btla-hvem
schiffs
cae
c-sis
treosulfanfludarabine
treosulfanflu
mixed-type
n918
haplo360
ucbt558
n528
haplo158
ucbt370
acetyldinaline
jeopardized
inconsiderable
b-d
de-tangle
misrur
rem2
2-tailed
isoflavonesslice
almond
β-glucosidase
bioplex
cd33hladrnegcd14
haplo-
cah
blooms
cd161
n148
mk-8776
thiotepa-based
gradeii
cr6
permeabilised
methylphosphonodiester
sl-o-facilitated
tpor
teniposide-cytarabine
vincristine-cyclophosphamide
inherentacquired
methyl-gag
re-inductions
discrimative
str-gs
tq21p22
papovavirus
jl
radio-iodide
prnp
horners
encasement
stat6-deficient
transcription-6
cd1-deficient
vpcytbi
gowere
sirna-2
u937r
kinase-positive
rgbm
co-option
pan-vegf
glomeruloid
perimeters
cediranib-treated
rgbms
pdgf-c
therapy--characterized
pseudopalisading
morphology--without
-790
samd9samd9-l
disease-freed
transplant-treated
intralesional
fvbn202
neu-specific
macrophagecolony-stimulating
bm-cells
cytokl
d90
papulosquamous
dermatopathologist
succeeding
ci-mtz
ci-cytarabine
pre-resectional
normocytic
normochromic
thp-cop
allo-geneic
bimbcl-2
7p-
9p-
conjuction
acidbase
non-lc
precursor-b-all
cd158e
pkh26high
lapu2009cells
5-colour
lapu2009u2009subset
esterase-
pas-
----71
----12
hypothesizes
werexa0how
g-pbmcs
g-pbmc
engraftment--including
cp2--were
alkylator-associated
best-documented
inhibitor-associated
anaplasia
b5-fc
330-mediated
hhf35
idh1-mutant
graft-failure
nu2009u200967
nu2009u200951
cd4cd45ra
tpl2
cot1
iminxa0vitro
ps-1145
nices
base-case
celgenes
£-
cbts
non-ebmt
nct00309842
therapy-persistent
lin-cd34cd38-lowcd45ra-ckit-cd26
30s
isoelectrofocusing
hba2
delta-77t-c
hpfh
tq22q22tq24q11
sangstatgenzyme
atg-f
cystostatic
cetus
bulk-dose
escalating-dose
m4-m6
m1-m3
bv-containing
steroid-free
non-selected
rhinopharynx
meatus
pharyngeal
allogeneic-sct
regularity
biomathematical
asd
nct01822509
deescalation
cacna1d
slc4a4
kcnk5
timeless
tgf-βbmp
rasmitogen-activated
oncologistshematologists
cml-therapy-free
stem-cell-dependent
rs213210
rs17220087
rs17213693
hla-dob
b-associated
pu200912
factor‑α-related
rstrail
tbi-including
aml89
rists
border-zone
concentrically
stenting
cilostazol
seattles
gouty
v-aml
endothelial-integrated
non-vascular-associated
endothelial-like
euthanasia
chemotherapy-cycles
literature-search
12q
incompetency
tsa-sensitized
dyshematopoietic
nct01168219
udt
filgrastim-induced
aphaeresis
burkitts-like
multiclonal
ii-intensive
haematomas
ief
allogenotyping
ief-matched
extended-spectrum
four-times
c-group
haplos
bastion
pagets
drz
dzr
p-allohct
qm-fish
icrf
dmnci
inoculums
lsa2-l2
uch
aprel
mrel
hrel
dliim
nonconcurrent
n310
n404
re-labeled
clinicomorphological
timelines
helperinducer
cytotoxicsuppressor
nk-t
torso
isointense
undocumented
intensifications
lacy
cytoplasm-containing
microvacuoles
non-ato
low-to-intermediate-risk
kgla
cytrabine-
fludarabine-induced
forgo
extrameningeal
octreotide
subdivisions
reaffirm
vinorelbinenavelbine
vinorelbine-based
vinorelbine-sensitivity
n127
n110
understating
post-etpv
hotbed
delta-12
pgj3
δ12-pgj3
hematopoietic-prostaglandin
h-pgds
hql-79
epa-supplemented
lsc-cfu
cox-derived
prostanoids
pdlt
ifnbc
hlamlc-compatible
ric-hcts
tokai
high-sf
low-sf
coli-
casei
rhamnosus-bacteremia
faeces
resistogram
lactobacillus-bacteremia
undermine
exercise-
nkg2cnkg2a-
msdli
tbicyclophosphamide
electronically
assessement
hydroperoxycyclophosphamide
hl-60h3
kir-positive
tq13p13
der12t
my906
wt2
okt6
all-antigen
okt9
english-written
emit
damps
microgramkgd
secondlater
g-csfgm-csf
e-rfc
5-parametric
lineage-selected
units-megakaryocytes
cfu-mega
burst-granulocytes-monocytes
pregraft
multifold
allo-act
dpb1
dpb1-matched
dpb1-mismatched
cev14
cev14-pdgfrbeta
re-engraft
nonrelapse-mortality
chictr-och-10000940
solgmralpha
embolus
standardgood
donor-to-male
allo-reaction
ptbp2
portrays
inclusionexclusion
single-step
m→m
f→m
f→f
m→f
hd-aracmitox
b-particle-emitting
a-particle
bismuth-213
actinium-225
anti-cd33-
supradiaphragmatic
nalm-36
nalm-37
lambda5
vpreb
add1q
bcp-iii
bcp-iv
nalm-36kl
authenticity
bcp-type
hypernatremia
hermanos
ameijeiras
hah
havana
aml-allo
aml-auto
promyelcytic
cost-intensive
oligomerized
bclxl•bak
mcl1•bak
pi3k-akt-mtor1
il7rα
gsi-resistance
gsi-resistant
aitl
ptcl-nos
enteropathy-associated
asteroides
diaphysis
diaphyseal
loosening
dvp
giemsa-banded
t-zone
paracortex
architecturally
uchl1-
l26-
l60
faintly
4kb5
mb1
cd45r
millimeter
hyperlipoproteinemia
scec
limited-stage
mutlidimensional
five-dimensional
frame-work
gvhdp
mssa
ventricles
1000microl
nka
assertion
pkc412-
ccl5-receptor
cxcr4-receptor
αccl5
ccr5-targeting
p-akt-positive
ccl5-encoding
p-stat5-positive
fvii
thecal
metrizamide
may-grünwald-giemsa
gatla
periodontium
thermographic
amlm0
or90
phbcr-abl-positive
tmj
allo-bmts
a-bmts
cd3kg
shorthair
caliber
transmurally
myeloidhistiocytic
izing
blcml
javelin
axitinibxa0xa0avelumab
avelumab
neoavax
simons
nct03341845
availableabstract
mac387
breast-
colorectal-cancers
praxis
cohort-
result-directed
standardizationharmonization
ppllsg
fourty-four
akir-matching
ocurred
akir-matched
ikir-matched
ikir-matching
haplotype-bb
haplotype-bx
ikir-match
haplotype-ab
-bb
kir-matching
cd4u2009×u2009106l
-u2009×u2009106l
gvlgvh
gamlcg
subject-
time-to-treatment
d419
myeloidmonocytic
resurged
purging-free
irradiation-free
i-hds
rituximab-supplemented
cd45ra-negative
carcd45ra-
re-challenged
puma-induced
a2780s
puma-mediated
igk-kde
jal-sg
aml-85
poorabstract
rq
tmli
conformally
channelled
persuasive
inv16-associated
1840s
nu200au200a10
nu200au200a9
vγ9
monopoiesis-promoting
kcl22alpha
cebp-induced
cebps
isoprenylcysteine
carboxylmethyltransferase
icmt
cysmethynil
mutant-expressing
m30
m19
expanded-access
nct02312037
nu2009u2009139
nu2009u2009183
ablt315i
dcc-
bcr-able255v
one-and-a-half
gaze
internuclear
procoagulants
dipodascus
capitatus
hemocultures
microdilution
γ-rays
α-particles
α-particle
sublethal-type
il-32α-overexpressing
il-32α
il-32α-induced
out-hospital
antidiarrheal
kir2dl4
chromoprobe
reallocating
heptahelical
cxcl-11
leukocyte-chemotactic
chemokine-neutralizing
receptor-blocking
cxcr4-antagonists
chemokine-targeting
idenication
5akt
ofchildren
rnai-based
polyplexes
polyester-based
bcpv
bcpvs
nanoplexes
bcpv-sirna
lipofectamine2000™
intra-cellular
n-rasg60e
k-rasv14i
k-rast74p
k-rasa146t
cd33-related
cd33rsiglecs
deep-coverage
pvod
11q-
t11p22p13q23
insp12qq
nontandem
pxa0nowell
dxa0hungerford
jxa0rowley
20thxa0century
ppp2r5c
32d-bcr-abl
chemosynthesis
non-silencing
sc-treated
nucleofection
ppp2r5c-sirna-treated
ppp2r5c-sirna799
subprogram
transcriptionchromatin
cbx5
hoxameis-independent
esc-like
mllhoxmeis
antigen-a
one-locus
tkis-induced
euthyroid
receivingtkis
25-homozygous
6-heterozygous
rsj16
schistosoma
japonicum
cd95l
anergic
apc-dependent
mir-155-knockout
thorasic
teleomorph
apiosperma
clsi
m38-a2
aspiratebiopsies
mastocyte
kitd816vmutation
hy-poxia
reoxygenation
interleukin-3pseudomonas
il3pe38kdel
receptoril3r-positive
il3r-negative
il3r-positive
flt3is
parp1is
palb2
lig4
parp1i
flt3i-induced
ncd25
ncd38
medip-seq
dpp6
r7
regenerative-associated
a46
misappropriating
nct00326170
pwwp
proline-tryptophan-tryptophan-proline
atm-dnmt3-dnmt3l
red-ox
bvr
rm-124
locomotory
malonodialdehyde
3hl-
strychnine-insensitive
n-methyl-d-aspartic
5-ht2a
glutamatergic
stat5-induced
stat5a-induced
pkd
mimicks
iur
koala
metamyelocytic
information-bearing
ion-trap
lactotriaosylceramide
gm3
neolactotetraosylceramide
nlc4
β-n-acetylglucosaminyltransferase5
β3gn-t5
mis-segregation
az3146
ki-328
mutant-kit-expressing
d816v-kit
d816v-kit-expressing
nomius
ionization-time-of-flight
mapk-interacting
mnki-57
mnk2-specific
mnki-4
thr70
explicit-solvent
snapshots
δgexpt
energy-contributing
dihedral
c179180dupcg
c5053delgcca
c178182delacgtinsttt
c243244insgtcg
c923924insctc
danger-associated
kdm1a-targeting
compound-mediated
cycle-regulation
i418v
e450a
e453l
e455k
reenter
f359cvi
look-back
tq12q22
runx1lpxn
lpxnrunx1
rls
prame-derived
pra100
pra142
pra300
pra425
prame-driven
phosphorylatesde-activates
ckit-itd
ckit-wt
higher-phosphorylation
gsk3beta
mif-173
rs755662
-174
sars-cov-1
ttv
t-als
t-al
hgvs
c512dupt
nucleotidexa0c6869delag
bic
designationxa0187delag
brac1-mutated
t-lpd
methotraxate
crvo
adductor
oxacillin
drained
hips
ym155-treated
chronology
setd2-h3k36me3
dot1l-h3k79me2
mlf
lozenge
runx1-eto-induced
runx1-eto-dependent
fas−1377ga
rs1800682
fasl−844tc
rs763110
haplotypic
near-to-background
scarrying
tnfr2-expressing
set-nup214
snucml-02
cpcml
choriomeningitis
pd-ligand
alphapd-l1
der9tq34q20
mhas
drps
mha
grk4
spectrometry-tandem
unc-grk4-v
grb2-sos-ras-mapk
grb2-gab2-pi3k-akt
bcr-abl-grb2
phospho-bcr-abl
ad-sh2-ha
sh2-phospho-bcr-abl
point-mutated
ad-sm-ha
ad-sh2-ha-mediated
avl
avr
troponin-i
coronaries
anterolateral
alc-d28
outcomexa0in
cd4cd25highfoxp3
ccng2cyclin
shbmi1
pkcζ-ampk-jnk-erk
ccng2-mediated
rs2228001
rs17655
939glngln
751gln
mesylateimwas
cml-ag165
transcriptional-profiling
foxo-dependent
inter-trial
managements
nemo
s1981-phosphorylated
pidd
serines
inhibitiondepletion
contention
gmall-2003
idaflag
csn3
madm
manp
-3-binding
-3-dependent
gfp-fused
-3-independent
customizable
rictormtorc2
over-reactivation
rictor-foxo3a
floaters
bcva
neovascularisations
panretinal
photocoagulation
somaticsniper
mutect
variant-calling
kinase-1-positive
flk1
flk1cd31-cd34-
impairedinaccurate
andhra
pradesh
χ904
χ091
irx3
t-progenitor
tissue-inappropriate
syk-dependent
syk-positive
anti-cd33-mediated
3q-q29
2p-p15
dcls
spectroscopy-based
flt3-interacting
drugsthe
non-kmt2a-r
acin1-nutm1
acin1
nutm1
saf-ab
acinus
pias
numt1
nutm1-rearranged
ras-gtpase-activating
k-ras-induced
k-rasg12d
aex5-kts-
features-overexpression
ex5
ktskts-
ex5ex5-
nipts
subchromosomal
ergfli1
pml-rar-α
donor-brother
-methylenetetrahydrofolate
677c--t
1298a--c
mnk-eukaryotic
mnk-dependent
mnk-eif4e
receptorxa0car-t
limbic
tomography-scan
full-body
rectosigmoidoscopy
vpa-mediated
afs
auditing
npm1-mutations
npm1-wildtype
tcrζ-regulating
factorsplicing
asfsf-2
fcεriγ
cml-cr
fceriγ
splieced
wtas-
wtas
wtascml
wtas-and
splices
intra-macrophage
mcl-1-silenced
tom70-silenced
tom70
bak-bak
homo-oligomer
release-mediated
α-naphtylbutyrate
myelodysplasiaaml
inxa0a
g-csf-dependent
kw-2449
depository
pstiing
sofewares
ap-related
wdr35
ormeloxifen
k-de-gel
ormeloxifen-induced
erks
mbp-1
promoter-binding
impeder
diamide
lpscytokines
s-glutathionylation
generationinos
nox2-mtros-nfκb
l-ca
l-cas
ms5
panipembetamipron
panipenembetamipron
carbapenem-resistant
cavitary
ptprg-positive
oncosuppressive
cd45ra-selected
mismatch-expressing
leukemia-engrafted
acm-induced
ligandfas
acmimatinib
acm-mediated
down-regulations
hif1α--
cacg
1006cg
∼600
∼45
∼100
ccl19
e-region
anaphase
hiperfect
cdh1-skp2-p27
gold-nanobeacons
au-nanobeacons
actuators
nanobeacons
codification
l-ic-enriched
qlt0267
blast-phenotype
myeloid-bc
megakaryoblastic-phenotype
17p-loss
lymphoid-bc
trisomy-p-loss
cellhpc
cd341
bcr-abl11
inmpc
patientsincluding
lymphocytesinterestingly
sideline
mi-219-a
transcription-independent
1u2009h
jak-independent
npas2
bcl2bax
coincidences
weeping
vorinostat-induced
46xyadd1p13tp11q22der16tp13p46xy1
fusionmap
fusionfinder
1ppp13
kat6acrebbp
kata6a-crebbp
inv16pq22tpq22
inpp5d
gm-csf-dependent
d672a
hiv-cml
-bis4-hydroxy-phenolpropane
polycarbonate
resins
impact-resistant
sealants
dentistry
estrogen-like
cd11bitgam
cdna-arrays
prodifferentiating
kinase2
dlx4-tv2
rxa0xa382
nxa0xa078
rxa0xa
125b
abl1-kinase
ligation-dependent-pcr
tki-treatment
hla-genotyping
splits
rearranges
10q24
imatinib--the
workable
voriconazole-induced
haloperidol
post-complete
edcnhs
cd133-marked
r2u202fu202f
pitpna
loc100132273
pgpabcb1
dnr-based
betterintermediate
flt3-asp835
y589
k602
sh2-binding
e598
y7
d835h
d835a
pulseless
anti-factor
n610
onco-leukemo-genesis
4-ap
kn-62
250k
iglc1
vegf-expressing
vegfvegfr-positive
underweightnormal
vaso-occlusion
7q--7
mutation-like
downstreams
ampkmtorp70s6k
ferroptotic
iscu
iron-sulfur
dha-induced
updown-regulated
mir-1469
mir-1972
chtcrs
cma1
hchtcr
megakaryopoeisis
ofxa0chromosome
monosomyxa07
arm-specific
mkl1
2gen
deryty1q12q25
1q25-qter
yq12
1q25
rabgap1l
yq12-qter
bcr-v-abl
30‑fold
defuse
tophat‑fusion
rnf213-solute
slc26a11
megakaryocytoid
dmlf
dref
atrophied
bsk
nonsilent
cbf-rearrangements
mutatome
cbfbmyh11-
runx1runx1t1-rearranged
herc
zfhx
nonprimary
y-chromosomes
p15-pcdna
21-nt
p15-pcdna-k562
p15-k562
interference-k562
sti571-k562
prel-hscs
mirna-centric
kuruma
shrimp
marsupenaeus
japonicus
mjmlf
mlf1-interacting
hepatopancreas
wssv
47xy6
47xy6del5q22q33
del5q22q33
radon
radiation-related
taml-eto
inv16cbf
tpml-rar
kitflt3
leukemogenetic
region-v-abelson
triadelphia
pulvinata
monomicrobial
ciii
ci-iv
cycle-based
databank
gusb
impurity
beaded
runx1-eto-expressing
lin-c-kitsca-1
runx1-eto-associated
orthodontic
rhinitis
alternaria
infectoria
triple-combination
1beta-converting
enzyme-like
proapoptosisapoptosis
p53-impaired
p73-regulatory
del11q22
5p-terminal
5q-terminal
11q-interstitial
r5pq
del11qq
dup21qqxy2
xeno-transplantation
lin-scac-kit
aee788
sb-559457
nonpeptidyl
rhtpo
p70s6s6
sb-
rhtpo-
sb-induced
mds-ol
bcrabl-harboring
differentiationproliferation
ebv-lcl
del7q22q36
del7pp22
biochemicalfunctional
camks
camk
camkii
lxxll
kn62
36-item
role-physical
res-hl60
2677gg
2677tt
n400
cd34cd38-il1rap
cd34cd38-il1rap-
antagomir-30a
intern
sawa
regulary
antp-tpr
tpr2a
self-maintaining
pig-6
vβ21
slxxv
jβ
p210bcr-abl-positive
myecloid
3p13-p
fryl
af4p12
furry
vtp50469
n175
fiberoptic
idic21p
47xy21idic21px2
ybt-5
ybt
kmt2a-related
epz004777
α-naphthyl
48xy
10mllt3
kmt2a-associated
occupations-1988
aloha
herbicides
glycosylphosphatidylinositol-specific
gpi-pld
gpi-anchored
x-114
semi-quantitive
h78q
w79c
d171g
l71fs-ter94
v91fs-ter94
bcr-abl-harboring
phase-like
lhr
slco1bgg
slco1btt
abcbcc
abcbct
sprouty-related
evh1
domainprotein2
spred2
plko1-shspred2
phosphorylated-erk
citrate-phosphate
trifluoroacetic
tfa
tfa-peptides
dctfa
cp-peptides
dccp
low-functioning
acecs
mcecs
cecs
mkk
mkk4
-1304tg
rs3826392
-1044at
rs3809728
-1304tt
-1304gg
-1304g
-1304t
mkkat
-1304gt
c480cg
c480u2009g
c480cc
erectile
sequelaes
bip
shaperon
calnexin
shaperons
homoharringtoninecytarabine
aclarubicinara-c
hhtara-c
chg-treated
mitoxantroneidarubicinthphomoharringtoninedaunorubicinaclarubicin
saft
3-rapid
tail-to-tail
dtx2
upk3b
runx1-reversed
upk3b-dtx2
runx1a
chimerize
5metc
intermediate-riskcytogenetically
methylene-tetrahydrofolate
algerians
677t
pu2009u20091e-6
1298c
pu2009u20099
e-6
677t1298a
677t1298c
cd95apo-1
cd4fas
cd8fas
sox2ot
pheochromocytoma
pc-12
sh-sox2ot
isoform2
si-mcl-1
mir-211
mtorp70
aktmtorp70s6k
mir-211mcl-1
sox2ot-mir-211-mcl-1
h37rv
h37rv-infected
cyp3a5-a6986g
cgc
non-gg
non-tt
sensitivekcl22-s
resistantkcl22-r
shp-1shp-2
revalidate
factor（cf）for
（p210）transcript
scale（bcr-
ablis）in
leukemia（cml）
cwp291
hashimotos
lfa-1intercellular
vla-4vascular
d8s1179
d21s11
d7s820
csf1po
d3s1358
d13s317
d16s539
d2s1338
d19s433
vwa
tpox
d18s51
d5s818
fga
antigen-expression
blastsdendritic
aml49
blastmaturation
dcacd1abc
cd137-l
magnifies
cbf-specific
near-perfect
revaccination
aml-m2b
xq24
-765gc
rs689466
-1290ag
rs689465
nitroblue-tetrazolium
semi-quantity
8-cpt-camp-induced
probe-specific
fish-tested
accuracyspecificity
analysisinterpretation
cotransduced
nup98-hox-induced
nup98-fused
co-overexpression
hox-induced
icers
epc1
epc2
mll-mutated
kd-induced
mycmax
granulo-monocytes
cd34cd133
δ70
δ63
129svev
pmlraralpha-induced
leukemia1-eto
xa0gm-12
atropine
900microl
46xytp21q26del5q
aml-ahd
delves
virosecurinine
securinegaxa0suffruticosa
virosecurinine‑treated
domain‑containing
inositol‑5‑phosphatasexa02
post‑virosecurinine
ship‑2
gstm1-gstt1-
gstm1-gstt1
receptorsligands
ras-mapkerk
missensenonsense
aberrationsaml
sfpq
nonclassic
precursor-like
kmt2a-menin
mtor-raptor
mutated-flt3
vidaza™
combinationxa0
m-bcrabl
b3a2b2a2
207l
neurofibromatosis-1
17q11
pcrfluorescence
nf1-deleted
kitv560g
scf-responsive
xln
l270p
kindred
quantitative‑polymerase
leser-trélat
sks
rainwater
c91
c92
ru2009u6
ru2009u52
ru2009u69
ru2009u55
ds-ml
tet-foxp3
ato-treated
foxp3-mediated
gsk3β-mediated
tet2-foxp3-lyn-akt
axis-modulated
mll-x
x-mll
mof1
fgfr1beta
fgfr1-specific
fgf-2fgfr1beta
harming
blk
glucosyle
lass
rhbdd1
trbv
rte
e2a-pbx1-translocated
aurkb-selective
barasertib-hydroxyquinazoline-pyrazol-anilide
transcriptional-translational
cry1
cry2
ckiε
pre-imatinib
crisis-phase
preconception
16u2009000
cytogeneticsgenetic
nondrinking
ormoderate
orhigh
beverage-specific
orwine
spreds
ras-erk
hematogenesises
scf-stimulated
transcripton
above-menthioned
1the
fv2-associated
dehydrogenase-elevating
fv2r
sffv
sffv-infected
l-ic-specific
dccd34cd38
dccd34
unkilled
progenitorinitiating
dcprogenitor
countu2009u200950u2009×u2009109l
decompressive
megavoltage
conformal
paraprotein
kappa-type
m₁
m₂
m₃
m₄
m₅
m₆
cd106
lmp2-aa
1ec2
supt-1
co-marker
10l
infectionreactivation
oligonucleotide-polymerase
10⁻³
acid-atra
camptothecin-induced
abnormality--the
p53wild
transactivation-competent
pml-nuclear
tap73pml-nb
p53-nonfunctioning
p53mutant
phosphrylated
pmltap73
pml-nb
cci-006
hif1αlow
meis1-expressing
aml--10
nonmonocytic
leukemias--were
fgf13
millionth
donnall
withstood
neuroretinopathy
amn
visual-deteriorating
bcr-abl01
⩽3
duplicationitd
g105
postvalidation
tp34p15
panelists
macrothrombocytopenia
fechtner
macrothrombocytopenias
chain-a
aml-1
uncorroborated
transcriptsmirnas
mirbasemiranda
gene-mirna
omic
pu200910
israelita
einstein
dicpp
i12q10
tnftnf
sgitrl
gitr-gitrl
11gdl
cytochemisty
mp0
hyperbasophilic
tpo-induced
c-mpl-presenting
c-mpl-deficient
c-mpl-proficient
tpo-associated
autophagolysosomes
vsp34
p-bcl-2
over-expressions
nkcas
nkca
ltnk
tapi-0
alliaceus
12p11
abl1-bcr
tq25p23
low-to-intermediate
nxa0xa0601
pxa3xa-6
cd34u2009u2009aml
3un-translated
mir-203survivinbmi-1
prognosisdiagnostic
clinical-relevant
pei2
polymersirna
sirnapolymer
lipid-modification
acid-substituted
polyq
htt
hypk
mlf2
exon1
rewarded
sm-csf
lams
phagocytosis-associated
chromosome-like
positivities
46xy-7mar20
dnmt3bgene
rs2424913
rs1569686
rs2424908
rs6087990
rs6119954
ctat
tgat
cgat
ttgc
informaiton
dexi
collagenepinephrine
β-arrestins
β-arrestin
β-arrestin1
β-arrestin2
growth-interacting
tgif
holoprosencephaly
tgifs
anti-cycle
tc1tc2
cd3cd8cd28
cd8cd45ro
cd8cd45ra
aamds-ra
5-color
marrowmedian
dilutional
an-najah
hospitaln
nnuh
onn
88n
diagnosisn
remaindern
gaza
infectionsn
gn
mostn
remissionn
firstn
myeloid-b
myeloid-t
sub-classifies
lineage-matched
person-sv
errsv
anti-hla-i-specific
teachable
cmpdmds
dalpha25-dihydroxyvitamin
bufalin-induced
rala
endomembrane
linchpin
mis-localized
confering
rtizol
-concentration
ctl-secreted
coreceptor-mutated
peptide-major
pmhci
polychromatic
pp-503
marrow-resident
fvs
38-kd
26292fv-pe38
32716fv-pe38
redlk
kdel
26292fv-pe38-kdel
46xytq23p
reverse-transcriptional
hematotoxins
higher-stage
hscfv
pww20
pet32a
β-d-thiogalactoside
iptg
6×
hscfv-eta
periplasmically
membrane-elisa
anti-aml-reactive
non-aml-bearing
il-2dt
hypoproliferation
aches
necrotizing-like
site-inducing
t21p22qq22
t8qq22q22
aqueduct
hyperventilation
barbiturate
bcr-abltq34q11
extubation
leukemiacllis
leukemiacmlis
leukemiab-cll
high-granulocyte
bibliographical
mutant-bcr-abl
gr-1myeloid
omacetaxine-treated
b220leukemia
madin-darby
mdck
jaagsiekte
jsrv
dntpase-defective
hdaa
cardiac-specific
smrs
full-genome
multi-platform
ucml
scml
rcml
cre-lox
krasg12d-a
fetalneonatal
mll-enl-driven
monte-carlo
anion-transporting
1a2
oatp1a2-transfected
naringin
slco1aga
-1032ga
slco1aga-1032ga
slco1agg
domain-related
crox
pyrrole-imidazole
q22qq
b-ll
b-lymphoblasts
gender-
fmf
gc-a
r761h
p369s
cytogenetis
jinnah
postgraduate
bibliographies
-nt
rs1884444
rs6682925
tggg
tccc
95ciu200au200a-
leukoblasts
shitake
lentula
beta-glucans
cage-side
lhme
foxp3dtrgfp
ccl3-ccr1ccr5
cxcl12-cxcr4
jih-4
tandem-repeat
anaggressive
transfertransplantation
arfink4a
mscv-myc
mscv-myc-induced
trl-01
adherence-dependent
hess-5
cd41b
frizzled-4-dependent
wnt-ligandfrizzled-receptor
mid-term
i6p10
dup6p
low-copy
etv-7
intra-axial
hemorrhage-related
co-stimulators
cd-1bb
cdzcar-t
bbzcar-t
cdbbzcar-t
inclined
glucocorticoid-responsive
h3k4-specific
mllset
ugr
bone-mineral
hyperparathyroidism
areal
bmds
hyperparathyroidismthere
osteomalacia
tumour-transformed
cd94nkg2c
npm-ma
npmcaml
pet-32a-npm-ma
bl21
2g3
3f9
anti-npm-ma
npmcamls
primer-probe
questionnaire-based
bmsct
tryptases
beta-tryptase
par-2
fllsy-nh2
sb230580
beta-tryptase-induced
-morpholinoanilino-n6-cyclohexyladenine
reversine-aurora
shkbp1
5q--5
tmll
rorc2
il17-a
il23th17
il17-secreting
exon3-skipping
trip12
s-methyltransferase
derq10q10
trans-dihydronarciclasine
hyu-01
lysm-ptp1b--
midlife
hypersphosphorylation
jak-dependent
leukemiasignificance
nxa0xa0120
cotransplantation
nthl1
rmll
rmll-related
epipodophyllotoxin-mediated
over-ride
lsct-unit
antibody-testing
wore
ffp2
smyd2
kmt
r-pfi2
smyd2finally
l-ascorbic
scurvy
nct00329498
aml-m5-derived
proteinantigen
parental-specific
aml-m5-specific
all-round
hla-drb
drb35
venezuelan
related-a
nkg2d-expressing
mi-3454
mll1-rearranged
6q-q
9p-p
geometrical
dienoic
cis-9trans-11
c9t11
trans-10cis-12
t10c12
cla-treated
gorwth
hematopoesis
mcdl
akt-induced
jmjd3
pml-rarα-
pml-rarα-mediated
mixbix
mesendodermal
mixl1-transduced
trepan-biopsy
erythron
ns398
fluorimeter-based
duxap10
esbl-producing
twelfth
cefpirome
tigecycline-mediated
ef-tu
t-box
predendritic
leukemia-mediated
leukoencephalopathyretinoic
tp22q22-positive
nm032172
dihs
carotene
functions--differentiation
capn2
micro-array
tp14q22
c11orf41
11p14
c11orf41-runx1
ph-ca
mthfrts
quinquennium
food-frequency
2r3r2r2r
blood-stained
heterocomplex
hyc-kit
membranecytosolic
n822k-coexpressing
gene-transfected
cd40-activated
cd40-b
pp65-encoding
cathepsin-g
δexon7
nontranslocated
flt3-downregulation
ddx3
hnrpu
matrin-3
importin-7
hauspubp7
ube2n
erp29
rbp2
jarid1a
trs
p11q13
mcgh
loc253012
locates
bet-bromodomain
-oxoglutarate-dependent
fourier-based
recast
dnf
lhs
pre-albumin
hs-crp
patient-generated
pg-sga
short-acting
mtorc-mychnrnppkm
hnrnppkm
pparγβ-catenin
bcr-ablmtorhnrnp
pparγβ-cateninbcr-ablmtorhnrnppkm
endocrinopathies
q22q68
q22q32
cd34cd19cd56
non-stimulated
nilotinib-sensitive
i21q10
endoreduplication
low-performance
high-comorbidity
advisement
1000xa0bp
kir-genotype
rr1
spirit-1
kir2ds1-
low-gata2-expressing
gata2low
ase
patient-dependent
disease-dependent
well-tolerable
lsc-ipic
cd34cd38⁻cd123
rna-related
asp816tyr
asp816his
crmlfs
foxm1b
microrna-7
stably-transfected
mir-7-overexpressed
mir-7-transfected
bcr-ablpi3kakt
non-clustered
ehr
ehrs
signal-related
phospho-cdc2
guideline-
non-progressive
subperiosteal
lubrication
explainable
inconsequential
pneumonia-driven
amebic
amebiasis
establishedthe
hellenica
zygoascus
meyerae
grapes
multi-classification
regularized
mrogl
three-class
misattributed
misinterpretable
fewxa0recurrent
non-robertsonian
evacuating
relinquish
supporter
paf1c
complexion
1-mt
chmp5
t-fish
cxcr4-sdf-1
g-pml-raralpha
aplluc
mb4
phospho-flt3flt3
grp94hsp90b1
nefarious
grp94
rewires
response-induced
bearer
incites
meis1abdb-like
hlf
crisprcrispr-associated
h3k36me
sgrna
atypicality
athano-gene
bag1
bag1s
bag1bag3
grupo
brasileiro
citometria
fluxo
gbcflux
resource-restricted
glycosyl-phosphatidylinositol
therapying
jak2-stat
hmyadm
myadm
myadm-like
322-residue
anti-hmyadm
networked
habitually
annulled
il2rγnull
gas2dn
yfp
cd34yfp
nu200au200a3
nu200au200a2
hnrpdl
bcr-abl1-mediated
tki-binding
pmp22
pmp22-sirna
46xyinv16pq46idemdel7q22q46idemt19q34qp2
3cbfb
del7q22q32
t19q34qp
intranosocomial
p210bcr-abl-transformed
sdf-1alpha-induced
tat-cdc42v12
sdf-1alpha-chemotactic
pi99m
c315ct
c435ga
co-clustered
leukemia-af9
descend
glycylcyclines
non-ic
cd137-cd137l
arg-882
processive
tumour-peptides
dendritic-like
dlc
mutz-3-derived
fastdc
toxa0compare
p30-induced
histone-methyltransferase
p30-expressing
p30-mll1
prevalented
rarecryptic
mllaf10
mllaf17
mllaf6
dekcan
tlserg
aml1mds
aml-m51
r-band
acidosis
nrvcms
stretched
caspase-parp-dependent
nrvcm
t11ppq23
interphase-fluorescence
100xa0×xa0109
leukocytoreduction
leukocytoreductive
treg-induced
t-effector
detoxificant
heterodimerizing
small-maf
maff
mafg
mafk
rs9610915
enzastaurin-induced
tlr2-r752q
tlr4-d299g
tlr4-t399i
52xa0patients
pe-positive
pe-negative
g145r
c777a
a785g
g516t
t516a777g785
26-plex
xa0gy
tbi-mtx
alkylator-mtx
1acute
rab45
c-iap1
c-iap2
cml-aldehyde
dehydrogenasehicd34
pontinruvbl1
pontin
47xyinv6p23qcxyder7tq25pcxydel13q21cxy21c15
47xyder7tq25pc
deletion-insertion
der7tq25p15
105-probe
abl1--
abl1-negative
shock3
c57bl
pu1--
camr
neogenesis
syk-mcl-1
q22q22runx1-runx1t1
10q22
45x-xtq24q22cpxx
ed64
e64d
n-acetylcisteine
non-mutational
mi-63
lympholeukemia
3stem
il-3scf-dependent
mn1-telhoxa9
d276n
e279a
nu2009u2009400
fibrinolysis-related
pdpn-expressing
pdpn-negative
facsaria-sorted
tmc
hscthy-1
hscthy-1⁻
bcr-abl1control
lab-specific
leucémie
⩾350u2009ngml
daunorubicin-metabolizing
cbr3
ier5
γ-ray
tmpp-induced
activitycd34
aldhhicd34
ier5-suppressed
nf-yb
transcriptinal
targeted-fish
ue2fa65
dasatinib-the
leukemia-including
n171
tki-exposed
c-helix
-exposed
coagulatory
thromboembolectomy
thr-157
bcr-abl-y177-akt-mediated
truncal
leukemia-intrinsic
14-intron
14-exon
touchdown
templated
bcr-ab1l
pre-analytic
4hpr
arpe-19
throphoblast
tgc
exponential-phase
septation
autolytic
gist-t1
gist882
nonallelic
hamadryas
cynocephalus
a-chains
c-chains
t-cell-deficient
h-2dk
decayed
ε-globin
hs5
5-azacytidine-c
tsh-r
b-cpap
nthy-ori
rtsh
countscell
agentthe
hamster-human
alpha-galactosidase
yy2
mbtps2
ocsc
platinum-induced
gl-1
alendronate
aln
anx5
alpha-induced
metallothionein-i
f1d
sacrifices
sris
tcca
cpf
protoplast
subgenomic
gpthbc
hbcag
cytopathologic
lx-1
adjudged
bvac-induced
bvac
dabrafenib
azacitidine-induced
abl1-dependent
undisclosed
35smethionine
-346
-268
cocaine-induced
drgs
ontologies
phophoinositide
tissue-cultured
heterotransplanted
-bis2-chloroethyl-1-nitrosourea
heterotransplants
xrs-1
knotted
xrs
rejoin
mir203
melandrium
syn
silene
latifolia
dioecious
heteromorphic
germination
cfbe41o-
non-cf
cfbe41o-wt-cftr
peptidoglycan
pgn
5az-treated
mda231
hmec
muscovy
ducklings
dhbv
congenitally
pekin
ducks
heritability
parieto-occipital
telencephalon
explicable
rosette-like
conformity
mono-di-nucleosomes
micronm
vm
5-methylthioadenosine
microalgae
chlamydomonas
cxa0reinhardtii
sxa0quadricauda
paramecium
asexual
amicronucleate
macronucleus
pyramidine
offending
hobs
laser-assisted
osteoblast-osteocyte
caf-1
sts-
methane
zsg
1p34
ubiquinol-cytochrome
uqcrh
hbmsc
protein‑4
trnas
queuosine
hxgc3
hff
queuosine-modified
queuine
ribosyltransferase
tgrase
western-blotting
luminal-a
regioselective
laurate
novozym
regioselectivity
5-azacytidin
llli
ifm
blcl
non-burkitts
langer-giedion
vimentin-negative
ion-pair
flax
lycopene
lcb
aba
roentgenography
dcbld2
smyth
eav
vitiliginous
sl101
5-azacytidine-induced
bl101
leghorn
ovhv-2
vil-10
kazal
hspc-supporting
co-inheritance
antenatal
wide-spread
labyrinthine
spongiotrophoblast-derived
cancels
5-azacytidine-substituted
cabazitaxel
docetaxel-refractory
hsg-aza1
myoepithelial
hsg-aza3
keratinizing
intra-arterial
lamellar
azr1
axons
oligodendroglia
cycloleucine
ethionine
non-delayed
methylases
tgr
hprt-
carbonarius
nrl-369
czapeak
suberoyl-anilide
n-hexane
brine
shrimps
lemna
carboxykinase
pepck
c-c-g-g
hha
undermethylation
med-3
zinc-fingers
zhx2
duchenne
dmd
haf-afs
6-ac
antiherpetic
iuc
thp-1ar
azacitidine-mediated
uck2
mtf-1
pb1
dihydro-5-azacytidine
dulbeccos
flask
multinucleation
ball-like
stick-like
cardiomyoplasty
y2
teratocarcinoma
nct02158936
anti-cytokine
mettaloproteinases
tel-pdgfr-beta
fip1l1-pdgfr-alpha
mutationsfunctional
cell-growth
milman
azaserine
prolactin
ivarie
sod-h
alpha-actin
flattening
several-fold
exfoliation
suprabasal
cdp
fluke-associated
ncoi
acci
sub-region
r6
nanofibers
hydrophilicity
phytic
hepatoma-targeting
pendants
ultraviolet-visible
self-assemblies
tumefaciens
t-dna
nopaline
45x
ad5-transformed
e11
b1pkc
pdbu
-tetradecanoyl-phorbol-13-acetate
b1pkc-aza
unprogressed
1-induced
ad5
paracentromeric
aprt-
uok121
uok143
non-sclc
nuclear-encoded
msh1
epi-lines
centering
rfx
sengupta
erhlich
rfx5
transfections
cadmium-sensitive
glut2
liver-derived
rnam5c
rcmts
nsun3
cdk9p-tefb
5-aza-sensitive
nsun1
5-aza-resistant
nsun1-brd4-associated
rnam5crcmt-mediated
mitochondrial-specific
hoc1a
er-chaperones
hsp71
azacytidine-treated
erythropoietin-producing
repcs
intraarterial
dichloromethotrexate
hal
mchc
14c
gi-8xa0µm
atf4chop
ose
caveolae
gp40
cytophysiological
azares
separations
octadecylsilane
methanol-phosphate
macaca
mulatta
fascicularis
aml29
mds10
orrcrcripr
-14cazacytidine
multiphasic
cellsplasma
ringers
zta
p3hr1
5-iodo-2-deoxyuridine-treated
zta-expressing
akata
rael
maj
galactokinase
nxa0xa0154
nxa0xa039
nxa0xa0260
5-azacytidine-resistant
il13
pss
tissue-derived
hyper-methylated
elk4
claudin-2
ly-294002
mir-497
gcra
myc-amplified
contact-noninhibited
contact-inhibited
fluoromethyl
yet-unidentified
hsp25
b-crystallin
taxane-resistant
skg-iiia
stramonium
tropane
mycotoxins
tester
wp3101p-wp3106p
at--ta
gc--at
gc--ta
styphimurium
n4-aminocytidine
cumene
chp
t-butyl
bhp
enng
3-chloro-4-dichloromethyl-5-hydroxy-h-furanone
nitrosourea
53-bp1
5-aza-mediated
csv3
somatotroph
adenohypophyses
rassf3
rare-cutting
e18
n2a
dnmt‑1
d324
hcmv‑infected
hcmv‑ie
hcmv‑gb
5aza-treated
mt-zn
actinomycin-d
c2g2
autoactivate
multiphenotypic
mrts
muscle-like
ttc1240
myf-5
alpha-smooth
sm-1
sm22
megsin
pnets
fazarabine
dimethylacetamide
penultimate
5-aza-c-induced
subfiber
30-nm
250-
panther
asia-inclusive
multiregional
mrct
harmonisation
e17
2000-november
xa0450
mrcts
mus-20
dim-1
growth-phase-dependent
mlv-neo1
hygromycin
nidulans
neurospora
crassa
protoplasts
hyg
conidial
gateways
cixutumumab
custirsen
dulanermin
carboxymaltose
indibulin
ditosylate
tafluprost
albiglutide
azelnidipine
budesonideformoterol
lutein
niacinsimvastatin
pitrakinra
relaxin
sagopilone
selumetinib
sir-spheres
tasimelteon
tiv
tru-016
vernakalant
zeaxanthin
aav1serca2a
at-7519
carisbamate
formoterol
propionate
imexon
saxagliptin
sch-530348
ziconotide
abt-888
jx-594
bilastine
benzoyl
tositumomabiodine
ibutamoren
kw-0761
pollen
xch
gper1
seven-transmembrane
upcpgi
irs-20
log-phase
uvra
uvrb
uvrc
uvr
vasoocclusive
pumpkin
embryogenic
-dichlorophenoxyacetic
auxin-free
auxin
5-aza-deoxycitidine
cdcs
46xxr5pq
agouti
avy
gfp-reporter
mir-199a-3p
agomir
β1-induced
npdfs
habituated
iaa
non-habituated
habituation
phytohormones
indole-3-acetic
abscisic
hec
o-glycosides
micropropagation
rooting
mir156
flowering
seedling
suckling
adrenalectomy
iggs
lmx1a
h3k14ac
irreversibility
t-ucrs
uc416a
cell-restricted
promoterreporter
nonendothelial
epiglottis
stereological
5-mec
distachyon
35s
bd1
bd2
5-azacr
tmprss4
cpl
streptozocin
rickets
thiosulfate
diethyldithiocarbamate
non-mendelian
oryza
herbicide-resistant
cereals
progressionwe
emergentexpanding
older-onset
postdeterministic
l1210ddp
prospero
anabolite
methylcytidine
dna-modulatory
allabstract
embryoid
ssea-1
5-zac
mesoderm-derived
neurites
depolarizing
noggin
hdf
ag3204
g1-arrest
lifespans
sc3
homogenized
mycelium
promoterless
xg-7
5azc-induced
5azc
brdu-positive
uo31
protein-gapdh
gapdh-depleted
nci-h358
p53-proficient
gapdh-depleting
mds-mld
u2009s
fviii
q10
pcsk9
triacylglycerol
co-addition
citreonigrum
guttate
assemblage
sclerotiorin
sclerotioramine
dechloroisochromophilone
pencolide
5-azacytidine-treated
relays
metastatization
ptgs
nptii
dihydroxypropyladenine
fibrinoid
hla-ii
lineage-cd34cd38-cd90
fgfr4-expressing
supershifted
hepatectomy
drug-pretreated
mir-518a-5p
sncrnas
hematopoiesis-related
u33
hsapir019420
mir-548av-5p
mir-151a-3p
mir-125a-5p
sncrna
circumspectly
xrs-5
dhmeq
perennial
peony
7xa0d
5xa0mc
unigenes
ad7
describeda
nucleoid
transcription-translation
cylindromatosis
oxytocin
foot-and-mouth
fmdv
nano-micelles
finer
pharmaceutics
objectivate
peptidyl-trna
papth
acylate-trna
substrate-binding
dna-rna
rgp1
rgu-cho
rgu
equilibrates
elongate
5µm
gmaza
dmaza
myhc
momulv-based
vb71
3u2009×u20093
d28
c1d5
pfsos
mesosome
electron-transparent
thicken
svep1
mba-15
da3
tfiib
gnt-iva
gnt-ivb
flagellin
hrf
dcl3
dcl2
maintainance
reparray
repeat-specific
f-
aza-cytidine
reactivators
raavcmvlacz
pulse-labeling
hpt
1-naphthalene
auxins
node-like
hcn2
hcn4
asc-derived
ap1903
gmcllr
gmclhr
δcd19
icaspase-9
5-long-terminal
effectivenessefficacy
sizexa
full-text
oyster
crassostrea
5-aza-cyd
dna-mediated
kinase-deficient
y1
c21
21-hydroxylated
bglii
digestions
h2s
hcy-induced
bend3
nahs
ifng
nmd
ptc-containing
spc-a1dtx
fh535
gcv-refractory
elf-153
32n
cd34cd61-
cd34cd61
cd34-cd61
endomitotic
karyocyte
azacitidine-associated
ara-cvp-
dauno
vp-16amsacrine
vp--azacytidine
ara-cdauno
ara-cvp-16
daunoara-c
efsabstract
co-amplification
insulator
callus
supertransformed
unpolyadenylated
hinged
goalspossibilities
adenines
dh5-alpha
fv3
puc19
ampicillin
metalloproteinases-9
care-treated
mlh
5mec
anti-5mec
uncoiling
btscs
14c-azacitidine
fibrinogen-albumin
fari
high-fari
low-fari
revised-international
rhythmically
beta-type
reconciled
ev-1
analogies
cytogeneticipsswpss
classed
skmcs
langendorff
thinning
cornea
aza-deoxycytidine
ns0
17beta-hydroxysteroid
type7
hsd17b7
cholesterol-independent
microlcra
alpha-amino
alpha-aba
preactivated
aptogenic
cyclophosphamid
mrllpr
mrl
l-histidine
patch-methylated
gd13
telencephalic
lin-cd34cd38low-cd90cd45ra-
azacitidine-resistance
teratological
teratogens
metallothioneins
scc25cp
h69cp
h69
sw2cp
hmt-iia
hmt-if
factorization
mapk-driven
virus-positive
post-ae
vectorial
abcc
basolateral
mdckii
nih-3t3
x-ray-sensitive
hemizygosity
rerevertants
dnaase
rprl
rgh
gh3b6
gh3cdl
trh
-azacytidine
meristem
vicia
faba
sau3a
chromocenters
ovoid
post-ahsct
assuring
zdcyd
cblc
epi-cblc
epimutation
sanfh
multinuclear
myosin-positive
leiomyoma
at-mscs
mscgm
skgm-2
myh8
myh1
acta1
at-msc
myopodin
chrysosporium
cbhi1
phlr
catabolite
trp1
mirna-b
adpr
ebv-harboring
semenogelin
tmx
znf350
reponse
h1o
h1x
5-azacytidine-mediated
allele-restricted
prader-willi
sphingosine-1
s1pr5
nct01839240
cdc2l1
skin-tissues
cdk11p58
tamoxifen-withdrawn
5-azae2
hormone-related
k8k18
k18
k8
krt8
21-nucleotide
9-amino
mir-203a
mir-203b
bcl2adenovirus
albumin-bound
myogenically
btr
m5c
phox2b
micro-metastatic
micronb
macronb
micronb-shphox2b
nsun6
pericentriolar
extranuclearcytoplasmic
uv-damaged
cv-1
zf-l
ee2
aza-lipo
bbd
ctnt-positive
cardiotrophin-1
ct-1
pi-plcγ2
pi-plcβ1-dependent
cladosporium
resinae
nrl-6437
czapeak-dox
mtdna-specific
polga
vitc
striated
-266
apap
apap-induced
rasfs
5-aza-dcmp
sigmoidal
nonmyogenic
bc3h1
alpha-cardiac
admscs
adult-derived
cd73-positive
cd73-admscs
cd73--admscs
fluffy
fluf
conidiation
cytembena
mycelia
diploids
heterokaryons
azac-treated
viral-specific
brdu-treated
nmri-mice
embryolethal
surpasses
embryotoxicity
embryotoxic
abbv-075
rassf5
rassf5a
rassf5b
rassf5c
22-oxa-1alpha
beta-glycerophosphate
5brdu
rpob
qβ
meningioma-like
donor-cells
fcdr
footpad
cuttings
shoots
kanamycin
sip1
filipino
cephalic
pyknotic
margination
light-
nucleosidic
chemo-drugs
marrow-cr
lsos
mtases
psk
5-ac-induced
rii-
intratubular
vasa
klf11
sub-threshold
micro-computed
nondegradable
iκsr
cd45locd34
bl-derived
cocultivation
orip
phenotype-dependent
nicotiana
ipt
a33
transacting
non-polyposis
hnpcc
npat
3p21-p22
ligase-mediated
tsss
mtase-dna
pbr322
aza-c-induced
reca-dependent
replication-dependent
fleas
fungicide
ancestors
population-level
trifluorothymidine
f3tdrr
mutability
bm-epcs
penk
α7nachr
pathway-mediated
epiphyseal
methyl-rich
-chloroethyl-6-dioxo-1-piperidyl-1-nitrosourea
n-trifluoroacetyl
adriamycin-14-valerate
replicase
thr210ala
tyr410his
azc-induced
tos17
matsumae
introgression
rz35
calli
cytosine-methylation
cng
nonparenchymal
taxa
semi-conservative
mixed-field
polyagglutinability
galactosyltransferase
gal-t
3gal-t
enzyme-deficient
thomsen-friedenreich
leukosialin
co-occupied
55-kilodalton
troma-1
endo-a
gng7
hyperacetylate
bioreactor
acellular
sarcomeric
detectors
d6
prl-deficient
prl-
k-balb
ha22tvgh
cell-regulatory
tet2dnmt3aidh
greater-risk
prototrophy
mirlet7b
kmt2a-aff1
netropsin
kmt2a-aff1-expressing
srbc
unc1999
unorganized
regenerates
rooted
phytohormone-independent
undercondensations
pulverized
quail
tq2
qefs
mcf10
nucleophile
aza-ctp
utp
15n-ctp
chromatograms
ha22
ef2
characterizedxa0by
isxa0transient
non-respondersxa0here
α5
vector-free
kyse30
kyse70
fludarabine-refractory
5azacytidine
cryptogenic
int-2-high-risk
igmu
lcr-deficient
alphafucosyltransferases
alphafuc-t
lactosamine
lec11
lec12
lec29
lec30
ethylnitrosourea
lex
betafuc
alphaglcnac
vim-2
neunac
cal-b
co-solvent
co-solvents
cal-b-catalysed
hexanepyridine
biotransformed
postmeiotic
corpora
lutea
epididymal
5azc-treated
minichromosomes
agrobacterium-mediated
orthologues
hetero
oec-m1
collagen-induced
daphnetin
gliogenesis
premyelinated
cellsoptic
myelinated
ensheathed
astroglia
5-az-treated
momps
treatment-dependent
griseus
iap-related
dmnts
teac
g10
transgene-specific
adcy5
evx1
antiestrogens
estrogen-independent
zraza
aqp9
grhl2
aza-a
dma
in-line
flowing
cubilin
megalin
expressor
bli
hut
hsa-mir-9
hsa-mir-137
hsa-mir-
8-
uncoated
mer-
3-flanking
cd4pos
foxp3pos
th17-treg
nupr1
panin
krasg12d-induced
congruently
beta-gal
beta-defensins
uvrd
im-9-p
hprl
spinach
5-methylcytidine
inter-simple
ms-issr
issr
dlk1⁻dio3
cd77
ebna-2
eli
methanol-precipitable
cesium
alb
ck18
glucuronyltransferase
acid-schiff-positive
as52
gc--cg
6-thioguanine-resistant
mcg
mds-msc
traversed
rituximab-bendamustine
iadademstat
5-truncated
kiaa0649
skews
hepatomas
buoyant
superhelical
1qh
c-band
duffy
febs
lett
hivlai
superinfected
hivrf
superinfecting
neomycin-resistant
proneo
ach2rf
equalize
post-inoculation
nxa0xa0178
fld-2
inflorescences
emf1
tfl1
leafy
lfy
ap1
mepscs
neurotransmission
pt24-c3
hmecs
growth-arrested
postselection
stomata
beet
chloroplasts
apozygotic
myxoploidy
methylationdeacetylation
platinum-refractory
del5qoccur
l4
rpl4
ucbmscs
cardiomyocyte-specific
oscillations
rhythmic
faers
ror
trastuzumab-containing
azacd
gel-based
mir-27a-5p
averts
deoxygenated
neovasculature
reinjection
s-phase-restricted
aza-affected
q-family
q-containing
isoacceptors
trnatyr
trnahis
trnaasn
synchronizing
histolytica
ehmeth
trophozoites
non-f
wnt5a-s
wnt5a-l
siwnt5a-s
laminin-coated
mlc-2alpha
desmin-positive
folinate
nonproducing
ghc1
-ccgg-
hedgehog-interacting
hematopoietic-specific
napa
napb
chlorine
mchr1
population-
op-1
icms
sam-dependent
periodate
adox
ocn
newts
ontogenic
schistosome
mansoni
anti-fecundity
schistosomes
cell-by-cell
ca46
hut78
z138
dna-mt
mutant-infected
26k
kdm4b
rsph9
xr-v15b
cross-sensitivity
4nqo
jeggo
triticale
rye
intermixed
unsustained
chloroplast
cpdna
dmss
detergent-resistant
reca
lexa
dcm
bacteriostatic
orotic
acetal
-14c
anti-adenoviral
n4-derivatives
silyl
n4-methyl-6-azacytidine
rm-1
antineplastic
post-preparation
deoxycytidine-triphosphate
5deoxy-azacytidine
vdre
hydroxylases
balloon-like
nonrandomness
ectodermal
l5178y
5-fcdr
ef1α
dimethylaminohydrolase
homocysteine-induced
phenol
si-nets
lama1
min-1
ddah2
erythroleukaemic
explantation
hsv-1-infected
dmso-mediated
mart1
trp-2
5-azactytidine
previ-ously
af-fected
antigen-peptide
light-mediated
peptide-exchange
peptide-specificities
multimerized
fotemustine
rwpe1
ar-sensitive
rbl1
igrp
anti-tumourigenic
co-medication
1300-fold
tn-syndrome
tn-antigen
cord-derived
hucmscs
dll4-notch
photochemical
6-azacytosine
6-azathymine
c600
biannual
sarcomere
myofibers
transients
ttx
ryanodine
span-xb
cat-reporter
orotidine
proenzyme
c-h-ras
retransformation
n-alkyl
pylorus
epimutagen
metameres
phytomeres
synanthous
a0az0
a1az1
kvdmr1
5-azapyrimidines
5-methyluracil
pseudouridine
-dihydrouracil
purine-specific
monocytic-macrophage
anll-type
gcna1
erod
o-deethylase
tcdd-induced
anti-forssman
pyrroline-5-carboxylate
7sl
iii-directed
hgccs
hnf1alpha-deficient
weiss
hnf1alpha
recycle
chlorella
il-3a
mcviji
cviji
czechoslovak
lyd9
pa6
l-gm
mt4
nondifferentiating
s--sydonol
insulin-stimulated
tera
pa-1
z5c
non-ageing
trifoliate
cilfy
ga3
416b
20-
mngc
mngcs
co-variate
multi-arm
multi-stage
drom
adamts8
adamts
top-i
myotube
hmsc
electrospun
polycaprolactone
biomed
mater
az2
brdurd
pseudomutation
tpg
mekc
mononucleotides
bodipy
ha-a
tgf-alpha
acholeplasma
laidlawii
fermentans
dna-polymerase
metal-induced
ku-80
autoantigen
rat-1
bdf
micp
65-fold
k562sr
epsilon-globin
stretching
rbmscs
cardiomyocyte-related
rasgrf2
c-banding
pi-plcbeta1
pls3
gata6
aib
k-l
mecdapi
beta-carotene
vaa
betaca
-dimethylhydrazine
post-approval
ebnas
cheptage
elijah
nu2009u200936
34u2009×u2009109l
198u2009×u2009109l
solanum
ruiz-lealii
2n
malformed
aflp
low‑grade
prokaryotes
nvp-hsp990
reexposure
mir-146a-5p
planktonic
autoinducer-2
luxs
metk
glucocorticoid-treated
he3
ad2
13s
12s
clonic
barretts-associated
receiver-operator
kyse220
beta-subunit
rifampin-sensitive
rifampin-resistant
dim-2
integrase
cde
succinyl
t-pa
velde
sasako
microphthalmia
exencephaly
ﬂow
genotype-dependent
eyfp
high-efficacy
low-efficiency
y-specific
dyz2
yqh
astrogliosis
myelinating
non-pitting
u2-os
surroundings
isoschizomeric
ki-balb
bfu-e-derived
cfu-e-derived
herv-h
nell1
inflexible
straining
uracil-dna
luteus
ripk2
pft-alpha
mesoangioblasts
lipus
malleability
prima1
sall1
galgt2
mle-12
mt-if
mt-ig
mt-iia
kcn
10microl
hu-treated
kidney-293
mhc-specific
n-phosphonacetyl-l-aspartate
pala
d-ribose
pala-treated
6-phosphate
libitum
8-azaadenine
5-azauracil
proneness
fbpase
beh
lloq
high-concentration
ribofuranosyl
bioisostere
pyranosyl
disaccharides
stalling
ripening
vps
perturbators
silmitasertib
palliate
nors
xrs5
radioprotection
wr-1065
wr-
re-exposes
iwg-mrt
runoff
bicarbonate
-151
hpac
cardiogenesis
hper2
miglitol
penectomy
scrotectomy
erythrocytic
mir-369
mir-615
mir-410
pre-mir-663
kmt1e
chaf1a
riii
gp52
cpt-k
malfunctional
comprehend
lenalidomide-resistant
imid-sensitive
opm2
nci-h929
imid-resistant
depress
natrium
cholate
antigen-c
lirilumab
kirhla-c
ucmscs
mongrel
α-actin
β-mhc
f-cells
diurnal
hfmscs
adjoining
myotube-like
myofilaments
disc-like
troponin-t
21-d
3huridine
effectiveness-tolerability
rituximab-based
rituximabs
kml-1
gem-induced
mono-therapy
volasertib-resistant
tropi
hasc
beatsmin
hascs
colx
armigera
instar
larval
amps
ic-9
stanozolol
fgf-4
infarcted
5-fluorouracil-induced
c3a
methyl-assisted
glycemia
mfn2
electroretinogram
preventreverse
glucosuria
hyperphosphatemia
hyperkalemia
lactated
ringer
protonated
bisulfite-i
muntjac
crossing-over
segregants
concentration-related
cfue
bfue-derived
e-clusters
pyrazofurin
afmscs
afmsc
cardiac‑specific
cardiomyocyte‑like
-micron
formate
n-formylguanylribosylurea
m11-x
treg-cells
th1-cells
-257
capsids
mahlavu
snu475
leiomyosarcomas
sk-ut1
sk-lms1
mes-sa
mds-risk
go-gofit
slow-govulnerable
no-gofrail
go-go
slow-go
expectationswishes
developed--the
reversion-inducing
sacc
acc-m
methylnitrosourea
c86agm2
hprtm
electrofocusing
non-ribosomal
nrps
clade
rho-globin
culture-induced
pretreatments
noncardiac
cyd
heat-denatured
5-azacytidine-sensitive
5-azacyti-dine-treated
t-effectors
foxp3interleukin-17
revivification
lyt-
ampda
aktb
hnmscs
hepatocyte-like
hlcs
hpheps
limit-dilution
ptl-p
lectin-mediated
tumor-lysis
facteur
thymique
fts
intrathymic
alpha-mhc
gsk-3alpha
neuroblasts
tropomyosin
trkc-mirp
trkc-mir1
1-ln-pc-a
azacitidine-arms
azacitidine-containing
ice-cold
polypropylene
romi
pdx1
glucose-stimulated
repeat-induced
mip
premeiotically
ascobolus
masc1
01910na
edc
nhk
region-
cpr
ery
oxidizes
guanines
h2ax-gfp
ebna-1
spumavirus
hfdl
pfuml
amnion
rapid-deaminator
-31delc
melanization
mdgi
lcfu
iri
luminal-like
lenalidomide’s
del4q25
narcissus
lusc
nadh-diaphorase
hepatocytic
mex-
oxygenated
afb1
non-aflatoxigenic
post-harvest
dna-methylase
submerged
antibioticus
rhodomycin
spore
combination-arm
nonprotocol-defined
001with
antigen-like
ociad2
qdna
non-epidermoid
azc-treated
st-dmrs
cpgi
recycled
uck1
h3k4-me
acc-lc-91
acc-lc-176
recbc
miaa
mnme
ssra
tmrna
hepa
microrna-193b
k‑ras
ehsp100
medusa
5-azacytidine-treatment
b116
tiers
p-face
intramembranous
e-face
unensheathed
ensheathment
scavenges
nkg2a-negative
xrs-5-like
over-condensed
dscs
aminoacylation
dl-ethionine
5-methylcytidine-deficient
dl-ethionine-treated
n-methyl-n-nitronitrosoguanidine
h-2db
bl6t2
tum-
tum
egf-generated
somata
cotreated
dsred
cashmere
goats
uros
overexcretion
uroporphyria
nesting
1-beta-d-arabinofuranosyl-5-azacytosine
per-145
per-163
ara-actp
dhactp
deoxy-derivative
unsightly
zip13--
bmt-aza
lr-
hr-mdsaml
tumorigenicaggressive
non-aza
pk-cells
g2-period
3d41
dihydrobipolaroxin
suberohydroxamic
exrna
bhuvanagiri
mareks
mdv
mdv-derived
mdcc-msb1
msb1
rp1
bamhi-h
hyperleptinemia
5´-azacitidine
pharmacoavailability
chemotherapy-like
acca
hplcmsms
-d-free
accessions
human-derived
folate-free
folate-deprived
e-cluster
culture-derived
normoblasts
micronucleated
mn-pce
kimsv
adipocytic
foxg1
refrigerated
postmitotic
pik3cg
tscs
tsc-enriched
anti-telomerase
methosulfate
pcps12
dcm-
rth
metallothionein-mrna
chse
gdf9
rsu202fu202f-
rsu202fu202f
whole-mount
prg2
k562-r5-aza
myoblast-like
ec-cells
α-mhc
il19
il-19
cpg-dna
hrf20
daf-
sangivamycin
utf1
kyse140
5-azacytidine-2-deoxycytidine
5-azacitine
non-5-azacytidine
ssh1l
neuropathology
brdurdr
curvilinear
descendant
ada-positive
cis-
5-azatsa
72-hr
triphasically
inter-conversion
bimodally
ha821
o6agtase
acnu-resistant
egfr-target
lowintermediate-1
wastage
cyclinxa0d1
revitalized
a5pb10
psv2neo
phosphohydrolase
aminohydrolase
5nase
gla
transdifferentiating
fzb
hisg428
ochre
hisg46
extragenic
sequel
fasd
mbps
mbd1b
mbd3a
mbd3b
hatching
2dpf
6dpf
s-adenosyl-l-homocysteine
dna-enzyme
novikoff
analog-substituted
32s
coelectrophoresis
cscl
55s
zk-58
growth-limiting
fibroblast-specific
fsp1
nickel-induced
nickel-silenced
growth-arrest
ramosa
stimulants
stimulant-dependent
prcyp707a1
gr24
rdi
rheumatologic
anti-extractable
anti-ena
c-to-t
h19igf2
snb19
hs683
depots
nanofiber
aza-exposure
nonmutagenized
assemble
fmsns
sol-gel
unaccompanied
gemcitabinecisplatin
dba2j
slpi
secale
cereale
triticum
aestivum
1rs
condenses
nsc19
injury-induced
serpins
crma
nexin
pni
prostate-derived
pdef
dihydro
azacytidine-containing
antiadhesive
gluthathione
♀bmscs
pbn
5azac-treated
oligodactyly
nitrotyrosine
arrythmia
alpha-actinin
sloex
serca-2
mlc-2a
mlc-2v
useless
stochasticity
sge
dibutyryl
n-tubulin
neurogenin-2
neurofilament-m
luciferin
proliferationmigration
snai2
tcf8
zfhx1b
10u2009mcgkg
d1-d8
d4-d8
5u2009mcgkg
ribamidyl
vulnificus
tp53m214k
orotate
cycloheximide-treated
7sk
p-tefb-releasing
bicalutamide
unt
nht
pten-positive
pten-negative
antiandrogenic
hrs60
taqi
sau3ai
idmrs
nonreceptive
an3-ca
dnmt-a
reran
sdc-treated
poundsquality-adjusted
poundsqaly
ldc-treated
bsc-treated
npc1l1
hutu-80
5-methylnicotinamide
mock-methylated
double-methylated
sc-es
nt-es
excitotoxicity
mk-801
endoreplication
meristems
hemoglobin-f
h5n1-mediated
h5n1-infection
wet-to-dry
kp1212
tautomerism
tautomers
enolic
tautomeric
round-shaped
3ap
t3ap
t5am
β-galactoside-binding
1-beta-d-arabinofuranosyl-5-aza-cytosine
gapped
m13mp19
p-labeled
ara-5-aza-cmp
14p3hb
photoperiodically
non-inductive
photoperiodic
21-bp
tre-1
tre-2
tre-1s
mt-4
mct-1
cd8xa0and
8xa0is
behçets-like
orogenital
aphtosis
ileocaecal
no-esa
apoptotic-like
succinylacetone
carotids
rag-2
az1
pachytene
spermatocyte
lyase
nk-92mi
rprl-deficient
methanesulfonate-induced
bicolor
k-12
qp
etk-1
hepatocyte-specific
alpha1
beta4
dusp5
polylactic
ultroser-g
c57bl6f1
dossiers
cpg-3
s49
mutable
mitotic-checkpoint
inducting
microcephaly
dnmt3aa
dnmt3bb1
hatched
l-cell
runx3-induction
tritium-labeled
high-specific
deblocked
5-azacytidine-free
methylatedsilenced
jmjd2c
1-ln
1-ln-ems-10
colonieslung
heritably
htlv-1-positive
htlv-1-pcr
sepharose
prns-1
hgh-v
17q12-q21
zona
zpbp2
ormdl3
gsdma
nuli-1
ctcf-binding
clinically-meaningful
aar
aml-001
001-like
sub-analysis
ag-stained
organizers
ramets
shading
entomophthoramycosis
dihydrodiol
clastogens
aneuploidogens
c-band-positive
htlv
htlv-1-related
scleritis
subendothelial
sl3-clf
-kbp
ecori
kbp
inter-ethnic
aza-ms
p53r172h
endog
5-mcdg
promoter-enhancer
tryptophan-mediated
nxa0xa0115
time-interaction
non-ck
rumex
acetosa
rhoeo
y-bodies
prorenin
ren
estradiol-17β
phenylhydrazine-induced
samd14
alpha6iv
alpha5ivalpha6iv
col4a5col4a6
transplantationmyelodysplastic
gadd45alpha
docetaxel-mediated
17-
nm-1
berenbaums
ra-treated
acycloguanosine
apoptosis-stimulating
d6ac
conformers
gibbs
2-deoxyribose
puckers
energetically
h-bonds
o5ho2
c2h2o2
c2h2o5
conformer
mct-3
in-part
adp-ribosyltransferase
anglo
iss
aza-exposed
beforehand
transfusion-dependentneutropenic
t-helper-cell
mtor-modulation
maize
lpa1
shi
myo-inositol
paramutagenic
eucaryotes
trna-guanine
transglycosylase
q-deficient
gc3m
meager
ag-dependent
coselected
parental-type
diverge
plt-
axa0rare
55u202fgl
axa0risk
pu202fu
1xa0risk
0xa0risk
65xa0patients
axa0simplified
macrophage-
tnf-alpha-
wi-l2
electrocatalytic
restriction-modification
nalidixic
coumermycin
-117
jensen
killifish
pcb126
maxima
pollyea
k562h
630-kb
amplisome
amplisomes
pfge
mtx-sensitive
cytosine-specific
unreplicated
ascsems
5-azacytydine
hepatoma-derived
aflatoxin
dmn
β-iii-tubulin
nf-h
teratocarcinoma-derived
esa-refractory
sotatercept
daps
dapr
icr-191
-a
egfp-expressing
karyoplasts
cytoplasts
cho-ki
dose-survival
radio-sensitive
repair-proficient
split-dose
mid-
exencephalic
size-dependent
lage
trag3
anti-ny-eso
azavor
small-colony
competency
repulsive
myocardiocytes
hh29
hh39
ncfu
ab1157
lr68
jc3890
error-free
tk702
tk501
post-uv
ab2463
ab2470
ab2494
hepatoblastoma-derived
ileocolonoscopy
cxg
marrow-induced
osteoblast-induced
anomeric
furanoses
stereoselective
n-benzyl
open-chain
aza-c-glycosides
homoazasugars
hydrogenolysis
d-ribo
isosteres
-linked
hoursabstract
incb024360
tol2
medaka
oryzias
latipes
eth
uv-irradiation
tumor-inducing
kusa-mtag
cov
positive-sense
covs
proofreading
exoribonuclease
high-fidelity
exon-
mhv
mhv-exon-
p250
nsp14
replicationimportance
proofreading-deficient
nonviable
70-fold
bvdu
ag-negative
231br
multipurpose
wp2uvra
laci
af-2
tak-924mln4924
pev
ivsubcutaneously
nct01814826
oxaloacetic
readthrough
5-acr
pulverization
cd11acd18
normosol
admixtures
t90
ptkx-1
ltk-
101bu1
reexpressors
pha-activated
cd48-
full-scale
col-1a1
sox-9
transpositionally
lct14
lct13
collision
dna-topo
oligo-clonal
pgk1
biexponential
md-2
unimpeded
hgf-mscs
haemodynamic
cercopithecus
lower-and
intermediate-2-and
c-kit⁺lin⁻
dart1s
transposons
dart1
pyl-stb
ndart
osclpp5
pyl-v
b-lymphoblast
polynucleotide
polydg-z5c
double-helical
left-handed
unsubstituted
polydg-c
anoikis-resistant
mir-26
hsa-thc
δh
δs
betayac
betayacmbd2--
mbd2--
1-acetyl-2-phenylhydrazine
reversions
simultaneity
bi-lineage
mov13
transcription-competent
prostatic-carcinoma
pc346c
tsu
hsa-mir-191
mesenchymal-like
rt-pcrthe
alonethe
mannerand
cellsthe
l1cam
hec1b
cd3-zeta
tcrcd3
ribonucleosides
dzeb
dm-dnk
ralv
binge
alcoholism
neurodevelopment
aie
aie-induced
t-ag
free-viral
skm1
aza-r
aza-s
anti-p21ras
non-luminal
methylation-negative
folliculo-stellate
tpitf1
pit-1
ptfe
cytometrical
inbreeding
gefitinib-resistant
kiss-1
nu2009u2009190
intervertebral
soxc
rec1
siads
gastritis-metaplasia-carcinoma
ohcs
chemically-deafened
pou4f3
newly-generated
cochlear
c86s1a1
x-encoded
sinogenic
retro-clival
endonasal
transphenoidal
endocranial
p66shc
koreth
km-h2
non-o1non-o139
non-o1non-o139-induced
o67
btax
pair-wise
despiralization
hyperalgesia
nick-translation
detergent-solubilized
oligo--adenylate
5azct
5azcd
5-iodo-2-deoxyuridine
nc-37
ifn-producing
bjab
p3hr-1
mtsv
sedimenting
autolyze
hematomas
gametocidal
aegilops
3c
adjusts
ccfdna
hdv
alpha-sarcomeric
vk
misalignment
pbor-il-3
ltr-driven
fvbn
linc00629
mir503hg
apoprotein
polyribonucleotides
polyriboinosinic
polylysine
tungstate
buttermilk
doublet
radiolysis
hydrated
plc-prf-5
dmso-
5-azac-treatment
x-chromosomes
shuffling
gre
copurify
growth-regulating
pdgfs
endocardium
pdgf-bb
multi-donor
stemprogenitor-cell
hoxb5
system-defined
-diaminobutanone
glk
glk--
glk-
af293
brla
dnmt1-associated
dnmt-
chromatin-related
haemorrhage-related
entertained
-120
hypoxanthine-aminopterin-thymidine
k1b6me
refractile
rad51ap1
spc25
ld-il2
3hdeoxycytidine
5-aza-c-treated
3hdcyd
hpall
5-cmecgg
mspl
5-meccgg
clevage
cytosine-residue
uninhibitedabstract
xa0×xa0109l
-04
nonproducer
suge
etbr
wih
fetal-hemoglobin
macronuclear
encystment
colpoda
inflata
danon
single-base
mir-18b
retraction
purkinje
intracortical
pruning
neuritic
myelin-associated
collaterals
hef1α
puppies
organismal
prestudy
p-type
arabinonucleoside
serca2
ad-
azac-dna
active-site
paf-1
peroxisomes
l-a
lr-smd
aza-responder
oh2d3-sensitivity
btics
f3bt1
p815y
orgin
thymus-dependent
null-cell
cbf2
carbamoyl
rps6ka6
rsk4
endodermal
9-aminoacridine
umudc
mucab
samab
multicopy
pgw1700
pse117
pyg8011
5azacr
sulfamethoxazoletrimethoprim
scraping
pcdh
pcdha4
pcdha13
cin2
noninferior
luteoloside
ljfns
ly49
ly49a
ly49g
rma-e3
pro-2
m-amsa-induced
mdamb468
du99
dtr
microbead
yes1
hippo-dependent
hippo-independent
mycelial
proteosomes
gallstone
etar
ptpn12
tpa-inducible
venetoclaxven
agentshmas
goldstandard
non-enriched
best-supportive
biosimilars
pbmscs
pbmsc
distally
smchd1
beckwith-wiedemann
myelodysplasticsyndromet-mdshas
oxaliplatinl-ohpexposure
azacitidineaza
cancerct4anxm0
b-iii
wild-type3
capecitabinecapand
l-ohpxelox
eox
hsgf-2
pseudorabies
prv
prgf
mysteries
gh3d6
epcam-positive
light-sensitive
protoperithecia
factor-y
somaclonal
nipponbare
mite
mping
regenerants
5azc-treatment
bract
epimutagene
mi5az
pro-fibrotic
basepairs
cyclopentanyl
let-7bezh2
kdm2blet-7bezh2
continuously-administered
end-of-cycle
post-disease
xedar
hematoxicity
leus
emtb
2s
5az-induced
ngf-treated
smc-specific
blunts
cytokinesis-blocked
crand
patients50received
evaluative
neutropenia55
leukopenia47
thrombocytopenia61
cdkis
tm-
m36d3
preallogeneic
nct00660400
z5cyd
rec-
uvr-
proflavine
time-response
2-dimensional
col-tgel
schwarz
hef
bsc-1
factorxa01
non‑cancerous
cisplatin-sensitivity
mc2
catalysts
hydrolyze
-1000
kcat
phospho-c-jun
oxp
cmab
erratic
indolocarbazole-derived
chemoresponse
ngf-induced
β-myosin
bw-90
ccm
fiv
cyclic-amp
fhv-1
pcna-positive
vz
svz
gcl
egl
four-and-a-half
fhl1
nbe
life-extending
top-ranking
-g
snurf-snrpn
pws
anti-dr
anti-cd4
6-hr
ccb
fluorescence-in
situ-hybridization
x-chromosomal
epistasis
5-azac-mediated
panc1
clavatus
patulin
pseurotin
n-acetyl-d-glucosamine
ethylmorphine
phosphate-cytochrome
100a
4-azacytidine
very-low-level
rararsrcmd
units8
ifngr
condensation-inhibition
hatscs
mcao
lcmsms
cleaned
mcx
ymc
m80
positive-ion
msi-associated
ehrlichs
ppj
iva
ivb
subcultivation
pleiomorphic
flavivirus
bivalency
val3
foxa2
hcmv-mie
high-producing
tensin3
tns3
vwa2
amaco
spap
mdsspap
bcbm
poly-adp
3-kinaseinhibitors
hormone-receptor
pax3
nemo-like
nlk
mir-bartp
reca430
umucd
sebright
campine
feathering
hens
extraglandular
bat-26
eb-mnng
eb-5-aza
regressor
wc-1
wc-2
light-dependent
oncotarget22157
neuroprotective
5-azactydine
dmba
interchanges
submetacentric
5-az-induced
c33
saccharin
5-azas
ifp
thb
dexamethasone-resistant
naaso2
swrj
mlp
oc-14
c-fos-overexpressing
plf-68
oa-like
plf-68-untreated
η
instantaneous
x-1
flattened
hyperploid
deacylation
7zfps
p16atfs
p16atf
dna-met
intermediate-to-very
p005
470-fold
rbe2f
nar
albumin-negative
enzyme-altered
biomembrane
tubb3
ovcar-3
jhoc-5
jhoc-8
id3
l-14-i
pmscs
cardiac-like
noninbred
3h5-aza-2-deoxycytidine
target-discovery
tfdp3
ddx53
fcxa0xa06
fcxa0xa
quasispecies
disorganizes
qbeta
male-gender
risk-scores
azacitidine-lenalidomide
beta-adrenergic
pman
nell
nell2
wj
tnt
α‑cardiac
wjmscs
zika
barley
chlorophyll
membrane-active
tcrbeta
p1450
p3450
ust
p40
epiphyses
calves
migrations
streak
intracoronary
intramyocardial
right-left
hltf
daze
vp-16azacytidine
stemstromal
muscodor
yucatanensis
ergosterol
non-sensitive
excision-repair
5-deoxy-azacytidine
loxl4
5mdctp
mdctp
rmscs
patience
calvaria
bmp-7
cbfa1
ns0cf
cares
bmt-11
de-acetylation
expedient
lec1
bbm1
wox4
drug-exposed
antagonise
myeloma-loaded
lupus-inducing
apulia
mage3
carcinogen-containing
b1e
b2e
ac3h
myofiber
cocaine-associated
cue-induced
bla
m33
post-coitus
3beta-hsd
hucb-mscs
multipotentiality
tapbf
c-methylation
glutenin
glu-1
prolamin
glu-1by8
-1dx2
ras-1
400-fold
non-tumors
ls-174t
halothane
nucleocapsid
aza-ckg
rmetase
chemotherapeutically
9-beta-d-arabinofuranosyladenine
anti-cdc2
cda2
mcf-7twist
down-regulator
l6c5
v1ar
microcolonies
-154
6c-myc
mnso4
direct-acting
prior-remitting
m-amsa-aza
nonmaintained
hsv-2-infected
guinea-pig
salinity
skm1-s
pangenomic
aslx1
aza-resistance
il-4-secreting
il-17a-
il-21-secreting
endoreduplicated
diplochromosomes
fmr1-nluc
dinardo
mir-378a
synthesis-dependent
fluoropyrimidines
pcilo
orbitals
computations
c2-endo
c3-endo
pucker
chicn0
c4-c
ord
croton
flk
sofia
pvrs
azacitadine
at1c
microngml
epo-dependent
g-csf-mediated
missegregation
adart
equator
poles
unsegregated
mlv-based
untransduced
spectrophotometrically
snu-c4
3hdurd
3hara-ac
fura-induced
pfdn2
cpccd1
araac
dazc
vilen-01
88xa0
7xa0proceeded
72xa25
hematologic-thrombocytopenia
72xa0
parkin
dna-methylases
5-aza-c-dna
point-mutation
-73
bst-2
vea
velb
laea
post-treated
sediment
meristematic
neuroblastic
charcoal
irt
enteric-coated
auc∞
fasted
gem-resistant
5-mcyt
lec
patientsbackground
11-
neuroglial
descriptively
rationally-designed
uvb-exposed
embryonically
ciita-piv
rdrp
mirtrons
dhazacr
hsc39
hsc57
early-flowering
usitatissimum
segregant
out-crosses
radioprotector
gembumel
pert
alp3
alp2
dark-cultivated
alpha-2-glycoprotein
g418-resistant
tgtf1
undifferentiation
zfp206
rex-1
beta-mhc
semi-
v-fes
retransformants
rt6
rt6-nonexpressing
nonlymphatic
latexin
tmem131
tcf7
nod2card15
1beta
dhpa
ethi
cagctg
doublets
ccgcgg
triplets
menopausal
l-540
hsp-90
fischers
dye-exclusion
3hcholine
microvilli
fistulas
h3n2
drug-passaged
single-active-x
a-11
ray-induced
coli-derived
bb10
bb16
2-hr
th-17
adriamycin-sensitive
cldn6
sm23
m25
g839
bristle
4-methylumbelliferyl
beta-naphthyl
int-2high
emu-myc
267b1-xr
profusion
anti-bovine
fetax
aspartame
amaranth
81xa0cycles
xa0cycles
mds-phenotype
coexistingparaneoplastic
enu-induced
f-reticulocytes
deaminaseuracil
cdyuprt
cdyuprt-mscs
mock-mscs
egfp-mscs
ldl-ara-c
azacitidinexa0xa0ld-ara-c
multi-variance
belinostataza
4-cycle
tet2dnmt3a
mei-9l1
prophylaxisepisodes
cycle-1
cycle-2
cycle-5
discord
succinylcholine
tef-1
mef2-c
mef2-a
mef2-d
alpha1a
alpha1b
cgp20712a
beta1-selective
carbachol
cisplatin-containing
p1798
mltfusf
cytosine-5methyltransferase
den-2
th-36
virto
prpp
amido
tppt
slc44a4
colon-specific
pre-differentiated
intramyocardially
phh
minkowski
ada-
low-adherent
apoptoticnecrotic
interlinked
suprabasin
sbsn
teratology
conceptus
peri-implantational
pre-gastrulation
tesc
ncbi
oct‑1
turkeys
idur
runx1-mutations
avida
trim22
bclt
ndeii
coexposed
ahr-mediated
blinding
tgf
tbx5
stereochemical
carcinogen-transformed
laquinimod
adventitial
ddah-2
chow
cavernosa
methionine-fed
riggs
chc1l
zhx-2
lung-colonizing
low-metastatic
cd40lg
pricked
medicated
methanolysis
vasts10
panxa0xa05-aza
nct01613976
caffeine-treated
preaxial
prior-to-transplantation
calidoustus
westerdijkiae
diketopiperazine
w7
il-6-type
phytohemagglutinin-activated
retinas
3hcytidine
cdg
autoradiograms
herve
sk-n-dz
hervw-like
fetal-like
reticuloendotheliosis
webs
internist
pediatrician
adora2a
mycnos
5-bp
cgggg
sgecs
trks
germinated
nonproductive
ebna-6
ebna-4
dllc
5-azcs
activity-regulated
guerin
autosome
unestablished
aza-5
lameness
igf1rs
unoccupied
masc2
pre-implantation
rex1
ssea-4
decapitation
bifurcated
lightheadedness
blast-2
cellsplatelet
streptolydigin
36-wells
a-actinin
inhibition-related
ill-fated
mycn-amplified
cbz
pc-3xa0cells
cfz
café-au-lait
neurofibromas
-dmh
focicm2
carcinogen-treated
em9
aa8
trauma-induced
ivp
ixp
ixa
mtbi-induced
stiffer
xenogenizing
1-p-chlorophenyl--dimethyltriazene
dm-cl
pi-plcbeta1-specific
overproducing
revertible
perinecrotic
cryodestruction
fruiting
eturmiunum
blight
harsh
pseudothecial
disables
hdgs
sijka
mubi1
supertransformants
mubi1-bar
agm
serv
alv-e
ev-3
ev-6
ev-18
ev-19
rt-beta
gag-pol
noninduced
nondefective
pdt-derived
ad-mscs
fat-soluble
anti-obesity
adipokines
add17p
metenolone
sarcomeres
sk-mel28
igr
mirna125b
end-binding
traverses
aphi
mevu
ethylmethane
sulphonate
xenogenized
mesenchymal-to-epithelial
uc-msc
iiii
mash-1
kainate
periventricular
neurosphere-forming
tmem196
myeloproferativemyelodysplastic
low-intermediate-1
intermediate-2-high
-0
min-max
crmrd-
cinnamaldehyde
h-2kkdk
2high
intermediate-group
pu2009u200910
120-kb
stopped-flow
two-channel
coil
hemispheres
cingulate
phylogenetically
kossa
2u2009ml
3u2009ml
insulin‑like
igf‑1
expressivity
control-
ethanol-fed
cosubstrate
carlson
c-k
dystrophies
beta-myosin
ld10
biexponentially
3hdhac
3hdhactp
chef18
sorghum
endosperm
endosperm-specific
late-passage
t-type
cyd-dcyd
pseudogout
rhomboid
nsc-
5-phosphates
radioprotective
virostatic
mef2a
lunatus
diethylene
mrna18s
sn6
unfertilized
dcmp-aminohydrolase
dcmpase
disaggregated
paracentrotus
lividus
4sl
hivtc
vda
tempol
underutilized
mk-patients
40-ic
t1alpha
folate-metabolizing
3rg
-6u2009bp-6u2009bp
xrccgg
ikkalphabeta
11q25
iglon
b-fgf
designate
purine-pyrimidine
bv2
dmφ
feto-maternal
lung-tumor-associated
vvv
cis-pt
apobec3g
a3g
j774
alv-transformed
deb
prerenal
uraemia
postrenal
hypoperfusion
nephrotoxins
renovascular
uraemic
chloroethylnitrosourea
hypophosphataemia
hypouricaemia
haematuria
ultrastructures
cd-30
coalesced
activins
cardiosphere-derived
cpcs
cdx2-transgenic
cdx2-expressing
l-type
capacitance
cav
pafs
tnni3
vsv-g
pseudotyped
hiv-1-based
post-gene
l6e9
confluency
high-efficiency
ef-1alpha
h-strand
resuspended
elongating
piggybac
cd28-mediated
copiescell
phaeochromocytomas
beta-transforming
maj-globin
wasteland
embarrassment
riches
epidrug
eno2
hcv-associated
cpb2
hnf1α
tuber-bearing
methanesulphonate
gpt-
revertibility
fourteenth
behaviorally
hypoactivity
bladders
albumin-binding
micrognathia
unigene
camk2b
arfgef1
gtex
lncrna-mirna-mrna
nesprin-1
anesthetized
cardiac-myogenic
nesprin
concentrationthe
mcf-7-tam
re-sensitized
pib
blast-resistance
insulin-induced
rassf2a-silenced
v79a03
ach2
3cycles
aracr
polyadenylic
disaggregation
p53-negetive
pi-plcγ1
aktpi-plcγ1
erk-selective
mirnasmirs
rat-liver
non-competitively
nabt
b8g3
nectar
mxa0reukaufii
80h5
spi
mhch
mhcl
lyt
phosphonoformic
hesc-mps
archetypical
hesc-mp
epicc
low-stiffness
mechano-transduction
freundii
restrictase
nu2009u2009171
tsu-pr1
bgt
subcultured
extraneous
trypsinized
microfibrils
polygonal
acinic
myelination
siglec-7
cryopreservable
tetrahymena
apelin-apj
hisc3076
9aa
myelosysplastic
bursa
kms-11
h929
-350
sp17-positive
sp17-negative
ciliate
zdcyd-induced
p53-dominant
detached
zdcyd-treated
zdcyd-activated
alternating-type
camsa
5-azacytidineamsa
hd-aracamsa
refusals
ic-group
im-group
equiaxial
glc-6-pd
h4-ii-e
tap-1
tap-2
bsecre
nficcaat
xc
position--90
procollagen
metalloproteinases-1
preeclamptic
anp
analyte
cross-induced
third-order
architectonics
second-order
uacc812
sum102pt
hcc‑38
uacc‑3199
curcumin‑induced
mhm
fibroblastlike
thy-1-negative
anti-t3
thy-
black-positive
sune1
dh-5-azacr
multiploid
sal-like
pigmentosus
pax4-overexpression
c8161
txnrd
multi-acetylation
5-cg-3
pon1
wound-healing
testified
sunitinib-resistant
--gl3
mt2
hypergravity
sgag
matrix-related
2008c13
polarographic
anhydrous
two-electron
alpha-lipoic
oric
naei
kms
female-suppressing
androhermaphroditism
bisexual
hermaphrodite
doubles
y-linked
sta
log-logistic
weibull
aic
stripped
mononucleosomes
dnasei-sensitivity
erythroid-derived
beta-form
nct01926587
ras-effector
morning280
stromalstem
cb-msc
expandable
cb-mscs
jak2-selective
dose-ranging
site-
muty
mutm
ndk
rifr
mutators
hafs
mef2
nrcs
reallocation
inaccurately
rudd
tftr
controlsabstract
orphan-drug
15phsr
aip
b-5
a-5
radioautography
misonidazole
transformant
sec-1
-anhydro-1-beta-d-arabinofuranosylcytosine
tgfbeta1--
tgfbeta1-
30xa0min
nontumors
ttc40
5-ttc40
sirna-induced
hogg-utr
sediments
ecoriim
autogenous
22p
lab-on-a-chip
microbioanalytical
digitally
microdispenser
ml-
microsystem
macroscale
lw
ismc
hismc
mutagen-induced
mwh
flr3
hairs
b-hiv1
endocytotic
3grade
3-lineage
qf-pcr
dkd
epp
semi-dominantly
lowint-i
int-iihigh
cellular-biological
ppf
polycomb-associated
nordic-italian
int-i
sct0
neurectoderm
neuroaxes
apomixis
paspalum
de-regulation
apomictic
apomixis-controlling
parthenogenesis
m5c-rmts
aza-ip
c→g
methylation-iclip
crprhi
9l-1
il-15ra
var1
var2
del3
decitibine
sgc7901vcr
microphthalmia-associated
radish
hepatitis-b-virus
adprt
ctc-276p
bled
reticulocytopenia
rpobrifr
response-predicting
etched
unbinding
ng-1
nitrosoguanidine
chimpanzees
dfat
redifferentiate
h3s10
ac-treated
ramt
ag-staining
ngg
daur
600-nm
p10q10
embryo-specific
pcdh-alpha
c1300
venaza
ok432
5acdr-alone
ingest
non-reciprocal
brdu-resistant
rex
aristolochic
blcap
5-azacyd
hcnt1-expressing
3-hr
precipitable
α-pd-1
fenaux
2000-defined
non‑receptor
y6
marrow-mesenchymal
hbm-mscs
mscs-cm
myofibrils
t-tubules
m-mulv
b29
gh-expressing
caf1
hnf4
epitope-tagged
h5
glucose-free
hnf4tag
buc
buc6
buc9
buc10
buc11
line-like
β-mercaptoethanol
tub-b
t3-ti
lifecycle
1970-may
ild-
ildpatients
phytophthora
infestans
inf1
inf1-silenced
non-silenced
ggt-positive
samsah
actinorhodin
coelicolor
k562wt
hpaii-digestionpcr
k5612adm
non-mdr-type
l-azaserine
tgrhatr
lt50
latitudes
climates
atice1
irisin
fndc5
mdck-t1
oncogenically
10q21
inositide-specific
d133e
d280g
plcg2
q548r
xrs-6
xrs-4
folate-mediated
il-p40
retro-aza-mds-001
xa88
dph4
polynucleotides
nondiffusible
triphosphatase
contiguously
neurocytes
proadipocytes
intestinalization
kibra
ha-376
hent1-mediated
gal4
gal4-mediated
azac-resistant
nfkb2
mirna-27a
mirna-138
g9ai
oxanosine
membrane-transport
bpdcns
microenvironment-induced
paraplegia-20
spartin
5-azacytidine-sensitizing
dualmultiple
5-azacytidine-based
pcc4-aza-1
meanpatient
n815
psi-crip
psi-cre
875u2009cycles
2011u2009cycles
monocular
81mcl
resurge
pseudo-guillain-barré
konopleva
antibody-im7
heterogeneous--presumably
oncoprotein-induced
codependent
reece
hospitaluniversity
leukemiastem
co-chair
dznep-induced
stress-regulated
dznep-mediated
redesign
tenets
undeniably
philosophical
lsc-induced
niche-lsc
sdf1cxcl12
vcamvla-4nf-κb
newly-recognized
definitively-ordered
hl-60vcr
hl-60rs
multidrug-resistance-related
breast-cancer-resistance
arsenic-trioxide
cooccurrence
gpr56highcd34low
dnmt3anpm1
r882-mutated
cd34gpr56
cdkn1cp57
survivalproliferation
tnf-expressing
nf-κb-independent
genetic-risk
ccl3--
tspan3
thexa0mechanism
cmlchronic
ground-breaking
pik3c3vps34
rb1cc1fip200
wdfy3alfy
fyve
pu1-deficient
csf1rhigh
drug-inducible
nodscidil2rγ-null
tim3-negative
tim3-positive
unharmed
lum
scorpion
pesv
δ12
-prostaglandin
aldol
synthon
diastereoselective
corona
eppert
fuller
u937-transplanted
ezh2-enrolled
exodus
impinges
scribble
apobec3c
adar1p150
mll-transformed
blueberries
sall4-binding
cycs
dad1
g1-
tumorigenecity
emaciation
swell
c57b6
formative
mbnl3
cd44v3
canthin-6-one
pyrrolidinedithiocarbamate
cmrs
1-oncogene
2-oncogene
stat5b--
propagates
leukemiawe
lt-hscs
cd45high
mutation-targeted
brdu-li
cd19cd10
cd19cd34
vdr--
tet2-dependent
cycle-arrested
cyclinb
lsc-xenograft
-dipentyloxacarbocyanine
ma9-transformed
ma9-lscs
distills
homedomain
mll-subordinate
hox-mediated
aldhbrightcd34high
aldhbrightcd34low
aldhbrightcd34-
la-related
larp4b
larp4b-knockdown
lsc-rich
co-presence
stemness-regulatory
stemness-state
ergu2009u2009u200985
ergu2009u2009u200985high
drug-screen
monocultured
bioimaging
steers
yi-qi-yang-yin-tang
yqyyt
yqyyt-containing
heterogenecity
mir-34a-mediated
1-signal
2-p53
igg1κ
tq21q31
gcr
lincrna-3q
bajaj
inxa0facilitating
mcfs
ripper
0ne
hudred
featuresgenes
jak2-activating
p2x7-pbx3
p53s
mhdm2
pnc-27
necrobiosis
flu-refractory
flu-resistant
flu-resistance
cysteinyl-leukotrienes
cytokine-independence
jak2v617f-evoked
erythroid-lineage
eporcre
polycythemia-like
erythropoietin-independent
gene-dose
gene-induced
mll-leukemia
p27--
ma9-induced
hm-induced
hm-aml
cd117-cd11bhi
cd117cd11bhi
cd117cd11blo
ma9-lcs
hm-lcs
notch1-driven
integrin-associated
macrophage-induced
dpp8
dpp9
atlsc
atlscs
fosb
c-kit-scf
malignancy-induced
doacs
thromboprophylaxis
gslcs
nordy
alox-5
gslc
evolutionary-conserved
rspo
oncogene-addicted
imunophenotype
bloodgerber
aldhint
gsca
gilliland
carolyn
felix
ott-mal
zhao
metabolicepigenetic
tcrαδ-c-myc
fla2
flb1
non-side
mll-dependent
telomere-lengthening
ae-htert
humanizing
lscs-released
lmvs
mir34a
mirctrl
lmvsmirctrl
lmvsmir34a
chromium-release
misinterpret
aldh⁺
sulfone
9d
sum159
mdsc-recruitment
arginase1-producing
ibr2
lrh-1-positive
prestimulation
ctl-target
tp22q34
dek-nup124
whole-chromosome-6
rpk1
500-kb
rpp14
rph10
c6orf80
jak-inhibitors
localizationmutation
brb
cytoplasmic-negative
regulators-mirnas
s100a9ko
cd11bly6g-ly6c
cd11bly6gly6c
hierarchal
tde-associated
amiloride
nonessential
peg-arg
citrulline
nonrepressed-2
l-arg-depleting
evi1-r
unseen
non-stereotyped
ighv1
ighv3
hcdr3
cd123-mdcs
tnf-alpha-related
2fc
diachronic
time-structured
filariasis
microfilariae
seer13
classical-form
post-aa
non-ed
ifn-dose
phase-iii
u2009g
transformationaml-mld
semi-landmark
furnace
life-expectancy
aging-specific
aging-effect
ider17q
q10t
reportshere
ider17q10t
treatmenta
der15tq22q21ider17q10t
chemotherapydifferent
disproportions
nonsmoker
controlsreferents
referents
pccr
or20
n254
or4500
fludarabineatgcyclophosphamide
high-voltage
power-lines
fdcp-mixa4
nulled
ca2-ion
cyclotron
mtrms
csx
refinery
dumps
laborerequipment
workersmovers
constructionresource
randomness
census-tract-level
cnn-loh
cnn-lohs
11q-11q25
allama
iqbal
lahore
myelo-megakaryocytic
cyogenetically
maximizes
self-reporting
neurodermatitis
cfu-leukemia
bm-stroma
trfs
normal-to-low
bratislava
small-
middle-sized
reaferon
pliofilm
jobdepartment
lta-mej
lta-mejs
pilots
islanders
multivariable-adjusted
telomeretelomerase
risk-matched
21xa0
k700e
q157pr
kgy
hla-partially
excesses
haematopoesis
amltld
jalsg-aml
non-tld
amlnon-tld
cell-dose
p036
sleepiness
rcm
huntly
topologic
biopathology
sapienza
splenectomyno
fich
lrg
orthopaedic
decompressions
osteotomies
weight-bearing
hrt
pre-high-dose
hdt-related
leukemiasmyelodysplastic
cns-tumors
acute-lymphoblastic-leukemia-type
tumor-development
neoplasm-development
region-matched
nonconditional
2x3
5hidac
calgb-group
ancxl
leukemia-predisposing
nonpathogenic
nfatc3
nfat5
oxido-reductase
pesticidesherbicides
aaan
zygomycete
neurobehavioural
non-verbal
arithmetic
recursive-partitioning
perinatalparental
plasma-containing
gene-environment
nzcr
registrations
reticulosarcoma
gall-bladder
sawmill
rs10258429
slc22a5
rs274558
rs2235040
multi-component
hmds
non-hmds
rcud
aml-pfs
aml-progression
polychemotherapyleukocytapheresis
salah
azaïz
tunis
tptd-hoxb4
neurofibromatoses
tabriz
sns
risk-factors
age60
q12h×6daunorubicin
isochrome
policy-marker
blastsmicroliter
canceration
esft
cellstem
isth
ksth
nu202fu202f107
nu202fu202f117
c444u202fu202f1gu202fu202fa
c1100delc
del5395
pi157u202ft
chek2-positive
chek2-negative
period-specific
aff1af4
mllt3af9
mllt1enl
mllt4af6
pm10
motorized
geocoded
residences
unmeasured
megakaryoblasticerythroblastic
m7m6
hbw
corrected-for-gestational
agds
vp-000
s-anll
italians
latinos
aspertate
proxy-interviewed
self-interviewed
reexamining
thyroid-like
3xa0cm
grey-brown
microfollicular
macrofollicular
colloid-like
cdxa010
ttf1
criteriacytogenetic
catheterisations
oncohematologic
catheterisation
germs
telomere-maintenance
t726m
v1090m
a243v
processivity
cirrhosis-associated
brob
1abstract
scorescytogenetic
del7q31q35
wbc100
lpds
por35
or36
gingivitisperiodontitis
atra-target
hoxa10v2
ramba
high-nucleoplasmic
nb4-resistant
centralisation
dependant
studiesxa0havexa0been
burkitt-like
hemovigilance
tie-1
hba1c
intermountain
diversilab
occupant
pretransplantation-
abstraction
transplantation-conditioning
lympho-haemopoietic
extra-pulmonary
birth-weights
clinikal-laboratory
treatment-and-prophylactic
non-autopsied
diseasethe
embalmers
non-whites
cmllbc
a-ra-c
non-myelogenous
gender-specific
adipor1
adipor2
ii-ivgvhd
-infinity
no-effect
nonsignificantabstract
event-tree
fibrillogenesis
opsonization-
phagocytosis-linked
c3bir
c1qr
c5ar
idac-treated
restrospective
non-hyperleukocytosis
nonhyperleukocytic
bfm-
m5-subtype
bclp
complain
exposure--and
heaters
reexamine
microdistribution
plutonium-239
americium-241
uranium-233
intrathoracic
©rsna
wage-subsidised
516gt
gtu2009u2009tt
c516gt
pu2009t
cd16-cd56
pro-thrombotic
broached
anti-oncologic
ret40f
impregnation
red-cell
5q-may
chronicphase
nonimatinib
rubric
all-leukemia
late-occurring
mrci
hld
understandable
aml-q22
cracow
aminophenazone
subgrouped
alpha-ifn-based
ficat-arlet
pediatric-specific
ultraviolet-b
25oh-
oh2-d3
age-groups
nonepidemic
photo-
cd6-depleted
nonbreast
snbcs
faecium
ci3
rate-dependent
c4d-positive
gansu
g463a
pcr-ldr
clabsis
nu202fu202f324
factor-adjusted
pu202fu202f678
non-academic
non-biologic
alerted
nci-sponsored
nilotinib-therapy
non-existent
n671
endovascular
tugt
non-frail
pre-frail
symptom-related
socio-relational
under-reported
lippalate
zhu
-528
achondroplasia
neo-mutations
grandmothers
chi2-test
abruptness
inheriting
co-inherited
cr-bsi
device-specific
t-lymphocyte-depleted
lymphopoiesis-associated
response-failure
lineaged
drb1-matched
th-edearly
10u202f×u202f109l
1u202fgl
countu202fu202f10u202f×u202f109l
post-ahct
relative-risk
mini-beam
non-african
dialed
pre-pregnancy
dyshematopoiesis
hla-a2-a3-a11
hla-dr1
-dr2
-dr3
-dr4
-dr11
hla-dr3
hla-dr4
hla-dr2
hla-b8
positivehla-b8
novi
fitters
xa01
nopho-aml-
nopho-aml-84
-88
pmfsmf
mysec-pm
ruxolitinib-treated
onh
unitsm2d
substantive
5-item
t-cell-repleted
cd94nkg2
1y
4y
8y
58u2005972
miners
well-investigated
case-referent
meatworkers
meatworker
mini-ice
non-infusional
consolidation-1
consolidation-2
eldergli
sae
edemas
rotator
excerpta
medica
-dr-identical
risk-guided
patienttreatment
endocrinology
bu-
linear-quadratic-exponential
lqe
linear-quadratic
multiplies
priors
posteriors
gy-1
person-gray
kermas
r-tl
pristane-induced
qtl
radiation-exposed
gasoline-impacted
leaking
defensible
theraphy-induced
m--f
atrau2009u2009dnrda
atrau2009u2009ato
blankets
munitions
rifle
m-allo
nm-allo
ptb
g-csf-dlis
tpml-raralpha
taml1-eto
emf
14u2009bp
ins14u2009bp
osor
dfsor
primitively
anti-interleukin-5
interleukin-5-producing
rr11
interdependence
ever-smoking
cys34
adductomics
hsa-cys34
nxa0xa041
two-third
psct
aunts
uncles
cousins
petrochemicals
benzene-containing
liquids
meta-smrs
meta-smr
referral-based
analysisabstract
lymphomachronic
rru2009u
methodologically
jak2-targeted
estudio
tratamiento
hemopatias
malignas
score1
is⩽10
angiogenesis-promoting
tgf-α
cytokine-risk
heinrich
heine
matteo
pavia
under-express
prelabor
during-labor
ratiocd
orcd
orprelaborcd
fetusinfant
precesarean
glngln
lyslys
concurring
physiopathogenic
apoptosis-inhibitory
trls
refute
meats
ifn-hydroxyurea
ph-cml
urate-lowering
lysis-related
allopurinol-induced
mpe
hla-b58
dr9
dr14
hla-dr9
sequencingdenaturing
ssdhplc
ssdhplc-detectable
ssdphlc
fvc
dlco
kilometer
ionizations
manmade
masse
inclusively
45standard
fpc
scarlet
growth-factors
scnir
streptozotocin
stz
pdl
cryoprecipitate
university-affiliated
still-evolving
bt-all
mll-germline
osdfs
age14
varices
meta-analytic
pseudo-diagnosis
hayfever
controls--confirming
unreliability
estuaries
presentationantibiotic
proofing
cml-ig4
pre-shortened
cml-g2
telomere-associated
cml-wt
pre-senescent
telomere-induced
creatinines
nonneurotoxic
pp21
rsrs
four-variable
mspc
osteohematology
plzfrar
jagged1notch
pox
carcinogenic-dna
related-cancer
thrombopietic
nonuniversity
microcytosis
int-1-risk
nxa0xa0203
appliedareas
reviewexpert
polychotomous
bloc
severities
nonvascular
stepdown
hbm
irreplaceable
milk-derived
triphosphatedeoxcytidine
dialling
pethemahovon
ic-apl
94xa0
progenitor-stromal
µgm2d
chictr-tnc-10000955
61u2009775
15u2009608
intermediate-high-risk
within-cluster
pseudovalues
recklinghausens
runx1-regulated
ikaros6
ikaros6these
gdr
inducted
omim
transcatheter
ta-tma
cnsc
oldhat1
l1m7
mer90
alralpha
homoplasy
co-migration
aflp-aflp
silico-ngs
pre-tt-all
my-positive
l-pre-pre-b
ifn-alpha-2b
ara-canthracycline-containing
quizartinb
wether
ineligiblerefractory
lenalidomide-related
ires-mediated
cd2cd3
cd2-cd5-cd7
graft-related
donorhost
patients-especially
type-demonstrate
mfaml
less-than-high-risk
sfgm-tc
activepersistent
ampliseq
bench-top
kinase-stat
hygienist
welders
electricians
torino
nonstatistically
petrol
karnataka
dysthrombopoiesis
maori
non-maori
maorinon-maori
toxics
nata
discloses
monosomy7trisomy
partial-ips
setsip
indentified
pips-ecs
patency
cancer-caused
diagnosisu2002a
courseu2002during
conclusionu2002the
dangers
post-randomization
semi-parametric
c481t
g590a
803ag
857ga
non-ionising
hertz
al-risk
leukaemia--multiple
never-drinker
j-shaped
non-cirrhotic
hyper-reactive
malarial
flavanols
epicatechin
flavanol
procyanidin-rich
cocoa-derived
niños
roberto
río
mesoblastic
nephroma
azoospermic
oligo-asthenozoospermic
normozoospermic
miuml
demostrated
inmediately
uncorrected
forabstract
above-stipulated
substratified
time-since-exposure
hematopoietic-to-stromal
pathogeneticpathophysiologic
emphatically
lille
raras
tser
677cc
register-based
under-ascertainment
factor-kb
hi-pu2009u20092
hi-eu2009u20091
pcyru2009u20091
nct01895842
fat-free
bioelectrical
waist
10-kg
10-cm
-ve-ve
veve
ve-ve
-veve
flow-score
flow-scores
non-transfusion-dependent
doses2
cisplatin-etoposide-based
reintensification
tmy
n420
n430
ifn-failure
n128
unobservable
baxter
cs3000
pheresis
purities
mtx-related
runx1xa0and
d816d820
difficile-associated
cdad
denominators
s-nhl
s-st
srsf2mut
zrsr2mut
u2af35mut
zrsr2muttet2wt
triploidy
tp34pll
wtap
perineural
rat-2
n7-methylguanine
mutagenised
rs1800734
ue
dvt
xpc3
mthfrct
cyclophosphamide-treated
677c1298c
m-mf
t-mf
m-mfs
t-mfs
bimodality
poliomyelitis
person-to-person
time-space
like-sex
discordant-sex
genesabstract
pre-lhspcs
pre-lhspc
ins2akita
morrbid
mpnaml
lr-mdas
upstaged
registrants
underexposure
seveso
all-cancer
high-exposure
latency-related
lymphohemopoietic
accident-related
cardiovascular-
endocrine-related
decadron
merck
dohme
eight-eight
vad-cvad
43-gene
leuko-erythroblastic
olmsted
flice
death-domain-like
beta-converting
enzyme-inhibitory
fliplong
flipshort
raebraebt
riskintermediate-1
mds-amlaml
hyl1
residence-matched
tyrtyr
hisarg
weight--a
growth--particularly
1-standard-deviation
1-unit
tyas
power-frequency
urged
inhabited
microt
flt3kdms
squid
exteriorly
exterminations
unstabilized
preanalytical
t10ba3
muromonab-orthoclone
countu2009u200910u2009×u2009109l
fibrinogenu2009u200910u2009×u2009109l
forgetfulness
leptospira
serovar
serogroup
therapy-limiting
cytosar-u
upjohn
kalamazoo
mich
scchn
noxa-mcl1
ahmadabad
gujarat
nxa0xa55
venipunctures
eleventh
choice-an
sibling-is
atraarsenic
atodaunorubicin
atraatomethotrexate
atoatrachemotherapy
orcombined
orall
oraml
scrapings
geneome
diversiﬁcation
haplogroups
heteroplasmies
waist-to-hip
whr
lympho-haematopoietic
terarubicin
thp-adr
avc
se10
assessedxa0in
gm-csf-treated
post-bt
drb4
dqa1
subdiagnostic
disease-manifestation
i21q
sideward
heightens
multi-regression
ibm-pcxt
antipyretics
anlls
caa
cku2009u2009treated
mrc-uk
non-home
mononuclear-blood-cell
gonadotropin-releasing
gnrh
gccr
high-survival
lineage-cd34cd38-
hsce
phenotypesthis
nu2009u20094543
imust
inaccuracies
ud-
id-bmt
gwangju-chonnam
aracdaunorubicin
aplasias
average-risk
rri
dmft
csf-receptor
sulphuric
mists
normalgstt1
arbeitsgemeinschaft
fuer
gynaekologische
onkologie
hlnhl
allll
122u2009373u2009bc
myeloleucosis
alpha-interpheron
cumfm
late-terminating
lateness
adjmad
100--the
estimator--for
three-parameter
300-rad
doses--
sarcomaa
linezolide
male-to-male
overestimates
setbp1-mutated
leukemiahypereosinophilic
adnormalities
oncology-haematology
lichtheimia
splenectomies
psvt
exteriorization
psvts
collects
non-lymphatic
varese
smts
task-based
granulo-
nonpreleukemia
g2dhe
-77-kb
overexpression-neoplasia
qol-adjusted
fine-gray
mdsamlaa
iso-bmi
gastrostomy
kgm2conclusion
malnutritionwhat
known•
patientswhat
new•
secs
non-hl
subsetxa0of
andxa0subjective
tease
p450s
2dc19
cyp450
descended
time-weighted
twa
ascribable
post-accident
cdi-associated
baffling
tenuous
consolidation-mobilization
daunoblastin
premobilization
chlorination
trihalomethanes
dentoalveolar
anti-cytomegalovirus
mutations-based
single-lineage
deviated
postpones
on-shore
shipyard
electrician
welder
ormh
electricité
france--gaz
hydro
hydro-québec
microtesla
1-betad-arabinofuranosylcytosine
nu2009u9
lbmd
fnbmd
disregarded
specificallymethods
dialing
pre-labor
plcd
raceresults
allconclusions
determinedimpact
nine-yr-old
adv-associated
adv-induced
variant-apl
aml98
aml04
nu2009u2009729
npm1-flt3-itd-
identifyed
mdrfish
mdr-fish-
clon
agressive
antileukemical
african-americans
adenocancer
fancb
hla-b13
hla-b55
nomogram-prediction
heteroallelic
g2fgnfgn
neocassette
gata2-null
granulomonocytosis
lineage-biased
hypomorphism
hyperreactive
mf-related
intersections
themthe
noncompliant
noncancer-related
10-yr-old
hla-2-loci-mismatched
ifn-responders
early-death-rate
2004with
swedens
parishes
urbanity
t3801c
modelswe
ci–
typesmoreover
calciphylaxis
viscous
catamnesis
oro-
hypo-pharynx
adj
mds-cas
mds-ca
pre-hdt
post-hdt
advanced-disease
ssf
tral
neurologists
assigns
c1294cg
rs1056836
c-392ag
rs2740574
c638ga
rs9282861
c667ag
rs1801030
hypopituitarism
peri-transplantation
p4502e1
etheno-dna
haematotoxins
alkylating-agent-related
-20q-
nll
185-gene
selector
l-r
h-r
meta-regression
u-shaped
well-adjusted
europeanusa
jpn
cauc
-1del1p
-9del9q
french-american-british-type
unpack
secular
setd1b
cooccurred
thrombogenic
cathethers
icns
kyushu
scintimun
90yy-anti-cd66
radiotoxicity
radiosynthesis
18ff-anti-cd66
18f-acylation
n-succinimidyl-ffluorobenzoate
18fsfb
18f-
99mtc-labeled
99mtctc-anti-cd66
pet-based
area-matched
super-silac
pxd000441
pa1
corn-producing
hog-
chicken-raising
pesticide-
fertilizer-using
non-nationals
henna
conspiratory
broadspectrum
dna-aneuploidies
elbmarsch
16-mo
germanys
boiling-water
reactor
5-km-radius
factors--including
sources--for
ldhfbg
elderly-specific
multimorbidity
co1
n1663
24u2009hours
stem-cell-derived
induction-induced
apl-type
asian-pacific
boygirl
pogonis
twelve0
aml-iii
aml-iii93
13xa0to
15xa0of
hsct-related
ifi-attributable
ketamine
o11
amph
myleloid
b-allnhl
interleukin-2recombinant
262microliters
354microliters
591microliters
689microliters
nil2
combustion
traffic-related
butadiene
ortho-xylene
sua
ltls
aucwbc
aucsua
suaauc
candidin
non-anergic
death-rate
neutrophil-lymphocyte-monocyte-blast
cd34cd
cd34cd-
stemprimitive
38-
nodscid-il2rγ-chain
usur
prearranged
thorotrast-exposed
radiochemical
thorium
bone-seeking
228ra
waianae
mathematic
episodically
21down
ds-tl
hsa21
hsa21-encoded
mir-125b-2
ds-amkltl
gata1s-mutated
st18
21-associated
myall
2188microl
less-responsive
selb
smap1
tirap
13-mbp
adventists
proscription
baptism
ex-smokers
smoking-leukemia
post-herpetic
epopodophyllotoxins
ctep
nmat
maslows
guangci
2011-december
non-hemorrhagic
non-early
ppvs
5mc-dependent
mbd4-deficient
abattoir
6-trichlorophenol
pelts
lymphomagen
ppb
post-labelling
toxin-specific
benzene-dna
scnaml
delta716
radium
226ra
alpha-radiation
icrp
prelabour
bacterial-fungal
perihilar
pcca
iccas
pccas
leukemiabmt
hypoproliferative
ptrp547
ppro784thr
populationsn
byn
fromn
third-look
celiotomy
second-look
highlightedthe
physiopathologic
marcoule
reprocessing
indoors
exposure-effect
protein-expressing
htlv-ii
--12
cvl
hiv-negativity
anti-megakaryocytic
cdw41cdw42
fmc56
fmc8
leukemiajuvenile
rivno
zhytomyr
chernihiv
semirural
pdlim
pdlim7
ppdlim2
blastlike
po4
n-telopeptide
postdasatinib
jwa
454ca
454a
del17q-derived
alpha-pml
5xa0mcgkg
multi-hospital
weight-based
thrombohaemorrhagic
ias3
two-edged
high-interest
arl8b
phaall
under-studied
under-identified
univariant
pretherapeutical
febrility
non-cytogenetic
preterminal
ashkenazi
sepharadic
iga-myeloma
approachabstract
oogs
microscopies
nonblastic
reduplication
fung
yl
nonfiltered
smoking-aml
10p15-p14
gln5his
rs2245191
rs10508293
rs3209896
untagged
nm-bmt
nses
icd-9
erythroid-hyperplasia
cyp2d
cyp2d3
cyp2e
gstt1null
leuke-mia
mll-defined
ae24
fzd3
tanners
ashkelon
cellsmcl
pre-conception
spent-phase
frustrated
bqm--25
non-blastic
time-distribution
fertility-related
oriente
ecologic
locality
kolb
becker
scheller
zugmaier
pralle
wahrendorf
havemann
hesse
toluene-derivatives
acute-graft-versus-host
ara-c-5-triphosphate
fluorescent-polymerase
alf
carba-ns
rt-nested
cross-contamination
klang
hukm
ghkl
smdsaml
mnd
sp100
11q23-associated
inv11p12q23
morbid-mortality
brain-tumor
mid-region
field-densities
low-exposure
cardio-facial-cutaneous
costello
leopard
abnormalitiesareas
n9686
prepregnancy
mesenchymoma
fibroadenomas
health-
af4mll
apl-st
arac-activating
phxa0all
mig-97
iol
btm
repartition
postdonation
sub-processes
areva
radiation-monitored
abi-aspirate
wtl
non-hodkgins
muco-cutaneous
pyridostigmine
leukoses
hrc
raceethnic
effacement
memberane
thrombo-embolism
post-autohct
letermovir
chal
17u2009315
16u2009710
435u2009021
as2o3-based
dyspepsia
68-na
fog1
cell-culture
oss
moabs-
organomegalies
bmt-ctn
z-scores
z-score
5runxrunx1t1
vascularcardiac
second-third-fourth-line
nu2009u2009570
nu2009u2009248
nu2009u2009251
teae
hyperlipidemiahypercholesterolemia
polycythaemic
hydroxy-urea
cdkg
anthracycyclines
managable
gfi136n
ct4n1m0
46xytq22q46idem-9add9p46xy3
034dose-optimization
n2712
kinase-internal
cd34cd2
ide17
zbtb16rarα
stat5brarα
ipsswpss
cd34cd38-cd47
jutland
irrs
mrrs
cytotoxic-t
sub-setting
institution-based
intermediate-adverse
hla-genotypically
wls
tanh
-1x
randomization-based
finite-sample
predomos
domotic
bi-functionally
cancersin
b-cml
oxoreductase
shoemaker
painter
tuff
stillbirths
cot
infancy-that
exposome
roadways
roadway
intra-subtype
nonoccupational
cmlabstract
papulopustular
erk-1
mrad
speedier
n1999
n1111
n2704
mtxcsatcd
dna-polymerase-alpha
venovenous
work-related
endocrine-
cardiac-
lung-complications
orbital-ms
frailties
katsahianbiet
katsahian
hydrothorax
stemregenin1
sr1-generated
night-shift
job-exposure
jem
hr-
hais
hai-associated
labordelivery
tetralogy
fallot
ductus
arteriosus
zhytomir
family-cancer
fdrs
anachronistic
illegally
autocatalytic
confrontational
veras
svcam-1
pro187ser
xrccgln
readingwriting
pre-school
vineland
vabs
temperament
vabss
mann
whitney
kruskal
wallis
temperamental
postictal
pupil
mazandaran
ambiance
grown-up
shortfalls
re-appraised
tja
-176
thrombembolic
omf
disordersabstract
followback
sheos
sheo
eatingdrinking
lai
inject
-488
stubborn
divergences
nondetectable
inv16pq57
tp22q57
inf-alfa
cytokin
n-acetyl-transferase
dioxins
inescapable
non-anthropogenic
installers
plumbers
laborers
patientxa0our
hev-rna
dose-risk
nondrinkers
closely-
fully-matched
under-utilized
ntbi
butyltin
dibutyltin
dbt
deworming
bts
dbt-free
tumor-binding
fev1fvc
myelosuppresive
ium2per
hemopoesis
pabmt
overshooting
concentrationabstract
hla-abdrb1-matched
aer
galpha16
cycler
rtq
reopening
hosp
pericardiostomy
oat
countu20099l
ageu2009u200965
treatment-specified
nu2009u13
inter-independent
dysfunction-induced
splicingprocessing
wernickes
primer-polymerase
kir2dldldldl2
kir2ds1-sds1
kir-ssp
myeloid-lymphoblast
2ds7
2ds6
inxa0dnmt3a
oxygennitrogen
uniting
dnat2
relatedly
ppcs
kcal
lownull
ied
pu200au200a002
pu200au200a014
iodine-131
irradiations
rd-1
confederation
mycology
brighteners
reinterviewed
dysmyelopoietic
177lu
hemopatías
atraanthracycline-based
non-ionizing
mortalitydischarge
hemorrhoid-like
microbiome-based
non-sibling
sics
hyperemesis
95confidence
polyhydramnios
paraná
record-based
mithoxantrone
refador
lachema
15x
zavedos
pharmacia
apbsc
rigidly
diagnosisabstract
beta-thalassemiahb
malignancysolid
allotransplantednon-amlmds
period-
registry-specific
asterisk
ipn
giii-iv
agvh
gii-iv
ct-ci
chemicalsabstract
dn-apl
stromas
inequitable
urdt
intermediate-intensity
tpc1
tpc2
stt
deferring
infectedneutropenic
intermediatehigh-dose
conductors
psychiatrists
masterfile
1137ins
1096ins
363ins
-butadiene
cytokines-
gelatinase-associated
ngal
srage
mflx
tosufloxacin
tflx
practitioner-
patient-perceived
lymphoreticulosarcoma
clinical-genetics
hlms
arthrosis
hlm
tjas
estey
haematolymphoproliferative
hlpd
residence-
non-thyroid
primaries
virus-
currative
tf-binding
co-binding
co-regulating
co-regulator
dna-aneuploidy
ph-ve
bcrve
incubators
purpurogenum
acromonium
strictum
chiba
blackother
rad-172
6-containing
cd44h
v7
v10
v4
bcr-abl10is
sxa0maltophilia
vanillin-functionalized
v-rgo
v-rgo-induced
8-oxo-dg
dna-regulating
harshness
rgo
hole-meal
tomsk
siberia
technogenic
cancer-combating
hla-a11
abstractu3000u3000myelodysplastic
géolocalisation
pédiatriques
geocap
île-de-france
300-m
heavy-traffic
tumourscell
chewers-alcohol
smokers-alcohol
pcnamcl-1
chlorambucil-treated
medicaments
acclimatization
lymphomonocytosis
elfmfs
elfmf
mutrms
pneumoconioses
brucellosis
out-flattening
cytotoxiccytokine
non-reactivation
fcrγ-cd3ζnk
nk-adcc
nk-ifnγ
cytotoxicifnγ
higher-than-expected
transplantationallo-hsct
expectoration
patientsp
crump
paustenbach
hyogo
warissara
jutidamrongphan
tissue-invasive
terminase
lmv
donor-constellation
c325y
ul56
bilirubins
nxa0xa0201
1199ga
vegfi
interruptionreduction
coagulopathyp
-255
tankers
vapors
tank-cleaning
clds
replication-associated
functionxa0of
damage-sensing
nu2009u2009192
nu2009u2009333
p-valueu2009ucohort
angiopioetin-2
clinicoprognostic
cd13-positive
cd13-negative
cd13-aminopeptidase
cd11c-leucamc
cd11b-leucamb
tnf-β
apoptosisacceleration
infusedkg
pv-b19
infectiosum
prima-1met
arterio-occlusive
ato-only
bch-apl2005
mll-rearrangement-negative
endotracheal
mds1-evi1-like-1
rpn1
asymptotically
three-tier
65xa0yr
10-yr
dose-capping
2xa0m²
cg1
cg2
neuropathological
35-nucleotide
worksite
pmrs
asbestos-related
poisonings
homicides
brickmasons
roofers
concreteterrazzo
finishers
boilermakers
styrene-exposed
varian
nonleukemic-derived
zoonotic
churchill
primaries-standardized
mp-sir
hcmv-antibody
anti-cmv-igg
d-r
plzf-rar
alpha-related
hague
srg
mrg
12-gy
basophileseosinophiles
malignencies
lft
atgalg
t-mdst-al
6mp6tg
vm26
tis
non-heart
angiograms
infusate
astrological
zodiac
llme
lysosomatropic
iiiv
instituterome
fanca
automatized
transgenomic
s-tk
radioenzyme
umicroliter
umicroliters
t0m0
mayak
alpha-exposure
pu-239
non-radiation
otolaryngologist-head
otolaryngic
dbar
observed-to-
tumorleukemia
nct00106015
matched-cohort
osteo-hematopoietic
permutational
dict
thrombopoeitic
thrombopoeitin
19pter
①among
low-intermediate-risk
χ462
χ382
χ610
χ833
mirs-374b
-454
mirs-p
-15b
treatment-requiring
promyelocytic-derived
anti-tissue
tf-dependent
nonconvex
regularization
lqu2009u2
regularizations
convex
dcbcl
pensioners
hematolymphoproliferative
exposure-information
aorxa0xa
nonenrollment
aitd
b46
département
bym
overdispersion
south-west
départements
2-case
leukemiamyelofibrosis
macroglobulinemiamyeloma
bmbs
terapéutica
hemopatía
maligna
tri-oxide
mdr-1-associated
m0-m1
singleassociated
uic2-
intermediatefavorable
re-emerge
nitrosamines
proliferativerenewal
lana-1
hif-1alphain
obob
littermate
halfway
psma7
ikbkg
gse37642
regimen-dependent
californians
mutations-including
asxl1-have
sardinia
ddt
insecticide
sprayed
dwellings
shelters
muml
amega
dpo
front-end
madras
jude-type
backward-stepwise
lesion-specific
candiduria
bacteriuria
evolutionally
χ025
epirubicin-based
dose314
tetrasomies
n290
donormale
fdmr
gene-microrna-expression
crohem
timen
desumed
case-case
ttaggg4
bleedingleukostasis
lph
coefficient-based
nonsenseframeshift
mll-independent
preinduction
shouldnt
nore
treatment-eligible
broome
fhc
cih-dac
amsacihdac
mica-mismatched
nct00506922
maxillectomies
drpm
reexamination
tomograms
radionucleotide
laxatives
nonoperatively
non-age-adapted
lpa96lpa99
hijacks
1aca2
topoisomerase2β
top2β
birth-related
dose-response-like
relativity
pericardiectomy
toyama
non-reversible
myelomonopoiesis
myelomono-cytic
declarations
nxa0xa0427
stim2
nxa0xa0224
rrxa0xa
osteoarticular
pre-existent
much-debated
norways
age-estimations
mevalonic
isoprenoids
factor-kappa-b
chemo-attractant
cxa0neoformans
emaco
rhd-e
mdr-reversal
mdr-efflux
g-csf-associated
well-sustained
t-cell-receptor
cd14abstract
motor-driven
razors
dryers
b-field
mtesla
rates-of-change
teslasec
s-ldh
microkatl
gm-tad
rotatingly
spleenliver
cerebro-spinal
severelethal
ex-cigarette
registrars
5-km
1distance
95-cl
radiation-epidemiological
s-mdsaml
nanb
cerevisae
phosphorous
repletion
mcfus
mcfu
exacter
-129
n-ds
jh6
v722i
p132t
p132a
tttc
monocyte-depleting
onko-kiss
under-going
icc-apl-01
eudractct
cysteine-to-threonine
survivable
non-radiotherapy
phycomycosis
overlying
tdra
bcr-to-abl
alois
gianantonio
rosti
dusts
sawdust
lanzhou
cvct
fancq
enteroviruses
chemotherapyrecently
ue2f65
cd49b
hla-b44
supertype
p0003
alpha-2c
megaunits
aht
raebraeb
intelligence-derived
cytobiological
invariability
oligomonoclonal
dismaturation
erytropoetic
plasmacytes
carboplatinpaclitaxel
alkylator-related
mdsal
steroid-deprived
dlx3
thoughtfully
more-prolonged
candidemic
b-susceptible
reaffirmed
vasodilator
meta-predictive
mpn-specific
non-mpn-specific
dasa-pah
judiciously
temptation
metaphyseal
nbl
affectation
vanilmandelic
interview-based
alpha-track
ab0-mismatched
rh-g-csf-mobilized
history-breast
history-early
menarche
non-parity
syndrome-localized
k06
nxa0xa01248
nxa0xa0150
cixa0xa63
nondeletion
nosopoiesis
female-to-male
calpain-calpastatin
ccs
proteases--calpains--performing
inhibitor--calpastatin
calpastatin
capn1
m-calpain
amountactivity
microrna-500
mir-500
mir-500low
mir-500high
b-myosin
gtpasekras
recentlythe
transplantationwith
pathwaysperhaps
imatinibit
similarlypatients
paronychia
ebv-pcr
genomesmcg
mabthera
novarid
hcup-nis
mos-ph
ucud
with-ds
mtdna4977
with-
without-ds
dsmt-ndsratio
non-dsmt-ndsratio
bach1-mir-155
82xa0
atrau2009u2009idarubicin
senectus
null-cellnull-all
tie-2tec
cve
xa0×xa0108kg
pxaxa0×xa0108kg
misoprostol
choledocholithiasis
very-poor-karyotype
aida-0493
aida-2000
rinsky
benzene-associated
assessors
spectratype
abo-identity
abo-compatibility
chemoirradiation
interleukin-2-producing
htlp
race-adjusted
non-8
patients--103
leukemia--and
armitages
trend-test
rs3798577
p-trend
c-allele
rs1801132
rs2228480
rs2228480rs3798577
rs2234693rs9340799
rs2234693
rs2077647
c-risk
t-risk
hrpf
piece-wise
l-mds
h-mds
mad-1
fludarabinebu-based
netilmicin
cidal
lhm
f1i
f1c
lung-tumor-bearing
nodesmouse
leisure-time
heart-disease
deactylase
centrosome-specific
pericentrin
cmlcp
extral
es-fluorescence
q-rt
adult-like
c000000154
hsp70-specific
c92f3b1
mel-1
mel-2
mel-5
aso2
clarks
hsp70-negative
mel-5-positive
hsp70-positive
mel-5-negative
positivemel-5
hsp70mel-5
hla-b-
hla-c-
hla-drb1-
hla-dqb1-matched
permissibility
y-chromosome-encoded
pcdh11y
usp9y
nlgn4y
y-encoded
hla-binding
x-paralogous
11q-qter
2q-q
nonbiological
nbfs
texas-md
ut-mdacc
virginmemory
engl
non-low-risk
gtts
gender-adjusted
postautotransplantation
homografts
technologist
jcv
pre-cyclophosphamide
laa-sensitive
laa-enhanced
laa-suppressed
laa-insensitive
zavedos-zvd
zvd
mercapto-purine
asn630arg631
lys630
three-nucleotide
fdcp-2
1-negative
nct00003593
laferon
haematolymphopoietic
preconceptionprenatal
single-intermediate
cytarabinein
single-id
non-hematology
observed52
pu200au200a031
pu200au200a074
stratage
infectionspatients
venulitis
oxaliplatin-containing
pyrrolizidine
alkaloid-containing
vodi
upper-quadrant
pericentesis
coagulolytic
oxaliplatin-based
institut
gustave-roussy
mechloretamine
midexpiratory
post-cya
non-tumour-related
photo-exposed
gbps
efu2009u200950
pre-anthracycline
let-7a-5p
mir-199b-5p
thrombosis1
anectodal
sequaela
langerhanscell-histiocytosis
wellbeing
preadolescents
psychotherapy
therapy-linked
kinshasa
kuc
bio-clinical
nino
nina
rainy
dependant-kinase
terminations
4--breast
one--testicular
donabedians
structure-process-outcome
feverinfection
apl91
training-validation
del13q14
11q22-q23
imd
eumds
cd4foxp3cd25cd127lowcd45ra-cd27-
tregem
cprm
clinicoradiologic
abcb4
gct-cm
gct-cm-induced
crkp
taspase1-mediated
fyrn
fyrc
siah-mediated
polyubiquitinylation
decoys
key-players
nlrs
injurystress
q705kcard-8
c10x
q705kc10x
ev-pca
d-3
d-7
ev-associated
zymuphen
d-0
d-5
evs-related
d-xa0pgml
4q21
der4
forces-namely
obliterated
imperviousness
suicides
vincristine-adriamycin-dexamethasone
hypoalbuminaemia
myelosuppression-associated
consolidation-intensification
transplant-induced
angio-invasive
otolaryngology
poor-mobilizing
nonpoor-mobilizing
mechlorethamine-procarbazine-containing
abvd-treated
pvb
thpo-r
patient-important
folate-associated
gambian
stx11
cys1
periconceptional
folate-sensitive
incompleteness
ikgge
covariance
cliques
subgraphs
non-implanted
azd5153
leukaemiasmyelodysplasia
fbmt
pre-uninduced
pre-induced
allosct-based
--4
institute-rome
nonretinoblastoma
114xa0patients
level2
prevelance
splemomegaly
precursor-b-acute
split-signal
tlx3
greenred
fusion-signal
false-positivity
january-december
risk-modifying
n505
n1010
travelled
ncdb
mini-methotrexate
proteincrp
adamts-13multivariate
u200au200a
500u200agl
epr-
pu200agata-1
registering
hsct-ci
signaling-60
beta60
hmlh60
pre-pmf
15u2009×u2009109l
hmr
acdvp16
duration-escalation
inducedxa0distinct
jeikeium
intracutaneous
cbfa
ts16
disomic
21q11
ds-specific
non-disjoined
ds-anll
ds-nonleukaemic
counterregulatory
bmasp
double-labelling
bmbx
-211
urd-pbsc
rinma
nct00785525
sinusoidal-obstructive
syndromesos
overdosewe
busulfan–fludarabine
defibrotideliver
h63d
hemochromatosisboth
first-known
nonseminomas
non-anthracycline-containing
fasg
fec100
fec50
5-fuepirubicin
ellencecyclophosphamide
neosar
medicoeconomic
low--approximately
oseltamivir
elixhauser
nonteaching
ptdm
1mb
cd34cd15-
cd34cd14-
cr-rate
cross-referencing
phtn
nonthrombotic
post-tips
in-stent
omani
antithymoglobulin
kaplan-meier-estimated
bad-risk
n76
mace
nrascblezh2
mugl
c282y
technicians
leukocytosisthrombocytosis
osha
epas
benzene-related
mll-pafc
indiscriminately
proleukemogenic
e2a-hlf
s-mds
mechlorethamine-containing
2gm2
cyclophosphomide
methobrexate
s-amls-mds
sdm
cinrm
revised-ipss
20yr
35yr
waterbeds
gata-1gata-3
miscarriagestillbirth
mapk8
tp53-myc-prkac
hnrnpa2b1
cytogenetic-specific
beta-o-linked
o-glcnac
erythropoietins
epo-treated
iuwk
mll9601
mll9602
prediposed
clinico-laboratory
care-associated
ha-bsi
poorvery
non-pct
sieglova
converted-aml
overweightobesity
sllcll
taller
fatness
continents
repairers
linemen
non-saa
georgii
nonelectrical
milligauss
idsa
accpsccm
non-adapted
ratesystolic
creactive
clinico-haematologic
erythremic
diguglielmo
del5q13q
i8q
add11
3mar
fmea
events-free
non-mature
depressions
diagnosedacute
basalioma
mycbp2
ikarosmycbp2c-myc
tnf-308
tnf-863
-863
χ53
df-2
propro
bacillary
angiomatosis
quintana
5mum2
ph-suppression
doap
o-prism
tfeb
self-generation
six-
clonesabstract
epipodophyllotoxin-associated
null-gstt1
wild-type-gstt1
post-traumatic
ptss
npcss
sentieri
out-clinic
aml-hl
aktpi-plc
pi-plcbeta1cyclin
epo-induced
non-typhoidal
harare
non-hiv
vue
non-central
bk-hc
hla-dr1-
ii--iv
allele-associated
hyper-responsiveness
sf3b1mutdnmt3amut
post-chronic
post-ld
ldt-aml
-dqb1-matched
never-smokers
healthiness
rifnalpha2b
rifnalpha2b-based
interleukin-11
gehan-breslow
autotransplant-supported
qlq
c-30
assessements
cgaqol
up-and-go
lactococcus
lactis
helix-loop
ida-related
deigs
klc3
snord3b-1
nfatc4
xcr1
lefty1
iisalp
w515kl
calr-positive
asahii
inkin
accesses
hickman-broviac
hla-drb107
hla-drb103
hla-dqb104
hla-drb104
-dqb103
-dqb102
d-xylose
ibmfs
fabrca
tbd
shwachman
washington-born
unmarried
engraftment1
foramen
ovale
right-to-left
spinster
spns
spns2
spns3
pspns3
sema3c
gsta3
slc15a1
psmb10
tnfrsf10d
psmb2
cml-risk-allele
risk-allele
tdrkh
inconstant
kantarjians
nonthyroid
graft-
ⅰⅱ
χ639
χ157
χ153
χ831
χ287
scid-x1
methylguanine
suicided
firefighter
leukemia--regardless
treatment--since
rs7590760
mctr
lancashire
small-area
monotonic
townsend
incineration
xa0ng
teqm3
pseudo-pelger-huët
pinteraction
rican
spongiocavernous
pe-bmt
givenintended
non-transferrin
non-multidrug-resistant
grounding
residentially
nonvertical
cutpoints
qtd
qtcd
cytologico-clinical
pdk
pdk2
pdk3
adsorbent
eorgy
post-polycythaemic
olanzapine
psychotropics
normalabnormal
pathophysiolgy
half-brother
full-sib
imprecisely
sex-match
female----male
bricks
prefabricated
-xa0
productiondistribution
productschemicals
ceps
vegf-receptor2
french--american--british
svegfr2
n315
n178
andxa0low-density
werexa0independent
factorsxa0for
easy-to-use
calr-1
calr-2
acid-locked
pna-lna
loop-mediated
intra-batch
inter-batch
60u202fmin
cd-like
chiplamp
kendalls
taub
undeveloped
busulphan-based
fetuin-a
ageu200a70
sokal-risk
tactic
evr
predonisolone
treatment-relevant
anti-brdu
diff-
case-controlled
ki-67-positivity
apoptosisproliferation
equalized
raeb-tmds-aml
baxbad
bcl-2bcl-x
baxbadbcl-2bcl-x
auers
splinters
allele-disease
smcd
ⅲ
non-teratoma
culturingexpansion
sorting-based
zygomycosisa
csf-
diligent
14c-imatinib
nu200au200a64
sitestypes
swedish-
powerlines
multitransfused
nonlymphocyctic
radiotherapy-chemotherapy
mantel-cox
amfotericin
periperal
analogously
twinning
mascota
parotitis
orifice
r88
msp-based
msp-derived
massarray-based
sequence-context
discriminator
lrf
aml14i
aml14ni
neuropsychologic
cancercigarette
nonarteritic
naion
profibrinolytic
photofluorographic
mycbcl2
breed-specific
boxer
arteriothrombotic
cv-
at-aes
at-ae
nct00048672
nct00038649
nct00050531
nct00254423
nct00129740
nct01570868
fibrinolytic-type
dyslipidaemia
hospital-matched
eminent
rasa4
multivitamin
ds-leukaemia
forpolycythemia
erythropoietin-independence
megakaryocyte-specific
malena
casp9u2009-u20091263au2009u2009g
rs4645978
casp9u2009-u2009712cu2009u2009t
rs4645981
casp9u2009-u2009293275del
cgtgaggtc
agtgcgggga
-293del
rs4645982
ex5u2009u200932gu2009u2009a
rs1052576
casp9u2009-u20091263
casp9u2009-u2009712
g-del-c-a
g-del-t-a
multidimensionality
casp9u2009-u2009293del
caspau2009u2009g
-712cu2009u2009t
oxaloacetate
syntomycin
non-causal
alphanumeric
designations
promyelocyteearly
stat5b-rara
r276w
d-sorbitol
d-galactose
d-glucose
clinical-stage
f8
l19
f16
f8-il2
antibody-cytokine
cpeb4
fittingly
convection
viabilities
thrombocythemiarecent
mpn-working
mpn-wg
indiathis
alpaca
thrift
cachectic
lethargic
nonregenerative
progranulocytes
cd172a-positive
therapies-ie
midostaurin-a
abreast
ever-changing
unlocked
atra-driven
myeloid-differentiation-associated
nod-severe
pro-differentiative
multimutation
mpn-treatment
ultrasonic
acylcarnitines
10⁻⁶
10⁻⁵
10⁻⁴
anti-protozoa
anti-leukemiceffect
overexuberant
erythroid-myeloid
mpd-aml
r-cd80
r-cd86
belgrade
⁻
nonlobulated
nvp-auy922-ag
constative
patient-access
hydroxyurea-related
inhibitorselect™
combia
bliss
tacs
⩽50
cdkcrk
fascaplysin
reference-drug
leukemiamyeloid
gata-3-positive
cmlxa0and
administrationxa0type-two
ngs-
clia-certified
lpb
aldhdim‑expressing
aldhdim-expressing
fixed-duration
engrafter
nonengrafter
leukemic-ltc-initiating
noncharacterized
intermediate-risk-group
2-chloro-3-alkyl--naphthoquinone
2-chloro-3-ethyl-7-trimethoxy--naphthoquinone
poly-γ
mt-tfa
dissipations
gssg
2-chloro--naphthoquinone
diallyl
dads
annexin-fitc
anti-lc3
dads-induced
dads-
atg-induced
complement-independent
tnfrsf8
cd30-targeted
chondroid
chondroblastoma
analyser
nurse-like
xe
cohens
vn
banded
pki67
contenting
dnns
single-layer
vrlmethods
shredded
analysesresults
mum-1
fgfr1-rearranged
pdcl
ilt7
non-pdc
orchidectomy
notopterol
isothiocyanatefitcpropidium
expresstion
irta1
mzls
multilobulated
megakaryocyticgranulocytic
prv-1
methodist
der1p36
eyeball
haze
retro-bulbar
fibrocollagenous
lympho-monocytic
fluoro-deoxyglucose-avid
dispersely
aspirationbiopsy
nct01844765
pvet
lf-mf
hf-mf
adipogenicosteogenicchondrogenic
hd-derived
mpn-msc
activina
hln
features1
dyads
cd45lowssclowcd14-cd123
cd45lowssclowcd14-cd123u2009u2009clec12a
cavia
porcellus
zoopath
cystadenoma
follicular-compact
hepatopathies
cardiomyopathies
nephropathies
re-starting
re-initiated
n-phenyl-4-thiazol-5-ylpyrimidin-2-amines
4-indol-3-yl-n-phenylpyrimidin-2-amines
non-tumoural
nc-svt
andxa0detection
ephb4-mediated
haematologistshaematopathologists
multinuclearity
megaloblastosis
stat5s
tackling
case-only
ganglioside-dependent
ganglioside-deficient
ganglioside-rich
t26
19-amino
t26-positive
aml-fab
patients-283
mpns-for
npm1mut-transformed
pathology-confirmed
ring-enhancing
dura-based
metalloenzyme-inhibitor
cell-1
--epicatechin
v-positive
combatting
benignreactive
post-pvet
scarcewe
100u200a×u200a10l
symptomsforty-two
basilar
nu200au200a13
midlung
nu200au200a2hyperleukocytic
lchlangerhans
salmon-
axa0dramatic
seldi-tof
amazonas
proximate
carboxyfluoresceine
succinimidyl-ester
dssn
distyrylstilbene
oligoelectrolyte
nras-g12d
acmlcnl
pelger-like
non-pelger
clumping
macropolycytes
polyglobulia
opossums
didelphis
virginiana
utcvm
lepidic-predominant
trichoblastoma
osteoma
captive
elbow
regularities
ipnd
reduction-oxidation
fox-related
vibsanol
vibsane-type
pkcerk
pamps
crit
u200agdl
ro6867520
ro-bir2
bir2
apoptotic-related
abstaining
ixp10
xixp10
xidicxq13
x-inactive
cid-o
nu2009u20099116
cid-o3
transanal
stress-at
ones-on
non-starving
dcmr
100u2009×u
u2009l-1
vertebroplasty
hhms
hhm
time-horizon
cost-utility
€quality-adjusted
€qaly
latrogenic
addmition
mistreated
augmentin
ncb
abt-199-treated
lublin
822ngml
1099ngml
multi-analytical
transplantationhistory
paleness
fdgpet
hemodiluted
bmas
clotscores
hba1
ihc-bm
bmtp
cd123-aptamer-mediated
zw25
cy30
cd123u2009u2009aml
ligand-modified
cd123u2009u2009cells
aptamer-mediated
hu-resistantintolerant
hematoxylin-eosin-stained
cd99-positive
bcr-calcineurin-binding
1-abl1
-cm
bm2
sbb
anbe
anae
m0-
vegf-vegf
anti-vegfr
re-infiltration
histopathologies
medicarpin
tbid
ros-jnk-chop
med-induced
uninsurance
t2n0m0
retroperitonealy
pmhc
pasd1
melana
wt-134
muc-958
pjp
imputation
investigator-adjudicated
haematopathies
invades
outcompeting
short-timescale
dualxa0pulse
butxa0we
ousting
dermatitis-like
csfr3
rs3pe
leukemia-bone
2-photon
calvarium
cells-bm
cd2-associated
physical-qol
ii-negative
kawasaki
re-attracted
haploidy
hard-to-classify
frk
delocalisation
cnpm1
16pq22
46xxder12tq24q22der16inv16p13q22t
lymphomaleukaemia
dmins
invq6
chirurgic
lam3
karytype
tumor-selected
star-isolated
nb157
desires
t3p-dmso
2-amino-chromene-3-carbonitriles
malanonitrile
π-stacking
compressing
non-cultured
tri-phasic
interferon-alpha2a
treatment-free-remission
hlpds
sign-out
addendum
hematopathologist
finalized
flt3-mutation
therapy-response
therapy-options
rhetoric
hype
performedlight
microulcerations
velutinosus
leucine-zipper
ots167
non-respondent
trepanobiopsy
preblastic
cd62-l
cd183
cellsvs
χ499
pχ734
fish-ccyr
peptidase-42
splice-variants
polymorphism-arrays
18f-fluorodeoxyglucose-positron
fdg-pet
fdg-uptake
orazi
bauman
hihc
h-mdsrcc
mcpg-odn-trp2-lipo
region-abl-positive
fdg-avid
superscan
nizams
emcts
follows--skin
granulocyticmegakaryocytic
cord-like
effacing
underwhelming
n-5-tert-butylisoxazol-3-yl-n-phenylurea
flt3-itd-bearing
n-5-tert-butylisoxazol-3-yl-n--methoxyimidazo-apyridin-2-ylphenylurea
therapic
ach
kleihauer
rh-d
elevated-hbf
foeto-maternal
ldct
cxr
bcr-abldelexon7
abldelexon7
free-text
rank-l
april-producing
tocopherols
tocotrienols
anti-cancerous
γ-tocotrienol
splenosis
rupturesplenectomy
5-centimeter
blurring
a2b-induced
bay-treated
mitoxantrone-cytarabine-etoposide
techniques--besides
thawing--are
hsc-progenitor
outcompeted
list-mode
meanly
granulocyte-lineage
cd34-positivecd33-positive
cd34-positivecd10-positive
sarcomaprimitive
espnet
hcu
non-aml-related
pppm
lymphomaleukemiaplasma
not-reached
fluorescence-in-situ
atm-deletion
u2029
automatable
erhytroblasts
raman-based
micro-spectroscopy
mds-rs
dilema
bcrabl-es
rapidness
rfds
selex
10xa0nm
patientsfor
cholangiography
wdsm
thrilling
cmdscs
tumor-evolution
herewith
tggrm1epv
grm1
gp100-peptide
gr-1hi
gr-1int
cd11cf
monocytic-lineage
euroflow
kh1c12
kk1b10
kk1d04
muay
aggressor
punched
gni
asr
oceania
effaces
gsk621
eif2αatf4
mtorc1-overactivated
neoformation
mdasi
mdasi-cml
debriefing
known-group
reliabilities
soreness
cramping
remembering
hystiocitoid
craniotomy
tumour-like
lympho-hemopoietic
igh-light-chain
rakicidin
diene
c-14
c-15
c-16
4-methylester
€7606
jiangsu
recognises
thailands
siriraj
issuestwo
tirosine-kinase
non-consecutive
intra-familiar
decisionsmonitoring
trx-1
1-methylpropyl
2-imidazolyl
px-12
macroglobulinaemia
extracranial-intracranial
opting
eortcmycosis
retro-spectively
re-classify
idachidac
antibacterials
ppx
institution-specific
oct-2
prkg2pdgfrb
tq21q33
-5-kts
-5kts
5-kts
5kts
cd11bgr-1cd44
cd11bgr-1il-17a
cd62lcd4
cd62lcd8
mutantion
cd131
sensorimotor
plms
somatosensory
spect
inos-producing
il-13-producting
il-4ralpha--
chmfl-074
5hu9
score03
tgi
tgfα
1jak2
nxa0xa02233
low-platelet
xa0×xa0109
nct01493414
sar103168
pyrido
pyridimidine
ic02
p-130cas
ctv1
clinicopathology
jak2xa0inhibitor
interphases
acidarsenic
haemostaseological
countxa0500xa0×xa0109
avws
non-standard
demographical
angiocientric
angiodestructive
lymphoproliferation
bebv
mum1
bob-1
ish
rhogef
tmjs
symptom-management
psycho-emotional
discouraged
distraction
dual-species
cells-including
mdscs-was
medium-grade
micropapillary
innumerable
thoughtful
fdg-positron
pointers
ulceronodular
hercs
hect
herc1
-promoting
2-phenylaminopyrimidine-type
hematlogic
glanzmanns
subsite
hypermetabolic
cd45cre
cd45-expressing
eca
monocyticendothelial
angiopoietintie-2
ruled-out
2006the
cd22cd7cd5
pre-pdc
m0-aml
bmtb
aml-md
bmtbs
nonpharmacological
cns-penetrating
non-medicare
marketscan
prediagnosis
ctla-4b7
dont-eat
counter-receptor
sp142
e1j2j
interdigitating
myeloid-driven
categorizable
muramidase
cycd68
ultrasonograph
huamanized
self-probing
scorpions
treatmentn
who-eortc
non-hyperleukocytic
grief
pervading
emotionally
camaraderie
lipid-polymeric
nano-system
lphn
lphns
ha-doxga-lphns
doxga
anasarca
nsp
cdr1
cdr2
crr1
crr2
n-1-benzylpiperidin-4-yl--dimethoxy--methyl--diazepan-1-ylquinazolin-4-amine
sa-β-galactosidase
ratification
discontinuity
non-is
cxm
office-based
obps
luks-pv
panton-valentine
leucocidin
pvl
v-pe7-aad
qrt-polymerase
luks-pv-induced
n249
-diamino-4-methoxyflavone
dd1
ser136
thr389-phosphorylation
dd1-mediated
disrepute
postodontectomy
associative
8-yr
malperfusion
karyotype-phenotype
1qq32
1q--1q
der6tqp-23
1qp11
fab-class
intra-parenchymal
carbuncle
saucerization
flow-cytometer
macroeconomic
-bi97d6
bakbax-dependent
anti-myeloperoxidase
anti-cd68
anti-lysozyme
75xa0mlmin
xa0m2
interferon-αstem
oligopeptides-conjugated
as-ni
niche-targeted
megaloblasts
neoplasm-bpdcn
exhibitors
anti-cd71
post-separation
ifn-i-producing
genotypical
thexa0bcr-ablxa0fusion
pyrosequencing-based
dbs
pval617phe
plys385fs47
plys700glu
deletedamplified
clb-aml
c₀
3000u2009ngml
ugt1a28
500u2009ngml
800u2009ngml
c₂
50u2009ngml
u2009ngml
topped
overtake
dichotomizing
restraints
late-appearing
45xyinv3q21qidem
metastasis-bearing
cancer-suffering
cobalt-peg5000
huargico-peg5000
huargico-peg5000-induced
lods
thioaptamer
overburdened
pharmacist-monitored
shaped-some
microlubulated
margins-hypoechoic
bi-rads
histopthological
fschigh
sschigh
fsclowssclow
crampy
concentration-response
ly96
arrb2
comt
rs6853
wsr
patient-population
non-ms
pelvisgenitourinary
eyesgonads
lymphatichematopoietic
nano-biotechnology
cytosensing
glassy
gce
nano-materials
polydimethyl
pdda
cnts
devd-peptide
biotin-gly-asp-gly-asp-glu-val-asp-gly-cys
au-s
retest
dpv
benignity
ibto
baghiatallah
ly6b
th2m2
cytometery
restlessness
moderate-to-marked
alpha-galactosylceramide
alpha-galactosylceramide-loaded
nontender
unequipped
cd40-deficient
cd40-cd40l
poc
patienthospital
promeyelocytic
retrieving
oxygen-activated
800nm
760nm
phlegmonous
extractions
tracheotomies
monocyte-differentiated
pathologist-assigned
histiocytosis-affected
pa59e
pg12v
pq61r
telehematology
cytologists
aml-2001
telediagnosis
elastase-expressing
macrophagesmicroglia
mln
tq33q32
methodsaims
ccdc88c
ccdc88c-pdgfrb
systemic-onset
jia
fratricide
dara
parthenolide-saha
ic50u202fu202fu202fµm
nmzl
neuro-image
hippel--lindau-related
hippel--lindau
platelet-activating-factor
unfrequently
tenaciously
neoplastic-like
fatally
tnk-cell
cd303bdca-2
clinch
brasil
tlr2-binding
pep2
penetrated
tlr2-dependent
dklaklak2
tlr2high
tlr2low
pep2-dklaklak2
nonhemopoietic
nhns
acrosome
polycomorbidities
ageu2009u200980
broncopulmonar
toxin-mediated
ccr2-expressing
lama84u202fcells
cd34u202fu202fstemprogenitor
lgk-974
xav939
wnt-driven
kerala
stunting
anthroplus
postpubertal
mid-parental
mu2009u200921
fu2009u200915
angiocidin
angiocidincytosine
p-cmyc
psycinfo
well-implemented
fgfr1-associated
tracheobronchitis
n210
averse
irrational
imatinibcytarabine
imatinibinterferon
imatinibifn
disordersmyelodysplastic
aetiopathogenetic
protract
modificationdrug
igfr1
ogs
macrocephaly
α‑tomatine
glycoalkaloid
lycopersicon
esculentum
tomatidine
tomatine
membrane‑associated
12‑o‑tetradecanoylphorbol‑13‑acetate
anti‑leukemia
sub-typing
mc-differentiation
mc-component
myelomastocytic
wnk1
mapk7
clec12a-
cytogeneticngs-based
lymphopath
noncutaneous
misclassifications
misgrading
-oxoallkyl--dimethoxy--naphthoquinone-s17
dmnq-s17
-bis
2-methoxy-4-nitro-5-sulfophenyl-2h-tetrazolium-5-carboxanilide
eletrophoretic
haematogones
meta-heuristic
succeeds
pu202f
transplant-variant
cyto-id
tipping
myxovirus
clacd162
cidp
naf-sensitive
latterly
methodologists
mimick
targeted-therapy
permutations
deploying
clinicaltranslational
tri-epoxide
pro-drug-minnelide
havexa0shown
polyribocytidylic
cellselectroporation
encephalopathic
prefibroticearly
döhner
erdheim
cd1a-negative
periaortic
infiltrationfibrosis
xanthelasmas
108x1
143x1
smudge
alpha-naphtyl-acetate
cd20dim
fmc7dim
chaindim
bcl-1jh
tgf-β1-mediated
itregs
cystinecysteine
ppversus
ppbcr-abl1-negative
skinfold
gonadotrophins
norwegians
pituitary-gonadal
dst-
non-dst
dst-guided
dst-treated
non-dst-guided
sarcomams．
wannan
fars
serglycin
100xa0000
maternities
iugr
pre-conceptual
post-partum
obstetrician
practise
thrombogenicity
nu2009u20091633
nu2009u20091097
p95
p95a
lel
rsr
pell
mo-aml
digitalizing
xplore
handsearching
septicemia-induced
haptoglobin-hemoglobin
cd163-expressing
d-mediated
src-3
ncoa3
plantkingdom
amphiphiles
side-scatter-gated
cd75
karyotypexa0asxl1
patientsxa0without
asxl1-
novoxa0aml-mrc
ofgene-expression
previously-identified
genetically-defined
prognostically-relevant
infero-lateral
auricle
pedsql
brisk
norimatinib
klf-4
hαt
α-tryptase
tpsab1
hymenoptera
patient´s
wbrt
high-output
particulars
literaturen
describen
implementations
decade-long
hereto
rt-multiplex
overlap-neoplasm
metachromatically
tryptase-staining
holstein
monopegylated
registration-directed
5xa0×xa0108
10xa0×xa01010
ae1ae3
perceive
functional-assessment-of-cancer-therapy-leukemia
hospital-anxiety-and-depression-scale
72-hours
βu2009u
βu2009u08
oms
α-isoform
solubility-driven
gsk-3αβ
gasc1
aml-m6b
b19-induced
dunedin
choct1
choct745
nerve-conduction
peroneal
faggot
mnt
mycmaxmad
e6apc843a
-1751
perfusion-weighted
cd177
κλ
re-exposition
mln9708-mln2238
mln2238
mln9708
annexinv-pi
nfκb1
mln22238
hivhepatitis
organopalladium
nn-dimethyl-1-phenethylamine
dmpa
-ethanebisdiphenylphosphine
dppe
cyclopalladated
pd2rc2
7b
7b-induced
palladacycle
c1192cu2009u2009t
hemograms
denser
nurture
self-manage
vasculitis-like
∼67
inxa0aml
il-1il1r1p38mapk
chromosome-positivity
inter-leukemic
β1integrin
tnt-like
rhogtpases
microsurgery
biq
aziridine
bis-aziridinyl
bis-dimethylamine
isostere
therapy-attributable
reimbursed
femura
gö6976
3-hydroxyisoindolin-1-one
10a-q
palladium-catalyzed
brd4-inhibitory
10e
80u202fnm
365u202fnm
humanpromyelocytic
emls
pn-mpn
pn-mpns
inocculum
myelo-erythropoiesis
myelo-erythroid
lymphomas2
monomorphous
killer-lymphoid
markers3
diagnosis4
semiquantitatively
trem-1trem-2
designu2003case
objectiveu2003myeloid
methodsu2003a
resultsu2003at
conclusionsu2003spinal
basepair
knowleges
actualisation
opinionleaders
synergistic-to-additive
piperlongumine
pl-hdaci
c2-chloro
c7-c8
olefin
exudate
pas-positive
thioaptamers
pinkish-red
administration-licensed
myloblasts
lam0
flavokawain
fkb
kava
chancre
uhplc-q-tofms-based
metabolomoc
d-glutamine
d-glutamate
hypotaurine
uhplc-
deserved
ccg1891
56xyxyy57idemy19
46xytppxy1
one-plus-one
plasmidic
jak2wild
arms-pcr
gdnacdna
nitidine
microenvironmentniche
adelphi
self-completion
euroqol
5-dimensions
eq-5d-3l
eq-5d
visual-analog
fact-general
freshly-drawn
anonymization
tsukuba
t-credo
contemplates
thereshold
billons
non-diagnosis
discrete-continuous
pexmetinib
arry-614
tie-2p38
daunorubicin-selected
tanimoto
pubchemdatabase
similars
propertiesand
polys
monos
myeloid-appearing
cebpαmutations
eliding
genetically-identical
confonders
gpr56cells
cd34-and
cd34fractions
cd34cd38-lsc
abcb1p-glycoprotein
abcg2bcrp
pcrkl
pgp-negative
aatc
th1-enriched
aatc-containing
aatc-induced
th1-enriching
del5q-negative
del5q-positive
monolobated
ube2g2
vegf-mediated
non-pneumocystis
nct00020800
if-a
ciap
non-tumor-associated
non-tdln
ln-targeting
np-conjugate
taa-np
cpg-np
nonendogenous
tdln-targeting
non-tdln-targeting
ln-resident
3granulocyte-macrophage
gö6983
mpd-associated
u937mdr
reducingxa0bm
assayxa0model
jak2-stat3
therapyalthough
myeloloid
acceleratedmyeloblastic
131i-hum-437
romanowsky-stained
10e6kg
tpn
m-krasg12d
nmh
nf-kappab-regulated
hga
karnofskylansky
2tki
invasion-associated
hk36me2h4k16ac
cldn1cdh1
h3k36me2h4k16ac
zmynd8-overexpressed
hmc-1--hmc-
sm-related
p53mva
responsesresults
p53mvagemcitabine
p00042
p027
p0017
mcl-1-dependence
protein-mediated
vorinostatgo
complex-1
ifnα-regulated
bmi1-silenced
bime2f7
lncap-il6
cnto
lncap-il-6
uraciltegafur
arginine-deplete
β-arrestin1-induced
4t1il-1beta
il-1beta-induced
sc66
col11a1
delve
β-blocker
50u2009×ul
iago
campare
beween
imcr
hoxa4-
15meis1
β-lactamases
esbl
carbapenemase
colistin-resistant
acinetobacter
dreadfully
b-rafv600e
goodness-of-fit
gsk3β-dependent
phosphorylation-dead
liberated
degradation-independent
non‑hodgkins
kappa‑light‑chain‑enhancer
st2825
l265p‑expressing
l265p‑associated
interferon‑β
l265p‑dlbcl
myddosome‑assembly
excellences
carboxy--dichlorofluorescein
af17
hermes-3
imatinibe
if-alpha
btk-dependent
mid-1990s
rs5744174f616l
rs2072493n592s
mentorship
estonian
fa-2-b-β
murrill
ilk-targeted
leaflets
p4-atpase
flippase
tmem30a
n585
single-marker
casp7
discovery-bmt
humanexome
single-variant
gene-level
drm
testis-expressed
tex38
skat-o
or51d1
alpp
emid1
slc44a5
hhat
lyzl4
clat
diseases-oncology
gsk-3βgalectin-3-regulated
transcription-dependently
inhibited-either
formation-which
26-kda
mtnf-α
17-kda
dysre-gulation
c-fes
coiled
l145p
l334p
hf-treated
hl-60dnr
mackay
tpog-aml-97a
tpog-apl-97
apl-2001
genomic-based
p50--
hussein
mds-htf
samlmds-htf
non-poor
ue2fa1
anti-plgf
errf
erbb2-positive
lapatinib-resistant
bt-474
errf-enhanced
instigators
bevacizumab-treated
tme-targeting
-δ
cyslt1r
montelukast
cyslt1r-expressing
montelukast-induced
k562jurl-mk1
inxa0vivo-like
cyclooxygenase-2cox-2
leukemialymphoma-1a
tcl1a
tcl1a-upstream
tcl1a-repressive
mir-484
tcl1as
pan-evi1
normal-tissue
evi1tcl1a
tcl1a-high
337-patient
phospho-kinase
bcr-induced
ca-flux
evi1-targeted
bbi608-resistant
apoptosis-modifying
nominating
ortholog-paired
angptls
r-maclo-ivam
mipi
pdt-generated
photooxidative
gata-1fl
gata-1s
compartmentation
hydrolysed-catalpol
h-catalpol
hydrolysed-aucubin
h-aucubin
catalpol
aucubin
iridoids
lymphatic-specific
hematopoietic-myeloid
nondifferentiated
bc-induced
unstained
dni
cd123-neutralizing
cytarabinedaunorubicin-treated
dutp-nick-end
tnf-α-treated
cryptotanshinonetnf-α-induced
tellurium
as101
exofacial
pi3kaktbcl2
heightening
reposition
vla-4-mediated
aml1-rearranged
kit-d816-positiveaml1-eto-positive
who-based
sig1r
mortalitythis
shrnai
piga
6pupd
mutationsevolution
tryptase-containing
heparin-complexed
marrow-
serum-tryptase
tryptase-rich
integrin-dependent
fibril
anti-interleukin-3
7g3
il-3-mediated
luciferase-transfected
cb17-prkdc
scidj
4t1-luciferase
cancer-survival
period-analysis
ralb-tbk1
swogs
hla-drlowcd14cd11bcd33
tgfβ-dependent
ebc1
usurped
rogue
δ-tocopherol
δ-t
tocopherol
ppar-γ
umcl
edd
a2780ip2
ovcar5
beta-independent
nanoliposomal
-dioleoyl-sn-glycero-3-phophatidylcholine
dopc
sirnadopc
es-9
a2780ip9
es-4
a2780ip3
thbd
rsac
2729c
2729a
rs3176123
lrp-positive
k562i-s9
-acetyloxycyclohexylamino-
-trimethyl-4-oxo-
-tetrahydro-1h-indazol-1-yl-benzamide
bj-b11
bj-b11-induced
anti-survival
agnps
polyol
cross-interactions
m5-type
mln8237s
lcl204
perk-eif2α
recolonizing
cd52-targeted
spleen-preserving
post-splenectomy
ratios-
sigm
md4
hen
xbp-1s
haad
anti-malaria
historical-control
u200965
groupscrcri
pu2009umedian
alpep
pmlrara-mediated
phenocopying
loxl
copper-dependent
metalloenzymes
atp7a
fit-frail
ly-6g-transgenic
αgr-1
αly-6g
depletion-resistant
predominatealthough
cd33aml
widest
nx0101
hn10py01
alv-j-infected
ndv
hl-60doxo
hl-60np16
hl-60vp16
pre-mitochondrial
f-12509a
phosphatidyl-inositol
cd28-cd80cd86
vkmyc
hospital-level
myd8
l265s
y196h
y196n
y196d
y196f
y196x
mutation-carrying
patientfamily
asynergistic
small-bowel
semicircular
microperforation
7-ketocholesterol
7kc
β3ilk-mediated
cxcl9cxcl10
well-informed
ascato
non-quantitative
re-constituted
myms
pd-1b7-h1
lymphocyte-mediated
eurocare-5
tq23q21
kmt2a-usp8
myeloproliferative-like
hll
cewbc
pre-apheresis
death-ligand1
monocytic-myeloid-derived
dxa0xa026
meku2009→u2009erk
pi3ku2009→u2009akt
dusp-flank
proximal-promoter
biib021
b3adp210
32dp210-t315i
akt-mtor-ulk1
biib021-triggered
biib021-treated
non-t-cell-inflamed
vegfang-2
blys
blys-mediated
tumorspheres
enveloped
mtrop2
mtrop2-specific
x3
pro-myeloma
abr-238901
ps-odn
corniculatus
bieb
mds-e
mds-ne
garment
radiotherapy-only
mitigators
gmb-475
shc
ium2d
ifn-alpha-plus-ldac
combretastatin-a4
ca-4
combretum
caffrum
-diaryl-2-azetidinone
β-lactam
-trans
isomerization
ca-432
snail-related
bcr-abl-associated
c935xa0xa04at
pt360ifs33
pv152g
ps217ifs4
pr311
pr369
cis-apcn
δ716n
smad4n
-n
bv8prok2
cic-associated
anti-vegf-resistant
zmym2-fgfr1
hepatospenomegaly
cd45u2009u2009cd34u2009u2009cd13
n-hydroxyl
sulfationglucoronidation-based
interleukin-6stat3
atovaquone-treated
chac1
redd1-mediated
oncology-bone
aieop-tmo
phosphatidyl-inositide
4ebp-1
sub-aml
8u2009u2009dose-dense
ham-ham
21u2009u2009standard
nu2009u2009203
gene-i
5-triphosphate-modified
ppp-rna
s159
mcl-1wt
mcl-1s159a
∼95
a419259
s32s36
belinostat-mediated
k310
p52
belinostatbortezomib
k40
disparities-using
rp-in
zinc08764498
hit1
zinc12891610
hit2
met-318
10-ns
abl-hit
flai-5
idaraubicin
flai-5ara-cu2009u2009ida
lyn-mediated
myl-r
myl
mir181
∼11-
lyn-targeting
mir181b
mir181d
lyn-dependent
mcl--untranslated
ca2-
patch-clamp
ca2-imaging
kv-like
kinase-ii
blood-depressing
substance-1
substance-2
dermatopathology
genoptix
ganoderic
ga-a
ga-as
ga-a-treatment
pathophysiologies
tmes
granzyme-b-producing
antibody-
b220mac-1
26-fold
lgms
infertility-related
unwillingly
childless
ters-induced
ters-primed
vehicle-primed
didox
-dihydroxybenzohydroxamic
seg-fish
seg-fish-
tki-combined
glanulocyte-colony
ilk-independent
t315-mediated
tles
dcc-2618
-dichloroacetophenone
dpa
rbc-ti
pyoluteorin
ks04
ks18
abt-
sorafenibobatoclax
obatoclaxsorafenib
lc3-green
stromal-induced
efficientin
nf-κbthese
chemoresistancemay
targetnot
non-m5
leukemia-m5
hypoxia-prodrug
efface
pedf
vegf-exposed
relocate
profligate
x2
metal-based
mcl-1inhibitors
9-substituted
β-carboline
reuteri
end-labelling
tnf-activated
reuteri-mediated
probiotics-based
altas
aesa
computes
post-selection
mutex
abbreviation
blca
cesc
endocervical
coad
dlbc
esca
hnsc
kich
kirp
laml
lihc
pcpg
prad
skcm
stad
thym
ucec
ucs
uvm
k562-rc
k56-rd
ic50u2009u200920xa0µm
ic50u2009u200925xa0µm
k562-rd
ic50u2009u200930xa0µm
25xa0µm
cpga-stat3
cpga-sirnas
cpg-sirna
2-pronged
mpy
translocation-2
wt1-meg3
colchicine-binding
adenosquamous
n202
readmit
sw1
cd137pd-1ctla-15
cd137pd-1ctla4cd19
t-cell-factor-7
tcf7lef1
af1q-positive
b-mfs
primarymetastatic
af1qtcf7cd44
sulcus
stat4--
neddylated
cullins
mediator-producing
11c
non-registered
renal-
flan
ovca
trif
scov3
post-
animal-based
paclitaxel-exposed
mosecs
mosec-specific
tlr-5
flici
paracoccidioides
gp43
b16f10-nex2
interleukin-12p40
re-stimulated
flicip10
aair
venetoclaxu2009u2009hypomethylating
withxa0more
longer-follow
skeptical
n194
ifnhu-treated
plk3
ship-deficient
il-33-expressing
non-ap
stop-studies
ggtase-i
ggtis
genotoxin
roadblock
lnps
dlin-mc3-dma
lnp-sirna
ionizable
lnp-bcr-abl
lnp-ctrl
p110alpha
p110beta
flt-3-stimulated
btsa1
bax-mediated
btsa1-induced
tlr7-
kit-l
humankind
anti-braf
ceramidesphingosine-1-phosphate
lama84-s
bcr-ablraserk
complex-independent
ley-expressing
ley-positive
lnc-myd88
first-approved
beti-pr
jmjd6
β-catenin-tcf7l2-jmjd6-c-myc
srp
ckto-
multi-client
cytoprotectivedrug
indeno-cisoquinolines
-methoxybenzyl--dimethyl-6h11h-indeno-cisoquinolin-5-one
iiq-16
indeno-cisoquinoline
methylation-derived
mdnlr
hypo-γ
normal-γ
α‑kg
idh1xa0andxa02
idh1‑mutant
patientsacute
mildest
hd-ecm
seamless
umin000013288
boomers
climbed
noncolonized
latin-american
externalized
her2-negative
ps-expressing
r723
v617f-transgenic
jak1-
jak3-dependent
ahcc
al-ebmt
well-calibrated
as2o1
implem
ented
gds
modena
still-unpublished
linfomi
gisl
invigorated
progrowth
enhancerspromoters
cell-burden
coopt
n4-behenoyl-1-beta-d-arabinofuranosyl
bhac-based
n149
mutations-however
swath-based
data-independent
dia-ms
alpha-synuclein
glucose-dependence
pan-tki
aplf
aplf––
dnrdnr
wwp1
wwp1-depleted
ut7gr
g-csf-pe40
microenvironmentxa0tme
fcmr
toso
fcmr-deficient
processingpresenting
wye-687
cellsprogenitor
wye-687-induced
p70s6k1
ser-473
whiling
mtorc-regulated
hl-60u937
group-aml-97a
aml-97a
dermatologist
failsafe
mycflipl
hem-ap
aca-ap
broader-target
cslcs
pcnsls
79b
flagging
ufa
gsk-3α-specific
typeu2009i
endometabolic
aa-induced
aa-treated
u0126-evoked
u0126-elicited
rosmitochondria-dependent
cd5-negative
amds
chemotherapybest
rebounds
psc-8
psc-833-modulated
adultpediatric
untethered
sufu
sufu-gli
proteinsufu
mimetics-small
gli-associated
antitubulins
nc-mdscs
taxane-
h9m
lin-kit
kiki
sca1-bcrablp210
tryosine
mscv-mll-af9-ires-gfp
inhibitor-dasatinib
provied
hiv-seropositive
106l
8-methyl-n-vanillyl-6-nonenamide
hl-525
7-hydroxystaurosporin
models-most
phase-and
mcl-1-overexpressed
tcmk-1
colony-formingreplating
noninfected
ohsvs
macrophage-dominant
ohsvulbp3
myeloid-dominant
anti-pd-1-sensitive
igm-secreting
pxa0wt
compliment
lde225u2009u2009nilotinib
sclttatre-bcr-abl
uncured
splines
time-periods
surv-mdr
cox-mdr
asn822lys
4cen-q11
kit-regulated
mir-222
1-β-d-arabinofuranosyluracil
arau
ak-aml
rs471760
rs4655226
rs818194
cda-ht3
k27q
hla-allele
crl4-cereblon
crl4crbnimid-e3-ubiquitin
eccne1
seliciclibroscovitine
i-ai-e
anti-bb
aur-a
thr288
aspirin-induced
mcl-1flice
flipxiap
apirin-induced
recalled
pp2aaktmcl-1
fpgc
financially
21-gene
casewise
endeavour
poly-adenosyl
manumycin-induced
survivalu2009u200926
rsi
utilisation
renowned
cml002sti571
migrationmetastasis
recruitmentactivation
trichloro-dioxoethylene--tellurate
rasextracellular
c-raf-1
non-silencing-control
mcl1-silencing
mcl1-silenced
ltx-315
logically
uroacitide
imatinib-im
ccl2ccr2
cxcr2-positive
tak1s
taml1runx1-etorunx1t1
mir-368
mir-382
sub-g0
wa-induced
50nm
sequestosome1
tacsir
tacmtx
tumorigenicity-2
l-ficolin
jte-607
her2epidermal
cprostatein
klf-deficient
klf-dependent
anti-mcl1bcl-xl
her2-targeted
hl-derived
hdlm-2
irf4-negative
bound-cd40l
pbad
pfkhr
il-18rα
akt-s473
il18rα
copayment
imatinib-resistances
drst
marrowrelated
arv-825
bet-protein
p-stat
brd4-protac
ld-cml
gcn2
invt16q22
e21r
bevacizumab-related
spdt
early-spdt
mid-spdt
post-lt12
late-spdt
gfp-lt12
coagulant
non-duplicate
calcoaceticus-baumannii
acb
gram-positives
nu2009u2009269
mdr-acb
homoharritonine
lls
pre-testing
discrete-choice
mixed-methods
welcomed
impurities
typhaneoside
typ
typhae
benzoimidazo-d4thiadiazole
benzoheterocyclic
alpha-bromoacryloyl
ic72microm
l265p-expressing
pbtk
fancl
indies
response-guided
defending
provocatively
sgd
muramyl
slc15a4
mtp-pe
cd27-
nadpreduced
glutathioneoxidized
whey
piannexin
pi3kbcl-2
lnp
surface-functionalized
αpd-l1
αpd-l1-lnp
pd-l1-targeted
rt-induced
ct2a
pathway-directed
non-ia
microgd
angiogenesis-independent
symbiosis
mo7e-p210
hspa8
transcrition
5-dependent
ccnd1cdk4
15-deoxyspergualin
vegf-b
anti-vegfr-2
p-vegfr1
cd7-directed
cd7ko
ethically
smzl
pecam-1
flipi
mechamism
self-sufficient
reminisce
c-jun-n-terminal
5amp-activated
u2009hr
ser51
p-eif2αeif2α
sxbp1
thr183tyr185
p-jnkjnk
p-ampkα
ser413
p-foxo3a
p-aktakt
thr32
p-foxo3afoxo3a
ser2481
mtormtor
24u2009hr
interfering-rna
si-rna
perk-chop-dependent
ampk-related
foxo3a-dependent
e4f1
e4f1-associated
pi3krhorockmlc
20xl
7aad
cytarabine-exposed
aktbcl-2
α2b-adrenoceptor
tram
cbpp300-interacting-transactivator-with-an-ed-rich-tail
cited2-knockdown
cbpp300-activity
cbpp300p53
cited2-deficient
akt-signaling
akt-pathway
phlda3
tumor-associating
ncam1-associated
mapk-signaling
imidazole-based
ccne1
time-to-next
disease-defining
ucm-1336
surmounts
ccsp-rttateto7-stat3c
ttr-treated
cerebrally
longtime
pneumonectomy
2erk
ci-1040
disease-risk
flu-
ar-score
nintedanib
bibf
vegfr--3
fgfr--3
pdgfr-α-β
susars
dose-leukemia
checkpoint-inhibitor
αpd-1
m2-to-m1
disease-zeng
reeves
qu
callahan
sluder
gelfand
poznansky
azd2811
phospho-histone
especialidades
pediátricas
seguro
buparlisib
bkm-
p-ps6ktotal
ps6k
p-foxo3total
glycan-binding
galectin-1-targeting
donorstem
ubm
rbm25
lymphopoietin
tslp-dependent
sihottip
dj-1
casper
treatment-by-centre
variance-covariance
non-zero
nucleolin-nfκb-dnmt1
fakmapk
pparα
emilia
3-kinaseaktmtor
meaning-making
2-way
-102
derived-suppressive
proapoptosis
discharge-eligible
re-admission
arru2009u
nd-aml
cytarabineu2009u2009an
7u2009u2
1u2009lu2009t
vsu2009u20094
formaldehyde-exposed
cd34xa0cml
drug-class
κbp65
gallotannin
multi-biological
m2182
facscalibur
becton
dickinson
gallotannin-induced
6u202fcell
445u202fcell
ccdgs
93u202fcell
ccsdgs
ferroptosis-mediated
k562nr
ico
cid-binding
her2-carζ
myd88cd40-based
her2ζico
her2-carcd28ζ
tumorssignificance
mucormycosis-related
artemis
iiialpha
syn-
3rd-party
meth-a
cm2
allo-tt
alll
mr⁴
oasl1
cd8α
cross-presenting
bal-driven
120d-os
120d-am
7-kc
lmscs
oxiapoptophagy
9-step
nonmitochondrial
carbons
cationized
hard-to-transfect
snrp-1
fc-snrp-1
ad-lacz
grh2
adipocyte-abundant
odd-numbered
mono-cultured
conflicted
k562im-r
febuxostat-pretreated
cladribine-based
mlh1--nf1-
ina-6
anbl-6
her1
her4
trastuzumab-based
cd163ccl3
m2c
relocalizes
reportable
okamuranus
lmwf
imwf
hmwf
fucoidan-free
myd-88
dnr60
dnr90
gene-association
peril
pursing
wouldnt
non-achievement
flubuatg
double-7
algorithm-driven
1tp
2tp
bok
aml-differentiation-promoting
daph5-dianilinophthalimide
nonadjacent
prominant
cgygpkkkrkvgg
rpa
cd-123
9-dephosphorylation
α5β1-integrin
flip-flopped
88myd88
nu2009u2009173
cn-amlcr1
mud-bmt
mouse-acute
csf-1csf-1r
anti-cd40anti-csf-1r-treated
anti-ox40
anti-pd-1ox40
actbl2
amtn
lyzl1
ccbe1
cks2
triaging
transcriptasehtert
siams
siam
non-siam
bax--
dose-dependence
leukocidin
gstm0
stomatitismucositis
ln-residing
mφs
mφ-
pi3k-v-akt
mφ-secreted
2-transgenic
akt1-mediated
survival-promoting
siso
b7s
tritium
dose-mortality
rate10
goodness
nadph-dependent
goldi
u2osmtx
nvp-laq824
acid-derived
baf3p210-t315i
nick-end
cages
paer
glucopsychosine
glucopsychosine-induced
glucopsychosines
h4k5ac
msc-educated
cml-msc-educated
hd-msc
cml-msc
lymphocytes-mediated
chemoresidual
cll1cd117-
nonclinically
tetraiodothyroacetic
tetrac
calcineurin-inhibitor
evolution-conserved
d-2-hydroxyglutaric
aciduria
ollier
npm1mut-aml
glands-derived
prok1--a
glands--was
gpr-induced
pscc
co-deletion
androgen-responsive
mdsc-diminishing
smad4apc
nct03069352
component-based
lt-lscs
kpt-9274
4nampt
nampt-binding
cd4cd25cd127low
by18
-cd57cd3-cd56
infusionhidli
mix-hsct
vemac
chemotherapy-combined
hidli
8l
46xx46xy
cytoarchitecture
remoteness
precoded
socioprofessional
isco68
isco88
urbanization
nominally
single-parenthood
motorway
infrastructures
il-1r1--
il-1r1
il-1βil-1r1
prpf8sf3b1
mdsmpn-rs
akn-032
ic3
cyclooxygenase-derived
pge2-mediated
nvp-aew541
nvp-aew541-induced
opscc
dac-7
n200
da-7
dnrarac
prime-boost
vacciniav-cea6d-tricom
rfowlpoxf-cea6d-tricom
cea-expressing
rv-cea6d-tricom
rf-cea6d-tricom
astalanine
cea-specific
trp-catabolizing
ido--
dcaf15
mir-idac
fats
hydroxylate
acc2
myelointensive
cordon-bleu
cobll1
ikkγ
nilotinib-dependent
cobll1-mediated
cp-bc
cobll1b
isocaloric
diet-fed
ki67high
pax6sey3h
phasexa0ii
phosphoinosityl-3-kinase
p110β
pcn5603
pcn9
nitrogen‑containing
adriamycin‑resistant
hl‑60a
v‑propidium
s‑phase
pad4
jak2v617f-driven
postgerminal
inhibitors-of-apoptosis
panvac
prostvac
melflufen
gm14
lentiviral-transduced
ergothioneine
ett
octn1-mediated
nitrobenzylmercaptopurine
artimisinins
unimpaired
fgfr1-driven
subsidy
bv6ms275-induced
bv6ms275-mediated
bv6ms275
nec-1
nonseptic
der6tq23q23
penetrating
hiv-tat
lk15
tat-lk15
dnasirna
phosphatidylinositol-5-triphosphate
ipi-145
duvelisib
ifn-α-induced
cd33hladr-lowcd14
cd33hladr-cd15-
cphsp
cxcr4s338x
cxcr4fs
-mutated
tki-receiving
imatinib-naïve
oscp1
clda
nxa0xa0261
sf3b1srsf2u2af
-da
calgranulin
h9m-driven
an1-type
domain-2a
airap
aip-1
buffering
proteotoxicity
airap-like
proteotoxic-stress
plasma-levels
airap-downregulation
airap-overexpression
hsf1-regulated
airap-silencing
zfand2aairap
adaptor-inducing
interference-directed
cml-sc
stemness-promoting
pro-stemness
transcriptsu2009u200910
pheresed
fvb
fvb-neun
site-dependent
ct26-bearing
pstat5-dependent
tsn
incompetent
procaspase-
cd3cd28-stimulated
brain-blood
highjack
cns-border
culminate
value96
value95
value99
value0066
µgkg
inhabitant
atf3-deficient
atf3-regulated
sact
tail-vein
cybatm1a
antitumoural
ps⩾ci-
midh1-cholangiocarcinoma
hispidulin
anactive
anantitumor
throughan
hispidulin-induced
state-specific
trf2
k24
thisxa0ubiquitination
s13t330
facilitatesxa0the
itsxa0transactivation
p53xa0compromised
withxa0wt
poorxa0response
volasertib-induced
induction-consolidation-maintenance
rarecare
cachexia-inhibiting
hcc-associated
rhil-1beta
pi-3
il-1beta-mediated
meningitisbrain
ei
eis
it-901
chelated
nonchelated
cux1-inactivating
∼54
cux1mid
cux1low
pik3ip1
acidized
2-n-morpholino-ethanesulfonic
sub-familyxa0g
memberxa02
acidification-induced
acidification-associated
pi3k‑akt‑mtor-s6
microenvironment-associated
smo-sufu-gli
smo-gi-rhoa
mtor-s6k1
foxe1
foxf1
foxl1
wnt2b
hedgehog-related
shh-subgroup
vismodegib
by-passing
gli-dna-interaction
glabrescione
destabilizers
gli-deacetylation
4sc-202
gli-dependent
m2-tams
cal27
lp11w
e1b-19k
baalcmir-3151
tp53-mediated
gmr-v449e
fdb1
phosphoinositide-3-kinases
pi3k-γ
herpeszoster
rolexa0in
wexa0developed
crispra
dicas
survivalapoptosis
gas6-as2
gas6tam
indolinone
formationsurvival
bibf1000
or500
bibf1120
mono-mac1
im-intolerant
tlr-4myd88
myd88negative
platinum-taxol
myd88positive
tov21g
dismally
cell-supportive
high-specificity
ve1
gata3t-bet
multi-systemsingle-system
unifocal
technologists
cd200l
cd200s
c6-cd200s
c6-cd200l
c6-original
vkas
doac
k762rg-csfr
g-csfr-mediated
pu1-regulated
e2997
bfl1
ld-pmn
a-674563
z-vad-cho
a-674563-induced
k6pc-5
a-674563xa0at
signalings
bu-cy2
lymphoid-type
azd9150
arsenious
initally
pegfp-survivin
pegfp-h1
hl-60survivin
hl-60egfp
ggm-csf
atra-inducible
mek-
ggm-csf-induced
s427g
i448v
s427gc-raf
i448vc-raf
tumor-predisposing
intracrine
non-superior
linc-itgb1
nvp-adw742
igf-lr
fibronectin-integrin
fakpi-3kerk
pi3k-δ
nkg2d-fc
ll2
cucurmosin
cus
cell-nodscid
k562-nodscid
nu2009u2009145
nu2009u2009449
secondthird-generation
imtkis
factornutrient
cml-enriched
moscatilin
cav-1
⁄
mek⁄
g₂
⁄m
il-17b
il-17rb
il-17b-il-17rb
chemotherapy-guo
h-z
niu
l-t
qiang
w-t
s-h
caliper
5th-7th
fludarabineiv
fm100
non-auxotrophic
postpolycythemic
postthrombocythemic
consensually
myc-max
benzene-adjusted
pkc-beta
e-methylphenyl-sulfonyl-2-propenenitrile
gvhd-positive
asxl2-mutated
docosahexanoic
au-ncs
au-nc
nano-bioprobe
red-nir
reduction-cum-stabilization
au-nc-cd33
nanotoxicity
nano-bioprobes
bcl6-repressed
leukemia-repopulating
elaborates
tcr-gene
within-subject
hilmo
self-destruction
fludrocortisone
rationalisation
xa0ppm
confidently
tin2
rararsrcmdmds-u
mielodisplasie
grom-l
-130
remicade
ucbs
single-ucb
nct01067300
epoietin
bulge
os-95
-50p
hsctostoxicity
no-toxicity
-78p
mcfc
almds
non-chelated
tt3
tt3a
tt3b
β-2-microglobulin
tt2
znf140
ras-
fos-related
igf‑ir
mdsleukemia
picropodophyllin
crebbp-
micronutrient
erythroid-stimulating
cfu-en
angio-kit
sf3b1-mutant
valence
slc25a37
mitose
cd45side
major-histocompatibility-complex
anti-mica
unstudied
denying
coombs-negative
beneficiary
ced
ribophorin
rpn2
lenalidomide-based
disproportional
earlylow-risk
nrbc
anti-angiogenetic
synthetases
fia
morphometry
esd
5q31-q32
atypias
haemosiderosis
bulbi
bulb
haemosiderin
haemophthalmus
resorbed
operatively
reddish
lipid-related
ldl-r
total-
del20qq
hbcl-2
bmcm
burst-promoting
oftentimes
non-liver
overpassing
non-ischemic
microfluidics
svegfr-1
mds-raeb-2
non-msdt
ospt
failuremyelodysplastic
gene-by-gene
dkc1
ligandreceptor
s100a9cd33
attentions
pcps
microrna-22
re-shaping
emphasising
irak-inh
cd33hla-dr-lin-
cd33-mediated
lumber
wats
p-mtor
concentration-dependency
iwg-2006
irae
intermediate-1low
medicaremedicaid
lowlowintermediate
system-revised
prophagocytic
antiphagocytic
dels
dems
abat‑del‑dem
co‑expressed
lncenst00000444102
arginate
epo-beta
upd7q
organically
shoulders
alphatnf
fmlp-stimulated
endomitosis
karyokinesis
16n
furrow
romano
grom
colony-
depressants
bordered
rrnas
pb-fish
etv6tel
serotonergic
fluoxetine
n-n
binocrit
xa0iu
therapy-anemia
fact-an
rhou2009u
nh-mds
s34y
q157p
snrnp
speckles
e-3
xe-2100
neut-x
neut-y
hypo-granular
howell-jolly
diaphanous
mdia-related
mdia1
diaphq
formins
drf1
drf1--rhob--
drf1--rhob-
sarcoid
igd
igd-like
13-cra
high-dose-chemotherapy
188re-cd-66-mab
u2af1s34f
irons
as2s3
cereal
gases
anll-mds
mds-005
carbonylation
blasts-
carbonylated
tibc
u2af3
u2af1-mutated
mdas
long-arm
sideroblastosis
mlsm7
cd114
who-2008
non-transferrin-bound
1000xa0ngml
δu2009u
rigidity
plac
raeb-blast
raeb-bc
dot-like
cd141bdca-3
thrombomodulin-positive
micc
nkcc
e-path
uncaptured
case-finding
myelodsplastic
-108
scio-469
xcips
lyonization
unmarked
acmia
plt-r
tpo-r
delq
n4-palmitoyl-1-beta-d-arabinofuranosylcytosine
goasguen
studyn
sf3b1n
e622d
h662q
interestinglyn
p114
wedge-spread
5p15
pdcd6
bucy-based
adrenocorticotropin
yisui
lixue
benzanthracene
modelpbs
modellow
modelhigh
sf3b1-mutated
sf3b1-
cmi
legionella
leuven
xq13
apg101
daa-i
imdsflow
pla2g4a
eya2
growth-differentiation
hepcidin-ferritin
stfr
granulocytemacrophage-colony-forming
rbc-transfusion
rbc-td
bmfs
1-locus-mismatched
n＝
＋
p＝
sourcing
dicq10p10
chemoradio-therapy
hypo-expression
1q-deregulated
bgl
igg-lambda
filopodia
drf1-
drf1--
pelgeroid
rockville
dishematopoiesis
clinicalmorphological
tqq34
csfirpdgfrb
5q33-q35
csfir
sublocalize
bracketed
centimorgans
q34-qter
ckk
l1200
d5s62
efficacyeffectiveness
esa-naïve
sesm
c-reaction
non-iron
mir-134-mediated
chr17
sanzs
icsh
non-td
transfusion-dependency
cy-flu-atg
cy-atg
expectant
n-finger
mir-550a-5p
quinazoline-based
tandutinibs
pbcfdna
del5q-mds
andu2009u20098
nephelometric
hns
units16
nct00600860
fcv
adducin
subcategorized
anemiaaa
wt1p
ipss-based
exa0rostratum
rcv
gtp-bound
gdp-bound
vo2max
100xa0iul
70xa0
incidentalomas
non-secreting
fab-classified
freshly-isolated
oligosnp-based
5q-myelodysplastic
androgen-treated
cd62l-
iwgmc
cytogeneticists
minimacs
il27
delta-like-1
pref-1
notchdeltaserrate
12-o-tetra
decanoylphorbol-acetate
culture-expanded
stoma
medicaretricare
iron-overloaded
chelation-naïve
prechelated
14x
5x
cytoscan
750u2009k
pasa
outcomes9
mutations10
u2009patients
ipss-r11
three-cell
dysgranulopoïesis
cd34-selectedt-cell-depleted
relatedhaploidentical
nct01082133
asxlxa01
idhxa01
idhxa02
pre‑lscs
mds-skm-1
annexinxa0vpi
13xa0proteins
sirna-survivin
della
porta
malcovati
wo
doxercalciferol
cd271
brightly
kruskal-wallis
msccd34
classes-myelodysplastic
myeloproliferative-have
46x-y
yty1q12q21
ty1
overload-related
dispersible
palatability
fct
swallowed
phosphorylated-fak
pfak
arthrocentesis
double-puncture
anti-differentiation
pro-erythroblasts
trail-positive
growth-restricting
ck-mds
nhi
antimalignancy
l-threitol--bis-methanesulfonate
dihydroxybusulfan
activatoryinhibitory
dc-lineage
cdc1s
ilt2
cdc1
reveled
ppha
marrowstem
e-mds
hypofunctional
int-favorable
int-adverse
srsf2-
astalt
iron-chelator
srsf2-p95
contradistinction
pwm
cowan
soya
in-person
glycitein
alips
who-2016
transductionkinases
disease-phenotype
cross-matched
mdspreleukemia
examiners
cfu-mks
translocating
marrow-failure
iron-induced
lpi
aminothiols
ironferritin
cysteinylglycine
nxa0xa020
biologist
hellström-lindberg
near-triploidy
hbme-1
hbme-1cd235a-positive
topotecan-cytarabine
kleijnen
ksr
low-intermediate-1-risk
karyocytes
pelger
sweeping
hstcl
anti-c
proplatelet
hspa9
mkt-077
leukaemogens
leukaemogen
sudemycin
ezatiostat
surveilling
viewpoint
setd2-deleted
competitiveness
refered
diseasesmyelodysplastic
prpf40b-regulated
hematopoietins
branchsite
hsh155
branchpoint
footnote
neovascularity
enumerates
tet2rs2454206
tet2rs12498609
asxl1rs3746609
open-heart
roi
o2--releasing
fmlp-induced
microgramsbody
atox
rps
sparc-null
s-tpo
misclassified
raeb1-rs
raeb2-rs
n-1
7p-p
6q23
operator-dependent
ki-
anaemias
tng
ngs-1
ngs-2
α-thalassemia
atmds
cresyl
aa-
identical-sibling
isds
n228
maml2
cooh-terminal
mll-maml2
×10⁹l
peripheric
diepoxybutane
stirred
areb
areb-t
medium-high
agrochemical
agenesis
rhepog-csf
q-syndrome
subunit-associated
gstt-1
co-chaired
spivak
keynote
morel
gpvi
ahru2009u
translation-inhibiting
emetine-induced
fitter
mds-relevant
aclarubin
hypo-mds
anti-hla-dr
pc10
tricot
mds-rars
rarst
melodysplastic
b-progenitors
cartilaginous
igmk
l256p
pseudo-pelger-huet
diagnosismanagement
non-activated
total-nucleated
erythroid-predominant
bi-regional
cr-rates
kdm6b
vav-kdm6b
alimentary
osteoprogenitors
r-huepo
samd9samd9l
haemoglobinopathies
vγ
raeb-aml
vδ4
vδ8
pathogen-associated
bcps
cnsv
tachyzoites
hypocoagulable
factorswe
ldasct
bld
dysmegakaryocytopoiesis
dysgranulocytopoiesis
cc-5013
non-deletion
tq24p13
golub
aml-m5b
tailing
cd13cd11bcd16
pdw
papillomatosis
1lt
tfi
prolapse
sciatica
vacuolized
variaglobin
arthropathy
appearedworsened
chelation-treated
sorror
noncellular
hemopathic
abnormalites
tendential
colony-forming-unit
microcytofluorometry
dispensed
petri
1ra
mini-panel
ogata
granulocytecd34
uhmk1
random-start
iep
activation-related
dna-pol
ebv-bzlf
cmv-dna-pol
cbmnc
alpha-2-hs-glycoprotein
tht
dup
rampant
eb-2
sld
rφ
hematon
pcz
rigours
licencing
acid-suppressing
scatters
ndw
plcg1
well-stratified
alc9l
p⩽
lmr⩾5
ipss-r-independent
rennes
excepted
nh4
fas-dependent
snpa
er-targeted
er-associated
bap31
pmds
nct00844441
non-neurotoxic
end-
leukomogenesis
lq-hq
moose
l-ferritin
neuroferritinopathy
ftmt
pantothenate
multocida
artefacts
promegakaryoblasts
incorporations
tim-3-galectin-9
ligand-positive
cd71mito-
dissipate
importation
lt-mds
thrombomimetic
differentation
hemorragic
rflp-methylation
aml-tmds
y397
hsp90αβ
apoptic
dominantsecondary
combs
bohring-opitz
anophthalmia
intercase
model-1
gene-only
model-2
reduced-intensity-conditioning
signal-regulating
polymorphonuclears
kras2
clinico-hematological
lowint-1
ub
hnrnpa1
advia
myeloblastspromyelocytes
cytogram
ace-536
actriib
del7q-
hlh-like
il-10il-12
tgf-βtnf-α
mock‑treated
xxa0protein
v‑fluorescein
double‑stained
cytometic
‑dichlorodihydrofluorescein
risk-to-benefit
antivascular
ag3340
mds-001
neulasta
∝l
gm-colonies
clone-derived
receptor-initiated
erythropoietic-
cytogenetic-remitting
colonycluster
caspase-3-positive
pversus
g-score
facit-fatigue
questionnaire-core
non-5q
atgam
less-advanced
rearranging
cause-effect
⁹⁰y-labeled
y-cd61
cd61-positive
mf1
tcr-bv
hla-a2402
bvs
interactomic
relapse-directed
forego
malakoplakia
raebt-mds
leukemiaalthough
dyshaematopoiesis
wlodarski
cd34c-kit
mds-002
erythroid-responding
pgc1β
abcb7
bmis
galunisertib
alk5
abmfs
bd-like
non-transfused
lowint-
ezh2-dset
intermediate-higher
gpiib
protein-losing
deltaalb
mirnas-regulated
suggestively
20q-20q
embodied
post-solid
3m
arr
nu202fu202f20
ttce
sugp1
pro-hepcidin
ob-rl
ob-rs
progenesis
samespots
enrichnet
vinculin
fermitin-3
normalizationreduction
extra-chromosomal
u43604
c10orf10
pou2af1
biosynthesis-chondroitin
vulval
necrotic-looking
self-supporting
tasmania
hpca
palo
karyotype-dependent
2468a--t
1642a--c
pre-study
cd10control
combinationsthe
disordersthe
patientthe
dmds
py700
32dcl3
lowhigh
atothalidomide
nbmcs
quinine-treated
pur-alpha
demyelination
g-rich
unfathomable
high-through-put
qol-e
cross-reacted
fab-ra
iontorrent
intramedullar
lymphohlastic
iymphoblastic
monolinear
dysplasia--in
bilinear
inter-correlation
ccd34
factual
mteloid
cfu-meg
covariable
fliplflips
epipharyngeal
nmc
cyfluatg
bufluatg
jslh
indium-111
annealing
diaph1
cd14toll-like
hax1
erythroferrone
erfe
gse58831
epo-r
20q-8
trans-
plantation
rtkras
mds-patients
binuclear
tim3cd8t
undegraded
smap1-deficient
mir-93
krn8601
ibmf
ama
clone-original
dihydrorhodamine123
dhr
rs1800975
rs2228000
rs1799793
micromegakaryocyte
megacaryocitic
pachymeningeal
hemorrahages
decifits
iwgm-mds
mds-modcs
snhl
rrms
unitskgd
low-gradeearly-stage
fadd-like
autoamplification
1-locus
vegfplt
stringently
ucbsct
acronym
boehringer
mdsin
transfuse
80u2009gl
raeb-20
raeb-t-12
lobules
sptcl
positron-emission
erythroid-megakaryocytic
hematopoletic
groupin
mds-al
2-cda-related
ncd
xcip
qualms
mcda
myelodysplasia-like
chip-derived
stk4
units-erythroid
del5q5q-
egr1krox20
diaphanous-related
gene-targeting
srf-target
p53-family
hpchsc
3sss
3ss
structure-dependent
mature-appearing
mdr-aml
der16tq11q11
hnrnpd
brca1-bclaf1-sf3b1
expressionsplicing
processespathways
tlr2-f217s
2500ngml
hepcidinferritin
srsf2p95h-which
aml-in
srsf2-wild-type
sado
nct00521430
nct00732316
-dihydroxy
raeb-taml
asserted
contradict
reckoned
regulatorysuppressor
eia-4705
eia-5258
rs-rcmd
santini
hb9
uil
setbp1-wild
gm-progenitors
beggs
eggers
ce3
prednisonevindesine
vepesid
daunorubicin-cytarabine-pretreated
idarubicinvepesid
cytardbine--or
dexniguldipine-containing--therapy
finite-dimensional
receptor-independent
s-epo
50ul1
robo2
robo-slit2
seric
dw
haematopoeitic
hp-i
¹³c-urease
infai
urease
campylobacter-like
idh-1
47xy1i1q10
arabinosine
xanthomatized
xanthomized
nonnegligible
ist-responsive
27xa0
nu2009u2009169
tcf4oe
cfu-es
tcf4kd
erythroidmk
threaten
overloading
gypa
hemoglobinuria-type
prhi
cf-dna
multi-modality
micromatrix
sf3b1k700e
fluoxymesterone
hsa-mir-21
evolute
donates
dehydroascorbic
dehydroascorbate
dependent-manner
thymi
dn2
v-d
nephrotic-range
crescentic
corticosteroid-responsive
arthrodesis
equinovarus
mir-451a
14-antibody
nimustine
monomyeloid
tnfrsf4
exjade
icl670
srfs2
pheno-
-144
inthe
2n-4n
nhej-mediated
pkcs
xrcc4
1o
2o
furosemide
mirtazapine
prochlorperazine
qt-prolonging
nf-κb-activating
mir-125amir-125b
hematopoitic
iron-loaded
hiv-uninfected
hivmds
hinzii
convoluted
emperipolesis
edag
dexter
ltbmcs
unelucidated
h2ak119ub1
bmi1-driven
cd4cd25foxp3tregs
compartmentalized
apoptosis-like
fasfas-ligand
haplogroup
cd16xcd33
mds-nk
transcriptionepigenetic
qbend10
aldehyde-fixed
reassigned
rhil-6
h6000
lucs
n-butyl
cyanoacrylate
who-mds
cytohistochemical
micro-megakaryocytes
cucurbitacins
bronchiseptica
lci
stromalhematopoietic
bejar
syndyomes
raweb
myelogeous
szent
laszló
bcl2-related
tq31p15
non-cr1
spgf
superoxideperoxides
δψmit
humanistic
co-variable
ipssipss-r
esa-treated
xa0100xa0miuml
80xa0gl
-308a
andersons
mononucleosis
u202fgl
spitzoid
spitz
beckman
mnec
mnes
hypogranularity
14c-autoradiography
p95l
p95r
mutatedwild
noninterstitial
myeloid-leukemic
dc-stimulating
standard-medium
cytokine-method
ca-ionophore
qualityquantity
dcantigens
blast-antigens
dcleu-proportions
pre-analysis
antileukemia-directed
dc-primed
units-granulocyte-monocyte
trilinear
lowintermediate-i
pha-dependent
medlan
hydroxyurea-associated
dermatomyositis-like
cmv-r
cmv-ctls
recipientdonor
as2s2
d11s1363
d11s1338
uucb
hemodynamics
rcit
iit
precision-medicine
spag6
spag6-shrna
ns-018
unit-granulocytemacrophage
asp816val
ttl
hxa0aspergillata
pancolitis
hypovolemic
bmnc
kobe
cxcl12-abundant
mdsaml-mrc
tunel-negative
cxcl12-high
bcl-2cd34
cxcl12-low
raebs
survivalantiapoptosis
intermediate‑
apoptosis‑related
‑9
p53‑dependent
6ploh
epag
terminologies
nct02775383
disease-focused
alarming
variousxa0clinical
pf-4
sophistication
neoplasm-related
ccaus
donorgraft
novosecondary
eol
cd34u2009u2009hematogones
2me
fe3o4
mnps-fe3o4
apoptotically
5q34
g-allele
splicing-modulating
surfaced
ipss-rsct
up-staged
mtpss
transplantation-failure
high-riskchronic
level-
nct00397813
enigma
hypoxia-independent
mdssignificance
disconnection
steidl
1355this
asunercept
prbcs
postreaction
lenalidomide-dependent
mir-29s
mφ
il-1b
cd34cd117
q3w
q2w
improvement-erythroid
runx1-knockout
hscmpp
meg
runx1-deficient
tek
jam3
pcdh7
hsc-meg
hscsmpps
collagenases
d262n
erythroid-affiliated
gfi1b-d262n
gfi1b-spi1
spi1-knockdown
gfi1b-d262n-expressing
spi1-gfi1b
zrsr2-located
chromosome-are
3-splice
u12
u12-type
u2-type
zrsr2-deficient
unlimitedly
intrigued
cost-of-illness
icts
non-medical
comparators
112-gene
tpp1
1-alpha
mds-mf
sema3a
hs27
iron-chelation
diagnosis-16
old-18
7vs
tending
fosteabine
minitransplants
rewarding
mir-146
underdiagnosis
seattle-puget
definiteprobable
cd34blast
fcm-score
precize
cd34low
mcm2
epo-stimulated
higher-volume
pre-esa
monocytehistiocyte
2-me-induced
colorimetry
idicxq13
idicx-positive
investigator-reported
neoplasmsmdsmpn
hydroxycarbamidehu
nix-mediated
glycoa
a-hsct
s-hsct
isolatedu
double-dose
sdnam-1
sgrade
sdnam-
denuded
dmk
presume
hornchurch
rhce
ferrum
aa-rcc
1-hydroxyvitamin
d-group
xrcc6
npcrc
pnh-type
pnh-
telomeropathies
rtel1
rpl5
ercc6l2
mkaml
mkmds
isgs
loc100131626
fitc-dextran
tce
assignable
δfd
curve-based
nonconservative
non-cc
igg2
th1-biased
pustules
scarring
speckle
non-congenital
malformative
runx1dc
lineage-sca1c-kit
end-systolic
end-diastolic
il-12il-2
asxl1g643fs
usefully
topobiology
itcz-os
itcz
patho-clinical
ukgd
mul
fcmss
theproportion
erythrokinetics
erythrokinetic
microscopy-based
up-modulation
over-production
pu1-dependent
mdsn
evaluatedn
anti-5-mc
m-score
coq10
oradj
thighs
nkg2d-mediated
tp53-mutant
differentiationwe
plcβ1
mdsthe
nonsevere
slan
ψ
pus7
trna-derived
rhoads
iwgc
implausible
elliptocytosis
ici-induced
rechallenged
serum-derived
cdr-3
descends
sf2
zvadfmk
alpha-inducible
tumor-relevant
jervine
g-csf-r785lys
study-iii
reds-iii
scoreu
paigg
pift
glycocalicin
gci
pre-ahct
5-trisubstituted-3-triazole
clickelectrophilic
clickoxidative
5-alkynyl-3-triazole
mir9
franco-american-british
ysk
exon10
monosomic
stain-positive
shru2009u
highintermediate
anti-wt1
life-core
countxa0lb
hyper-cellular
b1-positive
htert-positive
prorubricytes
rubricytes
alfacalcidol
bhac-amp
adls
botc
reignited
biasing
stratificationthe
transplantationthere
patientsmyelodysplastic
approachesmyelodysplastic
carethe
warrantedthe
mdsa
half-century
decortication
amlt
cd94nkg2a
mud-hct
sardinian
family-specific
hypermutated
syndrome-specific
nuclear-cytoplasm
mutationperson
mcrhi
icllm
cd8tregteffem
teffem
5q13
q15
syndrome-unclassified
g-cor
g-noc
g-lor
g-dp
g-corg-noc
g-lorg-dp
alitretinoin
kindly
non-breast
t-based
nag
nag-elmo1
staph
zymosan-activated
zas
f-mlp
dr15-positive
versus-negative
rh-scf
raet1
raet1l
raet1l02
brackets
megaloblastoid
enr
43xa0
post-esa
hypothalamo-neurohypophyseal
hypodipsic
concealed
regular-dose
overlook
gat
rucaparib
pi-shen
tinf2
wisely
runx3-expressing
goodvery
radioisotopic
-u200916
sweet’s
non-tender
flt3-nonmutated
esophagogastroduodenoscopy
more-homogeneous
aicve
xenotransplantations
hyposegmentation
beneficially
cebp-ϵ
non-gf
lenalidomide-induced
pre-defined
lobulation
daunorubicin-loaded
cdte
qds
dnr-cdte-cd123
alip-
controlsp
hbh
gpi-aps
gpi-aps-
aiims
rigosertib-induced
ontime
atr-x
case-to-case
20q11
non-fibrotic
plasmocytes
non-purified
early-acting
spliceosomopathies
hivu2009u2009patients
hivu2009u2009mds
hivu2009-u2009mds
fab-subgroups
u-par
drb
human-murine
flr
hio
axa0felis
hmw
lst
stereotype
b-lcls
b422
b423
tp13p15
gnas1
r201
telesto
cd34cd33cd38
or2
13-ra
as-e1
s-g2m
arthropod
guideline-based
gbis
response-rate
higher-doses
end-of-infusion
rifn
sgot
corynebacterioides
loy
g6pd-deficient
cholecalciferol
mika
maka
tpx2
reaffirms
leave-one-out-cross-validation
hypocentre
xa0km
thal
raebi
raebii
ferrokinetics
single-hla-drb1-mismatched
echinocandin-resistant
id-2
neurocortical
mycobacteriosis
bronchiectasis
chymase
-dichlorodihydrofluorescein
exposure-toxicity
mds-unclassifiable
mds-eo
kir-l
epoetin-α
rrc
drug-costs
rcu
transfusion-intensity
chemo-refractoryrelapsed
c79
crcl
conglomerate
therapythis
mdssld
mdsmld
mdseb
rs34631763
icgc
identifier01355913
cfms
r132s
denture
malady
hypocupremia
pro95
cbcs
kmcl
5yos
lenalidomidedexamethasone
quiredex
nct00480363
antigen-activated
seroreactivity
ba21
lgl-bmf
pre-diagnosed
pa-igg
re-elevation
casp9-deficient
n-ethyl-nitrosourea
spliceosome-related
mds-ci
nld
anti-tnf-alpha
runx-214
c-kitsca-1lin-
serumplasma
mir-146b-5p
hypolobulation
47xx
mel1s
sdsdel7q
microparticle-associated
stroke-like
caudate
afnd
ly-ifn
compound-based
splicing-modifying-compounds
short-duration
gpr68
len-induced
len-resistant
calcium-
calpain-dependent
suprahepatic
fmlf
cdc42-specific
fgd4
inotropic
d7s486
der9t
peroxidesgsh
superoxidegsh
dialyzed
post-aplastic
unit-megakaryocyte
bmld
asx
eosinophiles
disease-management
12u2009gy
birbeck
polyoxyl
por10
dyshemopoietic
hr-cgh
cd34cd38-thy1
emps
poikilocytosis
leukoerythroblastic
loss-
ring1a
recessed
psti
spikes
nct00744536
mdspnh
mo2
ia-
usages
progenitorprecursor
pirche
pirche-ⅰ
pirche-ⅱ
pu202fu202f007
howeverxa
ready-for-use
mdsepo
directives
-06
-003
nonbeneficial
goal-concordant
hyperfibrotic
gata-1low
mir-320a
iodoor
anti-iudrbrdu
c-oxidase
bmhdf
mt-dna
tryptase-
mds-driver
depl
tpd
tpd-derived
lowreduced-intensity
ses1
ses5
scoresxa0or
nxa0xa095
flamsa-sequential
anti-d
dsas
sociedad
española
transfusion-burden
usp24
mir-125b-1
11q24
intermediate-3
harrells
hci
cn-rcmd
weight-of-evidence
exposure-disease
lipomatosis
hemosiderin
syndrome-unclassifiable
syndrome-not
mds-nos
pbscmarrow
therapies-in
backbone-for
vk2
rhu-epo
radiation-therapy
aamds
rs228593
rs4793191
rs9567623
rs1801320
rs3835
rs2267437
rs1805388
55-
akt-pi3k
pdgfr-β
egr1-
transfusion-need
sct-specific
institutebrigham
1h-mrs
perioperatively
bcrabl-unknown
cgu2009u2009gg
non-sideroblastic
e98k
d140a
del20
cytopeniau2009u20096
visualise
5qq
18qq
haematopoetic
endangering
transfusion-dependant
microl-1
t-lglmds
hypergranulated
stevenson
rival
bis
enrs
proliferationdifferentiation
∼85
erythropoietin-beta
nonprogressive
hfob
specialise
cdv
trma
enanthate
trt
del13q12q14
del5q13q33
vsaa
del5
subgrouping
r-loops
αβ-
proteincreatinine
feg
ft4
thyrotropin
u20094
52xa0
nu2009uxa0
ra-s
2p-
photographed
four-point
kariotype
lis
icoshighpd-1-
non-fa
ngs-derived
niche-induced
qpl
nk-a
asxl1--
lin-c-kit
p0004
p0008
lisbon
gzero-phase
ukrainian
populationthe
volodymyr
ity
nrcrm
cardio
radiochemistry
reactors
ussr
ores
montefiore
somers
dxy
kurtin
cd45cd34cd38-lin-
cd45-cd34-cd38-lin-
change-of-function
ccam
fh2-r
reaction-positive
ipss-ra
pas-negative
survival-
skm-1xa0cells
sf3b1-k700e
mnf
populationsthe
fibrosis-driving
mf-2
leptinr
α-smagli1
procollagenⅰcd45
ⅰcd45
rbbp4
tp8
late-effects
preculture
re-emerged
discordances
refractoryresistant
lentivectors
rps14-deficient
l-leucine
morphants
bsg
slc16a1
cd147-mct1
beclomethasone
bdp
paper-based
giemsa-banding
cdw41
sanitary
anvisa
lobbying
erythropoetin
consort
abstractu3000u3000single
lansoprazole
rabeprazole
ilslelmkl
tetramercd45raccr7-cd27-cd28-
r3-specific
isrctn32763606
organiser
cytomorphologists
ppro103arg
dna-related
nonenhancing
nonvital
mir-595
rpl27a
del11q14q23
godfrey
epog-csf
chelatable
luminol-dependent
rhil-8
cellsmscs
fbxl5
fbxl5-deficient
mdsms
megakaryopoietic
lymphoma-xl
decremental
high-serum
acantholytic
nondysplastic
mxa0massiliense
hypovitaminosis
e14-e
online-only
substantively
765igf-methotrexate
igf-mtx
pictographical
aics
scd44
n0
microfluorometrically
wg
wilmstumor-1
methodscut-offs
mistrg
mds-pdx
nonspecific-appearing
perplexing
kikuchi
no-lysis
draq5
cytopeniascytoses
neoplastic-specific
ptdins5p
calif
mc-lineage
gi-tract
asp-816-val
mc-associated
mastocytosis-related
pre-pre-mast
lowlowint
internet-based
bfi
p15ink4b-methylated
msct
aml-mrcderived
rpge2
il32
preplanned
ppgf
gpgf
perimeter
add11p
inaugural
chun
hagemeijer
für
monoubiquitinate
fancd2fanci
alpha-fp
bmfmdsaml
bmfmds
trts
protein-deficient
single-born
pkc-α
pi-plcβ1pkc-α
gata-2-deficient
intronrss-kde
syndromeaplastic
p046
trib1-trib2
trib1-trib3
ligates
trike-treated
u2af1mt
u2af1q157
alpha-thalassaemia
male-female
quantstudio
scientificu200e
wt1abl1
β-arr1
nescs
gfap-expressing
neurofilament
1b3
2-loci
pha-icc
transgenically
pha-primed
paindiscomfort
anxietydepression
self-care
eq-vas
s-bm
crat
ipscs-with
lesions-we
srsf2-mutant
reticulum-associated
erad
nhd13bok-deficient
nccss
nccs
raredouble
nih-defined
mfc-
thts
mouths
post-receptor
etu
r-ef
variate
i-z
i-h-z
i-o-z
high-ses
steroid-like
normo
u2009×u2009104
-u2009×u2009104
microgdl
1500microliter
mab-defined
nat-9
annexin-
guilt-by-association
non-rars
protease-activating
facu2009u2009dfo
esirnas
non-io
sucrosomial
non-del
decoding
u2af1-s34f
dreaming
semi-limiting
single-cpg-site
fe-s
mds-cbc
sub-haploinsufficient
-20del20q
mtdna-mutator
prewarning
cytometryresults
microforms
ider20q
scd95
fas-receptor
epo-alpha
50xa0mul
hemoglobulin
red-blood
h-score
therapy-planning
c-mpl-mediated
postsignaling
desferal
nedaplatin
conduit
hr-weighted
il27ra
apo-gs
arginine-rich
misinterpretations
pid
mds-eos
mds-bas
mds--
g-6-pd
relaxing
metallopeptidases
der17tq13p13
nma-
nma-hsct
dlre1c
fc-γ
myocutaneous
thromboelastography
teg
disease-altering
axa0number
non-germ
chemohma
colony-initiating
hugm-csf
red-score
15q24
recently-described
breda
filgrastim-treated
plastic-embedded
h-ferritin
cd163u2009u2009macrophages
help-seeking
pccp
epithet
dichotomic
bayes
myeloplastic
fish-ipa
codetectable
dcmlr
clonalleukemia-derived
contaminations
non-converted
non-leukemia-derived
synergically
ricnonmyeloablative
flumelphalan
morphology-negative
fcm-intermediate
nonpharmaceutical
ag221-c-001
misrecognition
nmd-insensitive
minhemon
mds-mdsmpn
ddmds
lc-acr
vld-ac
ld-acr
alloanergization
adli
8-mdsmpn
behcets-like
cyflutbi200
mnda-expressing
blastsin
mrp-cam
mrpcam-
mrp1-
mll-fryl
non-functioning
intrafemorally
r273h
cd34poscd38low
antioxidogram
proteic
glrx
prdx
ao-score
hnesophageal
c9orf43
efhb
entpd7
fam160b2
helz2
inpp5j
e259k
e2n
e259k-transduced
erythropoietin-induced
p55c-fgr
hayashi
fhl2-null
fhl2-loss-mediated
non-il-12-treated
il-12-treated
plk-1
x-cgd
tcrvβ
unpleasant
thermometer
tingling
oligocentric
ril
cysp
mtx-tac
mtx-cysp
mtx-based
eban
macrophagemonocyte
autostimulation
pl-ac
mir-661
fcrii
v-pi-
plasmacytic
s100a9-induced
alarmins
caspase-1-like
cytometry-fluorescence
thermostable
fluorescence-conjugated
kap1
repairgraphical
mds-fab
muftis
hybridised
supportively
n54
cd34tp53
3xa0xa0
multi-system
kir2dl-ligand
b-lymphocytopenia
hematolymphopoietic
regurgitation
meg-csf
wrists
cancidas
v-fend
rps-14
fluidic
serum-containing
fas-fc
cd34-derived
cd34thy1
cd34cd38-thy-1
cd38-thy1
diaminobenzidine
pbnc
pndc
wll
tavi
glycophorins
eryptosis
unobstructed
channeling
highint-2
reportsn
aimsn
maharaj
nakorn
chiang
investigatedn
r625c
h662qn
q699h
tendedn
confirmedn
databasen
whereasn
p53-gene
nct00803530
over-diagnose
aneuploidia
12--with
olliers
non-len
depicting
63d3
rad-t-
rtk-ras
anti-infection
hi-em
u2af35s34f
runx-1
21q-21q
envelop
znf333
chr11
iie
promace-mopp
cytomegalovirus-seropositive
cmds
perpetuating
neurosurgery
pph
antioncogenes
pentra
chlorazol
image-recognition
convolutional
mir-584
three-fourths
discounting
liberates
pp2acα
synthases
anti-inos
talin-1
αiibβ3
srsf2s
sicam
svcam
nonblast
mdssmpns
rarsrars-t
intron-splicing
meayamycin
ikkalpha
xiong
notch-hes
specks
prion-like
mdsrefractory
intralaboratory
tet2kdkdezh2δδ
hyper-dmrs
tbu
cytbu
tbucy-conditioned
cytbu-conditioned
mir-320
mir-320c
i7q
cxxc4
amino-substituted
lgwors
mo-4
colombiense
nu202fu202f210
nu202fu202f250
littoral
angioma
tumefactive
gradient-echo
purportedly
cd45lo
cd45hisshi
th17tregs
das28-crp
cleanly
rnadna
atri
u2af1s34f-expressing
substratification
empowering
hspa9b
multinodular
goiter
ingesting
miul
mum2
angiotensin-receptor
aceiarb
mds-cos
bcas4
signalingtranscription
22-gene
cytometryfcm
cd13cd16
guideline-adherent
spectrins
rod-like
αi
αii
βi
spectrin
eryl
megl
eryls
density-centrifugation
blast-enriched
cd2-cd3-cd5-cd8-cd19-cd20-
ped-mds-mf
ped-pmf
ped-mds
fibrosis-related
proplatelets
il2-activated
lin-cd34cd123cd45ra
ki-67cd127-foxp3cd25hicd4
therapyconclusions
leukemiaa
anisocytosis
mdsmyelodysplastic
intermediatehigh-risk
cella
α-4
mnda-dim
well-hla-matched
tlk199
-238
lvf
g4mterc--
ildr1
overrepresentations
knockinknockout
iads
otolaryngologists
tracheotomy
laryngectomy
laryngotracheal
nonparatrabecular
back-to-back
haplo-mac
urgeatly
non-complexed
mln4924belinostat
belinostat-induced
mln4924-activated
intra-s
inhibitiondownregulation
rs1617640
4sc-202-induced
pre-leukaemia
endotoxin-activated
-million
tabular
homotetramer
endoreduplicative
pc10-positive
pcna-labelling
tra2β-pe
internationaleuropean
nucleosomal-size
log-likelihood
high-response
nct00179621
intraplatelet
high-r
five-tier
disease-development
del-5q
enrolls
pre-il2
lmrd
post-preemptive
preemptivexa0low-dose
iso-
gastroenterology
sykwt
tel-syk
il-2-inducible
itk-syk
myeloexpansion
prediseases
myelofibrosis-type
ltstmpp
r788
tel-syk-induced
syk-induced
mad2l1
exclusions
tom20
q-banding
tnfri
tnfrii
traf-2
mxn
fam
fam-treated
mxnarac
bevy
peg-asparaginase
upd6p
odk-0801
cd56cd56-
refineries
srr
age-range
hls
2006-
bmery
dxyu2009u
organise
cutpoint
basse-normandie
francim
adicap
640-gene
41-gene
ffas
dr15-negative
azotemia
bchns
transesophageal
blue-stained
thalassaemic
haplo-cord-hsct
uroacitides
cda-
rdp
sdp
specifiedcomplicated
pre-phases
´normal´
nonmineralized
fgf-23
fgf23
fgf‑23
rab20
cd32-dim
udagawae
cd34-stained
diseasemyelodysplastic
kansasii
paratracheal
reoperation
nmf
receptor-based
adp-induced
kir-advantageous
kir-kir-ligand
cmv-match
kir-genes
over-simplistic
semimetals
ggh
tdo
gluten
gluten-free
post-chernobyl
ob-r
monokine
maitake
hematomorphologic
oftnf-receptor
fasfas
mcv100
suspective
anti-tif1γ
relapsing-remitting
auricular
ada-rbc
mds-scs
cds1
tp11p11
q23p12
t17p
arouse
psychologically
zymographic
bm-mnc-conditioned
xn-series
wnr
wdf
wt1c-abl
tva
feret
size-related
pttm
mildnonspecific
melting-curve
non-mpn
stain-lyse-wash
three-tube
ly-2157299
β-d-mannuronic
m2000
spliceasome
cooperations
k-dependent
periostin
vka
tp21q24
bmam
5a3del
-181
benefitthe
bcl-xsbcl-xl
mdia1mir-146a
species-induced
good-quality
bach
selenomethionine
administration-dependent
selenium-induced
del5q33q34
del5p
del9q21q31
alpha5beta1
alpha5
alpha-hydroxy-vitamin
dysmonocytopoiesis
mannuronic
mtl
del7q31
sandozschering-plough
ld-ara
tetx
runxx
cr1p
ada-scid
antibiotic-induced
syndromes--refractory
leukemia--were
tocopherol-alpha
iron-free
hla-high
hla-dp1
cell-epitope
tp13q24
zanamivir
280xa0×xa
non-western
bucharest
pathogeny
refractor
receptor-specific
thrombocythmia
mdswe
subphylum
stat3-arg1
mcmd
ucmdmcud
dysplasiamultilineage
cytopenia-dysplasia
bronchi
lessens
tbri
mplw515l
anti-pcna
c3orf9
borrowing
simulation-based
frequentist
anti-epor
actinomucor
amidst
cd71cd45-
tumoural
gpi-ap-
cd59-
cd160
nd1-s
monocytestncs
trisphosphate
asxl-1
gorlin
suvmax
tegafururacil
dose-dependant
raebaml
ketones
samlmds
doppel
dpl
prnd
t-hoxb4-h
mouse-repopulating
lenalidamide
thalidomideato
pathogen-specific
nitrites
arginines
8-og
dd-mdsal
sf-mutant
flow-abnormal
microdomains
coalescence
ut7
750xa0k
low-int1
mds-rcc
fas-fas
tgf-β-mediated
14u202f×u202f107
msdlow
nu202fu202f223
msdhigh
nu202fu202f1214
15u202f×u202f107
mudlow
nu202fu202f197
mudhigh
nu202fu202f1102
pu202fu202f009
pu202fu202f10
pu202fu202f80
attest
antibody-masking
nhd13rag1ko
pak7
dyse
rcacc
as-e2
vk2s
hesitant
non-representative
p000
tpot
n555
reaction-denaturing
pcr-dhplc
g105g
g145g
aed
tfbs
snp-containing
thresholding
transfac
agrochemicals
micromks
mdsrcc
mutationvariant
atd
aupd14q
childhood-
hhmc
4-lncrna
stk
monocytoses
phorbol-myristate-acetate
cd11cd18
i9q
all-ogeneic
afop
seymour
suppl
granulocyte--macrophage
doileu
500u2009muml
mpss
tpss
elt
t-lgll
xerosis
triglyceridemia
btbd9
btbpoz
lbxcor1
lyons
pleiotropy
cd4natural
cnb
long-
therapy-neutropenia
fact-n
neutropenia-specific
oligodendrogliomas
oligoastrocytomas
iteration
proneoplastic
incompetence
physician-assessed
methionyl
aggregometer
dont-eat-me
cv1
handicapped
velcro
velcro-cd47
protein-engineering
cd47-targeting
capnocytophagia
complicationsthree
transfusion-transmissible
meaningfulness
thrombo-vascular
cyclosphosphamide
age-risk
ra-free
factor-mobilised
-intake
major-
studies-
hepatomegay
jas
brain-dead
aeg-1
aeg-1--
aeg-1δhep
aeg-1δmac
crts
8-oxog
mutyh--
pregnancypuerperium
rs12553612
ifna8
parkinson
stumps
rls-associated
attentive
tdsfs
first-cycle
obesity-driven
iyengar
sparingly
subcapsular
mega-dose
ak2
cardio-vascular
chronotropic
innervation
nct01085058
aneurysms
protein-1alpha
ruvolo
gregg
semenza
dysesthesias
cnf
kshvhhv8
mfr
post-ct
hbv-induced
awm
granulocyte-macrophage-colony-stimulating
donor-cell-derived
adhd
gwa
metaplasia-dysplasia-carcinoma
nonalcoholic
hmo
discretionary
non-hmo
arid
host-intrinsic
dysbiotic
deliberately
crc-specific
acfs
best-case
worst-case
cox-2-derived
rcbtb2
high-riskproliferative
non-hyperdiploid
polygenetic
e4697
multiepitope
melanomaexperimental
six-arm
370d
210m
mart-
melanoma-specific
anti-gm-csf-neutralizing
nabs
osconclusions
counterintuitive
aom-il10--
il10--
cell-deplete
rs3802842
colca1
colca2
abvd-equivalent
patient-basis
pet-negative
brand-new
ebvhl
a-01
a-02
cd14dull
granulocyte-derived
longer-acting
caregiving
exhausting
kora
ssc-mir-133b
mitochondria-related
n-phenylbenzamide
kinome-wide
jhdm1b
h3k36me2
nt16
vp16-rar
vp16-rxr
hydroxydibenzoylmethane
hdb
dibenzoylmethane
hdb-induced
x-ray-derived
biaryl
offsetting
rapamycin-based
mtor-inhibitors
phosphatydilinositol
pi3k-inhibitor
remarkedly
u937t-aml1-eto-xenografted
anti-self-renewal
mir-193a-aml1-eto-β-catenin
p-p70
p-s6k
protein-epsilon
aod
aod-development
adhesion-proteins
tube-formation
target-kinases
abl-2
map-kinases
hindlimb-ischemia
aod-events
observation-time
aod-frequency
aml1-mtg8-targeted
25-nucleotide
am2
am4
aml1b
mtg8b
skno--40
kasumi--70
alphaiib
dolichol-dependent
asparagine-linked
5-hour
interferon-augmentable
fcr-positive
nk-susceptible
sgc7901ddp
cispaltin
hypoglycosylated
protochordates
dr4dw4
dr4dw14
dw4-positive
dw14-positive
bakmcl-1
gx-induced
cross-presented
anti-pr1hla-a2
8f4
onions
apples
msto-211h
sub-g₁
lcmr1
noxa0ay148462
non‑small‑cell
two‑hybrid
s‑transferase
pull‑down
plasma-free
pre-tyrosine
f-t-d-r-l-q-q-y8-i-s-t-r-g-l-g
y8
polysialic
13d9
n-propionylated
mannosamine
telangiectasia-derived
-abl1-negative
ylisgdspv
yigsgdspv
yiiigdspv
yiilgdspv
yiisgispv
yiisgdlpv
yiisgdswv
yiisgdspl
withylisgdspv
peptide-specificity
ebv-blcl
cd69cd45ro-cd8and
cd45raccr7-cd8cells
granule-dependent
cells-myelodysplasiamyeloid
mlf1ip-in
cellomics
arrayscan
vti
mlf1ip-silenced
aminoethyl
dami
kinase-interacting
atp-substrate-competitive
marrowblood
tissueblood
dehalogenation
trichloroacetic
lymphocyte-dependent
bcl-2-expressing
effector-to-target-cell
sd-36
wt--mhcii--
mhci--
mhcii--
mcp-cml
28-d
dosefrequencies
lsdl
cc-90011
bu-auc
care-givers
trial-and-error
usp13
autophagy-lysosome
nipt
nipt-induced
tim-3-mediated
m22
de3
solutes
beta-d-thiogalactoside
his10-tagged
m22scfv-eta
periplasmic
metal-ion
size-chromatography
cd64-positive
mlc-generated
g-10
fcmu
leu-4
leu-2a
aml-ns8
nms-p937
expecially
mstu200au200a
abdominal-type
on-cogenes
e2a-hepatic
mll-enl-mediated
hypo-morphic
glis2
stipulates
target-organ
vav1-cre
stat5abnullnull
slamf1
stat5-independent
mexicanin-i
myb-induced
anti-sail
sail-targeted
polo-box
plk-family
imatinib-resistantimatinib-intolerant
bcr-ablsfks
hla-nonidentical
antidonor
cd34lin-
stroma-dependence
recontouring
neuropeptides
benzothiazole
bexins
iwp2
ic50xa0xa0358xa0nm
au-nanoprobes
au-nanoprobe
tp53-modulating
ki23819
angiostatin
kringle
kringles
beta1-
beta2-integrins
alphambeta2-integrin
beta2-integrin-mediated
peritonitis-induced
emigration
nfkappab-related
epors
γ-radiation
mtor4e-bp
bcl-xlmcl-1
tilting
bnipl1
rps13
stk3
snx27
wdhd1
sag
rbx2
sag--
sag-scf
ra-mln4924
conformation-modifying
conformation-based
lic-specific
tcls
ppp3ca
d25d2
pri--nor-d2
pri-5202
double-point
19-nor
vdddmf
bmsfs
lnclacz
lncinterleukin-2
il-2-transduced
4800pg
advlacz
advil-2-treated
indole-2-carboxylic
mcl-1-bim
avastin
erbitux
iph--7f9
iph-2101
kir-transfected
imp-3
igfii
amazonia
ittaca
hr-nbl
ss1dsfvpe38
anti-mesothelin
mesothelin-expressing
lyn-specific
non-liganded
amp-pnp
src-specific
blastretriever
rcd19-
lb-ptk2b-1t
clk
raralpha-specific
monocytes-macrophages
ha-based
biodegradability
gsh-responsive
phosphatidyl-inositol-3
lecb
morbility
phosphorylation-activation
-trimethoxybenzoyl-3-iodoacetamido-6-methoxy
benzobfuran
5-trimethoxybenzoyl
benzoheterocycles
benzobthiophene
n-methylindole
iodoacetamido
c-7
iodoacetylamino
c-4
trimethoxybenzoyl
thr421
ser424
as2o3-inducible
ser235ser236
ser240ser244
thr37thr46
mtorp70s6k
malignant-cell-selective
retinamides
g1a
pd-r
oxphos-reliant
bakbax-
cml66
cml66-targeted
cml66-derived
yyidtlgri
hla-a2402-restricted
cml66-specific
flavopiridols
activation-mediated
precursor-acute
osteoblast-mediated
nherf1
phosphatase-1α
pp1α
nherf1-pp1α-taz
proteasome-generated
puromycin-sensitive
slamf7
guanine-rich
tmpyp4
96xa0h
lineageprogression
hostility
fgf2-induced
lik
unvaried
pml-rar-induced
ly2603618
etv6-aml1
biotherapeutics
gmcsf-receptor
ic-10ngml
mrp-associated
willems
aml—not
“off-target”
non-life
ricin-a
gametopoiesis
aml‑derived
aml‑mscs
k562‑adm
k562k562‑adm
stainingxa0pox
hybridizationxa0fish
co‑culture
interleukinxa0il‑6
il‑32
il‑6
spindle‑shaped
semiallogeneic
hla-dp101
hla-dp401
gclc
ncorsmrt
ag1295
leukaemogenetic
circba
sphk2
lymphocytoxicity
t-cel-associated
sumo-conjugating
juxtaposes
alpha-mediated
alpha-plzf
g4-binding
aq1
myc-related
ube2o
coreceptors
alphabeta-mediated
hla-cl
associatied
newly-identified
c-kitscf
c-kit-directed
ah130
heteronuclear
ra-treatment
nb4-s1
jnkβ-cateninsurvivin
γ-cateninβ-cateninsurvivin
triamine
pentaacetic
oncohaematology
e2-related
ech-associated
keap1nrf2
pi3kptenaktmtor
apogossypol
bi79d10
rs11846
bax--bak--
sh2-kinase
aml-stroma
n-demethylation
n-trideuteromethyl
cancer-targeting
self-injections
mult
natural-killernk-resistant
cycels
endotoxic
αkgidh1
idhmutations
antibody-streptavidin
radiobiotin
anti-cd45-sa
cell-sensitive
sar-transduced
time-honored
accell
nonviral-based
tra-induced
subapoptotic
tra-resistant
mr-2
tra-inducible
ttgii
rig-e
bfl-1a1
transcription-modulating
degradating
nifuroxazide
mechanistic-based
complement-
k-cell-mediated
k-cell
k-cell-revealed
sst2
sequesters
mst2
hematogenesis
especailly
pro-matrix
non-proteolytic
hemopexin
pex9
gst-pex9
b1b2
b3b4
integrin-interacting
fpgvpldthdvfqyrekayfc
p3ap3b
anti-p3
gst-b3b4
p3p3ap3b
17-allylaminogeldanamycin
collagen-binding
α2β1
rac1-induced
c-alpha
chromatin-mediated
halogen
bromo-deaza-sah
scghvd
α-methylene-γ-butyrolactone
c1-c10
cyclopropane
hla-dpb-specific
gabp
gabpα-null
prkd2
il-000
prodigy
g1xa0arrest
p-prb
caspase-9xaxa0andxa
pneumococcus
phospholipase-c-γ2
rip-1
turban
c-ets-1
oncogene-specified
tyrosine-phosphorylation
pi-3-kinase
myeloidn
vesseln
studiesn
anti-vegfn
real-timen
vivoin
multimerize
b-cell-derived
phosphorylated-axl
p-axl
sykζ-associated
γ2
specific-inhibitor
r428
non-rtks
obscures
alfa-2c
preload
yaml568
kinase-inhibition
diferuloylmethane
mitosis-arrested
cells-morphologic
cell-internalizing
phe-phetyr-any-leu-arg-ser
ffyxlrs
dklaklak₂
ligand-directed
cgfywlrsc-gg-dklaklak₂
tgf-beta-stimulated
clone-22
tsc-22
tgf-beta-inducible
flt3-tkd-transduced
pentaspan
cd133-based
anti-cd133
oncotyrol
competencies
ffg
hta
msea
vfitc
ser-136
ser-112
guanine-to-thymidine
pdgf-responsive
ifn-inducers
ifn-augmented
fmulvgag
gag-tg
gag-specific
anergized
co-incident
pmnb
mirna143
mirna143-induced
cercosporamide
clinical-translational
1hpt
zinc-binding
anti-cd38-based
trans-dominant-negative
nonamers
a2402
nonamer
mhc-binding
a0201
crossreacted
mpd-et
imf-could
reconciliation
mcim2
mcimi-m195
2-p-isothiocyanatobenzyl-cyclohexyldiethyl-enetriaminep
entaacetic
212bi-hum195
tdflt3-transformed
tdfltd
tdflt3
anti-tdflt3
fab2-like
antibody-tnf
antitransferrin
chain-tnf
transfectoma
cd33-ablated
prethymic
mi-m195
anti-mouse
hug1
il3-dependent
il3-dependency
ligand-stimulated
9cyclin
b-cell-related
pi3kδ-targeted
pi3kδvps34
pi3kdv-in-01
lymphoma-type
sdf‑1
alkylamide
deep-vein
vanderbilt
guc
maxizyme
chromium-51
non-crossreactive
line-encoded
missing-self
shiga
stx
enterohemorrhagic
ehec
stx-induced
paediatric-type
nonsteroid
ampk-mtor-akterk
aktmek
overgrowing
embryology
y704
y729
y744
y764
py704vlq
py744lrc
2-py
r609
e638
oxygensulfur
antibody-derived
tcr-derived
aafps
t-pmlrarα
t-runx1runx1t1
t-deknup214
aml-inducing
deknup214
tpmlrarα
tdeknup214-positive
pmlrarα-
deknup214-positive
mir-133a
tip60-dependent
dc-specific
nonintegrin
dc-sign
microbicides
composes
anti-blast
midostaurins
kit-targeted
b10br→cba
cba-derived
cdr3-size
vβ13
cd8vβ13
constituency
gut-infiltrating
tumor-presensitized
cd44cd62l-lo
antihost
presensitization
lpaat-beta
nb4-mr2
500xa0ngml
leukemia-selective
rgel
non-recombinant
hum195-rgel
gna11
azd6244arry-142886
azd8055selumetinib
azd8055selumetinib-induced
interleukin-9
hil-9
hil-9-cdna
rhil-9-eta
hodgkin-derived
l540cy
p815-hil9r
hil-9-eta
hil-9r-expressing
as2
eif-5a
hypusine
epsilon-4-amino-2-hydroxybutyllysine
butylamine
epsilon-amino
4-aminobutyl
tp40
tki-imatinib-nilotinib
cminhatinfty
moderate-high
imatinib-nilotinib
mud-sct
oncogene-directed
ephb4-vav1
under-expressing
k562-r-ephb4-sh
re-sensitivity
vav1might
p13q12
tumorigeneis
oncometabolites
oncometabolite-induced
quelled
muc1-based
ppbiost659bst20170400cf1f1bst-cf1figurexa01number
muc1-targeted
c-abl-a
stress-has
pd-related
α-synucleinopathies
countriesregions
admiral
aesis
embryo-foetal
thais
mnk-mediated
cytarabine-inducible
cytarabine-mediated
tretinoin-mediated
nct01820624
2-log10-unit
survivin-deregulated
randomizes
tarp
rarretinoid
endoribonuclease
rnase-l
sniper
iap-mediated
pml-dependent
furanopyrimidine
flt3aurka
bpr1k871
ic22
mia-paca2
il9
smad4dpc-4
smad2jv
prescreened
iiixa0clinical
c-met-high
c-met-driven
gsi
neutrophil-mediated
il-2-enhanced
cd33cd3-bispecific
cd3cd45ra-ccr7
afucosylated
nvs32b
opsonized
phototargets
mitochondrion-targeting
photodamaged
4-pdt-treated
mcf-7c3
mda-mb468
4-pdt
broad-specificity
lymphoid-derived
nb4ra
nb4ramdr
nb4as
gmr-targeted
ovc
mir-pmcl1
tarbase
pairing-up
westernwestern
interferingxa0rna
echinacea
purpurea
myeloid-competent
nfic
radioisotope-labeled
dm5
gp23dm5
hs-543
toxicokinetic
rugged
pmcmc
transcriptionalepigenetic
rassf2-mediated
proximity-based
rassf2-proximal
gtpase-related
rac-mediated
sds-mscs
scps
ossicles
rps3
aur-a-specific
apblast
hypoxia-selective
micromonospora
hypoxia-adapted
ha-cml
lodgment
gal-3
stemblast
4lymphoid
oxime-analog
transducin
3log
triptolide-induced
protooncogen
carboxyamidotriazole-orotate
cto
exosome-stimulated
traj7
adipocyte-rich
bm-resident
lithiumu202fu202fnilotinib
lu202fu202fn
k562-cell
gemini-23-yne--hexafluoro-d3
bmscs-dependent
terphenyl
anthranilic
mll-encoded
supercomplex
chromatin-modulating
dimerizationoligomerization
responses--defined
bm--occurred
tribbles-1
hexosamine
hbp
gfat
udp-glcnac
hbpo-glcnacylation
hbpo-glcnac
thieno-dpyrimidine
6-position
-methylaminoethoxy
isoferritins
over-estimation
productionrelease
isoferritin-inhibitory
ae-negative
c646-induced
toxicity-guided
dasatinib-dependent
nonexclusive
oliguria
brd4-specific
rfp-expression
rfp-high
rfp-low
-intermediate
mcf-7dr
hum0
cd56-expressing
allo-antigens
cd80-transfected
ponatinib-
forskolin-reduced
45a
lysozomes
calicheamicin-antibody
equiv
b220gr-1mac-1
control-transduced
pax5b220gr-1mac-1
si-109
cerebloncullin
authors-
retinoid-x
nb4-lr1
dual-liganded
tissue-selective
affinityavidity
ctl-tumor
non-lymphoablative
anti-self
anti-foreign
clockδ19
mania
lithiums
cholecystokinin
rbm15
c-myc-ko
rbm15-ko
hsc-niche
host-defense
calorie
induced-increase
mdm2-only
mdmxmdm2
18-amino
u2009×uxa0m
biomarker-specific
scfvs
chrysophanol
-chloroethylamino
methyl--dihydroxy--anthraquinone
sk--bis
2-chloroethylaminomethyl--dihydroxy--anthraquinone
sk-31662
-hydroxyethylaminomethy--dihydroxy--anthraquinon
sk-31694
hindiii-digested
30-sec
sk-31690
glevec
bcrablp210
myc-eukaryotic
eif4f-responsive
autoinhibited
channel-like
lead-compound
bt5-demonstrates
fgfr-3
hydrophobicaromatic
hypereosinophilias
eosinophile
anti-il-5
das-iap
das-meiap
kt-1
neutralising
endlessly
ashtert
astanks
astanks-promoted
mcl-1short
mcl-1long
ir-cml
niads
ir-k562
eus-guided
eus-fnab
chip-dna
anti-eto
tiled
ceas
excavated
smrtmrid
projecting
crescent
meniscus
cml-66
cml-28
differentiation-linked
null-all
antibody-defined
patientdrug-specific
braf-mutant
propolis
cape-mediated
z172
cyclinxa0a
cyclinxa0e
cyclinxa0b
cape-treated
gsi-i
gsi-ix
gsi-xii
b-ml
gsi-sensitive
ptyrstat3
ptyrstat5
stat3-inhibitors
rll-12
ril-12
32dc13
mfg-based
32dil-12
lama-87
microvesicle
dosageimplications
ab-opsonized
complement-depleted
complement-repleted
four-membered
thiotanib
thiotanib-induced
reforming
nd2158
-unmutated
eµ-tcl1
late-
early-myeloblastic
crispr-suppressor
adenoassociated
raav
antibody-aav
myoleukemia
hepg2-r
mcl--utr
mcl-1-deficient
ire1alpha
βarr2
mplw515l-mutant
βarr2-knockout
βarr2--
mpl-mutant
tamoxifen-induced
cre-conditional
usurps
thr735
ser186
re-import
cd82signal
transcriptioninterleukin-10
il-10e-cadherin
icim
morphology-dependent
recombinantly
vegfvegf-a
unc2025
unc2025results
mertk-expressing
mertk-targeted
125i-
131i-
catabolized
radiometal
acid-cytarabine
aminopeptidase-2
metap2
pkpharmacodynamic
metap2-specific
maldi-seldi-ms
35s-met
ft-icr-ms
rich-like
eef2
glyceraldehye
cyclophillin
cypa
metap1metap2
1d2d
deubiquitinylase
imt-resistant
driving-resistance
k562rimt
exsomal
mtor-independent
beclin-1vps34
spautin-1
pi3kakt-nf-kappab
noxa-usp9x-mcl-1
pemetrexed-induced
hiv‑1
hiv‑2
virusxa0hiv
pi‑based
hiv‑associated
unconnected
nelfinavirxa0nfv
nonpeptidic
polyprotein
nfv
pharmacophore-based
mll-mediated
arachnoid
product-targeted
lineage-targeted
moab-based
vaccinology
adduces
bcr-abl-based
refractoryrecurrent
cd123-cars
hingetransmembrane
292cd8ahtm41bbz
bbz
292cd8ahtmcd28z
716cd8ahtmcd28z
28z
292cd28htm
cd28z
292cd28htmcdbbz
41bbz
cdbbz
nct04318678
pgl
pallida
hsct-associated
cfh-related
eight-yr-old
arteriolar
mcla-117
cell-redirecting
clec12apos
ec50xa0xa044xa0ngml
ec50xa0xa068xa0ngml
mcla-117-induced
obatoclax-promoted
pteridin-h-one
mutants-selective
therapy-responder
fev
buchwald-hartwig
cross-coupling
ptdins5p-4-kinases
pip4ks
pip4k
ppins
target-induced
itpkb-deleted
itpkb--
a20-luciferase
gnf362
mll-af9-egfp
c1498-luciferase
antigen-responsive
acid-arsenic
ezn-2208
peg-sn38
cotargets
hoxa9myeloid
meis1pre-b-cell
mll-fusiontet1hoxa9meis1pbx3
azd1152-hqpa-mediated
azd1152-hqpa-induced
expanse
bathing
fluorescein-tagged
ky01
ae-silenced
usp25
fr-β
cd336
cd2781
cd2665
cd-417
cd-2314
lg100364
dosage-
occc
focal-adhesion
occcs
fakpi3kakt
pf-
pf271
pf228
ovise
ovmana
pf271abt-737
post-genomic
cpsf3
read-through
mek-mediated
my-10
liquid-suspension
single-hit
hif1
nano-drug
3-kinaseprotein
endogenic
b3a2-specific
b3a2-peptide
non-pulsed
chromosal
identifybinding
strucure
antibody-calicheamycin
cd4car
cd4-expressing
deltan
p73alpha
p300-mediated
phosphoacetylated
mastocytoma-derived
1-treated
fr-negative
rar-associated
6s
dideazatetrahydrofolate
cb-derived
cb-nk
exvivo
car33vh
my96car
domain-only
zeroing
tcr-mediated
h0xa10
teto-hoxa10
tetracycline-responsive
tet0-h0xa10
rasgrp4
ybx1
lymphoid-clone
lineage-il-7r-c-kitsca1
lineage-il-7r-c-kitsca1-
nip
klasa
thrombin-driven
h1975
mlf1-knockdown
protease-cleavable
crabp
mcl-1-overexpressing
ucsdaml1
balbc-rj
wellcome
beckenham
bl-22
cd4xa0xa0t
regulator-like
tgm2-mediated
egfr-mediated
rhtrail-c3
dr4-mediated
trail-c3
inhibitor-κb
maces
akr1c
jasmonic
mej
mso
phosphorothionate
self-digestion
idarubicin-treated
punctuationaggregation
lc3b-i
autophagosome-associated
lc3b-ii
idarubicin-mediated
r178e
trp53r178e
trp53--
p53r178e
mdm2--
indistinguishably
attesting
logp
dcg066
untargetedunbiased
pkbakt-dependent
chrf
thioglycollate-induced
effectivetherapy
bcr-ablp210
16x
antimicrotubule
s1pr3
receptor-tyrosine-kinase
fabsc
bssc-format
cd3-antibodies
flt3-antibody
4g8
cd3-antibody
ucht1
fabsc-antibody
bssc-antibody
ubiquitin-tagged
multisubunit
b-ap15
regulatory-particle-associated
bcr-abl-containing
quadruplex
telomestatin
sot-095
telomestatin-treated
post-myelodysplasia
hla-b44-restricted
hmsd
hmsd-v
mha-specific
hmsd-v-encoded
acc-6
cpec
necdin
glucose-dependent
mini-icefilgrastim
hidacamsafilgrastim
b-cd34
hidacamsa
5amsacrine
b-cdmicrol
hidacamsag-csf
mini-iceg-csf
betulinic-acid-treated
a-nk
gcm3
fcs-supplemented
inhibitory-cell
i-expressing
cross-reacts
hla-c-expressing
kir2dl3-transgenic
hla-cw3-positive
preadministration
ptkis
cyclization
loperamid
featureless
on-bead
chaperonesinhibitors
α-synuclein
complex-disease
hgal9
beta-galactosides
traumatically
postinjury
postburn
hydroxy-pp-me
heterocycle
hypermetaphase-fish
bcr-ablmetaphases
uncultivated
bcr-ablcabl
stilbenoid
g6
jak2-v617f-mediated
g6-dependent
jak2-mediated
arsenic-binding
s-dimethylarsino-glutathione
zio-101
gsk690
ex917
gsk690jnj-26481585-mediated
gsk690jnj-26481585
gsk690jnj-26481585-induced
autogenous-leukemic
b43
nonlymphohematopoietic
hmw-bcgf-induced
lmw-bcgf
hmw-bcgf
bcgf
moab-induced
fpgsfolylpolyglutamate
fpgh
fpghrfc
cpreb-all
fpghfpgs
549-fold
58-fold
95-fold
178-fold
triplebody
spm-2
fk506mycophenolate
alloscts
fk03
beta-thalassemias
hurler
lymphohistiocytoses
methotrexate-
methylprednisolone-sparing
rhs432
rhs43
rhs42
rhs32
rhs2
bcl-2-overexpressing
hl-60bcl-2
bt-a
bt-b
diptoindonesin
ifit3
stat1-targeted
g-induced
eosinophil-related
l-hes
m-hes
anti-tyrosine-kinase
800-kb
fip1-like
1-platelet-derived
serosal
hdhodh
flavindependent
ecyclin-dependent
aktpkb-dependent
serine473
buttress
aktpkbp27kip1
kinase-targeting
eg5-aso
dna--topo
sds--kcl
receptorvdr
vdr-targeting
chaperoned
3akt
pre-lsc-like
effectsin
microneedle
apd1
apd-l1
hollow-structured
microneedles
microchannels
sprayable
paralell
hsc-platelet-apd1
hek293t-derived
imrt
non-imrt
pre-imrt
wedges
anthropomorphic
30cm
cranio-caudal
tlds
oncor
step-and-shoot
dptv
dptv65gy
dptv45gy
dptv50gy
dptv18gy
zgdhu-1
indifferent
akt-β-catenin
akt-activated
nkh1
bromelain
bm-pr
dichlorofluores
dcfda
pineapple
brpf
finger-containing
13-d
brpfs
nonclass
fpo
ni--d
polony
7thxa0annual
anti-flt3xa0when
stat5-p
ra-chemotherapy
thesexa0relapses
ancestralxa0pre-leukemic
pmlrara-expressing
rachemotherapy
anti-flt3
stem-cell-directed
auz454
ath686
pmlrar-α
cost-friendly
feedingfasting
fasting-induced
metforminhypoglycemia
pp2a-gsk3β
b56δ
pp2a-b56δ
-phenylaminopyrimidin-4-ylthiazole-h-one
cardiotoxity
overrode
cell-to-lymphocyte
cd8-enriched
cd4-enriched
3-kinase-akt
nras-mutant
ha-bcr-abl
glo-i
amidox
4egi-1
polysome-bound
translation-dependent
s65
mtorc1-independent
ole
oleo
33-targeted
gemtucumab
mono-substance
drd2
lead-in
nct02096289
flaw
mitochondrial-based
momulv
lixsn
lncix
m-aml
lilrb1
irf7-sapkjnk
cd38-chimeric
cd38-dependent
marrow-like
caspase-9-based
stat5-activating
brequinar
bismuth
leukaemia1
apoe
ras-targeted
phosphatidylinositiol-3-kinase
dids-sensitive
mdb3
mdb3-d16
mdb3-mediated
out-comes
ligand-inducible
wordsacute
substructures
pb-cfcs
pb-cfc
cfcsml
peroxisome-proliferator
ppars
non-steroidogenic
tnf-alpha-dependent
monokines
vsv-induced
antiautophagic
cd19⁺
cd5⁺
autophagy--lc3-ii
bcl-2-beclin-1
linc00449
post-embryonic
ephephrin
epha2-negative
epha2-knockout
if7
compound-2
compound-2-induced
compound-2-sensitive
precedents
pyrazolocurcumin
dimethylcurcumin
pyrazole
n-p-phenylcarboxylic
kxa0cells
pyrazolo
universitys
aml1-mds1-evi1
ame
ph-al
co-evolution
trans-endothelial
asfe
higher-potency
flo
hematocrits
gill
carp
copperzinc
fxa0columnare
zonula
acp
cytokines-related
methylotrophic
pichia
pastoris
km71h
anti-cd33-scfv
alpha-mating
alpha-mf
incs
dibasic
kex2
ste13
cs-scfv
eaea
incs-scfv
anti-cd33-scfvs
biacore
c-ablsrc
dok2
chlorambucilfludarabine
chlorambucilfludarabine-induced
i-mismatched
locus-matched
stimulator-responder
pha-b
restimulations
vbeta-specific
nontherapeutic
sel
ic9-carcd33
cell-stimulatory
histogenesis
gins2
lever
kynurenines
anti-lscs
cd8-dependent
receptor2
ddx5
c-8
myelofibrosisacute
progenitor-enriched
crispr-modified
ifnγ-
nf-κb-associated
cytokines-induced
atmp53p21waf1
p38jnk
dusp
dusp1-inhibited
t-restricted
elf-1-like
myb-responsive
transformationmaintenance
leukemia-blast
myb-silenced
frzb
phleukemia
bv173-dependent
phcells
microrna-regulated
seco-steroid
jkf
p46
d-based
2-r-2-hydroxyglutarate
shuts
2-hg-mediated
antihelminthic
tak1--ikappab
ikk--ikappabalpha
niclosamide-induced
p18ink4c
c-kitlow
lsklow
p18--
p18-deleted
tcf3-hlf-positive
tcf3-pbx1-positive
vpreb1
cfps
cd64-specific
r201k
pi9
cfp
lennerz
hla-b4405
hla-b4405-reactive
staf50
argininer-to-cysteinec
trimc-specific
phospho-focal
k562dr
survivin-rna
survivin-rna-transfected
survivin-expressing
ischemiareperfusion
naively
dt-scf
on-column
denaturant
myr-akt
myr-akt-expressing
cobblestones
mtss1mim
sclttabcr-abl
lineage-depleted
mtss1-overexpressing
bcr-abl-mtss1
asb-2
roc2
u200adamage
u200amember
serineu200athreonine
polo-u200abox
cbx2
sumo-triggered
cbx4
rnf4
cbx2-depleted
tumorogenicity
saha-mediated
night-sweats
repeats-crispr
transferrin-coupled
mutationsthe
hu-scf
epiphodophyllotoxins
raralpha-plzf
tq23q21-apl
anchorage-deprived
tq23q21-associated
lidamycinldm
ldp
il3ldp
i131lf132l
il3ldm
xa0times
10000xa0times
singlemultiple-dosing
120xa0d
clz-8
domain-containingxa07
thioredoxin-interacting
synthase-1
mpges-1
pgh2
w515k
anti-dr4
ay4
hn9
snu899
ay4-sensitive
ay4-induced
ews-fli1
yk-
ets-driven
stat3-activating
tel2etv7
teletv6
tel2
tel2-expressing
welldocumented
dermatomal
mitosis-specific
sb431542
proteasomal-dependent
diarylacrylonitrile
trans-stilbene
monotreatment
hscp
cdc42-guanosine
depolarized
sh2-u-box
u-box
sh2-u-box-carrying
k562-xenografts
k562r-xenografts
hitwalker
ash1l
kdm2a
∼90
resistance-induced
polymer-mediated
il2α
68gapentixafor
emitter-labeled
177lu90ypentixather
cxcr4-directed
intra-interindividual
az521
nugc
scm-1
osu-a9
osu-a9-induced
ptyr105-pkm2
e3999
abcb1-mediated
2-cyano--dioxoolen--dien-28-oic
cyto-toxic
cddo-me-induced
target-selective
thr-766
4-anilinoquinazoline
c-iap
hematosis
rs3740392
rs3740390
rs11191439
neut
ahn-12
1b4m-dtpa
90y-anti-cd45
anti-daudi
minors
1-acid
drug-drugfood-drug
oct-1-influx
crls
crl
guanosine-specific
nitrobenzylthioinosine
nbmpr-sensitive
cd3cd-
cd3cd
post-sct-derived
cd56cd94
hsp70hla-e
tkd-activated
evi1-non-expressing
carboxyterminal
hlaf
cmpd1
pserine727
perkmapk
pu-h71-tpp
π-π
dissipated
hsp90s
1p32
amidopyridines
pser2-rnap2
a-lak
highly-enriched
cona--prestimulated
cona-activated
cona-pbl
pfwt
af4-af9
pfwt-mediated
28-residue
deltaacd
aml1-mediated
cbf-regulated
83c
aml1-acd
e76k-expressing
c-nucleoside
punctuate
isg20
smoothened-a
intersects
pathways-rasrafmekerk
notch-as
non-quinone
17-demethoxy-reblastatin
17-dr
hygroscopicus
17-dr-induced
bcr-abl-deregulated
escortphosphatase
reacquisition
cd26-targeting
cd26-car
self-antigen-driven
anti-cd-1bb-car
gephyrin
gphn
mll-gphn
15-amino
fas-r
brl49653
15-deoxy-delta
j2
su-dhl
sup-m2
lg100268
disease-bearing
type-3
hypersensitization
vesicules
positionnement
adenosine-monophosphate
activated-protein
jsh
pdgf-receptor
syndromeschronic
stroma-modifying
in-vitro-activated
lgls
major-histocompatibility-complex-matched
mcl-1-sensitive
host-directed
saliphe
bromodomain-promoter
hipp
eif4a1
t-αβ
innate-like
plzf-raralpha
plzf-raralpha-positive
αcd3
gv
-retinoic
reformation
mitochondrum-related
24-
tgf-β-pai-1
metalloprotease-1
minibodies
diabody
perugia
pml--
topoiibeta
grb
ma1
u-251
tblr1-rarα
crick
crispri-mediated
mir29c
mir29b2
bet-inhibitor-induced
ludwig
boltzmann
onc
axa0first
pre-l-nsc
axa0solid
axa0second
lentivector
acid-stimulation
rnaseiii
22-base
all1af9
51cr-labeled
rarrxr
triplicate
lysate-pulsed
abcb1-c1236t
ube1l
ubiquitin-related
bh3-domain
gdc-0199abt-199
cell⁻cell
cell⁻matrix
fc-
c3-expressing
prodigiozan
lvl
bloodacd-a
pre-lvl
post-lvl
a192
α-cd99-a192
multi-valent
nanoworm
16u202fh
nanoworms
independence-1
sk-1sphingosine
sk-1s1p
lama-4ima
sk-1--
sk-1s1p2
pp2a-dependent
lama4ima
32dt315i-bcr-abl1-derived
sk-1s1ps1p2
wild-type-
mutant-bcr-abl1
lipoprotein-based
pharmacological-based
sevearl
fusionu2009u2009ve
phu2009u2009ve
-ve
prkc
topoii
topoii-mediated
multiple-activity
pibf
bg9
srik-nkl
mot
r-cll
md-e
729ph6neo
srih-batl
srik-bt-pll
myeloidmonoblast
killert
irak-2
irak-4
replication-defective
psi-2
cfuml
mabel
membrane-expressed
anti-pd-1pdl1
cog449
lak-cells
sw742
exportin1
kpt-330a-1331852
mtorce-bp1
mnk1eif4e
c528s
runx-inhibition
switch-mediated
runx-silencing
dα25oh2d3
1α25oh2d3
1α25oh2d3-responsive
dr3s
dr3-containing
controling
non-dr3
1α25oh2d3-induced
park2
parkinsonism
arjp
fra6e
pacrg
anti-cd3-stimulated
amd3465
db126
wh187
processing-deficient
wt1-expressing
hla-a-negative
wt1-nonexpressing
target-but
to-the
hg--01
baf3-flt3-itd-luc
licenced
dox-inducible
ut-7u202fcells
cgp-57148
p190bcr-abl-
p210bcr-abl-expressing
phenotype-independent
cotransduction
tumors-platinum-resistant
thr-338
inhibitor-binding
bulkier
hck-t338m
inhibititor--imatinib
generation--dasatinib
bosutnib
inhibititors--ponatinib
hematooncology
bcl6-corepressor
gcb-
abc-dlbcl
shepherdin
peptidyl
rna‑binding
musashi‑2
largazole
microrna-106a
gvl-mediating
bv16
qdr
vds
18-hr
euthymic
nylon-wool
cd44xa0positive
cd133xa0negative
cd44cd133-
cd44cd24-
argentinian
oncogeneiety
proteolytically-activated
protease-generated
n-end
proteolytically-generated
ubr1ubr2
p85alpha
aminothiazole-pyridine
15i
chmfl-pi3kd-317
6u202fnm
adp-glo
pikk
t308
vectorize
atelocollagen
2xa0xenografted
atelocollagen-vectorized
atelocollagen‑mediated
af4-derived
alphascreen
low-volume
z-factor
vs-5584
sch772984
cd44v6car
leukemia-inhibitory
tci
concentration-controlled
frustratingly
a-1201477
crnde
cbmcs
iodide-103
as2s2pi-103
gitr-ig
leukemia-expressed
target-antigen-dependent
uccs
1-receptor
vegfr1-r2
α-receptor
triazoloacridinone
c-1305
ricr
hemapoietic
1996u2009u200913
1996u2009u200920
spectrometryxa0rg3039
rb-1
cd64-directed
h22scfv-map
pbmc-derived
three-amino
m33-meis1
m33-meis1-transduced
g1-to-s
d-prb
pml-rarα-negative
c000000302
chromate
micro-cytotoxicity
targeteffector
oncoprotein-targeted
rar-dependent
strail
ectodomain
strailwt
straildr4
straildr5
colo357
panctu1
rtraildr4
rtrailwt
n-benzoylstaurosporine
nc9
transamidase-
κ-light-chain-enhancer
erucylphosphohomocholine
cd38lowneg
rna-editing
adar1-dependent
lin-scakit
cml-directed
monocyte-lymphocyte
histone-
mek-inhibition-induced
28kda
caspase-cleavage
asp127
asp157
drug-triggered
d127a
d157a
mcl-1δnull
medium-throughput
lower-throughput
snmp-treated
nup98-fusion-dependent
nup98-fusion
nup98nsd1
nup98jarid1a
nup98ddx10
nup98-fusion-driven
nup98-fusions
mtorc1s6k4ebp1
rsk1
jagged2
dll-3
heterobifunctional
podosomes
circ-fbxw7
mir-18b-5p
circ-fbxw7-transfected
oxaliplatin-induced
umin000029879
umin000031343
umin000033144
umin000034243
lfa-1icam
cɛ
pkcɛ
mk-impaired
pkcɛ-related
dot1bl
-3theta
fk228-induced
treatmentsareas
phorbols
prohibitin
pgcsil-gfp-phb
dcpss
suum
c-tag
his-tagged
m7gpppg
m7gdp
nematode
36-fold
cd34thy-1
unrealized
mir-197
plk1-related
c-kit-negative
expression-positive
tak-960
chp100
ls141
18xa0hours
mechanisms-based
phospholipid-based
pmb
pmbus
epipmbus
glfg
nup98-homeobox
3-aba
anti-parp
adriamycin-treated
asparp
latest-
ml390
mapkk
tribbles-binding
tlsfus
totipotent
alzheimer
photoprotein
aequorin
aequorins
e1-vector
photoproteins
tmprss2-erg
wobble
heterodimerizes
c-mycmax
7b5
ha-2pos
ebv-lcls
ha-2neg
cdh13-derived
cdh13-transduced
cnlacml
t640n
tak-1
hla-a24-positive
thymomas
triphosphate-mimetic
touted
adroitly
acidall-trans
consense
5-tcaggtcatgacctga-3
ra-rare-pmlrara
pmlrara-
sumo-proteasome
asp522
a-helics
v-erba
tel-abl1
nup214-abl1
bcr-abl1-abl1--
bcr-abl1-abl1
ddx5-targeting
2f5
biotin-labeled
trim25
incongruity
ir-26
atp-non-competitive
pd0325901-induced
rafmek
aktp70
polycations
pcx
pcxsirna
gleevec™
miniaturization
telomerase-transfected
mid-dose
plotting
2-deltadeltact
ligand-regulated
rares
headneck
bromodomain-based
voruciclib
corylin
cullen
corylifolium
medik
marrow-located
lys05
pik-iii
lin-sca-1c-kitcd48-cd150
lys05-mediated
kinaseflk2stk-2
rapalogs
anti-eif4e
torkinhibs
intramembraneous
xpo1crm1
chondroma
mcl-1bcl-2
41-fold
insure
precaution
myelocytesabstract
jasin
gent
hoeijmakers
kanaar
cd34bcr-abl
flt-3itd-induced
kdxa0xa05xa0nm
aptamer-drug
apt-mtx
o6-guanine-alkyl-transferase
seiter
o-bromothenylguanine
pattmz
sclerosus
atrophicus-like
hsf-1
leif
hillestad
nf-kappab2
r726a
cml-leukemia
dot1l-mediated
advocating
cyp27b1
1-α-hydroxylase-25ohd3
cross-linkers
hd-tki
abc-family
37u2009000-fold
survivin--ym155--is
il6stat3-signaling
t-eif4e
sumo-mediated
cda-ii
cda-ii-induced
aml1-eto-activated
aml1-etorunx1
cistrome
betbrd4
azd5153-treated
1irs1extracellular-signal
lsd1mtor
cp-
dual-bromodomain
dbbi
mice6
abbv-744
abbv-07514
ar-containing
ar-dependent
trioxide-dependent
akt1akt2
as2o3-dependent
s6k1s6k2
gab
pser
pleotrophic
subtler
hsa-mir-12462
aml-rr
t-5224
h146
h196
dms114
4eg-i
sp1-targeted
leukemia-dependent
rg6016
gsk-2879552
dah-treated
tmb-h
hybridization-capture
ncor1
ociaml-1
ociaml-5
h2o2-sensitive
receptor-selective
all-antigen-positive
prrs
retrovirus-specific
lineage-predominant
generalizations
prmt4
cut-and-sew
diversifying
truncated-bid
hht-induced
dose-volume
midh2-dependence
1-carbon
gshros
pin1lsd1
tadeltanp73
arsenic-mediated
dual-treated
p53p73
oligomerizing
bcr-cc
swiftly
helix-stabilizing
staple-containing
bioenergy
8-cl-atp
oxi4503
rims
richly
lscs1
bespoke
hbo1
kat7
k14
rnaxa0polymerasexa0ii
chemotherapycytokines
cd16a
4g8-sdie
flt3-transfectants
su011248
semaxanib
rtks--vascular
split-kinase
hksr-2
vdre-type
vdr-rxr
d-treated
d-dependent
hoshii
b-leukemia
emu-tcl-1
fate-tracking
ilsc
pan-bcl2
lda-treated
streptavidin-biotin
534d
522d
zch-aa4
l48
papain
norcantharidin
nctd-conjugated
nctd-3a4
3a4-negative
energy-sensing
downexpression
bcg-cultured
bcg-cell
rasraf
protein-targeting
rapa-mycin
rapamycin-induced
a-derivative
rapamycin‑induced
azd8055-based
azd8055abt-737
azd8055-mediated
leukemic-phase
pyst2
5-hydroxylase
s5-dbd-pa
fv-4
fv-4r
flv-induced
flv-susceptible
plsf
flv
mesylat
footsteps
ph-dependence
sy-1365
nct03134638
sy-1365-induced
nuclearcytoplasm
crm1-dependent
npm1-mutated-specific
mers
ph-chromosome-positive
bcrabl-targeting
target-profile
co-responsible
setd1a
interleukin-6-induced
emodin-induced
selfrenewing
inhospitable
ly2857785
arp1
pbx-1meis-1
antagonistkiller
lc-3iii
im-sensitiveresistant
k562k562r
integratively
clusterviz
4-binding
taming
conquer
cytotoxic-agent-related
laudably
pathwayscascades
polζ
parvum-treated
endotoxin-stressed
2-globulin
wehi3
tnf-resistant
tnf-sensitive
parvum-endotoxin-treated
parvum-endotoxin
mll-containing
depositing
menin-mll-mediated
mi-503
psat1
psph
c-labeled
menin-dependent
huáng
qín
jiāng
cuspidatum
hŭ
zhàng
carbenoxolone
1-octanol
cx25
cx25-dependent
s1p-dependent
depletable
sapk
c-abl-deficient
c-abl-mediated
isrs
onc201-treated
atf4-mediated
onc201-induced
enjoyment
frustration
inabilities
baxbak-mediated
antigen-34
c59t
affinitive
25-dihydroxy-vitamin
sil-6r
isoprenylated
c3ha
chelerythrin
nh3
telomeric-silencing
translocation-driven
me2
nadphnadp
malate-aspartate
irem-1
anti-irem-1
prdxs
ii-v
h7-induced
ros-erk-cebpβ
calmaf10
gfi1--
xbcl-2
gfi1s
raralpha403
1-methyl-4-phenylpyridinium
lysophosphatide
lpaat
trichinella
spiralis
t7
h7402
a200711
pegfp-n1-a200711
hoechst-pi
anti-hepatocellular
eskm
factorxa03xa0runx3
cellxa0msc‑mediated
as2o3‑induced
msc‑mediated
microrna-processing
muc1-silenced
α-l-rhamnose
d6-ma
detachment-induced
ic7
facilitative
mcl-1s159
-dioxopyrazolidine
-chloro-4-fluorophenyl--nitro-2-furylmethylene--pyrazolidinedione
pyzd-4409
bi-1
vflow
integrase-binding
mll-ibd
ibm2
ibd-mllmenin
ibd-in
hiv-in
af9-binding
11a
pinp
hdm2p53
cgm097
stromal-secreted
anca
neutrophil-derived
azurocidin
anca-associated
cd52-directed
ii--
9cdk9
shcdk9
skgt4
skgt4-shcdk9
skgt4-derived
40µm
flo-1
more-specific
suppressor-induced
shuangshen
ssg
notoginseng
rg1
macorphages
casucci
off-tumoron-target
time-to-first-treatment
cll-cell
ucb-derived
nk-target
mir-106b-5p
gs-9973
entospletinib
bcr-mediated
ct4td
beta-particles
bismuth-bi-labeled
actinium-ac
225ac-lintuzumab
astatine-at-labeled
pretargeting
target-to-normal
cd19b
cd56nk
appended
phthalimide
q34q22
proteosome-dependent
mis-pair
tcr-
shp099
cfo
trnaval
myd88nf-κb
ibrutinib-resistant
7-dimethoxyquinoline-4-yloxyaniline
semicarbazide
2-trifluoro-nn-dimethylacetamide
12g
312u202fnm
384u202fnm
sti571-sensitive
kbm-5sti
phosphor-specific
az960
h2o2-scavenger
prx-iii
apoptotic-response
co-staining
tortuosity
fibrosclerotic
ifn-activated
oligopyrimidine
frontrunner
de-ubiquitinases
pyr41
vdac1
vdac
thioredoxinthioredoxin
δaml1-eto
trans-regulatory
reign
b-cell-restricted
phosphoglycoprotein
b-cell-directed
rtp801
p-4e-bp1
p-70s6k
hoxa9-locus
interarray
freeze-thawed
rppas
nf-
nf-b
ci06
lckyes-related
lyns
anyhow
signaling-associated
kb003
receptor-αr
subunit-expressing
prv1
tipped
aspp2
aspp2κ
dgtp-mediated
t-lymphopenia
9-beta-d-arabinofuranosylguanine
2-amino-6-methoxy-arabinofuranosylpurine
gw506u
micromh
tcgf
rs11695471
rs2289195
rs734693
rs2276598
rs1465825
rs13401241
rs7581217
rs749131
rs41284843
rs7560488
non-fab-m3
maillard
p-hydroxyphenyl-2-butenal
hpb242
fructose-tyrosine
hsc4
camp-regulatory
p90rsk
pmncs
d227a
seam
seam-pa
pa-seam
sea-reactive
sag-mab
pml-sensitive
rara-pml
rait
radioantibody
target-to-nontarget
affinity-enhancement
tumor-to-nontumor
htnf-alpha
tnf-b
receports
tnfs
htnf-r55
htnf-r75
tnf-r55
tnf-r75
multi-r
non-multi-r
tfp
generative
serique
damage-sensor
b-pac-1
b-pac-1-induced
b-pac-1-mediated
dataxa0demonstrate
retrovirus-transformed
leukemia-presensitized
c3hsw--b6
cytoplasmicnuclear
mac-2
h2db
h2i-ab
leukemia-line
tumor-stimulated
il-4-
restimulated
cross-protective
leukemiaeleven-nineteen-leukemia
fluorochrome-linked
ac-devd-cho
anti-cr1
pd166285
g-quartet
gq-odn
t40214
t40231
sk2
cd1381
sk2-
abc294640
3–mediated
nct01410981
acid-dependent
tki-sunitinib
intertumoral
pre-validated
bcr-abl-fusion
bcr-bl
cml-apbc
silencing-mediated
hypochromia
eltanexor
cd95fasapo-1
fas-triggering
α-tocopheryl
α-tos
hcg-pml-rarα
tp15q11
nup98top1
top1nup98
not-therapy-related
pga
pga1
di-m-pga2
vmat-based
death-4
nb4r1
hl60r
monocyticmacrophagic
dap5p97
hypercalcemic
ucb-1350883
bi97c1
bi112d1
mim-1
bcl-xl-dependent
pglu-glu-asp-cys-lys
ml3
differentiation-permissive
mn1vp16
interferon-response
co-targeted
snai3
scrt1
nutrient-deprived
teriflunomide
dhodh-targeted
hla-phenotypically
microkilogramskg
-422
104kg
acyltripeptide
fk-565
fr-39868
celltarget
peptide-expressing
tmd7
ociaml-6
notch1-mutated
inhibitorsgsi
rxr-specific
mfh
survivaltransformation
∼60-
mvct-based
plumbagin‑treated
inhibitorxa01a
kinasexa04
plumbagin‑mediated
minigene
bcl-a1
a-375
mel-ho
mel-2a
e-endothelial-selectin
e-selectin-mediated
psgl-1cd162
re-engineered
scfv2-fcγ1
tfr1-mediated
scfv2-fc
anti-tfr1
fcrn
ic1xa0µgml
ery-1
ha-2-expressing
tcr-modified
anti-hla-a2
hla-a2-matched
thieno-dpyrimidine-based
unit-granulocytes
unit-erythrocytes
units-erythrocytes
baalc-high
mekk1
mkp3dusp6
herrmann
perforin-
fasl-employing
perforin-utilizing
maladaptive
zip7
vks
k5
vk1
subeffective
grp78-targeted
bmtp-78
dklaklak2-containing
anechoic
candida-infection
liver-biopsy
stromal-cell
bst2
wee-1
ccdk8cdk19
lee011
ly2835219
at7519
terampeprocol
rgb
«
medecine
»
impaction
tcn-pm
cypgs
cypg
interleukin-32
short-length
warheads
cd105-
targeted-therapies
biennial
trainees
vigyan
bhavan
targeted-agents
asparagus
racemosus
arp
ficoll-hypaque
af4fel
ltg9af9
ltg19enl
ltg19
mll-ltg9
mll-ltg19
mll-chimeric
hla-a0201-
γ-radiation-induced
ras-positive
nras-
kras-positive
ras-expressing
nras-positive
wee1mtor
methylation-modifying
docking-based
bioevaluation
5-arylidene
mao-a
mao-b
nmu1
nmu2
nms
amidated
heptapeptide
co-segregated
vasoconstriction
differentiationmaturation-inducing
-tetradecanoyl
pro-vided
1alpha25oh-ene-d3
1alpha25oh-oxo-16-ene-d3
perfusate
1alpha25oh-oxo-d3
rwleu-4
24-oxo
sp2509
pan-hdi
5-dimethyl
thiazlyl-5-diphenyltetrazolium
jaiswal
t-leukemias
scfvs-saporin
hematopoieis
antidifferentiative
gmil-4or
gmifn-alpha
gmil-4
interdependency
anti-biotin
adp-ribosyltransferases
cholera-toxin
toxin-related
art1
art4
art2-which
adp-ribosylation-is
art2
paralogues
cd296
cd297
lv-10
darinaparsin
dar-induced
dars
csa500
carbohydrate-recognition
oliv
aps-2i
u202f×u202f105
rhamnose
galacturonic
galactosidase
g-4
bio-active
fendrr
hurfendrrmir-184
kinase-ras-map
zk118182
µgl
beta-particle-emitting
poz-zf
beta-platelet-derived
mog-g-uvw
confered
il-6signal
non-seleno
peroxidases
podosome
dgn462
purpose-created
indolinobenzodiazeprine
pseudodimers
igns
qur
aggf1
ryfklshlqmhsrkh
hla-drb-restricted
hla-drb-matched
cd4cd25foxp3gitrcd127-
nknk
anti-wt
wt-pulsed
dr4-matched
interleukin-5granzyme
bfoxp3
b7-h3-targeted
non-prodrug
nonmutants
uncharacterised
multiple-reaction
sumo1
sumo-interacting
defensins
bi-d1870
abls
overexpansion
delimotecan
4901t-0128
t-2513
carboxymethyl
triglycine
me15392
t-0055
metabolise
shp-
itims
cd33-induced
alpha-cd33
dffry
dffry-derived
palliative-use
gist-type
bms-536924
igf1rir
otssp167
fast-onset
apoptotic-inactive
hla-encoded
ul40
cd94-nkg2a
cd94-nkg2c
ul40-encoded
nineteenth
radiolabelling
vascularised
jak2y
crlf2jak2
mll1-fps
expressionactivation
anti-p-
anti-e-selectin
cdc25s
d609
d609-induced
n-succinimidyl--pyridyl-dithio-propionate
hum195-gelonin
hum195-it
m195-gelonin
abt-737-resistance
nctd
mylabris
abt-737-triggered
rnf6
little-studied
prep1
pbx1rnf6
y352
anus
8c
ic50u202fu202f283u202fnm
znf198
cep110
csk2
abemaciclib
mutated-
17-aminogeldanamycin
3-angelate
pep005
peplus
pkc-delta
egfp-pkc-delta
selenoenzyme
tightly-regulated
mono-flavonoid
anti-malignant
erkakt-mtor-stat3-notch
almost-standard
nonvirally
mllbcr
aidber
apurinic-apyrimidinic
ber-mediated
tor
pi3kakttor
astori
region-anti-human
excd80-cd33scfv
hspc-enriched
anti-l-ic
3flk2
hsp90-associated
kinomic
mccd123
sm-chronic
nonindolent
tissue-nonspecific
tnap
osteoblast-produced
rx-5902
phosphorylated-p68
clec12axcd3
clec12a-eng
il7
clec12a-engcd123il7rα
cd123il7rα
il7rα-mediated
utx-null
o-bromophenol
nitrosoacrylate
β-indole-α-oximinoesters
saponification
diamines
actitivies
uvi5008
multiepitarget
indole-based
skp2--
p53-defficient
tcl1-tgp53--
silybum
marianum
trap-elisa
s-type
jh-ix-179
lpsu2009u2009polyic
fsl-1
lpsu2009u2009r848
systems-wide
nonstop
mcf-7doxr
rhenium-188-labeled
biokinetics
188re-anti-cd20
radiopharmaceutical
membranecytosol
sphk
hochest
sphk1s1p
nkp30ncr3
nkp44ncr2
nkp46ncr1
taspase1--
noncleavage
uncleaved
mllncnc2ncnc
mlls
hsf1-mediated
therapy-triggered
a-sepharose
cl-4b
7s-fraction
fc-receptor-bearing
antibody-associated
aacc
bcr-abl1kit
pakts473
internalizes
pan-erbb
ci-1033
bcl2l11bim
vivo-transplantation
11q23-positive
kinaseproline-rich
hmw-maa-specific
cycle-regulatory
kcl-22m
alpharxr
numa-
stat5b-rar
atra-regulated
dr3
dr6
wt31
tp53wild-type
tp53deleted
tp53mutated
notch1-specific
preosteoclasts
bolstered
mhc-ligands
peptide-sequencing
mhc-associated
vegf-toxin
fps
27-amino
t15
srcc-abl
48u2003h
syky348
cd154lil-4
sl-ic
sl-ics
scid-repopulating
db1976
103-fold
domain-specific
stepwise-integrated
mir107-myb
mir-378-granzyme
mir10a-map4k4
clinicalpharmacologic
galnt1
targetedmirna-directed
b41
pectolinarigenin
stat3dna
1hdac1
extra-large
leukemin
malignamcy
discoverer
tingdong
confusions
zhangs
pyrrolo-b5benzothiadiazepines
cml-chemoresistant
ril-2-generated
ril-2ml
exploitment
tp13q25
etv6-ntrk3
ntrk3
etv6-sterile
ap-1060
nonmem
ellicott
semimechanistic
pk-pd
hcc-t
mcl-1eat
butyrate-stimulation
interferon-related
stat2
p21waf-1
butyrate-treatment
homonymous
ataluren
-hla-matched
tcd-allosct
allo-reactivity
patient-mismatched
hla-dpb1-directed
recipient-
nr-101
hcb
ioh-nps
bmp-nps
hsp70bag3
cd19-targeting
sb2o3
sbiii
phenanthroline
a126v
l218p
phenylstibine
welner
dinucleotide-dependent
xenotransplants
pd180970
c-mpl-positive
cold-target
ifn-enhanced
not-too-distant
furthest
iodine-125
rg7356
amleligible
supraproportionally
tmdd
improvementrg7356
h-22
il-3granulocyte-macrophage
fcri
phorbolester
hug1-m195
ch3
β-2
adrb2
adrb2camp-dependent
igmkappa
six-transmembrane
steap1
lsd1-kd
gsk3-specific
earmarks
dna-pi
escapethe
arh77
double-
cd19cd33
fv-2ss
fv-2rr
allophenic
fv-2
fv-2rr-mediated
antigenicity-determining
ha-3
vtepgtaqy
ha-3t
ha-3-
vmepgtaqy
ha-3m
thr--met
hif‑1α
aptamer-based
ctlrs
mincle
shh-driven
notoriety
e3s
receptorpdgfr
nt157
cpc-apc
sia
sia-containing
sialoglycans
sialoglycan-siglec
sialidases
shields
unsusceptible
malonyl-coa
vegfvegf-r
vegf-r-2
hif-1alpha-induced
m2-skewed
macrophage-recruitment
m2-polarization
tams-related
vis-a-vis
hypoxia-primed
chemoattract
m2-macrophage
eotaxinoncostatin
4t1balbc-syngenic-mice-model
hbeag-positive
bsms
bsm
cd30-specific
ki-4
h22xki-4
fcalphar-specific
a77
a77xki-4
cd30-expressing
mdms
mdm-mediated
mir221
mir222
mir451
nxa0xa033
quantitatereal
coerced
stop-insertion
tbsms
stat3-recruiting
traps-vari
clinician-friendly
deactivating
axotomy
flk-1
co-administer
jalpha18
cd1d-dependent
da-teddi-r
lk-induced
tu5
dermal-interstitial
ddc-idcs
dc-t-cell
monocyticdendritic
vlcs
hpvopc
hpv-specific
effectorsuppressor
prednisolonevinblastine
lch-iv
inteleukin-3
proteins-gads
skap55
pkcα-involved
fixation-resistant
gads
ptclnot
ptclnos
gadsdok2skap55itk
lentivirus-based
pok
si-pokemon
pokemon-silenced
herv-derived
entrain
αcd20
platinum-
taxol-based
ccr5-dependent
chemokine-chemokine
pbktopk
kinase-defective
diffusible
colorectum
pdes
camp-mediated
prions
spongiform
encephalopathies
tses
prpc
scrapie
prpsc
prionprion-like
sys1
subfractionated
ltc-1c
isotope-based
sidmap
tracer-based
bcr-abl-expression
scfv-fcc21
peritubular
pro-invasive
myoid
cell-poor
hgf-cdk4r24c
tals
nlns
plns
pln
wm-relevant
wm-specific
myd88l265p-directed
tyramide
amplification-free
multispectral
cell-centric
co-evolve
tumour-rejecting
formyl-peptide
gi-protein-coupled
fpr2
pignatelli
menainv
csf-1-mediated
erprher2-
c3-dependent
anti-pdl-1
pvr-like
nectin-2
pvr-tigit
pcdlbcl
dlbcl-lt
cd68cd4
anti-pd-1anti-pd-l1
c-di-gmp
lm-based
lm-mb
tumortarget
nonlymphoablative
tumour-killing
m2-associated
indisputably
t-infiltrating
results-and
expectations-there
fruition
cd73hi
cd73--
plgf-induced
pgs
pdl2
regdc
chemoattraction
slb
anisamide-polyethylene
glycol-polycaprolactone
aeaa-peg-pcl
anti-fibrotics
melanoma-infiltrating
activateddeactivated
autocrine-paracrine
p15e
rmb-1
anti-p15e
alginate
19f8
er-is5
dactolisib
phospho-4e-bp1
phospho-src
neuropilin-2
nrp2
receptorreceptor
clrramp2
clrramp3
anti-am
alphaamrs
alphaamr
alphaamr-treated
amrs
antibodies--consisting
fab-fragment
cells--can
gde7
cd62llow
tumor-restraining
fprs
hh-induced
hh-dependent
corrupted
check-point
mamps
gemcitabin
ccl2mcp1
ccr2-positive
ccl2-neutralizing
cd11highgr1
heslop
pexa-vec
pexastimogene
devacirpvec
hemoatologic
stambpl1
pvrig
lpp
cecr1
arhgef6
chemotherapic
deterring
cancerpc
mtor-regulated
epo-epor
herceptinr
rituxanr
fc-receptor-dependent
anti-pd1-resistant
344sqr
344sq
344sqp
incb023843
fgr1intcd11b
hggs
clinicalxa0ex
tme-driving
flagged
gp130757ff
xil-1rt1--
il-1rt1--
il-11stat3
il-1rt1
guillain-barré-like
charcot-marie-tooth
clumsy
bottlelike
electrophysiologic
m-wave
ands
interpretative
spillage
n-acetyl-dinaline
ci-994ara-c
ci-994daunorubicin
ci-994mitoxantrone
iev
hdts
postponing
hcd
rad52
nondegrading
alcysten
marine-based
neurolymphomatosis
antracyclines
rchop-hd
dxm
vincristine-daunorubicin-prednisone
cytarabine-cyclophosphamide
methotrexate-dexamethasone
vincristine-prednisone
cyclophosphamide-cytarabine
bland-altman
gm2course
epilobium
oeb
ellagitannin
pediatricians-
citostatics
lamins
tecam
carmustine-based
ivlbcl
lbcl
pre-flt3
shih
tzu
meningoencephalomyelitis
gme
methotrexatemercaptopurine
teniposidecytarabine
stroke-induced
cytosine-beta-d-arabiofuranoside
doublecortin-positive
monoexponential
nci-ctc
medullariscauda
pseudotumour
halichondrin
warhead
hydroxydaunomycin
r-bendamustine
intermediatehigh
all-95
-oriented
-triphosphate
ecotoxicity
fbal
subspicatus
putida
sewage
hdaci-sensitive
cbpg
assay-directed
negative-sense
template-associated
ntp
ntps
conduits
anti-htlv-1
2-cdaara-c
formamidine
3-positions
exocyclic
palatine
f-fluorodeoxyglucose
m-component
non-hr
malaysia-singapore
delayed-intensification
successor
scnsl
cns-active
rotations
mononucleotide
nrtis
zalcitabine
mononucleoside
s-acyl-2-thioethyl
sate
biolabile
monophosphorylation
bissate
asthma-like
ataxic
cer
glucosylation
interphasic
sphingomyelinase-mediated
dl-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
galactosylation
galactosylceramide
galcer
galcer-enriched
krabbes
dnr-
glucosylceramide-enriched
gauchers
sphingomyelin-derived
thioguanine-containing
bcl-xl-deficient
bax-
caspase-9-
bax-deficient
methotrexatecytarabine
polylactide-co-glycolide
comatrix
cytarabine-loaded
comatrices
5-o-dipalmitoylphosphatidyl
2-c-cyano-2-deoxy-1-beta-d-arabino-pentofuranosylcytosine
dpp-cndac
anti-neovascular
dpp-cndac-liposomes
aprpg-modified
non-modified
venetoclaxs
cross-section
osteopenic
mne
nalm-6r
berlin-frankfurt-munich
protocol--bfm
protocol--ny
helpersuppressor
raro
t-memory
dominic
solimando
aubrey
waddell
blount
lamar
parkway
maryville
tearing
hyperemia
microcysts
parma
dhap
zevalin
z-beam
r-dhap
r-ice
48-fold
ara-c-sensitive
dck-as
3-kinase-like
rad17
cndac-induced
chrc5
skvcr
cemvlb
muller
pkc-dependent
drug-stimulated
ceramide-driven
mtxarac
anabolicanti-apoptotic
leukemia-microenvironment
cd44cd44v
cd34cd38-cd90-cd45ra
aml-pdx
1-beta-d-arabinofuranosyl-cytosine
reassortments
mdr1a
mdr1b
assortments
lmb
2-c-cyano-2-deoxy-1-β-d-arabino-pentofuranosyl-cytosine
cndac-treated
thalamus
thl
atp-induced
atp-stimulated
neurochemical
agrp
arcuate
synthesome
nonresectable
mef2d-fusion
m-fusion
survival-supporting
m-fusion-targeting
mef2d-hnrnpul1
cleavage-resistant
pericatheter
extra-ventricular
papez
high-intermediate
ara-cdp-choline
liponucleotide
cdpdiacylglyceroldcdpdiacylglycerol
ara-cdpdiacylglycerol
5-diphosphate
lecithin-derived
promastigote
amastigote
vitrectomized
nonvitrectomized
h9-arac
muo
sulci
cu2
cu2-induced
2xa0cycles
r-dhap-mtx
dcp
hptlc
isolator
toes
involuntary
pmlbcl
7u2009u56
isid
misid
cem0
cemara-c7a
cemdck-
kpc34
studiedwe
all-mll
linesa
cytarabineflt3
rituximabcyclophosphamide
rhgm-csfara-c
sm-20
ngf-deprived
armpit
idaram
r-idaram
angelicin
hl-60dox
deblocking
e--bromovinyl-2-deoxyuridine
ehd
group-ct
group-ra
8ct
thoraco-abdomino-pelvic
dysesthesia
rdwbrt
farac
4xa0gy
remissionu2009u2009partial
93xa0
farac-ric
bioconjugates
liberate
cobalamin
transcobalamin
intrapulmonary
small-dose
cracking
ligating
okazaki
hyper-cvadma
dexamethasonemethotrexate
2u2009gm2
pre-rituximab
tbusate
top1ccs
3-blocking
tdp1--
tdp2
atl-104
wccnr
countercurrent
mfg-dhfr-irescd
l-asparaginasetreated
snc
β-gal
ependymal
aq
dcx
psa-ncam
foreshadow
who-although
diagnosis-developed
pd835y
c2503gt
fittest
spectrofluorimetric
infuse
fludarabineara-cg-csf
couplet
ccg-1882
ccg-1961
m36
gentamycin
azlocillin
cephradine
netilmicincefotaxime
carbenicillinazlocillin
ydeo
mdtef
6g
tolc
copp
leser-trelat
2-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine
fiac
noncompetitively
durd
cfiac
hdcy
plasms
cyclophoshamide
socioeconomical
quad-specific
radio-conjugated
chemotherapy--
chop-dexa-beam
backache
imunohistochemistry
overa
vesanoid
multilaser
-dipalmitoyl-sn-glycero-3-phosphocholine
pasp
pasp-g-c8
ph-temperature
dual-sensitive
cptlps
cptsls
cty
gastrosplenic
yttrium-90
amy-1
comla
toposide
nod-scid-il2rγnull
arabinosidecytosine
nonlinearly
ara-cdna
cddpara-c
ikappabs
cgcs
ifosphamide
post-bfm
palmar
g-csfg-csfr
f-ara-a-mediated
depocyte
kerato-conjunctivitis
neuroaxis
aa3
bfm-all-95
hd-mtx-based
lymph2cx
cns-ipi
ighbcl-1
dnrara
yttrium-y
δae
unsteadiness
pcr-analysis
jc-virus
piol
eyedrops
downgrade
arl
meam
mcp-842
protocol--mcl-842
chemotherapyrhug-csf-mobilized
cytarabine-mitoxantrone
chemotherapyrhu-g-csf-mobilized
a200
a100
6-thioquanine
a23
cstd
isolators
bt-cml
mdr1pgp
d-serine
dao
neuroectodermic
teratoid
atrt
hedgehog-pathway
ldacdata
practitionersdata
hh-pathway
dioc2
bibw22s
idaara-c
seventies
3-o-acyl
-di-o-acyl
-anhydro
dioxane
aracs
f-machop
skw-3
nb-nhl
lcal
megachemotherapy
one--bone
syringe
bucye
cannulation
peg-asp
coall
clofarabinepeg-asp
hidacpeg-asp
matilde
response-tailored
parpi-resistant
non-parpi
genotoxin-induced
non-cholinergic
fluorines
dfdctp
rabusertib
cpx-351-induced
tp53-null
chk1-targeted
ot-82
double-chain
protonatable
phosphatidylglycerol
anti-b4-blocked
d12
meningeosis
suboccipital
time-survival
3hnitrobenzylthioinosine
l-valyl-ara-c
p-aminohippurate
ki-ras2
subpanels
-o-cyclocytidine
3-hydroxydaunorubicin
olivacine
l-cells
mimosine
ftm
kushen
heterodinucleoside
5-fdurd
ccl228
ccl-fu
ccl227
leptotrichia
internationalized
progressors
wtp
meac
neuroradiological
26th
all-91
bcrpmxr
h69dau
nyhvm
teniposide-resistant
nyh
tnp-351
ara-ccbmn
rituximab-induced
cisplatindaunorubicin
f-fac
anhydro
fluorination
bombardment
hexagonal
h-bn
adsorbs
nbo
a-lch
fdur
p-nitrobenzyl
thioinosine
non-cytarabine-containing
1-o-alkyl
1-s-alkyl
thioether
ara-cdp-rac-1-o-hexadecyl-2-o-palmitoylglycerol
ara-cdp-rac-1-s-hexadecyl-2-o-palmitoyl-1-thioglycerol
cytoros
1-o-acyl
m5076
3-lewis
ahod0031
calvarial
opn-signaling
on-demand
mobilizations
700xa0cgycyclophosphamide
xa0gm2simustine
8xa0gm2iv
m-rels
m-rel
home-based
cerebli
chelitis
0-or2
2-or4
daunorubicin-derived
propylene
pg-free
evomela
irvine
solubilizing
captisol
lajolla
nhl17
cha
microglial-specific
esi
derivatization
k562bcl-xs
k562neo
hexamethyl
fludarabineara-c
titrate
oligopeptidase
nb-1
arabinoside-treated
46xytq21p15
47xy11
5-deoxyfluorouridine
postincision
gap-filling
nh32
genotoxicants
diphenyleneiodonium
scns-dlbcl
12xa0h
ln-229
ln-308
jp-8
20microgml
thr-821
degradability
wastewater
wwtp
effluents
biodegradation
uv-c
photolysis
uv-ch2o2
milli-q
photodegraded
aops
pseudo-first
r-thp-cop
ikzf1plus
aff1-kmt2a
cghsnp
b-other
pax5-myo1g
pax5-ncoa6
s-dependent
chromosome-type
post-myelosuppressive
shortages
mid-2000s
len-mec
plga-comatrices
centrocytic
noac
mogamulizumab
krn-deamino-3-morpholino-13-deoxo-10-hydroxycarminomycin
krnarac
dnaarac
diphosphates
abnm-13
n4-alkyl-ara-c
c-atoms
n4-acyl-ara-c
equipoise
-style
cryotherapy
trf-r
non-haem
ara-cdp-dl-ptba
ester-linked
ara-cdp-l-dipalmitin
microdontia
v-shaped
bfm86
hidac-asnase
parylene-c
sio2
-pulsed
78-kda
ferrioxamine
iron-starved
desr
desa
iron-regulated
aspnj
earthworm
26x
65x
cect
malins
bfm-95
mcp-841
bfm-90
daunorubicinara-c-thioguanine
idarubicinara-c-thioguanine
pet-positive
hdca
udca
gm2cycle
dmtx
-oh2d3-induced
vagal
sil2r
ara-amsa
hr-leukaemia
-upper
caebv
svg-jc
3-deoxycytidine
s-180
3-deoxy-ara-c
5-o-acetyl
ukall
undistinguishable
odor-associated
ncic
fmau
anti-herpes
ng2-glia
intracerebroventricular
self-sufficiency
metronomics
st4
pf382
up-modulates
facpgm
ed-b
functionalised
maleimide
fragments-liposomes
subcutanous
mcl01
r-hcvad
cp-4126
semi-continuous
quinolone-derivative
hyphal
radicular
upto
kbqkg
tumor-to-normal
atiii
uracil-arabinoside
farag
juliusson
combinationsequential
len5
isrctn58492795
primaryrelapsedrefractory
leukemia-meningeal
detaching
me6tren
tris2-dimethylaminoethylamine
cell-mobilizing
matchpoint
efftox
pi-pi
per-164
45-min
sftg
thiabendazole
clofibrate
aneugens
aneugenic
7-hydroxystaurosporine
ara-c-pretreated
cleavageactivation
loop-deleted
bcl-2delta
ds-tam
ld-ca
pmaip1noxa
hlh-94
aigues
ladulte-94
lala-94
tcr-expressing
pre-alphabeta
hox11
plml
polyhydroxy-substituted
3harac
non-cpec-treated
reniform
ess
arat
beeam
5-chloro-arac
cytidine-deaminase
ic8
ic05
cytostatically
fumes
workshift
microgm3
excision-repairable
onslaught
bereft
lichtman
status-based
magrath
ivac
cycloc
-diesters
c16--c22
glycogenolysis
microgramsming
activitythe
ara-cdex
bara-c
pre-chemo
pltu20099l
d1-d3
napd
lymphomau2029
analysisu2029
cbr
observedu2029
cisplatin-dna
autobmr
intrapleurally
intrapleural
syncytiotrophoblast
l-mimosine
promace
cytabom
anti-cd41
anti-cd61
cd-160130
gelliposomes
gl-ara-c
cl-ara-c
thin-film
f-ara-c
lengthen
carbodiimide
ksl
hgg
cell-line-derived
cdxs
human-cytokine-producing
nodcg-prkdcscidxa0il2rγtm1sugjic
nodscid-il2rγ--
nodcg-prkdcscidil2rγtm1wjlszj
hunog
prkdc
nrg
nodrag--il2rγ--
nrgs
nrg-sgm3
unconditioned
fmuo
hyperesthesia
aml92
simplifying
vincristinemethotrexate
cyclophosphamide6-tg
daunorubicinhydroxyurea
ara-c6-tg
genipin
drug-releasing
e2491
i0129
s0521
c-jun-mediated
cep-1347
peg-ara-c
heterotopia
subependymal
heterotopias
interkinetic
parentheses
harr
amino-derivatives
aza-michael
ua911
rl-g
pronucleotide
rl-7
smase
spacio-temporal
sphingomyelin-enriched
raft-associated
hydrocortison
abcc10
mrp7
g208a
a70t
hcda
hcda-70t
2-fluoro-5-iodo-ara-c
ed-50
iritis
cytarabineara-cis
vomitingcinvare
recanalization
85th
u937ar
aml-2ar
hcq-regulated
death-related
hcq-induced
protein-lc3
hfs
tarabine
mfe
osteryoung
square-wave
stripping
preconcentration
anodic
anions
lnh-ii-85
vm-
hdacmi
daunorubicin-arac
cholangiopancreatography
ercp
arac-containing
colony-stimulating-factor
unmodulated
ng107
ara-cytosine
aracdp-choline
ara-uridine
elliotts
jijoye
carmustine-related
90xa0min
glcnac-ara-c
glcnac2-ara-c
ara-cs
g-401
r-mpv
feverish
intraabdominal
vincristine-doxorubicin-dexamethasone
t-vad
---
chop-r
hdara
sericin
lauryl
catanionic
patientsxa0who
sm-acute
aggregatessheets
cd117ve
accumulatexa0in
nullizygous
bax-expressing
adnexa
epidermotropism
whorling
µg
beam-campath
carcinomatous
cancerostatic
cloturin
yoshida
large-b
pmlcl
doxorubicin-containing
rhoc
algae
bmah
postsynaptic
itlipac
tomography-computed
r-bac
ctr-iv
ctr-v
demised
hyfr-tbi
sr-all
ccg-1952
locked-in
quadriplegic
chiasm
10x109l
n581
nct00378365
supra-physiologic
translatability
rosuvastatin-based
behenoyl-ara-cacyl-c
unmetabolized
17beta-estradiol
bell-shaped
d385i836
icteric
isoagglutinin
3xa0xa03xa0cycles
r-cytarabine
govtrial
nct03054883
indistinct
bdnfegf-treated
co-stained
neostriata
co-labeled
brduneun
co-infusion
cytosine-b-d-arabinofuranoside
thacydex
borna
bdv
nonsegmented
warm-blooded
blastoid-variant
chaser
hl-60bcl-2delta
hl-60bcl-xldelta
p19bcl-2delta
ewall
reinductions
ynk-01
ara-c2
8b
8c-e
sonicated
1-beta-d-arabino-furanosylcytosine
empty-vector
antisense-expressing
m125
dioleoylphosphatidylethanolamine
hemisuccinate
oalc
t-80
ph-triggered
r18
cell‑like
2-f-ara-a
hormone-releasing
lh-rh
risk-organ-positive
ffluoro-2-deoxy-d-glucose
tomography-guided
p388d1
ashap
phosphite
hydrophosphonylation
o-methyl
phosphonic
cd3cd4cd25foxp3
free-radical
-carboxy--dichlorodihydrofluorescein
o-dhap
metachromasia
basophil-specific
cdw17
infusion-pump
vinylacetate
1-ml
evaporative
activator-induced
remyelination
1--ages
2--ages
3--ages
anthracenes
pfn
grb-
pfn-dependent
three-hour
dfl
da-epoch-r
hdt-asct
kpcda
pediatric-based
clathrin-alk
ichct
and-more
recently-the
six-decade
co-labeling
anti-fas-induced
culture-grown
prednisone-poor
gc-sensitive
prednisone-good
4-thio-fac
35so4
nb-2a
oligonucleosomal-dna
hmw-dna
serum-deprived
hmw-
vcmp
griseofulvin
treatment-recovery
2-fluoro
2-fluoro-5-iodo-aracytosine
ugts
mrp1-positive
hl60mrp
hl60dnr
single-6
stoichiometry
cld
p-c
if-rt
centrosome-associated
pharmacometabolomics
dodecanamide
dimethylamide
ltb4-dma
lipolytic
antifibrosis
sclerectomy
lentinula
thioguanineara-cdaunorubicin
supra-additively
cdw
29-
11b-adhesion
intranasal
daunoxome-dnx
physiotherapy
glucuronidating
gli1-inducible
ice-based
hsv1-tk
sarcoma-bearing
u937bcl-xl
ara-cbryostatin
ara-c-related
1-beta-d-arabinofuranosyluracil
sr-bi
psychosexual
sal-aida2000
aida-based
bfm-type
sometime
radiotherapy-induced
ds-diabody
mpv3
mtx5
h184
a1n4
matu
hexadecyl
hydrochlorides
arabinonucleosides
ara‑c‑sensitive
ara‑c‑resistant
lc3‑i
lc3‑ii
egfp‑lc3
autophagolysosome
autophagy‑related
tropisetron
vomiting24
hdm200
8u2009gy
hdm140
tri-culture
100u200a000
mitoxantrone-hidac
non-flag
fkbp5
bcl-xlxs
cnsp
idurd
phosphonoacetate
paa
intravaginal
4-azido-ara-c
2-fluoro--dideoxy-4-azido-ara-c
base-catalyzed
4-azido
2-oh
unreactive
irf8-promoter
lomustin
monosialoganglioside
n-trifluoroacetyl-adriamycin-14-valerate
aracdpdg
dpfudr
antibody-free
druglipid
ldacato
in-turn
survivin-dependent
25000microliter
gr3
gr2
vincristinecyclophosphamide
concominant
selection-related
non-selection-related
nsr
coall-
pler
fdutp
tas-102
tumefaction
chcsf
alkalinization
dpp-cndacch
analogue-resistant
mclr
mtxifodep
aracttdep
azido
achiral
reductants
arachis
distearate
all97
ps-exposing
-451ga
rsct
rs1048977
-33delc
all-89
all-93
all-96
nhl13
-nervous
system-directed
mpf-defined
early-to-late
spdp
sata
mp-pl
bhpd
ab40
b3-liposomes
p-bcl2
ara-cmp-l-dipalmitin
mpc-11
ycub-2
ycub-5
ycub-6
ic80
synergistic-to-antagonistic
ycub-
additive-to-antagonistic
betweenxa02004
-xaxa
15-marker
6-colour
unheated
srd
edi-oct
oculus
sinister
t-arac
t-arac-5-triphosphate
t-aractp
tri-phosphates
t-aracmp
aracmp
cr-deaminase
dcr-kinase
t241
e0771
s180j
ara-c-derived
5-di-
c3d2f1j
4-factor
farge
sa-lpsjkt
induced-cardiomyopathy
telomers
rgdsk
5-diphosphate-5-l--dipalmitin
hd-l-pam
egr
cytoreducing
gnrh-a
afc
dthd-ara-c
end-infusion
arauarac
isothiocyanate-conjugated
dibucaine
butacaine
polymerizable
5-o-acyl
4-n-acyl
opc
cephalexin
ng⋅hml
pellucidum
polyamino
phea-d-val-leu-lys-cytarabine
drug-polymer
amli-mtg8
codox-mivac
hominis
mbucy
gemutuzumab
potentiometric
ion-selective
electrodes
trueness
o-eshap
lymphocyte-predominant
3h-nbmpr
woodchuck
-deoxy-2-fluoro-beta-d-arabinofuranosyl-5-iodocytosine
-deoxy-2-fluoro-beta-d-arabinofuranosyl-5-methyluracil
woodchucks
feau
3a-c
n4-acyl
mdckii-mdr1
seg
c-18
quantitations
-dihexadecanoyl-sn-glycerol-3-phosphocholine
drug-lipid
liquid-crystalline
lightly
poly2-hydroxyethyl
chemomobilization
u202f×u202f106
multisubstrate
u-87m-g
f-araa
fludara
arabinosyluracil
daunoru-bicin
higer
r-b
early-pod
nu2009u2009127
nu2009u2009134
ara-c8c
g24r
egfp-tagged
ceb
oxidised
dextrans
glu-ara-c
ethylenediamine-introduced
attendances
rituximabbendamustine
rbrc
crunconfirmed
rchop
prednisone-based
cdk-1
cdk-inhibitor
dna-electrophoresis
myxoid
transmittance
bends
hmw-vwf
peckham
ball-1
dual-operator
rutincytarabine
transport-related
ﬁndings
9-β-d-arabinofuranosylguanine
t-alllbl
ion-pairing
post-apbsct
allxa0between
6-mercaptopurineten
biphenotype
ophir
loyola
belém
cytosine-cbhac
acyl-cbhac
morf-cbp
cbp-morf
ecotoxicological
micropollutants
isotherm
cytr
single-solute
efom
adsorbates
amphipathic
cholesterol-containing
measurably
stall
rad9-hus1-rad1
clinical-outcome
pi-mrd
childhood-t-all
cumulative-incidence-of-relapse
pi-mrd-positive
pi-mrdn
pc-mrd-positive
any-level
har
phentolamine
sympathomimetic
sinoatrial
tetrodotoxin
hexamethonium
nitrara-c
ndp
ma44gem
gem-refractory
ma44
foetuses
fp-mediated
ietd-fmk
single-system
ah-66f
ah-60c
ah-109a
ah-66
well-placed
preconditions
asynchronously
poiv
b9604
virucidal
mt-r
dw-mri
mitoxantronecytosine
0microl
epigastralgia
cefozopran
intralumbar
roughness
pethema-acute
all-ph-08
pethema-cstibes02
cstibes02
anode
electrolysis
scge
16h
zorubicine
hdtahct
rlif
1crpr
d-fac
noradrenaline
postganglionic
nucleotide-induced
transmitter
udp-induced
n-type
omega-conotoxin
alpha2-adrenoceptor
uk-
microfluorimetry
depolarisation
firing
enteropathy-type
etcl
acvbp
microgramskilogram
ld-arac
aieop-all
lesional
hepatorenal
tlm
piblood
piskin
malay
hdace-tbi
roentgen
non-phagocytic
som
or4
leukostasis-induced
ischemiaxa0a
anginal
diaphoretic
painxa0ekg
precordial
blastsxa0coronary
remissionxa0hyperleukocytosis
cell-toxic
bm-
pcns
rhadinoviruses
brivudin
5-substituted
acyclovir-resistant
f-reticulocyte
units--erythroid
moscow-berlin
all-mb
coli-asp
sr-
flotetuzumab
ngkg
irrscytokine
irrcrs
pifer
crcrhcr
nct02152956
pentobarbital
2-oxopropyl
oxo-ara-c
one-electron
smithkline
beecham
juncture
layer-by-layer
triple-hit
dhl
gliomatosis
vin
dicep
beamasct
py-stat3
lkn-1
units-granulocytemacrophage
calbindin
neuroprophylactic
mki67
resynthesis
ara-cdp
v-beam
cy-total
cyfractionated
tbihigh-dose
tbicytarabine
neurotoxin
bhac-ev
2-aminoanthracene
non-cytokinesis
depocyt
dioleoylphosphatidylcholine
drug-bilayer
amv
beetles
nfil3
first-round
hxd4arac
triesters
d-arabinofuranosylcytosine
idlbclbl
and01
mttara-c
dnmara-c
sobuzoxane
r-mad
cis-ddp
mcl-5
huara-c
8-meiqx
1-nitropyrene
1-np
2-nitrofluorene
o-toluidine
lindane
gad
organotypical
post-hatched
thip
baclofen
caca
gad-like
eaa
toposhap
cisplatindexamethasone
pb-all
toddlers
telaml1-
above-listed
dmac
hyperchromicity
waf1
ara-c-specific
intraorbital
extractability
cfar
fcrcfar
y842h
homoeostatic
hcdd
lymphotoxicity
mcvac
itl
betaf1
iel
hl60ad
l-buthionine-sr-sulfoximine
undamaged
3h-arac
burkitt-lymphoma
non-hodgkin-lymphomas
epstein-barr-virus-transformed
80-gy-irradiated
pv701
enteralparenteral
opiates
p010
ifosfamideetoposide
beta-d-arabinofuranoside
phenylarsine
flamsa-atg-tbi
beac
waveform
mass-selective
waveforms
collisional
thio-tepa
cellebellar
l-asparaginase-associated
transfussion-associated
dexamethasone-based
hrcns
wasu01
litersh
liters
administrering
rensonable
suspection
bebenoyl
unbalances
unbalance
white-matter
polyvinyl
silicone
ara-ctpase
vpx
dntpase-deficient
mice-bearing
ccrf-cemact400
ccrf-cemvcr1000
hl-60ida40
hl-60dnr250
lrp-expressing
hd-r
3hdthd
ethylester
d-cycloserine
microdialysis
irregularly
polymerase-alpha
polymerase-beta
enzon
piscataway
skye
xiiia
tris-hcl
n4-stearoyl-
antiherpesvirus
5-mono-
hsv-
1-infected
r-chop-like
lmb2001
treatmentdrug
nonintense
nonintensely
adriblastine
fused-silica
loq
aml-xh-99-m3
ld-bhac
lysopc
prominin-1
as2o3-pretreated
pml-expressing
polygalacturonic
carboxymethylated
pga-arac
l1210arac
lymphocyte-
two-dose
ethyleneglycol
dimethacrylate
egdma
h80vp20e15
predisolone
pbzrs
pbzr-specific
pk11195
chemosensitizes
efflux-competent
dnr-sensitize
efflux-incompetent
b-t-cell
target-sensitive
cytosine-beta-d-arabinoside
target-insensitive
pre0901
safetytoxicity
dose-escalationde-escalation
eltrombopagu2009u2009hidac
observationally
aml-84
cytarabineetoposidedaunorubicin
aml-88
antibiotic-prescribing
ultrasonication
cyt-nlc
non-aggregated
tp53-deleted
activationinhibition
r-mpv-aaa
xa0gm2
mpv-a
biomaterials
sals
alpha-naphthyl-butyrate
italy-berlin-frankfurt-münster
clinicianparent
all3
arabinosylcytosins
faara-c
conduces
cara-u
cara-c
natp
transport-deficient
cemaracc8
rl7g
fis-ham
sub-mtd
abeta
tauthr231
pin1-mediated
juglone
caters
bitemporal
ascended
r-beam
nxa0xa047
peedck
unprotected
peedck2
hemoregulatory
not-quantifiable
pos-nq
neg-mrd
nq-mrd
pos-mrd
idaara
plexuses
icv
fump
liposome-treated
3-deoxy-3-substituted
4a-d
7a-d
8a-d
oxirane
pheromone
silesian
lederle
ph-step
ndna
replicon
14cdthd
n146
reconsulted
metacarpalphalangeal
primpol
primase
primertemplate
pre-steady-state
1-beta-d-arabinofuranosylthymine
c-delta
disassembled
spink1
h-beta-d-arabinofuranosylcytosine
mercaptoethanol
n-t-butyl-alpha-phenylnitrone
osed
sayed
3bp
cace
rituximab-chop
osi
hexosaminidase
1-ss-d-arabinofuranosylcytosine
p53-mutant
wtk1
pbml
membrane-localized
3h-dttp
5-hydroxyl
camptothecin-resistant
pace-rt
-fu
ngy
eff
nonnodal
aminal
postural
pheromones
rituximab-naive
methotrexate-cytarabine
lpli
25u2009ngml
floxuridine
cpsf6-rarg
metaarsenite
naas2o3
kml001
arabinoside-resistant
kml001-induced
kml001-treated
hd-chemotherapy
post-cy
post-ara-c
hd-cy
dcmp-deaminase
mum2d
therapy-biologic
fact-brm
toi
physicalfunctionaltreatment-specific
socialfamily
sfwb
ewb
40suppl
neutrophil-poor
dfci-all
ns-101
cd19cd5
anti-clastogenic
methylmethane
eshaox
2xa0gm2
eafu
interstitial-alveolar
diosgenin
dg-ara-c
meckels
extra-axial
cgns
cas-3
cas-9
isoflavonoid
rotenone-treated
dystonic
lesioned
shptp1
sv-40
dop
ufp-512
dexabeam
--xa0
umin000003434
5-alkyl
5-oh
cm-2
r-hds
advanatage
neuroanatomical
mobilizer
intrasplenically
hypercortisolemia
wolfberry
cort
cr-induction
indentify
12u2009h
200u2009µgm2
lme
subconfluent
unpurified
binucleates
5-elaidic
egfr-
safeties
ivt
convection-enhanced
14c-arac
hbl100
cochran-mantel-haenszel
v-z
n-carboxybutyryl-1-beta-d-arabinofuranosylcytosine
chi-glu-ara-c
ara-
n4-hexadecyl-
n4-octadecyl-1-beta-d-arabinofuranosylcytosine
nh-arac
no-arac
no-ato
foscarnet-resistant
acyclovir-sensitive
blood-l
csf-l
ρu2009u
centrum
r-hypercvad
preplerixafor
postplerixafor
remobilization
turbt-only
bonn
intra-cerebrospinal
intra-csf
aml-94
lymphomanhl
x25
il-3-induced
trilateral
suprasellar
gm-iva
microfilament-disrupting
microfilament-directed
axa0total
prednisonedoxorubicin
isotretinoin
arabinofuranoside
mcmarac
mcmvh
heat-inactivation
excitotoxic
heat-sensitive
doncologie
pédiatrique
sfop
b-type
explant-derived
cellswell
-dimethoxyflavone
peduncle
subtotally
cd34u2009cells
uveoretinal
solutol
polydisperse
acid-polyethylene
fa-peg-fa
sm-cer
p53p56
pkczeta
cell-permeant
c6-cer
pkczeta-overexpressing
drug-
h2o2-treated
histology-based
bu200a-cell
5-dimethylthiazol--diphenyltetrazolium
n6l
pseudopeptide
double-resistant
lhrh
gll-19
cd49c
cd51
nabut
rpf
histocytic
nci-funded
slims
lirs
lc3gabarap
tetramethylrhodamine
14caafc
half-line
1-beta-d-arabinofuranosyl-5-fluorocytosine
1-beta-d-arabinofuranosyl-5-fluorouracil
afu
-anhydro-1-beta-d-arabinofuranosyl-5-fluorouracil
excretions
non-l2-fab
non-ph1
kbara-c
kbvcr
kbara-cvcr
flow-mediated
fmd
fiau
5-deoxy
5-mercapto
5-nh2-fmau
sjl
b7-igg
b7-iggs
tumor-antigen
necroses
rpls
tonic-clonic
alertness
diphenylhydantoin
sf-sp
tegafur
fragmentography
second-phase
vr-cap
mrfp
gtnb
damascus
grm²
chase-r
r13
r23
5-nt
pyrimidine-specific
bruises
tlp
leucencephalopathy
5000microl
nct00599937
excises
vpg
tdp
atrip
alinc
pci-34051
mac-1-cd45-
3h-cytarabine
lg-nhl
hg-nhl
proteinaceous
tem1
scfv-cm6
tem1-expressing
flt3mutant
flt3wild
inds
ngfi-b
p-iii-p
mbuf
3hcytosine
c18pca
folliculotropic
deoxynucleosidetriphosphates
at2
ikv
pp-2a
superfusion
depofoam
intracavitary
hdc-asct
df-cytarabine
neuraxis
14co2
hekmrp5i
dfm
atf4-dependent
safflower
chow-fed
reaction-capillary
pcr-ce-based
4microg
4490microg
transcriptsmicrog
standard-duration
noacs
extended-duration
sdf-1α-induced
mylodam
sosvod
septicemic
mlhr
gemcitabine-based
idaol
hd-ida
graves
jlsg-02
deescalating
atra-ato-based
atra-anthracycline
atra-ato-anthracycline
atra-anthracycline-cytarabine
7-y
chemotherapy-replacing
-reducing
nct01987297
salidroside
tbc-asct
melphalan-conditioned
beam-asct
4-nh2
bioconjugate
ha-ara
nanoassemblies
nasfa-bsa
fr-positive
hco-60
cycle-regulating
disconsciousness
nutraceuticals
self-medicate
drug-nutraceutical
miapaca
ventrally
periglomerular
beambus
hd-pam
gabab
ukccsg
copadm
etoposidehigh-dose
cyve
bhaccytosine-c
araccytosine-c
bhacbehenoyl-c
palisaded
9α11β-prostaglandin
f2α
pgf2α
akr1c2
5α-dihydrotestosterone
2800-fold
anhydro-ara-5-fluorocytidine
aafc
submaxillary
microgranules
ermap
ermap-shrna
ermap-shrnak562
biphenylamine
terminal-phase
auc0-infinity
-deoxy-2-fluoro-beta-d-arabinofuranosyl-5-iodouracil
-deoxy-2-fluoro-beta-d-arabinofuranosylcytosine
glucuronide
5-dimethyl-thiazol-2-yl--diphenyltetrazolium-bro
arac-ocd
ocd-grop-arac
ifm99
4-azidocytidine
cd-13-
cd34progenitors
ddrt-pcr
inctr
equatorial
benda-eam
bldlbcl
ddcn
ddun
ddtn
associated-protein
cd34p-gp
cyt-plga
lyophilization
freeze-dried
thermograms
fickian
ccv
vd1
vd2
sa1
adriamycin-containing
antipurine
heat-acclimated
stha
ltha
preoptic
poa
thermoregulation
dialysate
lhour
epoch
methotrexateifosfamide
v-epoch
oxime
single-photon
anzccsg
tissueplasma
acylations
5-o-laurate
hexane-pyridine
435-catalyzed
-anhydro-1-beta-d-arabinofuranosyl-5-fluorocytosine
cytarazid
primer-template
daunorubicinu2009u2009aracu2009u2009cladribine
clam
cladribineu2009u2009aracu2009u2009mitoxantrone
n-ethylmaleimide-sensitive
snap25
beta-amyloid
beta-app
sapps
beta-appdeltadelta
kainic
nccn-ipi
harells
photocatalyst
tio2
light-driven
cuwo3
photocatalytic
ldc-nps
ecto-atpase
ecto-nucleotidases
planted
agitation
metothrexate
ghee
siee
socially
eatl
pre-terminal
edap
cndag
pseudoarthrosis
acetabular
acetabulum
strangely
cytarabinecisplatin
non--cross-resistant
9a-f
9a-ce
9f
ip-implanted
9e
four-hour
lactosyl
lbc-cgl
arabinosylcytosine-cytarabine
parapharyngeal
masseter
fenestration
masticatory
5-sx8-f
hesmf
n-ethyl-
mutageniccarcinogenic
itlc
ventriculomeningitis
incb053914
gclvol
vgepp
hyper-cmad
c1d10
noncleaved
cndactp
chain-extension
3-terminus
ddcnc
hl-60ara-c60
yc137
apoplexy
dose-modifying
bep
electrolytic
ara-cam
vgpr
nadoc-induced
fluorescens
5-regioselectivity
etherpyridine
whole-cells
thermostability
re-emphasize
lc-ms-based
conjectured
anti-ara-c
3hara-u
atra-plus-chemotherapy
mpmtx
phase-active
5-iodouracil
hilus
seizure-induced
pilocarpine
minipump
epileptogenic
retching
emetic
cd4pd-1foxp3
pd-1treg
cd4cd25highpd-1
cd4cd25highpd-1-
rr-hl
bucya
cyclophoshpamide
diethylpyrocarbonate
side-chains
2-dcf
9-beta-d-arabinofuranosylcytosine
btki
fau
cmtmr
ifogm-csf
cygm-csf
dtic-containing
atp-based
q22runx1-runx1t1
q12h×3
two-center
sod1g93a
vesicle-entrapped
da-treated
raralpha1
leu290val
arg394trp
met413thr
european-american
ino-vate
ip-chemotherapy
auc-ratio
cbs-transfected
rs3797418
rs6082527
mustards
t-line
b-line
cytozar
low-intermediate-grade
anthracycline-cytosine
guises
acrosyringeal-based
ifn-alphaara-c
granta-519
cym
blbll
multi-variable
aids-blbll
b-non-hodgkin
berlin-frankfurt-muenster-based
nact
o4-dinitrophenyl
-ethoxycarbonylpiperazin-1-yldiazen-1-ium--diolate
2h
decomposing
prednisolonehd
layered
clickable
bioconjugation
mucosal-associated
mait
67gallium
flucy
ara-amp
intraventricularly
anthracycline-lacking
neurology
mcls
bbc3
sw1573
bucyvp16
gp120iiib
gp120bal
gp120
codox-m
microbe
staffed
fred-siguier
paul-brousse
villejuif
tsa58
p53-inducing
scleral
hscf
enap
phosphodegron
phosphomimetic
lymphomatosis
blg
lmb-89
slime
ifnara-c
cml91
normal-phase
zorbax
filgrastrim
lenograstrim
-161
igg-kappa
gapstatin
cbfbmyh11-positive
edss
d7pbb
hcvad
d14bmb
hcvad-treated
mfggic
cdarac
55-yr-old
oxygen-free
ciae
2-fdc
r-codox-mivac
burkittburkitt-like
cara
lys27gln
ala70thr
cda70thr
dck24val
multidrugs
arac-l-5fdu
fm3a0
fm3atk-
tbiu2009u2009cyclophosphamide
busulfanu2009u2009cy
tbiu2009u2009cyu2009u2009etoposide
fludarabineu2009u2009cytarabine
low-yield
sbsp
n4-palmitoyl-ara-c
triethyl
trifluoride
5-n-butyl
areflexia
inhomogeneous
follow-on
hgbl
paratrabecular
intermediate-sized
4xa0cycles
gdp-ml
mtxcytarabine
rr-t-all
xa0ns
chitosan-based
triple-phase
monocytic-monoblastic
subhyaloid
pegfilgrastim-mobilized
bclo
l4a6
c26-a
c26-g
senticosus
rf-aml
mixed-linkage
syc-522
hplc-purified
all--the
aall01p2
hara-c
ancestim
non-allo
counter-parts
hl-60pcep4
85-kda
bnml-clara-c
pmlbl
triangular
thermotolerant
hyalinospora
video-assisted
vaths
dull
brownish
blastomyces
itr
yellow-green
tufts
noac-ldl
noac-liposomes
mdr-1-
inv16p13q22cbfb-myh11
ionotropic
grik2
6q16
runx1-grik2as
runx1-grik2
cytarabinehd-ara-cas
syndromehfsin
oftherapyidarubicin
heparinoid
lotion
hypoallergenic
moisturization
ofa
sulfinic
grp
refill
pseudintermedius
sxa0pseudintermedius
aml-2arc
polyglycerol
adipate
dxmp
cyt-ara
pri
octameric
eshaphdt
analyzedthere
tota1
relapseand
lase
callpreb
vm7-fold
senp2
interassay
femalesnine
pbsc-supported
tachypneic
tachycardic
110u2009bill
daunorubicin24
contrast-enhancing
neuro-oncology
aminotransferases
receded
5-trihydroxystilbene
kitc
hoechstpropidium
14c-cytidine
ancitabine
origin-specific
synthesome-based
hm-csf
interleukins-3
aztreonam
cs-682
ara-cytidine
2-chlorodeoxyadenosine-selected
non-inferior
f1l
vgf
fludarabinebusulfan4melphalan80
hypothermia
cysteinate
6y-pefs
polymerized
2min
microstructure
ageor60
meningitis-specific
×106kg
mtxara-c
chromonychia
striae
non-hotspot
hotspot-mutated
rnu2
rad3
ara-cdp-dl-dipalmitin
diglyceride
chestabdomenpelvis
lam-sa
nct00590837
flt3-itdhighnpm1wt
vacht
dbcamp
disease-appropriate
p-glycoprotein-rich
moppabvd
ccr-5
prodrug-liposomes
avidin
unreacted
ultrogel
aca-22
intramuscularly
m7-aml
antimicrob
chemother
cytomegalovirus-infected
jehova
transductions
k7
pll-glu-ara-c
t70
t70-c10-glu-ara-c
sdac-based
pu200apu200au200a
r-chop-14
r-choep
bischloroethylnitrosourea
acid-tyramine
ara-ha-tyr
ha-tyr
resistantrelapsed
n-hl
25xl
bacteriemia
ttd
ceop
gemia
murphys
c-ets
acn
beta-anomer
methoxide
ct-dna
groove-binding
spherules
intraneuronal
tauopathies
70-kd
carboxy-terminus
et16cipc
c16opc
c16ops
c16ops-n-ac
c16pcmp
stromal-dependent
fgf2-treated
anti-tumorous
cardio-specific
neurohumoral
blin
prostheses
semiconservative
ihcp
ingress
loadings
k-562r-
t50
literskg
apl97
il2no
il2-
pbcs
sdca
deoxypyrimidine
arabinosylthymine
phospholipid-nucleoside
1-beta-d-arabinofuranosylcytosine-5-diphosphate-l--dipalmitin
doseweight
bearded
mucoid
prime-time
intratracheally
absl1
intraesophageally
runxor
units-spleen
pre-infusion
multiply-relapsed
augqds
charge-dipole
mercaptopropionic
chemo-photothermal
18ffluorodeoxyglucose
interim-pet
cadpr
nonhydrolyzable
dhax
symptom-free
seraspenide
non-curable
etoposidecyclophosphamide
2-fluoropyrimidine
dtks
dtmpk
microcystic
208ga
mafs
chinese-americans
caucasian-americans
arg104
r104m-d133a
l-form
polydactyly
fgf4
metacarpal
deformed
multamin
ngc
ngm
otlertuzumab
53xa0
nxa0xa0156
chain-terminating
ctnas
-dideoxycytidine
brca1--
ctips332a--
nuclease-dead
mre11d20a-
comets
imuvert
n-3-benzyloxycarbonylcarboline-1-ylethylamino
benzylesters
6a-r
arag
16-hr
l1210f
childrenxa
hibernation-like
heterocellular
anisotropic
mycalamide
r-ma
-difluorodeoxyguanosine
dfdg
drafted
disutility
pu2009limitations
anhydro-araic
3-acetate
anhydro-arac
non-inhibitory
3-hydroxyl
3-regioselectivity
general-base
kobs
degt
chain-positive
cbvhigh
cbvlow
samplings
risk-7p
risk-normal
tp22q23mll-mllt13q-
risk-others
tp13q13ott-mal
khall-93
settingprevious
cells100
1-d2ca
1-d2
dmps-group
tunicates
mnps
polatuzumab
belantamab
mafodotin
3-positive
u2009mlmin
cockcroft-gault
aiguë
lymphoblastique
or30
phenoidentical
on-therapy-relapsed
raal
hi-coap
cytarabine-anthracycline-based
choep
-times
germfree
o4
r-nhl
sd-r
atg4
pixy
mni
hematopetic
50s
isobologram-analysis
dmpm
pmdm
washings
wehi-3-grafted
charachteristics
o-desmethylvosaroxin
deuterated
infusor
average-flow-rate-to-indicator-setting
needles
panel-reactive
pp1alpha
dextran-coated
anti-hcmv
4y-rfs
micro-complex
lfts
ptsp53
vomitingretching
anti-emetics
il-17a-treated
il-10-
anti-il-17a
meca
ouest-est
autres
goelams
aa-ipi
mzbl
stage-iv
wechsler
belimumab
unubiquitinated
time-concentration
ccrfcem0
ccrfcemara-c7a
ccrfcemara-c3a
epipodopyllotoxins
non-dna
bacopa
monniera
caglp
5-monophosphates
inserting
pau
montesinos
fernández
articlethe
cyclophosphamide-etoposide
tam8
tbi-cytarabine-melphalan
arac-c
rostral
trophinin
bystin
trophinin-positive
double-label
bystin-positive
2a-d
5a-d
5-deoxy-5-fluorouridine
5-dfur
op9
bing
neel
flumel140
nxa0xa0151
vmaxkm
nasolacrimal
pmse
strada
lisinopril
beta-blocker
gynecologist
team-which
practitioner-was
solicited
6-pound
10-ounce
p-4055
rituximab-chop-eshap
chop-eshap-hdt
phosphatidyl-dcmp
aracyt
actp
5-nts
mirna‑mrna
venn
circrna‑mirna‑mrna
hubgenes
kif23
racgap1
atad2
kif11
hsacircrna000596
hsacircrna104315
hsacircrna400068
hsacircrna101958
rs5030743
rs1130609
tril
ly12
araa
postirradiation
logarithmically
hrr
daha
mini-chop
prednisoneprednisolone
pharmacotherapies
f951
agreed-on
nonfluorescent
dihydrorhodamine
r-codox-mr-ivac
nigerian
5-fdurd-arac
5-fluoro-2-desoxyuridylyl--arabinocytidine
int0129
trpv1
thiarabine
epirubicin-containing
6-mop
cl-6b
reactivator
unexamined
subgranular
sgz
exercise-induced
instilled
phosphoramidate
bland
16p-p
vcr-resistant
adr-
bleocytarabine
mcl2
ki-67-expression
mipi-b
l-10
anti-cd3×anti-cd19
icam-3
glucose-functionalized
terpolymer
dispersity
multidrug-conjugating
cardio-oncology
non-cleaved
flagidarubicin
flagida
5f
tcc-s
adjunction
anosmia
as-odn
as-odns
glycidamide
min-mice
wt-mice
lauric
la-ara
nfs
oilwater
lphl
ag-nor
leukotic
chemotherapeuticals
lilly
catfish
orfs
5-cl-arac
carboquone
jlsg-96
dlbclbl
2-yr-old
large-
krwawienie
przewodu
pokarmowego
miejsca
krwawienia
jest
canterbury
christchurch
honorary
lecturer
beatson
straiton
eluent
phenomic
plch
electrodiagnostic
kshv-induced
lana
phrenic
postphrenicotomy
hemisection
cyt-a
transection
loov
rituximab-sensitive
rscl
rrcl
pgp-blocking
isoprenoid
sdb-ethylenediamine
b-diffuse
4-amino-1-beta-d-arabinofuranosyl-h-pyrimidinone
5-sodium
octadecyl
coo
nr1-nr2b
polymer-protein
poly-lactide-co-glycolide
mapkstat5
weakening
chemo-fog
chemoprotectants
cyclotherapy
tenovin-6
leptomycin
dmso-cryopreserved
bradyarrhythmia
5-fdurdara-c
ja7
hcc-selective
peg-pd
galactosylated
gal-peg-pd-liposomes
asialoglycoprotein
cytosine-containing
compartmental
i-meta-iodobenzylguanidine
chorion
sv28
v5er
pala-resistance
cisp
fludarabineamsacrinecytarabine-busulphan
flamsa-bu
ac-d-ac
beam-induced
vater
efnb1
5-methylene
regioselectively
markovnikov
mtp53
intrathecal-methotrexate
it-mtx
nonhaematological
cp2pr
sctasct
ump-cmp
ventriculolumbar
panniculitis-like
phase-shifting
otorrhea
-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosylcytosine
4-thio-factp
2-deoxy--difluorocytidine
cisplatincytarabine
jnkc-jun
double-masked
rgdv
cnh2n1co-rgdv-ara-c
c11h23co-v-ara-c
combretastatins
bmec
aml-bmec
dislodged
vascular-targeting
bicuculline
-tetrahydropyridin-4-ylmethylphosphinic
tpmpa
gabac-receptor
cis-4-aminocrotonic
gabac
nomega-nitro-l-arginine
all-bfm-95
p-all
splitted
chromatins
blood-hemoglobin
beam3ck
shv-1
62-yr-old
homobarringtonie
hce
idamycin
medication-induced
endocrinopathy
dhapeshap
methylglyoxal-bis-guanylhydrazone
moppabvd-like
relapseabstract
microgravity
weightlessness
plb
asca
aml-scmc-2009
dmpc
langmuir-blodgett
e3-deleted
jok-1
salt-3
ed-40810-
dntpntp
blamed
eio
practising
prejudicial
-hexahydroxystilbene
micma
2-amino-5-dimethoxyphenyl--ethoxy-2-oxoethyl-4h-chromene-3-carboxylate
sha
serca3
cxl017-induced
heroin
tcrdelta
bfm-86
a549-cd
reattach
chipped
cyanoacrylates
expansor
anisocoria
fnd
triflate
h441
dei
personalisation
cross-validate
influencingcontrolling
lymphomadlbcl
pneumoniaacute
434-na
low-normal
g-actin
microfilamental
cyclophosphamidevincristinedoxorubicindexamethasone
rituximabmethotrexatecytarabine
intravitreally
chinchilla
fluorophotometry
electroretinography
b-wave
electroretinograms
solid-lipid
vpgs
solvent-free
cetrorelix
vincristineprednisone-based
stc-1
rho1
ether-pyridine
5-fluorocyclocytidine
mjma
r-hdam
cv1-p
imines
phosphonates
l-arginine-metabolizing
fludarabinetotal
methylazoxymethanol
infralimbic
randomizations
treatment-white
atrawbc
2000microl
dawbc
treatment-morphology
dam3v
tc-ner
xpb
unwinds
cyclophosphamide-induced
hilic
presystemic
messa
non-stealth
dmdhfr
dmdhfr-cd
glyconanoparticles
triphenylphosphine
galactose-functionalized
pgma-edadtcaupph3-st-laemaaunp
asgpr
clec7a
fundament
5-o-stearate
hexane
apo2
hd-mitoxantrone
hd-approach
nt-proanp
d-2
1-beta-d-arabinofuranosylcytidine
ida-idarac
ida-arac
aceg-csf
cd42a
melanized
erg-induced
erg-driven
benzofurans
mapextracellular
prostratin-induced
prostratin-mediated
hypoglycorrhachia
mdp
lta-induced
tefinostat
chr-2845
monocytemacrophage-targeted
carboxylesterase-1
hce-1
monocyticmonoblastic
non-monocytoid
aml-toxic
tefinostat-responsive
monocytoid-lineage
liponucleotides
carboxamide
1h-
beta-galactosidases
tp15q
chop21
adora1
131-iodine
chemosensitivitya
hs-5-mediated
ielsg32
cytolysins
bc2
eqtx-ii
snrs
low-wt1low-mdr1
high-wt1
high-mdr1
high-wt1high-mdr1
anthracendione
hdaccytbi
glut
gluts
mcl35
mipi-c
--10
ventriculography
2-c-cyano-2-deoxy-1-beta-d-arabinofuranosylcytosine
sk-mel-28
astroglial-enriched
astroglial
alpha-phosphono
stereoselectivity
homoallylic
alphabeta-unsaturated
funduscopic
farnesyltransfease
defaulted
oka
hdr
b-form
bending
cytarabine-substituted
high-proliferation
postadministration
hygromas
hct-asct
alllbl
ink4aarf--
b-alllbl
mtx-arac
ara-cdp-dl-pba
rarapml
anaesthetized
corticosterone-p-ara-c
ip-
hucb
eilatin
farther
hopeless
disoriented
novelties
lobule
pyknosisnecrosis
membrane-intact
12xa0hr
abc-
c000000206
hgf-supported
il-3-supported
2-c-cyano-2-deoxy-1-β-d-arabino-pentofuranosylcytosine
ccle
cepp
2300microliter
slowdown
six-hour
mtx-r3
gr753f
3-cycloc
xyloc
d50
cytarabine-aot
thermosensitive
dast
polymerisation
fibroin
pro-sexual
copulatory
impy
dfp-10917
-273
usf1
usf2a
daun
cytdaun
marrow-engrafting
ewsfli1
syndlbcl
cns-intensive
nxa0xa038
ta1538
mirdb
slc9a1
depoara-c
ad5-siv
hsv1-sr39tk
mdr1-sensitive
pcr1
pcr2
amlu2009u200925
allu2009u200922
flag-mitoxantrone
diagnosisu2009u20095u2009×u2009109l
relapseu20099l
postinjection
-bcr-abl
apo-2
procure
turbulent
cvvh
bll
two-induction
diastereoisomers
5-phosphotriester
phenylphosphotriester
amylose
bacteriology
ancconclusion
diverts
tacrolimussirolimus-based
1n
r-chop21
90m
n355
germinoma
900m2
n-90
n-97
bf
z-dex
fludarabine-arm
control-arm
squalenoyl
sqgem
cd36-high
cd36-negative
megakaryoblast
dn-cdk4
dn-cdk2
standstill
sti571formerly
médico
toxicitymortality
cytoprotectant
mrp7-transfected
46-fold
116-fold
sn--fold
56-fold
mrp7-conferred
nontaxane
mrp7-mediated
etb
tolbutamide
atp-sensitive
et-1-induced
astrogenesis
uvn
posturo-locomotor
ivad
r-fc
bii
dcd
gc-ms
apo-2ltrail
hl-60hsp70
apo-2ltrail-induced
anuric
hl60-r
hl60-s
platinumii
palladiumii
-diamino--dideoxy-thymidines
d-erythro-
d-threo
mcl2l
5-positions
thymiplatin
cis-dichloro-diamino--dideoxy-d-threo-thymidineplatinumii
polybutylcyanoacrylate
r-ifn-alpha
-fluoro-2-deoxy-beta-d-arabinofuranosyl-5-iodocytosine
-fluoro-2-deoxy-beta-d-arabinofuranosylthymine
mdsanll
ala200
ara-c25
minofr
antinucleosides
abt199
fludarabine-sensitive
kit-overexpressing
trkaiii
trkai-ii
susd5
nos1
gabra5
slc18a2
mrpl33
toxt
jm2
ky895
intracraneal
malt-type
situs
inversus
totalis
rotate
hdacvp-16
adeb
btz-containing
hsf1-pser326
low-hsf1-pser326
s326a
s326e
hsf1-phosphorylation
ara-canthracycline-based
k562ptet-onets2
doxycycline-induced
doxycycline-uninduced
neam
iceminiice
hypertg
idarubicin-cytarabine
cm1
retriever
tcrγ
aml-m6er
schlafen
slfn11-negative
liberating
p-n
cemarac8c
210-fold
106-fold
coinfusion
devd-fmk
udg
nitroprusside-induced
3-o-decanoyl
eserine
3-ester
lower-income
fpyr
fdpyr
p1cp
bsap
comparingrt-qpcr
cadeguomycin
cadeguomycin-treated
hypoglossal
mundipharma
ielsg
ss-odn
oat1-
oat3-mediated
3h-mtx
oat1
oat3
oa-ara
amidation
deaminators
ara-uara-c
stomachs
avnb
bisindolylmaleimide
january-2014
chemo-sensitization
ep-anll
hidacasnase
slfn11-positive
variola
aravinoside
daurd
palmo-ara-c
plugging
asphyxia
cell-size
microfluorometric
micronucleation
hpma-based
nanotherapeutics
co-polymers
aspartases
r-eshap
hdmtx-based
parp-cleaving
dnm-treated
dnm-combined
-arac
hepdirect
toxicologically
arabino
aurothioglucose
c-fos-like
fos-ir
ventromedial
vmh
plugged
reincubation
non-s-phase
cnt2
temperature-
na-
l-advp
nhl-bfm
high-dose-methotrexate
se-
andersen-gill
azapeptide
n4-deacylation
bucyclophosphamide
hent4
preservatives
5-dimethyl-thiazol-2-yl--diphenyl
l-beta-d-arabinofuranosylcytosine
megakaryocyticblastic
chomosome
aall1131
clof
antidote
pseudo-hyperkalemia
emptying
dibenzyline
denervated
innervated
ganglionic
aphthoid
unintentionally
on-chip
pod24
beta-d-arabinofuranosylcytosine
5-palmitate
5-benzoate
mnpces
bm-cd34
cemcp-4055
aplidium
wmlpl
gemzar
d2ca
cranium
lamellae
reac
cell-differentiating
adr-ara-c
-mercaptopurine
4-thio-beta-d-arabinofuranosylcytosine
colony-counting
18ffac
bromination
hbr
trimethylsilyl
trifluoromethanesulfonate
megackaryocyte
wrongly
sinusoid
hexavalent
crvi
timeliness
osms
sedativeanalgesic
agent-
indices-neither
dnr-specific
rverse
-rara
rearrangementsthe
psap
k-r
baumannii
hypodermic
smnc
isnt
tgase
itbs
sham-controlled
dlpfc
cfugm
undispensable
egil-classification
sbeam
ebeam
rx-ki
rx-positive
podophyllotoxine
cd95apo-1-ligand
nucleotide-degrading
mono-exponential
t∼24
cl-arac
nxa0xa048
macrolides
warmia
mazury
lymphomapcnsl
mdr-phenotype
pcr-mimic
pcr-fragments
transcription-pcr-assay
mdr-cell
aml-m3v
hypercoagulation
g20210a
bda
ckc
xs52
bsc40
e3l
lzp
gflg
primigravida
materna
iodide-digitonin
6-hydroxydopamine
6-ohda
genomic-length
3hdfdc
pulse-chase
returnedxa0positive
4-substituted
19f
ec3
anti-aids
alpha-macroglobulins
frogs
intermingled
neuromelanin
mitochondria-initiated
k562sirna-hsp70
knk437
lactam
laiv
flumist
ferrets
ld70
dpav
ssisrr
burkitts-type
100xl
mbi
cytarabine--
time-scheduled
radioautograms
cyclocytidine-derived
claeg
beam-alemtuzumab
id-mtx
nct00003934
nucleoside-analogue
benzyloxycarbonyl-val-ala-asp-fluoromethylketone
emotion
demographically
benfotiamine
paraptosis
durie-salmon
eshapdhap
araninosyl
il-6ralpha
il-6gp130
daunorubidomycin
cesarian
revises
tzt
cclg
vincristinedaunoblastinal-asparaginasedexamethasone
vdldd
vdld
cyclophosphamidecytarabine6-mercaptopurine
d80
ultra-early
χ237
χ767
χ245
χ198
χ875
epichlorohydrin
2-deoxyribosyltransferase
lrndt
magnetite
vibrating
magnetometry
vsm
arabinosyl-nucleosides
hdr2
aaml0631
cart-related
gi-aes
5-oxoproline
pyroglutamic
genechemotherapy
dissolving
x-100
extracardiac
zevalin-beam
n179
crests
mirna-transcript
mimic-
antagomir-based
leed
cylocide
verifies
slugs
flcl
rifn-
cybm
d-fish-bm
d-fish-pb
grin1
meg-01-grin1--
lysosome-related
pro-cell
memantine
nxa0xa0180
r-hyper-cvadrituximab
r-mc
nxa0xa0350
nxa0xa0374
lr-eshap
aracdp
centrocyte-like
tissue-type
dicetylphosphate
opp
dmpccholdcp
dppccholdcp
kuokco
il1beta
mob
alcamc
caya
ciu
ratiou
h9-ddc
sarcoma-180
betatgdr
hpmpc
z-pro-prolinal
jtp-4819
gastroenteric
mrda
conventional-
bueam
crf-sb
simulative
telescoping
intraoperatively
hemodyalisis
rehara-c
v-binding
g0-g1-phase
cdp-choline
ctpphosphocholine
phosphocholine
cdp-choline-diacylglycerol
cholinephosphotransferase
ndts
ctndt
all-rez
time-to-relapse-
site-of-relapse-adapted
ipts
mlcc
cis-pfluda
physiological-like
cd2cd3cd4dimcd8-cd34-cd45dim
ddr1-specific
ddr-in-1
pre-clinic
lvtiicdd-transduced
50u2009nm
cancer-propagating
cem4xarac
cem20xarac
2-deoxy-5-fluorouridine
hent1slc29a1
lnh-80
180-
7u2009u20093-based
vdup1
ask1
bcoad
i-converting
acetyl-ser-asp-lys-pro
captopril
sa2
hpp-cfc-1
subconjunctivally
dnr-containing
upswing
c1p
chemotherapy-selected
upregulations
ida-hdac
microciml
epimer
4-homocytidine
fa5-bucy
ssb
deactivated
myelodepression
beam-allo
beam-auto
mitoneet
nl-1
sw-1573
hs27a
chemotherapy-activated
gm-csfplacebo
u2009×u200910eu2009u20096kg
3-ll
ara-cdp-dl-pca
ara-cdp-dl-mba
thioether-lipid
conjugatekg
vicinal
dendrimeric
p-glycoprotein-associated
-80-foldp
lc50and
lc50normal
cellstumour
haematotoxicity
r-deprenyl
r-2-hmp
k-induced
14--specifically
tp13q32
ectonucleotidase
entpd1
cd39-expressing
cd39-p2ry13-camp-oxphos
amlthis
hepato-renal
expedites
lamba1
retracted
jatinder
lamba
co-author
eic
co-authors
lambas
promace-cytobom
6xa0cycles
waldeyer
rasrho
zaragozic
cytoresistance
gp-plga-modified
magnetosomes
abms-p
spectrometry-mass
sign-sensitive
step-like
h630
nonmature
neurofilaments
gm-h
chromatographs
toothache
hypermobility
lewy
alpha-syn
a53t
a30p
feii-induced
ssbs
feii
hicau
hidau
hidau-treated
pkcmu
lnhl
12hr
k-562adr-i
boosters
ff-10502
suit-2
masonic
namtg
nf-kappab-related
mll-10
aall0631
kmt2a-g
umin000004801
id-aracu2009u2009g-csf
transplantation-ineligible
tbuasct
non-asct
low-hypodiploid
duringthe
5ab
1500-fold
p-o
transcorneal
ldarc
n4-long-chain
acyl-1-beta-d-arabinofuranosylcytosine
hydroxyapatite
n-ethylmaleimide
c12
amidase
anhydro-ara-fc
pl98k104xa0xa0q
phase-arresting
higher-level
isopycnic
m33a
met33
autoclaved
viscoelasticity
sulfite
intracerebrospinal
racemates
sn-a
sn-b
multilocular
ebv-directed
tcr-profiling
sns-itac
beaming
definedthe
thymic-independent
antigen-cytotoxic
toxogen
antibody-forming
thymic-dependent
da-epoch
nonmyelosuppressive
maver-1
ushers
f-se-ara-c
kinase-activated
amv133
cflipl
j111
micellization
carboplatinum
1gm2
bmi2
bmi3
parabolic
platelet-transfusion
cd36glycoprotein
gpiv
r-hcvad-am
succinyl-ara-c
beta-oxidation
nhl-bfm-
pb-lbl
blb-al
centroblastic
dlbcl-cb
pb-lbl-
alcl-groups
nhl-subtypes
nhl-subtype
vcaa-based
sural
unassisted
sternberg
aminopropyl
nonpolar
sorbents
x1
pcchol
a-all
prohibitory
chemoresistance-reversal
bcl-extra
p388-s
p388-r
iemad
discolored
differenciation
derivertive
tris
abpth-n
abpth-c
cytarabine-binding
trp27
cellsneural
nscsnpcs
ischemia-induced
nscnpc
nscnpc-conditioned
medium-induced
bry
pma-related
sub-additive
scotoma
sc-1
oci-ly18
ym-155
tail-derived
sub-cutaneous
ciliary
cntf
rifnalpha-2b
opcs
ptc-1
shh-induced
shh-related
opal
nicaraven
g-pbhsc
rad9--
75a25mei
ficks
kj
multiplied
d-arabinosyl
araatp
aranucleotides
aranucleoside
sshht
cchcl
l5
tiuxetan-beam
deauville
bryostatins
pilonidal
sacrococcygeal
anguis
arasc
58th
guillain-barre
deproteinization
g-pcnsl-sg-1
r-life
pyrolysis
agglomeration
lymph-nodes
dose-adjustments
apsct
phscs
phsc
vbi
cyclo
r-dhaox
copadl
lasp
cell-suspended
cmaxs
auc-dependent
8-hr
liberalised
idm
treatment-regimen
induction-therapy
decontaminated
nonprotective
dideoxynucleosides
dideoxy
60xa0min
gags
non-fluorescent
ptir
compositional
gas-phase
gm2dose
end-dose
feamu2009u200910
tarac
3htarac
setting-and
reduced-chemotherapy
setting-continues
extirpated
pro-egcg
pre-drug
anti-a1
k252a
trkb-mediated
colo-colic
necrosed
flexure
chloroma-extra-medullary
phlpp
5-cdna
-1b
mvls
trehalose
epc-mvls
freeze-drying
fragmentations
pol5551
lutheran
mizoribine
perchloric
cpnts
bel7402
serie
lmb89
anthracyline-
beambeac
aces
pre-atra
2-chloroadenosine
gapdh-proficient
ic1
et-a
b-domp
mitochondria-associated
ciprofloxacine
nxa0xa0118
mtx-rdi
nlphl
post-auto-sct
100u2009µm
gshgssg
bzb
abdominopelvic
time-intensified
ara-c-ab
tumorcidal
fewest
sympathectomized
guanethidine
midac-
counts9l
counts×l
fingerretinoic
plzfraralpha
noa
q-cytogenetic
non-apbsct
gemox-r
homozygosis
dvpm-chop
cdalf
cdasf
pchi01
pchi007
peg-rhg-csf
bendamustinerituximab
ipe-pyridine
bendaeam
sphyngomyelinic
fe3o4sio2-cytarabine
stöber
fe3o4sio2
zetasizer
fdump10
feverinfections
nct00804856
46xytq22q12
α-fused
petechia
rag2-m
leukemia-laden
liposome-leukemia
resuspension
dp-treated
archaea-inspired
membrane-spanning
tetraether
spherulites
dspe-peg
surface-modified
bot
acidato
trioxidecompound
3-azido-3deoxythymidine
h9razt250
chain-restricted
x109l-x109l
post-neutropenia
post-neutropenic
16-
mue
bfm-study
pk-c
dibutyrate
istituto
18f-fluoro-deoxy-d-glucose
gmp-derived
lgmp
group-2008
cclg-2008
arabinosyladenine
atra--ct
c-gp
cgpcll
cgpfc
l1210bdurd
5-fluoro-dcyd
concentrationtime
exponents
constant-rate
adhesion-dependent
c-ablp73
aids-nhl
dhap-treated
nhl--group
nhl--were
li-fraumani
bglut
synechococcus
bh4-glucoside
bh4
sarcosine
nfps
glycine-recognition
darcy
vargas
stomatotoxic
hma-
ldac-based
sampler
megestrol
xa0ml
samplers
influent
solids
inspected
mdr1a-
mdr1b-
mrp1-deficient
bcrp1-overexpressing
meft6400
v-form
int-0129
6raralpha
non-v-form
dt388gmcsf
subepidermal
blistering
s-2
maintenance-intensification
desensitized
erbb2-overexpressing
mcf-7erbb2
first-step
lymphomawe
downstaging
dmem-s
hct-15-p
cafestol
gemcis
hyper-cvadmtx-ara-c
imsut
single-institute
siblinghla-matched
tt677
620210a
g1691a
magnetization
shrnaara-c
92xxyytq34q11x2
unabated
combotox
rfb4
hd37
rhamnosylated
rhamnosylation
α-l-rhamnosidase
enzyme-activated
rha-rhb
fundal
pseudo-chediak
higashi
drug-tolerant
dtls
qa-induced
1s
acpd
bfgf-potentiated
oal
emzl
chlamydia
nnoad
vsb
diphenyl
lentivirus-transduced
negative-strand
all-2
r-87
folstein
nonprogressors
4-chlorophenyl
-aryl-3-triazol-1-yl-3-deoxythymidines
-3-fluorophenyl-3-triazol-1-yl-3-deoxythymidine
tsk
succesfully
co-application
af070523
inadvertant
cosine
chronotolerance
diave
dexamethazone
cd437-mediated
chennai
120-min
beagles
clofarabine-including
plh
cannabis
lr-all
epigallocatechin
poorxa0prognosis
doxercalciferolcarnosic
post-arac
γ-retroviral
creutzfeldt-jakob
al90
toxicitytreatment
ctll-2
weifang
monoacid
du145r
350-fold
scid-based
pkrdcscid
rag-based
minl
sprague-dawly
anti-ricin
cpecs
biochim
biophys
csras
tara
mk-8242
12g5
a540
5nt-positive
glcnglcn-biant-pa
phs
glcnac-transferase-v
cell-kinetic
crf-r1
heptane
sulfonic
uv-absorption
protocol--the
berlin-moscow-91
bm-91--for
bm-91
bfm-90m
-november
mb-91
survival--80
chloroleukemia
c51
admara-c
acid-competitive
huc-msc
spermiologic
whocriteria
42-
oligoasthenozoospermia
resolvable
negativization
nitrofurantoin
degreesc
adriblastin
euromrd
r-chop-based
5-fu-
cto-percutaneous
6-tguo
cemara-cg
cemara-cb
dhls
nsc399555
post-hidac
daunorubicin-dnr
cytarabine-ara-c
ubiquitin-based
lymphomamcl
ph-responsiveness
uvvis
cell-cycle-phase-specific
minimised
exeresis
ara-utp
abep
peg-asnase
h1437
igl
hgl
ramp
tk-6
4-oxygen
hl60adm
sirnacd44
knownxa0about
childrenxa0with
lew
npkcdelta
npkcepsilon
43-kda
36-kda
talpha
mukg
dna-self-strand-breaking
cndacmp
dna-copy
abcb6
abcb8
g-csfara-c
waardenburg
pt-dna
top1-dna
igrov-1
ido1cd39
goralatide
i7p
elderly--
old--they
7q-specific
idic7q
idic7q11
cytogenotoxic
pccds
permeate
semiempirical
tri-phosphate
bav3
bav3e3gd
polε
rad18
rad18--
gh2ax
holoenzyme
chemosensitivity-directed
post-1989
alongwith
del5q31q33
tq13q12
der20
pyramidale
a673
apo-2l
apo-2l-induced
effusive-constrictive
cyclonucleosides
r-ivad
treatment-subgroup
ancova
regionabl
neisseria
preloading
ara-ccbdca
cpt-ss-ara
carrier-free
myeloblastiques
arguable
sgc8
pcl-ss-arasgc8-bsa
self-assembling
1alpha-product
meoh
atom-transfer
1alpha-vinyluridine
18f2-fluoro-2-deoxy-glucose
hdtsct
toxicol
appl
r-hypercvadr-ma
aphd
nd-cns
vim3arac
mitoguazone
pipetting
bm60
bmnpv
bmnpv-infected
r-hcvadr-ma
gmsm2
5-dfur-
carboplatin-
tp53i11
mtns
mex
myelodysplasticmyelo-
f1p1l1-rarα
stat5b-rarα
cleavage-enhancing
46xxdup1q21q32add5q33tq34qidemder22t8
tp36q22
graaph
corticosensitive
corticoresistant
2-desoxycytidine
methotrexate-cytarabine-rituximab
histocytosis
pediatric-like
2-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil
grapefruit
non-secretory
l1-l3
cytarabinecyclophosphamide
teniposideara-c
vincristinedoxorubicin6-mpprednisone
epidophyllotoxin
crt-
radiated
dl-isomers
xiangya
12-hr
factor-bb
met-his
dt388il
dab389il
necropsied
dab389il2
4-n-stearoyl
4-n-gemc18-slns
4-n-gemc18
tone-footshock
fcno-ext
self-potentiating
genealogical
unfrequent
yu-311
rybp
protocol--a
osea
heteronemin
mcl-002
nxa0xa0170
nonbulky
concn
pacap
postibrutinib
exonucleases
ill-looking
tachypnoeic
karyoyptic
r998
arap
poz
h9rarac100
ulbp-2
ulbp-3
ulbp-2ulbp-3
optimalization
5-and
dicarboximides
abc50
post-cultivation
uv-
trimidox
111indium-dtpa
ynbg
mir-378-transfected
crocin
consolidationreintensification
∶
neutolophilic
mucilaginosus
actg
crus
megachop
paraaortic
highest-ranked
rs1203633
htert-transfected
c-myc-transfected
r-dexabeam
inhl
pkcbetaii
nxa0xa054
nsabp-b31
bcirg
finher
docetaxel-based
tch
settingthe
radio-labeled
vg19
hl-60xa0cells
flushes
cml-blastic
nf-κbmurf1-dependent
cxa0laurentii
obturation
araump
aracmpctp
cellsorted
-cdp
-ctp
jurkatadr
ensheathing
msae
ld50s
glasdegibu2009u2009ldac
pupillary
cream-colored
nanoagent
cy-msa-g250
cyanine
kaempferol
butenolides
1a-c
l-cysteine
purine-containing
adenine-containing
phosphonothioanhydride
tartrate-resistant
tracp-5b
thermogravimetric
htert-hpne
mitomycinxa0c
vf
6u2009cycles
superfractionated
6mp-riboside
tit-treated
pefs-5y
signficantly
carpal
dnar
slx4
5-suberate
depodur
lip-ara-c
wbcl
n92
rd-sct
self-initiated
anticonvulsants
supertypes
dp2
dp1
dpb1-typed
dp3
cll-associated
ofailr
ab-dependent
200microliters
hoffmann-la
tcrαβt-all
tcrγδt-all
cdkn2acdkn2b
chlvpp
igh-crlf2
p2ry8-crlf2
nct00005596
nct00005603
sub-stages
ppcl
lxrrxr
advanced-line
m0-m7
ud-cbt
mrd-oriented
fcr-ibrutinib
br-ibrutinib
pre-national
pi3ki
bcri
btki-exposed
pi3ki-exposed
discontinuation-free
pred-induced
dual-staining
allmy-
dossier
slvl
treatmentdespite
institute-working
nci-wg
ph1bcr-abl
intra-cerebral
rtk-dependent
pdx-all
paks
pak2
pak2-directed
pdgfrb-dependent
flt3d835h
frax486
hd-l-asp
docetaxelestramustine
exisulind
castration-recurrent
re-sampling
pseudo-values
c61-lnp
atl-pi
iatl-pi
n96
jak2calr
jak2calr-
jak2-calr-
cb-t
rd-t
urd-t
ttft
cll4
g-bmpbs
nudt15
rs116855232
cd45-high
cd45-low
nct00430118
vcap-amp-vecp
rnf220
sjcrh
morphocytochemical
tnftnf-receptor
p55-
p75-stnfrs
stnfrs
p55-stnfr
p75-stnfr
palifosfamide
chloroacetaldehyde
bioavailabilities
palifosfamide-tris
glycoengineered
ga101
phbcp-all
berlin-munster-frankfurt
188re-mab
all-7
resonate
atcls
bcr-ablve
-173
primary-source
tcr-alphabeta
-delta
al-1988
alhr-1990
i-asparaginase
i-asp
alhr88
24gy
al851
t10ba-31
phospho-eif4ep-eif4e
p-eif4e-targeted
graft-vs-lymphoma
all-2009
dnmt3ar2
npm1-flt3-itd
npm1flt3-tkd
tumor1
nct00281983
tya
ukall2003
il7rhighsh2b3low
etv6-runx1-negative
absentlow
acute-
ia-iia
rs3824662
abl-class
b-2
egfr-targeted
pythiosis
oomycete
pythium
insidiosum
abmtr
allosc
autosc
chemo-free
venetoclaxrituximab
venetoclaxobinutuzumab
ibrutinibvenetoclax
adbw
anti-cd23
gd-2008-all
cdw52
polyglutamylation
lectin-separated
cellpro
scmc
9-o-acetylated
sialoglycoproteins
oacsgp
achatinin-h
galactosamine
nu2009u200984
five-mirna-based
inpp5f
tbi-free
calgb-8811
ph⁻
erm-d8
haplo-rd
fludarabinecyclophosphamiderituximab
llmpp
reanalyze
o-dex
orrcr
imatinib-combined
nhl-bfm95
6q14-q24
icans
leukemiab-all
cll-training
cll-validation
mboat1
cd38-expression
hcl-related
igcccg
stwp
pbll
gelf
sctthe
uncontaminated
rad12
drop-off
scd138
co-infused
dc-induced
tr1-induced
aieop-bfm-all
culture-confirmed
haplo-tx
seqth
m-urd
per-
woefully
zap-70cd38
zap-70-cd38-
self-sustained
abdominoperineal
lar
tolerability-determined
epcam-mnps
hr-mud
granulocyte-colony-stimulating-factor-mobilized
nct00365287
nct00305682
nct00303719
β2m
fcm-
back-tracking
afro-caribbean
azt-ifn
pinkels
all-6
all-9
all-8
seta
setb
dexamethasonedxm
labar
all-4
labar’s
hdtauto-hct
negative-
t-prolymphocytic
l-12
l-6
rft8
rft12
rft2
double-color
tbi-mel
stepped
ivo
nipent
matthews
stripecke
sex-combination
calrjak2mpl
masp-2
age-at-diagnosis
typescript
13q-l
13q-h
nct01500733
timescale
ebf-1
znf423
tcl6
tcl6-silenced
tcl6-overexpressed
p-lfs
cd54-
lsa2l2
gvg
cord-haplo
hokkaido
vp16tbi
cll11
zap-70-positive
p-asp
dlbl
lala87
metformins
bcl1
polymer-drug
metal-free
kskese
polymer-pirarubicin
factor-interacting
hpip
gynecology
obstetrics
globule
nhl-98
ivcourse
mcp841
tel-aml1-positive
hvgr
slnd
rlnd
sln
hclv
30arm
midostaurinu2009u2009soc
midostaurin-treated
nct01883362
r-r
non-cmv
fluctuates
nonfractionated
fralle
5y-os
lincrna-p21
c-219
cdl0
gompertz
ucart7
dleu1
uhrg
fcr-treated
scnas
scna
95cixa0xa-
94a-138a-561a
94c-138g-561g
heh
hx-cd
pre-progression
cd19-car
cam307
iwcll
pre-dose
flow-cytometrically
di-n-butyl
dbp-purged
resonate-2
helios
protocol-specified
del17ptp53
d1-mrna
i-gist
s-gist
pml-negative
cd49dlow
cd49dhigh
hrcd49d
hcls
um-ighv
um-hcl
la-nsclc
crt-related
rounder
pptp
npm1mutflt3-tkdmut
cbf-rearrangedflt3-tkdmut
npm1wtcbf-negative
anti-cc
trustworthy
groups-low
re-imbursement
nu202fu202f83
nu202fu202f72
nu202fu202f73
onfh
pu202fu202f015
pu202fu202f037
nct01607580
hrfs
hr2
1-page
all874
all911
all9
cnsi
bva
bvl
phall202
elak
luml
tradename
maastricht
aato
6-mercaptopurine-methotrexate
latinamerica
ibr
between-trial
urdm
hcl-variant
p-388
impactn
wt1and
wt1n
50x109l
ibrutinib-treated
lower-than-median
taci
staci
mrd-driven
bcrabl1-negative
btg
crlf
non-ph-like
therapyu2009u2009asct
low-activity
ensg5
ccd52
ccd20
smica
smicb
sulbp2
superfamilies
tm4sf
chop-21
chop-o
lrp16
rcd
vpd
tbi-vp-16-cy
tbi-vp16-cy
met-
galactorrhea
nu2009u200961
non-t-aml
nu2009u2009681
ik
limitedextensive
nct01799889
cll-8
flu-bu-mel
flu-bu-mel-based
fcgrs
s-b2m
balbcbyj
intensive-induction
short-arm
all-bfm90
11q23mll-positive
tmli-containing
non-tmli
tax1
htlv-1n
crs-related
u-mrd
mrd4
mrd6
eot
allacute
vpcy
g3a
g3b
18gy
nagl-1
mu-
poor-outcome
allr3
bushen
ybg
aall0232
c-mtx
nct00075725
coli-asparaginase
fludarabine-cyclophosphamide-rituximab
fludarabine-cyclophosphamide
5f9
rs10519612
rs17007695
nonmyelotoxic
14q32igh-translocations
allohsct2
flubutbi
cll5
cll8
nct00281918
atraatoanthracyclines
①short-term
506u78
stcl
nu2009u2009304
pb-haplohct
17ms
phg
pinkel
bearman
anti-asparaginase
gria1
sphincter
chope
remissionpartial
cirs
del17
-cda
efree
non-isolated
2-efs
fxiii-a
fxiii-a-positive
cclg-all2008
pcr-mrd
mrd-sr
mrd-hr
mrd-ir
nct00613457
low-stage
poly-ubiquitination
lvad
tp53-defective
epi-vnr
nausea-vomiting
mismatched-unrelated
fusionmutation
divpi
gnd
berlin-frankfurt-muenster-85
rg2
ntal
raft-membrane
ntal-knockdown
ntal-kd
bui
tq32q11
abcm
2b17
mir-27a
tel-aml1-negative
ne-mediated
ne-resistant
nu2009u200960
hla-abdr
flcs
λ
ratio-only
non-m7
rhr
5-transmembrane
cd34bright
cd62e
cd144
ibrutinib-rituximab
d-pbscli
d2hgdh
col18a1
fgf19
cluego
pluggin
p-iii
p-ii
bcr-abl1g6pdh
nct00844298
otd
graall
graall-2003
graall-2005
nct00222027
nct00327678
estramustine
cr2cr3
admire
fcm-r
n129
osa
hair-like
fmc7
clinico-haematological
b-allpatients
stanfordnorthern
ncog
cavop
m-bacop
stanfordncog
hcl-c
hcl-v
investigator-assessed
marrow-relapsed
scandinavians
srhr
riskhigh
asp84-lys69
asp84
non-asp84-lys69
qw
confirmative
nct00090051
d21
re-intensification
steroid-containing
pre-allohct
rr-cll
dimethylbusulphan
phu2009all
pu2009u2009u2009u
slco1b1c521tc
cll-ipi
akaikes
cu2009u
barcelona-brno
gcllsg
o-cll1
postpolycythemia
verapostessential
ppvpet
ezh2-mutated
cd10weak
cd10strong
nu2009u200977
csf2ra
cemri
msd-hscts
androgen-regulated
androgen-responsiveness
all-02
t-allt-cell
anxieties
crlf2-d
hdthsct
tn-cll
vhrr
sr-gvhd
cr--10
srl
srl-st
nonskin
srl-csa-st
yogyakarta
non-aml-m3
10p
rs10828317
axicabtagene
ciloleucel
cell-transforming
net1
mir-206-in
questionxa0we
followedxa0by
bloodxa0and
dao-pei
adult-inspired
chemoth
g-wilcoxon
nxa0xa0215
rgrfs
chictr-onc-12002739
probalities
iteratively
ink4-locus
p-efs
tacl
a5971
cns-negative
44xa0
lexs
cd4cd25hi
citrm
anti-pdgfra
corticosteroid-resistant
pathogen-recognition
tlr10
cgga
tisidb
cns-dlbc
cr2pr2
abd
mcd3
b-lin
t-lin
bu-cycy-tbi
tbiara-ccyatgccnuara-cbucyatg
presymptomatic
ror1neg
ror1pos
ror1-hi
ror1-lo
prst
esphall
tnatural
cmbl
scd83
bio-informatics
significantly-associated
independently-associated
sequellae
hrds
total-therapy
scmc-all-2005
fablmb
hl-a-identical
bclpds
slow-u200ago
relapsedu200arefractory
spts
conventional-adult
c219-negative
c219-
jsb
jsb-
jsbi-
kaplan-meyer
bkv-hc
all-2005
low-middle
multi-dosing
imid-based
chsp70
m-25
scd62l
hla-m
hla-mis
a-3v
pml-raraabl
flt3-length-mutations
bcr5
flt3-mutations
2nd-hsct
cdg7sdie-mab
fc-expressing
posttransplant-targeted
granylocytic
mutant-wild-type
mutantwt
ato-related
ludaopei
p53dna-binding
response-adaptive
nonrelapsing
3h1
3dfs
etvp
lymphoma-berlin-frankfurt-munster
bcl2-
b2-m
table--projected
calasp
vecd
scd23
cd58-
ight-cell
nxa0xa0202
orxa0
musculature
pediatric-derived
deintensification
hsv-1-derived
vector-associated
virus-dependent
cd70il2
ifrt
flcr
ibrutinib-exposed
treatment--1
planned--1
clmtx
1-antigen-mismatched
ld-fcr
plcγ2
pplcγ2
epipodophillotoxin
magnetobeads
m450
x4
cll10
clb-r
clb-ob
ttnt
anti-cd9
ctcr
scd3
scd3-
cd3tcr
vincristine-daunorubicin
vincristine-doxorubicin-cyclophosphamide
triaditis
annamycin
erwinia-asparaginase
erwinia-asp
pbx-interacting
s-mtx
mkw
anti-mkw
fic
unop
allo-hct1
ighv-cll
fcrl2
allthe
high-birth
daunomycin-cytosine
rasheczema
us40782
us34465
elutriated
intravesicle
astra
zeneca
wilmington
philadephia
bence-jones
bjp
cd36-
elderlyphysically
o-clb
ighv-unmutated
diameteru2009u20095
obinutuzumab-monotherapy
all-ds
all-nds
fhd
nct02042690
il-2histamine
norton-simon
ddx3x
nct00535873
neutralizing-rifn
alpha-ly
interferon-2α
peg-ifnα
lvp--
cd2-negative
rr-all
flamsa-like
primary-refractory
ii-iviii-iv
rr-t-cell
ehlers-danlos
baff-r
all2003
tpmta
anti-bcr-ablt315i
rs0
rs2xa0xa0
lal81
lal87
kir3dl3
bcri-refractory
palifermin-treated
objectiveto
coldx
aml-89
unoxidized
chi7
lymphoma-leukemia
beta-myh11
cell-specifics
level-grouped
technigue
applyed
additonal
non-hematopietic
quality-of-evidence
cd56dimcd57nkg2c
nonfollicular
all93
ra-sct
bch-2003
bcp-alls
ebf1-pdgfrb
ib3
lrfs
lgm
natulan
sucbt-ebmt
8-allele
acp-196
ukallxi
cd10-positive
alc-15
a-alc
hla-b62
pre-t-cell
l-asparaginase-related
8-colour
rs79716074
cpsnps
icg-loaded
cellquest
ttcf3-pbx1
approvable
a-189
c9343
bendamustineu2009u2009rituximab
tnpm-raralpha
arsenic-related
ihp
dct-2
perpendicular
sppd
plls
prolymphocytes
am-all
15u2009gy
18u2009gy
flt3-tkdflt3-itd
sfm
cellgro
ino-treated
bfm-like
ibrutinib-refractory
super-high
ii-c
131i-lym-1
lym-1
anti-lym-1
age⩾35
⩾35
seven-drug
rodst
m3t
m4eoinv16
m5t
panmyeloid-associated
progenitor-
paediatric-based
cd23-positive
nxa0xa050
distort
g-pmbl-p
gray-zone
g-pmbl-nm
xcl
bcr-dependent
kinasessignal
very-low-risk
decreased-intensity
cll-specific
ucart19
pre-allograft
nrd
b-dopa
mvpp
emp1
ctnnd1
17p-tp53mut
vadcvad
cep12
tbi-
ct-mac
gvhd-relapse-free
haplo-hctptcy
zap-70-negative
s-form
anti-cd19-car
chictr-onn-16009862
chictr1800019622
allo-related
allo-unrelated
2cr
1pr
bcr-ablp185
cd40-l
bcr-ablgm-csfil-12
dslim
cyclosporine-amycophenolate
bcr-abl1–like
pu2009-
ngs-mrd-
earlylate
l-sign
colombian
9-o-acsgs
9-o-acsa
galnac
9-o-acsg
epirubicin-cyclophosphamide
risk-prediction
xa0pu2009u
tetherin
momlv
htetherin
bfm-all
callg2008
no-enough
gain1q
sat-α
ighv-um
proliferation-sensitive
pcr-b
gemcitabine-cisplatin
allo-stem
cd4cd8-mhcii
cd4-cd8mhcii-
hmasxa0xa0chemotherapy
300xa0ul
monocytesxa0xa03xa0×xa0109l
goserelin
restratification
superagonist
antiasparaginase
cscc-hn
early-stable
lmrs
imrs
vith
undernourishment
nourished
undernourished
es-sclc
pcyc-
cross-trial
ibmi
unwashed
ue2fa
higher-than-median
scmc-all-2009
-2005
5-fulv
nu2009u2009107
comparably-treated
cdigm
cdtdt
groupsin
non-ifn-α
non-ifn
bfm-a
behenoyl-cytosine-arabinoside
300microl
svegfr1
svegfr1csf
svegfr2csf
svegfr2serum
cd7aml
nu2009u2009281
nu2009u2009125
nu2009u2009105
nu2009u2009104
post-hsct1
post-hsct3
cpre-b
abn12p
hhct
ibrutinib-based
ublituximab
zanubrutinib
ivap-2
maldi-toftof
tetrahydropyranyl
8xa0cycles
leukemiachronic
hiv-bl
qus
amplitude-dependent
sigm-
ib-nhl
non-rit
rcu2009mlminu2009m2
rc4
csamtxpse
csapse
diagonal
pre-enrichment
ikzf1del
eortc-clg
vincristine-steroid
hoelzers
volunteered
ayt
pxa0mut
nk-aml-nos
suggestxa0aml-mrc-m
cll3
estrogen-receptor
aall0331
tigh
extrathoracic
17u2005p
cd20-antibody
phosphoinositol-3
chemo-reduced
iwf
sc-initiating
sc-ic
anzchog
all8
l-asn
wmd
tallmo
all2008
fcm-marker
rituximab-refractory
photoactive
th9402
photophysical
histone-dependent
histone-modifier
hta-
all-87
gvhd-guided
ipsswm
safti
stnfrp55
nucks
ikzf1bcr-abl
ikzf1bcr-abl-
ikzf1-bcr-abl-
mutationthe
cd100
p06
adversity
ctra
nhl-89
nhl-96
rs4673
rs3957357
rs1883112
circklhl8
circfcho2
urd-hct
cbfb-myh11abl
s-methylation
nct01905943
g-fc
d8
dual-positive
l10
l10m
d-crlf2
b-neg
d19
lala
lala-
malnourishment
induction-i
induction-ii
agencys
gvhd-involved
ars2
casp8ap2
phospho-proteins
phospho-s6
p-4ebp1
stricter
cd13neg
fmr
infl
cdkn2arb1
knras
p2ry8
n138
surrogacy
patientswe
b-alltwenty-one
eightcomplete
transplantationtreatment
19in
stetting
temper
trerna
osu-cll
pva
siop
cw2
300-
rall-2009
nmc-hct
convexity
mrdu2009u
consolidation-related
-thioguanine
bcr-ablsrc
upstaging
ha-8
nast
all87
chrs
allo-sctthe
time-to-first-event
rifs
itmtx
d1853n
s707p
f858l
p1054r
l1472w
y1475c
aall0622
intercycle
nhl-bfm90
nhl-bfm86
pcrt
non-atraato
atraato-based
fludarabine-ineligible
n177
subject-related
donor-types
suppressionbut
probabilitythis
hourigan
gormley
ossenkoppele
gj
terribly
c-statistic
flipping
idealin
othus
voltaire
absurd
sadly
mei-jie
ucb-sct
rs2304206
total-dose
protruding
jeb
g6pt1
leukemiaslymphomas
sequoia
contusion
allvr589
chemo-radio
b‑all
59‑gene
a26
b44
dq2
dq6
hla-dq1
dq1
leucemie
aigue
catania
jdelta1
vdelta2
vdelta3
ddelta2
end-labeled
southerndot
undernutrition
cure-oriented
next-to-normal
nct03173417
all-mscs
gain1q21
t-pbsct
promising-and
antibody-related
tls-ergu2009leukemia
not-tested
highvery-high
donor-marrow
cytogenetically-defined
cllhl
crtc1-maml2
crtc3-maml2
crtc-maml2
clinicopathologically
wk-all-2000
tango
taxane-containing
lymphomaxa02
phasexa0iii
cll14
gradexa03
dirichlet-multinomial
chooses
parameterizations
cross-product
bio-chemotherapy
parameterizing
dirichlet
cvpp
-test
4-drugs
r-il-2
roussel
uclaf
ium-156
neurocardiac
pshrv
holter
lfhf
teleangiectasia
lmt-89
one-single
cd20-expression
insulin-sensitizing
dysg
dysm
dyss
auch
ph-only
nu2009u2009322
risku
rru
hla-a33
nu202fu202f89
nu202fu202f301
nu202fu202f50
pu202fu202f11
pu202fu202f65
pu202fu202f61
nhr
hir
bioflavonoids
dna-dsbs
bp-all
negtive
q25
cxxc6
d100m
5-point
sil-17
prbneg
p53abn
nonisotopic
prbnegp53abn
tbi6
fludarabinemelphalan-conditioned
versus-
-504
cgvhdthe
χ901
χ307
χ447
χ665
χ517
χ673
pumc
s3cmr
vs-24
non-s3cmr
⩽
earlyprefibrotic
early-pmf
mplw515k
symptom-driven
peb
dexamethasone-sensitive
bcl-2-negative
ki-67-negative
calc1
ifn-treatment
t-rna
pseudouridinecreatinine
0a
anti-igm
mrd0
mrd0mrd1-
v-erb-b2
glor
ghir
non-mscs
epipharynx
trf-l
histopathogenesis
vh-ms
vh-mutated
vh-unmutated
pefs5y
pos5y
doxorubicin-iron
doxorubicin-associated
co-infusing
atra-arsenic
stratification-directed
fcr-based
ighv-mutated
locoregionally
t-precursor
nhlcll
sflcr
ic-bfm
mrdd-3
pefs5
untreatedpre-treatment
kappalambda
ct-p10
bch-03
cclg-08
atm-nsvs
gab1
ccg-503
deletes
eef2-specific
i-binding
isa51
wds
abos
a--c
selection-bias
vpdl
fcyclophosphamide
increased-risk
p30-
white-blood-cell
ialt
jbr10
anita
mϕc
ttel-aml1
tmll-af4
tbcr-abl
injures
r-fcm
testiclesovaries
helper-1
ath-1
cd4cd25cd40lcd62llo
t-cell-enriched
ii-iv°
iii-iv°
variant-complex-
u-bm
u-cb
lowno
igh-epor
uncategorized
malign
berlin-frankfurt-münster-95
svcssms
poms
gt354m
gr396q
gr398w
sl359v
gc373r
11q17p
tki2
rch-acv
pcdh17-targeted
retroviral-particle
genemapper
lees
eml-
emil
cr9
low-ferritin
high-ferritin
⩾1000u2009ngml
propriety
u200980
mann-whitneys
cnot3
ukall-cna
ik6-positive
ik6-negative
busulfan-cyclophosphamide-melphalan
bu-cy-mel
asct1221
chemo-only
2-cdap
chlp
2-cda-treated
small-noncleaved-cell
rfsos
nen
frequentxa0with
k79
nhl-bfm-90
mpdn
embt
cd3cd19
monounsaturation
cns-cb-
cnscb
cnscb-
cnsu2009u2009priorrt
c313gg
-risk-genotypes
time-variant
33b
rhd-123
substages
rais
haz
below-
fca
low-intermediaterisk
flubu2tbi400
copies104abl
therexa0werexa0201xa0patientsxa0with
104abl
bcris
torelapses
ramp-up
nct02141282
aild
imllr-b-all
primografts
non-del11q
frl
acalaobi
chlobi
tl-ifr
tl-ofr
ht-stela
nu2009u2009260
fsa
p-2efs
bestbetter
g-bmpb
g-pb
one-yr
rs20551
penalizes
tacrolimus-based
conjoint
multi-colour
δtl
post-germinal
formularifis
apl07
methcorr
hd-all
ida-intensified
hbz
cleansed
il-21u2009ngml
u2009d
pisa
ncc
agvhd-specific
prognosiswe
malnutritionmean
pu200au200a011
pu200au200a012
pu200au200a043
pu200au200a041
pu200au200a042
pu200au200a006
pu200au200a018
pu200au200a026
pu200au200a831
pu200au200a036
pu200au200a663severe
del17pp
t-heh
kanagawa
biclonal
ighbcl-2
bsct
slowest
zeta-chain-associated
cpfs
gbtli-all-93
homoheteroduplex
gbtli-all-99
eaals
eaal
nxa0xa061
t-regs
posthoc
10u2009679
n9815
n864
⩽80
n369
non-dli
lal-1308
pcr-marker
mrdu
vmp
obinutuzumab-chlorambucil
rituximab-chlorambucil
paraproteinemia
inhibitorxa0ibrutinib
vecabrutinib
ulocuplumab
moga
ifn-agr
scl19a1
rs2838958
cd19cd3-bispecific
alc-29
isd-hematopoietic
isd-sct
allic
lodgement
37-kda
37lrp
laminin-binding
monocytic-oriented
r140w
r172g
crlf2-high
crlf2-low
galphas
microrna-210
increasingdecreasing
agomirantagomir
daunorubicindexamethasonel-asparaginase
daunorubicindexamethasonevincristine
translocationsduplications
two-tired
ipss-independent
m-ud
tleukemic
mir15amir
ucd
imcd
2019a
patientsfamilies
lowand
dys-aml
non-dys-aml
p0-karyotype
p1-karyotype
p1-compared
p0-subgroup
grouptransplant-related
bcr-responsive
mito-flag
merrits
bm-157
pb-157
hhd
wbcdiag
fcm-minir
pro-t
bfr
xinjiang
halotype
auto-pbscs
-196
diseases-free
ud-ucb
lifr-as1
ptpn11-
nonsyndromic
tnfrsf1b
gg-ctla4-cbu
cb-cc
kiel-classification
fcl
33rd
sp-selectin
r-dri
n224
epigenetically-driven
gwmb
14q32igh
q32igh
pmlrar∝
pml-rar∝
ccg-160
3r3r
event-predisposing
anthracycline-cytosine-arabinoside
tdmp
tbi-mac
aeab
ducb-tcf
ducb-other
pu20091
cs-a
cs-a1
cs-a3
pxa050
allegedly
n184
n185
cp-27
t-nhls
nxa0u
slg
b-nhl83
b-nhl86
prophylaxistreatment
hemorrhage-associated-mortality
hnk
paraptosis-like
pu202fu202f027
centric
anti-bcl2
idh1g105
idh1105ggt
idh1105ggc
mutatedflt3-itdflt3wt
azoospermia
brief-course
remission-103
transducin-like
lesser-risk
pptps
cd34cd38-cd58-
cd58-fitccd10-pe
cd19-apc-cy7cd34-percpcd45-vioblue
cd38-apc
cd34cd38-cd58-group
cd34cd38-cd58-lpcs
flt3-mus
alms
flt3-alm
flt3-mu
mtxpgs
tgns
dsi
b-al
lymphomun
hrrr
alc-22
alc-0
alc-22alc-0
cd19-car-t
b-phenotype
ciu202fu202f-
gradexa0xa0ii
nxa0xa0213
thiotepaother
nxa0xa0110
pu202fu202f36
restaged
murano
cmeanssnominal
exposure-progression-free
neutropeniainfection
mel100
achondroplastic
vdelta2ddelta3
mll-af4t-
mll-af4-
cgcr
gstm3
gstm4
deldhl
daunorubicin-intensified
anthracycline-intensified
abexinostat
non-aids-defining
pbschs
accr
chlorambucil-obinutuzumab
psoriasis-associated
frs
non-fi
stc
pefs12
sflcκλ
sflcκ
10xa0×xal
group-i
group-ii
cobomarsen
flt3m
salvageasct
fdg-pet-negative
specificitythe
delocalize
m-7
viiivon
ctrfree
or7
amel
autoallosct
autoallo
em-mpo-positive
electron-microscopic
tal-1
cclg-all-2008
khon
kaen
dba44
fccam
onsets
hyper-c
cscc
pre-autologous
3-tiered
blast-based
2-tiered
cmdp
7-litre
fenwal
5-litre
aminco
celltrifuge
non-radiation-based
lal1
pfx
lal2
whic
bcr-signaling
dnpep
fa-ref
bf-ref
snp309g
mdm2snp309gg
mdm2snp309tt
hox11l2t
f2-isop
eicosanoids
atraas2
idela
spg20
nr2f6
obi-3424
binets
chc
tce-x
tce-fd
dpb01
countrys
a-317
c-1610
13q14x1
13q14x2
cr-
non-splenomegaly
χ303
no-splenomegaly
χ470
χ204
χ351
χ148
sattf
esphall2010
4g7sdie
patient-individual
cdk5c
cdk5--c
cdk5--
slos
iv-s
era1
era2
dominancy
daunorubicincytarabinethioguanine
preleukemia-aml
aall0433
induction-1
therapy-outcomes
scorexa0xa080
hemibody
ahbi
uhbi
lhbi
mismatch1
chcl
nhlb-all
cms-based
zrb
ara-czrb
idarabicin
non-basal
aldh-1
pmh
n336
atg-group
enrolledtreated
17p-deleted
venetoclax-treated
case-specific
iexa
fgt-mrd-positivity
coall-treated
single-tube
cd160fca
ical
anthracycline-naive
allo-pbpct
double-staining
hoxa-positive
hoxa-negative
abnomalities
clinical-effectiveness
microculture-kinetic
r-bmtpbsct
u-bmt
u-cbt
non-intensified
pd-0332991
hsa-mir-124a
cdk6-rb
grade-iv
tlx-3
stil-tal1
bmf-free
c2546delc
mdsaml-free
a3a11
igh-hts
opal1
npm1-mtnpm1-wt
hc2
convalescence
anticipatedabstract
mtxara-cpsl
six-drug
hdais
etoposide-tbi
assimilate
coall-oriented
d13s25
ld-atra
neuroepithelioma
mtr
∼29
b56γ
histoincompatibility
urd-recipient
recategorized
prelymphodepletion
tk-1
allopbpct
l86
l97
four-colourssingle-tube
cd45-ecd
cd16-pc5
hdnhl
96-well-plate
throughputthis
pyrograms
npclc-all2008
clllymphocytic
q17p
acutexa0lymphoblastic
anthocyanins
anthocyanin-rich
gpr
ibrutinib-induced
cro
c2-specific
g-b
leukaemiaretinoic
d-1
18fdg
prognosis‑associated
gse10186
de‑rnas
lncrna‑mrna
gba3
t‑cell
hma-ven
snhg12
lnm
mlk3
e-box-binding
calpain-mediated
asia-pacific
aml-1-eto
hics
tanzanias
mabtenance
cll-10
bruton’s
gdc-0199
allogeneic-transplantation
underprivileged
pma-activated
protrusions
bb-targeted
klrg1
subtype-oriented
third-plus
md-pii
sudhl-4
cpg-oligonucleotide
esphall2004
17p-cll
sloan-kettering-new
york-ii
msk-ny-ii
deletiontp53
smad-
smad-4
smad-7
28bp
hydroxymethyltransferase
cshmt
pcr-aflp
pcr-with
ctpp
2r2r
loucy
bucyvp-16
allo-transplant
-2014
ranku2009u
mantel-byaru2009u
gata1-mutations
fwi
high-lc3b
bsmi
apai
apai-taqi
fluu2009u2009bu
fluu2009u2009mel
fluu2009u2009ivbu-based
fbiv
fluu2009u2009pobu-based
fbpo
fluu2009u2009mel-based
fluu2009u2009ivbu
burkitt-type
pcms
m-ptlds
pt-pcms
pt-pcm
ch-all
pys
nppsc
85tu2009u2009c
pu2009u2009c
pu2009u2009a
m6c
pre-august
tbcrabl1
intracranially
runxs
10-min
aml-8a
non-italian
eortc-lcg
achive
regimen-associated
daclizumab
il-2ras
urd-pbsct
cmc5
cmc3
anti-graft-versus-host
mirna-ish
bhrf
diana-mirpath
hi-fcr
hi-ww
spa-1
spa-1--
atmchk
digitalmlpatm
ftbivp-16
cd19b4
pirche-i
b-mature
pkcβ
mir-223-negative
b-lpds
implicitly
mrd1-positive
b-all9l
t-all9l
chromosomegene
rhil-11
childrenadolescent
pbc-all
failurefree
transformationfree
all-time
daas
daa
6-mpu2009u2009mtx
wt1-low
wt1-inter
wt1-high
hla-incompatible
deah-box
nm001358c664cg
pr222g
allo-cbt
ikzf1-
nu2009u200972
asparaginase-related
adam29
postautologous
alc-28
alc-cc
alc-21
cdriii-specific
sgbm
lal-86
remainders
non-markov
44-fold
dhfr-overproducing
pelif
m-proteins
ighv-ngs
20k
speedy
pld
acc-1
tki-containing
rs153109
rs17855750
dfsrfspfsefs
venr
sequalae
myelosuppresion
pharmacokinetic-targeted
acalabrutinib-obinutuzumab
venetoclax-obinutuzumab
bfm-oriented
hd-6mp
bufluvp
cd56dimcd56bri
cd56dimcd56bright
failurerejection
n542
nct01371981
uygur
mir-15amir-
nonrecipients
cements
n387
bmad
umd
rs2274407
expressionor7
ldh-5
ccg-1884
益气补肾颗粒
gdli
orcr3
tel-aml1-
s-beta
us-based
informatively
violates
dic-positivity
elnfav
cetlam-12
hemr
npm1mutabl1xa0×xa0100
cd1o
coall-92
lfss
ric1
ric2
d8d1
hclc
oligoprobing
public-private
rwd
rwe
often-retrospective
nonparticipation
truong
cin-related
fluent
cas9-assisted
phosphoribosyl-transferase
recombineering
∼42
matched-hsc
lower-than-expected
susceptive
epacadostat
cell-modulating
transgenics
knock-ins
tpo-receptor
pre-cryopreserved
ptw
post-thaw-and-wash
prepares
high-incidence
outcomesabstract
hla-donor
ibrutinib-responsive
my-t-bcr
ldmcs
clonogenically
rareity
aml-qol
psychometricians
interclass
non-disease-specific
in-host
semi-mechanistic
piecewise-constant
approximations
fl-stimulation
wt-flt3-mapk
de-intensified
holistically
cd123-based
overcalling
undercalling
ube2c
ubiquitin-fold
aerosolised
team-based
morale
family-centered
at-home
lax
impinging
fd-resistant
fd-sensitive
sibim
sibecn1
shatg7
shlamp2
fd-induced
becn1-dependent
jakarta
ablack
adjudication
vesus
atezolizumabu2009u2009bevacizumab
t-effectorifn-γ
known-groups
distribution-based
anchor-based
mids
27-item
seven-item
swb
subscale
six-item
therapy-biological
boomerang
merges
chemotherapy-elicited
observationsresults
pd-l
modelsconclusions
fatp2
fatp2-mediated
micro-tese
hgscs
oviductal
bprn
nadhms
polycomb-evi1-ptenaktmtor
evi1-activated
evi1-regulated
5-parameter
cbl-mutant
pi3kδi
mtori
beers
pik3cb
pik3cb-related
hdls
well-poised
sqcc
fgfr-targeted
fgfr1-expressing
qlq-cml24
β3kom
fwbi
treatmentmanagement
nxa0xa0325
haemoglobinuriaacute
pnhaml
treatment-by-prognostic-factor
2g2r1y
1g1r2f
2g1r1y
1g2r1y
1g1r1y
χ978
χ870
χ822
χ485
p、efs
22qq34
ends-pcr
kaiser
permanente
kpsc
freeareas
includedexpert
allelically
irradiation-and
hochu-ekki-to
keishi-bukuryo-gan
ppv-alone
lactulosemannitol
apoptosis-driven
interleukin-1β-producing
reovirus-based
oc-mediated
tumor-infiltration
outcome-adaptive
deep-seated
last-ditch
cd73-adenosine
ecto-5-nucleotidase
ectonucleoside
diphosphohydrolase
rerandomization
64xa0
radiologicimaging
treatmentoutcomes
nct02130557
ala-based
kms18
slc36a1
slc15a2
therapists
gm-csfinterleukin
il-3il-5
signosomes
leucodepletion
optia
idl
leucodepletions
936ct
rs1531289
rs1870377
rs2305948
time-of-flight-based
cross-analysis
cd-11b
cd-13
cd-33
cd-7
cd-4
aimf
myeloma-promoting
holobiont
multiomic
mycobiomes
hypervirulent
pathogenomics
velutinosus-specific
aspartyl
proteinases
fut2
mycobiome
α-diversity
genome-level
host-infecting
holobiont-infecting
fda-mandated
49u2009×u2009109l
catheter-associated
-nr
nurse-delivered
filgrastim-sndz
filgrastim-ref
kinaseextracellular-signal
map-erk
binimetinib
scns
patient-by-patient
smoking-associated
glv-1h68
virally-mediated
gsta1a
-567t
-69c
-52g
gsta1b
-567g
-69t
-52a
gsta1aa
gsta1ab
gsta1bb
bustling
t-cell-targeted
cr-28
cr-b
biomarker-panel
msc-administration
products-polymorphisms
rs4135385
rs11079571
rs7832767
cmlcml
8-item
conductedfifty-eight
ratepoor
dysmorphy
ds-leukemia
eortc-qlq
c30
aggregatedmisfolded
double-membrane
damagedsuperfluous
myeloidplasmacytoid
nafp
tafp
tafp-conditioned
membrane-intercalating
non-mixed-lineage
sw620ad300
llc-pk-mdr1
sw620ad300u202fcells
abcb1-atpase
tumor-destructive
tumor-protective
ɣδ
vaccinal
brexucabtagene
autoleucel
convene
slide-scanning
welcoming
cellular-level
leukemiainitiating
design-based
sufficiency
triplenegative
mtnbc
prsd
vegf-d
cd3u2009u2009cells
cd8u2009u2009t
smet
ukirish
ukireland
bcr-abl1abl1is
bcr-abl1gusis
material1
r18p11q21
evidence-and
non-empiric
das181
sialidase
cxcr4mut
β--glucan
usehla-haploidentical
meditations
haematologically-diseased
lilacinus
radiosensitivities
icafs
trlmds
large-population
hbv-specific
cd127hi
factorsregulators
leucocytosismonocytosis
cd45cd25
spis
foy
fut
ageu2009u200921
pdgfr-α
1-way
s0313
ld-nhl
stage-modified
nct00070018
myeloblast-rich
proerythroblast-rich
myeloblast-
myeloblastsnonerythroid
proerythroblastserythroid
ases
t-specific
inv16-specific
signalingsmall
cyn
gep-nets
gep-net
vegf-pathway
nmes
nucifora
leuk
rhoades
klampfer
skno
runx1-s291fs300x
runx1mut-transduced
cd34cd123cd45ra
cbipsc
runx1mut-upregulated
ih-induced
llc1
ih-exposed
subvariants
euus-consensus
ecnm
asm-t
myeloid-monocytic
offs
cd34cd117dim
cd34cd117bri
emp3
azu1
two-site
actigraph
adms
hermes
procas
post-caspofungin
sepsisabscesses
anorectal
sepsisabscess
non-operative
breslow
hypothesis-free
cncs
15q13
age6
hypermutations
nanovaccines
αox40
mannosylated
αpd-1αox40
nup98r
nup98-bptf
bptf
nurf
nurf301
baf3itd
goya
rcos
rco
marlene
diag
nostic
humice
2009-defined
transcript-level
gln751casp312g
xrccmet
tuberculosis-endemic
u-sct
r-sct
ue2f62
255-item
n319
ablb
rassi
vrotsos
cytom
crossed-over
closed-loop
pharmacist-led
amlgrowth
treatmentto
cn-amlthe
in-solution
filter-aided
fasp
imac
silac-labelled
studiesms-based
tp23q34to
relapseprecursor
signalingthe
effectprevious
tolerances
rtradiotherapy
wellthe
responsesthe
studiesfor
histotype
amlfms-like
anti-decay
macif
non-pnh
clonea
carney
hirsutism
lipochrome
inhibin-a
calrenin
complexa
methylationacute
hsctwe
lipopolysaccharide-binding
protein-lipopolysaccharide
acetate-induced
developmentinterleukin
relapsesimatinib
statesevasion
futureacute
cmlto
raav-expressing
oligodinucleotide
raav-cea
cea-tg
pdca1
raav-cea-odn1826
cancershuman
mannernext-generation
antigen-receptor-derived
cllchronic
microdomain
specimensmic2
relapsethe
survivalmutations
resistancecompared
nct00428558in
specificitypediatric
thrombopoietin-mediated
mutationsa
imfcontrasting
4h11
jurl-mk1
ps-1
leukemiagrowth-inhibitory
dermatofibromabenign
non-x
brown-yellowish
scalloped
touton
kp1ki-m1p
xanthogranulomatous
pathwaystwo
myelo-monocytes
ln2
recirculating
show--using
analyses--that
imatinib-responder
eradicatedchronic
patientscxcr4
hil-3
anti-my10
thrombocytic
mixed-erythroid
lymphokineinduction
d3-sensitive
responsewe
jak2mpl-unmutated
respectivelydisease-specific
vfs
complicationsurvivors
lpa99randomized
qifi
therapyduring
patientsdasatinib
vivoaberrant
althe
human-chinese
1p-9q22q-
aco2
arsa
naga
pgd
1p32human-chinese
assaysingle
g-csfwe
leukemiasfrom
futurelittle
possiblea
controlsrecently
cellsleukemic
lineagemyeloid
bmy
chi018
leukemiain
cancerthe
utilitymeasurableminimal
studieslysozyme
mirna-16
pre-mir-
lowa
desirablerecurrent
translationaml
progressionacute
selectionbcr-abl
cellsimiquimod
respectivelywe
ox-2
cd200-dependent
therapya
aacracute
o6-guanine
repairwe
i10q
telocentric
chromosome-10-specific
anaphasea
malignanciesemerging
nonstrain-limited
expedientthe
free-flow
subtypestrail
transitionwe
r-erbb2
lak-resistant
activityantigenic
cd200rs
monocytesmyeloid
cd200cd200r
cd200-specific
cd200-mediated
ppo
syndromethe
therapiesthe
resultsantibody-based
reviewalthough
trialsearly
cd1d--
anti-cd1d
b16ls9
il-10--
amlto
post-progenitor
stnfri
-1563
rhil-11-treated
rhil-11-induced
humansthe
disorderrecent
studiesalthough
efficacychimeric
studyby
aml-0
relapsewe
vanished
licssignaling
amldok-1
hu-pdx
cd34hscs
modelmost
changesacute
early-b-all
smig
cd10cd66c
remissioncd66c
anaphylatoxins
c3ar
c5ar1
bgp
cell-cam
crossreacting
cd34-cd33
subpopulationswe
bhd
folliculin
flcn
c998cu2009u2009g
pser333
c755tu2009u2009c
pl252p
eventsthe
imatinibthe
lymphomasb-cell
intentbiologic
rh-il-1beta
rh-il-6
rh-g-csf
pre-culture
treatmentacute
mechanismto
fap
icc-cafs
icc-fbs
icc-promoting
patientsmyelofibrosis
outcomecyclins
cholangiocarcinomamicrornas
possibleclinically
patientsgenetic
evolutionsetbp1
aspscr1
dvl2
luc7l3
khsrp
parp14
nono
sfpq1
med15
rbm10
aspscr1-tfe3
med15-tfe3
rbm10-tfe3
neat1-tfe3
kat6a-tfe3
neat2malat1-tfeb
alveolarnested
tfe3xp11
papillae
alterationsmicrophthalmia-associated
leukaemiapatients
d324n
leukemiamutations
tp23q34-positive
mutationswe
disparitieswe
tryptase-negative
phenomenonpatients
glycodelin
elucidatedwhen
developedto
amlseveral
demonstratedmonoclonal
lyphocytic
m1-m4
my8
surfacethe
mc-tryptase
asp--val
ds16
sctbs
developmenttwo
amlabstractu3000u3000acute
ether-a-gò-gò-related
hergappears
leukemiasan
im-mediated
blockin
assayin
feasibleinvariant
bl-cfc
pl-plc
pl-linked
5637cm
factorsthe
therapeuticsthe
outcomesallogeneic
chemotherapy-conjugated
go-bound
lekemic
i-auc
cyto-reductive
aml19
clinicgemtuzumab
leukemiato
xmeis1
arches
xmeis1b
xgli-3
xzic3
pre-pattern
antero-posterior
xmeis1a
glizic
pathwaymeis1
antibody-identified
antibody-measurable
empowers
vamp-7
light-cytometric
visualizations
recalibrated
contextualization
diseasesthe
outcomeco-expression
subtypemarginal
organssystemic
drugsb7-h1
parametersclinical
amlanti-leukemic
therapyacute
discussedwe
amlprotein
remissionto
d1-d2
managementthis
disordersin
casesisocitrate
s-hcl
cd72
lyb-2
nonreducing
pulpa
cig-negative
pre-pre-b-cell
leukemiass-hcl
dfsacute
transcriptsthe
plateletperoxidase
pro-t-all
t-i
prothymocytes
pathwayswe
mrdmutated
paperthe
patientsaberrant
triple-marker
cd66-
time-saving
less-informative
proceduresthe
plasmocyte
relapsethis
pro-pre-b-myeloid
leukemiascell
leukemiassurvivin
leukemiasfifty-seven
acid-differentiated
regulatedadherence
leukemiasprogress
antigenst
constituve
intereference
relapsea
chemotherapyrearrangements
effectivea
other-lineage
antigen-free
heterogeneitythe
myd116
63-amino-acid
regan
leukemiasa
patientscurative
lesionsthe
lymphoplasma-proliferative
cisplatinproliferating
amlaberrant
managementthe
lacto-n-fucopentaose
mpalmixed-phenotype
mll-cyclic
domain-swapping
tafii250
domain-swapped
subtleties
phenotypea
nct00266136a
gmp140
endothelial-leukocyte
leu-8
lec-cams
sialyl-cd15
leukemiaheat
transplantationwe
actins
actg1
3d-structure
detectablerecent
favourablegemtuzumab
scoreswe
cd8alpha
cd8alpha-
treml4
metallophilic
nondisjunction
translocationwe
cmlpurpose
efficacyflt3
wphi
scd14
scd163
patientsmicrobial
treatmentthe
treatmentvγ9vδ2
pcg14
therapyone
warrantedtargeting
retentionin
nox2-driven
amlimprovements
dimethylsulfoxide-induced
tlr4md2cd14
md2cd14
expressionneutrophils
datastudying
mucin-domain
tim-3-
mylotargrelapse
positively-selected
cellsthis
characteristicsto
duplicationthe
lspcs
adcc-facilitated
csl362-mediated
csl362-induced
controversialoutcome
mylotargthe
cd11bhifhily6clo
mhc-iilo
mhc-iihi
phd2-haplodeficient
better-oxygenated
phd2-
better-oxygenized
m-mulv-infected
m-mulv-based
nihswiss
anti-beta-galactosidase
nondescript
osteoclastsearly
rearrangementsphiladelphia
g-csf-negative
pxa0xa0c
indoleamine--dioxegenase
8-azaguanine-resistant
knowninterleukin-3
amlave9633
post-smd
cmll
casesclonality
ser-4
fc-receptor
l3t4
coxsackievirus-adenovirus
anti-pan
ctc-positive
marker-dependent
patientscirculating
anti-vegfa
fs120
fs164
fs188
fswt
fs188wt
vegfr1-dependent
plgf2
anti-vegfvegfr
vegfa-targeted
chemotherapywe
therapycd33
wt1-negativethe
granulescancer
cancerto
macrophage-associated
maas
ki-m1p
ham56
ln5
ki-m4p
dako-drc
1-antichymotrypsin
enzyme-cytochemical
ki-my2p
lineage-sca-1c-kit
macrophagessignificance
macrophagescancer
aacrthe
vegfplgf
angio-index
tie-2vegfplgf
prognosisbone
riskthe
differentiationnine
therapiesacute
gd2-car
gd2-car3
cyflu
pxa003
pxa03
cd45cd33cd11bcd163
pxa0126
lymphocyte-population
cellsrecent
cellsnatural
feasibleseveral
diseaseour
studiesgemtuzumab
characteristicscytogenetically
infusionsone
amlcd56
mutationsflt3-itd
observationcertain
outcomeexpression
resultsthis
featuresvacuolization
specimensaccurate
hla-drcd14
cd200high
patientspatients
death-suppressor
bax-alpha
proteinsalthough
therapeuticallythe
stratificationpatients
pan-mpo-positive
t-linaege
pro-thymic
mpo-postive
vivo-positive
ex-vivo-negative
vitro-positive
laboratoriescd13
amlrelapse
therapytyrosine
hsctallogeneic
hsnf2
rbap48
hkrt-1
adipsin
signaturescancer
unitwe
dmso-pretreated
atradifferentiating
leukemiashost
outcomewe
patientsearly
cgl-bc
nca-containing
density-gradients
seriesthe
mll-af4-associated
mll-af4-driven
expressionwe
acmlthe
erythropoiesispresence
addressedthe
pbl-dlbcl
multilobated
pbl-dlbcls
agvhddespite
amlrecent
mve
expelling
ltc-dc
ltc-derived
nodesblastic
kleppe
kornelia
polyak
peruses
regimenscertain
agvhdcirculating
kirnkg2a-
hyporesponsive
cd56-cd16p75airm1-
viremic
transplantationnatural
chemotherapycancer
levelstumour
recent-onset
pgpcd34
bcp-glycoprotein
stroma-conditioned
populationautologous
mc38cea2
side-scatter
natural-killer-cell
transcriptacute
postnuclear
cosediment
cosediments
prelysosomal
proteinswe
furtherleukaemic
age62
cellswe
gvhdrecently
lin-hladrdc
erythroidcd34
neutrophilsmonocytes
analyzedadministration
cytokinesthe
tall-
bipotentiality
intactbone
expressionclinical
overexpressionmany
lialpha2sn
u24
ifn-alphathe
amlalthough
cmlpatients
asd-
beta-cell
leukemiamost
ab-targeted
expressionaml
deathac133
pre-adipocyte
doubted
multi-talented
non-pgp-related
actioncellular
remissionfor
cmlflow
marrowsthe
46xx45x
heteromorphism
bmtwe
progenitor-forming
stresshigh
cliniconc201
treatmentbackground
pxa090
u202fa
patientsoverexpression
managementidentification
-derived
unknowna
targetwe
reviewpatients
exploredmyeloid
patientsthis
significancestanniocalcin1
outcomesthe
b-allsgenetic
stnf-rii
amlsepsis
dec-205
multilectin
dcl-1
dec-205dcl-1
2q24
cotranscription
cotranscribe
intergenically
studiesacute
casessome
killingthe
subsetacute
diagnosisvenous
artfully
transfected-hek293t
s30
s30-t1
s30-t1-dox
treatmentaptamers
antigensleukemia-initiating
cd3d
regioncytogenetic
patientselderly
p815ab
tumorself
cotransferred
tryptophan-degrading
cd40-modulated
mimotope
diabetogenic
micethe
procalcific
diabetesacquisition
amltrace
gadd34-related
peg-3
gadd34-induced
gadd34-mediated
raresistance
grb2-related
gads--
slp-76
agentsthe
practicebiomarkers
beta-interferons
anti-jun
postreceptor
inhibitionthe
-h2
aml-m5differentiation
assessmentthis
chemotherapypalliative
patientstyrosine
dateacute
differentgenomic
9qq11
xqq
bcr-3
chromosomesthree
three-line
cympo
studyto
bsab-driven
n297a
k322a
amlantiapoptotic
pd-1-mediated
cytogeneticswe
decision-makingkinase
lscshuman
genesdrug
paleclear
-v600e
inaspirable
unrepresentative
caseshairy
plannedthe
leukemiast-cell
sctalthough
111in-
90y-labelled
comparisonthe
patientsvaccination
infectionstargeting
wsu-bl
igm-lambda
bl3
bl4
myeloidmonocyte
providedparaffin
treatmentthis
protein-signal
ccacholangiocellular
markersa
stsem
infusates
late-infectious
autograftswe
cmlmacrophages
m3dc
phentoype
ontology-based
recalling
patientscytogenetic
cellthe
detectionthe
mast-cell
disorderssystemic
cd14-high
cd14-low
cgvhdallogeneic
3-fucosyl-n-acetyllactosamine
oligosaccharide
granulocyte-specific
granulocyte-associated
desialylation
neuraminidasethe
mdr-1-encoded
p-170-
p-170p-170-
strategiesbone
chromosomea
alphagalcer
alphagalcercd1d
perforingranzyme-b
nkt-cell-mediated
anti-hiv-specific
hd-ctx
rhil-3-treated
anti-nerve
srebp-1
pgc1-α
outcomesto
-branched
alpha-d-mannoside
trimannose
mannose-specific
fitc-dx
monomannose
exdocytosis
concatenation
cellsmacrophage
oncogenewe
investigatedexperimental
inhibitionresults
cd11bcd15hladr-
patientsconclusions
aacrpurpose
5c2
discussedto
dchip
gcrma
biology-oriented
researchersintensity
rc2a
cytofluorograph
cess-b
anti-rc2a
rarc2aad
anti-u937
rau937
cytofluorographic
significancerabbit
hyaluronan-binding
hyaluronectin
hyaluronan-coated
anti-hyaluronectin
hyaluronectin-producing
monocytesa
trialsinhibitors
idain
monitoringoptimal
38-channel
glutamates
polyglutamatestotal
gghfpgs
outcomedecreased
markerminor
cmlin
paraffin-section
tingible
cd163-
sarcomaparaffin-section
therapytumor
malignanciescd200
differentiationmicrornas
insq11q34q21
tuple1
22q11an
jiang
vivoneoplastic
monitoringin
leukemiamast
malignanciesderegulation
t22p14q34q
22q--4p14
4pq34
abl--bcr
leukemiafluorescence
my-b-lineage
my-allamong
amlmultidrug
leukemiaswe
definedrecently
leukemiacd34
risk-stratificationsirt2
h1neo
cd34cd71-
inhospital
erk5-targeted
anti-erk5
macrophagesthe
studythe
ei501
tq32q13
nadph-oxidase
pu1indirubin
stainsthe
hybridation
dlidonor
patientsseveral
lacto-n-fucopentaose-iii
lnf-iii
marrownormal
richacute
t-lineage-associated
amlprogress
treatmentan
cbf-amlthe
dcil-15p38inhib
th1th17
anti-il-10
transplanta
-add
generecently
cross-evaluation
protocolsflow
significancescd30
ot-2
n-hydroxy-nor-l-arg
t-allthis
progenitorsan
clonescant
cd33cd11bcd14hla-drlow
llnl
b-lla
t-lla
were1
66t-all
responsemultiparameter
vitamin-treated
ctr-cdna
oh2d3-differentiated
promegakaryoblastic
meg-j
bin67-isotype
16-amino
t47d-type
kuestner
cellscertain
1st-4th
shorter-term
personalized-medicine
assaysthe
diagnosistwo
malignanciesgenetic
ngftrka
pd-1cd4cd8
cd57cd62l-
esam
hematopoietic-reconstituting
esamhigh
collagenase-treated
cellsreliable
cmlosteopontin
interactionsleukemic
regenerationacute
profilingcell
toxa0explore
virus-1cd4cd56
triphosphate-binding-cassette
cellsto
triplegia
therapymalignant
120a
120b
receptorstumor
amlnumerous
variableone
practicetobacco
warrantedstudies
hv-dcs
deal-
casesfor
tetraspan
cd34cd82
haemopoiesiscd82
ms4a4a
ms4a
fcrβ
ms4a2
htm4
ms4a3
lymphomams4a4a
investigatedthe
cellsprevious
hemosiderin-laden
reticulincollagen
bu-treated
antigen-pcna
gsa-i
gsa-i-positive
patientsallogeneic
leukemiacml66
thr617asn
helix-helix
differentiationto
jak2--a
disorders--distinction
pv-exclusion
progressionaccumulation
2018acute
hemic
lineagein
tumorsacute
trans-vivo
tvdth
pap-specific
cd8ctla-4
il-35-dependent
il-35-secreting
therapeuticsafter
fcmdiagnosis
46xx46xxtp36q21
46xxtp36q21tq32q21
tp36q21tq32q21
leb
alpha-n-3-acetylgalactosaminyl
tp36q21at
cd34cd38cd19
cd34cd38-cd19-cd33-
vivoexpression
quinoxalin-2-one
p18-deficient
inhibitorsbecause
algorithmsthe
histoprocessing
diagnosisthe
proteinsrunx1
studya
han-pc1
amlinappropriate
diversitytrisomy
infusedin
methodologywe
anti-leucocyte
haematosarcomas
chemotherapyacute
progressiont-cell
wordsinformation
factorthe
flaer
flaer-alexa
fluor
cd157-pe
fasccanto
cd157-flaer
cd157flaer
cellsacute
effectin
importancemicroarray
cytokine-associated
vitro-elicited
vivo-induced
prosaposin
vitro-activated
ambiguityacute
amlnucleophosmin
transplantationchemotherapy
ccr1low
ccr2low
ccr3low
ccr4intermediate
ccr5intermediate
ccr7lowintermediate
cxcr2low
cxcr3intermediate
cxcr4high
groupsnormal
17f11
processthe
productionamong
cr1the
il-2ra55kd
hgm-csrf145kd
csfr145kd
cd120a
tnfr55kd
cd120b
tnfr75kd
cd121a
80kd
140kd
cdw127
75kd
cdw128
il-8r
cd130
platelet-large
p-lcr
thrombocytosis-related
abovewe
eoccyclin
implicationsa
dataflow
patientshigh
5q-qter
backcrosses
5q23-q35
limb-girdle
diastrophic
treacher
tq33-q34q11
leukemiasthe
significanceacute
relapsebone
persistenceactive
disrupteda
mutationisocitrate
fortilin
mcl1-interacting
serum-stimulated
sirna-fortilin
sirna-mcl1
fortilinr21a
fujise
-47549
cellsmyeloid
saas
shg62
shg66
egfbfgf
gythe
saa-specific
saas-specific
hereover
therapiesmost
hbms
desulfation
megakaryocytopoiesis-inhibiting
il-9-fold
desulfated
megakaryocytesadherence
ceacams
21qq
amltwo
anti-pdl1
ig-containing
responsesin
u-sf
serum-dependent
clone-1
vitd3-
signalinghigh-dose
cellslow
perfluorooctanesulfonate
pfos-associated
core-functional
leukemiaperfluorooctanesulfonate
cd56-cd16
cd33bright
cd57nkg2a
cd57nkg2c
subsetsectopic
rottweilers
bernese
retrievers
cd11d-
snap-frozen
chromosomeblast
studieddiagnosis
anti-flt-1
myelomonocytes
plgf-dependent
mrdthe
myeloid-positive
capacitiesthe
incleukemia
mrnato
strategiesprame
cells-tissues
mif-sirna-loaded
m5bacute
mpnthe
prothymocytic
unsynchronized
two-parameter
leukemiawestern
46xyt9q31q11q34
hindiii-ecori
chromosomescytogenetic
precursorslangerhans
actionthe
scoresserum
yt
constructenthusiasm
drugsalterations
actin-bundling
sinus-lining
veiled
deficient-mice
cell-membrane-bound
diseasestudies
reviewedearly
crisisa
mk-8628
cohortbromodomain
bcl11b--
bcl11bffcd4-cre
reg3β
dedifferentiating
cardiomyocyte-dependent
osm-induced
osm-secreting
67a4
9c4
9c4ga-
9c4ga
e-cad-positive
e-cadga-
e-cadga
polychromatophilic
column-purified
9c4-
anti-ga
9c4-positive
e-cad-
cfu-e9c4
stagesthe
patientchronic
anti-carbohydrate
antigenicities
ra-hl-60
n-acetyllactosaminyl
y-hapten
1----r
sialosyl-x-hapten
lacto-series
sialosylated
lactosylceramide
fucolipids
fucogangliosides
induction-dependent
functionglycolipid
strategiescancer
rpj3
126-bp
duplicon
orangutan
human-chimpanzee-gorilla
duplicons
translocationa
mll-af4-dependent
af4-dependent
cancersthe
downregulationendometrial
investigatedin
neoplasmstherapy-related
transplantwe
cellsgene
genespreferentially
amlnext
lactic-dehydrogenase
m0ml1
durationsthe
outcomehistone
etpearly
neededleukemias
genesto
resistanceacute
t-lineage-affiliated
casethe
n-cadherin-
-g1
anat
incin
metastasis-incompetent
metastasis-refractory
marrow-specific
lymphoma-related
d4mit21
d4mit53
tlsr5
tgfbr1previous
tgfbr1
baryshinkov
vi-series
vim-12
vim-13
vim-d5
ico-gm1
ico-g2
e-receptor
myphall
leu19
vla
anti-leu
effectorsthe
inositol-5-phosphatase
bcr-abl-gfp
ship--
cd34-lin
analyzedprevious
antigensa
thoracopulmonary
askin
del13
tp22symbolsee
text3
shortthree
csc-1
bgmk
cem-ss
k-resistant
and-sensitive
markera
indicatorflow
nucleophosmin-anaplastic
sigm-stimulated
functionalthe
approachthe
random-bred
ho-
non-thymic
examinedexpression
issuehigh
completiona
researchepigenetic
relapseless
il-4-dc
ifnα-induced
mutz-dc
societywe
propertieshox
follicular-patterned
microcarcinomas
allo-responsethe
hla-dr4-h2-e
ltcl
histiocytet
dlbcl-hat
hodgkin-like
hrs-like
crippled
mana
understoodthe
synthesisthe
knownabnormal
ldquooncogene
addictionrdquo
crossroadscrosstalk
pathwayshistorically
time-integrated
tiacs
biodistributions
iterated
determinism
studychromosomal
therapieswe
cellsa
t-score
sctwas
pyridinium
sctbone
jcm2
cellsbenzoporphyrin
signaturelong
casesto
quinoline-3-carboxamide
onlymyd88
compartmentalisationthe
compartmentalisation
carcinomamyelosarcomas
rhtnf
expressiontumor
antibodiesa
cd1acd14-
flt-3-ligand
cd1cd14-
experimentswe
activationthe
3-integrins
lfa-169
1-integrins
vla-123
vla-51
2-integrin
lfa-157
2-integrins
vla-43
vla-29
stateinteractions
hereinwith
transplantationdna-fingerprint
regimenon
ltdacute
findingchronic
transplantalpha-interferon
networksthe
i-matched
lymphocyte-leukemia
hla-a-b-c-restricted
lymphoblastoid-cell
leukemiaclinical
30overweight
observedthe
survivalwilms
populationthere
tiltam
contextpatients
tthe
subdiploidal
all--189
all-prob--19
all--139
all-b--5
all-t--26
aml--34
3--acute
2--biphenotypic
asynchronic
all-prob
all-t
all-prob--18
all--137
shortest--in
leukemiaecotropic
cell-surface-marker
cellsmost
neededacute
rap1gdsq21
tq21p15
tq25p15
10q25
nup98-add3
add3-nup98
rap1gds1
nonhomeobox
leukemogenesisthe
aml-m2there
amlpediatric
divert
cxcr3ligand
remissionsgiven
perturbationthe
tcr-delta
sildb
taldb1
tcr-alpha
taldb
retricted
analysischromosomal
etiopathogenesispediatric
regulatory-protein
kinase-kinase
topologies
cellsunderstanding
potentialdespite
lineagetwo
leukemogenesistransient
tissuesthe
l8313
gm-csa
stil-3
granulocytosisthy
cd68kp1
cd68pg-m
terminal-deoxy-nucleotidyl-transferase
cd61linker
leukemia-splitting
monoblasticmyelomonocytic
supra-maximal
therapymyeloid
vivopatients
definedregulatory
patientsash2l
relevancecd56
criteriathe
cd4cd56cd68
22-yr
angulated
cd45rb
negativehematopoietic
filgrastimchronic
lewisx
trisaccharide
fc--lytic
fc--treated
beta-genes
featuresamong
aminopeptidase-n
granulocytescd13
feverto
responsepreviously
cd30v
cd30l
mechanismsproliferation
leu9
t55
okt16
ahig
cellsphenotypes
cohortreceptor
purposesthe
-2-hydroxyglutarate
-2-hg
-2-hydroxyglutaric
non-hyperplastic
-2-hgl
subpopulationthe
subtypesalterations
analyzedacute
highlightedmyeloid
anti-cd80
discussedthis
databasemyeloid
peptide-β-glucan
recurrencea
amloutcome
cllthe
origin-presenting
marrow-mnc
thawn
xvivo
-fl
macs-depleted
factor-alpha-containing
amlhealthy
dc-contact-relevant
feasable
anti-leukaemia-directed
amlfunctional
logmultiparameter
cd300a
cd300
aminophospholipids
transformationpolycythemia
cml-cb
notedblast
multimer
seldi-tof-ms
approachesclinical
1pd-l1
managementacute
pre-angiogenic
clonedasatinib
leukemiahelicase-like
risk-stratificationmitogen-activated
abnormalitychronic
amlflow
chemotherapyolder
cytogeneticsthe
ccn3
kinasechronic
ssx-1
hom-mel-40ssx-2
hom-tes-14scp-1
scp-3
rt-pcr-analyses
ct-genes
scp3a
hom-mel-40sxx-2
ny-eso-
vaccinescancertestis
mutationgenotypic
progenitorself-153
b-lineage-associated
consideredten
investigationcostimulatory
samlbackground
leukemiaamlto
subsetsthe
sezary
lowest--in
n-acetyl-beta-d-hexosaminidase
alpha-d-mannosidase
beta-d-glucuronidase
disordersactivity
pre-pregnant
sema7a
integrin-
pdpn-dependent
sema7a-knockout
cancersignficance
patientschronic
cd34lowcd33high
cd11bhighgm-csfrhigh
cd4cd34high
cd4lowcd34high
cd4highcd34high
transacetylase
predifferentiation
dyad
dse
-318
-296
in373
maxmax
apoptosiswe
approachesacute
wt1mutflt3-itdposto
outcomebcr-abl1
cellsmyeloid-derived
deathmost
differencesalthough
5area
minisequencing
researchhypermethylation
ki-24
entitiesmyeloid
m2baso
usedradiolabeled
nontwined
nonconstitutive
vd2-dd3
abnormalitiesan
b7-
sequencingdefinition
therapyalkylating
arylsulphatase
malignancylysosomal
researchthe
fbt3
tn-positive
polyagglutination
progressionexpression
213bi-radiolabeled
patientspreclinical
penta
mpzf
vlig
vkappaiv
p80
vlg
vkappai
vkappaiii
vlambda2
vlig-transduced
vlig-based
malignanciesthe
antibody-bound
gogemtuzumab
angio-regression
ecincreased
b-allin
progressed-transformed
progressioncancer
leukemiatyrosine
cscsaccumulating
pvwe
early-t
late-t
pakistanacute
myelofibrosisthis
histopatholology
reviewedthis
glioma-induced
mdsto
sesame
oil-treated
chemical-treated
hypolocomotion
harderian
etiologiesleukemias
diagnosismultidrug
i-iiia
neoplasmatic
responsedendritic
progressionvarious
amlleukemic
counterpartthe
nsclcabt-263
cancerinterferon
cancermultiple
anti-cll
tcr-vβ7
mhc-like
modulationchronic
d5s166
bacs
sequence-tagged
d5s479
d5s500
5qloss
cml-myeloid
mf-myeloid
cml-lymphoid
discussedthe
amlcalicheamicin-conjugated
graftspositive
strategiesin
amlserum
approachesmyeloid
characterizedthe
lgblpd
caldesmon
ninjurin1
anti-cd58
tfpi
groupsthe
25a11
anti-cdcp1
cpto
pathologistto
cd66a
cd66acyt
pp60c-src
reprecipitated
tyr527
dc2s
dc2-associated
lymphoid-appearing
diseaseinitially
outcomealthough
cd13aminopeptidase
mediateda
antiproteinase
occurredproteinase
centimorgan
b-related
emphasizeda
reportedepidermal
abl-signaling
ccmut2
candidate-based
muc-1
go-201
pathwayschronic
aacrbackground
cmlimatinib
approachacute
amltumor
microenvironmentthe
ch-f42
2h4
sialated
glycoproteinwe
formationthe
discontinuationchronic
aml-m6v
sialyl-tn
aml-m6vflow
barriersmyeloid
antibodieswith
antibodygemtuzumab
leukemiab-cell
periodbiphenotypic
myeloperoxidasempo
cell-acute
cd3c
leukemiaanll
cd3cd22cd79a
biclonalmixed
identificationthe
amlsignal
amlww
progressionthe
treatmentwe
therapyanthracyclines
lin-hla-drcd56-cd123cd11c-
lin-hla-drcd56
lin-drcd56cd123cd11c-
pdc-like
pdlcs
pdlc
pdlcpdc
discusseda
cd34hla-drcd33cd13
del7p13-
tq10q10
utrastructurally
mhh25
rpmi1640
establisheda
glu-cer
1-phenyl-2-decanoylamino-3-morpholino-1-propanolol
kg1a200
k562mdr-1
lac-cer
monosialo
disialo
pdmp-treated
pdmp-mediated
phosphorylationprevious
tipifarnibto
mucin-1
glycoforms
patientspresent
bmwas
abnormalitymulti-parameter
cd10calla
pvu
gliomaastrocytoma
transformationthe
tq21q23and
tp32q23
b4cd19
callacd10-
smlg-
cmu-
ba-2cd9
vim-d5cd15
breakpointeight
varietiesa
lscsconsiderable
trailthe
bxa0cells
cd40tlr-9
cd40bcr
cd40bcrtlr-9-dependent
cd27-igd-
extra-follicular
cd40tlr-9-dependent
apoptosis-prone
revaccinations
mesonephros
nonhaematopoietic
embryosit
chemotherapythe
semht
serosal-based
candidateswilms
gpbbto
cd14-derived
patientsdendritic
mpdthe
applicationleukemia
patientsdespite
multiplication-stimulating
antiinsulin
radioreceptor
g-100
rnaase
-potent
tib-49
taken-up
evsmyeloid-derived
viabilitym195
nonmegakaryoblastic
hyperlobated
balm-25
nu-b1
l3-type
igjh
ckappa
clambda
addxq
add3p
add7p13
add14q
marl
mar2
mar3
marinc
particulara
effectsallogeneic
topoii-inhibiting
sinealu
linel1
quercetin-exposed
leukemiasgenetic
sctcd8
scd80
ctla-4-ig
es-ml
colon-26
rifn-γ
tnf-transfected
tap1-deficient
tap-deficient
patientswhile
two-rounds
unclearhybrid
advancespatients
si6
speerately
classificassion
signgle
mothis
mute
genesthe
tumoursneopterin
leukemialong-term
amldecitabine
viral-induced
discussedconcordance
undiluted
peridinine
percp-conjugated
dver
vitrothe
okb2
call-negative
cellsas
trialsmany
ctcsf
fecgm-
fecg-csf
cd34bm
presursor
pv-90
q11p13
p13q21
pp13
leukaemiawe
etoposide-stabilized
etoposide-initiated
significantlyrearrangements
neoplasmsdeletion
patientsgastric
deltanoids
deltanoid
ketoconazole-deltanoid
precursor-t
eta-kdel
cd33-eta
potentiala
leukemiacore
subgroupflt3
neckmyeloid
differentiationl3mbtl1
single-use
therapydendritic
themfor
fosjun
genes--myd116
myd118
family--play
wordsby
patientsprotein
statexa0information
forxa0transposase
diseaselineage
researchwt1
profilepivotal
ghrf
d20s22
rbl2
q-q
hemopoiesisdeletions
single-analyte
dnarna-based
tier-1
cd49dcd29
pbx1acute
leishman-stained
simultaneouslycytomorphology
imfsince
kg-1-derived
linedendritic
failedbcr-abl1
systemac133
diseasehuman
mddscs
foxp3u2009u2009tregs
pakt1
pfoxo1
mfa1xa0expressing
foxo1-target
chip-assay
oscc-p
fimau2009u2009p
pg-mfi-induced
pakt1-pfoxo1
mfa1
fima
fimbriae
dc-signhicxcr4hi
pakthipfoxo1hibim-lowfoxp3hi
idohi-
treatmentmost
hcgbeta
cpipp
hcgbetahcg
hcgbetaa
amlthere
organotropism
atps
poly-n-isopropylacrylamide
itaconic
copolymerized
ligand-conjugated
8000-dextran
t500
antibody-polymer
antibody-conjugate
reusea
cutisthe
kinasesthe
system-aml
resistancehistone
amlflt3
cancerimpaired
ominouswe
sarcomasgranulocytic
blaststhe
testedstem
amlannexin
tem1cd248
cd248
cd248-based
d11s470
d11s860
nup98-rap1gds1
armadillo
malignancywe
identifydevelop
mitochondrion-localizing
anti-cis
tan-iia
5-dimethylthiazol-2-y5-diphenyltetrazolium
translationally-controlled
caspase--3
futuretanshinone
th2-associated
mediators--including
aams
tgf-β--were
generically
junction-associated
claudin-1
cldn1
cldn2
helminth-infected
trypanosomiasis
cancerslandmark
cpdr
erg-mab
erg-positive
lymphangiomas
angiosarcomas
hemangioendotheliomas
focal-to-extensive
settingserg
deduction
canalicular
56c6
lymphomaswe
egf-receptor
erbb-receptor
leukemiaepidermal
a-positive
sameproliferative
formalin-
b5-fixed
formalin-and
samplesparaffin-section
monitoringwe
t-helper-1-associated
markerminimal
frequencyreciprocal
amldespite
agentsacute
membrane-impermeable
sulfo-nhs-ss-biotin
aplthis
n-myc-driven
proteinssignificance
aacrenhanced
t16
cd34-mpo
cd34mpo-
3-beta-d-galactosyl-transferase
polyagglutinable
tn-specific
progressionexposure
breakpointindividual
presentedthe
o-sialoglycoproteins
35-s
treatedhl-60
tconv
dot-plots
hypergranular-
microgranular-type
recurrenceour
suspicionblastic
gal-1
settingwe
macrosialin
markermonoclonal
cd80-dependent
strategiesthe
paracrineautocrine
receptor-3this
pge-2
myeloidm
ulb
cellsdendritic
hpaii-digested
radioactive-
fluorescein-labelled
amplificationclonal
evolvingmyelofibrosis
pgpusing
optionsthere
timecd71
blin-allzeta-associated
blin-all
changeswe
t-biphenotypic
leukaemiabiphenotypic
leukemiadepletion
importantin
cancerit
lc-characteristics
idc-specific
lc-specific
bcrp-induced
lc-like
relb
mutz3-bcrp
progenitorsepidermal
criterionin
lymphoid-expressed
patientsnormal
cd30ki-1
nonembryonal
leiomysarcomas
fibromatoses
lipomas
liposarcomas
ganglioneuroblastomas
cbaxdba2
modelthe
diagnosisbackground
ac141
deletionthe
igv-like
igc-like
cgm6
nca-95the
nca-95
medicinethe
rhil-1
characteristicswe
cd13apn
expressionnormal
effectsa
amlnew
wt1donor
pathwaythe
1opl
l--p
g--s
protocolssingle
ccd3-
marrowexpression
apoptosisacute
maturationacute
tp22q32
iso-like
analyzeda
casesmutations
h1s
phosphorylationhistone
cellscellular
ablde
1coexpression
percent2myeloid
tq1q1
tq11p11
frequentwe
all--22
anll--3
hd--12
nhl--6
wilms--10
sa--8
diseaseprecursor
cord-blood-derived
pseudoemperipolesis
12vs
cs1
microenvironmentmarrow
mkb-1
hypo-tetraploid
recombinatorial
al-mrd
t-students
testthe
entitieschronic
cmlalthough
transplantationminor
meis1b
pbx1b
xpbx1b
developmentpbx1
mpnmyeloproliferative
lymphocyte-depleting
post-rist
differentiationthe
monocyte-targeted
polyclonalclonal
markerscoexistence
ebvexpression
hematopoesisleptin
dc-associated
ico-ii
iaico-ii-
yac-based
dpc4
progressdeletions
investigatedcd25
disordersidiopathic
conditiona
diseaseautologous
outcomeminimal
diseasemyeloblastomas
patientsone
chromosomethe
transplantationthe
amlno
futurecerebrospinal
staterecent
3a1
blastsearly
myeloidhistiocyte
biotin-dutp
oxid
bicyclam
sdf-1alphacxcr4
interactionsacute
nonligand
inhibition-inducing
uptaked
cellsmucin1
diseaseactivation
biomarkersimbalances
parasitize
parasitizes
prognosisbcl-2
mtt-95
diversities
m7a
cd66b-positive
nbt-assay
c2m
pgk-1apgk-1b
subgroupscomplex
toxicityadvances
amldistinguishing
failurethe
discussedleukemias
qydpvaalf
hla-peptide
sctcytomegalovirus
cd1ahla-dr
agentswe
cd25-expression
genemutations
disordersnew
developacute
therapyobjective
tlr-4-dependent
dnmyd88
targetsdespite
vdbp
myelodysplasiain
cd34cmp
submodules
pu1sp1
phospho-stats
lscacute
linesto
beta-galactose
agar-colony
remissiona
unknownthe
sparc-defective
differentiationin
homosexual
hla-drla
lama
fti-mediated
fasrfasl
fti-induced
bclxs
caspase-3the
transformationchronic
orosomucoid
haptoglobin2
orosomucoid2
at4
importancethe
cympo-negative
monoclonally
wordsthe
lowobjectives
pb-derived
subtypesthe
b-lymphocyte-specific
k562chronic
patientscore-binding
outcomeit
outcomein
t-cell-related
appurtened
sectionsthe
strategiesnk
tumor-monocyte
ly6chicx3cr1low
presenters
re-educating
phasefor
reportedgemtuzumab
l4f3
cd33-bright
cd33-dull
5f1
anti-cd17
t5a7
cellsninety-eight
pharmacokinetics-pharmacodynamics
fc-fcγr
fcγr-expressing
strain-induced
lectin-deficient
rtb
spodoptera
frugiperda
reassociated
deglycosylated
gmcsf-ricin
asialofetuin
developmenttreatment
alleo
hyper-eosinophilic
hyper-eosinophilia
hesacute
cellscell
controversialthe
caseslymphoblastic
behaviorthe
neutropeniato
patients--frequent
y735s
l347p
malignancieshistone
wehi-tg
q12-qter
cellshuman
lineage-related
diagnosiscostimulatory
cytokine-initiated
flt3flk2stk-1
heat-stable
il-6-stimulated
synthesis-independent
cytokine-triggered
multi-phenotypic
tri-phenotypic
bmyeloidmegakaryoblastic
composant
survivaleighteen
bmtactivated
cmlincreasing
sctseveral
mirna-15a
c-myb-mir-15a
hematopoiesisthe
cmlargininosuccinate
gant61resistance
aacrchronic
biomarker-stratified
utilityclinical
cosegregate
d21s1265
d21s167
malignancylinkage
respectivelyin
allcytogenetic
cellsrelapse
cd33neg
trialsthe
ir938f
cd53-
phycoerythrin-pe
telaml-1
cd28rc
cd28b7
allo-bmtthe
lineagesthe
cellsmyeloperoxidase
geneto
aorta-gonad-mesonephros
region-derived
cellswhile
envisionedrunx1
nct00602771tipifarnib
nct00602771
impactindividual
patientearly
ddcs
cd1a-expressing
vivo-derived
galectinsthe
survivalwe
transfusionsanti-neutrophil
cd44cd24-low
reticuloendotheliosis-associated
rev-a
rev-t
rev-trev-a-induced
igm-negative
rev-trev-a-infected
pre-b-pre-t
heavy-
ct-3-
rev-trev-a
post-hatching
cla-3
5m19
ha-5
interleukin-2-stimulated
bmtclinical
alla
cbas
mrdrapid
amlgenes
14-kda
mrp-14
mrp-8
transmigrating
mab24
mrp-14-generated
amlrecently
patientsdysregulation
cytogenetically-visible
d5s414
il-9-d5s414
disordersloss
cyclingaberrant
neoplasmhematologic
outcomesurvivin
malignancyacquired
changesa
prognosischronic
self-renewalwhile
casesusing
treatmentit
rrebna1
rrp53
rrexpected
ebna5
otherwe
rmss
ewsr1fus-tfcp2
27u2009y
meis1-ncoa2
ewsr1-tfcp2
fus-tfcp2
tfcp2
meis1-ncoa2-positive
fascicular
ewsr1fus
tfcp2-associated
discussedrecently
diseaseacute
subtypesmicrornas
backbone-alkylated
imidazoles
carbene-to-metal
eightnine-step
sonogashira
pearlmans
arylated
buchwald
n-arylation
imidazolium
≈20u2009
4-position
vivothe
practiceazacitidine
tp13q23
ng2-
inv11p13q23
groupmonoclonal
patientsstudy
aels
erythroblastsneoplastic
cd30l-
cd3cd30
cd30lil-4r
subsetcd30
emlextramedullary
chclonal
levelthe
overexpressionprevious
cgm2
cea-like
variantwe
leukemiashumanized
discontinuationprevious
diagnosisin
populationquality
resultsnearly
amlstem
cases-75
cases-66
investigationmyc
anlage
sac-derived
lympho-dendritic
f418
fscs
non-hormone
leucyl-beta-naphthylaminidase
pdgf-alpha
l25
miic
ii-enriched
cd1cd18
icams
cd80b
cd86b
t-dependent
mislead
differenta
challengethis
cellsin
malignanciesassays
mcd83
mclrecombinant
nct02013648in
qfc
psgl-
psgl-1-dim
upregualtion
marrow-transplant
ifn-γr--
bu40
cancertumor
2q-
t2p-
t9q
myeloblastoid
megakaryocytoid-lineage
myelo-megakaryocytoid
coursea
patientsmalignant
dosesbenzene
cmloverwhelming
lqb-a-n-tosyl-5-deoxi-pterocarpan
lqb-223
phagokinetic
lqb-223-mediated
chemoresistance-related
lqb-223-induced
phenotypesdrug
approachesthe
investigationminimal
countrieswe
hemoglobinour
discussedacute
fractionsaltered
bcr-abl-ires-gfp
nodscid-beta2microglobulin--
p210-
amlaccumulating
observedan
significancebecause
drugsdasatinib
myclodysplastic
cd16b
granulocytesthe
bone-marrows
-197
thy-all
anti-all-serum
-113
leukaemiaterminal
cafcs
compartmentsacute
dense-granular-positive
dg-positive
lymphoid-crisis
call-tdt
calltdt
allto
01the
transplantationgemtuzumab
progressionthere
studiesimputation
right-angle
ralscd45
forward-angle
falsrals
rals
patientstumor
cellshalf
therapydespite
cellsit
remissionexpression
αctla-4
αcd40
t-cellregulatory
nonredundantly
evaluationsignificance
seenhumanized
mdslong
t-11
rosette-associated
t-11-positive
cytochemistries
okt-11
-dalton
tp50
amlmonoclonal
il-2-cik
il-15-stimulated
il-15-cik
therapiespdcd2
pit-falls
toolhuman
lineagebiphenotypic
collectionseveral
prognosismicrorna-340
drugsmodulation
expansionthe
abnormalitiescertain
survivalan
cd195
obuense-induced
proceduresa
131-tositumomab
hemopoiesisour
4-demethylepipodophyllotoxin
ethylidene-beta-d-glucoside
parallelism
cellsdna
il15-dc
il4-dc
high-precursor
mart-1-specific
sk-mel-24
leukemialarge-scale
amltribbles
donorsthe
modificationslimited
patientsprimary
platelet-rich
reuptake
ssri
testingthere
dc-t
adaptive-type
transcriptionalthough
obf
memory-efficient
distributional
gaussianity
non-gaussian
moderated
t-testoptimal
predominatechronic
prognosisto
cd14b
m1-m2
cd17
parametersthirty-six
tq22q-12
nongranular
dust-like
casesacute
developmentthe
ber-ep4
ber-ep4-expressing
monocytic-myeloid
sirp-α
phrodogreen
casesearly
dihydropteridine
dhpr
cmin5
malignanciesurinary
microenvironmentin
susceptibilitychildren
agonist-fused
lipidated
rlipo-ova
bm-dcs
cd44cd62l-
rova
cd27cd43
metabolism1
uptake2
glucose3
phosphomannose
rna-interference-mediated
typesit
abmtautologous
viewpoliovirus
pathwayrecent
chemotherapyin
amlit
anti-pd-l1pd-1
evasionpancreatic
tcr-induced
pd-1-transfected
rt-pcrrecently
abo-incompatibilitya
fashionminimal
turn-round-time
fashioned
identifiablewe
inccytarabine
phasethe
attemptsfor
bindingerg
colo-205
hydrodynamics-based
anti-carcinoembryonic
graftingreconstitution
survivalmononuclear
mesothelium
unknownpodocalyxin
f-statistic
maanova
subtypesmicroarray
therapieschronic
i-dc
naiveresting
vaccineprimary
ehe
bcl-2-igh
di-tri-methylated
af4-family
thereto
memoryhematopoietic
toxicityas
classificationthere
practicemyelodysplastic
blastsmutations
entangle
hematopoiesislocally
activitynk
testicular-specific
coagulum
leukemiasnormal
funchisq
many-to-one
fantom5
cancermost
antibodiesrecent
gm-490
biglycan
betaglycan
p75lngfr
il-8ra
il-8rb
rhodopsin
se2
maturationtwo
dasatinibthe
intriguingcd65s
tg-ace
c-domain
tg-nko
tg-cko
interleukin-4rα
c-domain-specific
ace-mediated
substratesproducts
mt1g-overexpressing
nb4mtoe
a12
aml-apc
vaccinesthe
amlsall4
developmentleukemic
samlmyeloproliferative
diseasechronic
hsa-mir-10a
hsa-mir-151
hsa-mir-96
usf2
cmlmicrornas
unknownwilms
vertiginous
diseasetreatment
factorsin
cd34-pos
reportedthe
countwe
slc7a7
ylat1
yl-mediated
cat1
macrophage-differentiated
differentiationl-arginine
folliculogenesis
ewes
earlymidpregnancy
metabolisable
live-weight
slaughter
bouins-fixed
underfed
underfeeding
restrictionthis
antibody-driven
ps-targeting
kor-sa3544
kopn-57bi
cd19kor-sa3544
chaine
techniquethe
adiposopathy
anti-atherogenic
hypoadiponectinemia
lcl-7
a28
a31
self-mhc-restricted
a2-restricted
tcr-restricted
17v
melanoma-reactive
wordsto
cancerseffective
ips-t
cd4-modified
cd40lhigh
helper-like
effectiveanti-leukemic
leukemiacd4
conditionuntil
patientsazacitidine
cd20--
c-mu--
bmyall
tmyall
b-t--myall
azurephilic
featuresmetaphase
gvlbmi-1
ico-11
prognosticallythe
leukemiasinternal
deathantibody-targeted
poxvirus-based
cea-transgenic
cea-transfected
mc38-cea
differentiationrearrangements
amla
patientseph
fcγr-mediated
dr5-agonistic
drozitumab
dr5-mediated
cd40-agonistic
misdiagnosisrecent
osteomyelytis
diseasegranulocytic
positiveph
diseasemobilization
l-8313
troci-bm
diagnosiscompact
e-r
causethe
morphologicalcytochemical
diseasesin
childrenthe
nalm-19
b239
b240
bloodbased
assessmentquantitative
cytotoxicitygemtuzumab
toxicityhum195
outcomepediatric
bcsaccurate
entitywe
particleboard
plywood
carpeting
formaldehydeformaldehyde
allb
cd34ob-rw
observedob-r
hscta
nct00372593cd33
ebvcs
blast-1
51microl
collectionwe
cmlresistance
uncontested
resistancethe
collagen-mediated
anti-cd29
anti-beta-1
rgd-containing
grgdtp
microenvironmentone
articlequiescent
pmic2
013-positive
optionmyeloproliferative
valine-to-phenylalanine
cd34cd38-cd90lin-
lympho-myeloid-erythroid
michalevicz
revel
natn
bi3c5
rfb7
bi3c5my10
lgemlglgm
rft12-negative
lympho-angioproliferative
pbdcs
cd91
mirs-221
-222
erythropoiesisthe
ucb-dc
ucb-lc
ucc-dc
describedcancer-associated
expressionacute
midostaurinadvanced
cellscd117
functionhematopoietic
descriminate
cd45-ssc
leukemiagating
males2
cellspatients
leukemiachemotherapy-induced
malignancieshigh-dose
nanotheranosticsnearly
ig-mu
ig-kappa
t-precursor-cell
lineageon
pvthe
tumorsgranulocytic
unstablechronic
pathology-specific
cd34leukapheresis
cd34l
2cd34
amlcd178
strategyexpression
leridistim
myelopoietins
leridistims
ic96
il-3ralphabetac
rhil-
combinationleridistim
unknownpreclinical
dgkζ
dgkζ-deficient
dgkζ--
aacrefforts
melanomacancer
anti-icam-3
actionexpression
sialosyl-i
anti-i
anti-sialosyl-i
nuh2
i-negative
sialosyl-i-positive
one32
fourten
sialosyl-i-negative
tenten
monocytesexpression
patternstoll-like
bra55
lca-positive
anti-lca
lca-unrelated
anti-mhc
antibodythe
establishedimatinib
genethe
processin
dimethylhydrazide
modelinggemtuzumab
deletiona
gvhdwe
myelomonocytic-associated
emct
β2-adrenoreceptors
β3-adrenergic
β3-ar
sr59230a
lymphoidhematopoietic
cellshscs
ter119
subtracting
featureacute
responsetp53
responsemesenchymal
patientsdyskeratosis
mepacrine
cd62
b-fg
delta-spd
atpadenosine
mpdbleeding
relapsetreatment
1p35
tp35q34
bcr-negative
cgls
cmlclinical
units-granulocytic
toxicityseveral
amlfus1
smith-magenis
idic17p11
i17q-associated
leukemiaan
populationaside
cellst
flt3itdmutations
diseasea
progressionthis
agentsbryostatin
inhibitorspreviously
aimwe
tnbcaberrant
pha-680626
mutationemergence
fal
pna-binding
ficoll--uropoline
mobilizationfailure
anti-mcp
anti-daf-mediated
c9
membranemost
retract
describedwe
polyamine-catabolizing
aminoguanidine
cu-dependent
cuao
nn-bisbuta--dienylbutane--diamine
pao
tetrachloromethane
n1n12-diacetylspermine
n1-acetylspermidine
cuao-induced
myeloid-leukaemia-bearing
deathin
accuracythe
variationacute
mdscsmyeloid-derived
ryanodine-sensitive
acid-alpha
receptorthe
pd-l1hi
advl1412
aldhpos
aldhneg
propertiesaldehyde
calicheamicin-γ1
calicheamicin-γ1-resistant
gocalicheamicin-γ1
therapeuticsgemtuzumab
flmc
differentiationcd7-positive
conditionsto
underwaymylotarg
cellswith
nonadherencerising
mllfoxo3a
rearrangementacute
gag-m
gag-1
phaseto
a-specific
exact-sequence
malignanciesalternative
ur-
-oh2
butyrate-associated
monocyte-directed
cellscurrent
agein
therapyagonistic
desiredprognoses
preparationsthe
zch-ff9-fitcto
zch-ff9-fitc
cancersubiquitin-like
outcomeacute
cd38cd56cd19
plasmacell
maf-mdr-8
tkisbeyond
anhydrases
malignanciescarbonic
cancerscd3cd56-
evolutioncytogenetic
abo-rh-
lakewood
-cd7
type-d
ferromagnetic
supermacs
bergisch-gladbach
clono-specific
transplantationa
regenerationendocan
massgranulocytic
naevi
histiocytes-macrophages
patientsgalectin
cmloxidative
acetone-fixed
helpwe
lymphomasclerosing
suzanne
mutationsin
prognosisacute
faslprlpr
faslprlprhmrp8bcl-2
hmrp8bcl-2
cellsfas-deficient
unknowntwo
therapyseven
variationschronic
progressionrecent
desoxyribonucleic
testingrecent
m1b
positivityt
m2cd13-t
m4cd13
cd36inv16
m5lack
antigendel11q23
erythropoiesisa
blastschemotherapeutic
amlcurrently
observedstrategies
factorscurrent
efficacymucin
relapsecd34
cd45r0
userecently
b-allmorphologic
crcthe
cd1acd83-
cd1acd83
gm-csf-injected
aloneimatinib
mande
parafollicular
cd20cd10-cd5-
neoplasmsthe
template-independent
allfrom
tdt-nonpositive
tdtnp
nonpositive
rearrangementterminal
del12p13etv6
set-nup214-mediated
leukemogenesisset-nup214
amlpoly
pbmc-mediated
hu-mouse
igg2g4
g2g4
anti-cd200-g1
anti-cd200-g2g4
cd200-expressing
patientscd200
diseaseanalysis
methodwilms
qbend-10
timewith
cf-mrna
non-invasively
pathologiescirculating
jugal
anti-cd1a
corium
ratemorphologic
dinaciclibs
mcl1-to-bcl-xl
centromere-
micro-comparative
micro-cgh
mcb
r11p--qq14a
r11p--qq14
potentialthe
amlcytogenetic
cmlhypoxia-inducible
m1-m5
leukemiatwo
sqclc
baxa
markermerkel
group-aml97
abnormalitywe
aff
mllt
11mll
patientstransformation
recurrenceactivation
expressedmutations
cd-positive
erythroblastswe
decadeswe
mpnsmyeloproliferative
inhibitorsgenomic
ponatinib-associated
vaestyrosine
casesfocal
mutationwe
brd4lung
markerleukocytes
icost
regulatorycd4
validationmicrorna
delta-chain
featureswe
reconstitutionthe
caryotypic
b-cllbiosynthesis
vision-
chromosomesalthough
anti-lactofucopentaose
abmttwo
aacrcirculating
respectivelychildhood
ppp1r16b
trps1
jak2asxl1
anti-htlv-i
particle-agglutination
pa-test
hypothesisa
effectbetween
lm-llo-e7
lm-e7
cd86low
post-lm-llo-e7
lm-e7-pulsed
lm-llo-np
tq31q31
tp31q22
der7tq21q13
tq33p15del5q13q31
tq26q25
complexitycomplex
mulv-infected
lengthier
60-bp
ghi75
vmp55
unreduced
futurecaspase-8
kasumi-4
q34q11q13
oncogenesa
sensitivitypredictive
studyanaphase
freezethawing
platlet
signalprolonged
lim-only
tan1
il7-receptor
growththe
amlrefractory
neoplasiasin
retrospectivelythe
predictionacute
chararacteristicshematopoietic
chararacteristics
althoughxa0epha4
epha4-deleted
isografted
epha4-knockout
receptoracute
leukemiacirculating
persistscurrent
presentedconventional
cut-like
cutl1
modesduring
diseaserecombinant
oncologistsconsiderable
leukemialymphoid
leukocyte-specific
py955
py969
dye-efflux
10-times
rhodamine123-pump
anti-p-glycoprotein
modulator-sensitive
feasiblealthough
relevancethe
confirmationthe
treatmentincreasing
importanttp53
inhibitorsrecently
cns-lch
lch-nd
classbispecific
pathwaysthe
subtypecell
rfb-
cd-34
rfb-1
cd-33-
cellsleukaemic
patientsnucleophosmin
positivitythe
leukemiaskinase
anti-kit
kit-specific
ktn0158
lymphocytoses
sil-2
scd4
esterasein
apobec1
lipidsimatinib
therapyrecently
depthacute
diseaseleukemia-associated
applicationsthe
sdf1cxcr4
vla4vcam-1
cd44osteopontin
rs13347
inhibitorsin
cyig-
mll-actn4
mll-11q23
assessmentmll
cexposure
outcomecd7
anti-gata-1-
anti-gata-2-specific
lineagesto
differentiationoma-aml-1
setwhile
ecdlangerhans
casesaberrant
lackingit
determinedthis
renieranycin
bistetrahydro-isoquinolinequinone
bishydroquinone
hq-rm
cellsrenieranycin
sfm-1
imdm
beta-mercaptoethanol
cholesterin
imdm-based
pharmaceutical-grade
conditionsin
malignancymicrorna
p56lck
p60src
p59fyn
lymphocytesin
dlgg
slow-growing
openarray
mir-20b
mir-let7e
mir-454
uncorrelated
adhesioncostimulatory
datetranslocations
-enriched
procedure-
counterpartsin
druga
gnkg168
pu2009promyelocytic
sigirr
il1r8
il1rl1
7u2009r
cd8b
il-37
remissionbackground
significancefibroblast
rt-pcr-amplified
markerswithin
practicethe
tel-pdgfrb
receptor-tyrosine
lineageetv6-pdgfrb
scalethe
haftl-1
ly-1
irrevocable
ly-5
therapiesin
tcr-zeta
cd3-epsilon
dutp-biotin
s2448
p-rps6
mfcthe
cids
cid-initiated
mpl-induced
cid-regulated
amlmutations
mcs-2
bt-my
b-tmy
b-t-my
investigatedto
di-allelic
hla-like
tca-positive
transformationtca
cellscd95
nd2
rotenone-mediated
deathwe
syndromesflow
macrophage-stimulating
dec205
blast-rich
ebcs
cd34cd38hla-drcd13cd33
mdsknowledge
vla-2
vla-3
hcam
usefulisolated
cellstyrosine
tumorsto
cd62lhigh
durationflt3
mutationsalthough
deltex1
phosphatidylinositol-5-trisphosphate
pouring
tumour-targeted
echinospora
applicationsantibody-targeted
eosinophiliasthe
settingacute
testinghomeostasis
patientdendritic
pre-progenitors
pre-cfu
34dr-
cmlmanipulation
notch7
fbxw6
phf7
runx7
mechanismwe
malignanciesin
curator
therapyphiladelphia
therapychimeric
clrs
dcir
tag-72
anti-mr
th1-attracting
mucin-mediated
gf-dependent
gf-independent
recruitmentto
myeloids
lnf-iii--termed
cellsnormal
fab-m0we
hemoglobin-haptoglobin
hb-hp
monocytemacrophage-restricted
glucocorticoid-enhanced
cd163-mediated
nonmembrane-bound
cd163the
reviewedred
33-ds16-ds19
fcγriii
leukemiablasts
bsscfvs
ds19-ds16
33-ds16
thermic
lysisa
cd3cd4cd8
sirpalpha1
sirps
sirpalpha
sf126
progressionmyeloid-derived
α-2a
calr-negative
left-shifted
cellsderived
regiona
targetnucleophosmin
z-tests
learns
jackknife
criteria-statistical
utility-the
pairthree
outcometyrosine
rxrrxr
sr11236
sr11246
sr11249
sr11256
lgd1069
rarrxr-specific
sr11238
anti-ap-1
trepal
situationsthe
ratesacute
aml-ic
aml-ics
promisingwe
inhibitionlin28a
implicationsthe
hla-drpartly
tdtcd13
cd13tdt
follow-uptwo
tissuesto
factorsover
strategya
leukemogenesisrepopulation
fluidto
elucidatedto
tq21p21
invins3q21q26
6pp23a
6pp23
biopsiesan
autosensitization
b-cell-mediated
intra-thymic
d21s65
regionthe
amlobjective
myelofibrosismyelofibrosis
cd40-targeted
vaccinationvaccination
ifn-alphagm-csf
ifn-alphail-4gm-csf
ifn-alphagm-csf-treated
impairedthe
d7s2456
d7s677
noncontiguous
7complete
lineage--five
myelomono-erythromegakaryocytic
monoclonals
nonreactivity
crisisthe
ki67dna
brdurd-labeling
brdurd-li
dtpot
ki-67-derived
ki-67-gf
tb-
tb-all
leukemiacell
pu1-initiated
cancertight
myelopoiesisto
heterogeneousthe
neoangiogenesisangiogenesis
26-gauge
techniquewe
cancerrecently
cervixto
cd3xcd123
re-targeting
nsgβ2m--
mpo-7
km-3
t-all-1
catovsky
protein-altering
graph-based
cellnext-generation
q24q15
cd2cd7
prothymic
lblwe
chemotherapypromoter
implant-associated
rps10
rpl17
rps29
rpl18a
blockadewe
myxofibrosarcoma
grabbing
myxofibrosarcomas
dc-sign--positive
pdamuc1
muc1-tolerant
muc1-mediated
prognosisalthough
allseveral
cd40-stimulating
cellsphiladelphia
hb-sag
examinees
patientsenzyme
mixed-lineal
thy--17
lineal-different-marker
polypotent
precursor-cell
originthe
cd15cd65s
proposalfor
allsbone
patientscyclin
regulationa
leukemiaby
genesexpression
prognosisin
hyper-activated
tgfbr1pten
2cko
cell-to-tregs
p-stat3y705
hnsccthe
amlglobal
co2-dependent
rcg
co2-independent
htb-126
c-glutamine
13c-citrate
13c-malate
13c-2-hydroxyglutarate
idh2-related
13c-accumulation
13c-2hg
idh-silenced
12c-2hg
htb-125
patientsmitochondrial
amllong
nxs2
9464d
th-mycn
patientsrecently
malignancieswe
amlterminal
v10-containing
shareabnormal
mib1
pcna-labelled
omf-associated
haematinic
respectivelygrowth
tgfbetasmad-dependent
cosl
cd30ki-1-positive
kp1-positive
thistiocytic
ebm11
histiocyte-specific
mechanismat
viv
maturationwe
listmode
forthe
deae-sephadex
globo-
ganglio-series
glc-cer
globotriaosylceramide
gb3
gb4
gb5
asialo-gm1
ga1
gm1b
neuraminic
n-glycolyl
ga1nac-gm1b
controversialrisk
nct00209833to
limitedblastic
outcomescytotoxic
giventemozolomide
n6o2-dibutyryl
hematopoiesisdifferentiation
futurein
hmlh7
hmsh4
patientsmicrosatellite
pmaefficacy
infidelitysix
trialsthis
misguided
re-defined
outcomecytofluorimetric
oh2d-8
clongenic
pbsctthe
transplantationu2009u2009adult
hsctu2009u2009tt
transplantationu2009u2009fetal
nltu2009u2009newborn
ntt
cd62l-cd44
nltu2009u2009ntt
lineagethe
crispr-pooled
spry3
fgfraserk
gsk3a
spry3-deleted
cd11bcd15cd14-hla-dr-
cellsinternal
33-marker
state-regulated
leukemiasunder
l-dcs
dmso-6
cryopreservor
rhil-4
rhtnf-alpha
pre-or
cryopreservations
befor
cryopreservationthis
featurescd56
vivointrinsic
morphological-cytochemical
jvm
cd20-encoding
formationnumerous
l3mbtl
d-lethal3
d-l3mbt
midleg
corticosensitivityresults
gas2-calpain2
calpain2
calpain1
gas2δ
diseasesgrowth
il-6-
lif-mediated
discussedcells
hhsc
cy5
cy-5
alpha-kit
brightest
pe-alpha-cd34
cy5-alpha-kit
cd34kit
cd34kit-
cd34-kit-
cellscontradictory
protein1
relapsesignificant
phosphatase-anti-alkaline
therapiesfour
stratificationcytogenetic
gfd8
b-myb
controlwe
malignanciescohesin
treatmentschronic
caseswe
determineddisseminated
hey1
yihragrtar
fusionsnup98
trialsto
strategiesfms-related
coplots
questionsin
interchangeablethe
zoom-in
mbt-2
effectthe
identificationacute
lipidglycolipid
cd1d1
typescd1
c2-beta
anti-20s
standard2
diseasesbecause
usecd33
discussedcurrently
requiredb-lymphoblastic
resistancerecent
hat-encoding
myst4
ncoa2
myst3-linked
myst3-amls
progenitorthe
promyelo-granulocytes
nalm-1
nalm-16
granulocytotoxic
granuloagglutination
x-haptene
groupwe
amlmicrorna-186
hm57
antibodiesto
pseudoautosomal
diseasepcr
cellscancers
alonein
3-fucosyl-n-acetyl-lactosamine
ssea-i
promegakaryoblast
differentiationseveral
factorreceptor
treatmentall-trans
amldel
non-autologous
cd8beta
tetramer-binding
forwardthe
control--
cp--
bc--
bmi-1glyceraldehyde-3-phosphate
cmlbmi-1
polybrene
nonselectable
situintercellular
differentiationduring
hccgrowing
reasonsa
dtg
preservein
dnaearly
alpha2-beta-globulin
non-identity
alpha2h-globulin
ferritinserum
cl66
phasesmyeloperoxidase
childrenalthough
prognosisa
supraglottis
subglottis
maltabstract
wordslymphoreticular
mdx-11
amlsixteen
carcinomathe
cellselevated
leukemiathrough
leukemiacellular
cd34thy-1-
thy-1acute
eradicationacute
c-1498
anti-flk-1
post-implantation
tube-like
rudimentary
amlreducing
predictionthere
leukemiaamong
assumptionsthe
fluxcytosolic
changesfamilial
leukemiaperipheral
amlinformation
strategytelomere
leukaemiaaltered
regulatoractivator
studiesbasophils
idhi
nm23-h1-mediated
m0myeloidnatural
administeredbone
ech1
pfn1
cd11bly6gly6cint
careobjective
ara-cthe
mf-treated
pbpcmultiple
dataa
knownthe
43-yr-old
carcinosis
discontinuationduring
karyotypemutations
amlmyeloablative
responserelapse
frizzled2
shh-dependent
p-mitogen
wnt3a-dependent
progressiondeciphering
illustratedas
okt11
therapyt
novo-amlto
mir‑155
21-residue
proteinxa0ii
nt21mp
receptorxa04
mir‑p5p
genexa088
proteinxa053-induced
accordinglyfebrile
responseimatinib
cellsmany
rve
erathe
gmcsfil-4
nlgp-dcs
mhcs
hematopoiesisrecent
populationchildren
dcmp-85
n-all
myeloid-aml
lymphoid-aml
therapythree
leukemiascurcumin
outcomeactivation
beta-emitter
90y-ab
human-mantle-cell
needle-shaped
neoplasmsauer
aberrationsto
pathwaysthis
antilysozyme
antimyeloperoxidase
mbcls
mbcl
weak-to-moderate
nonevaluable
resemblesto
amlinternal
blastsconjugate
promisingalthough
diseasesomatic
phosphatidylinositol-linked
lineage-hla-drcd11c
lineage-hla-dr
31-fold
small-intestine
cancermyeloid
sample-gene
heatmaps
metadataaccurate
endosome-derived
t-cell-proliferation
anti-tgf-beta-neutralizing
t-cell-functions
tgf-beta-secreting
ontogenesisa
pathwaysacute
lymphomaschronic
aml-apcs
serum-enriched
vitellus
twig-resembling
cd54--lfa-1
pro-adhesive
cd34-cd43
bindig
mutationsbim
centurythe
therapycytokine-induced
patientshematopoietic
regimensdecitabine-based
nb6
d3following
recoveryperipheral
naphthol-as-d-chloroacetate
evolutionwe
tcases
prognosisplasma
nih-3t3hckit
p145c-kit
phenotypesa
del5q31patients
mutationsacute
unknownsignal
p-oh
cellschemotherapy
dementias
synucleins
γ-synucleins
β-synuclein
β-synucleins
amlsα-synuclein
mycale
hentscheli
32d-ras
32d-
lineageneg
cd45raroneg
cd11cneg
cd116low
cd34neg
pdcl-specific
apdcl
bdca-4
lilra4
mponeg
ccd3neg
ccd79aneg
apdclthe
siglecs-5
anti-siglec-9
siglec-5
targetcd33
abnormalitiesaplastic
ccd18
fcd29
scd15
nonstatic
receptors--including
cd11cd18--were
afpa
lyoplastin
ancrod
piglets
beta-thromboglobulin
beta-tg
processthis
studiescomplete
decisionsimproved
phenotypewe
translocationlittle
patientsclassification
progressionsouthern
supportin
patientsan
gdi
evolutionmany
objection
deparaffinized
synaptophisin
cd68-pgm1
cd68-kp
transposing
factorsflow
lps-binding
mlbp
mcd14
mlbp-expressing
diseaseall
p1-log
typein
expression-profiling
lymphoid-tissue
marginal-zone
nmzlclinical
bat-25
quasi-monomorphic
bat-40
rer-
bat-
amlbat-25
limitedthe
allmembers
misidentification
intraspecies
spi-801
spi-802
misidentificationa
anti-gpiib-iiia
anti-gpib
relatedthe
snx9
progressionin
characterizedcd13
fibroblast-related
platelet-endothelium
hemangiopericytomas
mulvs
10a1
mo4070a
mo10a1
mulv-induced
prothymocyte
processmurine
nkh-1
hematologic-myeloid
ncam-expressing
cd8cd3-
cd8locd3lo-int
coursethe
tie-
sorting-gated
differentiationgrowth
cytcd22
karyotypefetal
patientsmutation
dcsclinical
r796k
elucidatedthe
tumour-permissive
malignanciesnovel
patientsincreased
oh2-vitamin
protectin
linesthe
as-e1high
as-e1low
logas-e1
α-hemoglobin-stabilizing
ahsp
derivationaccurate
consideredwe
karyotypeduring
prognosisrearrangements
three-domain
upari-iii
upari
uparii-iii
uparthe
megakaryocyte-platelet
volunteersusing
syndromenext-generation
sequencing-positive
sequencing-negative
hypereosinophiliathe
chemoresistantthe
cmllong-term
enriched-in-renal-carcinoma
ercdcs
carcinoma-secreted
cxcl8il-8
cancerneutrophils
listeria-based
lmdd-mpfg
m1-polarized
pcmusashi2-numb
diagnosisdiagnosing
anti-ctl-associated
renca-bearing
cp-induced
surfaceoverexpression
chemotherapygemtuzumab
inhibitorsprotein
j11d
rm-lif
rh-lif
lif-induced
cellsfour
subfractionhere
lymphoid-related
markersin
tg-8
levelan
bandloss
arraycghthe
typesincreasing
shiftwe
172-amino
fortilin-mcl1
weidner
mnjoyan
-37438
mcl1-targeted
fortilin-targeted
fortilinfortilin
swall
monocytoids
swalls
cd14negcd19poscd34pos
cd14poscd19negcd34neg
gomylotarg
non-cd33-mediated
go-mediated
capacitymulticenter
disordersdasatinib
il-6murine
transrepress
populationsdonor
confirmationmyeloid
ch-11-induced
htr-9
h398
tnfr1-mediated
utr-1
fasfasl-
signalingrecent
tepw
wpre
piga-deficient
cultureparoxysmal
igsxa0xa03xa0xaxa0×xa0z
46xxtq22q22
tumororbital
therapystandard
surveillancegerm
rarewe
therapychronic
automate
non-hiv-related
fidelio
ibm-compatible
fidelios
heuristics
interprets
leukemiascytogenetic
therapiesglioblastoma
cd33cd
cellsthere
inanll
toolglucose
ib4
hl-60-doxorubicin-resistant
patientscd38
cmlvariants
strategywe
cd34cd90-
cd34dr-
infusedthis
cancercyclin-dependent
hydrolysable
scfvcd33strail
cd33-restricted
cd33-independent
leukemiasgemtuzumab
plb-p
cd13aminopeptidase-n
gm-csfcd13aminopeptidase-n
cpla-lipoxygenase
cpla2
diseaseleukotrienes
pa682
considerationt
dpp4cd26
t-granulocyte-macrophage-csf
t-gm-csf
t-interleukin-3
t-il-3
-il-3
fl-gm-csf
hematopoiesisdipeptidylpeptidase
monitoringacute
cmlas
patientshigh-dose
relapsegranulocytic
dap10
ccr-γδt
ccr-specific
ccr-t
malignanciesdespite
ignite
malignanciesfor
controlsto
self-peptides
self-peptide
lineagehuman
aml-m0m1
analysisto
cd31-codon
hpa-1
hpa-3
hpa-5
prophylaxisdisparities
lcsc
lcscthe
h-rs
anti-monocytemacrophage
x-hapten
h-rs-like
treatmentsacute
leukemogenesishomozygous
algorithmsgemtuzumab
transplantationthis
regimensthis
-cd10
-cd19
-cd13
-cd33
-cd14
pre-fibrotic
leuke
antibodymoab
resistancemdr
ozogamicinrecently
aloneloss-of-function
okt3il-2
okt3il-
cryogenic
okt3il-2-activated
overgrow
abmtin
7q22-q
low-malignant
7q33
sts-markers
shgc-3275
d7s725
7q-region
smzlto
wexa0used
fromxa0rcc
il-1r-dependent
il-1-il-1r
patientsimatinib
unknownleukemia
amlepigenetic
leukemiadisorders
treatmenttmtp1
oncoretrovirus
6bg
cd45egfp
6bgbcnu-treated
cmlphospholipasexa0cxa0δ1
methodsleukemia
compoundthe
cohortthe
liquid-chromatography-mass
gas-chromatography-mass
hgdh
supernatantslevels
microbially
ccl3mip-1α
ccl4mip-1β
cd16dim
cd16bright
cd56brightcd16dim
ccl19mip-3β
ccl21slc
cxcr3cxcl10
cd56dimcd16bright
ccr5ccl5
ccr5ccl3ccl4ccl5
cx₃cr1cx₃cl1
cxcr1cxcl8
chemokine-activated
chak
cirrhosisnatural
rc-2a
cd49f
testedlong-term
pointsan
unknownets2
actionregulators
therapy-
chemical-related
exposuretwo
cd34cd38-cd123cd33cd90-
aspiratewe
all-expressed
ox40-targeting
vegf-f
diseasewe
strategyacute
glandthe
zenkers-acetic
mrddespite
markersmonitoring
amloncogenic
racesfusion
myd88l265p-mutated
cd19cd22lowcd23-cd25cd27cd45cd38lowsmigm
smigm-cd10-cd19cd20cd27cd38lowcd45
b-memory-cell
inhibitorsclassification
amlt-cell
notch1–ccn3
notch1-fl
notch1-icd
k562ccn3
ccn3rccn3
k562control
rccn3
elucidatede-cadherin
aml-m2in
dasatiniblymphocytosis
ratioto
cancerscancer
infectionchildhood
exercise-dependent
cd-9
cd-10
cd-19
my-9
techniquesa
patientsplasma
aberations
potentialacute
amlpan-raf
mrpurpose
nonhematolymphoid
samplesa
conceptshigh-throughput
morphologycytochemistry
instanceall
ambiguousacute
tumorsa
feasibleacute
cdd8
13f6
sialyl-x
3-fucosyltransferase
nonsialylated
3-sialylated
6-sialyltransferase
3-sialyltransferase
6-sialyltransferases
3-fucosyltransferases
sialylationto
prognosisnucleoporin
re-investment
npcr
controlfollowing
amlcd97
cancersdevelopment
leukaemiacytokine-induced
neoplasmsmonitoring
cellscd38
diseasemultiple
cmpdsfusion
rod-shaped
criticizes
mdsjohn
genesflow
chemotherapyseveral
anti-cd200r
cd200-deficiency
cd200r-expressing
hltbmcs
vla6
mac1
2-chain
amlhuman
populationmds
wm-21
fmc-8
transplantationtwo
solubly
fabm4
fabm5
leukemiahuman
seriesto
statusfor
anti-cd3a
anti-cd3b
anti-cd3c
ccd3a
ccd3c
brdu-incorporating
cd1-
mcd3-
co-caps
co-modulates
oedipus
thymusanti-cd3
pegvorhyaluronidase
pegph20
pvha
decompressed
ha-accumulating
kbm3
iap2birc3
bu-induced
bu-sensitive
resistancebusulfan
and--in
cases--electron
antialkaline
pd-2b11
uchlkb5
ln1
ln3
np57
procedureextramedullary
ighg
ighg4
igha
calpha
progenitorsseventeen
csf-1rcd40
reinvigorates
transplantationfetal
unobtainable
bedsidebone
cd48pml-rara
patientsnew
survivalthere
treatmentchronic
therapiesan
igfbp-rp2
iddm
markerconnective
neoplasmsacute
10a1-induced
a1-induced
nct00799799thirteen
tq21p
t4q11p
genesa
patientsextensive
cd33-associated
allin
targetsdifferential
sampleswe
lmp-1ebv
survivalneoplastic
ficollhypaque
lineagebone
modalitiescontext
elsewherethe
v-reler
v-rel
killer-specific
discussedimatinib
ly49q
ly49q-deficient
cell-triggering
itim-independent
itim-dependent
regimensthe
leukaemiathe
aberrantthe
mrp14
cd143
ecgs
mpox
nace
lf-positive
m4b
lfin
patientsmutations
follow-upchronic
tx15p11q22
tx15
levelsnonrandom
mastocytosis-specific
trepans
e26-infected
amv-transformed
e26helper
amv-specific
size-selected
polya-terminating
gag-related
p135
gagpr76
pr180
e26-specific
productsreplication-defective
vbeta-valpha14jalpha281
dx5
cdld
malignanciesc1498
percentageshematopoietic
sorter-fluorescence
factormegakaryocyte
apoptosisthe
monotherapyimatinib
malignanciesto
dc-maturing
scc-associated
cd11chla-drhi
sccto
alltwenty-four
gvhdbetween
amino-propeptide
piiinp
aminopropeptide
vodplasminogen
amlroughly
growsactivating
amk-ckmonosomal
go-201-treated
differentiationchronic
diagnosiscurrently
p11p13
abnormalitythe
leukemiasdespite
therapycyclin-dependent
d7s658
d7s655
patientspartial
organochlorines
abovein
bcr-genomic
mz93
nk-markers
cd3varepsilon
precursorthe
decisionsas
patientsalthough
expectedacute
dataimatinib
hdlm-3
hdlm
ribosomaldna
amplificationcoamplification
rdna-the
5qter
9pter
hd-recurrent
9p2
retroposons
tumor-gene
rearrangementalthough
11g7
11g7r
myelo-granulocytic
g-cfc
m-cfc
hpca-1
lineagea
gp96
pan-specific
developmentfunctions
tollil-1
relapsemeningioma
leukemia-differentiating
ld-1
partially-purified
regulatorswe
wt1-specifc
transplantationleukemia
amlhigh
radiation-inducible
krt14
microvillous
mvl
cd45ro-
patientsdrug
amlsmicrornas
lymphomastotal
leukemiacd44
fa-aml
il-3rα-positive
il-3rα-negative
cd34il-3rα
il-3rα-neutralizing
targetpatients
malignanciescopper
assessmentflow-cytometric
decisionsthe
myoglobinmonitoring
mir-181ato
imdcs
transendothelium
profilin1
escapedendritic
leukemiamicroarray
benefit-riskon
granulomonopoietic
mpolf
cd68cd68
studiesthe
studiesbcr-abl
studymic2
enavatuzumab
anti-tweak
vivo-responsive
enavatuzumab-treated
enavatuzumab-triggered
enavatuzumab-induced
thrombosispolycythemia
2-hydroxyglutaric
2-hga
rs-2-hydroxyglutaric
phenomenex
strata™-xl-a
oo-diacetyl-l-tartaric
xevo
tq-ms
infarctionthis
isac
unanimity
tcrab
tcrgd
ventured
disordersat
cascadeleukemic
analysiswe
diseaserearrangements
ki67a
processbone
fine-mapping
pegasus
ar-coactivator
klk3psa
klk3
sdhab
androgen-ar
sensitivityall-trans-retinoic
il-4-dependent
propels
ra-
cellsnicotinamide
mcl-1to
investigationgraft-versus-host
regulationcd7
inhibitorsalthough
oh2d
trans-differentiate
devastation
focalization
leukemiaapoptotic
mcs2
aml-involving
1939-august
non-japanese
oxygen-rich
3-fluoro-3-deoxy-l-thymidine
¹⁸f-flt
g2s
patientsgenomic
contenteight
futurealthough
cycd13abstract
treatmentmajor
glutathion
disulphide
cellspyrrolidinedithiocarbamate
unclearnotch
evaluatedthe
chinesethe
subjectsmeasurement
microwells
lfa
contact-induced
contact-mediated
proliferationacute
recurrencedespite
cd42bcd61
featuresto
lifeof
laboratoriesacute
informationthe
cellsmyeloproliferative
patientsfollowing
beta-galactosidase-expressing
4-methylumbelliferyl-beta-d-galactopyranoside
p2y
leukemiabiphenotypic
differentiationrearrangement
leukemiaas
myeloperoxidasehistiocytoid
sbinhibition
tanshinonexa0iia
tan‑iia
bxpc‑3
time‑xa0and
studypancreatic
spurs
aspergillosiswe
allosctthis
epics
antibodiesbeckman
predictearly
umpo
uppo
poemcd
poem-cd
iem
expressionthe
at-iii
statisticallyhaemostatic
malignanciesalthough
paf-receptors
paf-rs
differentiationplatelet-activating
specialize
mcmc
dataselection
aml-m0minimally
anti-canine
6cc8
6c8
zap-70-expressing
bcr-stimulated
sykzap-70
cellschronic
mutationacute
decisionspurpose
kwar23
tumor-opsonizing
sirpa
anti-cd70sirpα
therapycancer
leukemiafew
adult-amkl
mutiparameter
gig-1
anti-gig-1
sardjito
diagnosedthe
add14q32
der14tq13q32
3qq
k19
ck19
supportthe
mini-hiv
vif
vpu
supt1
necessarywe
groupprognosis
metal-related
beryllium
aerosols
beryllium-containing
icp-ms
beo
beso4
be-exposed
lifeinvestigation
strategymyeloid-leukemic
issueextensive
clarifiedv-atpase
iif
hsctbackground
ulex-e
testesdoes
tb-lymphoid
pca-1
myelomonoblasts
mbm
recloning
kitmicrobial
hydridoma
self-directed
heteroantibodies
anti-ce
lyzed
hcabstract
kvorjak
macrophagessee
uyghur
themleukemia-initiating
amlmultiparameter
aml-dcdendritic
escalationcalcitonin
cn-amlatp1b1
elsevier
editor-in-chief
il-10cd19
cd127cd25
liannv
apologizes
readership
cytotoxity
chemopreventionalthough
survivaleffective
sarcomaintensified
crisisblast
amlsingle-cell
phosphoserine
detectableevidence
reportedscreening
karyotypesapproximately
40f
elucidatedin
non-cross-reacting
counterpartswe
o-sulfated
sf-mdr
ch-296
provirus-specific
p008
rh-123
rh-123dull
hyperlobulation
cd19-based
cmlb-cll
cd19-cells
ph-b-cell
subsetthe
monitoringrecent
acyloins
hexanal
heptanal
4-cis-4-decenal
discussedconcentrations
125i-protein
a-binding
trans-scirpusin
borassus
flabellifer
her2ct26
her2-specific
t172
tsa-mediated
vpi-double
amlgemtuzumab
rcuda
receptorwe
amlrna-binding
anit-cd52
-as
transcriptionpolymerase
6-induced
anti-ifn-beta
ifn-betainterleukin
vivoalthough
invdelq23
chemotherapeuticsthe
amlykl-40
cytobrushing
individualsduring
discussedin
cd117-cd11b
proliferationthe
cd11bhicd27low
txb21--
txb21-deficient
txb21
cd11bhicd27hi
txb21-
il-15rα-dependent
methotrexatecytopenias
del9qacute
aberrationsbone
remissionsfew
fibroleukin
globule-egf
gene-conditional
pten-ko
signaturesthe
duplicationatp-binding
mastocytomas
blue-positive
avidin-positive
ri-bound
mechanismsintroduction
interestimatinib
reversalin
myelolipomas
cotton-top
tamarin
responsechronic
pathwayacute
46xy44xydel1qdel
methyl-green-pyronin
factorbased
hpv-dna
cd208
cd123cd11c
cd25hla-dr
cd123cd11c-
cd37-deficient
cd37--
hyalinosis
anti-glomerular
iga-containing
transmodulation
lindsley
groupdata
eradicationchronic
cd40lcd154
blastsconflicting
afresh
amlquercetin
proliferationwe
findingsaml
gse47352
analyzedglioma
amlcd
therapiestherapy-related
cobind
possiblewe
sitethe
caseslength
amloverexpression
reaction-related
lineagescanthin-6-one
criticalin
aggravationwe
discussedrecent
schwannian
phosphataseanti-alkaline
sheath-related
perineurial
cd34vimentin
pseudoinfiltrative
cd34vimentin-positive
hamartomatous
dosemyeloablative
1g2
endoglin-specific
44g4
arginine-glycine-aspartic
marrowa
bcr-ablp190
combitta-p190
tumour-maintaining
inactivationpharmacological
childhoodto
featuresmesenchymal
leukemiaflt3-internal
activatorbcr-abl
mrdminimal
camal
anti-camal
camal-expressing
statethe
treatmentsome
all-cell
tumour-injected
cellsgemtuzumab
cytokine-conditioned
ndrg
co-treating
stimuliwe
neededconventional
impactthe
allcontradictory
mtv-50
vbeta6
anti-mtv-7
anti-major
i-ad
i-ed
sag-reactive
dotscan
belov
vega
remedios
mulligan
barber
christopherson
hlda8
proposedin
2008lung
cd4tils
nk-tils
foxp3tils
ncrt
cd8tils
post-ncrt
pre-ncrt
mdsc-tils
cell-damaging
ubiquitylating
huwe1
ubiquitylates
pp5
resistancein
patientsmcl-1
ril-21
tbl1xr1
pl265p
tbl1xr
tnfaip3a20
undetermineda
possibilitiesthe
cn-amlmicrornas
chemotherapyafter
fpca
bcr-ablpredicting
tia-
antigenswe
b-and
allsflow
adenosis
nonpapillary
non-atypical
naa
lesionsapocrine
importers
slc2a
hexokinases
essentialalthough
amlchromosomal
lineage-specificity
promoter-specificity
chromatin-dependence
haematopoiesisthe
phenomenons
cmlmethylation
approachgenomic
chloroaluminum
alpc
mpbsc
photoradiation
photokilling
pbltf-1
targetsacute
amlwilms
resistanceover
petthe
chess-playing
treatmentlong
leukemiacd33
pxd000441as
t20q34q11p13
5-bcr
3-abl
t20
rearrangementchromosome
naphtol
cloneswe
chromosomestobacco
jaspamide
hemiastrella
criteriacd4
applicationsplastic
cellsb-cell
non-constitutive
translocation-gene-rated
leukaemiablood-cell
therapytreatment
characteristicsacute
determinedacute
motilitythe
cd5-signalling
cd5-mediated
patientsb-chronic
phosgene-induced
regulationmicrornas
levelcd33
expressionsacute
patientssome
adipocytokines
patientsfat
datemonoclonal
p-gpmdr-1
under-estimated
spicules
lipid-adhesive
paraneoplastic-associated
milieusweets
1-at
allproteolysis
p2u200a10
mast-cells
ts-try
cd74-positive
neoplasmsthymic
diseasehigh
kinapse
synapsing
receptor-rich
tcr-rich
csmac
kinaptic
isik
patrolling
cells5-aza-2-deoxycytidine
amlleukemia
outcomerecent
b-ii
cycd79α
scd22
p190-positive
aieop-bfm-all2000
reactionwe
non-sialylated
vep-9
entityin
amldisrupting
ldf
rareness
myopericytomas
fdcs
patientslong
amlwith
m1d
differentiationabstract
rho-kinase
imatinibevidence
amlhaemorrhage
fg-rich
enhancergroucho
transformationnup98-hoxa9
m-07e
malignanciesgrowth
interferon-resistant
cdw90
cd34thy-1lin-
cd34thy-1-lin-
thy-1-fraction
wordsclassical
abi-1
leukemogenesiscongenital
targetschronic
centromeric-associated
levelwe
amlgstm1
ncd8cd62l
mcd8cd62l
aamlthe
domain-independent
tnf-alphato
oncomorphologic
malignancythe
all‑trans‑retinoic
atra‑induced
post‑induction
arrayxa
27xa0apl
825xa0lncrnas
xa0mrnas
nonhsat076891
tcons00022632‑xloc010933
differentiationlong
lin-drcd11c
lin-drcd123
lin-dr
restudied
il-3-containing
leukemiasin
forthcomingin
cd11clow-d11bhighcd8alpha-i-alow
cd11ccd8alpha
cell-associate
pca-2
dyscrasiastwo
cyclophosphamidefludarabine-based
amlfirst-generation
glycophosphoprotein
cd34cd117-
leukemogenesisit
pd-1pd-l1-targeted
pd-1-
pd-l1-specific
cd3γ
ß₂-microglobulin
cd3δ
marrowmesenchymal
acid-nonresponsive
chemoresistancep-glycoprotein
advemp
advp
go35
therapyspecific
ly6gly6clow
ly6g-ly6chigh
collagen-producing
fsp1-positive
αsma
cellsmacrophages
markersacute
etv6-aml1-positive
diseasemethylation
uea
notedwe
poorthe
ran-gtp-dependent
regulatorsnup98
cytofluorimetry
rodomin
uic-2
treatmentcell
treatmentimatinib
treatmentoverexpression
genome-environment
cubas
episomic
rag2-deficient
exhausted-like
aktn-ras-induced
mds-jsn04
retrotranscriptase
dose-and-time-dependent
incdeletions
hmb-45
melan-a
il-3g-csf
approachesthree
resistanceresistance
cn-amlchromosomal
amlearly
fcsssc
cd45-pe
proportionsa
detouched
glycoprotains
growthrecently
waf1cip1
clarifiedcell
micromilieu
subset-selective
cd1c-cd141-
cd206mrc1
cd207langerin
descibes
cancerdendritic
strategiesrituximab
leukemiascd34
interleukin-1alpha
il1alpha
-sem
il1alpha-il3-flt3l
il1alpha-il3-scf
cmlit
lngfr
modified-cells
cells48
il-7-transduced
il-7-modified
allo-t-cell
cytokine-transduced
blastsmyeloid
tisc
gfptg
strategyalthough
defecta
cd11bcd13
actionacute
cn-amlto
exposure-dose-response
biomarker-based
network-derived
precursorsa
abnormalatypical
authorsthe
diseasemyeloid
anti-cd86
anti-tgf-β
unknownaml
d-835
markerphosphatase
mesylatechronic
entitiesleukemia
tumor-produced
parameterearly
anti-lex
ircs
hx
reticulohistiocytoma
r-s
b-5-fixed
paranuclear
altered-appearing
studyusing
lgll
distinguishedthe
stat6-mediated
mannerwe
patientsidentification
associationsanthracycline
n211
n781
n312
diagnosisacute
tumorsvascular
granulocyte-precusor
superinduced
supresses
cancersmutations
del6q13q21
del6q24
700-bp
bamhixbai-digested
myeloidt-cell
c-myb-related
sup-hd1
nshd
1ppq22
b-lymphocyte-associated
mrdpbsch
pre-treatmentwe
4-hpr-mediated
su-dhl4
cd20-mediated
2-val-ala-asp-fluoromethyl
z-vad
dnase-hypersensitive
sectm1
hgmw
248-amino-acid
hydropathic
golgi-like
processesthe
clb-mpo1
toxicitiesfourteen
cmlcancerous
47xx21i21q10x2
syndromehere
amlregulatory
factorin
γ9δ2t
tegs
vγ9vδ2t
teg001
gmp-grade
poorly-engineered
untouched
ntr6541
myelomaγ9δ2t
leukemiacd79
cd33cd34-
aml-m2to
alpha-subunit
alpha16
pyroglu-glu-asp-cys-lys2
cellsg
datadespite
nct00781040we
nct00781040
nct01349972the
3-cell
il-2-containing
clonoid
erythroblastoid
toxicitycytotoxic
36-kd
chemotherapyproliferating
nucleus-to-cytosol
signatureshistology
cmlbcr-abl
cxcr4-
ly6g-positive
myeloidgranulocytic
plerixafor-treated
amlprognostic
atg8
gabaraps
gabarapl1
gabarapl2gate-16
cellsautophagy
significanceto
kung
sutherland
p144
p17
psip1
cdc2l5
activitygranulocyte-macrophage
p75-associated
ngf-driven
ngf-dependent
p75-ngf
ikappabbeta
p75-irak-mediated
base-substituted
2-fluoro-ara-c
2-fluoro-5-methyl-ara-c
fmac
2-fluoro-5-ethyl-ara-c
feac
pseudoisonucleosides
exploredthe
noxia
premalignantpreinvasive
intercepted
respectivelycd33
thomsens
donorsleukocytes
node-pore
size—ap-1060
nalm-1—based
benchsideflow
benchside
p145abl1
centrosome-centriole
expressionabnormal
early-evolved
cd206tie2
wnt-1
macrophage-containing
intra-epithelial
vivomany
cd2-lymphocyte
cd11acd18-intercellular
cd2-lfa-3
antibodiesmajor
patientsloss
21qisodicentric
grinl1a
mo-dcs
c-kithi
tq24q24
mixed-lymphocyte-tumor-cultures
mltcs
mixed-lymphocyte
cs-1-derived
diabetessevere
vivocomplex
amlincreased
transplantsexploiting
meningesleukemia
amlcalcitonin
mortalityallogeneic
bfgf…
il-17…
cells…
synergyzed
tumorchimeric
risk-stratificationwe
cellscml
closerdespite
approachescore-binding
leukemogensbenzene
unknownubiquitin-specific
01061177monitoring
leukemiavarious
cellsconcentration
gsto
leukemialenalidomide
time-specific
populationassociation
prognosisgenomic
regimensserial
ico-35
k503
granulocytesico-35
decisionsnew
15sensitive
completedcd52
amlmatrix
lymphpblasts
0th
prednisolonethe
chain-
beta-chains
at-
puc
statesin
serum-
epithelial-acinar
correctthe
autoantigen-specific
cell-tropic
coligation
c3dg-binding
cd21cd19
bcrligand
bcrcd21
coligation-promoted
baff-sustained
c3dg-coated
autoantigen-presenting
promotedfoci
belowgranulocytic
fcmyeloperoxidase
cr2the
losschronic
supernatantsthe
malignancieslarge
correlational
pc-associated
pc-identification
cd229
cd319
agentsaurora
twe
tissuetumor
rhbdd2
rhbdl2
parl
ascc
mutationto
gbm-initiating
hsa-mir-29a
hsa-mir-29b
hsa-mir-221
hsa-mir-222
hsa-mir-93
hsa-mir-106a
vim2
mhc-class
vid1
3-fal
respectaccording
reviewchronic
2h4-
2h4uchl1
precursorsthe
il-7-stimulated
moab-stimulated
mixed-cell
transplantationan
pmn13f6
pmn7c3
pmn8c7
pmn7c8
-6206
005abstract
wordsin
patientsdysfunction
patientsgemtuzumab
genetwo
cd34cd133-
ror-
amlcytokines
glc4
glc4-cddp
dexamethasone-inducible
odn-induced
filamentcd15
vla-alpha
glc4-cddpas
paperclipdespite
embalming
exposuresthere
overexpressionover-expression
originthere
adultscd2
hmfg-2
odn-conjugated
hmfg-2-coated
vivomonoclonal
nodcg-prkdcscidil2rgtm1wjlsz
cd25-negative
amlcd25
treatmentmutations
optionsacute
lat-positive
anti-lat
histopathologists
dream6flowcap2
cd11csirp-1α
cxcl-1
type-iv
cd305lair-1
differentiationhuman
amlapoptosis
tobacco-induced
disarray
progressionmyelodysplastic
stainingwe
tf4
ucmsc
cessationnatural
cam-positive
agd
mobilized-
qifikit
lkp
cam-agd
lkp-cd34
cd62l-agd
transplantas
prognosisets
malignanceschfr
therapiesmyeloid
leukemiasantibody
osbp-related
forchronic
gc-dlbcls
igm-related
cd23-cd27
tkisdespite
hin-200
inducible-200
ifi200
pctm
pristane
mndal
mnda-like
ifi203
upreg-u-late
tcrζ-transfected
cd3t
tcrζ-upregulated
cytotoxicityt-cell
45xx
featuresa
1-integrin
cd34l-selectin-positive
cd34l-selectin-negative
cd34hla-drdim
l-selectin-negative
cd34hla-drbright
fluoresence
cd34dimvla-4bright
cd34dimlfa-1bright
marrowto
m3drug
phenotypescalreticulin
11qq32
mannera
laipmeasurable
cd86-cd80-
cd40-hla-dr
advisability
progressionloss
cd15although
processgranulocyte
pointsin
pgm-1
teleangiectatic
cleargranular
hemangiopericytoma-like
h-caldesmon
nkic3
crlf2-positive
cmltherapeutic
scd126
responseil6
interventionstwo
phasesalthough
therapeuticschromosomal
rcd2
cd2l
gal-beta
l-fucose
fucosidase
-diethyloxacarbocyanine
confirmedevaluation
nf1children
lzm
expression-associated
allmixed
childdata
bcr-ablph
cd34cd71-cd38-
cd34cd71cd38
controlin
investigatedrecurrent
tnfifn-stimulated
non-beta1
beta7
stromahuman
monomac6
m5aml
g19
j4
cd10cd
cd2cd
cd5cd
mymy
cd13cd
unknownacute
regulatordownstream
p120gap
myelodysplasiathe
vivocolorectal
polya-
v-amv
c-amv
sulfoxidetotal
consideredmost
stratificationasxl1
a-chain
mem75
anti-tfr
lcproper
q32-q35
7q31-qter
7q-qter
megabasepairs
t7q35
ctlpreviously
dotschips
blastsbone-marrow
myelo-peroxidase
cd7cd33-
prognosisthis
aacrhigh
antibodydependent
crossreactivity
anti-ml
cellsrabbit
syndromein
lineagesresults
agentsadministration
hematopoieitc
dosethis
analysissorting
cd34lin
antigen-linked
enumerator
lymphoiderythroid
occursleukemia
clinicallyifn-alpha
lym
tdel11q23
pointthe
givennumerous
scf100
beta1-integrin-mediated
aminopeptidase-n-like
cd13we
slit-like
ectatic
siderophages
haphazardly
smudged
leukemiacd19
fatalbenzamide
studiesrecurrent
amlproteasome
amlmicrorna
20q-q12
eventsrecent
syndromeshort
elementsthe
therapiesdespite
non-integrin
mac-2-binding
mac-2bp
α4-fucose
dc-sign-binding
dc-sign-dependent
hoxa1--
hoxa-1
postnosf2
sialoprotein
gbx2
m-ras
col4a1
foxq1
fgf5
characteristicshomeobox
epigenetic-orientated
therapiesearly
inv16the
faraway
androgen-receptor
zc3h13
mll1-zc3h13
rolechromosomal
foon
tood
analysisamong
failurerecent
caat
arthritisthe
diseasean
cbacaj
protein-expression
neutronsthe
antihormonal
nonorgan-confined
therapiesantihormonal
relapserelapse
bmfms
promisingthis
amlmdsallogeneic
ig-gene
neoplasiaduring
hel-dr
hel-drcd80
alloproliferative
futureto
chemotherapyhum195
resistancemll
ihtlv-i-producer
htlv-i-harboring
cellseight
leukemiasmixed-phenotype
undirected
proteinquest
ti-1
phorbol-12
nse-activity
granulo-monocytoid
differentiationa
amlac133
bcr-abl™
significancetrisomy
unavailableflow
lectin-5
motif-like
19q-43
kdwe
investigatedbeclin-1
approachesimatinib
helpfulmalignant
examplesmultiparameter
cd19scc
cd10-cd
cd10-cd34-
cd10-cd34
cd10cd34
cd10cd34-
myb-all
mye-b-all
antigensthe
hscsmyelodysplastic
rareblood
cd4cd25cd127
cd14hla-dr
il-10-producing
examinedil-35-producing
patientsrecent
ct26her2
ct26her
ctl-resistant
therapytherapeutic
aacrimatinib
membranethe
epigeneticsblastic
sj25-c1
gentrak
00372593diagnostic
infallible
conspicous
figure76
vh4
vh3
investigatedbone
useadoptive
skinthe
questionedleukemia
describedbefore
backgroundsmultiple
typesmacrophages
ptc-enriched
unfixed
cd36moab
cd15moab
cd14moab
typeplasmacytoid
reconstitutionhaploidentical
myelomamultiple
cn-amlrecently
classificationthe
autophagydecreased
newly-devised
patientsgranulocyte
adultsnearly
s-if
small-degree
aberrencies
casesone
noninterleukin
ldgf
ccrf-hsb-2
ldgfs
specifican
trialsdue
cd56-cd34-
ucbacf
il-15-driven
acfcd56
lymphokine-activate
ucbcd34
ucbcd14
antibasogranulin
bb1
t-cell-restricted
therapyin
lscshematopoiesis
mrcsnpm1-mutated
therapyprimary
pracownia
diagnostyki
kliniki
hematologii
krakow
unification
scalemonitoring
postproliferative
slex
confirmedetv6
normal-
high-receptor-expressing
patientscd34
malignanciestransforming
rarα1treatment
kilodaltons
3h12
p3u1
hr1k
markeran
za-treated
cancersdna
diseasebezafibrate
leukaemogenesisthe
marker-
3hleucine
gm-rather
gm-csfeffects
peri-implantation
lymphocytesregulated
triple-stains
cd7cd5cd3
cd7cd4cd8
cd7cd2cd3
cd7cd38cd34
tdtcd7surface
fitcpepecy5
percp
tdtcd7cycd3
thymocytic
featurespatients
adf
2we
uemura
macher
degregorio
scudder
buehler
knapp
feizi
decasaccharide
viii3neuacv3-fuc-nlc8cer
dodecasaccharide
x3-neuacvii3fuc-nlc10cer
sialofucooligosaccharide
sequencea
genotoxicities
topoii-independent
valuesquercetin
usedmutations
janus-2
tetra-primer
diagnosticschronic
normalthere
microendocytosis
oh2d3-treated
cytologythe
multi-nucleated
oc-induced
treatmentazacitidine
amlgiven
amldifferentiating
screeningmicrornas
onesthe
sampleimatinib
acid-like
tnf-rs
tnf-rp55
tnf-rp75
tnf-receptor
tnf-alpha-driven
gm-csfil-3-induced
tnf-alpha-triggered
tnf-alpha-signalled
tnf-rp55tumour
cellstargeting
abt-737ovarian
t-related
originwe
hla-drcd103
hla-drcd14cd103
b2a99
b2a2-positive
variantvery
imunophenotyping
cd19cd10cd34
prob-all
kor-sa35443
outcomebalanced
brazilthe
mrd-parameters
mrd-marker
mc-derived
mc-related
alpha-tryptase
mcas-confirming
populationpatients
non-confounding
kernelisable
prosvm
structurethe
midhalterations
p-glycoproteinp-170
tük
leukemiap
d-cyclin
cyclin-d1-negative
cyclin-d2
d-cyclins
ccnd1igh
sj1d1
l138
d3hl60
sj1d1d3hl60
l138p
my7my9
choicesprospective
vimd5
my10-positive
my10-negative
vimd5-positive
vimd5-negative
activityin
preleukemiaras
cytogeneticschronic
survivalphiladelphia
methodimatinib
eosin-stained
n-cam
tumorrecent
lymphoid-lineage-associated
two-eightfold
serthr-rich
stabc
stbc
rt-pcrsouthern
stbccyt1
stccyt1
stbccyt2
stccyt2
stabccyt2
stabccyt1
lineshuman
prognosisadvances
understoodchronic
t-mdsamltherapy-related
survivalvenetoclax
tdt-anll
myeloidcd7
transformationmyeloproliferative
u71
wm-15
mou48
fibrocytesblasts
perineurium
trunks
fibrohistiocytic
cartilage-forming
peptide-cleaving
mdswilms
observedabstract
thiolated
bioanalytes
dieletric
retro-transcription
transcription-nested
scrutinize
medium-income
settingbiomarkers
lscsleukemia
patientsperipheral
anticytotoxic
fieldthe
controlbackground
markersimportant
lscskindlin-3
pd-1this
plerixaforthe
ciml
il-12il-15il-18
integrin-β1
cytokine-enhanced
sema7aintegrin-β1
ecosystems
hpc-enriched
usurping
pro-b-cell-specific
pro-b-cells
myc5
re-injected
b-macrophage-restricted
pax5-null
blimp
ebf
ebf-encoding
therapypresented
investigatedas
mart1-specific
cd8αβ
antigenxa0hla
haplotype-homozygous
antigenrecent
leukapheresisso
density-increasing
sustention
gimemaminimal
subregion
breakpointwe
fgr-1
nonlymphatic-ablated
entitiescutaneous
alacute
mrcl
functionexpression
prognosis-prediction
drug-development
cancer-types
data-types
squamous-cell-carcinoma
kidney-cancers
tissue-of-origin
characteristicsthe
treatmentcancer
20-cut-off-level
myelomonocytic-differentiated
adultstranslocations
cancerwith
micro-thrombocytopeniawiskott-aldrich
micro-thrombocytopenia
entitiesacute
ceramidelow
ceramidenormal
runx1-cbfa2t1
mopholocid
lymphocic
nsenaf
respectten
regs
cross-hybridizing
onlycarcinoembryonic
developmentdouble-strand
treatmentradiotherapy
karpas
ebv-genome-specific
hexosemonophosphate
complement-opsonized
lipopolysaccharide-oil
complementopsonized
phagocytesa
discusseddespite
infiltrationadhesive
fab-aml
stratificationmarrows
scoparia
flavonoidic
rutin-induced
diseasesignals
performedpatients
infantsthe
75-probe
toxicityin
hadoop
mahout
computationdata
medium-large
lymphomasubcutaneous
hbfwe
themleukemia
cancerepigenetic
genewe
chemotherapydrug
therapyclec12a
alpha-treated
cmlall-trans
proteinstranslocations
treatmentribosomal
002analyses
valpha24nkt
alpha-galcer-pulsed
cd4v
24nkt
trail-expressing
diseasednmt3a
contextp-glycoprotein
positive-selection
cd90cd110
t-allalthough
strategiespotent
cellssustained
responsesacute
ctclretinoic
scd105
stgf-beta1
complicationsangiogenesis
techniquechronic
leukemiasthis
pd-l1-
patientwe
requiredregulatory
cd20cd19
cd7scl
b-nkl
survivalthe
recurrenceovarian
fetuins
inhibitorsacute
blooddespite
podocalyxin-positive
podocyteswe
crane
oncogenein
diagnosissurface
samplesacute
bcr-abl1we
dusty
progenyrecent
mechanismspurpose
negativecd34
cd7-cd34
cd7-cd34-
tpo-responding
tpo-non-responding
cd7-aml
koreait
aberrationsseveral
panleukocytic
ester-inducible
activationhuman
hybridization24-color
combinationaccumulation
entitycd4
amlchimeric
markers--microsatellites
vntr-
conversed
cdnagenetic
atlsmall
myeloid-endothelial
α5β1
tnfα-treated
flk-1vegfr2kdr
anti-α5
proangiogenicprovasculogenic
erythropoietin-receptor
streptavidin-conjugated
r-phycoerythrin
anti-r-phycoerythrin
epr-positive
cd45-dull
transferrin-receptor-positive
glycophorin-a-intermediate
epr-positivecd45-intermediate
epr-expression
cellserythropoietin-receptor
patientsmyeloproliferative
cd56cd7cd3-
hla-dr-cd33cd56cd16-
cd34hla-dr-cd33-cd7cd56
cd34hla-dr-cd7cd56
lineagesit
tumorsthe
binding-defective
k257v
tctps
discussedmcl-1
sfnab
dd-haplotype
parenchymatous
cellsliter
swc3
outcomegalectin-3
hccthe
cd11b-negative
themselvesthe
ox2
ifps
cd200r-cd28
tumor-t-cell
cd200r-cd28-transduced
nct01640301acute
engagementspontaneous
preventionacute
etcgranulocytic
evolutionmutations
up-expression
-5253
outcometwenty-nine
pgp-negativemrp-positive
pgp-positivemrp-positive
importantgemtuzumab
aacrstandard
gsa
predictionsacute
-dehydroxyvitamin
monocyte-induced
granulocyte-induced
-dihydroxy-16-ene-23-ynecholecalciferol
acid-protein
mnda-dna
differentiationprotein-dna
applicationsnanobodies
subvolumes
fmiso-
faza-pet
mc-c
gr1mac1
thioglycolate
-which
histoneshox
evaluatedin
remissiondespite
msf
fgsreciprocal
fgs
diseaseover
stlmc
rhil-3short-term
disfigurement
zk
vegf-rtks
pdgf-rtkss
treatmentcup-like
ltc4s
bcr-ablleukotriene
tensionto
ionization-tandem
1α25-hydroxycholecalciferol
inhibitorsby
transformationto
hra
k562-leukocyte
ags-leukocyte
productionhuman
hdmp-induced
mtthe
neededbackground
d7s1503
d7s1841
regionmonosomy
conductedacute
cancercd44s
biosynthetically
35s-cysteine
cd22-positivesurface
single-dimension
comigrated
125ilactoperoxidase-labeled
subserves
pseudo-lymphoid
cdw13
p12p11
tp23q14
morphologyan
amlm3
m3m
nonlineage
m4-eos
fcithis
plannedibrutinib
medicinemyeloid
transformationthis
monitoringpatients
pd-1-ligand
sv40-human
d1-dmba3
d1-dmba-3
lesionselucidation
thyroid-ab-titers
disordersa
amlmany
situationwe
notrecently
nm1
mdcswe
93-kilodalton
leukemia--aml
leukemia--cml
p74
cdc15fch
defectivehl-60
decision-makingin
markersdysregulation
availablefms-like
ssccd2cd13cd33cd34cd117
ssccd10-cd16-
tpml-raraa
responseoverexpression
humansunlike
medicinemanagement
leukemiaultrastructural
rearrangementwe
esophagogastric
v-regions
cd96-specific
th-111
maturated
cd96-binding
cd96-s32f
mini-antibodies
mini-antibody
affinity-maturated
potentialcd96
breasthematolymphoid
outcomespossible
testedon
alpha4fucosyltransferase
fuc-tiii
alphafucosyltransferase
fuc-tiv
plasma-type
fuc-tvi
alpha-fucosyltransferases
mutatedto
cellsout
d7sq31
tpp13
subtypepatients
outcomeswe
cancerdenosumab
gift-21
d2f2
ag-naive
cd8--
β2-microglobulin-deficient
cancerwe
hmnc
analysistranslocation
pi0
bum
splosh
qvalue
lbe
methodsin
cellsexpression
pbx1a
cd34-subpopulations
patientsbaalc
refactory
overgoing
mphi
sub-division
momphi-lineage
cd45-blast
fcmcd
fcmcd45
amldetermination
pathwayhypomethylating
outcomesanthracyclines
treatmentautophagy
therapybcr-abl
complicationcardiotoxicity
t101
mcs1
lymphocytemyeloid
progenitorswhen
txa0cell-devoid
chemotherapyxa0rendered
pathways-including
interferonsting-played
sinusmeckels
trans-foramen
non-cohesive
malignanciesundifferentiated
leukemiaexciting
non-apl-type
morphologybecause
articlewe
colton
cellmonosomy
amlrecurrence
low-fat
flaxseed-supplemented
fsls
cafs-including
derived-1α
factor-all
fslf
fs-containing
flaxseed
differentiationthis
histamine-releasing
gtag
c-ets1
-918
smooth-muscle
cd3-t-cell
nkg2ce
emphasizedtwo
interestkit
trichloroethylene
riskbenzene
availablethe
akirin-2chronic
vivoaml
95c3
104d2
104d
95c
cd34c-kit-
nodscids
c-kita
underperformed
hematologistoncologists
reportedalthough
nont-all
resultsthe
pkceta
hematopoiesistype
accountwe
smigg
il-3rhigh
il-3rmiddle
il-3rlow
hypermelanotic
melanophages
cd34cd38-aml
doubtaccording
phosphatidylglucoside
ptdglc
anti-ptdglc
dim-21
cd34ptdglc
maturationphosphatidylglucoside
practicemastocytosis
malignancytwo
patientsbcr-abl
leukemiadiagnostic
thy-1-positive
leukemiasacute
ccyrchronic
amlcd81
malignanciesdeoxycytidine
leum3
aa-deficient
g0-g
nonreplicating
analysisdetection
hmrn
treatmentresponse
diffuse-large
agesthe
technics
setbp1-mutationchronic
genotypethe
amlinduction
multiclonality
outlived
cellsone
cellswntbeta-catenin
1to
lesionserg
recoverythe
samlthe
remarkedthe
leukemiaapproximately
leucaphereses
tbv
recirculations
challengeanimal
interestalterations
survivalto
blastsunderstanding
photoproduct
p-p38α
pt390-gsk3β
c-cbl-ahr
cd15lex
cdw65vim2
cd15sslex
cd11alfa-1
cd11bmac-1
cd45o
non-cytotype-restricted
cd11a-
resultsin
cancer-infiltrating
cd11ccd11bcd8-
cd11ccd86
decision-makingchronic
investigationalthough
alk1
cml-cpdasatinib
factormatrix
t-ra
t-ra-induced
t-ra-resistant
ttnpb
am580
sr11217
raralpha-selective
alpha-antagonist
raralpha-dependent
cellsall-trans
viabilitydeath
mcl1bcl2
familiesduring
100-kd
anti-calla
surface-labeling
effectsantibodies
amlsequential
myeloidmonocytoid
cd2--
cd5--
origincd7
s100a7aflt3-itd
applicationin
amlpu1
potentialneoplasms
phosphatase-anti
anti-bromodeoxyuridine
micro-groups
amlcircular
diseaseto
differentiationcd18
cd45ro-t-
cd20-b-lymphocytes
ph1-cml
clonally-transformed
myelofibrosislittle
implicationsacute
taberrant
c23
toolgreat
v-mpl
mplv
synegic
s-igm
mplv-transformed
105-kda
pathwaysv-mpl
reviewconsiderable
eftud2
eftud2-deficient
eftud2-mediated
tlr4-nf-κb
qh
inv9
9q12
discussedpericentric
responsepatients
findingspatients
aacralthough
patientsupregulation
hcd96om
hcd96omto
amlderegulation
asbestos-associated
tumor-types
hyper-igm
patientsmyd88
presentedwe
infusionimportant
achatininh
atnh
achatina
fulica
9-o-acetyl
agglutinate
agglutinating
o-acetylated
atnhachatininh
implicationsclonal
szabolcs
adultsthe
cytogeneticsto
transformationswe
dcadoptive
keyhold
clinicianacute
wordsdetection
literaturethe
isrctn24251487acute
u95av2u133a
leukemiasaccurate
virus-donor
triazene-pretreated
mtlc1
cea-related
balwe
negativitywe
sizein
r-3-methoxy-3-oxo-2-stearamidopropyl
r-temospho
r-temospho-treated
sfllrn
aypgfk
thrombocytopeniain
analyseswe
vivosignals
phasechronic
non-nucleolar
warrantedcytogenetics
self-fusionpartial
paint-positive
spoke-like
amplificationthe
lglts
describedclones
imimatinib
b-lymphatic
lsdm
monocytoid-shaped
nasdcae
nbealpha
outcomesnext-generation
ck-amlrecently
leaked
plateletendothelial
caseleukemia
tumor-macrophage
tmf
tmfs
breast-like
2-positive
ck14
ck17
usedouble
agentacute
usedsparse
nalm-35
cd179a
cd179b
add9p11
termleukemic
engraftmentperipheral
studiesallogeneic
cellsautologous
unknowndespite
casesthe
observationexpression
cd14moderate
fasapo-1cd95
xanthogenate
smases
cellsapoptosis
patientsdroplet
discussedbecause
mek2
rafras
pik3capten
countsearly
cases--14
eprara-c
patient--idavp-16
resistanceexpression
detectiondetection
myeloid-antigen-positive
trialsdonor
-cases
inv16p13q22del16q22tp13q22
tpq11
dupiqq
tp12q24
tdicpp
invdel16t
l3-associated
dupi
detectedusing
counterstructure
paracrine-
autocrine-acting
anti-cd30l
plasmacells
alpham
cd30-cd30l
cellscd30
datasetsgenome-wide
infectionsanalysis
pre-natal
markerswhile
nc-amlnearly
mpb-n
mpb-c
proliferationexpansion
327-fold
51-fold
mannerin
mdsmicroarray
strategiesmultipotent
culturecell
ceacam1--
ltddynamic
pg-ml
red-shifted
s65t
sralpha
sralpha-s65t
fluorescence-negative
vivorecombinant
system-engrafted
ciea
microcomputed
pd-1-positive
aml1-eto-leukemic
vivocell
previouslythe
imatinibreal-time
conceptsacute
psap-driven
psap-antipol
psap-antitop
psap-lacz
lipofection-mediated
pcdna3
psap-antipolpsap-antitop
originattainment
illustratedthe
dcfin
tissuesprevious
balthe
cells1
glutaminyl-peptide
cyclotransferase-like
amlmylotarg
diseasespolymyositis
junction-specific
nk-amlwe
antihemoglobin
paraffin-reactive
casesflow
anllcd56
il-3gm-csf-treated
cd34microl
bfu-eml
lymphocyteby
biopsiesthe
durationfifty
anlltissue
performedacute
glass-adherent
lag-1
cd4cd11c-
lymphofollicules
complement-receptors
follicules
dc1s
self-defense
bcr-triggered
homoaggregation
vivotwo
leukemiabufalin
chemotherapyt-cell-targeting
all-1-specific
all-1-rearranged
ltdcd1d-restricted
pericyte-wrapping
ccl-28
secretionlittle
anae-
discriminitive
cytometrythe
characteristicsmicro
dr-negative
dr-positive
entityflt3
leukemiahigh
human-to-mouse
c57bl6rag2nullil2rgnull
brg
sirpahumanhuman
brgshuman
sirpanodnod
sirpa--
brgsnod
cellscytologic
malignanciessodium
oxygenate
tale-class
meis1-
pbx-depleted
hbae3
pu1-positive
gata1-overexpression
meis1-morphant
pegifna
adamts13
postsplenectomy
complicationspegylated
diagnosiscd56
pd1lo
pdl1hi
pd1hi
pdl1lo
diseasechromic
bis-indolic
bisinds
st1346
atra-potentiating
bis-indols
bis-indolenhancing
bis-indol
antineutrophilic
p-anca
crescents
enalapril
gvhdgraft-versus-host
mechanismswe
systemacute
cd33-coding
peiper
respectivelyinterlineage
isel-technique
ki-s1
proliferating-cell
outcomeapoptosis
amicus
cobe-spectra
autopbsc
interferon-y
tumorsdiagnosis
polymorphnuclear-mdscs
siglec-
acid-siglec
lpls
l265
triton-x-114
leukemiaterminal
amlfaithful
crgemtuzumab
anti-marco
possiblegranulocytic
beta-tcr
bigenotypic
ontogenetically
specificityambiguous
malignanciesthis
activitycord
executor
caspase-3-compromised
ae9a-driven
diseaseaml1-eto
chromatography-microsphere-based
sec-map
semi-automatic
non-cd
sh2d1a
glud1
translocationin
mfcmultiparameter
dual-negative
discussedchromosomal
selectiona
leukemiawhether
groupelderly
outcomeinfant
potenciespolysomy
cellularities
amlactive
d-value
isotypic
altough
treatmentattaching
malignancies--nine
12--were
genesthirty-two
methodsowing
leukemiasto
tymoszuk
her2neu-driven
subsets--mhc
flo--similar
stat1-deficient
therapymost
mart--35
tnfr-i
anti-tnfr-ii
linesconflicting
ag-pulsed
ag-loading
lineschemotherapy
doseforty-two
wrights-stained
anllthe
celhes
risk23
bcr-abl-inhibitors
cellstargeted
pre-investigational
gankyrin
ganlyrin-cdna
ganlyrin
vil-cregankyrinff
mx1-cregankyrinff
scln
l-26
homogeneous--uniform
mixed--even
nonmarking
homogeneous--collections
extramarrow
aggregatesthe
colony-forming-cell
pre-cfc
amlmicroarray
activityogg-oxoguanine
fab3
ricd64
sulfhydryl-specific
o-phenylenedimaleimide
o-pdm
h425
520c9
interventiona
progressionnatural
il-16
nonexpanded
il-16il-17
il-16-responsive
cd4lowcd8high
laboratoriesa
fibrinogen-like
fgl2
sublimat
susa
m0-m
biphenotypical
negativein
debateangiogenin
cellssince
mir-pmxd1
efficacygemtuzumab
lmo2we
cellscolorectal
nct00480363increased
mircode
starbase
hoxa9insrkrit1mybspry2ube2v1wee1znf711
prognosisrecently
familyco-stimulatory
-methylation
mct4slc16a3
cd38abstract
wordstransplantations
leukaemogenesistreatment-related
cd11bcd14-
ceacam1a
amltlrs
differences--primarily
subcategorization
chimerismremission
interestwe
managementimatinib
entityan
blast-negative
47xx46xx18
outcometo
taskan
h-2q
h-2a-derived
peptide-dependent
h-2kbdb
anti-kb
anti-db
ligand-deficient
kg1-b
kmoe
kg1-rev
chrf-288
cellsmature
plasmaprotein
progressthe
transplantationcd56
alpha-gal
galalphagal-betaglcnac-r
alphagalactosyltransferase
ralphagt
anti-gal
pgap
his6
nickel-sepharose
udp-gal
vaccinesthis
criterials
leukaemia377
pregnancymanagement
phenotypeblinatumomab
mdswnt
stratificationtherapy-related
levelantiapoptotic
trucking
usedxa0methodology
withxa0osc
pg313
c939axa0xa0g
modalitiesisocitrate
non-prescription
alterationsthe
investigationsustained
tpo-rusing
suboptimalchimeric
bim-depleted
nil-
ima-induced
activatedit
cd56butyltin
cytokeins
hypoplasty
bm-tma
2e12
hpb-all
7c11
vitromonoclonal
indirectlydistinct
technology--globally
seenacute
snap-tag
self-labeling
markerssnap-tag
g1sg2m
propertieschronic
cellsleukocyte
leukemiatwenty
nanotherapeutic
ferrimagnetic
vortex-domain
nanoring
fvio-mediated
eat-me
thermotherapy
or16
populationchromosome
31d8
crdespite
amldna-fingerprint
sarcomagranulocytic
cycd79
cytometrywe
cmldna
allo-hsctacute
kit-negativity
kit-positivity
non-gists
kit-negative
tinctorial
desmoids
gist-like
stellate-shaped
collagenous
s100-positive
osteoclastoma
vlp-specific
vlp-induced
assembly-defective
l1-specific
assembly-deficient
il-12-secreting
non-il-12-secreting
ag-expressing
peptide-sensitized
survivalmicrornas
clinicalchromosome
plexiform
histiocyte-like
populationcancer
transplantationnucleophosmin
leukemialeukemia
aacron
disordersaberrant
markersflow
oksml-expressing
monopolycistronic-
retrovirallentiviralepisomal-
transcriptomic-epigenetic
mll-af4-overexpressing
transcriptomedna
developmentaldifferentiation
pluripotencyinduced
ly6gly6c
pkr-1
leukemiadifferential
b-aml
nonvaccinated
tnf-alpha-aml
gm-aml
dg-sep
wb-lysis
droplet-based
inhibitionchromosomal
anti-ssea-1
neuac
beta-4fuc
gal-epitope
monosaccharides
cellsanti-ssea-1
fanca--
emergenceexpansion
trp53i13
pilrb
transformationfanconi
leder
leder-stained
diagnosiswe
abnormalin
unrecognizable
dicq21p11
casewe
n-ras-expressing
late-erythroblast
ccnd1-negative
non-nodal
anti-sox11
d1sox11-positive
non-mantle
cmc38221001
diseaseserum
diseasesdevelopment
rhabdomyosarcomamyeloid
methanol-fixed
mip-1alpha-r
ccr5we
go-therapygemtuzumab-ozogamicin
milestonesidentification
tkisbcr-abl
idotdo
idotdo-overexpressing
ido-kyn-ahr-mediated
amlelevated
leukemiagenomic
site-distribution
unneeded
20-fold-higher
cfsemax
proapoptoticchronic
criteriato
resistanceclinical
373a
interpolating
pnl2
nonmelanocytic
angiomyolipoma
a103
melan-amart-1
t311
hmb
angiomyolipomas
bcrabl-activated
bcrabl-y177
grb2-sos
cotransducing
cellsthese
grb2-mediated
unlyzed
cytometryacute
leukaemiasthe
1g7
124pgaqkrkk
dna-cellulose
leukemiaheparan
antigensdetection
cellsintrinsic
tumorsc-kit
datasetindividual
phenotypescd2
progressionprogress
platelet-mediated
end-arterial
markerswe
sequenceit
samplesmicroarray-based
pu2009nu2009u4
remissionover
cfu-dcs
cd34flt3-
cd34flt3
fl-generated
cd83cd86
gm-csftpofl
antibioticsacute
amlpatients
noninflamed
infantswe
mψ
monocytesmψ
tumor-exposed
sirpα-kd
pi3kp85
myelopathycontroversy
backwardsacute
predictionidentification
cessationthis
1variant
cellscd47
amlimipridones
mcl-1-gfp
cellsinterleukin-6
3g8
r-nk
cellsbispecific
daunorubicinsimultaneous
serine-esterase-positive
retrosternal
axa0diagnosis
mayxa0include
dysrhythmias
afterxa0testing
treatmentxa0to
bothcomparisons
erythromegakaryocytic
markergata
aminoxyrone
ax
hsrheat
antigen-loading
miics
tap-dependent
clip-negative
clip-
cellsduring
uncertainpresence
lw-bcgf
controversialleukemic
relapsenot
mechanismschronic
mechamismto
cd14cd66
2-parameter
leukemiasusing
myeloidendothelial
tnfalpha-associated
tnfalpha-expressing
β-catenin-binding
β-cateninlef1
interactionacute
survivalidarubicin
fluorochrome-conjugated
fc-mediated
methodsacute
harvest-time
upregulationsorafenib
naphthyl-asd-chloracetate
napthyl
inducersacute
100cgy
self-antigenallogeneic
tunicamycin-treated
less-marked
itselfthe
ccyrcompared
calichdmh
cmc-544
acid-labile
-acetylphenoxy
butanoic
acbut
-600
bcls
cd22-targeted
malignanciesantibody-targeted
citypatients
pathwayscd56high
cardenolides
digoxin-like
dlif
dlifs
cellsplant-derived
nos2-
tnf-producing
tip-dcs
bay117082
kamebakaurin
interleukin-16-
potentialnuclear
crisisthirty-four
haemopoiesisthe
anti-tdt
tdt-protein
tdt-transcript
lya
crosslineage
fab-diagnoses
lya-
p12q22
approachesrecurrent
kmc
bms2
whitlock-witte
kmc-recognized
kmccd9
proadhesive
biomarkersacute
cd5tdt
hsctcirculating
cd4cd25cd127-
nonethelesshere
chemotherapypreliminary
albumin-modified
turnover--osteocalcin
b-alp
ictp--were
pthcalcium
s-ictp
periodthere
hsctimatinib
alv-j-induced
alv-j-mediated
hp45
4dcd100
df1
mir-125
alvs
idh2acute
deficientmirnas
illnessgranulocytic
cellspancreatic
expansionmyelodysplastic
resistanceimatinib
differentwe
octylglucopyranoside
eg2
pbes
rhil-2-treated
clarifiedwe
anti-fyn
serpentine
gro-alpha
gro-beta
t-allthe
protein-mcp-1ccl2
pf-4varcxcl4l1
parcccl18
lymfoid
momentchemokines
mutz-11
gm-csfralpha
2-to-12
der16tpq23x2
cytokine-dependency
alterationscontinuous
lysed-whole-blood
lymphocyteblast-cell
virus-type
infectionflow
warrantedwe
apha
societymixed
response-assessment
cxcr3--
cd200r-deficient
cd11bly6c
cd11bgr1-
formwe
microgmlto
diseasewilms
dok-1dok-2
cd200--
signallingcd200r
experiencecancer
wayshigh
acidtotal
fucosetotal
seromucoid
hexoses
activityaccelerated
p185her2
cd19cd10-
cd66a-4l
cd66a-4s
abundantallotransplantation
kras∗
kras∗-mediated
kras∗-expressing
kras∗-irf2-cxcl3-cxcr2
compartmentcoexpression
amlcurrent
sialyl-fucosyl-lactosamine-epitope
sa-lex
leukocyte-endothelial
lecam-1
fuct-3
ecb
sa-dilex
colo--fold
sialyl-substituted
sialyl-neolactotetraosyl
lm1
neu-gc
sialyl-norhexaosylceramide
neugc-nlc6
lyso-lm1
inactiveabstract
cd33antibodies
multipaint
populationbetween
homeobox-containing
hb24
cytopreparations
leukemogenesishomeobox
leukemiadifferentiating
mafia
transgene-expressing
subdermal
macrophage-depleted
theorize
macrophagecancer
7-aminoactinomycin
7-amd
studychromatin
subjectsin
can-abl
can-abl1
vitamin-d3-induced
u937cells
leukemia-prone
cellsleukemia-specific
ma14
ma63
mcs-1
mac3
populationabstract
wordscd15
amldownstream
two-loci-mismatched
developmentsan
eachwhile
mpo7
panelsthe
donorto
semaphorin-3a
furin-resistant
fr-sema3a
furin-like
proprotein
convertases
progressionprevious
patientsresponse
importancepluripotent
patientsmyeloid-derived
safetycurrent
therapysterile
ngr
ngr-containing
factor-alphatnf
ngr-drug
cngrcg-tnf
murine125i-ngr-tnf
125i-tnf
cd13-expressing
ngrcd13
systemthe
mopc315
g-coated
apc-mb
apcs-mb
fractalkine
abcd-1
cc-type
id-specific
lackingalthough
strategiesnew
progenitorsthere
miceresults
treg-depleting
anti-rankl
polyfunctionality
rank-expressing
mdscconclusions
rankl-rank
anti-mu-heavy
mu-heavy
non-tested
mu-chain
drugsimatinib
kyiv
may-grünvald-giemza
acnse
lsab
patientssuppressor
scirrhous
outcomefocal
mrdrelapse
mts1cdkn2
d9s104
mtapase
geneacute
sas-1
colonies1000
patientspr1
pva-cryogel
dmaam
epoxy-derivatized
cryogels
antibody-labeled
gelsbeads
a-cryogel
adsorbents
comparedthe
mfi501
lidamycin
lidamycin-treated
treatmentapoptosis
pbmnccd34
ltc-cfc
cmlmonocyte-induced
effectchloroma
casesdifferentiation
n278
trialsdetection
hyposensitivity
lingual
masticator
cd56cd3-cd4-
b-cell-
nk-cell-lineage
neoplasmsclinical
treatmentneural
hospitalfor
cmlbm
trialsautologous
diagnositic
leukemiaslysosomal
kinase-coupled
sirpalpha2
sirpalpha1-reactive
sirp-binding
cc2c6
counterreceptors
adhesionsignal-regulatory
responseleukemia
survivalaltered
lir-1
kir-
receptor-major
pan-hla
leukemiasalthough
outcomea
targetsmyelodysplastic
rtv
25oh3
compoundshiv-1
lineage-positive
cd34cd56-cd19-cd33-
cd34cd56-cd19-
populationin
bp-3
mus-1
mus-2
peyers
peripheryto
micecytokine
kb8
low-p-gp-expressing
protocolsprogress
clinico
clinical-cytogenetic
discussedcytogenic
cd39cd26
no-return
tr1-like
tcr-stimulating
contextsnatural
depletioncalcitriol
hiseq2000
mirna-offset
mornas
mir-10b-5p
mir-19b-3p
mir-543
3-mor-
t15q-17q
emphasizedone
phenylpteridine
bibw22bs
bibw22
bibw
mdrthe
il-13-neutralizing
allostimulating
relapsethree
365-amino-acid
börjeson-forssman-lehmann
notch1-induced
hematopoiesisplant
rareli-fraumeni
versicans
versican-derived
matrikines
versikine
2de
complexly
non-perfect
variancetwo-dimensional
lymphomacd81
networksmicrornas
detailacute
hexamethylene-bis-acetamide
date--a
d20s465
targetleukemia
inhibitionin
describedcd
familythe
treatmentnew
agentseosinophilia
amlhomeobox
ag-
sialyl-lewisx
lewisa
trifucosylated
blood-group
cellsfc-
potentialten
bcl2-jh
purgin
practiceminimal
reactivationin
t1-t3
tspan7
alloverexpression
amlsup-regulation
-chromosomal
leukemia-aml1
hla-a-matched
aml1-containing
proteinsrecurrent
colon-cancer-cell-associated
non-lymphoid-non-myeloid
a3kawakami
non-glycosylated
colon-cancer-associated
non-colon
colon-cancer
analyzedrecurrent
karyotypesalthough
pe-labeled
banker
pecy5-labeled
cd34-gated
ssc-gated
pcna-gated
subsetscheckpoint
tfrc
inha
stat5py694
10-protein
stat3ps727
reviewacute
implicationsmyelodysplastic
settingt-cell
c-erba-1
c-erbb-2
alphampo
16-hour
eudistoma
amo1
5e10
transplantationthy-1
soonthe
denitrophenol
synthase--fumonisin
tnf-r2
previouslytnf
axitinib-treated
brazilin
stratificationthere
apoptosisarry-520
differentiationexpression
triphosphate-nick
typesacute
impactwilms
cd68r
problematicthe
ell-inducible
ell-mediated
ell2
ell3
ells
chictr-ppc-14005297whether
karyotypeacute
gcpl
gastroscopy
ifnα-responsive
slfn4
helicobacter-infected
slfn5
galpha12
gtpase-deficient
galpha12q229l
galpha12ql
growth-factorserum
galpha12ql-transformed
protein-spots
3-folds
maldi-ms
myeloid-leukemia-associated
galpha12-mediated
set-protein
expressiongalpha12
amlgenetic
expressiontwenty-three
markersto
agentscancers
requiem
mlk3apoptosis
institutesbased
if10
p3-x63-ag8-u1
if10-defined
plasmin-alpha
2-plasmin
microcirculationplasma
survivalvascular
isha
kosha
transtrans-muconic
tt-ma
oel
2003benzene
cd34ve
reactivitycd133
cd90thy-1
cd34-associated
antigenac133
demonstratedwe
smy15a
vim-d
agentsfever
dual-expression
transformationin
channelcontrol
diseaseselevated
nolan
systemssignal
therapiesto
collectionthe
explantsfibroblast
limitedassociation
mdc-mediated
b7-h1-blocked
reviewedprimary
amltransferrin
mrdthis
progenitorsdasatinib
46xxder1tp21
q22tq23q12der15tq23q22der17tp21
qxxwe
qxx
malignancymyelofibrosis
mthlto
mthl
genespatients
targetpermanent
potentialex
undefinedmicrorna-195
cheong
monoblastsepithelial
cd19-cd34
improvedacute
valuethis
killinghuman
transporterserlotinib
lineage-foreign
my-neg
t-neg
therapyan
lps-negative
polymixin
hemopoietin-1
studiesmlaa-34
mdstwo
managementinsensitivity
expressionalthough
actrn12607000325404recent
vivoseventy-eight
allbetween
reportthree-way
patientsmirna-133
amlextensive
n-nitroso-n-butylurea
i-region
significancethe
55kd
markersinterleukin-2
186-fold
ap1903-mediated
mdx-010
cellscells
treatmentrisk
cd34cd41
cd34cd41-
scl-expressing
sublocalization
metaplasiaan
respectivelyhistone
biomarkerschemokines
non-cic
v6
metastasis-promotion
tranfer
cd44v6kd
modela
coca
tspan8
cd44v6-promoted
cd44v6kd-tex
cic-tex
cellstaken
imatinibmicrornas
aurkathis
crclinical
ico-02
lymphosarcomamice
requiredto
pdcmdcs
tdtposin
interleukin-18
dunn
microgmouse
il-18-induced
anti-asialo
balbc-nude
c3h-gldgld
fasl-fas
mpalmixed
microglia-glioma
insuranceat
triphosphate-hydrolyzing
neural-crest
lineschildren
bisatellited
anll-m2
diseasesa
diseaseswe
microchimerisms
detectionto
ap-1fosjunegr-1
originstwo
disordersduring
der18t
der6tder17tder21tder5t
statesthe
protocolschronic
obligated
therapyimatinib
f96982
pts-positive
f98982
f14512the
pro-b-allto
neoplasmto
pgpacute
m-mdsc20-fold
pmn-mdsc15-fold
mertk--
axl--
tyro3--
coimplantation
hypoplasiato
expectancyin
respectivelybeta-2-microglobulin
findingcup-like
biomarkersto
cellscurcumin
analysedwe
hd28
anti-mub
factor-activated
microheterogeneity
licr-lon-hmy2
antennae
ocily1
growth-dependent
erkap-1
gm-csfhuman
yellow-tan
rubbery-to-firm
extrascrotal
targetingcd9
modelscytogenetic
tumorsthymidine
treatmentat
cd5cd1acd8
subcategorize
cd8cd1a-
cd8cd1a
thymiccortical
etp-
t-all-myeloid
chloroacetateesterase
gschloroma
amlb-cell
cytometrymedulloblastoma
abnormalitiesusing
leukemiapatients
neoplasmsdetection
patientscxc
patientsabnormal
htlv-i-negative
primarily-cultured
blooda
mcl-1recombinant
32dp210clone
b-modified
transfera
ja-cml
46x-yt8
hypertriploid
pathwaya
tnfrsf7
birc5survivin
chemotherapydefects
prognosiscxc
pronase
borohydride
exoglycosidase
anaylsis
galnacoh
sialylationstructures
cd79ab-
card11-
prmd1
decapitating
non-insulin-dependent
mody1
13-centimorgan
d20s169
d20s176
18-centimorgan
d20s17
controlled-rate
hiv-1-producing
mds-t
phxbc2
mds-i
32pttp
oligodta
bromoadenosine
replicationwe
-m1
-m16
patientsuntil
negative-cases
survivalleukemic
marrow-originated
interclonal
chemotherapypatients
discussedfifty-nine
translocationchronic
mdsmononuclear
chaperone-based
hsp70pc-f
hsp70-pc
muted
hsp70-peptide
dc-tumor
aberrationsacute
therapybrutons
malignanciesacute
p-valueu200a
ihca
ihcadetection
prostratins
hiv-1prostratin
reportedaleukemic
amlsomatic
leu-22
df-t1
leucosialin
antigenthree
z-119
z-181
e1--a2
pg2
cytokinephiladelphia
findingsthe
vivorecent
sctprimitive
groupsacute
frequences
abnormatility
decisionsthis
relapseto
diseaseapoptosis
cellscd71
fibrin-cytoplasmic
fcf
coagulationthe
controlvacuole
hemopoiesisto
genesacute
allalemtuzumab
aspirateswe
cofocal
cml-sp-cd15
cml-ap-cd15
cmlcml-bp-m-cd13
cml-bp-ml-cd13
cml-sp
cml-bp-m
pkat
cml-bp-ml
adapnp
chae
cml-bp-lymphoidperipheral
cml-bp-lymphoid
investigatedcirculating
b7-negative
c1498b
antibody-depletion
b-ctla-4
ctla-4minus
signminus
targetsthe
allleukemic
sahel
co-expressions
obstaclescd123
osx-cretdtomato
tdtosx
extra-skeletal
inductionthe
tlr4myeloid
190-fold
46-
930-fold
250-fold
589-fold
pre-expansion
4-hc-resistant
5-factor
transferto
resultschronic
beva
mllall1
circulated
para-aortal
icam-3lfa-1
icam-1lfa-1
tnf-alphatnf
receptor-activated
responseintercellular
populationacute
my17
mcpyv
foam-based
foams
propylnitrosourea
pnu
lestm
lexf
intercross
manly
backcross
pnu-induced
ril-33
il-33-mediated
il-33-st2-myd88-stat1
wm-53
diethylenetriaminepentacetic
cdtpaa
149tb
153sm
152tb
emitter
regiv
pcdhb9
cddp5-fluorouracil
cddp-sensitive
warrantedacute
clonethe
ante-mortem
lysozymes
dilations
testswe
bcr-xabl
controversialit
eupafolin
princeps
cellseupafolin
evolutionimatinib
strategiesacute
ulna
tumorsan
ps4
10-kb
probewe
flwe
strategymass
discussedazacitidine
syndromeshaematological
adultsit
outcomevascular
therapyadministration
activitysingle-chain
aplblast
abnormalitiesbcl2
alterationout
mediastina
specialistsin
retinoid-regulated
causexa0amlthe
anti-macrophage
fixative-resistant
wop
macrophage-restricted
anti-calgranulins
histiocytosistrue
pg-m1-negative
sectionsa
therapyepigenetic
trialthe
cross-blocking
conceptgenetic
cytogeneticscytogenetic
amlconstitutive
sizn1
meis1sizn1
sizn1hey1
sizn1sall4
non-invaded
populationcxc
investigationperipheral
moesin
antimoesin
antidiazepam-binding
drs-1
hctwe
entnf
manganous
nonsecretory-type
ptnf
inhibitor--can
micetransgenic
malignanciesgiven
laser-capture
panendothelial
ifn-α2b-treated
pmnmdsc
mdcdc
pd-l1cytotoxic
pointsa
strategiesrefractoriness
exonuclease-based
transcriptase-mediated
g6pdh
d1g6pdh
mclthe
cellssimulated
chemoresistancea
holdout
osteosarcomaosteosarcoma
japanin
parameterswe
cd10-cd20-
cd10cd20-
btm-
justifiability
costsveno-occlusive
amllwe
myelomathe
countswe
xscid
mfci
fluidarea
involvementexpert
interventionintroduction
lowit
relapsesmall
tfrseveral
productionwe
targetsantibody-drug
cyclelbh589
mirnasthe
discontinuationtherapy
bloodgene
100u2009unitsm2cpx-351
four-channel
lyve-1
micro-anatomy
wmlymphoplasmacytic
non-wmlpl
wellextramedullary
outcomesrecent
allwilms
caseshla-dr
livesthe
factor-negative
malignancydespite
adnexanerve
amlautologous
ric-hctrelapse
groupswe
imatinibimatinib
reconsideredrecent
lymphocyte-activation
foxp3-independent
futuretype
tumor-necrosis-factortnf
pro8
asp10
120-fold
mock-transfectants
protein-kinase-c
p55the
convolute
trialsexploratory
m10
m16
mlil
cd27p
m5bp
mlilthe
therapydetermining
disordersclonal
cell-marker
t-allcell-marker
crsss
non-template
crss
rags
directionbreakpoint
changesthe
tumorthe
heterogeneitysix
sensitivitythe
tkithe
clone-sorting
g-csfil-11
il-11ralpha
assaywe
cd3-stimulated
zap-70-
cellsactivated
bw-sp3
regressors
progressor
vitro-restimulated
amlbackground
countsan
imatinibgleevec
leukemiadna-fingerprint
amlmllthe
therapiesprogress
m1egr-1
typewe
priorityacute
therapymultidrug
mb-1cd79a
sn8
lymphocytescd79
ut-7e8
ut-7g6
ut-7e
activationchronic
nano-lcmsms
pth2r
cd34itga6
processesinteractions
smc1aobjective
anti-sall4
sall16
questionsall4
trialdespite
cxcl7-llc
control-llc
ires-llc
presentedumbilical
7-binding
6ckine
protein-3beta
cd40-mediated
tcr-transgenic
trp-2-specific
ad5-il2
oxide-producing
diseaseshematopoietic
leukemiasc-kit
anti-tac
4h3--both
first-layer
second-layer-only
typesa
diseasesabstractu3000u3000single
therapyheat
patientsincreasing
machinerytumor
spindle-shape
reviewmastocytosis
pooljuvenile
warrantedalthough
malignanciesan
baalc-associated
npr3
igfbp7-expression
okb1
okb4
okb7
avidin-biotin
okb1-okb2okb4-okb7-
okb1okb4
okb1-
okb7-
okb4-
okb1-okb4-
okb-
okb2-okb4-
okb
methodsmonoclonal
achievementto
complicatedalthough
cancersee
rivoltini
settingto
detectionthis
diseasechromosomal
therapygenetically
anti-cd33mab
anti−cd33−calicheamicin
amlmab
anti-pax5
stromaseveral
follow-upan
alphagc
alphagc-pulsed
il-12-overexpressing
il-12-stimulated
ag-loaded
alphagccd1d-restricted
detectionhematopoietic
granula
b-precursor-cell
malignanciestwo
ageexpression
amlcyclin-dependent
observationin
rbbp8
chr18
neoplasmsvascular
cd117-cd34-hla-dr-
der15ider17q10
harmonizes
formulathe
hsctup
gp-170
lyag
tdt-cd7-
tdtcd7-
tdt-cd7
tdtcd7
abnormalitieswe
ny-br-1-specific
physiopathogeny
48xyy8tq14p12
tf-positive
tenase
tf-negative
cell-count
ps-
relapseas
cd1a-derived
factor-r
hla-drhi
interleukin-3-r
cd123-negative
ptalpha
ptalpha-negative
bloodtonsillar
kb90
leu-m3
factorblast
populationsacute
addressedflt3
ester-promoted
dmso-promoted
ra-differentiated
serum-factorsdefensins
serum-factors
outlinedseveral
techniquesline
diseasestumor
leu-mcd1
4b3
monoribosomes
differentiationstudies
hayflick
mll-enl-transformed
v-sea
lineageidentification
failedresistance
biopterin
o-ii
activityurinary
cd34cd7cd5
antibodieschronic
feasiblethe
nectins
nectin-like
cd155--
cd155-deleted
co-optive
futureisocitrate
ptlpd
expressionpost-transplant
cytoadhesins
gpib
anti-cd49d
glycosylphosphatidyl-inositol
elucidatedadhesion
lovo-induced
rage-mediated
narrowband
mjcm2
erythemogenic
biomarkerderegulated
cd2cd4cd7
2j
therapyelderly
mutationdnmt3a
mda-mb-231t
phospho-p65
ikbα
erk-mapk
amlgrowing
disposes
azoxymethanedextran
factormacrophage
nf-κbil-6stat3
settingin
self-proteins
adhhm
self-reactive
anti-glucocorticoid-induced
alphagalcer-loaded
anti-gitr
complicationselevated
cytoadhesion
factorsfunctional
timethis
informationflow
gvlthe
rheb-induced
fti-resistant
m184l
clinicallysodium
trail-treated
leukemiatreatment
superfamilymultidrug
prp1pzer1p
l19h1
pinch
antigensdifferential
amlidentification
gctsto
pu1-induced
il-32β
thp-1il-32θ
combinationshypomethylating
pd-l1cd14
tumor-positive
tumor-negative
ln-
cordon
celltreg
cd34-cd33cd11b-
thrombinactivated
spawn
spontaneously-formed
pancytokeratin
pneumosphere-forming
allohctwe
studieswe
auto-antigen
tp22q32bcl10-igh
tq32q21igh-malt1and
tq21q21birc3
api2-malt1
auto-negative
futuremulti
all1the
decisionsbecause
ccg-2861
cdw14
requirementsthe
futurebetter
stagings
tia1
washless
brdurd-labeled
cellswashless
subgroupsacute
bcl-2-family-protein
observedwe
m2-pk
typings
classificationto
c57blxcbah
regionschromosome
patientsco-occurrence
cd30l-bearing
scd30
th2-polarized
statecd30l
sc-2
transformational
leukemogenesis-associated
applicationsleukemogenesis
dsthis
activityapoptosis
j0443increasing
sirpαcd47
two-antigen-mismatched
100the
pro-myeloperoxidasempo
proforms
c-kitnew
naf-inhibitable
monocytomacrophage
-oh2-d3
definying
oncomirnas
upmirs
dnmirs
lin-sca-1c-kit-
lsk-
hsc-containing
lscsa
fab-variants
t-cd19
patientsexaminations
pmfwe
patientsmllt11
samplesdata
relevanceto
0058approximately
880-kb
r166
leukaemiafamilial
as02
resistanteight
unknownalthough
mrna-positive
mrna-negative
leukemiaone
wt1-kts
wt1kts
g1g0-accumulation
syndromecellular
functionthe
rhflt3-l
laboratoriesdetermination
rm10
anti-c-abl
responsivenessa
btastat
bta
trak
cfhrp
helas3
fh-specific
fh-like
antigencytokine-induced
pixy321
reticulo-endothelial
examinedmonoclonal
int-dacthe
lymphomaexpression
line--chloroma
calphostin-c-induced
pcna--a
unfinished
declinerecovery
time-pattern
transportdrug
lipopolysaccharide-detecting
beta-linked
b16f10-induced
practiceover
studyduring
lackingthe
gdp-fucosebeta-d-n-acetylglucosaminide
3-alpha-l-fucosyltransferase
ftiv
fucosyltransferases
varythe
trialsa
prognosistelomerase
neutropeniatumor
compartmentssunitinib
ifn-α2
biomarkerstwo
roizman
borrowed
amlmost
pra3
anti-mb-1
anti-b29
leum1
bm1
peroxidase-based
chromogen
membrane-staining
caplike
phenotype--t-cell
lysozyme--were
round-cell
tissueparaffin
anti-t8
t-suppressor
anti-t8-positive
anti-my9-positive
metaphases34
tpo-mediated
activationcells
sti571to
outcomehtert
leukemiathis
cgl-bfu-e
l243
r1b19
wghs
progressionhuman
treatmenttyrosine
postprogenitor
tumor-antigen-presenting
intra-cancer
hierarchya
leukemiaaccurate
hla-dr-associated
hnp-
propeptides
bindingcompetition
hla-dr-restricted
cho-drb
defensin-expressing
oligodeoxyribonucleotide
lscto
bcsh
patientstelomere
diseasecore-binding
mrt-pcr
malignanciesgene
conditionsextramedullary
m6-ercd71
inxa0vivoautologous
dosesthe
jiafever
-1384
cytokine-responsive
anti-hedgehog
cppatched
myalls
my-alls
featuresthe
processrearrangements
dateepigenetic
aelaml-m6to
units--granulocyte-monocyte--and
units--granulocyte-erythrocyte-monocyte-megakaryocyte--per
reviewedmyelodysplasia
investigationthe
cellsblast
amldifferent
treatmentchromosomal
leveltyrosine
micechronic
hpd-l1
hpd-l1-expressing
anti-hpd-l1
pd-l1-expressing
reinvigoration
lin-cd34cd38
formationreplating
y694
pstat5a
lymphoidmyeloid-restricted
ag-mimetic
pmaionomycin
nf-at
kappab1
nf-atp
cd28re
-617
-209
tax-mediated
lymphocytesifn
proliferativedifferentiative
lineagewe
regimenthis
ml-dsmyeloid
cdw1
chemotherapyfrequency
b1a
transplantatypical
diseaseflow
cancerneratinib
cw3
cw4
remissionfrequencies
cohortthere
porus
acousticus
collagen-rich
haemosiderin-laden
fibromatous
inhibitionacute
mat1
iih
81-aa
pm9
affix
tfiih-core
δcak
fragmentation-depletion
leukemogenesismat1
okt3-coated
okt3-dependent
okt3-triggered
del9q12-q22
myeloperoxidases
n-acetylmuramyl-l-alanine
namlaa
namlaa-positive
peptidoglycan-degrading
crystalloid-containing
french-american-british-classified
aaa4
lineagen-acetylmuramyl-l-alanine
leukemiawilms
ighccnd1
childde
yetmicrornas
resistanceall-trans
investigatedoverwhelming
samlpatients
cell-microenvironmental
interactionstreatment
angiomodulin
cycloxygenase-2
tie-2-positive
marrowangiogenesis
iga-lambda
atelectasis
aggregations
carboxy-ionophores
nucleiccytoplasmic
methoxymorpholinyl-doxorubicin
anthracyclineswe
toxicitywe
amllodgement
ut7-p210
pd98056
map-kinaseerk
t5q13
afmb347yf9
gatap18104
mdsdeletions
discernment
call-133
therapycd20
amlplasminogen
multiaspect
damacy
asthmatics
leukocytesmulticolour
clinicallycomplex
mc29
mws
proteinsthe
anti-il-15
2000il-15
leukemogenesisdna
h12
nct00965224relapse
cylindric
ribosomal-lamellar
complexesa
cd7cd4cd8-cd3-
mir-1224
effectsradiation
blastoma
transformationwe
associationbiphenotypic
transferexpression
efficacyacute
survivalchildhood
sarcomato
leukemialeukemic
lectin-carbohydrate
presupposes
biosignaling
croco
cd15-specific
glycobiological
neoglycoenzyme
alpha-mannosides
alpha-fucosides
n-acetylgalactosaminides
recognitive
interactionsmediation
functioncell
ig-cdr-based
c36l1
repolarize
mif-cd74
pfc
hsc-b
collectionsfast
u937to
cacc
dependencyinvestigating
pox-negative
pox-positive
sectionsmyeloid
ldh-b
chemoradiotargeted
accumulationto
regionlittle
plgas
growth-suppressor
depositionaccumulation
thermostat
1-a
monophenotypic
amlbaso
abnormalityde
cd45cd117cd2cd25
d20s206
d20s119
ut654
redesignation
genea
malignomasthe
cell-infiltrated
vip-mediated
125i-vip
nalm
lymphocytesthis
amliron
lstra
p21rasgap
pathwayabstract
proliferationinterferon
heterogenousthe
gain-of-function-mutations
asp-816--val
gly-839--lys
t-nk-cell-associated
lfa-2
technologyto
sub-cloneswe
g-csp
delineatedacute
igm-positive
1-driven
class-switched
2-driven
igg4-positive
igg-positive
iga-positive
featuresaccording
techniquesacute
availablebasophils
diseasebone
α-bb
human-her2
monocytotropic
promyelocyticmyeloblastic
hiv-1jr-fl
htlv-iiiba-l
j-hl-60
vitromonocytotropic
amldyshematopoiesis
tempering
vegf-a165
nrp1-expressing
nem
nems
gr1-
pdgfb
sema3a-expressing
factorspre-b
cd34cd20-
cd34-cd20
cd34cd20
cd5cd23-cd11c-
cd5cd23cd11c-
cd5cd23cd11c
remissionwilms
sambur
cdai
protocolsfifty-eight
rpci-wm1
h-igm
κ-light
allcd38
mutz-8
tq21q10
patientssall4
opgreceptor
opgrankl
surnatant
osteoblastogenesisimatinib
osteoblastogenesis
tkischronic
responsethis
agentsit
diseasethis
kat4
glostrup
ly-bc
investigatedantibodies
picturemyeloid
corticosteroidsalthough
prak
stagesunderstanding
full-penetrance
fluoroenzyme
anti-tryptase
cd1dhicd5
pda-bearing
microbial-dependent
tlr4-nlrp3
leukemiadonor
amldysregulation
sorafenibtrastuzumab
cd44v
2v
10v
-6v
-9v
amlcd44
materialdetermination
b2a3ela2
arabinoside-containing
outcomeevaluable
diagnosesmyeloid
examinedextramedullary
alonepatients
transplantationbb
protocolsthe
re-create
diseaseearly
u-a10
lysosensor
yellowblue
dnd-160
lamp-2
eccentrically
3h-daunorubicin
phenotypethe
bodyacute
-isocitrate
tar-tat
hiv-rtta
dox-dependent
deletionsinactivating
nutlin3a
cd10cd34to
usea
lenwhile
fa1
studiesin
abt-199-specific
bcl2bclxlmcl1
phosphadydilserines
072rbl94a
downregulationb-cell
osorganic
tfrin
caller
availablesomatic
bala
collagenasegelatinase
12-o-tetradecanoylphorbol-13
tpa-dependent
tnf-r1
anti-tnf-r1
anti-tnf-r2
tnf-alphamatrix
coelomic
non-hematogenous
my-associated
decisionsmodern
diagnosisobesity
ficoll-hypaque-isolated
rm-srbc
rosette-negative
calla-specific
cyto-mu
identifiedmononuclear
patientsetoposide
leukemiasmicromirnas
earlierimatinib
fd-tpo
fdc-p2
megakaryocyteerythroid-specific
tpo-stimulated
warrantedcure
466we
diseasepretreatment
requiredvarious
therapymicrorna-125b
irx-2
d1s430
d3s1611
d11s29
d14s65
d17s520
cytogeneticallylittle
cmlcmpd
cp-14
0-i-ii
monitorised
cml-1cll
clspreferentially
mdssthe
polymorphonucleocytes
scorable
500patient
proceduremonitoring
cbahxc57bl6f1
ighr
tcrbetag
l-mls
tcrbetar
l-ml
cells--mpo
fixperm
buffered-formaldehyde-acetone
cd15mpo
cd7ccd13
cd2ccd13
cd33ccd13
mpoccd13
superantagonist
sant7
shuil-6r
proliferationmaintenance
enzymochemical
mudc
cd40-
dc-nk
responseseveral
cap10-like
hclp46
vitrowe
transplantationchemotherapy-induced
11-antibody
refrigeration
cd4cd8kappalambdacd19cd56cd5cd20cd10cd3cd45
formulationwe
presentationto
involvementca
2-deleted
d2mit126
d2mit185
sfpi1pu1spi1
generadiation-induced
amlawareness
kib3
prekeratin
samlt-mn
scenariosa
tgf-β-targeted
blooddraining
determinedthe
syndromesdespite
mature-cell
fmc32
fmc34
mortalityage-related
trim41
zfp62
mapk9
cnot6
ccr4-not
leukemiarecurrent
ceruloplasmin
myeloblast-type
75a
genotypewe
2p13-p14
d2s134
nib1519
iv3
ivg8
microenvironmentto
implementeda
cellsour
cd10-cd19
kp-l-ry
mll-af5q31
af5q31
af4laf4fmr2-related
studiesinfant
rategastrointestinal
d20s481
250-kb
p201e16
p29m7
aa368224
20qa
cellsfor
dic-related
infectionsserum
ccyrbcr-abl1
lifecongenital
myeloblaststo
sfps
nsrp70
chemotherapyto
lymphocytesthe
resi-dual
amlmir-181a
tim-3pd-1-
pd-1pdl1
tim-3galectin-9
reducing-albeit
eliminating-both
amltumor-associated
cytogeneticsdebate
hif1alpha
sdf1alpha
cancermicrornas
cd3cd4-cd8
formationa
ba-1t-mcs-2-
tba-1-mcs-2-
mcs-2ba-1-calla-t-
ba-1-mcs-2-calla-t-
cig
ba-2-
determinationsperipheral
toolaml
b12-related
markersproduct
j-spec
il12-
bcytotoxic
cxcr2cd11bly6ghi
cd11bly6ghi
insufficientacute
diedwe
amlirem-1
cryostorage
manipulationsthe
targetsin
pre-bcr
muh
lambda5vpreb
hsl11
hsl96
hsl2
non-b-
non-t-alls
vpre-b
developmentthree
transformationgenetic
afterwardswe
igll1
22deletions
approachescd33
inconclusivea
diseasewith
non-lymphohemopoietic
procedurecd34
mb2
115d8
eber-1
antigenabstract
epo-
assessmentthe
managementtransfusion-dependent
yth
leukaemiablast
ca-supported
mobilizable
threshold-dose
cd45-ra
eventsmegakaryocytic
siadhwe
c-activating
activityseveral
cd153
cd30l-deficient
cd30cd30l
cd11b⁺hla-dr⁻
cd11b⁺hla-dr⁺
anti-cd3-mediated
gata3⁺cd4⁺
scaffold-hops
gsk-
4-cyanophenylglycinamide
29a
developmentinhibition
tpa-sensitive
tpathe
autograftthe
myd118gadd45b
myd116gadd34
apoptosismyeloid
neutralisation
cd34-blast
functionwe
diseaset
mpnsthe
pathwayscpne3
unit-granulocyteerythroidmacrophagemegakaryocyte
bnkmyeloid
ftoc
cytocd22
analysispresence
surveillancechronic
calgranulins
mac387cae-
mac387cae
mac387-cae
s100-macrophages
cat-scratch
dermathopathic
settingstable
fractionate
fmet-leuphe
n-formylmethionyl-leucyl-phenylalanine
achievednext-generation
therapythalidomide
all-therapy
reticulohistiocytomas
xanthogranulomas
dermatofibromas
histiocyte-
mhc-i-related
ly49e
non-mhc-i-related
mhc-i-triggering
dx5-
nov-002
ii-iiic
acxa0→xa0t
αxa0xa
βxa0xa080
non-ph-positive
agentssirna
berh2
lrearly
combinationshandling
jalsg-all87
prednisolonea
articlein
k562pu1kd
k562pu1oe
mt-1
mt-1g
mt-1a
jdp
jdp2
pu1-bound
levelspu1
anomalyacute
aml-cn
differencesacute
responsesingle
lxr-independent
oxysterol-cxcr2
igg-derived
cd19-cars
hinge-ch2-ch3
ch2
ror1-specific
malignanciesonly
amltherapy
bar-abl
facsimile
nodesmyelosarcoma
amlextracellular
pcdlbcl-lt
pd-l1pax5
w51
w51-associated
pd16
ag1295-sensitive
granularly
reticuli
histiocytestwo
persistenceacute
unknownlevels
transplantationreticulated
ab9
pancytopeniain
cdla
allo-mlr
effectsdendritic
reportedcontroversial
amlcarnitine
neededtargeted
gzms
gzma
tcnk
gzm
25oh2d3
activationwe
discussedepidemiologic
aggressivesclerosing
htlv-iiib
ml-1hiv-1
hl-60hiv-1
thp-1hiv-1
u-937hiv-1
droppedthe
intermediate-to-large
entitiesthe
myelomadespite
cfdnaleukocyte
pwb
sil4r
leucopenic
cytopeniat
pdc-associated
costaining
targetstyrosine
associationthirty
transplantationblastic
classificationprimary
fimh
4-dependent
2-independent
a1110--g
t1130--a
t370
i377
daf-positive
gpi-anchoring
transformationfailed
caf7
caf7intermediate
caf7high
participatesthe
studiesarchived
46x-ydert1q1
46xderyty1q
or2q12
deryty1
disorderswe
activityacute
pgps
dodecylsulfate
strategiesexpression
establishedwith
l-2-hydroxyglutaric
translocationrapid
cfu-assays
g2-
exisulind-treated
exisulind-mediated
samlmdstreatment
recordable
pax-5cd34
doublestainings
cd79a-positive
doublestaining
periodthe
therapy-naïve
splnd
pplns
integrin-family
ang-1ang-2-tie-2
ang-1ang-2tie-2-
typerecently
lineagesuntil
assumedapoptosis
bloodleukocytes
unclearalthough
technologiescd34
cellsover
aplacute
pc-1
pca-1-
t10-staining
dyscrasiasa
hcabdlcabd
iga-her2-lcabd
iga-her2
dicsix
clonesaberrant
patientsaccurate
diseasemastocytosis
non-metachromatic
infiltratesan
factortreatment
scrutinyacute
gvpcss
bcrc-abl
cmloncogene
il13rα2-cars
cd28ζ
il13rα2-carcd28ζ
il13rα2-carδ
il13rα2-expressing
sma560
il13rα2-negative
il13rα2-positive
il13rα2-car
reconstitutiontransplantation
dosesnatural
ci-cultivation
cytokine-cultured
ci-treated
dcblood
approachespatients
cce
nlp
somefor
factorsdespite
propertiesenrichment
leukemiaexpression
defecthaemopoietic
mdsfunctional
nsclcrecently
amlresponse
iga2
b16f10-egfr
egfr-transfected
caseseight
hsctusing
inhibitorsepigenetic
cancerradiotherapy
q13q33
del5q13q35
d5s672
gata-p1804
anomaliesacquired
imcsmyeloid
abnormalitiesacute
control-pn
networksderegulation
myaml
consideredabstract
d-klaklak2
anti-cd19peptide
anti-cd33peptide
iceflanflan
ice-flan
nonmobilizers
ice-novia
pltl
icenoviawithout
rhil-10
rhil-10-treated
polychemotherapyexpression
m1acute
leukemiaphysiological
siteschromatin
outcomebackground
alemtuzumab-mediated
cips
m1m5
populationmany
cancermyeloid-derived
chemoattracted
vegf-containing
therapytargeted
antigenscd33
cd34lineage-
populationsabstract
quintuplicate
nonexistentit
lncrnamessenger
histone-related
leukemogenesislong
therapyphenotypes
crisisto
pre-dcs
pre-cdc1
pre-cdc2
pre-dc
peptidase-4
n901
neoplasiasperipheral
ferrara
4nqo‑induced
gr‑1cd11b
dihydrosphingosinexa01-phosphate
lcb3
populationbackground
ehf
licsgemtuzumab
bmtneutrophil
akxd23
akxd-23
provirally
akv
differentiationmyeloid
aacrbcl-2
observationscertain
1pd-1pd-1
mannose-modified
man-mps
metman-mps
metman-mps-reset
collagen-degrading
interiors
significanceprecursor
cd68-
infarctiona
nowthalidomide
paradigminteractions
cd34high
leukaemialeukaemia-propagating
useful--either
contradictory-information
m1-m6
m2-cd34
m3-cd13
m5-cdw65
37-marker
dlikiller
signr3
signr3-specific
mϕs
cd115ly6cint-low
pnad
hev-like
slns
mlns
cd11bcd11cint-high
cd11bcd11cint
pkh67-labeled
cd115ly6chigh
cd11bhighly6chigh
cd11cint
targetprospective
experiencein
battling
burdentoll-like
conditionsthe
cmlsequential
coxsackievirus
a21
cva21
responsiblethe
prognosticationb-cell
follow-upmyelodysplastic
formaldehyde-acetone
residentinfiltrating
bcp-leukemia
lymphoblasticundifferentiated
bcp-cell
b-i
enl-mll
teletv6-aml1
bonafide
emulation
b-lymphocytesa
therapyincreasing
fdaon
precursorsleukemic
alpha-il-2ralpha-
il-2rbeta-
chain-specific
p64
il-2ralpha-chain
il-9r
il-4r-
il7r-
il-9ril-2r
125i-il-2
il-9expression
smsystemic
cd34cd38-cell
non-m2b
aml-m5acute
giemsa-wright
monocyte-granulocyte-specific
phenotypesthe
proliferationcell
treatmentdonor
mllgaan
mllgan
d11s1364
d11s1356
instabilityrearrangements
unknownmicrorna-34a
meioses
21q-
two-point
d16s522
d16s451
d16s289
informativeness
deviance
npl
fra16b
e2f-4
sox3sox3
pbxmeis-binding
pbx1meis1-binding
regulatorssox3sox3
respondersthe
drugsleukemia-initiatingrepopulating
cd38-targeting
mor202
tak-079
upcoagulation
studyacute
antigensterminal
phospho-rps6
puma-bh3
cultureblasts
sids
leukaemie
availabletransient
scheduleswe
leukemialymphomaexpression
hspcs--however
chemotherapy--particularly
mirna-320c
mirna-1275
taurocholenate
regenerationhematopoietic
myaall
mya-
mya
expressedthe
amlincreasing
cellsan
patientschromosomal
damageto
int-dc
cd34-dc
necroticapoptotic
amlour
batf2
cd8αdendritic
mr-87
ph-acute
p190c-abl
anti-abl
agentsome
my1
m4-
my7-
my4-
identifiedin
proliferationhyperproliferative
quantization
gmlvq
lvq
diagnosisflow
toolsthe
transfusionswe
amlsurvivin
courseperivascular
tissuesgranulocytic
32p-proteins
10-microns-diameter
morphologicallycytochemically
casesabstract
wordsduring
diseaseprame
processingmaturation
clarifiedshwachman-diamond
exometranscriptome
dux4-rearranged
znf384-rearranged
etv6-runx1-like
mef2d-rearranged
b-rest
jakstat-class
rasrafmapk-class
p80r
diagnosticsnovel
cofactorsto
maffuccis
nonmesodermal
leukemiamaffuccis
monocyte-oriented
hcd30c2
cd30v-expressing
cd30v-negative
traf5
pclp
sialomucin-type
endoglycan
haemangioblasts
identifiedacute
discussedseventy
spectral-karyotyping
mir-182
fractionthe
warrantedduring
cellsconjugated
paracrine-acting
cd30l-expressing
counterreceptor
th2-like
cytokine-receptors
cells-produced
blastscd30
experiencethe
characterizable
cd19mpo
illustratednine
latent-stage
left-shifting
mpdsfollowing
notedextramedullary
vim-c6
vim-d2
vib-c5
vic-y1
vie-g4
vil-a1
specifially
unclassifiable-mo
b-last
data-analytical
anti-cd3-redirected
tetra
hl-60tr
cellscd9
cellscd34
karytypic
stimulationhepatitis
phophorylation
mini-magnetic
phosphorated
over-phosphorylation
apoptosisleukemia
cellspotential
karyotyperecently
cd14cd16-
cd14brightcd16dim
cd14dimcd16bright
transplantationin
definedcholangiocarcinoma
receptors-2
myd88-tirap
tlr4-ligand
adaptor-like
lymphocytestirap
cd34alphigh
therapyprevious
tu3
omics-based
physicianthe
i-tositumomab
lpstnfifn
tnfifn
der1tp13p
p13p
diseasescytogenetic
m900
m906
iii-like
igg-like
m900-induced
m906pbd
m900pbd
cd56-mediated
therapeuticscd56
rhod
labelings
patientsexpression
ltalpha
cycleapoptotic
p871l
ercc2
k751q
hmlh
v219i
s31r
rag1tm1mom
mhc-ii-
interleukin-3granulocyte
factorerythropoietin
p210deltash2
sh1
p210bcr-ablthe
osu-03012
osu
17-n-allylamino-17-demethoxygeldanamycin
remainthe
donal
markersmuch
lymphomamantle
bpdcnmyeloid
4-nitroquinoline-1-oxide
cancer-resistance
reverser
reversers
testedmarkers
b4-positive
tg1
amlelderly
amlbispecific
inducing-chemotherapy
anti-pd-1ctla-4
mpalthe
tumorscellular
promisingly
multi-receptor
axitinib-mediated
raeb-2patients
mirnasmicrornas
cellsproteomics
intraobserver
subtypesthis
oncoproteinmucin1
transcriptsone
cd200-cd200r-compex
cd200-cd200r-complex
camls
micromethod
cellwe
j5-
ba2-
okb2-
ba1-
al15
tumorsmetabolic
hormone-integrin
l-thyroxine
3-triiodo-l-thyronine
numberviability
ataxia-telangiectasia-mutated
tetrac-initiated
tetrac-induced
cytometrya
inhibitorshispanic
germline-encoded
reorders
svms
cellb
tumornontumor
kernels
mislabeled
discussedtranscription
cd123differential
ccd3-negative
p2y1
p2y2
p2u
apyrase
ecto-apyrase
ecto-nucleotidasesthe
leukemogenesisinfant
ogp
ogp-treated
granulocyte-erythrocyte-monocyte-megakaryocyte
bfu
testmoreover
granulocyte-megakaryocyte
factorosteogenic
amllate
patientsresearch
cn-amlacute
hiratsuka
reviewover
vagueness
cmpd-nos
postfollicular
which-even
lymphoma-may
doimodpathol3800225a
doimodpathol3800225
c-mp1
casesit
markersleukemic
blastsgranulocytic
trail-dr5
disordersboth
all-human
6-yr-old
maturation-specific
well-chosen
raspdgfr
cd31-positive
n-exoaminopeptidases
iv-like
dfp
diprotin
n-aminopeptidases
n-aminopeptidase
lobulitis
pre-assigned
esm-1
neoplasmsblastic
evolutionmutation
amldnmt3a
gridding
respectivelymicroarray
rundc3b
mapk-inducible
hspa5
ltddna
aml-m5the
markerthis
delta-1
elucidatedit
flt3flk-2
fl-mediated
post-5-fluorouracil-treated
mscv-fl
cytokinereceptor
cytomatrix
rgds-containing
anti-cd18
anti-cd54
mannosyl
pyranosides
marrowadhesive
bsp-1
blue-negative
6p21the
mature-b
folate-modified
interferon-γ-inducible
trp2-specific
cd8cd28
navitoclaxbcl2
cml-mbcwe
amlrecurrent
marker-devoid
gene-tagged
respectivelypreclinical
cell-depleted-bone
c3hsw--b
literatureto
theclinical
barrierscharacterization
leukaemiasbacterial
mlc-
g-csfkgd
erythropoietinkgd
recoveryallogeneic
testedhistone
amlcd33
cancerthis
casesdue
htert-mutz3
scf-rcd117c-kit
informationwe
npy-like
p-npy-li
medianinterquartile
survivalneuropeptide
huh-6-cl
tong
csf-producing
donorshaplocord
neoplasmsclonal
studiedplacental-like
myelomahematopoietic
ddii
neoplasmdna
survivalin
amlindividuals
lkb5
ki-b3
anti-s-100
anti-alpha
dako-m1
killerkiller
anti-leu-7
small-to-moderate
leu-7-positive
compound-heterozygous
cbfb-gfp
dn1
lck-cre
leukemiarecent
hmrp8-aml1-eto
hmrp8-aml1-eto-transgenic
aml1-eto-related
t11qq23
nfatinternal
ad-si-il-17
th1-dominant
herethe
two-loci
cell-donor
depletiona
eosinophil-
basophil-type
phenotypescd22
tpa-stimulated
hcd30c1
b-site-dependent
receptor-upregulating
anti-gp130
gpx7
gpl30
kinaseaml-193
killer-activating
scfv-nkg2d
scfv-nkg2d-mediated
ligand-negative
q23q24
q27q23
ehr4
mlr4
ziemin-van
poel
d11s272
d11s273
d11s219
etsoncogene
cancerstranslocations
patientsdata
lowerthere
vim-2-mediated
drugimatinib
patientsbone
iodolabeled
lactoperoxidase
processhuman
fvax
preimplanted
teff-to-regulatory
teff-to-myeloid-derived
double-producing
pd-1pd-l1-
ctla-4-negative
counter-regulate
lymphangioleiomyomatosis
receptorspulmonary
lam7
tdt-ve-aml
regimensdata
hl-60dmin
hl-60hsr
observedas
feasiblemutated
cml-ecp
disconnect
nilotinibthe
hematopathologysystemic
il3-treated
patientspretreatment
neoplasmsgranulocytic
8-chlorophenylthio-camp
rp-isomer
8-bromo-adenosine-
monophosphorothioate
rp-8-br-camps
sp-8-br-camps
camp-increased
levelsduring
wax-embedded
mbkb5
anti-ema
tal1b5
2b11cd45
cd14-specific
cml-dcthe
bcg-cws
diseasemicrornas
leukaemiaproliferation
identificationa
precursor-alls
cmlhigh
muc1-st
glycoform
tam-like
abl1-directed
cd15cd33-cd34-
clonesevere
homopentamer
liquid-liquid
npm1-targeting
strategiesnucleophosmin
cureblastic
syndromesmonitoring
futuremyeloproliferative
usage-optimized
extracellular-transmembrane
wbd
test-tube
time-efficient
isachuman
patientsseminomas
diseaseoncogenic
baalcto
jl1
cd38-lo
ociaml
bimodulatory
leukemiaconventional
tp32q11
tald
t-non-hodgkins
pheno-type
unknownimatinib
lifeintensive
raremyeloid
targetin
bct‑100
hcc4006
decarboxylasexa01
channeled
α‑difluoromethylornithine
dfmobct‑100
apoptosisarginine
cd34cd10
haemopoiesisthirty-seven
availablecd33
fluorographs
electrophorograms
35s-labeled
17k
36k
16k
120k
35k
dalton
macrophagesin
mcl1there
ams
a-naphthyl-acetate
a-naphthyl-butyrate
diseaseschronic
camal-mediated
cellsmaintenance
m5to
detectedpatients
underestimatedacute
amltetraploidy
follicluar
myeloid-dendritic
basophiliathe
l-ornithine
lscsleukemic
ζ-globin
sensitivitychronic
endogenous-like
mll-fusion-induced
plzf-high
plzf-driven
chemotherapypersistence
chemotherapygranulocyte
vp500
vic-e
403-fold
ligandthe
cellsanti-apoptotic
debateaberrant
d11s939
d11s924
protein-tyrosine-kinase
mllwe
unclearvimentin
analysisninety-six
targetspurpose
rejectionhla-mismatched
analysisacute
restorationreimplantation
125i-csf-1
v-fms
populationtumour
detectedstate
significancea
differentiationthirty-two
lscs-targeted
leukemiassince
hl-cz
hiv-ltr
nre
nrf
genestrans-activating
amlsingle‑cell
amlcombination
understoodmyeloproliferative
cd90several
asxa0regulatory
q22-q25
casesan
patientstet2
stabilitybased
disordersserglycin
cmlhematopoietic
hada
n2tada
n2ada
transduced-marrow
vectorstwo
hyperleucocyte
nhal
eryth-lineage
naiver
initiatedthe
clonogenicityall-trans
leukemiascd71
othersmajor
45-kda
approximately190
tgase-catalyzed
tgase-specific
enzymehuman
transcriptase-like
regulationwe
chimerization
self-fusion
self-fusions
donorsa
msmyeloid
knownacute
savitz
–295
–391
goldstein
–230
infante
–109
state-of-the-science
referencedover
mdah-2774
eventsovarian
mitochondrially-targeted
bystander-like
infiltrationallogeneic
proteindna
ki-67dna
pcnadna
nonreplicated
dnausing
wide-scale
cd34cd14
anthraquinone-derivatives
mitoxantrone-generated
node-homing
blastsabnormal
empless
progenitorsaltered
aptamer-hybrid
mirna-29b
deltact
expressionsthe
unit-endothelial
cfu-ecs
endothelial-colony
ibiditm
culture-inserts
nf-κb-dna
hcc-induced
protein-3α
fusionsjuvenile
patientsderegulation
adultsfew
leukaemiato
trialswe
treatmentmicrosomal
developmentacute
lil-stat
il-1-inducible
band-shift
lps-and
il-1-responsive
lilre
site-like
differentiationcytokines
processesalthough
standardsnext-generation
lps-responsive
ch12
lx
ch12lx
up-regulations
lps-stimulation
cd14-independent
samlan
recoverycutaneous
malignanciesa
tlr9‑associated
odn‑m362
12q12-q14
12q12-q
170-kb
d12s1504
d12s1509
cytotype
ly--my
existfifty-six
cscsthe
malignanciesdna
phospho-proteomicsvalproic
cd117cd34-
cd117cd15
cd117cd10
hladr-cd34-
cd34hladr-
frequenciesin
cytokinehemopoietin
prl-r
prlprl-r
nklak-target
responseour
pd-1pd-l2
pd-l1b
4-stromal-derived
hsc-mobilizing
off-labelin
technologyalu
institutionsto
non-m4non-m5
smallflow
tumorsdna
epithelium-cadherin
hoxb4-induced
killernatural
examineda
pyranocoumarins
--4-
o-acetyl-3-
o-angeloyl-
cis-khellactone
peucedanum
praeruptorum
phospho-mek
apc-induced
differentiation-treatment
leukemiadifferentiation
3internal
flt3i836
arg1-positive
21-y-old
72-y-old
perirenal
plump
fascicles
congenitalinfantile
angiofibroma
amlzoledronic
b7cd80
cd80cd28
cd28il-12
cd45ra-ccr7-
functionsthe
responsethe
pancd66
d14hd11
9a6
prognosisdespite
cloneselection
myelomonocytic-positive
lymphoid-negative
survivalbetween
cd68-expressing
allo-restricted
cd68-derived
cellscd68
125iurokinase
sulphate-stable
upa-pai-2
125iupa
cd11alow
cd11bhigh
sigmlow
cd11ahigh
cd11blow
sigmhigh
adhesionwe
neoplasmsin
lg14
alpha-tos
hrtrail
cd38-silenced
expressioncd38
achievedacute
patientshypomethylating
haplomismatched
outcomenatural
clarifiedmyeloid
populationit
melanomatnf-related
cml-n-1
cml-c-1
cellsperipheral
repairmonoclonal
bmtone
nilotinibnilotinib
nsaidlittle
mpa-dmba-treated
mpa-dmba-induced
slower-progressing
factorsacute
modeldevelopment
clipdisease
biopsiesin
appropriateacute
dapk2
ca2calmodulin-regulated
maturationthe
materialthe
46xytq34q11tp32p21
proto-oncogeneacute
scf-responding
egfrt
89zr-cetuximab
non-transduced
egfrt-modified
implicationsstudies
relapsedetection
parsimony
mc3
vitrogranulocyte-macrophage
regionwe
protocolsdetection
micrornato
ltvspwy
dau═aoa-ltvspwy-nh2
daunomycin-peptide
dau-containing
dau═aoa-leu-oh
dau-conjugate
drugdaunomycin
flt3itdthe
stratificationimatinib
gmp-140
padgem
lactosaminoglycans
protease-sensitive
125ip-selectin
3hglucosamine-labeled
peptiden-glycosidase
cellsp-selectin
treatmentcirculating
cgvhdchronic
discussedisolated
resistancefrom
cd56cd16cd57
cd56cd117-cd16cd94nkg2aeomes
cd56cd117cd94nkg2a-rorγt
il-22-producing
ilc3
stat5-signaling
ilc3tyrosin
therapythirty-one
rdthe
antibodiesthe
hemostasic
tq23q14
leukophoresed
functionacute
drugscancer
cd80ctla-4
humility
decadethe
nct01061177leukemic
subtypesacute
laca
l801
electron-microscope
mll-ptdthe
amlfarnesyl
l833
l883-a
l833-b
studiesa
limitedchronic
rfc3
creb-knockdown
technologyevaluation
interventionan
79xa0
dependant-kinaseabnormalities
limitedprimary
lentil
lectin-binding
valuethe
transplantationacute
tdtcd19cd10cd7cd2cd4
methodscdx2
cmlusing
antigensadoptive
kshvhuman
kshv-infected
200-amino
periodate-reactive
classificationcytochemical
cell-released
leukemogenesisspectrins
pro-alpha-tryptase
frequentlyco-express
2d7
basophilsdespite
cd45rocd27cd57-
cd45ro-cd27-cd57
sctantigens
malignancyto
evolutionthe
hmasdna-hypomethylating
wt-hl60
ecto-
ectopeptidase
perturbants
cd13previous
vivowe
actionsann-joong-kuey-jian-tang
evokedprogress
pictureclonality
amlhedgehog
αher2
antibody-sialidase
siglec-e
mcl1delta4a
pcnamcl1
3a2
mandatorymyeloid
kinasethe
amld10
pgcell
targetsglioblastoma
prelminary
e-group
discoveredpost-translational
amlmounting
siglec-8the
amltargeted
rar-alpha-transduced
cellsalthough
8-kilobase
rearrangementa
lymphomamyeloid
approachescd34
studiedcytogenetically
cd277
btn3
antigenpresenting
butyrophilins
butyrophilin-like
erythrodermic
monocytes-derived
knt
neoplasia-induced
knt-derived
donorsbone
acid-sensing
slr
slr14-treated
slr14
p21cipwaf
macrophagesneutrophils
phosphorylationpurpose
unexploredthe
ultracentrifuge
hmsmany
investigatedprognostic
diagnosisexpression
ev-pcahaemostatic
dliadoptive
agglutin
bryostatin-5
bryo-5
laf4
2q-12
tq11q23
newren
r3-peptide
ilslelmkl-specific
r3-pulsed
cd8r3tetramercd45raccr7-cd27-
cellsspecific
disorderspatients
5qqq24
fusioncytogenetic
diagnosismyeloid
discussedmicro
neu3
sialosylnorhexaosylceramide
rsk90
gm3-rich
nearest-neighbour
clustering-based
nns
settingsdeep
t-cell-inducing
tnfα-secreting
ptcstudying
polycythemia-smokers
polyglobuly
essential-hemorrhagic
hti
kineticsin
bms-225975
feasiblehsp90
histiocyte-associated
pax5-
cytogeneticepigenetic
exgen
fitc-on
chemosensitizationantisense
7alpha-hydroxy-4-cholesten-3-one
hypocholesterolemiahypocholesterolemia
nk-cell-
tvq22q22v
amlthirty
tlr8-myd88-irak4
g1g2
levelsabstract
streptavidin-red670
sa-red670
subpopulationwe
apoptosishepatic
ul-38
auls
populationimatinib
t21
n-terminal-truncating
gestation-matched
ds-fl
disorderdown
supportserum
neoplasmspast
clustercolony
triose
t11l17
t4q4
75reports
regimensin
differentiationcutaneous
beta1-r
helminthic
reactivitythe
extrathymic
discussedan
sepsisin
fl-haigg
bindingreceptor
rhadinovirus
rrv
hhv-8kaposis
siv-infected
coinfected
vcd200
methodsevaluation
cellsinfection
tc-12
th-3
tc-6
tactile
lineageto
patientsthrombocytopenia
pathwaypediatric
lectin-agglutination
therapyforty
lambdakappa
bl-cml
believedcytofluorographic
leukemialeukemias
vivohematologic
survivalcytogenetic
inhibitorslsd1
blockadepatients
lymphoid-monocytic
casesblast
limitedmicroarray
investigatedpossible
ma4
pro-b-acute
ma4-mediated
ma4-driven
ma4-expressing
kras-mediated
m-csf-differentiated
melanoma-conditioned
mcmimφ
anti-cd10
61cr-labeled
sp-cd34cd38-
spcd34-
leukemia-ic
spcd34cd38-
nycomed-norway
anti-bdca-1cd1c
anti-bdca-2
cychrome
pharmingen
reagentsflow
high-gradient
cd34hla-drlo
bm-ha
bm-cml
cd34hla-drlocd38lo
macs-enriched
mncwe
cancerlow
mono-specific
amlbi-specific
il-6pe4e
lt12il-6r
factor-toxins
evaluatedwe
fcrγ
pi3kγ-dependent
pdac-bearing
pci32765
cd34cd117c-kit
g--t
asp816--tyr
d814y
d817y
cd34cd117-positive
factor-independence
cytomorphologiccytochemical
etcninety-eight
four-microsatellite
d7s515
d7s522
neoplasiasdeletions
b-allas
progressionhydatidiform
groupsmyelodysplastic
cgrin
stratificationbiphenotypic
b5-
allcd10
seven-span
7-tm
cellscirculating
rarera
anllto
furtherwe
functionsbone
60b8
evalution
non-carcinomatous
neo-expression
neo-expressed
vacs
marrowsplenic
d265h
multiple-cell-lineage
amlclinicopathological
methylaton
disordersp15ink4b
gc-treated
cx3cr1loccr2ly6chi
ly6cmed
il-4ralpha
point-mutational
inv3q
allchildhood
ppardelta
co-operated
vd-mediated
patientsvascular
florescent
colorschronic
reversionin
hematopoiesisaberrations
leu-19
gliadin
enzymically
peptic-tryptic-
peptic-tryptic
alpha-gliadin
phosphomannan
saccharides
v8
v9
potentialcd44
hla-drtdt-calla-phenotype
hla-drtdt-calla-ba-2
hla-dr-ta-d3
hla-drtdtcalla
directionsa
transplantationhaploidentical
subtypeswe
wordsthis
myelolipomata
extra-renal
calretinin
myelolipomatous
ck20
gcdfp
brst-2
synchrony
rejectionmurine
analysiscirculating
mortalityt-cell
anti-cd3cd28-stimulated
nct02678338cd47
futuremyelodysplastic
mabstem
cre-loxp-mediated
translocators
leukaemogenesischromosomal
receptorafter
signalinganaplastic
persistsnineteen
maintenancein
cd4cd14
mnk-al
a-mpo
childrenmalignancies
cancersepigenetic
apoptosisto
allo-peripheral
sossinusoidal
lymphomaan
t-allmyeloid
ci-1
bu60
him95
hi247
cslex1
galbeta
fucalphaglcnac
oligosaccharide-polyacrylamide-biotin
oligosaccharide-bsa
sialyl-lewis
neuacalphagalbetafucalphaglcnac
endo-beta-galactosidase
sulfo
cslex-1
6-linked
3-linked
anti-lewis
6c7
fh6
heca-452
anticarbohydrate
organ-level
ultrasmall
pluronic-stabilized
srcstat3
teratomawe
targetsnovel
fujiwara
trialstargeted
il-6-unresponsive
cytokinessomatic
orosomucoids
transplantthis
cp-cmlchronic
nct01902329vadastuximab
targetingthe
subsetsalthough
stat5b-transduced
vaccinethe
mutationnucleophosmin
pu2009120
outcomeinteractions
sanin
cfu-cml
1dish
cfu-cml-formation
g-csfdish
rhil-4dish
g-csf-directed
skinsoft
bcl-15
ck15
ck7ck20
epithelialneuroendocrine
skinmerkel
cd34hla-drmpo
tassociation
malignanciesobjectives
tbg
kgml
tbgthe
resultsacute
myeloidnk-precursor
lymphohematological
complicatedcd56-positive
cellshigh
wellmoderately
wordsserum
precursorsspecific
technologiesclinical
macrophagelike
trialsconventional
sarcomasystemic
advantagesnpm
discussedinduction
copeptin
groupcopeptin
leukemogenesiswe
leukemiasflow
reviewedwe
expressionjunb
cells-based
amlcebpa
lymphosarcomas
signalsa
cytokeratin-19
ba46
lactadherin
ba70
northern-hybridization
provenance
p717
anti-lactadherin
leukocyte-function
p718
st486
clec-2
clec1b
clec-2-dependent
membrane-organizing
clec-2-expressing
cd37n
--n
podoplanin-induced
clec-2-deficient
microcontact
migrationthis
dsdown
srspontaneous
genomics-based
shortlisted
testingearly
nct00785525we
interventionscomplex
pathwaysthere
nacneoadjuvant
leucoconcentration
cellsantisense
nodscid-b2m--
discontinuationit
tpa-added
tpa-free
lineageleukemic
fishacute
tumor-escape
cd85k
pt-all
pt-allto
m0-m3
influencealpha-naphthyl
limitedknowledge
trial-modified
inter-sample
within-class
jcm
kullback-leibler
nanobiodiagnostic
biofunctionalized
uv-visible
pico
aptasensor
nanodiagnostic
nanotechnologiesgold
tq23
cd7cd34
developmentcd7cd34
investigatedtyrosine
fnfebrile
anti-ccr5
il-6-stat3
retinoid-metabolizing
precipitous
effectshaplotype-mismatched
degradation1
cyclins2
skp2-
s-phase-positive
settingachieving
gene-chip
profilesto
survivalevent-free
heptamer-nonamer
chi-octamer
line-i
4g7
limitationsacute
aimedtyrosine
malignanciesrearrangements
liverthe
toxicitythe
cells--including
cells--in
amlduring
haemoblastosis
after-doxorubicin-treatment-aml
degranulationwe
mye-euniter
ifnbeta
parallelled
patientstreatment
compartmentsmyelodysplastic
significancerecent
inconsistencycurrent
introductionxa0xa0
xa0currently
objectivesxa0xa0
xa0the
zap‑70
heavy‑chain
high‑resolution
resultsxa0xa0
xa0patients
conclusionsxa0xa0
cllintroductionxa0xa0
trialsleukemic
rsvm
llc-ln7-conditioned
2multiparameter
featuresthere
cmlstroma-supported
defectl-selectin
workersbenzene
neoplasmsto
ld78
alphaavidin
runx1r174q
t2-all
1p-23
tcrδ
tet2p1962t
alterationsfamilial
vivoparp-1
agvhdacute
sclarea
futurethis
124-kd
antigenwe
evaluatedaccurate
monocytesabstract
brightcytokine-induced
maintenanceas
cd13my7
cd33my9
celltranslocations
specimensthe
intermediate-late
stroma-noncontact
progenitorscd34
relapsenucleophosmin
wd-emt
pd-emt
blastic-emt
lesionsin
ssx-2cancer-testis
patientsjanus
slice
leukemiaanalysis
chromothripsischromothripsis
patientsachieving
neoplasmspatients
agrs
cd28-based
granuloma-like
autotoxicity
th2-cytokine
pkh-26
gf-cultured
gf-induced
cd45cd13cd34cd38
disregulated
numberkg
cd34hla-drcd33
hla-dr-cd33-subpopulation
genesprevious
gpiib-iiia
transformationmyeloid
pml‑rarα
pmlnls‑
pcmv‑ha‑ne
nb4‑ha‑ne
aplpromyelocyte
graftsseveral
bcp-alldysregulation
bandings
bcr-u
bcr-he
p22q11
t13
q34q11q21
p21q32q11
tx12
ph-bcr
ph-bcr-cml
basiscytogenetic
abnormalitiesidentifying
single-color
cellsdespite
bioanalyser
dna-500
sizing
d839
productsmutations
reconstitutionserum
fluorine-18
fluoro-2-deoxy-d-glucose
t-amlchromosome
resistance-protein-mediated
warrantedthis
infantspediatric
biomarkersmicrornas
fieldincreasing
bd-ca2
interferon-producing
pmplasmacytoid
transplantationour
womenthe
predictivesevere
cd138-purified
myd88traf6
anti-b7-h1
conclusionsan
fab-m1m5a
fab-m2m4m5b
cd13low
cd14low
il-3gm-csf
tnf-alphain
riskin
pathogenesismecom
cd123chimeric
deacetyl
reviewedrecent
ia-positive
ia-negative
mo-m4
antigensit
pml-rarαtranscriptional
evi1-silenced
gpr54-ligand
evi1-dependent
aacroverexpression
tap2
discrepancytransporter
samethe
cellsgranulocyte
amlgraf
yap1-kmt2a
fusion-negative
msk-impact
sefs
kmt2a-yap1
yap1kmt2a-rearranged
hyalinized
diseasesclerosing
methionine-labeled
rhamnogalacturonan
rg-ii-stimulated
eg7-lymphoma
rg-ii
ova-pulsed
pathwaywe
determinationthe
add7q11
snord
dlk1-dio3
14qii-1
rbp16
developmentapart
debatableidentification
mpdmbc
jbibii
amllthe
amltq22q22
vα24
vβ11
cd1d-positive
cd1d-negative
cd1d-independent
αgalcer-loaded
cd1dinvariant
para-orthic
lymph-nodal
aplalthough
nk-amlthe
quicklyflow
whatsoeverbackground
vertebras
epidurally
thrombembolia
gsgranulocytic
trialschronic
damagethe
therapyddit4
patientsfactors
h-mdsit
non-metastasized
nsg-hla-a2hhd
self-tolerant
preselects
intra-femoral
intra-venous
timehistomorphological
m6-aml
criteriacriteria
reviewolder
cn-amlin
microarrayswe
70--solid
37--acute
21--chronic
15--myelomatosis
50--by
anticomplementary
patients--different
detectedcirculating
allo-hsctbrain
nct01893320vosaroxin
casesabnormal
patientsmonitoring
dcn
hemoreplacement
pctto
mediated-at
partially-by
iga-mediated
antibody-opsonized
ecv-304
m7-down
amlforty
hsctrelapse
chemotherapymutations
gvhdprospective
patientsprogranulin
diagnosisnucleophosmin
interventionaberrant
targetswe
elusivethe
v-erbb-induced
strategiesan
lymphomaspaul
stressedtwelve
comc
comc-mediated
mapk-ho-1-dependent
migration-mediated
activatedas
ontogenythe
lymphomaincreased
tfralthough
cytopeniasmyelodysplastic
applicationquiescent
cytosolantisense
attributesacute
dlcmost
soyasaponin
sosa
tlr2-
tlr4-induced
mutz-3-cell
peptidoglycans
raster
maturation-like
aureus-induced
pgn-
myofibroblastomas
proteinscd34
studiesxenotransplantation
microenvironmentchronic
exploitedtp53
recipientsin
targetsphiladelphia
databronchopulmonary
etv6the
questionedwilms
diseasesmultidrug
telomeric-associated
cd34leukaemic
tep1
trf1
cmltelomere
contributethe
investigationacute
hbmsc-derived
protein2
mzf-2
n-phosphonacelyl-l-aspartic
pala-resistant
relapsedetermination
cellstumor
modelsacute
mpogiven
strategieslenalidomide
follow-upthe
exhausteddysfunctional
anti-ctl
reinvigorate
hepatitis-like
reactived
cloneserologic
9e8
foundwe
leukemiasm195
leukemiacd4cd56
nucleotides--adenosine
subforms
malignized
non-t-
leukosisestimation
centuryleukemia
ci-activated
cmleffective
anti-3rd
sialyl-lex
glcnac-
dlbcl-like
germinal-center
irf4-expressing
toxicitya
wm85
cc9
eb4
muc18
hemopoiesisdespite
subgroupminimally
rs-aml
rs-mds
pd-l-untranslated
ongoinginhibitory
managedacute
neoplasmscd79
marrowextramedullary
clonenm23-h1
foundchromosomal
1f5
complement-containing
fcalphari
double-transgenic
cd20-directed
investigationswe
prognosisexpression
mir-1244
leukemiamicrornas
diagnosisdrug-associated
allo-hsctthis
hpb-aml-i
derived-preadipocyte
preadipocytesin
cellsprotein
cellscancer
nodshi-scidil-2
rγ
epithelial-likemesenchymal-like
behaviorsacute
analysisaldehyde
amlmore
vivodespite
tricarbocyclic
cellscotylenin
fibro-osteosclerotic
myelofibrosis-myeloid
inflow
casesrecently
preclinicalearly
histocytes
histocyte-related
targetslow
effectsmesenchymal
best-spread
tumorsobservations
tn-
fluorescent-activated
pomatia
burst-forming-unit
licr-lon-r10
snu-5
snu-16
gt3tkb
micro-metastasis
methothelial
met5a
cancerswe
clinicallymalignant
cd34egfp
promotersto
amlten
chemilumimetrically
ascides
nhlca
svv
factorsinsulin-like
requiredgene
damage-
anti-tgf-beta1
tgf-1-mediated
bcl-xlto
patientsflt3
discouragingtwo
11-associated
monocyte-macrophage-associated
pathwayimatinib
deviationchronic
granulocytemonocyte-colony
gm-csf-mobilized
laf-1
cd34cd44
laf-3
cd34l-selectin
vasculitidesone
differentiationpatients
yb5b8
exploredafter
importancemutations
toxicogenomics
assessmentbenzene
ipsstelomere
microenvironment-including
programs-can
checkpoint-modulating
di-gmp
cdgcheckpoint
invokes
therapieschordoma
tragic
informationexcessive
prep1ii
cmyb-positive
prep1meis-pbx
pbx-meis
t-lymphoid-cell
infiltrationwe
approachesin
pan-acute
crthe
sculpturing
zfblp1
zfmcl-1a
hepatogenesis
zfmca
postfertilization
hnf-1alpha
-3beta
4alpha
zfmcl-1a-mediated
hyperplasiaapoptosis
outcomesin
neutropeniathe
key-properties
hivhematopoietic
cd27-expressing
csf-scd27
pelikine
m1960
markerreportedly
institutioncd43
unknownmyelomastocytic
mzg
twin-twin
twinobservation
-c-kit
-hla-dr
myelodysplasiaa
cd3ƹ
upreglulated
cd3-binding
pd-1c-met
dvd-ig
cellular-mesenchymal
c-met-expressing
c-met-overexpressing
proteinsdevelopment
phenotypeselderly
fucosyl-
st6gal1
cctranslocations
biomarkerthe
survivalrecent
anti-cd137
b16ova
integrities
batf-3-dependent
crosspresentationcrosspriming
crosspriming
performedprolonged
conclusionalthough
responseunderstanding
icam-1cd54
bcd86
bcd80
lymphocyte-tumour
investigationclinical
spi1-induced
p38mapk14
dec1
leukemiatranscriptional
trilineage-myelodysplasia
46xyt12
p21q12p13
936e2
t12p21q12p13
qp13we
qp13
htlv-2
tax2
cd3tcrαβcd4cd25cd45rocd69
kinasenf-κb
tax2-established
tax2-mediated
cd34-depleted
populationscells
bsig-t-my
b-sig-t-my
bcig-sig-t-
fashionalthough
articlepretreatment
subtypesblockage
anti-pd-ligand
cd45-gating
cd-antigen
poortrisomy
my-b
liverspleen
daunorubicinall-trans
covariateswe
cd38-related
respectivelymyeloid
cd170
amlsialic
self-lipids
methyl-lysophosphatidic
mlpas
mlpa-specific
cd1c-expressing
self-lipid
lipid-specific
cd7ccd3cd1-cd3-cd4-cd8-were
my-pro
shps-1
downregulatory
beforeone
beforeduring
spontaneousactivated
cd3cd95
spontaneouslps-stimulated
resectioncombined
precisely-timed
requiredaberrant
peritonealovarian
tcrδ-deficient
il-17-deficient
vγ6
vγ1
vγ4
il-17-secreting
testeddna
prognosisfollowing
timescostimulatory
alb6
anti-p24
alb-9
calla-negative
user-guided
flowmass
institutionswhen
survivalaml
debulked
diseasetumor-induced
advantageretroviral
leukemogenesisaml-associated
nt-amlpatients
megakaryocyte-erythroid-specific
tcpc
uropathogenic
tir-domain
cft073
δtcpc
uroepithelial
il-6il-1
uti-associated
non-prostate
bg-1
limitationsprostate
presentedt-cell
nonsuppressive
hyperprogressive
d8s263rmc08p029
d8s256rmc08p025
8q-q
identificationchronic
patientgastrointestinal
alone-and
radioisotopes-to
leukemiaduring
proteinto
therapyidentification
antibodiesdifferent
targetslymphoid
progressionto
cdr-grafted
gem-ozo
sub-pg
calml
calkg
nonbinding
fdacd33
icsbpirf8
tumorsplasmacytoid
recipientsendothelial
erythroblastspure
elicitorsince
karyotypefms-like
systemscytogenetics
involvedcd7
trisomywe
amlqualitative
lcms-esi-it-tof
capicua
cic-s
muc16
rgpd8human
ranbp2
gvhdgraft
anti-haemostatic
tfpatients
dc-controlled
th-phenotype
malignanciespancytopenia
foxn1
cd205
leukemiasit
amlvascular
leukemiacanonical
scbsdb
scbsdbs
kk4
jh4
vj
jk5
scbstafv
patientscd33
normocellularto
nca-55
anti-nca
dual-labeling
yb5b8cd34cd33-
yb5b8cd34cd33
leukemogenesisprogression
diseasegene
findingsthis
leukemiadysfunctioning
iv-3
fabm1
rmonoclonal
25-kda
pro-mbp
naturethe
knowncirculating
patientsapproximately
monoblastoid
ut16
erkmap
ptp-1c
ptp-meg2
p19-ptp
hptp
ptp-u1
tcr-3
haemato-lymphoid
fosb-expression
amlhistone
leukemiareports
car-specific
pre-transfer
itams
cmlimatinib‑based
pre-b-lymphocytes
transformability
mu-h
fabm0
ceacam1-transfected
m1s
m2s
pls
n327
cellpreleukemic
lymphocyte-conditioned
rage-pathway
age-cml
leukemiax-linked
therapydifferences
platformacute
m4e
classificationabstract
wordswe
treatmentcontemporary
formationwe
cd11ccd11bly6chi
cellsxa0such
antibody-synthesizing
vacuolations
diagnosisa
29we
effectsvaccination
chemotherapygene
scd40
cd40-based
unknowncd40
bouins
lackingto
precursorswe
biosimilarity
ab-stimulated
discussedcd4cd56
pcrmajor
xg-1
top-7
zoom-isoelectric
zoom-ief
2-dge
up-down-fold
saa1
hierarchyon
unit-fibroblast
sspb
fcb
cxcr-6
regimensto
survivalgranulocytic
discrepanciesthe
differentiationdifferentiation
informationmutation
pm81
toxicitiesthe
negativeblastic
ror2
cllhairy
ctla-4cd152
pdl1cd274
hu-cb-brgs
65-kda
anti-p65
mf11
double-antibody
endpointsthe
mitoses10
s100-protein
purposeswe
completionchronic
rarethe
analysisa
ce-epcs
cd34lin--enriched
ce-epc
vwf-positive
alsosystemic
8g12
cd45-rb
cd45-ro
ra-ro-
unit-gm
34ra
34ra-
unit-erythrocyte
45ra-
amlexpression
lncrnasacute
carcinoma-cholangiocarcinoma
hcc-cc
databasebiphenotypic
malignancy-derived
microenvironmentsmall
ystssall4
ysts
cellsblasts
2beta
pebp2b
pair-rule
cleidocranial
cbfb--
runx2-dependent
developmentcore-binding
5nucleotidase
leukaemiaspyrimidine
c1g
c1m
tl-specific
pics-j
bfu-mk
c1g-treated
crin
negativethe
samplesour
iscomatrix
cd8α-
iscomatrix-based
clonesa
pd-1tim-3negcd4em
pd-1negtim-3cd8
ctla-4neg
agentsalthough
adultsconflicting
advocatedfifty
linesnucleophosmin
malignanciesrecent
continuance
amlcertain
cancertargeted
insulin-resistant
laboratoriescytogenetic
futurebleeding
allosctdonor
deprotected
pronetelomeres
elucidatednpm1
featuressurvival
pax5-dependent
progenitor-specific
leukemiacorrect
lps-lps-binding
micrograms24
relationshipabstract
exposureimatinib
o-aminobenzamide-based
hydrazide-based
13e
apoptosispreviously
cd95apo1
aspirationgranulocytic
imthe
significanceaberrant
pre-tt
myeloid-lineage-associated
microcell-mediated
cn-amlcytogenetically
hemorrhageadministration
gvhdcd34
less-specific
rearrangementsa
chromosome-5q
tgf-gbbmp
bmp4-induced
bmp4-stimulated
granulocytenmacrophage
bmp4smad5
haploinsufficiencypatients
p2rs
p2r-expression
p2y2r
p2y4r
p2r
strategyextracellular
interactionnatural
αgd2
huk322a
cpg-odn
gd2-expressing
scidbeige
anti-cd40xa0xa0cpg-treated
chromosomet
cd2cd5cd7cd34
deriveda
ε-
α-hemoglobin
thr58
c-myc-mirnas
tam-specific
cd-163
lgmn
akute
esi-msms
dpps
approachestwo-dimensional
leukemiapolycythemia
periodminimal
amlvitamin
melanomalangerhans
h120
cmlinteractions
hyper-crosslinking
bpblast
cytokine-rich
progenitorsin
25-dihydroxyvitamin-d
22r-1
25-oh-triene-d3
waf1cip1p21
20-epi-conformation
hydrogens
c-19
tcr-independent
γδt-cells
dnam-1-ligands
bcwm1
mwcl-1
cd184cxcr4
remissionwe
pu202f50
clonalitythe
trialsf14512
necessarytranslocation
neotx
neotx-induced
annexin-1
enmzl
diagnosisannexin-1
precursorstwo
cd117spleen
pyrroles
carboxyalkylpyrroles
cep-induced
oxidation-associated
amlgenerating
2015the
environmentally-related
tumorsalthough
tissueswe
mtk1
mtk
megakaryoerythromegakaryoblastic
surfacewe
cyto-histomorphological
classifysubclassify
elevationinfiltration
total-t
activated-t
bronchioloalveolar
expressiontransforming
dctumor
dcct26
vivodendritic
pre-t-alls
lineageblast
diseaseaml
differentiation-inhibiting
cytokines--c-kit
mix--together
25-dihydroxy
populationwe
technicalfeasibility
italyto
n‑glycans
lectin‑based
stromal‑derived
maldi‑toftof‑ms
core‑fucosylated
microenvironmentmesenchymal
ds-3032b
175-gene
-gene
inhibitorssignificance
vivocancer
aacrearly
cd59membrane
cd59macif
fciii
complement-sensitive
cd59macif-deficient
pax3fkhr
mechanismsvitamin
adultschronic
cd11ccd11bcd8-cd209a
cd1ccd19-
tidc
tidcs
tonically
paralyzed
shp-2-dependent
markersrelapse
allosctallogeneic
csf-tau
dysintegrity
leukemianhl
non-b-all
sandwich-type
innotest
htau-ag
studychildren
m5dcyd
imuno-technique
microcolumn
normalising
psicre
hydroxyureathe
laboratorygenomic
ig-secreting
icbt
icbt-resistant
looh
studiescytogenetic
cvn
toxicogenomic
formaldehyde-dna
leukemiaformaldehyde
riskwe
msto
escapethis
investigatedwe
systemadenosine
myeloblastsa
apoptosisthis
leukemiahematologic
auto-transplantationacute
cryo-induced
cryo
cryo-ineffective
cryoablation
alcamcd166
alcam
directivity
tumour-supportive
anti-alcam
cryo-resistant
dual-combination
pleuripotential
originatechronic
b-catenin
studiesbone
cellsproteasome
particularlyassessment
phospholinoleate-palmitoleate
p-mapa
tlr-associated
hematopoiesiswe
approachflow
diseasesmyeloproliferative
gata-1-expressing
sca-2
er-mp12
hemoglobin-
sca-2-
er-mp12-negative
populationsince
vivoleukemia
rs61764370chronic
dihto
karyotypethe
bils
hemimegalencephaly
hme
fcd
rasmussen
bil
seizure-driven
elusiveepithelial-mesenchymal
cytotoxicitydifferent
pathwayaberrant
aggressivelythe
retinasto
alveolar-capillary
ph1all
amixl
gm-csfinterleukin-4
auto-t
ctlsthe
derivationabstract
relapsestreatment
diseasedetermination
uhkt-944
atlwe
nonmodulating
aplit
wsu-nhl
46-yr-old
bl1
bl7
leu-10
myeloid-monocyte
12-o
tetradecanoylphorbol
criteriacutaneous
modalitiesfor
b4b1-jsmig-
b4b1jsmigg
durationgradual
imatiniboptimal
demethylasesacute
programscurrent
combinationthe
efficacybryostatin-1
karyotypefish
statusthis
coevolve
tumoursquantification
revivalvδ2
alpha-1-anti-trypsin
alpha-1-at
alpha-1-act
block-like
okt-10
okm-1
portrayed
mexican-american
discussedblast
tumorigenesisfusion
diseaserecent
leukemiahypomethylating
nrbcs
myeloid-erythroid
courseerythroleukemia
runx1etv6
amplification--defined
cells--whereas
disorders--three
cancertherapy-related
pentraxins
chain-derived
alλ
alκ
λ-
myd88l265p-mutation
fusionsacute
cellsprame
mechanismthe
cd7-targeting
nanobody-based
pg001
pg002
oncopterin
n-aminopropylbiopterin
implicationsrecent
tie1
uncertainrecent
hospital-specific
closed-doorxa0inquiry
ministration
jak2-mutational
egressed
platelet-
smp
laf
alpha-1-microglobulin
scr1
etiopathogenetic
interwoven
dakar
ulvwf
propeptide
osteomyelosclerosis
hydroxyeicosatetraenoic
hete
12-hete
15-hete
5-hete
thrombocythemias
fgf-2-induced
thrombin-induced
kcatkm
phycoerythrin-conjugated
ich3
birma-k3
betatg
anticoagulated
hyperthrombocytosis
vwfag
malonyldialdehyde
frs2alpha
puerperium
prethrombotic
val617phe
erythrocytoses
thrombocytoses
thrombo-embolic
bcr-gene
thrombocytopoietic
a-mds
14cserotonin
shbi
antiatherogenic
quotients
dhcc
pigt
pigt-pnh
piga-pnh
infrahepatic
viiirwf
thrombocytaemia
polycythemias
hoa
cavernoma
mds-mps
sulfinpyrazone
krems
pigmentosa-like
echinococcosis
publishes
aisa-e
aisa-m
140-kd
sps
thrombophilias
vale
paraíba
phereses
thrombocytopoiesis
dyskinesia
venipuncture
k3edta
epigenetically-deregulated
vaquez
cools
interferonopathies
jakinibs
baricitinib
ihes
ring-sideroblasts
chemotherapy-responsive
heartburn
sucralfate
volume-number
materia
e-cigarette
glatiramer
isomeric
particulates
nsp15
hexameric
mers-cov
abpp
abps
coronavirus-2
coronaviruses
machrs
n-desmethyltamoxifen
48xa0hours
lungplasma
10×
distancing
approvedinvestigational
mpro
workflow-i
workflow-ii
repurpose-able
rbd
anti-plasmodial
rosario
costeffective
anti-tb
bedaquiline
warn
disease-gene
guildify
invertebrate
rotifer
manjavacas
rotifers
rna-polymerase
zikv
mosquito-borne
non-structural
visualisation
chembl
co-degs
co-upregulated
co-downregulated
nisoldipine
felodipine
isoprenaline
dtis
free-living
amoebae
amoebic
naegleria
fowleri
balamuthia
mandrillaris
nitracrine
s-protein
laxative
bisoxatin
host-based
antiplasmodial
glutamyl
benznidazole
nifurtimox
cmt-3
hpi
qsp
raids
pro-oxidative
ebola
bullosa
rdeb
β2-agonists
hr-nb
haemonchus
contortus
anthelmintics
diarylamidine
diminazene
worms
drug-susceptible
asic
adpkd
hybcom
asamet
antihypertensives
gonorrhoea
gonorrhoeae
prestwick
gonococcal
antimicrobial-resistant
time-kill
ntg
spotlighted
ebov
self-protective
favipiravir
sarilumab
castanospermine
uv-4
sars-cov-2-induced
l-dopa-induced
irbd
non-covalent
progesterones
physiochemical
alpelisib
udp-galactose
redo
sars-cov-clpro
one-sixth
orm
rafoxanide
drug-aes
impase
wuhan
arbidol
disease-19
falcipan-2
trematodes
helminths
asxl1-mt-ki
etv5
casiopeina
iii-ea
bcr-abl1is⩽
docetaxels
pre-mitotic
il-13rmir-126a
dox-mdsc
mir-126a
exosomal-mediated
onin
il-13th2
il-13r
s100a8a9-dependent
assuaging
calcium-channel
birinapant-induced
emricasanidn-6556
birinapantidn-6556-induced
birinapantemricasan
fourth-ranked
csnk2a1-pdgfrb
mebendazole-induced
plscr1
depalmitoylation
thioesterase
myeiogenous
ieukemia
inhibtor
ph-mdsaml
radotinib-induced
cdki-cdk-cyclin
functionals
scatterplots
rae1ε
ct26-derived
y591
psd007
84-gene
post-pdt
eado
pro-tumourigenic
ibru2009u2009ven
nu2009u2009651
mir-6816
ghrh
ghrh-r
lines-k-562
kg-1a-and
mia-602
ribonucleoproteinhnrnp
gastroscopic
cholangial
interleukin-7il-7
jak1stat5
cd11bf
cd11bgr-1loly6chi
tim-mediated
x-11
noxa-mediate
x-11-induced
endoperoxide
cells-apoptosis
bsc-only
low-cytotoxicity
abt-199cs055
alpha-sma
hetero-dimerization
fkbp
12-kda
fk506-
rapamycin-binding
fkbp-rapamycin
ap21967
fn3r
frbt2098l
hf2s
complexus
ff-
hma-sensitive
menk
52-bp
adil-17a-transduction
nct01702064
seaweeds
dichloro-dihydro-fluorescein
osu-a9-related
prophylaxis-use
treatment-use
04qaly
45qaly
00qaly
18qaly
93qaly
csc-r
ifn-regulated
csc-r-specific
irf5m-csf
refractory-relapsed
-pyridinyl
c1206
c1206-induced
p-mek
cdk1cyclin
tetrahydrocurcumin
multitransmembrane
rip1tag2
curca-treated
ca2cyt
curca-induced
curca
ca2-targeted
auraptene
prenyloxy
labeling-positive
sew-2871
euglena
gracilis
ewe
gmdsc-specific
chebulinic
terminalia
chebula
cd34⁺cd38-
peruvoside
g₂m
cyclophosphamide-hydroxydaunomycin-oncovin-prednisone
processesxa0including
anti-flt1
peg-cored
vegf-flt1
single‑agent
pan‑hdac
factor‑related
anti‑trail
proxy-report
canals
subperiosteum
manufactures
incyte
£7123
£5033
therapeuticsareas
complement-dependent-
cdcadcc
nk-92-
mismatch-
therapiesexpert
cancerabbreviations
ceacam-1
itimitam
inhibitoryactivatory
inter-species
niche-leukemic
unite
phospho-stat3-dependent
rtki-resistant
pstat3-
utilitarian
u202fngml
rons
carbonaceous
openable
nitrogen-doped
nanotube
ncnc
corked
bio-distribution
gold-corked
nanodelivery
decoupled
becn1beclin
p-thr172-ulk1
p-ser555
prkaaampkα
nci-bl
48th
eigenvalue
linearized
dioscin-induced
dioscin
factor-dna
myelomonocyticgranulocytic
dioscin-treated
therapy-goals
northwestern
ndrg2-induced
ndrg2-overexpressing
u937-ndrg2
u937-mock
s9
δc
interpopulation
population-derived
pharmacokinetic-derived
jak2-driven
mpn-driving
testo
inb
kinaseinhibitor
idcn
multilesional
idcns
clinico-morphologic
thp1-pdl1
hesperetin
chemopreventivechemotherapeutic
confırmed
pentoses
interruptionsdiscontinuations
tumor-mutational
jurisdictions
vancomycin-based
prifle
baccatin
semisynthesis
iii-treated
sb1518
jak2wt
set-2
mdsc-polymorphonuclear
hdac-hdac6
dihydromyricetin
dmy
-dihydroflavonol
dmy-enhanced
p38-stat1
ginseng-derived
quadrupled
k1747
ctx-40
zampanolide
zmp
covalent-binding
c-myc-targeted
cytotoxicityxa0cdc
tccm
ldha
iab
fm3a
pi3kakt-
mekerk-independent
fbw7α
gskβ
ser159
plcγ2--
comorbidityies
tki-therapy-duration
dis-satisfaction
ageconclusions
tnfαtnf
bv6ifnα-induced
interference-imposed
toams
nilotinib-more
inhibitors-results
trivedi
alkanone
6-gingerol
anti-mir-27b
6g-induced
s1pr
fty720-induced
flip-flop
apoptosispyroptosis
biomathematics
cmlmpn
cell-sustaining
p-aurora
γ-tubulin
ntpdase
entpds
entpd
hd-mscs
3xa0ma
fillers
filler
quality-based
bundled-care
cycle-regulated
ku-mediated
hr-dependent
mi-223
mcl-1-stimulated
hydroxyurea-
olaparib-induced
dideoxynucleoside
alovudine
lg-induced
emvs
rna-lipoplexes
anti-viral-like
emv
affinity-based
exosome-mimetic
nvs
cd19car
vpa-treated
dasatinibvpa-induced
extracellular-related
bv8-positive
il-17r-knockout
syndrome-free
self-mutagenesis
tkis-resistance
middle-
coetaneous
mepesuccinatehomoharringtonine
paclitaxelabt737
jnkbim
abt-737paclitaxel
adverse-effects
ifn-γ-
perforin-producing
mdsc-enriched
antibiotics-treated
ultra-centrifugation
performance-based
excel-based
2nd-gen
-cancer
r-square
unearthed
ski-178
n-1e-4-dimethoxyphenylethylidene--methoxxyphenyl-1h-pyrazole-5-carbohydrazide
ski-178-induced
multidrug-resistantrecurrent
imatinibu2009→u2009nilotinib
imatinibu2009→u2009dasatinib
subjectively
zno
fsc-ssc
dex-injected
dex-treated
dasfree
tet-dioxygenase
ifngm-csf
tirosine
ihnibitors
1gtki
ephrinb2-fc
mekinase
tyr204
ic₅₀s
affluence
14c-quizartinib
equivalentsg
336u2009h
radio-detector
radio-hplc
mono-oxidative
biotransformations
dealkylation
cd19cd2
cd20cd11c
rituximabcladribine
oh2d3-stimulated
mnk-induced
merestinib
leukemia-acute
sal-aml
nct03188874
apl204
haemodynamics
soss
convenes
grapevine
februaryxa02014
ptpn11mut
rs1527423
non-achievementloss
refills
hasfordeutos
nu2009u2009153
orpeto
mesoindigo
aml-vte
cen-a
indiameeting
gdc
volcano
gesa
cd13cd33hla-dr-cd34-
pml-rar3
brodersen
ibmfss
ccp
pre-stages
phenomenological
ambivalence
cognitively
curative-intended
january-2017
rescheduling
alterationrescheduling
pxa0pxa0xa
wwtr1
development-regulating
maftools
clusterprofiler
survminer
mirnasmir
myh15
atp13a2
hsa-let-7a-p
hsa-mir-500a-5p
hsa-mir-500b-5p
linc00987
lacat143
thcat393
thcat531
khcat230
kansl1l
runx1-evi1
runx1-dependent
condensin
ncaph
high‑expression
ciu2009u8
statinslow
epitope-matched
ost
loosened
covid
vodsos
npm1flt3-itdwt
relapseprimary
n631
pv617f
ato-
atoatra-based
pels
microrna-181
ak1high
ak1low
cva
moreoverxa0megakaryocytes
15-ecm
haplo-matching
5-allele
pre-pdcs
atract
fourth-generation
czop
amk
cfpm
glycopeptide
cephems
hla-dr-cd14
cd1d-
ptptt
hct2
kir3dl-ligand
dsd
y-chromosome-related
transplant-outcomes
n425
scd40l
rna-processing
endurance
ik--
mo-myeloid-derived
zap
pu2009ru2009u
pu2009nu2009u200921
right-heart
2gtkis-dasatinib
e-cigarettes
gene-internal
kazal-type
spink2
linyi
100xa0×xa0109xa0cellsl
leukocytapheresisexpert
atou2009u2009all-trans
atou2009u2009atra
atrau2009u2009ida
cadquality-adjusted
cadqaly
moh
systema
pre-ato
post-ato
budgetary
epices
wu-5
trioxide-induced
cd33pgx6score
mycobiome-bacteriome
intrakingdom
interkingdom
eha
aversa
tabilio
terenzi
velardi
ruggeri
capanni
urbani
martelli
disease-characteristics
nu2009u2009312
nu2009u2009158
adjusted-p027
early-mortality
pp0022
ppp001
apl-initiating
tp11p13myst3-crebbp
polg
samd4b
eys
krtap
sptbn5
s-t-aml
s-amlt-aml
microrna-425
atold-atra
atro
howlader
rheingold
subtype-defined
mullighan
mirna-181a-3p
cd4-bearing
tax1-transduced
tax2-transduced
tumorcancer
jak1jak3
ofxa0erythroblasts
karyotypexa0abnormalities
hadxa0no
appearancexa0a
aspiratexa0revealed
butxa0negativexa0forxa0myeloperoxidase
mpoxa0cd33
cd61xa0cd41
lymphoidxa0and
mdsxa0the
pathway-dependent
ocm-1
macrocarpa
butylated
hydroxytoluene
arsenate
arsenates
arsenate-loaded
reductively
tax-driven
a549pt
phenanthridine
sanguinarine
trioxidesanguinarine
as2o5
lpo
fhpd
arsenic-treated
antidotal
atrazine
cat-tox
arsenic-intoxicated
hergikr
aclqts
probucol
xyy
boric
tgsh
150th
antiinfectious
ingenious
bullets
saos-2adm
dimercaprol
8-w
18-w
28-w
na-treated
sham-treated
homeopathic
arsenicum
alba
arsenic-metal
nanobins
nrf2keap1
teleost
waterborne
termiticide
meso--dimercaptosuccinic
dmsa
metalloids
l-buthionine
plant-based
pectoral
hy-line
arsenic-supplemented
gsh-px
tannic
zro2
nitritenitrate
pentavalent
comutagen
-dimethoxy--naphthoquinone
dmnq
sorbus
cardio-protective
kinase-mb
bo-1012
c-myc-mediated
corn-soybean
askg
adg
lymphaden
hyperoside
hyp
hghpo4
speciation
dmaa
organoarsenicals
glassworkers
promyleocytic
a549r
bret
pmlsumo
rnf4-induced
sumoylation-
pcscs
metalloid
myoatrophic
atrogin-1
as2o3-related
iks
geldalamicin
norfluoxetine
donepezil
ion-channel
dicumarol
baxbak-independent
atos
oads
anti-cd154lfa-1
allo-primed
potentized
homoeopathic
f127
pf-127
pf-127s
ato-releasing
flavanone
mta-based
endodontics
proroot
gallus
cardiomyoblastoma
celltissue
200c
album-200c
succussed
melphalan-induced
oxides
oxyhydroxides
sulfides
wetland
riverbed
extractants
arsenopyrite
hno3
hno3h2o2
as-rich
extractant
pacing
tail-length
sumo-dependent
htlv1
arsonolipid-containing
par-4-mediated
p53-bnip3
self-cyclizing
1u2009c
bel-7402
antigastric
guinea-pigs
microgramhand
laterals
10x8x5
as2o3-m
as2o3-loaded
asg
pectoralis
feathers
alloys
wc-co
carbide
dq12
methylarsonic
methylarsonous
dimethylarsinic
dimethylarsinous
masiiio
iododimethylarsine
arotinoid
mcicr
herg-hsp70hsp90
as2o3-caused
l-buthionine-sulfoximine
ias3-induced
naaso2-
gsh-homeostasis
monomethylarsonic
eugenol
monoterpene
oxidationreduction
5-fm
bmoe
delocalizes
1ppm
2ppm
4ppm
itpr1
yellowknife
nwt
geochemical
ore
roasting
sediment-water
diffusive
amodiaquine
hochuekki-to
isis-301012
linaclotide
mk-0822a
alicaforsen
bg-9928
dolasetron
licofelone
ortataxel
apoa-i
fidarestat
ato‑treated
hpasmcs
o2•-
tnfalpha-provoked
caspase-8bid
arsenide
gaas
arseniciii
coproporphyrin
drug-rna
biopolymer
as2o3-polynucleotide
b-dna
arsonolipids
phosphonolipids
arsonolipid
cubes
posses
mir-1294
tead1
ao-positive
clarias
batrachus
post-breeding
icp-oes
hpv-e6
liposome-delivered
radical-mediated
ros-producing
mda-7
gst-mda-7
microggd
vpavcr
redistribute
wernicke
cuzn-sod
arseniasis
as2o3-supplemented
gizzard
cvvhd
chromatography-hydride
generation-atomic
xa0ngxa0hml
pro-oxidants
arsenic-sensitive
as4o6
fli
dmaiii
karyopyknosis
nahco3
-dimercaptopropanol
energy-deprived
sck
fsaii
diffuses
trioxide-
thermoradiotherapy
atorif
ae2
c1-hco3-
-diisothiocyanodihydrostilbene--disulphonic
ugg
micelle-based
peo-b-pcclc6-sh
oxidativeanti-oxidative
mpml
hpml
trim5α
postentry
doped
bdd
swv
vibrations
dimercaptopropanesulfonic
meic
mercuric
hexachlorophene
pentachlorophenol
smelter
asm3
chemoembolization
atonp
px-478
pentoxide
v-pi
ip3r
gxxxcgkstc
platinated-chemotherapeutic
fumigant
dazomet
termiticides
chlorpyrifos
fipronil
imidacloprid
termites
reinfestation
termite
infestation
pram-1
hip-55
assemblages
rda
minu2009uxa0ppm
roaster
harbin
as₄s₄
hl60rho0
hg-ct
icpms
monomethylarsonate
dimethylarsinate
hg-ct-icpms
hhnotch
weathering
hyperkeratoses
iso17q
deltavarphim
tyr15
p34cdc2
aso2-
aso-
langmuir
freundlich
temkin
isotherms
as2o02
asiiikg
dimercaptosuccinic
bapsa
1700s
tiron
trioxide-treated
juxtaglomerular
rs10748835
ias
rs11191453
trioxide-loaded
upa-targeted
trypan-blue
hypercoagulobility
ecis
frequency-dependent
as4o6-induced
beclin-1-induced
htlv-i-induced
b-alpha
as-ifn
mitochondrion-toxic
nutritiants
lamotrigine
sp4
nanovehicles
polyacrylic
ang-lp-paa-msn
ang-lp-paa-msnato
blood-glioma
ato-sol
l-02
pc-treated
fifteenth
arsenical-containing
ccnf
trim5alpha
n-tropic
n-mlv
b-mlv
eiav
organoarsenical
arsthinol
rmhtrail
k562ao2
8226s
gsh-sensitive
p65p50
ikappab-alpha
ashl3
asloh2
trigonal
trioxides
nitrosative
lius
pd169316
bioindicator
benzobfluoranthene
bbf
mercuryii
dimethoate
linuron
tbto
thiram
4-amino--naphthalimide
ihh
devitalization
10u2009µm
baxbcl2
-cl-510
apl-selective
trimetazidine
th17-
dmaiiigs
a216v
s214l
a216t
l217f
d-d
chst3
hplc-icp-ms
dmav
tao
ameloblastomas
non-administered
thioctic
codon-specific
u87-p53r273h
u87-p53wt
mesenchymal-derived
dithiol
pmir-203
rounding
bishydroxymethylpyrrole
chemophysical
-h
microgramsm3
atm-chk2
rekindling
oral-as2o3
8305c
phosphine
impregnated
arsine
agno3
tetras
diarsenic
cholinesterase
gmta
wmta
hog1
plasma-membrane
fps1
osmoregulation
pxa02o3
nb4‑r1
cofilin‑1
as2o3‑treated
cleaved‑poly
inas
gaas-treated
ht-3
plasma-mass
a549xa0cells
resveratrol-mediated
microtubule-targeted
as2o3-treatment
tri-sodium
hpbmc
puerarin
hip1pdgfβr
cell-host
lzp-f3
ntub1
np14
as2o-10
orthodox
monomethylarsenous
masiii
dimethylarsenic
fccp
valinomycin
v-iii
rrp15-like
toxscore
sludge
trad-mn
tradescantia
aimto
electronmicroscopy
as2o25
223ra
bidimensionally
as-induced
4xa0ppm
as-exposed
naaso₂
fluoride-arsenic
kg-l
vzs
post-arsenic
pre-arsenic
melarsomine
bfgf-
vegf-stimulated
jurkatr
cardio-protection
hormone-
as-mal
thl-induced
eas5
arsenolite
feiii
exafs
oligotrophic
apl-ato
apl-ct
dieldrin
tetraacetate
nol-3
nop-1
arsh
arsenite-oxidizing
periplasm
vtan4
dq481466
vtw33
dq481482
as2o3-provoked
sirpα-targeting
aromatica
scfv-as2o3-stealth
ser243
gsk-3βser9
as2o3-target
mla
monocrotaline
ca-positive
pig11
phosphorothioated
ctt
huhh
hcc-cell
ato-naïve
arsenobetaine
tmao
l-aa
α-toc
smod477g
beta-elemene
etme
mems
cdc-2
homo-oligomers
mda-6
photoinduced
co-relating
dmasv
ias-exposed
maato
roxarsone
ref1-positive
te671
17h1
mi-adms
mn-adms
mi-bdms
mn-bdms
micegroup
73asiii
at-induced
alpha-tubulin
mtln3
hormesis
hormetic
intratesticular
multi-angle
cd-t
as-t
metal-tolerant
sublimates
poisonous
acidatra
daunorubicindnr
factortf
tpq31
tradescantia-micronucleus
trad-mcn
aldrin
-benza
hanthracene
heptachlor
tetrachloroethylene
vapor
pias1
pias1-mediated
uhd
homeopathy
bso-sensitive
ikknf-kappab
metal-organic
zif-8
xrpd
sorption
paecs
na2haso4
cuzn
cgpx
30h
nrf2-ho-1
pml-iv
vm‑associated
sw-620
hne1-lmp1
acr3
73asoh3
hxt3
hxt7
gal2
hexose-inhibitable
hxt1
asoh3
as2ox
potentization
stathmin-knockdown
arrestapoptosis
sheec1
lcsm
fluo-3
nanodiamonds
chemotherapydifferentiating
agents-associated
raralpha-x
curry
gmz27
mitigatory
psao
rfbp
stoichiometries
100ppm
-activated
phospho
b-as
environ
vasodilatation
sulphydryl
reprotoxicity
hpg
f1-
20u202fppm
mdc-labeled
mdagsh
cne-2z
endothelialization
trioxide-eluting
trim5
ytterbium
carcass
d-penicillamine
inhalational
crlcdsdbr
range-finding
no-observed-adverse-effect
noael
humic
mrcsr
dps
hydroxyanisole
bha
hemeoxygenase-1
subarctic
muskrats
squirrels
lpu
squirrel
inhabiting
channa
punctata
2n32
fishes
hgii
ch3asoh2
ato-treatment
100-nm-scale
endosomallysosomal
mda-7il-24
ros-inducer
hpr
nsc656240
bht
as₂o₃group
acc-2
multidrug-resistance-associated
sulphoximine
intracellular-free
oxaliplatin-
orthovanadate
co-exposed
near-basal
tectum
sharpening
zyh005
deltapkc-delta
torsadogenic
iherg
propafenone
cisapride
nano-ato
t98g-mutated
vacuolar-type
kp46
gibba
uo
ptot
isgu
avos
ros-autophagy
drv
dspcchol
energy-dispersive
overstimulated
homicidal
self-poisoning
8-oxodg
8-nitroguanine
nitrative
pci-1
gata4-nf-κb
abrasion
phenylarsonic
arsanilic
chows
hizikia
hizikia-diet
vx2
ets-2
sumo2
deconjugation
lys65
lys160
rnf4-dependent
senps
hs-sultan
cz-1
pcli
mrp1-overexpressing
gb1
etaas
ato-liposome
endmt
massons
myelocyte-like
pu202f2o3
precombination
stress-based
nitroxynil
parafilaria
bovicola
cemadr5000
physical-chemical
jvm-2
ccaspase-3
ccaspase-9
shee
phalloidin
n-propylthiouracil
ptu
thyrotoxic
atg5-atg12
ded
mcn
anti-lewisite
herbo-mineral
hepcon
p73-dapk2
colestyramine
73as
4group
hepg2as
sgc7901as
nanocrystalline
nanowells
nanocrystals
ugml
cancer-array
mediatory
remediation
dpdt
phaso
vasomotion
isometric
trimcyp
trimers
restriction-sensitive
chinas
anthropogenic
aacs
semiconductors
chitin
glutamate-cysteine
24hr
gsh-turnover
naaso2-induced
isodon
mog-induced
dl-buthionine
sr-sulfoximine
acupuncture
periodontosis
re-endothelialization
pcaecs
pcasmcs
hif-1-dependent
lncapgstpi
kip1p27
dithiols
krebs-henseleit
as2o3in
ina
tg-interacting
poisoned
as2o-2
aeh
humsc
hmsc-bm
plzf-rarα-associated
proneural
ato-activated
epm
withxa0ato
as2o3kg
kunming
coc1
rf-induced
cy3
wee1hu
trioxide-mediated
anxa6
lipid-binding
promyeloytic
emdr
ato-sensitive
rd-es
glutathione-dependant
antiperoxidative
ta-induced
sequestrum
trioxide-resistant
eccuhk1
subchronic
bak--
nrea
monomethylmonothioarsonic
asto
asto-induced
polysaccharidesglycopeptides
catb
catl
no-asa
b7h3
ca3aso
trisulfide
amoxicillin
dalteparin
nevirapine
as2o3-inhibited
tox
releasable
cuoac2
ato-cu
putridity
acetyl-11-keto-beta-boswellic
akba
frankincense
ser-51
pkcδpkr
peif2
regulatesinhibits
60-yr-old
dichromate
dichromate-induced
napoleon
jesuits
16-positive
nrcfs
abt-737-inhibited
tetraphenylarsenium
glc4sb30
mrp1-mediated
dscr1
jab1
tae
rapl
napl
em-dr
menadione
aoa
tak-242
punctatus
u118
chlorinated
biphenyls
pisum
xinhai
ht93a
electrophysiology
proarrhythmic
pml-associated
as2o3-nps
gsdme-n
arsenicin
as2o3-eluting
det
hcp
k562-n
dexamethasome
myla
psim
fluo-4
ato-provoked
cc-t6
0g
pao-induced
microextraction
spme
headspace
-anthraquinone
aqs
aq8
aq9
aq17
alamethicin
red-sensitive
bongkrekic
hcd133
-c6
mock-c6
hmtiia
ac4man
prodrug-like
ato-loaded
dspe-peg-1000-ac4man
ac4man-ato-lip
ato-lip
ac4man-rho-lip
micronm3
micron67
arsenoplatins
arsenoplatin-1
pt-as
ptas
k562as-3
as2o3-resistance
methylmercury
devitalizing
hiv-2
wildly
ferrooxidans
eraf
metalloprotein
as2o3-sensitive
as2o3-on
as2o3-off
p42p44
rheumatosis
ec8712
trioxideg
na2seo3
tpa-differentiated
bapta
biota
post-mining
palaeotoxicity
atodnr
recalcification
low-as
middle-as
high-as
il-12β
antimonyl
oxygen-related
hmt-1
sbv
znii
alloantigen-primed
anti-lfa-1
as2o3ab
lupus-prone
bxsb
betagalt
lhrh-i
pirh2-dependent
asiii-mediated
c-cells
a-cells
bfgf-stimulated
bce
micropocket
sy-5y
mdah
ilkm-3
t-apml
echinococcus
granulosus
protoscoleces
grp-78
k-1
pro-myelocytic
herg-channel
arsenicosis
tachycardias
5-dimethylthiazol-2-yl--diphenyl-2h-tetrazolium
dihydrogen
trim5alpha-independent
dichlorofluorescein
cestodes
eg-atg8
calcareous
corpuscles
tracheae
adenoepithelium
naaso2-treated
a2780ato
cyto
dncb
ttcm
juss
ling
ld10s
chlordecone
monosodium
tetraethyl
ld20s
hedgehog-gli1
methyloxoarsine
arsonate
cd95-expression
redox-related
zerumbone
tcm-derived
pmlrarα-dysregulated
zbtb16rara
phosphoacetylation
bde
shee85
o-2
photometry
asna1
sub-apoptotic
no-carrier-added
75seseleniumiv
proton-induced
arsenicg
lps-dependent
p38-kinase
phc
noncirrhotic
apo2trail
lcxa0h
isosmotic
salinities
oxidation-sensitive
ica-l
vapour
hplc-icpms
proteinspeptides
swelled
mt1f
mt1x
mt1e
pax5-pml
weight-1
oh-
supplementations
smearing
pk227t233del
pml-rara-transduced
canstatin
balbc-nunu
4-hp
ga2o3
devd-caspase
daxx-
sumoylation-defective
r-hepg2
intragastric
hexcer
capcell
dhs1p
acetonitrile-water
srm
hex2cer
a-go-go-related
kvlqt1mink
sigmaas
smelters
phb-overexpression
as4s4-induced
panacea
pariah
sk-n-be2
1-d
inhibition-based
tric
as203
hewl
ruminococcus
adlercreutzia
jinke
as₂o₃-induced
chromated
impingers
karyolysis
bowmans
impedance-based
salvarsan
lithospermum
erythrorhizon
1microm
deflection
cono
cdso4
pbch3coo2
hgcl2
bino
stannous
sncl2
matrix-matched
la-icp-ms
kbm5r
mutamouse
8-no2-g
tonnes
hexokinase-2
fenton
stagnated
svec
vasoreactivity
eamax
ld25
sk-cha-1
p-c-jun
p53-responsive
sulphide
8226s-ator05
pmtor
pp70s6k
ssa
as2o3-bsa-ns
thiol-binding
nist
kbro3
titrant
u200angl
χu200au200a
bsao
16th
atra-like
so2
prx3
sulfiredoxin
hyperoxidation
nanoformulated
paju
dmsa-fe3o4
adm-as2o3
mir-491
cocarcinogenic
procaspase-1
pp2a-a
atoascorbic
antimonials
nb4r4
ova-challenged
pmlvi
b7‑h4
mhcc97‑h
time-to-onset
aprindine
murines
jnk3
dextropropoxyphene
thallium
retrotransposition
ingestions
5-ala-induced
ad-p16
ae9anras
sulindacato
sulindacato-induced
dpts
ato-arrested
hsp70wt
hsp70ssdd
hsp70ssaa
plk1-mediated
teflon
agitated
ttm
ppvi
sbi-0206965
mtor-targeted
qle
mt-2a
specie
spectrofluorometrically
allium-root
sulindacs
8-oxo-2-deoxyguanosine
igfl1
ttgs
gondii-infected
toxoplasma-infected
fabricius
225zl
second-relapse
atolena
tribble
trib3pml-rarα
2o3
permanganate
perchlorate
trypanocide
configurational
ato‑induced
-iii
oxidation-reduction
mthfd1
shmt1
terpolymers
peo
d2o
cdcl3
abcran
ias-treated
ias-induced
n2o
as-oh
γ-gt
s-conjugate
xct
alpha-amylase
beta-amylase
invertase
non-reducing
anatomopathological
dpd-treated
gst-s
carcinogen-sensitive
impulse
cca-treated
melphalan-prednisolone
α-helix
albumins
nrf2-are
ethionamide
cx43sirna
subchronically
agreeing
microbeam
mu-xanes
epifluorescence
mir-548c-3p
therefrom
mkk6
zipk
post-entry
a3g-mediated
treatability
hdaxx
ad-pml
relaxes
gauze
arsenite-resistant
pak-104p
neonatologist
as2o3ascorbic
azaspirane
atiprimod-induced
annii
etmrs
pro-viral
p65p52
irgdtgn
sprague‑dawley
oxymatrine
shh-mb
uw402
mitophagosome
eniii
myh
vp16-induced
gcvu2009u2009ato
laglambda-1
ndeb
k2cr2o7
mir-18a
microcrystals
sustainably
haitanensis
smelting
tacoma
dithiarsolane
acetarsol
determinative
queas3
znf198fgfr1
ca2i-elevations
spironolactone
ner-inhibitor
non-survivor
di-calcium
silicate
mono-calcium
fibroblast-induced
thr18
ck1
raav2
posttransduction
10058f4
lxr-β
lxr-α
t1dm
as-hb
arsenite-mediated
dodc
gc-1
spg
malonaldehyde
rcr
zos
cysteine-reactive
anti-vwf
l-lactide
hep-co90
n-acetyl-beta-d-glucosaminidase
ir-
self-organizing
wpc
plasma-atomic
icp-aes
tca8113
arsenism
2-methoxyestrodial
pip3
topiramate
aminotransferase-glutamate
89srcl2
unaided
prereplicative
bafa1
lc-3b
prkar1a
prkar1a-rara
tnx
phosphatequinone
klf9
tc‑71xa0cells
rd‑es
resistance‑associated
metallodrugs
as-mediated
ibds
ato-nfcs
atoplcl
bmi1-
suz12-knockdown
crureus
kalium
peel
apme
apae
fingerlings
catla
ionoregulatory
nci-h2052
gc-resistant
-3zeta
invalidation
mt-h9c2
mt-tg
hplc-hg-afs
hg-afs
3xa0µm
sxa0phase
2xa0µm
u-contaminated
microbacterium
micrococcus
shinella
nitrogen-free
flourish
quicklime
quicklime-fly
leachability
groot
sloot
astm
gata-6
nami
trichloride
microm-hr
selenite-induced
multi-nuclei
aquaglyceroporins
aqp7
redox-modulating
n-4-hydroxyphenylretinamide
volatilization
ube2i-mediated
pcgf2
ube2i
pcgf2-ube2i
10-hydroxycamptothecin
c3h1
minnows
salmo
chironomids
microgramsliter
arsenite-loaded
large-pore
m-lpmsn-niaso
-fa
rmrna
ca2-induced
ca2-threshold
glpf
fps1p
phe-64
arg-219
uncompetitive
wsu-cll
prdx-1
h89
weir
orh-2014
hngml
tra-differentiation
lv1
nb-mlv
nonprimate
mrp-expressing
fen1
arsenic-free
mugm3
mugliter
superparamagnetic
17-beta-estradiol
hgnet-bcor
phkh1
semiquinone
hydroxypropyl-β-cyclodextrin
bioaggregate
biodentine
acetylcoa
adenosinemonophosphate
hydroxybutyrateacetoacetate
cpaec
syncytia
syncytium
rodenticides
rodenticide
arsacetin
bibr
mattresses
trimethylantimony
methylantimony
sh-groups
album-30
hbsag-induced
pmlhbsagtgo
pml--hbsagtgo
zr75
factor-cvascular
vegf-cvegfr-
angiogenesislymphangiogenesis
cdna-transfected
chovegf-c
peritonei
as2o3-untreated
aponecrosis
pan-
cell-lymphotropic
growthtransmission
gp46
bipgrp78
amo-23a
gap-junction
intracorporal
pchm
pchm-derived
76as
76ascl3
distillation
aaph
kalmegh
assorted
oec‑m1
aimacs
ser631
succussion
sid
buthionine-sulfoximine
aloin
finos
fcd206
ceph
pyknosis
jcs-16
pgi2
latters
ferula
msurvivin
t34a
surivint34a
d-vc
sixpc
mn-superoxide
scfvcd44v6
mal-peg-pdlla
as-nps
scfv-as-nps
aconitase
companied
plhc-1
vagotomy
atobortezomib
atobortezomib-mediated
eriodictyol
chromosomaln
inductionn
vegfn
cancersn
indicaten
kg-1n
n-acetyl-l-cystein
sigm5
datsa
dbtsa
dmdms
dedms
dnpdms
dipdms
francesco
lo-coco
biotransfomation
alpha-haloketones
glu155
4-nitrophenacyl
t47-d
lucida
thiol-based
metallomics
esiesi-
square-discriminant
ddn
nrf2-null
uv-radiation
nci-h1975
l858rt790m
camk4
cycle-p21
piperidine
wastewaters
aeration
-dichlorophenol
anti-lc3b
vadt
mrp1-related
k562ra
hydatidosis
protoscolices
hydatid
zfh
nonpeptide
paoiii
v-pe
tao2
sabc
beta1-subunit
lyh7
arsonoliposomes
arsonoliposome
sw900
arrhenius
pco
jag2
gaas-
inas-treated
4an
protoplasmic
nheksvtert
-xa0µm
radiation-mediated
herpesvirushuman
breech
non-polar
ddx3y
cscs-like
mb-fi
salicylic
hpasm
refutes
mu-calpain
stimulus-responsive
nkk-105
strychnine
chloral
mirna-19a
asams
teasams
tat-egfp
egfp-as2o3-ams
polyvinylpyrrolidone
biu-87
ato-msns-rgd
ato-msns
gclm--
msrs
sod-1
fluorescently-labeled
poly-caspase
flivo
high-mortality
lungbody
aso3
stroma-directed
lqt2
dspc
pr-wt
pr-bl-mut
ars-alb
preservative-treated
solid-state
cca-wood
raqp9
haqp3
haqp7
haqp9
haqp10
erk8
nanovehicle
rgd-lp-chmsn
rgd-lp-chmsn-ato
tβ
epoxyeicosatrienoic
eets
-eet
organosilicon
ppppp
skin-infiltrating
xas
dipped
dipping
claudin-5
teer
hematonosis
pp-ddt
antimonate
cvb3
as3-induced
edds
glda
fourier-transform
a-172xa0cells
as2o3-chemosensitization
u-2
recuperated
paa-ato-msn
allay
afp-producing
afpgc
flue
leached
ph-independent
mineralogical
hif-1α-dependent
vindesin
brmc
homicide
adpo
dragging
rationalizes
metal-associated
storyline
heroic
overshadow
phototactic
huh-7adm
nhes
nhes-like
gö
concanamycin
fluorometry
pmapk
s326
pi103
5-utr-deleted
jurkatbcr-abl
5utr-
ku7
253jb-v
sp-dependent
electroanalytical
impedimetric
h4k16ac
atg4b
nephrologists
alnps
mfw
rsans
shell-core
caecs
vacuolin-1
endothelium-dependent
pb-pk
jk-gms
wb-f344
ca-dependent
recharged
groundwaters
nwtp
low-temperature
mascot
pu20092o3
p-perk
ins-1
d241g
lsg15
cell-frequency
asifn-alpha
hn2
cross-linker-induced
3aocddp
unsuccussed
6ch
30ch
200ch
avogadros
thal-induced
dex-induced
album-200
kinkaseki
non-effect
arsenic-radiation
calcined
calcination
gsse
lipoperoxidation
porewaters
haps
2-nitroimidazole
br-ipm
anoxia
chloro-ipm
mcf7-hgh
minc
3-mercaptopropionic
needful
i83cll
asnps
herbicide
leachate
ccl24
pml-i
nonprotein
atg4d
vda-like
tlt
isoquinoline
electron-emitting
radioarsenic
porosity
radiopharmaceuticals
si-p38
gfp-pig11
case-pe
msr
fsk
gnt
-3ε
phenoxybenzamine
glc4adr
subsurface
arsenic-bearing
feso4
caco3
usepa
physicalchemical
tclp
splp
pd173074
ultrahigh
nhjd
realgar-containing
-folds
hsa-as2o3nps
h9c-1
mir-190
ucps
chromane
nested-methylation
mppc
lysolipid
dppcmppc
thriving
brafv600e-positive
betps
bet-protacs
bet-protac
ibrutinib-sensitive
ca2-signaling
bird-2
bda-366
bcl-2s
bh4-domain
bcl-2a1
cavalli
nct02055820
1l
goyabo21005
filanesib
hf1a3
hf28
anti-bcr-induced
ibl-202
tp53-ko
cyclohexenyl
bcl2-bim
non-diabetic
rsk2ser227
ntkd
monographs
pimavanserin
photolytic
drug--drug
bcr-ablu2009u2009all
ip3rs
bcl-2-ip3r
disruptor-2
lenalidomide-dexamethasone
carfilzomib-
daratumumab-based
tirabrutinib
loxo-305
arq-531
bcl2-selective
bcl2-expressing
g179e
umbralisib
submicron
brbg
ven-br
ven-bg
a041202
biopharmaceutics
middle-out
blombery
gly101val
sez4
riva
braf-v600ek
ldc526
r482g
r482t
acylhydroquinones
acylchlorohydroquinone
tdc
btk-mediated
mirna-10b
cobimetinib
perpetrators
trailtl32711
18-gene
treatmentsee
9-ing-41
cdk-9
bay-1143572
kpum-uh1
tmd8
crem
glucocorticoid-resistance
celsr2
pubmedmedline
nnrtis
cobicistat
qs1189
venetoclaxgdc-0980
penta-refractory
dtx-resistant
ded-containing
dedd
cd19car-t
wnt16b
rhoarac1
aihas
waiha
uneffective
stamina
dna-sequencing
drmomp
proteinrearrangement
caenepeel
ramsey
nangia
ocaratuzumab
scalar
small-ki
g101v
all-zefix
xa0hours
l-902688
serd
novel-agent
oxo-aglaiastatin
vcx
tgr-1202
u2009µgml
ryrs
ca2-release
ryr
ls-007
veng
tp53-m
ofxa0tp53-m
iwwm
vs-4718
npm1flt3-itdtet2dnmt3awt1
hescs-derived
winding
27-pe38kdel
casp8p41
chemokine-receptor
mccar
venetoclax-containing
rheostat
inotuzumab-ozogamicin
evi1hi
r98s
rpl10
culmination
freeing
pbcl-2
non-del17ptp53
post-progression
£qaly
jnj
jnjabt-199-mediated
jnjabt-199-induced
recrudescence
btkplcg2
granta
bcl2bim
mcl1bim
venetoclax-cobimetinib
bortezomibdexamethasone
o2-sensing
mcuc
erve
venclexta
nephrotoxicities
acau2009u2009obi
ibuu2009u2009obi
venu2009u2009obi
hti-induced
cd20-targeting
bcl2high
bcl2low
matter-induced
leber
1511this
parinaud
hypesthesia
pet-scan
actuation
b‑lymphocytes
q4w
pre-venetoclax
btkis
rule-of-five
bio-enabling
lbfs
slbf
ip3r2
signalosome
gclb
c55
ubiquinone
sqr
thenoyltrifluoroacetone
23c
c-n
nf-abt-199
mcl1-selective
g-chop
crc0344
crc0076
18f-fdg-pet
mivebresib
dhlthl
trap-6
pdgf-mediated
clinicou200apathological
chlorambucilobinutuzumab
fupb
fubp
p100-degradation
bcl-2-driven
therapyxa0with
ror1hi
29h
a-1592668
venetoclax-rituximab
nonbenzodiazepine
plx2853
eµ-myc
cog-n-603x
cog-n-623x
acid-reducing
hct-early
2017-december
venetoclaxdli
-564
non-btk
lymphoid-like
bak1-independent
rde
bcl2-inhibitor
kx
computational-experimental
dcpt
single-compound
polypharmacology-based
t-pllsignificance
patient-customized
primograft
risk-all
ven-responsive
hiv-specific
dacomitinib
panher
bt474
neratinib-resistant
lnh
pan-jak
lpl-del
lpl-nml
σ1
nci-h69
nci-h23
erkakt
photrexa
pxn-mediated
pbcl-2-s87
pxn
absorptive
pd-1cd8
apoptosis-targeted
model-dependent
bcl2-null
bcl2-deficient
mcl1-deficient
oxadiazole
cyclisation
6i
vu661013
hht-based
pi3kaktxiap
k0706
bhk-21
brp800
action-inhibition
au-nanoconjugate
enamel
microdontic
euk-134
hydroxylamine
bos-i
arenaviruses
lasv
junv
picv
arenavirus
hspg-dependent
cb1r
cb2r
heteromers
endou
glisoxepide
å2
ars-type
multilayer
tsppi
sdtp
maleimides
locally-administered
cudox
insonation
locally-activated
cyaa-e7
htk
mass-production
4a6
nci60
psmb5
micelle-encapsulated
mdc-dox
aik-t8
aik-t4
skn
pinna
nano-liposome
nano-talazoparib
nanotlz
ogf
naltrexone
ogfr
nano-delivery
pln-associated
pln-induced
multi-cytokine
pln-encapsulated
pln-alen
pln-delivered
propel
cyp4
pd5-nh2-phen2no
phen2hbf4-
-phenanthroline
pdgfr-positive
ligandxa0angiopoietin-2
ldmc
maximum-dose
ccr2tie2-
folate-linked
receptor-directed
fr-expressing
polyacetylenic
bp-e-f1
pilosa
tumor-resection
nanoengineering
nanoagents
cordifolia
altc
aminosteroids
l19-tumor
l19mtnf-α
domain-b
wehi-164
k7m2
fa-cs-nps
ifn-γ-positive
instability-high
c-jun-n-terminal-kinase
ccl2-blocking-antibody
ccl2-driven
morus
tcr-dependent
proteus
fa-cusdtxpei-ppix-cpg
fa-cdpp-cpg
dtx-enhanced
docetaxel-enhanced
ephrin-a1
frax
receptor-2met
cabozantinibs
downregulators
lps-injected
mtd-capecitabine-treated
ldm-capecitbine-treated
capecitabine-treated
folate-hapten
dfg-d
dfg-din
activationresistance
dose-proportionally
proof-of-target-engagement
hla-independent
nox2-independent
amplifiers
cfus-8
mcwe
znpc
post-resection
neoglycoproteins
thyrocytes
drug-sensitivityresistance
3d-3-culture
max-overexpressing
middle-age
troubleshoot
thus-far
xing
-97
iodide-
il-4-driven
unhindered
traf-6
tripeptidyl
wedelia
wedelolactone
wce
ikkαβ
xenograph
b16d8
hap
icf05016
qa-phosphoramide
hemc-ss
31f
pg-targeted
poeg-st-pmor
il-36γ
doxu202fu202fil-36γpoeg-st-pmor
chemo-gene
teas
phytomedicines
calloselasma
rhodostoma
cr-laao
szs
mfszs
cd25-targeting
gastro-resistant
posanantes
externally-facing
stagegrade
in-tf
computerised
anaphylactoid-type
site-specifically
nanobody
azide-functionalized
core-cross-linked
site-selectively
cyclooctyne
maleimide-cysteine
chemoorthogonal
nb-functionalized
necroptosis-induced
sap130
ceh
itib
-dioxygenase-1
ido1-related
ido2
ido1-mediated
navoximod
indoximod
s1ps1pr1
chemotherapy-enhanced
b16f10-gfp
s1p-s1pr1
anti-cytokineanti-angiogenic
fecal-pellet
gnavus
lcp-gmp
nonmegaloblastic
ifn-λ2
ovo
inspirational
nanotechnological
encloses
densest
nanobiologics
apoa-is
rhdl
hdl-derived
microfluidic-based
technologys
zirconium-89
89zr-hdl
nanobiologic-facilitated
nature-inspired
lxa0monocytogenes
pcz-susp
pcz-tab
tmtx
nbmpr-p
m-cpaptx
action-positive
collage
stroma-modulating
effectsevents
biochemistries
co-prescribed
farmesylation
ft-ase
agents--farnesyltransferase
gtp-ase
petach
tikva
microenvironmentexperimental
thiol-disulfide
iso-1
antiii
galsomes
α-gc
lanac
trp2
anti-tnbc
vs38
non-pathogenic
panc-02
calendula
apt-
xanthinexanthine
cyano-morpholino-doxorubicin
octanolpbs
flow-through
p-gp-containing
ment1
cur-peg
non-dc
multiple-drug-resistance
mdr-gene-knockout
thymidine-labelling
5-ful-ohp
ct26-specific
mc38-specific
tec-family
marrow-expressed
redundant-resting
rlk
tcd4
cxcr4cxcl2
galiellalactone
prenyl
ps-mediated
tissue-micro-array
insulinomas
pbs-liposomes
clodronate-induced
treg-
acrophase
units--granulocytemacrophage
multi-purpose
tnf-αrelease
tnf-αand
drug-naive
taxane-induced
viralbacterial
glycyrrhizin
autophagy-inhibiting
loxs
12-lox
12r-lox
aluminum-chlorophthalocyanine
ether-co-maleic
resuits
myelosuppressed
abhsct
gyfraction
hdc-abmt
anti-cd3-induced
costimulated
terrae
workload
anti-pneumococcal
neurometabolic
open-lung
auto-ctl
gemella
treosulfan-containing
megatherapy
retrobulbar
vapec-b
microgramkg
upt
slt-1
jgct
non-ficolled
nvivo
pbhsc
tbpa
4-hc-treated
hdcabmt
bexxa
idecs
no-dopamine
escape-avoidance
anti-b4-br
injurious
plaintiffs
antiferritin
qci
ga-67
sacroiliac
casts
hydroxydoxorubicin
dsrct
end-tidal
narrows
eggct
panniculus
lomac
p-glycoprotein-
lymphoepithelioma
bace
chagasic
cardiopathy
etl
intertransfusion
15-minute
m-vac
visceral-dominant
audiotaped
plasma-incompatible
krd
d-positive
d-negative
tenascin-c-ar
busulfan-etoposide
hd-vic
enthusiastic
egct
npn
xip
autogvhd
nurse-led
dwell
askins
daunomycine
cyad
plvm
bloodless
uun
tun
mtese
radio-guided
aispc
photosensitization
vector-related
retro-
sdf
np23
pro-b-1
crlf2r
lvs
gois
syndrome--the
treatment--should
nt303
t199c
malays
t152c
nrasg12
nrasq61
il-3rβ
cd7cd34-
thiol-reactive
abl-induced
marthas
vineyard
ttlshort
ttlshorthigh-risk
ca10
narrow-specificity
okt-3
b43-pap
d100s
atg-f-based
pro-dli
hbvr
pex
aco1
cd-56bright
sb4
rigfbp7
perlecan
moderate-
remission-bmt
myeloid-negative
asessed
gipss
aon
αcd19-aon
anti-leu2
lsc4
interferon-α2a
p-12
txu
txu-pap
znpcs2p2-pdt
el9611
b975
high-burden
5ylfs
second-remission
conjectures
cdc-evs
msc-evs
cdc-ev
cfu-leuk
bleo
protonation
arbinoside
mofs
structure--activity
granulocyto-
erythropoesis
compensatory-functional
quinone-containing
fluphenazine
direct-
indirect-acting
ruboxyl
parasitophorous
f-type
h-atpase
vanadate
melittin
n-6-aminohexyl-5-chloro-1-naphthalenesulfonamide
methyl-ccnu
dna-linked
d-dna
ml-9
pyrrolopyrimidines
adamts-4
wp631
iodomycin
thermo-sensitive
microcontainers
polymethyl
photoincorporated
4ddm
13-oh
4-demethoxydaunorubicinol
aldoketoreductase
dimethyl-sulfoxide
h69lx4
emt6ar
9-alkyl
morpholinyl
energy-driven
bisintercalating
wp762
daunosamine
m-xylenyl
ultratight
herring
enthalpic
p-xylenyl
bis-anthracycline
imi-30
d-ring
neidle
nakata
hopfinger
wp-bromo-4-epidaunorubicin
alpha-manno
wp401
cgtacg
cgatcg
cgcgcg
cggccg
daunorubicindoxorubicin
daunosamines
mrp-transfected
mrp-overexpressing
bi-functional
baumycin-producing
d788
baumycin-negative
11-deoxy
11-deoxydaunorubicin
sdspage
pdh120
unwind
unidirectionally
pc4-a5
intermediate-level
cmea
dibromodulcitol
rvp
vmaxkkm
k0
surface-active
dn-htert
wt-htert
hal-01
dihydroxyanthraquinone
luv
right-handed
squaric
resistance-modulating
ureters
chamomilla
chamomile
doxol
5-iminodaunorubicin
irp-1
irp-2
disassemble
chitinases
peucetius
spvi
lividans
chic
daunomycin-pretreated
v-like
glutaraldehyde-treated
methb
perhexiline
p388adr
h6
poly-l-aspartic
methylketone
14-bromo
bouvardin
burkitt-82
13-s-dihydro
epirubicinol
epidaunorubicin
dihydro-beta-agarofuran
adoap
roap
expediency
deoxyoligonucleotides
bisanthracycline
kbmdr1
licochalcone
magnolol
tdp-d-glucose
-dehydratase
near-homogeneity
saccharopolyspora
erythraea
psi-type
handedness
nematic
nitroxyl
extracapsular
nciadr-res
cyclophane
hexamer
multivalency
hostguest
clpm
mdr2
3hdnm
stereospecificity
racemic
racemate
mp-mtx
nr-160
mnp-fe₃o₄
polyene
detorubicin
e-adm
rbz
n-trifluoroacetyladriamycin-14-valerate
thp-adm
n-l-leucyl-daunorubicin
-methoxymorpholinodoxorubicin
riordan
protein-concealed
intercalator-induced
lamp2-stained
methylamine
beta-aib
psi-urd
aminoacridine
ah66
ic50-values
outwards
tyr193
trp229
hetero-association
phenanthridines
5-dtpgpcpa
hnrna
valexon
g-less
sp1-protein
sp1-activated
rebeccamycin
nb-506
2-amino
p388adm
n-solanesyl-nn-bis-dimethoxybenzylethylenediamine
pmb-decaprenylamine
calcium-blocking
sarcosomes
sarcosomal
nadphcytochrome
nadphferricytochrome
nadhacceptor
s-126
s-240
se-independent
c-11-hydroxyl
4-demethoxydaunomycin
anthrapyrazole
ci-937
tyrt
g-specific
ri24
albolongus
enissocaesilis
candidacidal
phagocyting
feulgen-stained
eep
4-nitro-o-phenylenediamine
dsdafe
electrochemically
aph
cc531mdr
cc531rev
fehad3
quelamycin
microgl-1
input-output
biosynthesized
coeruleorubidus
me130-a4
epsilon-pyrromycinone
epsilon-isorhodomycinone
nazionale
tumori
farmitalia
zbinden
ufa-dm
gw-8510
rho0
muw1
actinomadura
aklavinone
submitochondrial
nitrile
13-dihydro
5-imino
auc-idaolauc-ida
ag1
aklavinone-11-hydroxylase
rdme
rhodomycins
purpurascens
anthracyclinones
phenylglyoxal
pgp-rich
chrb30
adkg
dmkg
vinblastine-resistant
kb-v1
deae-sepharose
mdr1-transfected
high-capacity
aerosolization
reproliferation
datop
autoradiographically
dnrk
o-methyltransferases
4-o-methyltransferase
3h-ttp
rubomycins
h-87
amp-dependent
13-tret-butoxycarbonyl
-methyl
antiblastomic
lio-1
enzyme-template
substeps
3-fluoro-4-demethoxydaunomycin
anthracycline-dna
lamellarins
polyaromatic
lamellarin
benzylisothiocyanate
n-methyl
rhodesiense
d-bsag
d-bsas
d-ag
polyisobutylcyanoacrylate
d-pica
c-13
lymphadenosis
l-5178
karminomycin
baumycins
baumycin
deoxysugar
dnmz
four-electron
calsequestrin
csq
exocytotic
dihydropyridine
jsm
vrp
microecology
nanoerythrosomes
wehi-150
ionisation
octanucleotide
anthracenediones
dcgcgcg2
dcg5mecgcg2
5mecpg
noes
n-acylated
bruneomycin
streptonigrin
n-hydroxysuccinimide
3-azido-3-deamino
adnr
multi-spectroscopic
hypochromicity
efrn
electroactive
cntp
electrochemistry
daun-based
daun-ol
azd5438
r547
mdckii-abcc1
akr1c3-mediated
ehr2
ca2-buffering
ehr2dnr
ehr2vcr
streptomycetes
exponentials
polyda-dt
polydg-dc
y-site
5-ml
turbidity
edisylate
drug-containing
fluidization
n-trifluoroacetyladriamycin
ad41
mdr-p-gp
mdr-specific
k562r7
alpha-hydroxyisopropyldihydrofuran
3d-quantitative
epgrnov
epgdau
dxol
pterygium
turners
sarcolysine
ftorafur
ferrite
aklanonic
polyketides
pkss
r1128
dodecaketide-specific
cuvette
h35
hypochromism
dm-heparin
accumulationretention
wilcoxons
msba
adnr-3
doxazosin
terazosin
hvrl
3hdaunorubicin
3hdigoxin
llc-ga5-col150
apical-to-basal
basal-to-apical
apth
100-kda
atp-independent
proliferation-independent
npf
canaliculus
3hdaunomycin
fluidizers
a2c
-diphenyl-5-hexatriene
uncompetitively
d-cpg
upfield
spin-spin
interproton
mdr-modulating
n-alkylation
ethers
propanolamine
n-alkylated
mirabilis
l-forms
cl-a
pp1c
prb-c
nephroprotective
nmofs
doxorubicindaunorubicin
nmof
prodrug-activating
cemvlb1000
cemccrf
coagulability
mrk20-fab2
kopm-28
pepleomycin
7-deoxypyrromycinone
7-deoxyaglycone
obeyed
7-deoxydaunorubicin
deoxyaglycone
7-deoxyaglycones
lcat
hob
dlkp
l23p
l23r
tolmetin
acemetacin
flufenamic
ketoprofen
mrp-mediated
carneae
dsdt
taxonomically
zimet
trouet
mllitd
tyrosine-rich
alu-repeats
novoaml
tfiid
iiaiid
streptovaricin
iiaiiddna
rifamycin
daunomycin-al3
al3
oxyhemoglobin
injure
adriamycinol
trovafloxacin
cephazolin
rgcsf
3-nh2
ch2o
drbm
hexamethyleneimine
advp3000
s1-m
4-epiadriamycin
b3lyp
daunomycinone
s12
s13
3-halo
d1-resistant
reductase-deficient
dppa
methoxime
glc--mass
pertrimethylsilyl
glycone
d5w
normosol-r
enthalpies
calculus
carminomycin-resistant
p-388c
viscometry
dna-daunomycin
aminoglucose
double-helix
sw-r120
ht1080dr4
mccoys
placenta-conditioned
ab-daunomycin
matuc7
epitheloid
matup
matuc8
rbx
ceramide-
mcf-7adrvp
amidine
5-tc-3
microlml
nv-loaded
thermoresistance
epgp
epgrdb
thermoresistant
akm
avm
cor-l23r
190k
cor-l23
non-p-glycoprotein
malpighian
ramsay
optically
mrp2-like
p-glycoprotein-like
swa
hypercvxd
n-demethylmenogaril
akr1a1
akr1b1
akr7a2
dna-membrane
micronuclear
da-dt
gbtli
aristololactam-β-d-glucoside
biogenetic
mdr1-g185
adnrt
viscometric
dau-induced
sin-1
uhplc-msms
meg-csa
base-induced
cycloaddition
pre-ejection
peplvet
myothermic
cardiectomy
polarographically
abv
wk-x-34
99mtc-sestamibi
mcf7mx
5-cfda
microtitration
au-nps
emt6p
h69p
3h-azidopine
c-9
ecto-5nt
cyto-5nt
radiochemically
gnrh-r
gnrh-iii
lamprey
bond-linked
dau-gnrh-iii
8lys
dau-4lysac-gnrh-iii
4ser
typexa0i
daunorubicin-gnrh-iii
tempo-oh
pnl
ferredoxins
ferredoxin
sp1-dna
mut2glut1
mitotane
pgp-overexpressing
dmb
gnrh-i
gnrh-receptor
transmitral
cdmp
3hryanodine-binding
3hryanodine
befunolol
fem-x
tiapamil
fvp3
polymerizing
ag-dnr
reversins
mdr1-expressing
sf9
reversin
daunomycinpeptide-1
p125
verapamil-sensitive
water-salt
cholester
textures
pbcn
intercalator-conjugated
10-drug
antibiotics-induced
adm-
acms
preheating
adm-induced
p388s
alkalinisation
dnm-resistant
khellin
visnaga
furanocoumarins
drug-transporting
r101933
4-oh
daunorubicins
-dideoxy
diaminoacridine
intercalant-enzyme
avidin-coated
covalink
daunomycin-
dialysability
dialysed
ls2
4-oh-cyclophosphamide
4-ea
trichloracetic
ly335979
frtl-5
mptk-6
involutional
necrobiotic
bis-daunomycin
reattachment
imagestream
jolkinol
epgrn
epgrd
ht-29rd
cyclized
alkyne-azide
carminomycinol
evaporated
quinone-modified
nn-dibenzyldaunorubicin
cyanomorpholino
closely-related
hipsc-cms
7r
beta-alanine
enthalpy-entropy
oligopeptidic
intralysosomal
gm3639
kt-5720
mdr1-dependent
emoxyl
polygraphic
kb-c2
verapamil-stimulated
kb-a1
triptycene
tt0
tt13
west-berlin-protocol
aml-therapy-study
chromophore-modified
4-demethyl-6-o-methyldoxorubicin
4-demethoxy
dna-daunorubicin
tetracaine
mtx-tetrahydrofolate
mtxra
trans-stimulation
noncooperative
mbec4
mpmvs
atp-regenerating
re-co
os-co
i2113
i2025
auc0----infinity
plga-dnr
partitions
extravasal
vii81
h-sds
anthracyclines-induced
prolidase
imidodipeptides
ph-metric
betaav-x
drrb
dnrx
coeruleobidus
dauw
dnri
self-resistance
sarp
mst-16
ametantrone
monohydroxylated
doxorubicin-stimulated
daunomycin-treated
adriamycin-
etoposide-resistant
sbc-3adm
sbc-3etp
lichrospher
rp-18
gadd45b-deficient
mkk4-jnk
aldose
dl-glyceraldehyde
cys299ser
concentrationdose
rubeomycins
carminomycins
c-1
g571a
mdra
heptadeoxynucleotide
dm-pn7
pt10p-nq
dmpo
rnv
rwma
s-glutathione
glucosyl
tropica
phosphorescence
carubicin
7-con-o-methylnogaril
manganeseii
hydroxyrubicin
wp900
intravesicular
equiactive
auc24hdosem2
auc24h
5637dr
phloridzin
-dihydroxychalcone
equilibria
2-fluoro-4-demethoxydaunomycin
2fd
dg-c5
da-t5
19f-nmr
downfield
neighbour
791t36
spin-trapping
plasmic
deoxyglucose
atp-depleted
decays
3-deamino-3-morpholino-13-deoxo-10-hydroxycarminomycin
13-deoxo-10-hydroxycarminomycin
r20x2
ecm-coated
drc-resistant
3brpa
transporter-expressing
daunomycin-dna
dcgcgcgatcgcgcg2
bisintercalator
duborimycin
cis-aconityl
d-glu
amphoteric
w-7
n-piperidinemethylenedaunorubicin
lichrosorb
rp-8
fluorimetrically
nephrosis
tubulotoxic
beta-adrenoceptor
hvr
helix-coil
self-complementary
fraying
drugnucleotide
13-dihydrodaunomycinone
7-deoxyaklavinone
epsilon-rhodomycinone
w1
7-deoxy-13-dihydrodaunomycinone
galilaeus
w2
7-deoxy
zeta-rhodomycinone
taguchi
dmebp
tres
overhauser
noe
5-ca
nogalose
5-tgc
hydrogen-bonding
31p
waring
9-hydroxy
sep-pak
kb-chr-24
tubocurarine
psio2
plga-psio2-dnr
plga-psio2
spin-labeled
luna
microbore
icrf-159
vant
stern-volmer
coq10-treated
coq
cnt-based
expounded
ddss
3h-daunomycin
3h-dm
benzbromarone
4-iodo-4-deoxydoxorubicin
grippe
kdau600
cl6
4-deoxyadriamycin
4-deoxyadm
4-demethoxydnr
7-omen
pvda
25nl
permeability-glycoprotein
semiquinones
100000ml
blending
polyn-isopropylacrylamide-co-polystyrene
etching
etch
silane
tm6
dpdhn
lawsone
monoclinic
2yly
kdau400
kdau500
cemvbl100
steroid-binding
progesterone-adenine
propafenone-type
dcgatcg2
dtggggt4
hydrogenated
hepc
dicetyl
hepc-liposomes
epc-liposomes
dnrm
n-acetyldaunorubicin
n-acetyl-dnr
3hdnr
p388bra
p388br
2-thiouracil
melanin-producing
urbatsch
benzo
fagopyrum
cymosum
trev
meisn
fago-c
nuchal
a549mdr
mdr-transgenic
rnca
water-mediated
biosensing
pges
rgo-pges
rho-123
bzq
azidoprazosin
3-epidaunorubicin
sn1
sn2
talla
gp37
ichikawa
sn1-ra
sn2-ra
i88
mir-33b
cis-aconitate
darpins
lmrcd
darpin
rh-tnf
l-m
bm-ca
su-dhl-4
rc-k8
host-metal-guest
dimyristoyl
daunomycin-nephrotic
14c-acetate
ll-348
poly-β-ketone
regio-
oxetane-based
ketosynthase
extender
quinonoid
3hltc4
n-acetyl-lte4
s--dinitrophenyl-glutathione
s-conjugates
claudin-low
vanadate-sensitive
6-methylpretetramid
fourth-ring
tetracenomycin
dba-2
b10d2o
d-99
resistance-reversing
kb--11
koenigs-knorr
ppgpp
t7-infected
-dinitrophenol
anti-phage
lds-751
mitroxantrone
nu7026
cellbead
vrap
f-hyperthermia
tetragonal
dcpg
cyclohexene
octahedral
gbp21
gbp21ldv
anti-parallel
ß
jh8802
jh8302
dehydrogenasesreductases
curcuminoids
bb19
bcec
papp
7-o--dideoxy-2-fluoro-alpha-l-talopyranosyldaunomycinone
bromides
anti-afp
naei-l43k
oxolinic
ergot
psychoactive
1-propylagroclavine
1-pat
25xa0kgy
ccrf-vcr1000xa0cells
525a
oxycodone
oxycodone-induced
lc-fl
carminazine
3-brpa
13-cyclohexylidene
rch
tumor-diagnostic
radiotracers
a2780ad
jy
18ffdg
11ccholine
fe3o4-magnetic
k562-nvcr
bh-acdmp
n-trifluoroacetyladriamycin-14-valerate-ldl
daudox
dox-caacgtg
dau-
ah-j
gao
y-g
liaw
hydroxyls
drug-cell
ldl-daunomycin
daunomycin-sensitive
daunomycin-resistant
cdop
rcdop
3hnabv
-kda
nabv
nitrene
membrane-related
acetonitrile-
na2
hpo4
triethylamine
bisquinone
hl-60-rv
hl-60-r8
35ssulfate
tendons
1v
procollagens
vpl
k-h30
k-h300
microspectrofluorometry
daunorubicin-formaldehyde
daunoform
dauf
dox-
dau-treated
mesophases
mesophase
chromophores
iremycin
antharcyclines
7-deoxyanthracyclinones
hydroquinones
8s
microsequencing
cardiological
po5
hypoxicacidic
13-deoxyanthracyclines
daunosaminyl
adriamycinone
nacnbh3
duanorubicin
colchicine-resistant
mcf-7adriar
compressibility
adept
acetylcholine-induced
14-chlorrubomycin
14-chlorcarminomycin
162-fold
ml1s
chromospheres
cyclosporins
mdr-like
scv
ak-based
rifapentine
sitafloxacin
scv-related
rgbp
fnv
ethanolamine
sasca
4-deoxy-doxorubicin
iododoxorubicin
fce23762
tetra-o-acetate
tet-oahcs
oxazolinodoxorubicin
sw707
lovodx
mes-sadx5
idarubicinal
lactic-co-glycolic
4-methoxy-11cdnr
11csam
arb
baf3-kit
baf3-kitdelta27
baf3-wt
mdr1-encoded
r669c
w1108r
plz4
akt-foxo1
nalm-6ik6
sup-b15ik6
p-foxo1
elecsys
blends
nano-tio2
n-methylurea
isocyanates
trisubstituted
amidino
drbh
23na
pcddh45
dna-unwinding
fork-like
blunt-ended
feiii-anthracycline
feiii-adriamycin
dnrr1
dnrr2
h6101
caesius
dnrj
dnrij
afsr
redd-orf1
eryc1
helix-turn-helix
cholinesterases
acetyl-
buche
microcatl
drzx
ncatg
dnr-a
dnr-a-hsa
deltah
deltas
drcol
dm5cgtpsam5cg
nogalamycins
platination
-dinitrobenzoate
neuronally
lnh-i-80
cyclofosfamide
chromosomelike
rp-2
workbench
umu
dox-resistant
p388r
acetohydroxamic
tba-reactive
l-phenylalanine
mopc-315
spet
99mtc-tetrofosmin
11ccolchicine
11cverapamil
11cdaunorubicin
n-11cacetyl-leukotriene
dubin-johnson
spin-trapped
transatlantic
daunomycins
thermodynamically
triethylenemelamine
exchange-type
baii
co-n7
a-dna
z-dna
deoxypolynucleotides
polyda-t
donating
tan1120
k562-dxr
daunomycin-antibody
cis-aconitic
cis-aconityldaunomycin
drugantibody
doxdnr
dvvmp
vvap
vvp
emoksil
swcnts
doping
agagcl
single-walled
sugar-modified
nlb
flavoproteins
carbazilquinone
2hh
dh-epi
da-ida
top2alpha
antimutator
pheasant
flbz
metyrapone
stimulative
daunorubicinone
doxorubicinone
repercussion
surflex
virus-8
p388rm
p388rx
photoirradiation
photoirradiated
hydroxyl-dmpo
air-free
tafi
adhesively
bisdioxopiperazine
cardioprotector
-acridinylamino-methanesulfon-m-anisidide
drug-monoclonal
ly-2
ly-2-
idarubicin-anti-ly-
anti-ly-
drn-10
two-state
violamycin
dpsb
thp-doxorubicin
n-demethyl
literm2
gnrh-based
impedimetry
4lysbu
gnrh-iii-4lysbu8lysdauaoa
maleylated
mbsa-dnm
l1210s
l1210r
rdmb
monooxygenation
10-decarboxylation
lle
hypodermal
doxilcaelyx
dvcp
half-of-the-sites
hormone-iii
epgptetryb-1
epgrdbtetryb-1
tetracycline-dependent
aperef1
ethr
rhor
inwardly
motive
ortho-vanadate
vpmr-5
transferase-deficient
vtgm-6
cleavable-complex
chaires
d-e-c6
ceramide-induced
deoxydaunorubicinol
deoxydaunorubicin
deglycosidation
dc-3f
microgramsmouse
5-bromotetrandrine
brtet
ad300
mcf-7th
s-odn
i-treated
sc33428
sccl
through-put
broths
cinerubin
daufmor
daufhex
atp-driven
-160
3hcolchicine
lsa2-l2-mtx
cr1r12
tetraphenylphosphonium
3hgdau
danorubicin
asystole
fels
prophages
nonlysogenic
taq100
monolysogenic
lysogenic
taq100f1
taq100f2
taq1535
taq1535f1
taq1535f2
taq98f1d
taq1538f1d
1-cured
2-cured
ag-4-atp-mwcnt
popc
serrs
13-cyclohexylidenhydrazone
cch
13-hydrazone
cyclohexane
nkly
glc4p-gp
bcml
nbds
non-hydrolyzable
hpp
rhpp
rhppg
ladirubicin
pretreatednon-pretreated
my-emd
ly-emd
2-chloroethyl-1-nitrosourea
20-h
methoxy-morpholino-doxorubicin
phfs
epprdb
p-glycoprotein-dependent
sitesmyocyte
mössbauer
fe-anthracycline
fe-adm
17beta-d-glucuronide
morr
bso-treated
carbonyl-reducing
dehydrogenasereductase
antihelicase
drrab
drra
bacteriol
cumulation
amsahidac
diacarb
5-iminodaunomycin
drug-metal
5-iminodaunomyciniron
bioreductive
noel
lambdamycin
granatomycin
4-dmdr
hard1
nath
nath-hard1
tc-mibi
kb-chr--11
dnrs
vcd
m109
p-288
butyrolactone-type
autoregulator
nadp-glycohydrolase
taurochenodeoxycholate
taurolithocholate
ursodeoxycholate
taurodeoxycholate
anthracyline-resistant
urd40
interference-based
pharmacodymanic
c14
sugar-phosphate
beta-glycosidase
enzyme-prodrug
galactoside
dnr-gla3
dnr-gsa3
nanoerythrosome
neryt
ir-768xa0xa0drb
mpeg-b-plga
chemo-photodynamic
all-bfm-90
coo-
7-deoxydaunomycinone
anti-adriamycin
sm-5887
mx-2
-oh
cholesterol-enriched
enantiomeric
tc-sestamibi
icrf-193
triaziquon
nonlamellar
glucuronosyl
14cdoxorubicin
guanine-cytosine
annealed
5-dtgagctagctca
caspasexa
leukaemomycin-producing
imet
prototrophic
4-methoxy
ha117
g238c
g460a
a719g
oim
wbla
sco
dxrdnr
-disrupted
l-histidinol
deltata-p73
p73deltaex2
ta-p73
difloxacin
pbr
4-epimer
iivp-16
4-demethoxyadriamycin
nn-dimethyladriamycin
nn-dimethyldaunomycin
morpholinodaunomycin
cyanomorpholinodaunomycin
cyanomorpholinoadriamycin
chlorhydrate
dfr
hemocytoblastosis
lio-i
gs-platinum
photolabelled
photolabelling
ceramide-dependent
beta-ketoacyl
malonyl
ksalphaksbeta
mcat
malonyl-acp
apo-acp
brafdel
pik3r1-g376r
one-thread
10-microl
methysticin
3-indolepropionic
eppp
daunomycinol
7-con-omen
dis-nogamycin
7-con-o-methylnogalarol
phenobarbital-pretreated
3-compartment
non-p-glycoprotein-mediated
dipole-charge
lmrr
promoter-bound
wp608
dna-modified
cosynthesis
ferulate
5-id
photosensitize
mirna-mrna-signaling
daunorubicin-blocked
4-o-demethyl
4-o-methyl
cv-1raf
hyperatomarin
annulatum
mnpe
-diphenyl-2-picryl-hydrazyl
hyb-241
gp180
gp180-
ap-endonuclease
aziridinyl
benzoquinone
bioreduction
polyethoxylated
proflavin
dhaq
4-dnr
4-adr
o-dox
oxazolinodaunorubicin
o-dau
doublehelix
5-cga-3
uncomplexed
stacked
8-s-fluoro-idarubicin
deprotonation
4-epi-2-bromo-daunorubicin
ceme1000
transmembranal
reoperations
retinotomies
bis-dioxopiperazine
icrf-186
n-morpholinomethyl
dioxopiperazine
icrf-154
icrf-198
daun02-daunorubicin
125iiodipine
-dihydropyridine
bolton-hunter
edman
nanotubes-drug
cntsgce
cathodic
ox26
transcytosis
rbe4
n-5-dimethyl--methoxy-4-methylsulfonylamino
phenylamino-4-acridinecarboxamide
14-valerate
eo9
maph
vanadate-dependent
esotropia
dnr-binding
inverts
outward-facing
6-deoxy
alpha-linkage
c9-carbonyl
krs
p94l
actkr
stereospecificities
ta97a
s9788
b30
desacetyladriamycin
5-imino-daunorubicin
anthracycline-stimulated
oxyradical
efrcd
efrab
efref
pgy1
doxa
tk24
frequency-domain
saecgs
3h-dnm
oncolysate
ait
cgt
carbonyl-stretching
f-ida
br-dnr
pira
pocal
c-trifluoromethylation
four-step
polymethacrylic
pmaa
pmbaam-co-maa
hcm
igf-i-dependent
npld
l61
drugcopolymer
dna-incising
k50
repair-specific
bromazepam
chlordiazepoxide
flurazepam
tma-dph
datpatp
glucuronides
gb6
epirubicin-glucuronide
doxorubicin-nitrophenyl-glucuronide
morphofunctional
atcc27952
electron-transport
fdx1
fdr2
putidaredoxin
emulsifiers
pz0
pzth
peptide-daunorubicin
ala-leu
operons
glycosidation
glycal
sos-chromo-spottest
sta-plates
b-plates
bromocresolpurple
cd64-targeted
cd64-binding
nona-arginine
sr9
sr9-mediated
siho-1
ho-1-silencing-mediated
subperiod
vesicant
n-butanol
aids-ks
hyperkinetic
myocardiopathy
flunarizine
billingham
pai-1-deficient
daunorubicin-pretreated
lsm
loop-column
amperometric
so4
ta3
lvfs
n-dna
reorientation
redox-cycling
quinoid
s-wave
8226doxint5
menogarol
7r-o-methylnogarol
13-dihydro-derivative
-dimethoxybenfluron
oracin
-2-hydroxyethylaminoethyl--dioxo--dihydro-11h-
indenocisoquinoline
ratio---
dpdtmax--
kpas
dimethoxybenfluron
dpdtmax
cosmomycin
cosd
impairement
factor-x
liver-synthesized
oxazoline
anthraquinone-stimulated
2m-80
dna-drug
succinylated
drugabstract
beagle
mebcd
1-naphthol
microm-daunomycin
protectors
guanylyl
eadm
reductase-dependent
oxazolidine
doxoform
gc4
bh-smp
atp-energized
doroshow
davies
reextraction
daunol
bmscsn
wp811
isoflavonoid-induced
microliterml
lbr-v160
lbr-d160
hbd
mitomycins
acid-sensitive
syngeneically
bld-1
whi
nonelectrostatic
crystallizes
ferroxidase
thls
iron-catalyzed
flounder
4dd
hr20
pq37
chromotest
beta-g
sosip
4demethoxydaunorubicin
dmdr
irradiating
dcfh2
pyocyanin
kam32
mdea
threading
overstretching
mitolactol
reductase-1
acetylenic
antitumor-promoting
seu2009u
butyllithium
ltxa
dau-dex
gdiii
pgp-gfp
anti-intercellular
hb8065r
daunorubcin
laurisulfate
1t
rh--
4-o-acyl
multispecificity
exporters
chromophor
adsorb
microsheres
microsperes
re-extraction
dlbst
l--dihydroxyphenylalanine
∆fosb
zif268
daun02
ß-galactosidase
glcn
reattached
fovea
d218
v218
cepharanthin
grg
prg
pyrogenic
pyrogen
betulin
gene-encoded
p-glycoproteins
alis-409
alis-421
silicon-substituted
257pmdr
alis
pgp170
n-tert-butoxycarbonyl-l-cysteine
1-thio-beta-d-glucose
substoichiometric
7s-
acetylshikonin
acetoxyisovalerylshikonin
mcf-7vp
astragali
polybotrys
daunoblastina-induced
formononetin
m-ea
dgdc
trans-e-flupentixol
sdr
cbrs
lasix
perfluorodecalin
polydeoxynucleotides
propionyl
self-acylation
propionyl-coa
dpsg
phosphopantetheine
tut-7
silicic
k562vcr30
k562vcr150
mip-1beta
mip-3alpha
prespore
rhegmatogenous
plana
p-dfs
diploic
hyper-diploic
znfe2o4
ivgtt
citrifolia
messadx5
noneffluxable
daun-
dox-associated
mdckii-mrp1
mdckii-mrp2
schistocytes
chorea
nih-g185
atp-hydrolysis
amplification-associated
abrs
v19
antifolate-resistant
pancytosis
4-n-benzyldemethylrifampicin
dnr-dna
dnr-dna-treated
doxorubicin-producing
-hd
rhizosphere
igh-pcr
ptpd-nioswcnts
ptpd-nioswcnts1b23dtfbcp
cacodylate
tilt
3-ipa
h295r
6cg
6cb
6cg-dau
anthracycline-producing
bavachinin
tephrosin
candidone
vldd
dxl
dimas
tpl-induced
cmfvp
dibromdulcytol
murf-1
mafbx
biricodar
vx-710
incel
mipu1
ns-snps
c4y
v93i
v244m
gnrh-iii-dau
tert-butoxycarbonyl-alanine
oxyferrous
mek-mapk
hgf-mediated
bmh
rtp
v88i
v88
non-localized
14cadriamycin
14cdaunomycin
topoii-dna
energy-depleted
clerocidin
topoiialpha
uninephrectomy
upht
24huper
coiv
deoxyaglycones
methanol-
epi-lip
epi-ltsl
t-dnr
lattice
12-as
steffimycin
steffimycinone
bh-acamp
epalrestat
30nm
sequence-selective
helix-forming
triplex-forming
hbag
hbab
rodamin-123
v79s
v79adm
mz3
anti-mdr
polyaldehyde
adipic
drug-dextran
isonitrile
3t3mdr1
14c-rubomycin
af3p21
chloromethylketone
n-acetyl-leucyl-leucyl-norleucinal
qao
jurkatb
g322a
jurkatb5
jurkatb8
tenascin
β-1
p-nitrobenzaldehyde
c-wrt-7
lps-hyporesponsive
acodm
gly-gly
gly-phe-leu-gly
fucosylamine
polymer-bound
isovolumic
pc-v40
vincristine-selected
pc-v160
pc4
xp-k
xp-c
xp-e
xp-h
n-acetoxy-2-aaf
zor
nanoerythrosome-dnr
topoisomerase-like
acm-a
saitama
hav6
resealing
blg2
blg3
blg4
aroylhydrazone
isonicotinoyl
pih
sih
o-108
fermentations
anthracyclinone
daunorubicin-producing
99tcm-gluconate
extinction-associated
dnr-ol
homonuclear
14cdocetaxel
lucanthone
hyaluronidase-mediated
cracked
ribbons
nonfamilial
tpps4
3σ
am1
vision-threatening
bergapten
xanthotoxin
104-fold
deoxytransferase
14-diethoxyacetoxy
bis-intercalation
mono-intercalation
condense
bis-intercalators
fadha
stiffening
saml-ahd
mcf7-r
nih-mdr-g185
nasal-paranasal
npop
angiocardiography
pfr
pfredc
sulfolane
aromatization
tnfr80
tnfr60-induced
tnfr60
tnfr80-mediated
adnr-3-hsa
dpsy
dnrh
scotti
etodolac
phosphoethanolamine
nf-κb-expressing
monoher
cardiomyopathic
intramembrane
air-water
kaw
phamdr1
bisanthracyclines
14-bromocarminomycin
14-bromorubomycin
14-acetoxycarminomycin
14-n-imidazolylrubomycin
mycoides
stimuli-responsive
znps
znp-liposome
tov2223g
5-bromotetrandrin
dnrbrtet-mnps
self-prepared
a-bc
c7d
second-harmonic
α-ketol
doxorubicin-dnafeiii
epirubicin-dnafeiii
mdr-reverting
sw-rr160
mdr-modifying
2r160
flavin-mononucleotide
heterocomplexes
calgb10403
calgb9511
nucleophylic
ms-2
dpsa
dnro
dnrn
cal-am
pp1pp2a
aclarubicin-native
polyelectrolytes
na-gradient
fd18
lcc6mdr
anthranilamide
epi-adm
demethoxy-daunorubicin
dm-dnr
cisddp
anti-p-gp
coall-82
coall-85
epic1
polydadt
l-nhl
chemosensitisers
chemosensitiser
bro
olivomycin
uncoupler
picp
ictp
-epicatechin
quinizarin
2-trihydroxychalcone
hydrocarbon-induced
dnrg-dpsabcd
dnrc
dpse
na-conductivity
bisquinones
tt24
sgc8c
kinase-7
nanocrystal
mq-580
atp-
alkavinone
x-plor
sandwiched
kink
cop-x
alpha-phase
bisdioxopiperazines
oc-nyh
vxld
jurkatmrd
non-group
17-beta-d-glucuronide
kiapp
tkrnai
anti-abcb1
fmn
dtgca2
thermodynamical
dependences
pnu-159548
13-hydroxy
pnu-169884
panneerselvam
vogel
c-w
complement-enhancing
cardiocytes
aspar
r59
anamorphic
white-rot
bjerkandera
adusta
decolorize
post-production
adm-administered
nl‑101
damage‑inducing
anti‑aml
dnr‑induced
cleaved‑caspase‑3
cleaved‑caspase‑7
double‑strand
γ‑h2ax
isoflavonoids
smegmatis
mar70
dcgtnacg
2-aminoadenine
axrt
cineangiography
periodleft
gt1b
gq1b
map-2
neurite-bearing
nsmase2
da-ic50
da-induced
4-o-sulfate
δdpsamut
daunorubicin-protease
nonidet
cema7r
three-component
caf-dna
polysomes
vcfc
lvws
5-fluoro-uracil
tiamulin
4edx
4dmdr
4dxdx
squab
pecking
arcamone
kh30
r100
thermotropic
tay-sachs
barts
isethionate
daca
n-2-dimethylaminoethylacridine-4-carboxamide
ci-921
tfos
daunomycin-conjugated
dauno-tfos
ndmtmx
hl-60rv
4-dmdnr
4-demethoxy-3-deamino-3-aziridinyl-4-methylsulphonyl-daunorubicin
alkycycline
polyethyleneglycol-containing
pfmlh
atpmin
170-kilodalton
anti-gp170
bromsulphalein
7-deoxydaunorubicinol
multiorganic
ki-values
no-1
mitozantrone-keyhole
haemocyanin
5-brtet
cellseach
ε-rhodomycinone
avre
hydropathy
apa-sg
hemicholinium-3
nmn
permease
hd37-dgrta
microbubble-mediated
simdr1
dcgm5cgcg
b-z
cholesteric
l5222
190-kda
h69ar
mrp-specific
hn-i
hn-ivp-2
hn-idxr-ii
dact1
redetachment
dyslipoproteinemia
high-cholesterol
cav-3
tyrosine-enriched
icma
b2d
sturgeon
periretinal
14-hydroxy-daunorubicin
dihydrodaunomycin
vcmf
bithiazole
pett
schisandrin
gnrh-iiidauaoa
4lys
4lysac-gnrh-iiidauaoa
butyryl
4lysbu-gnrh-iiidauaoa
holographic
lb100
mir-181b-1
orbitofrontal
ofc
fos-expressing
reexposed
heroin-associated
acyl-coa
aortas
flavoenzymes
-naphthoquinone
arylation
-naphthoquinones
hcho
dcgcgcg
pdph
dnr-d3
post-nuclear
14cidr
14cdnr
rgd-binding
enzyme-labile
p-95
hmrp1
4-epi-daunorubicin
chopped
6-mercapto-purine
maintenance-therapy
eeg-examination
diazoquinone
roct2
nacn
n-cyanomethyl
nicks
4-dmdnol
7-hydroxyaglycone
dfdt
duroquinone
21-carbon
non-intercalating
idarubicinidarubicinol
esirna
mcf-7r
polydg-m5c
anaerobically
phosphate-generating
acetohexamide
ketone-containing
levobunolol
c-14-unsubstituted
perhydro-3-oxo--diazepinium
vp-dvmp
houée-levin
gardès-albert
faraggi
klapper
reductant
stimulationinhibition
deltacp
solvent-accessible
binding-induced
beta-glucuronidases
cyanoborohydride
8cr
8cs
tissue-targeting
gdept
acth-stimulated
propofol
glycoengineering
ac4mannac
cyanomorpholinyl
diamine
tilorone
-acridinylaminomethanesulphon-m-anisidide
tras
cardioselective
ida-mab
drug-mab
glabra
bgml
topoi
evicts
rrr
qz59
qz59-sss
rubomycin-producing
non-labeled
stereoselectively
toremifene
hyphenated
rsdxa0xa
argon
11-amino
imino-
waksman
henrici
sensu
hütter
red-pigment
leukaemomycin
anthracycline-formaldehyde
doxf
epidoxorubicin-formaldehyde
epidoxoform
epif
transbilayer
fluidizing
vdlp
net-uptake
pa-dau-aunps
apt-dau-aunps
sigmoidoscopy
s-shaped
dna-directed
polymethylmethacrylate
cemvm-1
blmr
acrr
carminomycinone
o-demethylation
dfurd
96-kda
daunomycin-mab
midecamycin
pcg2
glaucescens
n-iodosuccinimide
beta-l-gluco
mode-of-binding
dna-ligand
dun
dun-induced
gnrh-ii
ligand-dna
triple-regulated
sg611-pdcd5
polyu
dnr-tio2
4-dmdnrkg
dxkg
mlv-m
undirectional
adr-ol
f860191
l-cycloserine
lipid-mediated
fe2o3
incidencehowever
patientsobjectives
effectwe
non-statistically
downgraded
flavonols
2-chlorobenzoyl
dau-a
dau-c
nppa
myh7
dr-19
a-431
maas2
is1612
is21
25bp
mybpc3
442bp
bgl1
monolysogens
pgp-inhibiting
chemosensitizer-containing
8226dox6
dvpm
p-105
unimers
iminium
all-scid
re-proliferations
hrp-h2o2
p-hydroquinone
nonsaturable
cis-inhibition
123i-mibg
123i-bmipp
diastole
phosphorylcholine
csa-resistant
hairpins
emt6vrp
rl-14
taucb
healon
bcrp-mediated
tps-a
13-dihydrocarminomycin
chromatograph
dihydrocarminomycin
met-dx
deo-dx
iodo-dx
cassette-type
trnaphe
bis-intercalating
drugdna
unstacking
hexanucleotides
topii
h-89
ii-interacting
mrp1-transfected
s1mrp
apda
peg-poly
pll-poly
dnr-tf-nps
ehr1
ehr8
carboxyatractyloside
manyfold
tfo
dauno-tfo
n-trifluoroacetylation
ppt
tgge
alpha-l-gluco
alpha-l-manno
alpha-l-galacto
sf25
ls180
daunomycin-dextran-sf25
liposomally-encapsulated
mcf7adr
h69vp
todralazine
lineweaver-burk
alpha2-antiplasmin
myocytolysis
infectiontransfection
p-gps
puromycin-purified
stacks
nitroxides
polymer-oxaiv
polymer-drb
oxaii
d-vrp
b-triple
phosphorylatable
pdr5p
p-gpmdr1-expressing
polydg-c2
polyda-t2
loxapine
chartreusin
a132
r-factors
full-matrix
dcymp
dcvp
acm-mp
tg-pec
demethyl
formamidinodaunorubicins
t-independent
super-enhanced
liposome-containing
wollner
bge
rwis-induced
vasoconstrictor
dnp-sensitive
nonnuclear
n-acetyl-13s-dihydrodaunomycin
dnr-cm
seml
dgcgaagc
novantron
ips-cms
ips-derived
ppt1
nagi
d-bands
q-bands
nponp
akr1c3-overexpressing
gar
gar-dependent
topoisomerase-ii-dna
gar-mediated
anticryptosporidial
elliptinium
oocyst
lasalocid
14-hydroxycarminomycin
-methylpiperazinyl
c-junap-1-dependent
mrp-efflux
aminooxyacetylated
mcm6
adriamycin-14-octanoate
ad-14-octa
adriamycin-14-acetate
ad-14-ace
membrane-lipid
nca-90
mcf-7w
pyrrolo-dpyrimidine
mli
lysotracker
mitotracker
dtgtaca
dtgatca
angstrom
dcgtacg-daunomycin
dcgatcg-daunomycin
pnipam-co-ps
kph
atracht
apl-cht
anll-non-apl
anll-cht
non-ring-hydroxylated
vα
patinets
as1411ntrs
all-treated
lymphoma-treated
induction-phase
fluoroorotate
epprnov
actiii
divergently
cyclasedehydrase
orf1
ca-independent
iodorubicin
drug-carrier
nsc-123127
nsc-82151
polydgdc
marky
breslauer
fluctuational
premelting
dnrub
photodegradation
photostability
3hactinomycin
pi--pi
n--pi
si-mdr1
16c
enantioselective
norverapamil
d617
h69dau4
htdr
metalligand
dhb
adr-induced
iminodaunomycin
ulp1
siz1delta
11mer
dauno-gt11
epimeric
4-epidaunorubicin
avermitilis
dnmv
decost
vcf
cyclophosphamide-resistant
phenylbutenoid
cassumunar
3-deamino-3-epi-hydroxy-4-deoxy-4-amino-daunorubicin
dsbcytotoxicity
nbd2
ltrmdr1
dimethylallyl-kaempferide
reveived
r3327-at1
3-activity
fradr
aao
inet
stereochemically
vacuo
125i-hdl
non-multidrug
parallel-stranded
d-74
mitx
pgp-independent
radioiodination
791t
daunorubicin-augmented
p-gp-associated
hxd2gropcho
dnrnaphii
dnriaphii
msd1
msd2
gal-2
hyper-cvdd
dcgtacg
deformations
paef82
efra
efrb
m2t
me7
tpt-resistant
5idnr
mp11
mp11h2o2
colorless
mcf-7adrr
air-saturated
decarboxylated
daunorubicin-ol
c4-oh
p-gp-binding
rmax
n-acetyl-daunorubicin
nn-dibenzyl-dnr
claiming
pgp-9
selamectin
doramectin
moxidectin
salt-induced
calmodulin-stimulated
azinomycin
b-smase
sw-rr120
pgp-containing
2r120
iron-based
adr-925
microtissues
dnr-content
dna-content
cor-l23p
vbii
dox2
dau3
dau4
p53gln22ser23
hcc1
expulsion
p-gp-egfp
haq
pfrecq1
p388dox
tgfβ-1
remeta
anthrapyrazoles
dc-3fadii
actd
tm9
125iiaap
proil-1β
kapp
xr9576
nondependent
alcohol-dependent
staphyloferrin
petrobactin
siderophore
sbne
asba
npes
npe
bmca
bmcb
hrfc
k562ptet-onp53
hrfc-b
-dimyristoyl-sn-glycero-3-phosphocholine
dmpccholesterol
brewster
hl-60w
3h-cyclosporin
rasd1
membrane-
a-to-b
b-to-a
hbcrp-
sigma2
pb28
sigma1
hl60thp
umcc-1vp
e-fabp
-3-sigma
stratifin
mitoxantrone-selected
tg-i
tg-ii
annulus
left-ventricular
3hmpp
vrp-mediated
bromo
iodo
gallates
n-dodecyl
-tetrahydro-naphthalene
-tetrahydro-anthracene
acosamine
cisplatin-transferrin
pdr
eadr
eads
2-deoxy-l-fucose
2-deoxy-l-rhamnose
nn-dimethyldaunorubicin
morpholinodoxorubicin
nn-dimethylated
4-hydroxyalkenals
4-hda
hapten-protein
diazotization
m-abs
dm-bsa
anti-dm
dm-hsa
anti-rabbit
headgroup
phaseaqueous
dau-uc7
sky1
13-dihydrodaunorubicin
n-acetyldaunorubicinol
phenolate
doxorubicin-daunomycin
7-chloro-4-nitrobenz-2-oxa--diazole
cooch3
beta-rhodomycinone
rmn
rmn-containing
akv-containing
pidrug
ultravioletvisible
verapamil-resistant
1-ethyl--dimethylaminopropylcarbodiimide
n-hydroxysulfosuccinimide
electron-transfer
dnrf
gly185
gsv-2
vsv-1
chemical-chemical
reworsening
jr-311
bis-dioxopiperazines
myofibrillar
dna-chitosan
e-rosette-positive
174h64
174h64-dm
kln-205
peroxidation-preventive
adr-treated
biosyntheses
pegasil
fab-ms
1-monopalmitin
monoglyceride
rickettsia
tsutsugamushi
plaquing
scrub
typhus
rickettsial
pfh45
ssdna-dependent
friche
ehr2didox-1
ehr2didox-2
ehr2didox-3
13-oh-didox
pcag-lacz
picogram
cem-vbl
neighbor-exclusion
polydg
polydc
polyda
polydt
ktp
-adriamycinone
snarf-1
beta-ketoacylacyl
dpsd
alkycyclines
pq-resistant
aml-2pq100
aml-2pq400
u-a40
u-a200
c12-im
lhermittes
non-enzymic
amino-sugar
raz
4-demethoxy-13-hydroxydaunorubicin
non-biopsied
anthracyclinic
antimicrotubular
dna-acting
edvsec
pdh47
ahtg
ahtgdexdnr
autoregulators
nile-red
mcf7r
9-deoxydoxorubicin
9-dam
4-dam
demethoxy
orientations
wp700
amino-
nitro-substituted
abcc1-mediated
abcb1-
dna-anthracycline
pigram
s--dinitrophenylglutathione
glucuronate
dnr-d2
britton-robinson
3h-nab-daunorubicin
anthracycline-binding
teichoic
adbms-p
rhodamin
s66
ryr2
-dpdt
myh7b
xr9051
h69lxad
mc26
p388dx
vpm
guggulsterone
b-ring
self-reduction
fe3-doxorubicin
ferricytochrome
bipyridine
fe3-daunorubicin
alpha-ketol
cdase
ox26-mediated
titanocene
cytosine-rich
normochromatic
dxr-psa-peg3
5atcg
k-x
gresh
pullman
dyn
-466
mrp-gene
pacdb
5-terminal
monohydroxygenases
hexenal
afterload
pmr-spectra
e2-late
xvir03
11-hydroxyaklavinone
leu-dnr
leu-leu-dnr
ala-leu-dnr
hypoxy
4-epi
carbamates
ca-exposed
pre-treatments
disproportionation
dismutation
dickens
strohl
dauc
aamt
daud
dauk
cell-renewal
ph-gradients
dqf
rmd
paced
13-dihydro-dox
celastraceae
daunorubicin-binding
dnr-bp54
ct-mediated
aan
b4121
htb
riminophenazines
125iiodomycin
gsh-mbcl
p388r-84
aminosugar
4-haloderivatives
aq10
cacl2
decylubiquinone
csa-sensitive
kt6149
sm5887
liblomycin
pc-0
pc-5
limulus
leukapheretic
protein-glycoprotein
α-mannose
cona-ova
dxz
quercitrin
bisans
cultivable
incredibly
erg6
pdr5
gal4p
turcz
baill
dibenzocyclooctadiene
sw-
r120
lmr-
lmr-4
dnag
rhein
--the
feiiisalophenecl
wba
doh
d-dna-treated
pgp-inhibitory
dme
hl-60jd
u937aq
tetralysine
linewidth
r123psc833
dnrpsc833
ughetto
quigley
yoruban
etude
ic0
hdacdnr
dm-treated
daunomycin-ss
dichroic
-dihydroxyl-
mndo
pm3
drug-peptide
4lys-gnrh-iii
glp-his-trp-lys-his-asp-trp-lys-pro-gly-nh2
stabilitydegradation
argillaceus
mtra
mtrb
protectants
anthramycin
acidifying
k562hht300
ccrf-cemvlb100
daunoblastina
parallel-factor
parafac
fra-parafac
excitation-emission
eb-dna
interferents
non-competing
platinum-anthracyline
n-ethyl-13-dihydrorubomycin
diaphorase
bmccu
bmbccu
dubliniensis
phe335
dxp
v12m
q126stop
q141k
f208s
s248p
e334stop
f431l
s441n
f489l
flp-in-293
zosuquidar3hcl
cmda
deltatm
dcgatcg
p41212
gnrh-iii4lysbu8lysdauxa0xa0aoa
meg-01nu
ngdl
ionol
gossypolone
d-enantiomer
l-gossypol
co‑ip
rh123-negative
akrs
r170c
p180s
akr1c4
a142t
ehr3
bisn1-isobutyloxycarbonyloxymethyl--dioxopiperazine
pall-2
lz-8
lz-100
hydroxylapatite
polyda-polydt
mch-wt-1
mch-wt-3
hydrogen-bonded
casq
hcasq2
muscle-related
daunorubicinebselen-treated
nitratenitrite
hl60rdnr
aclacynomycin
aclavinone
diaminopropane
osi-211
kbm-3b
25abc
ggdm
annulation
n-acyl
n-acetylcarminomycin
n-d-phenylalanylcarminomycin
n-d-phenylalanylrubomycin
ho342
time-resolution
anthraquinone-containing
13-deoxydoxorubicin
cemdox
expelled
polyi-c
r-3327
dunning
em2
5-dimethylthiazol-2-yl
mcf-7vp-16
gmp-amp
cgas
nknt-3ntcp
mbiv
mbiii
naphthazarin
non-intercalated
ferradin
viii87
ring-b
rm22-f5
multidose
rhodamin-123
ayurveda
nsmase
q13q22
coverslip
fluorometer
nkli
n-ethylrubomycin
glc4-adr150
10-fold-resistant
13-dihydrodaunomycindcgtacg
13-dihydrodaunomycin
daunomycindcgtacg
alza
anthraquinonyl
glucosaminosides
dihydroxylated
cal2
microspectrofluorimetry
polyvalency
hg-829
permeates
5-gc
sphingomyelinase-deficient
dr-22
gcat
ghost-glutaraldehyde-daunorubicin
ghost-cis-aconityl-daunorubicin
bllpm
valinomycin-induced
ototoxic
otoacoustic
dpoaes
3-h-uridine
7beta-hydroxycholesterol
no2-
lpoh2o2no2-
-di-tert-butylhydroquinone
gs-dnp
delta-hch
3-o-benzoyl
n-bromosuccinimide
dehydrohalogenation
-unsaturated
l-lyxo
trans-isomers
mrk16-pe
mo-7
gf-d8
ii-alpha
multidrug-
half-wave
hexadeoxynucleotide
1h-31p
sub-classify
poeg-b-pvbind
ribociclib
mdckii-abcb1
13-dihydro-4-deoxy-4-iododoxorubicin
epi-ntsl
epi-solution
a-bound
vaccine-bound
bis-intercalated
ah66dr
nci-cairo
calcium-free
temperature-jump
microseconds
gssg-r
propafenones
o-beta-glucuronyl
dnr-ga3
fma
mri-h-207
dau-ha-ms
base-pairs
a-cop
caffeine-induced
hpcm
ic50cfu-gm
lrpp-gp
my-cfuc
second-step
dn-sensitized
monochromatic
532-nm
na⁺
ecl3
dnol
ca5
avml
nft
9nc
9nc-resistant
u-937cr150
u-937wt
pcl5
pcl200
nfkappab-linked
skintests
-dichloro-4-demethoxydaunorubicin
bio-zno
100cu
ce-lif
hplc-lif
cinerea
tcfl5
trim24
map3k12
shoc2
man1a1
aluminium-salen
mbr-8
-morpholinyl-3-deaminodaunorubicin
meo
rtah
t-killers
dna-breathing
mtmas
a2780r
nn-diethyl
sj-g5
sarcoplasm
csacrem
amino-containing
lsa2
rs2868177
rs13240755
decompensated
mtck
smtck
umtck
leukaemomycin-blocked
sba-sugar
non-exchangeable
2d-cosy
pigment-protein
above-optimal
mcghee
wh
pank-integrated
bg200
dnrqs
compensations
minor-groove
homopolymeric
mdr1-as
mdr1-as-treated
-relative
tetramethylrosamine
abcb1-expressing
4-o-a-l-cladinosyl
cdnr
genistin
2008wt
2008mrp1
folate-rich
l-leucovorin
anti-thy
13-keto
c15-npy-dauno-hyd
c15-npy-dauno-mbs
half-and-half
dpsh
dnru
dnrv
pdh45
4-demethoxy-anthracycline
ciop
acla-a
photonic
sn5c
sn6-daunorubicin
sn5c-daunorubicin
2-iodo
unblocked
anthracycline-pretreated
tsh-dm
tsh-alpha-lactalbumin-dm
coralyne
acetoxy
rnapii
mrp1abcc1
14c-mevalonate
17-mer
ak-5
k-h100
k-h200
k-h400
mdr1-gene
high-level-resistant
isotropic
periodicity
leukothrombocytopenia
kinectin
4-demethyl-6-o-methyl-doxorubicin
dna-interaction
38c-13
centhour
nabd
cytofluorescence
preovulatory
bcl-xlong
apoptosis-susceptible
c8-ceramide
oligonucleosome
prehierarchal
nabh3cn
13-dimethylketals
3-deamino-3-piperidino-
3-deamino-3-morpholino
bromoacetyl
oc125
p-fluorosulfonylbenzoyl
dnr-oc125
virginiae
virginiamycin
vmsr
bara
l1210dox
l1210dnr
l1210ctx
265f4
pcdr
dmph
graphene-gold
ggn
azanaphthacene--dione
pfdh60
9-oh-e-resistant
9-oh-e
nmhe
hydroxylysine
phocae
salmonis
non-bile
16-doxylstearic
16-dsme
5-ds
nitroxide
×m
linkage-directed
99mtc-daunorubicin
4-epirubicin
ecce
388mitox
pleiotropically
procarcinogens
14-bromrubomycin
14-chlor-
p102
posteroseptal
akinesis
free-wall
ironiii-adr-925
one-ring
dnrd
aame
aklaviketone
tcmi
tr-
nonbile
carboxydichlorofluorescein
bromosulphthalein
l-asp-containing
mcf7dxr
deoxydinucleotides
alanyl-leucyl-dnr
dobutamine
sdr21c1
xn
8-pn
cbr1-mediated
-hexanedione
tmd0
l0
tmd0l0
tissue-isolated
cardiolipin-containing
dihydroanthraquinone
as605240
rlip76
awasthi
pmsf
dnp-sg
r-hypoxanthyl-
anthracycline-ironiii
lvefrn
nucleosil
min--
aspp
dmdrol
h9-ddcw
two-ring
half-times
ao108
roseola
da2b
13-dihydrocarminomycinone
br-daunomycin
im-9r
7h
8axh
8eqh
qct
qtr
rut
benzoylated
mpeg-b-ocl-bz
qct-loaded
6-hitc
tsms
pbcims
b-s
kbv-1
mcf-7s
tritosomes
stutzman-engwall
h6125
cyclodiprenyl
dunnione
c-amp
c-gmp
10xa0wt
v-104
pipecolinate
acridone
gg918
thiolipid
dppte
swcnts-dnr
sc-33428
beromycin
denaturated
vasorelaxing
oxide-mediated
sibfa
mwcnts
au-mwcnts
cdau
14-bromine
14-amino
bruceantin
cochromatographs
lkmb
ja3933
orf3
cg5
nonylphenol
np-9
3hab-dnr
rubomycin-resistant
ruboxyl-resistant
datv
fundoscopic
n-dimethylated
3h-mannose
adolescent-onset
fos-lacz
sno
h039
snof
snog
snoh
4-hydroperoxy
vdxd
dnr-protein
quench-flow
d-lys⁶-gnrh-i
epo-mediated
p131s
chromatography-fluorescence
lipoprotein-free
hdl-supplemented
wp652
bis-daunorubicin
dcgtacg2
ggp
vaccenic
t10-frac
pc3-txr
du145-txr
succinimide
mnp-fe3o4
ccbas
hrp-like
decolorization
nctc
galactose-containing
α-chymotrypsin
lysnbu
-inducing
vi-antigen
m-mode
apoe-containing
lad-loaded
pe-
kcl-induced
s-alp
13-deoxydaunorubicin
coilin
pk2
dnmdna
dnrq
dnrp
biphenol
phenoxyl
7-methoxy-4-trifluoromethyl-coumarin
mdfa
khamin-oi
a-b
demethoxycurcumin
bisdemethoxycurcumin
coall-protocols
all-rez-bfm
microfluorimetric
buckling
restorable
complex-forming
microm-induced
mycorrhizal
1-deoxy-d-xylulose
apocarotenoids
cyclohexenone
mycorradicin
mi-18
erba
glp-his-trp-ser-his-asp-trp-lys-pro-gly-nh2
id80
n-leu
hepa-1c1c7
3-mc
bprc1
ahrarnt
chromiumiii
16-sasl
agents--menogarol
menogarol-treated
dox-sensitive
k562mxn
iialphabeta
r9
vincristinevinblastine
usresponder
hysteresis
free-radical-mediated
olindensis
maggiemycin
tfrag
kb-24
dc-3fvcrd-5l
c494
lalw-2
cemvcr
hcaecs
mbr-system
ct-all
r-vpm
kruh
-1652
breuninger
-5347
drug-glutathione
peg-pll-plga
dnr-peg-pll-plga
dm-c
daunomycin-nephrosis
amphethinile
11-deoxydoxorubicin
β-lactams
nora
norb
norc
3hdau
363k
photoincorporation
sl-rubomycin
nmps
polyanions
pdr-pge
cemrr
tbz
t-g
ddna
ru38486
ru49953
mdr1-v185
helicoidal
cholesterics
daunorubicin-triggered
purr
cnmodnm
cnmoadm
modnm
nsaia
na-sal
na-sal-induced
microcca
dimethylthiourea
basepaired
pa317-derived
glucocerebrosidase
dl-pdmp
nb-dnj
ter199
3fd
dctgcag2
3fddctgcag2
dctgcagfd
icrf-187kg
leinamycin
four-stranded
anhydrides
pfdh
deathnecrosis
dtatata2
9-hydroxyl
c299s
zopolrestat
ebpc
sorbinil
ciprofibrate
fenofibric
leguminosae
quasipanaxatriol
dau-efflux
grind
h-bond
lung-tumor
p388r84
fccl-1
mtgsh
b16m-f10
l-gln-adapted
ib16m-gln
granulosum
ga-l1210-tet
perfluoroacyl
daunomycinon
stylopine
oxidase-dependent
template-primers
membrane-disrupting
sem-la
v20c
polydeoxyribonucleotides
da-t
auger-electron
c-troponin
complement-induced
4-dmdrol
mians
msba-mians
ehr8r
tgf-beta1-induced
bd-fmk
mild-moderate
porphyrin-daunomycin
wrap53
lovo-ida-1
riext
lovo-dox-1
ic50int
lovo-ida-
lovo-dox-
lovo-sensitive
arrowdeltapsim
heart-related
ccsq
biophysics
propenals
oxopropenylation
propenal
fmet-leu-phe
rdes
slower-growing
deltapsi
single-cysteine
q-loop
deoxytetranucleotides
2m-tocsy
2m-noesy
2m-noe
allanll
vindoline
ger
lrp130
11-deoxydaunomycin
v185
renaturation
3hnabd
6-keto
so-fed
clo-fed
clo-dm
so-dm
kbmdr
deseases
cerubidin
drrc
torsade-de-pointes
histidinol
dpscd
c5vr5
feudomycin
anthracycline-iron
aptasensors
butylcycloheptylprodigiosin
undecylprodigiosin
u2009dfmin
ambazone
mdr1-transgenic
moperone
loxoprofen
p388adr7
reduction-responsive
bis-ans
14-carminomycyl-n-pyridinium
14-n-succinimidocarminomycin
alcohol-methanol
crb
ar3
quercetine
ldldaunomycin
chloroquinone
b-2-m
l-aspa
k562vp-h2
u-14c-glucose
drrabc
pibr25
erme
pdrrab25
pdrrc25
pdrrabc25
salicylaldehyde
gadd45a-
313bp
mbp-drrc
b-nhl-bfm-
gaughan
aaronson
5-hydroxy
5-benzyloxy
6a-d
beta-d-galactosidase-labeled
ensartinib
vp35
ifn-antagonist
cgas-sting
tp23q25
flop
nbd-pc
4-o-tetrahydropyranyl-adriamycin
decilorubicin
arugomycin
ditrisarubicin
ipla2
-microm
end-line
bjp-lambda
n-benzyladriamycin-14-valerate
ad-198
dnr-ga-cys-cdte
rajidnr
neryt-dnr
orange-red
4-dm
gycolbissulfosuccinimidyl
3-cyano-4-morpholinyl
nab3h4
3h-glucosamine
surface-membrane
coall-80
f-dau
tgt
cerium
gp150
mechanic
yoyo-1
ugt2b7
pgp-egfp
yrrl
half-chair
8r-fluoroepimer
8s-fluoroepimer
nanomicelles
mpefeii
cleavage-inhibition
mnp-fe3o4-dnr
ydag
ydba
ydagydba
an9
an9-treated
dnr-d5
dnrtet-plga-pll-peg-nps
double-emulsion
evaporationdiffusion
dnrtet-plga-pll-peg-tf-nps
a40p
brentuximab-vedotin
3-benzamido
albino-swiss
s105a
pgc
silencer-u6-neo-gfp-shrnamdr1
pgy
mbp-dnro
moflomycin
cha-5
thp-1a
oxomorpholinyl
dhm3
origami
lps-treatment
leukemia-development
bcgs
sg611-vstm1
sg611
sextet
magnetically
odnr
8226-dox40
gramicidin-d-resistant
gramicidin-d
ionophore-resistant
131i-labelled
atg-dex-dnr
ts-moab
cuprous-phenanthroline
metal-catalyzed
rz-protected
wp760
dnr-oc-125
oc-125
nih3t3mdr1
agalactiae
cyla
cylk
acid-sensitivity
dnroaphii
preb1-all
geil
preb-1
preb1-
preb2-all
kq
c-hus
subadditivity
mdr-mdck
rpo
cmcs
free-dnr
n-tosyl-l-phenylalanyl
dichloroisocoumarin
α1-hsa
uss
ida-sln
aminoanthracenedione
unit-spleen
nanocontainers
-cyano-4-morpholinyl-3-deamino
micro-raman
glove
fingertips
csq2
hsppase1
eppprnov
ohkasp
ohka
16-mer
jatrophane
daue
13-chc
pdpk
phosphorus-containing
phosphomonoesters
pme
tetraplex
pyrenemethylamine
3htaurocholate
imino
7-deoxynogarol
dppd
single-electron
hdlps
aq4
1h-1h
route-1
route-2
interactional
myxobacteria
nannocystis
phenylnannolone
ethyl-substituted
nc4
cfif
dark-grown
hm1
fusion-competence
h-1-h-2
cross-peaks
dqf-cosy
c-2-endo
2c-5g
3a-4t
3sb
3sbh5
r316
thrombo-cytopenia
irinotecan-treated
tmq-resistant
thg
kcp-4
is5
is1634
tn6097
tn5393
ra-u
interferon-inducing
4-epi-adr
3-n-acetyl-adr
anthracycline-bound
kbmrp
carnosol
bmal1--
non-positively
dna-ssbs
five-membered
marel
polyp-aminobenzoic
diels-alder
c8-c9
olefinic
fluorohydroxyketone
cem-mdr1
abcb1-ligand
epi-dxr
response-
ce-icdof-led-fld
p-450-like
vasodilating
uv-2237-admr
estradiol-17beta
lycurim
l-53
photoconversion
substratesmodulators
uic2-shift
goda
fluoro-aluminate
t‑all
amphibian
hump
qmax
steepness
microf-1
alkylidene
3-desamino-3-dimethylformamidine
nirt
nira
phylla
phylt
daunorubincin
pyridines
niguldipine
balb3t3dsred
intraportal
nano-pore
15nm
95nm
43nm
psio2-co2hdnr
npm-translocation
cuins2
dnr-muc1-qds
muc1-qds
lognormal
codon-harmonized
tled
pregastric
bisdaunorubicins
dmdr-ol
garf
4-hydroxylase
lovo-idol-1
polymethoxyflavonoids
arabinnoside
photoenhancement
riboflavin-binding
dioxygen
daade
eatwt
eatdnm
eateto
eatcis
ictc
icuc
nadph-glutathione
125i-alpha
2m-ch3nh2
receptorscell
utp17
polymer-linked
lvedd
vinr
taxr
afr
ehr2mitox
mcss
hctp21--
dna-ssb
ggpp
crte
phytoene
crtb
schisandrol
titania
ceo₂tio₂nps
megaterium
bromide-exposed
apcr
arg506--gln
v-erb-ber
v-erb-b
ctns
acgd3
mitochondria-specifically
mitosomal
blueing
4-hydroxyl
orientational
chemotherapies-induced
fullerene
faggots
idnr
idox
alspc
ip--po
iv--ip
aptamer-daunorubicin
flagellum
flagellate
hnata
cal-62
ftc-133
lu-49888
bis-pyranobenzoquinones
dimefluron
micrograml
sacs
benzoylhydrazone
-benzoquinone
citrated
c5-hydroxytryptamine
vat-d
seccellsml
oh-dnr
gluthatione
dnrr-mutants
dxrr-mutants
auml
u-1285dox900
u-1285
dmrp
tbt
d-dnm
vitk3
nephron
kcd-232
hypolipidemic
dr-induced
dnr-tet-tf-peg-pll-plga
nirf
oct-modified
ccl4-induced
ccl4-ehi
mnpes
mnnes
drugpurine
plcγ1
3-aml-83
tra96023
cyclopeptolide
mdr-cem
dau-loading
dnr-igg1
dnr-bsa
alkylresorcinols
wi38
virus-excreting
-daunorubicin
polydgdc2
dane
np40
13-cyclopentylidene
stress-time
inactivators
ndmd
14-c-thymidine
mrk16-fab2
r482ts187t
apt-dau
reachieved
ehr2vp16
3hvp16
d4-gdi
ma16c
p-fn
lflc
3e6
phn1
phn2
distearoyl-sn-glycero-3-phosphocholinecholesterol
dc-g-m5c-g
allm
topoli
mrp-like
u18666a
ldl-derived
ldl-mediated
u18r
rhodamines
ultrafast
u-937cr
helix-bending
reinert
bsep
clexc
ebetag
intralateral-ventricle
recidivism
alpha-fetoprotein-producing
akr1c30
akr1c31
akr1c32
akr1c33
ketosteroids
dnx-induced
sjw
idf
dna-rubomycin
odna
viscosimetric
-bromoethylphenol
re-reversal
cal33
mctss
u2009min
e217g
estriol
equimyelotoxic
multi-drug-resistance
demethylmenogarol
adriamycin-dna
adm-dna
mdck-mdr1
ap-to-bl
gf-120918
rfu
nl1tc
anti-drug
4-demethoxydoxorubicin
sbfm
polydgm5dc
ve-cad
cflips
n-heterocyclic
carbene
nhc
cervicodorsal
extended-mdr
r8gd
accessioned
ec90
synthesis-inhibiting
folate-peg-chems
f-l-dnr
pheg
dacm
myomirs
sub-acute
con-c
dg-c
polyhydroxyalkanoates
bpmo
dm-positive
wattskg
oligoethylene
glycol-based
trypomastigotes
ce1
l-ribo
rubomycin-sensitive
scapular
blda-trna
blda
svt
ft-adm
14-hemipimelate
fad-104
anthracycline-group
n-tetradecyl-β-d-maltoside
heat-resistant
w-h75
b-h103
cemr2
lanosterol
bss
casy1
heptameric
cho-adrr
primer-templates
dntp-binding
ccrf-ceme1000
doxml
elongator
ikaphelp1
dau-sl
calk
oligoarginine
dau-conjugates
rubomicin
ruboxil
tetranucleotides
entropies
plhc-1dox
plhc-1wt
pgp1-mediated
prdvcr
prdmaf
prddnr
elan
hypertension-susceptibility
plce1
atp2b1
aptld
ast-120
hbl
por-dnr
sarps
1-antagonist
diazan
ngpe
fas-sensitive
drug-support
reactant
novatrone
anti-3ll
lde-odnr
polyda-tda-t
homopolymer
entropy-driven
appt
epineural
copolymer-dnm
bdsc
dcvp-l-asp
hd-tm
mpi
histone-depleted
histone-dna
mrp1-egfp
n-me-ser
lysac
usl
g2-accumulation
bisbenzylisoqunoline
isotetrandrine
fangchinoline
dauricine
armepavine
spomt7740
o-methoxy
o-methylation
7-hydroxy-8-o-methoxy
3-o-methoxy
mono-o-methoxy
e55d
n52s
his-
pvui
anthrapyrazolone
hd-scr
corpses
4330tc
cmfv
n-morpholinemetylenedaunorubicin
dhprs
charge-voltage
qvt
flavonoid-drug
bdm-12
taua
crce
snoal
demethylepipodophyllotoxin
photodamage
sharma
4-arylpyridines
coproporphyrins
ad-delo3-rgd
xg
atpi
peg-conjugated
cy7
temperature-dependence
q-37
br339
2hida
amb-plc
under-agarose
p-388k
epi-dox
leu-dox
rnov
harringtonine-resistant
ikappabalpha-sr
dipicolinic
zerumbet
wave-mixing
xm
spion
tmpypdnmapt-s8spion
na-chitosan
bsa-dxr
ah66p
bsa-ga
dosecycle
6anad
rpm-5
mdr3-expressing
moab20b7
hl-cr
actin-myosin
cross-bridges
iprl
irhc
wif-b
pksv-prcol50
pksv-pr
-acetyl-beta-hexosaminidase
bmv
rubdg
rab4
rab14
cem-ccrf
mnpfe3o4
pentagalloylglucose
angiographic
cystoid
hyperfluorescence
silybin
monolignol
gsno
cys-226
cys-227
-phenanthrenequinone
daunophilin
antitumorals
br-80
iddnr
pkc-alpha
piperazinediones
mbr-60
rubpy
thru-hole
skvlb
nan3
n-n-pentyl-quinidinium
n--azo-n-pentyl-21-deoxyajmalinium
ajmaline
daup
10-carboxy-13-deoxycarminomycin
at-at
at-ta
gc-at
gc-gc
gc-cg
bp86tz2p
e-fragment
fdp-e
elastase-alpha
e-alpha
pnis25
pnir25
prs25
pnirs25
cefoperazone
uhf-field
cariocytes
ad280
ad143
doa
chr-24
rev-2
3hcepharanthine
avebiv
iv-vii
7-deoxydoxorubicinol
7-deoxydoxorubicin
tnfactd
polysulfated
cd9‑targeted
sup‑b15
dddox
ss14
iron-trafficking
pcf
pcf-d
microgramsdevice
auramycinone
9-methyl-10-hydroxydaunomycin
rhi-nhc
pmaas-s
adr-dna
mtma
afgf
blast-colony
duplexed
245-bp
vb6
cysh
isoguanine
ps-duplex
ic-containing
platelet-mimetic
nanoconstructs
platelet-interactive
plasminogen-activator
32d3
ruxolitinib-based
end-of-study
hydroxyurea-resistant
ruxolitinib-randomized
twitter
hashtag
mpnsm
ph¯
mpn-unclassifiable
etpv
ser523
tyr570
jak2v617fjak2wt
ocls
het
ipset
n-glycosylated
mutation-enhanced
transplant-age
et-prognostic
set2
vehicle-
gata1low
electron-microscopy
peripolesis
polylobated
qatari
jh2-mediated
jak2jh1-jh2
jak2s
mpl-negative
v617f-
s505n
anti-jak2
jak2-v617f-dependent
azd1208ruxolitinib
ruxolitinibnilotinibprednisone
αc-helix
αc
jh1-jh2
epor-8yf
mutant-induced
tyr-343
tyr-460
tyr-464
v617f-induced
jak-family
fast-follower
mechanism-related
follower
xiia
obp
mpn-directed
pma-triggered
ipset-thrombosis
v617f-mediated
mpl-dependent
homomultimers
erythropoietin-stimulated
2-v617f
jak2jak1
vz3
7j
thrombocytapheresis
interferon-α2
peg-ifnα2
mpn10
k-antagonists
unprovoked
jakv617f
pegylated-interferon
mvt
pn‑mpns
non‑myeloid
myelofibrosisleukemia
mplw515
icves
infigratinib
mf-associated
thromboelastometry
cft
firmness
zhangpi
tempi
w515r
rs10974944
neo-epitope
response-2
hydroxyurea-resistanthydroxyurea-intolerant
fibrosis-free
mssd
bnanc-modified
ph-mpns
hypercytosis
creb3l1
tn-et
pv-initiating
mplwt
ruxolitinib-induced
group-myeloproliferative
treatment-european
w515a
trvmax
pht
non-frameshift
rigidifies
5mcg
myeloproliferative-myelodysplastic
mpn-saf
mpn-10
proration
multi-symptom
jak2-associated
lysyl-oxidase
acvr1
ehpvo
variceal
stat5-deficient
k539l
r683g
lnk--
lnk-deficient
hu-related
aspi
clopidogrel-treated
aspirin-treated
antiaggregatory
slc14a2
pv617f-positive
fty720-p
prepmf
hepatology
venopathy
pre-jak2
vb6-deficient
vwfrco
cd20cd5
cd20cd5-
nghrml
tpo-independent
adp-inducible
ru202fu202f
u202f×u202f109l
hrpr
nqot
ifn-α-based
proud-pv
continuation-pv
recql5
ikaros-deficient
archchip
archchip-related
archchip-associated
mutationsmb
ut7-mpl
once-
melcatle
bsaxi
ifn945
og-500
mosaicc
lcp4
943e4
product-sizing
rifn-α
c1849gt
w515lk
swedes
cell-on-cell
micropore
mf-are
antiaggregant
hyperactivates
n-domain
inter-relationship
frrs
mir-1268a
fut1
v625f
f625
y613
calr-mediated
mpljakstat
epitrochlear
system-polymerase
jak2-unmutated
maskedprodromal
calrdel52
mpn-ph-
jak2v617f-mediated
jak2v617f-dependent
socss
cish
3translated
dickkopf-3
α-granules
jak2v617f-associated
thrombocythemiaet
osteosclerosisp
iwg-mrt-ecnm
ogx-427
obene
mpn-relevant
mipss70
mplw515kl
mpla497-l498ins4
mplw515rq516e
jak2-deficient
predictively
pt-yrs
jak2v617fjak2
thrombocythemic
peg-ifnα-2a
chcr
ruxolintib
pu2009conclusions
prth
rifnα
rbbp6
mpn-t
bergamo
rs4495487
high-count
mpl-mutations
post-et-mf
post-pv-mf
jak2-mutations
mpl-mutation
tet2-mutation
crlf2-rearranged
virchows
grb2sos
-308ga
mpnu
tnf-238
svts
jak2v617f-bmt
wt-bmt
cmpd-u
nvp-bsk805
jak2v617f-bearing
jak2v617
dna-hypomethylators
self-perpetuating
rag2--il2rγ--
jak2v617i
jak2v617i-positive
axa0subgroup
homomultimeric
rs12343867
rs12340895
mybl2δ
kraslsl-g12d
pyrrolidinium
cis-location
jak2n
v617fn
polycytemia
mutation-homozygous
calrs
hplc-profiles
dolichol
endosomal-lysosomal
antiplatelets
calrins5
rs3816769
rs10758669
ruxolitinib-related
ppmf
ptmf
rotem
pv-like
et-like
et-specific
mpn-targeted
purine-scaffold
nonsplanchnic
pci34051
µmlchip
sentinels
qst
rlt
erythrocyte-derived
leu583-ala586delinsserglnpro
leu583-ala586delinsser
jak2ex13indel
il-5r
plateletpheresis
lacnac
b4galt1
β4galt1
ecfc
non-active
cml-t
mpn-cvt
mpn-vt
mpn-not
myelofibrosis-msc
efcab6
non-jak
osss
emulsifier
mutaquant
jak2-v617f-expressing
jak2-v617f-positive
52u2009bp
del52
ins5
polyploidisation
grn163l
xrcc1399
gab1-dependent
csf3rt618i-mutated
mcalr
mfbxw7
neoepitope
vitro-expanded
comfort-i
comfort-ii
histone-lysine
atox1
skar
eif4g
1u202f×u202f1011
cortistatin
cdk8-dependent
ps727
f-dc
one-alk
vias
rhc
a→c
t→c
high-oxygen-affinity
ruxo
ph-mpnmbl
thirteenth
bcr-abl1u2009u2009negative
gbd
calr-mpl
v617f-driven
cmwp
sca-1-positive
ksls
fmpn
cml-n
lobation
hypofibrinolysis
mpn-svt
alc-based
admiraal
thrombogram
platelet-poor
ly30
creebp
inc424
monocyticmacrophage
phospho-jak2
11791230del
frame-shifting
rs2201862
hbs1l-myb
rs9376092
thrb-rarb
rs4858647
sanger-
pyro-
pcr-rt
masitinib
target-seq
tp36p
down-modulating
mut-calr
anti-jak
dna-melting
aucxa0xa
v617f-transduced
incb18424
bms-911543
jak2v617f-heterozygous
vte-related
u2003we
non-vte
non-vte-related
12k
pv-related
tss-c
pf4-loxtgtg
mpls505n
jak2-mutation-positive
chz868
nu2009u2009219
mpn-symptom
mpn-clone
arrbs
thombocythemia
5-base
⩾grade
⩾l
self-management
etiopathogenic
mipss70-plus
gipps
forward-looking
t875n
t875
d873
pre-mf
overt-mf
jak-inhibitor
interferon-associated
jak2-wt
g6-induced
tyr-221
jak2s523l
dtpl
two-fifths
jakarta-2
lubcam
megakaryo-
incb16562
keratinocytic
cryosurgery
acitretin
arginase-1-specific
ucns
nephrol
hemato-lymphoid
cd34-mvd
ρxa0xa
cd105-mvd
mwu
tm-resistance
gro-α
sustainer
chr9
gesus
pxa0xaxa0xa
xa0xa00
gbp2
qbead
g4-forming
g4znpc
nanowires
i463t
calr-deficient
phnegmpns
phnegmpn
calr-dependent
ripretinib
asxl1∆∆
rs182123615
k509i
verapost-essential
mpl-unmutated
calr-ins5
ins5-hpcs
2v617f
non-protein-coding
il28b
axa0protein
ruxolitinib-persistent
ruxolitinib-naive
jak2loh
calr-driven
rifn-alpha2
multidetector
reduced-duration
region-abl1
r795s
tporw515
delta5tpor
y112
y78
tporw515a
ir-exposed
feedbacks
pdgfrβ-cev14
tophi
noncarriers
jak2k539l
ser552
baf3-mpl
thrombopoietin-dependent
fop-fgfr1
erbb1egfr
egfrc329r
3po
-u202fngml
bbt594
l884p
er-golgi
semhts
baf3-epor
patientswith
pharmacobiological
ly2784544
baf3-jak2v617f-gfp
calrdelex9
fp-mpn
pact--
snama
csvt
m-act
non-pv
pvtl-2
stat5pim-2
f594
f595
f617
heparin-induced
tpormpl
peg-ifn-α-2a
abc-pcr
ltl
teloscore
kotecha
hyperactivate
jakis
svr
hemoglobinplatelet
exercise-based
anti-lgi1
ut-7tpo
stxb2
pgim
txm
thrice-daily
tyr371
transposon-tagged
ctrls
cep85l-pdgfrb
mf-initiating
exon-10
bain
sub-category
fancc
monoubiqitination
mir-125a-induced
calrm
interferon-α2-treated
jak2-rearrangement
3y
rux-associated
e846d
r1063h
gandotinib
mpn-propagating
cd34cxcr4-se
y201f
pf-pmf
f-pmf
cd34-microvessel
pdl1pdl2
pcm1-jak2-positive
eosinophila
kdm4cjmjd2c
settingxa0-xa0concerning
contributexa0-xa0both
cn-lohs
mpn-patients
slam
lskcd48-cd150
elc
g935r
y931c
e864k
baf3-jak2v617f
pai-1ag
anti-phospholipid
ph-neg-cmns
fmi
calr-mutant-specific
calrwt
cre-inducible
lna-qpcr
kinasexa02
mysec
tar-seq
w515kln
mpn-subtypes
post-capillary
pre-capillary
mpn-subtype
val617
jak2r564q
jak2r564q-expressing
patient-individualized
e-cfcs
12-positive
prm
crt-fs
er-retention
ishbt
reputed
mf-sb
pf4icrejak2v617fwt
mpn-uk
thrombopoesis
billionl
ampn
ptch2
ptch2--
on044580
erys
pv-derived
tf-bearing
assesed
cementless
-triazole
d7sq
d8sp
d9s157
d9sq
d9s
d7s
d8s
d13s
hsecurin
cpg-activated
plc-β3
plc-β3-ct
stat5-binding
ccaatenhance-binding
assessedwe
eklf-positive
eklf-negative
circrna-long
cytokine-optimized
nodscidil2rcgnull
aml-reactivity
irma
as-rt-pcr
rrps
recalibration
pentanoic
2s-5-oxo-2-nitrobenzene-4-yl
sulfonyl
amino-5-pentylamino
nit
cell-clusters
flow-self-organizing-maps
flowsom
healthynormal
layering
ir-pcml
erythrosine-b
exclusionary
rns-induced
mrpl21
mrps37
dhx37
rpp40
ercc3
gtf2f1
myh14myl6myl12a
vcl
traffickingsecretion
alpha-x
slc2a3
hetero-cos
50-cos
trainingvalidation
β--d-glucan
bfp
bfp-se
optofluidics
vitals
lin-hla-drcd123
lin-hla-drcd123bdca-2
transcriptomic-based
insertion-derived
non-der22
rpe20
wcp5
rpf9
rpn22
redd5s23
d5s721
aml1-eight-twenty
app-high
app-h
app-low
app-l
×109
database-guided
multiple-choice
qlq-cml
phu2009cases
ohsu
cd34cd26
g-light
self-rating
humann
fas-as1
quantitativen
thatn
cohort1
cohort2
pme1
arpp19
tiprl
ardap
hsc-
niche-regulating
high-dna
wasu2009u200990
tu2009xa0xa0u2009-xa
pu2009xa0xa0u
metalloproteinase-7
differentn
rnan
reversen
informativen
myanmarese
white-centered
preretinal
ohl
ofxa0selected
deps
hist1h1d
hist1h3a
psme1
thrap3
ibsafe
gynaecomastia
hemodilution
plot-based
ageu2009u200920
microrna-381
mir-381
cis-stilbene
p0039
treatmentleukemia
dnam-1-tigittactile
tigittactile
smc1amlh1
aso-rt-pcr
phu2009u2009b-lymphoblastic
phu2009u2009b-all
cml-lbc
phu2009u2009clone
gene-driven
pu2009mut
hhv-5
urea-based
moac
fasp-prepared
imac-enriched
fasp-based
xn4
nox5
atm-γ-h2ax
xn4-induced
vats
non-transbronchial
riluzole
107u2009×u2009109l
environment-sensitive
hb-based
hboc-201
biopure
irhr
acutisation
multivariateadjusted
non-hypermethylation
genesexons
fusion-transcripts
chrna
cracs
cractools
xa0in
resultsxa0
chrnas
aml-inv16
xa0all
collinear
non-collinear
vtd
hw
aplv
eukemogenesis
ru-ski
ope
amld
amlpt
dcepcs
dcecs
dc-epcs
tel-mn1
multidrug-resistant-related
neuro-fuzzy
slowly-dividing
gscshscs
aqp-1
aqp1
ggti-19
ftiggti
nonsuppurative
oro-dental
ltbi
aml-elaborated
newly-diagnosis
hrv
teicoplaninvancomycin
axa0myeloproliferative
let-7d
mir-574
sprouty1
tetraploidytetraploidy
ntt-acute
nt-karyotype
xxyy
add18p21del20q12q
del20q12q13
pp709s
dots-tat
unreached
pre-bp
bdc
upgradation
fr-2
leukocyte-endothelium
2xa0776xa0450
nondisabled
8xa0329xa0350
tas4464
tas4464-induced
dasatinib-based
suspends
bcrabl1-independent
wnt6
wisp1
fzd8
rlq
blurry
ltt
hg-positive
hg-negative
yas
semistructured
antepartum
myodesopsia
kirenol
siegesbeckiae
igml
sella
turcica
vo2peak
ergospirometry
school-aged
hbsc
index-moderate-to-vigorous
cancer-treated
kouchkovsky
abdul-hay
thein
ershler
yates
baer
32dc-kit
salonia
bifi
tumour-antigen
effector-cell
cibersort
ki67xa0xa0cd8
hla-dr-cd33
gu2009intestinalis
salarin
maganti
sfkbcr-abl
stat3tyr705
p-stat3try705-positive
surface-marker
yls
usyls
osi-461
rock-myosin
rtct
mtoxphos
ari-4175
m-m
sov
botulism
p53⁺
mc-38
regionalized
nanomedicine-based
methyltryptophan-paclitaxel
d-1-methyltryptophan
d-1mt
tubulin-stabilizing
∼115
p-supar
mrsa-sepsis
abk
gene-virotherapy
sg511-becn
empd
mesenchymalization
dtxl-arg
g4723a
ign
x-adc
codepletion
mb-pdt-treated
pegifna2a
pseudoleukemia
cisplatin-inducing
padef
rt-pcrig-tcr
hdil-2
vls
bld-1-kla
kla
peptide-kla
repairmicrosatellite
vegf-blockade
folfoxiri
linnegcd11cpos
trade-offs
i-chain-related
shedding-derived
smic
nonblocking
smic-neutralizing
tlra
cytlra
menk-treated
gln-treated
chemogenetics
dreadds
ha-egcg
hgs-ovca
systems-approach
pharicin
rar-α
lipoprotein-cholesterol
nci-h28
nct02273102
tlr3-
lnc-il7r
piccisplatin
efficaciousness
metagenomics
unculturable
δfret
acupressure
α-fucosyltransferase
egfrmapk
cand-tec
crgs
wep
fatigue-related
12-minute
sterile-site
a1555g
-propyl-1h-benzodimidazol-1-ylmethyl--biphenyl-2-carboxylic
-biphenyl-2-carboxamide
k562-resistant
18a-f
no-mediated
chemotherapy‑resistant
rt112
lcl‑161
thp-1-derived
kif4a
la-ep2006
eu-sourced
nitroxoline
adapter-inducing
tyrosine-22
boehmite
ce6
ce6mltsab
phototreatment
scale-child
scale-parent
unitkg
kir-ligand-mismatched
speckle-tracking
precore
cma3
sp1‑related
s-cm-hpad
ch-ca-spe
gallinarum
casseliflavus
vanc1
vanc-positive
m-health
glycopeptide-resistant
ly2510924
likert-type
serds
efficacy-enhancing
ccts
dual-therapeutic
nkg2d-l
mecapegfilgrastim
cancerogensis
eclucidated
atrovastatin
prescribled
cardio-cerebral
chemotherapeutics-treated
cp-dox
hm-hlh
1e10
f3ii
edrp
ldrp
iyiy-i2-bodipy
yiyi-i2-bodipy
dej
cryosections
mhpf
nddh
apoptosis-inducting
ceramide-tamoxifen
autophagic-driven
c6-ceramide-tamoxifen
kg-1u202fcell
αb-crystallin
αb-crystallin-deficient
mir-1300
ect2
re-educate
clg
b16-hcxcr4-gfp
clgs
egs
plx4720
plx4720-treated
lrba
cic-dux4
ewing-like
tme-induced
biomodulators
anaphylatoxin
anaerobius
adheres
pcwbr2
anaerobius-treated
pcwbr2-integrin
rab7
proregenerative
bacteriophages
tmtnf
stnf
dn-tnf
mca-injected
tnfr2-fc
let7a
tnfr2-dependent
anti-il-33
pvsripo
il-ra
nkg2dζ
nkg2dζ-nk
il-6high
pias3
mhc-haploidentical
effecter
smyd3
sdabs
sdab
wg-sfps
tax1bp1-ko
phosphorylated-stat3tyr705
albt3
a17lko
α-emitters
lipid-nps
rna-nps
17α-aed
oncophagy
siglec-15
lsec
tj-m
subdiaphragmatic
bethanechol
chrm1
ikk-α
tlr-based
strit
extra-tumoral
177lu-labeled
5-oxo-ete
5-hedh
idicy
metastasis-induced
anti-cd115
desaturate
sapienate
aptamer-liposome-cpg
il-4rα-liposome-cpg
fam-cpg
k-ras-driven
epha3
fapα
fapα-targeted
ifn-α-
mdcb
ovh-ampd-1
ampd-1
ddrs
lymphangiectasia
homingpersistence
8-gene
spats2l
kbm5-sti571r
kbm7-sti571r
vnp20009
ciglitazone
zeb1-ko
miz1-mediated
transrepressional
mycv394d
mycv394d-aml
crt-expressing
map7
genesmicrornas
map7high
sdc-1
runx1-cbfβ
wz811
arhgap9
let-7f
mcl1δmyelo
ebvd
haplohsct
90xa0d
dcaml
atpγs
t2δt3
δt2t3
δt2δt3
aquaporin-8
b1647
p27-pcdna-k562
p110δd910ad910a
nrm-j
nox-a12
vps34-in1
m3814
csge
xospata
egcsf
no-egcsf
dock1
ricmac
btn3a
anti-btn3a
nk-ll
pre-emptiveprophylactic
conduce
mtm
lrg1
mir-214
scamp
scamp1
aml-ppllsg
leukemia-berlin-frankfurt-munster
adil3
adil3-mnsod
adil3-ppa
za4
rpph1
eif2
trml
mrx102
hdac6i
pam2-odn
9000appm
hocsg
class-defining
epi1
pd-1-directed
spatially-resolved
cytometrymass
hoxa-as2
clod-lip
2ci
nd-mscs
2013-august
somaticgermline
somatic-protective
somatic-hazardous
germline-protective
germline-
germline-hazardous
90y-dota-30f11
imatinib-exposed
tcea1
goelams-lam-ir-2006
hypomaturation
hypermaturation
k116w
ifitm
rbct
aslan003
il1β-induced
reoviruses
huc-mscs
a6-cps-vcr
csf3rt618i
m-e5
mr-gnbi
cpkp
procell
hoxa9dna
riskscore
17u2009f
7u2009a
anti-cd300f
anp32a
growth-enhancing
npm1-a
gsta2
fcu202fu202f
pu202fu202fe-13
itm2a
2d1
3g1-fc
ut7epo
hms-101
wave1
pi3k-ⅲ
fut6
nilotinib→dasatinib→chemotherapysct
imatinib→chemotherapysct
icur
imatinib→nilotinib→chemotherapysct
nat10
aj-374
5-aza-responders
oxidativereactive
cell-cyclebcl2
cd34spc
mds-without-excess-blasts
mds-noeb
ros-high
mds-with-excess-blasts
mature-spc
flt3itdnpm1wild-type
npm1mutated
ki67lowbcl2high
cd34aml
redoxpro-survival
ros-low
foxp3i1
xgvhd
hnk-induced
aml-runx1mut
aml-runx1wt
dock1high
caes
ponatinib-treated
brcp
netboost
lt-
lt‑
splice-isoform
3-hf
plc-β2
h90
pu1-s41
s140a
lam97
lam08
registration-to-transplantation
mlf1s
aupbsct
auhsct
dtps
ski-ii
arq531
prq
nb4-lr2
cd26-mediated
cd6-positive
pathway--unlike
cells--our
monocytic-granulocytic
126-kilodalton
vim2-reactive
cdw65l
megakaryoblastict
anti-mac-1
clomifene
ht1080-bearing
cb-17icr-scid
ms-5-conditioned
mscf
anti-mscf
fdgr3
ms-5-cm
dasatinib-dosed
blv
blv-infected
il-0
allo-hsct-associated
miha-mismatched
cd115u2009mdscs
mdsc-treated
resampling-based
clad
correctionamelioration
lad-1
tq22q21pml-rarα
cd18-
band-specific
yac-clone
der1tpder21t
wgahigh
wgalow
mhpcs
rhlow
rhhigh
enteroviral
vp1
insulin-containing
rh-gcsf
cd34cd14-cd11b-
cd34-cd14-cd11b
cd14cd11bhi
icam-grabbing
kir2dl2kir2dl3
single-kir
kir2dldldl1
oc-like
leukemic-clones
h1f0
st7l
cbll1
cgp62221
4β-hydroxycholesterol
parent-and-active-metabolite
cd3both
tcd-pbsct
1rejection
deltalngfr
mutz2
i-interactive
deficiently
phagocyte-derived
nkp46nkg2d
granulocyte-erythroid-macrophage-monocyte
cm-cfc
pu1-dna
cyclopropyl
p-substitution
n-acetylglucosamine-galactose
ala-pro-phe-cmk
hpcts
cd16cd56nkg2d
cd16cd56-
anti-ulbp2
mapk-specific
srbcs
nuclear-antigen
myelopeptide-4
mp-4
phe-arg-pro-arg-ile-met-thr-pro
metabolicmorphological
pml-antibody
quantared
amd3100-mobilized
neor-containing
myeloablated
amd3100-mediated
erythroid-restricted
low-to-medium
scaled-up
mispaired
msh6-containing
mutsα
pcna-interacting
pip-boxes
yb-1pcna
mutsαpcnagt
nick-directed
pip-box-containing
ing1b
pbmc-dc
donor-to-donor
non-sensitizer
lcsdcs
non-sensitizers
2-mbt
nhptcl4
coso4
intercentromeric
laboratorian
whole-organism
bq-mediated
myb-deficient
cmybhkz3
c-myb-dependent
pdc2
ifn-alpha-producing
no-donating
s-nitroso-acetyl
8-br-cgmp
anti-cd11cd18
hdaci-bml-210
n-phenyl-n-2-aminophenylhexamethylenediamide
230-kd
p185-
p210-expressing
p230-expressing
monocytemyeloid
gfp-
ngfr-expressing
prkg2
self-repair
col2
col10
rheb-overexpressing
sc-65303
cd15cd11b
cd41-cd14
cd41cd14-
cd34cd15-cd11b-
profoundfrequent
nitrosourea-induced
dose-modification
pdgf-positive
13hh4
cryopreservation-reimplantation
hsacirc0001857
hsacirc0012152
mir-pepidermal
egfrmapk1
mir-pegfrmapk1
gonococci
untreated-hl60
opai-expressing
opai
ultrathin
ser5
ser2-phosphorylated
distances25
non-hospitalized
insertionally
gpix
gp1balpha
c-znf
c-znf-deficient
lau-a1
63ag8
microfluorometry
e-rosette-enriched
s-s-linked
gata-9
u937-derived
1s-luciferase
fabm2
biphenotypism
t11v
morphologiccytochemical
t-lgl-type
rbioconductor
epihet
deh
co-epigenetic
lti
erythro-normoblasts
proteincbp-
3pqpqq22
psp-treated
resgen
40k
psp-induced
ier2
gadd45ab
gestosis-complicated
collagen-overproducing
hul-p
myofibroblast-like
pericyte-like
pericyte-myofibroblast
cdw18
anti-glycoprotein
anti-gp
cikm5
anti-cr
antiglycolipid
activation-linked
vip-2b
il2ri
anti-il
neutrophiliceosinophilic
cdw12
monocytegranulocyte-associated
calmodulin-binding
gam-igg
gam-igg-cbp
cm-biotin
vbeta5
snf
rsnf
snf-integrated
juxt
lsvm
rsnfi
10x5-fold
fda-led
maqcseqc
brca-er
brca-subtypes
aml-os
kirc-os
12-step
-biphenyl-2-amine
carbazomycin
u2005m
leukemia--defining
eosinophilicmast
dc-precursors
dc-model
bra7g
c3bc4b
cr1-negative
243r
cr1-mediated
daf-negative
sdf-1-binding
i-tac
migrationadhesion
nf-κβ-dependent
i-tac-induced
mapkp
traffickingadhesion
myelomonocytic-like
p21h-ras
1-beta-arabinofuranosylcytosine-treated
sub-clinical
icosig
icosl-
icosl-negative
factortumor
selectin-type
moon-1
cd38-mediated
alpha-human
mcd8
alpha-hcd38
ab-induced
elastase-induced
fibrinopeptides
microlcms-mrm
angpt-2
se-sel
method-
msid
chromatogram
isotope-labelled
siss
angpt-
sflt-5
pai-375
esm-5
accentuating
kallikrein-kinin
hla-e0103
monocyteneutrophil
splayed
retinotectal
innervate
tctp-deficient
misprojection
organ-on-chip
multi-compartment
bio-activation
rptec
cyp2r1
pump-driven
d3-containing
cd45ssc-lin
cd06
cd12
cd02
lymapl
lym-apl
iiiiiiv
cd10-cd15cd19cd24
triton-soluble
triton-insoluble
csk-involving
flt3-cd150cd48-
lthsc
flt3-cd34-cd49b-cd229-
lthscs
ob-ablated
npm-rara
tbc1d15-rab21
tp15-p13p15
m-f10
fra11p
a-inducible
ph1-al
anti-t12
proteome-level
surface-markers
cd34⁺cd123⁺
10-plex
labelling-based
proof-of-principle-study
benzyl-alpha-galnac
anti-vla4
anti-vla5
galnac-o-serthr
o-glycosylated
vla4-
vla5-dependent
emi1
apccdh1
su6656
y142f
imatinib-caused
apccdh1-induced
cd34-lownegative
cd34low-sca-1c-kitlin-
stap-1
kuopio
mscall
mscnsall
hscall
46xytqtq13q24del7q22
sp-d
rhsp-d
ram-phenotype
ram-aml
amkl-subtype
non-ram-amkl
myelopathy-tropical
erythbroid
cfu-a
-avrainvillamide
s-alkylation
cys275
thr199-phosphorylated
130-kd
alterationsacute
ribe
micrornaome
non-l2
xiii-a
plateletsmegakaryocytes
promyleocytes
cd45dimcd13cd33cd117cympo
hla-dr-cd34-cd14-cd15-
p733t
gp105
endo-beta-n-acetylglucosaminidase
carlsson
sasaki
fukuda
-12795
c-supar
supar-derived
fpr-mediated
poly-lacnac
stroud
handa
salyan
levery
hakomori
reinhold
--778
sialosyl-lex
glcnacs
slex-containing
e-selectin-dependent
cd56cd3
anti-cd11a
complement-regulatory
centromere-il9-d5s525-d5s558-d5s89-d5s526
-d5s393-d5s399-d5s396-d5s414-egr1
t17q31p11q11
d5s399
d5s396
del9q12q33
gse78718
gse45301
gse9589
networkanalysis
lysosomal-associated
itgav
30a
spma
ols
beta-regression
benzene-methylation
line-15
b7bb-1
b70
cmrf-7
alpha-fucosyl-n-acetyl
m2-m5
i-dependent
mcp-dominant
cr1-dominant
inexorably
il-01
renewal-regulatory
hippoyap
fab-m5b
adrm1
tpa-responsive
multiscreening
skil
cotinine
nk-cell-derived
tnf-alpha-stimulated
prodigious
128xa0µgl
ppxa
metalloproteinase-10
876u2009ngl
841u2009ngl
dextran-hydrazide
la-n-i
ig-drug
26xa0
ruthenium-based
ciscruiii
cisdruiii
apheresis-collected
double-layered
nonclonogenic
pmepercoll-treated
mnoab
gp130-dependent
shp2mapk
gp130-mediated
hematopoiesisstudies
ccn
3qqp11
tp15q23
inv11p11q23
der5tq13q23
insp11q23q24
p15q21q23
cd11ccd14high
il-15rαil-15
l-selectin-specific
tpter----1pqqpqter
oxidativeelectrophilic
accordantly
nrf2-silenced
akr1abbcc2
akr1bbcc2
sulforaphane-inducible
pa377t
py401n
pp214l
inactive-specific
fmc27
wm21
two-layer
raw264
preosteoclast-like
pocs
osteoclast-specific
srankl-stimulated
b-dependent
srankl-induced
hematolymphoid-associated
cryostat-cut
neutrophil-monocyte
ift
ethanol-fixed
wg-anca
half-moon
leukemia-hand
hematopathologisthematologist
htsc
vla-1
ethiologic
group-5a
pcna-sirna
neutrophil-lineage
39-antibody
open-resource
visne
stimulating-factor
all0496
activator-inhibitor
cd119ifngr1
interleukin-6r
factor-κb2
cd33-cd34
ig-linked
smigm
mb-1-positive
mfgs
rd114
envelopes
mfgs-gc
precautionary
short-medium
g-csf-stimulation
felv-c
galv-pseudotyped
felv-c-
rd114-pseudotyped
pseudotypes
succinate-cytochrome
ebvlcl
monocyte-isolated
cell-isolated
ebvlcl-isolated
cd14lowcd16
tlda
slc2a13
slc33a1
hbgdl
leu-9
cdd1
47xyxy21mar
cd38-----cd38bright
surface-antigen-defined
lbh-589
egt-mediated
pd-l1-mediated
repopulative
cd34ac133
ac133-selected
coccidiosis
lymphotactin
eimeria
selectin-mediated
n-acetyllactosamine
wegli
asialo-substrates
sialyl-lex-specific
vim-8
poly-n-acetyl-lactosaminoglycan
lewis-type
kappad
concentration-dependant
centromere-positive
mabcomplement
4hcabstract
c-erba1
thrombocytopoesis
iaiia
ibix
gpiaiia
zinc-finger-containing
wt1delz
dfss
t71
unify
cellsmyelodysplastic
treatment-failed
psca
retarget
cfss
near-uniform
ci-induced
rhcd40l
inoperative
m-kinase
phospholipid-independent
chromosomopaties
hystopathologic
disease-stage
factability
sulphatepolyacrylamide
camal-treated
thermoplasmonic
ptnps
nanotoxicology
ptnp
interleukin-1-beta
ptnp-induced
cimf-
whoecmp
400xl-1
forme
fruste
heterohomozygous
whocmp
anlla
alpha-interferon-treated
lectin-activated
torok-storb
glc
lactoneotetraosylceramide
lactonorhexaosylceramide
lactoisooctaosylceramide
q-bend
43a1
-abstract
studiedwhile
transferrin-dependent
bcl-2tg
tcr-cd3
stimulation-driven
ot-1tg
aire
nontelomeric
rt-coding
nonpathological
c2c7
nevirapine-treated
abr
rab7b
endosomelysosome-localized
rab7b-silenced
rab7b-mediated
differentiationinduction
re-introducing
33d1
nldc-145
fbl-3-derived
globo-series
ssea-3
globo-h
liquid-orderedliquid-disordered
native-type
gsl-enriched
nanodomains
vmat1
vmat2
vmats
junbdeltadelta
macrophage-osteoclast
osteopetrosis-like
mafosfamide-treated
granulocyteerythroidmacrophagemegakaryocyte
mafosfamide-resistant
scfabstract
post-typhoid
pseudo-sheathing
55°
firecracker-like
clinched
alpha-subunits
17alpha-ethylinestadiol
∼15ngl
ee2-responsive
vitellogenin
vtg
metabolomes
beta-transcript
beta-ag
pngd
hematopoietic-like
willebrands
flk-2flt-3
clb-cd19
igg1kappa
5q-5q33
il2b
gr1a1
nsmpd
hyper-responsive
csf1-induced
ngfi-a
gene-a
nab2
pre-mir-p
wt31-
il-1alpha-stimulated
deltaj
vddj
v2d
v3d
v1ddj
ddj
epsiloncycd3
developmentwe
ap-ncd13
naucc-4
ap-n
hl-8
165-kda
wm15
ap-b
arphamenine
cd277j
γδtcr
cd7scd3-cd4-cd8-
p-gpmulti-drug
cd7scd3-
pd173955
anti-fab
detachabead
dynal
bi-3c5
pancreoprotective
h-lys-glu-asp-trp-nh2
aplto
sspb-cd34
mpb-cd34
ldts
egr1d5s23
pre-alp
60-kd
carboxy-peptidase
enkephalins
mcl1-
mdm2-
mek-inhibitors
mcl1-antagonist
mdm2-inhibitor
hdm201
mcl1-inhibitor
mek-protein
mta-resistant
pc6mta-
pc-6
superorder
osteoglossomorpha
bonytongues
knifefishes
osteoglossomorph
non-mormyrid
monophyletic
mormyridae
outgroup
teleostei
well-supported
hiodon
alosoides
pantodon
buchholzi
osteoglossum
bicirrhosum
scleropages
arapaima
heterotis
niloticus
gymnarchus
ivindomyrus
opdenboschi
notopterus
chitala
ornata
xenomystus
nigri
papyrocranus
afer
morpho-anatomical
taxon
electroreception
reverse-transcriptase-polymerase
bcr-abl-free
zymosan-induced
zymosan-dectin-1
pma-pkc
stg
recesses
sd-1
rip-10
rkl
rgm-csf-responsive
rip-10-neutralizing
chromosome-bearing
post-baseline
window-specific
quantile
minimizer
l1-type
criteriaacute
3-dzneaplanocin
tetrahydropyranyl-doxorubicin
rna-minus
ribo-minus
exon-derived
circ-hipk2
receptor-triggered
granulopoiesis-specific
castat5a
lef-1-dependent
narf
g-csf-triggered
200u2009nt
codon-optimized
scatterplot
cd-18
cd-14
hypergranulocytosis
p21cip-1waf-1
hemoablated
mozkat6amyst3
lsk-cd48-cd150
lsk-cd34-flt3-
anti-proteinase
anti-pr3
pr3-epitopes
i2ntf
i2ctf
aav1
aav1-i2ctf
i2pp2a-based
tpo-dependent
mplpf4crepf4cre
bilobated
cd34⁺-hematopoietic
mir-23a27a
m-bcr-2
vector-derived
myelomonocyte-specific
snf2-like
mi-2beta
minor-h
col-blam
d-dimertat
sil
virus-producing
gpenvam12
lgec
cd24-expressing
cfu-macrophage
r2cd23
eol3
anti-fcr2cd23
h107
t18p22q23q12
t13p22q23q34
probings
t-b
t15q
cd7-deficient
ndr
anti-ndr
ndr-gfp
gf-109203x
gfx
cd56dimcd33
6-morpholino-sydnonimine
romanovski-type
nonneutrophil
magnetic-bead-coupled
bcsscs
aml-1b
mbspms
cebp-epsilon
cebp-beta
cebp-delta
cebp-zeta
c-juns
cmp-14c-sialic
antifreeze
gainac
edrs
ly6ae
rh123medhi
rh123lo
35s-methionine-labeled
double-sandwich
membrane-rich
crelox
vil-10-transduced
hirschsprungs
hsa-mir-34a
hsa-mir-34b
hsa-mir-34c
cd83↓
antigen-abc↓
cd40↓
cd86↑
factor-κ
osteosarcopenia
nik-associated
cb-17
scidscid
pre-cultured
bm-scid-hu
bi3c8
competitiveadditive
cmrf-44
maturationactivation
promonocyte
urs
zeta-transplanted
zeta-signaling
wm-65
non-haemopoietic
non-lineage-specific
haemopoietically-derived
field-effect
transistors
isfet
sensorelectronic
colony-induced
g-csf-responding
mir‑29a
ischaemia‑reperfusion
hbvsmc
hbvsmcs
htlv-1-mediated
htlv-associated
45xx-7tq21q26
megakaryocyteplatelet
cdw49b
tp31q24
nfia-cbfa2t3
nfia-runx1t1
9q31
suplps
taunf-alpha
ikappabikappabalpha
mad-3
suplps-stimulated
cell-chemoattractant
anti-icam-1
innate-
graziano
fanger
-5378
-2941
center-specific
il-2ra
euclidian
n-aryl-
silver-nhc
agnhc2
topographical
pseudocholinesterase
thrombin-at
fibrinogenfibrin
phospho-kinases
diosgenin-induced
spirocyclic
complexity-bearing
ter-phenyls
newly-shaped
inds1
melt1
inds7
mels3
metacore
hnf4-alpha
mels3-treated
btbd4
zbtb46gfp
cdc-specific
pre-cdcs
zbtb46gfpgfp
dibutylate
pdbu-induced
hlb-1
rpmi-8057
anti-hlb-1
sig-positive
hypergranulation
oh2-cholecalciferol
inducer-specific
vitd3-induced
retinoid-specific
cellsretinoic
anti-leu-19
kg1a5
tcgfinterleukin
15-yr-old
2-r
okt1
agil
125i-anti-tac
pha-p
2-rtac
hut-102
atl-2
t9transferrin
cdk2-specific
cdk-specific
pre-chilled
receptor-abelson
fcigg
leu-11
2-stimulated
pre-nk
mpo-antigen
lak-cell
iccu
tetrahydrobenzimidazole
tmq0153
baf-a1
tmq153-induced
microtumor
leukemia-1a
aml-1a
mnase-seq
nucleosome-based
steroid-thyroid
apigetrin
7-hydroxyflavone
apigeninchrysinflavone7-hydroxyflavoneluteolinnaringenin
apigenin-induced
26-mer
168-h
berf-1
mtv6
d8mit4
zfp148
znf148
gf-mediated
propre-b
aml-opc
crowdsourcing
lineage--lin-
nonprimitive
-1um
-um
1um
bm-mal
tm-mal
bt-mal
estrone-treated
erythroeosinophilic
glycoporin
eosinomonocytic
lama-88
luxol
jaffe
leukemiaslymphoblastic
j-96
j-41
fusion-controlled
tcs-1
heterogenously
backward-looking
norsegoline
dibezine
unit-cells
-m
receptorlow
electronmicroscopic
marrow-borne
mcd22
ccd22cd19tdt
ccd3cd7tdt
fackler
civin
-11061
kmt-2
-diamino-n--1-oxotridecyl-2-piperadinylmethylh
exan-amide
t11qter----11qqqppter22qter----22qq
pter----11qqqter
del10p13
t9q31q11q34
t22q13q34q11
mar1
marq
marq46xx
mar1tq34qxxtq34q11
anti-c5ar
ex-1
unlabelled
c5ar-specific
c5a-specific
c5adesarg
sialosyl-tn
anti-tn
ie3
anti-sialosyl-tn
tkh2
cd2-cd19-tkh2
oligonucleosomic
vessels200×
antiphosphotyrosine
region-fcr
r-induced
myeloleukemic
five-way
t22q12qq14q34q
mi-pcr
c-kitcd117
flt-3cd135
multitargets
tf1-derived
nk-differentiation
cd34cd38-cd7
cd34cd38-cd7-
lymphoid-affiliated
ifnbeta1
non-opsonized
m-cm
polylactosaminoglycan
viitala
matteson
-18928
m-lamp-1
h-lamp-1
h-lamp-2
endo-h
endo-f
h-lamp-
polylactosaminyl
polylactosaminoglycan-containing
anti-bl4
gp54
josh-7
3erythropoietin-driven
factorerythropoietin-driven
faa
fad2
fourty-one
ctla
ulex
europaeus
uea-j
vwfcells
pdgfalphabeta
indocarbazole
wbcdx
10u2009×u2009109l
wbcmax
43u2009×u2009109l
43u2009×u2009109la
leu-5
recloned
900-band
q22-q35
anti-cd69
un6
thy-1bright
glanzmann-like
willebrand-factor
gpib-ix-v
β1-integrins
cd29-cd49b
trap6
delta-granule
a2-analogue
u46619
leukocyte-adhesion
aml-clones
all-clones
64a
fabm5b
57a
fabm6
stc-gene
stc-go
castleman-type
infolding
cuffs
dasatinib-susceptible
insulitic
mcab-treated
k562ir‑derived
label‑free
interferon‑induced
lifralpha
gcsfr-gp130
gcsf-induced
gcsfr-lifralpha
7qqqqpq
14qp12
21q21
b1-b2
naive-memory
7p14
tp14
1-family
cdw49d
lymphocyte-homing-associated
cleia
abdomino-perineal
vesicoctaneous
intragranulocyte
fdrv210
mucicarmine
haloes
phosphatidylinositol-phospholipase
tear-drop
klingemann
nk-92-mediated
nk-92-lysis
lak-lysis
cd58-deficient
okm-2t
cd102-deficient
anti-cd102
anti-cd54-
anti-cd102-treated
anti-cd58-treated
nk-lysis
cannnot
emfs
elf-emfs
normalneoplastic
clbrs
gnrha
ici-related
ici-based
ici-naïve
il-17-
th17th1
blast-sized
lymphocyte-sized
allogenenic
nalm-26
-dihydroxyanthraquinone-2-carboxylic
anti-fibrosis
anti-leu-2
gm-assay
c-fos-expressing
stnt
ki-67abstract
preb1
preb4
lineage-bipotent
r38
r38-
ra-inducible
neo-positive
opa52-expressing
jun-n-terminal
opa52
piliated
opa-
opsonin-independent
opa52cd66-mediated
networkanalyst
interleukine-6interferon
set1a
set1b
mll1-mll4
wbp7
pigp
gpi-glcnac
wbp7--
anchor-dependent
lps-triggered
ico-13
tetra-span
peta-3
gp27
14a2h1
balm-1
alpha-granule
pd98059-treated
mpd-ds
gata1f
c-i
spermidinespermine
ra-related
interferon-alpha-containing
-7del7
ehz2
-o-tetra
decanoylphorbol-13-acetate
tx8
thymus---10
marrow---
muearly
prothymocytesearly
mycobacteriums
tlr7-deficient
mpo-induced
mpo-catalyzed
muteins
mutein
sézarys
trans-golgi
micrometers
delta-4
s17
mbd4s17
cs17
cd34cd7cd45ra
delta4-fc
delta4
spinning-nuclear
pautrier-like
interactor-1
cd34progenitor
α4-abi-1
winklemann
self-healing
band-like
elastolytic
oz-receptor
superoxide-generating
parathion
lc-ptp
tpt-dependent
der15t
t6q-
hfcl
sphase
ctk
il-1-producing
agm-s3
ah20399aa
neo-crp
alpha-neo-crp
percoll-enriched
neo-crpbright
neo-crpdim
anti-neo-crp
thp-
alpha-cd16
alpha-fc
alpha-cdw32
alpha-neo-crpabstract
nectin-1
cd96-expressing
outermost
cd96cd155
trigonocephaly
cd96-driven
cd2cd58
lfa-1cd54
non-adhesive
2-interferon
first-hits
runx1-haploinsufficient
differentiation-impaired
runx1-deficiency
tnf-knockout
tnf--
misbalance
nxa0xa0535
cd56u2009u2009pu2009u
lpa2012
exhaled
practicemethods
jeko
-dimethylheptane
methylbenzene
o-xylene
dodecane
-di-tert-butylbenzene
4-methyldecane
hexadecane
hexanol
cyclohexanol
150dah
senegalese
solea
senegalensis
ssvasa
kg⁻¹
melanomacrophage
myclobutanil
conazole
agrichemical
ascomycetes
imperfecti
basidiomycetes
agrarian
myclobutanils
500ppm
bcl-xlbak
notch4-intracellular
notch4-ic-transduced
beta2-microglobulin--
analayzed
nu202fu202f330
nu202fu202f200
nu202fu202f129
nu202fu202f22
nu202fu202f0u202f×u202f106
nu202fu202f226
nu202fu202f305
lowe
granulocyticmacrophage
stressemergency
hemitoxin
pre-ind
curcumin-related
caspases-9
xyinv3q21q26
normal-looking
retranslocation
d-24-hydroxylase
ad-hl60
promyelomonocytic
pge2-treated
linethe
hu-s-pbmsc
ibm-mncs
180-kd
af5
prkg1
pard3
epha8
adipocytokine
microgranule
responseto
chnpp
theassessment
kf
rh-l4
fance
fad1
1693delt
513g--a
ivsa--g
yj
fast-greenneutral-red
eosinophil-associated
eosinophil-derived
l-c
hexamethylene-bisacetamide
bmp-
aplwe
co-clustering
scd5
ccd5
flk-2
bm-pbpc
astronaut
assayabstract
aif-1
lyve-1xlkd1
fyb
p2ry1
cmt1
ic3b
attt
oct185
differentiation-regulated
antigenes
gram‑positive
gse6535
treeview
340xa0andxa0485xa0degs
nadhubiquinone
ndufb2
ndufb8
ubiquinol‑cytochrome
b0-b4
t0-t3
b2-b3
pre-call
b0-b1
b0
t2-t3
markersabstract
m1-ur21
gp130-activation
receptor-complex
receptor-complexes
polydimethylsiloxane
pdms
photomultiplier
iga-coated
concns
pepsinogen
isofocusing
sighting
flowthrough
polycarbonated
thy1-
-5-fold
neutrophil-to-tumor
dot-positive
fungally
chr-79888
b-cell-activating
ly1-positive
cd23-
cdw70-
cd77-
cdw70
non-defective
e-1
adrsv
cd10cd19
cd3cd22
cd7cd33
hladrcd13
invariance
nondisulfide-linked
antitac
h-31
tu27
mhc-nonrestricted
thy-1low
-dihydroxyphenyllactic
atrara
erk-nf-κb
appurtenant
bryo-1
preculturing
precultures
bryo-1-stimulated
cd14-depleted
bryo-1-induced
47xy21
aml1-eto-transduced
transcends
ponnazhagan
vcmvp-lacz
virus-binding
anll-m3
xenoengraftment
cd56low
cd56lowcd33
na-t-mncs
htlv-1-seronegative
bestatins
atra-inducing
diisocyanate
10h
md1
nodose
105kda
rp105md1
artemin
rp105
nociceptinorphanin
3a1leu-9
okt-4leu-3a
hu-ets-1
11q23----q24
11q24----qter
highxa0aggressiveness
mcl1-dr4
mcl1-roles
pebp2cbf
ache-r
r-banded
l-17m
nsd1--
gata1-induced
catalytically-inactive
nsd1n1918q
set-domain
nsdn1918q
gata1-controlled
d21s216
d21s211
cd56neg
nk-activating
aft024
beigenudexid
cd4and
cd45cd34-cd38-
cd45cd34-lin-
allo-mixed
hl-60-dc
thp-1-dc
k562-dc
tiss
pypycapypypypy
51-bp
tcr-deltaalpha
cnbr-activated
carbonyldiimidazole-activated
dystrophin-related
dystrophin-associated
dapc
alpha-dystrobrevin
α-db
anti-α-db
relocalizations
adam21
syntrophin
tgn51
eif38
α-db-associated
pallidum
tp92
txa0pallidum
monicytic
pro-caspase-1
1caspase-8aspase-3
amln20
ngml-
pseudotyping
hil-4
hgm-csf
mil-2
transmembraneintracellular
hil-4gpi
hgm-csfgpi
vlp-bound
hil-2gpi
mil-2gpi-coactivated
il-2-specific
hsa-mir-15a
patientsmaterial
markersresults
detectedconclusions
proliferation-specific
g1-s-associated
leach
rp11-bac47p3
rp5-pac963k15
cosnrl9
370-kb
scantiness
rpb7
rpl6
cellsimatinib
4-aml
alpha-expressing
dioctanoyl-pa
pa-treated
pa-differentiated
mutant-erk
mouse-anti-human
mouse-originated
zch-f9
scfv2f9
cd4-phenotype
deficiency-formerly
syndrome-encompasses
cxcl12cxcr4-dependent
3-ligandxa0flt3l
flt3l-independent
elisaplus
mdm4-s
iib-iiia
ut-7epo
ut-7epo-mpl
cd34-cd41
leukemic-associated
cd19--lineage
infidelity--
cd33-cd13
cd13-cd15
hladr-cd14cd11b
ngs-ready
mxpcr
hemogenic
heps
fibroblastsmarrow
psc-based
rvc-588
glicoprotein
cytotoxic-late
ccaatenhanced
duct-ligated
hepatoprotection
ldas
lrrc25
lowlyintermediately
anti-leu-m1
bouin-fixed
jak2stat5c-myc
smad3-dependent
hmos
3sl
3sl-bound
caveolae-dependent
anti-cd33-br
b-chain
anti-cd33-br-treated
cns-associated
p-170-positive
p-170-negative
sj16
rsj16-treated
tm2
intermyeloid
ri-expression
32fc
high-fc
cellsmin
ri-mediated
ri-agonists
b558
oxidase-requiring
fra16q22
rbc8
keratin18
icp-ms-linked
metal-tagged
distinguishably
4-plex
metal-conjugated
megakaryocyte-platelet-related
facs-iv
tsp
tsp-mediated
cytoadherence
syndromesmyelodysplastic
tp14p11
3p14
6p11
stroma-containing
shear-resistant
anti-p-selectin
codistribution
quant
cjd
alpha-hemoglobin
edrf
adversarial
ganite
mcgans
blr
knn
logr
hdacida
mcgan
andos
lcd18sn
erk-activation
himeg-1
cd14a
pbl-cm
sam-1
pbl-cm-induced
nu-b1-positive
mini-peptide
gadd45αa
cd4-negative
adex1cacd4
46xyt22q34q13q11
autologous-hematopoietic
plasmid-based
obfuscates
hetastarch-prepared
calcitriol-treated
amplification-mediated
poly-herbal
cytodifferentiative
indicuss
6c3
c-ki-ras-2
il-1a
sil-2ra
antigen-stimulation
fcε
fcεr
myosin-ii
trimodal
anbmc
pro95his
pro95leu
pro95arg
pro95ala
pro95thr
24-bp
ezh2mut
p2-nucleotide
p2x1
sds-electrophoresis
endoglycosidase-f
46-kd
influxmobilization
cd34-cd38
micromanipulation
cd19igm
miyake
chromium-labeling
rpmi-8402
cd4cd56hn
p13-p11
9q12-q34
q12-q31
hes6
myeloblastic-promyelocytic
51-release
ecom-g
ecom-m
cnlp
bactenecin
stefin
gp91
phox
ly6-g
nop56
hnrpa1
ifi202a
ifis204
ifi204-related
ly6-e1
lrg21
backtrack
momlv-based
talus
myeloregenerative
osteomyelo-fibrosis
g1-g0
-2029
-224
-2450
-315
motheaten
anti-cluster
anti-cd235a
anti-235a
anti-41
anti-42
anti-14
anti-45
anti-feline
anti-cd21-like
anti-cd172a
anti-granulocyte
anti-cd45-like
macrophage-based
tuberculosis-infected
easy-to-perform
myeloid-monocyte-erythroid
normoploid
il-4tnf-alpha
il-4tnf-dc
qzyme
origintype
ethylbenzene
35-k
ifit2
infgr2
erythromyeloblastoid
geneontology
count-rate
microvesicles-like
rcrs
hiv-based
not-prestimulated
tomers
prostaglandin-e1
megakaryocytes-enriched
lxrαβ
bacteriallps
trap-positive
trap-negative
trapacp5
ctsk
calcr
anti-osteoclastogenic
macrophagephagocytic
aimspα
osteoclastmacrophage-related
ostm1
stainable
hemosiderin-storaging
3-colour
cd34drcd38-subpopulation
cd34dr-subpopulation
cd34cd38-subpopulation
lybc-cml
myb-ets
-transformed
nonintuitive
residuals
among-
permuting
hb-2
sn-1036
plasmablasts
super-repressor
nab-induced
nab-
prb-bound
ccl3l1
zebrafishmouse
myc-mediated
tgmycspo
nu2009u2009130
significancen
advancesn
2-oxoglutarate-dependent
issuesn
s-2-hydroxyglutarate
s-2hg
directionsn
all-90
swarm
giemsa-negative
gmpr
fra6a
d6s260
blood-diseases
p21wafcipsdi-1
caspase-3caspase-7
staining-negative
rhuil-3
alpha-specific
m07-e
csf-independent
interstitial-
ac8
p120v-abl
euphohelioscopin
granulocytemonocytic
red613
cd56cd8
gp78
46xxtp13q13
gtpgdp-binding
rab2
gdpgtp-binding
transgenomes
cd13cd33cd34-hla-dr-
necrosis-alpha
activityprogression
sirpα1
α1-knockdown
k562sirpα1kd
gsk-3β-ser9
aneusomies
mihcag-mismatched
mac1ly6-gly6-c
alloactivated
evi-2
site-2
csfgm
csfg
p-190
cd164
hesop9
mll2wbp7
mll2--
dcswe
gp130-sharing
gp130-dimerizing
studzinski
feverdengue
dhfdss
dv-infected
eiii
ddx46
translocation-mediated
less-understood
mll-deficient
igg-coated
thp-1-t
cd18cd11a
very-late
icam-6
cd18cd11b
cd61cd51
macrophagemonocyte-specific
plasmacytomashybridomas
ser-782
s782a
6-times
tautomycetin
phospho-ser-782
phosphorylation-dephosphorylation
flt3itdnpm1mut
mcd34
anti-mcd34
highest-expressing
leukemic-type
rm-csf
tce-treated
tce-exposed
unitsgranulocyte-macrophage
nadasenadpase
cripples
e226q
lxsn
pg13
vector-containing
stenodactylin
caudex
adenia
stenodactyla
depurination
mhh
amlm7
j2e
mlf1-expressing
km-102
cellleukemic
radiotherapeutics
post-therapeutically
cd15slex
tyrosine-phosphatase
cd15s-
pinco
lineage-dependent
ram-1
amphotrophic
phylogenomics
8a1
resistin-like
relm
relmbeta
relms
relmalpha
rp-derived
nkh
double-marker
cd3nkh1
cd8nkh1
thy-1lo
rpd3
alpha-cd3
alpha-hdac3
mastopoiesis
mc-proliferative
anti-hdc
k562flt3
flt3-sirna
k562flt3-sirna
m177
klf7
klf7--
klf7-overexpressing
mecl-1
pa28alpha
ga-induced
40-kda
du528
du980
hgprt-deficient
anticodon
isoacceptor
6-thioguanine-induced
butirate
cfu-bi
stroma-adhesive
cfu-bl
n-omega-ethoxycarbonyl-4-quinolones
meg-01s
kinase-c
hl-60-mzf-1
diphenylamine
poly-l-lysine-coated
multispot
cytocentrifugation
es-chl
es-a
siglec-5-dependent
fluxing
co-cross-linking
beta2-integrin-dependent
neutrophil-inducing
monocyte-inducing
gpi-80-positive
transferrin-receptor-negative
anti-gpi-80
ccdc88a
socs4
sm-criteria
organ-function
fab-subclasses
my-7
67-kilodalton
subsegment
sublocalized
non-hla-restricted
1a8
er-mp20
bm-myeloid-derived
ly-6cintly-6ghigh
ly-6cg
-dibutyrate
e26-transformants
mep21
mep26
eos47
mep17
e26-transformed
bursal
arih1
dnah2
csmd1
⩾7
myelomonocytic-lineage-biased
npm1-rnai
pgcsil-gfp-npm1-shrna
npm1-rnai-lv
mdr1-shrna
